date generated: 2024-12-16

Background

Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch

Input profiles

Here is the first few lines of the input profile.

The profiling data being passed to mitch
cancer incidence
A1BG -0.1624750 0.0020388
A1BG-AS1 -0.3989024 0.0029418
A1CF 0.9616946 -0.0015391
A2M -0.7927841 -0.0004251
A2M-AS1 -0.6770865 0.0057066
A2ML1 1.4917204 0.0000406

Here are some metrics about the input data profile:

Profiling data metrics
Profile metrics
num_genes_in_profile 21922
duplicated_genes_present 0
num_profile_genes_in_sets 17585
num_profile_genes_not_in_sets 4337
profile_pearson_correl -0.10672
profile_spearman_correl -0.1176

Here is a plot of the input profiles. Note the dynamic ranges.

Here is the contour plot of the profile including all detected genes.

Input genesets

Here are some metrics about the gene sets used:

GMT file of genesets:
Gene set metrics
Gene sets metrics
num_genesets 13188
num_genesets_excluded 4273
num_genesets_included 8915

Gene sets by quadrant


Number of significant gene sets (FDR<0.05)= 440

Interactive enrichment scatterplot

All sets with FDR<0.05. Try hovering over the points.

Top N sets irrespective of FDR. Try hovering over the points.

A heatmap of S values for top results


A plot of effect size versus significance


Significance is the -log2(p.adjustMANOVA) and effect size is the s.dist which is the hypotenuse of the s scores.

Results table

Top N= 50 gene sets
set setSize pMANOVA p.adjustMANOVA s.dist s.cancer s.incidence p.cancer p.incidence
GOBP THELARCHE 5 1.92e-03 0.05270 0.965 0.71300 -0.6510 5.77e-03 0.011700
GOMF N ACETYLLACTOSAMINIDE BETA 1 3 N ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY 6 3.24e-04 0.01390 0.889 0.71200 0.5340 2.54e-03 0.023600
Tachykinin receptors bind tachykinins 5 2.00e-03 0.05430 0.881 -0.85600 -0.2080 9.19e-04 0.421000
GOBP LOBAR BRONCHUS EPITHELIUM DEVELOPMENT 5 4.53e-03 0.09310 0.876 0.82500 -0.2940 1.41e-03 0.254000
GOBP AORTA SMOOTH MUSCLE TISSUE MORPHOGENESIS 6 1.38e-03 0.04140 0.831 -0.81400 -0.1640 5.52e-04 0.486000
GOBP REGULATION OF CORTICOTROPIN SECRETION 5 6.73e-03 0.11900 0.830 -0.81400 0.1630 1.62e-03 0.528000
GOCC ATP BINDING CASSETTE ABC TRANSPORTER COMPLEX 6 3.34e-03 0.07860 0.830 -0.36200 0.7470 1.24e-01 0.001540
GOBP TACHYKININ RECEPTOR SIGNALING PATHWAY 8 3.24e-04 0.01390 0.828 -0.81700 0.1350 6.23e-05 0.508000
GOCC TROPONIN COMPLEX 9 3.07e-05 0.00213 0.825 0.64200 0.5180 8.50e-04 0.007100
GOBP CHONDROBLAST DIFFERENTIATION 5 1.15e-02 0.16700 0.809 -0.69900 0.4070 6.77e-03 0.115000
GOBP EPINEPHRINE SECRETION 7 5.21e-04 0.01970 0.803 -0.69500 -0.4020 1.45e-03 0.065500
GOMF CCR6 CHEMOKINE RECEPTOR BINDING 5 1.26e-02 0.17700 0.799 0.69900 -0.3870 6.76e-03 0.134000
GOMF 3 KETO STEROL REDUCTASE ACTIVITY 5 1.08e-02 0.16100 0.797 0.21800 -0.7660 3.99e-01 0.003000
GOBP LOBAR BRONCHUS DEVELOPMENT 6 4.29e-03 0.09050 0.787 0.77800 -0.1240 9.70e-04 0.600000
GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT 7 2.77e-03 0.06910 0.786 -0.41400 0.6690 5.81e-02 0.002180
GOMF KERATIN FILAMENT BINDING 6 1.91e-03 0.05250 0.784 0.60100 0.5040 1.09e-02 0.032400
GOBP NEURAL FOLD FORMATION 7 2.21e-03 0.05820 0.781 0.20500 -0.7540 3.48e-01 0.000549
GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB 5 1.68e-02 0.20800 0.780 0.50500 -0.5940 5.04e-02 0.021500
GOMF LIPID ANTIGEN BINDING 5 1.68e-02 0.20800 0.780 0.50500 -0.5940 5.04e-02 0.021500
GOMF PROSTAGLANDIN E RECEPTOR ACTIVITY 5 1.73e-02 0.21100 0.777 0.57100 -0.5270 2.70e-02 0.041100
GOBP PROTEIN O LINKED FUCOSYLATION 5 1.45e-02 0.19100 0.777 -0.27600 0.7260 2.85e-01 0.004920
GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS 7 3.59e-03 0.08260 0.774 0.51300 -0.5790 1.88e-02 0.007950
GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY 10 3.62e-04 0.01510 0.766 -0.61200 0.4620 8.06e-04 0.011500
GOCC ALPHA BETA T CELL RECEPTOR COMPLEX 5 1.83e-02 0.21500 0.752 0.23100 -0.7150 3.70e-01 0.005590
GOBP NEGATIVE REGULATION OF EPINEPHRINE SECRETION 5 1.01e-02 0.15500 0.749 -0.70400 -0.2570 6.40e-03 0.321000
GOBP MESENCHYME MIGRATION 5 1.11e-02 0.16400 0.746 -0.71700 -0.2070 5.50e-03 0.422000
GOBP BRANCH ELONGATION INVOLVED IN MAMMARY GLAND DUCT BRANCHING 5 2.46e-02 0.25100 0.743 0.52000 -0.5310 4.40e-02 0.039900
GOBP REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY 7 3.87e-03 0.08620 0.734 -0.72700 0.0992 8.61e-04 0.650000
GOBP NEGATIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE 6 1.39e-02 0.18800 0.728 -0.55000 0.4760 1.95e-02 0.043300
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR 7 5.83e-03 0.11000 0.726 0.27900 -0.6710 2.02e-01 0.002120
GOMF AMINOACYL TRNA HYDROLASE ACTIVITY 5 2.34e-02 0.24500 0.725 0.19300 -0.6990 4.55e-01 0.006820
GOBP REGULATION OF GLUCOSYLCERAMIDE CATABOLIC PROCESS 5 2.14e-02 0.23400 0.723 -0.10500 0.7160 6.83e-01 0.005590
GOBP N ACYLETHANOLAMINE METABOLIC PROCESS 5 2.77e-02 0.26400 0.720 0.65000 -0.3100 1.18e-02 0.231000
GOBP ADENYLATE CYCLASE INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY 7 7.23e-03 0.12500 0.717 -0.62600 0.3500 4.12e-03 0.109000
GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE 8 3.77e-03 0.08470 0.716 0.38400 -0.6050 6.03e-02 0.003040
GOMF ALCOHOL DEHYDROGENASE NADPLUS ACTIVITY ZINC DEPENDENT 7 8.16e-03 0.13500 0.714 0.56500 -0.4370 9.68e-03 0.045200
GOCC GARP COMPLEX 5 3.33e-02 0.28500 0.711 -0.55200 0.4490 3.26e-02 0.082400
GOBP POSITIVE REGULATION OF FEAR RESPONSE 7 4.59e-03 0.09370 0.709 -0.70900 -0.0175 1.16e-03 0.936000
GOBP CORTISOL SECRETION 5 1.99e-02 0.22600 0.708 -0.70300 -0.0839 6.47e-03 0.745000
GOMF MHC CLASS IB RECEPTOR ACTIVITY 7 8.75e-03 0.14200 0.708 0.57300 -0.4150 8.60e-03 0.057100
GOCC EARP COMPLEX 5 3.39e-02 0.28600 0.701 -0.62400 0.3210 1.57e-02 0.214000
Zinc efflux and compartmentalization by the SLC30 family 5 3.60e-02 0.29300 0.699 0.36600 -0.5950 1.56e-01 0.021200
GOBP THYMOCYTE MIGRATION 7 3.14e-03 0.07590 0.698 0.57400 0.3980 8.51e-03 0.068500
GOMF HEMOGLOBIN ALPHA BINDING 5 2.59e-02 0.25500 0.697 0.69600 -0.0367 6.99e-03 0.887000
GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION 6 1.24e-02 0.17500 0.693 -0.00295 -0.6930 9.90e-01 0.003270
GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX 6 1.45e-02 0.19100 0.693 0.09770 -0.6860 6.79e-01 0.003620
GOBP NEGATIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT 5 3.67e-02 0.29500 0.689 0.63300 -0.2730 1.42e-02 0.290000
GOMF CARBOHYDRATE PROTON SYMPORTER ACTIVITY 7 4.40e-03 0.09190 0.682 0.31800 0.6030 1.45e-01 0.005750
GOBP NEGATIVE REGULATION OF NOREPINEPHRINE SECRETION 6 9.90e-03 0.15300 0.681 -0.61900 -0.2840 8.60e-03 0.228000
GOBP MAINTENANCE OF ANIMAL ORGAN IDENTITY 5 4.15e-02 0.31100 0.681 0.59800 -0.3260 2.05e-02 0.207000


Results (complete table)


Click HERE to show results for all gene sets

Complete results
set setSize pMANOVA p.adjustMANOVA s.dist s.cancer s.incidence p.cancer p.incidence
GOBP THELARCHE 5 1.92e-03 5.27e-02 0.96500 7.13e-01 -6.51e-01 5.77e-03 1.17e-02
GOMF N ACETYLLACTOSAMINIDE BETA 1 3 N ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY 6 3.24e-04 1.39e-02 0.88900 7.12e-01 5.34e-01 2.54e-03 2.36e-02
Tachykinin receptors bind tachykinins 5 2.00e-03 5.43e-02 0.88100 -8.56e-01 -2.08e-01 9.19e-04 4.21e-01
GOBP LOBAR BRONCHUS EPITHELIUM DEVELOPMENT 5 4.53e-03 9.31e-02 0.87600 8.25e-01 -2.94e-01 1.41e-03 2.54e-01
GOBP AORTA SMOOTH MUSCLE TISSUE MORPHOGENESIS 6 1.38e-03 4.14e-02 0.83100 -8.14e-01 -1.64e-01 5.52e-04 4.86e-01
GOBP REGULATION OF CORTICOTROPIN SECRETION 5 6.73e-03 1.19e-01 0.83000 -8.14e-01 1.63e-01 1.62e-03 5.28e-01
GOCC ATP BINDING CASSETTE ABC TRANSPORTER COMPLEX 6 3.34e-03 7.86e-02 0.83000 -3.62e-01 7.47e-01 1.24e-01 1.54e-03
GOBP TACHYKININ RECEPTOR SIGNALING PATHWAY 8 3.24e-04 1.39e-02 0.82800 -8.17e-01 1.35e-01 6.23e-05 5.08e-01
GOCC TROPONIN COMPLEX 9 3.07e-05 2.13e-03 0.82500 6.42e-01 5.18e-01 8.50e-04 7.10e-03
GOBP CHONDROBLAST DIFFERENTIATION 5 1.15e-02 1.67e-01 0.80900 -6.99e-01 4.07e-01 6.77e-03 1.15e-01
GOBP EPINEPHRINE SECRETION 7 5.21e-04 1.97e-02 0.80300 -6.95e-01 -4.02e-01 1.45e-03 6.55e-02
GOMF CCR6 CHEMOKINE RECEPTOR BINDING 5 1.26e-02 1.77e-01 0.79900 6.99e-01 -3.87e-01 6.76e-03 1.34e-01
GOMF 3 KETO STEROL REDUCTASE ACTIVITY 5 1.08e-02 1.61e-01 0.79700 2.18e-01 -7.66e-01 3.99e-01 3.00e-03
GOBP LOBAR BRONCHUS DEVELOPMENT 6 4.29e-03 9.05e-02 0.78700 7.78e-01 -1.24e-01 9.70e-04 6.00e-01
GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT 7 2.77e-03 6.91e-02 0.78600 -4.14e-01 6.69e-01 5.81e-02 2.18e-03
GOMF KERATIN FILAMENT BINDING 6 1.91e-03 5.25e-02 0.78400 6.01e-01 5.04e-01 1.09e-02 3.24e-02
GOBP NEURAL FOLD FORMATION 7 2.21e-03 5.82e-02 0.78100 2.05e-01 -7.54e-01 3.48e-01 5.49e-04
GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB 5 1.68e-02 2.08e-01 0.78000 5.05e-01 -5.94e-01 5.04e-02 2.15e-02
GOMF LIPID ANTIGEN BINDING 5 1.68e-02 2.08e-01 0.78000 5.05e-01 -5.94e-01 5.04e-02 2.15e-02
GOMF PROSTAGLANDIN E RECEPTOR ACTIVITY 5 1.73e-02 2.11e-01 0.77700 5.71e-01 -5.27e-01 2.70e-02 4.11e-02
GOBP PROTEIN O LINKED FUCOSYLATION 5 1.45e-02 1.91e-01 0.77700 -2.76e-01 7.26e-01 2.85e-01 4.92e-03
GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS 7 3.59e-03 8.26e-02 0.77400 5.13e-01 -5.79e-01 1.88e-02 7.95e-03
GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY 10 3.62e-04 1.51e-02 0.76600 -6.12e-01 4.62e-01 8.06e-04 1.15e-02
GOCC ALPHA BETA T CELL RECEPTOR COMPLEX 5 1.83e-02 2.15e-01 0.75200 2.31e-01 -7.15e-01 3.70e-01 5.59e-03
GOBP NEGATIVE REGULATION OF EPINEPHRINE SECRETION 5 1.01e-02 1.55e-01 0.74900 -7.04e-01 -2.57e-01 6.40e-03 3.21e-01
GOBP MESENCHYME MIGRATION 5 1.11e-02 1.64e-01 0.74600 -7.17e-01 -2.07e-01 5.50e-03 4.22e-01
GOBP BRANCH ELONGATION INVOLVED IN MAMMARY GLAND DUCT BRANCHING 5 2.46e-02 2.51e-01 0.74300 5.20e-01 -5.31e-01 4.40e-02 3.99e-02
GOBP REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY 7 3.87e-03 8.62e-02 0.73400 -7.27e-01 9.92e-02 8.61e-04 6.50e-01
GOBP NEGATIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE 6 1.39e-02 1.88e-01 0.72800 -5.50e-01 4.76e-01 1.95e-02 4.33e-02
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR 7 5.83e-03 1.10e-01 0.72600 2.79e-01 -6.71e-01 2.02e-01 2.12e-03
GOMF AMINOACYL TRNA HYDROLASE ACTIVITY 5 2.34e-02 2.45e-01 0.72500 1.93e-01 -6.99e-01 4.55e-01 6.82e-03
GOBP REGULATION OF GLUCOSYLCERAMIDE CATABOLIC PROCESS 5 2.14e-02 2.34e-01 0.72300 -1.05e-01 7.16e-01 6.83e-01 5.59e-03
GOBP N ACYLETHANOLAMINE METABOLIC PROCESS 5 2.77e-02 2.64e-01 0.72000 6.50e-01 -3.10e-01 1.18e-02 2.31e-01
GOBP ADENYLATE CYCLASE INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY 7 7.23e-03 1.25e-01 0.71700 -6.26e-01 3.50e-01 4.12e-03 1.09e-01
GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE 8 3.77e-03 8.47e-02 0.71600 3.84e-01 -6.05e-01 6.03e-02 3.04e-03
GOMF ALCOHOL DEHYDROGENASE NADPLUS ACTIVITY ZINC DEPENDENT 7 8.16e-03 1.35e-01 0.71400 5.65e-01 -4.37e-01 9.68e-03 4.52e-02
GOCC GARP COMPLEX 5 3.33e-02 2.85e-01 0.71100 -5.52e-01 4.49e-01 3.26e-02 8.24e-02
GOBP POSITIVE REGULATION OF FEAR RESPONSE 7 4.59e-03 9.37e-02 0.70900 -7.09e-01 -1.75e-02 1.16e-03 9.36e-01
GOBP CORTISOL SECRETION 5 1.99e-02 2.26e-01 0.70800 -7.03e-01 -8.39e-02 6.47e-03 7.45e-01
GOMF MHC CLASS IB RECEPTOR ACTIVITY 7 8.75e-03 1.42e-01 0.70800 5.73e-01 -4.15e-01 8.60e-03 5.71e-02
GOCC EARP COMPLEX 5 3.39e-02 2.86e-01 0.70100 -6.24e-01 3.21e-01 1.57e-02 2.14e-01
Zinc efflux and compartmentalization by the SLC30 family 5 3.60e-02 2.93e-01 0.69900 3.66e-01 -5.95e-01 1.56e-01 2.12e-02
GOBP THYMOCYTE MIGRATION 7 3.14e-03 7.59e-02 0.69800 5.74e-01 3.98e-01 8.51e-03 6.85e-02
GOMF HEMOGLOBIN ALPHA BINDING 5 2.59e-02 2.55e-01 0.69700 6.96e-01 -3.67e-02 6.99e-03 8.87e-01
GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION 6 1.24e-02 1.75e-01 0.69300 -2.95e-03 -6.93e-01 9.90e-01 3.27e-03
GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX 6 1.45e-02 1.91e-01 0.69300 9.77e-02 -6.86e-01 6.79e-01 3.62e-03
GOBP NEGATIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT 5 3.67e-02 2.95e-01 0.68900 6.33e-01 -2.73e-01 1.42e-02 2.90e-01
GOMF CARBOHYDRATE PROTON SYMPORTER ACTIVITY 7 4.40e-03 9.19e-02 0.68200 3.18e-01 6.03e-01 1.45e-01 5.75e-03
GOBP NEGATIVE REGULATION OF NOREPINEPHRINE SECRETION 6 9.90e-03 1.53e-01 0.68100 -6.19e-01 -2.84e-01 8.60e-03 2.28e-01
GOBP MAINTENANCE OF ANIMAL ORGAN IDENTITY 5 4.15e-02 3.11e-01 0.68100 5.98e-01 -3.26e-01 2.05e-02 2.07e-01
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION 5 4.02e-02 3.07e-01 0.68100 -6.18e-01 2.88e-01 1.67e-02 2.65e-01
GOBP EPINEPHRINE TRANSPORT 11 2.09e-04 1.02e-02 0.68100 -6.11e-01 -3.00e-01 4.48e-04 8.49e-02
GOBP SYNAPTIC TRANSMISSION GLYCINERGIC 5 3.12e-02 2.76e-01 0.68000 -6.79e-01 4.41e-02 8.55e-03 8.65e-01
FasL/ CD95L signaling 5 4.11e-02 3.09e-01 0.68000 2.94e-01 -6.13e-01 2.55e-01 1.76e-02
GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER 5 4.05e-02 3.08e-01 0.67900 -2.69e-01 6.23e-01 2.97e-01 1.58e-02
SARS-CoV-1 modulates host translation machinery 33 1.26e-09 2.68e-07 0.67900 4.16e-01 -5.36e-01 3.45e-05 9.67e-08
GOBP PEPTIDE MODIFICATION 5 4.58e-02 3.26e-01 0.67800 -4.77e-01 4.82e-01 6.46e-02 6.21e-02
GOMF HEXOKINASE ACTIVITY 5 2.61e-02 2.56e-01 0.67800 1.29e-01 6.66e-01 6.19e-01 9.95e-03
GOBP HEAT ACCLIMATION 5 4.68e-02 3.28e-01 0.67500 5.12e-01 -4.40e-01 4.74e-02 8.85e-02
GOBP CARDIAC SEPTUM CELL DIFFERENTIATION 5 3.94e-02 3.06e-01 0.67200 -6.49e-01 1.74e-01 1.19e-02 5.01e-01
Tyrosine catabolism 5 4.89e-02 3.35e-01 0.67100 -4.67e-01 4.81e-01 7.03e-02 6.26e-02
GOBP FUSED ANTRUM STAGE 6 2.51e-02 2.53e-01 0.67000 -5.85e-01 3.27e-01 1.31e-02 1.65e-01
GOCC NEUROFIBRILLARY TANGLE 5 4.23e-02 3.14e-01 0.66900 -6.34e-01 2.14e-01 1.41e-02 4.07e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 5 PRODUCTION 7 5.24e-03 1.02e-01 0.66800 5.68e-01 3.51e-01 9.22e-03 1.07e-01
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA 8 8.40e-03 1.38e-01 0.66500 3.99e-01 -5.33e-01 5.09e-02 9.05e-03
GOBP PH REDUCTION 6 2.25e-02 2.41e-01 0.66500 -1.78e-01 6.41e-01 4.50e-01 6.54e-03
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 5 2.45e-02 2.51e-01 0.66400 -3.48e-01 -5.66e-01 1.78e-01 2.83e-02
GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION 8 6.48e-03 1.17e-01 0.66400 6.40e-01 -1.79e-01 1.73e-03 3.82e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY NOREPINEPHRINE EPINEPHRINE 6 1.26e-02 1.77e-01 0.66200 -5.90e-01 -3.00e-01 1.23e-02 2.03e-01
GOBP REGULATION OF BINDING OF SPERM TO ZONA PELLUCIDA 5 2.58e-02 2.55e-01 0.66100 5.78e-01 3.21e-01 2.52e-02 2.13e-01
GOCC OUTER DENSE FIBER 6 2.48e-02 2.52e-01 0.66000 -2.03e-01 6.28e-01 3.88e-01 7.77e-03
GOMF 3 CHLOROALLYL ALDEHYDE DEHYDROGENASE ACTIVITY 5 3.34e-02 2.85e-01 0.65900 6.55e-01 7.91e-02 1.12e-02 7.60e-01
GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS 8 9.12e-03 1.46e-01 0.65700 3.55e-01 -5.54e-01 8.25e-02 6.69e-03
GOBP REGULATION OF LUNG BLOOD PRESSURE 5 5.33e-02 3.50e-01 0.65700 -5.54e-01 3.54e-01 3.20e-02 1.71e-01
GOBP POSITIVE REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION 6 2.24e-02 2.40e-01 0.65700 -6.49e-01 9.92e-02 5.87e-03 6.74e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL CHEMOTAXIS 5 5.51e-02 3.57e-01 0.65700 5.02e-01 -4.23e-01 5.18e-02 1.01e-01
Formation of the anterior neural plate 10 9.36e-04 3.09e-02 0.65500 -6.25e-01 -1.98e-01 6.23e-04 2.79e-01
GOBP FATTY ACID OMEGA OXIDATION 5 5.19e-02 3.45e-01 0.65300 5.96e-01 -2.66e-01 2.10e-02 3.02e-01
GOBP ELASTIC FIBER ASSEMBLY 9 4.98e-03 9.90e-02 0.65300 -5.91e-01 2.78e-01 2.15e-03 1.49e-01
GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION 6 3.18e-02 2.80e-01 0.65200 5.26e-01 -3.86e-01 2.57e-02 1.02e-01
GOCC MANNOSYLTRANSFERASE COMPLEX 5 3.01e-02 2.72e-01 0.65200 -2.52e-01 -6.01e-01 3.29e-01 1.99e-02
GOMF BH3 DOMAIN BINDING 6 3.21e-02 2.80e-01 0.65200 3.86e-01 -5.25e-01 1.02e-01 2.59e-02
GOBP VOLUNTARY SKELETAL MUSCLE CONTRACTION 5 5.68e-02 3.62e-01 0.65100 -3.72e-01 5.35e-01 1.50e-01 3.84e-02
GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY 8 9.71e-03 1.51e-01 0.65000 3.11e-01 -5.71e-01 1.28e-01 5.15e-03
Type I hemidesmosome assembly 11 4.14e-04 1.66e-02 0.64900 5.48e-01 3.47e-01 1.63e-03 4.64e-02
GOMF TYPE I INTERFERON RECEPTOR BINDING 14 9.01e-05 5.42e-03 0.64900 6.39e-01 1.10e-01 3.43e-05 4.74e-01
Developmental Cell Lineages 5 5.52e-02 3.58e-01 0.64800 -5.81e-01 2.88e-01 2.45e-02 2.65e-01
Developmental Lineage of Pancreatic Acinar Cells 5 5.52e-02 3.58e-01 0.64800 -5.81e-01 2.88e-01 2.45e-02 2.65e-01
GOBP REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS 7 1.77e-02 2.12e-01 0.64800 3.09e-01 -5.70e-01 1.57e-01 9.02e-03
GOBP ALANINE METABOLIC PROCESS 5 2.91e-02 2.69e-01 0.64800 3.51e-01 5.45e-01 1.74e-01 3.49e-02
GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING 6 3.07e-02 2.74e-01 0.64700 5.92e-01 -2.61e-01 1.21e-02 2.68e-01
GOBP REACTIVE GLIOSIS 6 3.44e-02 2.87e-01 0.64700 -4.84e-01 4.29e-01 4.02e-02 6.86e-02
GOCC NUCLEAR STRESS GRANULE 6 3.33e-02 2.85e-01 0.64700 -5.40e-01 3.56e-01 2.20e-02 1.31e-01
GOBP NUCLEAR MIGRATION ALONG MICROTUBULE 5 5.94e-02 3.70e-01 0.64500 -3.58e-01 5.37e-01 1.65e-01 3.76e-02
GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION 7 2.01e-02 2.28e-01 0.64400 -4.26e-01 4.83e-01 5.07e-02 2.68e-02
GOBP POSITIVE REGULATION OF INTRACELLULAR LIPID TRANSPORT 5 5.14e-02 3.44e-01 0.64300 -1.61e-01 6.23e-01 5.33e-01 1.59e-02
GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION 8 3.70e-03 8.40e-02 0.64300 3.85e-01 5.15e-01 5.93e-02 1.16e-02
GOBP ADULT FEEDING BEHAVIOR 9 5.07e-03 1.00e-01 0.64300 -6.15e-01 1.89e-01 1.41e-03 3.26e-01
GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY 5 5.13e-02 3.44e-01 0.64300 -1.52e-01 6.24e-01 5.56e-01 1.56e-02
GOBP DTMP METABOLIC PROCESS 6 3.44e-02 2.87e-01 0.64200 5.48e-01 -3.36e-01 2.02e-02 1.54e-01
GOBP INTESTINAL EPITHELIAL CELL MATURATION 6 2.03e-02 2.28e-01 0.64200 6.34e-01 1.02e-01 7.19e-03 6.67e-01
GOBP GLUCOSYLCERAMIDE CATABOLIC PROCESS 8 1.01e-02 1.55e-01 0.64200 -2.42e-01 5.94e-01 2.36e-01 3.61e-03
GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY 8 1.22e-02 1.74e-01 0.64000 -4.28e-01 4.77e-01 3.62e-02 1.95e-02
GOBP RNA IMPORT INTO MITOCHONDRION 5 5.37e-02 3.52e-01 0.64000 6.17e-01 -1.70e-01 1.69e-02 5.11e-01
GOBP SPERM MITOCHONDRIAL SHEATH ASSEMBLY 6 3.52e-02 2.90e-01 0.64000 5.49e-01 -3.28e-01 1.98e-02 1.64e-01
GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY 8 1.22e-02 1.74e-01 0.63900 -5.11e-01 3.84e-01 1.23e-02 5.99e-02
GOCC CYTOPLASMIC SIDE OF ROUGH ENDOPLASMIC RETICULUM MEMBRANE 5 4.73e-02 3.30e-01 0.63900 4.53e-02 -6.37e-01 8.61e-01 1.36e-02
GOBP PROGESTERONE BIOSYNTHETIC PROCESS 6 2.20e-02 2.38e-01 0.63800 6.34e-01 7.35e-02 7.16e-03 7.55e-01
GOBP VESICLE TETHERING TO GOLGI 5 3.62e-02 2.93e-01 0.63800 -6.03e-01 -2.09e-01 1.96e-02 4.18e-01
GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY 5 4.12e-02 3.09e-01 0.63800 -6.32e-01 -8.65e-02 1.44e-02 7.38e-01
GOBP GLIAL CELL FATE SPECIFICATION 7 7.95e-03 1.33e-01 0.63800 -4.78e-01 -4.22e-01 2.84e-02 5.34e-02
GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS 10 4.21e-03 9.00e-02 0.63600 3.75e-01 -5.14e-01 4.00e-02 4.86e-03
GOMF LYSOZYME ACTIVITY 9 7.44e-03 1.27e-01 0.63600 3.91e-01 -5.02e-01 4.23e-02 9.17e-03
Acetylcholine inhibits contraction of outer hair cells 5 5.89e-02 3.69e-01 0.63600 -5.94e-01 2.26e-01 2.14e-02 3.81e-01
GOBP ETHANOL METABOLIC PROCESS 11 5.48e-04 2.03e-02 0.63600 3.72e-01 5.15e-01 3.24e-02 3.10e-03
GOBP XENOBIOTIC GLUCURONIDATION 6 3.56e-02 2.90e-01 0.63200 5.82e-01 -2.48e-01 1.36e-02 2.94e-01
GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY 6 2.81e-02 2.66e-01 0.63200 6.30e-01 -5.24e-02 7.57e-03 8.24e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS NAD OR NADP AS ACCEPTOR 6 1.94e-02 2.23e-01 0.62900 2.76e-01 5.65e-01 2.42e-01 1.65e-02
GOBP REGULATION OF OOCYTE MATURATION 7 2.08e-02 2.30e-01 0.62800 -2.24e-01 5.87e-01 3.05e-01 7.15e-03
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components 7 2.34e-02 2.45e-01 0.62700 -5.39e-01 3.21e-01 1.36e-02 1.41e-01
GOBP SPINAL CORD OLIGODENDROCYTE CELL DIFFERENTIATION 5 3.76e-02 2.97e-01 0.62700 -2.97e-01 -5.52e-01 2.50e-01 3.25e-02
GOBP LIMB JOINT MORPHOGENESIS 7 1.72e-02 2.11e-01 0.62600 -6.22e-01 6.94e-02 4.37e-03 7.51e-01
HDL clearance 5 6.91e-02 3.95e-01 0.62500 -3.06e-01 5.45e-01 2.37e-01 3.48e-02
GOBP CELLULAR RESPONSE TO HISTAMINE 6 2.26e-02 2.41e-01 0.62400 -5.97e-01 -1.84e-01 1.14e-02 4.36e-01
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY TYPE I 5 7.05e-02 3.99e-01 0.62400 -5.35e-01 3.22e-01 3.85e-02 2.13e-01
FLT3 signaling through SRC family kinases 6 2.77e-02 2.64e-01 0.62300 -3.49e-02 -6.22e-01 8.82e-01 8.32e-03
GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 5 7.27e-02 4.04e-01 0.62000 5.32e-01 -3.18e-01 3.92e-02 2.18e-01
GOMF TRAIL BINDING 5 3.84e-02 3.02e-01 0.62000 3.90e-01 4.82e-01 1.31e-01 6.20e-02
GOBP METANEPHRIC S SHAPED BODY MORPHOGENESIS 5 5.77e-02 3.65e-01 0.62000 -6.17e-01 6.05e-02 1.69e-02 8.15e-01
GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT 38 2.87e-09 5.60e-07 0.61900 3.55e-01 -5.07e-01 1.55e-04 6.24e-08
GOBP GLOMERULAR ENDOTHELIUM DEVELOPMENT 5 5.88e-02 3.69e-01 0.61900 -6.15e-01 7.05e-02 1.73e-02 7.85e-01
GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE 8 1.50e-02 1.95e-01 0.61800 5.46e-01 -2.90e-01 7.45e-03 1.56e-01
GOBP MEMBRANE TUBULATION 5 7.27e-02 4.04e-01 0.61800 -5.44e-01 2.94e-01 3.51e-02 2.55e-01
GOCC INNER DYNEIN ARM 5 6.71e-02 3.91e-01 0.61800 -1.89e-01 5.88e-01 4.63e-01 2.28e-02
GOBP POSITIVE REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION 5 7.15e-02 4.02e-01 0.61700 -5.60e-01 2.61e-01 3.02e-02 3.13e-01
GOBP SUGAR MEDIATED SIGNALING PATHWAY 9 4.82e-03 9.71e-02 0.61700 -6.14e-01 -6.39e-02 1.43e-03 7.40e-01
GOMF BMP RECEPTOR ACTIVITY 8 1.66e-02 2.06e-01 0.61500 -5.09e-01 3.45e-01 1.26e-02 9.13e-02
GOBP LYMPHOCYTE ANERGY 7 2.91e-02 2.69e-01 0.61300 4.61e-01 -4.05e-01 3.47e-02 6.37e-02
GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN 20 1.22e-05 9.82e-04 0.61300 6.13e-01 -2.72e-02 2.10e-06 8.33e-01
GOMF TORC2 COMPLEX BINDING 5 7.77e-02 4.15e-01 0.61300 5.21e-01 -3.23e-01 4.37e-02 2.11e-01
GOBP NEURON FATE DETERMINATION 10 2.49e-03 6.31e-02 0.61300 -5.98e-01 -1.35e-01 1.06e-03 4.60e-01
GOCC R2TP COMPLEX 5 4.50e-02 3.24e-01 0.61200 -2.53e-01 -5.57e-01 3.27e-01 3.09e-02
GOBP CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION 7 2.76e-02 2.63e-01 0.61100 -5.40e-01 2.87e-01 1.34e-02 1.89e-01
GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION 8 1.54e-02 1.98e-01 0.61100 -5.67e-01 2.27e-01 5.44e-03 2.67e-01
GOBP OSMOSENSORY SIGNALING PATHWAY 7 3.00e-02 2.72e-01 0.61100 4.38e-01 -4.26e-01 4.50e-02 5.08e-02
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS 5 7.92e-02 4.19e-01 0.61100 -5.18e-01 3.24e-01 4.51e-02 2.09e-01
Specification of the neural plate border 16 6.72e-05 4.16e-03 0.61100 -5.89e-01 -1.60e-01 4.50e-05 2.67e-01
NFE2L2 regulating inflammation associated genes 5 6.21e-02 3.76e-01 0.60600 -6.06e-01 1.54e-02 1.89e-02 9.53e-01
GOMF SEROTONIN BINDING 10 6.77e-03 1.20e-01 0.60600 -5.18e-01 3.14e-01 4.56e-03 8.57e-02
GOBP ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS 8 1.40e-02 1.88e-01 0.60600 5.95e-01 -1.13e-01 3.57e-03 5.80e-01
GOBP POSITIVE REGULATION OF BASEMENT MEMBRANE ASSEMBLY INVOLVED IN EMBRYONIC BODY MORPHOGENESIS 5 8.47e-02 4.32e-01 0.60600 -4.76e-01 3.75e-01 6.54e-02 1.47e-01
GOBP REGULATION OF THE FORCE OF HEART CONTRACTION BY CHEMICAL SIGNAL 6 2.54e-02 2.54e-01 0.60500 -5.32e-01 -2.89e-01 2.41e-02 2.20e-01
GOCC POLAR MICROTUBULE 5 8.57e-02 4.33e-01 0.60500 -4.25e-01 4.31e-01 9.97e-02 9.54e-02
GOBP REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY 7 3.12e-02 2.76e-01 0.60500 4.95e-01 -3.48e-01 2.33e-02 1.11e-01
GOBP DENTINOGENESIS 6 4.76e-02 3.30e-01 0.60300 -2.29e-01 5.58e-01 3.32e-01 1.79e-02
GOBP APOPTOTIC CHROMOSOME CONDENSATION 6 4.87e-02 3.35e-01 0.60300 -5.48e-01 2.51e-01 2.00e-02 2.88e-01
GOMF METAL ION SEQUESTERING ACTIVITY 5 4.90e-02 3.35e-01 0.60200 5.40e-01 2.67e-01 3.66e-02 3.01e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX 6 5.02e-02 3.40e-01 0.60100 -5.43e-01 2.56e-01 2.12e-02 2.77e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED PTERIDINE AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN 7 2.80e-02 2.66e-01 0.59500 5.79e-01 -1.37e-01 7.94e-03 5.30e-01
GOBP REGULATION OF ASYMMETRIC CELL DIVISION 5 6.19e-02 3.76e-01 0.59500 -5.89e-01 -8.32e-02 2.25e-02 7.47e-01
GOMF CYCLASE INHIBITOR ACTIVITY 5 5.26e-02 3.47e-01 0.59400 2.83e-01 5.22e-01 2.74e-01 4.31e-02
GOMF O PALMITOYLTRANSFERASE ACTIVITY 5 7.06e-02 3.99e-01 0.59400 -5.93e-01 2.65e-02 2.17e-02 9.18e-01
GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 5 8.10e-02 4.22e-01 0.59300 -1.61e-01 5.71e-01 5.34e-01 2.70e-02
GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE 9 1.40e-02 1.88e-01 0.59300 -4.69e-01 3.64e-01 1.49e-02 5.89e-02
GOBP MEIOTIC CELL CYCLE PROCESS INVOLVED IN OOCYTE MATURATION 6 5.81e-02 3.66e-01 0.59300 -3.61e-01 4.71e-01 1.26e-01 4.57e-02
GOCC CALCINEURIN COMPLEX 6 2.80e-02 2.65e-01 0.59300 -3.69e-01 -4.65e-01 1.18e-01 4.87e-02
GOMF TYPE 2 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING 5 9.44e-02 4.49e-01 0.59200 -4.64e-01 3.68e-01 7.26e-02 1.54e-01
GOBP REGULATION OF PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 6 4.80e-02 3.31e-01 0.59100 -5.78e-01 1.23e-01 1.41e-02 6.02e-01
GOCC MEMBRANE ATTACK COMPLEX 7 2.48e-02 2.52e-01 0.59100 5.91e-01 -1.60e-02 6.78e-03 9.42e-01
GOBP CARDIAC PACEMAKER CELL DEVELOPMENT 8 1.14e-02 1.67e-01 0.59100 -5.73e-01 -1.41e-01 4.97e-03 4.89e-01
Regulation of NPAS4 mRNA translation 9 8.09e-03 1.34e-01 0.59100 -5.90e-01 -2.28e-02 2.17e-03 9.06e-01
GOBP NEURAL PLATE REGIONALIZATION 6 5.31e-02 3.49e-01 0.59000 -5.55e-01 1.99e-01 1.85e-02 3.99e-01
GOBP TRANSDIFFERENTIATION 7 2.85e-02 2.67e-01 0.58800 -5.82e-01 8.49e-02 7.66e-03 6.97e-01
GOBP CHROMOSOME ATTACHMENT TO THE NUCLEAR ENVELOPE 7 2.57e-02 2.55e-01 0.58600 -5.86e-01 5.54e-04 7.20e-03 9.98e-01
CLEC7A/inflammasome pathway 6 5.82e-02 3.66e-01 0.58500 5.31e-01 -2.46e-01 2.43e-02 2.96e-01
GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION 11 3.64e-03 8.31e-02 0.58500 -5.83e-01 4.41e-02 8.13e-04 8.00e-01
GOBP CARBON DIOXIDE TRANSPORT 15 5.14e-04 1.95e-02 0.58500 5.80e-01 -7.06e-02 9.95e-05 6.36e-01
GOBP REGULATION OF LIPID TRANSPORTER ACTIVITY 6 6.38e-02 3.79e-01 0.58400 -4.37e-01 3.87e-01 6.35e-02 1.00e-01
GOMF XMP 5 NUCLEOSIDASE ACTIVITY 6 5.75e-02 3.65e-01 0.58400 -2.23e-01 5.40e-01 3.45e-01 2.19e-02
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS 5 8.74e-02 4.37e-01 0.58400 -5.63e-01 1.56e-01 2.93e-02 5.46e-01
GOBP FORMATION OF ANATOMICAL BOUNDARY 7 1.77e-02 2.11e-01 0.58200 -4.07e-01 -4.17e-01 6.22e-02 5.62e-02
GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS 6 6.21e-02 3.76e-01 0.58000 2.65e-01 -5.16e-01 2.61e-01 2.85e-02
GOBP TRYPTOPHAN CATABOLIC PROCESS TO KYNURENINE 5 9.20e-02 4.44e-01 0.57900 5.54e-01 -1.69e-01 3.18e-02 5.13e-01
Activation of RAC1 downstream of NMDARs 7 4.28e-02 3.15e-01 0.57900 -4.17e-01 4.02e-01 5.58e-02 6.58e-02
Trafficking of GluR2-containing AMPA receptors 15 1.07e-03 3.46e-02 0.57900 -4.91e-01 3.07e-01 9.96e-04 3.92e-02
GOBP REGULATION OF GAMMA AMINOBUTYRIC ACID SECRETION 8 2.36e-02 2.46e-01 0.57900 -5.37e-01 2.16e-01 8.50e-03 2.91e-01
GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION 6 4.67e-02 3.28e-01 0.57800 1.03e-02 5.78e-01 9.65e-01 1.42e-02
GOBP PROLACTIN SECRETION 5 6.89e-02 3.95e-01 0.57800 -5.62e-01 -1.35e-01 2.96e-02 6.00e-01
Metal sequestration by antimicrobial proteins 6 3.52e-02 2.90e-01 0.57700 5.03e-01 2.84e-01 3.29e-02 2.29e-01
GOBP POSITIVE REGULATION OF UTERINE SMOOTH MUSCLE CONTRACTION 8 1.51e-02 1.96e-01 0.57600 -5.68e-01 -9.50e-02 5.37e-03 6.42e-01
GOBP PATTERN SPECIFICATION INVOLVED IN KIDNEY DEVELOPMENT 8 1.73e-02 2.11e-01 0.57600 -5.76e-01 -1.11e-02 4.78e-03 9.57e-01
GOMF GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR ACTIVITY 5 1.07e-01 4.75e-01 0.57600 4.58e-01 -3.49e-01 7.63e-02 1.76e-01
GOMF PRIMARY AMINE OXIDASE ACTIVITY 7 4.46e-02 3.22e-01 0.57500 -4.40e-01 3.69e-01 4.36e-02 9.05e-02
GOBP REGULATION OF MICROVILLUS LENGTH 7 2.58e-02 2.55e-01 0.57400 5.65e-01 1.04e-01 9.67e-03 6.34e-01
GOCC BASAL CORTEX 5 1.02e-01 4.67e-01 0.57300 -5.22e-01 2.37e-01 4.32e-02 3.58e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 13 PRODUCTION 7 2.54e-02 2.54e-01 0.57100 5.52e-01 1.47e-01 1.15e-02 4.99e-01
GOBP REGULATION OF GLUCAGON SECRETION 8 1.28e-02 1.78e-01 0.57100 -4.99e-01 -2.78e-01 1.46e-02 1.74e-01
GOBP HYPOTHALAMUS CELL MIGRATION 6 6.76e-02 3.92e-01 0.57100 -5.12e-01 2.52e-01 2.99e-02 2.85e-01
GOMF CCR1 CHEMOKINE RECEPTOR BINDING 5 9.79e-02 4.57e-01 0.57000 1.51e-01 -5.50e-01 5.58e-01 3.33e-02
FLT3 signaling by CBL mutants 7 3.46e-02 2.88e-01 0.56800 5.28e-02 -5.66e-01 8.09e-01 9.50e-03
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE 6 3.81e-02 3.00e-01 0.56800 -4.74e-01 -3.14e-01 4.45e-02 1.83e-01
GOBP GLUTAMATE REUPTAKE 6 7.21e-02 4.04e-01 0.56800 -3.09e-01 4.77e-01 1.90e-01 4.31e-02
Nef Mediated CD8 Down-regulation 7 4.30e-02 3.15e-01 0.56800 -5.23e-01 2.21e-01 1.65e-02 3.11e-01
GOBP SCHWANN CELL PROLIFERATION 9 1.97e-02 2.25e-01 0.56600 -4.79e-01 3.03e-01 1.29e-02 1.15e-01
GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY 6 7.53e-02 4.12e-01 0.56600 -3.74e-01 4.25e-01 1.12e-01 7.13e-02
GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION 7 4.25e-02 3.14e-01 0.56600 1.87e-01 -5.34e-01 3.91e-01 1.44e-02
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS 5 8.82e-02 4.37e-01 0.56600 -5.66e-01 3.95e-03 2.85e-02 9.88e-01
GOMF CELL ADHESIVE PROTEIN BINDING INVOLVED IN BUNDLE OF HIS CELL PURKINJE MYOCYTE COMMUNICATION 5 7.80e-02 4.17e-01 0.56400 5.49e-01 1.32e-01 3.36e-02 6.10e-01
Viral mRNA Translation 83 2.22e-16 1.80e-13 0.56400 2.77e-01 -4.92e-01 1.33e-05 9.35e-15
GOBP CARBOHYDRATE MEDIATED SIGNALING 11 4.90e-03 9.80e-02 0.56400 -5.64e-01 -5.39e-05 1.20e-03 1.00e+00
GOBP INTESTINAL HEXOSE ABSORPTION 5 7.89e-02 4.18e-01 0.56400 5.49e-01 1.27e-01 3.34e-02 6.24e-01
GOBP POSITIVE REGULATION OF CORTICOSTEROID HORMONE SECRETION 7 3.95e-02 3.06e-01 0.56300 -5.53e-01 1.05e-01 1.12e-02 6.31e-01
GOBP PRIMARY ALCOHOL CATABOLIC PROCESS 13 9.12e-04 3.03e-02 0.56300 4.16e-01 3.79e-01 9.36e-03 1.79e-02
Peptide chain elongation 83 2.92e-16 2.11e-13 0.56200 2.76e-01 -4.89e-01 1.33e-05 1.26e-14
STAT5 Activation 7 2.47e-02 2.51e-01 0.56100 -2.96e-01 -4.76e-01 1.75e-01 2.90e-02
GOBP MYOSIN FILAMENT ORGANIZATION 6 7.72e-02 4.15e-01 0.56100 -3.03e-01 4.72e-01 1.99e-01 4.53e-02
GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION 9 2.00e-02 2.27e-01 0.56100 2.38e-01 -5.08e-01 2.17e-01 8.36e-03
GOBP POSITIVE REGULATION OF GASTRULATION 6 4.10e-02 3.09e-01 0.56000 -3.65e-01 -4.25e-01 1.21e-01 7.17e-02
GOBP REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION 8 2.08e-02 2.30e-01 0.56000 -5.58e-01 -3.79e-02 6.23e-03 8.53e-01
GOBP SKELETAL MUSCLE ATROPHY 5 9.08e-02 4.43e-01 0.55900 -1.86e-02 -5.59e-01 9.43e-01 3.04e-02
GOBP PROTEIN LOCALIZATION TO CENP A CONTAINING CHROMATIN 16 2.26e-04 1.08e-02 0.55800 -3.00e-01 -4.71e-01 3.74e-02 1.12e-03
GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY 9 2.10e-02 2.32e-01 0.55800 5.00e-01 -2.47e-01 9.35e-03 1.99e-01
Eukaryotic Translation Termination 86 1.61e-16 1.68e-13 0.55800 2.91e-01 -4.76e-01 3.11e-06 2.23e-14
GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 8 3.35e-02 2.85e-01 0.55800 4.82e-01 -2.80e-01 1.82e-02 1.70e-01
GOBP POSITIVE REGULATION OF AGGREPHAGY 6 4.25e-02 3.14e-01 0.55700 -4.24e-01 -3.61e-01 7.18e-02 1.26e-01
GOCC ELONGIN COMPLEX 5 8.25e-02 4.26e-01 0.55700 5.37e-01 1.45e-01 3.74e-02 5.75e-01
Sensory perception of salty taste 6 4.60e-02 3.26e-01 0.55600 5.01e-01 2.41e-01 3.35e-02 3.08e-01
GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION 7 4.82e-02 3.32e-01 0.55600 -5.19e-01 1.98e-01 1.73e-02 3.65e-01
GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY 8 2.30e-02 2.43e-01 0.55500 -5.55e-01 -1.47e-02 6.55e-03 9.43e-01
GOBP NEGATIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION 5 1.05e-01 4.72e-01 0.55400 -8.46e-02 5.48e-01 7.43e-01 3.39e-02
GOCC ANKYRIN 1 COMPLEX 7 5.49e-02 3.57e-01 0.55400 4.50e-01 -3.22e-01 3.90e-02 1.40e-01
GOCC GROWTH CONE MEMBRANE 8 3.72e-02 2.96e-01 0.55400 -3.75e-01 4.07e-01 6.64e-02 4.59e-02
GOCC ENDOLYSOSOME LUMEN 5 1.28e-01 5.12e-01 0.55300 -3.62e-01 4.18e-01 1.61e-01 1.06e-01
GOCC SIGNAL PEPTIDASE COMPLEX 5 1.20e-01 4.97e-01 0.55200 2.16e-01 -5.08e-01 4.04e-01 4.90e-02
GOBP ISOCITRATE METABOLIC PROCESS 5 8.40e-02 4.31e-01 0.55200 -1.71e-01 -5.25e-01 5.08e-01 4.22e-02
GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION 12 7.47e-03 1.27e-01 0.55100 -4.28e-01 3.47e-01 1.03e-02 3.73e-02
GOMF STRUCTURAL CONSTITUENT OF SKIN EPIDERMIS 36 9.58e-09 1.76e-06 0.55100 4.42e-01 3.29e-01 4.53e-06 6.30e-04
GOCC 3M COMPLEX 5 1.31e-01 5.16e-01 0.55100 -4.08e-01 3.70e-01 1.14e-01 1.52e-01
GOBP NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM 8 3.71e-02 2.96e-01 0.55100 4.64e-01 -2.96e-01 2.30e-02 1.47e-01
GOMF 4 GALACTOSYL N ACETYLGLUCOSAMINIDE 3 ALPHA L FUCOSYLTRANSFERASE ACTIVITY 6 4.80e-02 3.31e-01 0.55000 4.78e-01 2.72e-01 4.26e-02 2.49e-01
GOBP HYDROGEN SULFIDE METABOLIC PROCESS 5 1.32e-01 5.19e-01 0.54900 3.89e-01 -3.88e-01 1.32e-01 1.33e-01
GOBP TRNA THIO MODIFICATION 5 1.32e-01 5.19e-01 0.54900 -3.73e-01 4.03e-01 1.48e-01 1.19e-01
GOBP PURINE RIBONUCLEOSIDE SALVAGE 6 4.82e-02 3.32e-01 0.54900 -2.82e-01 -4.71e-01 2.31e-01 4.59e-02
Defective LFNG causes SCDO3 5 7.75e-02 4.15e-01 0.54900 3.87e-01 3.89e-01 1.34e-01 1.32e-01
DNA Damage Reversal 8 3.95e-02 3.06e-01 0.54800 -4.09e-01 3.65e-01 4.49e-02 7.40e-02
GOBP UTERINE SMOOTH MUSCLE CONTRACTION 10 1.05e-02 1.58e-01 0.54700 -5.47e-01 1.07e-03 2.72e-03 9.95e-01
GOMF GLUTATHIONE HYDROLASE ACTIVITY 5 8.49e-02 4.32e-01 0.54700 5.06e-01 2.08e-01 4.99e-02 4.21e-01
GOBP ACETATE ESTER METABOLIC PROCESS 6 5.71e-02 3.63e-01 0.54700 -5.36e-01 -1.12e-01 2.31e-02 6.33e-01
GOMF AMINE BINDING 12 7.48e-03 1.27e-01 0.54700 -4.71e-01 2.77e-01 4.69e-03 9.63e-02
GOBP MICROGLIAL CELL PROLIFERATION 8 3.61e-02 2.93e-01 0.54700 -5.01e-01 2.18e-01 1.41e-02 2.85e-01
GOBP NEGATIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 5 1.34e-01 5.21e-01 0.54500 -4.50e-01 3.08e-01 8.14e-02 2.33e-01
GOBP EMBRYONIC SKELETAL JOINT MORPHOGENESIS 11 4.14e-03 8.91e-02 0.54500 -4.64e-01 -2.86e-01 7.70e-03 1.01e-01
GOMF NADPH OXIDASE H202 FORMING ACTIVITY 5 1.35e-01 5.24e-01 0.54500 -4.33e-01 3.30e-01 9.35e-02 2.01e-01
GOBP DISTAL CONVOLUTED TUBULE DEVELOPMENT 5 1.12e-01 4.84e-01 0.54500 -5.40e-01 7.23e-02 3.65e-02 7.79e-01
GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS 5 1.33e-01 5.21e-01 0.54500 2.95e-01 -4.58e-01 2.54e-01 7.61e-02
GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION 11 1.19e-02 1.72e-01 0.54400 -4.62e-01 2.88e-01 7.96e-03 9.86e-02
GOBP REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION 9 2.54e-02 2.54e-01 0.54400 -4.87e-01 2.43e-01 1.14e-02 2.07e-01
GOBP G1 TO G0 TRANSITION INVOLVED IN CELL DIFFERENTIATION 6 6.96e-02 3.97e-01 0.54300 -2.52e-02 5.43e-01 9.15e-01 2.13e-02
Defective GALNT3 causes HFTC 18 2.46e-04 1.15e-02 0.54300 5.39e-01 6.84e-02 7.53e-05 6.15e-01
GOBP SIRNA PROCESSING 8 4.23e-02 3.14e-01 0.54300 -3.71e-01 3.96e-01 6.90e-02 5.25e-02
GOMF PROTEIN ARGININE DEIMINASE ACTIVITY 5 8.95e-02 4.39e-01 0.54200 5.05e-01 1.97e-01 5.04e-02 4.46e-01
GOBP REGULATION OF SOMITOGENESIS 6 4.99e-02 3.39e-01 0.54200 3.77e-01 3.89e-01 1.10e-01 9.85e-02
Eukaryotic Translation Elongation 87 7.01e-16 4.10e-13 0.54200 2.63e-01 -4.74e-01 2.16e-05 2.16e-14
GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION 5 1.27e-01 5.10e-01 0.54200 5.10e-01 -1.83e-01 4.84e-02 4.79e-01
GOBP CELL CELL JUNCTION DISASSEMBLY 5 1.21e-01 4.99e-01 0.54100 -5.27e-01 1.24e-01 4.13e-02 6.31e-01
GOBP SYNAPTIC SIGNALING VIA NEUROPEPTIDE 6 5.89e-02 3.69e-01 0.54100 -5.20e-01 -1.47e-01 2.72e-02 5.34e-01
GOCC AP 2 ADAPTOR COMPLEX 11 9.00e-03 1.45e-01 0.54100 -5.34e-01 8.60e-02 2.17e-03 6.21e-01
MET Receptor Activation 6 7.16e-02 4.02e-01 0.54100 5.40e-01 -2.47e-02 2.20e-02 9.16e-01
Adrenoceptors 9 1.19e-02 1.71e-01 0.54000 -3.26e-01 -4.30e-01 9.02e-02 2.55e-02
GOMF ALL TRANS RETINAL BINDING 5 8.78e-02 4.37e-01 0.53900 4.71e-01 2.62e-01 6.79e-02 3.10e-01
GOBP REGULATION OF SNRNA TRANSCRIPTION BY RNA POLYMERASE II 5 8.62e-02 4.34e-01 0.53900 -2.99e-01 -4.49e-01 2.47e-01 8.22e-02
GOBP FLAVONOID GLUCURONIDATION 5 1.24e-01 5.04e-01 0.53900 5.23e-01 -1.30e-01 4.30e-02 6.14e-01
GOBP L LEUCINE IMPORT ACROSS PLASMA MEMBRANE 5 1.42e-01 5.33e-01 0.53900 -4.27e-01 3.28e-01 9.80e-02 2.04e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL 5 1.38e-01 5.28e-01 0.53900 -4.65e-01 2.72e-01 7.19e-02 2.92e-01
SARS-CoV-2 modulates host translation machinery 45 2.31e-08 3.88e-06 0.53800 3.15e-01 -4.36e-01 2.58e-04 4.03e-07
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS 8 4.32e-02 3.16e-01 0.53700 2.84e-01 -4.56e-01 1.64e-01 2.54e-02
GOBP REGULATION OF PHENOTYPIC SWITCHING 6 8.97e-02 4.40e-01 0.53700 -4.96e-01 2.05e-01 3.54e-02 3.83e-01
GOMF BENZODIAZEPINE RECEPTOR ACTIVITY 9 1.42e-02 1.90e-01 0.53600 -4.97e-01 -2.01e-01 9.83e-03 2.96e-01
Activation of C3 and C5 6 8.49e-02 4.32e-01 0.53600 -1.40e-01 5.18e-01 5.53e-01 2.81e-02
GOBP PROXIMAL DISTAL PATTERN FORMATION INVOLVED IN NEPHRON DEVELOPMENT 5 1.08e-01 4.77e-01 0.53600 -5.34e-01 -4.40e-02 3.86e-02 8.65e-01
GOBP REGULATION OF SARCOMERE ORGANIZATION 9 2.27e-02 2.42e-01 0.53600 -5.29e-01 8.27e-02 5.95e-03 6.68e-01
GOCC SEX CHROMATIN 6 8.80e-02 4.37e-01 0.53600 -5.07e-01 1.72e-01 3.14e-02 4.67e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME 5 1.45e-01 5.38e-01 0.53600 -4.17e-01 3.36e-01 1.06e-01 1.93e-01
GOCC MICROTUBULE MINUS END 7 3.98e-02 3.06e-01 0.53500 -5.19e-01 -1.33e-01 1.75e-02 5.43e-01
Pre-NOTCH Processing in the Endoplasmic Reticulum 6 5.46e-02 3.56e-01 0.53500 3.24e-01 4.26e-01 1.70e-01 7.08e-02
GOBP FLAVONE METABOLIC PROCESS 6 8.69e-02 4.36e-01 0.53400 5.14e-01 -1.46e-01 2.93e-02 5.35e-01
GOBP POSITIVE REGULATION OF SARCOMERE ORGANIZATION 6 8.72e-02 4.36e-01 0.53300 -5.15e-01 1.40e-01 2.91e-02 5.54e-01
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY 8 4.74e-02 3.30e-01 0.53300 -3.85e-01 3.69e-01 5.94e-02 7.11e-02
GOMF GUANYLATE CYCLASE REGULATOR ACTIVITY 8 2.92e-02 2.70e-01 0.53300 5.30e-01 5.30e-02 9.40e-03 7.95e-01
GOBP RESPONSE TO MUSCLE INACTIVITY 9 3.25e-02 2.81e-01 0.53300 -3.59e-01 3.93e-01 6.21e-02 4.11e-02
GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION 7 4.00e-02 3.06e-01 0.53200 -5.05e-01 -1.66e-01 2.06e-02 4.48e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS 8 4.12e-02 3.09e-01 0.53200 -5.03e-01 1.73e-01 1.38e-02 3.98e-01
Post-transcriptional silencing by small RNAs 7 5.26e-02 3.47e-01 0.53200 -5.30e-01 4.68e-02 1.53e-02 8.30e-01
Formation of the ternary complex, and subsequently, the 43S complex 45 2.62e-08 4.35e-06 0.53100 2.39e-01 -4.74e-01 5.54e-03 3.66e-08
Multifunctional anion exchangers 9 1.44e-02 1.91e-01 0.53100 4.63e-01 2.60e-01 1.62e-02 1.77e-01
GOBP CARDIAC MUSCLE CELL CARDIAC MUSCLE CELL ADHESION 7 4.57e-02 3.26e-01 0.53100 5.26e-01 6.76e-02 1.59e-02 7.57e-01
GOBP REGULATION OF BONE DEVELOPMENT 9 3.28e-02 2.83e-01 0.53100 -4.26e-01 3.16e-01 2.70e-02 1.00e-01
GOBP FOREBRAIN NEURON FATE COMMITMENT 7 3.55e-02 2.90e-01 0.53000 -4.09e-01 -3.38e-01 6.10e-02 1.22e-01
GOBP VASCULOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS 5 1.51e-01 5.47e-01 0.53000 -3.49e-01 3.99e-01 1.76e-01 1.23e-01
GOCC BBAF COMPLEX 10 1.67e-02 2.07e-01 0.53000 -5.22e-01 9.35e-02 4.29e-03 6.09e-01
GOBP ANGIOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS 5 1.50e-01 5.44e-01 0.53000 -4.34e-01 3.04e-01 9.28e-02 2.40e-01
GOBP NATURAL KILLER CELL CHEMOTAXIS 10 2.30e-02 2.43e-01 0.53000 3.38e-01 -4.08e-01 6.42e-02 2.56e-02
GOMF ADRENERGIC RECEPTOR ACTIVITY 10 8.77e-03 1.42e-01 0.52900 -3.07e-01 -4.31e-01 9.27e-02 1.82e-02
GOCC INSULIN LIKE GROWTH FACTOR BINDING PROTEIN COMPLEX 5 1.24e-01 5.04e-01 0.52900 -5.27e-01 4.11e-02 4.13e-02 8.74e-01
GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA 11 5.43e-03 1.04e-01 0.52900 -4.01e-01 -3.44e-01 2.12e-02 4.82e-02
GOMF EPINEPHRINE BINDING 6 7.28e-02 4.04e-01 0.52800 -5.24e-01 -6.47e-02 2.61e-02 7.84e-01
GOBP CELLULAR RESPONSE TO WATER STIMULUS 6 7.90e-02 4.18e-01 0.52800 -5.28e-01 5.29e-03 2.51e-02 9.82e-01
GOBP RESOLUTION OF DNA RECOMBINATION INTERMEDIATES 6 1.06e-01 4.74e-01 0.52800 -3.65e-01 3.81e-01 1.21e-01 1.06e-01
GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY 9 3.31e-02 2.84e-01 0.52700 2.68e-01 -4.54e-01 1.63e-01 1.85e-02
GOBP CELLULAR RESPONSE TO PEPTIDE 13 7.90e-03 1.33e-01 0.52700 -3.71e-01 3.75e-01 2.07e-02 1.94e-02
Selenocysteine synthesis 86 7.30e-15 3.58e-12 0.52700 2.60e-01 -4.58e-01 3.08e-05 1.99e-13
GOBP RESPONSE TO PEPTIDE 20 5.90e-04 2.14e-02 0.52600 -3.72e-01 3.72e-01 3.95e-03 3.94e-03
GOBP POSITIVE REGULATION OF MONOCYTE EXTRAVASATION 5 1.55e-01 5.51e-01 0.52600 -3.28e-01 4.12e-01 2.04e-01 1.11e-01
NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose 5 1.35e-01 5.22e-01 0.52500 -5.16e-01 1.00e-01 4.58e-02 6.99e-01
GOCC NEUROFILAMENT 10 2.29e-02 2.43e-01 0.52500 -4.60e-01 2.54e-01 1.18e-02 1.65e-01
GOBP SENSORY PERCEPTION OF UMAMI TASTE 7 4.59e-02 3.26e-01 0.52500 5.12e-01 1.15e-01 1.89e-02 5.97e-01
GOBP TYROSINE CATABOLIC PROCESS 6 1.10e-01 4.79e-01 0.52300 -3.31e-01 4.05e-01 1.60e-01 8.54e-02
GOCC CHROMOSOME CENTROMERIC CORE DOMAIN 17 3.85e-04 1.58e-02 0.52300 -3.10e-01 -4.21e-01 2.71e-02 2.62e-03
GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS 5 1.44e-01 5.36e-01 0.52200 -1.49e-01 5.01e-01 5.64e-01 5.25e-02
GOBP PUTRESCINE BIOSYNTHETIC PROCESS 5 1.07e-01 4.75e-01 0.52200 4.90e-01 1.82e-01 5.80e-02 4.80e-01
Formation of a pool of free 40S subunits 93 6.22e-16 3.82e-13 0.52200 2.19e-01 -4.74e-01 2.70e-04 2.61e-15
Interleukin-36 pathway 7 4.09e-02 3.09e-01 0.52100 2.82e-01 4.38e-01 1.96e-01 4.49e-02
GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H 6 1.06e-01 4.74e-01 0.52100 -2.31e-01 4.67e-01 3.27e-01 4.77e-02
GOBP NEGATIVE REGULATION OF FEEDING BEHAVIOR 6 9.12e-02 4.43e-01 0.52100 -7.15e-02 5.16e-01 7.62e-01 2.87e-02
GOBP NEGATIVE REGULATION OF INTRACELLULAR LIPID TRANSPORT 5 1.01e-01 4.65e-01 0.52000 3.04e-01 4.23e-01 2.40e-01 1.02e-01
GOBP UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY 5 1.58e-01 5.56e-01 0.52000 4.50e-01 -2.62e-01 8.17e-02 3.11e-01
GOBP NEURAL PLATE PATTERN SPECIFICATION 8 4.80e-02 3.31e-01 0.52000 -4.88e-01 1.79e-01 1.69e-02 3.80e-01
GOCC PICLN SM PROTEIN COMPLEX 6 1.14e-01 4.88e-01 0.51900 3.39e-01 -3.93e-01 1.51e-01 9.51e-02
GOBP REGULATION OF PRE MIRNA PROCESSING 6 7.22e-02 4.04e-01 0.51900 -4.94e-01 -1.60e-01 3.62e-02 4.96e-01
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 SIGNALING PATHWAY 6 1.13e-01 4.88e-01 0.51900 -3.22e-01 4.07e-01 1.72e-01 8.44e-02
GOBP REGULATION OF VITAMIN METABOLIC PROCESS 12 1.27e-02 1.78e-01 0.51800 2.95e-01 -4.26e-01 7.70e-02 1.05e-02
GOBP LATERAL MESODERM MORPHOGENESIS 5 1.19e-01 4.95e-01 0.51700 -5.05e-01 -1.09e-01 5.04e-02 6.72e-01
Reversal of alkylation damage by DNA dioxygenases 7 8.02e-02 4.20e-01 0.51700 -4.14e-01 3.09e-01 5.77e-02 1.57e-01
GOBP REGULATION OF RELAXATION OF CARDIAC MUSCLE 6 7.13e-02 4.02e-01 0.51700 -4.75e-01 -2.03e-01 4.40e-02 3.88e-01
GOBP POSITIVE REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE 7 6.65e-02 3.89e-01 0.51600 -5.07e-01 9.66e-02 2.02e-02 6.58e-01
NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake 5 1.56e-01 5.52e-01 0.51600 -4.78e-01 1.93e-01 6.41e-02 4.54e-01
GOBP HOST MEDIATED REGULATION OF INTESTINAL MICROBIOTA COMPOSITION 9 2.06e-02 2.30e-01 0.51500 4.91e-01 1.55e-01 1.07e-02 4.19e-01
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) 88 1.72e-14 8.10e-12 0.51500 2.69e-01 -4.39e-01 1.31e-05 1.03e-12
GOBP REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES 6 1.14e-01 4.89e-01 0.51500 -4.42e-01 2.64e-01 6.07e-02 2.63e-01
GOBP EMBRYONIC RETINA MORPHOGENESIS IN CAMERA TYPE EYE 6 8.71e-02 4.36e-01 0.51500 -5.15e-01 -1.90e-02 2.90e-02 9.36e-01
Dopamine receptors 5 1.48e-01 5.42e-01 0.51500 -5.02e-01 1.14e-01 5.18e-02 6.60e-01
GOMF DOPAMINE NEUROTRANSMITTER RECEPTOR ACTIVITY 5 1.48e-01 5.42e-01 0.51500 -5.02e-01 1.14e-01 5.18e-02 6.60e-01
GOBP SEPTUM PRIMUM DEVELOPMENT 5 1.30e-01 5.15e-01 0.51500 -5.14e-01 -2.84e-02 4.66e-02 9.12e-01
GOBP NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS 7 7.90e-02 4.18e-01 0.51400 2.39e-01 -4.55e-01 2.73e-01 3.72e-02
GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION 20 6.60e-04 2.35e-02 0.51400 4.70e-01 -2.08e-01 2.76e-04 1.08e-01
GOMF TYPE 1 ANGIOTENSIN RECEPTOR BINDING 6 1.19e-01 4.96e-01 0.51400 -3.83e-01 3.42e-01 1.04e-01 1.47e-01
GOBP RESPONSE TO NEMATODE 7 8.25e-02 4.26e-01 0.51400 3.00e-01 -4.17e-01 1.70e-01 5.61e-02
GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION 6 1.13e-01 4.87e-01 0.51400 -2.31e-01 4.59e-01 3.28e-01 5.16e-02
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY 8 4.88e-02 3.35e-01 0.51300 1.26e-01 -4.97e-01 5.36e-01 1.49e-02
GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY 10 1.20e-02 1.72e-01 0.51300 2.78e-01 4.31e-01 1.28e-01 1.83e-02
GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT 51 7.22e-09 1.34e-06 0.51200 1.82e-01 -4.79e-01 2.42e-02 3.25e-09
GOMF GLYCEROL CHANNEL ACTIVITY 5 1.16e-01 4.90e-01 0.51200 4.78e-01 1.84e-01 6.41e-02 4.76e-01
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION 8 4.66e-02 3.28e-01 0.51200 -5.05e-01 8.72e-02 1.34e-02 6.69e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR 16 3.57e-03 8.26e-02 0.51200 3.80e-01 -3.43e-01 8.46e-03 1.74e-02
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde 8 5.17e-02 3.45e-01 0.51200 -1.64e-01 4.85e-01 4.22e-01 1.75e-02
GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION 9 4.10e-02 3.09e-01 0.51200 4.24e-01 -2.86e-01 2.76e-02 1.37e-01
GOMF EXTRACELLULAR MATRIX PROTEIN BINDING 6 1.22e-01 4.99e-01 0.51200 -3.51e-01 3.73e-01 1.37e-01 1.14e-01
GOMF CCR2 CHEMOKINE RECEPTOR BINDING 5 1.21e-01 4.99e-01 0.51100 -1.39e-01 -4.92e-01 5.89e-01 5.68e-02
GOBP POSITIVE REGULATION OF GAP JUNCTION ASSEMBLY 6 8.57e-02 4.33e-01 0.51100 -5.07e-01 -6.79e-02 3.17e-02 7.73e-01
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION 6 1.11e-01 4.82e-01 0.51100 1.75e-01 -4.80e-01 4.59e-01 4.17e-02
GOBP EXOCRINE PANCREAS DEVELOPMENT 7 4.69e-02 3.28e-01 0.51000 -2.66e-01 -4.35e-01 2.23e-01 4.61e-02
GOBP LUTEINIZING HORMONE SECRETION 11 1.33e-02 1.83e-01 0.51000 -5.10e-01 1.16e-02 3.43e-03 9.47e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ENDOTHELIN 6 7.18e-02 4.03e-01 0.50900 -4.09e-01 -3.04e-01 8.30e-02 1.97e-01
GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM 10 3.09e-02 2.75e-01 0.50900 3.34e-01 -3.84e-01 6.72e-02 3.57e-02
GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION 10 2.61e-02 2.56e-01 0.50900 1.67e-01 -4.80e-01 3.60e-01 8.51e-03
GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS 20 2.08e-04 1.02e-02 0.50900 4.76e-01 1.80e-01 2.29e-04 1.64e-01
GOBP NEGATIVE REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS 5 1.57e-01 5.54e-01 0.50900 1.30e-01 -4.92e-01 6.13e-01 5.70e-02
Formation of intermediate mesoderm 8 4.29e-02 3.15e-01 0.50800 -5.08e-01 -3.80e-03 1.28e-02 9.85e-01
GOBP FATTY ACYL COA CATABOLIC PROCESS 5 1.77e-01 5.81e-01 0.50800 3.74e-01 -3.45e-01 1.48e-01 1.82e-01
GOCC INTERSTITIAL MATRIX 11 1.76e-02 2.11e-01 0.50800 -4.87e-01 1.44e-01 5.12e-03 4.09e-01
GOBP RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT 9 2.46e-02 2.51e-01 0.50800 1.07e-01 4.97e-01 5.78e-01 9.88e-03
GOBP METANEPHRIC DISTAL TUBULE DEVELOPMENT 7 8.08e-02 4.21e-01 0.50800 -4.68e-01 1.98e-01 3.20e-02 3.65e-01
GOBP CORTISOL METABOLIC PROCESS 12 6.10e-03 1.13e-01 0.50800 4.69e-01 1.94e-01 4.87e-03 2.44e-01
GOBP NORADRENERGIC NEURON DIFFERENTIATION 10 1.80e-02 2.13e-01 0.50800 -5.05e-01 -5.31e-02 5.67e-03 7.71e-01
GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION 16 3.90e-03 8.65e-02 0.50800 -3.17e-01 3.97e-01 2.84e-02 6.01e-03
GOBP ANAGEN 5 1.73e-01 5.78e-01 0.50700 4.34e-01 -2.63e-01 9.30e-02 3.08e-01
GOBP PROTEIN POLYUFMYLATION 5 1.12e-01 4.85e-01 0.50700 -3.40e-01 -3.76e-01 1.88e-01 1.45e-01
Acyl chain remodeling of DAG and TAG 5 1.77e-01 5.83e-01 0.50700 -3.27e-01 3.87e-01 2.05e-01 1.34e-01
Regulation of gene expression in early pancreatic precursor cells 8 3.53e-02 2.90e-01 0.50700 -4.82e-01 -1.56e-01 1.81e-02 4.45e-01
Response of EIF2AK4 (GCN2) to amino acid deficiency 94 5.06e-15 2.59e-12 0.50700 2.48e-01 -4.42e-01 3.16e-05 1.32e-13
Melanin biosynthesis 5 1.38e-01 5.28e-01 0.50600 5.05e-01 3.21e-02 5.03e-02 9.01e-01
GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY 7 8.32e-02 4.29e-01 0.50600 -2.09e-01 4.61e-01 3.38e-01 3.46e-02
L13a-mediated translational silencing of Ceruloplasmin expression 102 2.35e-16 1.80e-13 0.50600 2.14e-01 -4.58e-01 1.89e-04 1.22e-15
GTP hydrolysis and joining of the 60S ribosomal subunit 103 1.64e-16 1.68e-13 0.50600 2.13e-01 -4.59e-01 1.91e-04 8.28e-16
Serotonin receptors 11 2.29e-02 2.43e-01 0.50600 -3.80e-01 3.33e-01 2.89e-02 5.60e-02
GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY 6 1.21e-01 4.99e-01 0.50500 -4.56e-01 2.16e-01 5.30e-02 3.59e-01
GOBP NOTOCHORD MORPHOGENESIS 8 6.50e-02 3.83e-01 0.50500 3.56e-01 -3.58e-01 8.16e-02 7.95e-02
GOBP AXONOGENESIS INVOLVED IN INNERVATION 9 3.37e-02 2.86e-01 0.50500 -5.01e-01 5.83e-02 9.22e-03 7.62e-01
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux 43 3.46e-07 4.25e-05 0.50500 -4.29e-01 2.66e-01 1.13e-06 2.56e-03
GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING 5 1.69e-01 5.70e-01 0.50400 1.83e-01 -4.70e-01 4.78e-01 6.88e-02
GOMF PROTEINASE ACTIVATED RECEPTOR ACTIVITY 5 1.79e-01 5.83e-01 0.50400 -4.19e-01 2.80e-01 1.05e-01 2.78e-01
Fructose catabolism 5 1.44e-01 5.36e-01 0.50300 1.79e-02 5.03e-01 9.45e-01 5.16e-02
GOBP IRON COORDINATION ENTITY TRANSPORT 11 2.27e-02 2.42e-01 0.50300 -2.66e-01 4.27e-01 1.27e-01 1.42e-02
GOBP REGULATION OF KIDNEY SIZE 5 1.78e-01 5.83e-01 0.50300 4.32e-01 -2.57e-01 9.42e-02 3.20e-01
Formation of the posterior neural plate 10 2.41e-02 2.49e-01 0.50300 -4.99e-01 6.39e-02 6.33e-03 7.26e-01
GOMF FATTY ACID OMEGA HYDROXYLASE ACTIVITY 7 9.26e-02 4.45e-01 0.50300 3.16e-01 -3.91e-01 1.48e-01 7.32e-02
GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING 9 2.59e-02 2.55e-01 0.50200 4.85e-01 1.30e-01 1.17e-02 5.00e-01
GOCC PHAGOCYTIC VESICLE LUMEN 5 1.84e-01 5.89e-01 0.50200 -3.40e-01 3.69e-01 1.88e-01 1.53e-01
GOMF DENEDDYLASE ACTIVITY 6 7.91e-02 4.19e-01 0.50200 -2.58e-01 -4.30e-01 2.73e-01 6.79e-02
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CONTRACTION 8 6.06e-02 3.73e-01 0.50100 -4.64e-01 1.90e-01 2.32e-02 3.51e-01
GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY 19 1.53e-03 4.48e-02 0.50100 -4.26e-01 2.64e-01 1.32e-03 4.60e-02
GOMF NEUROPEPTIDE Y RECEPTOR ACTIVITY 9 2.76e-02 2.63e-01 0.50100 -4.91e-01 -9.80e-02 1.07e-02 6.11e-01
GOBP REGULATION OF EATING BEHAVIOR 7 8.71e-02 4.36e-01 0.50100 -4.60e-01 1.99e-01 3.52e-02 3.63e-01
GOBP ASTROCYTE CELL MIGRATION 9 3.94e-02 3.06e-01 0.50100 -4.85e-01 1.26e-01 1.18e-02 5.12e-01
GOMF PYRIMIDINE NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY 7 5.09e-02 3.43e-01 0.50100 3.32e-01 3.75e-01 1.29e-01 8.58e-02
GOMF ALKANE 1 MONOOXYGENASE ACTIVITY 5 1.76e-01 5.81e-01 0.50000 2.01e-01 -4.58e-01 4.37e-01 7.61e-02
GOCC HEMIDESMOSOME 8 3.40e-02 2.86e-01 0.50000 4.00e-01 3.00e-01 5.01e-02 1.42e-01
Transport and synthesis of PAPS 6 7.85e-02 4.18e-01 0.50000 3.73e-01 3.33e-01 1.14e-01 1.58e-01
GOCC INTRACILIARY TRANSPORT PARTICLE A 8 6.13e-02 3.74e-01 0.49900 -4.66e-01 1.79e-01 2.25e-02 3.79e-01
Ethanol oxidation 12 1.36e-02 1.85e-01 0.49900 4.85e-01 -1.17e-01 3.61e-03 4.83e-01
GOBP GLUTAMINE TRANSPORT 9 4.40e-02 3.19e-01 0.49800 1.86e-01 -4.62e-01 3.34e-01 1.63e-02
SRP-dependent cotranslational protein targeting to membrane 105 2.11e-16 1.80e-13 0.49800 2.02e-01 -4.56e-01 3.40e-04 7.00e-16
Ribosomal scanning and start codon recognition 52 2.07e-08 3.53e-06 0.49800 2.31e-01 -4.41e-01 3.93e-03 3.69e-08
GOBP OLFACTORY NERVE DEVELOPMENT 6 1.08e-01 4.77e-01 0.49800 -3.78e-02 4.97e-01 8.73e-01 3.52e-02
GOBP MEIOTIC ATTACHMENT OF TELOMERE TO NUCLEAR ENVELOPE 5 1.78e-01 5.83e-01 0.49700 -4.62e-01 1.85e-01 7.39e-02 4.75e-01
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM 5 1.43e-01 5.35e-01 0.49700 -7.75e-02 -4.91e-01 7.64e-01 5.73e-02
GOBP MEMBRANOUS SEPTUM MORPHOGENESIS 8 5.16e-02 3.44e-01 0.49700 -4.96e-01 2.73e-02 1.51e-02 8.94e-01
GOBP GLYCINE BIOSYNTHETIC PROCESS 5 1.53e-01 5.49e-01 0.49600 4.96e-01 8.11e-03 5.50e-02 9.75e-01
GOBP CELLULAR RESPONSE TO TEMPERATURE STIMULUS 5 1.85e-01 5.89e-01 0.49500 -4.43e-01 2.21e-01 8.62e-02 3.92e-01
GOBP CORTICOTROPIN SECRETION 7 9.05e-02 4.42e-01 0.49500 -4.63e-01 1.74e-01 3.38e-02 4.26e-01
GOBP PROTEIN UFMYLATION 6 8.68e-02 4.36e-01 0.49400 -2.28e-01 -4.39e-01 3.34e-01 6.27e-02
GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY 9 2.44e-02 2.51e-01 0.49400 4.01e-01 2.89e-01 3.72e-02 1.34e-01
GOBP EQUILIBRIOCEPTION 8 6.13e-02 3.74e-01 0.49400 4.76e-01 -1.31e-01 1.96e-02 5.20e-01
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation 35 9.77e-06 8.08e-04 0.49400 2.87e-01 -4.02e-01 3.33e-03 3.79e-05
GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C 12 1.19e-02 1.72e-01 0.49400 8.67e-03 -4.94e-01 9.59e-01 3.05e-03
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS 5 1.82e-01 5.86e-01 0.49400 4.59e-01 -1.83e-01 7.57e-02 4.79e-01
GOCC PARASPECKLES 8 4.91e-02 3.35e-01 0.49400 -3.48e-02 -4.93e-01 8.65e-01 1.58e-02
GOBP REGULATION OF NEUTROPHIL EXTRAVASATION 5 1.31e-01 5.16e-01 0.49400 4.35e-01 2.34e-01 9.23e-02 3.66e-01
GOBP MICROGLIAL CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 5 1.26e-01 5.09e-01 0.49300 -3.36e-01 -3.62e-01 1.93e-01 1.62e-01
GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY 9 4.69e-02 3.28e-01 0.49300 -1.83e-01 4.58e-01 3.41e-01 1.73e-02
GOBP HYPOTHALAMUS DEVELOPMENT 26 4.41e-05 2.91e-03 0.49300 -4.84e-01 -9.43e-02 1.94e-05 4.05e-01
GOBP GALACTOSE CATABOLIC PROCESS VIA UDP GALACTOSE 5 1.33e-01 5.21e-01 0.49300 2.12e-01 4.45e-01 4.12e-01 8.48e-02
Translation initiation complex formation 52 3.13e-08 5.05e-06 0.49200 2.31e-01 -4.35e-01 3.97e-03 5.72e-08
Erythrocytes take up oxygen and release carbon dioxide 8 7.39e-02 4.07e-01 0.49200 3.77e-01 -3.16e-01 6.45e-02 1.22e-01
GOBP REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY 11 2.71e-02 2.61e-01 0.49200 -2.75e-01 4.08e-01 1.15e-01 1.91e-02
GOBP REGULATION OF ARTERY MORPHOGENESIS 13 1.11e-02 1.64e-01 0.49200 4.75e-01 -1.27e-01 3.00e-03 4.27e-01
GOBP CENTRAL NERVOUS SYSTEM MYELIN MAINTENANCE 5 1.97e-01 6.09e-01 0.49200 -3.46e-01 3.50e-01 1.80e-01 1.76e-01
GOBP NEGATIVE REGULATION OF GLUCOCORTICOID METABOLIC PROCESS 5 1.81e-01 5.84e-01 0.49200 4.68e-01 -1.52e-01 7.01e-02 5.57e-01
GOBP MEIOTIC METAPHASE CHROMOSOME ALIGNMENT 5 1.43e-01 5.35e-01 0.49200 -1.24e-01 -4.76e-01 6.30e-01 6.54e-02
GOBP DORSAL ROOT GANGLION DEVELOPMENT 7 7.67e-02 4.14e-01 0.49100 -4.91e-01 1.22e-03 2.44e-02 9.96e-01
GOBP POSITIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION 5 1.38e-01 5.28e-01 0.49100 -1.79e-01 -4.57e-01 4.89e-01 7.67e-02
GOBP CARDIAC PACEMAKER CELL DIFFERENTIATION 10 2.66e-02 2.59e-01 0.49100 -4.90e-01 1.84e-02 7.26e-03 9.20e-01
Orexin and neuropeptides FF and QRFP bind to their respective receptors 8 7.59e-02 4.12e-01 0.49000 -3.39e-01 3.54e-01 9.68e-02 8.31e-02
Signaling by MST1 5 1.46e-01 5.40e-01 0.49000 4.75e-01 1.17e-01 6.56e-02 6.50e-01
Glucocorticoid biosynthesis 10 3.72e-02 2.96e-01 0.49000 4.32e-01 -2.30e-01 1.79e-02 2.08e-01
GOMF SPHINGOMYELIN PHOSPHODIESTERASE ACTIVITY 7 5.98e-02 3.71e-01 0.49000 2.52e-01 4.20e-01 2.48e-01 5.45e-02
GOMF GANGLIOSIDE BINDING 5 1.98e-01 6.11e-01 0.48900 -2.86e-01 3.97e-01 2.68e-01 1.24e-01
GOBP RESPONSE TO FOLIC ACID 9 2.60e-02 2.56e-01 0.48900 -3.06e-01 -3.81e-01 1.11e-01 4.76e-02
GOCC PLATELET DENSE TUBULAR NETWORK 11 2.81e-02 2.66e-01 0.48900 -4.13e-01 2.62e-01 1.78e-02 1.32e-01
Defective binding of VWF variant to GPIb:IX:V 7 9.84e-02 4.58e-01 0.48900 -4.46e-01 2.01e-01 4.12e-02 3.57e-01
Enhanced binding of GP1BA variant to VWF multimer:collagen 7 9.84e-02 4.58e-01 0.48900 -4.46e-01 2.01e-01 4.12e-02 3.57e-01
Removal of aminoterminal propeptides from gamma-carboxylated proteins 8 5.01e-02 3.40e-01 0.48800 6.59e-02 4.84e-01 7.47e-01 1.78e-02
GOMF UREA TRANSMEMBRANE TRANSPORTER ACTIVITY 7 6.08e-02 3.73e-01 0.48800 4.17e-01 2.53e-01 5.60e-02 2.46e-01
GOBP METANEPHRIC COLLECTING DUCT DEVELOPMENT 10 3.98e-02 3.06e-01 0.48800 -2.74e-01 4.03e-01 1.33e-01 2.72e-02
GOBP APOPTOTIC PROCESS INVOLVED IN HEART MORPHOGENESIS 7 6.62e-02 3.88e-01 0.48800 -4.62e-01 -1.57e-01 3.43e-02 4.71e-01
GOBP BASEMENT MEMBRANE ASSEMBLY 9 5.37e-02 3.51e-01 0.48700 -4.25e-01 2.38e-01 2.72e-02 2.16e-01
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S 53 3.08e-08 5.04e-06 0.48700 2.18e-01 -4.36e-01 6.13e-03 4.03e-08
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE 7 8.88e-02 4.38e-01 0.48700 8.37e-02 -4.79e-01 7.01e-01 2.80e-02
GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING 13 1.57e-02 1.99e-01 0.48700 -2.85e-01 3.94e-01 7.53e-02 1.38e-02
GOBP PROTEIN UNFOLDING 5 2.01e-01 6.15e-01 0.48700 2.72e-01 -4.03e-01 2.91e-01 1.19e-01
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation 10 2.45e-02 2.51e-01 0.48700 -4.82e-01 -6.38e-02 8.26e-03 7.27e-01
Passive transport by Aquaporins 13 5.73e-03 1.08e-01 0.48600 4.14e-01 2.55e-01 9.72e-03 1.12e-01
GOMF 7SK SNRNA BINDING 9 3.43e-02 2.87e-01 0.48600 -8.93e-02 -4.78e-01 6.43e-01 1.30e-02
GOBP REGULATION OF ADHERENS JUNCTION ORGANIZATION 5 2.00e-01 6.13e-01 0.48600 -2.52e-01 4.16e-01 3.29e-01 1.07e-01
GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY 8 7.93e-02 4.19e-01 0.48600 -3.40e-01 3.48e-01 9.62e-02 8.87e-02
GOBP NEURAL CREST CELL MIGRATION INVOLVED IN AUTONOMIC NERVOUS SYSTEM DEVELOPMENT 6 1.03e-01 4.69e-01 0.48600 -4.72e-01 -1.17e-01 4.55e-02 6.20e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR 7 7.68e-02 4.14e-01 0.48600 4.54e-02 4.84e-01 8.35e-01 2.67e-02
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells 5 1.35e-01 5.23e-01 0.48600 -3.56e-01 -3.31e-01 1.68e-01 2.01e-01
GOCC SIGNAL RECOGNITION PARTICLE 8 5.56e-02 3.59e-01 0.48500 -1.68e-02 -4.85e-01 9.34e-01 1.75e-02
GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING 9 2.88e-02 2.68e-01 0.48400 4.10e-01 2.58e-01 3.33e-02 1.80e-01
GOBP GLYCOSYLCERAMIDE CATABOLIC PROCESS 10 3.61e-02 2.93e-01 0.48400 -1.46e-01 4.62e-01 4.23e-01 1.15e-02
GOMF INTERLEUKIN 2 RECEPTOR BINDING 5 1.51e-01 5.46e-01 0.48400 1.32e-01 4.66e-01 6.10e-01 7.13e-02
GOBP CELLULAR GLUCURONIDATION 19 2.47e-03 6.31e-02 0.48400 3.88e-01 -2.89e-01 3.40e-03 2.91e-02
GOBP REGULATION OF CELL PROLIFERATION IN BONE MARROW 8 4.34e-02 3.17e-01 0.48400 -4.18e-01 -2.43e-01 4.06e-02 2.34e-01
GOBP RESPONSE TO FUNGICIDE 7 1.02e-01 4.67e-01 0.48400 -1.90e-01 4.45e-01 3.84e-01 4.16e-02
Cap-dependent Translation Initiation 110 3.36e-16 2.17e-13 0.48400 1.92e-01 -4.44e-01 4.90e-04 8.75e-16
Eukaryotic Translation Initiation 110 3.36e-16 2.17e-13 0.48400 1.92e-01 -4.44e-01 4.90e-04 8.75e-16
GOBP PHARYNGEAL ARCH ARTERY MORPHOGENESIS 10 2.81e-02 2.66e-01 0.48300 -4.83e-01 -1.08e-02 8.14e-03 9.53e-01
Respiratory syncytial virus (RSV) genome replication, transcription and translation 16 5.58e-03 1.06e-01 0.48300 1.95e-01 -4.42e-01 1.78e-01 2.18e-03
GOBP NEGATIVE REGULATION OF MYOBLAST PROLIFERATION 9 5.89e-02 3.69e-01 0.48300 -3.84e-01 2.93e-01 4.59e-02 1.28e-01
TRAIL signaling 8 6.12e-02 3.74e-01 0.48300 4.82e-01 -2.82e-02 1.83e-02 8.90e-01
GOBP CELLULAR RESPONSE TO NICOTINE 9 4.45e-02 3.21e-01 0.48300 4.80e-01 -4.72e-02 1.26e-02 8.06e-01
GOMF NEUROPEPTIDE ACTIVITY 29 5.32e-05 3.46e-03 0.48200 -4.75e-01 8.36e-02 9.48e-06 4.36e-01
Diseases of Base Excision Repair 5 1.39e-01 5.31e-01 0.48200 3.77e-01 3.00e-01 1.44e-01 2.45e-01
GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III 12 1.36e-02 1.86e-01 0.48200 -2.78e-02 -4.81e-01 8.67e-01 3.90e-03
GOBP ISOLEUCINE TRANSPORT 5 2.10e-01 6.27e-01 0.48200 -3.27e-01 3.54e-01 2.05e-01 1.71e-01
GOBP NOREPINEPHRINE BIOSYNTHETIC PROCESS 8 4.35e-02 3.17e-01 0.48200 3.94e-01 2.77e-01 5.34e-02 1.75e-01
Synthesis of PIPs at the late endosome membrane 10 2.70e-02 2.60e-01 0.48200 -4.79e-01 -4.83e-02 8.67e-03 7.92e-01
Signaling by membrane-tethered fusions of PDGFRA or PDGFRB 5 2.02e-01 6.17e-01 0.48200 -4.31e-01 2.15e-01 9.52e-02 4.05e-01
GOBP RESPONSE TO EPINEPHRINE 14 1.08e-02 1.62e-01 0.48200 -4.45e-01 1.85e-01 3.96e-03 2.32e-01
GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY 7 6.55e-02 3.85e-01 0.48000 3.97e-01 2.70e-01 6.86e-02 2.16e-01
GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY 23 1.73e-04 8.88e-03 0.48000 -4.53e-01 -1.60e-01 1.68e-04 1.85e-01
GOBP NEGATIVE REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION 5 1.53e-01 5.48e-01 0.48000 -1.53e-01 -4.56e-01 5.55e-01 7.77e-02
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II 5 2.12e-01 6.28e-01 0.48000 2.97e-01 -3.77e-01 2.50e-01 1.44e-01
Beta defensins 26 2.83e-04 1.26e-02 0.48000 2.40e-01 -4.16e-01 3.45e-02 2.43e-04
Defective CSF2RA causes SMDP4 7 6.79e-02 3.93e-01 0.47900 2.30e-01 4.21e-01 2.92e-01 5.40e-02
Defective CSF2RB causes SMDP5 7 6.79e-02 3.93e-01 0.47900 2.30e-01 4.21e-01 2.92e-01 5.40e-02
GOBP SPHINGOMYELIN CATABOLIC PROCESS 8 4.75e-02 3.30e-01 0.47900 2.04e-01 4.34e-01 3.18e-01 3.37e-02
GOCC PRESYNAPTIC ENDOCYTIC ZONE 9 6.23e-02 3.77e-01 0.47900 -3.69e-01 3.05e-01 5.51e-02 1.13e-01
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production 5 1.54e-01 5.50e-01 0.47900 -4.52e-01 -1.58e-01 8.01e-02 5.40e-01
GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS 14 1.15e-02 1.67e-01 0.47900 4.42e-01 -1.84e-01 4.20e-03 2.33e-01
GOBP CAVEOLA ASSEMBLY 6 1.28e-01 5.12e-01 0.47900 -4.77e-01 3.64e-02 4.29e-02 8.77e-01
GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY 21 8.72e-04 2.94e-02 0.47800 4.73e-01 -7.29e-02 1.76e-04 5.63e-01
GOBP HEME TRANSPORT 8 8.57e-02 4.33e-01 0.47800 -3.22e-01 3.54e-01 1.15e-01 8.33e-02
GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY 8 8.57e-02 4.33e-01 0.47800 -3.22e-01 3.54e-01 1.15e-01 8.33e-02
GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY 5 1.60e-01 5.57e-01 0.47800 -1.17e-01 -4.64e-01 6.51e-01 7.26e-02
GOBP INTRACELLULAR PH ELEVATION 7 6.79e-02 3.93e-01 0.47800 2.56e-01 4.03e-01 2.40e-01 6.46e-02
GOCC MYELIN SHEATH ABAXONAL REGION 6 1.59e-01 5.57e-01 0.47700 -3.66e-01 3.07e-01 1.21e-01 1.93e-01
GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE 11 2.62e-02 2.57e-01 0.47700 9.26e-02 -4.68e-01 5.95e-01 7.15e-03
GOBP INDOLE CONTAINING COMPOUND CATABOLIC PROCESS 9 4.65e-02 3.28e-01 0.47700 4.76e-01 -3.21e-02 1.34e-02 8.68e-01
GOBP KERATINIZATION 77 1.48e-12 4.77e-10 0.47700 4.75e-01 4.89e-02 5.79e-13 4.58e-01
GOBP POSITIVE REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION 5 1.53e-01 5.48e-01 0.47600 -4.33e-01 -2.00e-01 9.39e-02 4.39e-01
GOMF ACTIVIN RECEPTOR ACTIVITY TYPE I 5 2.17e-01 6.35e-01 0.47600 -3.75e-01 2.93e-01 1.46e-01 2.56e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR 14 1.41e-02 1.89e-01 0.47600 -3.41e-01 3.32e-01 2.70e-02 3.15e-02
GOBP POSITIVE REGULATION OF INTERLEUKIN 23 PRODUCTION 7 6.93e-02 3.96e-01 0.47600 4.02e-01 2.55e-01 6.53e-02 2.43e-01
GOCC POSTSYNAPTIC ENDOCYTIC ZONE 5 1.79e-01 5.83e-01 0.47600 -4.76e-01 -1.21e-03 6.54e-02 9.96e-01
GOMF DIPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 5 2.10e-01 6.26e-01 0.47600 -4.28e-01 2.08e-01 9.76e-02 4.20e-01
GOBP REGULATION OF CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION 8 5.95e-02 3.70e-01 0.47500 -4.72e-01 -5.31e-02 2.07e-02 7.95e-01
GOBP NEGATIVE REGULATION OF GONADOTROPIN SECRETION 8 4.80e-02 3.31e-01 0.47500 -4.04e-01 -2.50e-01 4.76e-02 2.21e-01
GOMF STEROL ESTERASE ACTIVITY 7 1.18e-01 4.94e-01 0.47500 -3.85e-01 2.79e-01 7.77e-02 2.02e-01
GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING 8 8.84e-02 4.37e-01 0.47500 -3.56e-01 3.14e-01 8.08e-02 1.24e-01
Defective C1GALT1C1 causes TNPS 18 1.74e-03 4.89e-02 0.47500 4.72e-01 5.85e-02 5.33e-04 6.68e-01
GOBP CONVERGENT EXTENSION INVOLVED IN AXIS ELONGATION 5 2.06e-01 6.21e-01 0.47500 4.43e-01 -1.71e-01 8.60e-02 5.08e-01
GOBP REGULATION OF NAD P H OXIDASE ACTIVITY 5 1.90e-01 5.96e-01 0.47400 -5.92e-02 4.71e-01 8.19e-01 6.83e-02
GOBP POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS 5 2.21e-01 6.39e-01 0.47400 -3.39e-01 3.32e-01 1.89e-01 1.99e-01
GOBP POSITIVE REGULATION OF CELL FATE COMMITMENT 17 4.29e-03 9.05e-02 0.47400 -4.56e-01 1.28e-01 1.12e-03 3.61e-01
GOBP REGULATION OF SERINE TYPE PEPTIDASE ACTIVITY 6 1.64e-01 5.63e-01 0.47400 3.54e-01 -3.15e-01 1.34e-01 1.81e-01
GOCC INTRACELLULAR CYCLIC NUCLEOTIDE ACTIVATED CATION CHANNEL COMPLEX 5 1.52e-01 5.47e-01 0.47400 2.44e-01 4.06e-01 3.44e-01 1.16e-01
GOMF NITRITE REDUCTASE ACTIVITY 7 8.80e-02 4.37e-01 0.47400 -4.73e-01 -3.43e-02 3.03e-02 8.75e-01
Diseases associated with surfactant metabolism 9 3.28e-02 2.83e-01 0.47300 2.95e-01 3.70e-01 1.26e-01 5.43e-02
GOBP NEGATIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT 5 2.18e-01 6.37e-01 0.47300 -4.02e-01 2.49e-01 1.19e-01 3.35e-01
TGFBR3 expression 28 1.67e-04 8.71e-03 0.47300 -4.34e-01 1.88e-01 7.07e-05 8.50e-02
GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION 5 1.86e-01 5.92e-01 0.47300 -2.22e-02 4.72e-01 9.32e-01 6.75e-02
GOBP RESPONSE TO GRAM POSITIVE BACTERIUM 6 1.04e-01 4.70e-01 0.47300 -2.68e-01 -3.89e-01 2.55e-01 9.88e-02
GOBP MONOCYTE EXTRAVASATION 11 3.05e-02 2.74e-01 0.47300 -1.38e-01 4.52e-01 4.28e-01 9.42e-03
GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL 7 1.22e-01 5.00e-01 0.47300 -2.90e-01 3.73e-01 1.84e-01 8.74e-02
Modulation by Mtb of host immune system 6 1.65e-01 5.65e-01 0.47200 2.85e-01 -3.76e-01 2.26e-01 1.11e-01
GOBP PEPTIDYL LYSINE OXIDATION 5 2.22e-01 6.39e-01 0.47100 -2.62e-01 3.92e-01 3.11e-01 1.29e-01
GOMF PROTEIN LYSINE 6 OXIDASE ACTIVITY 5 2.22e-01 6.39e-01 0.47100 -2.62e-01 3.92e-01 3.11e-01 1.29e-01
GOBP BRUSH BORDER ASSEMBLY 8 6.04e-02 3.73e-01 0.47100 4.64e-01 8.05e-02 2.30e-02 6.93e-01
GOBP VITAMIN E METABOLIC PROCESS 6 1.66e-01 5.66e-01 0.47100 -2.81e-01 3.78e-01 2.33e-01 1.09e-01
GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY 6 1.67e-01 5.68e-01 0.47100 3.00e-01 -3.63e-01 2.04e-01 1.23e-01
GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY 5 2.15e-01 6.33e-01 0.47100 1.95e-01 -4.28e-01 4.49e-01 9.72e-02
GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 9 6.72e-02 3.91e-01 0.47100 -3.91e-01 2.62e-01 4.23e-02 1.74e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 7 1.24e-01 5.04e-01 0.47000 2.77e-01 -3.80e-01 2.05e-01 8.18e-02
GOBP CELL PROLIFERATION IN HINDBRAIN 14 1.56e-02 1.99e-01 0.47000 -3.70e-01 2.90e-01 1.65e-02 6.06e-02
GOBP NECROPTOTIC SIGNALING PATHWAY 8 9.01e-02 4.41e-01 0.47000 2.38e-01 -4.05e-01 2.43e-01 4.75e-02
GOBP CYTOSOL TO ENDOPLASMIC RETICULUM TRANSPORT 5 2.28e-01 6.46e-01 0.46900 -3.14e-01 3.49e-01 2.24e-01 1.76e-01
GOBP FUCOSE CATABOLIC PROCESS 9 3.72e-02 2.96e-01 0.46900 4.23e-01 2.04e-01 2.81e-02 2.89e-01
GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION 17 6.56e-03 1.18e-01 0.46900 -3.64e-01 2.95e-01 9.30e-03 3.51e-02
GOBP ION CHANNEL MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 8 5.14e-02 3.44e-01 0.46900 3.84e-01 2.69e-01 6.02e-02 1.87e-01
GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION 11 3.67e-02 2.95e-01 0.46800 -4.10e-01 2.26e-01 1.84e-02 1.95e-01
Uptake of dietary cobalamins into enterocytes 9 4.11e-02 3.09e-01 0.46800 1.36e-01 4.48e-01 4.79e-01 2.00e-02
GOBP FOREBRAIN VENTRICULAR ZONE PROGENITOR CELL DIVISION 6 1.40e-01 5.31e-01 0.46800 -4.67e-01 3.04e-02 4.77e-02 8.97e-01
GOBP RETROGRADE TRANS SYNAPTIC SIGNALING BY LIPID 5 1.69e-01 5.70e-01 0.46800 4.43e-01 1.49e-01 8.62e-02 5.63e-01
GOBP INTERKINETIC NUCLEAR MIGRATION 5 1.57e-01 5.53e-01 0.46800 -3.64e-01 -2.94e-01 1.59e-01 2.55e-01
GOBP NEGATIVE REGULATION OF CELL KILLING 28 2.11e-04 1.03e-02 0.46700 4.27e-01 -1.88e-01 9.07e-05 8.58e-02
GOCC SPERM ANNULUS 5 2.15e-01 6.33e-01 0.46700 -4.41e-01 1.52e-01 8.76e-02 5.56e-01
GOMF ANGIOTENSIN RECEPTOR BINDING 9 7.26e-02 4.04e-01 0.46600 -3.21e-01 3.38e-01 9.51e-02 7.95e-02
GOBP REGULATION OF DEFENSE RESPONSE TO FUNGUS 5 2.02e-01 6.16e-01 0.46600 -4.62e-01 6.15e-02 7.37e-02 8.12e-01
GOBP AMMONIUM HOMEOSTASIS 5 2.27e-01 6.45e-01 0.46600 4.07e-01 -2.26e-01 1.15e-01 3.81e-01
GOBP RESPONSE TO HISTAMINE 10 3.85e-02 3.02e-01 0.46600 -4.65e-01 2.23e-02 1.09e-02 9.03e-01
GOBP CARDIAC FIBROBLAST CELL DIFFERENTIATION 5 1.67e-01 5.68e-01 0.46400 -2.02e-01 -4.18e-01 4.34e-01 1.06e-01
GOCC INTERCHROMATIN GRANULE 5 2.35e-01 6.52e-01 0.46400 3.03e-01 -3.52e-01 2.41e-01 1.73e-01
GOMF CCR5 CHEMOKINE RECEPTOR BINDING 7 1.02e-01 4.67e-01 0.46400 7.69e-03 -4.64e-01 9.72e-01 3.36e-02
GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT 9 7.44e-02 4.09e-01 0.46400 -3.21e-01 3.34e-01 9.49e-02 8.24e-02
GOCC DEUTEROSOME 6 1.42e-01 5.33e-01 0.46300 1.43e-03 -4.63e-01 9.95e-01 4.96e-02
GOBP EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS 17 2.34e-03 6.10e-02 0.46300 -4.14e-01 -2.08e-01 3.14e-03 1.38e-01
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling 11 3.64e-02 2.94e-01 0.46200 1.53e-01 -4.36e-01 3.80e-01 1.22e-02
GOBP CORTISOL BIOSYNTHETIC PROCESS 10 2.77e-02 2.64e-01 0.46200 3.98e-01 2.35e-01 2.91e-02 1.99e-01
GOBP PUTRESCINE METABOLIC PROCESS 7 8.47e-02 4.32e-01 0.46200 4.25e-01 1.81e-01 5.14e-02 4.06e-01
GOBP DNA INTEGRATION 8 7.57e-02 4.12e-01 0.46200 -4.62e-01 1.38e-02 2.36e-02 9.46e-01
GOMF TYPE 1 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING 5 2.38e-01 6.55e-01 0.46200 -3.51e-01 3.00e-01 1.74e-01 2.45e-01
GOBP SMOOTH MUSCLE ADAPTATION 5 2.25e-01 6.43e-01 0.46100 4.30e-01 -1.67e-01 9.57e-02 5.19e-01
GOMF NADH DEHYDROGENASE ACTIVITY 8 8.54e-02 4.33e-01 0.46100 -4.50e-01 9.97e-02 2.74e-02 6.25e-01
GOBP REGULATION OF AGGREPHAGY 7 8.03e-02 4.20e-01 0.46100 -2.95e-01 -3.54e-01 1.76e-01 1.05e-01
GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE 21 2.48e-03 6.31e-02 0.46100 -2.86e-01 3.61e-01 2.30e-02 4.20e-03
GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION 9 6.86e-02 3.95e-01 0.46100 1.61e-01 -4.32e-01 4.04e-01 2.49e-02
GOCC OMEGASOME 5 1.87e-01 5.93e-01 0.46000 -4.54e-01 -7.82e-02 7.89e-02 7.62e-01
GOBP MUCOCILIARY CLEARANCE 8 1.01e-01 4.65e-01 0.46000 2.70e-01 -3.73e-01 1.86e-01 6.78e-02
GOMF TRACE AMINE RECEPTOR ACTIVITY 7 8.39e-02 4.31e-01 0.46000 2.22e-01 4.03e-01 3.08e-01 6.49e-02
NFE2L2 regulating MDR associated enzymes 8 9.77e-02 4.56e-01 0.46000 -2.15e-01 4.07e-01 2.93e-01 4.62e-02
PDH complex synthesizes acetyl-CoA from PYR 5 1.77e-01 5.81e-01 0.46000 1.63e-01 4.30e-01 5.29e-01 9.56e-02
GOMF PYRUVATE DEHYDROGENASE ACTIVITY 5 1.77e-01 5.81e-01 0.46000 1.63e-01 4.30e-01 5.29e-01 9.56e-02
GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY 13 1.36e-02 1.85e-01 0.46000 5.64e-02 4.57e-01 7.25e-01 4.37e-03
GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION 10 5.52e-02 3.58e-01 0.46000 -2.21e-01 4.03e-01 2.27e-01 2.72e-02
GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT 9 6.50e-02 3.83e-01 0.46000 -4.46e-01 1.10e-01 2.04e-02 5.68e-01
GOBP PROTEIN INSERTION INTO MEMBRANE FROM INNER SIDE 5 1.92e-01 6.00e-01 0.46000 -5.30e-02 -4.56e-01 8.37e-01 7.71e-02
GOCC THO COMPLEX 5 1.84e-01 5.89e-01 0.46000 -1.10e-01 -4.46e-01 6.69e-01 8.41e-02
GOMF VINCULIN BINDING 11 3.99e-02 3.06e-01 0.45900 -4.20e-01 1.86e-01 1.59e-02 2.85e-01
GOBP MYCOTOXIN METABOLIC PROCESS 7 1.19e-01 4.95e-01 0.45900 -1.04e-01 4.48e-01 6.35e-01 4.03e-02
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus 7 1.03e-01 4.69e-01 0.45900 2.27e-02 4.59e-01 9.17e-01 3.56e-02
GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION 6 1.45e-01 5.38e-01 0.45900 -4.59e-01 -6.39e-03 5.14e-02 9.78e-01
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS 8 1.03e-01 4.69e-01 0.45900 3.62e-01 -2.83e-01 7.62e-02 1.66e-01
Defective GALNT12 causes CRCS1 18 2.79e-03 6.92e-02 0.45900 4.57e-01 4.32e-02 7.96e-04 7.51e-01
GOBP CARDIAC MUSCLE CELL FATE COMMITMENT 8 6.86e-02 3.95e-01 0.45900 -4.49e-01 -9.51e-02 2.80e-02 6.41e-01
GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX 5 2.11e-01 6.28e-01 0.45800 5.31e-02 -4.55e-01 8.37e-01 7.78e-02
GOCC TRANSLATION PREINITIATION COMPLEX 16 4.13e-03 8.91e-02 0.45800 -1.53e-01 -4.32e-01 2.89e-01 2.77e-03
ChREBP activates metabolic gene expression 8 8.58e-02 4.33e-01 0.45800 -4.52e-01 7.58e-02 2.69e-02 7.10e-01
GOBP NEGATIVE REGULATION OF ASTROCYTE ACTIVATION 5 1.77e-01 5.83e-01 0.45800 -4.20e-01 -1.83e-01 1.04e-01 4.79e-01
GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 7 1.16e-01 4.90e-01 0.45800 -6.75e-02 4.53e-01 7.57e-01 3.81e-02
GOCC EXTRINSIC COMPONENT OF PRESYNAPTIC MEMBRANE 6 1.85e-01 5.89e-01 0.45700 -3.52e-01 2.92e-01 1.35e-01 2.15e-01
GOCC STEREOCILIUM BASE 8 6.28e-02 3.77e-01 0.45700 4.16e-01 1.89e-01 4.15e-02 3.54e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 11 4.23e-02 3.14e-01 0.45700 4.08e-01 -2.07e-01 1.93e-02 2.34e-01
GOBP KETONE BODY BIOSYNTHETIC PROCESS 6 1.25e-01 5.05e-01 0.45700 1.99e-01 4.11e-01 3.98e-01 8.11e-02
GOBP POSITIVE REGULATION OF NEUROEPITHELIAL CELL DIFFERENTIATION 8 1.06e-01 4.74e-01 0.45700 -3.34e-01 3.11e-01 1.01e-01 1.27e-01
GOBP ANTRAL OVARIAN FOLLICLE GROWTH 12 3.34e-02 2.85e-01 0.45700 -3.84e-01 2.48e-01 2.14e-02 1.37e-01
GOBP MRNA METHYLGUANOSINE CAP DECAPPING 16 3.45e-03 8.03e-02 0.45700 -3.26e-01 -3.20e-01 2.40e-02 2.67e-02
GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION 5 2.31e-01 6.49e-01 0.45700 -4.29e-01 1.56e-01 9.66e-02 5.45e-01
GOCC MEIOTIC COHESIN COMPLEX 6 1.21e-01 4.98e-01 0.45600 -2.71e-01 -3.67e-01 2.50e-01 1.19e-01
GOBP PROTEIN DENEDDYLATION 11 2.15e-02 2.34e-01 0.45600 -3.93e-01 -2.32e-01 2.40e-02 1.83e-01
GOBP DIRECT OSSIFICATION 7 1.33e-01 5.20e-01 0.45600 -1.88e-01 4.16e-01 3.89e-01 5.69e-02
GOBP POSITIVE REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT 8 9.14e-02 4.44e-01 0.45600 -4.43e-01 1.07e-01 3.00e-02 5.99e-01
GOBP MATURE CONVENTIONAL DENDRITIC CELL DIFFERENTIATION 5 2.09e-01 6.26e-01 0.45600 4.55e-01 -2.03e-02 7.78e-02 9.37e-01
GOBP POSITIVE REGULATION OF SULFUR METABOLIC PROCESS 5 2.19e-01 6.37e-01 0.45500 -4.50e-01 6.72e-02 8.13e-02 7.95e-01
Eicosanoids 12 3.56e-02 2.90e-01 0.45500 2.98e-01 -3.44e-01 7.41e-02 3.91e-02
GOMF MELANOCORTIN RECEPTOR BINDING 5 2.17e-01 6.35e-01 0.45500 -5.28e-02 4.52e-01 8.38e-01 8.03e-02
GOBP TAURINE METABOLIC PROCESS 9 4.25e-02 3.14e-01 0.45500 -3.41e-01 -3.01e-01 7.63e-02 1.18e-01
GOBP RESPONSE TO GONADOTROPIN RELEASING HORMONE 6 1.89e-01 5.95e-01 0.45400 -3.55e-01 2.84e-01 1.32e-01 2.29e-01
GOCC NUCLEAR PORE OUTER RING 10 4.19e-02 3.12e-01 0.45400 -2.35e-02 -4.54e-01 8.98e-01 1.30e-02
GOBP COMPARTMENT PATTERN SPECIFICATION 5 1.75e-01 5.80e-01 0.45400 2.69e-01 3.65e-01 2.97e-01 1.57e-01
GOBP OMEGA HYDROXYLASE P450 PATHWAY 11 3.72e-02 2.96e-01 0.45400 8.74e-02 -4.45e-01 6.16e-01 1.06e-02
GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY 8 1.09e-01 4.79e-01 0.45400 -3.56e-01 2.81e-01 8.12e-02 1.68e-01
GOBP CELLULAR HYPOTONIC RESPONSE 11 3.22e-02 2.81e-01 0.45400 4.54e-01 -3.19e-03 9.19e-03 9.85e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 18 PRODUCTION 5 2.34e-01 6.50e-01 0.45300 -4.31e-01 1.41e-01 9.53e-02 5.84e-01
GOBP DIACYLGLYCEROL CATABOLIC PROCESS 5 2.30e-01 6.48e-01 0.45300 -1.18e-01 4.38e-01 6.46e-01 9.02e-02
Condensation of Prometaphase Chromosomes 11 4.10e-02 3.09e-01 0.45300 1.43e-01 -4.30e-01 4.13e-01 1.35e-02
GOCC TOM COMPLEX 7 1.44e-01 5.36e-01 0.45300 2.56e-01 -3.73e-01 2.40e-01 8.74e-02
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR 33 1.16e-04 6.76e-03 0.45300 3.22e-01 -3.18e-01 1.37e-03 1.56e-03
GOBP REGULATION OF LUTEINIZING HORMONE SECRETION 7 1.24e-01 5.04e-01 0.45200 -4.45e-01 7.97e-02 4.15e-02 7.15e-01
GOBP POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY 10 3.12e-02 2.76e-01 0.45200 -2.94e-01 -3.43e-01 1.08e-01 6.00e-02
GOBP POSITIVE REGULATION OF RECEPTOR BINDING 5 1.79e-01 5.83e-01 0.45200 -3.73e-01 -2.55e-01 1.48e-01 3.24e-01
GOBP OVIDUCT DEVELOPMENT 6 1.82e-01 5.86e-01 0.45100 -4.16e-01 1.75e-01 7.75e-02 4.59e-01
GOBP NEGATIVE REGULATION OF CELL MATURATION 8 1.03e-01 4.68e-01 0.45100 -1.66e-01 4.20e-01 4.16e-01 3.99e-02
GOBP COP9 SIGNALOSOME ASSEMBLY 5 2.28e-01 6.47e-01 0.45100 -4.42e-01 8.78e-02 8.67e-02 7.34e-01
Fibronectin matrix formation 6 1.39e-01 5.29e-01 0.45100 -4.32e-01 -1.29e-01 6.67e-02 5.85e-01
GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY 11 4.26e-02 3.14e-01 0.45100 -4.27e-01 1.44e-01 1.42e-02 4.07e-01
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) 107 1.39e-13 5.70e-11 0.45100 2.21e-01 -3.92e-01 7.70e-05 2.24e-12
Nonsense-Mediated Decay (NMD) 107 1.39e-13 5.70e-11 0.45100 2.21e-01 -3.92e-01 7.70e-05 2.24e-12
GOBP HYPOTHALAMUS CELL DIFFERENTIATION 12 1.79e-02 2.12e-01 0.45000 -4.11e-01 -1.83e-01 1.36e-02 2.71e-01
GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY 11 4.88e-02 3.35e-01 0.45000 2.52e-01 -3.73e-01 1.48e-01 3.21e-02
GOBP EPOXIDE METABOLIC PROCESS 5 2.35e-01 6.51e-01 0.45000 -1.17e-01 4.35e-01 6.50e-01 9.24e-02
GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY 12 2.58e-02 2.55e-01 0.45000 -1.95e-02 4.50e-01 9.07e-01 6.99e-03
GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY 9 7.53e-02 4.12e-01 0.45000 4.30e-01 -1.34e-01 2.56e-02 4.88e-01
GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY 5 2.43e-01 6.58e-01 0.45000 -4.18e-01 1.65e-01 1.05e-01 5.23e-01
GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY 6 1.92e-01 5.99e-01 0.45000 -3.83e-01 2.36e-01 1.05e-01 3.16e-01
GOBP ATRIAL SEPTUM MORPHOGENESIS 15 9.76e-03 1.51e-01 0.45000 -4.49e-01 -8.62e-03 2.58e-03 9.54e-01
GOMF CYCLOHYDROLASE ACTIVITY 5 2.23e-01 6.40e-01 0.44900 4.47e-01 -4.23e-02 8.32e-02 8.70e-01
GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY 5 1.81e-01 5.86e-01 0.44900 -2.72e-01 -3.58e-01 2.93e-01 1.66e-01
GOBP RESPONSE TO ACTINOMYCIN D 5 2.22e-01 6.39e-01 0.44900 3.03e-02 -4.48e-01 9.07e-01 8.30e-02
GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING 9 5.82e-02 3.66e-01 0.44900 -4.44e-01 -6.32e-02 2.10e-02 7.43e-01
GOCC DYSTROGLYCAN COMPLEX 7 1.51e-01 5.46e-01 0.44800 -3.14e-01 3.21e-01 1.51e-01 1.42e-01
GOMF ALPHA ADRENERGIC RECEPTOR ACTIVITY 6 1.29e-01 5.13e-01 0.44800 -3.16e-01 -3.18e-01 1.80e-01 1.77e-01
GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL 8 1.13e-01 4.86e-01 0.44800 -2.39e-01 3.79e-01 2.42e-01 6.34e-02
GOBP PROTEIN TARGETING TO PEROXISOME 9 4.81e-02 3.31e-01 0.44800 -2.38e-01 -3.80e-01 2.17e-01 4.86e-02
GOMF GABA A RECEPTOR ACTIVITY 16 5.20e-03 1.02e-01 0.44800 -4.18e-01 -1.61e-01 3.82e-03 2.65e-01
HDL assembly 8 1.14e-01 4.88e-01 0.44700 -3.73e-01 2.48e-01 6.80e-02 2.25e-01
GOBP POSITIVE REGULATION OF CELL PROLIFERATION IN BONE MARROW 6 1.54e-01 5.51e-01 0.44700 -4.45e-01 -4.41e-02 5.90e-02 8.51e-01
GOCC CORVET COMPLEX 7 1.46e-01 5.40e-01 0.44700 -3.97e-01 2.06e-01 6.91e-02 3.45e-01
GOBP POSITIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE 11 5.18e-02 3.45e-01 0.44700 -3.58e-01 2.67e-01 3.98e-02 1.25e-01
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 12 3.55e-02 2.90e-01 0.44600 -1.68e-01 4.14e-01 3.13e-01 1.31e-02
GOBP CELLULAR RESPONSE TO HYDROPEROXIDE 9 8.21e-02 4.25e-01 0.44600 4.13e-01 -1.69e-01 3.19e-02 3.81e-01
GOCC NF KAPPAB COMPLEX 5 2.63e-01 6.78e-01 0.44600 3.12e-01 -3.19e-01 2.27e-01 2.17e-01
GOBP GRANULOCYTE COLONY STIMULATING FACTOR SIGNALING PATHWAY 5 2.49e-01 6.64e-01 0.44600 4.15e-01 -1.63e-01 1.08e-01 5.27e-01
GOMF BETA 2 MICROGLOBULIN BINDING 9 9.10e-02 4.43e-01 0.44600 3.21e-01 -3.09e-01 9.53e-02 1.09e-01
GOCC MHC CLASS I PROTEIN COMPLEX 10 6.98e-02 3.97e-01 0.44500 3.18e-01 -3.11e-01 8.12e-02 8.81e-02
GOMF PYRUVATE TRANSMEMBRANE TRANSPORTER ACTIVITY 5 2.54e-01 6.69e-01 0.44500 4.03e-01 -1.91e-01 1.19e-01 4.60e-01
GOBP POSITIVE REGULATION OF METALLOPEPTIDASE ACTIVITY 8 1.09e-01 4.79e-01 0.44500 4.13e-01 -1.65e-01 4.29e-02 4.19e-01
GOBP LEUKOTRIENE B4 METABOLIC PROCESS 5 2.32e-01 6.50e-01 0.44500 5.80e-02 -4.41e-01 8.22e-01 8.74e-02
GOMF HISTONE H3K36 TRIMETHYLTRANSFERASE ACTIVITY 5 2.65e-01 6.79e-01 0.44500 -3.16e-01 3.13e-01 2.21e-01 2.26e-01
CDH11 homotypic and heterotypic interactions 7 1.48e-01 5.42e-01 0.44500 -4.00e-01 1.95e-01 6.70e-02 3.71e-01
GOBP EMBRYONIC BODY MORPHOGENESIS 11 3.98e-02 3.06e-01 0.44500 -4.42e-01 4.80e-02 1.11e-02 7.83e-01
GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING 6 1.96e-01 6.07e-01 0.44400 2.02e-01 -3.96e-01 3.92e-01 9.32e-02
GOBP PERICENTRIC HETEROCHROMATIN FORMATION 5 2.57e-01 6.72e-01 0.44400 3.97e-01 -2.00e-01 1.25e-01 4.39e-01
GOBP NEGATIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION 18 2.49e-03 6.31e-02 0.44400 -2.61e-01 -3.59e-01 5.54e-02 8.32e-03
Signaling by activated point mutants of FGFR1 11 5.45e-02 3.55e-01 0.44400 -3.32e-01 2.94e-01 5.64e-02 9.09e-02
GOBP LEUKOTRIENE D4 BIOSYNTHETIC PROCESS 6 1.36e-01 5.24e-01 0.44300 3.52e-01 2.70e-01 1.36e-01 2.52e-01
GOBP INTERNEURON MIGRATION 13 1.86e-02 2.17e-01 0.44300 -4.40e-01 -5.18e-02 6.02e-03 7.46e-01
GOCC CORNIFIED ENVELOPE 57 1.82e-08 3.18e-06 0.44300 4.32e-01 9.62e-02 1.62e-08 2.09e-01
GOMF DNA RNA HYBRID BINDING 5 2.09e-01 6.25e-01 0.44300 -4.31e-01 -1.00e-01 9.50e-02 6.98e-01
GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION 6 1.94e-01 6.03e-01 0.44300 -1.67e-01 4.10e-01 4.79e-01 8.21e-02
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION 11 5.57e-02 3.59e-01 0.44200 -3.03e-01 3.22e-01 8.18e-02 6.42e-02
GOBP REGULATION OF MYELOID DENDRITIC CELL ACTIVATION 5 2.08e-01 6.24e-01 0.44200 -1.10e-01 -4.28e-01 6.71e-01 9.72e-02
GOMF LAMININ 1 BINDING 7 1.56e-01 5.52e-01 0.44200 -2.34e-01 3.75e-01 2.83e-01 8.59e-02
GOBP AMP CATABOLIC PROCESS 5 2.45e-01 6.60e-01 0.44200 -1.04e-01 4.30e-01 6.87e-01 9.62e-02
GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE 8 7.04e-02 3.99e-01 0.44200 -2.94e-01 -3.30e-01 1.50e-01 1.06e-01
GOMF HMG BOX DOMAIN BINDING 13 1.47e-02 1.92e-01 0.44200 -3.95e-01 -1.97e-01 1.36e-02 2.18e-01
GOBP REGULATION OF LYSOSOME ORGANIZATION 12 2.73e-02 2.62e-01 0.44200 -4.41e-01 -2.44e-02 8.18e-03 8.84e-01
GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS 13 3.14e-02 2.77e-01 0.44100 3.84e-01 -2.18e-01 1.66e-02 1.74e-01
GOMF STRUCTURAL CONSTITUENT OF RIBOSOME 154 4.03e-19 5.50e-16 0.44100 1.31e-01 -4.21e-01 5.10e-03 1.64e-19
GOBP NEGATIVE REGULATION OF MAST CELL DEGRANULATION 5 1.92e-01 6.00e-01 0.44100 -2.76e-01 -3.44e-01 2.85e-01 1.83e-01
GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY 30 2.14e-04 1.04e-02 0.44100 -4.32e-01 9.13e-02 4.27e-05 3.87e-01
GOBP MOTOR NEURON MIGRATION 13 1.43e-02 1.90e-01 0.44100 -3.75e-01 -2.31e-01 1.91e-02 1.49e-01
GOBP REGULATION OF GLUTAMATE RECEPTOR CLUSTERING 6 1.42e-01 5.34e-01 0.44000 -3.79e-01 -2.24e-01 1.08e-01 3.41e-01
GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT 8 8.02e-02 4.20e-01 0.44000 1.40e-01 4.17e-01 4.92e-01 4.11e-02
GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX 9 8.77e-02 4.37e-01 0.44000 1.63e-01 -4.08e-01 3.96e-01 3.38e-02
GOBP NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS 8 1.22e-01 5.00e-01 0.44000 2.34e-01 -3.73e-01 2.53e-01 6.79e-02
GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY 16 7.44e-03 1.27e-01 0.44000 4.32e-01 8.16e-02 2.77e-03 5.72e-01
GOCC CHROMAFFIN GRANULE MEMBRANE 9 7.66e-02 4.14e-01 0.43900 -5.24e-02 4.36e-01 7.85e-01 2.34e-02
Terminal pathway of complement 8 8.71e-02 4.36e-01 0.43900 4.33e-01 7.58e-02 3.41e-02 7.10e-01
GOBP GLUCOSYLCERAMIDE METABOLIC PROCESS 11 5.16e-02 3.44e-01 0.43900 -1.63e-01 4.08e-01 3.50e-01 1.91e-02
p75NTR negatively regulates cell cycle via SC1 6 1.52e-01 5.48e-01 0.43900 4.16e-01 1.39e-01 7.75e-02 5.55e-01
GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN 6 1.44e-01 5.36e-01 0.43900 -2.28e-01 -3.75e-01 3.33e-01 1.12e-01
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION 15 1.04e-02 1.58e-01 0.43800 -7.75e-02 -4.32e-01 6.04e-01 3.80e-03
GOBP TELOMERE TETHERING AT NUCLEAR PERIPHERY 6 1.94e-01 6.03e-01 0.43800 -4.21e-01 1.22e-01 7.43e-02 6.03e-01
GOBP DISACCHARIDE METABOLIC PROCESS 10 5.47e-02 3.56e-01 0.43800 4.38e-01 -7.87e-03 1.65e-02 9.66e-01
GOMF 5S RRNA BINDING 9 8.88e-02 4.38e-01 0.43800 1.54e-01 -4.10e-01 4.25e-01 3.31e-02
Sphingolipid catabolism 12 2.13e-02 2.33e-01 0.43800 3.83e-01 2.12e-01 2.15e-02 2.04e-01
GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE REGULATOR ACTIVITY 5 2.09e-01 6.26e-01 0.43800 -1.42e-01 -4.14e-01 5.82e-01 1.09e-01
GOBP PROTEIN LOCALIZATION TO CELL LEADING EDGE 5 2.44e-01 6.58e-01 0.43800 -6.04e-02 4.33e-01 8.15e-01 9.32e-02
Crosslinking of collagen fibrils 16 1.65e-02 2.06e-01 0.43700 -3.00e-01 3.18e-01 3.79e-02 2.75e-02
GOBP GLYCINE IMPORT ACROSS PLASMA MEMBRANE 5 2.71e-01 6.85e-01 0.43700 -3.80e-01 2.15e-01 1.41e-01 4.05e-01
GOBP OTOLITH MORPHOGENESIS 5 2.75e-01 6.88e-01 0.43700 -3.52e-01 2.58e-01 1.72e-01 3.17e-01
GOBP ACTIVATION OF MEIOSIS 6 2.14e-01 6.31e-01 0.43700 -3.46e-01 2.66e-01 1.42e-01 2.59e-01
GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY 6 2.15e-01 6.32e-01 0.43700 -2.92e-01 3.25e-01 2.15e-01 1.69e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED IRON SULFUR PROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN 9 8.48e-02 4.32e-01 0.43700 4.24e-01 -1.03e-01 2.75e-02 5.94e-01
GOMF POTASSIUM CHANNEL ACTIVATOR ACTIVITY 5 2.28e-01 6.46e-01 0.43600 -4.18e-02 -4.34e-01 8.72e-01 9.26e-02
GOBP REGULATION OF FEMALE RECEPTIVITY 8 1.30e-01 5.14e-01 0.43600 -3.13e-01 3.04e-01 1.26e-01 1.36e-01
GOMF GLYCINE BINDING 10 4.67e-02 3.28e-01 0.43600 -4.20e-01 -1.17e-01 2.14e-02 5.23e-01
GOBP REGULATION OF NEUTROPHIL MEDIATED CYTOTOXICITY 5 2.78e-01 6.92e-01 0.43600 -3.43e-01 2.69e-01 1.84e-01 2.97e-01
GOBP URIDINE TRANSMEMBRANE TRANSPORT 6 1.44e-01 5.36e-01 0.43600 3.16e-01 3.00e-01 1.80e-01 2.03e-01
GOCC SPERM FIBROUS SHEATH 6 2.16e-01 6.34e-01 0.43600 3.37e-01 -2.77e-01 1.53e-01 2.40e-01
GOBP NEUROBLAST DIFFERENTIATION 8 8.67e-02 4.36e-01 0.43500 -1.15e-01 -4.20e-01 5.72e-01 3.97e-02
GOCC CLATHRIN COAT OF COATED PIT 18 6.68e-03 1.19e-01 0.43500 -4.31e-01 6.45e-02 1.56e-03 6.36e-01
GOMF GLUTAMATE SODIUM SYMPORTER ACTIVITY 5 2.40e-01 6.55e-01 0.43500 -1.87e-02 4.35e-01 9.42e-01 9.21e-02
GOBP METANEPHRIC PART OF URETERIC BUD DEVELOPMENT 6 1.67e-01 5.68e-01 0.43500 -4.29e-01 -6.85e-02 6.86e-02 7.71e-01
GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE RAFT 5 2.38e-01 6.55e-01 0.43500 3.81e-03 -4.35e-01 9.88e-01 9.23e-02
GOBP MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION 6 1.56e-01 5.52e-01 0.43500 -1.58e-01 -4.05e-01 5.04e-01 8.58e-02
Sulfide oxidation to sulfate 5 2.32e-01 6.50e-01 0.43400 4.33e-01 3.58e-02 9.36e-02 8.90e-01
GOCC ACTIVIN RECEPTOR COMPLEX 6 2.19e-01 6.37e-01 0.43400 -3.26e-01 2.87e-01 1.66e-01 2.24e-01
GOCC APICAL CORTEX 8 7.92e-02 4.19e-01 0.43400 2.28e-01 3.70e-01 2.64e-01 7.03e-02
GOCC TRANSCRIPTION FACTOR TFIIA COMPLEX 5 2.79e-01 6.92e-01 0.43400 2.50e-01 -3.55e-01 3.34e-01 1.69e-01
GOBP RESPONSE TO L ASCORBIC ACID 5 2.82e-01 6.95e-01 0.43400 3.09e-01 -3.05e-01 2.31e-01 2.38e-01
GOMF MUSCLE ALPHA ACTININ BINDING 15 2.24e-02 2.40e-01 0.43400 -2.81e-01 3.31e-01 5.99e-02 2.63e-02
GOCC CYTOSOLIC RIBOSOME 107 1.07e-12 3.54e-10 0.43400 2.04e-01 -3.83e-01 2.67e-04 7.32e-12
GOBP SENSORY PERCEPTION OF SWEET TASTE 7 1.17e-01 4.92e-01 0.43400 4.13e-01 1.34e-01 5.85e-02 5.40e-01
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN SALIVARY GLAND MORPHOGENESIS 5 2.24e-01 6.42e-01 0.43400 -4.26e-01 -8.40e-02 9.92e-02 7.45e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS 6 1.85e-01 5.89e-01 0.43400 4.33e-01 -3.21e-02 6.64e-02 8.92e-01
GOMF INOSITOL 1 3 4 5 TETRAKISPHOSPHATE BINDING 5 2.56e-01 6.71e-01 0.43400 -8.99e-02 4.24e-01 7.28e-01 1.00e-01
GOBP DISTAL TUBULE DEVELOPMENT 12 3.68e-02 2.95e-01 0.43400 -4.28e-01 7.16e-02 1.03e-02 6.68e-01
GOBP SPERMIDINE TRANSPORT 5 2.16e-01 6.33e-01 0.43400 -4.10e-01 -1.42e-01 1.13e-01 5.83e-01
GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY 7 1.67e-01 5.68e-01 0.43400 2.33e-01 -3.66e-01 2.86e-01 9.36e-02
GOBP POSITIVE REGULATION OF CHONDROCYTE PROLIFERATION 8 8.54e-02 4.33e-01 0.43300 -1.52e-01 -4.06e-01 4.58e-01 4.67e-02
Prednisone ADME 10 7.96e-02 4.19e-01 0.43300 3.43e-01 -2.65e-01 6.02e-02 1.47e-01
GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING 16 6.10e-03 1.13e-01 0.43300 -3.23e-01 -2.89e-01 2.55e-02 4.52e-02
GOBP POSITIVE REGULATION OF CGMP MEDIATED SIGNALING 5 2.10e-01 6.26e-01 0.43300 3.89e-01 1.92e-01 1.32e-01 4.58e-01
GOCC LARGE RIBOSOMAL SUBUNIT 107 1.50e-13 5.95e-11 0.43300 5.52e-02 -4.30e-01 3.24e-01 1.54e-14
GOBP REGULATION OF GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS 7 1.66e-01 5.66e-01 0.43300 2.10e-01 -3.79e-01 3.36e-01 8.26e-02
GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY 6 2.19e-01 6.37e-01 0.43300 -2.49e-01 3.54e-01 2.91e-01 1.33e-01
GOCC CHROMAFFIN GRANULE 14 2.70e-02 2.60e-01 0.43300 -1.94e-01 3.87e-01 2.10e-01 1.21e-02
GOBP FAT CELL PROLIFERATION 15 2.13e-02 2.33e-01 0.43300 -3.81e-01 2.06e-01 1.07e-02 1.67e-01
Hyaluronan biosynthesis and export 5 2.85e-01 6.97e-01 0.43300 -3.22e-01 2.89e-01 2.13e-01 2.63e-01
Histidine catabolism 8 8.08e-02 4.21e-01 0.43200 2.31e-01 3.65e-01 2.57e-01 7.37e-02
GOBP REGULATION OF BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS 5 2.76e-01 6.90e-01 0.43200 1.97e-01 -3.85e-01 4.47e-01 1.36e-01
GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I 15 2.08e-02 2.30e-01 0.43200 -3.90e-01 1.85e-01 8.84e-03 2.14e-01
Formation of lateral plate mesoderm 5 2.23e-01 6.41e-01 0.43200 -4.17e-01 -1.11e-01 1.06e-01 6.67e-01
GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 8 1.31e-01 5.16e-01 0.43200 -3.74e-01 2.16e-01 6.70e-02 2.91e-01
GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN 7 1.69e-01 5.70e-01 0.43100 2.19e-01 -3.72e-01 3.16e-01 8.84e-02
GOBP OVULATION FROM OVARIAN FOLLICLE 9 9.40e-02 4.48e-01 0.43100 -4.10e-01 1.34e-01 3.34e-02 4.87e-01
CD22 mediated BCR regulation 5 2.46e-01 6.60e-01 0.43100 7.84e-03 -4.31e-01 9.76e-01 9.54e-02
GOBP OTIC VESICLE FORMATION 8 1.35e-01 5.24e-01 0.43100 -3.44e-01 2.59e-01 9.17e-02 2.05e-01
GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR 6 1.84e-01 5.88e-01 0.43100 -2.63e-03 -4.31e-01 9.91e-01 6.77e-02
Cellular response to mitochondrial stress 8 1.34e-01 5.22e-01 0.43100 2.43e-01 -3.55e-01 2.34e-01 8.17e-02
GOBP REGULATION OF MONOCYTE EXTRAVASATION 7 1.63e-01 5.61e-01 0.43000 -1.55e-01 4.02e-01 4.79e-01 6.57e-02
GOBP ISOLEUCINE METABOLIC PROCESS 6 1.69e-01 5.70e-01 0.43000 -9.81e-02 -4.19e-01 6.77e-01 7.57e-02
GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY 7 1.63e-01 5.62e-01 0.43000 -4.02e-01 1.52e-01 6.55e-02 4.85e-01
GOBP NEUROBLAST MIGRATION 7 1.43e-01 5.35e-01 0.43000 -4.29e-01 1.80e-02 4.92e-02 9.34e-01
Biosynthesis of Lipoxins (LX) 6 1.85e-01 5.89e-01 0.43000 -4.30e-01 -5.75e-03 6.84e-02 9.81e-01
GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION 18 9.36e-03 1.47e-01 0.43000 -4.04e-01 1.46e-01 2.99e-03 2.84e-01
GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY 9 1.07e-01 4.75e-01 0.43000 2.73e-01 -3.32e-01 1.56e-01 8.46e-02
GOBP MICROTUBULE BASED PROTEIN TRANSPORT 14 3.12e-02 2.76e-01 0.43000 -3.18e-01 2.89e-01 3.94e-02 6.13e-02
GOBP DUMP METABOLIC PROCESS 7 1.73e-01 5.78e-01 0.43000 3.61e-01 -2.32e-01 9.80e-02 2.87e-01
Phospholipase C-mediated cascade; FGFR2 17 1.47e-02 1.93e-01 0.42900 -3.33e-01 2.71e-01 1.73e-02 5.33e-02
GOCC PWP2P CONTAINING SUBCOMPLEX OF 90S PRERIBOSOME 5 2.32e-01 6.50e-01 0.42900 -7.98e-02 -4.22e-01 7.57e-01 1.02e-01
GOCC MICROVESICLE 9 8.53e-02 4.33e-01 0.42900 4.28e-02 -4.27e-01 8.24e-01 2.65e-02
GOBP SKELETAL MUSCLE THIN FILAMENT ASSEMBLY 7 1.72e-01 5.76e-01 0.42900 -3.71e-01 2.15e-01 8.88e-02 3.25e-01
GOBP AXONEMAL CENTRAL APPARATUS ASSEMBLY 6 2.14e-01 6.31e-01 0.42900 -1.56e-01 3.99e-01 5.08e-01 9.02e-02
GOBP INTERLEUKIN 23 PRODUCTION 10 4.74e-02 3.30e-01 0.42900 3.87e-01 1.84e-01 3.39e-02 3.15e-01
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR 22 4.29e-03 9.05e-02 0.42900 3.44e-01 -2.56e-01 5.25e-03 3.76e-02
GOBP NEGATIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION 6 2.28e-01 6.47e-01 0.42800 3.18e-01 -2.87e-01 1.77e-01 2.24e-01
GOBP BRONCHIOLE DEVELOPMENT 6 2.09e-01 6.25e-01 0.42800 1.22e-01 -4.10e-01 6.06e-01 8.17e-02
GOBP MEIOTIC SISTER CHROMATID COHESION 13 2.27e-02 2.42e-01 0.42800 -4.20e-01 -8.45e-02 8.81e-03 5.98e-01
GDP-fucose biosynthesis 6 2.21e-01 6.39e-01 0.42800 -1.99e-01 3.79e-01 3.99e-01 1.08e-01
GOBP TRYPTOPHAN METABOLIC PROCESS 10 7.36e-02 4.06e-01 0.42800 4.11e-01 -1.17e-01 2.43e-02 5.20e-01
GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY 33 9.73e-05 5.83e-03 0.42800 -4.27e-01 -1.38e-02 2.14e-05 8.91e-01
GOBP LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS 6 1.73e-01 5.77e-01 0.42800 9.74e-02 4.16e-01 6.79e-01 7.74e-02
GOMF C X3 C CHEMOKINE BINDING 5 2.29e-01 6.47e-01 0.42700 -4.10e-01 -1.20e-01 1.13e-01 6.43e-01
GOBP CELLULAR RESPONSE TO FRUCTOSE STIMULUS 5 2.14e-01 6.31e-01 0.42700 3.40e-01 2.58e-01 1.88e-01 3.18e-01
GOBP HIS PURKINJE SYSTEM DEVELOPMENT 7 1.15e-01 4.90e-01 0.42700 -2.77e-01 -3.24e-01 2.04e-01 1.38e-01
GOMF WATER TRANSMEMBRANE TRANSPORTER ACTIVITY 18 4.53e-03 9.31e-02 0.42600 3.91e-01 1.70e-01 4.10e-03 2.11e-01
GOMF ACETYLESTERASE ACTIVITY 5 2.90e-01 7.03e-01 0.42600 -3.67e-01 2.17e-01 1.55e-01 4.01e-01
PTK6 Regulates Cell Cycle 6 2.29e-01 6.47e-01 0.42600 2.45e-01 -3.49e-01 2.99e-01 1.39e-01
GOBP REGULATION OF INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION 9 6.26e-02 3.77e-01 0.42600 2.77e-01 3.23e-01 1.50e-01 9.31e-02
GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN AXIS ELONGATION 6 2.22e-01 6.39e-01 0.42600 3.87e-01 -1.77e-01 1.01e-01 4.53e-01
GOBP ELASTIN CATABOLIC PROCESS 5 2.33e-01 6.50e-01 0.42500 -4.11e-01 -1.09e-01 1.11e-01 6.73e-01
GOBP CYCLIC NUCLEOTIDE TRANSPORT 11 6.70e-02 3.91e-01 0.42500 -2.29e-01 3.59e-01 1.89e-01 3.95e-02
GOCC DENDRITIC SPINE HEAD 7 1.82e-01 5.86e-01 0.42500 -3.41e-01 2.53e-01 1.18e-01 2.46e-01
GOBP PERIPHERAL NERVOUS SYSTEM AXON REGENERATION 8 1.27e-01 5.10e-01 0.42500 -4.09e-01 1.13e-01 4.50e-02 5.79e-01
GOBP MINERALOCORTICOID BIOSYNTHETIC PROCESS 12 2.86e-02 2.68e-01 0.42400 3.94e-01 1.58e-01 1.81e-02 3.44e-01
GOBP BEHAVIORAL RESPONSE TO NICOTINE 8 8.68e-02 4.36e-01 0.42400 2.78e-01 3.21e-01 1.74e-01 1.16e-01
GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING 11 5.62e-02 3.60e-01 0.42400 4.17e-01 -7.72e-02 1.67e-02 6.58e-01
GOCC SARCOPLASMIC RETICULUM LUMEN 9 7.31e-02 4.05e-01 0.42400 -1.20e-01 -4.07e-01 5.33e-01 3.47e-02
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C 5 2.26e-01 6.43e-01 0.42400 -1.80e-01 -3.84e-01 4.86e-01 1.37e-01
GOBP SEROTONIN RECEPTOR SIGNALING PATHWAY 8 1.42e-01 5.33e-01 0.42400 -3.61e-01 2.23e-01 7.73e-02 2.76e-01
Recycling of eIF2:GDP 7 1.46e-01 5.39e-01 0.42400 -1.15e-02 -4.24e-01 9.58e-01 5.22e-02
GOCC SMALL RIBOSOMAL SUBUNIT 70 3.84e-08 6.13e-06 0.42400 2.19e-01 -3.63e-01 1.56e-03 1.51e-07
Classical antibody-mediated complement activation 6 2.30e-01 6.48e-01 0.42300 2.13e-01 -3.66e-01 3.67e-01 1.20e-01
GOBP TOOTH ERUPTION 5 2.98e-01 7.10e-01 0.42300 -2.49e-01 3.42e-01 3.35e-01 1.85e-01
GRB7 events in ERBB2 signaling 5 2.18e-01 6.37e-01 0.42300 2.94e-01 3.05e-01 2.55e-01 2.38e-01
RUNX3 regulates WNT signaling 8 1.33e-01 5.20e-01 0.42300 1.39e-01 -3.99e-01 4.95e-01 5.04e-02
GOBP SNRNA MODIFICATION 6 1.63e-01 5.62e-01 0.42300 -3.45e-01 -2.44e-01 1.43e-01 3.00e-01
PP2A-mediated dephosphorylation of key metabolic factors 6 2.12e-01 6.28e-01 0.42300 -4.14e-01 8.64e-02 7.93e-02 7.14e-01
Vitamin B2 (riboflavin) metabolism 7 1.29e-01 5.13e-01 0.42300 3.96e-01 1.47e-01 6.94e-02 5.02e-01
GOMF CATECHOLAMINE BINDING 12 3.33e-02 2.85e-01 0.42200 -4.14e-01 -8.30e-02 1.30e-02 6.19e-01
GOBP RENAL PROTEIN ABSORPTION 9 1.16e-01 4.90e-01 0.42200 -2.75e-01 3.21e-01 1.54e-01 9.59e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED ASCORBATE AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN 5 2.24e-01 6.42e-01 0.42200 2.28e-01 3.55e-01 3.78e-01 1.69e-01
GOCC BCL 2 FAMILY PROTEIN COMPLEX 10 8.56e-02 4.33e-01 0.42200 1.79e-01 -3.82e-01 3.26e-01 3.67e-02
GOBP LEUKOTRIENE D4 METABOLIC PROCESS 8 9.16e-02 4.44e-01 0.42100 2.27e-01 3.55e-01 2.66e-01 8.21e-02
GOBP REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY 8 1.16e-01 4.90e-01 0.42100 -4.21e-01 5.15e-03 3.91e-02 9.80e-01
Regulation of CDH11 mRNA translation by microRNAs 11 5.93e-02 3.70e-01 0.42100 -4.12e-01 8.53e-02 1.79e-02 6.24e-01
GOBP PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING 6 1.76e-01 5.81e-01 0.42100 3.96e-01 1.43e-01 9.34e-02 5.44e-01
GOCC RIBOSOMAL SUBUNIT 174 1.28e-19 1.97e-16 0.42000 1.21e-01 -4.03e-01 5.98e-03 4.57e-20
GOBP INDOLALKYLAMINE METABOLIC PROCESS 11 6.44e-02 3.81e-01 0.42000 3.98e-01 -1.33e-01 2.21e-02 4.45e-01
GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE 10 8.81e-02 4.37e-01 0.42000 3.76e-01 -1.87e-01 3.95e-02 3.06e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN 32 5.25e-04 1.98e-02 0.41900 3.11e-01 -2.81e-01 2.31e-03 5.88e-03
Maturation of hRSV A proteins 13 3.97e-02 3.06e-01 0.41900 1.34e-01 -3.97e-01 4.04e-01 1.31e-02
Formation of the cornified envelope 124 9.53e-16 5.32e-13 0.41900 4.09e-01 9.05e-02 3.52e-15 8.17e-02
GOBP TRANS SYNAPTIC SIGNALING BY LIPID 7 1.44e-01 5.36e-01 0.41900 4.13e-01 6.87e-02 5.83e-02 7.53e-01
GOBP REGULATION OF RIBONUCLEASE ACTIVITY 9 1.09e-01 4.79e-01 0.41900 1.46e-01 -3.93e-01 4.50e-01 4.13e-02
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) 8 1.08e-01 4.77e-01 0.41900 -7.82e-02 -4.11e-01 7.02e-01 4.39e-02
Nef Mediated CD4 Down-regulation 9 1.12e-01 4.84e-01 0.41900 -3.83e-01 1.70e-01 4.68e-02 3.77e-01
Transport of organic anions 10 5.10e-02 3.44e-01 0.41900 3.11e-01 2.80e-01 8.84e-02 1.25e-01
GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL 12 5.96e-02 3.70e-01 0.41800 3.09e-01 -2.83e-01 6.42e-02 9.00e-02
GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION 8 1.54e-01 5.49e-01 0.41800 3.12e-01 -2.77e-01 1.26e-01 1.74e-01
GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE 6 2.37e-01 6.54e-01 0.41700 -1.84e-01 3.75e-01 4.35e-01 1.12e-01
Role of ABL in ROBO-SLIT signaling 8 1.14e-01 4.88e-01 0.41700 -4.14e-01 -5.04e-02 4.26e-02 8.05e-01
TICAM1-dependent activation of IRF3/IRF7 13 4.79e-02 3.31e-01 0.41700 2.73e-01 -3.16e-01 8.88e-02 4.87e-02
GOBP REGULATION OF ASTROCYTE ACTIVATION 8 9.41e-02 4.48e-01 0.41700 -3.08e-01 -2.81e-01 1.31e-01 1.69e-01
GOCC METHYLOSOME 13 4.81e-02 3.31e-01 0.41700 3.14e-01 -2.74e-01 4.98e-02 8.72e-02
Defective F9 activation 5 2.91e-01 7.04e-01 0.41700 -1.25e-01 3.98e-01 6.29e-01 1.23e-01
GOBP THREONINE METABOLIC PROCESS 5 2.31e-01 6.50e-01 0.41700 -3.49e-01 -2.29e-01 1.77e-01 3.76e-01
GOMF IODIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 5 3.05e-01 7.15e-01 0.41700 3.63e-01 -2.05e-01 1.60e-01 4.28e-01
GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE 12 6.12e-02 3.74e-01 0.41700 -2.99e-01 2.90e-01 7.31e-02 8.17e-02
GOMF FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVITY 5 2.38e-01 6.55e-01 0.41700 1.69e-01 3.81e-01 5.12e-01 1.41e-01
GOMF ARYL SULFOTRANSFERASE ACTIVITY 7 1.90e-01 5.96e-01 0.41600 -2.01e-01 3.65e-01 3.56e-01 9.48e-02
GOBP REGULATION OF SYNAPTIC VESICLE TRANSPORT 5 2.66e-01 6.80e-01 0.41600 4.16e-01 1.07e-02 1.07e-01 9.67e-01
GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS 10 9.72e-02 4.55e-01 0.41600 -3.27e-01 2.58e-01 7.36e-02 1.58e-01
GOBP INTERLEUKIN 21 PRODUCTION 5 3.03e-01 7.14e-01 0.41600 3.75e-01 -1.80e-01 1.46e-01 4.86e-01
GOMF RIBOSOMAL SMALL SUBUNIT BINDING 16 1.74e-02 2.11e-01 0.41500 5.87e-02 -4.11e-01 6.84e-01 4.44e-03
GOMF POLY ADP D RIBOSE BINDING 5 2.75e-01 6.88e-01 0.41500 -2.48e-02 4.14e-01 9.24e-01 1.09e-01
GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION 6 1.75e-01 5.80e-01 0.41500 -2.40e-01 -3.38e-01 3.08e-01 1.52e-01
GOMF CXCR3 CHEMOKINE RECEPTOR BINDING 5 2.33e-01 6.50e-01 0.41500 -3.29e-01 -2.52e-01 2.02e-01 3.29e-01
VEGFR2 mediated cell proliferation 19 1.21e-02 1.73e-01 0.41500 -3.41e-01 2.36e-01 1.00e-02 7.55e-02
GOBP REGULATION OF NK T CELL PROLIFERATION 7 1.52e-01 5.48e-01 0.41500 5.31e-02 4.11e-01 8.08e-01 5.96e-02
GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY 5 3.12e-01 7.21e-01 0.41400 -2.26e-01 3.48e-01 3.82e-01 1.78e-01
GOBP ONE CARBON COMPOUND TRANSPORT 26 1.15e-03 3.64e-02 0.41400 4.14e-01 -3.64e-03 2.55e-04 9.74e-01
GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O 10 8.08e-02 4.21e-01 0.41400 6.39e-02 -4.09e-01 7.26e-01 2.50e-02
GOCC RNA POLYMERASE I COMPLEX 13 2.63e-02 2.57e-01 0.41400 -1.35e-01 -3.92e-01 3.99e-01 1.45e-02
GOBP POSITIVE REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY 5 3.15e-01 7.22e-01 0.41400 -3.28e-01 2.54e-01 2.05e-01 3.26e-01
GOBP ENTERIC NERVOUS SYSTEM DEVELOPMENT 12 4.79e-02 3.31e-01 0.41400 -4.11e-01 5.10e-02 1.37e-02 7.60e-01
GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING PHOSPHATASE ACTIVITY 5 3.16e-01 7.24e-01 0.41400 3.04e-01 -2.81e-01 2.39e-01 2.76e-01
RHO GTPases activate PAKs 19 8.92e-03 1.44e-01 0.41400 -4.05e-01 8.41e-02 2.21e-03 5.26e-01
GOBP REGULATION OF COLLAGEN FIBRIL ORGANIZATION 9 1.19e-01 4.96e-01 0.41400 -1.86e-01 3.70e-01 3.35e-01 5.45e-02
GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS 9 1.24e-01 5.03e-01 0.41400 -2.29e-01 3.45e-01 2.34e-01 7.34e-02
GOBP POSITIVE REGULATION OF ACROSOME REACTION 11 4.27e-02 3.15e-01 0.41400 3.58e-01 2.07e-01 3.96e-02 2.35e-01
GOBP MAMMALIAN OOGENESIS STAGE 12 6.21e-02 3.76e-01 0.41400 -3.42e-01 2.32e-01 4.01e-02 1.64e-01
GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY 12 5.76e-02 3.65e-01 0.41300 1.62e-01 -3.81e-01 3.33e-01 2.25e-02
GOCC COPI VESICLE COAT 13 2.68e-02 2.60e-01 0.41300 -3.90e-01 -1.36e-01 1.48e-02 3.98e-01
GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY 15 1.76e-02 2.11e-01 0.41300 -4.07e-01 -6.91e-02 6.31e-03 6.43e-01
CASP8 activity is inhibited 11 7.67e-02 4.14e-01 0.41300 3.61e-01 -2.01e-01 3.81e-02 2.49e-01
Dimerization of procaspase-8 11 7.67e-02 4.14e-01 0.41300 3.61e-01 -2.01e-01 3.81e-02 2.49e-01
Regulation by c-FLIP 11 7.67e-02 4.14e-01 0.41300 3.61e-01 -2.01e-01 3.81e-02 2.49e-01
GOBP REGULATION OF CELL PROJECTION SIZE 11 4.18e-02 3.12e-01 0.41300 3.21e-01 2.59e-01 6.51e-02 1.37e-01
GOMF DEAD H BOX RNA HELICASE BINDING 8 1.51e-01 5.46e-01 0.41300 -3.78e-01 1.65e-01 6.38e-02 4.20e-01
GOCC ELASTIC FIBER 5 2.99e-01 7.10e-01 0.41300 -3.94e-01 1.21e-01 1.27e-01 6.38e-01
GOBP ACTIN FILAMENT NETWORK FORMATION 8 1.10e-01 4.81e-01 0.41300 3.95e-01 1.19e-01 5.30e-02 5.60e-01
NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis 9 1.13e-01 4.86e-01 0.41300 -3.96e-01 1.15e-01 3.96e-02 5.49e-01
GOBP PURINE NUCLEOBASE TRANSMEMBRANE TRANSPORT 8 1.04e-01 4.70e-01 0.41200 1.84e-01 3.69e-01 3.69e-01 7.04e-02
GOBP DETECTION OF VIRUS 6 1.89e-01 5.96e-01 0.41200 -1.34e-01 -3.90e-01 5.71e-01 9.79e-02
GOBP REGULATION OF FAT CELL PROLIFERATION 10 1.02e-01 4.66e-01 0.41200 -3.15e-01 2.66e-01 8.48e-02 1.45e-01
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY 13 5.15e-02 3.44e-01 0.41200 -2.61e-01 3.18e-01 1.03e-01 4.69e-02
GOCC BRCA1 C COMPLEX 6 1.82e-01 5.86e-01 0.41200 -2.03e-01 -3.58e-01 3.90e-01 1.29e-01
Noncanonical activation of NOTCH3 8 1.52e-01 5.47e-01 0.41100 1.61e-01 -3.79e-01 4.31e-01 6.36e-02
GOBP POSTSYNAPTIC MEMBRANE ASSEMBLY 7 1.74e-01 5.78e-01 0.41100 4.08e-01 -5.19e-02 6.15e-02 8.12e-01
GOBP NEGATIVE REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS 6 1.96e-01 6.08e-01 0.41100 -4.00e-01 -9.74e-02 9.00e-02 6.79e-01
GOMF RETROMER COMPLEX BINDING 9 7.56e-02 4.12e-01 0.41100 -2.70e-01 -3.10e-01 1.61e-01 1.07e-01
GOMF C X C CHEMOKINE RECEPTOR ACTIVITY 7 1.52e-01 5.47e-01 0.41100 4.02e-01 8.63e-02 6.56e-02 6.92e-01
GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING 10 6.52e-02 3.84e-01 0.41100 -1.15e-01 -3.95e-01 5.29e-01 3.07e-02
Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580 K2555) Translocation Mutant 7 1.35e-01 5.22e-01 0.41100 2.77e-01 3.03e-01 2.04e-01 1.65e-01
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580 K2555) Translocation Mutant 7 1.35e-01 5.22e-01 0.41100 2.77e-01 3.03e-01 2.04e-01 1.65e-01
GOBP NEGATIVE REGULATION OF TROPHOBLAST CELL MIGRATION 7 2.03e-01 6.17e-01 0.41000 2.30e-01 -3.40e-01 2.91e-01 1.20e-01
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION 12 6.41e-02 3.81e-01 0.41000 3.50e-01 -2.15e-01 3.60e-02 1.98e-01
GOBP NEGATIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY 5 2.70e-01 6.85e-01 0.41000 -4.08e-01 -4.03e-02 1.14e-01 8.76e-01
GOBP ACTIVATION OF PROTEIN KINASE C ACTIVITY 5 2.44e-01 6.58e-01 0.41000 -3.52e-01 -2.10e-01 1.73e-01 4.16e-01
GOMF L PROLINE TRANSMEMBRANE TRANSPORTER ACTIVITY 7 1.42e-01 5.34e-01 0.40900 3.67e-01 1.81e-01 9.25e-02 4.06e-01
GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION 11 7.76e-02 4.15e-01 0.40900 1.69e-01 -3.73e-01 3.32e-01 3.22e-02
GOBP SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION 10 6.76e-02 3.92e-01 0.40900 -3.96e-01 -1.03e-01 3.00e-02 5.73e-01
GOBP SKELETAL MUSCLE SATELLITE CELL MAINTENANCE INVOLVED IN SKELETAL MUSCLE REGENERATION 5 2.92e-01 7.05e-01 0.40900 -6.10e-02 4.05e-01 8.13e-01 1.17e-01
GOBP SEROTONIN UPTAKE 12 3.72e-02 2.96e-01 0.40900 -3.83e-01 -1.44e-01 2.16e-02 3.87e-01
GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY 6 2.60e-01 6.74e-01 0.40900 -3.07e-01 2.70e-01 1.93e-01 2.52e-01
Formation of ATP by chemiosmotic coupling 18 1.75e-02 2.11e-01 0.40900 2.57e-01 -3.18e-01 5.94e-02 1.94e-02
RNA Polymerase I Promoter Opening 26 1.49e-03 4.39e-02 0.40900 2.36e-02 -4.08e-01 8.35e-01 3.17e-04
GOBP XENOBIOTIC TRANSPORT ACROSS BLOOD BRAIN BARRIER 6 2.61e-01 6.75e-01 0.40900 -2.86e-01 2.91e-01 2.24e-01 2.16e-01
GOBP GUANINE NUCLEOTIDE TRANSPORT 11 7.93e-02 4.19e-01 0.40900 -1.77e-01 3.68e-01 3.09e-01 3.45e-02
GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE 10 5.95e-02 3.70e-01 0.40800 -3.29e-01 -2.42e-01 7.17e-02 1.85e-01
GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY 7 2.04e-01 6.19e-01 0.40800 -3.51e-01 2.09e-01 1.08e-01 3.37e-01
GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY 10 6.29e-02 3.77e-01 0.40800 3.67e-01 1.78e-01 4.43e-02 3.30e-01
Regulation of TP53 Activity through Association with Co-factors 14 4.08e-02 3.09e-01 0.40800 -1.92e-01 3.60e-01 2.14e-01 1.96e-02
STAT5 activation downstream of FLT3 ITD mutants 10 6.43e-02 3.81e-01 0.40800 -1.59e-01 -3.76e-01 3.85e-01 3.95e-02
TFAP2 (AP-2) family regulates transcription of cell cycle factors 5 2.46e-01 6.61e-01 0.40800 -3.39e-01 -2.26e-01 1.89e-01 3.81e-01
GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION 8 1.55e-01 5.52e-01 0.40800 1.46e-01 -3.81e-01 4.74e-01 6.23e-02
GOBP GLIAL CELL FATE COMMITMENT 13 2.60e-02 2.56e-01 0.40700 -2.48e-01 -3.23e-01 1.22e-01 4.36e-02
GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I 10 1.07e-01 4.75e-01 0.40700 -3.27e-01 2.43e-01 7.34e-02 1.84e-01
GOMF ACTIVIN RECEPTOR ACTIVITY 9 1.34e-01 5.21e-01 0.40700 -3.27e-01 2.43e-01 8.95e-02 2.07e-01
GOCC DYNACTIN COMPLEX 8 1.34e-01 5.21e-01 0.40700 -4.07e-01 1.88e-03 4.62e-02 9.93e-01
GOBP MESENCHYMAL STEM CELL MAINTENANCE INVOLVED IN NEPHRON MORPHOGENESIS 6 2.06e-01 6.21e-01 0.40700 -8.28e-02 -3.98e-01 7.26e-01 9.10e-02
GOBP RNA DECAPPING 19 5.15e-03 1.01e-01 0.40700 -3.50e-01 -2.07e-01 8.19e-03 1.19e-01
GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS 11 8.16e-02 4.23e-01 0.40700 -3.64e-01 1.82e-01 3.68e-02 2.96e-01
GOCC MYELIN SHEATH ADAXONAL REGION 6 2.30e-01 6.48e-01 0.40700 -4.04e-01 4.63e-02 8.66e-02 8.44e-01
GOBP RESPONSE TO CYCLOHEXIMIDE 5 3.29e-01 7.33e-01 0.40700 2.63e-01 -3.10e-01 3.08e-01 2.30e-01
GOBP FUCOSE METABOLIC PROCESS 16 1.13e-02 1.66e-01 0.40600 2.61e-01 3.11e-01 7.08e-02 3.10e-02
Activated point mutants of FGFR2 16 2.89e-02 2.69e-01 0.40600 -3.06e-01 2.66e-01 3.38e-02 6.51e-02
RIPK1-mediated regulated necrosis 29 1.63e-03 4.66e-02 0.40600 3.10e-01 -2.62e-01 3.86e-03 1.45e-02
Regulation of necroptotic cell death 29 1.63e-03 4.66e-02 0.40600 3.10e-01 -2.62e-01 3.86e-03 1.45e-02
GOMF EPOXIDE HYDROLASE ACTIVITY 8 1.70e-01 5.71e-01 0.40600 -3.13e-01 2.58e-01 1.25e-01 2.06e-01
GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR 7 1.64e-01 5.64e-01 0.40600 5.58e-02 4.02e-01 7.98e-01 6.55e-02
GOBP OTOLITH DEVELOPMENT 10 9.48e-02 4.50e-01 0.40500 -1.02e-01 3.92e-01 5.77e-01 3.16e-02
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY 12 4.04e-02 3.08e-01 0.40500 -1.29e-01 -3.84e-01 4.39e-01 2.12e-02
GOBP REGULATION OF LIPOPHAGY 5 3.21e-01 7.28e-01 0.40500 -1.70e-01 3.68e-01 5.11e-01 1.54e-01
GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION 5 3.28e-01 7.31e-01 0.40500 -3.42e-01 2.18e-01 1.86e-01 4.00e-01
GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION 8 1.29e-01 5.13e-01 0.40500 4.02e-01 4.75e-02 4.89e-02 8.16e-01
GOBP SYMPATHETIC NEURON PROJECTION EXTENSION 5 3.20e-01 7.28e-01 0.40500 -3.71e-01 1.63e-01 1.51e-01 5.27e-01
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis 9 1.38e-01 5.27e-01 0.40500 -3.12e-01 2.58e-01 1.05e-01 1.80e-01
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway 16 2.51e-02 2.53e-01 0.40500 3.81e-01 -1.37e-01 8.36e-03 3.42e-01
Phospholipase C-mediated cascade; FGFR3 12 6.87e-02 3.95e-01 0.40500 -2.08e-01 3.47e-01 2.12e-01 3.73e-02
GOMF RDNA BINDING 9 1.14e-01 4.89e-01 0.40500 -4.01e-01 5.57e-02 3.74e-02 7.72e-01
GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 17 2.40e-02 2.49e-01 0.40400 3.00e-01 -2.71e-01 3.21e-02 5.33e-02
GOMF TAP BINDING 7 1.96e-01 6.06e-01 0.40400 3.89e-01 -1.11e-01 7.50e-02 6.10e-01
GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION BY CALCIUM ION SIGNALING 7 1.70e-01 5.71e-01 0.40400 -4.03e-01 -3.32e-02 6.49e-02 8.79e-01
GOBP BLEB ASSEMBLY 11 7.66e-02 4.14e-01 0.40400 -3.90e-01 1.06e-01 2.51e-02 5.43e-01
GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY 7 2.16e-01 6.33e-01 0.40400 -2.97e-01 2.74e-01 1.74e-01 2.10e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 11 6.99e-02 3.97e-01 0.40400 -4.36e-02 4.02e-01 8.02e-01 2.11e-02
GOBP REDUCTION OF FOOD INTAKE IN RESPONSE TO DIETARY EXCESS 6 2.57e-01 6.71e-01 0.40400 3.71e-01 -1.58e-01 1.15e-01 5.03e-01
GOBP REGULATION OF MICROVILLUS ORGANIZATION 13 3.53e-02 2.90e-01 0.40400 3.98e-01 6.81e-02 1.30e-02 6.71e-01
GOMF FUCOSYLTRANSFERASE ACTIVITY 13 2.86e-02 2.68e-01 0.40300 3.44e-01 2.12e-01 3.19e-02 1.87e-01
GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS 5 3.00e-01 7.11e-01 0.40300 4.62e-02 -4.01e-01 8.58e-01 1.21e-01
Phospholipase C-mediated cascade: FGFR1 16 3.04e-02 2.73e-01 0.40300 -2.77e-01 2.93e-01 5.47e-02 4.25e-02
GOBP FOREBRAIN NEURON DEVELOPMENT 23 4.95e-03 9.85e-02 0.40300 -3.86e-01 1.17e-01 1.36e-03 3.29e-01
GOBP T HELPER 1 CELL CYTOKINE PRODUCTION 8 1.11e-01 4.83e-01 0.40300 3.29e-01 2.32e-01 1.07e-01 2.55e-01
GOBP PRIMITIVE STREAK FORMATION 10 8.13e-02 4.22e-01 0.40300 -2.89e-02 -4.02e-01 8.74e-01 2.78e-02
GOCC PHAGOLYSOSOME 7 1.91e-01 5.98e-01 0.40300 -3.96e-01 7.28e-02 6.94e-02 7.39e-01
GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY 6 2.35e-01 6.52e-01 0.40200 3.49e-02 -4.01e-01 8.82e-01 8.91e-02
GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE 5 3.32e-01 7.35e-01 0.40200 2.09e-01 -3.44e-01 4.18e-01 1.83e-01
GOBP POSITIVE REGULATION OF KERATINOCYTE APOPTOTIC PROCESS 5 3.14e-01 7.22e-01 0.40200 -3.89e-01 1.01e-01 1.32e-01 6.95e-01
GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION 8 1.76e-01 5.81e-01 0.40200 2.57e-01 -3.09e-01 2.08e-01 1.30e-01
GOBP NEGATIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION 5 3.04e-01 7.14e-01 0.40200 3.98e-01 -5.45e-02 1.23e-01 8.33e-01
Paracetamol ADME 26 7.99e-04 2.73e-02 0.40200 2.82e-01 2.87e-01 1.29e-02 1.14e-02
GOMF NATURAL KILLER CELL LECTIN LIKE RECEPTOR BINDING 8 1.76e-01 5.81e-01 0.40200 3.06e-01 -2.60e-01 1.33e-01 2.03e-01
GOCC AP 3 ADAPTOR COMPLEX 11 4.94e-02 3.37e-01 0.40200 -3.11e-01 -2.54e-01 7.37e-02 1.45e-01
GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY 6 2.68e-01 6.83e-01 0.40100 -2.11e-01 3.41e-01 3.71e-01 1.47e-01
GOCC FILTRATION DIAPHRAGM 9 8.76e-02 4.37e-01 0.40100 -3.43e-01 -2.09e-01 7.48e-02 2.78e-01
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN 6 2.49e-01 6.63e-01 0.40100 9.17e-02 -3.90e-01 6.97e-01 9.77e-02
Glucuronidation 24 5.43e-03 1.04e-01 0.40100 2.30e-01 -3.28e-01 5.08e-02 5.37e-03
GOBP RESPONSE TO ZINC ION STARVATION 9 1.37e-01 5.27e-01 0.40100 -1.86e-01 3.55e-01 3.33e-01 6.53e-02
GOCC EUKARYOTIC 48S PREINITIATION COMPLEX 14 2.68e-02 2.60e-01 0.40100 -1.04e-01 -3.87e-01 5.02e-01 1.21e-02
GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION 6 2.74e-01 6.86e-01 0.40100 -3.08e-01 2.56e-01 1.91e-01 2.77e-01
GOBP RNA SECONDARY STRUCTURE UNWINDING 8 1.60e-01 5.57e-01 0.40000 -3.87e-01 1.05e-01 5.83e-02 6.08e-01
GOBP DNA LIGATION INVOLVED IN DNA REPAIR 5 3.30e-01 7.33e-01 0.40000 -1.67e-01 3.64e-01 5.17e-01 1.59e-01
GOBP INHIBITORY SYNAPSE ASSEMBLY 23 3.32e-03 7.86e-02 0.40000 -3.99e-01 -3.16e-02 9.20e-04 7.93e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS 6 2.20e-01 6.37e-01 0.40000 3.95e-01 6.31e-02 9.36e-02 7.89e-01
GOBP POSITIVE REGULATION OF MAST CELL CHEMOTAXIS 5 2.59e-01 6.73e-01 0.40000 2.19e-01 3.35e-01 3.97e-01 1.94e-01
GOCC BRAHMA COMPLEX 14 3.92e-02 3.05e-01 0.40000 -3.91e-01 8.36e-02 1.13e-02 5.88e-01
GOMF MICROTUBULE MINUS END BINDING 13 6.06e-02 3.73e-01 0.40000 -3.21e-01 2.38e-01 4.50e-02 1.37e-01
GOBP POSITIVE REGULATION OF MAST CELL DEGRANULATION 12 6.59e-02 3.87e-01 0.40000 3.82e-01 -1.20e-01 2.21e-02 4.73e-01
GOBP REGULATION OF PROTEIN DEUBIQUITINATION 10 1.10e-01 4.79e-01 0.40000 1.67e-01 -3.63e-01 3.60e-01 4.69e-02
GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE 5 2.58e-01 6.72e-01 0.40000 -3.07e-01 -2.55e-01 2.34e-01 3.23e-01
GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION 15 3.08e-02 2.74e-01 0.40000 -3.92e-01 7.63e-02 8.53e-03 6.09e-01
GOBP DETERMINATION OF DIGESTIVE TRACT LEFT RIGHT ASYMMETRY 5 2.71e-01 6.85e-01 0.40000 3.75e-01 1.38e-01 1.46e-01 5.94e-01
GOBP OXALATE TRANSPORT 12 4.03e-02 3.08e-01 0.39900 3.42e-01 2.05e-01 3.99e-02 2.18e-01
GOMF LONG CHAIN FATTY ACID BINDING 17 1.23e-02 1.75e-01 0.39900 1.23e-01 3.80e-01 3.80e-01 6.74e-03
GOBP GLYOXYLATE METABOLIC PROCESS 8 1.15e-01 4.90e-01 0.39900 2.83e-01 2.81e-01 1.65e-01 1.69e-01
GOCC GABA RECEPTOR COMPLEX 18 1.02e-02 1.56e-01 0.39900 -3.88e-01 -9.17e-02 4.36e-03 5.00e-01
GOBP POINTED END ACTIN FILAMENT CAPPING 7 1.52e-01 5.48e-01 0.39900 -3.25e-01 -2.32e-01 1.37e-01 2.89e-01
GOMF NEDD8 TRANSFERASE ACTIVITY 7 2.08e-01 6.24e-01 0.39900 1.26e-01 -3.78e-01 5.64e-01 8.32e-02
GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING 11 9.49e-02 4.50e-01 0.39900 -3.15e-01 2.44e-01 7.02e-02 1.61e-01
GOBP BRONCHUS DEVELOPMENT 11 7.93e-02 4.19e-01 0.39900 3.91e-01 -7.88e-02 2.49e-02 6.51e-01
GOBP REGULATION OF MACROPHAGE FUSION 5 3.00e-01 7.11e-01 0.39800 -3.98e-01 3.81e-03 1.23e-01 9.88e-01
GOBP CHORIO ALLANTOIC FUSION 7 2.00e-01 6.12e-01 0.39800 8.04e-02 -3.90e-01 7.12e-01 7.37e-02
GOBP SECRETION OF LYSOSOMAL ENZYMES 7 1.79e-01 5.84e-01 0.39800 -2.94e-02 -3.97e-01 8.93e-01 6.87e-02
GOBP TELOMERIC LOOP DISASSEMBLY 9 1.37e-01 5.27e-01 0.39800 -1.57e-01 3.66e-01 4.14e-01 5.74e-02
GOBP VITAMIN D BIOSYNTHETIC PROCESS 10 1.14e-01 4.88e-01 0.39800 1.88e-01 -3.51e-01 3.04e-01 5.46e-02
GOBP POSITIVE REGULATION OF DENDRITIC SPINE MAINTENANCE 5 3.20e-01 7.28e-01 0.39800 -9.20e-02 3.87e-01 7.22e-01 1.34e-01
GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION 8 1.61e-01 5.59e-01 0.39800 8.75e-02 -3.88e-01 6.68e-01 5.75e-02
GOCC TRANSLOCON COMPLEX 5 2.94e-01 7.07e-01 0.39700 -3.67e-02 -3.96e-01 8.87e-01 1.26e-01
GOBP CELL FATE COMMITMENT INVOLVED IN PATTERN SPECIFICATION 11 8.56e-02 4.33e-01 0.39700 -3.78e-01 1.21e-01 2.98e-02 4.87e-01
Selenoamino acid metabolism 108 7.54e-11 1.89e-08 0.39700 1.83e-01 -3.52e-01 9.86e-04 2.53e-10
GOBP REGULATION OF INTESTINAL LIPID ABSORPTION 10 1.18e-01 4.93e-01 0.39700 -2.15e-01 3.34e-01 2.40e-01 6.75e-02
GOCC UBIQUINONE BIOSYNTHESIS COMPLEX 6 2.74e-01 6.87e-01 0.39700 1.94e-01 -3.46e-01 4.11e-01 1.42e-01
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION 6 2.09e-01 6.25e-01 0.39700 3.61e-01 1.65e-01 1.26e-01 4.84e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS 15 4.08e-02 3.09e-01 0.39700 -3.30e-01 2.20e-01 2.69e-02 1.39e-01
GOBP MUSCLE ATROPHY 11 5.66e-02 3.62e-01 0.39600 -3.57e-01 -1.73e-01 4.04e-02 3.21e-01
GOBP NEGATIVE REGULATION OF TELOMERE CAPPING 8 1.23e-01 5.01e-01 0.39600 -3.49e-01 -1.88e-01 8.77e-02 3.56e-01
GOMF OMEGA PEPTIDASE ACTIVITY 12 4.24e-02 3.14e-01 0.39600 3.40e-01 2.04e-01 4.15e-02 2.22e-01
GOBP REGULATION OF ACROSOME REACTION 18 1.52e-02 1.97e-01 0.39600 3.94e-01 -4.13e-02 3.82e-03 7.62e-01
GOMF MEMBRANE INSERTASE ACTIVITY 16 1.42e-02 1.90e-01 0.39600 -2.64e-01 -2.95e-01 6.72e-02 4.14e-02
GOMF MAP KINASE KINASE KINASE KINASE ACTIVITY 6 2.73e-01 6.85e-01 0.39500 -3.60e-01 1.62e-01 1.26e-01 4.91e-01
GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 9 9.23e-02 4.45e-01 0.39500 -2.50e-01 -3.06e-01 1.95e-01 1.12e-01
GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS 12 7.27e-02 4.04e-01 0.39500 3.68e-01 -1.42e-01 2.71e-02 3.93e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS 9 1.12e-01 4.84e-01 0.39500 -3.92e-01 -4.53e-02 4.16e-02 8.14e-01
Inhibition of Signaling by Overexpressed EGFR 8 1.46e-01 5.39e-01 0.39400 -2.98e-02 -3.93e-01 8.84e-01 5.42e-02
Signaling by Overexpressed Wild-Type EGFR in Cancer 8 1.46e-01 5.39e-01 0.39400 -2.98e-02 -3.93e-01 8.84e-01 5.42e-02
GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION 10 7.32e-02 4.05e-01 0.39300 -2.29e-01 -3.20e-01 2.09e-01 8.01e-02
GOMF OXYGEN SENSOR ACTIVITY 5 2.97e-01 7.09e-01 0.39300 -3.89e-01 -5.51e-02 1.32e-01 8.31e-01
Organic anion transport 5 2.81e-01 6.93e-01 0.39300 3.65e-01 1.45e-01 1.57e-01 5.74e-01
GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS 8 1.89e-01 5.96e-01 0.39300 3.12e-01 -2.39e-01 1.26e-01 2.43e-01
GOBP L CYSTINE TRANSPORT 6 2.27e-01 6.46e-01 0.39300 3.83e-01 8.77e-02 1.04e-01 7.10e-01
GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION 5 2.85e-01 6.97e-01 0.39300 -1.21e-01 -3.74e-01 6.40e-01 1.48e-01
GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT 5 3.49e-01 7.45e-01 0.39300 -3.38e-01 2.00e-01 1.91e-01 4.38e-01
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX 13 3.42e-02 2.87e-01 0.39300 -2.10e-01 -3.32e-01 1.90e-01 3.81e-02
GOBP NEGATIVE REGULATION OF RESPIRATORY BURST 6 2.86e-01 6.98e-01 0.39300 -2.25e-01 3.22e-01 3.41e-01 1.72e-01
GOBP REGULATION OF LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR 5 3.32e-01 7.35e-01 0.39300 -3.80e-01 1.00e-01 1.42e-01 6.97e-01
SIRT1 negatively regulates rRNA expression 30 8.04e-04 2.73e-02 0.39200 -2.52e-02 -3.92e-01 8.11e-01 2.05e-04
GOBP NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 7 1.76e-01 5.81e-01 0.39200 -1.06e-01 -3.78e-01 6.27e-01 8.35e-02
GOBP NOREPINEPHRINE SECRETION 14 3.01e-02 2.72e-01 0.39200 -3.73e-01 -1.22e-01 1.57e-02 4.31e-01
GOBP RNA 3 URIDYLATION 5 3.41e-01 7.40e-01 0.39200 -3.64e-01 1.45e-01 1.58e-01 5.75e-01
GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE 6 2.13e-01 6.29e-01 0.39200 3.34e-01 2.05e-01 1.57e-01 3.84e-01
GOBP T CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE 5 3.57e-01 7.49e-01 0.39200 2.89e-01 -2.64e-01 2.63e-01 3.06e-01
GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY 16 1.55e-02 1.98e-01 0.39200 2.81e-01 2.73e-01 5.20e-02 5.85e-02
GOBP OPTIC CUP MORPHOGENESIS INVOLVED IN CAMERA TYPE EYE DEVELOPMENT 7 1.67e-01 5.68e-01 0.39100 -3.45e-01 -1.84e-01 1.14e-01 3.98e-01
GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS 9 1.06e-01 4.74e-01 0.39100 -3.72e-01 -1.23e-01 5.35e-02 5.23e-01
GOBP PANCREATIC A CELL DIFFERENTIATION 10 8.93e-02 4.38e-01 0.39100 -3.86e-01 -6.24e-02 3.43e-02 7.33e-01
GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 10 1.28e-01 5.10e-01 0.39100 2.96e-01 -2.56e-01 1.05e-01 1.60e-01
GOMF INTRACELLULARLY CGMP ACTIVATED CATION CHANNEL ACTIVITY 6 2.10e-01 6.26e-01 0.39100 2.55e-01 2.96e-01 2.79e-01 2.09e-01
GOBP REGULATION OF INTESTINAL ABSORPTION 12 7.37e-02 4.06e-01 0.39100 -1.11e-01 3.75e-01 5.05e-01 2.46e-02
GOBP RHOMBOMERE DEVELOPMENT 8 1.47e-01 5.41e-01 0.39100 -3.87e-01 -5.29e-02 5.79e-02 7.95e-01
GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION 11 1.04e-01 4.70e-01 0.39100 2.42e-01 -3.07e-01 1.65e-01 7.81e-02
GOBP PROTEIN RETENTION IN ER LUMEN 8 1.58e-01 5.56e-01 0.39100 3.90e-01 -1.17e-02 5.58e-02 9.54e-01
GOMF BETA GLUCOSIDASE ACTIVITY 6 2.92e-01 7.05e-01 0.39100 -2.59e-01 2.92e-01 2.72e-01 2.15e-01
GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION 9 1.27e-01 5.10e-01 0.39000 -3.90e-01 1.61e-02 4.27e-02 9.33e-01
GOBP MAINTENANCE OF CENTROSOME LOCATION 6 2.20e-01 6.37e-01 0.39000 -1.64e-01 -3.54e-01 4.87e-01 1.33e-01
GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX 8 1.56e-01 5.52e-01 0.39000 -3.90e-01 -6.74e-03 5.60e-02 9.74e-01
GOBP PRESYNAPTIC MEMBRANE ORGANIZATION 6 2.56e-01 6.71e-01 0.39000 3.89e-01 -3.03e-02 9.89e-02 8.98e-01
GOBP EXOCYST LOCALIZATION 5 3.59e-01 7.51e-01 0.39000 -2.40e-01 3.07e-01 3.52e-01 2.34e-01
GOBP PYRAMIDAL NEURON DEVELOPMENT 9 1.27e-01 5.10e-01 0.39000 -3.90e-01 1.48e-02 4.29e-02 9.39e-01
GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DEVELOPMENT 5 3.61e-01 7.52e-01 0.39000 2.72e-01 -2.79e-01 2.93e-01 2.79e-01
GOBP DTTP METABOLIC PROCESS 5 3.03e-01 7.14e-01 0.39000 3.86e-01 5.59e-02 1.35e-01 8.29e-01
GOBP MICROGLIAL CELL MEDIATED CYTOTOXICITY 5 2.94e-01 7.07e-01 0.39000 -3.75e-01 -1.05e-01 1.46e-01 6.85e-01
Activated NTRK2 signals through PI3K 7 1.77e-01 5.81e-01 0.39000 -3.68e-01 -1.29e-01 9.21e-02 5.55e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB 18 2.57e-02 2.55e-01 0.38900 2.52e-01 -2.97e-01 6.42e-02 2.94e-02
GOBP TRNA TRANSPORT 6 2.84e-01 6.96e-01 0.38900 1.60e-01 -3.55e-01 4.98e-01 1.32e-01
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER 8 1.40e-01 5.31e-01 0.38900 -3.70e-01 -1.19e-01 6.97e-02 5.60e-01
GOBP TRICUSPID VALVE DEVELOPMENT 7 2.39e-01 6.55e-01 0.38900 -3.16e-01 2.27e-01 1.47e-01 2.99e-01
GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION 13 4.04e-02 3.08e-01 0.38900 -3.66e-01 -1.30e-01 2.22e-02 4.17e-01
GOMF MRNA METHYLTRANSFERASE ACTIVITY 13 3.69e-02 2.95e-01 0.38800 -3.25e-01 -2.12e-01 4.22e-02 1.86e-01
NR1H2 and NR1H3-mediated signaling 53 2.15e-05 1.58e-03 0.38800 -3.09e-01 2.36e-01 1.01e-04 3.02e-03
Signalling to p38 via RIT and RIN 5 2.79e-01 6.92e-01 0.38800 -3.05e-01 -2.40e-01 2.38e-01 3.52e-01
GOBP ENTRY OF BACTERIUM INTO HOST CELL 9 1.62e-01 5.61e-01 0.38800 -2.67e-01 2.81e-01 1.65e-01 1.44e-01
GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY 10 1.29e-01 5.13e-01 0.38800 -3.31e-01 2.03e-01 7.00e-02 2.67e-01
GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS 6 2.51e-01 6.66e-01 0.38800 1.12e-02 3.88e-01 9.62e-01 1.00e-01
GOCC TRANSCRIPTION EXPORT COMPLEX 11 6.16e-02 3.75e-01 0.38800 -2.14e-01 -3.23e-01 2.19e-01 6.32e-02
GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI 7 1.74e-01 5.78e-01 0.38800 3.48e-01 1.71e-01 1.11e-01 4.32e-01
GOBP NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY 9 1.53e-01 5.49e-01 0.38800 -1.59e-01 3.54e-01 4.09e-01 6.62e-02
GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT 56 1.78e-06 1.84e-04 0.38800 -6.09e-02 -3.83e-01 4.30e-01 7.16e-07
GOBP PYRAMIDAL NEURON DIFFERENTIATION 13 4.58e-02 3.26e-01 0.38800 -3.82e-01 -6.48e-02 1.70e-02 6.86e-01
GOBP FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY 5 3.19e-01 7.27e-01 0.38800 3.88e-01 1.89e-03 1.33e-01 9.94e-01
GOBP ELASTIN METABOLIC PROCESS 8 1.36e-01 5.24e-01 0.38700 -3.48e-01 -1.70e-01 8.83e-02 4.04e-01
IRF3 mediated activation of type 1 IFN 5 3.07e-01 7.16e-01 0.38700 3.83e-01 5.70e-02 1.38e-01 8.25e-01
GOMF ALPHA 1 3 FUCOSYLTRANSFERASE ACTIVITY 8 1.34e-01 5.21e-01 0.38700 3.33e-01 1.98e-01 1.03e-01 3.32e-01
GOBP FAS SIGNALING PATHWAY 8 1.38e-01 5.28e-01 0.38700 -1.56e-01 -3.54e-01 4.46e-01 8.25e-02
GOBP SUCCINATE METABOLIC PROCESS 7 2.01e-01 6.15e-01 0.38700 -3.87e-01 -1.22e-02 7.66e-02 9.55e-01
GOMF HEMOGLOBIN BINDING 9 1.33e-01 5.20e-01 0.38700 3.86e-01 -2.18e-02 4.49e-02 9.10e-01
GOBP POSITIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY 5 3.54e-01 7.47e-01 0.38700 3.54e-01 -1.55e-01 1.70e-01 5.49e-01
GOBP LACRIMAL GLAND DEVELOPMENT 7 2.39e-01 6.55e-01 0.38600 -3.39e-01 1.86e-01 1.21e-01 3.94e-01
GOBP NATURAL KILLER CELL CYTOKINE PRODUCTION 9 1.64e-01 5.63e-01 0.38600 2.36e-01 -3.06e-01 2.20e-01 1.12e-01
NFE2L2 regulating ER-stress associated genes 5 3.58e-01 7.50e-01 0.38600 -3.45e-01 1.75e-01 1.82e-01 4.98e-01
GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION 17 3.33e-02 2.85e-01 0.38600 -2.80e-01 2.66e-01 4.57e-02 5.74e-02
GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB 25 6.57e-03 1.18e-01 0.38600 2.33e-01 -3.08e-01 4.37e-02 7.68e-03
GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION 8 1.52e-01 5.47e-01 0.38600 -3.81e-01 -6.57e-02 6.23e-02 7.48e-01
GOMF SOMATOSTATIN RECEPTOR ACTIVITY 5 3.50e-01 7.45e-01 0.38600 -1.27e-01 3.64e-01 6.22e-01 1.58e-01
Defensins 32 1.62e-03 4.66e-02 0.38600 2.33e-01 -3.08e-01 2.25e-02 2.58e-03
GOBP MITOCHONDRIAL RNA MODIFICATION 8 1.84e-01 5.89e-01 0.38600 1.15e-01 -3.68e-01 5.73e-01 7.12e-02
GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY 7 2.44e-01 6.58e-01 0.38600 2.16e-01 -3.20e-01 3.22e-01 1.43e-01
GOBP RESPONSE TO INACTIVITY 12 8.83e-02 4.37e-01 0.38600 -3.26e-01 2.06e-01 5.04e-02 2.16e-01
GOBP FOREBRAIN NEUROBLAST DIVISION 6 2.30e-01 6.48e-01 0.38600 -3.57e-01 -1.46e-01 1.30e-01 5.36e-01
GOMF RRNA BINDING 62 3.14e-06 3.02e-04 0.38500 1.72e-01 -3.45e-01 1.95e-02 2.57e-06
Glycine degradation 6 2.27e-01 6.46e-01 0.38500 -3.46e-01 -1.71e-01 1.43e-01 4.69e-01
GOBP MUSCULAR SEPTUM MORPHOGENESIS 5 3.69e-01 7.58e-01 0.38500 -2.43e-01 2.98e-01 3.46e-01 2.48e-01
GOBP HYPOTONIC RESPONSE 13 5.61e-02 3.60e-01 0.38500 3.84e-01 -2.65e-02 1.65e-02 8.69e-01
GOBP RESPONSE TO 2 3 7 8 TETRACHLORODIBENZODIOXINE 5 3.18e-01 7.25e-01 0.38500 3.84e-01 2.84e-02 1.37e-01 9.12e-01
GOMF FERRIC IRON BINDING 9 1.14e-01 4.88e-01 0.38500 3.64e-01 1.26e-01 5.90e-02 5.12e-01
GOCC NPBAF COMPLEX 14 5.49e-02 3.57e-01 0.38500 -3.59e-01 1.38e-01 1.99e-02 3.73e-01
GOBP ALKALOID METABOLIC PROCESS 7 2.05e-01 6.21e-01 0.38500 8.72e-03 3.85e-01 9.68e-01 7.81e-02
GOMF SODIUM BICARBONATE SYMPORTER ACTIVITY 6 2.31e-01 6.48e-01 0.38400 1.57e-01 3.51e-01 5.05e-01 1.37e-01
GOCC TRNA SPLICING LIGASE COMPLEX 8 1.52e-01 5.48e-01 0.38400 -8.02e-02 -3.76e-01 6.94e-01 6.55e-02
GOBP PROTEIN RETENTION IN GOLGI APPARATUS 5 3.69e-01 7.58e-01 0.38400 -3.07e-01 2.31e-01 2.34e-01 3.72e-01
GOBP 4FE 4S CLUSTER ASSEMBLY 5 3.07e-01 7.16e-01 0.38400 -8.78e-02 -3.74e-01 7.34e-01 1.47e-01
GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION 6 3.04e-01 7.14e-01 0.38400 -2.87e-01 2.55e-01 2.23e-01 2.79e-01
CaMK IV-mediated phosphorylation of CREB 10 1.18e-01 4.94e-01 0.38400 -8.11e-02 3.75e-01 6.57e-01 3.98e-02
Negative regulation of activity of TFAP2 (AP-2) family transcription factors 10 1.13e-01 4.87e-01 0.38400 -3.81e-01 4.71e-02 3.69e-02 7.97e-01
GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT 13 4.50e-02 3.24e-01 0.38400 1.10e-01 3.68e-01 4.91e-01 2.17e-02
GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB 7 2.44e-01 6.58e-01 0.38400 1.84e-01 -3.37e-01 4.00e-01 1.23e-01
GOCC NBAF COMPLEX 16 3.49e-02 2.89e-01 0.38300 -3.69e-01 1.04e-01 1.06e-02 4.71e-01
GOBP CELLULAR RESPONSE TO IRON ION 7 2.41e-01 6.57e-01 0.38300 1.64e-01 -3.47e-01 4.53e-01 1.12e-01
GOMF OXALATE TRANSMEMBRANE TRANSPORTER ACTIVITY 10 9.27e-02 4.45e-01 0.38300 3.67e-01 1.10e-01 4.44e-02 5.45e-01
GOMF 5ALPHA ANDROSTANE 3BETA 17BETA DIOL DEHYDROGENASE ACTIVITY 6 3.06e-01 7.15e-01 0.38300 2.90e-01 -2.51e-01 2.19e-01 2.87e-01
GOCC EMC COMPLEX 9 1.06e-01 4.74e-01 0.38300 -2.85e-01 -2.56e-01 1.38e-01 1.84e-01
GOMF SPHINGOSINE 1 PHOSPHATE RECEPTOR ACTIVITY 8 1.75e-01 5.80e-01 0.38300 3.79e-02 -3.81e-01 8.53e-01 6.19e-02
GOMF LIPOPEPTIDE BINDING 10 1.40e-01 5.31e-01 0.38300 2.57e-01 -2.84e-01 1.60e-01 1.20e-01
GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING 11 9.79e-02 4.57e-01 0.38300 8.66e-02 -3.73e-01 6.19e-01 3.22e-02
GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT 27 2.40e-03 6.22e-02 0.38300 -3.83e-01 -5.52e-03 5.76e-04 9.60e-01
GOBP ER OVERLOAD RESPONSE 11 9.24e-02 4.45e-01 0.38300 4.46e-02 -3.80e-01 7.98e-01 2.91e-02
GOMF S METHYLTRANSFERASE ACTIVITY 10 1.20e-01 4.98e-01 0.38300 -3.74e-01 8.09e-02 4.06e-02 6.58e-01
GOBP CEREBRAL CORTEX REGIONALIZATION 7 2.14e-01 6.31e-01 0.38300 -3.82e-01 1.65e-02 8.00e-02 9.40e-01
GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION 11 6.87e-02 3.95e-01 0.38200 3.40e-01 1.75e-01 5.11e-02 3.14e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION 9 1.16e-01 4.90e-01 0.38200 -3.57e-01 -1.36e-01 6.38e-02 4.80e-01
FGFR3 mutant receptor activation 11 1.08e-01 4.77e-01 0.38200 -1.58e-01 3.48e-01 3.66e-01 4.58e-02
Signaling by activated point mutants of FGFR3 11 1.08e-01 4.77e-01 0.38200 -1.58e-01 3.48e-01 3.66e-01 4.58e-02
GOCC RADIAL SPOKE HEAD 5 3.60e-01 7.51e-01 0.38200 -3.58e-01 1.34e-01 1.66e-01 6.05e-01
GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 9 1.62e-01 5.61e-01 0.38200 -3.50e-01 1.53e-01 6.93e-02 4.27e-01
Toxicity of botulinum toxin type D (botD) 5 3.08e-01 7.17e-01 0.38100 -1.08e-01 -3.66e-01 6.75e-01 1.57e-01
Toxicity of botulinum toxin type F (botF) 5 3.08e-01 7.17e-01 0.38100 -1.08e-01 -3.66e-01 6.75e-01 1.57e-01
GOBP URINARY BLADDER SMOOTH MUSCLE CONTRACTION 7 2.34e-01 6.50e-01 0.38100 -3.67e-01 1.02e-01 9.22e-02 6.41e-01
GOBP URONIC ACID METABOLIC PROCESS 24 9.17e-03 1.46e-01 0.38100 2.96e-01 -2.41e-01 1.21e-02 4.13e-02
GOBP MACROPHAGE PROLIFERATION 12 8.86e-02 4.37e-01 0.38100 -3.50e-01 1.50e-01 3.57e-02 3.67e-01
GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION 9 1.57e-01 5.53e-01 0.38100 1.14e-01 -3.64e-01 5.53e-01 5.89e-02
GOBP CELL PROLIFERATION IN BONE MARROW 10 8.85e-02 4.37e-01 0.38100 -3.33e-01 -1.85e-01 6.86e-02 3.10e-01
GOCC WASH COMPLEX 13 4.09e-02 3.09e-01 0.38100 -2.48e-01 -2.89e-01 1.21e-01 7.14e-02
GOBP CARTILAGE CONDENSATION 19 2.49e-02 2.52e-01 0.38100 -2.81e-01 2.57e-01 3.41e-02 5.24e-02
GOBP GABAERGIC NEURON DIFFERENTIATION 18 1.19e-02 1.72e-01 0.38100 -2.67e-01 -2.71e-01 4.95e-02 4.67e-02
GOBP REGULATION OF MUCUS SECRETION 9 1.11e-01 4.83e-01 0.38000 3.16e-01 2.12e-01 1.01e-01 2.71e-01
GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS 16 2.43e-02 2.51e-01 0.38000 3.69e-01 9.41e-02 1.07e-02 5.15e-01
GOCC RIPOPTOSOME 6 3.12e-01 7.20e-01 0.38000 2.47e-01 -2.89e-01 2.95e-01 2.20e-01
AKT phosphorylates targets in the nucleus 9 1.48e-01 5.42e-01 0.38000 -5.45e-02 3.76e-01 7.77e-01 5.06e-02
Miscellaneous substrates 12 9.08e-02 4.43e-01 0.38000 3.44e-01 -1.61e-01 3.89e-02 3.33e-01
GOBP CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS 11 7.94e-02 4.19e-01 0.38000 -3.72e-01 -8.03e-02 3.29e-02 6.45e-01
GOCC CD95 DEATH INDUCING SIGNALING COMPLEX 6 2.95e-01 7.07e-01 0.38000 1.27e-01 -3.58e-01 5.90e-01 1.29e-01
SARS-CoV-2 modulates autophagy 11 8.33e-02 4.29e-01 0.38000 -3.77e-01 -4.81e-02 3.04e-02 7.82e-01
GOBP GONADOTROPIN SECRETION 18 1.79e-02 2.13e-01 0.38000 -3.79e-01 -2.96e-02 5.40e-03 8.28e-01
GOCC PYRUVATE DEHYDROGENASE COMPLEX 5 3.44e-01 7.41e-01 0.38000 -4.31e-02 3.77e-01 8.67e-01 1.44e-01
GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION 5 3.05e-01 7.15e-01 0.38000 -1.45e-01 -3.51e-01 5.76e-01 1.74e-01
GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX 6 3.09e-01 7.18e-01 0.38000 3.17e-01 -2.09e-01 1.78e-01 3.75e-01
GOCC SEMAPHORIN RECEPTOR COMPLEX 11 1.05e-01 4.71e-01 0.38000 -1.09e-01 3.64e-01 5.31e-01 3.67e-02
GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING 8 1.85e-01 5.89e-01 0.38000 5.90e-02 -3.75e-01 7.73e-01 6.63e-02
Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion 8 1.42e-01 5.33e-01 0.37900 2.48e-01 2.87e-01 2.25e-01 1.59e-01
GOMF DOUBLE STRANDED RNA ADENOSINE DEAMINASE ACTIVITY 6 2.77e-01 6.91e-01 0.37900 -3.63e-02 3.78e-01 8.78e-01 1.09e-01
GOBP PLASMA MEMBRANE TUBULATION 19 2.53e-02 2.54e-01 0.37900 -2.95e-01 2.39e-01 2.61e-02 7.17e-02
Interleukin-12 signaling 43 2.40e-04 1.13e-02 0.37900 2.26e-01 -3.04e-01 1.02e-02 5.55e-04
GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY 8 1.86e-01 5.92e-01 0.37900 3.74e-01 -6.14e-02 6.70e-02 7.64e-01
GOBP SOMATOSTATIN RECEPTOR SIGNALING PATHWAY 6 3.15e-01 7.22e-01 0.37900 -2.64e-01 2.71e-01 2.62e-01 2.50e-01
GOCC CBM COMPLEX 5 2.97e-01 7.09e-01 0.37900 2.31e-01 3.00e-01 3.71e-01 2.45e-01
GOBP DESMOSOME ORGANIZATION 10 1.14e-01 4.88e-01 0.37900 3.79e-01 -6.46e-03 3.80e-02 9.72e-01
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 29 1.28e-03 3.97e-02 0.37900 -8.95e-02 -3.68e-01 4.04e-01 6.01e-04
GOBP POSITIVE REGULATION OF TOOTH MINERALIZATION 7 2.34e-01 6.50e-01 0.37900 8.06e-02 -3.70e-01 7.12e-01 8.99e-02
GOBP CELLULAR RESPONSE TO VITAMIN 28 1.28e-03 3.97e-02 0.37900 -3.41e-01 -1.65e-01 1.79e-03 1.31e-01
GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY 10 1.39e-01 5.29e-01 0.37900 -3.40e-01 1.67e-01 6.28e-02 3.60e-01
GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE 8 1.70e-01 5.71e-01 0.37800 -3.77e-01 -2.83e-02 6.45e-02 8.90e-01
GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY 8 1.70e-01 5.71e-01 0.37800 -3.77e-01 -2.83e-02 6.45e-02 8.90e-01
GOCC FASCIA ADHERENS 9 1.61e-01 5.59e-01 0.37800 -3.61e-01 1.14e-01 6.09e-02 5.54e-01
GOBP FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION 7 2.51e-01 6.65e-01 0.37800 1.64e-01 -3.41e-01 4.52e-01 1.18e-01
GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR 5 3.60e-01 7.52e-01 0.37800 1.03e-01 -3.64e-01 6.91e-01 1.59e-01
Carnitine shuttle 13 7.71e-02 4.14e-01 0.37800 -3.40e-01 1.65e-01 3.37e-02 3.03e-01
GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY 9 1.38e-01 5.28e-01 0.37800 3.77e-01 2.11e-02 4.99e-02 9.13e-01
GOMF UNMETHYLATED CPG BINDING 9 1.63e-01 5.62e-01 0.37800 -3.58e-01 1.21e-01 6.29e-02 5.29e-01
GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY 9 1.37e-01 5.27e-01 0.37800 -3.77e-01 -2.64e-02 5.02e-02 8.91e-01
GOBP CHRONIC INFLAMMATORY RESPONSE 18 2.98e-02 2.71e-01 0.37800 3.30e-01 -1.84e-01 1.53e-02 1.77e-01
GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION 5 3.10e-01 7.19e-01 0.37800 -3.52e-01 -1.37e-01 1.73e-01 5.95e-01
GOBP SPINAL CORD PATTERNING 18 2.86e-02 2.68e-01 0.37800 -3.44e-01 1.56e-01 1.16e-02 2.52e-01
GOMF C X C CHEMOKINE BINDING 5 3.08e-01 7.17e-01 0.37700 1.54e-01 3.44e-01 5.51e-01 1.82e-01
GOCC FEMALE PRONUCLEUS 10 1.17e-01 4.91e-01 0.37700 1.14e-02 -3.77e-01 9.50e-01 3.90e-02
GOBP TYPE III INTERFERON PRODUCTION 5 3.10e-01 7.19e-01 0.37700 -1.42e-01 -3.49e-01 5.82e-01 1.76e-01
GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY 14 6.24e-02 3.77e-01 0.37700 -3.48e-01 1.45e-01 2.40e-02 3.49e-01
GOBP FATTY ACID ALPHA OXIDATION 8 1.78e-01 5.83e-01 0.37700 3.30e-03 -3.77e-01 9.87e-01 6.49e-02
Regulation of NPAS4 gene transcription 5 3.48e-01 7.44e-01 0.37700 3.74e-02 -3.75e-01 8.85e-01 1.46e-01
GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING 9 1.52e-01 5.48e-01 0.37700 -3.74e-01 5.02e-02 5.23e-02 7.94e-01
GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE 18 3.23e-02 2.81e-01 0.37700 2.39e-01 -2.91e-01 7.95e-02 3.24e-02
GOBP T CELL TOLERANCE INDUCTION 14 6.75e-02 3.92e-01 0.37600 3.19e-01 -1.99e-01 3.86e-02 1.97e-01
GOMF MOLYBDOPTERIN COFACTOR BINDING 6 3.06e-01 7.16e-01 0.37600 -3.48e-01 1.43e-01 1.40e-01 5.45e-01
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism 11 1.24e-01 5.04e-01 0.37600 -2.47e-01 2.83e-01 1.56e-01 1.04e-01
GOBP CYTOPLASMIC TRANSLATION 147 2.06e-13 7.91e-11 0.37600 1.18e-01 -3.57e-01 1.38e-02 7.75e-14
GOBP REGULATION OF FEAR RESPONSE 10 9.67e-02 4.54e-01 0.37600 -3.42e-01 -1.56e-01 6.13e-02 3.93e-01
Activation of the phototransduction cascade 11 9.47e-02 4.50e-01 0.37500 -5.39e-05 3.75e-01 1.00e+00 3.11e-02
GOMF BUBBLE DNA BINDING 8 2.19e-01 6.37e-01 0.37500 -3.00e-01 2.25e-01 1.42e-01 2.70e-01
Ficolins bind to repetitive carbohydrate structures on the target cell surface 5 3.21e-01 7.28e-01 0.37500 3.61e-01 1.04e-01 1.63e-01 6.88e-01
Bicarbonate transporters 10 9.32e-02 4.46e-01 0.37500 2.12e-01 3.10e-01 2.46e-01 9.00e-02
GOMF RETINOIC ACID RESPONSIVE ELEMENT BINDING 6 3.10e-01 7.19e-01 0.37500 -3.43e-01 1.51e-01 1.45e-01 5.23e-01
tRNA modification in the mitochondrion 8 1.79e-01 5.83e-01 0.37500 -9.61e-03 -3.75e-01 9.62e-01 6.64e-02
GOBP CELLULAR RESPONSE TO VITAMIN D 21 8.72e-03 1.42e-01 0.37500 -3.63e-01 -9.40e-02 3.98e-03 4.56e-01
GOCC CENTRAL ELEMENT 7 2.67e-01 6.81e-01 0.37500 -2.85e-01 2.44e-01 1.92e-01 2.64e-01
GOMF TITIN BINDING 13 8.39e-02 4.31e-01 0.37500 -2.05e-01 3.14e-01 2.01e-01 5.00e-02
GOMF POTASSIUM CHANNEL INHIBITOR ACTIVITY 5 3.11e-01 7.20e-01 0.37500 -1.63e-01 -3.38e-01 5.28e-01 1.91e-01
Influenza Viral RNA Transcription and Replication 130 8.17e-12 2.33e-09 0.37500 1.30e-01 -3.52e-01 1.07e-02 4.29e-12
GOBP INTERCELLULAR TRANSPORT 10 9.22e-02 4.45e-01 0.37500 2.46e-01 2.83e-01 1.78e-01 1.21e-01
GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION 14 5.90e-02 3.69e-01 0.37500 -3.65e-01 8.66e-02 1.82e-02 5.75e-01
GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION 6 2.86e-01 6.98e-01 0.37500 -3.49e-02 3.73e-01 8.82e-01 1.14e-01
GOBP POSITIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS 6 2.49e-01 6.63e-01 0.37500 1.53e-01 3.42e-01 5.17e-01 1.47e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE 5 3.79e-01 7.64e-01 0.37400 -1.57e-01 3.40e-01 5.42e-01 1.88e-01
GOBP MONOACYLGLYCEROL CATABOLIC PROCESS 7 2.64e-01 6.79e-01 0.37400 -3.15e-01 2.03e-01 1.49e-01 3.52e-01
FGFR1c ligand binding and activation 13 8.58e-02 4.33e-01 0.37400 -2.99e-01 2.25e-01 6.18e-02 1.60e-01
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS 7 1.91e-01 5.98e-01 0.37400 3.05e-01 2.17e-01 1.62e-01 3.21e-01
GOMF GLUCOSE BINDING 10 1.36e-01 5.24e-01 0.37400 -1.00e-01 3.60e-01 5.84e-01 4.85e-02
GOMF SEMAPHORIN RECEPTOR ACTIVITY 10 1.35e-01 5.24e-01 0.37400 -9.58e-02 3.61e-01 6.00e-01 4.78e-02
GOBP CDP CHOLINE PATHWAY 6 3.07e-01 7.16e-01 0.37400 3.52e-01 -1.25e-01 1.35e-01 5.96e-01
FGFR3 ligand binding and activation 12 8.83e-02 4.37e-01 0.37400 -7.68e-02 3.66e-01 6.45e-01 2.83e-02
FGFR3c ligand binding and activation 12 8.83e-02 4.37e-01 0.37400 -7.68e-02 3.66e-01 6.45e-01 2.83e-02
GOBP AMACRINE CELL DIFFERENTIATION 12 7.64e-02 4.14e-01 0.37400 -3.73e-01 -1.61e-02 2.52e-02 9.23e-01
GOBP GASTRIC MOTILITY 5 3.81e-01 7.65e-01 0.37300 -3.40e-01 1.55e-01 1.88e-01 5.49e-01
Defects of platelet adhesion to exposed collagen 8 2.19e-01 6.37e-01 0.37300 -3.20e-01 1.91e-01 1.17e-01 3.49e-01
GOMF GABA RECEPTOR ACTIVITY 19 1.47e-02 1.92e-01 0.37300 -3.64e-01 -8.09e-02 5.97e-03 5.41e-01
GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE 17 4.19e-02 3.12e-01 0.37300 -2.74e-01 2.53e-01 5.04e-02 7.10e-02
Influenza Infection 149 2.76e-13 1.03e-10 0.37300 1.30e-01 -3.49e-01 6.15e-03 1.75e-13
Digestion of dietary carbohydrate 6 2.54e-01 6.69e-01 0.37300 3.46e-01 1.38e-01 1.42e-01 5.57e-01
GOBP REGULATION OF MESODERMAL CELL FATE SPECIFICATION 6 3.25e-01 7.29e-01 0.37300 -2.18e-01 3.02e-01 3.55e-01 2.00e-01
GOMF ATP ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY 6 2.50e-01 6.65e-01 0.37200 1.66e-01 3.34e-01 4.82e-01 1.57e-01
GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS 14 3.77e-02 2.98e-01 0.37200 3.03e-01 2.17e-01 4.99e-02 1.60e-01
GOMF 7S RNA BINDING 7 1.93e-01 6.02e-01 0.37200 -2.82e-01 -2.43e-01 1.97e-01 2.65e-01
GOBP INDUCTION OF POSITIVE CHEMOTAXIS 13 6.13e-02 3.74e-01 0.37200 3.32e-02 3.71e-01 8.36e-01 2.07e-02
GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 14 6.88e-02 3.95e-01 0.37200 -1.58e-01 3.37e-01 3.06e-01 2.92e-02
GOBP REGULATION OF RIBOSOME BIOGENESIS 6 2.88e-01 7.01e-01 0.37200 -3.71e-01 2.13e-02 1.15e-01 9.28e-01
Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation 11 1.28e-01 5.12e-01 0.37200 2.16e-01 -3.02e-01 2.14e-01 8.26e-02
GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION 5 3.65e-01 7.55e-01 0.37200 -3.66e-01 6.61e-02 1.57e-01 7.98e-01
GOBP NEGATIVE REGULATION OF CELL VOLUME 5 3.27e-01 7.30e-01 0.37100 -3.55e-01 -1.10e-01 1.70e-01 6.70e-01
Glycogen breakdown (glycogenolysis) 11 1.28e-01 5.12e-01 0.37100 -3.06e-01 2.10e-01 7.88e-02 2.27e-01
GOBP CRANIAL GANGLION DEVELOPMENT 5 3.48e-01 7.44e-01 0.37100 -3.71e-01 -9.02e-03 1.51e-01 9.72e-01
GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX 8 1.93e-01 6.01e-01 0.37100 2.82e-02 -3.70e-01 8.90e-01 6.98e-02
GOBP REGULATION OF HEPATIC STELLATE CELL ACTIVATION 7 2.67e-01 6.81e-01 0.37100 -3.27e-01 1.76e-01 1.34e-01 4.21e-01
GOBP NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION 10 1.56e-01 5.52e-01 0.37100 2.99e-01 -2.19e-01 1.01e-01 2.30e-01
GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE 15 5.37e-02 3.52e-01 0.37100 -3.53e-01 1.13e-01 1.78e-02 4.50e-01
Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) 12 7.22e-02 4.04e-01 0.37100 -7.60e-02 -3.63e-01 6.48e-01 2.94e-02
GOMF DIHYDROPYRIMIDINASE ACTIVITY 6 3.30e-01 7.34e-01 0.37100 -2.69e-01 2.56e-01 2.55e-01 2.78e-01
GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION 9 1.24e-01 5.04e-01 0.37100 -2.13e-01 -3.03e-01 2.68e-01 1.15e-01
GOBP SULFUR AMINO ACID CATABOLIC PROCESS 9 1.68e-01 5.69e-01 0.37100 3.61e-01 -8.45e-02 6.08e-02 6.61e-01
GOMF TRANSPORTER ACTIVATOR ACTIVITY 8 1.65e-01 5.66e-01 0.37100 -1.30e-01 -3.47e-01 5.25e-01 8.92e-02
GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT 45 1.41e-04 7.86e-03 0.37000 -3.60e-01 8.76e-02 2.95e-05 3.10e-01
Replacement of protamines by nucleosomes in the male pronucleus 22 1.27e-02 1.78e-01 0.37000 7.54e-02 -3.62e-01 5.41e-01 3.26e-03
GOBP THYROID STIMULATING HORMONE SECRETING CELL DIFFERENTIATION 6 2.70e-01 6.85e-01 0.37000 7.73e-02 3.62e-01 7.43e-01 1.25e-01
GOBP POSITIVE REGULATION OF HEPATIC STELLATE CELL ACTIVATION 5 3.87e-01 7.68e-01 0.37000 -3.39e-01 1.47e-01 1.89e-01 5.68e-01
GOBP FLAVONOID METABOLIC PROCESS 11 8.50e-02 4.33e-01 0.37000 3.46e-01 1.31e-01 4.71e-02 4.52e-01
GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN THERMOCEPTION 5 3.78e-01 7.64e-01 0.36900 -1.05e-01 3.54e-01 6.85e-01 1.70e-01
GOBP NEGATIVE REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS 6 3.03e-01 7.14e-01 0.36900 3.64e-01 -6.46e-02 1.23e-01 7.84e-01
GOBP GAMMA AMINOBUTYRIC ACID SECRETION 13 8.74e-02 4.37e-01 0.36900 -3.27e-01 1.71e-01 4.09e-02 2.85e-01
GOBP D ASPARTATE TRANSMEMBRANE TRANSPORT 5 3.48e-01 7.44e-01 0.36900 2.74e-02 3.68e-01 9.15e-01 1.54e-01
GOCC CLATHRIN SCULPTED GAMMA AMINOBUTYRIC ACID TRANSPORT VESICLE 8 1.57e-01 5.55e-01 0.36900 -2.86e-01 -2.33e-01 1.61e-01 2.54e-01
GOMF LEUKOTRIENE C4 SYNTHASE ACTIVITY 5 3.17e-01 7.25e-01 0.36900 -2.01e-01 -3.10e-01 4.36e-01 2.31e-01
GOMF COENZYME A DIPHOSPHATASE ACTIVITY 5 3.94e-01 7.74e-01 0.36900 1.82e-01 -3.21e-01 4.81e-01 2.14e-01
GOBP DE NOVO NAD BIOSYNTHETIC PROCESS 8 1.91e-01 5.99e-01 0.36900 3.69e-01 -2.42e-03 7.08e-02 9.91e-01
GOBP INNER EAR RECEPTOR CELL FATE COMMITMENT 5 3.15e-01 7.22e-01 0.36900 2.45e-01 2.76e-01 3.42e-01 2.86e-01
GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY 9 1.27e-01 5.10e-01 0.36900 -3.11e-01 -1.99e-01 1.07e-01 3.01e-01
GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 22 1.21e-02 1.73e-01 0.36900 -3.66e-01 4.42e-02 2.96e-03 7.20e-01
GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION 8 2.24e-01 6.42e-01 0.36900 3.29e-01 -1.66e-01 1.07e-01 4.16e-01
GOCC FLOTILLIN COMPLEX 9 1.53e-01 5.49e-01 0.36900 -3.68e-01 -1.49e-02 5.57e-02 9.39e-01
GOCC ENDOLYSOSOME 26 8.31e-03 1.37e-01 0.36900 -3.10e-01 2.00e-01 6.25e-03 7.80e-02
GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION 7 1.99e-01 6.12e-01 0.36800 -2.71e-01 -2.49e-01 2.14e-01 2.54e-01
Cellular hexose transport 22 1.23e-02 1.75e-01 0.36800 3.65e-01 -4.57e-02 3.02e-03 7.11e-01
GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS 7 2.54e-01 6.69e-01 0.36800 -3.60e-01 7.68e-02 9.92e-02 7.25e-01
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION 11 1.12e-01 4.84e-01 0.36800 -5.03e-02 3.64e-01 7.73e-01 3.64e-02
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY 27 7.40e-03 1.27e-01 0.36800 2.38e-01 -2.80e-01 3.23e-02 1.16e-02
GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION 11 1.02e-01 4.66e-01 0.36800 -1.64e-02 -3.67e-01 9.25e-01 3.48e-02
GOBP SIGNAL COMPLEX ASSEMBLY 8 1.64e-01 5.63e-01 0.36800 -3.21e-01 -1.80e-01 1.16e-01 3.79e-01
Defective CHST3 causes SEDCJD 7 2.33e-01 6.50e-01 0.36800 -3.67e-01 -1.89e-02 9.26e-02 9.31e-01
APOBEC3G mediated resistance to HIV-1 infection 5 4.03e-01 7.80e-01 0.36800 2.79e-01 -2.40e-01 2.81e-01 3.53e-01
GOMF MITOCHONDRION TARGETING SEQUENCE BINDING 6 3.33e-01 7.35e-01 0.36700 1.99e-01 -3.09e-01 4.00e-01 1.90e-01
GOBP REGULATION OF MYOBLAST PROLIFERATION 25 9.76e-03 1.51e-01 0.36700 -3.25e-01 1.70e-01 4.84e-03 1.41e-01
GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION 28 3.20e-03 7.68e-02 0.36700 -3.67e-01 -2.17e-03 7.68e-04 9.84e-01
GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION 5 3.26e-01 7.30e-01 0.36700 -1.64e-01 -3.28e-01 5.25e-01 2.04e-01
B-WICH complex positively regulates rRNA expression 54 7.75e-06 6.62e-04 0.36700 -1.07e-01 -3.51e-01 1.75e-01 8.00e-06
GOBP REGULATION OF SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING 7 2.05e-01 6.20e-01 0.36700 3.08e-01 1.99e-01 1.58e-01 3.63e-01
GOBP REGULATION OF TRANSLATIONAL TERMINATION 8 2.28e-01 6.46e-01 0.36700 3.24e-01 -1.72e-01 1.12e-01 4.00e-01
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION 9 1.95e-01 6.06e-01 0.36700 -2.18e-01 2.95e-01 2.57e-01 1.26e-01
GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM 13 7.54e-02 4.12e-01 0.36700 3.64e-01 -4.40e-02 2.30e-02 7.83e-01
Interleukin-1 processing 9 1.73e-01 5.78e-01 0.36700 3.59e-01 -7.68e-02 6.24e-02 6.90e-01
GOMF RNA POLYMERASE I GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY 5 3.44e-01 7.42e-01 0.36700 6.82e-02 3.60e-01 7.92e-01 1.63e-01
GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 12 1.10e-01 4.81e-01 0.36700 -1.79e-01 3.20e-01 2.82e-01 5.51e-02
GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS 9 1.77e-01 5.83e-01 0.36700 3.54e-01 -9.61e-02 6.60e-02 6.18e-01
GOMF PHOSPHOSERINE RESIDUE BINDING 10 1.57e-01 5.54e-01 0.36700 1.66e-01 -3.27e-01 3.64e-01 7.33e-02
Gamma-carboxylation, transport, and amino-terminal cleavage of proteins 9 1.58e-01 5.56e-01 0.36600 5.01e-03 3.66e-01 9.79e-01 5.70e-02
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MATRIX ADHESION VIA FIBRONECTIN 5 4.06e-01 7.81e-01 0.36600 2.78e-01 -2.38e-01 2.81e-01 3.56e-01
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY 7 2.77e-01 6.90e-01 0.36600 -1.80e-01 3.19e-01 4.09e-01 1.44e-01
GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING 29 5.28e-03 1.02e-01 0.36600 2.91e-01 -2.23e-01 6.68e-03 3.79e-02
GOBP CORONARY VASCULATURE MORPHOGENESIS 19 3.27e-02 2.82e-01 0.36600 -2.66e-01 2.52e-01 4.47e-02 5.73e-02
GOCC CELL TIP 7 2.81e-01 6.94e-01 0.36600 -3.00e-01 2.10e-01 1.70e-01 3.36e-01
GOCC BETA CATENIN TCF COMPLEX 13 5.20e-02 3.45e-01 0.36600 -2.54e-01 -2.64e-01 1.13e-01 9.96e-02
GOBP RENAL ALBUMIN ABSORPTION 6 3.40e-01 7.40e-01 0.36600 -2.48e-01 2.69e-01 2.92e-01 2.55e-01
GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION 14 7.54e-02 4.12e-01 0.36600 -3.30e-01 1.59e-01 3.28e-02 3.04e-01
GOBP REGULATION OF GLOMERULAR FILTRATION 8 2.26e-01 6.44e-01 0.36600 3.36e-01 -1.44e-01 9.96e-02 4.81e-01
GOBP NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 6 3.39e-01 7.39e-01 0.36600 -2.89e-01 2.24e-01 2.21e-01 3.42e-01
GOBP ADENOSINE METABOLIC PROCESS 10 1.62e-01 5.61e-01 0.36600 -1.88e-01 3.13e-01 3.03e-01 8.61e-02
GOBP SOFT PALATE DEVELOPMENT 5 3.98e-01 7.76e-01 0.36500 -3.30e-01 1.56e-01 2.01e-01 5.45e-01
LDL remodeling 6 2.73e-01 6.85e-01 0.36500 -1.09e-01 -3.49e-01 6.43e-01 1.39e-01
Termination of O-glycan biosynthesis 25 4.40e-03 9.19e-02 0.36500 3.46e-01 1.16e-01 2.72e-03 3.15e-01
GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY 9 1.53e-01 5.48e-01 0.36500 4.49e-02 3.62e-01 8.16e-01 5.97e-02
GOBP BUD ELONGATION INVOLVED IN LUNG BRANCHING 7 2.14e-01 6.31e-01 0.36500 -3.35e-01 -1.46e-01 1.25e-01 5.03e-01
GOMF RNA POLYMERASE II ACTIVITY 9 1.34e-01 5.21e-01 0.36500 -3.14e-01 -1.87e-01 1.03e-01 3.31e-01
GOBP REGULATION OF HEART RATE BY CHEMICAL SIGNAL 6 3.39e-01 7.39e-01 0.36500 -2.98e-01 2.10e-01 2.06e-01 3.72e-01
GOBP CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING 5 3.30e-01 7.34e-01 0.36500 3.27e-01 1.63e-01 2.06e-01 5.29e-01
GOBP POSITIVE REGULATION OF FEVER GENERATION 7 2.39e-01 6.55e-01 0.36500 3.65e-01 1.46e-02 9.48e-02 9.47e-01
GOMF INTERMEDIATE FILAMENT BINDING 10 1.04e-01 4.70e-01 0.36500 2.67e-01 2.49e-01 1.44e-01 1.73e-01
GOBP REGULATION OF CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP 5 3.36e-01 7.36e-01 0.36500 -3.42e-01 -1.26e-01 1.85e-01 6.26e-01
GOMF MHC CLASS IB PROTEIN BINDING 7 2.78e-01 6.91e-01 0.36500 1.66e-01 -3.25e-01 4.47e-01 1.37e-01
GOBP REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION 7 2.06e-01 6.21e-01 0.36500 -2.44e-01 -2.71e-01 2.63e-01 2.15e-01
GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME 13 9.36e-02 4.47e-01 0.36400 3.22e-01 -1.72e-01 4.47e-02 2.84e-01
GOBP ESTABLISHMENT OF LEFT RIGHT ASYMMETRY 6 2.62e-01 6.77e-01 0.36400 3.09e-01 1.93e-01 1.90e-01 4.13e-01
GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS 6 2.99e-01 7.11e-01 0.36400 -5.87e-03 3.64e-01 9.80e-01 1.22e-01
GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT 16 4.72e-02 3.29e-01 0.36400 -8.49e-02 3.54e-01 5.56e-01 1.42e-02
GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL 6 2.97e-01 7.09e-01 0.36400 6.45e-03 3.64e-01 9.78e-01 1.22e-01
GOCC BBSOME 8 1.74e-01 5.78e-01 0.36400 -1.40e-01 -3.36e-01 4.94e-01 9.95e-02
GOMF ACETYLCHOLINE RECEPTOR BINDING 11 1.32e-01 5.18e-01 0.36400 -3.35e-01 1.43e-01 5.46e-02 4.11e-01
GOBP PODOCYTE CELL MIGRATION 7 2.54e-01 6.69e-01 0.36400 -3.61e-01 4.36e-02 9.79e-02 8.42e-01
GOBP PEPTIDYL PROLINE HYDROXYLATION 11 9.01e-02 4.41e-01 0.36400 -3.33e-01 -1.47e-01 5.61e-02 3.97e-01
GOCC TORC2 COMPLEX 9 2.01e-01 6.14e-01 0.36400 -2.23e-01 2.87e-01 2.46e-01 1.36e-01
GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT 12 1.10e-01 4.81e-01 0.36300 -3.35e-01 1.41e-01 4.46e-02 3.97e-01
GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL 6 3.27e-01 7.30e-01 0.36300 3.44e-01 -1.15e-01 1.44e-01 6.25e-01
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III 8 1.74e-01 5.78e-01 0.36300 -3.30e-01 -1.52e-01 1.06e-01 4.55e-01
GOBP REGULATION OF GLUCOCORTICOID SECRETION 10 1.43e-01 5.36e-01 0.36300 -3.60e-01 4.87e-02 4.88e-02 7.90e-01
GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX 10 1.12e-01 4.85e-01 0.36300 -1.53e-01 -3.29e-01 4.01e-01 7.15e-02
GOBP HEART TRABECULA FORMATION 15 4.09e-02 3.09e-01 0.36300 -3.48e-01 -1.02e-01 1.95e-02 4.94e-01
GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE 8 2.37e-01 6.54e-01 0.36300 -1.84e-01 3.13e-01 3.67e-01 1.25e-01
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 3 PHOSPHATASE ACTIVITY 5 4.11e-01 7.84e-01 0.36300 -2.19e-01 2.90e-01 3.97e-01 2.62e-01
GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE 6 2.89e-01 7.02e-01 0.36300 -5.25e-02 -3.59e-01 8.24e-01 1.28e-01
GOBP ISG15 PROTEIN CONJUGATION 6 2.61e-01 6.76e-01 0.36300 -2.62e-01 -2.51e-01 2.67e-01 2.87e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION 7 2.68e-01 6.82e-01 0.36300 3.50e-01 -9.44e-02 1.09e-01 6.65e-01
GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION 5 3.29e-01 7.33e-01 0.36300 -2.11e-01 -2.95e-01 4.15e-01 2.53e-01
GOBP RETINAL METABOLIC PROCESS 18 4.02e-02 3.07e-01 0.36300 1.94e-01 -3.06e-01 1.54e-01 2.45e-02
GOBP PEPTIDYL LYSINE HYDROXYLATION 8 2.32e-01 6.50e-01 0.36200 -3.34e-01 1.41e-01 1.02e-01 4.89e-01
GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY 11 1.04e-01 4.70e-01 0.36200 -3.59e-01 -4.96e-02 3.95e-02 7.76e-01
GOCC SPHERICAL HIGH DENSITY LIPOPROTEIN PARTICLE 8 2.42e-01 6.58e-01 0.36200 -2.04e-01 2.99e-01 3.18e-01 1.43e-01
GOCC T CELL RECEPTOR COMPLEX 16 5.60e-02 3.60e-01 0.36200 1.64e-01 -3.22e-01 2.55e-01 2.55e-02
GOCC SWI SNF COMPLEX 30 4.53e-03 9.31e-02 0.36200 -3.23e-01 1.64e-01 2.22e-03 1.21e-01
GOBP CRD MEDIATED MRNA STABILIZATION 11 1.43e-01 5.35e-01 0.36200 2.10e-01 -2.95e-01 2.29e-01 9.05e-02
GOBP INTERLEUKIN 5 PRODUCTION 19 1.57e-02 1.99e-01 0.36200 1.78e-01 3.15e-01 1.80e-01 1.75e-02
GOBP CHORIONIC TROPHOBLAST CELL DIFFERENTIATION 7 2.83e-01 6.95e-01 0.36100 -1.58e-01 3.25e-01 4.69e-01 1.36e-01
GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY 33 3.07e-03 7.47e-02 0.36100 -2.73e-01 2.37e-01 6.59e-03 1.86e-02
GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS 7 2.66e-01 6.81e-01 0.36100 3.53e-01 -7.62e-02 1.06e-01 7.27e-01
GOCC PROTEASE INHIBITOR COMPLEX 8 1.81e-01 5.84e-01 0.36100 1.27e-01 3.38e-01 5.34e-01 9.75e-02
GOBP MEMBRANE REPOLARIZATION DURING ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL 6 3.39e-01 7.39e-01 0.36100 -3.26e-01 1.55e-01 1.66e-01 5.10e-01
GOBP INTRACELLULAR CORTICOSTEROID RECEPTOR SIGNALING PATHWAY 14 5.91e-02 3.69e-01 0.36100 -3.60e-01 -2.92e-02 1.97e-02 8.50e-01
GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 15 6.37e-02 3.79e-01 0.36100 3.41e-01 -1.20e-01 2.24e-02 4.22e-01
GOMF DISACCHARIDE BINDING 5 3.67e-01 7.57e-01 0.36100 1.94e-02 3.60e-01 9.40e-01 1.63e-01
GOBP GALACTOSE TRANSMEMBRANE TRANSPORT 5 3.79e-01 7.65e-01 0.36100 3.59e-01 -3.04e-02 1.64e-01 9.06e-01
GOCC VOLTAGE GATED SODIUM CHANNEL COMPLEX 14 7.53e-02 4.12e-01 0.36100 3.45e-01 -1.05e-01 2.54e-02 4.98e-01
GOBP ACYLGLYCEROL TRANSPORT 8 1.74e-01 5.78e-01 0.36000 -1.94e-01 -3.04e-01 3.42e-01 1.37e-01
Dectin-2 family 28 3.88e-03 8.62e-02 0.36000 3.60e-01 6.71e-03 9.63e-04 9.51e-01
GOBP PROPIONATE METABOLIC PROCESS 5 3.91e-01 7.71e-01 0.36000 3.52e-01 -7.85e-02 1.73e-01 7.61e-01
GOBP NEGATIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 6 2.93e-01 7.05e-01 0.36000 -3.56e-01 -5.77e-02 1.31e-01 8.07e-01
GOBP DCMP CATABOLIC PROCESS 6 3.51e-01 7.46e-01 0.36000 2.37e-01 -2.71e-01 3.15e-01 2.50e-01
GOBP REGULATION OF THYROID HORMONE GENERATION 7 2.60e-01 6.74e-01 0.36000 -3.58e-01 3.88e-02 1.01e-01 8.59e-01
GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY 20 1.30e-02 1.80e-01 0.36000 1.79e-01 3.13e-01 1.66e-01 1.55e-02
GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY 6 2.71e-01 6.85e-01 0.36000 -3.09e-01 -1.85e-01 1.90e-01 4.34e-01
GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY 11 1.19e-01 4.95e-01 0.36000 2.84e-02 -3.59e-01 8.70e-01 3.92e-02
GOCC MULTIVESICULAR BODY INTERNAL VESICLE 6 2.73e-01 6.85e-01 0.36000 -1.68e-01 -3.18e-01 4.76e-01 1.77e-01
GOBP MANNOSE METABOLIC PROCESS 9 2.08e-01 6.24e-01 0.36000 -2.88e-01 2.16e-01 1.35e-01 2.62e-01
GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 30 3.99e-03 8.77e-02 0.36000 1.00e-01 -3.45e-01 3.42e-01 1.06e-03
GOBP ORNITHINE TRANSPORT 6 3.52e-01 7.46e-01 0.36000 -2.32e-01 2.75e-01 3.25e-01 2.44e-01
FGFRL1 modulation of FGFR1 signaling 13 1.02e-01 4.67e-01 0.36000 -1.97e-01 3.01e-01 2.19e-01 6.03e-02
GOBP REGULATION OF ODONTOGENESIS 19 3.51e-02 2.90e-01 0.36000 -3.10e-01 1.82e-01 1.92e-02 1.71e-01
GOBP SEQUESTERING OF METAL ION 10 1.17e-01 4.92e-01 0.36000 3.25e-01 1.54e-01 7.53e-02 3.99e-01
GOBP ATRIOVENTRICULAR NODE DEVELOPMENT 9 2.07e-01 6.23e-01 0.36000 -2.96e-01 2.04e-01 1.24e-01 2.89e-01
GOBP POSITIVE REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY 5 3.64e-01 7.54e-01 0.36000 3.57e-01 4.57e-02 1.67e-01 8.59e-01
GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION 5 3.94e-01 7.74e-01 0.35900 -8.05e-02 3.50e-01 7.55e-01 1.75e-01
Small interfering RNA (siRNA) biogenesis 9 1.91e-01 5.99e-01 0.35900 -3.45e-01 1.01e-01 7.33e-02 5.99e-01
GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION 7 2.96e-01 7.08e-01 0.35900 -2.11e-01 2.90e-01 3.33e-01 1.84e-01
GOBP ATRIAL CARDIAC MUSCLE TISSUE MORPHOGENESIS 6 2.95e-01 7.07e-01 0.35900 -3.54e-01 -5.91e-02 1.33e-01 8.02e-01
GOBP REGULATION OF ENAMEL MINERALIZATION 8 2.47e-01 6.62e-01 0.35900 3.01e-01 -1.96e-01 1.41e-01 3.37e-01
Intestinal absorption 5 3.74e-01 7.61e-01 0.35900 7.91e-03 3.59e-01 9.76e-01 1.65e-01
GOBP TRYPTOPHAN TRANSPORT 5 4.14e-01 7.85e-01 0.35900 -3.17e-01 1.67e-01 2.19e-01 5.17e-01
GOMF 11 CIS RETINAL BINDING 7 2.17e-01 6.35e-01 0.35900 2.62e-01 2.44e-01 2.29e-01 2.63e-01
GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION 14 8.82e-02 4.37e-01 0.35900 2.12e-01 -2.89e-01 1.69e-01 6.12e-02
GOBP SINOATRIAL NODE CELL DIFFERENTIATION 5 3.47e-01 7.44e-01 0.35800 -3.31e-01 -1.37e-01 2.00e-01 5.95e-01
GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY 7 2.50e-01 6.65e-01 0.35800 3.58e-01 1.99e-02 1.01e-01 9.27e-01
GOBP AUTOSOME GENOMIC IMPRINTING 5 3.50e-01 7.45e-01 0.35800 -3.37e-01 -1.21e-01 1.91e-01 6.40e-01
GOBP PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS 8 2.44e-01 6.58e-01 0.35800 -1.67e-01 3.17e-01 4.14e-01 1.20e-01
GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS 13 6.72e-02 3.91e-01 0.35800 -3.43e-01 -1.03e-01 3.21e-02 5.22e-01
GOBP FOLATE TRANSMEMBRANE TRANSPORT 5 4.11e-01 7.84e-01 0.35800 -1.46e-01 3.27e-01 5.72e-01 2.06e-01
GOBP COLLECTING DUCT DEVELOPMENT 15 7.22e-02 4.04e-01 0.35800 -1.73e-01 3.13e-01 2.45e-01 3.58e-02
Regulation of IFNA/IFNB signaling 22 1.90e-02 2.20e-01 0.35800 3.38e-01 -1.17e-01 6.06e-03 3.42e-01
Negative regulation of FLT3 15 5.20e-02 3.45e-01 0.35800 -2.05e-02 -3.57e-01 8.91e-01 1.66e-02
GOBP CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION 9 1.42e-01 5.33e-01 0.35800 -2.32e-01 -2.72e-01 2.28e-01 1.57e-01
GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION 14 5.68e-02 3.63e-01 0.35800 -8.41e-02 -3.48e-01 5.86e-01 2.43e-02
GOMF INTEGRIN BINDING INVOLVED IN CELL MATRIX ADHESION 5 4.24e-01 7.92e-01 0.35800 -2.68e-01 2.37e-01 3.00e-01 3.58e-01
GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION 12 7.59e-02 4.12e-01 0.35800 -1.90e-01 -3.03e-01 2.55e-01 6.91e-02
GOBP THROMBOPOIETIN MEDIATED SIGNALING PATHWAY 5 3.75e-01 7.62e-01 0.35700 3.57e-01 1.63e-02 1.67e-01 9.50e-01
GOMF PROFILIN BINDING 10 1.80e-01 5.84e-01 0.35700 -2.56e-01 2.50e-01 1.62e-01 1.71e-01
GOBP PHOTORECEPTOR CELL MORPHOGENESIS 5 4.07e-01 7.81e-01 0.35700 -1.18e-01 3.37e-01 6.47e-01 1.92e-01
GOCC GID COMPLEX 5 3.87e-01 7.69e-01 0.35700 -3.55e-02 3.56e-01 8.91e-01 1.68e-01
GOMF NEUROTROPHIN RECEPTOR BINDING 11 1.21e-01 4.99e-01 0.35700 -3.57e-01 1.59e-02 4.04e-02 9.27e-01
Scavenging by Class F Receptors 6 3.47e-01 7.44e-01 0.35700 1.54e-01 -3.22e-01 5.13e-01 1.72e-01
GOBP POSITIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS 8 1.90e-01 5.97e-01 0.35700 1.12e-01 3.39e-01 5.84e-01 9.66e-02
GOBP GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS 8 1.78e-01 5.83e-01 0.35700 -2.87e-01 -2.12e-01 1.59e-01 2.99e-01
Signaling by TGFBR3 48 1.18e-04 6.78e-03 0.35700 -3.55e-01 3.95e-02 2.10e-05 6.36e-01
Assembly of the ORC complex at the origin of replication 32 1.69e-03 4.79e-02 0.35700 -4.63e-02 -3.54e-01 6.50e-01 5.28e-04
GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY 10 1.71e-01 5.74e-01 0.35700 -3.24e-01 1.49e-01 7.57e-02 4.14e-01
GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 9 2.13e-01 6.29e-01 0.35700 -2.89e-01 2.10e-01 1.33e-01 2.76e-01
GOBP TRABECULA FORMATION 27 4.24e-03 9.03e-02 0.35700 -3.49e-01 -7.25e-02 1.68e-03 5.14e-01
GOBP REGULATION OF CORTISOL BIOSYNTHETIC PROCESS 7 2.21e-01 6.39e-01 0.35700 2.75e-01 2.28e-01 2.08e-01 2.97e-01
GOMF SPLICING FACTOR BINDING 6 3.09e-01 7.18e-01 0.35700 -1.91e-02 -3.56e-01 9.36e-01 1.31e-01
GOBP OVULATION 16 4.58e-02 3.26e-01 0.35600 -3.56e-01 1.06e-03 1.36e-02 9.94e-01
GOBP RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE 9 1.75e-01 5.79e-01 0.35600 -3.56e-01 -8.47e-03 6.44e-02 9.65e-01
Platelet Adhesion to exposed collagen 16 5.82e-02 3.66e-01 0.35600 -3.33e-01 1.25e-01 2.10e-02 3.85e-01
GOBP NEGATIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE 8 2.56e-01 6.71e-01 0.35600 -2.41e-01 2.62e-01 2.37e-01 2.00e-01
GOBP PENETRATION OF ZONA PELLUCIDA 9 1.70e-01 5.71e-01 0.35600 -3.34e-02 -3.54e-01 8.62e-01 6.57e-02
GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 33 3.59e-03 8.26e-02 0.35600 2.14e-01 -2.84e-01 3.31e-02 4.74e-03
GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS 9 2.09e-01 6.25e-01 0.35600 1.62e-01 -3.17e-01 4.01e-01 9.98e-02
GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS 7 2.56e-01 6.71e-01 0.35600 -3.55e-01 -1.73e-02 1.04e-01 9.37e-01
GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 7 3.02e-01 7.13e-01 0.35600 -2.90e-01 2.06e-01 1.84e-01 3.44e-01
GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY 36 1.26e-03 3.94e-02 0.35600 -3.52e-01 5.27e-02 2.60e-04 5.85e-01
GOBP COPPER ION IMPORT 6 2.76e-01 6.89e-01 0.35600 2.34e-01 2.68e-01 3.21e-01 2.56e-01
GOBP RIBOFLAVIN METABOLIC PROCESS 5 3.46e-01 7.43e-01 0.35600 3.05e-01 1.83e-01 2.38e-01 4.79e-01
GOBP NEGATIVE REGULATION OF MEIOTIC CHROMOSOME SEPARATION 5 3.99e-01 7.77e-01 0.35500 -3.49e-01 6.84e-02 1.77e-01 7.91e-01
GOBP REGULATION OF INOSITOL 1 4 5 TRISPHOSPHATE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 5 4.25e-01 7.93e-01 0.35500 -2.95e-01 1.98e-01 2.53e-01 4.44e-01
GOBP MYELOID PROGENITOR CELL DIFFERENTIATION 9 1.45e-01 5.38e-01 0.35500 -2.29e-01 -2.72e-01 2.35e-01 1.58e-01
GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT 24 1.02e-02 1.55e-01 0.35500 3.55e-01 -4.84e-03 2.59e-03 9.67e-01
GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT 19 4.02e-02 3.07e-01 0.35500 2.51e-01 -2.51e-01 5.80e-02 5.82e-02
GOMF CLATHRIN HEAVY CHAIN BINDING 11 1.22e-01 5.00e-01 0.35500 -3.55e-01 2.41e-03 4.15e-02 9.89e-01
GOBP INTRACELLULAR WATER HOMEOSTASIS 6 3.43e-01 7.40e-01 0.35500 3.38e-01 -1.09e-01 1.52e-01 6.42e-01
GOBP NEGATIVE REGULATION OF T CELL MIGRATION 6 3.54e-01 7.47e-01 0.35500 -1.61e-01 3.16e-01 4.94e-01 1.80e-01
GOBP RESPONSE TO L GLUTAMATE 15 5.72e-02 3.64e-01 0.35500 4.54e-03 -3.55e-01 9.76e-01 1.74e-02
GOMF RNA POLYMERASE I ACTIVITY 10 1.22e-01 5.01e-01 0.35500 -1.68e-01 -3.12e-01 3.58e-01 8.71e-02
GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL 6 2.79e-01 6.92e-01 0.35500 2.15e-01 2.82e-01 3.63e-01 2.31e-01
GOBP HEMATOPOIETIC STEM CELL MIGRATION 8 1.86e-01 5.92e-01 0.35500 -3.13e-01 -1.67e-01 1.25e-01 4.13e-01
GOBP REGULATION OF KERATINOCYTE MIGRATION 14 9.33e-02 4.46e-01 0.35500 -2.82e-01 2.14e-01 6.73e-02 1.65e-01
LTC4-CYSLTR mediated IL4 production 5 4.15e-01 7.85e-01 0.35400 -1.27e-01 3.31e-01 6.24e-01 2.00e-01
GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE 11 1.07e-01 4.76e-01 0.35400 -3.41e-01 -9.71e-02 5.03e-02 5.77e-01
FGFR1b ligand binding and activation 8 2.46e-01 6.61e-01 0.35400 -3.28e-01 1.33e-01 1.08e-01 5.15e-01
Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex 32 1.79e-03 4.99e-02 0.35400 -5.57e-02 -3.50e-01 5.86e-01 6.12e-04
GOCC MICROTUBULE BUNDLE 6 3.47e-01 7.44e-01 0.35400 -1.19e-01 3.33e-01 6.13e-01 1.57e-01
GOBP RESPONSE TO VASOPRESSIN 8 2.00e-01 6.13e-01 0.35400 3.42e-01 9.07e-02 9.40e-02 6.57e-01
GOBP NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS 10 1.68e-01 5.69e-01 0.35400 3.40e-01 -9.83e-02 6.28e-02 5.90e-01
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE 16 5.04e-02 3.41e-01 0.35400 -2.63e-02 3.53e-01 8.56e-01 1.46e-02
Acrosome Reaction and Sperm:Oocyte Membrane Binding 6 3.54e-01 7.47e-01 0.35300 1.47e-01 -3.22e-01 5.33e-01 1.73e-01
GOBP TONIC SMOOTH MUSCLE CONTRACTION 11 9.69e-02 4.55e-01 0.35300 -2.62e-01 -2.37e-01 1.32e-01 1.73e-01
Complex III assembly 24 8.04e-03 1.34e-01 0.35300 -9.13e-02 -3.41e-01 4.39e-01 3.78e-03
GOBP NONASSOCIATIVE LEARNING 6 2.99e-01 7.10e-01 0.35300 -3.41e-01 -9.40e-02 1.48e-01 6.90e-01
GOBP EXCITATORY CHEMICAL SYNAPTIC TRANSMISSION 10 1.20e-01 4.97e-01 0.35300 -2.46e-01 -2.54e-01 1.78e-01 1.65e-01
Arachidonate production from DAG 5 4.32e-01 7.96e-01 0.35300 -2.30e-01 2.69e-01 3.74e-01 2.98e-01
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION 14 8.57e-02 4.33e-01 0.35300 -1.19e-01 3.33e-01 4.41e-01 3.12e-02
RHO GTPases activate CIT 19 3.09e-02 2.75e-01 0.35300 -3.49e-01 5.32e-02 8.41e-03 6.88e-01
GOBP NOTOCHORD DEVELOPMENT 19 4.18e-02 3.12e-01 0.35300 2.53e-01 -2.46e-01 5.58e-02 6.37e-02
GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE 16 3.43e-02 2.87e-01 0.35300 2.09e-01 2.84e-01 1.47e-01 4.91e-02
GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS 6 3.67e-01 7.56e-01 0.35300 -2.60e-01 2.39e-01 2.71e-01 3.11e-01
GOBP REGULATION OF HOMOPHILIC CELL ADHESION 5 3.66e-01 7.56e-01 0.35300 9.41e-02 3.40e-01 7.16e-01 1.88e-01
GOMF GLUCURONOSYL N ACETYLGALACTOSAMINYL PROTEOGLYCAN 4 BETA N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY 6 3.56e-01 7.49e-01 0.35300 -3.19e-01 1.51e-01 1.76e-01 5.23e-01
Binding of TCF/LEF:CTNNB1 to target gene promoters 8 2.57e-01 6.71e-01 0.35300 1.77e-01 -3.05e-01 3.87e-01 1.35e-01
GOBP SKELETAL MYOFIBRIL ASSEMBLY 10 1.76e-01 5.81e-01 0.35300 -3.27e-01 1.33e-01 7.36e-02 4.68e-01
GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE 12 1.23e-01 5.02e-01 0.35300 -1.23e-01 3.31e-01 4.62e-01 4.74e-02
GOBP XENOPHAGY 14 9.69e-02 4.55e-01 0.35300 -2.55e-01 2.44e-01 9.90e-02 1.14e-01
GOBP REGULATION OF MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 5 3.74e-01 7.61e-01 0.35200 -3.47e-01 -6.33e-02 1.79e-01 8.06e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS 32 2.68e-03 6.73e-02 0.35200 -3.51e-01 2.90e-02 5.83e-04 7.76e-01
GOBP NEGATIVE REGULATION OF MIRNA PROCESSING 9 1.50e-01 5.44e-01 0.35200 -2.71e-01 -2.26e-01 1.60e-01 2.41e-01
GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX 9 2.18e-01 6.36e-01 0.35200 1.78e-01 -3.04e-01 3.56e-01 1.14e-01
GOBP REGULATION OF GASTRIC ACID SECRETION 6 2.88e-01 7.00e-01 0.35200 1.74e-01 3.06e-01 4.60e-01 1.94e-01
GOMF MICROTUBULE PLUS END BINDING 21 1.76e-02 2.11e-01 0.35200 -3.51e-01 -3.22e-02 5.40e-03 7.98e-01
GOBP PROTEIN SULFATION 6 3.35e-01 7.35e-01 0.35200 -3.49e-01 4.69e-02 1.39e-01 8.42e-01
GOBP PML BODY ORGANIZATION 7 3.13e-01 7.22e-01 0.35200 -2.45e-01 2.52e-01 2.62e-01 2.47e-01
GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS 5 4.07e-01 7.81e-01 0.35200 6.73e-02 -3.45e-01 7.94e-01 1.82e-01
G2/M DNA replication checkpoint 5 3.99e-01 7.77e-01 0.35200 3.50e-01 -3.48e-02 1.76e-01 8.93e-01
GOCC SMOOTH ENDOPLASMIC RETICULUM MEMBRANE 7 3.08e-01 7.16e-01 0.35100 1.79e-01 -3.02e-01 4.12e-01 1.66e-01
GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX 10 1.55e-01 5.52e-01 0.35100 1.01e-02 -3.51e-01 9.56e-01 5.45e-02
GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 9 1.54e-01 5.51e-01 0.35100 -1.91e-01 -2.95e-01 3.21e-01 1.26e-01
GOBP NEGATIVE REGULATION OF GLIOGENESIS 44 4.87e-04 1.89e-02 0.35100 -3.31e-01 1.16e-01 1.42e-04 1.85e-01
GOBP CHROMATIN LOOPING 15 6.97e-02 3.97e-01 0.35100 7.85e-02 -3.42e-01 5.99e-01 2.18e-02
Interleukin-23 signaling 9 2.23e-01 6.41e-01 0.35100 -1.97e-01 2.90e-01 3.06e-01 1.32e-01
GOBP L PHENYLALANINE METABOLIC PROCESS 8 2.64e-01 6.79e-01 0.35100 -2.03e-01 2.86e-01 3.21e-01 1.61e-01
GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION 28 6.70e-03 1.19e-01 0.35100 3.45e-01 -6.47e-02 1.60e-03 5.53e-01
GOBP POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION 12 1.21e-01 4.99e-01 0.35100 -3.39e-01 9.01e-02 4.21e-02 5.89e-01
GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE 35 2.37e-03 6.16e-02 0.35000 1.14e-01 -3.31e-01 2.45e-01 6.96e-04
GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION 38 4.18e-04 1.67e-02 0.35000 -1.72e-01 -3.05e-01 6.60e-02 1.16e-03
GOBP DERMATAN SULFATE BIOSYNTHETIC PROCESS 5 4.36e-01 7.97e-01 0.35000 -2.96e-01 1.86e-01 2.52e-01 4.70e-01
GOBP PRE MIRNA PROCESSING 17 4.58e-02 3.26e-01 0.35000 -3.48e-01 3.55e-02 1.30e-02 8.00e-01
GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING 8 2.67e-01 6.81e-01 0.35000 -2.00e-01 2.86e-01 3.27e-01 1.61e-01
GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION 13 1.19e-01 4.95e-01 0.35000 2.36e-01 -2.58e-01 1.40e-01 1.08e-01
GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS 7 2.51e-01 6.65e-01 0.34900 -1.02e-01 -3.34e-01 6.39e-01 1.26e-01
GOBP CELL AGGREGATION 23 2.33e-02 2.44e-01 0.34900 -2.41e-01 2.52e-01 4.52e-02 3.61e-02
GOBP N ACETYLNEURAMINATE METABOLIC PROCESS 11 1.23e-01 5.02e-01 0.34900 4.12e-02 3.47e-01 8.13e-01 4.65e-02
RHO GTPases Activate ROCKs 19 3.24e-02 2.81e-01 0.34900 -3.47e-01 3.76e-02 8.83e-03 7.77e-01
GOBP OLFACTORY BULB INTERNEURON DEVELOPMENT 7 2.97e-01 7.09e-01 0.34900 3.35e-01 -9.70e-02 1.25e-01 6.57e-01
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY 5 4.36e-01 7.97e-01 0.34900 -3.01e-01 1.75e-01 2.43e-01 4.97e-01
GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY 9 1.73e-01 5.78e-01 0.34900 -8.36e-02 -3.38e-01 6.64e-01 7.87e-02
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS 9 2.09e-01 6.25e-01 0.34900 -3.37e-01 8.96e-02 8.01e-02 6.42e-01
GOMF PHOSPHOTRANSFERASE ACTIVITY NITROGENOUS GROUP AS ACCEPTOR 6 3.62e-01 7.53e-01 0.34800 -3.22e-01 1.33e-01 1.72e-01 5.73e-01
GOMF DESUMOYLASE ACTIVITY 7 2.95e-01 7.07e-01 0.34800 8.39e-02 -3.38e-01 7.01e-01 1.21e-01
GOBP DUCTUS ARTERIOSUS CLOSURE 5 3.79e-01 7.64e-01 0.34800 -3.39e-01 -7.88e-02 1.89e-01 7.60e-01
GOBP ABSCISSION 6 3.72e-01 7.60e-01 0.34800 1.86e-01 -2.95e-01 4.31e-01 2.11e-01
GOCC ARP2 3 PROTEIN COMPLEX 9 2.30e-01 6.48e-01 0.34800 2.08e-01 -2.79e-01 2.79e-01 1.48e-01
GOBP PURINE NUCLEOSIDE TRANSMEMBRANE TRANSPORT 5 3.64e-01 7.54e-01 0.34800 1.64e-01 3.07e-01 5.26e-01 2.34e-01
GOBP PURKINJE MYOCYTE TO VENTRICULAR CARDIAC MUSCLE CELL COMMUNICATION 6 3.71e-01 7.60e-01 0.34800 3.00e-01 -1.76e-01 2.03e-01 4.56e-01
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) 9 1.88e-01 5.95e-01 0.34800 -1.34e-02 -3.48e-01 9.45e-01 7.10e-02
GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY 8 2.55e-01 6.70e-01 0.34800 -1.10e-01 3.30e-01 5.88e-01 1.06e-01
GOBP BRAINSTEM DEVELOPMENT 7 3.21e-01 7.28e-01 0.34800 2.20e-01 -2.69e-01 3.13e-01 2.18e-01
GOBP EMBRYONIC SKELETAL JOINT DEVELOPMENT 15 5.18e-02 3.45e-01 0.34700 -3.27e-01 -1.18e-01 2.85e-02 4.28e-01
GOMF PYRIMIDINE NUCLEOTIDE BINDING 5 4.40e-01 7.99e-01 0.34700 1.83e-01 -2.95e-01 4.78e-01 2.53e-01
GOBP LIPOPHAGY 7 2.97e-01 7.09e-01 0.34700 -8.41e-02 3.37e-01 7.00e-01 1.23e-01
GOMF THIOREDOXIN DISULFIDE REDUCTASE NADPH ACTIVITY 7 2.38e-01 6.55e-01 0.34700 2.40e-01 2.50e-01 2.71e-01 2.51e-01
GOBP MITOCHONDRIAL TRNA PROCESSING 13 1.01e-01 4.65e-01 0.34700 5.68e-02 -3.42e-01 7.23e-01 3.25e-02
GOBP SPERM EJACULATION 6 3.36e-01 7.36e-01 0.34700 -3.47e-01 8.87e-03 1.41e-01 9.70e-01
GOBP POSITIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION 7 3.14e-01 7.22e-01 0.34700 1.53e-01 -3.11e-01 4.84e-01 1.54e-01
GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 11 1.67e-01 5.67e-01 0.34700 1.89e-01 -2.91e-01 2.78e-01 9.52e-02
GOMF MHC CLASS I PROTEIN BINDING 18 5.47e-02 3.56e-01 0.34700 2.21e-01 -2.67e-01 1.04e-01 5.00e-02
GOCC GOLGI TRANSPORT COMPLEX 10 1.30e-01 5.15e-01 0.34700 -2.59e-01 -2.30e-01 1.56e-01 2.07e-01
GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION 12 9.30e-02 4.46e-01 0.34700 -1.35e-01 -3.19e-01 4.18e-01 5.56e-02
Packaging Of Telomere Ends 29 5.83e-03 1.10e-01 0.34600 4.08e-02 -3.44e-01 7.04e-01 1.34e-03
GOBP RETINAL BLOOD VESSEL MORPHOGENESIS 5 3.82e-01 7.66e-01 0.34600 -3.36e-01 -8.49e-02 1.93e-01 7.42e-01
GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY 12 1.00e-01 4.63e-01 0.34600 -3.38e-01 -7.74e-02 4.29e-02 6.42e-01
GOMF PHOSPHODIESTERASE I ACTIVITY 5 4.32e-01 7.96e-01 0.34600 3.23e-01 -1.24e-01 2.11e-01 6.31e-01
CTNNB1 S33 mutants aren’t phosphorylated 14 8.03e-02 4.20e-01 0.34600 -3.46e-01 1.63e-02 2.51e-02 9.16e-01
CTNNB1 S37 mutants aren’t phosphorylated 14 8.03e-02 4.20e-01 0.34600 -3.46e-01 1.63e-02 2.51e-02 9.16e-01
CTNNB1 S45 mutants aren’t phosphorylated 14 8.03e-02 4.20e-01 0.34600 -3.46e-01 1.63e-02 2.51e-02 9.16e-01
CTNNB1 T41 mutants aren’t phosphorylated 14 8.03e-02 4.20e-01 0.34600 -3.46e-01 1.63e-02 2.51e-02 9.16e-01
Signaling by CTNNB1 phospho-site mutants 14 8.03e-02 4.20e-01 0.34600 -3.46e-01 1.63e-02 2.51e-02 9.16e-01
Signaling by GSK3beta mutants 14 8.03e-02 4.20e-01 0.34600 -3.46e-01 1.63e-02 2.51e-02 9.16e-01
GOBP REGULATION OF IRON ION TRANSPORT 7 3.23e-01 7.28e-01 0.34600 2.71e-01 -2.15e-01 2.14e-01 3.24e-01
Regulation of NPAS4 gene expression 13 8.02e-02 4.20e-01 0.34600 -3.31e-01 -1.02e-01 3.89e-02 5.25e-01
GOBP REGULATION OF HYPERSENSITIVITY 7 2.42e-01 6.57e-01 0.34600 2.12e-01 2.73e-01 3.31e-01 2.11e-01
GOBP G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY 22 2.61e-02 2.56e-01 0.34600 -1.44e-01 3.15e-01 2.43e-01 1.06e-02
GOMF MYOSIN HEAVY CHAIN BINDING 13 7.17e-02 4.03e-01 0.34600 2.17e-01 2.69e-01 1.76e-01 9.26e-02
GOMF MRNA 5 UTR BINDING 22 2.84e-02 2.67e-01 0.34600 1.92e-01 -2.88e-01 1.19e-01 1.96e-02
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE 10 1.86e-01 5.92e-01 0.34600 -1.19e-01 3.25e-01 5.16e-01 7.54e-02
DEx/H-box helicases activate type I IFN and inflammatory cytokines production 7 3.12e-01 7.20e-01 0.34600 3.20e-01 -1.31e-01 1.43e-01 5.50e-01
GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING 26 1.38e-02 1.87e-01 0.34500 -3.12e-01 1.49e-01 5.97e-03 1.87e-01
GOMF VOLTAGE GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL 11 1.62e-01 5.61e-01 0.34500 -3.14e-01 1.44e-01 7.12e-02 4.09e-01
GOBP NEGATIVE REGULATION OF CYTOKINESIS 7 3.03e-01 7.14e-01 0.34500 3.33e-01 -9.02e-02 1.27e-01 6.80e-01
GOBP SYMPATHETIC GANGLION DEVELOPMENT 9 1.68e-01 5.69e-01 0.34500 -3.11e-01 -1.50e-01 1.06e-01 4.37e-01
GOBP PERIPHERAL NERVOUS SYSTEM AXON ENSHEATHMENT 29 9.60e-03 1.50e-01 0.34500 -2.64e-01 2.22e-01 1.38e-02 3.81e-02
GOMF GLYCOSPHINGOLIPID BINDING 10 1.98e-01 6.10e-01 0.34500 -1.88e-01 2.90e-01 3.03e-01 1.13e-01
FGFR2c ligand binding and activation 12 1.46e-01 5.40e-01 0.34500 -2.61e-01 2.26e-01 1.17e-01 1.76e-01
GOMF METALLODIPEPTIDASE ACTIVITY 8 2.19e-01 6.37e-01 0.34500 7.40e-02 3.37e-01 7.17e-01 9.88e-02
GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX 24 1.86e-02 2.17e-01 0.34500 -1.30e-01 3.19e-01 2.69e-01 6.75e-03
GOBP GLYCEROL TRANSMEMBRANE TRANSPORT 7 2.54e-01 6.69e-01 0.34500 3.19e-01 1.31e-01 1.44e-01 5.49e-01
GOMF GLYCEROL TRANSMEMBRANE TRANSPORTER ACTIVITY 7 2.54e-01 6.69e-01 0.34500 3.19e-01 1.31e-01 1.44e-01 5.49e-01
GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA 13 1.17e-01 4.92e-01 0.34500 -3.15e-01 1.40e-01 4.92e-02 3.81e-01
GOCC RSC TYPE COMPLEX 15 6.03e-02 3.73e-01 0.34500 -3.40e-01 -5.41e-02 2.24e-02 7.17e-01
GOMF STRUCTURAL CONSTITUENT OF CHROMATIN 78 2.86e-07 3.70e-05 0.34500 -1.11e-01 -3.26e-01 8.87e-02 6.29e-07
GOMF PEPTIDOGLYCAN MURALYTIC ACTIVITY 13 1.26e-01 5.07e-01 0.34500 2.25e-01 -2.61e-01 1.61e-01 1.03e-01
GOBP REGULATION OF FAS SIGNALING PATHWAY 6 3.00e-01 7.11e-01 0.34500 -2.78e-01 -2.03e-01 2.38e-01 3.89e-01
GOMF ALKALINE PHOSPHATASE ACTIVITY 6 3.32e-01 7.35e-01 0.34500 3.44e-01 2.53e-02 1.45e-01 9.15e-01
GOBP POSITIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 6 3.55e-01 7.48e-01 0.34400 6.54e-02 -3.38e-01 7.81e-01 1.51e-01
GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION 7 2.53e-01 6.69e-01 0.34400 -1.40e-01 -3.15e-01 5.21e-01 1.49e-01
Cell-extracellular matrix interactions 16 6.94e-02 3.96e-01 0.34400 -3.24e-01 1.17e-01 2.48e-02 4.20e-01
GOBP AIM2 INFLAMMASOME COMPLEX ASSEMBLY 5 3.69e-01 7.58e-01 0.34400 1.86e-01 2.90e-01 4.71e-01 2.62e-01
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 6 2.99e-01 7.11e-01 0.34400 2.18e-01 2.67e-01 3.55e-01 2.58e-01
Defective CHSY1 causes TPBS 7 2.91e-01 7.04e-01 0.34400 -3.43e-01 3.22e-02 1.16e-01 8.83e-01
GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION 8 2.65e-01 6.79e-01 0.34400 1.24e-01 -3.21e-01 5.45e-01 1.16e-01
Alpha-oxidation of phytanate 6 3.68e-01 7.57e-01 0.34400 3.24e-01 -1.15e-01 1.69e-01 6.25e-01
GOMF NEUROTROPHIN TRK RECEPTOR BINDING 6 3.58e-01 7.50e-01 0.34400 -3.36e-01 7.51e-02 1.54e-01 7.50e-01
GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION 12 8.98e-02 4.40e-01 0.34400 -2.59e-01 -2.27e-01 1.21e-01 1.74e-01
GOBP OBSERVATIONAL LEARNING 7 3.08e-01 7.16e-01 0.34400 -9.76e-02 3.30e-01 6.55e-01 1.31e-01
GOMF D LOOP DNA BINDING 5 4.52e-01 8.07e-01 0.34400 -2.54e-01 2.31e-01 3.25e-01 3.70e-01
GOMF PH DOMAIN BINDING 8 2.76e-01 6.88e-01 0.34400 -1.76e-01 2.95e-01 3.88e-01 1.48e-01
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS 10 1.85e-01 5.91e-01 0.34400 -3.31e-01 9.42e-02 7.02e-02 6.06e-01
GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT 15 7.67e-02 4.14e-01 0.34400 -3.37e-01 6.98e-02 2.40e-02 6.40e-01
Retrograde neurotrophin signalling 14 1.05e-01 4.71e-01 0.34400 -2.98e-01 1.71e-01 5.36e-02 2.67e-01
GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING 10 1.78e-01 5.83e-01 0.34400 -3.39e-01 5.42e-02 6.32e-02 7.67e-01
GOBP BLASTOCYST GROWTH 21 1.63e-02 2.04e-01 0.34300 -3.08e-01 -1.52e-01 1.46e-02 2.27e-01
GOBP DEFENSE RESPONSE TO TUMOR CELL 13 1.27e-01 5.10e-01 0.34300 2.13e-01 -2.70e-01 1.84e-01 9.23e-02
Major pathway of rRNA processing in the nucleolus and cytosol 172 4.67e-13 1.64e-10 0.34300 1.13e-01 -3.24e-01 1.02e-02 2.19e-13
GOBP S SHAPED BODY MORPHOGENESIS 7 3.14e-01 7.22e-01 0.34300 -3.21e-01 1.20e-01 1.41e-01 5.81e-01
GOBP ENDOSOMAL LUMEN ACIDIFICATION 12 1.36e-01 5.24e-01 0.34300 1.08e-01 -3.26e-01 5.16e-01 5.08e-02
GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE 6 3.76e-01 7.63e-01 0.34300 1.43e-01 -3.12e-01 5.44e-01 1.86e-01
GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS 23 2.30e-02 2.43e-01 0.34300 1.32e-01 -3.17e-01 2.74e-01 8.52e-03
Keratinization 209 1.09e-17 1.34e-14 0.34300 3.34e-01 7.81e-02 8.01e-17 5.17e-02
GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION 14 8.90e-02 4.38e-01 0.34300 -3.39e-01 4.99e-02 2.79e-02 7.46e-01
GOBP POSITIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE 7 2.98e-01 7.10e-01 0.34300 -3.40e-01 4.77e-02 1.20e-01 8.27e-01
GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY 16 5.14e-02 3.44e-01 0.34300 3.38e-01 5.76e-02 1.93e-02 6.90e-01
GOMF G PROTEIN COUPLED SEROTONIN RECEPTOR ACTIVITY 21 3.49e-02 2.89e-01 0.34300 -1.78e-01 2.93e-01 1.59e-01 2.01e-02
GOBP POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION 9 2.42e-01 6.58e-01 0.34300 2.30e-01 -2.54e-01 2.32e-01 1.87e-01
Synthesis of PIPs at the ER membrane 5 3.98e-01 7.76e-01 0.34200 5.07e-02 3.39e-01 8.44e-01 1.90e-01
GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION 11 1.69e-01 5.70e-01 0.34200 -1.47e-01 3.09e-01 3.98e-01 7.60e-02
GOMF GLUCOSYLTRANSFERASE ACTIVITY 19 4.35e-02 3.17e-01 0.34200 -3.23e-01 1.12e-01 1.47e-02 3.97e-01
GOMF GROWTH HORMONE RECEPTOR BINDING 8 2.80e-01 6.92e-01 0.34200 -1.83e-01 2.89e-01 3.70e-01 1.57e-01
GOBP REGULATION OF NK T CELL DIFFERENTIATION 6 3.18e-01 7.26e-01 0.34200 -3.24e-01 -1.10e-01 1.70e-01 6.40e-01
GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT 20 3.20e-02 2.80e-01 0.34200 -3.39e-01 4.73e-02 8.72e-03 7.14e-01
GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS 14 7.94e-02 4.19e-01 0.34200 -2.52e-02 -3.41e-01 8.70e-01 2.71e-02
GOBP FUCOSYLATION 17 3.45e-02 2.88e-01 0.34200 2.08e-01 2.72e-01 1.38e-01 5.23e-02
GOBP MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL 16 6.81e-02 3.93e-01 0.34200 -8.29e-02 3.32e-01 5.66e-01 2.16e-02
GOMF SPHINGOSINE 1 PHOSPHATE PHOSPHATASE ACTIVITY 7 2.49e-01 6.63e-01 0.34200 2.54e-01 2.29e-01 2.44e-01 2.95e-01
GOBP CELLULAR RESPONSE TO SODIUM ARSENITE 5 4.53e-01 8.07e-01 0.34200 2.82e-01 -1.94e-01 2.76e-01 4.53e-01
GOMF ACETYLCHOLINE BINDING 10 2.02e-01 6.16e-01 0.34200 1.66e-01 -2.99e-01 3.65e-01 1.02e-01
GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS 6 3.50e-01 7.45e-01 0.34200 2.36e-02 -3.41e-01 9.20e-01 1.48e-01
GOBP COBALT ION TRANSPORT 6 3.27e-01 7.30e-01 0.34200 -7.42e-02 -3.34e-01 7.53e-01 1.57e-01
GOCC DNA REPLICATION FACTOR C COMPLEX 5 4.39e-01 7.99e-01 0.34200 3.24e-01 -1.10e-01 2.10e-01 6.70e-01
GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE CLEARANCE 7 2.63e-01 6.78e-01 0.34200 -1.15e-01 -3.22e-01 5.99e-01 1.41e-01
GOCC TOR COMPLEX 12 1.53e-01 5.48e-01 0.34200 -2.27e-01 2.55e-01 1.73e-01 1.26e-01
GOMF ALPHA N ACETYLGALACTOSAMINIDE ALPHA 2 6 SIALYLTRANSFERASE ACTIVITY 6 3.07e-01 7.16e-01 0.34100 2.82e-01 1.93e-01 2.32e-01 4.13e-01
GOBP NEGATIVE REGULATION OF NEUTROPHIL MIGRATION 5 4.54e-01 8.08e-01 0.34100 -1.88e-01 2.85e-01 4.66e-01 2.70e-01
GOCC PERICILIARY MEMBRANE COMPARTMENT 5 3.92e-01 7.72e-01 0.34100 3.31e-01 8.46e-02 2.00e-01 7.43e-01
GOBP DORSAL SPINAL CORD DEVELOPMENT 20 2.54e-02 2.54e-01 0.34100 -3.37e-01 -5.47e-02 9.10e-03 6.72e-01
GOBP TYPE II PNEUMOCYTE DIFFERENTIATION 6 3.16e-01 7.23e-01 0.34100 -3.14e-01 -1.33e-01 1.82e-01 5.73e-01
GOBP G QUADRUPLEX DNA UNWINDING 7 3.33e-01 7.35e-01 0.34100 -2.72e-01 2.06e-01 2.13e-01 3.45e-01
GOMF CARBOHYDRATE KINASE ACTIVITY 20 3.40e-02 2.86e-01 0.34100 -6.45e-02 3.35e-01 6.17e-01 9.52e-03
GOBP PROLINE METABOLIC PROCESS 10 1.44e-01 5.36e-01 0.34100 1.57e-01 3.03e-01 3.90e-01 9.74e-02
GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS 8 2.70e-01 6.84e-01 0.34100 -3.22e-01 1.11e-01 1.14e-01 5.87e-01
GOBP UMP CATABOLIC PROCESS 5 4.59e-01 8.10e-01 0.34100 2.34e-01 -2.47e-01 3.64e-01 3.38e-01
Glycerophospholipid catabolism 7 3.17e-01 7.25e-01 0.34100 3.23e-01 -1.08e-01 1.39e-01 6.20e-01
GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION 18 3.19e-02 2.80e-01 0.34100 3.12e-01 1.35e-01 2.17e-02 3.20e-01
GOBP GLUCOCORTICOID SECRETION 12 1.41e-01 5.33e-01 0.34100 -3.21e-01 1.14e-01 5.42e-02 4.95e-01
GOBP MACROPHAGE FUSION 6 3.67e-01 7.57e-01 0.34100 -3.32e-01 7.78e-02 1.60e-01 7.41e-01
GOBP NOREPINEPHRINE UPTAKE 8 2.20e-01 6.37e-01 0.34000 -3.20e-01 -1.15e-01 1.17e-01 5.72e-01
GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 11 1.59e-01 5.57e-01 0.34000 3.32e-01 -7.54e-02 5.66e-02 6.65e-01
GOCC PARANODAL JUNCTION 8 2.60e-01 6.74e-01 0.34000 -6.40e-02 3.34e-01 7.54e-01 1.02e-01
GOMF BIOTIN BINDING 5 4.09e-01 7.83e-01 0.34000 2.00e-02 3.40e-01 9.38e-01 1.88e-01
GOBP RESPONSE TO THYROXINE 5 3.84e-01 7.67e-01 0.34000 3.10e-01 1.39e-01 2.30e-01 5.89e-01
GOBP THYROID GLAND DEVELOPMENT 31 6.66e-03 1.19e-01 0.34000 -3.16e-01 1.25e-01 2.29e-03 2.29e-01
GOCC KINOCILIUM 10 1.75e-01 5.80e-01 0.34000 3.40e-01 -1.45e-02 6.28e-02 9.37e-01
GOMF THYROID HORMONE TRANSMEMBRANE TRANSPORTER ACTIVITY 7 2.91e-01 7.03e-01 0.34000 7.05e-03 3.40e-01 9.74e-01 1.20e-01
GOBP INHIBITION OF NEUROEPITHELIAL CELL DIFFERENTIATION 6 3.66e-01 7.55e-01 0.34000 3.33e-01 -6.54e-02 1.57e-01 7.81e-01
GOBP NK T CELL PROLIFERATION 8 2.32e-01 6.50e-01 0.34000 6.02e-02 3.34e-01 7.68e-01 1.02e-01
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 10 1.48e-01 5.42e-01 0.34000 1.46e-01 3.07e-01 4.24e-01 9.33e-02
GOCC DENSE CORE GRANULE MEMBRANE 7 3.11e-01 7.19e-01 0.34000 -7.01e-02 3.32e-01 7.48e-01 1.28e-01
Translation 277 2.24e-20 4.58e-17 0.33900 8.68e-02 -3.28e-01 1.29e-02 4.95e-21
GOCC COHESIN COMPLEX 9 1.95e-01 6.06e-01 0.33900 -3.35e-01 -5.45e-02 8.19e-02 7.77e-01
RSK activation 5 3.97e-01 7.76e-01 0.33900 8.45e-02 3.28e-01 7.43e-01 2.03e-01
GOBP NEGATIVE REGULATION OF TUBULIN DEACETYLATION 5 3.94e-01 7.74e-01 0.33900 9.94e-02 3.24e-01 7.00e-01 2.09e-01
GOCC G PROTEIN COUPLED RECEPTOR DIMERIC COMPLEX 7 3.11e-01 7.19e-01 0.33900 -6.49e-02 3.33e-01 7.66e-01 1.27e-01
Josephin domain DUBs 10 2.14e-01 6.31e-01 0.33900 2.23e-01 -2.55e-01 2.21e-01 1.63e-01
GOMF C PALMITOYLTRANSFERASE ACTIVITY 5 3.90e-01 7.71e-01 0.33900 1.22e-01 3.16e-01 6.36e-01 2.21e-01
GOBP PODOSOME ASSEMBLY 21 2.13e-02 2.33e-01 0.33900 7.63e-02 3.30e-01 5.45e-01 8.84e-03
GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE 15 5.55e-02 3.58e-01 0.33900 -2.85e-01 -1.82e-01 5.58e-02 2.22e-01
GOBP REGULATION OF TRANSLATION AT POSTSYNAPSE 6 3.91e-01 7.71e-01 0.33800 -1.67e-01 2.95e-01 4.80e-01 2.11e-01
GOBP BEHAVIORAL RESPONSE TO ETHANOL 9 1.91e-01 5.98e-01 0.33800 8.33e-02 3.28e-01 6.65e-01 8.84e-02
GOBP REGULATION OF FOREBRAIN NEURON DIFFERENTIATION 5 4.53e-01 8.07e-01 0.33800 3.07e-01 -1.43e-01 2.35e-01 5.80e-01
GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS 10 1.50e-01 5.44e-01 0.33800 -3.07e-01 -1.42e-01 9.27e-02 4.37e-01
GOBP NEGATIVE REGULATION OF AMINE TRANSPORT 27 7.71e-03 1.30e-01 0.33800 -3.34e-01 -5.31e-02 2.65e-03 6.33e-01
GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 15 5.82e-02 3.66e-01 0.33800 -1.44e-01 -3.06e-01 3.34e-01 4.01e-02
GOCC MALE PRONUCLEUS 8 2.39e-01 6.55e-01 0.33800 -4.53e-02 -3.35e-01 8.24e-01 1.01e-01
GOBP GALACTOSE CATABOLIC PROCESS 6 3.13e-01 7.21e-01 0.33800 2.22e-01 2.55e-01 3.47e-01 2.80e-01
GOCC VARICOSITY 9 2.33e-01 6.50e-01 0.33800 -3.22e-01 1.01e-01 9.42e-02 5.98e-01
GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY 12 1.11e-01 4.83e-01 0.33800 -3.28e-01 -8.08e-02 4.92e-02 6.28e-01
GOBP FOLLICLE STIMULATING HORMONE SECRETION 8 2.38e-01 6.55e-01 0.33800 -3.33e-01 -5.27e-02 1.02e-01 7.96e-01
GOCC 9PLUS0 MOTILE CILIUM 5 4.07e-01 7.81e-01 0.33700 3.33e-01 5.66e-02 1.98e-01 8.26e-01
GOMF APOLIPOPROTEIN A I BINDING 5 4.49e-01 8.04e-01 0.33700 -3.18e-01 1.13e-01 2.18e-01 6.62e-01
Transport of fatty acids 8 2.38e-01 6.54e-01 0.33700 5.61e-02 3.33e-01 7.84e-01 1.03e-01
GOCC APICOLATERAL PLASMA MEMBRANE 23 1.84e-02 2.16e-01 0.33700 3.37e-01 7.78e-03 5.12e-03 9.48e-01
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1 6 3.99e-01 7.77e-01 0.33700 2.15e-01 -2.60e-01 3.62e-01 2.70e-01
GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS 13 1.17e-01 4.92e-01 0.33700 6.66e-02 -3.31e-01 6.78e-01 3.90e-02
GOBP MYOBLAST PROLIFERATION 34 4.05e-03 8.82e-02 0.33700 -3.24e-01 9.17e-02 1.06e-03 3.55e-01
GOBP RETINAL BIPOLAR NEURON DIFFERENTIATION 7 3.40e-01 7.39e-01 0.33700 -1.84e-01 2.83e-01 4.00e-01 1.95e-01
GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE 17 6.10e-02 3.73e-01 0.33700 6.89e-02 -3.30e-01 6.23e-01 1.85e-02
GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING 8 2.33e-01 6.50e-01 0.33700 3.28e-01 7.92e-02 1.09e-01 6.98e-01
GOBP RESPONSE TO L LEUCINE 15 6.88e-02 3.95e-01 0.33700 -3.33e-01 -4.87e-02 2.53e-02 7.44e-01
GOMF PROTEASOME ACTIVATING ACTIVITY 6 3.21e-01 7.28e-01 0.33700 -1.59e-01 -2.97e-01 4.99e-01 2.08e-01
PI-3K cascade:FGFR2 22 3.28e-02 2.83e-01 0.33700 -2.95e-01 1.63e-01 1.66e-02 1.86e-01
GOBP FOREBRAIN NEURON DIFFERENTIATION 42 6.05e-04 2.18e-02 0.33700 -3.35e-01 -3.44e-02 1.71e-04 7.00e-01
Chaperone Mediated Autophagy 20 4.53e-02 3.24e-01 0.33700 2.93e-01 -1.65e-01 2.33e-02 2.00e-01
Interleukin-2 signaling 11 1.28e-01 5.11e-01 0.33600 -1.35e-01 -3.08e-01 4.38e-01 7.67e-02
GOBP PEPTIDE CROSS LINKING 26 1.37e-02 1.86e-01 0.33600 3.31e-01 -5.70e-02 3.45e-03 6.15e-01
GOMF SEROTONIN RECEPTOR ACTIVITY 6 4.03e-01 7.80e-01 0.33600 -2.27e-01 2.48e-01 3.36e-01 2.93e-01
GOBP SULFATION 20 4.83e-02 3.33e-01 0.33600 -2.29e-01 2.46e-01 7.61e-02 5.70e-02
GOBP CORNIFICATION 9 2.04e-01 6.20e-01 0.33600 3.98e-02 3.34e-01 8.36e-01 8.30e-02
GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING 10 1.54e-01 5.50e-01 0.33600 -3.03e-01 -1.44e-01 9.67e-02 4.29e-01
GOBP BONE MARROW DEVELOPMENT 9 1.86e-01 5.92e-01 0.33600 -1.39e-01 -3.06e-01 4.71e-01 1.12e-01
GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS 10 1.91e-01 5.98e-01 0.33600 -4.86e-02 3.32e-01 7.90e-01 6.89e-02
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members 9 2.44e-01 6.58e-01 0.33600 3.09e-01 -1.31e-01 1.08e-01 4.97e-01
GOBP COBALAMIN TRANSPORT 8 2.84e-01 6.96e-01 0.33600 -1.22e-01 3.13e-01 5.50e-01 1.26e-01
GOBP MAST CELL DIFFERENTIATION 6 3.21e-01 7.28e-01 0.33600 1.79e-01 2.84e-01 4.48e-01 2.29e-01
GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS 8 2.65e-01 6.79e-01 0.33500 3.92e-02 -3.33e-01 8.48e-01 1.03e-01
GOBP NEGATIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 9 2.57e-01 6.71e-01 0.33500 -2.63e-01 2.08e-01 1.73e-01 2.79e-01
GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY 12 1.63e-01 5.63e-01 0.33500 -2.14e-01 2.58e-01 1.99e-01 1.22e-01
GOMF ARYLESTERASE ACTIVITY 6 3.30e-01 7.34e-01 0.33500 3.09e-01 1.28e-01 1.89e-01 5.87e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION 6 3.22e-01 7.28e-01 0.33500 -1.85e-01 -2.79e-01 4.33e-01 2.36e-01
GOBP MOTOR LEARNING 8 2.19e-01 6.37e-01 0.33500 -1.97e-01 -2.71e-01 3.35e-01 1.84e-01
GOBP POSITIVE REGULATION OF GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION 5 4.43e-01 8.00e-01 0.33500 -3.29e-01 6.47e-02 2.03e-01 8.02e-01
Phase 3 - rapid repolarisation 8 2.54e-01 6.70e-01 0.33500 5.27e-03 3.35e-01 9.79e-01 1.01e-01
GOBP MESONEPHRIC TUBULE FORMATION 10 1.55e-01 5.51e-01 0.33500 -1.48e-01 -3.00e-01 4.18e-01 1.00e-01
TLR3-mediated TICAM1-dependent programmed cell death 6 4.05e-01 7.81e-01 0.33500 2.52e-01 -2.21e-01 2.86e-01 3.49e-01
GOBP CELLULAR RESPONSE TO L LEUCINE 12 1.52e-01 5.47e-01 0.33500 -3.14e-01 1.17e-01 6.00e-02 4.82e-01
GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION 9 2.13e-01 6.30e-01 0.33500 -1.24e-02 -3.34e-01 9.49e-01 8.23e-02
GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX 9 2.11e-01 6.28e-01 0.33500 -3.34e-01 -2.01e-02 8.27e-02 9.17e-01
GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 19 3.35e-02 2.85e-01 0.33500 3.26e-01 7.41e-02 1.38e-02 5.76e-01
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE 9 2.58e-01 6.73e-01 0.33500 2.51e-01 -2.22e-01 1.93e-01 2.50e-01
GOBP ADP BIOSYNTHETIC PROCESS 5 4.04e-01 7.81e-01 0.33500 9.51e-02 3.21e-01 7.13e-01 2.14e-01
rRNA processing in the nucleus and cytosol 181 5.32e-13 1.81e-10 0.33400 1.14e-01 -3.14e-01 7.88e-03 2.96e-13
GOBP TRANSITION BETWEEN FAST AND SLOW FIBER 9 1.96e-01 6.08e-01 0.33400 9.44e-02 3.21e-01 6.24e-01 9.56e-02
GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 7 3.50e-01 7.45e-01 0.33400 2.50e-01 -2.22e-01 2.52e-01 3.10e-01
GOBP REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION 10 2.00e-01 6.13e-01 0.33400 3.25e-01 -7.85e-02 7.52e-02 6.67e-01
GOBP NUCLEOLAR CHROMATIN ORGANIZATION 9 2.43e-01 6.58e-01 0.33400 -3.15e-01 1.10e-01 1.01e-01 5.67e-01
GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX 6 3.23e-01 7.28e-01 0.33400 -2.74e-01 -1.90e-01 2.44e-01 4.19e-01
GOBP REGULATION OF CELL FATE SPECIFICATION 23 3.21e-02 2.80e-01 0.33400 -2.49e-01 2.22e-01 3.85e-02 6.52e-02
GOCC SMC5 SMC6 COMPLEX 9 2.14e-01 6.32e-01 0.33400 -1.43e-02 -3.33e-01 9.41e-01 8.32e-02
GOBP KERATAN SULFATE METABOLIC PROCESS 18 3.42e-02 2.87e-01 0.33400 2.78e-01 1.85e-01 4.14e-02 1.74e-01
GOBP REGULATION OF CENTRIOLE REPLICATION 22 2.73e-02 2.62e-01 0.33400 4.62e-02 -3.30e-01 7.08e-01 7.30e-03
Drug-mediated inhibition of CDK4/CDK6 activity 5 4.45e-01 8.02e-01 0.33400 6.35e-02 -3.27e-01 8.06e-01 2.05e-01
GOBP NEGATIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION 5 3.92e-01 7.71e-01 0.33400 -2.80e-01 -1.82e-01 2.79e-01 4.81e-01
GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY 15 7.15e-02 4.02e-01 0.33400 3.29e-01 5.71e-02 2.75e-02 7.02e-01
GOBP LYSOSOMAL MEMBRANE ORGANIZATION 15 1.01e-01 4.65e-01 0.33400 1.56e-01 -2.95e-01 2.96e-01 4.79e-02
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN 25 2.40e-02 2.49e-01 0.33400 2.46e-01 -2.25e-01 3.30e-02 5.16e-02
GOBP RESPONSE TO BACTERIAL LIPOPROTEIN 10 2.25e-01 6.43e-01 0.33300 2.44e-01 -2.28e-01 1.82e-01 2.13e-01
Fatty acids 15 1.03e-01 4.70e-01 0.33300 1.75e-01 -2.84e-01 2.41e-01 5.69e-02
GOBP PHASIC SMOOTH MUSCLE CONTRACTION 24 1.09e-02 1.63e-01 0.33300 -2.64e-01 -2.04e-01 2.53e-02 8.37e-02
GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING 7 3.38e-01 7.38e-01 0.33300 -1.28e-01 3.08e-01 5.56e-01 1.59e-01
GOBP DIADENOSINE POLYPHOSPHATE METABOLIC PROCESS 6 4.03e-01 7.80e-01 0.33300 2.88e-01 -1.67e-01 2.21e-01 4.78e-01
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY 8 3.02e-01 7.13e-01 0.33300 -2.60e-01 2.08e-01 2.03e-01 3.07e-01
GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY 7 3.33e-01 7.35e-01 0.33300 1.03e-01 -3.17e-01 6.37e-01 1.47e-01
HDR through MMEJ (alt-NHEJ) 12 1.11e-01 4.82e-01 0.33300 -3.04e-01 -1.36e-01 6.80e-02 4.16e-01
GOBP INNER CELL MASS CELL DIFFERENTIATION 8 2.48e-01 6.62e-01 0.33300 -3.30e-01 -4.72e-02 1.06e-01 8.17e-01
GOCC CHAPERONIN CONTAINING T COMPLEX 10 2.24e-01 6.42e-01 0.33300 1.96e-01 -2.69e-01 2.83e-01 1.40e-01
GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY 17 7.96e-02 4.19e-01 0.33300 -2.49e-01 2.21e-01 7.51e-02 1.15e-01
GOBP REGULATION OF LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL 5 4.38e-01 7.98e-01 0.33300 3.32e-01 -3.05e-02 1.99e-01 9.06e-01
GOBP REGULATION OF PODOSOME ASSEMBLY 13 9.43e-02 4.49e-01 0.33300 1.19e-01 3.11e-01 4.59e-01 5.22e-02
GOBP MIDDLE EAR MORPHOGENESIS 21 2.12e-02 2.33e-01 0.33300 -3.02e-01 -1.41e-01 1.67e-02 2.65e-01
GOCC B CELL RECEPTOR COMPLEX 5 4.16e-01 7.86e-01 0.33300 -6.16e-02 -3.27e-01 8.11e-01 2.05e-01
Mitochondrial translation initiation 87 4.85e-07 5.65e-05 0.33300 6.31e-03 -3.33e-01 9.19e-01 8.04e-08
GOBP CADMIUM ION TRANSMEMBRANE TRANSPORT 6 3.90e-01 7.71e-01 0.33300 3.16e-01 -1.03e-01 1.79e-01 6.63e-01
DAP12 signaling 27 1.15e-02 1.67e-01 0.33300 2.15e-02 -3.32e-01 8.47e-01 2.84e-03
GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX 5 3.99e-01 7.77e-01 0.33200 -2.97e-01 -1.50e-01 2.51e-01 5.62e-01
GOMF PLATELET DERIVED GROWTH FACTOR BINDING 11 1.42e-01 5.34e-01 0.33200 -3.22e-01 -8.16e-02 6.43e-02 6.39e-01
GOMF PEROXISOME TARGETING SEQUENCE BINDING 5 4.07e-01 7.81e-01 0.33200 -3.16e-01 -1.04e-01 2.22e-01 6.87e-01
GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY 21 2.19e-02 2.37e-01 0.33200 -1.30e-01 -3.06e-01 3.01e-01 1.53e-02
GOMF TRANSLATION INITIATION FACTOR ACTIVITY 44 5.76e-04 2.11e-02 0.33200 -1.64e-02 -3.32e-01 8.51e-01 1.40e-04
GOBP REGULATION OF COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY 5 4.31e-01 7.96e-01 0.33200 3.32e-01 2.80e-03 1.98e-01 9.91e-01
GOBP LUTEOLYSIS 6 3.25e-01 7.29e-01 0.33200 2.22e-01 2.47e-01 3.47e-01 2.94e-01
Gamma-carboxylation of protein precursors 8 2.72e-01 6.85e-01 0.33200 -4.04e-02 3.30e-01 8.43e-01 1.06e-01
Dissolution of Fibrin Clot 13 9.18e-02 4.44e-01 0.33200 1.53e-01 2.94e-01 3.38e-01 6.60e-02
DNA methylation 28 8.17e-03 1.35e-01 0.33200 -3.62e-02 -3.30e-01 7.40e-01 2.50e-03
Dermatan sulfate biosynthesis 10 2.09e-01 6.25e-01 0.33200 -3.18e-01 9.69e-02 8.21e-02 5.96e-01
GOBP ERBB2 ERBB4 SIGNALING PATHWAY 5 3.97e-01 7.76e-01 0.33200 -1.65e-01 -2.88e-01 5.24e-01 2.64e-01
Reactions specific to the complex N-glycan synthesis pathway 10 1.56e-01 5.52e-01 0.33200 1.93e-01 2.70e-01 2.92e-01 1.39e-01
GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY 11 1.66e-01 5.67e-01 0.33200 3.30e-01 -3.58e-02 5.82e-02 8.37e-01
GOBP GROWTH INVOLVED IN HEART MORPHOGENESIS 5 4.56e-01 8.09e-01 0.33200 -8.76e-02 3.20e-01 7.34e-01 2.16e-01
GOBP 2FE 2S CLUSTER ASSEMBLY 9 2.18e-01 6.36e-01 0.33200 -1.95e-02 -3.31e-01 9.19e-01 8.55e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS 17 8.16e-02 4.23e-01 0.33100 -2.45e-01 2.23e-01 8.03e-02 1.11e-01
GOMF LYSINE N ACETYLTRANSFERASE ACTIVITY ACTING ON ACETYL PHOSPHATE AS DONOR 6 4.05e-01 7.81e-01 0.33100 -2.93e-01 1.55e-01 2.14e-01 5.11e-01
Sema4D induced cell migration and growth-cone collapse 20 4.00e-02 3.06e-01 0.33100 -3.28e-01 4.95e-02 1.12e-02 7.02e-01
GOMF PYRIMIDINE NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 8 2.40e-01 6.56e-01 0.33100 1.02e-01 3.15e-01 6.18e-01 1.23e-01
GOBP PHAGOSOME ACIDIFICATION 7 2.81e-01 6.93e-01 0.33100 1.38e-01 3.01e-01 5.27e-01 1.68e-01
GOBP REGULATION OF ENDOTHELIAL TUBE MORPHOGENESIS 6 3.96e-01 7.75e-01 0.33100 1.10e-01 -3.12e-01 6.42e-01 1.85e-01
GOBP FLAVIN CONTAINING COMPOUND METABOLIC PROCESS 6 3.32e-01 7.35e-01 0.33100 2.85e-01 1.68e-01 2.27e-01 4.75e-01
GOCC RIBOSOME 221 1.13e-15 6.04e-13 0.33100 8.24e-02 -3.20e-01 3.48e-02 2.11e-16
EGFR interacts with phospholipase C-gamma 9 2.00e-01 6.13e-01 0.33100 -1.11e-01 -3.12e-01 5.63e-01 1.05e-01
GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX 6 3.43e-01 7.41e-01 0.33100 1.04e-01 3.14e-01 6.59e-01 1.83e-01
GOBP SENSORY PERCEPTION OF TOUCH 5 4.57e-01 8.09e-01 0.33100 8.51e-02 -3.20e-01 7.42e-01 2.16e-01
PTK6 promotes HIF1A stabilization 7 3.27e-01 7.31e-01 0.33100 3.26e-01 -5.70e-02 1.36e-01 7.94e-01
Digestion 17 5.54e-02 3.58e-01 0.33100 3.29e-01 3.48e-02 1.89e-02 8.04e-01
GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING 10 2.19e-01 6.37e-01 0.33100 -3.03e-01 1.32e-01 9.71e-02 4.69e-01
GOBP POSITIVE REGULATION OF PINOCYTOSIS 7 2.84e-01 6.97e-01 0.33100 -3.07e-01 -1.23e-01 1.60e-01 5.74e-01
Defective factor IX causes hemophilia B 7 3.35e-01 7.35e-01 0.33100 -8.70e-02 3.19e-01 6.90e-01 1.44e-01
GOBP DRINKING BEHAVIOR 9 2.23e-01 6.40e-01 0.33000 -3.30e-01 -7.03e-03 8.61e-02 9.71e-01
Aryl hydrocarbon receptor signalling 7 3.35e-01 7.35e-01 0.33000 3.19e-01 -8.53e-02 1.44e-01 6.96e-01
FGFR1 ligand binding and activation 17 8.30e-02 4.28e-01 0.33000 -2.30e-01 2.37e-01 1.01e-01 9.05e-02
GOBP BONE TRABECULA FORMATION 11 1.54e-01 5.50e-01 0.33000 -3.28e-01 -3.59e-02 5.93e-02 8.37e-01
GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE 5 4.06e-01 7.81e-01 0.33000 1.31e-01 3.03e-01 6.11e-01 2.41e-01
GOBP HYPERSENSITIVITY 12 1.15e-01 4.89e-01 0.33000 1.38e-01 3.00e-01 4.07e-01 7.21e-02
GOBP ARTERIAL ENDOTHELIAL CELL DIFFERENTIATION 6 3.33e-01 7.35e-01 0.33000 1.76e-01 2.79e-01 4.54e-01 2.37e-01
Branched-chain ketoacid dehydrogenase kinase deficiency 5 4.48e-01 8.04e-01 0.33000 -3.27e-01 4.40e-02 2.05e-01 8.65e-01
GOMF RNA POLYMERASE III ACTIVITY 10 1.61e-01 5.59e-01 0.33000 -1.69e-01 -2.83e-01 3.55e-01 1.21e-01
GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE 9 2.05e-01 6.21e-01 0.33000 -9.05e-02 -3.17e-01 6.38e-01 9.92e-02
GOBP HORMONE MEDIATED APOPTOTIC SIGNALING PATHWAY 5 4.82e-01 8.21e-01 0.33000 -2.43e-01 2.23e-01 3.46e-01 3.88e-01
GOBP ENDOTHELIAL CELL ACTIVATION 11 1.87e-01 5.93e-01 0.33000 1.19e-01 -3.08e-01 4.93e-01 7.74e-02
GOCC U12 TYPE SPLICEOSOMAL COMPLEX 25 2.18e-02 2.36e-01 0.33000 1.11e-01 -3.11e-01 3.37e-01 7.17e-03
GOBP NEGATIVE REGULATION OF ACTION POTENTIAL 6 3.96e-01 7.75e-01 0.33000 -9.81e-02 3.15e-01 6.77e-01 1.82e-01
GOBP ALDITOL BIOSYNTHETIC PROCESS 5 4.57e-01 8.09e-01 0.33000 3.21e-01 -7.70e-02 2.14e-01 7.66e-01
GOBP REGULATION OF CGMP MEDIATED SIGNALING 11 1.40e-01 5.31e-01 0.33000 3.06e-01 1.23e-01 7.89e-02 4.79e-01
GOBP GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 6 3.36e-01 7.36e-01 0.33000 1.58e-01 2.90e-01 5.03e-01 2.19e-01
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 11 1.97e-01 6.08e-01 0.33000 -2.79e-01 1.75e-01 1.09e-01 3.14e-01
GOMF L LACTATE DEHYDROGENASE ACTIVITY 5 4.62e-01 8.12e-01 0.33000 9.71e-02 -3.15e-01 7.07e-01 2.22e-01
Regulation of signaling by CBL 22 3.61e-02 2.93e-01 0.33000 1.31e-01 -3.03e-01 2.89e-01 1.40e-02
Mechanical load activates signaling by PIEZO1 and integrins in osteocytes 17 6.71e-02 3.91e-01 0.33000 -3.25e-01 5.24e-02 2.02e-02 7.08e-01
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX 5 4.22e-01 7.91e-01 0.33000 -6.33e-02 -3.23e-01 8.06e-01 2.10e-01
Signaling by FLT3 fusion proteins 19 3.89e-02 3.04e-01 0.32900 -3.25e-01 -5.09e-02 1.40e-02 7.01e-01
GOBP REGULATION OF SEROTONIN SECRETION 6 3.68e-01 7.58e-01 0.32900 -3.29e-01 -1.36e-02 1.63e-01 9.54e-01
GOBP AGGRESSIVE BEHAVIOR 8 2.97e-01 7.09e-01 0.32900 -3.07e-01 1.18e-01 1.32e-01 5.62e-01
GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS 8 3.06e-01 7.15e-01 0.32900 1.63e-01 -2.86e-01 4.25e-01 1.61e-01
GOCC CLATHRIN SCULPTED VESICLE 12 1.16e-01 4.90e-01 0.32900 -3.00e-01 -1.35e-01 7.18e-02 4.18e-01
GOBP SHORT TERM MEMORY 10 1.70e-01 5.71e-01 0.32900 -3.10e-01 -1.11e-01 8.97e-02 5.44e-01
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC 6 3.78e-01 7.64e-01 0.32900 2.05e-02 -3.28e-01 9.31e-01 1.64e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR 5 4.72e-01 8.16e-01 0.32900 3.01e-01 -1.34e-01 2.44e-01 6.05e-01
Ligand-receptor interactions 8 2.97e-01 7.09e-01 0.32900 -3.08e-01 1.16e-01 1.32e-01 5.71e-01
GOBP CITRATE METABOLIC PROCESS 5 4.73e-01 8.16e-01 0.32900 -3.00e-01 1.35e-01 2.46e-01 6.02e-01
Hydrolysis of LPC 9 2.16e-01 6.34e-01 0.32900 3.25e-01 5.17e-02 9.17e-02 7.88e-01
GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY 8 2.41e-01 6.56e-01 0.32900 -3.03e-01 -1.28e-01 1.38e-01 5.31e-01
HDL remodeling 10 1.74e-01 5.78e-01 0.32900 -3.14e-01 -9.65e-02 8.54e-02 5.97e-01
GOCC NEURONAL DENSE CORE VESICLE MEMBRANE 5 4.73e-01 8.17e-01 0.32900 -1.37e-01 2.99e-01 5.96e-01 2.47e-01
Regulation of expression of SLITs and ROBOs 149 2.06e-10 4.77e-08 0.32800 1.24e-01 -3.04e-01 8.79e-03 1.47e-10
GOBP POSITIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS 6 3.46e-01 7.43e-01 0.32800 -3.06e-01 -1.19e-01 1.94e-01 6.12e-01
Glutathione synthesis and recycling 12 1.29e-01 5.13e-01 0.32800 3.23e-01 5.82e-02 5.25e-02 7.27e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL 8 2.70e-01 6.85e-01 0.32800 3.28e-01 -4.14e-03 1.08e-01 9.84e-01
GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY 5 4.85e-01 8.23e-01 0.32800 2.28e-01 -2.36e-01 3.78e-01 3.60e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY 19 6.33e-02 3.79e-01 0.32800 -2.65e-01 1.94e-01 4.57e-02 1.44e-01
GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION 17 6.44e-02 3.81e-01 0.32800 -3.27e-01 1.94e-02 1.94e-02 8.90e-01
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS 8 3.04e-01 7.14e-01 0.32800 2.98e-01 -1.36e-01 1.44e-01 5.04e-01
GOBP NEGATIVE REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE 5 4.76e-01 8.19e-01 0.32800 -1.45e-01 2.94e-01 5.75e-01 2.54e-01
GOCC MICROTUBULE PLUS END 24 2.28e-02 2.42e-01 0.32800 -3.24e-01 5.02e-02 5.98e-03 6.70e-01
GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY 9 1.94e-01 6.03e-01 0.32800 2.02e-01 2.58e-01 2.94e-01 1.79e-01
DNA replication initiation 7 2.79e-01 6.92e-01 0.32800 -2.31e-01 -2.32e-01 2.89e-01 2.88e-01
GOBP MUCOSA ASSOCIATED LYMPHOID TISSUE DEVELOPMENT 8 3.12e-01 7.21e-01 0.32800 -2.72e-01 1.83e-01 1.83e-01 3.70e-01
GOMF OPSONIN RECEPTOR ACTIVITY 5 4.04e-01 7.80e-01 0.32800 -1.89e-01 -2.67e-01 4.63e-01 3.01e-01
Vitamin C (ascorbate) metabolism 8 2.33e-01 6.50e-01 0.32700 -2.14e-01 -2.48e-01 2.94e-01 2.25e-01
GOBP VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION 13 1.32e-01 5.19e-01 0.32700 -3.21e-01 6.37e-02 4.49e-02 6.91e-01
GOBP ALDEHYDE BIOSYNTHETIC PROCESS 18 4.11e-02 3.09e-01 0.32700 2.98e-01 1.36e-01 2.88e-02 3.18e-01
GOBP POSITIVE REGULATION OF AMYLOID BETA CLEARANCE 8 2.64e-01 6.79e-01 0.32700 -3.26e-01 -3.26e-02 1.11e-01 8.73e-01
GOMF HEPARAN SULFATE BINDING 7 3.66e-01 7.55e-01 0.32700 2.38e-01 -2.24e-01 2.75e-01 3.04e-01
GOMF MHC CLASS II PROTEIN COMPLEX BINDING 25 2.69e-02 2.60e-01 0.32700 2.68e-01 -1.88e-01 2.04e-02 1.04e-01
GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY 27 1.05e-02 1.58e-01 0.32700 -3.23e-01 -5.23e-02 3.68e-03 6.38e-01
GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY 13 1.00e-01 4.63e-01 0.32700 -2.99e-01 -1.34e-01 6.23e-02 4.05e-01
GOBP REGULATION OF COA TRANSFERASE ACTIVITY 10 1.87e-01 5.93e-01 0.32700 -3.25e-01 -4.11e-02 7.55e-02 8.22e-01
Miro GTPase Cycle 8 2.34e-01 6.51e-01 0.32700 -2.06e-01 -2.54e-01 3.13e-01 2.14e-01
GOBP PROTEIN NEDDYLATION 28 6.67e-03 1.19e-01 0.32700 -1.64e-01 -2.83e-01 1.34e-01 9.54e-03
GOBP POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION 7 3.60e-01 7.52e-01 0.32700 2.82e-01 -1.65e-01 1.96e-01 4.49e-01
GOBP NOREPINEPHRINE TRANSPORT 23 1.97e-02 2.25e-01 0.32700 -3.19e-01 -7.29e-02 8.15e-03 5.45e-01
GOBP REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE 10 2.19e-01 6.37e-01 0.32700 -3.13e-01 9.57e-02 8.70e-02 6.00e-01
GOBP POSITIVE REGULATION OF TRIGLYCERIDE LIPASE ACTIVITY 8 2.47e-01 6.61e-01 0.32700 -3.06e-01 -1.14e-01 1.34e-01 5.77e-01
GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL 10 1.95e-01 6.06e-01 0.32700 8.71e-03 3.27e-01 9.62e-01 7.37e-02
GOBP REGULATION OF GONADOTROPIN SECRETION 12 1.26e-01 5.09e-01 0.32700 -3.14e-01 -9.07e-02 5.98e-02 5.86e-01
GOBP CEREBELLAR GRANULAR LAYER FORMATION 6 3.71e-01 7.59e-01 0.32700 2.64e-02 3.26e-01 9.11e-01 1.67e-01
GOBP LUTEINIZATION 12 1.49e-01 5.43e-01 0.32600 -3.25e-01 2.57e-02 5.11e-02 8.78e-01
GOMF SUPERCOILED DNA BINDING 6 3.49e-01 7.44e-01 0.32600 -1.29e-01 -2.99e-01 5.83e-01 2.04e-01
GOBP POSITIVE REGULATION OF MIRNA PROCESSING 5 4.60e-01 8.11e-01 0.32600 -3.21e-01 5.68e-02 2.14e-01 8.26e-01
GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY 7 3.68e-01 7.57e-01 0.32600 2.45e-01 -2.15e-01 2.61e-01 3.25e-01
Antimicrobial peptides 74 1.98e-05 1.46e-03 0.32600 2.94e-01 -1.42e-01 1.25e-05 3.53e-02
GOMF CCR3 CHEMOKINE RECEPTOR BINDING 5 4.86e-01 8.23e-01 0.32600 -1.73e-01 2.76e-01 5.03e-01 2.85e-01
GOBP IODIDE TRANSPORT 9 2.77e-01 6.91e-01 0.32600 2.25e-01 -2.36e-01 2.42e-01 2.21e-01
GOBP MATERNAL PROCESS INVOLVED IN PARTURITION 5 4.87e-01 8.24e-01 0.32600 1.83e-01 -2.69e-01 4.78e-01 2.97e-01
GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN 6 4.17e-01 7.86e-01 0.32600 2.89e-01 -1.51e-01 2.21e-01 5.22e-01
GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS 27 1.43e-02 1.90e-01 0.32600 -3.31e-02 3.24e-01 7.66e-01 3.57e-03
GOMF BMP BINDING 20 5.79e-02 3.66e-01 0.32600 -2.47e-01 2.12e-01 5.57e-02 1.00e-01
GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS 8 3.21e-01 7.28e-01 0.32500 -2.36e-01 2.24e-01 2.48e-01 2.72e-01
GOBP COENZYME A METABOLIC PROCESS 18 7.59e-02 4.12e-01 0.32500 1.86e-01 -2.67e-01 1.73e-01 4.96e-02
GOMF GLUCOSE SODIUM SYMPORTER ACTIVITY 7 3.18e-01 7.26e-01 0.32500 3.25e-01 2.25e-02 1.37e-01 9.18e-01
GOMF DOPAMINE BINDING 6 4.16e-01 7.86e-01 0.32500 -2.94e-01 1.39e-01 2.12e-01 5.56e-01
Transcriptional regulation of pluripotent stem cells 28 1.20e-02 1.72e-01 0.32500 -3.24e-01 2.34e-02 2.96e-03 8.30e-01
GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY 5 4.90e-01 8.26e-01 0.32500 1.86e-01 -2.66e-01 4.71e-01 3.02e-01
Mitochondrial translation elongation 87 8.00e-07 8.93e-05 0.32500 -1.12e-02 -3.25e-01 8.57e-01 1.63e-07
GOMF HEPARAN SULFATE GLUCOSAMINE 3 SULFOTRANSFERASE 1 ACTIVITY 7 3.27e-01 7.30e-01 0.32500 -3.25e-01 5.74e-03 1.37e-01 9.79e-01
GOCC PLATELET DENSE GRANULE MEMBRANE 5 4.92e-01 8.26e-01 0.32500 -2.54e-01 2.02e-01 3.25e-01 4.34e-01
GOBP REELIN MEDIATED SIGNALING PATHWAY 8 2.39e-01 6.55e-01 0.32500 -2.41e-01 -2.18e-01 2.39e-01 2.85e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY 33 9.16e-03 1.46e-01 0.32500 1.92e-01 -2.62e-01 5.59e-02 9.27e-03
PTK6 Regulates Proteins Involved in RNA Processing 5 4.85e-01 8.23e-01 0.32500 2.88e-01 -1.49e-01 2.64e-01 5.63e-01
GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION 24 3.36e-02 2.85e-01 0.32500 -2.14e-01 2.44e-01 6.92e-02 3.87e-02
GOCC RIBONUCLEASE P COMPLEX 13 1.08e-01 4.76e-01 0.32500 -1.04e-01 -3.07e-01 5.17e-01 5.49e-02
Mitochondrial RNA degradation 10 2.44e-01 6.58e-01 0.32400 2.22e-01 -2.36e-01 2.24e-01 1.95e-01
GOBP PYRUVATE FAMILY AMINO ACID CATABOLIC PROCESS 10 1.68e-01 5.68e-01 0.32400 2.45e-01 2.12e-01 1.79e-01 2.45e-01
GOBP ANDROGEN CATABOLIC PROCESS 5 4.78e-01 8.20e-01 0.32400 3.03e-01 -1.14e-01 2.40e-01 6.58e-01
GOBP THALAMUS DEVELOPMENT 11 2.10e-01 6.26e-01 0.32400 -2.63e-01 1.90e-01 1.31e-01 2.76e-01
TGFBR3 PTM regulation 10 1.69e-01 5.70e-01 0.32400 -2.59e-01 -1.95e-01 1.57e-01 2.85e-01
GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 5 4.72e-01 8.15e-01 0.32400 -3.13e-01 8.58e-02 2.26e-01 7.40e-01
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells 15 6.96e-02 3.97e-01 0.32400 -1.94e-01 -2.60e-01 1.94e-01 8.15e-02
GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 47 2.50e-04 1.16e-02 0.32400 -2.73e-01 -1.75e-01 1.22e-03 3.77e-02
GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION 7 3.02e-01 7.13e-01 0.32400 -3.07e-01 -1.03e-01 1.59e-01 6.37e-01
GOBP POSITIVE REGULATION OF MELANOCYTE DIFFERENTIATION 5 4.35e-01 7.97e-01 0.32400 -3.19e-01 -5.92e-02 2.17e-01 8.19e-01
GOCC BASEMENT MEMBRANE COLLAGEN TRIMER 6 4.09e-01 7.83e-01 0.32400 -3.10e-01 9.51e-02 1.89e-01 6.87e-01
GOBP REGULATION OF CELL FATE COMMITMENT 43 2.15e-03 5.74e-02 0.32400 -2.79e-01 1.64e-01 1.55e-03 6.22e-02
GOMF DOUBLE STRANDED TELOMERIC DNA BINDING 9 2.29e-01 6.47e-01 0.32400 -4.01e-02 -3.21e-01 8.35e-01 9.51e-02
GOMF ICOSANOID TRANSMEMBRANE TRANSPORTER ACTIVITY 13 9.89e-02 4.60e-01 0.32400 2.39e-01 2.18e-01 1.35e-01 1.73e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN 6 4.29e-01 7.94e-01 0.32400 2.00e-01 -2.54e-01 3.95e-01 2.81e-01
GOBP PROTEIN NITROSYLATION 15 9.50e-02 4.50e-01 0.32400 3.23e-01 -2.07e-02 3.03e-02 8.90e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY 7 2.89e-01 7.02e-01 0.32400 -2.63e-01 -1.89e-01 2.29e-01 3.86e-01
GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY 11 1.51e-01 5.46e-01 0.32300 -3.00e-01 -1.22e-01 8.52e-02 4.85e-01
GOBP POSITIVE REGULATION OF ENAMEL MINERALIZATION 5 4.83e-01 8.22e-01 0.32300 1.28e-01 -2.97e-01 6.21e-01 2.50e-01
GOMF 2 ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY 6 3.87e-01 7.69e-01 0.32300 -7.35e-03 3.23e-01 9.75e-01 1.70e-01
GOBP IRON ION IMPORT ACROSS PLASMA MEMBRANE 5 4.81e-01 8.21e-01 0.32300 1.17e-01 -3.01e-01 6.50e-01 2.43e-01
GOMF MEDIUM CHAIN FATTY ACID COA LIGASE ACTIVITY 10 1.70e-01 5.71e-01 0.32300 -2.14e-01 -2.42e-01 2.41e-01 1.85e-01
GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I 24 2.51e-02 2.53e-01 0.32300 -3.20e-01 4.59e-02 6.66e-03 6.97e-01
GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT 23 3.51e-02 2.90e-01 0.32300 -2.99e-01 1.23e-01 1.31e-02 3.07e-01
GOBP ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 6 3.91e-01 7.71e-01 0.32300 3.23e-01 -1.95e-02 1.71e-01 9.34e-01
GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY 6 4.18e-01 7.87e-01 0.32300 -2.98e-01 1.25e-01 2.07e-01 5.95e-01
GOBP STARTLE RESPONSE 27 1.64e-02 2.05e-01 0.32300 -3.18e-01 5.57e-02 4.20e-03 6.16e-01
GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION 17 5.30e-02 3.49e-01 0.32300 -1.36e-01 -2.93e-01 3.33e-01 3.63e-02
GOBP DENDRITIC CELL APOPTOTIC PROCESS 11 2.11e-01 6.27e-01 0.32300 1.74e-01 -2.72e-01 3.17e-01 1.18e-01
GOBP MONOCYTE AGGREGATION 5 4.97e-01 8.29e-01 0.32300 2.35e-01 -2.21e-01 3.62e-01 3.92e-01
GOBP RETINAL CELL PROGRAMMED CELL DEATH 6 3.57e-01 7.49e-01 0.32300 -1.26e-01 -2.97e-01 5.93e-01 2.08e-01
GOBP TRUNK SEGMENTATION 5 4.86e-01 8.23e-01 0.32300 -1.32e-01 2.94e-01 6.09e-01 2.54e-01
Response of EIF2AK1 (HRI) to heme deficiency 14 1.17e-01 4.92e-01 0.32300 3.19e-01 -4.51e-02 3.85e-02 7.70e-01
GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION 15 1.21e-01 4.99e-01 0.32300 -2.67e-01 1.80e-01 7.30e-02 2.26e-01
GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 5 4.60e-01 8.11e-01 0.32200 3.21e-01 -2.57e-02 2.13e-01 9.21e-01
Activated NTRK2 signals through RAS 9 2.14e-01 6.31e-01 0.32200 -2.97e-01 -1.26e-01 1.23e-01 5.13e-01
GOBP GENITALIA MORPHOGENESIS 11 2.09e-01 6.25e-01 0.32200 -2.83e-01 1.55e-01 1.05e-01 3.73e-01
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY 6 4.34e-01 7.96e-01 0.32200 -2.29e-01 2.27e-01 3.31e-01 3.37e-01
GOBP RESPONSE TO INTERLEUKIN 7 15 1.14e-01 4.88e-01 0.32200 2.99e-01 -1.21e-01 4.52e-02 4.18e-01
Muscarinic acetylcholine receptors 5 4.46e-01 8.02e-01 0.32200 3.21e-01 3.11e-02 2.14e-01 9.04e-01
GOMF UBIQUITIN LIGASE ACTIVATOR ACTIVITY 10 2.20e-01 6.38e-01 0.32200 5.68e-02 -3.17e-01 7.56e-01 8.25e-02
GOMF DEATH RECEPTOR ACTIVITY 11 1.81e-01 5.84e-01 0.32200 3.22e-01 -1.90e-02 6.48e-02 9.13e-01
GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION 6 3.78e-01 7.64e-01 0.32200 -3.20e-01 -3.68e-02 1.75e-01 8.76e-01
GOMF SPHINGOSINE N ACYLTRANSFERASE ACTIVITY 7 3.78e-01 7.64e-01 0.32200 -2.33e-01 2.22e-01 2.86e-01 3.09e-01
GOMF CALCIUM POTASSIUM SODIUM ANTIPORTER ACTIVITY 5 4.94e-01 8.28e-01 0.32200 -1.69e-01 2.74e-01 5.13e-01 2.89e-01
GOBP HEMIDESMOSOME ASSEMBLY 6 3.52e-01 7.46e-01 0.32200 2.74e-01 1.69e-01 2.45e-01 4.74e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 58 1.39e-04 7.77e-03 0.32200 3.20e-01 -3.46e-02 2.51e-05 6.49e-01
GOBP MITOCHONDRIAL DNA REPAIR 6 3.73e-01 7.61e-01 0.32200 -6.10e-02 -3.16e-01 7.96e-01 1.80e-01
GOBP SMOOTH MUSCLE CELL MATRIX ADHESION 6 3.98e-01 7.76e-01 0.32200 -3.25e-02 3.20e-01 8.90e-01 1.75e-01
GOBP G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY 11 2.06e-01 6.21e-01 0.32200 -2.95e-01 1.28e-01 8.99e-02 4.64e-01
GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY 25 2.94e-02 2.70e-01 0.32200 -2.78e-01 1.61e-01 1.60e-02 1.64e-01
Synthesis of pyrophosphates in the cytosol 8 2.93e-01 7.05e-01 0.32200 -3.20e-01 3.14e-02 1.17e-01 8.78e-01
GOBP REGULATION OF ALDOSTERONE METABOLIC PROCESS 8 2.48e-01 6.63e-01 0.32100 2.67e-01 1.79e-01 1.91e-01 3.82e-01
VEGF binds to VEGFR leading to receptor dimerization 7 3.43e-01 7.40e-01 0.32100 -3.59e-02 3.19e-01 8.69e-01 1.43e-01
VEGF ligand-receptor interactions 7 3.43e-01 7.40e-01 0.32100 -3.59e-02 3.19e-01 8.69e-01 1.43e-01
RNA Polymerase I Promoter Escape 53 1.86e-04 9.46e-03 0.32100 -4.86e-02 -3.18e-01 5.40e-01 6.35e-05
GOBP ERYTHROSE 4 PHOSPHATE PHOSPHOENOLPYRUVATE FAMILY AMINO ACID METABOLIC PROCESS 18 4.66e-02 3.28e-01 0.32100 1.29e-01 2.94e-01 3.44e-01 3.07e-02
GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY 15 8.53e-02 4.33e-01 0.32100 -6.57e-02 -3.14e-01 6.60e-01 3.50e-02
Early Phase of HIV Life Cycle 14 1.43e-01 5.36e-01 0.32100 2.01e-01 -2.50e-01 1.93e-01 1.05e-01
GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY 14 9.49e-02 4.50e-01 0.32100 1.07e-01 3.03e-01 4.89e-01 4.98e-02
GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM 12 1.90e-01 5.97e-01 0.32100 2.44e-01 -2.09e-01 1.44e-01 2.10e-01
GOCC CALYX OF HELD 18 7.30e-02 4.04e-01 0.32100 -3.04e-01 1.02e-01 2.54e-02 4.53e-01
GOBP CELLULAR RESPONSE TO SALT 6 4.17e-01 7.86e-01 0.32100 9.72e-02 -3.06e-01 6.80e-01 1.95e-01
GOBP REGULATION OF DNA LIGATION 6 3.85e-01 7.68e-01 0.32100 2.21e-02 3.20e-01 9.25e-01 1.74e-01
Prostanoid ligand receptors 9 2.88e-01 7.01e-01 0.32100 2.50e-01 -2.00e-01 1.93e-01 2.99e-01
GOBP REGULATION OF AXON GUIDANCE 11 1.87e-01 5.92e-01 0.32000 -3.19e-01 2.99e-02 6.70e-02 8.63e-01
GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION 10 1.76e-01 5.81e-01 0.32000 -2.07e-01 -2.45e-01 2.58e-01 1.80e-01
GOBP PROTEIN MATURATION BY PROTEIN FOLDING 7 3.80e-01 7.65e-01 0.32000 1.88e-01 -2.59e-01 3.88e-01 2.36e-01
GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION 6 4.27e-01 7.94e-01 0.32000 -1.35e-01 2.90e-01 5.67e-01 2.18e-01
GOBP CONSTITUTIVE SECRETORY PATHWAY 7 3.34e-01 7.35e-01 0.32000 -9.68e-03 -3.20e-01 9.65e-01 1.43e-01
GOBP HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION 7 3.34e-01 7.35e-01 0.32000 -3.20e-01 -8.61e-03 1.43e-01 9.69e-01
GOBP T CELL MEDIATED CYTOTOXICITY 59 3.01e-04 1.32e-02 0.32000 2.48e-01 -2.03e-01 1.00e-03 7.08e-03
GOBP EMBRYONIC BRAIN DEVELOPMENT 16 8.09e-02 4.21e-01 0.32000 -3.20e-01 -1.44e-02 2.69e-02 9.21e-01
GOMF INSULIN LIKE GROWTH FACTOR II BINDING 8 2.54e-01 6.70e-01 0.32000 -2.79e-01 -1.57e-01 1.73e-01 4.41e-01
GOBP RESPONSE TO MUSCLE STRETCH 24 2.91e-02 2.69e-01 0.32000 -3.12e-01 7.16e-02 8.23e-03 5.44e-01
GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY 26 2.68e-02 2.60e-01 0.32000 -2.74e-01 1.64e-01 1.55e-02 1.48e-01
GOMF MYOSIN V BINDING 16 1.11e-01 4.83e-01 0.32000 2.43e-01 -2.08e-01 9.28e-02 1.50e-01
Mitochondrial translation 93 6.17e-07 6.95e-05 0.32000 9.33e-03 -3.19e-01 8.76e-01 1.00e-07
GOBP MALE MATING BEHAVIOR 7 3.24e-01 7.28e-01 0.32000 -3.15e-01 -5.22e-02 1.49e-01 8.11e-01
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE 17 9.32e-02 4.46e-01 0.31900 -2.79e-01 1.55e-01 4.60e-02 2.70e-01
Organic anion transporters 12 1.94e-01 6.03e-01 0.31900 2.26e-01 -2.25e-01 1.75e-01 1.76e-01
STAT3 nuclear events downstream of ALK signaling 10 2.17e-01 6.35e-01 0.31900 3.19e-01 -2.07e-02 8.10e-02 9.10e-01
GOBP SKIN MORPHOGENESIS 13 1.41e-01 5.32e-01 0.31900 -3.44e-02 3.17e-01 8.30e-01 4.76e-02
GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK 14 1.21e-01 4.98e-01 0.31900 3.35e-02 -3.17e-01 8.28e-01 3.98e-02
GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY 8 3.32e-01 7.35e-01 0.31900 -1.77e-01 2.65e-01 3.86e-01 1.94e-01
GOBP POSITIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 9 2.50e-01 6.65e-01 0.31900 -4.60e-03 3.19e-01 9.81e-01 9.77e-02
GOBP REGULATION OF PROTEIN KINASE C ACTIVITY 5 4.66e-01 8.14e-01 0.31900 3.18e-01 -1.66e-02 2.18e-01 9.49e-01
TICAM1,TRAF6-dependent induction of TAK1 complex 10 2.14e-01 6.31e-01 0.31900 1.84e-03 -3.19e-01 9.92e-01 8.09e-02
GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING 8 2.80e-01 6.92e-01 0.31800 -3.15e-01 -4.42e-02 1.23e-01 8.28e-01
GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR PRODUCTION 6 4.14e-01 7.85e-01 0.31800 6.21e-02 -3.12e-01 7.92e-01 1.85e-01
GOBP RESPONSE TO DISACCHARIDE 8 2.86e-01 6.97e-01 0.31800 -3.17e-01 -2.35e-02 1.20e-01 9.08e-01
GOBP MUSCLE CELL FATE COMMITMENT 17 6.92e-02 3.95e-01 0.31800 -3.17e-01 -2.85e-02 2.37e-02 8.39e-01
GOBP INNER DYNEIN ARM ASSEMBLY 15 9.20e-02 4.44e-01 0.31800 4.60e-02 3.15e-01 7.58e-01 3.47e-02
GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY 7 3.29e-01 7.32e-01 0.31800 -3.15e-01 -4.45e-02 1.49e-01 8.38e-01
GOBP EMBRYONIC CAMERA TYPE EYE FORMATION 11 1.67e-01 5.68e-01 0.31800 -3.08e-01 -8.13e-02 7.73e-02 6.41e-01
Signaling by cytosolic FGFR1 fusion mutants 18 7.33e-02 4.05e-01 0.31800 -3.08e-01 7.84e-02 2.35e-02 5.65e-01
GOBP PROGESTERONE METABOLIC PROCESS 16 8.48e-02 4.32e-01 0.31800 3.18e-01 4.46e-03 2.77e-02 9.75e-01
GOBP FOREBRAIN DORSAL VENTRAL PATTERN FORMATION 7 3.05e-01 7.15e-01 0.31800 -2.73e-01 -1.62e-01 2.11e-01 4.57e-01
GOCC GLYCOPROTEIN COMPLEX 21 5.15e-02 3.44e-01 0.31800 -2.96e-01 1.15e-01 1.87e-02 3.62e-01
GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY 7 3.33e-01 7.35e-01 0.31800 -3.43e-02 -3.16e-01 8.75e-01 1.48e-01
GOBP B CELL LINEAGE COMMITMENT 6 4.38e-01 7.98e-01 0.31800 -1.62e-01 2.73e-01 4.92e-01 2.47e-01
GOBP CERAMIDE CATABOLIC PROCESS 24 3.73e-02 2.96e-01 0.31800 -1.67e-01 2.70e-01 1.56e-01 2.21e-02
GOBP INNER CELL MASS CELL PROLIFERATION 14 9.31e-02 4.46e-01 0.31700 -2.67e-01 -1.72e-01 8.37e-02 2.66e-01
GOBP PARAXIAL MESODERM FORMATION 7 3.46e-01 7.43e-01 0.31700 1.39e-02 -3.17e-01 9.49e-01 1.46e-01
GOBP ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT 20 5.39e-02 3.52e-01 0.31700 -3.11e-01 6.36e-02 1.61e-02 6.23e-01
GOMF CALCIUM SENSITIVE GUANYLATE CYCLASE ACTIVATOR ACTIVITY 5 4.96e-01 8.29e-01 0.31700 2.92e-01 -1.25e-01 2.59e-01 6.27e-01
GOBP SPERMIDINE METABOLIC PROCESS 6 3.67e-01 7.57e-01 0.31700 2.87e-01 1.35e-01 2.23e-01 5.66e-01
GOBP REGULATION OF HETEROCHROMATIN FORMATION 22 2.33e-02 2.44e-01 0.31700 -2.15e-01 -2.34e-01 8.13e-02 5.78e-02
GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE 8 3.38e-01 7.38e-01 0.31700 -1.92e-01 2.53e-01 3.48e-01 2.16e-01
GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS 10 2.54e-01 6.70e-01 0.31700 -1.66e-01 2.70e-01 3.64e-01 1.39e-01
GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE 23 2.70e-02 2.60e-01 0.31700 -3.84e-02 -3.15e-01 7.50e-01 8.97e-03
APC truncation mutants have impaired AXIN binding 13 1.45e-01 5.36e-01 0.31700 -3.15e-01 3.57e-02 4.92e-02 8.24e-01
AXIN missense mutants destabilize the destruction complex 13 1.45e-01 5.36e-01 0.31700 -3.15e-01 3.57e-02 4.92e-02 8.24e-01
Signaling by AMER1 mutants 13 1.45e-01 5.36e-01 0.31700 -3.15e-01 3.57e-02 4.92e-02 8.24e-01
Signaling by APC mutants 13 1.45e-01 5.36e-01 0.31700 -3.15e-01 3.57e-02 4.92e-02 8.24e-01
Signaling by AXIN mutants 13 1.45e-01 5.36e-01 0.31700 -3.15e-01 3.57e-02 4.92e-02 8.24e-01
Truncations of AMER1 destabilize the destruction complex 13 1.45e-01 5.36e-01 0.31700 -3.15e-01 3.57e-02 4.92e-02 8.24e-01
GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT 17 7.77e-02 4.15e-01 0.31700 3.16e-01 -2.13e-02 2.40e-02 8.79e-01
NFE2L2 regulates pentose phosphate pathway genes 7 3.75e-01 7.62e-01 0.31700 -2.94e-01 1.19e-01 1.78e-01 5.87e-01
Scavenging by Class A Receptors 19 4.12e-02 3.09e-01 0.31700 -1.56e-01 -2.76e-01 2.40e-01 3.73e-02
Cytosolic sulfonation of small molecules 22 2.95e-02 2.70e-01 0.31700 7.01e-02 3.09e-01 5.69e-01 1.21e-02
GOBP NEGATIVE REGULATION OF OSTEOCLAST DEVELOPMENT 5 4.37e-01 7.97e-01 0.31700 -2.91e-01 -1.24e-01 2.59e-01 6.31e-01
GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY 9 2.63e-01 6.78e-01 0.31700 -3.15e-01 3.68e-02 1.02e-01 8.49e-01
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL OUTER MEMBRANE 15 1.27e-01 5.10e-01 0.31700 1.50e-01 -2.79e-01 3.16e-01 6.11e-02
GOBP TRANSCRIPTION ELONGATION BY RNA POLYMERASE I 7 3.23e-01 7.28e-01 0.31700 -8.27e-02 -3.06e-01 7.05e-01 1.61e-01
DAG and IP3 signaling 40 4.64e-03 9.43e-02 0.31700 -2.24e-01 2.24e-01 1.43e-02 1.42e-02
GOBP FOREBRAIN GENERATION OF NEURONS 52 2.22e-04 1.07e-02 0.31600 -3.03e-01 -9.04e-02 1.54e-04 2.59e-01
GOCC CARDIAC MYOFIBRIL 6 3.99e-01 7.77e-01 0.31600 6.91e-03 3.16e-01 9.77e-01 1.80e-01
GOMF INOSITOL 1 3 4 5 6 PENTAKISPHOSPHATE KINASE ACTIVITY 5 4.35e-01 7.96e-01 0.31600 -2.83e-01 -1.42e-01 2.74e-01 5.81e-01
GOBP CALCITONIN FAMILY RECEPTOR SIGNALING PATHWAY 8 3.41e-01 7.40e-01 0.31600 2.06e-01 -2.40e-01 3.13e-01 2.39e-01
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION 20 3.64e-02 2.94e-01 0.31600 -2.88e-01 -1.32e-01 2.60e-02 3.07e-01
GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION 15 1.05e-01 4.72e-01 0.31600 -3.16e-01 1.69e-02 3.42e-02 9.10e-01
CD163 mediating an anti-inflammatory response 9 2.34e-01 6.50e-01 0.31600 -3.04e-01 -8.64e-02 1.14e-01 6.54e-01
GOBP ADHERENS JUNCTION ASSEMBLY 13 1.58e-01 5.56e-01 0.31600 -3.02e-01 9.26e-02 5.91e-02 5.63e-01
GOMF RETINYL PALMITATE ESTERASE ACTIVITY 6 3.92e-01 7.71e-01 0.31600 3.82e-02 3.14e-01 8.71e-01 1.83e-01
GOBP POSITIVE REGULATION OF MUCUS SECRETION 6 3.62e-01 7.53e-01 0.31600 2.50e-01 1.93e-01 2.89e-01 4.12e-01
GOMF DEATH DOMAIN BINDING 11 2.21e-01 6.38e-01 0.31600 1.43e-01 -2.82e-01 4.12e-01 1.05e-01
GOBP NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS 7 3.62e-01 7.52e-01 0.31600 -3.11e-01 5.70e-02 1.55e-01 7.94e-01
GOBP THYROID HORMONE GENERATION 22 4.11e-02 3.09e-01 0.31600 -3.10e-01 5.77e-02 1.17e-02 6.39e-01
GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS 5 4.50e-01 8.05e-01 0.31600 -7.70e-02 -3.06e-01 7.66e-01 2.36e-01
Disinhibition of SNARE formation 5 4.38e-01 7.98e-01 0.31600 -2.87e-01 -1.32e-01 2.67e-01 6.10e-01
GOBP NEURONAL DENSE CORE VESICLE EXOCYTOSIS 7 3.12e-01 7.21e-01 0.31500 2.76e-01 1.52e-01 2.05e-01 4.86e-01
GOBP ORGAN INDUCTION 21 4.55e-02 3.25e-01 0.31500 -3.13e-01 3.33e-02 1.29e-02 7.92e-01
GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL 5 4.51e-01 8.06e-01 0.31500 3.06e-01 7.56e-02 2.36e-01 7.70e-01
GOMF DIACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY 5 4.96e-01 8.29e-01 0.31500 -9.80e-02 2.99e-01 7.04e-01 2.46e-01
GOCC PROCENTRIOLE REPLICATION COMPLEX 5 5.13e-01 8.36e-01 0.31500 1.91e-01 -2.50e-01 4.60e-01 3.32e-01
GOBP INTERMEDIATE FILAMENT ORGANIZATION 72 7.01e-06 6.15e-04 0.31500 2.79e-01 1.46e-01 4.20e-05 3.26e-02
GOCC CONE PHOTORECEPTOR OUTER SEGMENT 8 3.20e-01 7.28e-01 0.31500 -7.41e-02 3.06e-01 7.17e-01 1.34e-01
GOBP REGULATION OF DNA DAMAGE CHECKPOINT 20 3.47e-02 2.88e-01 0.31500 -2.36e-01 -2.08e-01 6.78e-02 1.07e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 6 4.32e-01 7.96e-01 0.31500 2.99e-01 -9.91e-02 2.05e-01 6.74e-01
GOBP HEME A METABOLIC PROCESS 10 2.53e-01 6.68e-01 0.31500 1.26e-01 -2.88e-01 4.90e-01 1.14e-01
Abacavir transmembrane transport 5 5.03e-01 8.31e-01 0.31500 -2.88e-01 1.28e-01 2.65e-01 6.21e-01
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY 13 1.70e-01 5.71e-01 0.31500 -2.80e-01 1.43e-01 8.00e-02 3.73e-01
GOBP POSITIVE REGULATION OF EXIT FROM MITOSIS 5 4.77e-01 8.19e-01 0.31500 3.14e-01 -2.28e-02 2.24e-01 9.30e-01
GOBP PROTEIN HYDROXYLATION 23 3.55e-02 2.90e-01 0.31500 -3.11e-01 4.73e-02 9.81e-03 6.94e-01
GOBP VITAMIN B6 METABOLIC PROCESS 5 4.73e-01 8.17e-01 0.31500 -3.14e-01 6.45e-03 2.23e-01 9.80e-01
GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM 23 2.15e-02 2.34e-01 0.31500 2.56e-01 1.83e-01 3.39e-02 1.28e-01
GOBP CARDIAC CELL FATE COMMITMENT 13 1.37e-01 5.26e-01 0.31400 -3.13e-01 -2.41e-02 5.03e-02 8.80e-01
GOBP REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH 12 2.01e-01 6.15e-01 0.31400 -1.81e-01 2.57e-01 2.77e-01 1.23e-01
GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX 7 3.95e-01 7.74e-01 0.31400 -2.08e-01 2.36e-01 3.40e-01 2.80e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING 6 3.77e-01 7.64e-01 0.31400 -1.17e-01 -2.92e-01 6.19e-01 2.16e-01
GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT 5 5.04e-01 8.31e-01 0.31400 -1.30e-01 2.86e-01 6.16e-01 2.68e-01
GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL 7 3.21e-01 7.28e-01 0.31400 -1.16e-01 -2.92e-01 5.96e-01 1.81e-01
GOBP HISTAMINE METABOLIC PROCESS 6 4.51e-01 8.06e-01 0.31400 -2.43e-01 1.99e-01 3.02e-01 3.99e-01
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS I PROTEIN COMPLEX 6 4.27e-01 7.94e-01 0.31400 3.05e-01 -7.57e-02 1.96e-01 7.48e-01
GOBP NEGATIVE REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION 5 4.63e-01 8.12e-01 0.31400 -3.12e-01 -3.84e-02 2.28e-01 8.82e-01
GOBP CARBOHYDRATE PHOSPHORYLATION 22 3.90e-02 3.04e-01 0.31400 -2.07e-02 3.13e-01 8.67e-01 1.10e-02
GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY 8 3.46e-01 7.43e-01 0.31400 1.90e-01 -2.50e-01 3.53e-01 2.21e-01
GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY 8 3.47e-01 7.44e-01 0.31400 -1.99e-01 2.42e-01 3.29e-01 2.35e-01
FGFR1 mutant receptor activation 31 1.45e-02 1.91e-01 0.31400 -2.88e-01 1.25e-01 5.56e-03 2.28e-01
Cardiogenesis 26 1.43e-02 1.90e-01 0.31400 -2.82e-01 -1.38e-01 1.29e-02 2.22e-01
GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION 7 3.47e-01 7.44e-01 0.31400 1.49e-02 3.13e-01 9.45e-01 1.51e-01
SHC-mediated cascade:FGFR2 22 5.25e-02 3.47e-01 0.31300 -2.71e-01 1.57e-01 2.78e-02 2.02e-01
GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING 9 3.03e-01 7.14e-01 0.31300 1.83e-01 -2.54e-01 3.42e-01 1.87e-01
GOBP REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING 6 4.37e-01 7.97e-01 0.31300 -2.95e-01 1.06e-01 2.11e-01 6.52e-01
GOMF NMDA GLUTAMATE RECEPTOR ACTIVITY 7 3.24e-01 7.29e-01 0.31300 -1.11e-01 -2.93e-01 6.10e-01 1.80e-01
GOMF PHOSPHOLIPASE A1 ACTIVITY 18 8.57e-02 4.33e-01 0.31300 2.89e-01 -1.22e-01 3.41e-02 3.71e-01
FGFR3b ligand binding and activation 7 3.33e-01 7.35e-01 0.31300 7.25e-02 3.05e-01 7.40e-01 1.63e-01
GOBP SOMATIC MOTOR NEURON DIFFERENTIATION 5 5.09e-01 8.34e-01 0.31300 -2.79e-01 1.41e-01 2.79e-01 5.84e-01
Downstream signaling of activated FGFR2 29 1.90e-02 2.21e-01 0.31300 -2.91e-01 1.16e-01 6.77e-03 2.79e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE 6 3.75e-01 7.62e-01 0.31300 2.73e-01 1.52e-01 2.46e-01 5.19e-01
GOBP REGULATION OF MICROGLIAL CELL ACTIVATION 20 5.58e-02 3.59e-01 0.31300 3.79e-02 -3.10e-01 7.69e-01 1.63e-02
Formation of the active cofactor, UDP-glucuronate 5 4.36e-01 7.97e-01 0.31300 -2.09e-01 -2.33e-01 4.19e-01 3.68e-01
GOCC SODIUM CHANNEL COMPLEX 24 3.26e-02 2.82e-01 0.31200 3.08e-01 -5.18e-02 8.98e-03 6.61e-01
GOBP CHONDROCYTE PROLIFERATION 25 2.05e-02 2.29e-01 0.31200 -3.05e-01 -6.68e-02 8.27e-03 5.63e-01
GOCC ENDOLYSOSOME MEMBRANE 17 9.23e-02 4.45e-01 0.31200 -3.03e-01 7.40e-02 3.03e-02 5.97e-01
rRNA processing 190 5.22e-12 1.53e-09 0.31200 9.95e-02 -2.96e-01 1.80e-02 1.93e-12
GOBP ENDODERMAL CELL FATE SPECIFICATION 8 2.97e-01 7.09e-01 0.31200 -3.11e-01 -3.14e-02 1.28e-01 8.78e-01
GOMF THIOESTERASE BINDING 9 2.85e-01 6.97e-01 0.31200 3.01e-01 -8.20e-02 1.18e-01 6.70e-01
GOMF OXO ACID LYASE ACTIVITY 7 3.49e-01 7.45e-01 0.31200 1.81e-02 3.12e-01 9.34e-01 1.53e-01
GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS 16 9.30e-02 4.46e-01 0.31200 3.12e-01 2.28e-03 3.06e-02 9.87e-01
GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION 9 2.48e-01 6.63e-01 0.31200 -3.06e-01 -6.18e-02 1.12e-01 7.48e-01
GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS 17 1.08e-01 4.77e-01 0.31200 -2.41e-01 1.98e-01 8.49e-02 1.58e-01
GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY 9 2.59e-01 6.73e-01 0.31200 -3.12e-01 -1.76e-02 1.05e-01 9.27e-01
GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS 10 2.00e-01 6.12e-01 0.31200 1.29e-01 2.84e-01 4.81e-01 1.19e-01
GOCC PRE SNORNP COMPLEX 7 3.93e-01 7.73e-01 0.31200 2.74e-01 -1.50e-01 2.10e-01 4.92e-01
GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY 13 1.64e-01 5.64e-01 0.31200 -3.00e-01 8.45e-02 6.08e-02 5.98e-01
GOMF TRNA CYTIDINE 5 METHYLTRANSFERASE ACTIVITY 5 4.87e-01 8.23e-01 0.31200 -3.10e-01 3.58e-02 2.30e-01 8.90e-01
GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS 11 1.68e-01 5.69e-01 0.31200 -2.76e-01 -1.46e-01 1.13e-01 4.03e-01
GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION 8 3.23e-01 7.28e-01 0.31200 3.06e-01 -6.24e-02 1.34e-01 7.60e-01
GOBP NEGATIVE REGULATION OF PHOTORECEPTOR CELL DIFFERENTIATION 6 4.28e-01 7.94e-01 0.31200 3.06e-01 -5.84e-02 1.94e-01 8.04e-01
GOBP MESENCHYMAL CELL PROLIFERATION INVOLVED IN LUNG DEVELOPMENT 6 4.14e-01 7.85e-01 0.31200 -3.12e-01 7.97e-03 1.86e-01 9.73e-01
GOBP NEGATIVE REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS 5 5.14e-01 8.37e-01 0.31200 -2.71e-01 1.54e-01 2.94e-01 5.51e-01
GOMF RIBOSOMAL LARGE SUBUNIT BINDING 14 1.08e-01 4.77e-01 0.31200 -1.04e-01 -2.94e-01 4.99e-01 5.69e-02
GOMF PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ACTIVITY 9 2.48e-01 6.62e-01 0.31200 3.05e-01 6.66e-02 1.14e-01 7.30e-01
GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT 19 7.68e-02 4.14e-01 0.31200 -2.87e-01 1.22e-01 3.05e-02 3.56e-01
Highly calcium permeable nicotinic acetylcholine receptors 9 2.95e-01 7.07e-01 0.31100 2.89e-01 -1.16e-01 1.33e-01 5.48e-01
CREB3 factors activate genes 8 3.11e-01 7.20e-01 0.31100 1.38e-02 -3.11e-01 9.46e-01 1.28e-01
GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION 31 1.73e-02 2.11e-01 0.31100 -2.52e-01 1.83e-01 1.51e-02 7.82e-02
GOCC BOX H ACA RNP COMPLEX 7 3.92e-01 7.72e-01 0.31100 2.80e-01 -1.36e-01 2.00e-01 5.32e-01
GOBP IMMATURE B CELL DIFFERENTIATION 12 1.59e-01 5.57e-01 0.31100 -3.07e-01 -5.27e-02 6.57e-02 7.52e-01
GOBP CELLULAR RESPONSE TO NUTRIENT 46 6.68e-04 2.37e-02 0.31100 -2.89e-01 -1.15e-01 6.92e-04 1.76e-01
GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING 15 8.80e-02 4.37e-01 0.31100 -2.71e-01 -1.54e-01 6.96e-02 3.03e-01
GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS 18 7.28e-02 4.04e-01 0.31100 3.11e-01 -1.38e-02 2.24e-02 9.19e-01
GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION 8 3.42e-01 7.40e-01 0.31100 1.27e-01 -2.84e-01 5.32e-01 1.65e-01
GOBP MYOFIBROBLAST DIFFERENTIATION 14 1.15e-01 4.89e-01 0.31100 -7.04e-02 -3.03e-01 6.48e-01 4.96e-02
GOBP WHITE FAT CELL DIFFERENTIATION 17 1.10e-01 4.81e-01 0.31100 -2.27e-01 2.13e-01 1.05e-01 1.29e-01
GOCC NSL COMPLEX 9 3.08e-01 7.17e-01 0.31100 -2.55e-01 1.78e-01 1.85e-01 3.55e-01
Diseases of hemostasis 17 1.10e-01 4.80e-01 0.31100 -1.98e-01 2.40e-01 1.57e-01 8.71e-02
Defective pyroptosis 34 6.42e-03 1.16e-01 0.31100 -1.42e-02 -3.11e-01 8.86e-01 1.72e-03
GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT 12 1.59e-01 5.57e-01 0.31100 -3.05e-01 -6.06e-02 6.75e-02 7.16e-01
GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION 9 2.83e-01 6.95e-01 0.31100 3.05e-01 -6.08e-02 1.13e-01 7.52e-01
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) 14 1.56e-01 5.52e-01 0.31100 -1.44e-01 2.75e-01 3.51e-01 7.44e-02
GOCC MYOSIN FILAMENT 24 4.42e-02 3.20e-01 0.31100 -1.89e-01 2.46e-01 1.09e-01 3.66e-02
GOBP CELLULAR RESPONSE TO ETHER 6 4.60e-01 8.10e-01 0.31100 2.07e-01 -2.32e-01 3.80e-01 3.26e-01
GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY 11 2.04e-01 6.19e-01 0.31100 -3.10e-01 1.94e-02 7.50e-02 9.11e-01
Cellular response to starvation 144 3.58e-09 6.86e-07 0.31100 1.04e-01 -2.93e-01 3.17e-02 1.31e-09
GOMF G RICH STRAND TELOMERIC DNA BINDING 10 2.69e-01 6.84e-01 0.31100 1.63e-01 -2.64e-01 3.73e-01 1.48e-01
GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX 13 1.22e-01 5.00e-01 0.31100 -1.58e-01 -2.67e-01 3.23e-01 9.55e-02
GOBP MITOCHONDRIAL RNA PROCESSING 21 5.60e-02 3.60e-01 0.31100 8.71e-02 -2.98e-01 4.89e-01 1.81e-02
MET interacts with TNS proteins 5 4.42e-01 8.00e-01 0.31000 1.89e-01 2.46e-01 4.64e-01 3.40e-01
GOMF PHOSPHATIDYLCHOLINE STEROL O ACYLTRANSFERASE ACTIVATOR ACTIVITY 6 4.53e-01 8.07e-01 0.31000 -2.71e-01 1.51e-01 2.50e-01 5.21e-01
GOBP REGULATION OF SKELETAL MUSCLE TISSUE GROWTH 6 4.53e-01 8.07e-01 0.31000 2.73e-01 -1.47e-01 2.47e-01 5.32e-01
GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY 7 4.03e-01 7.80e-01 0.31000 -2.47e-01 1.88e-01 2.58e-01 3.89e-01
GOBP PRIMARY AMINO COMPOUND BIOSYNTHETIC PROCESS 6 4.13e-01 7.84e-01 0.31000 3.10e-01 1.04e-02 1.89e-01 9.65e-01
GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY 17 1.10e-01 4.81e-01 0.31000 2.46e-01 -1.89e-01 7.92e-02 1.77e-01
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY 6 4.13e-01 7.84e-01 0.31000 -3.10e-01 -1.09e-02 1.89e-01 9.63e-01
Biosynthesis of EPA-derived SPMs 6 4.49e-01 8.04e-01 0.31000 -2.84e-01 1.23e-01 2.28e-01 6.01e-01
GOBP MELANOCYTE PROLIFERATION 5 4.97e-01 8.29e-01 0.31000 3.05e-01 -5.73e-02 2.38e-01 8.24e-01
GOBP DIAPEDESIS 6 4.50e-01 8.05e-01 0.31000 -1.26e-01 2.83e-01 5.92e-01 2.30e-01
GOBP DNA PROTECTION 5 4.97e-01 8.29e-01 0.31000 5.80e-02 -3.04e-01 8.22e-01 2.39e-01
GOBP ACETYLCHOLINE SECRETION 5 5.17e-01 8.39e-01 0.31000 -2.76e-01 1.40e-01 2.85e-01 5.88e-01
GOBP RENAL SODIUM ION ABSORPTION 12 1.74e-01 5.78e-01 0.31000 -3.10e-01 -4.72e-04 6.32e-02 9.98e-01
Defective factor VIII causes hemophilia A 5 5.05e-01 8.32e-01 0.31000 -8.65e-02 2.97e-01 7.38e-01 2.49e-01
GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN 13 1.72e-01 5.76e-01 0.31000 -9.92e-02 2.93e-01 5.36e-01 6.70e-02
GOCC EARLY PHAGOSOME 12 1.80e-01 5.84e-01 0.31000 2.67e-02 -3.09e-01 8.73e-01 6.42e-02
GOBP CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION 12 1.65e-01 5.65e-01 0.31000 -3.07e-01 -3.93e-02 6.54e-02 8.14e-01
GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY 7 3.20e-01 7.28e-01 0.31000 2.02e-01 2.34e-01 3.54e-01 2.83e-01
GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY 7 3.20e-01 7.28e-01 0.31000 2.02e-01 2.34e-01 3.54e-01 2.83e-01
GOBP TERPENOID CATABOLIC PROCESS 8 2.79e-01 6.92e-01 0.31000 1.43e-01 2.75e-01 4.85e-01 1.78e-01
GOBP KIDNEY MESENCHYME DEVELOPMENT 16 7.46e-02 4.10e-01 0.30900 -1.92e-01 -2.43e-01 1.84e-01 9.24e-02
GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY 10 1.98e-01 6.09e-01 0.30900 -2.47e-01 -1.87e-01 1.76e-01 3.07e-01
GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS 9 3.07e-01 7.16e-01 0.30900 -2.72e-01 1.48e-01 1.58e-01 4.41e-01
GOBP RETROGRADE TRANS SYNAPTIC SIGNALING 10 1.97e-01 6.08e-01 0.30900 2.07e-01 2.29e-01 2.56e-01 2.09e-01
GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY 5 4.95e-01 8.28e-01 0.30900 4.14e-02 -3.06e-01 8.73e-01 2.36e-01
GOBP VESICLE FUSION WITH GOLGI APPARATUS 9 2.61e-01 6.76e-01 0.30900 -3.56e-02 -3.07e-01 8.53e-01 1.11e-01
GOBP POSITIVE REGULATION OF SODIUM PROTON ANTIPORTER ACTIVITY 5 5.23e-01 8.42e-01 0.30900 -2.60e-01 1.67e-01 3.15e-01 5.17e-01
GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY 6 4.61e-01 8.11e-01 0.30900 -1.74e-01 2.55e-01 4.61e-01 2.79e-01
GOMF 14 3 3 PROTEIN BINDING 31 1.70e-02 2.09e-01 0.30900 -2.77e-01 1.35e-01 7.49e-03 1.92e-01
Sperm Motility And Taxes 9 3.05e-01 7.15e-01 0.30900 2.81e-01 -1.28e-01 1.44e-01 5.07e-01
GOBP GAMMA DELTA T CELL DIFFERENTIATION 13 1.85e-01 5.90e-01 0.30900 2.64e-01 -1.60e-01 9.93e-02 3.18e-01
GOBP HIPPOCAMPAL NEURON APOPTOTIC PROCESS 6 4.31e-01 7.95e-01 0.30900 -3.06e-01 4.04e-02 1.94e-01 8.64e-01
GOBP OTIC VESICLE DEVELOPMENT 15 1.41e-01 5.33e-01 0.30900 -2.72e-01 1.45e-01 6.80e-02 3.29e-01
GOBP ALDEHYDE CATABOLIC PROCESS 14 1.04e-01 4.70e-01 0.30900 2.27e-01 2.09e-01 1.41e-01 1.76e-01
GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM 18 7.48e-02 4.11e-01 0.30900 -3.08e-01 5.56e-03 2.35e-02 9.67e-01
GOBP NADPH OXIDATION 6 4.45e-01 8.02e-01 0.30900 -2.94e-01 9.43e-02 2.13e-01 6.89e-01
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA 17 7.01e-02 3.97e-01 0.30900 -1.14e-01 -2.87e-01 4.15e-01 4.08e-02
GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE 10 2.42e-01 6.58e-01 0.30800 -3.07e-01 2.56e-02 9.24e-02 8.89e-01
GOMF ICOSANOID BINDING 8 2.77e-01 6.90e-01 0.30800 2.51e-01 1.80e-01 2.20e-01 3.79e-01
GOBP CGMP BIOSYNTHETIC PROCESS 10 2.63e-01 6.77e-01 0.30800 -2.90e-01 1.04e-01 1.12e-01 5.70e-01
GOBP MESENCHYMAL CELL DEVELOPMENT 6 3.80e-01 7.65e-01 0.30800 2.09e-01 2.27e-01 3.76e-01 3.36e-01
Synthesis of PIPs at the early endosome membrane 15 1.46e-01 5.40e-01 0.30800 -2.50e-01 1.80e-01 9.39e-02 2.27e-01
GOMF METALLOAMINOPEPTIDASE ACTIVITY 24 4.52e-02 3.24e-01 0.30800 -2.62e-01 1.61e-01 2.60e-02 1.71e-01
Impaired BRCA2 binding to PALB2 24 2.10e-02 2.32e-01 0.30800 -2.34e-01 -2.00e-01 4.73e-02 8.93e-02
GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION 27 2.26e-02 2.42e-01 0.30800 -3.06e-01 3.48e-02 5.91e-03 7.54e-01
GOBP GLUTAMATE CATABOLIC PROCESS 7 3.35e-01 7.35e-01 0.30800 -2.84e-01 -1.19e-01 1.94e-01 5.86e-01
GOMF CYCLASE REGULATOR ACTIVITY 16 8.08e-02 4.21e-01 0.30800 2.76e-01 1.36e-01 5.58e-02 3.48e-01
GOBP ENDOTHELIAL CELL MATRIX ADHESION 8 3.51e-01 7.45e-01 0.30800 1.30e-01 -2.79e-01 5.25e-01 1.72e-01
GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT 11 2.13e-01 6.30e-01 0.30800 -3.06e-01 3.03e-02 7.88e-02 8.62e-01
GOBP RESPONSE TO THYROGLOBULIN TRIIODOTHYRONINE 5 5.12e-01 8.36e-01 0.30700 9.60e-02 -2.92e-01 7.10e-01 2.58e-01
GOBP POSITIVE REGULATION OF ENDOCYTIC RECYCLING 8 3.19e-01 7.27e-01 0.30700 -9.62e-03 3.07e-01 9.62e-01 1.32e-01
GOBP BRANCH ELONGATION OF AN EPITHELIUM 20 5.85e-02 3.68e-01 0.30700 1.48e-02 -3.07e-01 9.09e-01 1.75e-02
GOBP URATE METABOLIC PROCESS 12 1.69e-01 5.70e-01 0.30700 3.04e-01 4.39e-02 6.81e-02 7.92e-01
Endosomal/Vacuolar pathway 12 1.99e-01 6.12e-01 0.30700 2.95e-01 -8.71e-02 7.71e-02 6.01e-01
GOBP REGULATION OF HEPATOCYTE PROLIFERATION 16 1.22e-01 5.00e-01 0.30700 1.19e-01 -2.83e-01 4.09e-01 4.99e-02
GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS 17 9.56e-02 4.51e-01 0.30700 3.03e-01 -4.86e-02 3.04e-02 7.29e-01
GOBP CHITIN METABOLIC PROCESS 6 3.85e-01 7.68e-01 0.30700 2.51e-01 1.77e-01 2.87e-01 4.54e-01
GOMF CHITINASE ACTIVITY 6 3.85e-01 7.68e-01 0.30700 2.51e-01 1.77e-01 2.87e-01 4.54e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR 11 1.79e-01 5.83e-01 0.30700 2.77e-01 1.33e-01 1.12e-01 4.46e-01
GOBP RESPONSE TO INTERLEUKIN 13 5 4.51e-01 8.06e-01 0.30700 -2.49e-01 -1.79e-01 3.34e-01 4.89e-01
GOBP COMMA SHAPED BODY MORPHOGENESIS 5 5.29e-01 8.43e-01 0.30700 -1.78e-01 2.50e-01 4.91e-01 3.33e-01
WNT5A-dependent internalization of FZD4 15 1.21e-01 4.98e-01 0.30700 -3.06e-01 1.92e-02 4.00e-02 8.98e-01
GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION 11 1.77e-01 5.82e-01 0.30700 -2.68e-01 -1.50e-01 1.24e-01 3.90e-01
SMAC (DIABLO) binds to IAPs 6 4.42e-01 8.00e-01 0.30700 6.43e-02 -3.00e-01 7.85e-01 2.04e-01
SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes 6 4.42e-01 8.00e-01 0.30700 6.43e-02 -3.00e-01 7.85e-01 2.04e-01
SMAC, XIAP-regulated apoptotic response 6 4.42e-01 8.00e-01 0.30700 6.43e-02 -3.00e-01 7.85e-01 2.04e-01
GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS 20 6.19e-02 3.76e-01 0.30600 -3.31e-02 3.05e-01 7.98e-01 1.83e-02
Interaction With Cumulus Cells And The Zona Pellucida 11 2.49e-01 6.63e-01 0.30600 1.89e-01 -2.41e-01 2.77e-01 1.67e-01
GOBP INTESTINE SMOOTH MUSCLE CONTRACTION 8 2.96e-01 7.08e-01 0.30600 -2.93e-01 -9.05e-02 1.52e-01 6.58e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR 10 2.70e-01 6.85e-01 0.30600 -1.16e-01 2.84e-01 5.27e-01 1.20e-01
GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING 13 1.62e-01 5.61e-01 0.30600 -3.05e-01 2.45e-02 5.66e-02 8.79e-01
GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY 12 1.56e-01 5.52e-01 0.30600 2.82e-01 1.20e-01 9.11e-02 4.71e-01
GOMF TRANSFERRIN RECEPTOR BINDING 10 2.84e-01 6.96e-01 0.30600 -2.16e-01 2.17e-01 2.36e-01 2.35e-01
Lipid particle organization 6 4.10e-01 7.83e-01 0.30600 -3.01e-01 -5.75e-02 2.02e-01 8.07e-01
GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN 17 1.17e-01 4.91e-01 0.30600 2.45e-01 -1.83e-01 7.97e-02 1.92e-01
GOCC SEROTONIN RECEPTOR COMPLEX 5 5.30e-01 8.43e-01 0.30600 -2.55e-01 1.70e-01 3.24e-01 5.11e-01
GOMF SEROTONIN GATED MONOATOMIC CATION CHANNEL ACTIVITY 5 5.30e-01 8.43e-01 0.30600 -2.55e-01 1.70e-01 3.24e-01 5.11e-01
GOMF HISTONE METHYLTRANSFERASE BINDING 14 1.70e-01 5.71e-01 0.30600 2.49e-01 -1.78e-01 1.07e-01 2.50e-01
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION 9 3.04e-01 7.14e-01 0.30600 -9.39e-02 2.91e-01 6.26e-01 1.30e-01
GOBP SPHINGOID METABOLIC PROCESS 22 3.04e-02 2.73e-01 0.30600 2.24e-01 2.09e-01 6.93e-02 9.04e-02
GOBP EOSINOPHIL DIFFERENTIATION 6 4.71e-01 8.15e-01 0.30600 2.26e-01 -2.06e-01 3.38e-01 3.82e-01
Signaling by FGFR1 in disease 38 7.52e-03 1.28e-01 0.30600 -2.74e-01 1.35e-01 3.43e-03 1.50e-01
GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY 41 5.74e-03 1.08e-01 0.30600 1.82e-01 -2.45e-01 4.33e-02 6.57e-03
GP1b-IX-V activation signalling 11 2.36e-01 6.52e-01 0.30600 -2.88e-01 1.03e-01 9.83e-02 5.55e-01
Fertilization 26 3.86e-02 3.03e-01 0.30500 2.11e-01 -2.20e-01 6.20e-02 5.16e-02
GOMF CASPASE BINDING 13 1.40e-01 5.31e-01 0.30500 -9.05e-02 -2.92e-01 5.72e-01 6.85e-02
GOBP OOCYTE MATURATION 35 1.18e-02 1.71e-01 0.30500 -2.61e-01 1.58e-01 7.45e-03 1.06e-01
PI-3K cascade:FGFR1 21 7.08e-02 4.00e-01 0.30500 -2.51e-01 1.75e-01 4.68e-02 1.66e-01
GOBP CELLULAR RESPONSE TO ALDOSTERONE 7 3.38e-01 7.38e-01 0.30500 2.74e-01 1.35e-01 2.10e-01 5.35e-01
GOBP B CELL CHEMOTAXIS 7 3.39e-01 7.39e-01 0.30500 1.31e-01 2.76e-01 5.49e-01 2.06e-01
GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 6 4.42e-01 8.00e-01 0.30500 3.01e-01 -5.18e-02 2.02e-01 8.26e-01
Mitochondrial translation termination 87 3.95e-06 3.59e-04 0.30500 -1.75e-02 -3.05e-01 7.78e-01 8.99e-07
GOBP NUCLEAR MRNA SURVEILLANCE 11 2.03e-01 6.18e-01 0.30500 -3.11e-02 -3.04e-01 8.58e-01 8.13e-02
GOBP CD40 SIGNALING PATHWAY 15 9.38e-02 4.48e-01 0.30500 -2.36e-01 -1.94e-01 1.14e-01 1.94e-01
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 19 5.00e-02 3.39e-01 0.30500 -1.95e-01 -2.34e-01 1.41e-01 7.70e-02
GOBP T HELPER 2 CELL DIFFERENTIATION 18 1.04e-01 4.70e-01 0.30500 -2.50e-01 1.74e-01 6.59e-02 2.01e-01
Integration of provirus 9 3.13e-01 7.22e-01 0.30500 1.25e-01 -2.78e-01 5.18e-01 1.48e-01
GOMF SULFURTRANSFERASE ACTIVITY 11 2.39e-01 6.55e-01 0.30500 2.84e-01 -1.11e-01 1.03e-01 5.26e-01
GOBP RESPONSE TO GLYCOPROTEIN 11 1.76e-01 5.81e-01 0.30500 2.15e-01 2.16e-01 2.16e-01 2.16e-01
GOBP INTERNAL PEPTIDYL LYSINE ACETYLATION 8 3.44e-01 7.41e-01 0.30500 -2.96e-01 7.22e-02 1.47e-01 7.24e-01
GOBP CHIASMA ASSEMBLY 6 3.89e-01 7.70e-01 0.30500 -2.30e-01 -1.99e-01 3.28e-01 3.98e-01
GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING 22 3.73e-02 2.96e-01 0.30500 -2.93e-01 -8.14e-02 1.72e-02 5.09e-01
Deposition of new CENPA-containing nucleosomes at the centromere 46 1.35e-03 4.12e-02 0.30500 -2.58e-02 -3.03e-01 7.62e-01 3.69e-04
Nucleosome assembly 46 1.35e-03 4.12e-02 0.30500 -2.58e-02 -3.03e-01 7.62e-01 3.69e-04
GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY 50 2.00e-03 5.43e-02 0.30400 2.31e-01 -1.98e-01 4.66e-03 1.54e-02
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M 7 3.37e-01 7.36e-01 0.30400 -2.60e-01 -1.58e-01 2.33e-01 4.70e-01
GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY 21 3.68e-02 2.95e-01 0.30400 -2.21e-01 -2.09e-01 7.95e-02 9.70e-02
GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY 26 1.97e-02 2.25e-01 0.30400 1.01e-01 2.87e-01 3.75e-01 1.12e-02
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC 6 4.69e-01 8.14e-01 0.30400 -2.62e-01 1.54e-01 2.66e-01 5.14e-01
SUMOylation of transcription factors 20 5.20e-02 3.45e-01 0.30400 -2.97e-01 -6.74e-02 2.16e-02 6.02e-01
GOBP VENTRAL SPINAL CORD DEVELOPMENT 45 1.70e-03 4.81e-02 0.30400 -3.04e-01 -1.14e-02 4.18e-04 8.94e-01
GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY 5 5.38e-01 8.48e-01 0.30400 -2.05e-01 2.24e-01 4.27e-01 3.85e-01
GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY 5 5.24e-01 8.42e-01 0.30400 -2.83e-01 1.11e-01 2.73e-01 6.67e-01
GOCC HIGH DENSITY LIPOPROTEIN PARTICLE 25 4.38e-02 3.18e-01 0.30400 -2.52e-01 1.70e-01 2.90e-02 1.42e-01
Interleukin-12 family signaling 53 1.30e-03 4.03e-02 0.30400 1.62e-01 -2.58e-01 4.19e-02 1.18e-03
GOBP RELAXATION OF CARDIAC MUSCLE 17 9.50e-02 4.50e-01 0.30400 -3.03e-01 1.74e-02 3.03e-02 9.01e-01
GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY 31 7.97e-03 1.33e-01 0.30400 2.47e-01 1.77e-01 1.72e-02 8.86e-02
GOBP CEMENTUM MINERALIZATION 5 5.36e-01 8.47e-01 0.30400 -2.50e-01 1.73e-01 3.33e-01 5.03e-01
GOBP PLASMINOGEN ACTIVATION 26 1.81e-02 2.14e-01 0.30400 2.64e-01 1.50e-01 1.97e-02 1.86e-01
GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM 16 1.23e-01 5.01e-01 0.30400 8.70e-02 -2.91e-01 5.47e-01 4.39e-02
GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY 32 6.78e-03 1.20e-01 0.30400 2.38e-01 1.88e-01 1.96e-02 6.55e-02
GOBP PROTEIN DEMETHYLATION 8 3.69e-01 7.58e-01 0.30400 -2.50e-01 1.72e-01 2.21e-01 3.98e-01
GOBP ERK5 CASCADE 5 5.37e-01 8.48e-01 0.30300 -1.80e-01 2.44e-01 4.85e-01 3.44e-01
GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY 30 1.70e-02 2.09e-01 0.30300 3.01e-01 -3.62e-02 4.30e-03 7.32e-01
GOBP NUCLEOBASE CATABOLIC PROCESS 10 2.66e-01 6.81e-01 0.30300 -7.12e-02 2.95e-01 6.96e-01 1.07e-01
GOCC CEREBELLAR CLIMBING FIBER TO PURKINJE CELL SYNAPSE 7 3.52e-01 7.46e-01 0.30300 -2.89e-01 -9.21e-02 1.86e-01 6.73e-01
GOBP GERMINAL CENTER B CELL DIFFERENTIATION 8 3.06e-01 7.15e-01 0.30300 2.92e-01 8.06e-02 1.52e-01 6.93e-01
GOBP GPI ANCHOR METABOLIC PROCESS 32 1.14e-02 1.67e-01 0.30300 -2.51e-03 -3.03e-01 9.80e-01 3.01e-03
GOBP PROTEIN TO MEMBRANE DOCKING 5 5.26e-01 8.42e-01 0.30300 1.09e-01 -2.83e-01 6.73e-01 2.74e-01
GOBP REGULATION OF GROWTH RATE 5 4.99e-01 8.30e-01 0.30300 -5.76e-03 3.03e-01 9.82e-01 2.41e-01
GOBP RESPONSE TO HYDROXYUREA 11 2.40e-01 6.55e-01 0.30300 -2.89e-01 9.19e-02 9.75e-02 5.98e-01
GOBP GLUCOCORTICOID METABOLIC PROCESS 24 2.71e-02 2.61e-01 0.30300 2.82e-01 1.10e-01 1.67e-02 3.53e-01
Interleukin-18 signaling 8 3.74e-01 7.61e-01 0.30300 -2.07e-01 2.21e-01 3.10e-01 2.80e-01
GOBP POSITIVE REGULATION OF DNA CATABOLIC PROCESS 5 4.66e-01 8.14e-01 0.30300 -2.67e-01 -1.42e-01 3.00e-01 5.83e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS 14 1.78e-01 5.83e-01 0.30300 -2.31e-01 1.95e-01 1.34e-01 2.06e-01
GOCC BRCA1 A COMPLEX 7 3.46e-01 7.43e-01 0.30300 -2.75e-01 -1.26e-01 2.07e-01 5.65e-01
GOBP DETECTION OF LIPOPOLYSACCHARIDE 5 5.02e-01 8.30e-01 0.30300 -3.02e-01 1.23e-02 2.42e-01 9.62e-01
Fructose metabolism 7 3.42e-01 7.40e-01 0.30200 1.53e-01 2.61e-01 4.83e-01 2.32e-01
GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY 12 1.55e-01 5.52e-01 0.30200 -2.23e-01 -2.04e-01 1.82e-01 2.20e-01
GOBP RESPONSE TO INTERLEUKIN 9 5 4.63e-01 8.12e-01 0.30200 -2.50e-01 -1.70e-01 3.33e-01 5.10e-01
GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL 13 1.73e-01 5.78e-01 0.30200 3.69e-02 -3.00e-01 8.18e-01 6.12e-02
GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 14 1.37e-01 5.27e-01 0.30200 -2.95e-02 -3.01e-01 8.48e-01 5.15e-02
GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS 10 2.64e-01 6.79e-01 0.30200 -5.09e-02 2.98e-01 7.81e-01 1.03e-01
GOBP PEPTIDYL LYSINE DIMETHYLATION 5 5.41e-01 8.50e-01 0.30200 -2.39e-01 1.84e-01 3.55e-01 4.75e-01
Caspase activation via Death Receptors in the presence of ligand 16 1.41e-01 5.32e-01 0.30200 2.37e-01 -1.87e-01 1.00e-01 1.96e-01
GOBP INDOLE CONTAINING COMPOUND BIOSYNTHETIC PROCESS 5 4.87e-01 8.23e-01 0.30200 2.97e-01 5.34e-02 2.50e-01 8.36e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 34 1.28e-02 1.78e-01 0.30200 -2.86e-01 9.69e-02 3.95e-03 3.28e-01
TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation 5 5.38e-01 8.49e-01 0.30100 1.55e-01 -2.59e-01 5.49e-01 3.16e-01
GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS 25 4.66e-02 3.28e-01 0.30100 1.76e-01 -2.44e-01 1.27e-01 3.44e-02
GOMF POTASSIUM ION BINDING 13 2.05e-01 6.21e-01 0.30100 -2.19e-01 2.07e-01 1.71e-01 1.97e-01
GOMF D1 DOPAMINE RECEPTOR BINDING 6 4.61e-01 8.12e-01 0.30100 2.88e-01 -8.89e-02 2.22e-01 7.06e-01
GOMF HISTONE DEUBIQUITINASE ACTIVITY 7 4.26e-01 7.93e-01 0.30100 -2.32e-01 1.92e-01 2.87e-01 3.80e-01
Sodium-coupled phosphate cotransporters 5 4.68e-01 8.14e-01 0.30100 1.46e-01 2.63e-01 5.71e-01 3.08e-01
Estrogen-stimulated signaling through PRKCZ 6 4.81e-01 8.21e-01 0.30100 -1.98e-01 2.27e-01 4.01e-01 3.36e-01
GOBP REGULATION OF T CELL APOPTOTIC PROCESS 39 8.75e-03 1.42e-01 0.30100 2.26e-01 -1.99e-01 1.47e-02 3.15e-02
GOBP GAS TRANSPORT 22 5.50e-02 3.57e-01 0.30100 2.96e-01 -5.45e-02 1.63e-02 6.58e-01
GOBP CHEMOKINE C X C MOTIF LIGAND 12 SIGNALING PATHWAY 7 4.10e-01 7.83e-01 0.30100 1.00e-01 -2.84e-01 6.46e-01 1.94e-01
GAB1 signalosome 17 8.12e-02 4.22e-01 0.30100 -1.01e-01 -2.83e-01 4.69e-01 4.33e-02
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS 23 4.89e-02 3.35e-01 0.30100 2.95e-01 -5.83e-02 1.43e-02 6.29e-01
GOBP POSITIVE REGULATION OF STEROID HORMONE SECRETION 11 2.35e-01 6.51e-01 0.30100 -2.96e-01 5.36e-02 8.94e-02 7.58e-01
N-glycan antennae elongation in the medial/trans-Golgi 26 1.89e-02 2.19e-01 0.30100 1.80e-01 2.41e-01 1.12e-01 3.36e-02
GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION 8 3.41e-01 7.40e-01 0.30000 2.66e-02 -2.99e-01 8.96e-01 1.43e-01
GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION 5 5.46e-01 8.51e-01 0.30000 2.25e-01 -1.99e-01 3.83e-01 4.42e-01
GOBP NOREPINEPHRINE METABOLIC PROCESS 13 1.41e-01 5.33e-01 0.30000 1.41e-01 2.65e-01 3.80e-01 9.76e-02
Regulation of FOXO transcriptional activity by acetylation 9 2.57e-01 6.71e-01 0.30000 -2.60e-01 -1.51e-01 1.77e-01 4.34e-01
GOBP REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT 10 2.65e-01 6.79e-01 0.30000 -2.98e-01 3.98e-02 1.03e-01 8.27e-01
GOBP ANTEROGRADE DENDRITIC TRANSPORT OF NEUROTRANSMITTER RECEPTOR COMPLEX 5 4.65e-01 8.14e-01 0.30000 1.88e-01 2.34e-01 4.66e-01 3.64e-01
GOMF SODIUM INDEPENDENT ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY 16 9.55e-02 4.51e-01 0.30000 2.85e-01 9.53e-02 4.86e-02 5.09e-01
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES 11 2.51e-01 6.66e-01 0.30000 1.15e-01 -2.77e-01 5.09e-01 1.11e-01
GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS 5 5.22e-01 8.41e-01 0.30000 -2.93e-01 6.61e-02 2.57e-01 7.98e-01
GOBP SEROTONIN TRANSPORT 20 6.42e-02 3.81e-01 0.30000 -3.00e-01 -5.28e-03 2.02e-02 9.67e-01
SARS-CoV-1-host interactions 91 1.39e-05 1.10e-03 0.30000 1.43e-01 -2.64e-01 1.86e-02 1.36e-05
GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY 9 2.54e-01 6.69e-01 0.30000 2.38e-01 1.83e-01 2.17e-01 3.42e-01
GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT 20 7.77e-02 4.15e-01 0.30000 -2.87e-01 8.67e-02 2.63e-02 5.02e-01
GOBP NEGATIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS 5 5.18e-01 8.39e-01 0.30000 -2.96e-01 4.89e-02 2.52e-01 8.50e-01
GOBP PREPULSE INHIBITION 13 1.90e-01 5.97e-01 0.30000 -2.87e-01 8.67e-02 7.32e-02 5.88e-01
GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY 8 3.42e-01 7.40e-01 0.30000 -2.99e-01 2.44e-02 1.43e-01 9.05e-01
GOBP MAINTENANCE OF SISTER CHROMATID COHESION 11 2.29e-01 6.47e-01 0.30000 -2.99e-01 2.26e-02 8.60e-02 8.97e-01
GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 164 1.84e-10 4.33e-08 0.30000 -3.00e-01 -8.62e-03 3.48e-11 8.49e-01
GOBP NADH OXIDATION 6 4.14e-01 7.85e-01 0.30000 1.04e-01 2.81e-01 6.60e-01 2.33e-01
GOBP DIOL METABOLIC PROCESS 30 1.06e-02 1.59e-01 0.30000 2.40e-01 1.79e-01 2.29e-02 8.94e-02
Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells 30 2.70e-02 2.60e-01 0.29900 -2.30e-01 1.92e-01 2.95e-02 6.87e-02
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING 9 2.61e-01 6.75e-01 0.29900 -2.65e-01 -1.39e-01 1.68e-01 4.72e-01
GOBP DENTATE GYRUS DEVELOPMENT 24 3.01e-02 2.72e-01 0.29900 -9.67e-02 -2.83e-01 4.12e-01 1.63e-02
GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING 8 3.35e-01 7.35e-01 0.29900 -3.82e-03 -2.99e-01 9.85e-01 1.43e-01
GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX 13 1.43e-01 5.35e-01 0.29900 -1.42e-01 -2.63e-01 3.74e-01 1.00e-01
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING 27 2.98e-02 2.71e-01 0.29900 -2.94e-01 5.52e-02 8.18e-03 6.19e-01
GOCC RIBBON SYNAPSE 15 1.29e-01 5.13e-01 0.29900 5.73e-03 2.99e-01 9.69e-01 4.49e-02
GOBP EPITHELIAL STRUCTURE MAINTENANCE 35 5.20e-03 1.02e-01 0.29900 2.53e-01 1.59e-01 9.54e-03 1.03e-01
GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION 10 2.82e-01 6.95e-01 0.29900 -2.84e-01 9.37e-02 1.20e-01 6.08e-01
GOBP REGULATION OF MAST CELL ACTIVATION 18 1.15e-01 4.89e-01 0.29900 1.88e-01 -2.33e-01 1.68e-01 8.74e-02
GOBP HISTIDINE METABOLIC PROCESS 9 2.55e-01 6.70e-01 0.29900 1.97e-01 2.25e-01 3.05e-01 2.43e-01
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) 9 3.37e-01 7.37e-01 0.29900 2.45e-01 -1.71e-01 2.03e-01 3.73e-01
MET activates PTPN11 5 4.93e-01 8.27e-01 0.29900 -5.39e-02 -2.94e-01 8.35e-01 2.55e-01
GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY 9 3.39e-01 7.39e-01 0.29900 -1.94e-01 2.27e-01 3.13e-01 2.38e-01
GOMF TOXIN TRANSMEMBRANE TRANSPORTER ACTIVITY 9 3.13e-01 7.21e-01 0.29900 -2.92e-01 6.35e-02 1.29e-01 7.42e-01
GOBP CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP 6 4.42e-01 8.00e-01 0.29900 -2.99e-01 -2.10e-03 2.05e-01 9.93e-01
Regulation of TLR by endogenous ligand 21 4.52e-02 3.24e-01 0.29900 2.74e-01 1.20e-01 3.00e-02 3.40e-01
GOMF LIPASE INHIBITOR ACTIVITY 17 1.10e-01 4.81e-01 0.29900 -5.65e-02 2.93e-01 6.87e-01 3.62e-02
GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY 9 3.00e-01 7.11e-01 0.29900 -2.98e-01 1.98e-02 1.21e-01 9.18e-01
GOBP CARDIOLIPIN ACYL CHAIN REMODELING 5 4.68e-01 8.14e-01 0.29900 -2.07e-01 -2.15e-01 4.23e-01 4.04e-01
GOBP TELENCEPHALON REGIONALIZATION 13 1.97e-01 6.09e-01 0.29900 -2.78e-01 1.08e-01 8.22e-02 4.99e-01
GOBP SODIUM INDEPENDENT ORGANIC ANION TRANSPORT 15 1.19e-01 4.96e-01 0.29900 2.93e-01 5.83e-02 4.95e-02 6.96e-01
GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 16 9.10e-02 4.43e-01 0.29900 1.59e-01 2.53e-01 2.72e-01 7.99e-02
GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE 8 3.14e-01 7.22e-01 0.29800 -9.13e-02 -2.84e-01 6.55e-01 1.64e-01
GOBP GAMMA AMINOBUTYRIC ACID BIOSYNTHETIC PROCESS 6 4.11e-01 7.84e-01 0.29800 -2.67e-01 -1.34e-01 2.58e-01 5.71e-01
GOCC DENDRITE MEMBRANE 36 6.54e-03 1.18e-01 0.29800 -2.95e-01 -4.30e-02 2.17e-03 6.55e-01
GOBP REGULATION OF CYTOKINETIC PROCESS 7 3.81e-01 7.66e-01 0.29800 2.25e-02 2.97e-01 9.18e-01 1.73e-01
GOBP REGULATION OF CARDIOBLAST DIFFERENTIATION 5 4.94e-01 8.28e-01 0.29800 -2.93e-01 -5.61e-02 2.57e-01 8.28e-01
GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY 23 6.43e-02 3.81e-01 0.29800 2.06e-01 -2.15e-01 8.66e-02 7.39e-02
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PEROXISOME 19 6.12e-02 3.74e-01 0.29800 -1.24e-01 -2.71e-01 3.48e-01 4.09e-02
GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY 8 3.70e-01 7.58e-01 0.29800 1.09e-01 -2.77e-01 5.93e-01 1.75e-01
Meiotic recombination 52 5.92e-04 2.14e-02 0.29800 -7.97e-02 -2.87e-01 3.20e-01 3.41e-04
GOCC MITOTIC SPINDLE MIDZONE 13 1.42e-01 5.33e-01 0.29800 -2.34e-01 -1.84e-01 1.44e-01 2.50e-01
GOBP POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 9 3.22e-01 7.28e-01 0.29800 -8.69e-02 2.85e-01 6.52e-01 1.39e-01
GOBP POSITIVE REGULATION OF MAPKKK CASCADE BY FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 4.75e-01 8.18e-01 0.29800 2.52e-01 1.58e-01 3.29e-01 5.40e-01
GOBP REGULATION OF T CIRCLE FORMATION 5 5.51e-01 8.53e-01 0.29800 -2.34e-01 1.84e-01 3.66e-01 4.75e-01
GOBP HEPARIN BIOSYNTHETIC PROCESS 11 2.68e-01 6.82e-01 0.29800 -2.45e-01 1.68e-01 1.59e-01 3.33e-01
GOBP FOREGUT MORPHOGENESIS 10 2.83e-01 6.96e-01 0.29800 -2.86e-01 8.34e-02 1.18e-01 6.48e-01
GOBP CYTOCHROME METABOLIC PROCESS 5 4.73e-01 8.16e-01 0.29800 1.81e-01 2.36e-01 4.83e-01 3.61e-01
GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY 6 4.24e-01 7.93e-01 0.29800 -8.02e-02 -2.87e-01 7.34e-01 2.24e-01
GOBP PROTEASOME ASSEMBLY 12 2.01e-01 6.15e-01 0.29700 8.12e-03 -2.97e-01 9.61e-01 7.46e-02
GOBP CHONDROCYTE HYPERTROPHY 6 4.34e-01 7.96e-01 0.29700 -4.34e-02 -2.94e-01 8.54e-01 2.12e-01
GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS 9 3.44e-01 7.42e-01 0.29700 -2.07e-01 2.13e-01 2.81e-01 2.69e-01
Germ layer formation at gastrulation 16 9.59e-02 4.52e-01 0.29700 -2.68e-01 -1.28e-01 6.32e-02 3.75e-01
GOMF ERBB 3 CLASS RECEPTOR BINDING 5 5.39e-01 8.49e-01 0.29700 2.76e-01 -1.09e-01 2.84e-01 6.72e-01
GOBP GERM CELL MIGRATION 9 3.44e-01 7.41e-01 0.29700 2.25e-01 -1.95e-01 2.43e-01 3.12e-01
GOBP MESODERMAL CELL MIGRATION 5 4.75e-01 8.18e-01 0.29700 2.42e-01 1.72e-01 3.48e-01 5.05e-01
SHC1 events in EGFR signaling 14 1.35e-01 5.22e-01 0.29700 -9.25e-02 -2.82e-01 5.49e-01 6.76e-02
GOBP TOLERANCE INDUCTION TO SELF ANTIGEN 5 4.86e-01 8.23e-01 0.29700 2.79e-01 1.03e-01 2.81e-01 6.91e-01
GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE 11 2.03e-01 6.18e-01 0.29700 1.14e-01 2.74e-01 5.14e-01 1.16e-01
GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX 17 1.27e-01 5.10e-01 0.29700 -2.68e-01 1.27e-01 5.56e-02 3.66e-01
GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION 11 1.97e-01 6.09e-01 0.29600 -2.53e-01 -1.55e-01 1.47e-01 3.72e-01
GOBP HEPARIN METABOLIC PROCESS 17 1.31e-01 5.16e-01 0.29600 -2.53e-01 1.54e-01 7.05e-02 2.72e-01
GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION 6 4.55e-01 8.09e-01 0.29600 -2.95e-01 2.23e-02 2.10e-01 9.25e-01
GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION 8 3.31e-01 7.34e-01 0.29600 4.70e-02 2.93e-01 8.18e-01 1.52e-01
GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY 5 4.74e-01 8.18e-01 0.29600 2.07e-01 2.12e-01 4.22e-01 4.13e-01
FRS-mediated FGFR2 signaling 24 5.76e-02 3.65e-01 0.29600 -2.48e-01 1.61e-01 3.51e-02 1.72e-01
GOCC CLATHRIN SCULPTED MONOAMINE TRANSPORT VESICLE 5 5.10e-01 8.34e-01 0.29600 -2.96e-01 -1.44e-02 2.52e-01 9.56e-01
GOBP CYCLOOXYGENASE PATHWAY 9 3.07e-01 7.16e-01 0.29600 -1.79e-02 2.96e-01 9.26e-01 1.25e-01
GOMF ACETYLCHOLINE RECEPTOR INHIBITOR ACTIVITY 7 4.20e-01 7.88e-01 0.29600 -2.81e-01 9.19e-02 1.97e-01 6.74e-01
PRC2 methylates histones and DNA 35 9.78e-03 1.51e-01 0.29600 6.96e-03 -2.96e-01 9.43e-01 2.46e-03
GOCC ACTOMYOSIN 91 1.80e-05 1.35e-03 0.29600 -2.64e-01 1.34e-01 1.35e-05 2.75e-02
GOBP UREA TRANSMEMBRANE TRANSPORT 9 2.65e-01 6.79e-01 0.29600 2.42e-01 1.70e-01 2.08e-01 3.78e-01
GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR 11 2.04e-01 6.19e-01 0.29600 -2.70e-01 -1.21e-01 1.22e-01 4.86e-01
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function 25 2.46e-02 2.51e-01 0.29600 -2.24e-01 -1.93e-01 5.27e-02 9.46e-02
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function 25 2.46e-02 2.51e-01 0.29600 -2.24e-01 -1.93e-01 5.27e-02 9.46e-02
Defective homologous recombination repair (HRR) due to BRCA1 loss of function 25 2.46e-02 2.51e-01 0.29600 -2.24e-01 -1.93e-01 5.27e-02 9.46e-02
Defective homologous recombination repair (HRR) due to PALB2 loss of function 25 2.46e-02 2.51e-01 0.29600 -2.24e-01 -1.93e-01 5.27e-02 9.46e-02
GOBP MEMBRANE DEPOLARIZATION DURING SA NODE CELL ACTION POTENTIAL 5 5.09e-01 8.34e-01 0.29500 2.95e-01 2.34e-02 2.54e-01 9.28e-01
GOBP EPIGENETIC PROGRAMING OF MALE PRONUCLEUS 5 4.93e-01 8.27e-01 0.29500 -8.63e-02 -2.83e-01 7.38e-01 2.74e-01
GOMF LONG CHAIN FATTY ACYL COA HYDROLASE ACTIVITY 12 2.39e-01 6.55e-01 0.29500 -2.58e-01 1.44e-01 1.22e-01 3.88e-01
GOBP INFLAMMATORY RESPONSE TO WOUNDING 27 4.13e-02 3.10e-01 0.29500 1.63e-01 -2.46e-01 1.42e-01 2.70e-02
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT 9 2.78e-01 6.91e-01 0.29500 -2.78e-01 -1.00e-01 1.49e-01 6.02e-01
Regulation of PTEN localization 8 3.86e-01 7.68e-01 0.29500 1.45e-01 -2.57e-01 4.77e-01 2.08e-01
GOBP DIENCEPHALON DEVELOPMENT 75 3.35e-05 2.29e-03 0.29500 -2.90e-01 -5.21e-02 1.37e-05 4.35e-01
GOBP LUNG SECRETORY CELL DIFFERENTIATION 11 2.47e-01 6.62e-01 0.29500 5.15e-02 -2.90e-01 7.67e-01 9.53e-02
GOBP WATER TRANSPORT 28 1.65e-02 2.06e-01 0.29500 2.44e-01 1.66e-01 2.55e-02 1.29e-01
GOBP NEGATIVE REGULATION OF GLUTAMATE SECRETION 5 4.86e-01 8.23e-01 0.29500 -2.67e-01 -1.25e-01 3.01e-01 6.29e-01
GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE 20 9.48e-02 4.50e-01 0.29500 -2.46e-01 1.63e-01 5.73e-02 2.06e-01
GOBP POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION 10 3.10e-01 7.19e-01 0.29500 1.76e-01 -2.36e-01 3.35e-01 1.95e-01
GOBP PEPTIDE CATABOLIC PROCESS 19 1.09e-01 4.79e-01 0.29500 -2.19e-01 1.98e-01 9.92e-02 1.36e-01
GOBP LIVER REGENERATION 30 2.95e-02 2.70e-01 0.29500 1.65e-01 -2.44e-01 1.18e-01 2.07e-02
GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY 9 3.51e-01 7.45e-01 0.29500 -2.17e-01 1.99e-01 2.60e-01 3.01e-01
Glutamate binding, activation of AMPA receptors and synaptic plasticity 29 3.43e-02 2.87e-01 0.29500 -2.17e-01 1.99e-01 4.28e-02 6.39e-02
Trafficking of AMPA receptors 29 3.43e-02 2.87e-01 0.29500 -2.17e-01 1.99e-01 4.28e-02 6.39e-02
GOBP LOCOMOTORY EXPLORATION BEHAVIOR 16 1.09e-01 4.79e-01 0.29400 -2.87e-01 -6.42e-02 4.66e-02 6.57e-01
GOBP NEURAL PLATE MORPHOGENESIS 5 5.35e-01 8.47e-01 0.29400 6.60e-02 -2.87e-01 7.98e-01 2.66e-01
GOBP INTRACELLULAR GLUTAMATE HOMEOSTASIS 6 4.22e-01 7.90e-01 0.29400 1.28e-01 2.65e-01 5.86e-01 2.61e-01
Vitamin B1 (thiamin) metabolism 5 5.32e-01 8.45e-01 0.29400 5.50e-02 -2.89e-01 8.31e-01 2.63e-01
GOBP THIAMINE DIPHOSPHATE METABOLIC PROCESS 5 5.32e-01 8.45e-01 0.29400 5.50e-02 -2.89e-01 8.31e-01 2.63e-01
GOBP RNA CAPPING 15 1.58e-01 5.56e-01 0.29400 8.74e-02 -2.81e-01 5.58e-01 5.94e-02
GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY 8 3.86e-01 7.68e-01 0.29400 -2.62e-01 1.34e-01 2.00e-01 5.11e-01
GOBP NUCLEOPHAGY 21 8.69e-02 4.36e-01 0.29400 -1.87e-01 2.27e-01 1.38e-01 7.14e-02
GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 12 2.26e-01 6.43e-01 0.29400 -2.85e-01 7.26e-02 8.73e-02 6.63e-01
GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS 12 1.74e-01 5.79e-01 0.29400 2.48e-01 1.58e-01 1.36e-01 3.44e-01
GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS 13 2.20e-01 6.38e-01 0.29400 1.84e-01 -2.29e-01 2.50e-01 1.52e-01
GOBP LIMB BUD FORMATION 9 3.52e-01 7.46e-01 0.29400 -2.03e-01 2.13e-01 2.92e-01 2.69e-01
GOBP CONDITIONED PLACE PREFERENCE 5 5.32e-01 8.45e-01 0.29400 -5.14e-02 2.89e-01 8.42e-01 2.62e-01
GOBP ADHESION OF SYMBIONT TO HOST CELL 8 3.92e-01 7.71e-01 0.29400 2.45e-01 -1.62e-01 2.30e-01 4.27e-01
GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE 8 3.43e-01 7.40e-01 0.29400 -2.93e-01 -2.58e-02 1.52e-01 8.99e-01
GOBP REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 9 2.68e-01 6.83e-01 0.29400 -1.82e-01 -2.31e-01 3.44e-01 2.31e-01
GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE 22 6.58e-02 3.87e-01 0.29400 -2.85e-01 7.21e-02 2.08e-02 5.59e-01
GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION 10 3.14e-01 7.22e-01 0.29400 1.95e-01 -2.20e-01 2.86e-01 2.29e-01
GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX 7 4.00e-01 7.78e-01 0.29300 -2.41e-04 -2.93e-01 9.99e-01 1.79e-01
GOBP PROTEIN DESUMOYLATION 9 3.00e-01 7.11e-01 0.29300 -2.61e-02 -2.92e-01 8.92e-01 1.29e-01
Signaling by EGFR in Cancer 25 3.23e-02 2.81e-01 0.29300 -6.35e-02 -2.86e-01 5.82e-01 1.32e-02
GOBP REGULATION OF BARBED END ACTIN FILAMENT CAPPING 5 5.16e-01 8.38e-01 0.29300 2.93e-01 1.31e-02 2.56e-01 9.59e-01
GOBP MORPHOGENESIS OF AN EPITHELIAL BUD 14 1.49e-01 5.43e-01 0.29300 -2.89e-01 -5.17e-02 6.15e-02 7.38e-01
GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS 6 4.35e-01 7.96e-01 0.29300 -8.12e-02 -2.82e-01 7.31e-01 2.32e-01
GOBP REGULATION OF NEUTROPHIL DEGRANULATION 8 3.60e-01 7.51e-01 0.29300 -2.92e-01 2.83e-02 1.53e-01 8.90e-01
GOCC PHOTORECEPTOR DISC MEMBRANE 19 6.37e-02 3.79e-01 0.29300 1.67e-01 2.41e-01 2.07e-01 6.93e-02
Defective CHST14 causes EDS, musculocontractural type 7 4.27e-01 7.93e-01 0.29300 -2.79e-01 8.98e-02 2.01e-01 6.81e-01
GOBP ZYMOGEN INHIBITION 7 3.86e-01 7.68e-01 0.29300 -5.40e-02 -2.88e-01 8.05e-01 1.87e-01
GOMF PROSTANOID RECEPTOR ACTIVITY 11 2.73e-01 6.85e-01 0.29300 2.62e-01 -1.31e-01 1.32e-01 4.51e-01
GOBP SEROTONIN SECRETION 9 3.47e-01 7.44e-01 0.29300 -2.59e-01 1.37e-01 1.79e-01 4.76e-01
GOBP MRNA MODIFICATION 19 9.19e-02 4.44e-01 0.29300 4.39e-02 -2.89e-01 7.40e-01 2.90e-02
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 52 2.23e-03 5.86e-02 0.29300 -2.59e-01 1.36e-01 1.22e-03 8.99e-02
GOBP POSITIVE REGULATION OF PHOSPHOLIPASE A2 ACTIVITY 5 5.63e-01 8.58e-01 0.29300 2.01e-01 -2.13e-01 4.37e-01 4.10e-01
GOBP MICROGLIAL CELL MIGRATION 8 3.32e-01 7.35e-01 0.29200 -2.82e-01 -7.66e-02 1.67e-01 7.07e-01
GOBP NEUTROPHIL EXTRAVASATION 11 2.04e-01 6.19e-01 0.29200 2.33e-01 1.76e-01 1.81e-01 3.11e-01
Phosphate bond hydrolysis by NUDT proteins 7 3.64e-01 7.54e-01 0.29200 -1.72e-01 -2.37e-01 4.31e-01 2.78e-01
GOBP REGULATION OF CELLULAR RESPONSE TO HEAT 16 1.04e-01 4.70e-01 0.29200 -2.65e-01 -1.23e-01 6.66e-02 3.92e-01
GOBP SATELLITE CELL ACTIVATION INVOLVED IN SKELETAL MUSCLE REGENERATION 6 4.88e-01 8.25e-01 0.29200 -1.06e-01 2.72e-01 6.52e-01 2.48e-01
Chromatin modifications during the maternal to zygotic transition (MZT) 32 1.41e-02 1.89e-01 0.29200 -3.30e-02 -2.90e-01 7.47e-01 4.47e-03
GOMF THIOL OXIDASE ACTIVITY 6 4.53e-01 8.07e-01 0.29200 2.02e-02 2.91e-01 9.32e-01 2.16e-01
GOBP REGULATION OF PROTEIN NEDDYLATION 19 6.38e-02 3.79e-01 0.29200 -2.14e-01 -1.99e-01 1.06e-01 1.34e-01
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL 12 1.99e-01 6.12e-01 0.29200 2.88e-01 4.66e-02 8.37e-02 7.80e-01
GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION 9 3.57e-01 7.49e-01 0.29200 2.17e-01 -1.95e-01 2.59e-01 3.11e-01
GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI 9 2.72e-01 6.85e-01 0.29200 -2.25e-01 -1.86e-01 2.43e-01 3.33e-01
Coenzyme A biosynthesis 7 4.49e-01 8.04e-01 0.29200 1.93e-01 -2.19e-01 3.76e-01 3.16e-01
GOBP RRNA CATABOLIC PROCESS 14 1.46e-01 5.38e-01 0.29200 -2.80e-01 -8.27e-02 6.99e-02 5.92e-01
GOBP FRUCTOSE METABOLIC PROCESS 13 1.53e-01 5.48e-01 0.29200 2.00e-01 2.12e-01 2.11e-01 1.86e-01
GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 17 8.58e-02 4.33e-01 0.29200 1.99e-01 2.13e-01 1.55e-01 1.28e-01
GOCC ORGANELLAR RIBOSOME 89 8.76e-06 7.32e-04 0.29200 -1.92e-02 -2.91e-01 7.55e-01 2.08e-06
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 29 3.61e-02 2.93e-01 0.29200 2.34e-01 -1.74e-01 2.94e-02 1.04e-01
GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION 66 4.91e-04 1.89e-02 0.29200 -2.49e-01 1.52e-01 4.71e-04 3.28e-02
GOBP MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS 11 2.07e-01 6.22e-01 0.29200 -2.41e-01 -1.64e-01 1.66e-01 3.46e-01
GOMF RIBONUCLEASE P ACTIVITY 12 1.90e-01 5.96e-01 0.29100 -9.56e-02 -2.75e-01 5.66e-01 9.86e-02
GOBP AXO DENDRITIC PROTEIN TRANSPORT 9 3.53e-01 7.46e-01 0.29100 -1.49e-01 2.50e-01 4.38e-01 1.94e-01
GOBP REPLICATIVE SENESCENCE 17 8.78e-02 4.37e-01 0.29100 -2.43e-01 -1.61e-01 8.31e-02 2.50e-01
GOBP INTERNEURON MIGRATION FROM THE SUBPALLIUM TO THE CORTEX 6 4.65e-01 8.13e-01 0.29100 1.33e-02 -2.91e-01 9.55e-01 2.17e-01
GOCC MPP7 DLG1 LIN7 COMPLEX 5 5.60e-01 8.57e-01 0.29100 -1.42e-01 2.54e-01 5.82e-01 3.25e-01
GOBP CORPUS CALLOSUM MORPHOGENESIS 6 5.06e-01 8.32e-01 0.29100 2.05e-01 -2.06e-01 3.84e-01 3.82e-01
GOBP PHENOL CONTAINING COMPOUND CATABOLIC PROCESS 8 4.04e-01 7.80e-01 0.29100 -2.09e-01 2.02e-01 3.06e-01 3.22e-01
GOBP NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 6 5.05e-01 8.32e-01 0.29100 2.29e-01 -1.79e-01 3.31e-01 4.48e-01
GOBP PYRUVATE FAMILY AMINO ACID METABOLIC PROCESS 12 1.84e-01 5.89e-01 0.29100 2.57e-01 1.36e-01 1.24e-01 4.14e-01
GOBP P BODY ASSEMBLY 22 4.93e-02 3.36e-01 0.29100 -2.77e-01 -8.64e-02 2.43e-02 4.83e-01
GOBP GLUTAMATERGIC NEURON DIFFERENTIATION 15 1.82e-01 5.86e-01 0.29100 -1.82e-01 2.26e-01 2.22e-01 1.29e-01
GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY 10 2.49e-01 6.63e-01 0.29100 -2.68e-01 -1.11e-01 1.42e-01 5.43e-01
GOMF RNA DNA HYBRID RIBONUCLEASE ACTIVITY 6 4.23e-01 7.92e-01 0.29100 -1.95e-01 -2.15e-01 4.08e-01 3.61e-01
GOCC CYTOLYTIC GRANULE 14 1.60e-01 5.59e-01 0.29100 -2.39e-02 -2.90e-01 8.77e-01 6.07e-02
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION 13 1.90e-01 5.96e-01 0.29000 -2.90e-01 3.52e-03 6.98e-02 9.82e-01
GOBP LIPID DROPLET DISASSEMBLY 6 4.26e-01 7.93e-01 0.29000 2.39e-01 1.65e-01 3.10e-01 4.85e-01
GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY 5 5.68e-01 8.59e-01 0.29000 2.21e-01 -1.89e-01 3.93e-01 4.65e-01
GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY 7 4.53e-01 8.07e-01 0.29000 1.99e-01 -2.11e-01 3.62e-01 3.33e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS 5 4.97e-01 8.29e-01 0.29000 2.61e-01 1.27e-01 3.12e-01 6.23e-01
GOBP REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 5 5.19e-01 8.39e-01 0.29000 -2.89e-01 -3.06e-02 2.64e-01 9.06e-01
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane 10 2.40e-01 6.55e-01 0.29000 2.26e-01 1.83e-01 2.17e-01 3.17e-01
SUMOylation of intracellular receptors 29 3.42e-02 2.87e-01 0.29000 -2.64e-01 1.20e-01 1.39e-02 2.62e-01
GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY 31 2.26e-02 2.41e-01 0.29000 5.30e-02 -2.85e-01 6.10e-01 6.01e-03
GOBP REGULATION OF GLUCOKINASE ACTIVITY 5 5.22e-01 8.41e-01 0.29000 -2.09e-02 -2.89e-01 9.36e-01 2.63e-01
GOBP PROSTATE GLANDULAR ACINUS MORPHOGENESIS 6 4.34e-01 7.96e-01 0.29000 -2.63e-01 -1.23e-01 2.65e-01 6.03e-01
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I 10 2.70e-01 6.84e-01 0.29000 -2.87e-01 -3.51e-02 1.16e-01 8.48e-01
GOBP REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS 7 3.71e-01 7.59e-01 0.28900 -1.75e-01 -2.31e-01 4.24e-01 2.90e-01
GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 18 1.05e-01 4.73e-01 0.28900 -2.89e-01 2.21e-02 3.41e-02 8.71e-01
GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION 13 1.59e-01 5.57e-01 0.28900 1.66e-01 2.37e-01 3.00e-01 1.39e-01
GOBP LIPID GLYCOSYLATION 12 2.05e-01 6.21e-01 0.28900 4.58e-02 2.86e-01 7.84e-01 8.66e-02
GOMF MHC PROTEIN COMPLEX BINDING 34 2.03e-02 2.28e-01 0.28900 2.55e-01 -1.37e-01 1.02e-02 1.66e-01
GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 9 3.62e-01 7.52e-01 0.28900 1.69e-01 -2.35e-01 3.80e-01 2.22e-01
GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 34 2.21e-02 2.39e-01 0.28900 -2.14e-01 1.95e-01 3.12e-02 4.91e-02
GOMF PHOSPHATIDIC ACID BINDING 23 7.50e-02 4.11e-01 0.28900 -2.29e-01 1.76e-01 5.71e-02 1.43e-01
GOBP MESENCHYMAL STEM CELL DIFFERENTIATION 12 2.22e-01 6.39e-01 0.28900 2.89e-01 -1.56e-02 8.34e-02 9.25e-01
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 6 4.67e-01 8.14e-01 0.28900 -2.43e-04 2.89e-01 9.99e-01 2.20e-01
GOBP ESTROGEN METABOLIC PROCESS 37 1.58e-02 2.00e-01 0.28900 2.21e-01 -1.87e-01 2.02e-02 4.95e-02
GOBP OTIC VESICLE MORPHOGENESIS 10 3.26e-01 7.30e-01 0.28900 -2.17e-01 1.91e-01 2.35e-01 2.95e-01
GOBP PEPTIDYL LYSINE DEACETYLATION 5 4.92e-01 8.27e-01 0.28900 -2.15e-01 -1.93e-01 4.06e-01 4.54e-01
GOCC NEURONAL DENSE CORE VESICLE 25 3.74e-02 2.97e-01 0.28900 -2.85e-01 -4.48e-02 1.35e-02 6.98e-01
GOBP REGULATION OF NMDA RECEPTOR ACTIVITY 14 1.48e-01 5.43e-01 0.28900 -9.66e-02 -2.72e-01 5.32e-01 7.78e-02
GOBP PROLINE TRANSMEMBRANE TRANSPORT 9 2.92e-01 7.04e-01 0.28900 2.69e-01 1.05e-01 1.62e-01 5.86e-01
GOBP NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION 6 4.31e-01 7.95e-01 0.28900 -1.57e-01 -2.42e-01 5.06e-01 3.04e-01
GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY 9 3.31e-01 7.35e-01 0.28900 -3.85e-02 2.86e-01 8.41e-01 1.37e-01
GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION 44 5.21e-03 1.02e-01 0.28900 -2.80e-01 7.03e-02 1.31e-03 4.20e-01
GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION 29 3.89e-02 3.04e-01 0.28900 -1.82e-01 2.24e-01 8.93e-02 3.69e-02
Cleavage of the damaged purine 33 1.75e-02 2.11e-01 0.28900 3.82e-02 -2.86e-01 7.04e-01 4.46e-03
Depurination 33 1.75e-02 2.11e-01 0.28900 3.82e-02 -2.86e-01 7.04e-01 4.46e-03
Recognition and association of DNA glycosylase with site containing an affected purine 33 1.75e-02 2.11e-01 0.28900 3.82e-02 -2.86e-01 7.04e-01 4.46e-03
GOBP AMINO ACID NEUROTRANSMITTER REUPTAKE 10 3.26e-01 7.30e-01 0.28900 -1.83e-01 2.23e-01 3.16e-01 2.22e-01
GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR 28 2.89e-02 2.69e-01 0.28800 -2.88e-01 -1.52e-03 8.23e-03 9.89e-01
GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE 22 7.54e-02 4.12e-01 0.28800 -2.74e-01 9.15e-02 2.63e-02 4.58e-01
Metallothioneins bind metals 11 2.92e-01 7.05e-01 0.28800 -1.84e-01 2.22e-01 2.91e-01 2.02e-01
GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY 11 2.12e-01 6.28e-01 0.28800 1.92e-01 2.15e-01 2.69e-01 2.17e-01
GOBP CALCIUM ION IMPORT INTO SARCOPLASMIC RETICULUM 5 5.58e-01 8.56e-01 0.28800 -1.01e-01 2.70e-01 6.96e-01 2.96e-01
XBP1(S) activates chaperone genes 43 5.71e-03 1.08e-01 0.28800 -2.82e-01 6.02e-02 1.38e-03 4.95e-01
GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY 19 1.20e-01 4.98e-01 0.28800 -2.12e-01 1.95e-01 1.10e-01 1.40e-01
GOMF BHLH TRANSCRIPTION FACTOR BINDING 31 2.59e-02 2.55e-01 0.28800 -2.76e-01 8.36e-02 7.88e-03 4.20e-01
GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING 13 2.30e-01 6.48e-01 0.28800 -2.46e-01 1.49e-01 1.24e-01 3.51e-01
GOBP L LEUCINE TRANSPORT 10 3.28e-01 7.31e-01 0.28800 -1.82e-01 2.23e-01 3.19e-01 2.21e-01
GOBP TELENCEPHALON GLIAL CELL MIGRATION 26 4.59e-02 3.26e-01 0.28800 -2.78e-01 7.52e-02 1.41e-02 5.07e-01
GOBP CATECHOLAMINE UPTAKE 18 8.38e-02 4.31e-01 0.28800 -2.58e-01 -1.27e-01 5.79e-02 3.49e-01
GOCC CORE MEDIATOR COMPLEX 25 4.72e-02 3.30e-01 0.28800 3.75e-02 -2.85e-01 7.46e-01 1.35e-02
GOBP MARGINAL ZONE B CELL DIFFERENTIATION 8 3.70e-01 7.58e-01 0.28800 -1.66e-02 2.87e-01 9.35e-01 1.59e-01
Presynaptic nicotinic acetylcholine receptors 12 2.61e-01 6.76e-01 0.28800 1.69e-01 -2.33e-01 3.10e-01 1.63e-01
GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE 5 5.00e-01 8.30e-01 0.28800 1.43e-01 2.49e-01 5.79e-01 3.34e-01
GOMF LIPID PHOSPHATASE ACTIVITY 19 8.00e-02 4.20e-01 0.28800 7.16e-02 2.79e-01 5.89e-01 3.55e-02
GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY 8 3.78e-01 7.64e-01 0.28800 3.97e-02 -2.85e-01 8.46e-01 1.63e-01
GOBP ALDITOL CATABOLIC PROCESS 6 5.05e-01 8.32e-01 0.28800 2.56e-01 -1.30e-01 2.77e-01 5.81e-01
GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM 24 6.85e-02 3.95e-01 0.28800 -1.68e-01 2.33e-01 1.54e-01 4.77e-02
GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 19 1.21e-01 4.98e-01 0.28800 -1.77e-01 2.27e-01 1.82e-01 8.71e-02
GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY 6 5.11e-01 8.35e-01 0.28800 -1.65e-01 2.36e-01 4.85e-01 3.17e-01
GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION 6 5.09e-01 8.34e-01 0.28700 2.46e-01 -1.49e-01 2.97e-01 5.27e-01
GOBP URINARY TRACT SMOOTH MUSCLE CONTRACTION 9 3.26e-01 7.30e-01 0.28700 -2.87e-01 1.14e-02 1.36e-01 9.53e-01
GOBP AMMONIUM TRANSMEMBRANE TRANSPORT 13 2.10e-01 6.26e-01 0.28700 2.82e-01 -5.33e-02 7.79e-02 7.39e-01
GOBP POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION 5 5.25e-01 8.42e-01 0.28700 3.43e-02 2.85e-01 8.94e-01 2.69e-01
GOMF ANKYRIN BINDING 19 1.11e-01 4.82e-01 0.28700 2.69e-01 -1.00e-01 4.21e-02 4.50e-01
GOBP INNERVATION 27 3.66e-02 2.95e-01 0.28700 -2.86e-01 2.85e-02 1.01e-02 7.98e-01
GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY 19 1.16e-01 4.90e-01 0.28700 1.28e-01 -2.57e-01 3.35e-01 5.22e-02
GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS 9 2.96e-01 7.07e-01 0.28700 2.67e-01 1.05e-01 1.65e-01 5.84e-01
GOBP TESTOSTERONE BIOSYNTHETIC PROCESS 11 2.92e-01 7.04e-01 0.28700 -2.42e-01 1.54e-01 1.64e-01 3.76e-01
GOBP AUTOPHAGIC CELL DEATH 9 3.49e-01 7.45e-01 0.28700 8.58e-02 -2.74e-01 6.56e-01 1.55e-01
GOBP REGULATION OF HEXOKINASE ACTIVITY 6 4.62e-01 8.12e-01 0.28700 -3.21e-02 -2.85e-01 8.92e-01 2.26e-01
GOMF 5 N 7 METHYLGUANOSINE 5 TRIPHOSPHO MRNA HYDROLASE ACTIVITY 10 2.53e-01 6.69e-01 0.28700 -2.54e-01 -1.34e-01 1.64e-01 4.64e-01
GOMF STEROID HYDROXYLASE ACTIVITY 26 4.20e-02 3.13e-01 0.28700 2.85e-01 -3.10e-02 1.18e-02 7.84e-01
GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY 11 2.85e-01 6.97e-01 0.28700 1.18e-01 -2.61e-01 4.97e-01 1.33e-01
GOMF BILE ACID BINDING 10 2.74e-01 6.87e-01 0.28700 2.84e-01 4.15e-02 1.20e-01 8.20e-01
GOCC CIS GOLGI NETWORK MEMBRANE 10 2.52e-01 6.66e-01 0.28700 -1.48e-01 -2.46e-01 4.18e-01 1.79e-01
GOBP CILIUM DISASSEMBLY 5 4.98e-01 8.29e-01 0.28700 1.90e-01 2.15e-01 4.62e-01 4.06e-01
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY 8 4.03e-01 7.80e-01 0.28700 -2.59e-01 1.23e-01 2.04e-01 5.48e-01
RHOT2 GTPase cycle 7 3.77e-01 7.63e-01 0.28700 -1.91e-01 -2.14e-01 3.82e-01 3.27e-01
GOBP FACIAL NERVE MORPHOGENESIS 10 3.02e-01 7.13e-01 0.28600 -2.82e-01 5.13e-02 1.23e-01 7.79e-01
GOBP SMOOTH MUSCLE CELL CHEMOTAXIS 9 3.34e-01 7.35e-01 0.28600 -2.85e-01 2.70e-02 1.39e-01 8.88e-01
GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY 42 9.23e-03 1.46e-01 0.28600 -2.46e-01 1.47e-01 5.86e-03 9.93e-02
GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE 9 2.86e-01 6.98e-01 0.28600 -2.00e-01 -2.05e-01 2.99e-01 2.87e-01
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION 22 7.67e-02 4.14e-01 0.28600 -2.75e-01 7.82e-02 2.54e-02 5.26e-01
GOMF E BOX BINDING 58 7.35e-04 2.54e-02 0.28600 -2.86e-01 -1.56e-03 1.63e-04 9.84e-01
GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 5 5.77e-01 8.64e-01 0.28600 2.15e-01 -1.89e-01 4.06e-01 4.64e-01
GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY 16 1.27e-01 5.10e-01 0.28600 -4.72e-02 -2.82e-01 7.44e-01 5.07e-02
GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE 13 1.67e-01 5.67e-01 0.28600 -2.37e-01 -1.60e-01 1.39e-01 3.18e-01
GOMF OSMOSENSOR ACTIVITY 5 5.62e-01 8.57e-01 0.28600 2.70e-01 -9.54e-02 2.96e-01 7.12e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION 12 2.43e-01 6.58e-01 0.28600 -2.79e-01 6.33e-02 9.44e-02 7.04e-01
GOMF POLYOL TRANSMEMBRANE TRANSPORTER ACTIVITY 11 2.65e-01 6.79e-01 0.28600 2.84e-01 -3.40e-02 1.03e-01 8.45e-01
GOBP REGULATION OF GERMINAL CENTER FORMATION 8 3.63e-01 7.53e-01 0.28600 -2.85e-01 -2.51e-02 1.63e-01 9.02e-01
GOMF NAD DEPENDENT PROTEIN LYSINE DEACETYLASE ACTIVITY 7 4.50e-01 8.05e-01 0.28600 1.02e-01 -2.67e-01 6.39e-01 2.22e-01
GOBP CELLULAR RESPONSE TO DSRNA 22 5.86e-02 3.68e-01 0.28500 -5.14e-02 -2.81e-01 6.76e-01 2.26e-02
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT 25 5.02e-02 3.40e-01 0.28500 -4.06e-02 2.83e-01 7.25e-01 1.45e-02
Downstream signaling of activated FGFR1 31 2.96e-02 2.70e-01 0.28500 -2.65e-01 1.07e-01 1.08e-02 3.02e-01
GOMF AMINOPEPTIDASE ACTIVITY 38 1.55e-02 1.98e-01 0.28500 -1.70e-01 2.29e-01 6.90e-02 1.46e-02
GOBP SALIVA SECRETION 13 2.24e-01 6.42e-01 0.28500 2.71e-01 -8.78e-02 9.02e-02 5.83e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE 8 3.48e-01 7.44e-01 0.28500 -8.45e-02 -2.72e-01 6.79e-01 1.82e-01
GOMF INOSITOL PHOSPHATE KINASE ACTIVITY 11 2.36e-01 6.53e-01 0.28500 -2.74e-01 -7.78e-02 1.15e-01 6.55e-01
GOBP ATRIAL SEPTUM DEVELOPMENT 23 4.27e-02 3.15e-01 0.28500 -2.34e-01 -1.62e-01 5.18e-02 1.78e-01
BBSome-mediated cargo-targeting to cilium 23 5.54e-02 3.58e-01 0.28500 -2.27e-02 -2.84e-01 8.51e-01 1.83e-02
GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION 10 3.26e-01 7.30e-01 0.28500 -2.57e-01 1.23e-01 1.59e-01 4.99e-01
GOBP DNA LIGATION 16 1.59e-01 5.57e-01 0.28500 -8.79e-02 2.71e-01 5.43e-01 6.05e-02
GOMF NEUROPEPTIDE RECEPTOR BINDING 34 2.45e-02 2.51e-01 0.28500 -2.19e-01 1.83e-01 2.72e-02 6.55e-02
GOBP SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION 12 1.97e-01 6.09e-01 0.28500 -2.53e-01 -1.30e-01 1.29e-01 4.35e-01
GOCC MHC PROTEIN COMPLEX 24 7.12e-02 4.01e-01 0.28500 2.41e-01 -1.52e-01 4.12e-02 1.97e-01
GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS 17 1.00e-01 4.63e-01 0.28500 -2.51e-01 -1.35e-01 7.36e-02 3.35e-01
GOBP POSITIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT 8 4.15e-01 7.86e-01 0.28500 -2.37e-01 1.58e-01 2.46e-01 4.39e-01
GOBP POLYAMINE METABOLIC PROCESS 15 1.39e-01 5.31e-01 0.28500 2.72e-01 8.51e-02 6.86e-02 5.68e-01
GOBP ORNITHINE METABOLIC PROCESS 9 3.76e-01 7.63e-01 0.28400 2.10e-01 -1.92e-01 2.76e-01 3.18e-01
GOBP U4 SNRNA 3 END PROCESSING 8 3.46e-01 7.43e-01 0.28400 -1.03e-01 -2.65e-01 6.14e-01 1.94e-01
GOCC POSTSYNAPTIC CYTOSKELETON 13 2.06e-01 6.21e-01 0.28400 -2.84e-01 1.23e-02 7.63e-02 9.39e-01
Ubiquinol biosynthesis 13 2.45e-01 6.59e-01 0.28400 2.01e-01 -2.00e-01 2.09e-01 2.11e-01
GOMF PHOSPHOFRUCTOKINASE ACTIVITY 6 4.75e-01 8.18e-01 0.28400 1.36e-02 2.84e-01 9.54e-01 2.29e-01
FLT3 signaling in disease 28 2.16e-02 2.35e-01 0.28400 -1.86e-01 -2.15e-01 8.87e-02 4.90e-02
GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III 6 4.83e-01 8.22e-01 0.28400 -2.84e-01 1.57e-02 2.29e-01 9.47e-01
GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX 6 4.83e-01 8.22e-01 0.28400 -2.84e-01 1.57e-02 2.29e-01 9.47e-01
GOBP PITUITARY GLAND DEVELOPMENT 40 5.64e-03 1.07e-01 0.28400 -2.75e-01 -7.13e-02 2.63e-03 4.35e-01
GOBP PHOSPHATIDYLSERINE EXPOSURE ON APOPTOTIC CELL SURFACE 8 3.44e-01 7.41e-01 0.28400 1.19e-01 2.58e-01 5.62e-01 2.06e-01
GOMF STORE OPERATED CALCIUM CHANNEL ACTIVITY 9 3.55e-01 7.48e-01 0.28400 7.72e-02 -2.73e-01 6.88e-01 1.56e-01
GOBP CONVERGENT EXTENSION INVOLVED IN ORGANOGENESIS 5 5.64e-01 8.58e-01 0.28400 2.72e-01 -8.20e-02 2.93e-01 7.51e-01
SUMOylation of DNA methylation proteins 16 1.69e-01 5.70e-01 0.28400 -1.24e-01 2.55e-01 3.92e-01 7.70e-02
GOBP REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT 8 4.08e-01 7.81e-01 0.28400 -2.62e-01 1.09e-01 2.00e-01 5.93e-01
GOBP FERMENTATION 5 5.06e-01 8.32e-01 0.28400 -1.67e-01 -2.29e-01 5.17e-01 3.75e-01
GOMF MICROTUBULE SEVERING ATPASE ACTIVITY 9 3.32e-01 7.35e-01 0.28400 2.84e-01 2.41e-03 1.41e-01 9.90e-01
GOBP REGULATION OF PRIMARY MIRNA PROCESSING 5 5.26e-01 8.42e-01 0.28400 -2.77e-01 -6.08e-02 2.83e-01 8.14e-01
GOBP NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY 17 1.60e-01 5.57e-01 0.28400 -2.08e-01 1.93e-01 1.38e-01 1.68e-01
GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY 10 2.64e-01 6.79e-01 0.28400 1.17e-01 2.59e-01 5.23e-01 1.57e-01
RUNX2 regulates genes involved in cell migration 8 4.22e-01 7.90e-01 0.28400 -1.99e-01 2.02e-01 3.29e-01 3.23e-01
GOBP REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION 10 3.22e-01 7.28e-01 0.28400 -2.68e-01 9.30e-02 1.42e-01 6.11e-01
GOBP POST EMBRYONIC HEMOPOIESIS 5 5.05e-01 8.32e-01 0.28400 1.92e-01 2.09e-01 4.57e-01 4.19e-01
GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY 5 5.65e-01 8.58e-01 0.28400 2.71e-01 -8.31e-02 2.94e-01 7.48e-01
GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY 52 3.29e-03 7.84e-02 0.28300 2.49e-01 -1.35e-01 1.87e-03 9.22e-02
GOBP REGULATION OF MATRIX METALLOPEPTIDASE SECRETION 10 2.58e-01 6.72e-01 0.28300 2.32e-01 1.62e-01 2.03e-01 3.75e-01
GOBP PLASMA MEMBRANE RAFT ASSEMBLY 8 4.19e-01 7.87e-01 0.28300 -2.35e-01 1.59e-01 2.50e-01 4.37e-01
GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION 37 1.24e-02 1.75e-01 0.28300 -2.81e-01 3.26e-02 3.05e-03 7.32e-01
GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION 8 3.42e-01 7.40e-01 0.28300 -1.36e-01 -2.48e-01 5.05e-01 2.24e-01
GOCC EGG COAT 5 5.80e-01 8.64e-01 0.28300 2.38e-01 -1.54e-01 3.57e-01 5.51e-01
GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR 18 1.28e-01 5.10e-01 0.28300 7.66e-02 -2.73e-01 5.74e-01 4.53e-02
GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY 19 1.18e-01 4.93e-01 0.28300 -2.66e-01 9.72e-02 4.48e-02 4.63e-01
PINK1-PRKN Mediated Mitophagy 31 2.77e-02 2.64e-01 0.28300 6.15e-02 -2.76e-01 5.53e-01 7.74e-03
Atorvastatin ADME 9 3.00e-01 7.11e-01 0.28300 2.50e-01 1.33e-01 1.94e-01 4.89e-01
GOBP POSITIVE REGULATION OF CHROMATIN BINDING 9 2.94e-01 7.07e-01 0.28300 1.85e-01 2.15e-01 3.38e-01 2.65e-01
GOMF SODIUM ION BINDING 8 4.17e-01 7.86e-01 0.28300 -1.41e-01 2.45e-01 4.89e-01 2.30e-01
GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY 17 1.07e-01 4.75e-01 0.28300 2.63e-01 1.05e-01 6.06e-02 4.55e-01
Ketone body metabolism 9 3.38e-01 7.38e-01 0.28300 -1.29e-02 2.83e-01 9.46e-01 1.42e-01
GOBP BLOOD COAGULATION INTRINSIC PATHWAY 6 5.25e-01 8.42e-01 0.28300 -2.10e-01 1.90e-01 3.74e-01 4.20e-01
GOBP TERTIARY ALCOHOL METABOLIC PROCESS 22 5.12e-02 3.44e-01 0.28300 2.30e-01 1.64e-01 6.16e-02 1.82e-01
GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL 10 3.38e-01 7.38e-01 0.28300 -2.37e-01 1.54e-01 1.94e-01 3.99e-01
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING 12 2.62e-01 6.76e-01 0.28300 -2.63e-01 1.05e-01 1.15e-01 5.29e-01
GOBP NEUTROPHIL MEDIATED KILLING OF GRAM NEGATIVE BACTERIUM 7 4.39e-01 7.99e-01 0.28300 -2.80e-01 3.85e-02 1.99e-01 8.60e-01
GOCC COPII VESICLE COAT 16 1.42e-01 5.34e-01 0.28300 -2.83e-01 -3.23e-03 5.02e-02 9.82e-01
GOBP PEROXISOMAL TRANSPORT 20 6.85e-02 3.94e-01 0.28300 -1.47e-01 -2.42e-01 2.56e-01 6.14e-02
GOMF FOLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 5 5.74e-01 8.62e-01 0.28300 -2.59e-01 1.13e-01 3.16e-01 6.62e-01
GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS 9 3.05e-01 7.15e-01 0.28300 -2.58e-01 -1.15e-01 1.80e-01 5.51e-01
GOCC CHROMATOID BODY 13 2.41e-01 6.57e-01 0.28300 -1.34e-01 2.49e-01 4.02e-01 1.21e-01
GOCC POSTSYNAPTIC RECYCLING ENDOSOME 7 3.90e-01 7.71e-01 0.28200 1.54e-01 2.36e-01 4.79e-01 2.79e-01
Inhibition of DNA recombination at telomere 43 5.11e-03 1.01e-01 0.28200 -1.58e-02 -2.82e-01 8.58e-01 1.37e-03
GOBP POST ANAL TAIL MORPHOGENESIS 18 1.43e-01 5.35e-01 0.28200 -2.35e-01 1.57e-01 8.45e-02 2.49e-01
GOBP REGULATION OF TRANSLATIONAL ELONGATION 11 2.90e-01 7.03e-01 0.28200 9.23e-02 -2.67e-01 5.96e-01 1.25e-01
Signaling by FGFR3 in disease 21 1.06e-01 4.74e-01 0.28200 -1.92e-01 2.07e-01 1.28e-01 1.01e-01
GOMF GUANYLATE CYCLASE ACTIVITY 7 4.69e-01 8.14e-01 0.28200 -2.37e-01 1.54e-01 2.78e-01 4.81e-01
GOCC LATERAL PART OF CELL 5 5.86e-01 8.67e-01 0.28200 -1.90e-01 2.08e-01 4.61e-01 4.20e-01
GOBP POSITIVE REGULATION OF HEART RATE 25 3.79e-02 2.99e-01 0.28200 -2.61e-01 -1.07e-01 2.39e-02 3.53e-01
TRAF6 mediated IRF7 activation 26 6.10e-02 3.73e-01 0.28200 2.32e-01 -1.61e-01 4.08e-02 1.56e-01
GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 13 1.73e-01 5.78e-01 0.28200 1.81e-01 2.16e-01 2.59e-01 1.77e-01
GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT 9 3.24e-01 7.28e-01 0.28200 -4.78e-02 -2.78e-01 8.04e-01 1.49e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS OXYGEN AS ACCEPTOR 5 5.27e-01 8.42e-01 0.28200 2.71e-01 7.67e-02 2.94e-01 7.66e-01
GOBP NEGATIVE REGULATION OF ANOIKIS 18 8.86e-02 4.37e-01 0.28200 -2.08e-01 -1.90e-01 1.27e-01 1.63e-01
GOBP POSITIVE REGULATION OF G0 TO G1 TRANSITION 5 5.83e-01 8.66e-01 0.28200 1.48e-01 -2.40e-01 5.68e-01 3.53e-01
SHC-mediated cascade:FGFR1 21 1.06e-01 4.74e-01 0.28200 -2.25e-01 1.69e-01 7.38e-02 1.81e-01
GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS 21 7.87e-02 4.18e-01 0.28200 2.81e-01 6.22e-03 2.56e-02 9.61e-01
Negative epigenetic regulation of rRNA expression 70 1.71e-04 8.80e-03 0.28100 -3.91e-02 -2.79e-01 5.71e-01 5.54e-05
Smooth Muscle Contraction 42 8.44e-03 1.38e-01 0.28100 -2.73e-01 6.63e-02 2.17e-03 4.57e-01
GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY 10 2.66e-01 6.80e-01 0.28100 2.44e-01 1.40e-01 1.81e-01 4.45e-01
GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY 10 2.66e-01 6.80e-01 0.28100 2.44e-01 1.40e-01 1.81e-01 4.45e-01
GOBP REGULATION OF PHOSPHATE TRANSPORT 7 4.13e-01 7.84e-01 0.28100 -2.74e-01 -6.40e-02 2.10e-01 7.69e-01
GOBP OUTER DYNEIN ARM ASSEMBLY 22 6.11e-02 3.74e-01 0.28100 2.72e-01 7.14e-02 2.72e-02 5.62e-01
GOBP CYTOPLASM ORGANIZATION 15 1.66e-01 5.67e-01 0.28100 -4.79e-03 2.81e-01 9.74e-01 5.94e-02
GOBP RESPONSE TO CORTICOSTERONE 15 1.42e-01 5.33e-01 0.28100 -1.09e-01 -2.59e-01 4.66e-01 8.21e-02
Regulation of KIT signaling 16 1.47e-01 5.40e-01 0.28100 1.13e-03 -2.81e-01 9.94e-01 5.17e-02
GOBP BASEMENT MEMBRANE ORGANIZATION 38 1.56e-02 1.99e-01 0.28100 -2.57e-01 1.13e-01 6.10e-03 2.27e-01
GOBP REVERSE CHOLESTEROL TRANSPORT 20 1.20e-01 4.98e-01 0.28100 -1.92e-01 2.05e-01 1.36e-01 1.13e-01
GOBP NEURON FATE SPECIFICATION 36 1.31e-02 1.82e-01 0.28100 -2.81e-01 -4.92e-03 3.54e-03 9.59e-01
GOBP ADAPTIVE IMMUNE MEMORY RESPONSE 5 5.12e-01 8.35e-01 0.28100 -1.92e-01 -2.05e-01 4.58e-01 4.27e-01
GOBP MINERALOCORTICOID METABOLIC PROCESS 14 1.59e-01 5.57e-01 0.28100 2.50e-01 1.28e-01 1.05e-01 4.06e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 14 2.03e-01 6.18e-01 0.28100 -2.74e-01 6.14e-02 7.60e-02 6.91e-01
GOBP D AMINO ACID TRANSPORT 6 5.14e-01 8.36e-01 0.28100 -9.15e-02 2.65e-01 6.98e-01 2.60e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS 8 4.29e-01 7.94e-01 0.28100 -1.90e-01 2.07e-01 3.53e-01 3.11e-01
Zygotic genome activation (ZGA) 13 2.46e-01 6.61e-01 0.28100 1.36e-01 -2.46e-01 3.96e-01 1.25e-01
GOBP NEGATIVE REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE 5 5.19e-01 8.39e-01 0.28100 -1.27e-01 -2.50e-01 6.23e-01 3.32e-01
GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 14 2.28e-01 6.46e-01 0.28000 -2.14e-01 1.82e-01 1.67e-01 2.39e-01
GOBP MESENCHYMAL EPITHELIAL CELL SIGNALING 9 3.20e-01 7.28e-01 0.28000 -2.70e-01 -7.38e-02 1.60e-01 7.01e-01
GOBP MALONYL COA METABOLIC PROCESS 6 4.70e-01 8.14e-01 0.28000 -6.66e-02 -2.72e-01 7.78e-01 2.48e-01
GOCC COPI COATED VESICLE 25 3.94e-02 3.06e-01 0.28000 -2.58e-01 -1.09e-01 2.53e-02 3.48e-01
GOBP REGULATION OF POTASSIUM ION IMPORT 5 5.86e-01 8.67e-01 0.28000 1.45e-01 -2.40e-01 5.74e-01 3.53e-01
GOBP BODY MORPHOGENESIS 47 4.52e-03 9.31e-02 0.28000 -2.77e-01 4.34e-02 1.02e-03 6.07e-01
GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION 26 6.08e-02 3.73e-01 0.28000 -2.48e-01 1.30e-01 2.85e-02 2.51e-01
GOCC SWR1 COMPLEX 13 1.98e-01 6.09e-01 0.28000 -2.75e-01 -5.56e-02 8.65e-02 7.29e-01
GOMF INTERLEUKIN 6 RECEPTOR BINDING 7 4.17e-01 7.86e-01 0.28000 -2.74e-01 -5.87e-02 2.10e-01 7.88e-01
GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION 10 3.42e-01 7.40e-01 0.28000 1.37e-01 -2.44e-01 4.53e-01 1.81e-01
GOBP RNA GUANINE N7 METHYLATION 6 4.93e-01 8.27e-01 0.28000 1.41e-02 -2.80e-01 9.52e-01 2.36e-01
GOCC FIBRILLAR COLLAGEN TRIMER 12 2.04e-01 6.19e-01 0.28000 -2.22e-01 -1.70e-01 1.83e-01 3.08e-01
GOCC CELL CORTEX REGION 35 2.46e-02 2.51e-01 0.28000 -1.57e-01 2.32e-01 1.08e-01 1.77e-02
GOBP T CELL HOMEOSTASIS 45 8.91e-03 1.44e-01 0.28000 2.07e-01 -1.88e-01 1.61e-02 2.93e-02
NoRC negatively regulates rRNA expression 68 2.28e-04 1.08e-02 0.28000 -4.75e-02 -2.76e-01 4.98e-01 8.44e-05
GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS 26 5.35e-02 3.50e-01 0.28000 -2.72e-01 6.32e-02 1.62e-02 5.77e-01
GOBP BOX C D SNORNP ASSEMBLY 10 3.26e-01 7.30e-01 0.27900 6.91e-02 -2.71e-01 7.05e-01 1.38e-01
GOBP LEUKOTRIENE TRANSPORT 7 4.62e-01 8.12e-01 0.27900 -8.46e-02 2.66e-01 6.98e-01 2.23e-01
GOBP LIPOXIN METABOLIC PROCESS 5 5.44e-01 8.51e-01 0.27900 -2.77e-01 -3.29e-02 2.83e-01 8.99e-01
GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION 14 2.17e-01 6.35e-01 0.27900 -2.61e-01 9.82e-02 9.05e-02 5.25e-01
GOMF GALACTOSYLCERAMIDASE ACTIVITY 5 5.93e-01 8.71e-01 0.27900 -1.87e-01 2.07e-01 4.69e-01 4.22e-01
GOBP ESTROGEN BIOSYNTHETIC PROCESS 11 2.95e-01 7.07e-01 0.27900 7.52e-02 -2.69e-01 6.66e-01 1.23e-01
GOBP MESENCHYMAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 6 4.55e-01 8.09e-01 0.27900 -2.31e-01 -1.57e-01 3.28e-01 5.05e-01
RNA Polymerase I Transcription Termination 29 2.31e-02 2.43e-01 0.27900 -1.36e-01 -2.43e-01 2.04e-01 2.33e-02
GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN 9 3.50e-01 7.45e-01 0.27900 2.78e-01 -1.64e-02 1.48e-01 9.32e-01
GOBP POST EMBRYONIC EYE MORPHOGENESIS 7 4.40e-01 7.99e-01 0.27900 -2.79e-01 7.41e-03 2.02e-01 9.73e-01
GOBP NEGATIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 6 4.87e-01 8.23e-01 0.27900 -1.91e-02 -2.78e-01 9.35e-01 2.38e-01
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) 27 3.10e-02 2.75e-01 0.27900 -2.53e-01 -1.18e-01 2.31e-02 2.88e-01
GOCC HIPPOCAMPAL MOSSY FIBER 6 4.60e-01 8.10e-01 0.27900 2.48e-01 1.27e-01 2.92e-01 5.90e-01
GOMF GLUTAMATE GATED CALCIUM ION CHANNEL ACTIVITY 7 4.05e-01 7.81e-01 0.27900 -1.21e-01 -2.51e-01 5.78e-01 2.50e-01
GOBP MODULATION BY VIRUS OF HOST PROCESS 6 5.35e-01 8.46e-01 0.27900 -2.09e-01 1.84e-01 3.75e-01 4.35e-01
GOBP ENDOTHELIAL CELL FATE COMMITMENT 8 4.35e-01 7.96e-01 0.27900 -1.97e-01 1.97e-01 3.35e-01 3.34e-01
GOMF ALDOSE REDUCTASE NADPH ACTIVITY 12 2.10e-01 6.26e-01 0.27900 1.40e-01 2.41e-01 4.00e-01 1.49e-01
GOMF GTPASE ACTIVATING PROTEIN BINDING 11 2.95e-01 7.07e-01 0.27900 7.17e-02 -2.69e-01 6.81e-01 1.22e-01
GOBP BASE EXCISION REPAIR GAP FILLING 14 2.22e-01 6.39e-01 0.27800 -1.15e-01 2.54e-01 4.58e-01 1.00e-01
GOMF MONOATOMIC ION GATED CHANNEL ACTIVITY 30 2.87e-02 2.68e-01 0.27800 2.78e-01 5.90e-03 8.30e-03 9.55e-01
GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX 17 1.47e-01 5.40e-01 0.27800 -2.74e-01 4.98e-02 5.05e-02 7.22e-01
GOBP MESONEPHRIC DUCT DEVELOPMENT 8 3.55e-01 7.48e-01 0.27800 -1.35e-01 -2.44e-01 5.09e-01 2.33e-01
GOBP STRESS GRANULE DISASSEMBLY 7 4.02e-01 7.80e-01 0.27800 -1.44e-01 -2.38e-01 5.08e-01 2.76e-01
GOBP CARDIAC CELL DEVELOPMENT 92 3.12e-05 2.16e-03 0.27800 -2.74e-01 4.70e-02 5.41e-06 4.36e-01
GOCC EXORIBONUCLEASE COMPLEX 24 4.58e-02 3.26e-01 0.27800 -1.20e-01 -2.51e-01 3.07e-01 3.34e-02
GOMF PROTEIN DISULFIDE REDUCTASE NAD P H ACTIVITY 8 3.55e-01 7.48e-01 0.27800 2.43e-01 1.36e-01 2.35e-01 5.05e-01
GOMF ACYL COA BINDING 19 8.91e-02 4.38e-01 0.27800 -1.05e-01 -2.58e-01 4.30e-01 5.17e-02
GOMF RETINAL DEHYDROGENASE ACTIVITY 9 3.29e-01 7.33e-01 0.27800 2.72e-01 5.90e-02 1.58e-01 7.59e-01
GOBP STABILIZATION OF MEMBRANE POTENTIAL 17 1.32e-01 5.18e-01 0.27800 2.78e-01 1.72e-02 4.75e-02 9.02e-01
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX 14 1.65e-01 5.65e-01 0.27800 -1.27e-01 -2.47e-01 4.09e-01 1.09e-01
GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION 15 1.75e-01 5.80e-01 0.27800 2.78e-01 -1.47e-02 6.26e-02 9.22e-01
GOBP NADPH REGENERATION 21 1.01e-01 4.65e-01 0.27800 -8.94e-02 2.63e-01 4.78e-01 3.68e-02
GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE 7 4.08e-01 7.82e-01 0.27800 -1.16e-01 -2.53e-01 5.95e-01 2.47e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME 12 2.15e-01 6.32e-01 0.27800 1.18e-01 2.52e-01 4.78e-01 1.31e-01
Digestion and absorption 22 6.08e-02 3.73e-01 0.27800 2.56e-01 1.08e-01 3.77e-02 3.78e-01
Butyrophilin (BTN) family interactions 12 2.28e-01 6.46e-01 0.27800 -6.02e-02 -2.71e-01 7.18e-01 1.04e-01
GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY 11 2.64e-01 6.79e-01 0.27800 2.75e-01 3.76e-02 1.14e-01 8.29e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS 11 2.51e-01 6.65e-01 0.27800 -2.63e-01 -9.07e-02 1.32e-01 6.03e-01
GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY 11 2.73e-01 6.85e-01 0.27800 -7.56e-03 -2.78e-01 9.65e-01 1.11e-01
Regulation of TP53 Activity through Methylation 19 8.76e-02 4.37e-01 0.27800 -1.24e-01 -2.48e-01 3.49e-01 6.10e-02
Beta-oxidation of pristanoyl-CoA 9 3.73e-01 7.60e-01 0.27800 -2.66e-01 7.83e-02 1.67e-01 6.84e-01
GOCC PROTEIN PHOSPHATASE 4 COMPLEX 5 5.20e-01 8.40e-01 0.27800 -1.89e-01 -2.03e-01 4.64e-01 4.32e-01
GOMF CYTOSKELETAL ANCHOR ACTIVITY 23 9.16e-02 4.44e-01 0.27700 -1.63e-01 2.25e-01 1.77e-01 6.21e-02
GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION 17 1.35e-01 5.22e-01 0.27700 9.75e-03 2.77e-01 9.45e-01 4.78e-02
GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION 9 3.10e-01 7.19e-01 0.27700 2.24e-01 1.64e-01 2.45e-01 3.95e-01
CaM pathway 34 2.94e-02 2.70e-01 0.27700 -1.63e-01 2.24e-01 9.94e-02 2.36e-02
Calmodulin induced events 34 2.94e-02 2.70e-01 0.27700 -1.63e-01 2.24e-01 9.94e-02 2.36e-02
GOBP INSULIN PROCESSING 8 3.57e-01 7.49e-01 0.27700 -1.38e-01 -2.41e-01 5.00e-01 2.39e-01
GOBP EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY 6 5.34e-01 8.46e-01 0.27700 1.45e-01 -2.36e-01 5.37e-01 3.17e-01
GOMF INTERLEUKIN 1 RECEPTOR BINDING 17 1.23e-01 5.02e-01 0.27700 6.63e-02 2.69e-01 6.36e-01 5.46e-02
GOBP NEGATIVE REGULATION OF IMMATURE T CELL PROLIFERATION 5 5.85e-01 8.67e-01 0.27700 -1.05e-01 2.57e-01 6.85e-01 3.20e-01
Interaction between L1 and Ankyrins 30 3.95e-02 3.06e-01 0.27700 2.60e-01 -9.60e-02 1.37e-02 3.63e-01
GOMF CYCLASE ACTIVITY 20 1.28e-01 5.10e-01 0.27700 -1.93e-01 1.99e-01 1.35e-01 1.24e-01
Signaling by FLT3 ITD and TKD mutants 16 1.28e-01 5.10e-01 0.27700 -1.45e-01 -2.36e-01 3.16e-01 1.02e-01
GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING 24 8.41e-02 4.31e-01 0.27700 -2.17e-01 1.71e-01 6.51e-02 1.46e-01
GOBP CXCL12 ACTIVATED CXCR4 SIGNALING PATHWAY 5 5.57e-01 8.56e-01 0.27700 -5.61e-03 -2.77e-01 9.83e-01 2.84e-01
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 13 2.62e-01 6.76e-01 0.27700 -2.19e-01 1.69e-01 1.71e-01 2.91e-01
GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 13 2.59e-01 6.73e-01 0.27700 -1.51e-01 2.32e-01 3.47e-01 1.47e-01
GOBP LENS FIBER CELL DEVELOPMENT 14 1.84e-01 5.89e-01 0.27700 4.70e-02 2.73e-01 7.61e-01 7.74e-02
GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING 6 5.11e-01 8.35e-01 0.27600 4.54e-02 -2.73e-01 8.47e-01 2.47e-01
GOMF U1 SNRNP BINDING 6 5.40e-01 8.49e-01 0.27600 2.15e-01 -1.74e-01 3.63e-01 4.60e-01
GOBP INTRACILIARY RETROGRADE TRANSPORT 14 2.07e-01 6.22e-01 0.27600 -2.74e-01 3.66e-02 7.59e-02 8.12e-01
GOMF ER RETENTION SEQUENCE BINDING 5 5.50e-01 8.53e-01 0.27600 3.34e-02 2.74e-01 8.97e-01 2.88e-01
GOBP CLATHRIN COAT ASSEMBLY 19 1.29e-01 5.13e-01 0.27600 -2.62e-01 8.86e-02 4.82e-02 5.04e-01
GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 6 5.01e-01 8.30e-01 0.27600 8.88e-03 -2.76e-01 9.70e-01 2.41e-01
GOCC MICROVILLUS MEMBRANE 32 1.70e-02 2.09e-01 0.27600 1.34e-01 2.42e-01 1.91e-01 1.79e-02
GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY 33 2.85e-02 2.67e-01 0.27600 2.63e-01 -8.48e-02 8.97e-03 3.99e-01
GOMF CYCLASE ACTIVATOR ACTIVITY 11 2.92e-01 7.04e-01 0.27600 2.73e-01 -4.04e-02 1.17e-01 8.17e-01
GOMF O ACETYLTRANSFERASE ACTIVITY 9 3.85e-01 7.68e-01 0.27600 2.54e-01 -1.07e-01 1.86e-01 5.78e-01
Synthesis of Leukotrienes (LT) and Eoxins (EX) 20 9.19e-02 4.44e-01 0.27600 -3.63e-02 -2.74e-01 7.79e-01 3.41e-02
Maturation of protein 3a 9683673 9 3.90e-01 7.71e-01 0.27600 -1.28e-01 2.44e-01 5.05e-01 2.04e-01
Maturation of protein 3a 9694719 9 3.90e-01 7.71e-01 0.27600 -1.28e-01 2.44e-01 5.05e-01 2.04e-01
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX 21 1.15e-01 4.90e-01 0.27600 1.59e-01 -2.26e-01 2.07e-01 7.35e-02
GOBP NAIL DEVELOPMENT 11 2.43e-01 6.58e-01 0.27600 1.57e-01 2.27e-01 3.69e-01 1.92e-01
GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT 22 6.97e-02 3.97e-01 0.27600 -2.70e-01 -5.59e-02 2.82e-02 6.50e-01
GOBP POSITIVE REGULATION OF DNA LIGATION 5 5.44e-01 8.51e-01 0.27600 6.29e-02 2.69e-01 8.08e-01 2.98e-01
GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY 12 2.53e-01 6.69e-01 0.27600 1.08e-02 -2.76e-01 9.48e-01 9.84e-02
GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING 6 5.18e-01 8.39e-01 0.27600 -2.68e-01 6.35e-02 2.55e-01 7.88e-01
GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING 18 1.34e-01 5.21e-01 0.27600 2.73e-01 -3.77e-02 4.48e-02 7.82e-01
GOBP REGULATION OF DNA DEMETHYLATION 7 4.81e-01 8.21e-01 0.27600 2.46e-01 -1.24e-01 2.59e-01 5.70e-01
GOBP SNRNA TRANSPORT 6 5.25e-01 8.42e-01 0.27600 2.62e-01 -8.63e-02 2.67e-01 7.14e-01
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O 12 2.79e-01 6.92e-01 0.27600 9.76e-02 -2.58e-01 5.58e-01 1.22e-01
GOBP REGULATION OF FEEDING BEHAVIOR 27 5.94e-02 3.70e-01 0.27600 -1.21e-01 2.47e-01 2.75e-01 2.61e-02
Folding of actin by CCT/TriC 10 3.51e-01 7.45e-01 0.27500 1.21e-01 -2.47e-01 5.07e-01 1.76e-01
GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY 19 1.01e-01 4.65e-01 0.27500 -5.73e-02 -2.69e-01 6.66e-01 4.20e-02
GOBP NEGATIVE REGULATION OF FATTY ACID TRANSPORT 7 4.79e-01 8.21e-01 0.27500 -2.51e-01 1.12e-01 2.49e-01 6.06e-01
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 14 1.73e-01 5.76e-01 0.27500 -2.50e-01 -1.15e-01 1.05e-01 4.58e-01
GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION 5 5.57e-01 8.56e-01 0.27500 -2.75e-01 -1.75e-02 2.87e-01 9.46e-01
GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY 9 3.73e-01 7.61e-01 0.27500 2.69e-01 -5.97e-02 1.63e-01 7.57e-01
GOBP L LYSINE TRANSMEMBRANE TRANSPORT 7 4.79e-01 8.21e-01 0.27500 -2.51e-01 1.14e-01 2.51e-01 6.03e-01
GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY 7 4.79e-01 8.21e-01 0.27500 -2.51e-01 1.14e-01 2.51e-01 6.03e-01
GOBP POSITIVE REGULATION OF FERTILIZATION 5 5.53e-01 8.54e-01 0.27500 -3.27e-02 -2.73e-01 8.99e-01 2.90e-01
GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE 6 5.26e-01 8.42e-01 0.27500 2.62e-01 -8.47e-02 2.67e-01 7.19e-01
GOCC MULTI PASS TRANSLOCON COMPLEX 6 5.26e-01 8.42e-01 0.27500 2.62e-01 -8.47e-02 2.67e-01 7.19e-01
GOCC LIPOPOLYSACCHARIDE RECEPTOR COMPLEX 5 5.33e-01 8.46e-01 0.27500 -1.19e-01 -2.48e-01 6.44e-01 3.37e-01
GOBP URETERIC BUD FORMATION 7 4.07e-01 7.81e-01 0.27500 -1.84e-01 -2.04e-01 3.99e-01 3.49e-01
GOMF SODIUM CHANNEL INHIBITOR ACTIVITY 8 4.26e-01 7.93e-01 0.27500 -8.86e-02 2.60e-01 6.64e-01 2.02e-01
GOMF POLY PYRIMIDINE TRACT BINDING 26 7.12e-02 4.02e-01 0.27500 -2.12e-01 1.75e-01 6.12e-02 1.22e-01
GOMF CHLORIDE ION BINDING 9 3.88e-01 7.70e-01 0.27500 -2.53e-01 1.07e-01 1.89e-01 5.77e-01
GOCC ACTIN FILAMENT BUNDLE 92 8.05e-05 4.94e-03 0.27500 -2.34e-01 1.45e-01 1.06e-04 1.65e-02
GOBP KYNURENINE METABOLIC PROCESS 11 2.98e-01 7.10e-01 0.27500 2.70e-01 -5.07e-02 1.21e-01 7.71e-01
Regulation of CDH11 function 10 3.35e-01 7.35e-01 0.27500 -2.69e-01 5.68e-02 1.41e-01 7.56e-01
VLDLR internalisation and degradation 16 1.45e-01 5.38e-01 0.27500 -2.68e-01 -6.00e-02 6.33e-02 6.78e-01
Attachment of GPI anchor to uPAR 7 4.91e-01 8.26e-01 0.27500 1.67e-01 -2.18e-01 4.44e-01 3.18e-01
GOCC LATERAL ELEMENT 14 1.87e-01 5.93e-01 0.27500 -2.70e-01 -5.20e-02 8.06e-02 7.36e-01
IRS activation 5 5.52e-01 8.54e-01 0.27500 4.50e-02 2.71e-01 8.62e-01 2.94e-01
GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE 22 5.99e-02 3.71e-01 0.27400 -1.96e-01 -1.92e-01 1.12e-01 1.18e-01
GOBP NATURAL KILLER CELL PROLIFERATION 14 2.41e-01 6.57e-01 0.27400 -1.64e-01 2.20e-01 2.87e-01 1.55e-01
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY 8 4.43e-01 8.00e-01 0.27400 -2.28e-01 1.52e-01 2.64e-01 4.56e-01
GOMF PEPTIDE HORMONE RECEPTOR BINDING 20 7.89e-02 4.18e-01 0.27400 -2.22e-01 -1.61e-01 8.62e-02 2.12e-01
GOBP CORTICOSTEROID HORMONE SECRETION 19 1.30e-01 5.14e-01 0.27400 -2.65e-01 7.13e-02 4.58e-02 5.91e-01
Antigen Presentation: Folding, assembly and peptide loading of class I MHC 29 4.22e-02 3.14e-01 0.27400 5.19e-02 -2.69e-01 6.28e-01 1.21e-02
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY 11 3.25e-01 7.29e-01 0.27400 -2.33e-01 1.44e-01 1.81e-01 4.07e-01
GOBP GANGLION DEVELOPMENT 17 1.22e-01 5.00e-01 0.27400 -2.53e-01 -1.05e-01 7.09e-02 4.52e-01
GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD 23 5.71e-02 3.63e-01 0.27400 -1.17e-01 -2.48e-01 3.31e-01 3.97e-02
GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL 12 2.99e-01 7.10e-01 0.27400 -1.90e-01 1.97e-01 2.54e-01 2.38e-01
Synthesis of wybutosine at G37 of tRNA(Phe) 6 4.75e-01 8.18e-01 0.27400 -1.15e-01 -2.48e-01 6.25e-01 2.92e-01
GOBP EMBRYONIC HEART TUBE LEFT RIGHT PATTERN FORMATION 6 5.46e-01 8.52e-01 0.27400 -2.10e-01 1.75e-01 3.73e-01 4.57e-01
Prevention of phagosomal-lysosomal fusion 9 4.04e-01 7.80e-01 0.27400 2.11e-01 -1.75e-01 2.74e-01 3.64e-01
GOBP UTERUS MORPHOGENESIS 6 5.29e-01 8.43e-01 0.27400 -8.23e-02 2.61e-01 7.27e-01 2.68e-01
GOBP MIRNA CATABOLIC PROCESS 17 1.68e-01 5.69e-01 0.27400 -2.56e-01 9.68e-02 6.77e-02 4.90e-01
GOMF ALPHA N ACETYLNEURAMINATE ALPHA 2 8 SIALYLTRANSFERASE ACTIVITY 6 4.70e-01 8.15e-01 0.27400 -1.43e-01 -2.33e-01 5.45e-01 3.22e-01
GOBP NEUROTRANSMITTER REUPTAKE 34 2.02e-02 2.28e-01 0.27400 -2.73e-01 -1.13e-02 5.80e-03 9.09e-01
GOBP REGULATION OF PLASMINOGEN ACTIVATION 18 1.02e-01 4.66e-01 0.27400 1.77e-01 2.09e-01 1.94e-01 1.26e-01
MAPK1 (ERK2) activation 9 3.77e-01 7.64e-01 0.27300 -2.68e-01 5.54e-02 1.64e-01 7.74e-01
GOMF ALKALI METAL ION BINDING 19 1.49e-01 5.43e-01 0.27300 -2.04e-01 1.82e-01 1.24e-01 1.69e-01
GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY 33 3.47e-02 2.88e-01 0.27300 -2.36e-01 1.38e-01 1.91e-02 1.69e-01
GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS 16 1.40e-01 5.31e-01 0.27300 -2.52e-01 -1.05e-01 8.08e-02 4.66e-01
GOMF MONOAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY 12 2.55e-01 6.70e-01 0.27300 -2.73e-01 -4.43e-03 1.01e-01 9.79e-01
GOBP RESPONSE TO PROSTAGLANDIN D 5 5.31e-01 8.44e-01 0.27300 -2.06e-01 -1.80e-01 4.26e-01 4.86e-01
GOCC PROTEASOME CORE COMPLEX 20 1.23e-01 5.01e-01 0.27300 9.27e-02 -2.57e-01 4.73e-01 4.67e-02
GOBP REGULATION OF ENDOCYTIC RECYCLING 19 1.15e-01 4.90e-01 0.27300 3.52e-03 2.73e-01 9.79e-01 3.93e-02
GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT 10 3.45e-01 7.43e-01 0.27300 7.38e-02 -2.63e-01 6.86e-01 1.50e-01
GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION 5 5.80e-01 8.64e-01 0.27300 4.36e-02 -2.69e-01 8.66e-01 2.97e-01
GOBP MODULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL 7 4.17e-01 7.86e-01 0.27300 1.43e-01 2.33e-01 5.14e-01 2.86e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN 9 3.87e-01 7.69e-01 0.27300 -2.60e-01 8.43e-02 1.78e-01 6.61e-01
GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS 24 4.95e-02 3.38e-01 0.27300 2.30e-01 1.47e-01 5.13e-02 2.12e-01
Loss of Function of SMAD2/3 in Cancer 7 4.13e-01 7.84e-01 0.27300 -1.92e-01 -1.94e-01 3.78e-01 3.75e-01
GOCC COMPACT MYELIN 14 2.43e-01 6.58e-01 0.27300 -2.31e-01 1.45e-01 1.34e-01 3.47e-01
GOBP CLATHRIN COATED VESICLE CARGO LOADING 7 4.13e-01 7.85e-01 0.27300 -1.78e-01 -2.07e-01 4.15e-01 3.43e-01
GOBP CELL PROLIFERATION IN FOREBRAIN 26 4.18e-02 3.12e-01 0.27300 -2.53e-01 -1.01e-01 2.53e-02 3.74e-01
GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY 9 3.72e-01 7.60e-01 0.27300 2.71e-01 -3.31e-02 1.60e-01 8.63e-01
GOBP T CELL APOPTOTIC PROCESS 57 3.43e-03 7.99e-02 0.27300 1.87e-01 -1.98e-01 1.45e-02 9.63e-03
GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY 14 2.35e-01 6.51e-01 0.27300 2.52e-01 -1.04e-01 1.03e-01 4.99e-01
EGR2 and SOX10-mediated initiation of Schwann cell myelination 27 6.55e-02 3.85e-01 0.27300 -2.31e-01 1.44e-01 3.75e-02 1.95e-01
GOBP VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS 8 4.46e-01 8.02e-01 0.27300 -1.46e-01 2.30e-01 4.75e-01 2.59e-01
GOBP FOLIC ACID TRANSPORT 10 3.61e-01 7.52e-01 0.27300 -2.42e-01 1.26e-01 1.86e-01 4.90e-01
GOCC FANCONI ANAEMIA NUCLEAR COMPLEX 11 3.34e-01 7.35e-01 0.27300 -1.84e-01 2.01e-01 2.91e-01 2.48e-01
GOMF CENTROMERIC DNA BINDING 6 5.18e-01 8.39e-01 0.27300 -2.70e-01 3.49e-02 2.52e-01 8.82e-01
GOCC MULTIVESICULAR BODY LUMEN 6 4.73e-01 8.16e-01 0.27200 -1.47e-01 -2.29e-01 5.32e-01 3.31e-01
GOBP NEGATIVE REGULATION OF MATRIX METALLOPEPTIDASE SECRETION 6 4.71e-01 8.15e-01 0.27200 1.69e-01 2.13e-01 4.73e-01 3.66e-01
GOBP DOPAMINERGIC NEURON AXON GUIDANCE 6 4.70e-01 8.15e-01 0.27200 1.75e-01 2.09e-01 4.59e-01 3.76e-01
GOBP RESPONSE TO ETHER 15 1.74e-01 5.78e-01 0.27200 -4.07e-02 -2.69e-01 7.85e-01 7.11e-02
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS 15 2.25e-01 6.43e-01 0.27200 2.00e-01 -1.85e-01 1.80e-01 2.16e-01
GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE 7 4.33e-01 7.96e-01 0.27200 -7.31e-02 -2.62e-01 7.38e-01 2.30e-01
GOMF HISTAMINE RECEPTOR ACTIVITY 6 5.16e-01 8.38e-01 0.27200 -2.23e-02 2.71e-01 9.25e-01 2.50e-01
Repression of WNT target genes 14 2.46e-01 6.61e-01 0.27200 2.24e-01 -1.55e-01 1.47e-01 3.16e-01
GOCC CYTOCHROME COMPLEX 35 2.39e-02 2.48e-01 0.27200 5.90e-02 -2.65e-01 5.46e-01 6.56e-03
GOMF NUCLEOSIDE BINDING 8 3.85e-01 7.68e-01 0.27200 -7.25e-02 -2.62e-01 7.23e-01 1.99e-01
GOBP ERROR PRONE TRANSLESION SYNTHESIS 12 2.47e-01 6.61e-01 0.27200 -2.68e-01 -4.45e-02 1.08e-01 7.89e-01
GOBP SULFATE TRANSPORT 17 1.47e-01 5.40e-01 0.27200 2.72e-01 5.52e-03 5.24e-02 9.69e-01
GOBP GAP JUNCTION MEDIATED INTERCELLULAR TRANSPORT 6 4.88e-01 8.24e-01 0.27200 7.99e-02 2.60e-01 7.35e-01 2.71e-01
DAP12 interactions 38 1.28e-02 1.78e-01 0.27200 -2.60e-02 -2.71e-01 7.81e-01 3.90e-03
GOBP MEMBRANE RAFT ASSEMBLY 12 2.99e-01 7.10e-01 0.27200 -1.37e-01 2.35e-01 4.10e-01 1.60e-01
GOMF STRUCTURAL CONSTITUENT OF MUSCLE 41 1.49e-02 1.94e-01 0.27200 -1.05e-01 2.50e-01 2.43e-01 5.53e-03
GOBP REGULATION OF PINOCYTOSIS 12 2.47e-01 6.62e-01 0.27200 -2.68e-01 -4.47e-02 1.08e-01 7.89e-01
GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE 10 3.54e-01 7.47e-01 0.27200 -9.04e-02 2.56e-01 6.21e-01 1.61e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES 11 2.53e-01 6.69e-01 0.27200 1.67e-01 2.14e-01 3.37e-01 2.19e-01
GOBP ANTERIOR HEAD DEVELOPMENT 7 4.63e-01 8.12e-01 0.27200 -2.71e-01 2.30e-02 2.15e-01 9.16e-01
GOBP NATURAL KILLER CELL MEDIATED IMMUNITY 81 2.51e-04 1.16e-02 0.27200 2.50e-01 -1.06e-01 1.01e-04 9.75e-02
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants 19 1.06e-01 4.73e-01 0.27200 -6.66e-02 -2.63e-01 6.15e-01 4.70e-02
Signaling by Ligand-Responsive EGFR Variants in Cancer 19 1.06e-01 4.73e-01 0.27200 -6.66e-02 -2.63e-01 6.15e-01 4.70e-02
GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY 9 3.95e-01 7.74e-01 0.27100 -9.49e-02 2.54e-01 6.22e-01 1.87e-01
ERBB2 Activates PTK6 Signaling 13 2.72e-01 6.85e-01 0.27100 2.30e-01 -1.44e-01 1.51e-01 3.68e-01
GOCC GLYCINERGIC SYNAPSE 7 4.56e-01 8.09e-01 0.27100 -2.71e-01 -4.31e-03 2.14e-01 9.84e-01
GOBP VAGINA DEVELOPMENT 10 3.02e-01 7.13e-01 0.27100 -8.49e-02 -2.58e-01 6.42e-01 1.58e-01
GOBP POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 12 2.33e-01 6.50e-01 0.27100 -2.49e-01 -1.07e-01 1.35e-01 5.21e-01
GOBP CHEMOREPULSION OF AXON 6 5.27e-01 8.42e-01 0.27100 2.66e-01 -5.23e-02 2.59e-01 8.25e-01
GOBP REGULATION OF CD40 SIGNALING PATHWAY 6 4.81e-01 8.21e-01 0.27100 -1.17e-01 -2.45e-01 6.20e-01 3.00e-01
GOMF C ACETYLTRANSFERASE ACTIVITY 7 4.91e-01 8.26e-01 0.27100 2.45e-01 -1.17e-01 2.62e-01 5.93e-01
GOBP NEUROBLAST DIVISION 14 2.38e-01 6.55e-01 0.27100 -2.51e-01 1.02e-01 1.04e-01 5.10e-01
GOMF HORMONE RECEPTOR BINDING 31 2.97e-02 2.71e-01 0.27100 -2.70e-01 -2.07e-02 9.24e-03 8.42e-01
GOBP 7 METHYLGUANOSINE RNA CAPPING 7 4.29e-01 7.94e-01 0.27100 -1.07e-01 -2.49e-01 6.25e-01 2.54e-01
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY 9 4.13e-01 7.84e-01 0.27100 -1.94e-01 1.88e-01 3.13e-01 3.28e-01
GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR ACTIVITY 9 4.13e-01 7.84e-01 0.27100 -1.94e-01 1.88e-01 3.13e-01 3.28e-01
GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS 5 5.70e-01 8.60e-01 0.27100 -2.71e-01 -1.15e-02 2.95e-01 9.64e-01
GOBP POSITIVE REGULATION OF URINE VOLUME 13 2.61e-01 6.75e-01 0.27100 -2.56e-01 8.81e-02 1.10e-01 5.82e-01
GOBP CATECHOL CONTAINING COMPOUND CATABOLIC PROCESS 6 5.17e-01 8.39e-01 0.27100 -1.50e-02 2.70e-01 9.49e-01 2.52e-01
Phase 4 - resting membrane potential 19 9.42e-02 4.49e-01 0.27100 2.02e-01 1.81e-01 1.28e-01 1.73e-01
GOBP LABYRINTHINE LAYER MORPHOGENESIS 22 1.15e-01 4.90e-01 0.27100 2.04e-01 -1.78e-01 9.77e-02 1.49e-01
GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY 8 4.56e-01 8.09e-01 0.27100 1.86e-01 -1.97e-01 3.62e-01 3.36e-01
GOBP NEGATIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION 5 6.11e-01 8.78e-01 0.27100 1.76e-01 -2.06e-01 4.97e-01 4.25e-01
GOCC OUTER DYNEIN ARM 10 2.98e-01 7.09e-01 0.27100 2.46e-01 1.13e-01 1.79e-01 5.35e-01
GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING 16 1.60e-01 5.58e-01 0.27000 -2.68e-01 -3.56e-02 6.34e-02 8.05e-01
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 7 4.37e-01 7.97e-01 0.27000 -7.82e-02 -2.59e-01 7.20e-01 2.36e-01
GOMF TRIGLYCERIDE LIPASE ACTIVITY 24 5.61e-02 3.60e-01 0.27000 9.96e-02 2.51e-01 3.98e-01 3.30e-02
GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS 8 3.93e-01 7.72e-01 0.27000 -6.13e-02 -2.63e-01 7.64e-01 1.97e-01
GOBP SIALYLATION 10 3.73e-01 7.60e-01 0.27000 -1.57e-01 2.20e-01 3.89e-01 2.29e-01
Oncogene Induced Senescence 35 1.37e-02 1.86e-01 0.27000 -1.41e-01 -2.30e-01 1.48e-01 1.83e-02
GOBP RESPONSE TO TYPE III INTERFERON 10 2.94e-01 7.07e-01 0.27000 2.35e-01 1.33e-01 1.98e-01 4.65e-01
GOBP REGULATION OF OPSONIZATION 10 3.32e-01 7.35e-01 0.27000 -7.85e-03 2.70e-01 9.66e-01 1.39e-01
GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY 10 3.10e-01 7.19e-01 0.27000 -6.38e-02 -2.63e-01 7.27e-01 1.51e-01
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING 80 4.05e-04 1.63e-02 0.27000 -1.89e-01 1.93e-01 3.54e-03 2.77e-03
GOBP POSITIVE REGULATION OF OPSONIZATION 8 4.54e-01 8.07e-01 0.27000 -1.53e-01 2.23e-01 4.55e-01 2.75e-01
POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation 9 3.50e-01 7.45e-01 0.27000 -2.63e-01 -6.03e-02 1.71e-01 7.54e-01
GOMF DNA CLAMP LOADER ACTIVITY 9 3.81e-01 7.65e-01 0.27000 2.67e-01 -3.80e-02 1.65e-01 8.44e-01
GOBP CORONARY ARTERY MORPHOGENESIS 9 4.10e-01 7.83e-01 0.27000 -2.29e-01 1.44e-01 2.35e-01 4.54e-01
GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT 20 1.28e-01 5.10e-01 0.27000 -2.56e-01 8.68e-02 4.77e-02 5.01e-01
GOBP GLYCOSIDE CATABOLIC PROCESS 8 4.38e-01 7.98e-01 0.27000 -2.57e-01 8.39e-02 2.09e-01 6.81e-01
GOBP CITRULLINE METABOLIC PROCESS 7 4.55e-01 8.09e-01 0.27000 -2.70e-01 -1.60e-02 2.17e-01 9.42e-01
GOCC RISC LOADING COMPLEX 8 4.36e-01 7.97e-01 0.27000 -2.59e-01 7.60e-02 2.04e-01 7.10e-01
GOCC CDC73 PAF1 COMPLEX 7 4.92e-01 8.27e-01 0.27000 -2.48e-01 1.07e-01 2.56e-01 6.24e-01
GOBP RESPONSE TO INTERLEUKIN 3 6 5.54e-01 8.54e-01 0.27000 -2.19e-01 1.57e-01 3.52e-01 5.05e-01
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA 17 1.23e-01 5.02e-01 0.27000 -1.61e-01 -2.17e-01 2.51e-01 1.22e-01
CREB1 phosphorylation through the activation of Adenylate Cyclase 11 3.42e-01 7.40e-01 0.27000 -1.97e-01 1.85e-01 2.59e-01 2.89e-01
GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT 27 6.71e-02 3.91e-01 0.27000 1.22e-01 -2.41e-01 2.74e-01 3.04e-02
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME 11 3.42e-01 7.40e-01 0.27000 1.90e-01 -1.91e-01 2.75e-01 2.72e-01
GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS 16 2.00e-01 6.13e-01 0.27000 -2.44e-01 1.16e-01 9.17e-02 4.22e-01
GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS 11 2.78e-01 6.92e-01 0.27000 -2.63e-01 -6.01e-02 1.31e-01 7.30e-01
GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION 10 3.14e-01 7.22e-01 0.27000 2.64e-01 5.66e-02 1.49e-01 7.56e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE 18 1.39e-01 5.30e-01 0.27000 -8.10e-03 2.69e-01 9.53e-01 4.78e-02
Physiological factors 14 2.40e-01 6.55e-01 0.26900 -2.53e-01 9.33e-02 1.02e-01 5.46e-01
GOBP PROTEIN GERANYLGERANYLATION 6 4.96e-01 8.29e-01 0.26900 -7.09e-02 -2.60e-01 7.64e-01 2.70e-01
GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS 9 3.39e-01 7.39e-01 0.26900 1.13e-01 2.45e-01 5.58e-01 2.04e-01
GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION 5 6.14e-01 8.79e-01 0.26900 1.79e-01 -2.01e-01 4.89e-01 4.35e-01
GOMF TELOMERASE INHIBITOR ACTIVITY 5 5.53e-01 8.54e-01 0.26900 -2.54e-01 -8.87e-02 3.25e-01 7.31e-01
N-Glycan antennae elongation 15 1.59e-01 5.57e-01 0.26900 1.57e-01 2.19e-01 2.93e-01 1.42e-01
GOBP VENOUS BLOOD VESSEL MORPHOGENESIS 9 4.12e-01 7.84e-01 0.26900 -2.29e-01 1.41e-01 2.33e-01 4.65e-01
GOBP MITOCHONDRIAL TRANSLATION 130 6.09e-07 6.92e-05 0.26900 -5.81e-03 -2.69e-01 9.09e-01 1.17e-07
GOMF CARGO ADAPTOR ACTIVITY 20 1.35e-01 5.24e-01 0.26900 -1.15e-01 2.43e-01 3.72e-01 5.98e-02
GOBP RAB PROTEIN SIGNAL TRANSDUCTION 17 1.38e-01 5.28e-01 0.26900 6.90e-02 2.60e-01 6.22e-01 6.35e-02
PI-3K cascade:FGFR3 17 1.92e-01 6.00e-01 0.26900 -1.95e-01 1.85e-01 1.63e-01 1.87e-01
GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT 8 4.60e-01 8.10e-01 0.26900 -1.95e-01 1.85e-01 3.39e-01 3.65e-01
GOCC MICROTUBULE END 34 2.23e-02 2.40e-01 0.26900 -2.68e-01 -2.10e-02 6.83e-03 8.32e-01
GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN 10 3.50e-01 7.45e-01 0.26900 2.64e-01 -5.03e-02 1.48e-01 7.83e-01
GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING 6 5.49e-01 8.52e-01 0.26900 -2.45e-01 1.11e-01 2.99e-01 6.37e-01
Presynaptic depolarization and calcium channel opening 12 2.31e-01 6.49e-01 0.26900 2.17e-01 1.58e-01 1.93e-01 3.42e-01
GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX 11 3.35e-01 7.35e-01 0.26900 1.21e-01 -2.40e-01 4.87e-01 1.68e-01
GOBP REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE 8 4.17e-01 7.86e-01 0.26900 -2.69e-01 3.72e-03 1.88e-01 9.85e-01
MicroRNA (miRNA) biogenesis 26 4.78e-02 3.31e-01 0.26900 -2.56e-01 -8.00e-02 2.36e-02 4.80e-01
GOMF MORPHOGEN ACTIVITY 8 4.51e-01 8.06e-01 0.26900 1.16e-01 -2.42e-01 5.70e-01 2.35e-01
GOMF MANNOSIDASE ACTIVITY 15 2.30e-01 6.48e-01 0.26900 -1.42e-01 2.28e-01 3.42e-01 1.26e-01
GOBP TRNA 5 END PROCESSING 15 1.82e-01 5.86e-01 0.26800 -4.31e-02 -2.65e-01 7.73e-01 7.56e-02
GOBP GLYCOSIDE TRANSPORT 5 5.49e-01 8.53e-01 0.26800 2.40e-01 1.20e-01 3.52e-01 6.43e-01
GOBP C21 STEROID HORMONE METABOLIC PROCESS 36 1.65e-02 2.06e-01 0.26800 2.64e-01 4.91e-02 6.15e-03 6.10e-01
VxPx cargo-targeting to cilium 20 1.37e-01 5.26e-01 0.26800 -1.15e-01 2.42e-01 3.71e-01 6.08e-02
GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER 6 5.51e-01 8.53e-01 0.26800 2.42e-01 -1.16e-01 3.05e-01 6.23e-01
GOCC BRISC COMPLEX 5 5.64e-01 8.58e-01 0.26800 -2.63e-01 -5.40e-02 3.09e-01 8.34e-01
GOMF U4 SNRNA BINDING 6 5.30e-01 8.43e-01 0.26800 3.59e-02 -2.66e-01 8.79e-01 2.60e-01
GOBP NUCLEOSIDE TRANSPORT 10 2.99e-01 7.10e-01 0.26800 2.28e-01 1.40e-01 2.11e-01 4.42e-01
AMPK inhibits chREBP transcriptional activation activity 8 4.55e-01 8.09e-01 0.26800 -2.35e-01 1.29e-01 2.49e-01 5.29e-01
GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM 11 2.66e-01 6.80e-01 0.26800 -2.31e-01 -1.36e-01 1.85e-01 4.35e-01
FRS-mediated FGFR1 signaling 23 1.08e-01 4.77e-01 0.26800 -2.06e-01 1.72e-01 8.76e-02 1.54e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 18 1.70e-01 5.71e-01 0.26800 -1.28e-01 2.35e-01 3.46e-01 8.39e-02
GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 36 2.96e-02 2.70e-01 0.26800 1.37e-01 -2.31e-01 1.56e-01 1.67e-02
GOBP RESPONSE TO GRAVITY 9 3.35e-01 7.35e-01 0.26800 -2.10e-01 -1.67e-01 2.76e-01 3.86e-01
GOMF LAMININ BINDING 29 2.98e-02 2.71e-01 0.26800 1.55e-01 2.18e-01 1.48e-01 4.18e-02
GOMF VASOPRESSIN RECEPTOR ACTIVITY 6 5.03e-01 8.31e-01 0.26800 5.93e-02 2.61e-01 8.01e-01 2.68e-01
Killing mechanisms 11 2.79e-01 6.92e-01 0.26800 2.57e-01 7.49e-02 1.40e-01 6.67e-01
WNT5:FZD7-mediated leishmania damping 11 2.79e-01 6.92e-01 0.26800 2.57e-01 7.49e-02 1.40e-01 6.67e-01
GOBP BILE ACID AND BILE SALT TRANSPORT 29 2.95e-02 2.70e-01 0.26800 2.06e-01 1.71e-01 5.47e-02 1.11e-01
GOMF MHC CLASS I RECEPTOR ACTIVITY 13 2.57e-01 6.71e-01 0.26800 2.64e-01 -4.73e-02 9.99e-02 7.68e-01
GOMF HETEROTRIMERIC G PROTEIN BINDING 5 5.54e-01 8.55e-01 0.26800 -1.02e-01 -2.48e-01 6.94e-01 3.38e-01
GOBP ADENYLATE CYCLASE INHIBITING DOPAMINE RECEPTOR SIGNALING PATHWAY 5 5.88e-01 8.67e-01 0.26800 -2.66e-01 2.73e-02 3.02e-01 9.16e-01
GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY 5 6.17e-01 8.80e-01 0.26800 1.60e-01 -2.15e-01 5.35e-01 4.06e-01
GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS 9 3.41e-01 7.40e-01 0.26800 1.28e-01 2.35e-01 5.08e-01 2.22e-01
GOBP OSTEOCLAST PROLIFERATION 11 2.95e-01 7.07e-01 0.26800 -2.67e-01 -2.27e-02 1.26e-01 8.96e-01
GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS 63 2.18e-03 5.76e-02 0.26800 -2.28e-01 1.39e-01 1.71e-03 5.55e-02
Neurotransmitter clearance 9 3.98e-01 7.76e-01 0.26800 -2.58e-01 7.02e-02 1.80e-01 7.15e-01
GOBP PYRUVATE TRANSPORT 7 5.10e-01 8.34e-01 0.26800 1.77e-01 -2.01e-01 4.18e-01 3.57e-01
Transport of vitamins, nucleosides, and related molecules 38 9.90e-03 1.53e-01 0.26800 1.79e-01 1.99e-01 5.66e-02 3.36e-02
GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION 5 6.06e-01 8.76e-01 0.26800 -2.50e-01 9.62e-02 3.34e-01 7.10e-01
GOBP MONOTERPENOID METABOLIC PROCESS 6 5.18e-01 8.39e-01 0.26800 8.78e-03 2.67e-01 9.70e-01 2.57e-01
GOBP RESPONSE TO YEAST 7 4.77e-01 8.19e-01 0.26700 -3.21e-02 2.66e-01 8.83e-01 2.24e-01
GOBP NUCLEOSIDE SALVAGE 11 2.63e-01 6.77e-01 0.26700 -1.94e-01 -1.84e-01 2.64e-01 2.91e-01
GOBP BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY 6 5.60e-01 8.57e-01 0.26700 -2.18e-01 1.56e-01 3.56e-01 5.09e-01
GOBP PROTEIN LIPOYLATION 5 5.48e-01 8.52e-01 0.26700 -2.26e-01 -1.43e-01 3.82e-01 5.80e-01
GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 22 1.07e-01 4.74e-01 0.26700 7.55e-02 -2.57e-01 5.40e-01 3.72e-02
GOBP REGULATION OF REGULATORY NCRNA PROCESSING 16 1.53e-01 5.48e-01 0.26700 -2.48e-01 -9.92e-02 8.56e-02 4.92e-01
GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION 12 3.12e-01 7.21e-01 0.26700 1.44e-01 -2.25e-01 3.87e-01 1.77e-01
GOMF FIBROBLAST GROWTH FACTOR RECEPTOR BINDING 24 1.00e-01 4.64e-01 0.26700 -1.88e-01 1.90e-01 1.12e-01 1.06e-01
GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS 12 2.41e-01 6.57e-01 0.26700 1.16e-01 2.41e-01 4.87e-01 1.49e-01
GOBP EGG ACTIVATION 11 2.65e-01 6.79e-01 0.26700 1.60e-01 2.13e-01 3.57e-01 2.20e-01
GOMF 5 3 DNA HELICASE ACTIVITY 9 4.21e-01 7.89e-01 0.26700 -1.61e-01 2.13e-01 4.03e-01 2.68e-01
Synthesis of Ketone Bodies 8 3.98e-01 7.76e-01 0.26700 7.60e-02 2.56e-01 7.10e-01 2.10e-01
GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS 32 2.96e-02 2.70e-01 0.26700 -2.66e-01 -1.84e-02 9.12e-03 8.57e-01
Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) 18 1.78e-01 5.83e-01 0.26700 1.59e-01 -2.14e-01 2.42e-01 1.16e-01
GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS 14 2.07e-01 6.23e-01 0.26700 2.63e-01 4.39e-02 8.81e-02 7.76e-01
Removal of the Flap Intermediate 13 2.08e-01 6.25e-01 0.26700 -2.07e-01 -1.68e-01 1.95e-01 2.95e-01
GOBP KINETOCHORE ORGANIZATION 20 9.43e-02 4.49e-01 0.26700 -1.15e-01 -2.41e-01 3.74e-01 6.23e-02
GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 23 1.04e-01 4.70e-01 0.26700 1.12e-01 -2.42e-01 3.54e-01 4.43e-02
GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE 15 2.28e-01 6.46e-01 0.26700 -2.43e-01 1.09e-01 1.03e-01 4.65e-01
Glycosphingolipid biosynthesis 19 1.31e-01 5.17e-01 0.26700 2.66e-01 -1.14e-02 4.45e-02 9.31e-01
GOBP NK T CELL DIFFERENTIATION 11 2.66e-01 6.81e-01 0.26600 -1.66e-01 -2.09e-01 3.41e-01 2.31e-01
GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS 18 1.69e-01 5.70e-01 0.26600 -2.45e-01 1.05e-01 7.21e-02 4.40e-01
GOBP POSITIVE REGULATION OF CATECHOLAMINE SECRETION 12 2.73e-01 6.85e-01 0.26600 -2.66e-01 -3.58e-03 1.10e-01 9.83e-01
PKA-mediated phosphorylation of CREB 19 1.61e-01 5.59e-01 0.26600 -1.46e-01 2.23e-01 2.69e-01 9.31e-02
Beta-catenin phosphorylation cascade 16 1.87e-01 5.92e-01 0.26600 -2.65e-01 3.11e-02 6.69e-02 8.29e-01
Maturation of TCA enzymes and regulation of TCA cycle 20 1.16e-01 4.90e-01 0.26600 1.95e-03 -2.66e-01 9.88e-01 3.92e-02
GOBP METANEPHRIC GLOMERULUS VASCULATURE DEVELOPMENT 9 3.40e-01 7.39e-01 0.26600 -1.58e-01 -2.14e-01 4.12e-01 2.65e-01
GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY 7 4.31e-01 7.95e-01 0.26600 -1.75e-01 -2.00e-01 4.22e-01 3.59e-01
rRNA modification in the mitochondrion 6 5.53e-01 8.54e-01 0.26600 -1.02e-01 2.46e-01 6.66e-01 2.97e-01
Formyl peptide receptors bind formyl peptides and many other ligands 8 4.53e-01 8.07e-01 0.26600 -9.68e-02 2.48e-01 6.35e-01 2.25e-01
GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY 12 3.20e-01 7.28e-01 0.26600 1.96e-01 -1.80e-01 2.39e-01 2.81e-01
GOMF NEUROPEPTIDE RECEPTOR ACTIVITY 43 8.51e-03 1.39e-01 0.26600 -2.63e-01 -3.69e-02 2.80e-03 6.75e-01
GOMF COPPER CHAPERONE ACTIVITY 6 5.52e-01 8.54e-01 0.26600 9.68e-02 -2.48e-01 6.81e-01 2.93e-01
GOBP ADENOHYPOPHYSIS DEVELOPMENT 16 1.59e-01 5.57e-01 0.26600 -2.52e-01 -8.60e-02 8.15e-02 5.51e-01
GOBP LYMPH VESSEL DEVELOPMENT 31 5.31e-02 3.49e-01 0.26600 -1.82e-01 1.94e-01 7.98e-02 6.17e-02
GOBP PROTEIN LOCALIZATION TO PRESYNAPSE 11 3.16e-01 7.23e-01 0.26600 -2.73e-02 2.64e-01 8.75e-01 1.29e-01
GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS 14 2.58e-01 6.72e-01 0.26600 -2.34e-01 1.25e-01 1.29e-01 4.17e-01
GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY 7 4.83e-01 8.22e-01 0.26600 -2.63e-01 3.37e-02 2.27e-01 8.77e-01
GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY 11 2.91e-01 7.03e-01 0.26600 2.60e-01 5.52e-02 1.36e-01 7.51e-01
GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING 24 9.98e-02 4.62e-01 0.26600 -2.28e-01 1.36e-01 5.34e-02 2.47e-01
GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS 21 1.23e-01 5.02e-01 0.26500 2.53e-01 -8.05e-02 4.48e-02 5.23e-01
GOBP REGULATION OF SYNAPTIC VESICLE CLUSTERING 6 5.00e-01 8.30e-01 0.26500 9.53e-02 2.48e-01 6.86e-01 2.93e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY 7 5.04e-01 8.31e-01 0.26500 -2.44e-01 1.04e-01 2.64e-01 6.33e-01
GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY 7 5.15e-01 8.38e-01 0.26500 -2.10e-01 1.62e-01 3.37e-01 4.57e-01
GOBP MEDIUM CHAIN FATTY ACID CATABOLIC PROCESS 5 5.92e-01 8.70e-01 0.26500 -2.15e-02 2.64e-01 9.34e-01 3.06e-01
GOCC TRAMP COMPLEX 5 5.51e-01 8.53e-01 0.26500 -1.88e-01 -1.87e-01 4.67e-01 4.69e-01
GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH 10 3.45e-01 7.43e-01 0.26500 2.65e-01 -3.33e-03 1.47e-01 9.85e-01
GOBP VIRAL TRANSLATION 19 1.15e-01 4.90e-01 0.26500 -7.89e-02 -2.53e-01 5.51e-01 5.63e-02
Regulated Necrosis 56 4.84e-03 9.71e-02 0.26500 2.25e-01 -1.40e-01 3.64e-03 6.92e-02
GOBP POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY 5 6.22e-01 8.81e-01 0.26500 2.21e-01 -1.47e-01 3.93e-01 5.70e-01
GOBP REGULATION OF CHONDROCYTE DEVELOPMENT 6 5.24e-01 8.42e-01 0.26500 2.65e-01 1.18e-02 2.62e-01 9.60e-01
GOBP HINDBRAIN MATURATION 5 6.18e-01 8.80e-01 0.26500 -2.34e-01 1.24e-01 3.65e-01 6.30e-01
Zinc transporters 15 2.35e-01 6.51e-01 0.26500 2.38e-01 -1.15e-01 1.10e-01 4.40e-01
GOBP NEGATIVE REGULATION OF BEHAVIOR 12 3.09e-01 7.18e-01 0.26500 -2.46e-01 9.66e-02 1.40e-01 5.62e-01
HDMs demethylate histones 18 1.81e-01 5.86e-01 0.26500 -2.20e-01 1.46e-01 1.06e-01 2.82e-01
Role of second messengers in netrin-1 signaling 9 3.76e-01 7.63e-01 0.26400 -2.71e-02 -2.63e-01 8.88e-01 1.72e-01
GOCC POSTSYNAPTIC ENDOSOME 13 2.14e-01 6.32e-01 0.26400 1.70e-01 2.02e-01 2.88e-01 2.07e-01
GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA 16 1.51e-01 5.46e-01 0.26400 -1.60e-01 -2.11e-01 2.69e-01 1.45e-01
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY 7 4.95e-01 8.28e-01 0.26400 6.25e-02 -2.57e-01 7.75e-01 2.39e-01
GOBP PINOCYTOSIS 22 8.70e-02 4.36e-01 0.26400 -2.59e-01 -5.30e-02 3.56e-02 6.67e-01
GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY 13 2.14e-01 6.32e-01 0.26400 1.72e-01 2.00e-01 2.83e-01 2.11e-01
mRNA decay by 5’ to 3’ exoribonuclease 15 1.73e-01 5.77e-01 0.26400 -2.26e-01 -1.37e-01 1.30e-01 3.57e-01
GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS 26 5.59e-02 3.60e-01 0.26400 5.38e-02 2.59e-01 6.35e-01 2.25e-02
GOBP COBALAMIN METABOLIC PROCESS 9 4.24e-01 7.92e-01 0.26400 -2.32e-01 1.26e-01 2.28e-01 5.12e-01
GOMF ADENOSINE DEAMINASE ACTIVITY 12 2.61e-01 6.76e-01 0.26400 6.58e-02 2.56e-01 6.93e-01 1.25e-01
GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION 71 2.50e-04 1.16e-02 0.26400 -2.23e-01 -1.41e-01 1.13e-03 4.06e-02
GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS 11 3.23e-01 7.28e-01 0.26400 2.62e-01 -3.39e-02 1.33e-01 8.46e-01
GOBP RENAL SYSTEM VASCULATURE MORPHOGENESIS 8 4.33e-01 7.96e-01 0.26400 -2.63e-01 1.43e-02 1.97e-01 9.44e-01
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY 12 2.56e-01 6.71e-01 0.26400 -8.85e-02 -2.49e-01 5.96e-01 1.36e-01
Phosphorylation of Emi1 6 5.20e-01 8.40e-01 0.26400 2.62e-01 3.46e-02 2.67e-01 8.83e-01
GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING 6 5.49e-01 8.52e-01 0.26400 -6.35e-02 2.56e-01 7.88e-01 2.77e-01
GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY 6 4.93e-01 8.27e-01 0.26400 1.58e-01 2.12e-01 5.04e-01 3.69e-01
Ca-dependent events 36 3.46e-02 2.88e-01 0.26400 -1.68e-01 2.03e-01 8.07e-02 3.49e-02
GOMF SNRNA BINDING 48 5.46e-03 1.04e-01 0.26400 -3.25e-02 -2.62e-01 6.96e-01 1.71e-03
GOCC LAMININ COMPLEX 9 3.54e-01 7.47e-01 0.26400 1.14e-01 2.38e-01 5.55e-01 2.17e-01
Termination of translesion DNA synthesis 32 2.74e-02 2.62e-01 0.26400 -7.70e-02 -2.52e-01 4.51e-01 1.36e-02
GOBP RESPONSE TO INTERLEUKIN 17 18 1.39e-01 5.29e-01 0.26300 4.72e-02 2.59e-01 7.29e-01 5.70e-02
GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 30 5.51e-02 3.58e-01 0.26300 9.99e-02 -2.44e-01 3.43e-01 2.09e-02
Digestion of dietary lipid 7 4.46e-01 8.02e-01 0.26300 2.34e-01 1.20e-01 2.83e-01 5.83e-01
GOBP TUBULIN COMPLEX ASSEMBLY 8 3.97e-01 7.76e-01 0.26300 -2.34e-01 -1.21e-01 2.52e-01 5.55e-01
GOBP REGULATION OF CHLORIDE TRANSPORT 6 5.71e-01 8.61e-01 0.26300 2.12e-01 -1.56e-01 3.68e-01 5.09e-01
GOCC PSEUDOPODIUM 16 2.26e-01 6.44e-01 0.26300 -1.97e-01 1.74e-01 1.73e-01 2.27e-01
GOBP DGMP METABOLIC PROCESS 6 5.43e-01 8.51e-01 0.26300 -3.71e-02 2.60e-01 8.75e-01 2.69e-01
GOCC SYNAPTONEMAL STRUCTURE 35 2.74e-02 2.62e-01 0.26300 -2.62e-01 2.54e-02 7.34e-03 7.95e-01
GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY 26 5.08e-02 3.43e-01 0.26300 -1.11e-01 -2.38e-01 3.27e-01 3.53e-02
GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS 15 1.92e-01 5.99e-01 0.26300 -5.40e-02 -2.57e-01 7.17e-01 8.42e-02
GOBP ESTABLISHMENT OF GOLGI LOCALIZATION 8 4.75e-01 8.18e-01 0.26300 -1.70e-01 2.00e-01 4.04e-01 3.27e-01
GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT 12 3.25e-01 7.30e-01 0.26300 -2.16e-01 1.50e-01 1.95e-01 3.69e-01
GOBP REGULATION OF RNA BINDING 6 4.97e-01 8.29e-01 0.26300 -2.18e-01 -1.47e-01 3.56e-01 5.32e-01
GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS 25 7.06e-02 3.99e-01 0.26300 2.63e-01 1.14e-02 2.30e-02 9.22e-01
GOBP REGULATION OF APOPTOTIC PROCESS IN BONE MARROW CELL 5 6.05e-01 8.76e-01 0.26300 -2.58e-01 4.94e-02 3.18e-01 8.48e-01
GOBP RESPONSE TO INSECTICIDE 6 5.71e-01 8.61e-01 0.26300 2.16e-01 -1.49e-01 3.59e-01 5.27e-01
GOBP SEROTONERGIC NEURON AXON GUIDANCE 5 6.23e-01 8.82e-01 0.26300 -1.23e-01 2.32e-01 6.33e-01 3.69e-01
Interleukin-15 signaling 13 2.18e-01 6.37e-01 0.26300 -2.04e-01 -1.65e-01 2.02e-01 3.02e-01
Glycoprotein hormones 9 3.48e-01 7.44e-01 0.26300 1.89e-01 1.83e-01 3.27e-01 3.42e-01
GOBP REGULATION OF SODIUM DEPENDENT PHOSPHATE TRANSPORT 5 5.58e-01 8.56e-01 0.26300 -1.52e-01 -2.14e-01 5.56e-01 4.07e-01
GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION 10 3.69e-01 7.58e-01 0.26300 5.71e-02 -2.56e-01 7.55e-01 1.60e-01
GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION 32 5.19e-02 3.45e-01 0.26300 -1.89e-01 1.83e-01 6.49e-02 7.35e-02
GOCC INTRACILIARY TRANSPORT PARTICLE B 19 1.13e-01 4.86e-01 0.26300 -1.20e-01 -2.33e-01 3.64e-01 7.81e-02
GOBP C X C CHEMOKINE RECEPTOR CXCR4 SIGNALING PATHWAY 6 5.24e-01 8.42e-01 0.26300 -2.96e-02 -2.61e-01 9.00e-01 2.68e-01
Tie2 Signaling 18 1.23e-01 5.01e-01 0.26300 -1.55e-01 -2.12e-01 2.54e-01 1.20e-01
GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX 11 2.76e-01 6.89e-01 0.26300 -1.89e-01 -1.82e-01 2.78e-01 2.95e-01
GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS 9 4.24e-01 7.92e-01 0.26300 2.39e-01 -1.10e-01 2.15e-01 5.69e-01
GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS 9 4.35e-01 7.96e-01 0.26200 1.70e-01 -2.00e-01 3.76e-01 3.00e-01
GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING 32 3.57e-02 2.91e-01 0.26200 4.27e-03 -2.62e-01 9.67e-01 1.02e-02
GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT 24 6.81e-02 3.93e-01 0.26200 -2.49e-01 -8.36e-02 3.50e-02 4.79e-01
GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 21 9.30e-02 4.46e-01 0.26200 -2.43e-01 -9.92e-02 5.41e-02 4.31e-01
GOBP MITOCHONDRIAL RNA METABOLIC PROCESS 55 4.86e-03 9.72e-02 0.26200 8.37e-02 -2.48e-01 2.83e-01 1.44e-03
GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT 8 4.59e-01 8.10e-01 0.26200 -7.98e-02 2.50e-01 6.96e-01 2.21e-01
GOMF CONNEXIN BINDING 5 5.60e-01 8.57e-01 0.26200 -1.49e-01 -2.16e-01 5.65e-01 4.03e-01
GOBP INTRACILIARY ANTEROGRADE TRANSPORT 19 1.09e-01 4.79e-01 0.26200 -1.89e-01 -1.82e-01 1.55e-01 1.70e-01
GOCC SERINE PROTEASE INHIBITOR COMPLEX 6 5.43e-01 8.51e-01 0.26200 -2.78e-02 2.61e-01 9.06e-01 2.69e-01
GOMF DIPEPTIDYL PEPTIDASE ACTIVITY 12 2.73e-01 6.85e-01 0.26200 -2.58e-01 -4.24e-02 1.21e-01 7.99e-01
RUNX1 regulates transcription of genes involved in interleukin signaling 5 5.97e-01 8.73e-01 0.26200 2.62e-01 -1.07e-02 3.11e-01 9.67e-01
GOCC G PROTEIN COUPLED RECEPTOR COMPLEX 11 3.33e-01 7.35e-01 0.26200 -2.58e-01 4.47e-02 1.39e-01 7.97e-01
GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY 17 1.82e-01 5.86e-01 0.26200 -4.31e-02 2.58e-01 7.58e-01 6.53e-02
GOBP AORTA MORPHOGENESIS 38 2.26e-02 2.41e-01 0.26200 -2.58e-01 4.68e-02 6.00e-03 6.18e-01
GOBP REGULATION OF NEUROTRANSMITTER UPTAKE 18 1.88e-01 5.93e-01 0.26200 -2.21e-01 1.41e-01 1.05e-01 3.02e-01
GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY 18 1.91e-01 5.98e-01 0.26200 1.64e-01 -2.04e-01 2.28e-01 1.34e-01
GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS 7 4.57e-01 8.10e-01 0.26200 2.47e-01 8.67e-02 2.58e-01 6.91e-01
GOCC U4 SNRNP 10 3.82e-01 7.67e-01 0.26200 9.03e-02 -2.46e-01 6.21e-01 1.79e-01
GOCC CELL POLE 9 4.31e-01 7.95e-01 0.26200 -2.27e-01 1.30e-01 2.38e-01 5.01e-01
Reduction of cytosolic Ca++ levels 11 3.64e-01 7.54e-01 0.26100 -1.75e-01 1.94e-01 3.16e-01 2.64e-01
GOBP FIBROBLAST GROWTH FACTOR PRODUCTION 10 3.53e-01 7.46e-01 0.26100 -2.61e-01 -2.96e-03 1.52e-01 9.87e-01
GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 9 4.33e-01 7.96e-01 0.26100 1.39e-01 -2.21e-01 4.69e-01 2.51e-01
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY 15 2.32e-01 6.50e-01 0.26100 -2.51e-01 7.18e-02 9.20e-02 6.30e-01
GOBP CONVERGENT EXTENSION 15 2.50e-01 6.64e-01 0.26100 2.17e-01 -1.45e-01 1.45e-01 3.31e-01
GOBP BICARBONATE TRANSPORT 37 1.38e-02 1.87e-01 0.26100 1.97e-01 1.72e-01 3.81e-02 7.08e-02
Phenylalanine and tyrosine metabolism 11 3.50e-01 7.45e-01 0.26100 -9.68e-02 2.43e-01 5.78e-01 1.63e-01
GOBP AXIS ELONGATION 29 5.60e-02 3.60e-01 0.26100 4.61e-02 -2.57e-01 6.68e-01 1.66e-02
GOBP REGULATION OF HEART MORPHOGENESIS 8 4.06e-01 7.81e-01 0.26100 2.39e-01 1.05e-01 2.42e-01 6.06e-01
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY 12 3.34e-01 7.35e-01 0.26100 -1.93e-01 1.76e-01 2.47e-01 2.91e-01
GOMF NUCLEAR VITAMIN D RECEPTOR BINDING 13 2.46e-01 6.61e-01 0.26100 -4.60e-02 -2.57e-01 7.74e-01 1.09e-01
GOBP POSITIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY 5 6.29e-01 8.85e-01 0.26100 2.20e-01 -1.40e-01 3.94e-01 5.87e-01
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY 19 1.14e-01 4.89e-01 0.26100 2.24e-01 1.34e-01 9.08e-02 3.13e-01
GOBP SEQUESTERING OF TRIGLYCERIDE 18 1.49e-01 5.44e-01 0.26100 2.60e-01 2.44e-02 5.63e-02 8.58e-01
GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT 20 1.56e-01 5.52e-01 0.26100 2.27e-01 -1.28e-01 7.86e-02 3.20e-01
Acetylcholine regulates insulin secretion 10 3.15e-01 7.22e-01 0.26100 1.76e-01 1.92e-01 3.34e-01 2.92e-01
GOBP DENDRITIC SPINE MAINTENANCE 21 1.47e-01 5.40e-01 0.26100 -2.00e-01 1.67e-01 1.12e-01 1.86e-01
GOBP SNO S RNA PROCESSING 12 3.10e-01 7.19e-01 0.26100 -2.53e-01 6.41e-02 1.29e-01 7.01e-01
GOBP GRANULOCYTE COLONY STIMULATING FACTOR PRODUCTION 5 5.68e-01 8.59e-01 0.26100 -2.34e-01 -1.15e-01 3.65e-01 6.55e-01
GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION 15 1.86e-01 5.91e-01 0.26100 -1.04e-01 -2.39e-01 4.86e-01 1.09e-01
GOBP REGULATION OF SNARE COMPLEX ASSEMBLY 14 2.31e-01 6.50e-01 0.26100 -2.60e-01 -1.28e-02 9.16e-02 9.34e-01
GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT 10 3.57e-01 7.49e-01 0.26100 -2.61e-01 2.04e-03 1.53e-01 9.91e-01
GOBP MICROAUTOPHAGY 22 1.35e-01 5.22e-01 0.26100 -1.78e-01 1.90e-01 1.48e-01 1.22e-01
GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT 36 1.72e-02 2.11e-01 0.26100 -2.34e-01 -1.15e-01 1.53e-02 2.30e-01
TGFBR3 regulates TGF-beta signaling 8 3.99e-01 7.77e-01 0.26100 -2.07e-01 -1.58e-01 3.11e-01 4.38e-01
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism 12 3.32e-01 7.35e-01 0.26100 -2.15e-01 1.48e-01 1.98e-01 3.76e-01
alpha-linolenic acid (ALA) metabolism 12 3.32e-01 7.35e-01 0.26100 -2.15e-01 1.48e-01 1.98e-01 3.76e-01
VEGFR2 mediated vascular permeability 26 9.31e-02 4.46e-01 0.26100 -2.04e-01 1.63e-01 7.24e-02 1.51e-01
CHL1 interactions 9 3.54e-01 7.47e-01 0.26100 -1.83e-01 -1.86e-01 3.42e-01 3.35e-01
GOBP EMBRYONIC PLACENTA MORPHOGENESIS 26 9.39e-02 4.48e-01 0.26000 1.78e-01 -1.90e-01 1.16e-01 9.34e-02
GOBP HEPATIC STELLATE CELL ACTIVATION 9 4.32e-01 7.96e-01 0.26000 -2.32e-01 1.18e-01 2.28e-01 5.38e-01
GOCC U1 SNRNP 19 1.61e-01 5.59e-01 0.26000 7.55e-02 -2.49e-01 5.69e-01 6.01e-02
GOBP INTRACELLULAR STEROL TRANSPORT 37 2.90e-02 2.69e-01 0.26000 -8.02e-02 2.48e-01 3.98e-01 9.17e-03
GOBP REGULATION OF DOPAMINE SECRETION 25 1.03e-01 4.69e-01 0.26000 -1.97e-01 1.70e-01 8.86e-02 1.41e-01
Incretin synthesis, secretion, and inactivation 23 7.20e-02 4.04e-01 0.26000 -2.08e-01 -1.56e-01 8.44e-02 1.94e-01
GOBP NUCLEAR MIGRATION 25 1.01e-01 4.65e-01 0.26000 -2.19e-01 1.41e-01 5.86e-02 2.23e-01
Specification of primordial germ cells 11 2.95e-01 7.07e-01 0.26000 -2.41e-01 -9.62e-02 1.66e-01 5.81e-01
GOBP NOSE DEVELOPMENT 16 1.64e-01 5.64e-01 0.26000 -2.27e-01 -1.27e-01 1.16e-01 3.79e-01
GOCC SPECTRIN ASSOCIATED CYTOSKELETON 9 3.86e-01 7.68e-01 0.26000 2.57e-01 3.40e-02 1.81e-01 8.60e-01
Alpha-defensins 6 5.04e-01 8.31e-01 0.26000 2.04e-01 1.60e-01 3.86e-01 4.96e-01
GOCC MITOTIC COHESIN COMPLEX 5 6.19e-01 8.80e-01 0.26000 -2.49e-01 7.39e-02 3.35e-01 7.75e-01
Purine ribonucleoside monophosphate biosynthesis 9 4.33e-01 7.96e-01 0.26000 1.13e-01 -2.34e-01 5.57e-01 2.25e-01
GOMF U6 SNRNA BINDING 14 2.22e-01 6.39e-01 0.26000 -2.53e-01 -5.87e-02 1.02e-01 7.04e-01
GOBP NUCLEOBASE TRANSPORT 12 2.56e-01 6.71e-01 0.25900 1.44e-01 2.16e-01 3.88e-01 1.95e-01
GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY 6 5.07e-01 8.33e-01 0.25900 -2.21e-01 -1.36e-01 3.49e-01 5.64e-01
GOBP CYSTEINE METABOLIC PROCESS 10 3.44e-01 7.42e-01 0.25900 2.55e-01 4.63e-02 1.62e-01 8.00e-01
IRAK1 recruits IKK complex 12 2.69e-01 6.84e-01 0.25900 -7.91e-02 -2.47e-01 6.35e-01 1.38e-01
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation 12 2.69e-01 6.84e-01 0.25900 -7.91e-02 -2.47e-01 6.35e-01 1.38e-01
GOBP RRNA TRANSCRIPTION 40 1.67e-02 2.07e-01 0.25900 -2.59e-01 -1.86e-03 4.53e-03 9.84e-01
Uptake and function of diphtheria toxin 6 5.78e-01 8.64e-01 0.25900 1.39e-01 -2.19e-01 5.55e-01 3.53e-01
GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY 5 6.25e-01 8.83e-01 0.25900 -2.42e-01 9.30e-02 3.49e-01 7.19e-01
GOMF PROTEIN CARRIER CHAPERONE 34 2.11e-02 2.33e-01 0.25900 -1.59e-01 -2.04e-01 1.08e-01 3.93e-02
GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 16 2.11e-01 6.28e-01 0.25900 -2.54e-01 5.10e-02 7.88e-02 7.24e-01
Formation of the Editosome 8 4.81e-01 8.21e-01 0.25900 1.31e-01 -2.23e-01 5.21e-01 2.74e-01
mRNA Editing: C to U Conversion 8 4.81e-01 8.21e-01 0.25900 1.31e-01 -2.23e-01 5.21e-01 2.74e-01
GOBP REGULATION OF CHROMATIN BINDING 11 2.89e-01 7.01e-01 0.25900 1.45e-01 2.15e-01 4.06e-01 2.18e-01
GOBP NON PROTEINOGENIC AMINO ACID BIOSYNTHETIC PROCESS 16 1.62e-01 5.61e-01 0.25900 -1.81e-01 -1.85e-01 2.10e-01 2.01e-01
GOBP RESPONSE TO SALT STRESS 24 1.08e-01 4.77e-01 0.25900 2.36e-01 -1.05e-01 4.52e-02 3.71e-01
GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY 9 3.83e-01 7.67e-01 0.25900 5.49e-02 2.53e-01 7.76e-01 1.89e-01
GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS 15 1.83e-01 5.88e-01 0.25900 2.05e-01 1.58e-01 1.70e-01 2.90e-01
GOBP METANEPHRIC TUBULE MORPHOGENESIS 10 3.22e-01 7.28e-01 0.25900 1.95e-01 1.70e-01 2.85e-01 3.53e-01
GOCC NUCLEOSOME 114 2.90e-06 2.81e-04 0.25800 -1.37e-01 -2.19e-01 1.16e-02 5.23e-05
GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS 13 2.29e-01 6.47e-01 0.25800 -1.82e-01 -1.84e-01 2.57e-01 2.51e-01
GOMF NUCLEASE INHIBITOR ACTIVITY 6 5.56e-01 8.55e-01 0.25800 4.08e-02 -2.55e-01 8.63e-01 2.79e-01
GOMF OLFACTORY RECEPTOR BINDING 6 5.36e-01 8.48e-01 0.25800 2.53e-02 2.57e-01 9.14e-01 2.75e-01
GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 10 3.23e-01 7.28e-01 0.25800 -1.54e-01 -2.07e-01 3.98e-01 2.57e-01
GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL 28 6.28e-02 3.77e-01 0.25800 -2.57e-01 2.81e-02 1.87e-02 7.97e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVATOR ACTIVITY 5 6.37e-01 8.87e-01 0.25800 -2.08e-01 1.53e-01 4.21e-01 5.52e-01
GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING 8 4.36e-01 7.97e-01 0.25800 -2.57e-01 -2.44e-02 2.08e-01 9.05e-01
GOBP SEQUESTERING OF BMP IN EXTRACELLULAR MATRIX 5 5.68e-01 8.59e-01 0.25800 -1.90e-01 -1.74e-01 4.61e-01 4.99e-01
GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY 7 4.86e-01 8.23e-01 0.25800 -2.57e-01 -2.11e-02 2.39e-01 9.23e-01
GOBP S ADENOSYLMETHIONINE CYCLE 7 4.76e-01 8.18e-01 0.25800 5.47e-02 2.52e-01 8.02e-01 2.48e-01
GOMF PROLINE RICH REGION BINDING 17 2.05e-01 6.20e-01 0.25800 9.10e-02 -2.41e-01 5.16e-01 8.48e-02
GOBP ECTODERM DEVELOPMENT 20 1.60e-01 5.58e-01 0.25800 -2.31e-01 1.14e-01 7.35e-02 3.75e-01
GOMF STEROL TRANSFER ACTIVITY 24 1.16e-01 4.90e-01 0.25800 -2.08e-01 1.53e-01 7.84e-02 1.94e-01
Acyl chain remodelling of PI 17 2.18e-01 6.37e-01 0.25800 1.61e-01 -2.01e-01 2.50e-01 1.51e-01
Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy 15 1.90e-01 5.97e-01 0.25800 -2.30e-01 -1.16e-01 1.22e-01 4.37e-01
GOBP POSITIVE REGULATION OF HAIR FOLLICLE MATURATION 5 5.69e-01 8.60e-01 0.25800 -1.98e-01 -1.65e-01 4.43e-01 5.23e-01
GOBP POSITIVE REGULATION OF GONAD DEVELOPMENT 8 4.57e-01 8.10e-01 0.25800 -3.41e-02 2.55e-01 8.67e-01 2.11e-01
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ACTIVITY 7 4.59e-01 8.10e-01 0.25800 -2.21e-01 -1.33e-01 3.12e-01 5.43e-01
GOBP DITERPENOID BIOSYNTHETIC PROCESS 10 3.75e-01 7.62e-01 0.25800 2.96e-02 -2.56e-01 8.71e-01 1.61e-01
GOBP OXALOACETATE METABOLIC PROCESS 9 4.48e-01 8.04e-01 0.25700 2.04e-01 -1.57e-01 2.90e-01 4.14e-01
GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX 7 5.36e-01 8.48e-01 0.25700 -1.71e-01 1.92e-01 4.33e-01 3.78e-01
Free fatty acids regulate insulin secretion 10 3.25e-01 7.30e-01 0.25700 1.97e-01 1.66e-01 2.81e-01 3.64e-01
GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION 15 2.09e-01 6.25e-01 0.25700 2.54e-01 4.36e-02 8.91e-02 7.70e-01
GOBP ESTABLISHMENT OF MEIOTIC SPINDLE LOCALIZATION 6 5.29e-01 8.43e-01 0.25700 -2.50e-01 -6.08e-02 2.89e-01 7.96e-01
GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN 22 8.66e-02 4.35e-01 0.25700 2.17e-01 1.38e-01 7.80e-02 2.63e-01
GOMF FIBRONECTIN BINDING 30 6.27e-02 3.77e-01 0.25700 -2.39e-01 9.51e-02 2.35e-02 3.67e-01
GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE 31 4.90e-02 3.35e-01 0.25700 -3.43e-02 2.55e-01 7.41e-01 1.41e-02
GOMF KETOSTEROID MONOOXYGENASE ACTIVITY 5 6.26e-01 8.84e-01 0.25700 2.44e-01 -7.99e-02 3.44e-01 7.57e-01
GOBP RESPONSE TO FRUCTOSE 10 3.32e-01 7.35e-01 0.25700 1.23e-01 2.26e-01 5.01e-01 2.16e-01
GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY 11 3.70e-01 7.58e-01 0.25700 1.23e-01 -2.26e-01 4.79e-01 1.95e-01
GOBP MAMMARY GLAND FORMATION 7 4.62e-01 8.12e-01 0.25700 -2.25e-01 -1.24e-01 3.02e-01 5.71e-01
GOBP PHOTOPERIODISM 27 7.88e-02 4.18e-01 0.25700 -2.47e-01 6.96e-02 2.61e-02 5.31e-01
GOBP POLYAMINE BIOSYNTHETIC PROCESS 12 2.80e-01 6.92e-01 0.25700 2.48e-01 6.52e-02 1.36e-01 6.96e-01
Degradation of cysteine and homocysteine 14 2.88e-01 7.01e-01 0.25700 2.07e-01 -1.52e-01 1.81e-01 3.23e-01
Signaling by LTK 10 3.55e-01 7.48e-01 0.25700 -2.54e-01 -3.64e-02 1.64e-01 8.42e-01
GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS 23 1.28e-01 5.10e-01 0.25700 -2.18e-01 1.36e-01 7.08e-02 2.59e-01
GOBP ENDOCARDIUM MORPHOGENESIS 6 5.12e-01 8.35e-01 0.25700 -1.96e-01 -1.66e-01 4.07e-01 4.81e-01
GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 84 5.09e-04 1.94e-02 0.25700 -2.29e-01 1.16e-01 2.86e-04 6.67e-02
GOBP AROMATIC AMINO ACID METABOLIC PROCESS 31 3.42e-02 2.87e-01 0.25600 2.33e-01 1.08e-01 2.50e-02 2.99e-01
GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY 8 4.29e-01 7.94e-01 0.25600 -2.48e-01 -6.48e-02 2.24e-01 7.51e-01
GOMF SULFATIDE BINDING 6 5.61e-01 8.57e-01 0.25600 3.77e-02 -2.54e-01 8.73e-01 2.82e-01
Metalloprotease DUBs 27 4.97e-02 3.38e-01 0.25600 -1.58e-01 -2.02e-01 1.56e-01 6.93e-02
GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 57 6.58e-03 1.18e-01 0.25600 1.63e-01 -1.98e-01 3.30e-02 9.89e-03
GOBP PERICYTE CELL DIFFERENTIATION 11 3.78e-01 7.64e-01 0.25600 -2.06e-01 1.52e-01 2.37e-01 3.83e-01
GOBP ALLANTOIN METABOLIC PROCESS 9 4.48e-01 8.04e-01 0.25600 -1.35e-01 2.18e-01 4.84e-01 2.58e-01
Positive epigenetic regulation of rRNA expression 68 6.40e-04 2.29e-02 0.25600 -1.06e-01 -2.33e-01 1.30e-01 9.00e-04
GOBP NEGATIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS 5 6.29e-01 8.85e-01 0.25600 7.70e-02 -2.44e-01 7.66e-01 3.45e-01
GOBP METANEPHRIC GLOMERULUS DEVELOPMENT 16 1.81e-01 5.84e-01 0.25600 -2.41e-01 -8.69e-02 9.56e-02 5.47e-01
GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY 17 1.52e-01 5.48e-01 0.25600 1.58e-01 2.01e-01 2.61e-01 1.50e-01
GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY 18 2.06e-01 6.21e-01 0.25600 -1.70e-01 1.91e-01 2.11e-01 1.61e-01
GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT 6 5.78e-01 8.64e-01 0.25600 -9.67e-02 2.37e-01 6.82e-01 3.15e-01
GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE 16 2.35e-01 6.52e-01 0.25600 2.32e-01 -1.08e-01 1.09e-01 4.53e-01
GOBP STEROID HORMONE SECRETION 27 7.33e-02 4.05e-01 0.25500 -2.54e-01 2.60e-02 2.22e-02 8.15e-01
Relaxin receptors 8 4.12e-01 7.84e-01 0.25500 1.64e-01 1.96e-01 4.21e-01 3.38e-01
GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY 9 3.70e-01 7.58e-01 0.25500 1.57e-01 2.01e-01 4.13e-01 2.96e-01
GOCC SIN3 TYPE COMPLEX 20 1.69e-01 5.70e-01 0.25500 1.28e-01 -2.21e-01 3.21e-01 8.74e-02
GOMF METAL ION SENSOR ACTIVITY 8 4.14e-01 7.85e-01 0.25500 2.03e-01 1.55e-01 3.21e-01 4.47e-01
GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION 12 3.50e-01 7.45e-01 0.25500 -1.67e-01 1.92e-01 3.15e-01 2.48e-01
GOBP NEGATIVE REGULATION OF LAMELLIPODIUM ORGANIZATION 7 5.13e-01 8.36e-01 0.25500 -2.52e-01 4.04e-02 2.49e-01 8.53e-01
GOCC AXON HILLOCK 7 4.97e-01 8.29e-01 0.25500 1.10e-02 2.55e-01 9.60e-01 2.43e-01
GOBP DNA DOUBLE STRAND BREAK PROCESSING 20 1.21e-01 4.99e-01 0.25500 -7.61e-02 -2.43e-01 5.56e-01 5.95e-02
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 24 8.53e-02 4.33e-01 0.25500 -2.51e-01 -4.24e-02 3.30e-02 7.19e-01
GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS 17 1.56e-01 5.52e-01 0.25500 1.37e-01 2.15e-01 3.29e-01 1.25e-01
GOMF SINGLE STRANDED DNA 3 5 DNA EXONUCLEASE ACTIVITY 6 5.76e-01 8.63e-01 0.25500 -7.85e-02 2.42e-01 7.39e-01 3.04e-01
GOBP CARDIOLIPIN METABOLIC PROCESS 14 2.67e-01 6.81e-01 0.25500 4.80e-02 -2.50e-01 7.56e-01 1.05e-01
GOCC MKS COMPLEX 13 2.65e-01 6.79e-01 0.25500 -3.88e-02 -2.52e-01 8.09e-01 1.16e-01
Anchoring fibril formation 13 2.92e-01 7.04e-01 0.25500 -4.38e-02 2.51e-01 7.84e-01 1.17e-01
Regulation of CDH19 Expression and Function 7 5.41e-01 8.49e-01 0.25500 -2.10e-01 1.44e-01 3.35e-01 5.10e-01
GOBP NEURON FATE COMMITMENT 74 6.14e-04 2.20e-02 0.25500 -2.54e-01 -1.71e-02 1.56e-04 8.00e-01
GOBP TELOMERE LOCALIZATION 12 2.67e-01 6.81e-01 0.25500 -1.75e-01 -1.85e-01 2.95e-01 2.66e-01
GOMF 1 4 ALPHA OLIGOGLUCAN PHOSPHORYLASE ACTIVITY 5 6.02e-01 8.75e-01 0.25500 -2.53e-01 -3.11e-02 3.28e-01 9.04e-01
GOMF T CELL RECEPTOR BINDING 11 3.79e-01 7.64e-01 0.25500 1.32e-01 -2.18e-01 4.48e-01 2.12e-01
GOBP INTERLEUKIN 13 PRODUCTION 21 1.00e-01 4.64e-01 0.25500 2.06e-01 1.50e-01 1.02e-01 2.35e-01
GOCC GATOR1 COMPLEX 5 6.33e-01 8.86e-01 0.25400 -2.42e-01 8.00e-02 3.50e-01 7.57e-01
GOBP OVULATION CYCLE PROCESS 50 1.23e-02 1.75e-01 0.25400 -2.17e-01 1.32e-01 7.80e-03 1.07e-01
Synthesis of glycosylphosphatidylinositol (GPI) 17 1.61e-01 5.59e-01 0.25400 -1.12e-01 -2.28e-01 4.24e-01 1.03e-01
GOBP MITOCHONDRIAL GENE EXPRESSION 166 1.13e-07 1.61e-05 0.25400 1.31e-02 -2.54e-01 7.71e-01 1.66e-08
GOBP POSITIVE REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY 5 6.48e-01 8.91e-01 0.25400 -1.86e-01 1.73e-01 4.70e-01 5.04e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN ANOTHER COMPOUND AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN 7 5.08e-01 8.33e-01 0.25400 2.54e-01 -1.48e-02 2.45e-01 9.46e-01
GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY 8 4.79e-01 8.21e-01 0.25400 -2.44e-01 6.98e-02 2.32e-01 7.32e-01
PKA activation in glucagon signalling 17 2.24e-01 6.42e-01 0.25400 -1.29e-01 2.19e-01 3.59e-01 1.18e-01
GOCC INTERPHOTORECEPTOR MATRIX 6 5.34e-01 8.46e-01 0.25400 7.39e-02 2.43e-01 7.54e-01 3.03e-01
GOBP PEPTIDYL PROLINE MODIFICATION 29 4.38e-02 3.18e-01 0.25400 -2.21e-01 -1.25e-01 3.93e-02 2.44e-01
GOBP REGULATION OF T CELL CHEMOTAXIS 15 2.73e-01 6.85e-01 0.25400 1.79e-01 -1.80e-01 2.30e-01 2.27e-01
GOMF G PROTEIN COUPLED ADENOSINE RECEPTOR ACTIVITY 5 5.83e-01 8.66e-01 0.25400 2.21e-01 1.25e-01 3.92e-01 6.28e-01
Inactivation of CDC42 and RAC1 8 4.99e-01 8.30e-01 0.25400 -2.04e-01 1.50e-01 3.17e-01 4.61e-01
GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS 17 2.23e-01 6.40e-01 0.25400 -1.19e-01 2.24e-01 3.97e-01 1.09e-01
GOCC MYOFILAMENT 26 7.00e-02 3.97e-01 0.25400 5.05e-02 2.49e-01 6.56e-01 2.82e-02
GOCC NETWORK FORMING COLLAGEN TRIMER 6 5.70e-01 8.61e-01 0.25400 -2.49e-01 4.53e-02 2.90e-01 8.48e-01
GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT 10 3.36e-01 7.36e-01 0.25400 1.63e-01 1.94e-01 3.71e-01 2.88e-01
GOBP AMINO ACID BETAINE TRANSPORT 13 3.22e-01 7.28e-01 0.25300 2.14e-01 -1.36e-01 1.81e-01 3.96e-01
Activation of SMO 18 2.03e-01 6.18e-01 0.25300 -2.28e-01 1.11e-01 9.43e-02 4.14e-01
RUNX1 regulates transcription of genes involved in differentiation of HSCs 79 3.44e-04 1.46e-02 0.25300 -3.98e-02 -2.50e-01 5.41e-01 1.19e-04
GOBP REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE 6 5.26e-01 8.42e-01 0.25300 -2.23e-01 -1.20e-01 3.43e-01 6.12e-01
GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY 85 3.95e-04 1.61e-02 0.25300 -2.47e-01 5.79e-02 8.44e-05 3.56e-01
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION 8 4.39e-01 7.99e-01 0.25300 -2.46e-01 -6.08e-02 2.28e-01 7.66e-01
GOBP GLUTAMATE SECRETION NEUROTRANSMISSION 8 4.77e-01 8.19e-01 0.25300 -5.53e-02 2.47e-01 7.87e-01 2.26e-01
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors 12 3.25e-01 7.29e-01 0.25300 -2.50e-01 4.10e-02 1.34e-01 8.06e-01
GOBP ENDOCRINE HORMONE SECRETION 57 6.32e-03 1.16e-01 0.25300 -2.32e-01 1.02e-01 2.46e-03 1.84e-01
GOBP NUCLEOSIDE TRANSMEMBRANE TRANSPORT 8 4.28e-01 7.94e-01 0.25300 2.30e-01 1.07e-01 2.61e-01 6.02e-01
GRB2 events in EGFR signaling 13 2.71e-01 6.85e-01 0.25300 -3.30e-02 -2.51e-01 8.37e-01 1.17e-01
Activation of caspases through apoptosome-mediated cleavage 5 6.42e-01 8.89e-01 0.25300 1.07e-01 -2.29e-01 6.78e-01 3.75e-01
GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS 11 3.05e-01 7.15e-01 0.25300 2.07e-01 1.45e-01 2.34e-01 4.04e-01
GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS 31 3.72e-02 2.96e-01 0.25300 -2.28e-01 -1.10e-01 2.81e-02 2.89e-01
GOBP RESPONSE TO SODIUM PHOSPHATE 9 3.84e-01 7.67e-01 0.25300 -2.26e-01 -1.14e-01 2.40e-01 5.55e-01
GOBP ENDOSOMAL VESICLE FUSION 15 2.36e-01 6.52e-01 0.25300 -2.53e-01 9.45e-03 9.01e-02 9.49e-01
GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE 7 4.80e-01 8.21e-01 0.25300 -2.36e-01 -9.17e-02 2.80e-01 6.75e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION 49 1.04e-02 1.58e-01 0.25300 -2.49e-01 4.43e-02 2.57e-03 5.92e-01
GOBP CORONARY VASCULATURE DEVELOPMENT 48 1.49e-02 1.94e-01 0.25300 -1.17e-01 2.24e-01 1.63e-01 7.16e-03
GOBP DE NOVO AMP BIOSYNTHETIC PROCESS 8 4.47e-01 8.03e-01 0.25300 2.50e-01 3.92e-02 2.21e-01 8.48e-01
GOBP REGULATION OF PHOSPHOLIPID TRANSPORT 15 2.38e-01 6.55e-01 0.25300 1.56e-02 -2.52e-01 9.17e-01 9.08e-02
GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS 20 1.78e-01 5.83e-01 0.25300 -2.05e-01 1.47e-01 1.12e-01 2.54e-01
GOBP CELLULAR RESPONSE TO INTERFERON ALPHA 7 5.25e-01 8.42e-01 0.25300 5.72e-02 -2.46e-01 7.93e-01 2.60e-01
GOBP RESPONSE TO CORTISOL 6 5.28e-01 8.42e-01 0.25300 -2.22e-01 -1.20e-01 3.45e-01 6.12e-01
GOBP POSITIVE REGULATION OF PHOSPHOLIPID TRANSLOCATION 5 6.32e-01 8.86e-01 0.25200 5.76e-02 -2.46e-01 8.24e-01 3.41e-01
Synthesis of PIPs at the Golgi membrane 17 1.78e-01 5.83e-01 0.25200 -2.46e-01 -5.40e-02 7.85e-02 7.00e-01
GOCC CILIARY TRANSITION FIBER 8 5.04e-01 8.31e-01 0.25200 -1.62e-01 1.94e-01 4.28e-01 3.43e-01
GOBP ADENOSINE TRANSPORT 5 5.88e-01 8.67e-01 0.25200 1.21e-01 2.22e-01 6.40e-01 3.91e-01
GOBP AMPA GLUTAMATE RECEPTOR CLUSTERING 10 3.45e-01 7.43e-01 0.25200 -2.21e-01 -1.22e-01 2.27e-01 5.04e-01
GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS 36 3.06e-02 2.74e-01 0.25200 -2.52e-01 -2.77e-03 8.82e-03 9.77e-01
GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT 14 2.67e-01 6.81e-01 0.25200 2.51e-01 -2.60e-02 1.04e-01 8.66e-01
GOBP UV PROTECTION 12 3.59e-01 7.50e-01 0.25200 -1.94e-01 1.61e-01 2.44e-01 3.35e-01
GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX 7 5.31e-01 8.44e-01 0.25200 7.34e-02 -2.41e-01 7.37e-01 2.69e-01
GOMF MAP KINASE KINASE KINASE ACTIVITY 24 1.17e-01 4.92e-01 0.25200 -2.37e-01 8.69e-02 4.47e-02 4.61e-01
GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY 18 2.16e-01 6.33e-01 0.25200 1.86e-01 -1.70e-01 1.72e-01 2.12e-01
GOBP ERBB4 ERBB4 SIGNALING PATHWAY 6 5.97e-01 8.73e-01 0.25200 2.07e-01 -1.43e-01 3.79e-01 5.43e-01
GOBP PROTEIN DE ADP RIBOSYLATION 5 6.16e-01 8.80e-01 0.25200 5.83e-03 2.52e-01 9.82e-01 3.29e-01
Signaling by Leptin 11 3.57e-01 7.49e-01 0.25200 -2.50e-01 3.24e-02 1.51e-01 8.53e-01
GOMF URIDYLYLTRANSFERASE ACTIVITY 7 5.01e-01 8.30e-01 0.25200 2.50e-02 2.51e-01 9.09e-01 2.51e-01
GOBP POSITIVE REGULATION OF BEHAVIOR 24 1.26e-01 5.07e-01 0.25200 -2.17e-01 1.28e-01 6.56e-02 2.79e-01
GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION 11 3.17e-01 7.25e-01 0.25200 -2.32e-01 -9.70e-02 1.82e-01 5.77e-01
GOMF L ASCORBIC ACID BINDING 20 1.48e-01 5.43e-01 0.25200 -2.52e-01 8.64e-03 5.15e-02 9.47e-01
Activated NTRK2 signals through FRS2 and FRS3 11 3.26e-01 7.30e-01 0.25200 -2.43e-01 -6.60e-02 1.63e-01 7.05e-01
GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 12 2.92e-01 7.05e-01 0.25200 2.41e-01 7.31e-02 1.49e-01 6.61e-01
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 28 5.14e-02 3.44e-01 0.25200 -1.27e-01 -2.17e-01 2.45e-01 4.66e-02
GOMF SUMO LIGASE ACTIVITY 13 3.31e-01 7.34e-01 0.25200 -1.95e-01 1.59e-01 2.23e-01 3.22e-01
GOMF GAP JUNCTION HEMI CHANNEL ACTIVITY 6 5.49e-01 8.53e-01 0.25200 -4.09e-02 -2.48e-01 8.62e-01 2.92e-01
GOBP LENS FIBER CELL MORPHOGENESIS 6 6.00e-01 8.75e-01 0.25100 -1.62e-01 1.92e-01 4.91e-01 4.15e-01
GOMF NITRIC OXIDE SYNTHASE BINDING 10 3.76e-01 7.63e-01 0.25100 -1.82e-02 -2.51e-01 9.21e-01 1.70e-01
GOBP AMYGDALA DEVELOPMENT 5 6.46e-01 8.91e-01 0.25100 -2.27e-01 1.08e-01 3.80e-01 6.76e-01
Gluconeogenesis 25 7.90e-02 4.18e-01 0.25100 2.43e-01 6.43e-02 3.55e-02 5.78e-01
GOCC SMN COMPLEX 9 3.81e-01 7.66e-01 0.25100 -1.91e-01 -1.64e-01 3.22e-01 3.95e-01
Activation of HOX genes during differentiation 83 1.49e-04 8.08e-03 0.25100 -1.42e-01 -2.07e-01 2.54e-02 1.09e-03
Activation of anterior HOX genes in hindbrain development during early embryogenesis 83 1.49e-04 8.08e-03 0.25100 -1.42e-01 -2.07e-01 2.54e-02 1.09e-03
GOBP NUCLEUS LOCALIZATION 32 6.55e-02 3.85e-01 0.25100 -2.04e-01 1.47e-01 4.61e-02 1.50e-01
Regulation of MITF-M-dependent genes involved in apoptosis 19 1.70e-01 5.71e-01 0.25100 -2.49e-01 3.12e-02 5.99e-02 8.14e-01
GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY 7 5.43e-01 8.51e-01 0.25100 -1.08e-01 2.27e-01 6.22e-01 2.98e-01
GOCC COMMITMENT COMPLEX 5 6.40e-01 8.89e-01 0.25100 2.38e-01 -8.04e-02 3.57e-01 7.55e-01
CLEC7A (Dectin-1) induces NFAT activation 11 3.61e-01 7.52e-01 0.25100 -2.48e-01 3.73e-02 1.54e-01 8.30e-01
GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY 5 6.24e-01 8.82e-01 0.25100 1.62e-02 -2.51e-01 9.50e-01 3.32e-01
GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION 10 4.29e-01 7.94e-01 0.25100 1.90e-01 -1.64e-01 2.98e-01 3.69e-01
GOBP POSITIVE REGULATION OF DOPAMINE SECRETION 6 6.01e-01 8.75e-01 0.25100 -1.94e-01 1.59e-01 4.11e-01 4.99e-01
GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY 8 5.08e-01 8.34e-01 0.25100 -1.88e-01 1.67e-01 3.58e-01 4.14e-01
GOBP DE NOVO CENTRIOLE ASSEMBLY 6 5.70e-01 8.61e-01 0.25100 2.41e-02 -2.50e-01 9.19e-01 2.89e-01
GOBP HINDBRAIN TANGENTIAL CELL MIGRATION 5 6.50e-01 8.91e-01 0.25100 1.20e-01 -2.20e-01 6.42e-01 3.94e-01
Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition 12 2.81e-01 6.94e-01 0.25100 -2.15e-01 -1.30e-01 1.98e-01 4.36e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION 8 5.06e-01 8.32e-01 0.25100 2.05e-01 -1.45e-01 3.16e-01 4.78e-01
GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS 28 6.06e-02 3.73e-01 0.25100 2.46e-01 5.13e-02 2.45e-02 6.38e-01
Lectin pathway of complement activation 8 4.25e-01 7.93e-01 0.25100 1.71e-01 1.84e-01 4.03e-01 3.68e-01
GOMF INTRACELLULARLY CAMP ACTIVATED CATION CHANNEL ACTIVITY 8 4.33e-01 7.96e-01 0.25100 1.13e-01 2.24e-01 5.81e-01 2.73e-01
Plasma lipoprotein assembly 19 1.82e-01 5.86e-01 0.25100 -2.41e-01 6.82e-02 6.85e-02 6.07e-01
GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING 29 8.12e-02 4.22e-01 0.25100 -2.24e-01 1.12e-01 3.65e-02 2.96e-01
GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT 21 1.06e-01 4.74e-01 0.25100 -1.91e-01 -1.63e-01 1.31e-01 1.96e-01
GOBP CARDIAC MUSCLE CELL DIFFERENTIATION 126 1.81e-05 1.35e-03 0.25100 -2.28e-01 1.04e-01 9.66e-06 4.42e-02
GOBP BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS 12 2.78e-01 6.92e-01 0.25100 -1.93e-01 -1.60e-01 2.47e-01 3.37e-01
GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 13 2.90e-01 7.02e-01 0.25100 -2.51e-01 2.22e-03 1.18e-01 9.89e-01
GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION 24 7.77e-02 4.15e-01 0.25100 -1.94e-01 -1.59e-01 9.96e-02 1.79e-01
GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION 14 2.47e-01 6.62e-01 0.25100 -2.46e-01 -4.90e-02 1.11e-01 7.51e-01
Downstream signaling of activated FGFR3 24 1.27e-01 5.10e-01 0.25100 -2.19e-01 1.22e-01 6.35e-02 3.01e-01
GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION 10 3.94e-01 7.74e-01 0.25100 -2.49e-01 2.66e-02 1.73e-01 8.84e-01
GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM 24 1.33e-01 5.20e-01 0.25000 1.82e-01 -1.72e-01 1.23e-01 1.44e-01
GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION 14 3.07e-01 7.16e-01 0.25000 1.93e-01 -1.59e-01 2.11e-01 3.02e-01
GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING 33 2.98e-02 2.71e-01 0.25000 -1.70e-01 -1.84e-01 9.01e-02 6.81e-02
GOMF NEUREXIN FAMILY PROTEIN BINDING 9 4.67e-01 8.14e-01 0.25000 -1.99e-01 1.51e-01 3.00e-01 4.32e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 12 3.64e-01 7.54e-01 0.25000 -1.90e-01 1.63e-01 2.55e-01 3.27e-01
GOBP TRANSLATIONAL TERMINATION 15 2.83e-01 6.95e-01 0.25000 1.67e-01 -1.86e-01 2.61e-01 2.12e-01
RHO GTPases Activate Rhotekin and Rhophilins 9 4.69e-01 8.14e-01 0.25000 1.93e-01 -1.60e-01 3.16e-01 4.07e-01
GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION 27 6.65e-02 3.89e-01 0.25000 -2.43e-01 -6.10e-02 2.91e-02 5.83e-01
GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION 7 4.80e-01 8.21e-01 0.25000 -2.17e-01 -1.25e-01 3.21e-01 5.66e-01
Sema4D in semaphorin signaling 24 1.15e-01 4.90e-01 0.25000 -2.43e-01 5.81e-02 3.91e-02 6.22e-01
Transport of RCbl within the body 8 5.10e-01 8.34e-01 0.25000 -1.92e-01 1.60e-01 3.46e-01 4.34e-01
GOMF PROTEIN FOLDING CHAPERONE 67 3.13e-03 7.59e-02 0.25000 1.10e-01 -2.25e-01 1.19e-01 1.48e-03
GOMF MYOSIN II BINDING 12 3.25e-01 7.29e-01 0.25000 -1.58e-02 2.50e-01 9.25e-01 1.34e-01
Regulation of TP53 Activity through Acetylation 28 9.39e-02 4.48e-01 0.25000 -2.05e-01 1.43e-01 6.05e-02 1.90e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 21 1.56e-01 5.52e-01 0.25000 -7.67e-02 2.38e-01 5.43e-01 5.91e-02
GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION 6 5.62e-01 8.57e-01 0.25000 -2.50e-01 -1.14e-02 2.89e-01 9.61e-01
GOMF MHC CLASS I PROTEIN COMPLEX BINDING 6 5.57e-01 8.56e-01 0.25000 2.48e-01 2.82e-02 2.92e-01 9.05e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION 46 1.84e-02 2.16e-01 0.25000 -2.30e-01 9.68e-02 6.84e-03 2.56e-01
GOBP PROTEIN TARGETING TO VACUOLE 46 1.49e-02 1.94e-01 0.25000 -2.47e-01 3.80e-02 3.74e-03 6.56e-01
GOBP INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS 6 5.38e-01 8.49e-01 0.25000 2.29e-01 1.01e-01 3.32e-01 6.69e-01
GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE 19 2.01e-01 6.14e-01 0.25000 2.07e-01 -1.40e-01 1.18e-01 2.92e-01
GOCC SYNAPTIC CLEFT 22 1.10e-01 4.80e-01 0.25000 -2.41e-01 -6.46e-02 5.00e-02 6.00e-01
GOMF ORGANOPHOSPHATE PHOSPHATE ANTIPORTER ACTIVITY 7 4.77e-01 8.19e-01 0.25000 1.93e-01 1.58e-01 3.76e-01 4.69e-01
Conjugation of benzoate with glycine 6 5.36e-01 8.48e-01 0.25000 1.12e-01 2.23e-01 6.35e-01 3.43e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 37 4.52e-02 3.24e-01 0.25000 1.69e-01 -1.84e-01 7.51e-02 5.29e-02
GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 10 3.57e-01 7.49e-01 0.25000 9.96e-02 2.29e-01 5.86e-01 2.10e-01
GOBP SPHINGOID BIOSYNTHETIC PROCESS 14 2.36e-01 6.53e-01 0.25000 1.00e-01 2.29e-01 5.15e-01 1.38e-01
GOBP REGULATION OF ENDOCRINE PROCESS 40 2.97e-02 2.71e-01 0.25000 -2.36e-01 8.02e-02 9.64e-03 3.80e-01
GOBP DEFINITIVE HEMOPOIESIS 19 1.37e-01 5.26e-01 0.25000 -2.12e-01 -1.32e-01 1.10e-01 3.18e-01
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION 18 2.16e-01 6.34e-01 0.25000 1.23e-01 -2.17e-01 3.67e-01 1.11e-01
GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE 19 1.44e-01 5.36e-01 0.25000 8.67e-02 2.34e-01 5.13e-01 7.74e-02
GOBP FOCAL ADHESION ASSEMBLY 83 9.09e-04 3.03e-02 0.24900 -2.12e-01 1.31e-01 8.32e-04 3.89e-02
GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 47 9.29e-03 1.46e-01 0.24900 -2.42e-01 -5.98e-02 4.08e-03 4.78e-01
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH 27 9.63e-02 4.52e-01 0.24900 -2.31e-01 9.41e-02 3.79e-02 3.97e-01
GOCC ASTER 10 3.56e-01 7.48e-01 0.24900 -1.12e-01 -2.23e-01 5.39e-01 2.23e-01
GOBP REGULATION OF ANIMAL ORGAN FORMATION 27 7.76e-02 4.15e-01 0.24900 -2.49e-01 -4.05e-03 2.50e-02 9.71e-01
GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES 15 2.27e-01 6.46e-01 0.24900 -2.44e-01 -5.20e-02 1.02e-01 7.27e-01
GOBP GLUTATHIONE CATABOLIC PROCESS 7 4.78e-01 8.20e-01 0.24900 1.77e-01 1.75e-01 4.17e-01 4.23e-01
GOBP METANEPHRIC NEPHRON TUBULE MORPHOGENESIS 8 4.34e-01 7.96e-01 0.24900 2.08e-01 1.36e-01 3.08e-01 5.04e-01
GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING 11 3.24e-01 7.29e-01 0.24900 -2.28e-01 -9.95e-02 1.90e-01 5.68e-01
GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION 15 2.41e-01 6.57e-01 0.24900 -2.49e-01 -7.35e-03 9.52e-02 9.61e-01
GOBP BRANCHED CHAIN AMINO ACID TRANSPORT 13 3.40e-01 7.39e-01 0.24900 -1.80e-01 1.72e-01 2.60e-01 2.84e-01
GOBP ENDOCARDIAL CUSHION FUSION 5 6.45e-01 8.91e-01 0.24900 -2.37e-01 7.66e-02 3.59e-01 7.67e-01
Formation of tubulin folding intermediates by CCT/TriC 25 9.77e-02 4.56e-01 0.24900 2.49e-01 -1.10e-02 3.15e-02 9.24e-01
GOBP GLUCOSE IMPORT ACROSS PLASMA MEMBRANE 5 6.59e-01 8.96e-01 0.24900 1.97e-01 -1.52e-01 4.45e-01 5.56e-01
GOBP GEPHYRIN CLUSTERING INVOLVED IN POSTSYNAPTIC DENSITY ASSEMBLY 5 5.95e-01 8.72e-01 0.24900 2.15e-01 1.25e-01 4.05e-01 6.28e-01
GOBP MUCUS SECRETION 19 1.37e-01 5.27e-01 0.24900 2.02e-01 1.45e-01 1.28e-01 2.72e-01
GOBP POSITIVE REGULATION OF CELL KILLING 75 2.02e-03 5.46e-02 0.24900 1.74e-01 -1.78e-01 9.10e-03 7.86e-03
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) 20 1.29e-01 5.12e-01 0.24900 -2.24e-01 -1.08e-01 8.28e-02 4.04e-01
GOBP PROXIMAL TUBULE DEVELOPMENT 10 3.71e-01 7.59e-01 0.24900 6.06e-02 2.41e-01 7.40e-01 1.87e-01
GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE 6 5.34e-01 8.46e-01 0.24900 1.48e-01 2.00e-01 5.31e-01 3.96e-01
GOCC SPERM HEAD PLASMA MEMBRANE 6 5.47e-01 8.52e-01 0.24900 2.36e-01 7.72e-02 3.16e-01 7.43e-01
GOBP NEGATIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION 5 5.92e-01 8.70e-01 0.24900 -1.93e-01 -1.57e-01 4.55e-01 5.44e-01
GOMF C C CHEMOKINE BINDING 23 1.28e-01 5.10e-01 0.24800 2.43e-01 -4.99e-02 4.33e-02 6.78e-01
GOMF CO SMAD BINDING 9 4.11e-01 7.84e-01 0.24800 -2.42e-01 -5.74e-02 2.09e-01 7.66e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 28 9.52e-02 4.50e-01 0.24800 1.28e-01 -2.13e-01 2.42e-01 5.10e-02
GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY 5 6.27e-01 8.84e-01 0.24800 3.50e-03 -2.48e-01 9.89e-01 3.36e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE 5 6.06e-01 8.76e-01 0.24800 -2.37e-01 -7.53e-02 3.60e-01 7.71e-01
GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION 16 2.33e-01 6.50e-01 0.24800 -2.46e-01 2.97e-02 8.78e-02 8.37e-01
Constitutive Signaling by EGFRvIII 15 2.10e-01 6.26e-01 0.24800 -1.43e-01 -2.03e-01 3.39e-01 1.73e-01
Signaling by EGFRvIII in Cancer 15 2.10e-01 6.26e-01 0.24800 -1.43e-01 -2.03e-01 3.39e-01 1.73e-01
Condensation of Prophase Chromosomes 36 3.84e-02 3.01e-01 0.24800 3.37e-02 -2.46e-01 7.26e-01 1.07e-02
GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS 9 4.63e-01 8.12e-01 0.24800 9.96e-02 -2.27e-01 6.05e-01 2.38e-01
GOBP ARTICULAR CARTILAGE DEVELOPMENT 5 5.94e-01 8.71e-01 0.24800 -1.96e-01 -1.52e-01 4.47e-01 5.57e-01
GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION 10 4.26e-01 7.93e-01 0.24800 -1.04e-01 2.25e-01 5.71e-01 2.17e-01
GOBP GENERAL ADAPTATION SYNDROME 6 6.07e-01 8.76e-01 0.24800 -2.03e-01 1.42e-01 3.89e-01 5.46e-01
GOCC PRONUCLEUS 14 3.13e-01 7.21e-01 0.24800 1.47e-01 -2.00e-01 3.41e-01 1.95e-01
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH 12 3.15e-01 7.22e-01 0.24800 -3.07e-02 -2.46e-01 8.54e-01 1.40e-01
GOMF PROTON CHANNEL ACTIVITY 25 1.25e-01 5.07e-01 0.24800 1.44e-01 -2.02e-01 2.12e-01 8.09e-02
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION 15 2.17e-01 6.35e-01 0.24800 2.24e-01 1.06e-01 1.33e-01 4.78e-01
GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 13 3.04e-01 7.14e-01 0.24800 -2.17e-02 2.47e-01 8.92e-01 1.23e-01
GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE 17 1.92e-01 6.00e-01 0.24800 -2.44e-01 -4.22e-02 8.12e-02 7.63e-01
Cation-coupled Chloride cotransporters 7 5.61e-01 8.57e-01 0.24800 -1.67e-01 1.83e-01 4.45e-01 4.01e-01
GOMF PROCOLLAGEN PROLINE 4 DIOXYGENASE ACTIVITY 5 6.47e-01 8.91e-01 0.24800 -2.37e-01 7.28e-02 3.59e-01 7.78e-01
GOCC HAUS COMPLEX 7 5.60e-01 8.57e-01 0.24800 1.97e-01 -1.50e-01 3.67e-01 4.91e-01
GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS 5 6.03e-01 8.76e-01 0.24800 -9.58e-02 -2.29e-01 7.11e-01 3.76e-01
Tight junction interactions 28 7.77e-02 4.15e-01 0.24800 2.47e-01 -2.26e-02 2.38e-02 8.36e-01
GOBP POSITIVE REGULATION OF MESENCHYMAL STEM CELL PROLIFERATION 6 6.10e-01 8.77e-01 0.24800 1.77e-01 -1.74e-01 4.53e-01 4.62e-01
Na+/Cl- dependent neurotransmitter transporters 18 2.28e-01 6.46e-01 0.24800 -1.77e-01 1.73e-01 1.93e-01 2.04e-01
GOBP LIVER MORPHOGENESIS 25 1.02e-01 4.67e-01 0.24800 2.24e-02 -2.47e-01 8.46e-01 3.28e-02
GOBP TYPE B PANCREATIC CELL PROLIFERATION 26 7.93e-02 4.19e-01 0.24800 -2.42e-01 -5.08e-02 3.25e-02 6.54e-01
GOBP POSITIVE REGULATION OF FEEDING BEHAVIOR 10 4.28e-01 7.94e-01 0.24800 -1.04e-01 2.24e-01 5.67e-01 2.19e-01
GOBP POSITIVE REGULATION OF BONE MINERALIZATION 43 2.87e-02 2.68e-01 0.24800 -2.00e-01 1.46e-01 2.35e-02 9.71e-02
GOBP REGULATION OF TESTOSTERONE BIOSYNTHETIC PROCESS 7 5.62e-01 8.57e-01 0.24700 -1.91e-01 1.58e-01 3.82e-01 4.70e-01
GOMF MAP KINASE SCAFFOLD ACTIVITY 12 3.58e-01 7.50e-01 0.24700 -2.31e-01 8.93e-02 1.66e-01 5.92e-01
Voltage gated Potassium channels 42 3.06e-02 2.74e-01 0.24700 -1.33e-01 2.08e-01 1.35e-01 1.95e-02
Phase 2 - plateau phase 14 2.80e-01 6.92e-01 0.24700 -2.21e-02 2.46e-01 8.86e-01 1.11e-01
GOMF PEROXIREDOXIN ACTIVITY 7 5.63e-01 8.58e-01 0.24700 1.88e-01 -1.60e-01 3.88e-01 4.63e-01
GOBP GLOSSOPHARYNGEAL NERVE DEVELOPMENT 5 6.49e-01 8.91e-01 0.24700 -2.35e-01 7.69e-02 3.63e-01 7.66e-01
RUNX1 regulates transcription of genes involved in BCR signaling 6 6.07e-01 8.76e-01 0.24700 2.11e-01 -1.29e-01 3.72e-01 5.83e-01
GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION 7 5.51e-01 8.54e-01 0.24700 -9.53e-02 2.28e-01 6.62e-01 2.96e-01
Gastrulation 116 7.25e-06 6.31e-04 0.24700 -2.12e-01 -1.27e-01 8.12e-05 1.79e-02
GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS 5 5.97e-01 8.73e-01 0.24700 -2.01e-01 -1.43e-01 4.36e-01 5.79e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION 12 3.71e-01 7.59e-01 0.24700 2.04e-01 -1.40e-01 2.22e-01 4.01e-01
GOBP REGULATION OF MESODERM DEVELOPMENT 6 6.12e-01 8.78e-01 0.24700 -1.64e-01 1.85e-01 4.87e-01 4.33e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME 12 3.64e-01 7.54e-01 0.24700 -1.05e-01 2.23e-01 5.29e-01 1.80e-01
GOMF CALCITONIN FAMILY RECEPTOR ACTIVITY 6 6.04e-01 8.76e-01 0.24700 -2.21e-01 1.11e-01 3.49e-01 6.39e-01
GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX 26 1.19e-01 4.96e-01 0.24700 1.60e-01 -1.88e-01 1.57e-01 9.76e-02
Inhibition of replication initiation of damaged DNA by RB1/E2F1 11 3.66e-01 7.55e-01 0.24700 -2.46e-01 1.25e-02 1.57e-01 9.43e-01
GOCC U2 SNRNP 23 1.16e-01 4.90e-01 0.24700 -1.42e-02 -2.46e-01 9.06e-01 4.08e-02
GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS 12 3.30e-01 7.34e-01 0.24700 1.84e-03 -2.47e-01 9.91e-01 1.39e-01
GOBP KETONE BODY METABOLIC PROCESS 9 3.95e-01 7.74e-01 0.24700 1.80e-01 1.68e-01 3.49e-01 3.82e-01
GOBP REGULATION OF HIPPOCAMPAL NEURON APOPTOTIC PROCESS 5 6.28e-01 8.84e-01 0.24700 -2.47e-01 -8.04e-03 3.40e-01 9.75e-01
MET activates PI3K/AKT signaling 6 5.40e-01 8.49e-01 0.24700 -1.38e-01 -2.05e-01 5.59e-01 3.86e-01
GOMF CULLIN FAMILY PROTEIN BINDING 24 1.22e-01 5.00e-01 0.24700 -2.40e-01 5.54e-02 4.15e-02 6.39e-01
Calcitonin-like ligand receptors 10 3.87e-01 7.68e-01 0.24700 -2.96e-02 -2.45e-01 8.71e-01 1.80e-01
Activated NTRK3 signals through PI3K 6 5.84e-01 8.66e-01 0.24700 -2.45e-01 3.15e-02 3.00e-01 8.94e-01
GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT 29 7.45e-02 4.09e-01 0.24600 -2.44e-01 3.13e-02 2.27e-02 7.71e-01
GOMF FATTY ACID DERIVATIVE BINDING 18 1.64e-01 5.64e-01 0.24600 -1.01e-01 -2.25e-01 4.58e-01 9.87e-02
GOCC MHC CLASS I PEPTIDE LOADING COMPLEX 8 5.09e-01 8.34e-01 0.24600 2.26e-01 -9.78e-02 2.68e-01 6.32e-01
GOMF DYNACTIN BINDING 12 3.76e-01 7.63e-01 0.24600 -1.61e-01 1.86e-01 3.34e-01 2.64e-01
GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE 19 1.80e-01 5.84e-01 0.24600 -2.34e-02 2.45e-01 8.60e-01 6.41e-02
GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS 11 4.06e-01 7.81e-01 0.24600 -1.43e-01 2.00e-01 4.11e-01 2.50e-01
GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT 27 8.92e-02 4.38e-01 0.24600 -2.44e-01 3.03e-02 2.79e-02 7.85e-01
GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 66 2.99e-03 7.34e-02 0.24600 4.49e-02 -2.42e-01 5.28e-01 6.70e-04
GOMF PROTEIN TRANSPORTER ACTIVITY 40 1.86e-02 2.17e-01 0.24600 -9.39e-02 -2.28e-01 3.04e-01 1.27e-02
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS 12 3.22e-01 7.28e-01 0.24600 2.45e-01 2.63e-02 1.42e-01 8.74e-01
GOMF TELOMERASE RNA BINDING 21 1.18e-01 4.94e-01 0.24600 -2.12e-01 -1.26e-01 9.30e-02 3.19e-01
GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY 8 4.39e-01 7.99e-01 0.24600 1.71e-01 1.77e-01 4.03e-01 3.86e-01
GOBP INNATE IMMUNE RESPONSE IN MUCOSA 22 1.04e-01 4.70e-01 0.24600 -1.65e-01 -1.83e-01 1.80e-01 1.38e-01
GOBP DENDRITE SELF AVOIDANCE 14 2.60e-01 6.73e-01 0.24600 -2.41e-01 -5.07e-02 1.19e-01 7.43e-01
GOCC PROTEIN FOLDING CHAPERONE COMPLEX 40 3.49e-02 2.89e-01 0.24600 9.90e-02 -2.25e-01 2.79e-01 1.37e-02
GOBP NEGATIVE REGULATION OF CGMP MEDIATED SIGNALING 6 5.57e-01 8.56e-01 0.24600 2.37e-01 6.61e-02 3.15e-01 7.79e-01
Processive synthesis on the lagging strand 14 2.43e-01 6.58e-01 0.24600 -2.14e-01 -1.21e-01 1.66e-01 4.33e-01
GOBP AMINO ACID BETAINE BIOSYNTHETIC PROCESS 5 6.21e-01 8.81e-01 0.24600 2.42e-01 4.12e-02 3.48e-01 8.73e-01
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 11 3.45e-01 7.42e-01 0.24600 -5.93e-02 -2.38e-01 7.33e-01 1.71e-01
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 34 5.90e-02 3.69e-01 0.24600 1.06e-01 -2.21e-01 2.83e-01 2.54e-02
GOBP REGULATION OF PROTEIN GLYCOSYLATION 11 3.50e-01 7.45e-01 0.24600 4.32e-02 2.42e-01 8.04e-01 1.65e-01
The NLRP3 inflammasome 16 2.50e-01 6.65e-01 0.24600 5.88e-02 -2.38e-01 6.84e-01 9.86e-02
GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY 6 5.96e-01 8.72e-01 0.24600 -2.37e-01 6.44e-02 3.15e-01 7.85e-01
GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY 7 4.89e-01 8.25e-01 0.24600 -1.55e-01 -1.90e-01 4.77e-01 3.83e-01
GOBP POSITIVE REGULATION OF CILIUM MOVEMENT 13 2.91e-01 7.03e-01 0.24600 -2.42e-01 -3.91e-02 1.30e-01 8.07e-01
GOBP MANCHETTE ASSEMBLY 9 4.79e-01 8.20e-01 0.24600 -1.32e-01 2.07e-01 4.94e-01 2.81e-01
GOMF G PROTEIN BETA SUBUNIT BINDING 21 1.79e-01 5.83e-01 0.24500 1.28e-01 -2.09e-01 3.09e-01 9.68e-02
Formation of Senescence-Associated Heterochromatin Foci (SAHF) 17 2.32e-01 6.50e-01 0.24500 -2.36e-01 6.59e-02 9.15e-02 6.38e-01
Class I peroxisomal membrane protein import 19 1.62e-01 5.60e-01 0.24500 -5.07e-02 -2.40e-01 7.02e-01 7.00e-02
GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY 13 3.37e-01 7.37e-01 0.24500 -2.25e-01 9.91e-02 1.61e-01 5.36e-01
GOMF MAP KINASE ACTIVITY 16 2.28e-01 6.46e-01 0.24500 2.45e-01 1.14e-02 8.96e-02 9.37e-01
GOBP SEROTONIN METABOLIC PROCESS 10 4.46e-01 8.02e-01 0.24500 -1.66e-01 1.81e-01 3.64e-01 3.22e-01
Chylomicron clearance 5 6.01e-01 8.75e-01 0.24500 1.95e-01 1.49e-01 4.51e-01 5.63e-01
Regulation of MITF-M-dependent genes involved in cell cycle and proliferation 18 2.26e-01 6.44e-01 0.24500 1.13e-01 -2.18e-01 4.06e-01 1.10e-01
GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION 13 2.82e-01 6.95e-01 0.24500 6.88e-02 2.35e-01 6.68e-01 1.42e-01
GOBP VESICLE CARGO LOADING 31 4.68e-02 3.28e-01 0.24500 -2.28e-01 -9.04e-02 2.80e-02 3.84e-01
GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS 16 2.69e-01 6.83e-01 0.24500 1.23e-01 -2.12e-01 3.96e-01 1.41e-01
GOBP GAP JUNCTION ASSEMBLY 16 2.29e-01 6.47e-01 0.24500 -2.45e-01 -7.22e-03 8.95e-02 9.60e-01
GOBP EXPLORATION BEHAVIOR 32 5.60e-02 3.60e-01 0.24500 -2.45e-01 1.50e-02 1.65e-02 8.83e-01
GOBP REGULATION OF GLOMERULUS DEVELOPMENT 5 6.01e-01 8.75e-01 0.24500 -1.53e-01 -1.92e-01 5.53e-01 4.58e-01
GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE 13 3.10e-01 7.19e-01 0.24500 -2.45e-01 1.59e-02 1.27e-01 9.21e-01
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN 15 2.94e-01 7.07e-01 0.24500 1.31e-01 -2.07e-01 3.79e-01 1.65e-01
GOCC GABA ERGIC SYNAPSE 73 1.43e-03 4.25e-02 0.24500 -2.45e-01 1.59e-02 3.01e-04 8.14e-01
GOCC CATSPER COMPLEX 14 3.21e-01 7.28e-01 0.24500 1.97e-01 -1.46e-01 2.02e-01 3.44e-01
GOBP MESENCHYMAL TO EPITHELIAL TRANSITION 18 1.87e-01 5.92e-01 0.24500 -2.44e-01 -2.14e-02 7.28e-02 8.75e-01
GOBP SIRNA MEDIATED RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION 10 4.42e-01 8.00e-01 0.24500 -1.28e-01 2.09e-01 4.82e-01 2.53e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE 34 5.22e-02 3.45e-01 0.24500 5.10e-02 -2.40e-01 6.07e-01 1.56e-02
GOBP NEGATIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS 6 5.52e-01 8.54e-01 0.24500 -2.27e-01 -9.34e-02 3.36e-01 6.92e-01
GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS 9 4.05e-01 7.81e-01 0.24500 2.12e-01 1.23e-01 2.71e-01 5.22e-01
GOCC INTRACILIARY TRANSPORT PARTICLE 26 7.28e-02 4.04e-01 0.24500 -2.08e-01 -1.30e-01 6.66e-02 2.53e-01
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex 13 3.22e-01 7.28e-01 0.24500 4.70e-02 -2.40e-01 7.69e-01 1.34e-01
GOMF PHOSPHATIDYLCHOLINE BINDING 28 8.89e-02 4.38e-01 0.24500 -2.39e-01 5.45e-02 2.88e-02 6.18e-01
GOCC PEPTIDASE INHIBITOR COMPLEX 11 3.57e-01 7.49e-01 0.24500 2.92e-02 2.43e-01 8.67e-01 1.63e-01
GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY 29 6.90e-02 3.95e-01 0.24500 2.44e-01 1.38e-02 2.27e-02 8.98e-01
GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY 31 4.30e-02 3.15e-01 0.24500 -1.56e-01 -1.88e-01 1.32e-01 6.95e-02
Proton-coupled monocarboxylate transport 6 6.15e-01 8.79e-01 0.24500 2.02e-01 -1.38e-01 3.91e-01 5.59e-01
GOCC CORTICAL GRANULE 6 5.47e-01 8.52e-01 0.24500 1.25e-01 2.10e-01 5.95e-01 3.73e-01
GOBP DNA TOPOLOGICAL CHANGE 9 4.60e-01 8.10e-01 0.24500 -2.38e-01 5.52e-02 2.16e-01 7.74e-01
GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC DEPRESSION 6 5.84e-01 8.66e-01 0.24500 -2.44e-01 1.49e-02 3.00e-01 9.49e-01
GOBP PHENYLPROPANOID METABOLIC PROCESS 6 5.44e-01 8.51e-01 0.24500 1.58e-01 1.86e-01 5.02e-01 4.29e-01
GOBP T HELPER 17 CELL LINEAGE COMMITMENT 19 1.55e-01 5.52e-01 0.24400 -2.28e-01 -8.88e-02 8.57e-02 5.03e-01
GOCC DEATH INDUCING SIGNALING COMPLEX 9 4.71e-01 8.15e-01 0.24400 8.43e-02 -2.29e-01 6.61e-01 2.34e-01
GOBP CYTOPLASMIC TRANSLATIONAL INITIATION 38 2.72e-02 2.61e-01 0.24400 -5.06e-02 -2.39e-01 5.89e-01 1.08e-02
GOBP LIPID DROPLET FORMATION 13 3.53e-01 7.46e-01 0.24400 -1.52e-01 1.91e-01 3.44e-01 2.32e-01
FGFR2 ligand binding and activation 19 2.18e-01 6.36e-01 0.24400 -1.49e-01 1.93e-01 2.61e-01 1.45e-01
GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 49 9.18e-03 1.46e-01 0.24400 -6.35e-02 -2.36e-01 4.42e-01 4.32e-03
Interleukin-10 signaling 42 3.47e-02 2.88e-01 0.24400 1.53e-01 -1.90e-01 8.54e-02 3.33e-02
GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY 12 3.09e-01 7.18e-01 0.24400 -8.98e-02 -2.27e-01 5.90e-01 1.74e-01
GOMF JUN KINASE KINASE KINASE ACTIVITY 11 4.15e-01 7.86e-01 0.24400 -1.79e-01 1.65e-01 3.03e-01 3.42e-01
GOBP STEROID HORMONE BIOSYNTHETIC PROCESS 44 1.92e-02 2.22e-01 0.24400 2.44e-01 -6.03e-03 5.12e-03 9.45e-01
GOBP RESPONSE TO BILE ACID 7 5.53e-01 8.54e-01 0.24400 -6.91e-02 2.34e-01 7.52e-01 2.84e-01
GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY 10 4.25e-01 7.93e-01 0.24400 5.79e-02 -2.37e-01 7.51e-01 1.95e-01
GOCC SCAR COMPLEX 12 3.79e-01 7.64e-01 0.24400 1.27e-01 -2.08e-01 4.46e-01 2.12e-01
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template 38 2.56e-02 2.55e-01 0.24400 -7.41e-02 -2.32e-01 4.30e-01 1.32e-02
GOCC CORTICAL ENDOPLASMIC RETICULUM 6 6.20e-01 8.80e-01 0.24400 -1.73e-01 1.72e-01 4.62e-01 4.67e-01
GOBP ADENYLATE CYCLASE ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY 10 3.97e-01 7.76e-01 0.24400 -2.43e-01 -2.33e-02 1.84e-01 8.99e-01
GOMF TRNA SPECIFIC ADENOSINE DEAMINASE ACTIVITY 8 4.79e-01 8.21e-01 0.24400 2.03e-02 2.43e-01 9.21e-01 2.34e-01
GOBP AMINO SUGAR CATABOLIC PROCESS 14 2.52e-01 6.67e-01 0.24400 1.05e-01 2.20e-01 4.95e-01 1.55e-01
Biosynthesis of specialized proresolving mediators (SPMs) 19 1.72e-01 5.76e-01 0.24400 -2.42e-01 -2.84e-02 6.79e-02 8.30e-01
GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 14 3.09e-01 7.18e-01 0.24400 7.64e-02 -2.31e-01 6.21e-01 1.34e-01
Signaling by LRP5 mutants 6 6.15e-01 8.80e-01 0.24400 2.11e-01 -1.22e-01 3.71e-01 6.04e-01
GOMF ENONE REDUCTASE ACTIVITY 5 6.27e-01 8.84e-01 0.24400 2.40e-01 3.83e-02 3.52e-01 8.82e-01
TICAM1, RIP1-mediated IKK complex recruitment 18 2.31e-01 6.49e-01 0.24300 1.13e-01 -2.16e-01 4.07e-01 1.13e-01
GOCC COP9 SIGNALOSOME 34 3.63e-02 2.93e-01 0.24300 -9.44e-02 -2.24e-01 3.41e-01 2.36e-02
GOBP PROTEIN LOCALIZATION TO GOLGI MEMBRANE 5 6.34e-01 8.86e-01 0.24300 -1.36e-02 -2.43e-01 9.58e-01 3.47e-01
GOCC TUBULAR ENDOSOME 5 6.72e-01 9.01e-01 0.24300 1.61e-01 -1.82e-01 5.32e-01 4.80e-01
GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY 39 3.88e-02 3.03e-01 0.24300 -2.30e-01 8.05e-02 1.31e-02 3.85e-01
GOCC MIB COMPLEX 11 4.17e-01 7.86e-01 0.24300 -1.54e-01 1.89e-01 3.78e-01 2.78e-01
Activation of NOXA and translocation to mitochondria 5 6.62e-01 8.97e-01 0.24300 9.11e-02 -2.26e-01 7.24e-01 3.83e-01
GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS 8 5.27e-01 8.42e-01 0.24300 1.40e-01 -1.99e-01 4.94e-01 3.29e-01
GOCC ROD PHOTORECEPTOR OUTER SEGMENT 7 5.26e-01 8.42e-01 0.24300 2.22e-02 2.42e-01 9.19e-01 2.68e-01
GOCC RAGULATOR COMPLEX 6 5.61e-01 8.57e-01 0.24300 -2.29e-01 -8.21e-02 3.32e-01 7.28e-01
GOCC MLL1 2 COMPLEX 28 8.47e-02 4.32e-01 0.24300 -2.42e-01 1.72e-02 2.64e-02 8.75e-01
GOCC NASCENT POLYPEPTIDE ASSOCIATED COMPLEX 5 6.08e-01 8.76e-01 0.24300 1.40e-01 1.99e-01 5.89e-01 4.41e-01
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION 34 5.11e-02 3.44e-01 0.24300 -2.42e-01 2.49e-02 1.47e-02 8.02e-01
GOBP GLUTAMATE SECRETION 28 1.09e-01 4.79e-01 0.24300 -1.59e-01 1.84e-01 1.46e-01 9.25e-02
GOBP REGULATION OF RECEPTOR BINDING 16 2.37e-01 6.54e-01 0.24300 -2.43e-01 -5.30e-03 9.27e-02 9.71e-01
PKA activation 18 2.37e-01 6.54e-01 0.24300 -1.33e-01 2.03e-01 3.30e-01 1.35e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER 10 3.84e-01 7.68e-01 0.24300 7.28e-02 2.32e-01 6.90e-01 2.05e-01
GOCC KERATIN FILAMENT 87 1.90e-04 9.64e-03 0.24300 2.09e-01 1.23e-01 7.48e-04 4.68e-02
GOMF COBALAMIN BINDING 9 4.61e-01 8.11e-01 0.24300 -2.39e-01 4.03e-02 2.14e-01 8.34e-01
GOMF FUCOSE BINDING 8 4.81e-01 8.21e-01 0.24300 -2.42e-01 -2.19e-02 2.36e-01 9.14e-01
GOMF CARDIOLIPIN BINDING 11 3.33e-01 7.35e-01 0.24300 1.62e-01 1.80e-01 3.51e-01 3.00e-01
GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS 29 6.36e-02 3.79e-01 0.24300 2.33e-01 6.69e-02 2.97e-02 5.33e-01
GOBP NEGATIVE REGULATION OF AMINE METABOLIC PROCESS 6 5.62e-01 8.57e-01 0.24300 -7.95e-02 -2.29e-01 7.36e-01 3.31e-01
GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY 14 3.10e-01 7.19e-01 0.24300 -6.94e-02 2.32e-01 6.53e-01 1.32e-01
GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE CONTACT SITE 19 2.21e-01 6.39e-01 0.24200 1.42e-01 -1.97e-01 2.85e-01 1.38e-01
GOBP UV DAMAGE EXCISION REPAIR 12 3.82e-01 7.66e-01 0.24200 -1.22e-01 2.09e-01 4.63e-01 2.09e-01
GOCC COPI COATED VESICLE MEMBRANE 18 1.69e-01 5.70e-01 0.24200 -2.04e-01 -1.30e-01 1.33e-01 3.38e-01
Mitophagy 37 3.89e-02 3.04e-01 0.24200 1.49e-02 -2.42e-01 8.76e-01 1.09e-02
GOBP POSITIVE REGULATION OF OSSIFICATION 53 1.40e-02 1.88e-01 0.24200 -2.16e-01 1.09e-01 6.42e-03 1.71e-01
GOBP MIDBRAIN HINDBRAIN BOUNDARY DEVELOPMENT 7 5.76e-01 8.64e-01 0.24200 -1.76e-01 1.66e-01 4.19e-01 4.47e-01
GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY 15 2.83e-01 6.95e-01 0.24200 5.85e-02 -2.35e-01 6.95e-01 1.15e-01
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS 17 2.05e-01 6.21e-01 0.24200 -2.37e-01 -4.81e-02 9.04e-02 7.31e-01
GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 14 3.25e-01 7.30e-01 0.24200 -2.12e-01 1.16e-01 1.69e-01 4.51e-01
GOCC PLATELET ALPHA GRANULE MEMBRANE 16 2.59e-01 6.73e-01 0.24200 -2.36e-01 5.54e-02 1.03e-01 7.01e-01
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING COMPRESSION RESISTANCE 19 2.24e-01 6.42e-01 0.24200 -1.55e-01 1.86e-01 2.41e-01 1.61e-01
GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS 12 3.23e-01 7.28e-01 0.24200 2.34e-01 6.34e-02 1.61e-01 7.04e-01
SHC-mediated cascade:FGFR3 17 2.63e-01 6.78e-01 0.24200 -1.64e-01 1.78e-01 2.41e-01 2.04e-01
GOBP PROTEIN LOCALIZATION TO AXON 9 4.93e-01 8.27e-01 0.24200 -1.83e-01 1.59e-01 3.43e-01 4.10e-01
GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY 22 1.76e-01 5.81e-01 0.24200 -1.45e-01 1.93e-01 2.38e-01 1.16e-01
GOBP CORTICOSTERONE SECRETION 6 5.65e-01 8.59e-01 0.24200 7.43e-02 2.30e-01 7.53e-01 3.29e-01
GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY 9 4.27e-01 7.93e-01 0.24200 2.32e-01 6.90e-02 2.29e-01 7.20e-01
GOBP MITOCHONDRIAL RNA 3 END PROCESSING 6 5.77e-01 8.64e-01 0.24200 -3.34e-02 -2.39e-01 8.87e-01 3.10e-01
GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION 13 3.40e-01 7.40e-01 0.24200 2.31e-01 -7.08e-02 1.49e-01 6.58e-01
GOMF SIGNAL RECOGNITION PARTICLE BINDING 8 4.74e-01 8.17e-01 0.24200 -5.41e-02 -2.36e-01 7.91e-01 2.49e-01
GOBP TOLERANCE INDUCTION 29 8.84e-02 4.37e-01 0.24200 2.34e-01 -6.06e-02 2.92e-02 5.72e-01
GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS 14 3.15e-01 7.22e-01 0.24200 7.53e-02 -2.30e-01 6.26e-01 1.37e-01
GOBP INTRACELLULAR MRNA LOCALIZATION 15 2.83e-01 6.95e-01 0.24200 5.37e-02 -2.36e-01 7.19e-01 1.14e-01
GOBP ANTIBACTERIAL HUMORAL RESPONSE 58 7.04e-03 1.23e-01 0.24200 3.62e-02 -2.39e-01 6.34e-01 1.65e-03
GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 105 1.68e-04 8.72e-03 0.24200 6.79e-02 -2.32e-01 2.29e-01 4.04e-05
GOBP CELL PROLIFERATION IN MIDBRAIN 8 4.88e-01 8.24e-01 0.24100 2.41e-01 1.20e-02 2.37e-01 9.53e-01
GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION 26 1.28e-01 5.10e-01 0.24100 -2.04e-01 1.29e-01 7.13e-02 2.56e-01
GOBP NEUROPEPTIDE SIGNALING PATHWAY 101 1.77e-04 9.03e-03 0.24100 -2.39e-01 3.14e-02 3.22e-05 5.85e-01
GOBP SINOATRIAL NODE DEVELOPMENT 11 3.93e-01 7.73e-01 0.24100 -2.37e-01 4.42e-02 1.73e-01 8.00e-01
GOBP DE NOVO CENTRIOLE ASSEMBLY INVOLVED IN MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION 5 6.64e-01 8.97e-01 0.24100 8.20e-02 -2.27e-01 7.51e-01 3.79e-01
Protein lipoylation 10 3.90e-01 7.71e-01 0.24100 -6.86e-02 -2.31e-01 7.07e-01 2.05e-01
GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY 12 3.22e-01 7.28e-01 0.24100 -7.06e-02 -2.31e-01 6.72e-01 1.66e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME 7 5.66e-01 8.59e-01 0.24100 -2.25e-01 8.83e-02 3.04e-01 6.86e-01
GOBP REGULATION OF MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 6 5.58e-01 8.56e-01 0.24100 -2.12e-01 -1.14e-01 3.67e-01 6.28e-01
GOBP URATE TRANSPORT 11 3.48e-01 7.44e-01 0.24100 2.23e-01 9.31e-02 2.01e-01 5.93e-01
Linoleic acid (LA) metabolism 7 5.73e-01 8.61e-01 0.24100 -1.17e-01 2.11e-01 5.93e-01 3.34e-01
Acyl chain remodelling of PC 27 8.73e-02 4.36e-01 0.24100 2.40e-01 2.34e-02 3.09e-02 8.34e-01
GOCC LEWY BODY 8 5.25e-01 8.42e-01 0.24100 2.20e-01 -9.91e-02 2.82e-01 6.27e-01
GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY 7 5.79e-01 8.64e-01 0.24100 1.57e-01 -1.83e-01 4.73e-01 4.01e-01
GOBP NEGATIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS 5 6.55e-01 8.93e-01 0.24100 2.37e-01 -4.45e-02 3.59e-01 8.63e-01
GOBP ENDOCARDIUM DEVELOPMENT 12 3.07e-01 7.16e-01 0.24100 -1.58e-01 -1.82e-01 3.45e-01 2.74e-01
GOCC PHAGOCYTIC CUP 28 1.03e-01 4.68e-01 0.24100 2.25e-01 -8.53e-02 3.91e-02 4.35e-01
Transcriptional regulation by small RNAs 70 1.16e-03 3.65e-02 0.24100 -1.15e-01 -2.12e-01 9.69e-02 2.19e-03
GOMF CALCIUM DEPENDENT PHOSPHOLIPASE A2 ACTIVITY 17 2.60e-01 6.74e-01 0.24100 2.09e-01 -1.19e-01 1.35e-01 3.96e-01
GOBP HEXOSE PHOSPHATE TRANSPORT 7 5.27e-01 8.42e-01 0.24100 2.37e-01 4.14e-02 2.77e-01 8.50e-01
GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN 11 3.48e-01 7.44e-01 0.24100 -1.00e-01 -2.19e-01 5.65e-01 2.09e-01
GOMF FOUR WAY JUNCTION DNA BINDING 16 2.56e-01 6.71e-01 0.24100 -2.38e-01 3.34e-02 9.90e-02 8.17e-01
GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 30 7.42e-02 4.08e-01 0.24000 2.40e-01 -1.34e-02 2.28e-02 8.99e-01
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY 47 1.87e-02 2.18e-01 0.24000 3.71e-02 -2.38e-01 6.60e-01 4.83e-03
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR 12 3.92e-01 7.72e-01 0.24000 -1.40e-01 1.95e-01 4.00e-01 2.42e-01
GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION 7 5.65e-01 8.58e-01 0.24000 7.64e-02 -2.28e-01 7.26e-01 2.97e-01
GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY 9 4.62e-01 8.12e-01 0.24000 2.39e-01 -2.47e-02 2.14e-01 8.98e-01
GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION 14 3.13e-01 7.21e-01 0.24000 5.68e-02 -2.33e-01 7.13e-01 1.30e-01
GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY 14 2.70e-01 6.85e-01 0.24000 2.30e-01 6.99e-02 1.36e-01 6.51e-01
Constitutive Signaling by AKT1 E17K in Cancer 25 1.42e-01 5.33e-01 0.24000 -1.33e-01 2.00e-01 2.50e-01 8.31e-02
GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 30 7.29e-02 4.04e-01 0.24000 -2.40e-01 3.93e-03 2.28e-02 9.70e-01
GOBP CARDIAC VENTRICLE FORMATION 8 5.38e-01 8.49e-01 0.24000 -1.65e-01 1.74e-01 4.18e-01 3.94e-01
GOBP POSITIVE REGULATION OF HIPPO SIGNALING 11 4.19e-01 7.87e-01 0.24000 -2.11e-01 1.14e-01 2.25e-01 5.11e-01
GOBP RESPONSE TO METHIONINE 5 6.66e-01 8.99e-01 0.24000 2.26e-01 -7.98e-02 3.80e-01 7.57e-01
GOBP PURINE RIBONUCLEOTIDE SALVAGE 7 5.67e-01 8.59e-01 0.24000 -8.07e-02 2.26e-01 7.12e-01 3.00e-01
Transcriptional regulation of brown and beige adipocyte differentiation 29 1.06e-01 4.74e-01 0.24000 -1.60e-01 1.79e-01 1.36e-01 9.49e-02
Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 29 1.06e-01 4.74e-01 0.24000 -1.60e-01 1.79e-01 1.36e-01 9.49e-02
GOBP HEART GROWTH 96 4.04e-04 1.63e-02 0.24000 -2.29e-01 7.21e-02 1.06e-04 2.22e-01
GOBP REGULATION OF MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS 7 5.25e-01 8.42e-01 0.24000 -2.34e-01 -5.25e-02 2.83e-01 8.10e-01
GOBP POSITIVE REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS 15 3.03e-01 7.14e-01 0.24000 -1.03e-01 2.17e-01 4.89e-01 1.46e-01
GOCC MRNA EDITING COMPLEX 6 5.92e-01 8.70e-01 0.24000 2.40e-01 -1.03e-03 3.09e-01 9.96e-01
GOBP KERATINOCYTE DIFFERENTIATION 171 2.96e-07 3.76e-05 0.24000 2.40e-01 1.18e-02 6.39e-08 7.90e-01
GOMF ACROSIN BINDING 5 6.79e-01 9.04e-01 0.24000 1.54e-01 -1.84e-01 5.51e-01 4.77e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 24 1.44e-01 5.36e-01 0.24000 -2.24e-01 8.48e-02 5.71e-02 4.72e-01
Diseases associated with visual transduction 11 3.98e-01 7.76e-01 0.24000 -4.36e-02 2.36e-01 8.02e-01 1.76e-01
Diseases of the neuronal system 11 3.98e-01 7.76e-01 0.24000 -4.36e-02 2.36e-01 8.02e-01 1.76e-01
Retinoid cycle disease events 11 3.98e-01 7.76e-01 0.24000 -4.36e-02 2.36e-01 8.02e-01 1.76e-01
GOBP OPTIC NERVE DEVELOPMENT 20 1.76e-01 5.81e-01 0.24000 -2.40e-01 5.12e-03 6.34e-02 9.68e-01
Co-stimulation by ICOS 10 4.53e-01 8.07e-01 0.24000 2.15e-01 -1.07e-01 2.40e-01 5.57e-01
GOMF ACYL COA OXIDASE ACTIVITY 7 5.79e-01 8.64e-01 0.24000 -1.29e-01 2.02e-01 5.55e-01 3.54e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR 13 3.67e-01 7.56e-01 0.24000 -1.67e-01 1.72e-01 2.96e-01 2.84e-01
GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY 43 1.85e-02 2.17e-01 0.24000 -2.30e-01 -6.63e-02 8.94e-03 4.52e-01
Apoptosis induced DNA fragmentation 13 2.82e-01 6.95e-01 0.24000 -1.91e-01 -1.44e-01 2.32e-01 3.68e-01
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 79 2.05e-03 5.54e-02 0.24000 -2.08e-01 1.18e-01 1.36e-03 6.88e-02
Chondroitin sulfate biosynthesis 18 2.27e-01 6.45e-01 0.24000 -2.32e-01 5.84e-02 8.77e-02 6.68e-01
GOBP HYPEROSMOTIC SALINITY RESPONSE 10 4.56e-01 8.09e-01 0.24000 2.10e-01 -1.16e-01 2.51e-01 5.24e-01
GOMF 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE BINDING 9 4.23e-01 7.92e-01 0.24000 1.07e-01 2.14e-01 5.78e-01 2.65e-01
GOBP NEGATIVE REGULATION OF ERAD PATHWAY 7 5.13e-01 8.36e-01 0.24000 -1.04e-01 -2.16e-01 6.33e-01 3.23e-01
GOCC FIBRINOGEN COMPLEX 8 5.40e-01 8.49e-01 0.24000 1.64e-01 -1.75e-01 4.23e-01 3.91e-01
GOBP PROXIMAL DISTAL PATTERN FORMATION 34 3.65e-02 2.94e-01 0.24000 -1.69e-01 -1.70e-01 8.89e-02 8.59e-02
GOBP REGULATION OF POSTSYNAPSE ASSEMBLY 6 6.14e-01 8.79e-01 0.24000 -7.37e-02 2.28e-01 7.55e-01 3.34e-01
GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY 40 2.84e-02 2.67e-01 0.24000 2.38e-01 2.30e-02 9.08e-03 8.01e-01
GOBP CELLULAR RESPONSE TO ANTIBIOTIC 11 4.29e-01 7.94e-01 0.23900 1.75e-01 -1.63e-01 3.14e-01 3.49e-01
GOBP REGULATION OF ISOMERASE ACTIVITY 7 5.75e-01 8.63e-01 0.23900 -2.15e-01 1.05e-01 3.25e-01 6.29e-01
GOBP SOMATIC STEM CELL DIVISION 12 3.24e-01 7.28e-01 0.23900 -2.23e-01 -8.60e-02 1.80e-01 6.06e-01
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 20 2.12e-01 6.28e-01 0.23900 1.98e-01 -1.35e-01 1.26e-01 2.96e-01
GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS 8 4.80e-01 8.21e-01 0.23900 -2.33e-01 -5.47e-02 2.54e-01 7.89e-01
GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION 35 3.71e-02 2.96e-01 0.23900 -8.87e-02 -2.22e-01 3.64e-01 2.28e-02
GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS 10 4.64e-01 8.12e-01 0.23900 -1.63e-01 1.76e-01 3.73e-01 3.36e-01
GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE 10 4.33e-01 7.96e-01 0.23900 2.36e-01 -3.88e-02 1.96e-01 8.32e-01
RHO GTPases activate PKNs 56 4.38e-03 9.19e-02 0.23900 -1.59e-01 -1.79e-01 4.00e-02 2.05e-02
GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS 18 1.97e-01 6.08e-01 0.23900 -2.36e-01 -4.01e-02 8.32e-02 7.68e-01
GOMF ACYL COA HYDROLASE ACTIVITY 22 1.82e-01 5.86e-01 0.23900 -2.00e-01 1.32e-01 1.05e-01 2.85e-01
GOBP RESPONSE TO FLUID SHEAR STRESS 35 6.60e-02 3.87e-01 0.23900 -1.27e-01 2.03e-01 1.94e-01 3.79e-02
GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS 14 3.32e-01 7.35e-01 0.23900 1.05e-01 -2.15e-01 4.95e-01 1.64e-01
GOBP PROTEIN LOCALIZATION TO ENDOSOME 27 1.08e-01 4.77e-01 0.23900 -5.52e-02 2.33e-01 6.20e-01 3.64e-02
SOS-mediated signalling 7 5.78e-01 8.64e-01 0.23900 -2.11e-01 1.13e-01 3.35e-01 6.04e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION 14 3.38e-01 7.38e-01 0.23900 -1.32e-01 1.99e-01 3.91e-01 1.98e-01
GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE 18 2.48e-01 6.62e-01 0.23900 -2.02e-01 1.28e-01 1.38e-01 3.48e-01
GOBP CRANIAL SUTURE MORPHOGENESIS 9 4.44e-01 8.01e-01 0.23900 -2.36e-01 -4.02e-02 2.21e-01 8.34e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 31 5.27e-02 3.47e-01 0.23900 -2.13e-01 -1.08e-01 4.01e-02 2.97e-01
GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE SIGNALING 7 5.55e-01 8.55e-01 0.23900 2.37e-01 -3.08e-02 2.78e-01 8.88e-01
IRE1alpha activates chaperones 45 2.37e-02 2.46e-01 0.23900 -2.35e-01 4.15e-02 6.32e-03 6.30e-01
GOBP TRANSLATIONAL INITIATION 109 1.35e-04 7.58e-03 0.23900 5.47e-02 -2.32e-01 3.24e-01 2.76e-05
GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION 14 2.62e-01 6.77e-01 0.23900 -2.05e-01 -1.22e-01 1.83e-01 4.30e-01
GOBP IMMUNE RESPONSE TO TUMOR CELL 28 1.09e-01 4.79e-01 0.23900 2.19e-01 -9.51e-02 4.49e-02 3.84e-01
GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY 17 2.59e-01 6.73e-01 0.23900 -9.14e-02 2.21e-01 5.14e-01 1.15e-01
DNA Damage Recognition in GG-NER 36 3.26e-02 2.82e-01 0.23900 -1.14e-01 -2.09e-01 2.35e-01 2.96e-02
GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS 24 1.42e-01 5.33e-01 0.23900 -2.30e-01 6.29e-02 5.08e-02 5.94e-01
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL 20 1.82e-01 5.86e-01 0.23900 -2.38e-01 1.50e-02 6.53e-02 9.07e-01
Neurofascin interactions 6 6.32e-01 8.86e-01 0.23800 -1.55e-01 1.81e-01 5.10e-01 4.42e-01
GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY 12 3.20e-01 7.28e-01 0.23800 -2.10e-01 -1.13e-01 2.08e-01 4.99e-01
GOMF GLYCOGEN BINDING 7 5.86e-01 8.67e-01 0.23800 -1.54e-01 1.82e-01 4.80e-01 4.05e-01
GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 28 1.14e-01 4.89e-01 0.23800 -1.19e-01 2.07e-01 2.76e-01 5.86e-02
GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS 19 2.35e-01 6.51e-01 0.23800 1.84e-01 -1.52e-01 1.66e-01 2.52e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY 17 2.67e-01 6.81e-01 0.23800 2.10e-01 -1.13e-01 1.34e-01 4.21e-01
GOBP LEUKOCYTE AGGREGATION 12 3.82e-01 7.66e-01 0.23800 2.26e-01 -7.51e-02 1.75e-01 6.52e-01
GOBP SNORNA LOCALIZATION 6 5.82e-01 8.65e-01 0.23800 -4.88e-02 -2.33e-01 8.36e-01 3.23e-01
GOMF NETRIN RECEPTOR ACTIVITY 5 6.21e-01 8.81e-01 0.23800 1.26e-01 2.02e-01 6.26e-01 4.34e-01
GOMF PROLINE SODIUM SYMPORTER ACTIVITY 5 6.48e-01 8.91e-01 0.23800 2.38e-01 6.36e-03 3.57e-01 9.80e-01
GOBP COLLAGEN FIBRIL ORGANIZATION 65 7.17e-03 1.25e-01 0.23800 -1.52e-01 1.83e-01 3.38e-02 1.07e-02
GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY 13 3.41e-01 7.40e-01 0.23800 2.35e-01 -3.94e-02 1.43e-01 8.06e-01
GOBP GLOMERULAR EPITHELIUM DEVELOPMENT 26 1.10e-01 4.79e-01 0.23800 -2.38e-01 1.10e-02 3.59e-02 9.22e-01
Regulation of CDH11 Expression and Function 29 1.01e-01 4.65e-01 0.23800 -2.20e-01 8.98e-02 4.00e-02 4.02e-01
GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR 10 4.64e-01 8.13e-01 0.23800 -1.99e-01 1.31e-01 2.77e-01 4.74e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III 17 2.52e-01 6.68e-01 0.23800 -2.30e-01 5.94e-02 1.00e-01 6.72e-01
GOMF GLUTAMATE BINDING 8 4.92e-01 8.27e-01 0.23800 -2.35e-01 -3.35e-02 2.49e-01 8.70e-01
GOBP ZINC ION IMPORT INTO ORGANELLE 11 4.31e-01 7.95e-01 0.23800 1.30e-01 -1.99e-01 4.54e-01 2.54e-01
GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE 7 5.32e-01 8.44e-01 0.23800 2.32e-01 5.25e-02 2.88e-01 8.10e-01
GOBP TELOMERIC D LOOP DISASSEMBLY 7 5.57e-01 8.56e-01 0.23800 -2.76e-02 2.36e-01 8.99e-01 2.80e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR 9 4.89e-01 8.25e-01 0.23800 7.73e-02 -2.25e-01 6.88e-01 2.43e-01
GOCC POSTSYNAPTIC CYTOSOL 13 3.69e-01 7.58e-01 0.23700 -2.01e-01 1.27e-01 2.10e-01 4.29e-01
GOBP MACROPINOCYTOSIS 10 4.58e-01 8.10e-01 0.23700 -2.15e-01 9.99e-02 2.38e-01 5.84e-01
GOBP MUSCLE CELL DEVELOPMENT 199 2.25e-07 2.94e-05 0.23700 -2.12e-01 1.07e-01 2.56e-07 9.15e-03
GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS 10 4.70e-01 8.14e-01 0.23700 1.64e-01 -1.71e-01 3.68e-01 3.48e-01
Transcriptional Regulation by VENTX 41 2.63e-02 2.57e-01 0.23700 -2.34e-01 -3.89e-02 9.48e-03 6.67e-01
Translesion synthesis by POLI 17 2.66e-01 6.81e-01 0.23700 1.01e-01 -2.15e-01 4.73e-01 1.25e-01
GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY 11 4.28e-01 7.94e-01 0.23700 -2.09e-01 1.11e-01 2.29e-01 5.23e-01
GOBP THERMOCEPTION 8 5.47e-01 8.52e-01 0.23700 -1.73e-01 1.62e-01 3.98e-01 4.26e-01
GOBP NAD TRANSPORT 5 6.66e-01 8.98e-01 0.23700 -2.32e-01 4.88e-02 3.69e-01 8.50e-01
GOBP NEGATIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION 7 5.77e-01 8.64e-01 0.23700 8.67e-02 -2.20e-01 6.91e-01 3.12e-01
GOMF LONG CHAIN FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 15 2.40e-01 6.55e-01 0.23700 1.78e-01 1.56e-01 2.33e-01 2.94e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL 7 5.17e-01 8.39e-01 0.23700 -2.01e-01 -1.26e-01 3.58e-01 5.65e-01
GOBP POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 11 3.63e-01 7.53e-01 0.23700 2.20e-01 8.88e-02 2.07e-01 6.10e-01
GOBP POSITIVE REGULATION OF BLOOD CIRCULATION 36 4.10e-02 3.09e-01 0.23700 -2.33e-01 -4.41e-02 1.57e-02 6.47e-01
GOBP TRANS SYNAPTIC SIGNALING BY TRANS SYNAPTIC COMPLEX 7 5.14e-01 8.36e-01 0.23700 1.74e-01 1.61e-01 4.26e-01 4.62e-01
GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS 24 1.40e-01 5.31e-01 0.23700 2.33e-01 -3.88e-02 4.77e-02 7.42e-01
GOBP HAIR CYCLE PHASE 9 4.86e-01 8.23e-01 0.23700 5.91e-02 -2.29e-01 7.59e-01 2.34e-01
GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP 16 2.59e-01 6.73e-01 0.23700 -2.36e-01 8.29e-03 1.02e-01 9.54e-01
GOMF S100 PROTEIN BINDING 14 3.50e-01 7.45e-01 0.23600 -1.70e-01 1.65e-01 2.72e-01 2.86e-01
GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS 14 2.98e-01 7.10e-01 0.23600 1.72e-02 2.36e-01 9.12e-01 1.27e-01
GOBP REGULATION OF CALCIUM IMPORT INTO THE MITOCHONDRION 6 5.73e-01 8.62e-01 0.23600 2.13e-01 1.02e-01 3.65e-01 6.66e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION 25 9.35e-02 4.47e-01 0.23600 -1.56e-01 -1.78e-01 1.78e-01 1.24e-01
GOBP ALCOHOL CATABOLIC PROCESS 33 4.54e-02 3.25e-01 0.23600 2.01e-01 1.24e-01 4.54e-02 2.18e-01
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION 21 1.53e-01 5.48e-01 0.23600 -5.73e-02 -2.29e-01 6.49e-01 6.90e-02
GOBP RESPONSE TO GROWTH HORMONE 35 7.18e-02 4.03e-01 0.23600 -1.90e-01 1.40e-01 5.11e-02 1.53e-01
GOBP CATECHOLAMINE SECRETION 48 1.79e-02 2.13e-01 0.23600 -2.36e-01 1.07e-02 4.68e-03 8.98e-01
GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS 6 6.12e-01 8.78e-01 0.23600 3.54e-02 -2.33e-01 8.81e-01 3.22e-01
Stabilization of p53 43 1.94e-02 2.23e-01 0.23600 -9.13e-02 -2.18e-01 3.00e-01 1.35e-02
GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS 13 3.54e-01 7.47e-01 0.23600 2.29e-01 -5.78e-02 1.53e-01 7.18e-01
FLT3 Signaling 38 3.01e-02 2.72e-01 0.23600 -9.86e-02 -2.14e-01 2.93e-01 2.21e-02
Ubiquitin-dependent degradation of Cyclin D 39 3.08e-02 2.74e-01 0.23600 -5.68e-02 -2.29e-01 5.39e-01 1.33e-02
GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS 14 2.83e-01 6.95e-01 0.23600 -2.26e-01 -6.88e-02 1.44e-01 6.56e-01
GOBP REGULATION OF MALE GONAD DEVELOPMENT 8 4.97e-01 8.29e-01 0.23600 3.19e-02 2.34e-01 8.76e-01 2.52e-01
GOBP METANEPHRIC RENAL VESICLE MORPHOGENESIS 14 2.70e-01 6.85e-01 0.23600 -2.00e-01 -1.26e-01 1.96e-01 4.16e-01
GOBP SPLEEN DEVELOPMENT 38 3.00e-02 2.72e-01 0.23600 -2.11e-01 -1.04e-01 2.41e-02 2.65e-01
GOBP REGULATION OF ASPARTIC TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS 6 6.06e-01 8.76e-01 0.23600 -1.08e-02 2.36e-01 9.63e-01 3.18e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING 13 3.49e-01 7.45e-01 0.23600 -4.28e-02 2.32e-01 7.89e-01 1.48e-01
Co-inhibition by PD-1 21 2.09e-01 6.25e-01 0.23600 1.60e-01 -1.73e-01 2.04e-01 1.70e-01
GOBP DIOL BIOSYNTHETIC PROCESS 21 1.40e-01 5.32e-01 0.23600 1.30e-01 1.96e-01 3.02e-01 1.19e-01
GOBP POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY 9 4.31e-01 7.95e-01 0.23600 1.96e-01 1.31e-01 3.09e-01 4.96e-01
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION 18 2.58e-01 6.72e-01 0.23600 -1.27e-01 1.99e-01 3.51e-01 1.45e-01
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION 9 5.05e-01 8.32e-01 0.23600 2.05e-01 -1.17e-01 2.88e-01 5.44e-01
GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION 8 5.50e-01 8.53e-01 0.23600 1.84e-01 -1.48e-01 3.68e-01 4.70e-01
GOBP ASCENDING AORTA DEVELOPMENT 5 6.64e-01 8.97e-01 0.23600 -2.34e-01 2.97e-02 3.66e-01 9.08e-01
GOCC VESICLE COAT 62 6.23e-03 1.15e-01 0.23600 -2.34e-01 2.72e-02 1.44e-03 7.12e-01
GOCC LAMIN FILAMENT 5 6.86e-01 9.06e-01 0.23600 1.23e-01 -2.01e-01 6.33e-01 4.37e-01
GOBP COPI COATED VESICLE BUDDING 6 6.28e-01 8.85e-01 0.23600 -2.18e-01 8.86e-02 3.55e-01 7.07e-01
PECAM1 interactions 12 3.23e-01 7.28e-01 0.23500 -1.68e-01 -1.65e-01 3.14e-01 3.23e-01
GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC 13 3.74e-01 7.62e-01 0.23500 1.17e-01 -2.04e-01 4.63e-01 2.03e-01
Transcriptional regulation of granulopoiesis 53 8.11e-03 1.34e-01 0.23500 -8.78e-02 -2.18e-01 2.69e-01 5.97e-03
Respiratory Syncytial Virus Infection Pathway 110 2.12e-04 1.03e-02 0.23500 8.84e-02 -2.18e-01 1.09e-01 7.79e-05
GOBP FEMALE GENITALIA DEVELOPMENT 19 2.09e-01 6.25e-01 0.23500 -2.34e-01 2.08e-02 7.70e-02 8.75e-01
GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING 14 3.04e-01 7.14e-01 0.23500 -1.09e-02 -2.35e-01 9.43e-01 1.28e-01
TNFR1-induced proapoptotic signaling 24 1.66e-01 5.67e-01 0.23500 1.34e-01 -1.93e-01 2.55e-01 1.01e-01
GOBP IRIS MORPHOGENESIS 9 4.86e-01 8.23e-01 0.23500 -2.31e-01 4.61e-02 2.31e-01 8.11e-01
GOBP XMP METABOLIC PROCESS 7 5.95e-01 8.71e-01 0.23500 1.79e-01 -1.53e-01 4.13e-01 4.83e-01
Metabolism of porphyrins 27 1.35e-01 5.24e-01 0.23500 1.69e-01 -1.63e-01 1.29e-01 1.41e-01
GOBP PROTEIN REFOLDING 26 1.05e-01 4.71e-01 0.23500 -3.49e-02 -2.32e-01 7.58e-01 4.02e-02
GOMF DYNEIN HEAVY CHAIN BINDING 16 2.90e-01 7.02e-01 0.23500 -8.32e-02 2.20e-01 5.64e-01 1.28e-01
GOBP AUTOCRINE SIGNALING 7 5.78e-01 8.64e-01 0.23500 2.24e-01 -7.24e-02 3.06e-01 7.40e-01
GOCC ISWI TYPE COMPLEX 11 4.13e-01 7.84e-01 0.23500 4.35e-02 -2.31e-01 8.03e-01 1.85e-01
GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX 37 5.19e-02 3.45e-01 0.23500 -2.30e-01 4.67e-02 1.54e-02 6.23e-01
Signaling by ROBO receptors 194 3.29e-07 4.13e-05 0.23500 8.01e-02 -2.21e-01 5.43e-02 1.13e-07
GOBP REGULATION OF GTP BINDING 9 4.85e-01 8.23e-01 0.23500 2.31e-01 -4.15e-02 2.30e-01 8.29e-01
GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY 12 3.70e-01 7.58e-01 0.23500 2.35e-01 -1.01e-02 1.59e-01 9.51e-01
GOMF CHOLINE TRANSMEMBRANE TRANSPORTER ACTIVITY 7 5.19e-01 8.39e-01 0.23500 -1.65e-01 -1.67e-01 4.51e-01 4.43e-01
GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 26 1.16e-01 4.90e-01 0.23500 2.35e-01 -9.10e-03 3.84e-02 9.36e-01
GOCC INHIBITORY SYNAPSE 13 3.02e-01 7.13e-01 0.23500 -2.06e-01 -1.13e-01 1.99e-01 4.81e-01
GOMF G PROTEIN COUPLED OPIOID RECEPTOR ACTIVITY 7 5.72e-01 8.61e-01 0.23500 -4.64e-02 2.30e-01 8.31e-01 2.92e-01
RNA Polymerase III Transcription Initiation From Type 3 Promoter 28 7.86e-02 4.18e-01 0.23500 -9.36e-02 -2.15e-01 3.92e-01 4.87e-02
GOBP CARTILAGE MORPHOGENESIS 10 3.94e-01 7.74e-01 0.23500 -1.84e-01 -1.46e-01 3.15e-01 4.24e-01
Resolution of D-Loop Structures 35 4.63e-02 3.27e-01 0.23400 -2.28e-01 -5.29e-02 1.94e-02 5.88e-01
GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM 20 1.56e-01 5.52e-01 0.23400 -1.36e-01 -1.91e-01 2.91e-01 1.40e-01
GOBP CELLULAR RESPONSE TO UV C 5 6.38e-01 8.88e-01 0.23400 2.20e-01 7.98e-02 3.94e-01 7.57e-01
GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT 18 2.58e-01 6.72e-01 0.23400 -2.07e-01 1.10e-01 1.29e-01 4.19e-01
GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX 52 2.07e-02 2.30e-01 0.23400 1.20e-01 -2.01e-01 1.34e-01 1.21e-02
GOBP MONOACYLGLYCEROL METABOLIC PROCESS 14 3.57e-01 7.49e-01 0.23400 -1.63e-01 1.68e-01 2.91e-01 2.76e-01
GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 11 3.59e-01 7.51e-01 0.23400 -1.75e-01 -1.56e-01 3.16e-01 3.70e-01
Senescence-Associated Secretory Phenotype (SASP) 74 1.74e-03 4.89e-02 0.23400 -3.39e-02 -2.32e-01 6.14e-01 5.70e-04
GOBP INTESTINAL ABSORPTION 41 2.30e-02 2.43e-01 0.23400 1.27e-01 1.96e-01 1.59e-01 2.95e-02
GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION 22 1.99e-01 6.12e-01 0.23400 1.57e-01 -1.74e-01 2.03e-01 1.59e-01
GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX 14 3.28e-01 7.32e-01 0.23400 -2.30e-01 4.32e-02 1.37e-01 7.80e-01
GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS 7 5.25e-01 8.42e-01 0.23400 1.25e-01 1.97e-01 5.66e-01 3.66e-01
GOCC GOLGI CIS CISTERNA 13 3.82e-01 7.67e-01 0.23400 -1.33e-01 1.92e-01 4.07e-01 2.30e-01
GOBP PROSTATIC BUD FORMATION 8 5.02e-01 8.30e-01 0.23400 -2.31e-01 -3.77e-02 2.59e-01 8.53e-01
GOBP TONGUE DEVELOPMENT 21 1.47e-01 5.40e-01 0.23400 -2.03e-01 -1.16e-01 1.08e-01 3.57e-01
GOCC JUXTAPARANODE REGION OF AXON 12 4.12e-01 7.84e-01 0.23400 -1.31e-01 1.93e-01 4.31e-01 2.46e-01
GOBP ADENOSINE TO INOSINE EDITING 6 6.42e-01 8.89e-01 0.23400 -1.34e-01 1.91e-01 5.69e-01 4.17e-01
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS 6 6.44e-01 8.90e-01 0.23400 -1.66e-01 1.65e-01 4.82e-01 4.85e-01
GOBP BONE GROWTH 31 6.84e-02 3.94e-01 0.23400 -2.29e-01 -4.43e-02 2.71e-02 6.69e-01
GOBP CLATHRIN DEPENDENT ENDOCYTOSIS 48 2.48e-02 2.52e-01 0.23400 -2.22e-01 7.39e-02 7.90e-03 3.76e-01
GOBP CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT 9 4.35e-01 7.97e-01 0.23400 -1.83e-01 -1.46e-01 3.43e-01 4.49e-01
GOBP ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION 9 5.14e-01 8.36e-01 0.23400 -1.95e-01 1.28e-01 3.10e-01 5.06e-01
GOBP REPLACEMENT OSSIFICATION 29 1.04e-01 4.70e-01 0.23400 -2.26e-01 6.01e-02 3.55e-02 5.75e-01
GOCC FHF COMPLEX 5 6.33e-01 8.86e-01 0.23300 1.99e-01 1.22e-01 4.41e-01 6.37e-01
GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION 14 2.88e-01 7.00e-01 0.23300 8.02e-02 2.19e-01 6.03e-01 1.56e-01
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway 7 5.49e-01 8.52e-01 0.23300 3.68e-02 2.30e-01 8.66e-01 2.91e-01
Formation of the ureteric bud 21 1.44e-01 5.36e-01 0.23300 -1.68e-01 -1.61e-01 1.82e-01 2.01e-01
GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX 11 4.13e-01 7.84e-01 0.23300 2.65e-02 -2.32e-01 8.79e-01 1.83e-01
GOMF MHC PROTEIN BINDING 32 9.23e-02 4.45e-01 0.23300 1.10e-01 -2.05e-01 2.81e-01 4.43e-02
Sensing of DNA Double Strand Breaks 6 5.78e-01 8.64e-01 0.23300 -1.26e-01 -1.96e-01 5.92e-01 4.06e-01
GOBP EMBRYONIC FORELIMB MORPHOGENESIS 33 4.88e-02 3.35e-01 0.23300 -1.93e-01 -1.30e-01 5.49e-02 1.95e-01
GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA 20 1.58e-01 5.56e-01 0.23300 -1.67e-01 -1.63e-01 1.97e-01 2.07e-01
GOBP SUCCINYL COA CATABOLIC PROCESS 6 6.34e-01 8.86e-01 0.23300 8.47e-02 -2.17e-01 7.20e-01 3.57e-01
GOMF HISTONE H2A DEUBIQUITINASE ACTIVITY 5 6.83e-01 9.06e-01 0.23300 -2.19e-01 7.98e-02 3.97e-01 7.57e-01
GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 36 4.61e-02 3.26e-01 0.23300 -3.71e-02 -2.30e-01 7.00e-01 1.69e-02
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX 13 3.26e-01 7.30e-01 0.23300 -4.45e-02 -2.29e-01 7.81e-01 1.53e-01
GOBP CELL MIGRATION INVOLVED IN GASTRULATION 13 3.77e-01 7.63e-01 0.23300 2.11e-01 -9.78e-02 1.87e-01 5.42e-01
GOBP REGULATION OF INCLUSION BODY ASSEMBLY 17 2.83e-01 6.96e-01 0.23300 -1.14e-01 2.03e-01 4.16e-01 1.47e-01
YAP1- and WWTR1 (TAZ)-stimulated gene expression 14 3.47e-01 7.44e-01 0.23300 -2.15e-01 8.85e-02 1.63e-01 5.66e-01
GOCC WNT SIGNALOSOME 13 3.86e-01 7.68e-01 0.23300 -1.88e-01 1.38e-01 2.42e-01 3.89e-01
GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION 89 9.50e-04 3.12e-02 0.23300 -2.28e-01 4.85e-02 2.04e-04 4.29e-01
ZBP1(DAI) mediated induction of type I IFNs 20 1.93e-01 6.02e-01 0.23300 2.33e-01 -2.63e-03 7.15e-02 9.84e-01
FRS-mediated FGFR3 signaling 19 2.51e-01 6.65e-01 0.23300 -1.47e-01 1.81e-01 2.68e-01 1.73e-01
RUNX2 regulates chondrocyte maturation 5 6.38e-01 8.88e-01 0.23300 9.95e-02 2.10e-01 7.00e-01 4.15e-01
Hyaluronan metabolism 17 2.49e-01 6.63e-01 0.23300 -2.33e-01 6.03e-03 9.68e-02 9.66e-01
GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION INVOLVED IN INACTIVATION OF PROTEIN KINASE ACTIVITY 8 4.82e-01 8.22e-01 0.23300 1.28e-01 1.94e-01 5.29e-01 3.42e-01
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I 43 3.73e-02 2.96e-01 0.23300 -2.21e-01 7.24e-02 1.21e-02 4.11e-01
GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION 105 1.24e-04 7.09e-03 0.23300 -4.61e-02 -2.28e-01 4.15e-01 5.38e-05
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION 12 3.92e-01 7.72e-01 0.23300 2.26e-01 -5.35e-02 1.74e-01 7.48e-01
GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 53 1.08e-02 1.62e-01 0.23200 -4.16e-02 -2.29e-01 6.01e-01 3.98e-03
GOBP RNA 5 END PROCESSING 36 5.53e-02 3.58e-01 0.23200 1.87e-02 -2.32e-01 8.46e-01 1.62e-02
GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 14 3.27e-01 7.30e-01 0.23200 -2.31e-01 2.57e-02 1.35e-01 8.68e-01
Negative regulators of DDX58/IFIH1 signaling 34 5.34e-02 3.50e-01 0.23200 -5.19e-02 -2.26e-01 6.00e-01 2.23e-02
Nef mediated downregulation of MHC class I complex cell surface expression 9 4.57e-01 8.10e-01 0.23200 2.24e-01 6.11e-02 2.44e-01 7.51e-01
GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING 11 3.73e-01 7.61e-01 0.23200 2.08e-01 1.03e-01 2.32e-01 5.54e-01
GOBP L ALANINE TRANSPORT 10 4.24e-01 7.92e-01 0.23200 2.27e-01 4.78e-02 2.13e-01 7.94e-01
GOBP FACE MORPHOGENESIS 31 8.07e-02 4.21e-01 0.23200 -2.32e-01 8.45e-03 2.53e-02 9.35e-01
GOBP TETRAPYRROLE CATABOLIC PROCESS 13 3.91e-01 7.71e-01 0.23200 1.68e-01 -1.61e-01 2.95e-01 3.16e-01
GOMF POTASSIUM ION LEAK CHANNEL ACTIVITY 16 2.40e-01 6.55e-01 0.23200 2.12e-01 9.52e-02 1.42e-01 5.10e-01
GOBP REGULATION OF SYNAPSE STRUCTURAL PLASTICITY 7 5.46e-01 8.52e-01 0.23200 -2.25e-01 -5.51e-02 3.02e-01 8.01e-01
GOBP MYOTUBE CELL DEVELOPMENT 41 4.10e-02 3.09e-01 0.23200 -2.27e-01 4.65e-02 1.18e-02 6.07e-01
GOBP MEIOTIC CHROMOSOME SEPARATION 10 4.55e-01 8.09e-01 0.23200 -2.29e-01 3.81e-02 2.10e-01 8.35e-01
GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS 31 6.44e-02 3.81e-01 0.23200 -2.14e-01 -8.82e-02 3.87e-02 3.95e-01
GOBP RESPONSE TO LECTIN 21 2.12e-01 6.28e-01 0.23200 1.03e-01 -2.07e-01 4.12e-01 9.99e-02
GOBP NATURAL KILLER CELL DIFFERENTIATION 23 1.47e-01 5.40e-01 0.23200 -2.28e-02 -2.31e-01 8.50e-01 5.56e-02
GOBP ATP EXPORT 6 5.87e-01 8.67e-01 0.23200 9.30e-02 2.12e-01 6.93e-01 3.68e-01
GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 18 2.28e-01 6.47e-01 0.23200 -6.01e-03 -2.32e-01 9.65e-01 8.89e-02
GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY 25 1.26e-01 5.07e-01 0.23200 2.31e-01 1.85e-02 4.57e-02 8.73e-01
Role of phospholipids in phagocytosis 24 1.59e-01 5.57e-01 0.23200 -6.20e-02 2.23e-01 5.99e-01 5.85e-02
Highly sodium permeable postsynaptic acetylcholine nicotinic receptors 7 6.05e-01 8.76e-01 0.23100 1.62e-01 -1.65e-01 4.58e-01 4.49e-01
GOBP TRICARBOXYLIC ACID TRANSPORT 5 6.98e-01 9.11e-01 0.23100 1.74e-01 -1.53e-01 5.00e-01 5.55e-01
GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE 40 5.60e-02 3.60e-01 0.23100 -1.84e-01 1.40e-01 4.38e-02 1.26e-01
GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT 13 3.07e-01 7.16e-01 0.23100 1.71e-01 1.56e-01 2.85e-01 3.31e-01
GOBP POLY N ACETYLLACTOSAMINE METABOLIC PROCESS 10 4.03e-01 7.80e-01 0.23100 1.56e-01 1.71e-01 3.94e-01 3.49e-01
GOBP RETICULOPHAGY 21 1.64e-01 5.64e-01 0.23100 -2.23e-01 -6.10e-02 7.69e-02 6.28e-01
Aflatoxin activation and detoxification 18 1.96e-01 6.07e-01 0.23100 1.45e-01 1.80e-01 2.88e-01 1.86e-01
GOBP THYROID HORMONE TRANSPORT 10 4.36e-01 7.97e-01 0.23100 2.23e-02 2.30e-01 9.03e-01 2.08e-01
GOBP RESPONSE TO COBALT ION 9 4.42e-01 8.00e-01 0.23100 1.56e-01 1.70e-01 4.17e-01 3.77e-01
GOBP RIBOSOME ASSEMBLY 57 1.53e-02 1.98e-01 0.23100 1.02e-01 -2.07e-01 1.83e-01 6.81e-03
Pyrimidine catabolism 12 4.23e-01 7.92e-01 0.23100 1.80e-01 -1.44e-01 2.80e-01 3.86e-01
GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY 5 6.48e-01 8.91e-01 0.23100 -2.18e-01 -7.65e-02 3.99e-01 7.67e-01
GOBP SYNAPTONEMAL COMPLEX ORGANIZATION 26 1.54e-01 5.51e-01 0.23100 -1.35e-01 1.87e-01 2.33e-01 9.87e-02
GOCC PIP BODY 5 6.79e-01 9.04e-01 0.23100 -4.32e-02 2.27e-01 8.67e-01 3.80e-01
G2 Phase 5 6.52e-01 8.93e-01 0.23100 -5.73e-02 -2.23e-01 8.25e-01 3.87e-01
GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX 6 5.84e-01 8.66e-01 0.23100 -1.32e-01 -1.89e-01 5.76e-01 4.23e-01
Resolution of D-loop Structures through Holliday Junction Intermediates 34 5.25e-02 3.47e-01 0.23000 -2.17e-01 -7.79e-02 2.86e-02 4.32e-01
GOMF TRANSLATION TERMINATION FACTOR ACTIVITY 6 6.32e-01 8.86e-01 0.23000 5.40e-02 -2.24e-01 8.19e-01 3.42e-01
GOBP LUNG GROWTH 6 5.99e-01 8.73e-01 0.23000 -2.22e-01 -6.02e-02 3.46e-01 7.98e-01
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION 18 2.30e-01 6.48e-01 0.23000 -2.30e-01 -1.15e-02 9.10e-02 9.33e-01
GOBP PROTEIN LOCALIZATION TO NUCLEOLUS 17 2.19e-01 6.37e-01 0.23000 -1.91e-01 -1.29e-01 1.72e-01 3.59e-01
GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY 8 5.65e-01 8.58e-01 0.23000 -1.48e-01 1.76e-01 4.68e-01 3.88e-01
GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION 21 1.51e-01 5.46e-01 0.23000 -1.52e-01 -1.73e-01 2.28e-01 1.69e-01
Suppression of phagosomal maturation 13 3.94e-01 7.74e-01 0.23000 1.35e-01 -1.86e-01 3.99e-01 2.44e-01
GOBP LIMBIC SYSTEM DEVELOPMENT 120 2.63e-05 1.91e-03 0.23000 -2.05e-01 -1.05e-01 1.07e-04 4.63e-02
GOBP REGULATION OF MAST CELL CHEMOTAXIS 7 5.33e-01 8.45e-01 0.23000 1.49e-01 1.75e-01 4.95e-01 4.22e-01
GOCC CENTRIOLAR SUBDISTAL APPENDAGE 9 4.94e-01 8.28e-01 0.23000 -2.28e-01 2.82e-02 2.35e-01 8.84e-01
GOBP NEGATIVE REGULATION OF P38MAPK CASCADE 8 5.66e-01 8.59e-01 0.23000 1.52e-01 -1.73e-01 4.57e-01 3.97e-01
GOBP REGULATION OF MYOTUBE DIFFERENTIATION 47 3.57e-02 2.91e-01 0.23000 -1.71e-01 1.54e-01 4.30e-02 6.74e-02
GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 44 2.07e-02 2.30e-01 0.23000 -2.03e-01 -1.08e-01 1.97e-02 2.16e-01
Deactivation of the beta-catenin transactivating complex 39 3.06e-02 2.74e-01 0.23000 -1.39e-01 -1.83e-01 1.33e-01 4.78e-02
GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX 5 6.42e-01 8.89e-01 0.23000 -1.98e-01 -1.17e-01 4.44e-01 6.50e-01
Defective CFTR causes cystic fibrosis 48 2.05e-02 2.29e-01 0.23000 -8.73e-03 -2.30e-01 9.17e-01 5.87e-03
GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY 9 4.48e-01 8.04e-01 0.23000 1.88e-01 1.32e-01 3.28e-01 4.92e-01
Processing of DNA double-strand break ends 75 2.49e-03 6.31e-02 0.23000 2.78e-03 -2.30e-01 9.67e-01 5.75e-04
GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING 75 1.75e-03 4.91e-02 0.23000 -5.67e-02 -2.23e-01 3.96e-01 8.49e-04
GOMF RETINOIC ACID 4 HYDROXYLASE ACTIVITY 10 4.90e-01 8.26e-01 0.23000 -1.36e-01 1.85e-01 4.56e-01 3.10e-01
GOBP PEPTIDYL LYSINE TRIMETHYLATION 9 4.66e-01 8.14e-01 0.23000 -5.69e-02 -2.23e-01 7.68e-01 2.47e-01
GOBP NEURAL TUBE PATTERNING 31 8.86e-02 4.37e-01 0.23000 -2.28e-01 2.53e-02 2.77e-02 8.08e-01
GOBP HEAD MORPHOGENESIS 36 6.29e-02 3.77e-01 0.23000 -2.26e-01 4.20e-02 1.90e-02 6.63e-01
GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS 12 4.06e-01 7.81e-01 0.23000 2.20e-01 -6.50e-02 1.86e-01 6.96e-01
Translesion synthesis by POLK 17 2.83e-01 6.95e-01 0.23000 7.81e-02 -2.16e-01 5.77e-01 1.23e-01
GOCC DNA REPLICATION FACTOR A COMPLEX 12 4.26e-01 7.93e-01 0.23000 -1.43e-01 1.80e-01 3.90e-01 2.82e-01
GOBP NETRIN ACTIVATED SIGNALING PATHWAY 9 4.53e-01 8.07e-01 0.23000 2.03e-01 1.08e-01 2.92e-01 5.75e-01
GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT 32 5.74e-02 3.65e-01 0.23000 -1.77e-01 -1.46e-01 8.32e-02 1.52e-01
RIP-mediated NFkB activation via ZBP1 16 2.74e-01 6.87e-01 0.23000 2.29e-01 9.57e-03 1.12e-01 9.47e-01
GOBP MRNA 3 SPLICE SITE RECOGNITION 6 5.86e-01 8.67e-01 0.23000 -1.38e-01 -1.83e-01 5.58e-01 4.37e-01
GOCC CCAAT BINDING FACTOR COMPLEX 5 6.91e-01 9.09e-01 0.22900 -2.15e-01 7.89e-02 4.04e-01 7.60e-01
GOBP PROTEIN POLYGLUTAMYLATION 12 3.64e-01 7.54e-01 0.22900 -5.10e-02 -2.24e-01 7.60e-01 1.80e-01
GOMF NEUTRAL L AMINO ACID SODIUM SYMPORTER ACTIVITY 8 5.28e-01 8.43e-01 0.22900 3.84e-03 -2.29e-01 9.85e-01 2.61e-01
Regulated proteolysis of p75NTR 11 4.18e-01 7.87e-01 0.22900 1.00e-02 -2.29e-01 9.54e-01 1.88e-01
GOBP NEGATIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION 5 6.75e-01 9.03e-01 0.22900 -2.29e-01 1.66e-02 3.76e-01 9.49e-01
GOBP PRIMITIVE HEMOPOIESIS 8 5.46e-01 8.51e-01 0.22900 5.43e-02 -2.23e-01 7.90e-01 2.75e-01
GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION 26 1.08e-01 4.77e-01 0.22900 -7.26e-02 -2.18e-01 5.22e-01 5.48e-02
GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS 18 2.72e-01 6.85e-01 0.22900 -1.05e-01 2.04e-01 4.42e-01 1.34e-01
GOMF SIALIC ACID BINDING 22 1.99e-01 6.12e-01 0.22900 -2.12e-01 8.74e-02 8.52e-02 4.78e-01
RNA Polymerase III Abortive And Retractive Initiation 41 2.67e-02 2.59e-01 0.22900 -1.92e-01 -1.25e-01 3.32e-02 1.66e-01
RNA Polymerase III Transcription 41 2.67e-02 2.59e-01 0.22900 -1.92e-01 -1.25e-01 3.32e-02 1.66e-01
GOMF MOLECULAR TAG ACTIVITY 13 3.13e-01 7.22e-01 0.22900 -1.64e-01 -1.60e-01 3.05e-01 3.18e-01
GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS 32 1.05e-01 4.71e-01 0.22900 -1.51e-01 1.73e-01 1.40e-01 9.11e-02
GOBP MEIOTIC CYTOKINESIS 8 5.18e-01 8.39e-01 0.22900 -2.81e-02 -2.27e-01 8.90e-01 2.65e-01
GOBP FACIAL NERVE STRUCTURAL ORGANIZATION 8 5.64e-01 8.58e-01 0.22900 -1.97e-01 1.17e-01 3.35e-01 5.67e-01
GOBP ERROR FREE TRANSLESION SYNTHESIS 5 6.72e-01 9.01e-01 0.22900 2.42e-03 -2.29e-01 9.93e-01 3.75e-01
GOMF DIPEPTIDASE ACTIVITY 16 3.17e-01 7.25e-01 0.22900 -1.13e-01 2.00e-01 4.36e-01 1.67e-01
Methylation 14 2.98e-01 7.09e-01 0.22900 -8.98e-02 -2.11e-01 5.61e-01 1.72e-01
GOBP TRNA TRANSCRIPTION 13 3.34e-01 7.35e-01 0.22900 -2.21e-01 -5.90e-02 1.67e-01 7.13e-01
GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION 26 1.25e-01 5.05e-01 0.22900 -5.62e-03 -2.29e-01 9.60e-01 4.34e-02
GOBP NEGATIVE REGULATION OF SYNAPSE ASSEMBLY 8 4.92e-01 8.27e-01 0.22900 1.33e-01 1.86e-01 5.15e-01 3.61e-01
MAP3K8 (TPL2)-dependent MAPK1/3 activation 15 2.73e-01 6.85e-01 0.22900 -9.12e-02 -2.10e-01 5.41e-01 1.59e-01
GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY 54 1.96e-02 2.24e-01 0.22900 -2.11e-01 8.81e-02 7.24e-03 2.63e-01
GOBP ARF PROTEIN SIGNAL TRANSDUCTION 21 2.29e-01 6.47e-01 0.22900 -1.51e-01 1.71e-01 2.29e-01 1.74e-01
GOBP ERBB2 EGFR SIGNALING PATHWAY 8 5.42e-01 8.50e-01 0.22900 3.79e-02 -2.26e-01 8.53e-01 2.69e-01
GOBP T HELPER CELL LINEAGE COMMITMENT 23 1.65e-01 5.65e-01 0.22900 -2.28e-01 1.32e-02 5.80e-02 9.13e-01
GOBP NEGATIVE REGULATION OF MEMBRANE DEPOLARIZATION 7 5.79e-01 8.64e-01 0.22900 -2.28e-01 1.92e-02 2.96e-01 9.30e-01
GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE 6 6.56e-01 8.94e-01 0.22900 -1.59e-01 1.65e-01 5.01e-01 4.85e-01
Phospholipase C-mediated cascade; FGFR4 14 3.34e-01 7.35e-01 0.22900 -1.52e-02 2.28e-01 9.21e-01 1.39e-01
GOMF GUANYLYLTRANSFERASE ACTIVITY 7 5.51e-01 8.53e-01 0.22900 -2.16e-01 -7.45e-02 3.22e-01 7.33e-01
GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE 11 4.59e-01 8.10e-01 0.22900 -1.88e-01 1.30e-01 2.80e-01 4.55e-01
Synthesis of PG 8 5.67e-01 8.59e-01 0.22900 -1.23e-01 1.93e-01 5.47e-01 3.45e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION 21 2.21e-01 6.38e-01 0.22900 2.05e-01 -1.01e-01 1.04e-01 4.24e-01
GOCC MHC CLASS II PROTEIN COMPLEX 15 3.35e-01 7.35e-01 0.22900 2.12e-01 -8.45e-02 1.54e-01 5.71e-01
GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL 6 6.09e-01 8.77e-01 0.22800 2.25e-01 3.97e-02 3.40e-01 8.66e-01
GOBP NEGATIVE REGULATION OF NEURON MIGRATION 9 5.32e-01 8.45e-01 0.22800 -1.65e-01 1.58e-01 3.92e-01 4.11e-01
GOMF RNA METHYLTRANSFERASE ACTIVITY 62 4.21e-03 9.00e-02 0.22800 -1.41e-01 -1.80e-01 5.56e-02 1.42e-02
GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT 24 1.80e-01 5.84e-01 0.22800 -2.02e-01 1.07e-01 8.69e-02 3.64e-01
GOBP POSITIVE REGULATION OF HEAT GENERATION 10 4.42e-01 8.00e-01 0.22800 2.27e-01 2.79e-02 2.14e-01 8.79e-01
GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS 8 5.70e-01 8.60e-01 0.22800 1.34e-01 -1.85e-01 5.11e-01 3.66e-01
GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY 7 5.54e-01 8.54e-01 0.22800 -6.77e-02 -2.18e-01 7.56e-01 3.18e-01
GOMF AXON GUIDANCE RECEPTOR ACTIVITY 10 4.85e-01 8.23e-01 0.22800 2.10e-01 -9.04e-02 2.51e-01 6.21e-01
GOBP RESPONSE TO LITHIUM ION 16 3.26e-01 7.30e-01 0.22800 -1.46e-01 1.76e-01 3.12e-01 2.24e-01
GOBP BLOOD VESSEL MATURATION 8 5.19e-01 8.39e-01 0.22800 -3.55e-02 -2.25e-01 8.62e-01 2.70e-01
RNA Polymerase III Transcription Termination 23 1.33e-01 5.20e-01 0.22800 -1.87e-01 -1.31e-01 1.21e-01 2.76e-01
GOBP DENDRITIC TRANSPORT OF RIBONUCLEOPROTEIN COMPLEX 5 6.49e-01 8.91e-01 0.22800 -1.01e-01 -2.04e-01 6.95e-01 4.29e-01
GOCC PARANODE REGION OF AXON 12 4.28e-01 7.94e-01 0.22800 -1.93e-01 1.22e-01 2.47e-01 4.65e-01
GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 55 1.22e-02 1.74e-01 0.22800 -2.28e-01 -1.45e-02 3.50e-03 8.52e-01
GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA 7 5.46e-01 8.51e-01 0.22800 1.02e-01 2.04e-01 6.40e-01 3.50e-01
GOBP POSITIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 18 2.45e-01 6.60e-01 0.22800 -2.28e-01 1.13e-02 9.44e-02 9.34e-01
GOCC NUCLEAR EXOSOME RNASE COMPLEX 16 2.44e-01 6.58e-01 0.22800 -1.48e-01 -1.74e-01 3.06e-01 2.29e-01
GOBP CELLULAR RESPONSE TO PEPTIDOGLYCAN 6 6.01e-01 8.75e-01 0.22800 -2.15e-01 -7.49e-02 3.61e-01 7.51e-01
GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX 5 6.92e-01 9.09e-01 0.22800 7.06e-02 -2.17e-01 7.84e-01 4.01e-01
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A 39 3.56e-02 2.90e-01 0.22800 -8.91e-02 -2.10e-01 3.36e-01 2.34e-02
p53-Independent DNA Damage Response 39 3.56e-02 2.90e-01 0.22800 -8.91e-02 -2.10e-01 3.36e-01 2.34e-02
p53-Independent G1/S DNA damage checkpoint 39 3.56e-02 2.90e-01 0.22800 -8.91e-02 -2.10e-01 3.36e-01 2.34e-02
GOBP MITRAL VALVE DEVELOPMENT 14 3.52e-01 7.46e-01 0.22800 -5.49e-02 2.21e-01 7.22e-01 1.52e-01
GOBP L HISTIDINE TRANSMEMBRANE TRANSPORT 5 6.55e-01 8.93e-01 0.22800 -7.41e-02 -2.15e-01 7.74e-01 4.04e-01
GOBP FIBROBLAST MIGRATION 54 2.02e-02 2.28e-01 0.22800 -2.11e-01 8.72e-02 7.45e-03 2.68e-01
GOMF TRANSLATION INITIATION FACTOR BINDING 28 8.66e-02 4.35e-01 0.22800 -1.25e-01 -1.90e-01 2.52e-01 8.12e-02
GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS 13 3.66e-01 7.55e-01 0.22800 1.84e-02 -2.27e-01 9.09e-01 1.56e-01
GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS 15 2.89e-01 7.02e-01 0.22800 4.87e-02 2.23e-01 7.44e-01 1.36e-01
GOCC TRAPPIII PROTEIN COMPLEX 11 3.85e-01 7.68e-01 0.22800 -1.09e-01 -2.00e-01 5.30e-01 2.51e-01
p75NTR recruits signalling complexes 12 4.13e-01 7.84e-01 0.22800 6.57e-02 -2.18e-01 6.94e-01 1.91e-01
GOBP REGULATION OF SYNAPSE PRUNING 6 5.90e-01 8.68e-01 0.22800 -1.65e-01 -1.57e-01 4.84e-01 5.06e-01
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 16 3.22e-01 7.28e-01 0.22800 -1.97e-01 1.13e-01 1.72e-01 4.33e-01
Metabolism of cofactors 25 1.76e-01 5.81e-01 0.22800 1.69e-01 -1.53e-01 1.44e-01 1.87e-01
GOBP ASYMMETRIC NEUROBLAST DIVISION 5 7.06e-01 9.13e-01 0.22800 -1.43e-01 1.77e-01 5.80e-01 4.93e-01
GOBP VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT 10 4.56e-01 8.09e-01 0.22700 -2.27e-01 2.03e-03 2.13e-01 9.91e-01
HDR through Single Strand Annealing (SSA) 37 4.21e-02 3.13e-01 0.22700 -9.68e-02 -2.06e-01 3.08e-01 3.03e-02
GOBP SERINE TRANSPORT 9 5.05e-01 8.32e-01 0.22700 3.40e-02 -2.25e-01 8.60e-01 2.43e-01
Beta oxidation of hexanoyl-CoA to butanoyl-CoA 5 6.83e-01 9.06e-01 0.22700 2.25e-01 -2.96e-02 3.83e-01 9.09e-01
GOCC MYOSIN II COMPLEX 26 1.65e-01 5.65e-01 0.22700 -1.70e-01 1.51e-01 1.34e-01 1.83e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS 16 2.47e-01 6.62e-01 0.22700 1.38e-01 1.81e-01 3.40e-01 2.11e-01
GOMF STRUCTURAL CONSTITUENT OF EYE LENS 22 2.10e-01 6.26e-01 0.22700 -2.03e-01 1.01e-01 9.89e-02 4.11e-01
GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS 6 6.60e-01 8.96e-01 0.22700 1.46e-01 -1.74e-01 5.35e-01 4.61e-01
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION 8 5.74e-01 8.62e-01 0.22700 -1.77e-01 1.43e-01 3.87e-01 4.85e-01
GOBP MESENCHYME MORPHOGENESIS 61 5.20e-03 1.02e-01 0.22700 -1.96e-01 -1.14e-01 8.05e-03 1.22e-01
GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY 33 5.58e-02 3.59e-01 0.22700 -1.59e-01 -1.62e-01 1.15e-01 1.06e-01
GOBP NEPHRON TUBULE FORMATION 20 1.74e-01 5.78e-01 0.22700 -1.54e-01 -1.67e-01 2.34e-01 1.96e-01
GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION 23 1.34e-01 5.21e-01 0.22700 -1.65e-01 -1.56e-01 1.71e-01 1.95e-01
GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE 23 1.36e-01 5.24e-01 0.22700 -1.87e-01 -1.29e-01 1.21e-01 2.85e-01
GOMF OLFACTORY RECEPTOR ACTIVITY 338 5.02e-11 1.31e-08 0.22700 2.05e-01 -9.75e-02 9.29e-11 2.06e-03
GOBP DOPAMINERGIC NEURON DIFFERENTIATION 39 4.16e-02 3.12e-01 0.22700 -2.23e-01 -4.16e-02 1.59e-02 6.53e-01
Glycogen metabolism 22 1.84e-01 5.89e-01 0.22700 -2.26e-01 1.63e-02 6.61e-02 8.94e-01
GOBP CELLULAR RESPONSE TO MAGNESIUM ION 7 5.62e-01 8.57e-01 0.22700 -2.21e-01 -5.13e-02 3.11e-01 8.14e-01
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 19 2.46e-01 6.60e-01 0.22700 5.46e-02 -2.20e-01 6.80e-01 9.66e-02
GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 23 1.99e-01 6.12e-01 0.22700 1.97e-01 -1.12e-01 1.02e-01 3.52e-01
GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT 10 4.19e-01 7.87e-01 0.22700 1.35e-01 1.82e-01 4.59e-01 3.19e-01
GOBP ISOTYPE SWITCHING TO IGG ISOTYPES 15 3.49e-01 7.44e-01 0.22700 1.12e-01 -1.97e-01 4.54e-01 1.86e-01
HATs acetylate histones 97 2.17e-04 1.05e-02 0.22700 -1.55e-01 -1.66e-01 8.51e-03 4.76e-03
GOMF DEHYDROASCORBIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 8 5.58e-01 8.56e-01 0.22700 2.17e-01 -6.61e-02 2.88e-01 7.46e-01
GOBP STRIATUM DEVELOPMENT 20 1.92e-01 6.00e-01 0.22700 -2.20e-01 -5.56e-02 8.89e-02 6.67e-01
GOMF GAP JUNCTION CHANNEL ACTIVITY INVOLVED IN CELL COMMUNICATION BY ELECTRICAL COUPLING 8 5.12e-01 8.35e-01 0.22700 -2.14e-01 -7.45e-02 2.95e-01 7.15e-01
Expression and translocation of olfactory receptors 339 4.62e-11 1.23e-08 0.22700 2.07e-01 -9.30e-02 6.06e-11 3.26e-03
Aspirin ADME 41 5.91e-02 3.69e-01 0.22700 1.40e-01 -1.78e-01 1.20e-01 4.89e-02
GOBP TRNA METHYLATION 38 3.67e-02 2.95e-01 0.22600 -1.50e-01 -1.69e-01 1.09e-01 7.06e-02
GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY 9 5.01e-01 8.30e-01 0.22600 1.39e-02 -2.26e-01 9.43e-01 2.40e-01
GOCC PODOSOME 33 9.58e-02 4.52e-01 0.22600 -9.23e-02 2.07e-01 3.59e-01 3.98e-02
Assembly of collagen fibrils and other multimeric structures 59 1.13e-02 1.66e-01 0.22600 -2.17e-02 2.25e-01 7.73e-01 2.76e-03
GOBP POSITIVE REGULATION OF RESPIRATORY BURST 7 5.44e-01 8.51e-01 0.22600 1.66e-01 1.53e-01 4.46e-01 4.82e-01
GOBP MONOAMINE TRANSPORT 74 2.77e-03 6.91e-02 0.22600 -2.25e-01 -2.39e-02 8.15e-04 7.22e-01
Biosynthesis of DHA-derived SPMs 17 2.69e-01 6.84e-01 0.22600 -2.26e-01 8.32e-03 1.06e-01 9.53e-01
GOBP POLAR BODY EXTRUSION AFTER MEIOTIC DIVISIONS 5 6.47e-01 8.91e-01 0.22600 -1.56e-01 -1.64e-01 5.47e-01 5.25e-01
GOBP NEGATIVE REGULATION OF VASOCONSTRICTION 12 3.99e-01 7.77e-01 0.22600 -2.26e-01 1.54e-02 1.76e-01 9.26e-01
Olfactory Signaling Pathway 346 2.53e-11 7.07e-09 0.22600 2.10e-01 -8.34e-02 1.75e-11 7.69e-03
GOBP DETERMINATION OF DORSAL VENTRAL ASYMMETRY 11 3.86e-01 7.68e-01 0.22600 -1.31e-01 -1.84e-01 4.52e-01 2.89e-01
GOBP REGULATION OF GLUTAMATE SECRETION 19 2.71e-01 6.85e-01 0.22600 -1.53e-01 1.67e-01 2.49e-01 2.08e-01
GOBP INTERLEUKIN 10 MEDIATED SIGNALING PATHWAY 12 4.12e-01 7.84e-01 0.22600 2.21e-01 -4.98e-02 1.86e-01 7.65e-01
Nephrin family interactions 21 1.69e-01 5.70e-01 0.22600 -2.05e-01 -9.50e-02 1.03e-01 4.51e-01
Beta oxidation of butanoyl-CoA to acetyl-CoA 5 6.87e-01 9.06e-01 0.22600 -3.27e-02 2.24e-01 8.99e-01 3.86e-01
GOMF AMINOACYLASE ACTIVITY 5 6.48e-01 8.91e-01 0.22600 1.69e-01 1.50e-01 5.13e-01 5.60e-01
GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY 12 3.70e-01 7.58e-01 0.22600 -2.16e-01 -6.72e-02 1.95e-01 6.87e-01
GOBP OOCYTE CONSTRUCTION 8 4.99e-01 8.30e-01 0.22600 1.56e-01 1.63e-01 4.44e-01 4.24e-01
GOCC COSTAMERE 16 3.11e-01 7.20e-01 0.22600 -2.18e-01 6.02e-02 1.31e-01 6.77e-01
GOBP REGULATION OF SYNAPTIC VESICLE PRIMING 8 5.50e-01 8.53e-01 0.22600 -3.74e-02 2.23e-01 8.55e-01 2.75e-01
GOMF 2 IRON 2 SULFUR CLUSTER BINDING 24 1.87e-01 5.92e-01 0.22600 1.10e-01 -1.98e-01 3.53e-01 9.36e-02
GOBP CELLULAR RESPONSE TO INDOLE 3 METHANOL 5 6.62e-01 8.97e-01 0.22600 -2.17e-01 -6.23e-02 4.00e-01 8.09e-01
Cleavage of the damaged pyrimidine 38 6.28e-02 3.77e-01 0.22600 6.10e-02 -2.18e-01 5.15e-01 2.03e-02
Depyrimidination 38 6.28e-02 3.77e-01 0.22600 6.10e-02 -2.18e-01 5.15e-01 2.03e-02
Recognition and association of DNA glycosylase with site containing an affected pyrimidine 38 6.28e-02 3.77e-01 0.22600 6.10e-02 -2.18e-01 5.15e-01 2.03e-02
GOCC BLEB 9 4.91e-01 8.26e-01 0.22600 -2.25e-01 -1.79e-02 2.42e-01 9.26e-01
GOBP NEUTROPHIL APOPTOTIC PROCESS 7 6.04e-01 8.76e-01 0.22600 7.21e-02 -2.14e-01 7.41e-01 3.27e-01
Platelet Aggregation (Plug Formation) 39 4.93e-02 3.37e-01 0.22600 -2.26e-01 4.47e-03 1.46e-02 9.61e-01
GOBP MESANGIAL CELL DEVELOPMENT 6 6.03e-01 8.76e-01 0.22600 -8.98e-02 -2.07e-01 7.03e-01 3.79e-01
RHOBTB3 ATPase cycle 8 5.00e-01 8.30e-01 0.22600 1.68e-01 1.51e-01 4.10e-01 4.60e-01
GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION 35 8.21e-02 4.25e-01 0.22600 -2.11e-01 8.09e-02 3.08e-02 4.07e-01
GOBP THYMOCYTE APOPTOTIC PROCESS 19 2.73e-01 6.85e-01 0.22600 1.67e-01 -1.52e-01 2.08e-01 2.51e-01
Phosphorylation of CD3 and TCR zeta chains 20 2.40e-01 6.55e-01 0.22600 7.98e-02 -2.11e-01 5.37e-01 1.02e-01
GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN 18 2.12e-01 6.29e-01 0.22600 -1.81e-01 -1.34e-01 1.83e-01 3.24e-01
MAPK6/MAPK4 signaling 78 1.48e-03 4.36e-02 0.22600 -8.60e-02 -2.09e-01 1.89e-01 1.45e-03
The activation of arylsulfatases 8 5.01e-01 8.30e-01 0.22600 -1.61e-01 -1.58e-01 4.30e-01 4.39e-01
GOBP LYMPHOCYTE APOPTOTIC PROCESS 79 4.59e-03 9.37e-02 0.22600 1.45e-01 -1.73e-01 2.61e-02 7.89e-03
Z-decay: degradation of maternal mRNAs by zygotically expressed factors 10 4.81e-01 8.21e-01 0.22500 2.20e-01 -5.11e-02 2.29e-01 7.79e-01
GOBP KINETOCHORE ASSEMBLY 16 2.53e-01 6.69e-01 0.22500 -1.32e-01 -1.83e-01 3.59e-01 2.06e-01
GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY 7 5.85e-01 8.67e-01 0.22500 -9.15e-03 2.25e-01 9.67e-01 3.02e-01
GOBP NEGATIVE REGULATION OF LAMELLIPODIUM ASSEMBLY 5 6.55e-01 8.93e-01 0.22500 -1.99e-01 -1.05e-01 4.40e-01 6.84e-01
GOBP CARDIOCYTE DIFFERENTIATION 161 9.80e-06 8.08e-04 0.22500 -2.15e-01 6.69e-02 2.43e-06 1.43e-01
Vitamins 6 6.08e-01 8.77e-01 0.22500 -2.13e-01 -7.49e-02 3.67e-01 7.51e-01
GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT 8 5.79e-01 8.64e-01 0.22500 1.43e-01 -1.74e-01 4.83e-01 3.94e-01
Signaling by FGFR2 in disease 42 5.10e-02 3.44e-01 0.22500 -2.09e-01 8.31e-02 1.88e-02 3.51e-01
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER 13 3.56e-01 7.48e-01 0.22500 -2.23e-01 -3.01e-02 1.63e-01 8.51e-01
GOBP CAMP BIOSYNTHETIC PROCESS 10 5.02e-01 8.30e-01 0.22500 -1.20e-01 1.91e-01 5.11e-01 2.97e-01
GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING 12 4.41e-01 7.99e-01 0.22500 -1.77e-01 1.39e-01 2.88e-01 4.04e-01
GOBP METANEPHRIC MESENCHYME DEVELOPMENT 14 3.06e-01 7.15e-01 0.22500 -1.07e-01 -1.98e-01 4.90e-01 1.99e-01
GOBP PROTEIN LOCALIZATION TO MOTILE CILIUM 6 6.38e-01 8.88e-01 0.22500 2.95e-02 -2.23e-01 9.00e-01 3.44e-01
Hyaluronan uptake and degradation 12 3.61e-01 7.52e-01 0.22500 -1.95e-01 -1.12e-01 2.41e-01 5.02e-01
GOBP RESPONSE TO WATER DEPRIVATION 5 6.98e-01 9.11e-01 0.22500 -2.14e-01 7.00e-02 4.07e-01 7.86e-01
GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION 10 4.86e-01 8.23e-01 0.22500 2.16e-01 -6.43e-02 2.37e-01 7.25e-01
Formation of the nephric duct 17 2.32e-01 6.50e-01 0.22500 -1.70e-01 -1.48e-01 2.26e-01 2.91e-01
FOXO-mediated transcription of cell cycle genes 16 2.78e-01 6.92e-01 0.22500 -2.22e-01 -3.73e-02 1.24e-01 7.96e-01
GOBP CARNITINE TRANSMEMBRANE TRANSPORT 6 6.61e-01 8.97e-01 0.22500 1.17e-01 -1.92e-01 6.19e-01 4.15e-01
GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 5 6.54e-01 8.93e-01 0.22500 1.95e-01 1.12e-01 4.50e-01 6.63e-01
GOBP PIRNA MEDIATED RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION 5 6.73e-01 9.02e-01 0.22500 2.23e-01 2.82e-02 3.88e-01 9.13e-01
GOMF KINETOCHORE BINDING 6 6.41e-01 8.89e-01 0.22500 -2.22e-01 3.55e-02 3.46e-01 8.80e-01
GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY 23 1.79e-01 5.83e-01 0.22500 2.54e-02 -2.23e-01 8.33e-01 6.36e-02
GOBP REGULATION OF DNA CATABOLIC PROCESS 11 3.90e-01 7.71e-01 0.22500 -1.75e-01 -1.41e-01 3.16e-01 4.17e-01
Regulation of pyruvate dehydrogenase (PDH) complex 13 3.54e-01 7.47e-01 0.22500 3.97e-02 2.21e-01 8.04e-01 1.67e-01
GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION 22 1.94e-01 6.03e-01 0.22500 -2.23e-01 2.69e-02 7.00e-02 8.27e-01
GOMF CELL MATRIX ADHESION MEDIATOR ACTIVITY 9 5.43e-01 8.51e-01 0.22500 -1.65e-01 1.53e-01 3.93e-01 4.27e-01
MAPK3 (ERK1) activation 10 4.26e-01 7.93e-01 0.22500 -1.80e-01 -1.35e-01 3.25e-01 4.60e-01
Transport of connexons to the plasma membrane 19 2.36e-01 6.52e-01 0.22500 2.24e-01 -7.02e-03 9.03e-02 9.58e-01
GOBP TRABECULA MORPHOGENESIS 47 2.22e-02 2.40e-01 0.22500 -2.17e-01 -5.77e-02 1.00e-02 4.94e-01
GOBP NEGATIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 21 2.42e-01 6.57e-01 0.22500 -1.63e-01 1.54e-01 1.96e-01 2.21e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 28 1.42e-01 5.34e-01 0.22500 -2.03e-01 9.49e-02 6.24e-02 3.85e-01
GOMF SELENIUM BINDING 9 5.00e-01 8.30e-01 0.22400 -2.24e-01 -4.26e-03 2.44e-01 9.82e-01
Metabolism of ingested SeMet, Sec, MeSec into H2Se 7 6.20e-01 8.80e-01 0.22400 -1.23e-01 1.88e-01 5.72e-01 3.90e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX 9 5.44e-01 8.51e-01 0.22400 -1.70e-01 1.46e-01 3.76e-01 4.47e-01
GOBP NEGATIVE REGULATION OF VASCULAR WOUND HEALING 7 5.66e-01 8.59e-01 0.22400 2.16e-01 6.21e-02 3.23e-01 7.76e-01
Formation of axial mesoderm 14 3.22e-01 7.28e-01 0.22400 -2.18e-01 -5.51e-02 1.59e-01 7.21e-01
GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY 7 5.79e-01 8.64e-01 0.22400 -2.24e-01 -1.80e-02 3.05e-01 9.34e-01
GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY 13 4.03e-01 7.80e-01 0.22400 -2.05e-01 9.10e-02 2.00e-01 5.70e-01
GOBP BRANCHIOMOTOR NEURON AXON GUIDANCE 6 6.67e-01 8.99e-01 0.22400 -1.53e-01 1.64e-01 5.15e-01 4.87e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES 15 3.62e-01 7.53e-01 0.22400 -1.76e-01 1.39e-01 2.38e-01 3.52e-01
GOMF HISTONE METHYLTRANSFERASE ACTIVITY 69 8.00e-03 1.34e-01 0.22400 -2.07e-01 8.55e-02 2.89e-03 2.19e-01
GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 22 1.57e-01 5.54e-01 0.22400 -1.11e-01 -1.95e-01 3.67e-01 1.14e-01
GOBP ENDOTHELIAL CELL CHEMOTAXIS 28 1.12e-01 4.84e-01 0.22400 2.33e-02 2.23e-01 8.31e-01 4.11e-02
GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS 8 5.24e-01 8.42e-01 0.22400 2.17e-01 5.49e-02 2.87e-01 7.88e-01
GOBP PRONEPHROS DEVELOPMENT 9 4.68e-01 8.14e-01 0.22400 -1.92e-01 -1.15e-01 3.18e-01 5.50e-01
Tandem pore domain potassium channels 12 3.63e-01 7.53e-01 0.22400 1.89e-01 1.20e-01 2.56e-01 4.72e-01
GOMF GABA RECEPTOR BINDING 18 2.16e-01 6.33e-01 0.22400 -1.48e-01 -1.68e-01 2.77e-01 2.16e-01
GOBP GLIAL CELL MIGRATION 58 1.81e-02 2.14e-01 0.22400 -2.02e-01 9.73e-02 7.83e-03 2.00e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA ALTERNATIVE NONHOMOLOGOUS END JOINING 8 5.42e-01 8.50e-01 0.22400 -3.19e-03 -2.24e-01 9.88e-01 2.72e-01
GOBP HEART TRABECULA MORPHOGENESIS 32 7.24e-02 4.04e-01 0.22400 -2.11e-01 -7.67e-02 3.92e-02 4.53e-01
GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY 7 5.64e-01 8.58e-01 0.22400 -2.12e-01 -7.22e-02 3.31e-01 7.41e-01
GOBP CILIARY NEUROTROPHIC FACTOR MEDIATED SIGNALING PATHWAY 5 6.86e-01 9.06e-01 0.22400 -1.18e-02 2.24e-01 9.64e-01 3.86e-01
GOBP PROTEIN INSERTION INTO ER MEMBRANE 26 1.14e-01 4.89e-01 0.22400 -2.00e-01 -1.00e-01 7.70e-02 3.77e-01
GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION 21 1.76e-01 5.81e-01 0.22400 -9.01e-02 -2.05e-01 4.75e-01 1.04e-01
G2/M DNA damage checkpoint 72 3.99e-03 8.77e-02 0.22400 -9.22e-03 -2.24e-01 8.92e-01 1.03e-03
Acyl chain remodelling of PS 22 2.05e-01 6.21e-01 0.22400 2.17e-01 -5.36e-02 7.76e-02 6.64e-01
GOMF TESTOSTERONE 17 BETA DEHYDROGENASE NADPPLUS ACTIVITY 9 4.75e-01 8.18e-01 0.22400 8.99e-02 2.05e-01 6.41e-01 2.87e-01
GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING 10 4.35e-01 7.96e-01 0.22400 -9.96e-02 -2.00e-01 5.85e-01 2.72e-01
GOBP PIGMENT CATABOLIC PROCESS 11 4.47e-01 8.03e-01 0.22400 2.21e-01 -3.68e-02 2.05e-01 8.33e-01
GOCC RIBONUCLEASE MRP COMPLEX 9 5.34e-01 8.46e-01 0.22400 8.77e-02 -2.06e-01 6.49e-01 2.85e-01
EGFR Transactivation by Gastrin 9 4.70e-01 8.15e-01 0.22400 -1.94e-01 -1.12e-01 3.14e-01 5.60e-01
Interleukin-37 signaling 20 2.56e-01 6.71e-01 0.22400 -1.18e-01 1.90e-01 3.62e-01 1.41e-01
GOCC ATG1 ULK1 KINASE COMPLEX 9 5.06e-01 8.32e-01 0.22400 -2.24e-01 3.48e-03 2.45e-01 9.86e-01
GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY 9 4.85e-01 8.23e-01 0.22400 -2.17e-01 -5.48e-02 2.60e-01 7.76e-01
GOCC MCRD MEDIATED MRNA STABILITY COMPLEX 5 7.10e-01 9.14e-01 0.22400 1.96e-01 -1.07e-01 4.48e-01 6.78e-01
GOMF FATTY ACID ELONGASE ACTIVITY 7 5.98e-01 8.73e-01 0.22400 2.21e-01 -3.25e-02 3.11e-01 8.82e-01
GOMF ANNEALING ACTIVITY 8 5.56e-01 8.55e-01 0.22400 -2.21e-01 3.28e-02 2.79e-01 8.72e-01
FGFR4 ligand binding and activation 13 3.57e-01 7.49e-01 0.22400 4.23e-02 2.20e-01 7.92e-01 1.71e-01
GOBP FOREBRAIN REGIONALIZATION 24 1.78e-01 5.83e-01 0.22300 -2.18e-01 5.02e-02 6.48e-02 6.70e-01
GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY 40 6.83e-02 3.94e-01 0.22300 1.75e-01 -1.39e-01 5.52e-02 1.29e-01
RNA Polymerase III Chain Elongation 18 2.26e-01 6.45e-01 0.22300 -9.16e-02 -2.04e-01 5.01e-01 1.34e-01
GOCC RNA POLYMERASE III COMPLEX 18 2.26e-01 6.45e-01 0.22300 -9.16e-02 -2.04e-01 5.01e-01 1.34e-01
GOBP GLANDULAR EPITHELIAL CELL MATURATION 9 4.76e-01 8.18e-01 0.22300 9.17e-02 2.04e-01 6.34e-01 2.90e-01
Striated Muscle Contraction 35 6.05e-02 3.73e-01 0.22300 5.66e-02 2.16e-01 5.62e-01 2.69e-02
GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY 12 4.32e-01 7.96e-01 0.22300 7.88e-02 -2.09e-01 6.37e-01 2.10e-01
GOBP REGULATION OF CHROMATIN ORGANIZATION 32 6.72e-02 3.91e-01 0.22300 -1.76e-01 -1.38e-01 8.53e-02 1.78e-01
GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY 19 2.44e-01 6.58e-01 0.22300 -1.83e-02 2.23e-01 8.90e-01 9.31e-02
GOMF MUTLALPHA COMPLEX BINDING 7 6.23e-01 8.82e-01 0.22300 -1.24e-01 1.86e-01 5.71e-01 3.95e-01
GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION 10 4.84e-01 8.23e-01 0.22300 4.15e-02 -2.19e-01 8.20e-01 2.30e-01
GOMF DNA DEMETHYLASE ACTIVITY 5 6.99e-01 9.11e-01 0.22300 -2.17e-01 5.20e-02 4.01e-01 8.40e-01
FGFR2 mutant receptor activation 32 1.10e-01 4.81e-01 0.22300 -2.03e-01 9.29e-02 4.70e-02 3.63e-01
Complex I biogenesis 58 1.11e-02 1.64e-01 0.22300 -2.64e-02 -2.22e-01 7.28e-01 3.52e-03
GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION 9 5.48e-01 8.52e-01 0.22300 1.68e-01 -1.47e-01 3.83e-01 4.46e-01
GOCC INSULIN RESPONSIVE COMPARTMENT 7 5.73e-01 8.61e-01 0.22300 5.17e-02 2.17e-01 8.13e-01 3.20e-01
GOBP NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS 10 4.29e-01 7.94e-01 0.22300 1.55e-01 1.60e-01 3.95e-01 3.81e-01
GOBP CATECHOLAMINE TRANSPORT 63 8.26e-03 1.36e-01 0.22300 -2.23e-01 -8.88e-03 2.22e-03 9.03e-01
GOCC ACETYLCHOLINE GATED CHANNEL COMPLEX 17 3.07e-01 7.16e-01 0.22300 8.35e-02 -2.07e-01 5.51e-01 1.40e-01
GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT 44 4.09e-02 3.09e-01 0.22300 -2.20e-01 3.57e-02 1.15e-02 6.82e-01
GOBP DETECTION OF CALCIUM ION 13 3.63e-01 7.54e-01 0.22300 -2.21e-01 -2.93e-02 1.68e-01 8.55e-01
GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT 16 2.59e-01 6.73e-01 0.22300 1.55e-01 1.60e-01 2.83e-01 2.67e-01
GPER1 signaling 45 4.27e-02 3.14e-01 0.22300 -2.11e-01 7.04e-02 1.41e-02 4.14e-01
GOBP CELL SUBSTRATE JUNCTION ORGANIZATION 101 1.13e-03 3.60e-02 0.22300 -1.87e-01 1.21e-01 1.15e-03 3.57e-02
GOBP RNA SURVEILLANCE 18 2.33e-01 6.50e-01 0.22300 -7.31e-02 -2.11e-01 5.92e-01 1.22e-01
GOBP PROTEIN TARGETING TO LYSOSOME 31 9.09e-02 4.43e-01 0.22300 -2.21e-01 -2.46e-02 3.28e-02 8.13e-01
GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY 6 6.46e-01 8.91e-01 0.22300 -2.20e-01 3.50e-02 3.51e-01 8.82e-01
GOMF SUMO TRANSFERASE ACTIVITY 25 1.78e-01 5.83e-01 0.22300 -2.05e-01 8.78e-02 7.64e-02 4.47e-01
Mineralocorticoid biosynthesis 6 6.25e-01 8.83e-01 0.22300 2.20e-01 3.55e-02 3.51e-01 8.80e-01
GOBP NEGATIVE REGULATION OF PINOCYTOSIS 5 7.03e-01 9.12e-01 0.22300 -2.13e-01 6.44e-02 4.09e-01 8.03e-01
GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS 8 5.13e-01 8.36e-01 0.22300 -1.19e-01 -1.88e-01 5.60e-01 3.56e-01
GOBP ACROSOMAL VESICLE EXOCYTOSIS 9 5.39e-01 8.49e-01 0.22300 2.02e-01 -9.33e-02 2.94e-01 6.28e-01
GOBP PANTOTHENATE METABOLIC PROCESS 7 6.16e-01 8.80e-01 0.22300 8.56e-02 -2.06e-01 6.95e-01 3.46e-01
GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER 14 3.38e-01 7.38e-01 0.22300 2.21e-01 2.62e-02 1.52e-01 8.65e-01
GOBP PROTEIN OXIDATION 12 4.45e-01 8.02e-01 0.22300 -1.17e-01 1.90e-01 4.84e-01 2.55e-01
GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM 13 3.83e-01 7.67e-01 0.22300 1.90e-02 -2.22e-01 9.06e-01 1.66e-01
GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION 14 3.88e-01 7.70e-01 0.22300 -1.13e-01 1.92e-01 4.63e-01 2.14e-01
GOBP METANEPHRIC LOOP OF HENLE DEVELOPMENT 6 6.59e-01 8.95e-01 0.22300 -7.69e-02 2.09e-01 7.44e-01 3.76e-01
GOBP POSITIVE REGULATION OF SYNAPSE MATURATION 8 5.21e-01 8.40e-01 0.22300 2.05e-01 8.59e-02 3.15e-01 6.74e-01
Keratan sulfate biosynthesis 28 9.51e-02 4.50e-01 0.22300 1.57e-01 1.58e-01 1.50e-01 1.49e-01
GOBP HYALOID VASCULAR PLEXUS REGRESSION 7 5.68e-01 8.59e-01 0.22200 -2.09e-01 -7.55e-02 3.38e-01 7.29e-01
Signaling by FGFR in disease 62 1.49e-02 1.94e-01 0.22200 -1.97e-01 1.03e-01 7.20e-03 1.62e-01
GOBP CELL FATE SPECIFICATION 107 2.83e-04 1.26e-02 0.22200 -2.22e-01 -1.82e-02 7.40e-05 7.45e-01
GOBP MIDBODY ABSCISSION 17 3.01e-01 7.11e-01 0.22200 5.82e-02 -2.15e-01 6.78e-01 1.26e-01
PLC beta mediated events 48 3.97e-02 3.06e-01 0.22200 -1.15e-01 1.90e-01 1.67e-01 2.26e-02
Negative regulation of TCF-dependent signaling by WNT ligand antagonists 15 3.01e-01 7.12e-01 0.22200 2.13e-01 6.51e-02 1.54e-01 6.63e-01
GOMF L LEUCINE BINDING 6 6.21e-01 8.81e-01 0.22200 -2.15e-01 -5.45e-02 3.61e-01 8.17e-01
Translesion synthesis by REV1 16 3.41e-01 7.40e-01 0.22200 1.12e-01 -1.92e-01 4.36e-01 1.84e-01
GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS 11 4.12e-01 7.84e-01 0.22200 7.39e-02 2.10e-01 6.71e-01 2.29e-01
GOBP PRESYNAPTIC ACTIVE ZONE ORGANIZATION 7 6.24e-01 8.83e-01 0.22200 -1.91e-01 1.14e-01 3.82e-01 6.03e-01
Diseases of programmed cell death 66 9.65e-03 1.50e-01 0.22200 5.94e-02 -2.14e-01 4.04e-01 2.63e-03
GOBP ESTABLISHMENT OF SKIN BARRIER 34 6.36e-02 3.79e-01 0.22200 2.06e-01 8.31e-02 3.77e-02 4.02e-01
GOBP REGULATION OF VOLTAGE GATED SODIUM CHANNEL ACTIVITY 8 5.87e-01 8.67e-01 0.22200 -1.79e-01 1.31e-01 3.80e-01 5.21e-01
p75NTR regulates axonogenesis 9 4.84e-01 8.23e-01 0.22200 7.63e-02 2.09e-01 6.92e-01 2.79e-01
GOBP SNO S RNA METABOLIC PROCESS 15 3.57e-01 7.49e-01 0.22200 -2.05e-01 8.63e-02 1.70e-01 5.63e-01
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion 42 5.82e-02 3.66e-01 0.22200 -1.98e-01 1.01e-01 2.64e-02 2.60e-01
GOMF DOUBLE STRANDED METHYLATED DNA BINDING 5 7.02e-01 9.12e-01 0.22200 -2.15e-01 5.42e-02 4.05e-01 8.34e-01
GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS 9 5.25e-01 8.42e-01 0.22200 2.18e-01 -4.09e-02 2.57e-01 8.32e-01
GOBP TRNA 5 LEADER REMOVAL 13 3.73e-01 7.61e-01 0.22200 -1.15e-02 -2.22e-01 9.43e-01 1.66e-01
GOBP POSITIVE REGULATION OF PLATELET ACTIVATION 12 4.53e-01 8.07e-01 0.22200 -1.58e-01 1.56e-01 3.43e-01 3.51e-01
GOCC SCHMIDT LANTERMAN INCISURE 11 4.84e-01 8.23e-01 0.22200 -1.54e-01 1.59e-01 3.75e-01 3.60e-01
GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS 26 1.53e-01 5.49e-01 0.22200 -2.19e-01 3.38e-02 5.30e-02 7.65e-01
GOBP POSITIVE REGULATION OF AXON EXTENSION 33 1.11e-01 4.81e-01 0.22200 -1.87e-01 1.19e-01 6.30e-02 2.36e-01
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion 13 4.05e-01 7.81e-01 0.22200 -6.95e-02 2.11e-01 6.65e-01 1.89e-01
NRIF signals cell death from the nucleus 16 2.94e-01 7.07e-01 0.22200 -2.15e-02 -2.21e-01 8.82e-01 1.26e-01
Acyl chain remodelling of PE 29 1.28e-01 5.12e-01 0.22200 2.16e-01 -5.04e-02 4.41e-02 6.39e-01
GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT 16 2.95e-01 7.07e-01 0.22200 -2.21e-01 -2.09e-02 1.26e-01 8.85e-01
GOBP CYTOPLASMIC TRANSLATIONAL ELONGATION 5 7.16e-01 9.15e-01 0.22200 1.20e-01 -1.86e-01 6.42e-01 4.71e-01
GOMF HAPTOGLOBIN BINDING 10 5.01e-01 8.30e-01 0.22100 2.09e-01 -7.19e-02 2.52e-01 6.94e-01
GOBP REGULATION OF ADIPONECTIN SECRETION 7 5.64e-01 8.58e-01 0.22100 1.08e-01 1.93e-01 6.21e-01 3.76e-01
GOMF INTRACELLULARLY GATED CALCIUM CHANNEL ACTIVITY 18 3.07e-01 7.16e-01 0.22100 -1.61e-01 1.52e-01 2.37e-01 2.65e-01
GOCC SPERMATOPROTEASOME COMPLEX 5 6.95e-01 9.11e-01 0.22100 2.23e-02 -2.20e-01 9.31e-01 3.94e-01
Signaling by NTRK2 (TRKB) 25 1.42e-01 5.33e-01 0.22100 -2.16e-01 -4.86e-02 6.18e-02 6.74e-01
GOCC GPI ANCHOR TRANSAMIDASE COMPLEX 5 6.96e-01 9.11e-01 0.22100 2.20e-01 -2.23e-02 3.94e-01 9.31e-01
GOBP DORSAL AORTA MORPHOGENESIS 8 5.76e-01 8.63e-01 0.22100 -7.14e-02 2.09e-01 7.27e-01 3.05e-01
GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION 9 4.80e-01 8.21e-01 0.22100 -1.05e-01 -1.94e-01 5.84e-01 3.13e-01
GOBP FAT PAD DEVELOPMENT 9 5.05e-01 8.31e-01 0.22100 -2.20e-01 -2.22e-02 2.53e-01 9.08e-01
GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM 107 9.12e-04 3.03e-02 0.22100 1.38e-01 -1.72e-01 1.33e-02 2.09e-03
GOBP NEGATIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY 9 4.76e-01 8.18e-01 0.22100 1.30e-01 1.79e-01 5.01e-01 3.53e-01
Regulation of activated PAK-2p34 by proteasome mediated degradation 37 5.61e-02 3.60e-01 0.22100 -4.86e-02 -2.16e-01 6.09e-01 2.33e-02
GOMF BH DOMAIN BINDING 11 4.27e-01 7.93e-01 0.22100 -4.25e-02 -2.17e-01 8.07e-01 2.13e-01
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 9 5.22e-01 8.41e-01 0.22100 2.19e-01 -2.44e-02 2.54e-01 8.99e-01
GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT 15 3.62e-01 7.52e-01 0.22100 8.58e-02 -2.03e-01 5.65e-01 1.73e-01
GOMF FAD BINDING 39 4.79e-02 3.31e-01 0.22100 5.11e-02 2.15e-01 5.81e-01 2.03e-02
GOMF FRUCTOSE BINDING 6 6.45e-01 8.90e-01 0.22100 -1.11e-02 2.20e-01 9.63e-01 3.50e-01
GOCC GLYCOGEN GRANULE 6 6.12e-01 8.78e-01 0.22100 1.19e-01 1.86e-01 6.14e-01 4.30e-01
GOBP SUBSTRATE INDEPENDENT TELENCEPHALIC TANGENTIAL MIGRATION 9 5.50e-01 8.53e-01 0.22100 1.13e-01 -1.89e-01 5.57e-01 3.25e-01
GOBP SKELETAL MUSCLE SATELLITE CELL ACTIVATION 9 4.97e-01 8.29e-01 0.22100 4.78e-02 2.15e-01 8.04e-01 2.63e-01
GOBP CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION 6 6.30e-01 8.85e-01 0.22100 3.97e-02 2.17e-01 8.66e-01 3.57e-01
Amine ligand-binding receptors 40 7.33e-02 4.05e-01 0.22100 -1.69e-01 1.42e-01 6.48e-02 1.20e-01
GOBP OLIGOPEPTIDE IMPORT ACROSS PLASMA MEMBRANE 5 7.21e-01 9.17e-01 0.22000 -1.72e-01 1.38e-01 5.05e-01 5.94e-01
GOMF CARBOXYLESTERASE ACTIVITY 6 6.57e-01 8.94e-01 0.22000 2.14e-01 -5.17e-02 3.63e-01 8.27e-01
GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS 28 9.92e-02 4.61e-01 0.22000 1.59e-01 1.53e-01 1.45e-01 1.62e-01
Regulation of Expression and Function of Type II Classical Cadherins 32 1.15e-01 4.89e-01 0.22000 -2.04e-01 8.35e-02 4.58e-02 4.14e-01
Regulation of Homotypic Cell-Cell Adhesion 32 1.15e-01 4.89e-01 0.22000 -2.04e-01 8.35e-02 4.58e-02 4.14e-01
GOBP AXON CHOICE POINT RECOGNITION 7 5.78e-01 8.64e-01 0.22000 -2.12e-01 -5.94e-02 3.31e-01 7.86e-01
GOBP SUBPALLIUM DEVELOPMENT 26 1.17e-01 4.92e-01 0.22000 -1.68e-01 -1.43e-01 1.38e-01 2.08e-01
GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 46 4.29e-02 3.15e-01 0.22000 -2.09e-01 7.08e-02 1.43e-02 4.06e-01
GOBP MUSCLE HYPERTROPHY 106 6.90e-04 2.42e-02 0.22000 -2.11e-01 6.48e-02 1.79e-04 2.49e-01
GOMF INOSITOL TETRAKISPHOSPHATE KINASE ACTIVITY 5 6.62e-01 8.97e-01 0.22000 -1.57e-01 -1.54e-01 5.42e-01 5.50e-01
GOBP PRIMARY MIRNA PROCESSING 18 2.32e-01 6.50e-01 0.22000 -1.93e-01 -1.07e-01 1.57e-01 4.34e-01
GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTAXIS 6 6.10e-01 8.77e-01 0.22000 1.53e-01 1.59e-01 5.17e-01 5.01e-01
GOBP INTERMEDIATE FILAMENT BASED PROCESS 94 4.89e-04 1.89e-02 0.22000 1.88e-01 1.14e-01 1.59e-03 5.64e-02
GOMF N6 METHYLADENOSINE CONTAINING RNA READER ACTIVITY 11 4.66e-01 8.14e-01 0.22000 2.13e-01 -5.68e-02 2.22e-01 7.44e-01
GOBP REGULATION OF SISTER CHROMATID COHESION 15 2.95e-01 7.07e-01 0.22000 -1.87e-01 -1.15e-01 2.09e-01 4.39e-01
GOBP LOOP OF HENLE DEVELOPMENT 12 4.59e-01 8.10e-01 0.22000 -1.60e-01 1.52e-01 3.38e-01 3.63e-01
GOBP HEPATOCYTE APOPTOTIC PROCESS 20 1.98e-01 6.09e-01 0.22000 1.91e-01 1.10e-01 1.40e-01 3.95e-01
GOBP MATURATION OF LSU RRNA 23 2.04e-01 6.20e-01 0.22000 5.95e-02 -2.12e-01 6.21e-01 7.87e-02
GOBP REFLEX 22 1.92e-01 6.00e-01 0.22000 -1.83e-02 -2.19e-01 8.82e-01 7.51e-02
Activated NTRK2 signals through FYN 7 6.34e-01 8.86e-01 0.22000 -1.71e-01 1.39e-01 4.34e-01 5.25e-01
GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX 10 4.52e-01 8.07e-01 0.22000 2.04e-01 8.15e-02 2.64e-01 6.55e-01
GOMF NARROW PORE CHANNEL ACTIVITY 19 2.34e-01 6.50e-01 0.22000 2.16e-01 3.84e-02 1.02e-01 7.72e-01
GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 42 3.53e-02 2.90e-01 0.22000 -8.73e-02 -2.02e-01 3.27e-01 2.37e-02
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN WOUND HEALING 10 4.95e-01 8.28e-01 0.22000 -4.15e-02 2.16e-01 8.20e-01 2.37e-01
RNA Polymerase III Transcription Initiation From Type 1 Promoter 28 1.01e-01 4.65e-01 0.22000 -1.70e-01 -1.40e-01 1.20e-01 2.00e-01
GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING 13 3.69e-01 7.58e-01 0.22000 4.35e-02 2.15e-01 7.86e-01 1.79e-01
Response to metal ions 14 4.04e-01 7.80e-01 0.22000 -1.43e-01 1.67e-01 3.55e-01 2.79e-01
GOBP OOCYTE ANTERIOR POSTERIOR AXIS SPECIFICATION 6 6.66e-01 8.99e-01 0.22000 -7.69e-02 2.06e-01 7.44e-01 3.83e-01
Signaling by TGF-beta Receptor Complex in Cancer 8 5.21e-01 8.41e-01 0.22000 -1.80e-01 -1.26e-01 3.78e-01 5.37e-01
GOBP REGULATION OF CAVEOLIN MEDIATED ENDOCYTOSIS 6 6.70e-01 9.01e-01 0.22000 1.99e-01 -9.31e-02 3.99e-01 6.93e-01
GOMF WD40 REPEAT DOMAIN BINDING 5 6.64e-01 8.97e-01 0.22000 1.56e-01 1.54e-01 5.46e-01 5.50e-01
GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY 11 4.32e-01 7.96e-01 0.21900 -2.16e-01 -4.03e-02 2.15e-01 8.17e-01
mRNA decay by 3’ to 5’ exoribonuclease 16 2.71e-01 6.85e-01 0.21900 -1.70e-01 -1.39e-01 2.40e-01 3.35e-01
GOBP MONOSACCHARIDE CATABOLIC PROCESS 48 2.03e-02 2.28e-01 0.21900 1.29e-01 1.77e-01 1.21e-01 3.36e-02
GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION 18 2.99e-01 7.10e-01 0.21900 -2.03e-01 8.17e-02 1.35e-01 5.48e-01
GOBP GLUTATHIONE TRANSPORT 10 4.92e-01 8.26e-01 0.21900 2.18e-01 -2.64e-02 2.33e-01 8.85e-01
Nucleotide-like (purinergic) receptors 13 3.46e-01 7.43e-01 0.21900 1.49e-01 1.61e-01 3.52e-01 3.16e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 68 1.01e-02 1.55e-01 0.21900 2.07e-01 -7.11e-02 3.12e-03 3.11e-01
Cobalamin (Cbl, vitamin B12) transport and metabolism 21 2.40e-01 6.55e-01 0.21900 -6.66e-02 2.09e-01 5.97e-01 9.77e-02
GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY 26 1.43e-01 5.35e-01 0.21900 2.18e-01 2.43e-02 5.46e-02 8.30e-01
GOCC SAGA COMPLEX 23 1.54e-01 5.50e-01 0.21900 -1.48e-01 -1.62e-01 2.20e-01 1.79e-01
GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION 5 7.09e-01 9.13e-01 0.21900 5.59e-02 -2.12e-01 8.28e-01 4.12e-01
GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY 8 5.50e-01 8.53e-01 0.21900 2.20e-02 2.18e-01 9.14e-01 2.86e-01
NADE modulates death signalling 5 6.69e-01 9.00e-01 0.21900 1.90e-01 1.09e-01 4.63e-01 6.72e-01
GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE 6 6.80e-01 9.04e-01 0.21900 1.51e-01 -1.58e-01 5.21e-01 5.02e-01
GOBP DNA REPLICATION CHECKPOINT SIGNALING 20 2.40e-01 6.55e-01 0.21900 1.84e-02 -2.18e-01 8.86e-01 9.12e-02
Response of endothelial cells to shear stress 92 2.44e-03 6.27e-02 0.21900 -1.92e-01 1.05e-01 1.44e-03 8.28e-02
GOBP MEIOTIC SPINDLE ASSEMBLY 12 4.04e-01 7.80e-01 0.21900 -3.59e-02 -2.16e-01 8.30e-01 1.95e-01
GOBP ASPARTATE TRANSMEMBRANE TRANSPORT 20 2.32e-01 6.50e-01 0.21900 4.41e-03 2.19e-01 9.73e-01 9.03e-02
GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING 103 1.37e-03 4.14e-02 0.21900 -1.44e-01 1.64e-01 1.13e-02 3.96e-03
GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 25 1.60e-01 5.57e-01 0.21900 -2.18e-01 -1.00e-02 5.87e-02 9.31e-01
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 70 3.73e-03 8.44e-02 0.21900 -1.10e-01 -1.89e-01 1.13e-01 6.20e-03
GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY 38 4.61e-02 3.26e-01 0.21900 1.64e-01 1.45e-01 8.08e-02 1.22e-01
GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY 7 5.67e-01 8.59e-01 0.21900 1.67e-01 1.41e-01 4.45e-01 5.18e-01
GOBP SYNAPTIC VESICLE DOCKING 9 4.91e-01 8.26e-01 0.21800 9.17e-02 1.98e-01 6.34e-01 3.03e-01
GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS 37 6.67e-02 3.90e-01 0.21800 -2.18e-01 -9.26e-03 2.16e-02 9.22e-01
GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE 15 3.76e-01 7.63e-01 0.21800 -1.07e-01 1.90e-01 4.73e-01 2.02e-01
GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 11 4.28e-01 7.94e-01 0.21800 6.11e-02 2.10e-01 7.26e-01 2.29e-01
GOBP NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 10 4.67e-01 8.14e-01 0.21800 -4.82e-02 -2.13e-01 7.92e-01 2.44e-01
GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY 8 5.45e-01 8.51e-01 0.21800 2.14e-01 4.30e-02 2.94e-01 8.33e-01
GOBP PEPTIDYL ARGININE METHYLATION TO ASYMMETRICAL DIMETHYL ARGININE 8 5.97e-01 8.73e-01 0.21800 -1.80e-01 1.24e-01 3.79e-01 5.43e-01
Apoptotic cleavage of cell adhesion proteins 11 4.46e-01 8.02e-01 0.21800 2.18e-01 1.42e-02 2.11e-01 9.35e-01
GOBP TRANSCYTOSIS 21 2.34e-01 6.50e-01 0.21800 -4.03e-02 2.14e-01 7.49e-01 8.92e-02
GOBP CELLULAR RESPONSE TO ALDEHYDE 16 2.85e-01 6.97e-01 0.21800 1.99e-01 8.90e-02 1.68e-01 5.38e-01
Synthesis of active ubiquitin: roles of E1 and E2 enzymes 27 1.57e-01 5.54e-01 0.21800 4.74e-02 -2.13e-01 6.70e-01 5.57e-02
GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION 17 2.80e-01 6.92e-01 0.21800 -3.41e-02 -2.15e-01 8.08e-01 1.24e-01
GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME 30 9.74e-02 4.56e-01 0.21800 -7.51e-02 -2.05e-01 4.77e-01 5.24e-02
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I 9 5.64e-01 8.58e-01 0.21800 1.53e-01 -1.55e-01 4.27e-01 4.20e-01
ALK mutants bind TKIs 12 4.24e-01 7.92e-01 0.21800 6.81e-03 -2.18e-01 9.67e-01 1.92e-01
GOBP EPITHELIAL CELL FATE COMMITMENT 14 4.10e-01 7.83e-01 0.21800 -1.67e-01 1.39e-01 2.79e-01 3.66e-01
GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY 15 3.83e-01 7.67e-01 0.21800 1.26e-01 -1.78e-01 4.00e-01 2.33e-01
GOBP SCHWANN CELL DIFFERENTIATION 48 4.76e-02 3.30e-01 0.21800 -1.49e-01 1.59e-01 7.47e-02 5.67e-02
activated TAK1 mediates p38 MAPK activation 20 2.13e-01 6.29e-01 0.21800 -7.55e-02 -2.04e-01 5.59e-01 1.14e-01
Interferon alpha/beta signaling 74 9.22e-03 1.46e-01 0.21800 1.56e-01 -1.51e-01 2.00e-02 2.45e-02
GOBP NUCLEAR PORE LOCALIZATION 5 6.72e-01 9.01e-01 0.21800 -1.84e-01 -1.16e-01 4.76e-01 6.53e-01
GOBP RESPONSE TO SORBITOL 6 6.76e-01 9.04e-01 0.21800 9.54e-02 -1.96e-01 6.86e-01 4.07e-01
Diseases of Mismatch Repair (MMR) 5 6.89e-01 9.07e-01 0.21800 -3.48e-02 -2.15e-01 8.93e-01 4.06e-01
GOBP CAMP PKA SIGNAL TRANSDUCTION 5 7.05e-01 9.13e-01 0.21800 -2.74e-02 2.16e-01 9.15e-01 4.03e-01
GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION 11 4.71e-01 8.15e-01 0.21800 -2.13e-01 4.45e-02 2.21e-01 7.98e-01
GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION 14 3.58e-01 7.50e-01 0.21800 -1.79e-02 -2.17e-01 9.08e-01 1.60e-01
GOBP SNRNA PROCESSING 26 1.30e-01 5.16e-01 0.21800 -1.97e-01 -9.16e-02 8.17e-02 4.19e-01
GOBP CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 22 1.90e-01 5.96e-01 0.21700 2.12e-01 4.86e-02 8.52e-02 6.93e-01
GOBP REGULATION OF TOOTH MINERALIZATION 11 4.95e-01 8.28e-01 0.21700 1.24e-01 -1.79e-01 4.78e-01 3.04e-01
AUF1 (hnRNP D0) binds and destabilizes mRNA 42 4.59e-02 3.26e-01 0.21700 -2.03e-02 -2.16e-01 8.20e-01 1.52e-02
GOBP PHOTORECEPTOR CELL MAINTENANCE 43 6.18e-02 3.76e-01 0.21700 1.92e-01 -1.02e-01 2.95e-02 2.45e-01
GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY 12 4.27e-01 7.93e-01 0.21700 -2.17e-01 1.19e-02 1.93e-01 9.43e-01
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY 8 5.30e-01 8.43e-01 0.21700 1.85e-01 1.14e-01 3.64e-01 5.77e-01
GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION 30 1.06e-01 4.74e-01 0.21700 2.14e-01 3.85e-02 4.25e-02 7.15e-01
RHOQ GTPase cycle 57 2.68e-02 2.60e-01 0.21700 -1.71e-01 1.34e-01 2.54e-02 8.04e-02
GOBP BONE CELL DEVELOPMENT 18 3.04e-01 7.14e-01 0.21700 -2.03e-01 7.82e-02 1.36e-01 5.66e-01
GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION 8 5.44e-01 8.51e-01 0.21700 -2.09e-01 -5.90e-02 3.06e-01 7.72e-01
GOBP NEURAL PLATE DEVELOPMENT 8 5.29e-01 8.43e-01 0.21700 -1.23e-01 -1.79e-01 5.45e-01 3.81e-01
GOBP COMPLEMENT ACTIVATION LECTIN PATHWAY 11 4.50e-01 8.06e-01 0.21700 1.07e-02 2.17e-01 9.51e-01 2.13e-01
GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY 7 6.09e-01 8.77e-01 0.21700 1.07e-02 -2.17e-01 9.61e-01 3.20e-01
GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY 6 6.34e-01 8.86e-01 0.21700 -2.09e-01 -5.81e-02 3.75e-01 8.05e-01
GOMF NFAT PROTEIN BINDING 5 6.72e-01 9.02e-01 0.21700 1.20e-01 1.81e-01 6.42e-01 4.84e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 32 1.29e-01 5.13e-01 0.21700 1.16e-01 -1.84e-01 2.56e-01 7.23e-02
GABA receptor activation 57 2.27e-02 2.42e-01 0.21700 -2.05e-01 7.01e-02 7.28e-03 3.60e-01
SMAD2/3 Phosphorylation Motif Mutants in Cancer 6 6.29e-01 8.85e-01 0.21700 -2.02e-01 -7.80e-02 3.91e-01 7.41e-01
TGFBR1 KD Mutants in Cancer 6 6.29e-01 8.85e-01 0.21700 -2.02e-01 -7.80e-02 3.91e-01 7.41e-01
GOMF CD4 RECEPTOR BINDING 8 5.76e-01 8.63e-01 0.21700 2.14e-01 -3.35e-02 2.94e-01 8.70e-01
GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY 5 6.85e-01 9.06e-01 0.21700 -5.51e-02 -2.10e-01 8.31e-01 4.17e-01
GOBP POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 6 6.80e-01 9.04e-01 0.21700 -1.04e-01 1.90e-01 6.58e-01 4.20e-01
GOMF ADENYLATE CYCLASE ACTIVITY 15 3.88e-01 7.70e-01 0.21700 -1.45e-01 1.61e-01 3.30e-01 2.81e-01
GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS 13 4.40e-01 7.99e-01 0.21700 1.64e-01 -1.42e-01 3.06e-01 3.76e-01
Regulation of RUNX3 expression and activity 45 3.56e-02 2.90e-01 0.21700 -3.71e-02 -2.14e-01 6.67e-01 1.32e-02
Vitamin B5 (pantothenate) metabolism 19 3.01e-01 7.11e-01 0.21700 1.70e-01 -1.34e-01 1.99e-01 3.11e-01
NOTCH4 Activation and Transmission of Signal to the Nucleus 11 4.70e-01 8.15e-01 0.21700 3.75e-02 -2.13e-01 8.29e-01 2.20e-01
Phenylalanine metabolism 6 6.39e-01 8.88e-01 0.21700 2.12e-01 4.42e-02 3.68e-01 8.51e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS 5 7.05e-01 9.13e-01 0.21700 2.16e-01 -2.00e-02 4.03e-01 9.38e-01
GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY 12 3.90e-01 7.71e-01 0.21700 1.90e-01 1.04e-01 2.55e-01 5.31e-01
GOBP POSITIVE REGULATION OF BONE RESORPTION 19 2.34e-01 6.50e-01 0.21700 2.05e-01 6.94e-02 1.21e-01 6.01e-01
GOCC CRD MEDIATED MRNA STABILITY COMPLEX 6 6.78e-01 9.04e-01 0.21700 9.43e-02 -1.95e-01 6.89e-01 4.08e-01
GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY 21 1.95e-01 6.06e-01 0.21700 9.31e-02 1.96e-01 4.60e-01 1.21e-01
GOCC PTW PP1 PHOSPHATASE COMPLEX 7 5.87e-01 8.67e-01 0.21700 -6.44e-02 -2.07e-01 7.68e-01 3.43e-01
GOBP OUTER EAR MORPHOGENESIS 8 5.61e-01 8.57e-01 0.21700 2.16e-01 1.34e-02 2.90e-01 9.48e-01
GOBP NEGATIVE T CELL SELECTION 13 4.19e-01 7.87e-01 0.21700 2.09e-01 -5.82e-02 1.93e-01 7.16e-01
GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY 27 1.30e-01 5.15e-01 0.21700 -5.75e-02 -2.09e-01 6.05e-01 6.04e-02
GOBP LYMPHATIC ENDOTHELIAL CELL DIFFERENTIATION 8 6.00e-01 8.74e-01 0.21700 -1.13e-01 1.85e-01 5.81e-01 3.65e-01
GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 35 6.22e-02 3.77e-01 0.21700 -1.70e-01 -1.35e-01 8.25e-02 1.68e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS 17 3.42e-01 7.40e-01 0.21600 -1.35e-01 1.69e-01 3.34e-01 2.28e-01
RNA Polymerase III Transcription Initiation 36 5.72e-02 3.63e-01 0.21600 -1.45e-01 -1.60e-01 1.31e-01 9.58e-02
GOMF DNA DNA ANNEALING ACTIVITY 7 6.35e-01 8.86e-01 0.21600 -1.96e-01 9.11e-02 3.68e-01 6.77e-01
GOBP RESPONSE TO TUMOR CELL 44 6.08e-02 3.73e-01 0.21600 1.84e-01 -1.13e-01 3.43e-02 1.94e-01
Pre-NOTCH Transcription and Translation 68 7.08e-03 1.24e-01 0.21600 -2.36e-02 -2.15e-01 7.37e-01 2.16e-03
GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY 43 6.59e-02 3.87e-01 0.21600 -1.78e-01 1.23e-01 4.31e-02 1.64e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION 84 3.25e-03 7.77e-02 0.21600 -2.13e-01 3.50e-02 7.21e-04 5.79e-01
GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 21 2.59e-01 6.73e-01 0.21600 9.82e-02 -1.93e-01 4.36e-01 1.26e-01
GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION 9 5.27e-01 8.42e-01 0.21600 2.16e-01 1.86e-03 2.62e-01 9.92e-01
GOBP REGULATION OF FIBROBLAST MIGRATION 40 7.28e-02 4.04e-01 0.21600 -2.03e-01 7.44e-02 2.64e-02 4.16e-01
GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY 12 4.72e-01 8.15e-01 0.21600 1.53e-01 -1.53e-01 3.60e-01 3.59e-01
GOBP POLY A DEPENDENT SNORNA 3 END PROCESSING 8 5.67e-01 8.59e-01 0.21600 -2.16e-01 -9.93e-04 2.90e-01 9.96e-01
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 79 4.52e-03 9.31e-02 0.21600 3.11e-02 -2.14e-01 6.33e-01 1.02e-03
TP53 Regulates Transcription of Caspase Activators and Caspases 12 4.67e-01 8.14e-01 0.21600 -1.16e-01 1.82e-01 4.88e-01 2.74e-01
GOBP REGULATION OF CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR 8 5.44e-01 8.51e-01 0.21600 7.11e-02 2.04e-01 7.28e-01 3.18e-01
GOMF TAU PROTEIN KINASE ACTIVITY 22 2.32e-01 6.50e-01 0.21600 -2.08e-01 5.84e-02 9.16e-02 6.36e-01
GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION 23 2.38e-01 6.54e-01 0.21600 -1.61e-01 1.44e-01 1.81e-01 2.33e-01
GOBP PROTEIN LIPID COMPLEX ASSEMBLY 30 1.52e-01 5.47e-01 0.21600 -1.77e-01 1.24e-01 9.41e-02 2.40e-01
GOMF MHC CLASS II RECEPTOR ACTIVITY 9 5.02e-01 8.30e-01 0.21600 1.99e-01 8.28e-02 3.01e-01 6.67e-01
GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS 17 3.04e-01 7.14e-01 0.21600 8.76e-03 -2.15e-01 9.50e-01 1.24e-01
GOBP GDP MANNOSE METABOLIC PROCESS 8 5.83e-01 8.66e-01 0.21600 -2.11e-01 4.31e-02 3.01e-01 8.33e-01
GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS 10 4.69e-01 8.14e-01 0.21600 -6.85e-02 -2.04e-01 7.08e-01 2.63e-01
GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE 19 2.25e-01 6.43e-01 0.21600 1.28e-01 1.74e-01 3.35e-01 1.90e-01
GOCC PERICHROMATIN FIBRILS 6 6.75e-01 9.03e-01 0.21600 2.04e-01 -7.06e-02 3.88e-01 7.65e-01
GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT 10 5.04e-01 8.31e-01 0.21500 -2.14e-01 2.64e-02 2.42e-01 8.85e-01
GOBP B CELL RECEPTOR SIGNALING PATHWAY 61 2.16e-02 2.34e-01 0.21500 1.14e-01 -1.83e-01 1.23e-01 1.37e-02
Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 14 4.07e-01 7.81e-01 0.21500 8.81e-02 -1.96e-01 5.68e-01 2.03e-01
GOMF MECHANOSENSITIVE MONOATOMIC CATION CHANNEL ACTIVITY 6 6.88e-01 9.07e-01 0.21500 1.35e-01 -1.68e-01 5.68e-01 4.76e-01
GOBP CYTOLYSIS 7 6.01e-01 8.75e-01 0.21500 2.87e-02 2.13e-01 8.95e-01 3.28e-01
GOBP PERISTALSIS 12 3.89e-01 7.70e-01 0.21500 -1.52e-01 -1.52e-01 3.61e-01 3.62e-01
ROS and RNS production in phagocytes 33 8.81e-02 4.37e-01 0.21500 -2.11e-01 -4.33e-02 3.61e-02 6.67e-01
TNFR1-induced NF-kappa-B signaling pathway 30 1.48e-01 5.43e-01 0.21500 9.82e-02 -1.91e-01 3.52e-01 6.95e-02
GOBP CARDIAC ATRIUM MORPHOGENESIS 29 1.49e-01 5.43e-01 0.21500 -2.06e-01 6.18e-02 5.48e-02 5.65e-01
GOBP FOREBRAIN MORPHOGENESIS 13 4.42e-01 8.00e-01 0.21500 1.81e-01 -1.16e-01 2.58e-01 4.69e-01
GOMF LIPOPROTEIN LIPASE ACTIVITY 9 4.97e-01 8.29e-01 0.21500 1.13e-01 1.83e-01 5.58e-01 3.42e-01
GOBP EPIDERMIS MORPHOGENESIS 36 1.06e-01 4.73e-01 0.21500 -1.25e-01 1.75e-01 1.95e-01 6.91e-02
GOCC APICAL DENDRITE 16 3.68e-01 7.57e-01 0.21500 -1.23e-01 1.77e-01 3.96e-01 2.21e-01
GOBP SENSORY PERCEPTION OF SMELL 364 1.20e-10 2.88e-08 0.21500 1.93e-01 -9.43e-02 2.41e-10 1.99e-03
GOBP MAGNESIUM ION HOMEOSTASIS 11 4.78e-01 8.20e-01 0.21500 -2.11e-01 4.24e-02 2.26e-01 8.08e-01
GOBP REGULATION OF MUSCLE HYPERTROPHY 71 6.57e-03 1.18e-01 0.21500 -2.15e-01 -1.02e-02 1.76e-03 8.81e-01
GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS 32 1.23e-01 5.02e-01 0.21500 2.05e-01 -6.30e-02 4.43e-02 5.37e-01
GOBP PLATELET DEGRANULATION 7 6.05e-01 8.76e-01 0.21500 -2.05e-02 -2.14e-01 9.25e-01 3.27e-01
Autodegradation of the E3 ubiquitin ligase COP1 38 5.92e-02 3.70e-01 0.21500 -5.88e-02 -2.07e-01 5.30e-01 2.75e-02
GOBP NITRIC OXIDE CGMP MEDIATED SIGNALING 9 5.61e-01 8.57e-01 0.21500 -1.99e-01 8.20e-02 3.02e-01 6.70e-01
HuR (ELAVL1) binds and stabilizes mRNA 10 4.64e-01 8.13e-01 0.21500 -1.92e-01 -9.67e-02 2.94e-01 5.96e-01
GOBP NEGATIVE REGULATION OF FIBRINOLYSIS 13 4.08e-01 7.82e-01 0.21500 -1.57e-02 2.14e-01 9.22e-01 1.81e-01
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha 52 2.23e-02 2.40e-01 0.21500 -4.27e-02 -2.10e-01 5.94e-01 8.68e-03
GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS 14 3.35e-01 7.35e-01 0.21500 -1.41e-01 -1.62e-01 3.62e-01 2.94e-01
Regulation of IFNG signaling 14 4.18e-01 7.87e-01 0.21500 1.20e-01 -1.78e-01 4.36e-01 2.50e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 61 1.46e-02 1.92e-01 0.21500 -2.14e-01 7.86e-03 3.76e-03 9.15e-01
Formation of the beta-catenin:TCF transactivating complex 55 1.54e-02 1.98e-01 0.21500 -8.65e-02 -1.96e-01 2.67e-01 1.18e-02
GOBP NEGATIVE REGULATION OF FERTILIZATION 7 5.90e-01 8.69e-01 0.21500 7.39e-02 2.01e-01 7.35e-01 3.56e-01
Glycosphingolipid transport 8 5.59e-01 8.57e-01 0.21500 -3.51e-02 -2.12e-01 8.63e-01 3.00e-01
GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS 11 4.67e-01 8.14e-01 0.21500 -2.14e-01 8.29e-03 2.18e-01 9.62e-01
GOBP POSITIVE REGULATION OF KIDNEY DEVELOPMENT 9 5.64e-01 8.58e-01 0.21400 9.01e-02 -1.95e-01 6.40e-01 3.12e-01
GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY 15 3.13e-01 7.22e-01 0.21400 1.17e-01 1.80e-01 4.32e-01 2.29e-01
Zinc influx into cells by the SLC39 gene family 10 4.60e-01 8.10e-01 0.21400 1.74e-01 1.25e-01 3.40e-01 4.94e-01
GOMF TRANSFORMING GROWTH FACTOR BETA BINDING 23 2.21e-01 6.38e-01 0.21400 -2.07e-01 5.56e-02 8.57e-02 6.45e-01
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 62 2.07e-02 2.30e-01 0.21400 1.08e-01 -1.85e-01 1.40e-01 1.18e-02
Negative regulation of FGFR2 signaling 33 1.19e-01 4.95e-01 0.21400 -2.02e-01 7.27e-02 4.50e-02 4.70e-01
Regulation of mRNA stability by proteins that bind AU-rich elements 76 3.58e-03 8.26e-02 0.21400 -6.13e-02 -2.05e-01 3.56e-01 1.97e-03
GOBP RESPONSE TO LUTEINIZING HORMONE 7 6.37e-01 8.87e-01 0.21400 -2.01e-01 7.47e-02 3.58e-01 7.32e-01
GOMF TAT PROTEIN BINDING 10 4.59e-01 8.10e-01 0.21400 1.35e-01 1.66e-01 4.58e-01 3.63e-01
SCF(Skp2)-mediated degradation of p27/p21 50 2.78e-02 2.64e-01 0.21400 -2.69e-02 -2.13e-01 7.42e-01 9.33e-03
GOBP CELL ADHESION INVOLVED IN HEART MORPHOGENESIS 8 6.11e-01 8.78e-01 0.21400 -1.54e-01 1.49e-01 4.51e-01 4.66e-01
rRNA processing in the mitochondrion 9 5.60e-01 8.57e-01 0.21400 -2.01e-01 7.31e-02 2.96e-01 7.04e-01
GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN 12 4.50e-01 8.06e-01 0.21400 -2.10e-01 4.21e-02 2.08e-01 8.01e-01
Endogenous sterols 26 1.54e-01 5.51e-01 0.21400 2.12e-01 2.92e-02 6.12e-02 7.97e-01
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 29 1.61e-01 5.60e-01 0.21400 -1.90e-01 9.82e-02 7.63e-02 3.60e-01
GOCC ELONGATOR HOLOENZYME COMPLEX 6 6.77e-01 9.04e-01 0.21400 2.05e-01 -6.27e-02 3.85e-01 7.90e-01
GOBP VITAMIN K METABOLIC PROCESS 11 5.00e-01 8.30e-01 0.21400 9.86e-02 -1.90e-01 5.71e-01 2.75e-01
GOBP SURFACTANT HOMEOSTASIS 20 2.13e-01 6.30e-01 0.21400 1.75e-01 1.23e-01 1.75e-01 3.42e-01
GOBP MESANGIAL CELL DIFFERENTIATION 7 5.94e-01 8.71e-01 0.21400 -2.03e-01 -6.75e-02 3.52e-01 7.57e-01
GOBP POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION 9 5.72e-01 8.61e-01 0.21400 -1.16e-01 1.80e-01 5.48e-01 3.50e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 42 4.25e-02 3.14e-01 0.21400 -1.98e-01 -8.15e-02 2.66e-02 3.61e-01
Intrinsic Pathway of Fibrin Clot Formation 21 2.43e-01 6.58e-01 0.21400 -2.68e-02 2.12e-01 8.31e-01 9.23e-02
G-protein mediated events 53 3.78e-02 2.98e-01 0.21400 -1.19e-01 1.77e-01 1.33e-01 2.55e-02
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING 25 1.49e-01 5.44e-01 0.21400 -1.90e-01 -9.81e-02 1.00e-01 3.96e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 6 6.53e-01 8.93e-01 0.21400 -2.13e-01 -1.99e-02 3.67e-01 9.33e-01
GOMF HISTONE CHAPERONE ACTIVITY 12 4.51e-01 8.06e-01 0.21400 4.02e-02 -2.10e-01 8.09e-01 2.08e-01
GOBP REGULATION OF ANOIKIS 23 1.70e-01 5.71e-01 0.21400 -1.71e-01 -1.28e-01 1.55e-01 2.88e-01
Establishment of Sister Chromatid Cohesion 9 5.49e-01 8.53e-01 0.21400 3.69e-02 -2.10e-01 8.48e-01 2.74e-01
GOBP NEGATIVE REGULATION OF FATTY ACID BETA OXIDATION 6 6.87e-01 9.06e-01 0.21400 -9.89e-02 1.89e-01 6.75e-01 4.22e-01
GOCC CTF18 RFC LIKE COMPLEX 8 5.38e-01 8.49e-01 0.21400 1.58e-01 1.43e-01 4.38e-01 4.83e-01
p130Cas linkage to MAPK signaling for integrins 15 3.33e-01 7.35e-01 0.21400 -2.07e-01 -5.31e-02 1.65e-01 7.22e-01
GOBP MESENCHYMAL CELL MIGRATION 59 1.55e-02 1.98e-01 0.21400 -2.13e-01 -1.91e-02 4.72e-03 7.99e-01
GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION 37 9.78e-02 4.57e-01 0.21300 -1.93e-01 9.22e-02 4.27e-02 3.32e-01
GOBP GROWTH PLATE CARTILAGE DEVELOPMENT 19 2.31e-01 6.49e-01 0.21300 -1.66e-01 -1.34e-01 2.09e-01 3.13e-01
GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY 8 5.51e-01 8.53e-01 0.21300 2.00e-01 7.44e-02 3.27e-01 7.15e-01
GOBP SNARE COMPLEX ASSEMBLY 22 2.07e-01 6.22e-01 0.21300 -2.11e-01 -3.37e-02 8.71e-02 7.85e-01
GOBP DETOXIFICATION OF NITROGEN COMPOUND 5 7.35e-01 9.23e-01 0.21300 -1.74e-01 1.24e-01 5.02e-01 6.31e-01
GOMF ACTIVIN BINDING 11 5.12e-01 8.35e-01 0.21300 -1.47e-01 1.55e-01 4.00e-01 3.74e-01
GOMF WNT RECEPTOR ACTIVITY 17 3.55e-01 7.48e-01 0.21300 -1.60e-01 1.40e-01 2.53e-01 3.16e-01
GOBP MICROTUBULE ANCHORING 23 2.12e-01 6.29e-01 0.21300 -2.12e-01 2.09e-02 7.83e-02 8.62e-01
GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS 65 1.19e-02 1.72e-01 0.21300 9.20e-03 -2.13e-01 8.98e-01 2.99e-03
GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 10 5.42e-01 8.50e-01 0.21300 -1.23e-01 1.74e-01 5.02e-01 3.40e-01
Erythrocytes take up carbon dioxide and release oxygen 12 4.68e-01 8.14e-01 0.21300 1.97e-01 -8.07e-02 2.37e-01 6.28e-01
O2/CO2 exchange in erythrocytes 12 4.68e-01 8.14e-01 0.21300 1.97e-01 -8.07e-02 2.37e-01 6.28e-01
Activation of the TFAP2 (AP-2) family of transcription factors 11 4.53e-01 8.07e-01 0.21300 -2.09e-01 -3.94e-02 2.29e-01 8.21e-01
GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION 10 4.85e-01 8.23e-01 0.21300 -2.08e-01 -4.49e-02 2.54e-01 8.06e-01
GOBP VESICLE TETHERING 31 1.11e-01 4.83e-01 0.21300 -2.11e-01 -2.53e-02 4.16e-02 8.07e-01
H139Hfs13* PPM1K causes a mild variant of MSUD 5 7.01e-01 9.12e-01 0.21300 -2.11e-01 -2.78e-02 4.14e-01 9.14e-01
Maple Syrup Urine Disease 5 7.01e-01 9.12e-01 0.21300 -2.11e-01 -2.78e-02 4.14e-01 9.14e-01
GOMF ALPHA ACTININ BINDING 28 1.82e-01 5.86e-01 0.21300 -1.35e-01 1.65e-01 2.16e-01 1.32e-01
GOBP REGULATION OF BMP SIGNALING PATHWAY 117 6.27e-04 2.24e-02 0.21300 -1.98e-01 7.84e-02 2.17e-04 1.43e-01
GOCC PREFOLDIN COMPLEX 6 6.32e-01 8.86e-01 0.21300 -1.77e-01 -1.18e-01 4.53e-01 6.15e-01
GOCC HEMOGLOBIN COMPLEX 12 4.67e-01 8.14e-01 0.21300 1.99e-01 -7.47e-02 2.32e-01 6.54e-01
GOCC GAMMA SECRETASE COMPLEX 7 5.94e-01 8.71e-01 0.21300 -7.94e-02 -1.97e-01 7.16e-01 3.66e-01
Myoclonic epilepsy of Lafora 9 5.41e-01 8.50e-01 0.21300 6.96e-03 -2.13e-01 9.71e-01 2.69e-01
TP53 Regulates Transcription of Death Receptors and Ligands 12 4.56e-01 8.09e-01 0.21300 -4.56e-02 2.08e-01 7.84e-01 2.13e-01
Adrenaline,noradrenaline inhibits insulin secretion 28 1.50e-01 5.45e-01 0.21300 -2.12e-01 1.33e-02 5.19e-02 9.03e-01
GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS 16 3.54e-01 7.47e-01 0.21300 5.14e-02 -2.06e-01 7.22e-01 1.53e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 20 2.33e-01 6.50e-01 0.21300 -2.05e-01 -5.55e-02 1.12e-01 6.67e-01
GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY 7 5.86e-01 8.67e-01 0.21300 -1.71e-01 -1.26e-01 4.33e-01 5.63e-01
GOBP SKELETAL MUSCLE CELL DIFFERENTIATION 78 4.52e-03 9.31e-02 0.21300 -2.12e-01 -9.84e-03 1.18e-03 8.81e-01
GOBP RESPONSE TO HYPEROXIA 17 3.34e-01 7.35e-01 0.21200 -2.05e-01 5.62e-02 1.44e-01 6.88e-01
HSF1 activation 26 2.06e-01 6.21e-01 0.21200 1.27e-01 -1.70e-01 2.64e-01 1.32e-01
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION 36 9.72e-02 4.55e-01 0.21200 5.05e-02 -2.06e-01 6.00e-01 3.22e-02
GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY 14 3.43e-01 7.40e-01 0.21200 -1.62e-01 -1.37e-01 2.94e-01 3.74e-01
GOMF RECEPTOR SIGNALING PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY 5 7.17e-01 9.15e-01 0.21200 -2.76e-02 2.10e-01 9.15e-01 4.15e-01
GOCC SYMMETRIC SYNAPSE 8 5.83e-01 8.66e-01 0.21200 -1.46e-02 2.12e-01 9.43e-01 3.00e-01
GOCC NLRP3 INFLAMMASOME COMPLEX 7 6.01e-01 8.75e-01 0.21200 2.03e-01 6.08e-02 3.52e-01 7.81e-01
GOBP VASODILATION 49 2.42e-02 2.50e-01 0.21200 -1.70e-01 -1.26e-01 3.90e-02 1.27e-01
GABA synthesis, release, reuptake and degradation 19 2.49e-01 6.63e-01 0.21200 -6.85e-02 -2.01e-01 6.05e-01 1.30e-01
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane 18 2.88e-01 7.01e-01 0.21200 2.12e-01 1.17e-02 1.20e-01 9.31e-01
GOCC CLATHRIN ADAPTOR COMPLEX 26 1.89e-01 5.96e-01 0.21200 -2.04e-01 5.72e-02 7.16e-02 6.13e-01
Regulation of Apoptosis 40 5.18e-02 3.45e-01 0.21200 -8.30e-02 -1.95e-01 3.64e-01 3.28e-02
GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS 14 4.27e-01 7.94e-01 0.21200 1.21e-01 -1.74e-01 4.32e-01 2.60e-01
GOBP HRI MEDIATED SIGNALING 6 6.93e-01 9.09e-01 0.21200 1.11e-01 -1.80e-01 6.37e-01 4.44e-01
GOBP POSITIVE REGULATION OF TELOMERE CAPPING 17 3.35e-01 7.35e-01 0.21200 5.40e-02 -2.05e-01 7.00e-01 1.44e-01
GOBP RIBOFLAVIN TRANSPORT 6 6.38e-01 8.88e-01 0.21200 9.95e-02 1.87e-01 6.73e-01 4.28e-01
GOMF RIBOFLAVIN TRANSMEMBRANE TRANSPORTER ACTIVITY 6 6.38e-01 8.88e-01 0.21200 9.95e-02 1.87e-01 6.73e-01 4.28e-01
GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 28 1.86e-01 5.91e-01 0.21200 1.53e-01 -1.46e-01 1.61e-01 1.80e-01
GOMF SOLUTE PROTON SYMPORTER ACTIVITY 24 1.65e-01 5.65e-01 0.21200 1.05e-01 1.84e-01 3.74e-01 1.19e-01
GOBP DOPAMINE BIOSYNTHETIC PROCESS 12 4.49e-01 8.04e-01 0.21200 -1.81e-02 2.11e-01 9.14e-01 2.06e-01
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION 6 6.78e-01 9.04e-01 0.21200 -4.48e-02 2.07e-01 8.49e-01 3.80e-01
Downregulation of ERBB4 signaling 9 5.65e-01 8.58e-01 0.21200 6.55e-02 -2.01e-01 7.34e-01 2.96e-01
GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS 10 4.67e-01 8.14e-01 0.21200 1.56e-01 1.43e-01 3.93e-01 4.33e-01
NGF-stimulated transcription 38 7.88e-02 4.18e-01 0.21200 1.52e-02 -2.11e-01 8.71e-01 2.43e-02
GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY 36 9.31e-02 4.46e-01 0.21200 -2.10e-01 2.71e-02 2.93e-02 7.78e-01
GOCC CHROMOSOME PASSENGER COMPLEX 6 6.69e-01 9.00e-01 0.21200 -1.33e-02 2.11e-01 9.55e-01 3.71e-01
GOMF AMIDINE LYASE ACTIVITY 7 5.99e-01 8.73e-01 0.21200 7.39e-02 1.98e-01 7.35e-01 3.64e-01
GOBP NEGATIVE REGULATION OF CHOLESTEROL EFFLUX 22 2.64e-01 6.79e-01 0.21200 -1.20e-01 1.74e-01 3.28e-01 1.58e-01
GOBP REGULATION OF MIRNA CATABOLIC PROCESS 8 5.48e-01 8.52e-01 0.21100 -1.80e-01 -1.11e-01 3.78e-01 5.87e-01
GOMF ADENYLATE CYCLASE BINDING 12 4.36e-01 7.97e-01 0.21100 -1.73e-02 -2.11e-01 9.18e-01 2.06e-01
GOCC GBAF COMPLEX 14 4.28e-01 7.94e-01 0.21100 -1.76e-01 1.18e-01 2.55e-01 4.46e-01
GOMF VIRION BINDING 10 5.42e-01 8.50e-01 0.21100 1.86e-01 -1.00e-01 3.08e-01 5.83e-01
GOBP OPSONIZATION 16 3.14e-01 7.22e-01 0.21100 6.16e-02 2.02e-01 6.70e-01 1.61e-01
GOCC TETRASPANIN ENRICHED MICRODOMAIN 10 5.02e-01 8.30e-01 0.21100 1.28e-02 2.11e-01 9.44e-01 2.48e-01
Androgen biosynthesis 11 4.42e-01 8.00e-01 0.21100 9.32e-02 1.90e-01 5.93e-01 2.76e-01
GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX 8 5.52e-01 8.54e-01 0.21100 -1.89e-01 -9.50e-02 3.55e-01 6.42e-01
Modulation of host responses by IFN-stimulated genes 18 2.67e-01 6.81e-01 0.21100 -1.95e-01 -8.01e-02 1.51e-01 5.56e-01
DNA Damage Bypass 46 3.49e-02 2.89e-01 0.21100 -7.45e-02 -1.98e-01 3.82e-01 2.04e-02
GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 7 6.34e-01 8.86e-01 0.21100 2.08e-01 -3.43e-02 3.40e-01 8.75e-01
Translesion Synthesis by POLH 18 3.35e-01 7.35e-01 0.21100 1.06e-01 -1.82e-01 4.36e-01 1.80e-01
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 52 3.68e-02 2.95e-01 0.21100 -2.03e-01 5.64e-02 1.12e-02 4.82e-01
GOBP SPINAL CORD DEVELOPMENT 96 1.73e-03 4.88e-02 0.21100 -2.10e-01 1.58e-02 3.66e-04 7.89e-01
GOMF RETINAL BINDING 19 2.44e-01 6.58e-01 0.21100 1.85e-01 1.01e-01 1.62e-01 4.48e-01
GRB2:SOS provides linkage to MAPK signaling for Integrins 15 3.24e-01 7.28e-01 0.21100 -1.71e-01 -1.24e-01 2.52e-01 4.07e-01
GOBP COPII COATED VESICLE CARGO LOADING 18 2.83e-01 6.95e-01 0.21100 -2.08e-01 -3.43e-02 1.26e-01 8.01e-01
GOBP GROOMING BEHAVIOR 18 3.00e-01 7.11e-01 0.21100 -2.11e-01 9.61e-03 1.22e-01 9.44e-01
APC-Cdc20 mediated degradation of Nek2A 26 1.99e-01 6.12e-01 0.21100 7.83e-02 -1.96e-01 4.89e-01 8.39e-02
GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS 7 6.37e-01 8.87e-01 0.21100 -2.06e-01 4.35e-02 3.44e-01 8.42e-01
GOMF PHOTORECEPTOR ACTIVITY 13 4.41e-01 8.00e-01 0.21100 -2.01e-01 6.40e-02 2.10e-01 6.89e-01
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH 31 9.94e-02 4.61e-01 0.21100 -1.82e-01 -1.07e-01 7.99e-02 3.03e-01
GOBP TRACHEA FORMATION 7 6.36e-01 8.87e-01 0.21100 -2.07e-01 4.10e-02 3.43e-01 8.51e-01
GOMF GLUCURONOSYLTRANSFERASE ACTIVITY 33 1.40e-01 5.31e-01 0.21100 1.41e-01 -1.57e-01 1.62e-01 1.19e-01
GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 11 4.38e-01 7.98e-01 0.21100 1.67e-01 1.28e-01 3.37e-01 4.61e-01
GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION 21 2.67e-01 6.82e-01 0.21100 -6.42e-02 2.01e-01 6.11e-01 1.12e-01
Heme degradation 16 3.76e-01 7.63e-01 0.21100 1.89e-01 -9.32e-02 1.91e-01 5.19e-01
GOBP SKELETAL MUSCLE CELL PROLIFERATION 24 1.66e-01 5.66e-01 0.21100 -1.24e-01 -1.70e-01 2.92e-01 1.49e-01
RNA Polymerase III Transcription Initiation From Type 2 Promoter 27 1.31e-01 5.17e-01 0.21100 -1.50e-01 -1.48e-01 1.77e-01 1.84e-01
GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY 16 3.00e-01 7.11e-01 0.21100 -1.56e-01 -1.42e-01 2.81e-01 3.27e-01
GOBP RESPONSE TO ERYTHROPOIETIN 7 5.96e-01 8.72e-01 0.21100 -9.69e-02 -1.87e-01 6.57e-01 3.92e-01
GOCC GROWTH FACTOR COMPLEX 8 5.53e-01 8.54e-01 0.21100 -1.84e-01 -1.02e-01 3.68e-01 6.16e-01
GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION 7 6.51e-01 8.92e-01 0.21100 -8.98e-02 1.90e-01 6.81e-01 3.83e-01
GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME 15 3.35e-01 7.35e-01 0.21000 -8.08e-02 -1.94e-01 5.88e-01 1.93e-01
Metabolism of RNA 677 4.21e-20 7.39e-17 0.21000 -7.37e-03 -2.10e-01 7.44e-01 9.98e-21
GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY 47 3.17e-02 2.79e-01 0.21000 -1.89e-01 -9.30e-02 2.52e-02 2.70e-01
GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION 13 3.91e-01 7.71e-01 0.21000 7.09e-02 1.98e-01 6.58e-01 2.16e-01
Regulation of TP53 Activity through Phosphorylation 89 2.46e-03 6.31e-02 0.21000 -6.66e-03 -2.10e-01 9.13e-01 6.09e-04
GOBP ENDOCYTIC RECYCLING 83 7.15e-03 1.24e-01 0.21000 -1.23e-01 1.70e-01 5.25e-02 7.25e-03
GOBP B 1 B CELL DIFFERENTIATION 5 6.99e-01 9.11e-01 0.21000 2.01e-01 6.22e-02 4.37e-01 8.10e-01
GOBP ENDOCHONDRAL BONE MORPHOGENESIS 57 1.83e-02 2.16e-01 0.21000 -2.06e-01 -4.22e-02 7.14e-03 5.82e-01
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX 29 1.25e-01 5.05e-01 0.21000 -6.53e-02 -2.00e-01 5.43e-01 6.25e-02
Triglyceride biosynthesis 12 4.09e-01 7.83e-01 0.21000 1.16e-01 1.75e-01 4.86e-01 2.93e-01
GOBP EOSINOPHIL MEDIATED IMMUNITY 8 6.06e-01 8.76e-01 0.21000 -6.21e-02 2.01e-01 7.61e-01 3.25e-01
Formation of apoptosome 10 4.86e-01 8.23e-01 0.21000 -7.22e-02 -1.97e-01 6.93e-01 2.80e-01
Regulation of the apoptosome activity 10 4.86e-01 8.23e-01 0.21000 -7.22e-02 -1.97e-01 6.93e-01 2.80e-01
GOBP REGULATION OF SREBP SIGNALING PATHWAY 8 5.57e-01 8.56e-01 0.21000 -8.76e-02 -1.91e-01 6.68e-01 3.49e-01
GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY 24 2.37e-01 6.54e-01 0.21000 -1.78e-01 1.12e-01 1.32e-01 3.41e-01
GOBP REGULATION OF TRANSLATION AT SYNAPSE 8 6.14e-01 8.79e-01 0.21000 -1.89e-01 9.18e-02 3.55e-01 6.53e-01
ROBO receptors bind AKAP5 9 5.84e-01 8.67e-01 0.21000 -1.73e-01 1.20e-01 3.70e-01 5.34e-01
GOBP PROTEOGLYCAN METABOLIC PROCESS 85 6.25e-03 1.15e-01 0.21000 -1.77e-01 1.13e-01 4.84e-03 7.06e-02
GOBP NEGATIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION 6 6.39e-01 8.88e-01 0.21000 -1.65e-01 -1.30e-01 4.85e-01 5.80e-01
GOBP SULFUR AMINO ACID TRANSPORT 12 4.07e-01 7.81e-01 0.21000 1.39e-01 1.57e-01 4.03e-01 3.46e-01
Assembly of the pre-replicative complex 96 1.36e-03 4.13e-02 0.21000 -2.70e-02 -2.08e-01 6.48e-01 4.24e-04
GOBP REGULATION OF AMYLOID BETA CLEARANCE 19 2.44e-01 6.58e-01 0.21000 -1.73e-01 -1.19e-01 1.92e-01 3.70e-01
GOMF FATTY ACYL COA SYNTHASE ACTIVITY 7 5.97e-01 8.73e-01 0.21000 -1.02e-01 -1.83e-01 6.40e-01 4.01e-01
GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 22 2.57e-01 6.71e-01 0.21000 -1.97e-01 7.24e-02 1.10e-01 5.57e-01
GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 52 3.21e-02 2.81e-01 0.21000 -2.10e-01 8.96e-03 8.92e-03 9.11e-01
GOBP NEURON PROJECTION MAINTENANCE 11 5.22e-01 8.41e-01 0.21000 -1.60e-01 1.36e-01 3.58e-01 4.36e-01
GOMF ACETYLATION DEPENDENT PROTEIN BINDING 25 2.16e-01 6.34e-01 0.21000 -1.93e-01 8.12e-02 9.42e-02 4.82e-01
GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II 16 3.04e-01 7.14e-01 0.21000 -1.27e-01 -1.67e-01 3.79e-01 2.47e-01
GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS 30 1.65e-01 5.65e-01 0.21000 -1.82e-01 1.05e-01 8.50e-02 3.21e-01
GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY 7 5.96e-01 8.72e-01 0.21000 1.11e-01 1.78e-01 6.10e-01 4.15e-01
GOBP SOMATOTROPIN SECRETING CELL DIFFERENTIATION 5 6.89e-01 9.08e-01 0.21000 -1.69e-01 -1.24e-01 5.13e-01 6.31e-01
GOBP METHYLGLYOXAL METABOLIC PROCESS 6 6.78e-01 9.04e-01 0.21000 -2.83e-02 2.08e-01 9.05e-01 3.78e-01
GOMF COMPLEMENT COMPONENT C3B BINDING 8 6.23e-01 8.82e-01 0.21000 1.31e-01 -1.63e-01 5.20e-01 4.23e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I 8 5.76e-01 8.64e-01 0.21000 2.85e-02 2.08e-01 8.89e-01 3.09e-01
Diseases associated with O-glycosylation of proteins 68 7.25e-03 1.26e-01 0.21000 1.91e-01 8.55e-02 6.36e-03 2.23e-01
GOMF RAGE RECEPTOR BINDING 10 5.34e-01 8.46e-01 0.21000 5.52e-02 -2.02e-01 7.62e-01 2.68e-01
Defective homologous recombination repair (HRR) due to BRCA2 loss of function 41 5.22e-02 3.45e-01 0.21000 -7.71e-02 -1.95e-01 3.93e-01 3.08e-02
Diseases of DNA Double-Strand Break Repair 41 5.22e-02 3.45e-01 0.21000 -7.71e-02 -1.95e-01 3.93e-01 3.08e-02
GOMF PROTEIN KINASE C BINDING 51 3.12e-02 2.76e-01 0.21000 -2.09e-01 -1.87e-02 9.92e-03 8.18e-01
GOBP RESPONSE TO OZONE 5 6.94e-01 9.10e-01 0.21000 9.69e-02 1.86e-01 7.08e-01 4.72e-01
Free fatty acid receptors 5 7.32e-01 9.23e-01 0.20900 -6.14e-02 2.00e-01 8.12e-01 4.38e-01
GOBP MEIOTIC SPINDLE ORGANIZATION 18 2.78e-01 6.92e-01 0.20900 -2.00e-01 -6.23e-02 1.42e-01 6.47e-01
GOBP CELL DIFFERENTIATION IN SPINAL CORD 49 3.88e-02 3.03e-01 0.20900 -2.09e-01 2.87e-03 1.12e-02 9.72e-01
GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS 64 1.76e-02 2.11e-01 0.20900 -2.04e-01 4.68e-02 4.74e-03 5.18e-01
GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY 7 6.62e-01 8.97e-01 0.20900 -1.44e-01 1.52e-01 5.09e-01 4.87e-01
GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING 12 4.89e-01 8.25e-01 0.20900 1.09e-01 -1.79e-01 5.14e-01 2.84e-01
CD28 dependent Vav1 pathway 11 5.13e-01 8.36e-01 0.20900 8.51e-02 -1.91e-01 6.25e-01 2.72e-01
Regulation of MITF-M-dependent genes involved in pigmentation 41 7.59e-02 4.12e-01 0.20900 -2.03e-01 4.90e-02 2.42e-02 5.87e-01
GOBP NEGATIVE REGULATION OF MYELINATION 9 5.71e-01 8.61e-01 0.20900 5.89e-02 -2.01e-01 7.59e-01 2.97e-01
Regulation of PTEN mRNA translation 25 2.09e-01 6.25e-01 0.20900 -2.02e-01 5.36e-02 8.01e-02 6.43e-01
GOMF COMPLEMENT COMPONENT C1Q COMPLEX BINDING 8 5.98e-01 8.73e-01 0.20900 3.07e-02 -2.07e-01 8.80e-01 3.11e-01
GOBP REGULATION OF MEMBRANE TUBULATION 5 7.00e-01 9.12e-01 0.20900 -1.98e-01 -6.72e-02 4.43e-01 7.95e-01
GOMF RIBOSOME BINDING 94 1.41e-03 4.20e-02 0.20900 -4.91e-02 -2.03e-01 4.10e-01 6.57e-04
GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY 15 3.97e-01 7.76e-01 0.20900 -1.97e-01 7.02e-02 1.86e-01 6.38e-01
WNT ligand biogenesis and trafficking 25 2.26e-01 6.45e-01 0.20900 1.78e-01 -1.10e-01 1.24e-01 3.40e-01
GOMF CUPROUS ION BINDING 8 6.19e-01 8.80e-01 0.20900 -1.84e-01 9.87e-02 3.67e-01 6.29e-01
GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION 8 5.60e-01 8.57e-01 0.20900 -8.93e-02 -1.89e-01 6.62e-01 3.54e-01
GOCC CONDENSIN COMPLEX 8 5.60e-01 8.57e-01 0.20900 -8.93e-02 -1.89e-01 6.62e-01 3.54e-01
GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY 43 6.36e-02 3.79e-01 0.20900 -3.06e-02 2.07e-01 7.28e-01 1.89e-02
GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION 12 4.94e-01 8.28e-01 0.20900 -1.33e-01 1.61e-01 4.26e-01 3.33e-01
GOMF ALDEHYDE LYASE ACTIVITY 9 5.23e-01 8.41e-01 0.20900 8.33e-02 1.92e-01 6.65e-01 3.19e-01
GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 8 6.11e-01 8.78e-01 0.20900 6.63e-02 -1.98e-01 7.45e-01 3.32e-01
GOBP SOMATIC STEM CELL POPULATION MAINTENANCE 64 9.07e-03 1.45e-01 0.20900 -1.72e-01 -1.18e-01 1.71e-02 1.02e-01
GOMF PROTEASOME BINDING 17 3.34e-01 7.35e-01 0.20900 -2.56e-02 2.07e-01 8.55e-01 1.39e-01
GOBP PROTEIN TRANSPORT WITHIN LIPID BILAYER 6 6.49e-01 8.91e-01 0.20900 -8.14e-02 -1.92e-01 7.30e-01 4.14e-01
RHOT1 GTPase cycle 5 7.09e-01 9.13e-01 0.20900 -3.42e-02 -2.06e-01 8.95e-01 4.25e-01
GOBP ISOPRENOID CATABOLIC PROCESS 10 4.79e-01 8.21e-01 0.20900 1.18e-01 1.72e-01 5.17e-01 3.46e-01
Platelet calcium homeostasis 27 2.06e-01 6.21e-01 0.20900 -1.61e-01 1.33e-01 1.47e-01 2.33e-01
GOBP MESENCHYMAL STEM CELL PROLIFERATION 10 5.35e-01 8.47e-01 0.20900 2.02e-01 -5.18e-02 2.68e-01 7.77e-01
GOBP REGULATION OF MDA 5 SIGNALING PATHWAY 6 6.63e-01 8.97e-01 0.20900 3.18e-02 2.06e-01 8.93e-01 3.82e-01
GOCC GTPASE ACTIVATOR COMPLEX 11 4.57e-01 8.09e-01 0.20900 -1.96e-01 -7.13e-02 2.60e-01 6.82e-01
GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS 11 5.25e-01 8.42e-01 0.20900 1.29e-01 -1.64e-01 4.58e-01 3.47e-01
GOBP CHONDROITIN SULFATE METABOLIC PROCESS 25 2.19e-01 6.37e-01 0.20900 -1.94e-01 7.62e-02 9.29e-02 5.10e-01
GOBP PHOSPHOLIPID DEPHOSPHORYLATION 40 9.09e-02 4.43e-01 0.20900 -9.03e-02 1.88e-01 3.23e-01 3.97e-02
GOCC CASPASE COMPLEX 10 4.98e-01 8.30e-01 0.20900 2.02e-01 4.98e-02 2.68e-01 7.85e-01
RHOB GTPase cycle 66 1.91e-02 2.21e-01 0.20900 -1.89e-01 8.78e-02 7.88e-03 2.17e-01
GOBP MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT 6 7.02e-01 9.12e-01 0.20800 1.73e-01 -1.17e-01 4.64e-01 6.20e-01
GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY 10 5.33e-01 8.45e-01 0.20800 -4.27e-02 2.04e-01 8.15e-01 2.64e-01
GOCC STEREOCILIUM TIP 20 3.06e-01 7.16e-01 0.20800 1.07e-01 -1.79e-01 4.07e-01 1.66e-01
GOMF LYSOPHOSPHOLIPASE ACTIVITY 26 2.06e-01 6.21e-01 0.20800 1.95e-01 -7.40e-02 8.56e-02 5.13e-01
GOBP LYSINE METABOLIC PROCESS 8 5.59e-01 8.56e-01 0.20800 -1.79e-01 -1.07e-01 3.80e-01 6.02e-01
GOBP REGULATION OF NEURON PROJECTION ARBORIZATION 14 4.36e-01 7.97e-01 0.20800 -1.82e-01 1.02e-01 2.39e-01 5.09e-01
Base-Excision Repair, AP Site Formation 40 8.47e-02 4.32e-01 0.20800 5.85e-02 -2.00e-01 5.22e-01 2.86e-02
GOBP G1 TO G0 TRANSITION 19 3.29e-01 7.33e-01 0.20800 -1.28e-01 1.65e-01 3.36e-01 2.14e-01
GOBP POSITIVE REGULATION OF CELL MATURATION 9 5.21e-01 8.41e-01 0.20800 9.91e-02 1.83e-01 6.07e-01 3.41e-01
GOBP FLUID TRANSPORT 38 6.38e-02 3.79e-01 0.20800 1.01e-01 1.82e-01 2.82e-01 5.19e-02
GOMF AMINE TRANSMEMBRANE TRANSPORTER ACTIVITY 6 7.02e-01 9.12e-01 0.20800 1.76e-01 -1.11e-01 4.56e-01 6.36e-01
GOBP NATURAL KILLER CELL ACTIVATION 90 5.42e-03 1.04e-01 0.20800 1.52e-01 -1.43e-01 1.30e-02 1.92e-02
GOMF LIM DOMAIN BINDING 5 6.98e-01 9.11e-01 0.20800 -8.87e-02 -1.88e-01 7.31e-01 4.66e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR 43 6.19e-02 3.76e-01 0.20800 1.46e-02 -2.08e-01 8.68e-01 1.85e-02
Cobalamin (Cbl) metabolism 7 6.12e-01 8.78e-01 0.20800 -1.99e-01 -6.13e-02 3.62e-01 7.79e-01
Heme biosynthesis 13 4.56e-01 8.09e-01 0.20800 8.01e-02 -1.92e-01 6.17e-01 2.30e-01
GOMF ACID AMINO ACID LIGASE ACTIVITY 23 2.62e-01 6.76e-01 0.20800 1.62e-01 -1.30e-01 1.77e-01 2.80e-01
Synaptic adhesion-like molecules 19 2.71e-01 6.85e-01 0.20800 2.04e-01 3.99e-02 1.23e-01 7.63e-01
GOCC NUCLEAR REPLICATION FORK 39 7.68e-02 4.14e-01 0.20800 -2.08e-01 -1.27e-03 2.46e-02 9.89e-01
GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS 101 2.17e-03 5.76e-02 0.20800 6.81e-02 -1.96e-01 2.37e-01 6.43e-04
GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY 36 1.16e-01 4.90e-01 0.20800 -1.90e-01 8.47e-02 4.87e-02 3.79e-01
GOCC MULTIMERIC RIBONUCLEASE P COMPLEX 10 5.04e-01 8.31e-01 0.20800 -3.97e-02 -2.04e-01 8.28e-01 2.64e-01
GOMF RIBONUCLEASE P RNA BINDING 10 5.04e-01 8.31e-01 0.20800 -3.97e-02 -2.04e-01 8.28e-01 2.64e-01
GOBP THIAMINE CONTAINING COMPOUND METABOLIC PROCESS 6 7.04e-01 9.13e-01 0.20800 1.18e-01 -1.71e-01 6.17e-01 4.68e-01
Post-chaperonin tubulin folding pathway 22 2.08e-01 6.24e-01 0.20800 1.89e-01 8.64e-02 1.25e-01 4.83e-01
GOMF COLLAGEN RECEPTOR ACTIVITY 6 6.79e-01 9.04e-01 0.20800 -1.51e-02 2.07e-01 9.49e-01 3.80e-01
GOMF CYTIDYLYLTRANSFERASE ACTIVITY 9 5.20e-01 8.40e-01 0.20800 1.74e-01 1.13e-01 3.66e-01 5.57e-01
GOBP NEUROBLAST PROLIFERATION 82 6.04e-03 1.13e-01 0.20800 -2.03e-01 4.14e-02 1.45e-03 5.17e-01
GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY 16 3.69e-01 7.58e-01 0.20800 -2.03e-01 4.33e-02 1.60e-01 7.64e-01
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY 26 2.22e-01 6.39e-01 0.20800 -1.62e-01 1.30e-01 1.53e-01 2.52e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY 61 1.18e-02 1.71e-01 0.20800 -1.29e-01 -1.63e-01 8.25e-02 2.77e-02
GOBP GERMINAL CENTER FORMATION 14 4.05e-01 7.81e-01 0.20800 -2.07e-01 1.27e-02 1.80e-01 9.34e-01
Metabolic disorders of biological oxidation enzymes 33 1.21e-01 4.98e-01 0.20700 2.07e-01 -1.71e-02 3.98e-02 8.65e-01
Transcriptional and post-translational regulation of MITF-M expression and activity 60 1.26e-02 1.77e-01 0.20700 -1.54e-01 -1.39e-01 3.93e-02 6.22e-02
GOBP AORTA DEVELOPMENT 65 2.05e-02 2.29e-01 0.20700 -1.91e-01 8.08e-02 7.70e-03 2.60e-01
GOBP SENSORY PERCEPTION OF SOUR TASTE 9 5.18e-01 8.39e-01 0.20700 1.47e-01 1.47e-01 4.46e-01 4.46e-01
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING 14 3.78e-01 7.64e-01 0.20700 -5.76e-02 -1.99e-01 7.09e-01 1.97e-01
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM 14 3.94e-01 7.74e-01 0.20700 -2.07e-01 -1.65e-02 1.80e-01 9.15e-01
GOBP REGULATION OF RECEPTOR RECYCLING 24 2.44e-01 6.59e-01 0.20700 -1.04e-01 1.80e-01 3.79e-01 1.28e-01
GOBP DE NOVO PROTEIN FOLDING 42 6.70e-02 3.91e-01 0.20700 1.28e-02 -2.07e-01 8.86e-01 2.03e-02
GOBP CENTRIOLE ELONGATION 7 6.62e-01 8.97e-01 0.20700 9.94e-02 -1.82e-01 6.49e-01 4.05e-01
GOMF TRNA METHYLTRANSFERASE ACTIVITY 32 9.72e-02 4.55e-01 0.20700 -1.56e-01 -1.37e-01 1.28e-01 1.80e-01
GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION 27 1.86e-01 5.91e-01 0.20700 2.03e-01 -3.91e-02 6.73e-02 7.25e-01
Molybdenum cofactor biosynthesis 6 6.74e-01 9.03e-01 0.20700 -7.42e-03 -2.07e-01 9.75e-01 3.80e-01
GOBP PROSTHETIC GROUP METABOLIC PROCESS 6 6.74e-01 9.03e-01 0.20700 -7.42e-03 -2.07e-01 9.75e-01 3.80e-01
GOMF CHONDROITIN SULFATE BINDING 9 5.95e-01 8.72e-01 0.20700 1.32e-01 -1.60e-01 4.93e-01 4.07e-01
GOBP EPIDERMAL CELL DIFFERENTIATION 240 1.36e-07 1.89e-05 0.20700 2.06e-01 1.82e-02 3.66e-08 6.27e-01
GOCC AMINOACYL TRNA SYNTHETASE MULTIENZYME COMPLEX 10 4.84e-01 8.23e-01 0.20700 -1.24e-01 -1.66e-01 4.96e-01 3.65e-01
GOBP UREA TRANSPORT 11 4.58e-01 8.10e-01 0.20700 1.88e-01 8.77e-02 2.82e-01 6.15e-01
GOBP REGULATION OF ICOSANOID SECRETION 21 2.32e-01 6.50e-01 0.20700 -6.26e-02 -1.97e-01 6.19e-01 1.18e-01
GOMF PIRNA BINDING 5 7.01e-01 9.12e-01 0.20700 9.01e-02 1.86e-01 7.27e-01 4.71e-01
GOMF INTRAMOLECULAR PHOSPHOTRANSFERASE ACTIVITY 10 4.87e-01 8.23e-01 0.20700 -1.10e-01 -1.75e-01 5.46e-01 3.38e-01
GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX 263 4.31e-08 6.61e-06 0.20700 -1.82e-03 -2.07e-01 9.60e-01 7.58e-09
GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY 52 3.10e-02 2.75e-01 0.20700 -2.61e-02 -2.05e-01 7.45e-01 1.05e-02
GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE 27 1.92e-01 5.99e-01 0.20700 -5.27e-02 2.00e-01 6.36e-01 7.21e-02
GOMF PRE MIRNA BINDING 9 5.21e-01 8.41e-01 0.20700 -1.66e-01 -1.24e-01 3.90e-01 5.20e-01
GOCC CATALYTIC STEP 1 SPLICEOSOME 12 4.24e-01 7.92e-01 0.20700 -1.80e-01 -1.01e-01 2.80e-01 5.44e-01
GOMF U3 SNORNA BINDING 10 4.85e-01 8.23e-01 0.20700 1.27e-01 1.63e-01 4.87e-01 3.72e-01
GOBP PROTEIN TRIMERIZATION 17 3.76e-01 7.63e-01 0.20700 1.27e-01 -1.63e-01 3.64e-01 2.45e-01
GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT 19 3.14e-01 7.22e-01 0.20700 -1.99e-01 5.45e-02 1.32e-01 6.81e-01
Impaired BRCA2 binding to RAD51 35 9.36e-02 4.47e-01 0.20700 -3.89e-02 -2.03e-01 6.90e-01 3.77e-02
GOCC AXOLEMMA 15 4.03e-01 7.80e-01 0.20700 -6.03e-02 1.98e-01 6.86e-01 1.85e-01
GOBP RESPONSE TO WATER 13 4.62e-01 8.12e-01 0.20700 -1.90e-01 8.16e-02 2.36e-01 6.11e-01
GOBP REGULATION OF FATTY ACID OXIDATION 33 1.38e-01 5.27e-01 0.20700 -1.95e-01 6.72e-02 5.21e-02 5.04e-01
GOMF DIACYLGLYCEROL BINDING 13 4.36e-01 7.97e-01 0.20700 -1.41e-02 2.06e-01 9.30e-01 1.98e-01
GOBP DETERMINATION OF LIVER LEFT RIGHT ASYMMETRY 5 7.20e-01 9.16e-01 0.20600 2.06e-01 1.18e-02 4.25e-01 9.64e-01
GOBP PLASMA CELL DIFFERENTIATION 9 5.32e-01 8.44e-01 0.20600 -1.91e-01 -7.92e-02 3.22e-01 6.81e-01
GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY 6 7.06e-01 9.13e-01 0.20600 -1.76e-01 1.07e-01 4.55e-01 6.48e-01
GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS 49 5.64e-02 3.61e-01 0.20600 -8.90e-02 1.86e-01 2.81e-01 2.42e-02
GOBP REGULATION OF POSITIVE CHEMOTAXIS 25 2.10e-01 6.26e-01 0.20600 -3.04e-02 2.04e-01 7.93e-01 7.74e-02
GOBP DENDRITE ARBORIZATION 11 4.63e-01 8.12e-01 0.20600 -1.91e-01 -7.67e-02 2.71e-01 6.59e-01
GOBP COMPLEMENT DEPENDENT CYTOTOXICITY 13 4.14e-01 7.85e-01 0.20600 -2.02e-01 -4.33e-02 2.08e-01 7.87e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE 63 1.93e-02 2.23e-01 0.20600 -2.05e-01 2.56e-02 4.96e-03 7.25e-01
GOBP POSITIVE REGULATION OF STRESS GRANULE ASSEMBLY 7 6.41e-01 8.89e-01 0.20600 1.41e-02 -2.06e-01 9.49e-01 3.46e-01
GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 5 7.44e-01 9.26e-01 0.20600 -7.95e-02 1.90e-01 7.58e-01 4.61e-01
GOMF SHORT CHAIN CARBOXYLESTERASE ACTIVITY 6 7.09e-01 9.13e-01 0.20600 -1.64e-01 1.24e-01 4.86e-01 5.98e-01
GOCC TORC1 COMPLEX 6 7.07e-01 9.13e-01 0.20600 -1.75e-01 1.09e-01 4.59e-01 6.42e-01
GOBP STRIATED MUSCLE ATROPHY 7 6.04e-01 8.76e-01 0.20600 -1.36e-01 -1.55e-01 5.34e-01 4.77e-01
GOBP ENERGY RESERVE METABOLIC PROCESS 93 4.25e-03 9.04e-02 0.20600 -1.88e-01 8.35e-02 1.69e-03 1.64e-01
GOBP AMINE BIOSYNTHETIC PROCESS 37 7.00e-02 3.97e-01 0.20600 1.61e-01 1.28e-01 8.99e-02 1.76e-01
GOMF S ADENOSYL L METHIONINE BINDING 18 2.95e-01 7.07e-01 0.20600 -4.75e-02 -2.00e-01 7.27e-01 1.41e-01
GOMF RNA POLYMERASE ACTIVITY 30 1.16e-01 4.90e-01 0.20600 -1.30e-01 -1.60e-01 2.18e-01 1.30e-01
GOMF CGMP BINDING 15 3.51e-01 7.45e-01 0.20600 7.87e-02 1.90e-01 5.97e-01 2.02e-01
GOBP OXIDATIVE PHOSPHORYLATION 125 4.55e-04 1.78e-02 0.20600 3.60e-02 -2.03e-01 4.87e-01 9.01e-05
GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY 49 3.02e-02 2.72e-01 0.20600 -1.69e-01 -1.17e-01 4.02e-02 1.56e-01
GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 20 2.86e-01 6.98e-01 0.20600 -2.04e-01 2.49e-02 1.14e-01 8.47e-01
GOBP ENDOCRINE SYSTEM DEVELOPMENT 134 1.11e-04 6.50e-03 0.20600 -1.98e-01 -5.53e-02 7.38e-05 2.69e-01
GOBP CGMP METABOLIC PROCESS 16 3.83e-01 7.67e-01 0.20600 -1.96e-01 6.33e-02 1.75e-01 6.61e-01
GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS 7 6.11e-01 8.78e-01 0.20600 1.85e-01 8.95e-02 3.96e-01 6.82e-01
GOBP REGULATION OF PROTEIN ADP RIBOSYLATION 8 6.30e-01 8.85e-01 0.20600 -1.78e-01 1.03e-01 3.83e-01 6.14e-01
Lewis blood group biosynthesis 18 2.80e-01 6.92e-01 0.20600 9.94e-02 1.80e-01 4.65e-01 1.86e-01
GOBP MEMBRANE RAFT LOCALIZATION 7 6.70e-01 9.00e-01 0.20600 -1.69e-01 1.18e-01 4.39e-01 5.90e-01
GOBP RESPONSE TO LIGHT INTENSITY 15 4.16e-01 7.86e-01 0.20600 -8.79e-02 1.86e-01 5.55e-01 2.12e-01
Telomere Extension By Telomerase 22 2.32e-01 6.50e-01 0.20600 -2.03e-01 -3.05e-02 9.86e-02 8.05e-01
GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS 32 1.54e-01 5.50e-01 0.20600 -8.63e-02 1.87e-01 3.98e-01 6.76e-02
Regulation of MECP2 expression and activity 30 1.80e-01 5.84e-01 0.20600 -1.69e-01 1.18e-01 1.10e-01 2.65e-01
GOBP DIACYLGLYCEROL METABOLIC PROCESS 26 2.00e-01 6.13e-01 0.20600 -3.24e-02 2.03e-01 7.75e-01 7.31e-02
GOBP RADIAL GLIAL CELL DIFFERENTIATION 14 4.48e-01 8.04e-01 0.20600 1.11e-01 -1.73e-01 4.72e-01 2.62e-01
eNOS activation 13 4.03e-01 7.80e-01 0.20600 -1.88e-01 -8.34e-02 2.41e-01 6.03e-01
GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY 12 4.55e-01 8.09e-01 0.20600 -1.85e-02 -2.05e-01 9.12e-01 2.19e-01
DNA Replication Pre-Initiation 111 5.48e-04 2.03e-02 0.20600 -5.20e-02 -1.99e-01 3.44e-01 2.94e-04
GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS 22 2.08e-01 6.24e-01 0.20600 1.65e-01 1.22e-01 1.80e-01 3.21e-01
GOBP REGULATION OF RESPONSE TO TUMOR CELL 24 2.29e-01 6.47e-01 0.20600 2.02e-01 -3.73e-02 8.65e-02 7.52e-01
GOCC DENSE CORE GRANULE 38 1.04e-01 4.70e-01 0.20600 -1.94e-01 6.71e-02 3.82e-02 4.74e-01
E3 ubiquitin ligases ubiquitinate target proteins 55 2.93e-02 2.70e-01 0.20600 -9.08e-04 -2.06e-01 9.91e-01 8.37e-03
RORA activates gene expression 17 3.80e-01 7.65e-01 0.20500 -1.64e-01 1.23e-01 2.41e-01 3.79e-01
GOBP BONE TRABECULA MORPHOGENESIS 14 4.01e-01 7.78e-01 0.20500 -2.05e-01 -1.59e-02 1.85e-01 9.18e-01
GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS 21 2.94e-01 7.07e-01 0.20500 -1.85e-01 8.85e-02 1.41e-01 4.83e-01
GOBP ASPARAGINE METABOLIC PROCESS 5 7.03e-01 9.12e-01 0.20500 1.79e-01 1.01e-01 4.89e-01 6.95e-01
GOBP RETINA HOMEOSTASIS 54 4.49e-02 3.23e-01 0.20500 1.78e-01 -1.02e-01 2.35e-02 1.95e-01
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol 23 2.69e-01 6.83e-01 0.20500 -1.12e-01 1.72e-01 3.53e-01 1.53e-01
GOMF LACTATE TRANSMEMBRANE TRANSPORTER ACTIVITY 6 6.87e-01 9.06e-01 0.20500 2.04e-01 -1.96e-02 3.86e-01 9.34e-01
GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION 96 3.32e-03 7.86e-02 0.20500 -6.19e-02 1.96e-01 2.94e-01 9.22e-04
GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 60 3.36e-02 2.85e-01 0.20500 -1.60e-01 1.29e-01 3.23e-02 8.47e-02
GOBP POSTREPLICATION REPAIR 35 8.21e-02 4.25e-01 0.20500 -1.40e-01 -1.50e-01 1.52e-01 1.24e-01
GOBP REGULATION OF AMYLOID FIBRIL FORMATION 16 3.28e-01 7.31e-01 0.20500 -8.60e-02 -1.86e-01 5.52e-01 1.97e-01
Thyroxine biosynthesis 10 5.27e-01 8.42e-01 0.20500 -2.05e-01 -1.63e-03 2.61e-01 9.93e-01
GOBP ATP BIOSYNTHETIC PROCESS 86 4.78e-03 9.66e-02 0.20500 2.19e-02 -2.04e-01 7.26e-01 1.08e-03
GOBP NEGATIVE REGULATION OF LENS FIBER CELL DIFFERENTIATION 6 6.63e-01 8.97e-01 0.20500 -1.94e-01 -6.57e-02 4.10e-01 7.81e-01
GOBP STRESS INDUCED PREMATURE SENESCENCE 8 5.67e-01 8.59e-01 0.20500 -1.66e-01 -1.20e-01 4.15e-01 5.57e-01
GOBP RESPONSE TO VITAMIN A 15 4.30e-01 7.94e-01 0.20500 -1.55e-01 1.34e-01 2.99e-01 3.69e-01
Pentose phosphate pathway 12 4.75e-01 8.18e-01 0.20500 -2.29e-02 2.03e-01 8.91e-01 2.22e-01
GOBP REGULATION OF TOLERANCE INDUCTION 18 3.61e-01 7.52e-01 0.20500 1.19e-01 -1.67e-01 3.84e-01 2.20e-01
GOBP NUCLEAR BODY ORGANIZATION 17 3.21e-01 7.28e-01 0.20500 -2.00e-01 -4.27e-02 1.53e-01 7.60e-01
GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE 12 5.02e-01 8.30e-01 0.20500 -1.81e-01 9.57e-02 2.78e-01 5.66e-01
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT 35 1.34e-01 5.21e-01 0.20500 -1.82e-01 9.43e-02 6.29e-02 3.34e-01
Sodium-coupled sulphate, di- and tri-carboxylate transporters 5 7.02e-01 9.12e-01 0.20500 1.23e-01 1.63e-01 6.34e-01 5.27e-01
GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY 51 5.67e-02 3.62e-01 0.20500 -1.61e-01 1.26e-01 4.62e-02 1.20e-01
GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS 22 2.10e-01 6.26e-01 0.20500 1.30e-01 1.58e-01 2.92e-01 1.99e-01
GOMF MONOSACCHARIDE BINDING 72 1.79e-02 2.12e-01 0.20400 -1.41e-01 1.48e-01 3.92e-02 2.94e-02
GOBP REGULATION OF MICROVILLUS ASSEMBLY 6 6.75e-01 9.04e-01 0.20400 2.03e-01 2.62e-02 3.90e-01 9.12e-01
GOBP POSITIVE REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS 5 7.42e-01 9.26e-01 0.20400 -5.41e-02 1.97e-01 8.34e-01 4.46e-01
rRNA modification in the nucleus and cytosol 57 3.28e-02 2.83e-01 0.20400 4.75e-02 -1.99e-01 5.35e-01 9.48e-03
GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS 20 2.64e-01 6.79e-01 0.20400 -1.99e-01 -4.48e-02 1.23e-01 7.29e-01
GLI3 is processed to GLI3R by the proteasome 47 3.61e-02 2.93e-01 0.20400 -1.37e-01 -1.52e-01 1.05e-01 7.18e-02
Caspase activation via extrinsic apoptotic signalling pathway 25 2.45e-01 6.59e-01 0.20400 1.66e-01 -1.19e-01 1.51e-01 3.04e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS 12 4.71e-01 8.15e-01 0.20400 8.12e-03 -2.04e-01 9.61e-01 2.21e-01
GOCC SMALL SUBUNIT PROCESSOME 69 1.56e-02 1.99e-01 0.20400 4.03e-02 -2.00e-01 5.63e-01 4.05e-03
GOBP VESTIBULOCOCHLEAR NERVE DEVELOPMENT 11 5.18e-01 8.39e-01 0.20400 -1.98e-01 4.91e-02 2.55e-01 7.78e-01
GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY 72 1.40e-02 1.88e-01 0.20400 1.97e-01 -5.42e-02 3.89e-03 4.27e-01
GOBP NEGATIVE REGULATION OF RECEPTOR RECYCLING 5 7.56e-01 9.30e-01 0.20400 1.34e-01 -1.54e-01 6.04e-01 5.51e-01
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer’s disease models 22 2.91e-01 7.03e-01 0.20400 1.63e-01 -1.22e-01 1.85e-01 3.21e-01
Neurodegenerative Diseases 22 2.91e-01 7.03e-01 0.20400 1.63e-01 -1.22e-01 1.85e-01 3.21e-01
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks 55 2.33e-02 2.44e-01 0.20400 -7.70e-02 -1.89e-01 3.23e-01 1.54e-02
GOBP CARDIAC CHAMBER FORMATION 12 5.08e-01 8.34e-01 0.20400 -1.13e-01 1.70e-01 4.97e-01 3.09e-01
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY 13 4.65e-01 8.13e-01 0.20400 -1.94e-01 6.20e-02 2.25e-01 6.99e-01
GOBP GLUCAN BIOSYNTHETIC PROCESS 44 8.03e-02 4.20e-01 0.20400 -1.84e-01 8.80e-02 3.48e-02 3.12e-01
GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS 20 2.94e-01 7.07e-01 0.20400 -2.58e-02 2.02e-01 8.41e-01 1.17e-01
GOBP GASTRIC ACID SECRETION 13 4.60e-01 8.10e-01 0.20400 -4.87e-02 1.98e-01 7.61e-01 2.17e-01
GOCC SYNAPTOBREVIN 2 SNAP 25 SYNTAXIN 1A COMPLEX 5 7.54e-01 9.30e-01 0.20400 -1.10e-01 1.71e-01 6.69e-01 5.07e-01
GOMF SNRNP BINDING 9 5.73e-01 8.61e-01 0.20400 1.77e-02 -2.03e-01 9.27e-01 2.92e-01
GOBP TRANSLESION SYNTHESIS 26 1.61e-01 5.59e-01 0.20400 -1.60e-01 -1.26e-01 1.58e-01 2.66e-01
Synthesis of diphthamide-EEF2 8 5.77e-01 8.64e-01 0.20400 -8.55e-02 -1.85e-01 6.75e-01 3.65e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA 9 5.58e-01 8.56e-01 0.20400 -2.38e-02 -2.02e-01 9.02e-01 2.93e-01
Myogenesis 29 1.87e-01 5.92e-01 0.20400 -1.89e-01 7.67e-02 7.87e-02 4.75e-01
GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY 11 4.78e-01 8.20e-01 0.20400 -1.95e-01 -5.90e-02 2.63e-01 7.35e-01
GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE 7 6.32e-01 8.86e-01 0.20400 -3.39e-02 -2.01e-01 8.77e-01 3.58e-01
GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 26 1.77e-01 5.82e-01 0.20400 -1.97e-01 -5.18e-02 8.23e-02 6.48e-01
GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY 95 3.09e-03 7.51e-02 0.20400 2.02e-01 -2.63e-02 6.75e-04 6.57e-01
GOBP REGULATION OF RESPONSE TO NUTRIENT LEVELS 30 1.21e-01 4.99e-01 0.20300 -1.41e-01 -1.46e-01 1.80e-01 1.65e-01
GOBP CELLULAR RESPONSE TO L GLUTAMATE 6 6.93e-01 9.09e-01 0.20300 2.64e-02 -2.02e-01 9.11e-01 3.92e-01
GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION 49 4.35e-02 3.17e-01 0.20300 -2.03e-01 -1.62e-02 1.40e-02 8.45e-01
GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 94 5.52e-03 1.05e-01 0.20300 -1.41e-01 1.47e-01 1.83e-02 1.39e-02
GOCC SERINE TYPE ENDOPEPTIDASE COMPLEX 11 4.96e-01 8.29e-01 0.20300 1.24e-02 2.03e-01 9.43e-01 2.44e-01
Acetylcholine binding and downstream events 14 4.44e-01 8.01e-01 0.20300 7.20e-02 -1.90e-01 6.41e-01 2.18e-01
Postsynaptic nicotinic acetylcholine receptors 14 4.44e-01 8.01e-01 0.20300 7.20e-02 -1.90e-01 6.41e-01 2.18e-01
GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX 16 3.41e-01 7.40e-01 0.20300 -6.52e-02 -1.93e-01 6.52e-01 1.82e-01
GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION 27 1.56e-01 5.52e-01 0.20300 -9.38e-02 -1.80e-01 3.99e-01 1.05e-01
GOCC BASAL DENDRITE 6 7.17e-01 9.15e-01 0.20300 -1.52e-01 1.35e-01 5.20e-01 5.66e-01
GOMF CXCR CHEMOKINE RECEPTOR BINDING 18 3.55e-01 7.48e-01 0.20300 -7.75e-02 1.88e-01 5.69e-01 1.68e-01
GOBP RESPONSE TO FORSKOLIN 14 3.95e-01 7.74e-01 0.20300 5.01e-02 1.97e-01 7.46e-01 2.02e-01
GOBP REGULATION OF MITOCHONDRIAL DEPOLARIZATION 19 3.01e-01 7.12e-01 0.20300 -2.03e-01 -6.21e-03 1.25e-01 9.63e-01
GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION 10 5.60e-01 8.57e-01 0.20300 6.89e-02 -1.91e-01 7.06e-01 2.96e-01
GOBP REGULATION OF MEIOSIS I 6 6.93e-01 9.09e-01 0.20300 -2.16e-02 2.02e-01 9.27e-01 3.92e-01
GOCC ARYL HYDROCARBON RECEPTOR COMPLEX 8 5.82e-01 8.65e-01 0.20300 1.88e-01 7.63e-02 3.57e-01 7.08e-01
GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY 15 4.26e-01 7.93e-01 0.20300 8.74e-02 -1.83e-01 5.58e-01 2.19e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN 9 6.00e-01 8.74e-01 0.20300 1.82e-01 -8.87e-02 3.43e-01 6.45e-01
GOBP AUDITORY RECEPTOR CELL DEVELOPMENT 26 1.95e-01 6.06e-01 0.20300 2.03e-01 4.52e-03 7.34e-02 9.68e-01
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING 8 6.43e-01 8.89e-01 0.20300 -1.53e-01 1.33e-01 4.53e-01 5.16e-01
GOBP CELL DIFFERENTIATION IN HINDBRAIN 21 2.78e-01 6.92e-01 0.20300 -2.02e-01 2.18e-02 1.10e-01 8.63e-01
GOCC SUPER ELONGATION COMPLEX 5 7.59e-01 9.32e-01 0.20300 -1.52e-01 1.34e-01 5.57e-01 6.03e-01
GOBP NEGATIVE REGULATION OF LIPID TRANSPORT 47 6.44e-02 3.81e-01 0.20300 -1.94e-01 5.69e-02 2.11e-02 5.00e-01
GOBP REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY 6 7.17e-01 9.15e-01 0.20300 -1.63e-01 1.20e-01 4.89e-01 6.10e-01
GOBP MITOCHONDRIAL DNA REPLICATION 14 4.45e-01 8.01e-01 0.20300 6.47e-02 -1.92e-01 6.75e-01 2.14e-01
GOMF DYNEIN COMPLEX BINDING 23 2.15e-01 6.32e-01 0.20200 -1.91e-01 -6.67e-02 1.12e-01 5.80e-01
GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 70 2.01e-02 2.28e-01 0.20200 -1.75e-01 1.01e-01 1.12e-02 1.42e-01
GOBP RENAL SODIUM ION TRANSPORT 15 3.75e-01 7.63e-01 0.20200 -1.98e-01 -4.34e-02 1.85e-01 7.71e-01
GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE 6 7.18e-01 9.15e-01 0.20200 1.63e-01 -1.20e-01 4.90e-01 6.10e-01
GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III 9 5.62e-01 8.57e-01 0.20200 -2.01e-01 -2.39e-02 2.96e-01 9.01e-01
GOBP POSITIVE REGULATION OF RNA SPLICING 41 8.65e-02 4.35e-01 0.20200 3.50e-02 -1.99e-01 6.98e-01 2.72e-02
GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE 19 2.79e-01 6.92e-01 0.20200 -1.88e-01 -7.41e-02 1.55e-01 5.76e-01
GOBP RETINAL ROD CELL DEVELOPMENT 10 5.64e-01 8.58e-01 0.20200 7.34e-02 -1.89e-01 6.88e-01 3.02e-01
GOCC SMN SM PROTEIN COMPLEX 16 3.80e-01 7.65e-01 0.20200 2.53e-02 -2.01e-01 8.61e-01 1.64e-01
Cellular responses to mechanical stimuli 102 3.27e-03 7.81e-02 0.20200 -1.81e-01 9.13e-02 1.63e-03 1.11e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION 23 2.77e-01 6.91e-01 0.20200 -1.74e-01 1.03e-01 1.48e-01 3.93e-01
GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION 10 5.00e-01 8.30e-01 0.20200 -1.57e-01 -1.28e-01 3.90e-01 4.85e-01
Formation of TC-NER Pre-Incision Complex 49 3.52e-02 2.90e-01 0.20200 -9.80e-02 -1.77e-01 2.35e-01 3.21e-02
GOMF GAMMA TUBULIN BINDING 30 1.91e-01 5.98e-01 0.20200 -1.63e-01 1.20e-01 1.22e-01 2.56e-01
GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM 9 5.86e-01 8.67e-01 0.20200 1.98e-01 -4.02e-02 3.03e-01 8.35e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION 19 2.78e-01 6.91e-01 0.20200 7.99e-02 1.86e-01 5.47e-01 1.61e-01
Formation of WDR5-containing histone-modifying complexes 38 1.02e-01 4.67e-01 0.20200 -2.00e-01 2.77e-02 3.27e-02 7.68e-01
Adenylate cyclase inhibitory pathway 14 4.63e-01 8.12e-01 0.20200 -1.25e-01 1.59e-01 4.19e-01 3.03e-01
Nitric oxide stimulates guanylate cyclase 21 3.01e-01 7.12e-01 0.20200 -1.88e-01 7.34e-02 1.35e-01 5.60e-01
PERK regulates gene expression 31 1.55e-01 5.51e-01 0.20200 2.39e-02 -2.00e-01 8.18e-01 5.34e-02
GOBP LATERAL SPROUTING FROM AN EPITHELIUM 10 5.21e-01 8.40e-01 0.20200 -1.96e-01 -4.76e-02 2.83e-01 7.94e-01
GOMF GPI ANCHOR BINDING 8 6.43e-01 8.89e-01 0.20200 1.11e-01 -1.69e-01 5.88e-01 4.08e-01
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC 15 3.69e-01 7.58e-01 0.20200 1.90e-01 6.80e-02 2.03e-01 6.48e-01
GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION 26 2.39e-01 6.55e-01 0.20200 -1.66e-01 1.15e-01 1.44e-01 3.10e-01
GOCC MEDIATOR COMPLEX 34 1.20e-01 4.98e-01 0.20200 -6.95e-03 -2.02e-01 9.44e-01 4.19e-02
GOBP MACROPHAGE APOPTOTIC PROCESS 14 3.95e-01 7.74e-01 0.20200 -1.90e-01 -6.72e-02 2.18e-01 6.63e-01
GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY 5 7.48e-01 9.28e-01 0.20200 -1.95e-01 5.26e-02 4.51e-01 8.38e-01
GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS 23 2.06e-01 6.21e-01 0.20200 1.63e-01 1.18e-01 1.75e-01 3.26e-01
GOBP ADHESION OF SYMBIONT TO HOST 12 5.19e-01 8.39e-01 0.20200 1.53e-01 -1.32e-01 3.59e-01 4.30e-01
GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS 13 4.08e-01 7.82e-01 0.20100 1.50e-01 1.35e-01 3.49e-01 4.01e-01
Interleukin-6 signaling 11 4.96e-01 8.29e-01 0.20100 -1.99e-01 -2.94e-02 2.53e-01 8.66e-01
GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION 7 6.18e-01 8.80e-01 0.20100 -1.31e-01 -1.53e-01 5.48e-01 4.84e-01
GOMF NADH DEHYDROGENASE UBIQUINONE ACTIVITY 33 1.08e-01 4.77e-01 0.20100 -9.35e-02 -1.78e-01 3.52e-01 7.65e-02
GOMF IGE BINDING 5 7.09e-01 9.13e-01 0.20100 1.40e-01 1.45e-01 5.89e-01 5.75e-01
GOBP CANNABINOID SIGNALING PATHWAY 7 6.18e-01 8.80e-01 0.20100 1.52e-01 1.32e-01 4.86e-01 5.47e-01
GOBP CELLULAR RESPONSE TO NITROGEN LEVELS 12 4.42e-01 8.00e-01 0.20100 1.69e-01 1.10e-01 3.12e-01 5.10e-01
GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY 13 4.79e-01 8.20e-01 0.20100 7.11e-02 -1.88e-01 6.57e-01 2.40e-01
GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 20 2.55e-01 6.70e-01 0.20100 1.17e-01 1.63e-01 3.64e-01 2.06e-01
Initial triggering of complement 21 2.46e-01 6.61e-01 0.20100 1.84e-01 8.01e-02 1.43e-01 5.25e-01
GOBP REGULATION OF MACROPHAGE PROLIFERATION 7 6.83e-01 9.06e-01 0.20100 -1.23e-01 1.59e-01 5.72e-01 4.67e-01
GOCC BRUSH BORDER MEMBRANE 57 2.02e-02 2.28e-01 0.20100 1.39e-01 1.45e-01 6.99e-02 5.78e-02
GOMF INSULIN LIKE GROWTH FACTOR BINDING 19 3.20e-01 7.28e-01 0.20100 -2.00e-01 1.98e-02 1.31e-01 8.81e-01
Adenylate cyclase activating pathway 10 5.66e-01 8.59e-01 0.20100 -6.52e-02 1.90e-01 7.21e-01 2.98e-01
GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC 8 5.81e-01 8.65e-01 0.20100 1.08e-01 1.69e-01 5.97e-01 4.07e-01
GOBP INCLUSION BODY ASSEMBLY 23 2.72e-01 6.85e-01 0.20100 -6.92e-02 1.89e-01 5.65e-01 1.17e-01
GOBP REGULATION OF MUSCLE ADAPTATION 95 4.52e-03 9.31e-02 0.20100 -1.91e-01 6.29e-02 1.31e-03 2.89e-01
GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM 63 2.13e-02 2.33e-01 0.20100 1.17e-03 -2.01e-01 9.87e-01 5.84e-03
RNA Polymerase I Promoter Clearance 71 9.65e-03 1.50e-01 0.20100 -6.19e-02 -1.91e-01 3.67e-01 5.38e-03
RNA Polymerase I Transcription 71 9.65e-03 1.50e-01 0.20100 -6.19e-02 -1.91e-01 3.67e-01 5.38e-03
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING 36 1.39e-01 5.31e-01 0.20100 -1.71e-01 1.05e-01 7.58e-02 2.75e-01
GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS 7 6.83e-01 9.06e-01 0.20100 -1.13e-01 1.66e-01 6.05e-01 4.47e-01
GOBP RESPONSE TO X RAY 27 1.62e-01 5.61e-01 0.20100 -1.74e-01 -1.01e-01 1.19e-01 3.64e-01
GOBP APOPTOTIC DNA FRAGMENTATION 19 2.73e-01 6.85e-01 0.20100 -1.51e-01 -1.32e-01 2.55e-01 3.18e-01
Protein repair 6 7.23e-01 9.17e-01 0.20100 1.30e-01 -1.53e-01 5.82e-01 5.16e-01
GOCC INTERCELLULAR CANALICULUS 6 7.18e-01 9.15e-01 0.20100 -9.29e-02 1.78e-01 6.94e-01 4.51e-01
GOBP CEREBELLAR CORTEX FORMATION 24 2.61e-01 6.75e-01 0.20100 -1.85e-01 7.73e-02 1.17e-01 5.12e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION 15 3.65e-01 7.55e-01 0.20000 -9.89e-02 -1.74e-01 5.07e-01 2.42e-01
GOMF NOTCH BINDING 23 2.12e-01 6.29e-01 0.20000 1.04e-01 1.71e-01 3.87e-01 1.55e-01
GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS 26 1.84e-01 5.88e-01 0.20000 6.09e-02 1.91e-01 5.91e-01 9.19e-02
GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS 21 3.22e-01 7.28e-01 0.20000 -1.37e-01 1.46e-01 2.76e-01 2.46e-01
Interleukin-21 signaling 9 5.86e-01 8.67e-01 0.20000 2.40e-02 -1.99e-01 9.01e-01 3.01e-01
GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION 12 4.67e-01 8.14e-01 0.20000 1.97e-01 3.48e-02 2.36e-01 8.35e-01
GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR 9 5.68e-01 8.59e-01 0.20000 2.55e-02 1.99e-01 8.95e-01 3.02e-01
GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION 54 2.66e-02 2.59e-01 0.20000 -1.02e-01 -1.73e-01 1.97e-01 2.82e-02
DNA Damage/Telomere Stress Induced Senescence 57 2.55e-02 2.54e-01 0.20000 -5.11e-02 -1.94e-01 5.04e-01 1.14e-02
O-linked glycosylation of mucins 62 1.62e-02 2.04e-01 0.20000 1.80e-01 8.76e-02 1.42e-02 2.33e-01
GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION 16 4.23e-01 7.92e-01 0.20000 -1.45e-01 1.38e-01 3.14e-01 3.40e-01
GOBP MELANOSOME ASSEMBLY 18 3.47e-01 7.44e-01 0.20000 -3.07e-02 1.98e-01 8.22e-01 1.46e-01
GOMF PROTEIN METHYLTRANSFERASE ACTIVITY 95 3.50e-03 8.12e-02 0.20000 -2.00e-01 1.67e-02 7.76e-04 7.78e-01
GOCC CANONICAL INFLAMMASOME COMPLEX 17 3.32e-01 7.35e-01 0.20000 5.77e-02 1.92e-01 6.80e-01 1.71e-01
GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION 15 4.35e-01 7.96e-01 0.20000 8.10e-02 -1.83e-01 5.87e-01 2.20e-01
GOMF PHOSPHATASE ACTIVATOR ACTIVITY 19 3.46e-01 7.43e-01 0.20000 -1.85e-01 7.61e-02 1.63e-01 5.66e-01
GOBP PERICARDIUM MORPHOGENESIS 8 6.49e-01 8.91e-01 0.20000 1.62e-01 -1.17e-01 4.28e-01 5.65e-01
GOBP IMMUNOLOGICAL SYNAPSE FORMATION 16 4.06e-01 7.81e-01 0.20000 1.89e-01 -6.51e-02 1.90e-01 6.52e-01
GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS 15 4.33e-01 7.96e-01 0.20000 1.85e-01 -7.59e-02 2.15e-01 6.11e-01
GOCC SM LIKE PROTEIN FAMILY COMPLEX 89 2.43e-03 6.27e-02 0.20000 -1.34e-01 -1.49e-01 2.92e-02 1.54e-02
GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS 9 5.43e-01 8.51e-01 0.20000 -1.26e-01 -1.55e-01 5.11e-01 4.21e-01
GOBP CELLULAR RESPONSE TO COPPER ION 24 2.73e-01 6.85e-01 0.20000 -1.66e-01 1.11e-01 1.59e-01 3.45e-01
NIK–>noncanonical NF-kB signaling 46 4.97e-02 3.39e-01 0.20000 -6.90e-02 -1.88e-01 4.18e-01 2.77e-02
GOBP RECEPTOR LOCALIZATION TO SYNAPSE 57 4.75e-02 3.30e-01 0.20000 -1.42e-01 1.41e-01 6.37e-02 6.64e-02
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 23 2.80e-01 6.92e-01 0.20000 -8.08e-02 1.83e-01 5.02e-01 1.29e-01
ADP signalling through P2Y purinoceptor 12 22 2.51e-01 6.66e-01 0.20000 -1.97e-01 -3.04e-02 1.09e-01 8.05e-01
GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE 23 2.52e-01 6.68e-01 0.20000 1.03e-02 -1.99e-01 9.32e-01 9.78e-02
mRNA Splicing - Minor Pathway 52 4.45e-02 3.21e-01 0.20000 8.80e-03 -1.99e-01 9.13e-01 1.28e-02
GOBP SMOOTH MUSCLE CONTRACTION 109 1.21e-03 3.81e-02 0.20000 -1.99e-01 -1.81e-02 3.35e-04 7.44e-01
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 11 4.75e-01 8.18e-01 0.20000 -1.47e-01 -1.35e-01 3.98e-01 4.39e-01
GOCC LAMELLIPODIUM MEMBRANE 22 2.58e-01 6.72e-01 0.20000 -1.99e-01 -1.44e-02 1.06e-01 9.07e-01
GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM 86 7.33e-03 1.27e-01 0.20000 4.66e-02 -1.94e-01 4.55e-01 1.86e-03
GOMF JUN KINASE BINDING 11 5.55e-01 8.55e-01 0.20000 -1.54e-01 1.26e-01 3.75e-01 4.68e-01
SARS-CoV-1 targets host intracellular signalling and regulatory pathways 16 3.53e-01 7.47e-01 0.20000 -1.88e-01 -6.68e-02 1.93e-01 6.44e-01
GOBP REGULATION OF BONE MINERALIZATION INVOLVED IN BONE MATURATION 7 6.23e-01 8.82e-01 0.19900 1.38e-01 1.44e-01 5.27e-01 5.09e-01
GOBP RESPONSE TO GAMMA RADIATION 51 4.56e-02 3.26e-01 0.19900 -2.15e-03 -1.99e-01 9.79e-01 1.37e-02
GOMF PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR ACTIVITY 5 7.16e-01 9.15e-01 0.19900 -1.70e-01 -1.05e-01 5.11e-01 6.85e-01
GOMF RISC COMPLEX BINDING 5 7.60e-01 9.32e-01 0.19900 -1.80e-01 8.51e-02 4.85e-01 7.42e-01
GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY 24 2.46e-01 6.61e-01 0.19900 -1.97e-01 2.87e-02 9.42e-02 8.08e-01
GOMF EPHRIN RECEPTOR ACTIVITY 18 2.99e-01 7.11e-01 0.19900 1.11e-01 1.66e-01 4.16e-01 2.23e-01
GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS 66 2.31e-02 2.44e-01 0.19900 4.67e-02 -1.94e-01 5.11e-01 6.46e-03
GOMF SPHINGOLIPID TRANSFER ACTIVITY 9 5.65e-01 8.58e-01 0.19900 -1.95e-01 -4.36e-02 3.12e-01 8.21e-01
GOBP SUCKLING BEHAVIOR 12 4.45e-01 8.02e-01 0.19900 -1.38e-01 -1.44e-01 4.09e-01 3.88e-01
GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY INVOLVED IN REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 53 2.99e-02 2.71e-01 0.19900 -1.75e-01 -9.55e-02 2.76e-02 2.29e-01
NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis 5 7.40e-01 9.25e-01 0.19900 -1.99e-01 1.56e-03 4.40e-01 9.95e-01
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY 14 4.73e-01 8.17e-01 0.19900 -1.56e-01 1.24e-01 3.12e-01 4.23e-01
GOBP PROTEIN SIDE CHAIN DEGLUTAMYLATION 5 7.65e-01 9.33e-01 0.19900 1.64e-01 -1.12e-01 5.25e-01 6.63e-01
GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS 17 3.74e-01 7.61e-01 0.19900 -1.96e-01 3.29e-02 1.61e-01 8.14e-01
GOBP OOCYTE DIFFERENTIATION 66 3.04e-02 2.73e-01 0.19900 -1.36e-01 1.45e-01 5.58e-02 4.17e-02
GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS 20 2.62e-01 6.76e-01 0.19900 -1.51e-01 -1.30e-01 2.43e-01 3.16e-01
GOBP FATTY ACID HOMEOSTASIS 16 3.60e-01 7.51e-01 0.19900 1.90e-01 5.77e-02 1.88e-01 6.89e-01
GOBP ENDOCRINE PROCESS 87 8.85e-03 1.43e-01 0.19900 -1.79e-01 8.51e-02 3.81e-03 1.70e-01
G2/M Checkpoints 132 3.11e-04 1.36e-02 0.19900 -2.16e-02 -1.97e-01 6.69e-01 8.94e-05
GOBP REGULATION OF CHROMOSOME CONDENSATION 13 4.19e-01 7.87e-01 0.19900 -1.39e-01 -1.41e-01 3.84e-01 3.78e-01
GOCC GAP JUNCTION 28 2.23e-01 6.41e-01 0.19900 -1.69e-01 1.05e-01 1.22e-01 3.37e-01
Blood group systems biosynthesis 22 2.30e-01 6.48e-01 0.19900 1.27e-01 1.53e-01 3.03e-01 2.15e-01
Transcriptional Regulation by MECP2 60 2.98e-02 2.71e-01 0.19900 -1.98e-01 1.71e-02 8.05e-03 8.18e-01
GOMF ARRESTIN FAMILY PROTEIN BINDING 9 5.78e-01 8.64e-01 0.19900 -1.98e-01 -1.44e-02 3.04e-01 9.40e-01
GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS 8 6.49e-01 8.91e-01 0.19800 1.76e-01 -9.22e-02 3.89e-01 6.52e-01
GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT 32 1.67e-01 5.68e-01 0.19800 5.65e-02 -1.90e-01 5.80e-01 6.26e-02
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I 32 1.78e-01 5.83e-01 0.19800 -1.75e-01 9.38e-02 8.70e-02 3.58e-01
GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING 28 2.03e-01 6.18e-01 0.19800 -4.11e-02 1.94e-01 7.07e-01 7.56e-02
GOBP ENDODERMAL CELL FATE COMMITMENT 15 3.92e-01 7.71e-01 0.19800 -1.94e-01 -4.01e-02 1.93e-01 7.88e-01
GOBP RISC COMPLEX ASSEMBLY 10 5.85e-01 8.67e-01 0.19800 -1.71e-01 9.95e-02 3.48e-01 5.86e-01
GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING 95 2.79e-03 6.92e-02 0.19800 -3.45e-02 -1.95e-01 5.61e-01 1.01e-03
GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY 27 2.39e-01 6.55e-01 0.19800 -1.15e-01 1.61e-01 2.99e-01 1.48e-01
GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION 14 4.08e-01 7.82e-01 0.19800 -6.57e-02 -1.87e-01 6.70e-01 2.26e-01
Pre-NOTCH Processing in Golgi 18 3.48e-01 7.44e-01 0.19800 -1.35e-02 1.98e-01 9.21e-01 1.47e-01
GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY 21 3.32e-01 7.35e-01 0.19800 1.41e-01 -1.39e-01 2.64e-01 2.70e-01
SUMOylation of transcription cofactors 44 8.44e-02 4.32e-01 0.19800 -1.92e-01 4.81e-02 2.75e-02 5.81e-01
GOCC INTERMEDIATE FILAMENT CYTOSKELETON 237 1.69e-07 2.28e-05 0.19800 1.52e-01 1.27e-01 5.48e-05 7.81e-04
GOBP ACID SECRETION 45 9.42e-02 4.48e-01 0.19800 -1.31e-01 1.49e-01 1.30e-01 8.44e-02
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function 59 2.00e-02 2.27e-01 0.19800 -1.45e-01 -1.34e-01 5.32e-02 7.50e-02
GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE 85 1.07e-02 1.60e-01 0.19800 -1.73e-01 9.57e-02 5.79e-03 1.27e-01
GOBP FEMALE MEIOSIS I 13 5.03e-01 8.31e-01 0.19800 1.18e-01 -1.59e-01 4.62e-01 3.21e-01
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS 15 4.39e-01 7.99e-01 0.19800 -1.85e-01 7.02e-02 2.15e-01 6.38e-01
GOBP POSITIVE REGULATION OF RRNA PROCESSING 10 5.23e-01 8.42e-01 0.19800 -8.37e-02 -1.79e-01 6.47e-01 3.26e-01
GOBP REGULATION OF PEPTIDYL SERINE DEPHOSPHORYLATION 7 6.90e-01 9.08e-01 0.19800 1.09e-01 -1.65e-01 6.18e-01 4.49e-01
GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX 40 8.40e-02 4.31e-01 0.19800 -1.94e-01 -3.73e-02 3.36e-02 6.83e-01
GOBP VITAMIN D METABOLIC PROCESS 21 3.21e-01 7.28e-01 0.19800 8.36e-02 -1.79e-01 5.07e-01 1.55e-01
GOMF EXTRACELLULAR MATRIX CONSTITUENT CONFERRING ELASTICITY 10 5.45e-01 8.51e-01 0.19800 -1.97e-01 -1.89e-02 2.81e-01 9.18e-01
GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE 36 1.35e-01 5.24e-01 0.19800 -5.51e-02 1.90e-01 5.67e-01 4.87e-02
Propionyl-CoA catabolism 5 7.18e-01 9.15e-01 0.19800 -1.50e-01 -1.29e-01 5.62e-01 6.18e-01
GOBP REGULATION OF REMOVAL OF SUPEROXIDE RADICALS 6 7.23e-01 9.17e-01 0.19800 1.80e-01 -8.22e-02 4.46e-01 7.27e-01
GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS 9 5.86e-01 8.67e-01 0.19800 1.98e-01 9.28e-04 3.05e-01 9.96e-01
GOBP LENS FIBER CELL DIFFERENTIATION 36 1.51e-01 5.46e-01 0.19800 -1.54e-01 1.24e-01 1.10e-01 1.98e-01
GOMF PATCHED BINDING 8 6.15e-01 8.80e-01 0.19800 -1.97e-01 -1.98e-02 3.36e-01 9.23e-01
GOBP PARAXIAL MESODERM MORPHOGENESIS 10 5.20e-01 8.40e-01 0.19800 -1.70e-01 -1.00e-01 3.51e-01 5.84e-01
GOCC HOST CELLULAR COMPONENT 9 5.68e-01 8.59e-01 0.19700 -5.17e-02 -1.91e-01 7.88e-01 3.22e-01
GOBP AMMONIUM ION METABOLIC PROCESS 22 3.10e-01 7.19e-01 0.19700 -1.72e-01 9.65e-02 1.62e-01 4.34e-01
GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 10 5.17e-01 8.39e-01 0.19700 -1.16e-01 -1.60e-01 5.26e-01 3.81e-01
GOMF PEPTIDOGLYCAN BINDING 18 3.89e-01 7.70e-01 0.19700 -1.54e-01 1.23e-01 2.57e-01 3.66e-01
GOMF NEUROTRANSMITTER RECEPTOR REGULATOR ACTIVITY 13 4.24e-01 7.92e-01 0.19700 1.25e-01 1.53e-01 4.35e-01 3.41e-01
GOBP CENTROMERIC SISTER CHROMATID COHESION 10 5.48e-01 8.52e-01 0.19700 -1.97e-01 -1.41e-02 2.81e-01 9.38e-01
2-LTR circle formation 7 6.90e-01 9.08e-01 0.19700 1.01e-01 -1.69e-01 6.43e-01 4.38e-01
GOBP AROMATIC AMINO ACID TRANSPORT 10 5.45e-01 8.51e-01 0.19700 -1.96e-01 -2.40e-02 2.84e-01 8.95e-01
GOBP PROTEIN LOCALIZATION TO MICROTUBULE 17 3.95e-01 7.74e-01 0.19700 -1.85e-01 6.77e-02 1.86e-01 6.29e-01
GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS 9 5.91e-01 8.69e-01 0.19700 -8.21e-03 1.97e-01 9.66e-01 3.06e-01
GOBP FERROPTOSIS 9 5.53e-01 8.54e-01 0.19700 1.31e-01 1.47e-01 4.95e-01 4.45e-01
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases 14 4.80e-01 8.21e-01 0.19700 -1.59e-01 1.16e-01 3.02e-01 4.53e-01
GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE 13 4.95e-01 8.28e-01 0.19700 -7.43e-02 1.82e-01 6.43e-01 2.55e-01
GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM 37 9.69e-02 4.55e-01 0.19700 -1.87e-01 -6.28e-02 4.94e-02 5.08e-01
GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY 42 1.01e-01 4.65e-01 0.19700 -1.86e-01 6.50e-02 3.72e-02 4.66e-01
GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE 15 3.85e-01 7.68e-01 0.19700 1.82e-01 7.39e-02 2.21e-01 6.20e-01
GOCC PRP19 COMPLEX 14 4.12e-01 7.84e-01 0.19700 -1.84e-01 -6.88e-02 2.32e-01 6.56e-01
GOBP REGULATION OF STEROID HORMONE SECRETION 22 2.97e-01 7.09e-01 0.19700 -1.89e-01 5.37e-02 1.24e-01 6.63e-01
GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY 7 6.33e-01 8.86e-01 0.19700 1.59e-01 1.16e-01 4.67e-01 5.95e-01
GOCC AUTOLYSOSOME 13 4.59e-01 8.10e-01 0.19700 1.96e-01 1.52e-02 2.21e-01 9.25e-01
GOMF GPI LINKED EPHRIN RECEPTOR ACTIVITY 6 7.03e-01 9.12e-01 0.19700 -2.59e-04 1.97e-01 9.99e-01 4.04e-01
GOMF UDP XYLOSYLTRANSFERASE ACTIVITY 11 5.65e-01 8.58e-01 0.19700 -1.44e-01 1.34e-01 4.09e-01 4.41e-01
GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 6 6.78e-01 9.04e-01 0.19700 1.71e-01 9.65e-02 4.67e-01 6.82e-01
GOBP DENSE CORE GRANULE EXOCYTOSIS 10 5.31e-01 8.44e-01 0.19700 1.84e-01 6.86e-02 3.13e-01 7.07e-01
Nef and signal transduction 8 5.93e-01 8.71e-01 0.19700 -1.13e-01 -1.61e-01 5.80e-01 4.31e-01
POLB-Dependent Long Patch Base Excision Repair 8 6.05e-01 8.76e-01 0.19700 -1.87e-01 -5.99e-02 3.59e-01 7.69e-01
Negative regulation of NOTCH4 signaling 44 6.00e-02 3.72e-01 0.19700 -8.37e-02 -1.78e-01 3.37e-01 4.13e-02
GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT 17 4.07e-01 7.81e-01 0.19700 -9.59e-02 1.72e-01 4.94e-01 2.21e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 54 5.46e-02 3.56e-01 0.19700 7.27e-02 -1.83e-01 3.55e-01 2.03e-02
Interleukin-7 signaling 21 2.91e-01 7.03e-01 0.19600 -2.29e-03 -1.96e-01 9.86e-01 1.19e-01
GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS 47 6.81e-02 3.93e-01 0.19600 -1.95e-01 2.07e-02 2.05e-02 8.06e-01
GOBP PHOTOTRANSDUCTION 41 7.55e-02 4.12e-01 0.19600 6.69e-02 1.85e-01 4.58e-01 4.07e-02
GOCC PORE COMPLEX 24 2.33e-01 6.50e-01 0.19600 1.94e-01 3.14e-02 1.00e-01 7.90e-01
GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY 52 4.48e-02 3.23e-01 0.19600 -1.73e-02 -1.96e-01 8.29e-01 1.47e-02
GOMF G QUADRUPLEX DNA BINDING 11 5.49e-01 8.53e-01 0.19600 -1.86e-01 6.19e-02 2.85e-01 7.22e-01
DNA Double Strand Break Response 56 2.88e-02 2.68e-01 0.19600 -7.61e-02 -1.81e-01 3.25e-01 1.92e-02
GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION 24 2.51e-01 6.66e-01 0.19600 -1.32e-02 1.96e-01 9.11e-01 9.68e-02
GOBP PROTEIN LOCALIZATION TO CYTOSKELETON 59 4.76e-02 3.30e-01 0.19600 -1.27e-01 1.49e-01 9.05e-02 4.74e-02
GOBP REGULATION OF MITOTIC RECOMBINATION 7 6.49e-01 8.91e-01 0.19600 -4.61e-02 -1.91e-01 8.33e-01 3.82e-01
Vpu mediated degradation of CD4 39 9.44e-02 4.49e-01 0.19600 -3.02e-02 -1.94e-01 7.44e-01 3.62e-02
GOBP MATURATION OF SSU RRNA 52 3.97e-02 3.06e-01 0.19600 -5.46e-02 -1.88e-01 4.96e-01 1.88e-02
GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION 10 5.91e-01 8.69e-01 0.19600 1.71e-01 -9.52e-02 3.48e-01 6.02e-01
GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 16 4.06e-01 7.81e-01 0.19600 -1.94e-01 3.12e-02 1.80e-01 8.29e-01
GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS 18 3.75e-01 7.62e-01 0.19600 -1.87e-01 5.82e-02 1.69e-01 6.69e-01
GOBP NEGATIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 7 6.84e-01 9.06e-01 0.19600 6.47e-02 -1.85e-01 7.67e-01 3.96e-01
GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION 40 1.04e-01 4.70e-01 0.19600 -1.94e-01 2.66e-02 3.35e-02 7.71e-01
GOBP RESPONSE TO STILBENOID 8 6.01e-01 8.75e-01 0.19600 1.78e-01 8.21e-02 3.83e-01 6.88e-01
Erythropoietin activates Phospholipase C gamma (PLCG) 7 6.64e-01 8.97e-01 0.19600 6.84e-04 1.96e-01 9.97e-01 3.69e-01
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) 14 4.01e-01 7.78e-01 0.19600 -1.35e-01 -1.42e-01 3.82e-01 3.57e-01
RSV-host interactions 88 8.85e-03 1.43e-01 0.19600 6.83e-02 -1.84e-01 2.68e-01 2.89e-03
HDACs deacetylate histones 54 3.80e-02 3.00e-01 0.19600 -3.30e-02 -1.93e-01 6.75e-01 1.41e-02
Alpha-protein kinase 1 signaling pathway 10 5.25e-01 8.42e-01 0.19600 -1.00e-01 -1.68e-01 5.83e-01 3.57e-01
GOBP REGULATION OF METAPHASE PLATE CONGRESSION 14 4.07e-01 7.81e-01 0.19600 -1.70e-01 -9.78e-02 2.71e-01 5.26e-01
GOBP INTRACELLULAR LIPID TRANSPORT 50 7.25e-02 4.04e-01 0.19600 -9.40e-02 1.72e-01 2.50e-01 3.55e-02
GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY 22 3.14e-01 7.22e-01 0.19600 9.20e-02 -1.73e-01 4.55e-01 1.60e-01
GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION 17 3.49e-01 7.45e-01 0.19600 5.31e-02 1.89e-01 7.05e-01 1.78e-01
GOBP SODIUM DEPENDENT PHOSPHATE TRANSPORT 12 5.27e-01 8.42e-01 0.19600 1.80e-01 -7.80e-02 2.81e-01 6.40e-01
GOMF CARBONATE DEHYDRATASE ACTIVITY 14 4.41e-01 8.00e-01 0.19600 -1.96e-01 -1.62e-03 2.04e-01 9.92e-01
GOBP RESPONSE TO VITAMIN E 9 5.57e-01 8.56e-01 0.19600 -1.53e-01 -1.22e-01 4.27e-01 5.25e-01
GOBP REGULATION OF CELL MATURATION 22 2.54e-01 6.69e-01 0.19600 6.13e-02 1.86e-01 6.19e-01 1.31e-01
GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY 67 3.21e-02 2.81e-01 0.19600 1.37e-01 -1.40e-01 5.31e-02 4.70e-02
Creation of C4 and C2 activators 14 4.64e-01 8.13e-01 0.19600 1.89e-01 -5.20e-02 2.21e-01 7.36e-01
GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION 14 4.04e-01 7.80e-01 0.19600 -1.57e-01 -1.16e-01 3.08e-01 4.51e-01
GOBP REGULATION OF AMACRINE CELL DIFFERENTIATION 6 6.77e-01 9.04e-01 0.19600 -1.48e-01 -1.29e-01 5.31e-01 5.86e-01
GOBP PROTEIN DEGLYCOSYLATION 15 4.08e-01 7.81e-01 0.19600 2.38e-02 1.94e-01 8.73e-01 1.93e-01
Homologous DNA Pairing and Strand Exchange 43 6.38e-02 3.79e-01 0.19600 -9.80e-02 -1.69e-01 2.66e-01 5.47e-02
GOBP SLEEP 22 2.87e-01 7.00e-01 0.19600 -1.95e-01 2.03e-02 1.14e-01 8.69e-01
GOMF TRANSMEMBRANE EPHRIN RECEPTOR ACTIVITY 15 3.83e-01 7.67e-01 0.19600 1.71e-01 9.54e-02 2.52e-01 5.22e-01
GOBP SEQUESTERING OF IRON ION 6 6.77e-01 9.04e-01 0.19500 1.32e-01 1.44e-01 5.76e-01 5.40e-01
GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 21 2.79e-01 6.92e-01 0.19500 3.95e-02 1.91e-01 7.54e-01 1.29e-01
GOBP 3 UTR MEDIATED MRNA DESTABILIZATION 19 3.76e-01 7.63e-01 0.19500 1.20e-01 -1.55e-01 3.67e-01 2.43e-01
Hh mutants abrogate ligand secretion 46 6.23e-02 3.77e-01 0.19500 -3.53e-02 -1.92e-01 6.79e-01 2.41e-02
GOMF G PROTEIN COUPLED NEUROTRANSMITTER RECEPTOR ACTIVITY 12 5.15e-01 8.38e-01 0.19500 -1.91e-01 4.02e-02 2.52e-01 8.09e-01
GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION 14 4.42e-01 8.00e-01 0.19500 -1.95e-01 -4.36e-03 2.06e-01 9.77e-01
Translation of Replicase and Assembly of the Replication Transcription Complex 9694676 14 4.04e-01 7.80e-01 0.19500 -1.32e-01 -1.44e-01 3.94e-01 3.50e-01
GOBP NEURAL CREST CELL FATE COMMITMENT 6 7.34e-01 9.23e-01 0.19500 1.16e-01 -1.57e-01 6.24e-01 5.05e-01
GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS 39 1.32e-01 5.19e-01 0.19500 -1.68e-01 1.00e-01 7.01e-02 2.79e-01
GOBP REGULATION OF TELOMERE CAPPING 26 2.08e-01 6.25e-01 0.19500 -3.71e-02 -1.91e-01 7.43e-01 9.10e-02
GOBP UBIQUINONE METABOLIC PROCESS 18 3.58e-01 7.50e-01 0.19500 1.04e-02 -1.95e-01 9.39e-01 1.53e-01
GOBP GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION 12 4.93e-01 8.27e-01 0.19500 -1.94e-01 -1.73e-02 2.44e-01 9.17e-01
CD209 (DC-SIGN) signaling 20 2.75e-01 6.88e-01 0.19500 -1.48e-01 -1.27e-01 2.52e-01 3.25e-01
GOBP T TUBULE ORGANIZATION 6 7.36e-01 9.23e-01 0.19500 -1.41e-01 1.34e-01 5.49e-01 5.69e-01
GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER 33 1.33e-01 5.20e-01 0.19500 -1.87e-01 -5.33e-02 6.24e-02 5.96e-01
p53-Dependent G1 DNA Damage Response 52 3.96e-02 3.06e-01 0.19500 -6.91e-02 -1.82e-01 3.89e-01 2.30e-02
p53-Dependent G1/S DNA damage checkpoint 52 3.96e-02 3.06e-01 0.19500 -6.91e-02 -1.82e-01 3.89e-01 2.30e-02
GOBP RESPONSE TO INDOLE 3 METHANOL 6 6.79e-01 9.04e-01 0.19500 -1.29e-01 -1.46e-01 5.84e-01 5.36e-01
GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS 10 5.37e-01 8.48e-01 0.19500 -1.83e-01 -6.73e-02 3.17e-01 7.12e-01
GOBP RESPONSE TO NERVE GROWTH FACTOR 51 5.98e-02 3.71e-01 0.19500 -1.92e-01 3.40e-02 1.78e-02 6.74e-01
GOCC TRAPPII PROTEIN COMPLEX 11 5.49e-01 8.52e-01 0.19500 4.54e-02 -1.89e-01 7.94e-01 2.77e-01
Scavenging of heme from plasma 12 5.31e-01 8.44e-01 0.19500 -1.79e-01 7.77e-02 2.84e-01 6.41e-01
GOBP STRIATED MUSCLE CELL DIFFERENTIATION 305 1.81e-07 2.39e-05 0.19500 -1.65e-01 1.03e-01 6.66e-07 2.05e-03
Attenuation phase 24 2.85e-01 6.97e-01 0.19500 8.53e-02 -1.75e-01 4.70e-01 1.38e-01
Phosphate bond hydrolysis by NTPDase proteins 8 6.32e-01 8.86e-01 0.19500 1.95e-01 -2.77e-03 3.40e-01 9.89e-01
GOBP TYPE I PNEUMOCYTE DIFFERENTIATION 8 6.65e-01 8.98e-01 0.19500 -1.25e-01 1.49e-01 5.41e-01 4.65e-01
GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT 22 3.12e-01 7.21e-01 0.19500 -7.13e-02 1.81e-01 5.62e-01 1.42e-01
GOMF FK506 BINDING 10 5.79e-01 8.64e-01 0.19500 4.24e-02 -1.90e-01 8.16e-01 2.99e-01
GOBP CELL JUNCTION DISASSEMBLY 27 2.41e-01 6.57e-01 0.19400 -1.80e-01 7.41e-02 1.06e-01 5.05e-01
Dectin-1 mediated noncanonical NF-kB signaling 49 5.06e-02 3.42e-01 0.19400 -5.25e-02 -1.87e-01 5.25e-01 2.34e-02
GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 11 5.08e-01 8.33e-01 0.19400 1.84e-01 6.34e-02 2.91e-01 7.16e-01
GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION 10 5.42e-01 8.50e-01 0.19400 -5.84e-02 -1.85e-01 7.49e-01 3.10e-01
GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE 8 6.20e-01 8.81e-01 0.19400 1.92e-01 3.22e-02 3.48e-01 8.75e-01
GOMF NEUROTROPHIN RECEPTOR ACTIVITY 5 7.37e-01 9.24e-01 0.19400 5.24e-02 1.87e-01 8.39e-01 4.69e-01
GOBP SNRNA 3 END PROCESSING 20 2.78e-01 6.91e-01 0.19400 -1.42e-01 -1.32e-01 2.70e-01 3.07e-01
GOBP REGULATION OF POTASSIUM ION TRANSPORT 97 3.81e-03 8.53e-02 0.19400 -1.94e-01 -4.88e-03 9.53e-04 9.34e-01
GOBP RETINAL CELL APOPTOTIC PROCESS 7 6.47e-01 8.91e-01 0.19400 -7.67e-02 -1.78e-01 7.25e-01 4.14e-01
GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY 8 6.41e-01 8.89e-01 0.19400 1.92e-01 -2.52e-02 3.46e-01 9.02e-01
GOBP T HELPER 1 CELL DIFFERENTIATION 23 2.70e-01 6.85e-01 0.19400 -1.94e-01 4.74e-03 1.07e-01 9.69e-01
GOBP RESPONSE TO MUSCLE ACTIVITY 28 2.30e-01 6.48e-01 0.19400 -7.37e-02 1.80e-01 5.00e-01 1.00e-01
GOBP L GLUTAMATE IMPORT 39 1.31e-01 5.17e-01 0.19400 -7.94e-02 1.77e-01 3.91e-01 5.58e-02
ARMS-mediated activation 7 7.02e-01 9.12e-01 0.19400 -1.44e-01 1.30e-01 5.10e-01 5.51e-01
Defects in cobalamin (B12) metabolism 13 4.67e-01 8.14e-01 0.19400 -1.93e-01 -2.12e-02 2.29e-01 8.94e-01
GOCC NEURON PROJECTION TERMINUS 122 1.67e-03 4.74e-02 0.19400 -1.81e-01 6.87e-02 5.42e-04 1.90e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION 16 3.80e-01 7.65e-01 0.19400 -5.13e-02 -1.87e-01 7.23e-01 1.96e-01
GOMF DNA SECONDARY STRUCTURE BINDING 36 1.33e-01 5.20e-01 0.19400 -1.93e-01 1.31e-02 4.47e-02 8.92e-01
GOMF THIAMINE PYROPHOSPHATE BINDING 7 6.58e-01 8.95e-01 0.19400 1.90e-01 3.86e-02 3.84e-01 8.59e-01
GOBP WYBUTOSINE METABOLIC PROCESS 6 7.02e-01 9.12e-01 0.19400 -1.92e-01 -2.78e-02 4.16e-01 9.06e-01
GOBP AMP METABOLIC PROCESS 22 2.72e-01 6.85e-01 0.19400 3.20e-02 1.91e-01 7.95e-01 1.21e-01
GOBP HARD PALATE DEVELOPMENT 8 6.65e-01 8.98e-01 0.19400 -1.63e-01 1.04e-01 4.24e-01 6.09e-01
SCF-beta-TrCP mediated degradation of Emi1 42 7.86e-02 4.18e-01 0.19400 -5.51e-02 -1.86e-01 5.37e-01 3.74e-02
GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION 10 5.31e-01 8.44e-01 0.19400 -1.11e-01 -1.58e-01 5.42e-01 3.86e-01
GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT 19 3.09e-01 7.19e-01 0.19400 -7.47e-02 -1.79e-01 5.73e-01 1.78e-01
GOMF PRE MRNA 5 SPLICE SITE BINDING 6 7.34e-01 9.23e-01 0.19400 1.71e-01 -9.02e-02 4.67e-01 7.02e-01
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) 110 1.10e-03 3.56e-02 0.19400 -8.33e-02 -1.75e-01 1.31e-01 1.54e-03
GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION 11 4.97e-01 8.29e-01 0.19400 -1.34e-01 -1.40e-01 4.42e-01 4.22e-01
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known 37 1.44e-01 5.36e-01 0.19400 -1.81e-01 6.92e-02 5.71e-02 4.66e-01
GOBP REGULATION OF CELL KILLING 111 3.84e-03 8.59e-02 0.19400 1.48e-01 -1.25e-01 7.15e-03 2.30e-02
G1/S DNA Damage Checkpoints 54 3.49e-02 2.89e-01 0.19400 -8.58e-02 -1.73e-01 2.75e-01 2.75e-02
GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS 34 1.66e-01 5.66e-01 0.19400 1.84e-01 -6.12e-02 6.40e-02 5.37e-01
GOCC BETA CATENIN DESTRUCTION COMPLEX 12 4.67e-01 8.14e-01 0.19300 -1.47e-01 -1.26e-01 3.78e-01 4.50e-01
Binding and Uptake of Ligands by Scavenger Receptors 41 7.41e-02 4.08e-01 0.19300 -1.42e-01 -1.31e-01 1.15e-01 1.47e-01
GOBP TYPE II HYPERSENSITIVITY 5 7.42e-01 9.26e-01 0.19300 4.26e-02 1.89e-01 8.69e-01 4.65e-01
GOMF APOLIPOPROTEIN RECEPTOR BINDING 7 7.04e-01 9.13e-01 0.19300 -1.28e-01 1.45e-01 5.59e-01 5.06e-01
GOBP RNA METHYLATION 75 1.10e-02 1.64e-01 0.19300 -5.28e-02 -1.86e-01 4.29e-01 5.39e-03
GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT 19 3.20e-01 7.28e-01 0.19300 -4.89e-02 -1.87e-01 7.12e-01 1.58e-01
GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION 24 2.92e-01 7.05e-01 0.19300 -8.87e-02 1.72e-01 4.52e-01 1.46e-01
GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE 8 6.69e-01 9.00e-01 0.19300 -1.49e-01 1.23e-01 4.65e-01 5.48e-01
cGMP effects 16 4.17e-01 7.86e-01 0.19300 -1.91e-01 2.90e-02 1.86e-01 8.41e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION 7 6.65e-01 8.98e-01 0.19300 -1.92e-01 -2.24e-02 3.80e-01 9.18e-01
GOBP EPIBOLY 42 1.22e-01 4.99e-01 0.19300 -1.53e-01 1.17e-01 8.55e-02 1.88e-01
GOBP OLFACTORY BEHAVIOR 11 5.77e-01 8.64e-01 0.19300 -1.35e-01 1.38e-01 4.38e-01 4.28e-01
GOBP REGULATION OF MYOBLAST DIFFERENTIATION 73 1.66e-02 2.06e-01 0.19300 -1.93e-01 4.86e-03 4.35e-03 9.43e-01
Sensory perception of taste 47 5.14e-02 3.44e-01 0.19300 1.45e-01 1.27e-01 8.46e-02 1.32e-01
GOBP REGULATION OF AMINO ACID TRANSPORT 40 1.35e-01 5.24e-01 0.19300 -1.46e-01 1.26e-01 1.10e-01 1.67e-01
GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION 5 7.36e-01 9.23e-01 0.19300 7.17e-02 1.79e-01 7.81e-01 4.88e-01
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 40 1.25e-01 5.05e-01 0.19300 -7.06e-02 1.80e-01 4.40e-01 4.93e-02
GOMF MRNA 3 UTR AU RICH REGION BINDING 29 1.83e-01 5.87e-01 0.19300 -3.05e-02 -1.91e-01 7.77e-01 7.57e-02
Attachment and Entry 9694614 16 3.65e-01 7.55e-01 0.19300 1.53e-01 1.17e-01 2.89e-01 4.16e-01
GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX 8 6.13e-01 8.79e-01 0.19300 7.07e-02 1.79e-01 7.29e-01 3.79e-01
GOBP RANDOM INACTIVATION OF X CHROMOSOME 6 6.94e-01 9.10e-01 0.19300 -1.81e-01 -6.57e-02 4.42e-01 7.80e-01
GOBP REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT 5 7.31e-01 9.22e-01 0.19300 -1.06e-01 -1.61e-01 6.81e-01 5.33e-01
GOMF ORNITHINE DECARBOXYLASE REGULATOR ACTIVITY 5 7.31e-01 9.22e-01 0.19300 -1.06e-01 -1.61e-01 6.81e-01 5.33e-01
GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY 11 5.25e-01 8.42e-01 0.19300 1.90e-01 3.09e-02 2.74e-01 8.59e-01
GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS 9 5.67e-01 8.59e-01 0.19300 1.44e-01 1.28e-01 4.55e-01 5.05e-01
OAS antiviral response 8 6.47e-01 8.91e-01 0.19300 2.99e-02 -1.90e-01 8.84e-01 3.51e-01
GOBP POSITIVE REGULATION OF ODONTOGENESIS 8 6.30e-01 8.85e-01 0.19300 -1.92e-01 -1.88e-02 3.47e-01 9.27e-01
GOBP COENZYME A BIOSYNTHETIC PROCESS 10 6.08e-01 8.76e-01 0.19300 1.35e-01 -1.38e-01 4.61e-01 4.50e-01
GOBP CELLULAR RESPONSE TO MANGANESE ION 10 5.87e-01 8.67e-01 0.19300 4.77e-02 -1.87e-01 7.94e-01 3.06e-01
Prostacyclin signalling through prostacyclin receptor 19 3.40e-01 7.40e-01 0.19300 -1.93e-01 -4.08e-03 1.46e-01 9.75e-01
GOCC GEMINI OF COILED BODIES 11 5.02e-01 8.30e-01 0.19300 -1.09e-01 -1.59e-01 5.33e-01 3.60e-01
GOBP ENDOPLASMIC RETICULUM LOCALIZATION 10 5.79e-01 8.64e-01 0.19300 -1.91e-01 2.56e-02 2.96e-01 8.88e-01
GOBP T CELL LINEAGE COMMITMENT 35 1.61e-01 5.59e-01 0.19300 -1.82e-01 6.33e-02 6.24e-02 5.17e-01
GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE 17 4.14e-01 7.85e-01 0.19300 -7.04e-02 1.79e-01 6.15e-01 2.01e-01
GOBP PROTEIN RNA COMPLEX DISASSEMBLY 10 5.49e-01 8.52e-01 0.19300 -5.50e-02 -1.85e-01 7.63e-01 3.12e-01
GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION 23 3.14e-01 7.22e-01 0.19300 1.03e-01 -1.63e-01 3.93e-01 1.77e-01
GOMF GUANYLATE KINASE ACTIVITY 7 7.05e-01 9.13e-01 0.19300 -1.20e-01 1.51e-01 5.83e-01 4.90e-01
GOBP POSITIVE REGULATION OF AMINE TRANSPORT 39 1.33e-01 5.21e-01 0.19300 -1.78e-01 7.29e-02 5.41e-02 4.31e-01
Presynaptic phase of homologous DNA pairing and strand exchange 40 8.79e-02 4.37e-01 0.19300 -7.00e-02 -1.79e-01 4.44e-01 4.96e-02
GOBP GAMMA AMINOBUTYRIC ACID IMPORT 6 6.87e-01 9.06e-01 0.19200 -1.57e-01 -1.11e-01 5.06e-01 6.36e-01
GOCC COMPLEX OF COLLAGEN TRIMERS 19 3.20e-01 7.28e-01 0.19200 -1.84e-01 -5.64e-02 1.65e-01 6.70e-01
UCH proteinases 80 7.34e-03 1.27e-01 0.19200 -8.61e-02 -1.72e-01 1.83e-01 7.78e-03
Transcriptional regulation of testis differentiation 12 4.92e-01 8.26e-01 0.19200 4.28e-02 1.88e-01 7.97e-01 2.60e-01
Nicotinamide salvaging 19 3.48e-01 7.44e-01 0.19200 -1.10e-02 1.92e-01 9.34e-01 1.47e-01
GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION 8 6.27e-01 8.84e-01 0.19200 -2.91e-02 -1.90e-01 8.87e-01 3.52e-01
GOCC PHOTORECEPTOR OUTER SEGMENT 85 5.16e-03 1.01e-01 0.19200 1.01e-01 1.64e-01 1.09e-01 8.96e-03
GOBP SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION 10 5.37e-01 8.48e-01 0.19200 -1.64e-01 -1.01e-01 3.70e-01 5.81e-01
GOBP PHOSPHOLIPID HOMEOSTASIS 17 3.46e-01 7.43e-01 0.19200 -1.10e-01 -1.58e-01 4.34e-01 2.59e-01
GOBP NEUTROPHIL DIFFERENTIATION 11 5.58e-01 8.56e-01 0.19200 4.80e-02 -1.86e-01 7.83e-01 2.85e-01
GOMF LIPASE ACTIVATOR ACTIVITY 19 3.30e-01 7.34e-01 0.19200 -3.26e-02 -1.89e-01 8.06e-01 1.53e-01
GOBP BONE MORPHOGENESIS 97 4.57e-03 9.37e-02 0.19200 -1.92e-01 6.23e-03 1.07e-03 9.16e-01
GOBP POSITIVE THYMIC T CELL SELECTION 15 4.29e-01 7.94e-01 0.19200 -2.93e-03 -1.92e-01 9.84e-01 1.97e-01
GOMF IMMUNOGLOBULIN BINDING 22 2.96e-01 7.08e-01 0.19200 1.92e-01 -1.14e-02 1.19e-01 9.26e-01
GOCC MEIOTIC SPINDLE 14 4.70e-01 8.15e-01 0.19200 3.31e-02 -1.89e-01 8.30e-01 2.20e-01
GOBP NEUROTRANSMITTER UPTAKE 44 1.01e-01 4.65e-01 0.19200 -1.83e-01 5.96e-02 3.60e-02 4.94e-01
GOBP FIBRINOLYSIS 27 2.25e-01 6.43e-01 0.19200 -1.32e-02 1.92e-01 9.05e-01 8.47e-02
GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 35 1.31e-01 5.16e-01 0.19200 -3.03e-02 -1.90e-01 7.56e-01 5.21e-02
GOBP PHARYNGEAL SYSTEM DEVELOPMENT 31 1.59e-01 5.57e-01 0.19200 -1.86e-01 -4.93e-02 7.35e-02 6.35e-01
Nuclear events stimulated by ALK signaling in cancer 34 1.85e-01 5.89e-01 0.19200 1.19e-01 -1.51e-01 2.30e-01 1.28e-01
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 10 5.96e-01 8.72e-01 0.19200 -1.80e-01 6.85e-02 3.26e-01 7.08e-01
GOBP REGULATION OF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY 6 7.28e-01 9.21e-01 0.19200 -1.86e-01 4.96e-02 4.31e-01 8.33e-01
GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS 40 1.39e-01 5.29e-01 0.19200 -1.39e-01 1.33e-01 1.29e-01 1.47e-01
GOMF CHONDROITIN SULFOTRANSFERASE ACTIVITY 5 7.34e-01 9.23e-01 0.19200 -1.65e-01 -9.83e-02 5.23e-01 7.03e-01
GOBP REGULATION OF T CELL MEDIATED IMMUNITY 98 6.16e-03 1.14e-01 0.19200 1.82e-01 -5.99e-02 1.80e-03 3.06e-01
GOBP ENDOCRINE PANCREAS DEVELOPMENT 44 6.45e-02 3.81e-01 0.19200 -1.53e-01 -1.16e-01 7.97e-02 1.82e-01
GOBP ADENINE TRANSPORT 5 7.59e-01 9.32e-01 0.19200 -1.91e-01 1.44e-02 4.59e-01 9.56e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS 7 6.96e-01 9.11e-01 0.19200 -6.41e-02 1.81e-01 7.69e-01 4.07e-01
GOCC TRNA METHYLTRANSFERASE COMPLEX 6 6.95e-01 9.11e-01 0.19200 -1.78e-01 -7.15e-02 4.50e-01 7.62e-01
Signaling by BMP 30 2.25e-01 6.43e-01 0.19200 -1.58e-01 1.09e-01 1.35e-01 2.99e-01
GOBP REGULATION OF GUANYLATE CYCLASE ACTIVITY 6 6.89e-01 9.08e-01 0.19200 1.61e-01 1.05e-01 4.96e-01 6.56e-01
GOCC AMPA GLUTAMATE RECEPTOR COMPLEX 22 3.31e-01 7.35e-01 0.19200 -1.67e-01 9.51e-02 1.76e-01 4.40e-01
GOBP PARENTAL BEHAVIOR 13 4.70e-01 8.15e-01 0.19200 -1.89e-01 -3.14e-02 2.38e-01 8.44e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS 12 4.86e-01 8.23e-01 0.19200 -1.80e-01 -6.58e-02 2.80e-01 6.93e-01
GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION 14 4.18e-01 7.87e-01 0.19200 -1.42e-01 -1.28e-01 3.56e-01 4.06e-01
GOBP PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS 5 7.82e-01 9.40e-01 0.19200 -1.38e-01 1.33e-01 5.93e-01 6.07e-01
GOBP CHORION DEVELOPMENT 10 6.11e-01 8.78e-01 0.19200 -1.32e-01 1.39e-01 4.69e-01 4.48e-01
GOBP ESTABLISHMENT OF SPINDLE ORIENTATION 42 1.17e-01 4.91e-01 0.19200 -1.78e-01 7.09e-02 4.61e-02 4.26e-01
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 16 4.53e-01 8.07e-01 0.19200 1.54e-01 -1.13e-01 2.85e-01 4.33e-01
GOBP ANIMAL ORGAN REGENERATION 62 4.78e-02 3.31e-01 0.19100 1.35e-01 -1.36e-01 6.65e-02 6.40e-02
GOCC RNA POLYMERASE II CORE COMPLEX 13 4.45e-01 8.02e-01 0.19100 -1.29e-01 -1.41e-01 4.19e-01 3.79e-01
GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING 10 6.10e-01 8.77e-01 0.19100 -1.55e-01 1.12e-01 3.95e-01 5.40e-01
GOBP TRNA 3 END PROCESSING 6 7.26e-01 9.19e-01 0.19100 -1.88e-01 3.52e-02 4.25e-01 8.81e-01
GOBP CORNIFIED ENVELOPE ASSEMBLY 6 7.19e-01 9.15e-01 0.19100 -1.91e-01 8.40e-03 4.18e-01 9.72e-01
GOCC CHOLINERGIC SYNAPSE 10 5.87e-01 8.67e-01 0.19100 -3.47e-02 1.88e-01 8.49e-01 3.03e-01
GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY 11 5.60e-01 8.57e-01 0.19100 -1.87e-01 4.18e-02 2.84e-01 8.10e-01
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression 38 1.06e-01 4.74e-01 0.19100 -5.61e-02 -1.83e-01 5.49e-01 5.13e-02
GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL 7 7.06e-01 9.13e-01 0.19100 -9.73e-02 1.64e-01 6.56e-01 4.51e-01
GOBP CHROMOSOME CONDENSATION 46 9.77e-02 4.56e-01 0.19100 -1.75e-01 7.68e-02 4.02e-02 3.68e-01
GOBP TRANSEPITHELIAL TRANSPORT 35 1.15e-01 4.89e-01 0.19100 1.30e-01 1.40e-01 1.85e-01 1.51e-01
GOBP URETER DEVELOPMENT 18 3.40e-01 7.40e-01 0.19100 -1.77e-01 -7.09e-02 1.93e-01 6.03e-01
GOBP REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT 11 5.08e-01 8.34e-01 0.19100 -1.56e-01 -1.10e-01 3.70e-01 5.28e-01
GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE 36 1.16e-01 4.90e-01 0.19100 -7.28e-02 -1.76e-01 4.50e-01 6.71e-02
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 182 1.31e-04 7.42e-03 0.19100 1.01e-01 -1.62e-01 1.91e-02 1.63e-04
GOMF SMAD BINDING 74 1.61e-02 2.03e-01 0.19100 -1.90e-01 -9.39e-03 4.61e-03 8.89e-01
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint 61 3.24e-02 2.81e-01 0.19100 -1.66e-02 -1.90e-01 8.22e-01 1.03e-02
GOBP REGULATION OF OSTEOCLAST PROLIFERATION 6 7.29e-01 9.21e-01 0.19100 -1.87e-01 3.67e-02 4.28e-01 8.76e-01
GOCC OUTER KINETOCHORE 20 3.17e-01 7.24e-01 0.19100 -3.49e-02 -1.87e-01 7.87e-01 1.47e-01
GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA 24 2.28e-01 6.46e-01 0.19000 -1.40e-01 -1.30e-01 2.36e-01 2.72e-01
GOMF PHOSPHATIDYLCHOLINE FLIPPASE ACTIVITY 5 7.35e-01 9.23e-01 0.19000 1.27e-01 1.42e-01 6.24e-01 5.82e-01
GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE 53 4.00e-02 3.06e-01 0.19000 -9.85e-02 -1.63e-01 2.15e-01 4.01e-02
GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION 13 5.07e-01 8.33e-01 0.19000 -1.86e-01 4.23e-02 2.46e-01 7.92e-01
GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION 26 2.06e-01 6.22e-01 0.19000 -1.65e-01 -9.54e-02 1.46e-01 4.00e-01
GOMF NAADP SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 5 7.84e-01 9.40e-01 0.19000 -1.20e-01 1.47e-01 6.41e-01 5.68e-01
GOBP POSITIVE REGULATION OF BLOOD VESSEL REMODELING 6 7.32e-01 9.23e-01 0.19000 -1.84e-01 4.77e-02 4.34e-01 8.40e-01
GOCC STEREOCILIUM BUNDLE 64 4.30e-02 3.15e-01 0.19000 1.62e-01 -9.98e-02 2.49e-02 1.67e-01
GOBP OVULATION CYCLE 73 2.57e-02 2.55e-01 0.19000 -1.74e-01 7.61e-02 9.98e-03 2.61e-01
GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION 23 2.43e-01 6.58e-01 0.19000 -1.37e-01 -1.32e-01 2.54e-01 2.75e-01
Initiation of Nuclear Envelope (NE) Reformation 18 4.07e-01 7.81e-01 0.19000 8.14e-02 -1.72e-01 5.50e-01 2.07e-01
RHOU GTPase cycle 37 1.66e-01 5.67e-01 0.19000 -1.30e-01 1.39e-01 1.72e-01 1.44e-01
GOCC GOLGI LUMEN 93 3.37e-03 7.91e-02 0.19000 1.33e-01 1.36e-01 2.69e-02 2.33e-02
GOBP CRANIOFACIAL SUTURE MORPHOGENESIS 19 3.61e-01 7.52e-01 0.19000 -1.89e-01 1.94e-02 1.54e-01 8.84e-01
GOBP GLUCOSE CATABOLIC PROCESS 25 2.38e-01 6.54e-01 0.19000 3.88e-02 1.86e-01 7.37e-01 1.07e-01
GOMF SUMO BINDING 16 3.95e-01 7.74e-01 0.19000 4.74e-02 1.84e-01 7.43e-01 2.02e-01
GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS 16 3.75e-01 7.63e-01 0.19000 1.45e-01 1.23e-01 3.17e-01 3.93e-01
GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE 9 6.45e-01 8.91e-01 0.19000 -1.52e-01 1.14e-01 4.29e-01 5.54e-01
mTORC1-mediated signalling 23 2.47e-01 6.61e-01 0.19000 -1.06e-01 -1.58e-01 3.80e-01 1.90e-01
SARS-CoV-1 Infection 135 1.13e-03 3.60e-02 0.19000 6.83e-02 -1.77e-01 1.71e-01 3.76e-04
GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE 34 1.89e-01 5.96e-01 0.19000 -9.99e-02 1.62e-01 3.14e-01 1.03e-01
GOBP DEPYRIMIDINATION 8 6.13e-01 8.79e-01 0.19000 1.17e-01 1.50e-01 5.68e-01 4.63e-01
GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT 84 9.23e-03 1.46e-01 0.19000 -1.73e-02 -1.89e-01 7.84e-01 2.74e-03
GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 1370 1.40e-32 8.61e-29 0.19000 -1.87e-01 -3.20e-02 2.96e-31 4.69e-02
GOBP NEURONAL ACTION POTENTIAL PROPAGATION 10 6.00e-01 8.74e-01 0.19000 -5.55e-02 1.81e-01 7.61e-01 3.20e-01
Transcriptional regulation by RUNX3 84 7.31e-03 1.26e-01 0.19000 -6.28e-02 -1.79e-01 3.20e-01 4.55e-03
GOBP VENOUS BLOOD VESSEL DEVELOPMENT 16 4.62e-01 8.12e-01 0.19000 -1.33e-01 1.35e-01 3.58e-01 3.48e-01
GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION 10 5.54e-01 8.54e-01 0.19000 -1.76e-01 -6.99e-02 3.34e-01 7.02e-01
GOBP TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB 7 6.93e-01 9.09e-01 0.19000 1.87e-01 -3.28e-02 3.92e-01 8.81e-01
GOMF DEAMINASE ACTIVITY 32 1.74e-01 5.78e-01 0.18900 2.10e-03 1.89e-01 9.84e-01 6.36e-02
GOMF DNA TOPOISOMERASE ACTIVITY 7 6.62e-01 8.97e-01 0.18900 -1.76e-01 -7.03e-02 4.20e-01 7.48e-01
GOCC MEMBRANE COAT 96 5.23e-03 1.02e-01 0.18900 -1.89e-01 -6.38e-03 1.35e-03 9.14e-01
GOBP RRNA 3 END PROCESSING 10 5.44e-01 8.51e-01 0.18900 -1.40e-01 -1.28e-01 4.44e-01 4.85e-01
GOMF G QUADRUPLEX RNA BINDING 6 7.10e-01 9.13e-01 0.18900 -1.85e-01 -4.01e-02 4.33e-01 8.65e-01
GOBP REGULATION OF PROTEIN FOLDING 9 5.86e-01 8.67e-01 0.18900 -8.10e-02 -1.71e-01 6.74e-01 3.74e-01
GOBP GDP METABOLIC PROCESS 9 6.43e-01 8.89e-01 0.18900 -1.67e-01 8.98e-02 3.87e-01 6.41e-01
GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY 7 6.99e-01 9.11e-01 0.18900 4.92e-02 -1.83e-01 8.22e-01 4.03e-01
GOCC LSM1 7 PAT1 COMPLEX 5 7.46e-01 9.27e-01 0.18900 -6.60e-02 -1.77e-01 7.98e-01 4.92e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR 81 1.69e-02 2.08e-01 0.18900 5.97e-02 -1.79e-01 3.53e-01 5.23e-03
GOBP LYMPHOCYTE HOMEOSTASIS 73 3.01e-02 2.72e-01 0.18900 1.20e-01 -1.46e-01 7.65e-02 3.07e-02
GOBP EMBRYONIC HEMOPOIESIS 23 2.51e-01 6.66e-01 0.18900 -1.01e-01 -1.60e-01 4.02e-01 1.85e-01
GOCC CLATHRIN VESICLE COAT 34 1.91e-01 5.98e-01 0.18900 -1.63e-01 9.57e-02 1.00e-01 3.34e-01
GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY 25 3.00e-01 7.11e-01 0.18900 -1.52e-01 1.12e-01 1.87e-01 3.34e-01
GOMF DELTA CATENIN BINDING 9 6.49e-01 8.91e-01 0.18900 1.16e-01 -1.49e-01 5.46e-01 4.39e-01
APC/C:Cdc20 mediated degradation of mitotic proteins 63 3.37e-02 2.86e-01 0.18900 5.40e-03 -1.89e-01 9.41e-01 9.51e-03
GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 172 1.06e-04 6.33e-03 0.18900 -1.89e-01 9.96e-03 1.97e-05 8.22e-01
GOBP POLYOL TRANSMEMBRANE TRANSPORT 10 5.53e-01 8.54e-01 0.18900 1.70e-01 8.31e-02 3.53e-01 6.49e-01
SUMOylation of immune response proteins 11 5.68e-01 8.59e-01 0.18900 -1.84e-01 4.39e-02 2.91e-01 8.01e-01
GOBP ACIDIC AMINO ACID TRANSPORT 66 4.25e-02 3.14e-01 0.18900 -1.21e-01 1.45e-01 9.01e-02 4.12e-02
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 9 6.44e-01 8.90e-01 0.18900 9.00e-02 -1.66e-01 6.40e-01 3.88e-01
GOBP SYNAPTIC VESICLE MATURATION 21 2.91e-01 7.03e-01 0.18900 -1.74e-01 -7.43e-02 1.68e-01 5.56e-01
GOBP TELOMERE MAINTENANCE VIA RECOMBINATION 14 4.38e-01 7.98e-01 0.18900 -1.72e-01 -7.76e-02 2.65e-01 6.15e-01
GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS 10 5.48e-01 8.52e-01 0.18900 -1.09e-01 -1.54e-01 5.50e-01 3.99e-01
GOBP MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION 7 6.60e-01 8.96e-01 0.18900 -8.59e-02 -1.68e-01 6.94e-01 4.41e-01
GOCC CLATHRIN COAT 50 8.56e-02 4.33e-01 0.18900 -1.71e-01 7.93e-02 3.63e-02 3.32e-01
Citric acid cycle (TCA cycle) 32 1.50e-01 5.44e-01 0.18900 -9.00e-02 -1.66e-01 3.78e-01 1.05e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY 15 4.11e-01 7.84e-01 0.18900 -8.74e-02 -1.67e-01 5.58e-01 2.62e-01
CYP2E1 reactions 10 6.04e-01 8.76e-01 0.18900 -1.80e-01 5.53e-02 3.24e-01 7.62e-01
GOBP RIGHTING REFLEX 8 6.81e-01 9.05e-01 0.18900 -1.13e-01 1.51e-01 5.79e-01 4.60e-01
GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 21 2.84e-01 6.96e-01 0.18900 -1.55e-01 -1.08e-01 2.19e-01 3.93e-01
GOBP CELLULAR RESPONSE TO VIRUS 79 1.76e-02 2.11e-01 0.18900 1.84e-01 -4.13e-02 4.70e-03 5.26e-01
GOMF PEPTIDE HORMONE BINDING 48 7.08e-02 3.99e-01 0.18800 -1.88e-01 -1.89e-02 2.46e-02 8.21e-01
GOBP PARANODAL JUNCTION ASSEMBLY 6 6.96e-01 9.11e-01 0.18800 1.27e-01 1.39e-01 5.91e-01 5.54e-01
GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY 14 4.99e-01 8.30e-01 0.18800 -1.75e-01 6.87e-02 2.56e-01 6.56e-01
GOBP SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR 11 5.15e-01 8.38e-01 0.18800 -1.28e-01 -1.38e-01 4.61e-01 4.28e-01
GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING 23 3.34e-01 7.35e-01 0.18800 -1.42e-01 1.24e-01 2.38e-01 3.05e-01
GOBP INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE 8 6.33e-01 8.86e-01 0.18800 1.82e-01 4.91e-02 3.73e-01 8.10e-01
GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY 23 2.57e-01 6.71e-01 0.18800 -1.67e-01 -8.73e-02 1.66e-01 4.69e-01
GOBP UTERUS DEVELOPMENT 25 2.88e-01 7.01e-01 0.18800 -1.77e-01 6.40e-02 1.25e-01 5.80e-01
GOBP REGULATION OF PROTEIN KINASE C SIGNALING 18 3.40e-01 7.40e-01 0.18800 -1.13e-01 -1.51e-01 4.08e-01 2.68e-01
GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 19 3.48e-01 7.44e-01 0.18800 -2.68e-02 -1.86e-01 8.39e-01 1.60e-01
GOBP POSITIVE REGULATION OF MYELINATION 18 3.70e-01 7.58e-01 0.18800 2.24e-02 1.87e-01 8.70e-01 1.70e-01
Formation of definitive endoderm 16 3.85e-01 7.68e-01 0.18800 -1.56e-01 -1.05e-01 2.80e-01 4.67e-01
GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE 9 6.11e-01 8.78e-01 0.18800 1.36e-02 1.88e-01 9.44e-01 3.30e-01
GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE 20 3.83e-01 7.67e-01 0.18800 1.03e-01 -1.57e-01 4.24e-01 2.23e-01
VEGFA-VEGFR2 Pathway 94 9.03e-03 1.45e-01 0.18800 -1.80e-01 5.45e-02 2.56e-03 3.61e-01
GOBP SNRNA TRANSCRIPTION 20 3.14e-01 7.22e-01 0.18800 -6.93e-02 -1.75e-01 5.91e-01 1.76e-01
High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells 69 3.72e-02 2.96e-01 0.18800 -1.56e-01 1.05e-01 2.52e-02 1.31e-01
GOBP RAP PROTEIN SIGNAL TRANSDUCTION 12 4.87e-01 8.23e-01 0.18800 -1.27e-01 -1.38e-01 4.45e-01 4.07e-01
GOBP CEREBRAL CORTEX CELL MIGRATION 45 1.01e-01 4.65e-01 0.18800 -1.83e-01 4.05e-02 3.32e-02 6.39e-01
GOMF U1 SNRNA BINDING 8 6.59e-01 8.96e-01 0.18800 2.31e-02 -1.86e-01 9.10e-01 3.61e-01
GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING 53 5.05e-02 3.41e-01 0.18800 4.32e-02 1.83e-01 5.86e-01 2.13e-02
GOBP G2 MI TRANSITION OF MEIOTIC CELL CYCLE 6 7.21e-01 9.17e-01 0.18800 -1.35e-02 -1.87e-01 9.54e-01 4.27e-01
Gain-of-function MRAS complexes activate RAF signaling 7 6.64e-01 8.97e-01 0.18800 -8.28e-02 -1.69e-01 7.05e-01 4.40e-01
SHOC2 M1731 mutant abolishes MRAS complex function 7 6.64e-01 8.97e-01 0.18800 -8.28e-02 -1.69e-01 7.05e-01 4.40e-01
Signaling by MRAS-complex mutants 7 6.64e-01 8.97e-01 0.18800 -8.28e-02 -1.69e-01 7.05e-01 4.40e-01
Maturation of spike protein 9683686 5 7.86e-01 9.41e-01 0.18800 9.58e-02 -1.61e-01 7.11e-01 5.32e-01
GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 24 3.08e-01 7.17e-01 0.18800 7.26e-02 -1.73e-01 5.38e-01 1.42e-01
GOCC NEURON PROJECTION MEMBRANE 56 5.44e-02 3.55e-01 0.18800 -1.86e-01 2.16e-02 1.58e-02 7.80e-01
Loss of Function of TGFBR1 in Cancer 7 6.82e-01 9.06e-01 0.18800 -1.87e-01 -1.73e-02 3.92e-01 9.37e-01
GOBP AXON MIDLINE CHOICE POINT RECOGNITION 5 7.50e-01 9.29e-01 0.18800 -1.77e-01 -6.23e-02 4.93e-01 8.09e-01
GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 18 4.23e-01 7.91e-01 0.18800 1.60e-01 -9.76e-02 2.40e-01 4.74e-01
GOBP REGULATION OF CELL MATRIX ADHESION 121 2.67e-03 6.73e-02 0.18800 -1.75e-01 6.82e-02 9.03e-04 1.95e-01
GOBP DOPAMINE SECRETION 30 2.43e-01 6.58e-01 0.18700 -1.26e-01 1.39e-01 2.33e-01 1.88e-01
GOCC NADPH OXIDASE COMPLEX 13 5.09e-01 8.34e-01 0.18700 -2.27e-02 1.86e-01 8.87e-01 2.45e-01
GOBP RESPONSE TO MISFOLDED PROTEIN 18 3.83e-01 7.67e-01 0.18700 -1.87e-01 1.89e-03 1.69e-01 9.89e-01
GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS 29 2.55e-01 6.71e-01 0.18700 -1.34e-01 1.31e-01 2.13e-01 2.21e-01
GOBP ARGININE CATABOLIC PROCESS 10 5.75e-01 8.63e-01 0.18700 -1.85e-01 -3.05e-02 3.11e-01 8.68e-01
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY 21 3.54e-01 7.47e-01 0.18700 1.77e-01 -6.24e-02 1.61e-01 6.21e-01
Kidney development 45 6.90e-02 3.95e-01 0.18700 -1.45e-01 -1.19e-01 9.33e-02 1.67e-01
GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION 16 3.86e-01 7.68e-01 0.18700 1.22e-01 1.42e-01 3.99e-01 3.24e-01
GOBP MAST CELL ACTIVATION 65 4.61e-02 3.26e-01 0.18700 1.07e-01 -1.54e-01 1.35e-01 3.22e-02
GOBP LEUKOCYTE MEDIATED CYTOTOXICITY 139 1.37e-03 4.14e-02 0.18700 1.59e-01 -9.89e-02 1.20e-03 4.42e-02
GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION 30 1.91e-01 5.98e-01 0.18700 -2.99e-02 -1.85e-01 7.77e-01 7.96e-02
GOMF HISTONE READER ACTIVITY 17 4.01e-01 7.78e-01 0.18700 7.78e-03 1.87e-01 9.56e-01 1.82e-01
GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 13 5.34e-01 8.46e-01 0.18700 8.55e-02 -1.67e-01 5.94e-01 2.98e-01
GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 70 3.61e-02 2.93e-01 0.18700 -1.57e-01 1.02e-01 2.29e-02 1.41e-01
GOBP REGULATION OF PRO B CELL DIFFERENTIATION 8 6.54e-01 8.93e-01 0.18700 -2.97e-03 1.87e-01 9.88e-01 3.59e-01
GOCC KATANIN COMPLEX 5 7.84e-01 9.40e-01 0.18700 7.57e-02 -1.71e-01 7.69e-01 5.07e-01
GOMF CCR CHEMOKINE RECEPTOR BINDING 39 1.58e-01 5.55e-01 0.18700 1.05e-01 -1.55e-01 2.56e-01 9.42e-02
GOBP GROWTH HORMONE SECRETION 13 4.67e-01 8.14e-01 0.18700 -1.63e-01 -9.11e-02 3.07e-01 5.70e-01
Constitutive Signaling by NOTCH1 HD Domain Mutants 15 4.20e-01 7.88e-01 0.18700 1.70e-01 7.70e-02 2.53e-01 6.06e-01
Signaling by NOTCH1 HD Domain Mutants in Cancer 15 4.20e-01 7.88e-01 0.18700 1.70e-01 7.70e-02 2.53e-01 6.06e-01
Cristae formation 29 2.56e-01 6.71e-01 0.18700 1.20e-01 -1.44e-01 2.64e-01 1.81e-01
GOBP REGULATION OF GLIAL CELL MIGRATION 19 3.27e-01 7.31e-01 0.18700 -1.58e-01 -9.99e-02 2.33e-01 4.51e-01
GOCC CYTOSOLIC PROTEASOME COMPLEX 5 7.89e-01 9.42e-01 0.18700 1.08e-01 -1.53e-01 6.76e-01 5.54e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES 34 1.44e-01 5.36e-01 0.18700 6.06e-02 1.77e-01 5.41e-01 7.42e-02
GOBP EMBRYONIC HINDLIMB MORPHOGENESIS 27 2.72e-01 6.85e-01 0.18700 -1.69e-01 7.98e-02 1.28e-01 4.73e-01
GOMF PRE MRNA INTRONIC BINDING 13 4.62e-01 8.12e-01 0.18700 -1.33e-01 -1.31e-01 4.05e-01 4.14e-01
GOBP POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE 7 7.08e-01 9.13e-01 0.18700 -5.88e-02 1.77e-01 7.88e-01 4.16e-01
GOCC CONTRACTILE RING 11 5.86e-01 8.67e-01 0.18700 -1.72e-01 7.25e-02 3.23e-01 6.77e-01
GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX 26 2.43e-01 6.58e-01 0.18700 -1.86e-01 -2.07e-02 1.01e-01 8.55e-01
GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS 23 2.94e-01 7.07e-01 0.18700 -1.87e-01 -2.98e-03 1.21e-01 9.80e-01
GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 83 1.98e-02 2.25e-01 0.18700 -1.58e-01 1.00e-01 1.31e-02 1.14e-01
GOBP REGULATION OF PROTEIN LIPIDATION 11 5.22e-01 8.41e-01 0.18700 -1.48e-01 -1.14e-01 3.95e-01 5.13e-01
GOBP REGULATION OF SECONDARY METABOLIC PROCESS 15 4.95e-01 8.28e-01 0.18700 1.22e-01 -1.42e-01 4.14e-01 3.42e-01
GOBP KERATINOCYTE MIGRATION 20 3.92e-01 7.71e-01 0.18700 -1.21e-01 1.42e-01 3.48e-01 2.72e-01
GOMF CLATHRIN BINDING 55 7.58e-02 4.12e-01 0.18700 -1.14e-01 1.48e-01 1.43e-01 5.78e-02
GOBP GOLGI LOCALIZATION 14 4.59e-01 8.10e-01 0.18700 -1.82e-01 -4.00e-02 2.37e-01 7.95e-01
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY 8 6.75e-01 9.03e-01 0.18700 -6.10e-02 1.76e-01 7.65e-01 3.87e-01
GOBP FORELIMB MORPHOGENESIS 40 1.06e-01 4.74e-01 0.18700 -1.80e-01 -5.03e-02 4.91e-02 5.82e-01
GOBP TRANSCRIPTION BY RNA POLYMERASE I 68 2.50e-02 2.53e-01 0.18700 -1.85e-01 -2.13e-02 8.17e-03 7.61e-01
GOCC NUCLEAR INCLUSION BODY 12 4.98e-01 8.30e-01 0.18700 -1.66e-01 -8.63e-02 3.21e-01 6.05e-01
GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 26 2.15e-01 6.32e-01 0.18700 1.24e-01 1.40e-01 2.74e-01 2.18e-01
GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 31 2.22e-01 6.39e-01 0.18700 -6.96e-02 1.73e-01 5.02e-01 9.52e-02
GOBP PULMONARY VALVE DEVELOPMENT 24 3.19e-01 7.27e-01 0.18700 -1.63e-01 9.10e-02 1.67e-01 4.40e-01
GOCC UNIPLEX COMPLEX 6 7.42e-01 9.26e-01 0.18700 -1.79e-01 5.16e-02 4.47e-01 8.27e-01
GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION 6 7.05e-01 9.13e-01 0.18700 -1.64e-01 -8.98e-02 4.88e-01 7.03e-01
GOBP MATING BEHAVIOR 36 1.86e-01 5.92e-01 0.18700 -1.39e-01 1.24e-01 1.49e-01 1.96e-01
GOBP SMAD PROTEIN SIGNAL TRANSDUCTION 94 8.10e-03 1.34e-01 0.18700 -1.85e-01 2.25e-02 1.91e-03 7.06e-01
Signaling by CSF1 (M-CSF) in myeloid cells 30 1.70e-01 5.71e-01 0.18700 -1.36e-01 -1.28e-01 1.97e-01 2.26e-01
GOBP MOTOR NEURON APOPTOTIC PROCESS 21 2.96e-01 7.08e-01 0.18600 -8.74e-02 -1.65e-01 4.88e-01 1.91e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY 18 3.98e-01 7.76e-01 0.18600 2.46e-02 -1.85e-01 8.56e-01 1.75e-01
GOBP ACTIN CROSSLINK FORMATION 13 5.36e-01 8.48e-01 0.18600 -8.15e-02 1.68e-01 6.11e-01 2.95e-01
GOBP POSITIVE REGULATION OF TORC1 SIGNALING 50 5.38e-02 3.52e-01 0.18600 -1.56e-01 -1.02e-01 5.61e-02 2.13e-01
GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION 11 5.22e-01 8.41e-01 0.18600 1.32e-01 1.32e-01 4.50e-01 4.48e-01
Negative regulation of FGFR1 signaling 32 2.15e-01 6.32e-01 0.18600 -1.69e-01 7.76e-02 9.71e-02 4.48e-01
GOBP REGULATION OF RENAL SODIUM EXCRETION 8 6.60e-01 8.96e-01 0.18600 1.25e-02 -1.86e-01 9.51e-01 3.63e-01
GOBP MUSCLE ADAPTATION 120 2.86e-03 7.07e-02 0.18600 -1.77e-01 5.91e-02 8.27e-04 2.63e-01
GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS 8 6.86e-01 9.06e-01 0.18600 -1.02e-01 1.56e-01 6.17e-01 4.45e-01
Signaling by ERBB2 ECD mutants 16 3.92e-01 7.71e-01 0.18600 -1.51e-01 -1.09e-01 2.95e-01 4.52e-01
GOCC ANNULATE LAMELLAE 5 7.79e-01 9.39e-01 0.18600 -1.81e-01 4.38e-02 4.83e-01 8.65e-01
GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE 7 6.67e-01 8.99e-01 0.18600 1.64e-01 8.84e-02 4.53e-01 6.86e-01
GOMF ARACHIDONATE COA LIGASE ACTIVITY 10 6.25e-01 8.83e-01 0.18600 -1.54e-01 1.04e-01 3.99e-01 5.67e-01
GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY 8 6.89e-01 9.07e-01 0.18600 -1.44e-01 1.17e-01 4.79e-01 5.65e-01
GOMF VITAMIN B6 BINDING 53 8.55e-02 4.33e-01 0.18600 -1.29e-01 1.34e-01 1.04e-01 9.11e-02
Cross-presentation of particulate exogenous antigens (phagosomes) 6 7.17e-01 9.15e-01 0.18600 -1.81e-01 -4.26e-02 4.42e-01 8.56e-01
GOBP METANEPHRIC PROXIMAL TUBULE DEVELOPMENT 5 7.60e-01 9.32e-01 0.18600 3.22e-02 1.83e-01 9.01e-01 4.78e-01
GOMF N N DIMETHYLANILINE MONOOXYGENASE ACTIVITY 5 7.72e-01 9.36e-01 0.18600 -1.86e-01 1.52e-02 4.73e-01 9.53e-01
GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 52 4.99e-02 3.39e-01 0.18600 1.65e-01 8.68e-02 4.00e-02 2.79e-01
GOBP AGGREPHAGY 16 3.94e-01 7.74e-01 0.18600 -9.88e-02 -1.58e-01 4.94e-01 2.75e-01
GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY 9 6.19e-01 8.80e-01 0.18600 9.18e-03 1.86e-01 9.62e-01 3.34e-01
GOBP REGULATION OF CELL CYCLE CHECKPOINT 43 8.43e-02 4.32e-01 0.18600 -1.65e-01 -8.53e-02 6.08e-02 3.33e-01
Respiratory syncytial virus (RSV) attachment and entry 21 3.54e-01 7.47e-01 0.18600 1.79e-01 -4.86e-02 1.55e-01 7.00e-01
GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY 38 1.16e-01 4.90e-01 0.18600 1.73e-01 6.91e-02 6.56e-02 4.61e-01
GOBP REGULATION OF PROTEIN COMPLEX STABILITY 14 4.53e-01 8.07e-01 0.18600 -1.74e-01 -6.62e-02 2.60e-01 6.68e-01
GOBP NEGATIVE REGULATION OF B CELL DIFFERENTIATION 6 7.17e-01 9.15e-01 0.18600 -4.53e-02 -1.80e-01 8.48e-01 4.44e-01
GOBP ECTODERMAL CELL DIFFERENTIATION 6 7.08e-01 9.13e-01 0.18600 -1.66e-01 -8.30e-02 4.81e-01 7.25e-01
GOBP ENDODERM DEVELOPMENT 84 1.12e-02 1.65e-01 0.18600 -1.85e-01 -1.75e-02 3.38e-03 7.81e-01
Suppression of apoptosis 7 6.92e-01 9.09e-01 0.18600 -1.86e-01 -2.43e-03 3.95e-01 9.91e-01
GOBP GAMMA DELTA T CELL ACTIVATION 24 3.29e-01 7.33e-01 0.18600 1.37e-01 -1.26e-01 2.46e-01 2.86e-01
GOBP MOTOR BEHAVIOR 22 3.02e-01 7.12e-01 0.18600 -1.83e-01 -3.15e-02 1.37e-01 7.98e-01
Protein ubiquitination 73 2.12e-02 2.33e-01 0.18600 -7.48e-03 -1.86e-01 9.12e-01 6.11e-03
GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 52 5.67e-02 3.62e-01 0.18600 -1.80e-01 -4.45e-02 2.45e-02 5.79e-01
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY 17 4.55e-01 8.09e-01 0.18600 -1.36e-01 1.26e-01 3.30e-01 3.68e-01
GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING 10 6.25e-01 8.83e-01 0.18600 -9.36e-02 1.60e-01 6.08e-01 3.80e-01
GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY 10 6.06e-01 8.76e-01 0.18600 -3.56e-02 1.82e-01 8.45e-01 3.18e-01
GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY 16 4.07e-01 7.81e-01 0.18600 1.75e-01 6.13e-02 2.25e-01 6.71e-01
GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL 29 2.27e-01 6.45e-01 0.18600 -1.78e-02 1.85e-01 8.68e-01 8.51e-02
GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING 9 6.53e-01 8.93e-01 0.18600 8.61e-02 -1.64e-01 6.55e-01 3.93e-01
GOCC STRIATED MUSCLE THIN FILAMENT 22 3.05e-01 7.15e-01 0.18500 2.66e-02 1.84e-01 8.29e-01 1.36e-01
GOBP SIGNAL PEPTIDE PROCESSING 13 5.19e-01 8.39e-01 0.18500 2.80e-02 -1.83e-01 8.61e-01 2.52e-01
PKMTs methylate histone lysines 42 1.40e-01 5.31e-01 0.18500 -1.59e-01 9.47e-02 7.37e-02 2.88e-01
GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS 10 6.08e-01 8.77e-01 0.18500 -3.90e-02 1.81e-01 8.31e-01 3.21e-01
GOBP CENP A CONTAINING CHROMATIN ASSEMBLY 9 6.38e-01 8.88e-01 0.18500 -1.82e-01 3.61e-02 3.45e-01 8.51e-01
GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING 23 2.98e-01 7.09e-01 0.18500 -1.85e-01 -7.06e-03 1.24e-01 9.53e-01
GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY 35 1.68e-01 5.68e-01 0.18500 1.72e-02 -1.85e-01 8.60e-01 5.89e-02
Homology Directed Repair 116 1.33e-03 4.08e-02 0.18500 -8.99e-02 -1.62e-01 9.45e-02 2.58e-03
GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE 7 7.16e-01 9.15e-01 0.18500 7.16e-02 -1.71e-01 7.43e-01 4.34e-01
GOBP METANEPHROS DEVELOPMENT 89 7.09e-03 1.24e-01 0.18500 -1.76e-01 -5.82e-02 4.14e-03 3.43e-01
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 18 3.61e-01 7.52e-01 0.18500 -7.36e-02 -1.70e-01 5.89e-01 2.12e-01
GOBP REGULATION OF LIPOPROTEIN LIPASE ACTIVITY 14 4.72e-01 8.16e-01 0.18500 -1.84e-01 -2.29e-02 2.34e-01 8.82e-01
Hh mutants are degraded by ERAD 43 9.61e-02 4.52e-01 0.18500 -3.79e-02 -1.81e-01 6.67e-01 3.98e-02
G beta:gamma signalling through BTK 17 3.91e-01 7.71e-01 0.18500 -1.79e-01 -4.85e-02 2.02e-01 7.29e-01
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS 17 4.15e-01 7.86e-01 0.18500 -1.85e-01 5.79e-03 1.87e-01 9.67e-01
GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 270 9.72e-07 1.07e-04 0.18500 -1.85e-01 3.24e-03 1.65e-07 9.27e-01
GOMF DINUCLEOTIDE PHOSPHATASE ACTIVITY 8 6.62e-01 8.97e-01 0.18500 -8.75e-03 1.85e-01 9.66e-01 3.65e-01
GOCC CIA COMPLEX 5 7.53e-01 9.30e-01 0.18500 7.64e-02 1.69e-01 7.67e-01 5.14e-01
GOMF TRNA CYTIDINE METHYLTRANSFERASE ACTIVITY 9 5.94e-01 8.71e-01 0.18500 -1.51e-01 -1.07e-01 4.32e-01 5.79e-01
GOBP CELLULAR ALDEHYDE METABOLIC PROCESS 76 1.77e-02 2.11e-01 0.18500 1.84e-01 1.80e-02 5.50e-03 7.86e-01
GOBP BRANCHING MORPHOGENESIS OF A NERVE 10 5.61e-01 8.57e-01 0.18500 -1.52e-01 -1.06e-01 4.06e-01 5.61e-01
GOBP THORAX AND ANTERIOR ABDOMEN DETERMINATION 5 7.94e-01 9.44e-01 0.18500 1.46e-01 -1.14e-01 5.73e-01 6.59e-01
GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 17 3.73e-01 7.61e-01 0.18500 -1.44e-01 -1.17e-01 3.06e-01 4.05e-01
GOCC CYTOPLASMIC DYNEIN COMPLEX 22 3.37e-01 7.37e-01 0.18500 -1.81e-01 3.88e-02 1.42e-01 7.53e-01
GOBP POSITIVE REGULATION OF MITOPHAGY 14 4.44e-01 8.01e-01 0.18500 1.16e-01 1.44e-01 4.51e-01 3.52e-01
GOBP PROTEIN LOCALIZATION TO VACUOLE 85 1.32e-02 1.82e-01 0.18500 -1.84e-01 1.33e-02 3.29e-03 8.32e-01
GOMF PRIMARY MIRNA BINDING 9 5.95e-01 8.71e-01 0.18500 -1.50e-01 -1.08e-01 4.36e-01 5.75e-01
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 19 3.34e-01 7.35e-01 0.18500 -1.51e-01 -1.06e-01 2.53e-01 4.23e-01
GOBP NON PROTEINOGENIC AMINO ACID CATABOLIC PROCESS 16 3.98e-01 7.76e-01 0.18500 1.06e-01 1.52e-01 4.64e-01 2.94e-01
GOBP METANEPHRIC GLOMERULAR MESANGIUM DEVELOPMENT 5 7.70e-01 9.35e-01 0.18500 -1.85e-01 -6.78e-03 4.75e-01 9.79e-01
GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE 43 8.91e-02 4.38e-01 0.18500 -7.36e-02 -1.69e-01 4.04e-01 5.46e-02
GOBP C4 DICARBOXYLATE TRANSPORT 28 2.24e-01 6.42e-01 0.18500 2.54e-02 1.83e-01 8.16e-01 9.39e-02
GOCC MITOCHONDRIAL CRISTA 8 6.38e-01 8.88e-01 0.18500 -1.70e-01 -7.30e-02 4.06e-01 7.21e-01
GOBP REGULATION OF OVARIAN FOLLICLE DEVELOPMENT 6 7.11e-01 9.14e-01 0.18500 1.63e-01 8.73e-02 4.90e-01 7.11e-01
GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION 14 5.27e-01 8.42e-01 0.18500 -1.44e-01 1.16e-01 3.52e-01 4.53e-01
GOCC CATION TRANSPORTING ATPASE COMPLEX 18 4.19e-01 7.87e-01 0.18400 -5.28e-02 1.77e-01 6.98e-01 1.94e-01
GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS 68 4.52e-02 3.24e-01 0.18400 1.29e-01 -1.32e-01 6.50e-02 6.07e-02
Processing of Capped Intron-Containing Pre-mRNA 265 4.88e-07 5.65e-05 0.18400 -6.07e-02 -1.74e-01 8.91e-02 1.06e-06
Meiosis 82 9.29e-03 1.46e-01 0.18400 -1.02e-01 -1.54e-01 1.11e-01 1.61e-02
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS 14 5.01e-01 8.30e-01 0.18400 1.81e-01 -3.38e-02 2.41e-01 8.27e-01
GOBP MYELIN MAINTENANCE 17 4.44e-01 8.01e-01 0.18400 -1.74e-01 6.09e-02 2.15e-01 6.64e-01
GOBP REGULATION OF NODAL SIGNALING PATHWAY 5 7.53e-01 9.30e-01 0.18400 9.18e-02 1.60e-01 7.22e-01 5.36e-01
RUNX3 regulates p14-ARF 10 6.06e-01 8.76e-01 0.18400 2.35e-02 -1.83e-01 8.98e-01 3.17e-01
GOBP TERMINAL BUTTON ORGANIZATION 6 7.38e-01 9.24e-01 0.18400 -1.59e-02 1.84e-01 9.46e-01 4.36e-01
Signaling by FGFR2 IIIa TM 19 3.50e-01 7.45e-01 0.18400 -1.74e-01 -5.97e-02 1.88e-01 6.53e-01
GOBP CHOLINE METABOLIC PROCESS 6 7.09e-01 9.13e-01 0.18400 -1.12e-01 -1.47e-01 6.36e-01 5.34e-01
GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS 439 1.19e-09 2.60e-07 0.18400 1.73e-01 -6.23e-02 4.68e-10 2.53e-02
GOBP MESODERM MORPHOGENESIS 77 1.49e-02 1.94e-01 0.18400 -1.77e-01 -5.12e-02 7.27e-03 4.38e-01
GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 6 7.24e-01 9.18e-01 0.18400 1.81e-01 3.49e-02 4.43e-01 8.82e-01
GOBP CAMP METABOLIC PROCESS 23 3.18e-01 7.26e-01 0.18400 -2.67e-02 1.82e-01 8.24e-01 1.30e-01
GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY 8 6.92e-01 9.09e-01 0.18400 9.73e-02 -1.56e-01 6.34e-01 4.44e-01
GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY 5 7.50e-01 9.29e-01 0.18400 -1.33e-01 -1.27e-01 6.06e-01 6.23e-01
GOBP ENDOCARDIAL CUSHION FORMATION 31 1.77e-01 5.82e-01 0.18400 -1.69e-01 -7.36e-02 1.04e-01 4.78e-01
GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT 71 1.96e-02 2.24e-01 0.18400 -1.72e-01 -6.60e-02 1.23e-02 3.36e-01
Cellular response to hypoxia 61 3.29e-02 2.83e-01 0.18400 -7.80e-02 -1.67e-01 2.92e-01 2.44e-02
Cdc20:Phospho-APC/C mediated degradation of Cyclin A 60 4.22e-02 3.14e-01 0.18400 -2.17e-02 -1.83e-01 7.72e-01 1.44e-02
GOBP REGULATION OF CENTROMERE COMPLEX ASSEMBLY 6 7.62e-01 9.32e-01 0.18400 -1.32e-01 1.29e-01 5.77e-01 5.85e-01
GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING 1143 7.45e-26 2.29e-22 0.18400 -1.82e-01 -2.76e-02 3.04e-25 1.15e-01
GOMF HISTONE UBIQUITIN LIGASE ACTIVITY 10 6.32e-01 8.86e-01 0.18400 1.54e-01 -1.01e-01 4.00e-01 5.79e-01
GOCC INTEGRATOR COMPLEX 17 4.10e-01 7.84e-01 0.18400 -1.83e-01 -1.46e-02 1.91e-01 9.17e-01
GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 20 3.70e-01 7.58e-01 0.18400 -2.47e-02 1.82e-01 8.48e-01 1.58e-01
GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY 12 5.79e-01 8.64e-01 0.18400 -1.12e-01 1.46e-01 5.02e-01 3.81e-01
FCERI mediated Ca+2 mobilization 30 1.79e-01 5.83e-01 0.18400 -1.36e-01 -1.24e-01 1.99e-01 2.39e-01
GOBP PEROXISOME ORGANIZATION 34 1.57e-01 5.54e-01 0.18400 -4.92e-02 -1.77e-01 6.20e-01 7.38e-02
GOMF STRUCTURAL CONSTITUENT OF SYNAPSE 23 3.52e-01 7.46e-01 0.18400 -1.42e-01 1.17e-01 2.38e-01 3.33e-01
ER-Phagosome pathway 76 2.63e-02 2.57e-01 0.18400 5.28e-02 -1.76e-01 4.26e-01 7.96e-03
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME 8 6.33e-01 8.86e-01 0.18400 1.09e-01 1.48e-01 5.94e-01 4.68e-01
GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE 17 4.36e-01 7.97e-01 0.18400 3.80e-02 -1.80e-01 7.86e-01 1.99e-01
GOMF ACETYLCHOLINE RECEPTOR ACTIVITY 22 3.61e-01 7.52e-01 0.18400 1.63e-01 -8.53e-02 1.86e-01 4.88e-01
GOBP EPOXYGENASE P450 PATHWAY 17 3.78e-01 7.64e-01 0.18400 -1.21e-01 -1.38e-01 3.88e-01 3.24e-01
PI3K Cascade 43 1.36e-01 5.25e-01 0.18400 -1.64e-01 8.29e-02 6.28e-02 3.47e-01
GOBP SNRNA METABOLIC PROCESS 55 4.31e-02 3.16e-01 0.18400 -1.33e-01 -1.26e-01 8.75e-02 1.05e-01
GOMF N ACYLSPHINGOSINE AMIDOHYDROLASE ACTIVITY 7 6.99e-01 9.11e-01 0.18400 -1.30e-03 1.84e-01 9.95e-01 4.00e-01
GOBP L PROLINE BIOSYNTHETIC PROCESS 6 7.09e-01 9.13e-01 0.18400 1.26e-01 1.33e-01 5.93e-01 5.72e-01
GOBP ISOPRENOID TRANSPORT 5 7.65e-01 9.33e-01 0.18400 -1.80e-01 -3.71e-02 4.86e-01 8.86e-01
GOBP CELLULAR RESPONSE TO IONIZING RADIATION 70 2.01e-02 2.28e-01 0.18400 -8.01e-02 -1.65e-01 2.46e-01 1.69e-02
GOBP METANEPHRIC NEPHRON DEVELOPMENT 40 1.26e-01 5.09e-01 0.18300 -1.83e-01 -8.91e-03 4.49e-02 9.22e-01
GOBP POSITIVE REGULATION OF ASPARTIC TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS 5 7.56e-01 9.30e-01 0.18300 8.46e-02 1.63e-01 7.43e-01 5.29e-01
GOBP NEPHRIC DUCT MORPHOGENESIS 10 6.11e-01 8.78e-01 0.18300 -1.81e-01 2.88e-02 3.21e-01 8.75e-01
GOCC PAR POLARITY COMPLEX 6 7.10e-01 9.14e-01 0.18300 1.23e-01 1.36e-01 6.01e-01 5.65e-01
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX SUBSTRATE RELEASE 5 7.77e-01 9.38e-01 0.18300 -1.83e-01 1.08e-02 4.79e-01 9.67e-01
GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION 456 8.08e-10 1.80e-07 0.18300 1.69e-01 -6.97e-02 5.48e-10 1.07e-02
GOBP REGULATION OF SYNAPTIC VESICLE CYCLE 12 5.07e-01 8.32e-01 0.18300 1.50e-01 1.05e-01 3.68e-01 5.28e-01
GOCC P BODY 99 3.64e-03 8.31e-02 0.18300 -1.19e-01 -1.39e-01 4.00e-02 1.69e-02
GOBP ANDROGEN BIOSYNTHETIC PROCESS 10 6.02e-01 8.75e-01 0.18300 1.83e-01 -2.88e-03 3.16e-01 9.87e-01
GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 182 2.36e-04 1.11e-02 0.18300 8.15e-02 -1.64e-01 5.80e-02 1.34e-04
GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPTIC ACTIN CYTOSKELETON 7 7.10e-01 9.14e-01 0.18300 1.80e-01 -3.35e-02 4.09e-01 8.78e-01
GOBP INTESTINAL STEM CELL HOMEOSTASIS 6 7.58e-01 9.31e-01 0.18300 1.64e-01 -8.11e-02 4.86e-01 7.31e-01
GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE 5 7.65e-01 9.33e-01 0.18300 -4.04e-02 -1.79e-01 8.76e-01 4.89e-01
Orc1 removal from chromatin 58 4.12e-02 3.09e-01 0.18300 -6.74e-02 -1.70e-01 3.74e-01 2.49e-02
GOMF TELOMERIC DNA BINDING 38 1.34e-01 5.21e-01 0.18300 -3.18e-02 -1.80e-01 7.34e-01 5.44e-02
GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY 12 5.45e-01 8.51e-01 0.18300 5.57e-03 -1.83e-01 9.73e-01 2.72e-01
GOBP REGULATION OF PROSTAGLANDIN SECRETION 14 4.91e-01 8.26e-01 0.18300 2.61e-03 -1.83e-01 9.87e-01 2.36e-01
GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 68 2.13e-02 2.33e-01 0.18300 1.43e-01 1.15e-01 4.19e-02 1.02e-01
GOBP AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING 11 5.54e-01 8.54e-01 0.18300 1.77e-01 4.50e-02 3.08e-01 7.96e-01
GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION 13 4.89e-01 8.25e-01 0.18300 6.84e-02 1.70e-01 6.69e-01 2.90e-01
GOBP NAD CATABOLIC PROCESS 20 3.35e-01 7.35e-01 0.18300 6.19e-02 1.72e-01 6.32e-01 1.83e-01
GOMF ADENOSINE RECEPTOR BINDING 8 6.50e-01 8.91e-01 0.18300 1.76e-01 4.81e-02 3.87e-01 8.14e-01
GOBP MITOCHONDRIAL DEPOLARIZATION 24 3.19e-01 7.26e-01 0.18300 -1.76e-01 4.94e-02 1.36e-01 6.75e-01
GOMF PHOSPHATIDYLGLYCEROL BINDING 15 4.28e-01 7.94e-01 0.18300 1.11e-01 1.45e-01 4.58e-01 3.30e-01
Axonal growth inhibition (RHOA activation) 8 6.48e-01 8.91e-01 0.18300 5.59e-02 1.74e-01 7.84e-01 3.94e-01
GOCC FAR SIN STRIPAK COMPLEX 16 4.76e-01 8.19e-01 0.18300 -1.67e-01 7.38e-02 2.47e-01 6.09e-01
GOMF RETINOL BINDING 16 4.26e-01 7.93e-01 0.18300 1.78e-01 4.17e-02 2.18e-01 7.73e-01
IRAK2 mediated activation of TAK1 complex 9 6.16e-01 8.80e-01 0.18300 -4.80e-02 -1.76e-01 8.03e-01 3.60e-01
GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX 17 4.64e-01 8.12e-01 0.18300 -1.52e-01 1.02e-01 2.79e-01 4.68e-01
GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE 18 4.32e-01 7.96e-01 0.18300 -6.74e-02 1.70e-01 6.20e-01 2.12e-01
GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER 21 3.14e-01 7.22e-01 0.18300 7.51e-02 1.66e-01 5.51e-01 1.87e-01
GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS 19 3.42e-01 7.40e-01 0.18300 -1.13e-01 -1.44e-01 3.96e-01 2.78e-01
GOBP RESPONSE TO INTERLEUKIN 12 12 5.23e-01 8.42e-01 0.18300 5.31e-02 1.75e-01 7.50e-01 2.95e-01
GOBP RESPONSE TO INTERLEUKIN 2 9 6.03e-01 8.76e-01 0.18300 -1.01e-01 -1.52e-01 5.98e-01 4.30e-01
GOBP TRANSCRIPTION BY RNA POLYMERASE III 59 3.65e-02 2.94e-01 0.18300 -1.50e-01 -1.04e-01 4.64e-02 1.67e-01
Chylomicron assembly 10 5.90e-01 8.68e-01 0.18200 -1.79e-01 -3.56e-02 3.27e-01 8.45e-01
GOMF PHOSPHATIDYLCHOLINE TRANSFER ACTIVITY 5 7.75e-01 9.37e-01 0.18200 -1.82e-01 -7.02e-03 4.81e-01 9.78e-01
GOBP G0 TO G1 TRANSITION 36 1.63e-01 5.62e-01 0.18200 -1.82e-01 -8.12e-05 5.86e-02 9.99e-01
GOBP RESPONSE TO ANGIOTENSIN 41 1.59e-01 5.57e-01 0.18200 -1.51e-01 1.02e-01 9.42e-02 2.60e-01
GOBP POSITIVE REGULATION OF VESICLE FUSION 10 6.37e-01 8.87e-01 0.18200 -9.81e-02 1.53e-01 5.91e-01 4.01e-01
Regulation of beta-cell development 41 9.96e-02 4.62e-01 0.18200 -1.27e-01 -1.30e-01 1.59e-01 1.48e-01
GOBP REGULATION OF GAP JUNCTION ASSEMBLY 9 6.33e-01 8.86e-01 0.18200 -1.82e-01 -6.27e-03 3.44e-01 9.74e-01
GOMF TOXIC SUBSTANCE BINDING 10 6.16e-01 8.80e-01 0.18200 3.11e-02 -1.79e-01 8.65e-01 3.26e-01
GOBP DOPAMINE METABOLIC PROCESS 35 2.07e-01 6.22e-01 0.18200 -9.61e-02 1.55e-01 3.25e-01 1.13e-01
GOBP DICARBOXYLIC ACID CATABOLIC PROCESS 17 4.63e-01 8.12e-01 0.18200 -1.59e-01 8.84e-02 2.56e-01 5.28e-01
GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY 46 7.78e-02 4.15e-01 0.18200 -1.56e-01 -9.39e-02 6.73e-02 2.70e-01
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE 19 3.51e-01 7.45e-01 0.18200 -8.17e-02 -1.63e-01 5.38e-01 2.20e-01
GOBP APPENDAGE MORPHOGENESIS 147 6.81e-04 2.40e-02 0.18200 -1.82e-01 7.10e-03 1.41e-04 8.82e-01
GOBP TELOMERE ORGANIZATION 181 4.87e-05 3.18e-03 0.18200 -8.56e-02 -1.61e-01 4.71e-02 1.93e-04
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS 27 2.22e-01 6.39e-01 0.18200 1.01e-01 1.51e-01 3.63e-01 1.73e-01
Pyrimidine salvage 10 6.23e-01 8.82e-01 0.18200 4.60e-02 -1.76e-01 8.01e-01 3.35e-01
Evasion by RSV of host interferon responses 31 2.52e-01 6.68e-01 0.18200 1.41e-01 -1.15e-01 1.75e-01 2.67e-01
Synthesis of IP2, IP, and Ins in the cytosol 13 5.59e-01 8.57e-01 0.18200 -1.50e-01 1.02e-01 3.48e-01 5.23e-01
GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS 46 8.65e-02 4.35e-01 0.18200 1.75e-01 4.95e-02 4.02e-02 5.62e-01
GOMF FIBROBLAST GROWTH FACTOR BINDING 23 2.78e-01 6.92e-01 0.18200 1.50e-01 1.02e-01 2.13e-01 3.95e-01
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX 19 3.90e-01 7.71e-01 0.18200 1.81e-01 -8.97e-03 1.71e-01 9.46e-01
GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 54 8.51e-02 4.33e-01 0.18200 7.54e-02 -1.65e-01 3.38e-01 3.57e-02
GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE 18 4.06e-01 7.81e-01 0.18200 1.82e-01 -1.56e-03 1.82e-01 9.91e-01
GOBP REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS 7 6.76e-01 9.04e-01 0.18200 -1.12e-01 -1.43e-01 6.06e-01 5.13e-01
GOBP MUSCLE TISSUE DEVELOPMENT 429 1.63e-09 3.29e-07 0.18200 -1.79e-01 3.29e-02 2.20e-10 2.43e-01
GOBP LONG TERM SYNAPTIC DEPRESSION 30 2.65e-01 6.80e-01 0.18200 -1.36e-01 1.20e-01 1.97e-01 2.54e-01
GOBP MITOTIC SISTER CHROMATID COHESION 26 2.34e-01 6.50e-01 0.18100 -1.39e-01 -1.17e-01 2.20e-01 3.03e-01
GOBP PANCREAS DEVELOPMENT 77 1.37e-02 1.86e-01 0.18100 -1.38e-01 -1.18e-01 3.61e-02 7.42e-02
GOBP STRIATED MUSCLE TISSUE DEVELOPMENT 262 8.24e-06 6.93e-04 0.18100 -1.60e-01 8.48e-02 7.82e-06 1.81e-02
SUMOylation of ubiquitinylation proteins 39 1.19e-01 4.95e-01 0.18100 -1.63e-01 -8.00e-02 7.85e-02 3.87e-01
GOBP POSITIVE REGULATION OF GROWTH HORMONE SECRETION 9 6.05e-01 8.76e-01 0.18100 -1.24e-01 -1.32e-01 5.18e-01 4.93e-01
GOBP MICTURITION 8 6.48e-01 8.91e-01 0.18100 7.24e-02 1.66e-01 7.23e-01 4.15e-01
GOBP DENDRITIC CELL CHEMOTAXIS 23 3.45e-01 7.43e-01 0.18100 1.71e-01 -6.14e-02 1.57e-01 6.10e-01
GOBP SISTER CHROMATID COHESION 53 7.02e-02 3.98e-01 0.18100 -1.81e-01 -3.70e-03 2.24e-02 9.63e-01
GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION 33 2.33e-01 6.50e-01 0.18100 -1.38e-01 1.18e-01 1.71e-01 2.41e-01
GOBP RRNA BASE METHYLATION 8 6.69e-01 9.00e-01 0.18100 -4.59e-03 -1.81e-01 9.82e-01 3.75e-01
GOMF BETA 2 ADRENERGIC RECEPTOR BINDING 6 7.20e-01 9.16e-01 0.18100 1.61e-01 8.36e-02 4.95e-01 7.23e-01
GOMF ATP DEPENDENT PEPTIDASE ACTIVITY 7 6.89e-01 9.07e-01 0.18100 1.73e-01 5.40e-02 4.28e-01 8.05e-01
GOBP PEPTIDYL ARGININE MODIFICATION 13 4.86e-01 8.23e-01 0.18100 -1.45e-01 -1.09e-01 3.65e-01 4.98e-01
FGFR2b ligand binding and activation 10 6.43e-01 8.89e-01 0.18100 -1.42e-01 1.12e-01 4.35e-01 5.40e-01
Telomere Maintenance 86 8.94e-03 1.44e-01 0.18100 -9.18e-02 -1.56e-01 1.41e-01 1.23e-02
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 30 2.29e-01 6.47e-01 0.18100 1.03e-02 -1.81e-01 9.22e-01 8.64e-02
GOBP LYMPH VESSEL MORPHOGENESIS 23 3.51e-01 7.45e-01 0.18100 -7.34e-02 1.66e-01 5.42e-01 1.69e-01
GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS 6 7.26e-01 9.19e-01 0.18100 1.72e-01 5.79e-02 4.67e-01 8.06e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR 10 6.42e-01 8.89e-01 0.18100 -1.05e-01 1.47e-01 5.65e-01 4.20e-01
GOBP LABYRINTHINE LAYER DEVELOPMENT 44 1.13e-01 4.87e-01 0.18100 4.01e-03 -1.81e-01 9.63e-01 3.78e-02
Assembly Of The HIV Virion 16 4.83e-01 8.22e-01 0.18100 7.26e-02 -1.66e-01 6.15e-01 2.51e-01
HCMV Late Events 81 1.25e-02 1.77e-01 0.18100 -7.64e-02 -1.64e-01 2.34e-01 1.07e-02
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 13 5.17e-01 8.39e-01 0.18100 -1.80e-01 -1.69e-02 2.61e-01 9.16e-01
GOBP BONE MATURATION 26 2.90e-01 7.03e-01 0.18100 -3.29e-02 1.78e-01 7.72e-01 1.16e-01
GOBP FEAR RESPONSE 47 7.60e-02 4.12e-01 0.18100 -1.54e-01 -9.54e-02 6.85e-02 2.58e-01
GOBP BASOLATERAL PROTEIN SECRETION 5 7.58e-01 9.31e-01 0.18100 1.34e-01 1.21e-01 6.03e-01 6.39e-01
GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 13 5.03e-01 8.31e-01 0.18100 -5.09e-02 -1.73e-01 7.51e-01 2.79e-01
GOBP AMINE TRANSPORT 92 1.29e-02 1.79e-01 0.18100 -1.77e-01 3.46e-02 3.27e-03 5.66e-01
GOCC ENZYME ACTIVATOR COMPLEX 13 4.92e-01 8.27e-01 0.18100 -1.60e-01 -8.49e-02 3.19e-01 5.96e-01
GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT 14 5.41e-01 8.50e-01 0.18100 -1.15e-01 1.40e-01 4.58e-01 3.66e-01
GOMF PRE MRNA BINDING 40 1.21e-01 4.99e-01 0.18100 -5.12e-02 -1.73e-01 5.75e-01 5.79e-02
GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY 44 1.04e-01 4.70e-01 0.18100 -2.90e-02 -1.78e-01 7.39e-01 4.07e-02
GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 31 1.82e-01 5.86e-01 0.18100 9.79e-02 1.52e-01 3.46e-01 1.43e-01
GOCC LATE ENDOSOME LUMEN 8 6.60e-01 8.96e-01 0.18100 -3.54e-02 -1.77e-01 8.62e-01 3.86e-01
GOBP PEPTIDE BIOSYNTHETIC PROCESS 25 2.52e-01 6.68e-01 0.18100 1.06e-01 1.46e-01 3.60e-01 2.05e-01
GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS 54 8.53e-02 4.33e-01 0.18100 6.47e-02 -1.69e-01 4.11e-01 3.21e-02
GOBP NUCLEOSOME ORGANIZATION 119 1.55e-03 4.50e-02 0.18100 -9.04e-02 -1.56e-01 8.86e-02 3.22e-03
GOBP NEGATIVE REGULATION OF HIPPO SIGNALING 21 3.75e-01 7.63e-01 0.18100 -1.74e-01 4.65e-02 1.66e-01 7.12e-01
GOBP RESPONSE TO FOOD 38 1.25e-01 5.06e-01 0.18100 -1.53e-01 -9.50e-02 1.02e-01 3.11e-01
Nonhomologous End-Joining (NHEJ) 46 9.01e-02 4.41e-01 0.18000 -4.63e-02 -1.74e-01 5.87e-01 4.06e-02
GOBP LEFT RIGHT AXIS SPECIFICATION 13 5.16e-01 8.38e-01 0.18000 1.79e-01 2.28e-02 2.64e-01 8.87e-01
Peptide hormone biosynthesis 11 5.44e-01 8.51e-01 0.18000 1.31e-01 1.24e-01 4.53e-01 4.75e-01
GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION 61 4.49e-02 3.23e-01 0.18000 -1.79e-01 -2.33e-02 1.56e-02 7.53e-01
GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS 34 1.95e-01 6.06e-01 0.18000 -1.79e-01 2.16e-02 7.07e-02 8.28e-01
GOMF LYSINE N METHYLTRANSFERASE ACTIVITY 62 6.27e-02 3.77e-01 0.18000 -1.61e-01 8.13e-02 2.83e-02 2.68e-01
GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS 5 7.94e-01 9.43e-01 0.18000 -5.17e-02 1.73e-01 8.41e-01 5.03e-01
GOMF U2 SNRNA BINDING 6 7.48e-01 9.28e-01 0.18000 1.53e-02 -1.80e-01 9.48e-01 4.46e-01
EPHA-mediated growth cone collapse 29 2.80e-01 6.92e-01 0.18000 -1.46e-01 1.05e-01 1.73e-01 3.26e-01
GOBP REGULATION OF CHOLESTEROL EFFLUX 54 9.54e-02 4.51e-01 0.18000 -1.17e-01 1.37e-01 1.37e-01 8.15e-02
GOBP SMOOTHENED SIGNALING PATHWAY 140 1.02e-03 3.31e-02 0.18000 -1.80e-01 -3.25e-03 2.35e-04 9.47e-01
GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 75 3.50e-02 2.89e-01 0.18000 -1.63e-01 7.56e-02 1.44e-02 2.58e-01
GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY 14 4.99e-01 8.30e-01 0.18000 5.62e-03 1.80e-01 9.71e-01 2.44e-01
Glyoxylate metabolism and glycine degradation 18 4.34e-01 7.96e-01 0.18000 -4.64e-02 1.74e-01 7.33e-01 2.01e-01
GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE 32 1.72e-01 5.76e-01 0.18000 -1.21e-01 -1.33e-01 2.37e-01 1.92e-01
GOMF 3 5 RNA HELICASE ACTIVITY 6 7.69e-01 9.35e-01 0.18000 -1.45e-01 1.06e-01 5.37e-01 6.53e-01
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING 17 4.58e-01 8.10e-01 0.18000 -5.25e-02 1.72e-01 7.08e-01 2.19e-01
Release of apoptotic factors from the mitochondria 6 7.62e-01 9.32e-01 0.18000 1.68e-01 -6.47e-02 4.77e-01 7.84e-01
GOBP REGULATION OF FEMALE GONAD DEVELOPMENT 7 7.22e-01 9.17e-01 0.18000 -1.75e-01 4.35e-02 4.24e-01 8.42e-01
GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 33 2.05e-01 6.21e-01 0.18000 -1.79e-01 1.78e-02 7.52e-02 8.59e-01
Degradation of GLI2 by the proteasome 47 7.62e-02 4.13e-01 0.18000 -1.15e-01 -1.38e-01 1.71e-01 1.02e-01
GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 64 6.27e-02 3.77e-01 0.18000 1.26e-01 -1.29e-01 8.17e-02 7.54e-02
Inflammasomes 21 3.95e-01 7.74e-01 0.18000 8.71e-02 -1.57e-01 4.90e-01 2.12e-01
GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 61 6.70e-02 3.91e-01 0.18000 -1.59e-01 8.31e-02 3.12e-02 2.62e-01
GOBP RETROGRADE AXONAL TRANSPORT 21 3.16e-01 7.23e-01 0.18000 -1.23e-01 -1.31e-01 3.29e-01 2.98e-01
Membrane binding and targetting of GAG proteins 14 5.13e-01 8.36e-01 0.18000 2.29e-02 -1.78e-01 8.82e-01 2.48e-01
Synthesis And Processing Of GAG, GAGPOL Polyproteins 14 5.13e-01 8.36e-01 0.18000 2.29e-02 -1.78e-01 8.82e-01 2.48e-01
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION 10 6.27e-01 8.84e-01 0.18000 1.76e-01 -3.88e-02 3.37e-01 8.32e-01
GOBP REGULATION OF SECONDARY HEART FIELD CARDIOBLAST PROLIFERATION 10 5.87e-01 8.67e-01 0.18000 -1.65e-01 -7.01e-02 3.65e-01 7.01e-01
GOBP INFLAMMATORY CELL APOPTOTIC PROCESS 23 3.05e-01 7.15e-01 0.18000 -4.23e-02 -1.75e-01 7.25e-01 1.47e-01
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 9 6.43e-01 8.89e-01 0.18000 -1.06e-03 -1.80e-01 9.96e-01 3.51e-01
Receptor Mediated Mitophagy 10 6.39e-01 8.88e-01 0.18000 -1.64e-01 7.32e-02 3.69e-01 6.89e-01
Activation of gene expression by SREBF (SREBP) 41 1.69e-01 5.70e-01 0.18000 -1.40e-01 1.13e-01 1.22e-01 2.11e-01
Regulation of NF-kappa B signaling 17 4.57e-01 8.09e-01 0.18000 4.72e-02 -1.73e-01 7.36e-01 2.16e-01
GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS 10 5.98e-01 8.73e-01 0.18000 3.81e-02 1.75e-01 8.35e-01 3.37e-01
GOBP OUTFLOW TRACT MORPHOGENESIS 82 1.57e-02 1.99e-01 0.18000 -1.77e-01 -2.90e-02 5.54e-03 6.50e-01
GOBP POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC 54 5.32e-02 3.49e-01 0.17900 -1.45e-01 -1.06e-01 6.62e-02 1.77e-01
GOCC SWI SNF SUPERFAMILY TYPE COMPLEX 90 1.55e-02 1.98e-01 0.17900 -1.75e-01 3.84e-02 4.07e-03 5.28e-01
GOBP CENTRAL NERVOUS SYSTEM MYELIN FORMATION 8 6.80e-01 9.04e-01 0.17900 -1.03e-02 1.79e-01 9.60e-01 3.81e-01
GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS 21 3.61e-01 7.52e-01 0.17900 4.40e-03 -1.79e-01 9.72e-01 1.55e-01
GOMF TOLL LIKE RECEPTOR BINDING 14 5.26e-01 8.42e-01 0.17900 1.73e-01 -4.79e-02 2.63e-01 7.56e-01
GOBP CHAPERONE MEDIATED PROTEIN FOLDING 75 2.16e-02 2.35e-01 0.17900 -3.82e-02 -1.75e-01 5.68e-01 8.71e-03
GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION 21 4.02e-01 7.80e-01 0.17900 1.45e-01 -1.05e-01 2.49e-01 4.05e-01
Defective Intrinsic Pathway for Apoptosis 25 3.41e-01 7.40e-01 0.17900 1.33e-01 -1.20e-01 2.51e-01 2.97e-01
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 32 2.00e-01 6.13e-01 0.17900 1.77e-01 2.47e-02 8.23e-02 8.09e-01
FCGR3A-mediated IL10 synthesis 36 2.12e-01 6.29e-01 0.17900 -1.36e-01 1.16e-01 1.56e-01 2.28e-01
GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 11 6.10e-01 8.77e-01 0.17900 -6.39e-02 1.67e-01 7.14e-01 3.37e-01
Collagen formation 88 1.76e-02 2.11e-01 0.17900 -4.26e-02 1.74e-01 4.89e-01 4.81e-03
GOBP DETECTION OF MUSCLE STRETCH 7 7.36e-01 9.23e-01 0.17900 -1.55e-01 8.88e-02 4.77e-01 6.84e-01
GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION 9 6.56e-01 8.94e-01 0.17900 -3.03e-02 1.76e-01 8.75e-01 3.60e-01
GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING 21 3.21e-01 7.28e-01 0.17900 1.43e-01 1.07e-01 2.56e-01 3.95e-01
Translation of Replicase and Assembly of the Replication Transcription Complex 9679504 13 4.95e-01 8.28e-01 0.17900 -1.43e-01 -1.07e-01 3.71e-01 5.03e-01
GOBP RESPONSE TO BLUE LIGHT 6 7.22e-01 9.17e-01 0.17900 -1.36e-01 -1.16e-01 5.63e-01 6.23e-01
GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING 14 5.47e-01 8.52e-01 0.17900 1.43e-01 -1.07e-01 3.54e-01 4.87e-01
GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY 15 4.93e-01 8.27e-01 0.17900 1.77e-01 -2.33e-02 2.34e-01 8.76e-01
GOCC TRAPP COMPLEX 16 4.40e-01 7.99e-01 0.17900 -4.47e-02 -1.73e-01 7.57e-01 2.30e-01
GOBP T CELL MEDIATED IMMUNITY 126 4.08e-03 8.86e-02 0.17900 1.59e-01 -8.26e-02 2.12e-03 1.09e-01
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS 85 2.33e-02 2.44e-01 0.17900 -1.64e-01 7.14e-02 9.01e-03 2.55e-01
GOCC CHROMOSOME TELOMERIC REGION 166 1.46e-04 7.98e-03 0.17900 -9.18e-02 -1.53e-01 4.13e-02 6.52e-04
Elastic fibre formation 44 1.45e-01 5.37e-01 0.17900 -1.60e-01 7.91e-02 6.60e-02 3.64e-01
GOMF ALCOHOL DEHYDROGENASE NAD P PLUS ACTIVITY 24 3.58e-01 7.50e-01 0.17900 1.36e-01 -1.16e-01 2.50e-01 3.24e-01
GOBP CAMKK AMPK SIGNALING CASCADE 9 6.70e-01 9.00e-01 0.17900 -6.71e-02 1.66e-01 7.27e-01 3.90e-01
GOBP QUINONE METABOLIC PROCESS 23 3.53e-01 7.46e-01 0.17900 5.14e-02 -1.71e-01 6.70e-01 1.56e-01
GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 63 5.32e-02 3.49e-01 0.17900 -1.76e-01 2.82e-02 1.55e-02 6.99e-01
GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY 39 1.89e-01 5.96e-01 0.17800 -1.27e-01 1.26e-01 1.71e-01 1.74e-01
GOBP G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY 15 5.27e-01 8.42e-01 0.17800 -1.33e-01 1.19e-01 3.73e-01 4.24e-01
GOBP VITAMIN BIOSYNTHETIC PROCESS 24 3.04e-01 7.14e-01 0.17800 -2.09e-02 -1.77e-01 8.59e-01 1.33e-01
GOBP CEREBRAL CORTEX DEVELOPMENT 119 2.45e-03 6.30e-02 0.17800 -1.74e-01 -3.92e-02 1.05e-03 4.60e-01
GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY 12 5.62e-01 8.57e-01 0.17800 -3.57e-03 1.78e-01 9.83e-01 2.85e-01
GOBP NEGATIVE REGULATION OF BONE REMODELING 18 4.27e-01 7.93e-01 0.17800 1.53e-02 -1.78e-01 9.11e-01 1.92e-01
GOBP SEX DETERMINATION 18 3.79e-01 7.65e-01 0.17800 1.16e-01 1.35e-01 3.94e-01 3.21e-01
Role of LAT2/NTAL/LAB on calcium mobilization 16 4.30e-01 7.94e-01 0.17800 -1.59e-01 -8.01e-02 2.71e-01 5.79e-01
Transcription of E2F targets under negative control by DREAM complex 19 4.29e-01 7.94e-01 0.17800 6.14e-02 -1.67e-01 6.43e-01 2.07e-01
GOBP CEREBELLAR GRANULAR LAYER MORPHOGENESIS 8 6.53e-01 8.93e-01 0.17800 1.50e-01 9.59e-02 4.62e-01 6.39e-01
GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR 18 4.17e-01 7.86e-01 0.17800 -1.78e-01 -6.57e-03 1.91e-01 9.61e-01
GOMF PORIN ACTIVITY 6 7.52e-01 9.30e-01 0.17800 1.07e-02 -1.78e-01 9.64e-01 4.51e-01
GOBP RETINOIC ACID METABOLIC PROCESS 33 2.45e-01 6.59e-01 0.17800 1.08e-01 -1.41e-01 2.81e-01 1.60e-01
GOBP FORMATE METABOLIC PROCESS 6 7.25e-01 9.18e-01 0.17800 1.11e-01 1.40e-01 6.39e-01 5.54e-01
GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE 41 1.21e-01 4.98e-01 0.17800 -5.80e-02 -1.68e-01 5.21e-01 6.22e-02
Class C/3 (Metabotropic glutamate/pheromone receptors) 39 1.87e-01 5.93e-01 0.17800 -9.62e-02 1.50e-01 2.99e-01 1.06e-01
GOCC ENDODEOXYRIBONUCLEASE COMPLEX 5 8.09e-01 9.49e-01 0.17800 1.30e-01 -1.21e-01 6.15e-01 6.38e-01
GOBP L ASPARTATE IMPORT ACROSS PLASMA MEMBRANE 6 7.25e-01 9.18e-01 0.17800 1.37e-01 1.13e-01 5.60e-01 6.32e-01
GOBP REGULATION OF PROTEIN KINASE A SIGNALING 20 4.27e-01 7.93e-01 0.17800 1.40e-01 -1.09e-01 2.77e-01 3.98e-01
GOMF ATP DEPENDENT PROTEIN BINDING 6 7.27e-01 9.20e-01 0.17800 -1.50e-01 -9.49e-02 5.23e-01 6.87e-01
GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS 39 1.43e-01 5.35e-01 0.17800 1.75e-01 2.96e-02 5.81e-02 7.49e-01
GOBP REGULATION OF TORC2 SIGNALING 5 8.01e-01 9.46e-01 0.17800 5.98e-02 -1.67e-01 8.17e-01 5.17e-01
GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 87 2.36e-02 2.45e-01 0.17800 8.68e-02 -1.55e-01 1.62e-01 1.24e-02
GOBP REGULATION OF GLUCOSE METABOLIC PROCESS 97 1.66e-02 2.06e-01 0.17800 -1.30e-01 1.21e-01 2.67e-02 3.94e-02
Oxidative Stress Induced Senescence 88 1.00e-02 1.54e-01 0.17800 -7.83e-02 -1.60e-01 2.04e-01 9.66e-03
GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING 84 1.81e-02 2.14e-01 0.17800 -1.41e-03 1.78e-01 9.82e-01 4.86e-03
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding 31 2.56e-01 6.71e-01 0.17800 1.64e-01 -6.84e-02 1.14e-01 5.10e-01
GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING 16 4.99e-01 8.30e-01 0.17800 -1.59e-01 7.90e-02 2.70e-01 5.84e-01
GOBP TRICARBOXYLIC ACID METABOLIC PROCESS 15 4.62e-01 8.12e-01 0.17800 -5.81e-02 -1.68e-01 6.97e-01 2.60e-01
GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING 5 8.08e-01 9.49e-01 0.17800 1.01e-01 -1.46e-01 6.95e-01 5.72e-01
GOBP REGULATION OF GASTRULATION 16 4.26e-01 7.93e-01 0.17800 -1.04e-01 -1.44e-01 4.71e-01 3.19e-01
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins 64 4.90e-02 3.35e-01 0.17800 1.15e-02 -1.77e-01 8.73e-01 1.42e-02
GOBP PROTEIN DNA COMPLEX ASSEMBLY 201 2.74e-05 1.98e-03 0.17800 -8.54e-02 -1.56e-01 3.69e-02 1.41e-04
GOMF ANAPHASE PROMOTING COMPLEX BINDING 9 6.79e-01 9.04e-01 0.17800 9.09e-02 -1.53e-01 6.37e-01 4.28e-01
G beta:gamma signalling through CDC42 19 3.70e-01 7.58e-01 0.17800 -1.60e-01 -7.78e-02 2.28e-01 5.57e-01
GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE 11 5.66e-01 8.59e-01 0.17800 -6.43e-02 -1.65e-01 7.12e-01 3.42e-01
GOBP POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING 10 6.48e-01 8.91e-01 0.17800 1.58e-01 -8.12e-02 3.87e-01 6.57e-01
GOMF DEMETHYLASE ACTIVITY 35 2.25e-01 6.43e-01 0.17700 -1.46e-01 1.00e-01 1.34e-01 3.05e-01
GOBP PARAXIAL MESODERM DEVELOPMENT 18 4.18e-01 7.87e-01 0.17700 -1.77e-01 -1.05e-02 1.93e-01 9.38e-01
WNT mediated activation of DVL 8 6.63e-01 8.97e-01 0.17700 -1.67e-01 -6.03e-02 4.14e-01 7.68e-01
GOBP STRIATED MUSCLE CELL DEVELOPMENT 79 3.38e-02 2.86e-01 0.17700 -1.55e-01 8.70e-02 1.76e-02 1.81e-01
GOBP RESPONSE TO PROSTAGLANDIN E 24 2.84e-01 6.97e-01 0.17700 -8.26e-02 -1.57e-01 4.84e-01 1.83e-01
GOCC NMDA SELECTIVE GLUTAMATE RECEPTOR COMPLEX 9 6.36e-01 8.87e-01 0.17700 -3.95e-02 -1.73e-01 8.38e-01 3.69e-01
GOMF KINESIN BINDING 42 1.58e-01 5.56e-01 0.17700 -1.66e-01 6.33e-02 6.33e-02 4.78e-01
GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY 24 3.64e-01 7.54e-01 0.17700 1.33e-01 -1.17e-01 2.59e-01 3.22e-01
GOBP RESPONSE TO SALT 22 3.24e-01 7.28e-01 0.17700 -1.66e-01 -6.11e-02 1.77e-01 6.20e-01
GOBP NITRIC OXIDE TRANSPORT 5 7.71e-01 9.36e-01 0.17700 -7.91e-02 -1.58e-01 7.60e-01 5.40e-01
Generation of second messenger molecules 29 2.83e-01 6.95e-01 0.17700 7.09e-02 -1.62e-01 5.09e-01 1.31e-01
GOBP HINDLIMB MORPHOGENESIS 35 2.23e-01 6.41e-01 0.17700 -1.55e-01 8.57e-02 1.13e-01 3.80e-01
GOMF SEQUENCE SPECIFIC DNA BINDING 1564 4.37e-32 1.79e-28 0.17700 -1.74e-01 -3.10e-02 1.07e-30 4.10e-02
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING 6 7.38e-01 9.24e-01 0.17700 -4.83e-02 -1.70e-01 8.38e-01 4.70e-01
GOCC ALVEOLAR LAMELLAR BODY 8 6.53e-01 8.93e-01 0.17700 1.30e-01 1.20e-01 5.24e-01 5.57e-01
GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 40 1.26e-01 5.08e-01 0.17700 -1.61e-01 -7.43e-02 7.88e-02 4.16e-01
GOMF ALPHA CATENIN BINDING 10 6.26e-01 8.84e-01 0.17700 1.76e-01 -1.27e-02 3.34e-01 9.45e-01
Ub-specific processing proteases 162 2.76e-04 1.24e-02 0.17700 -5.66e-02 -1.68e-01 2.14e-01 2.33e-04
GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS 32 2.43e-01 6.58e-01 0.17700 5.35e-02 -1.69e-01 6.00e-01 9.89e-02
GOBP RESPONSE TO MURAMYL DIPEPTIDE 20 4.33e-01 7.96e-01 0.17700 -1.24e-01 1.26e-01 3.35e-01 3.31e-01
GOBP ENDOCARDIAL CUSHION DEVELOPMENT 54 6.28e-02 3.77e-01 0.17700 -1.64e-01 -6.58e-02 3.70e-02 4.03e-01
GOBP SUCCINATE TRANSMEMBRANE TRANSPORT 6 7.30e-01 9.21e-01 0.17700 1.50e-01 9.29e-02 5.24e-01 6.94e-01
GOMF SUCCINATE TRANSMEMBRANE TRANSPORTER ACTIVITY 6 7.30e-01 9.21e-01 0.17700 1.50e-01 9.29e-02 5.24e-01 6.94e-01
GOBP RESPONSE TO SODIUM ARSENITE 6 7.72e-01 9.36e-01 0.17700 7.58e-02 -1.60e-01 7.48e-01 4.98e-01
RAS processing 22 3.92e-01 7.72e-01 0.17700 1.52e-01 -8.99e-02 2.17e-01 4.66e-01
GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL 14 5.40e-01 8.49e-01 0.17700 1.67e-01 -5.84e-02 2.80e-01 7.05e-01
GOBP REGULATION OF RECEPTOR INTERNALIZATION 62 7.35e-02 4.06e-01 0.17700 -1.46e-01 9.98e-02 4.73e-02 1.74e-01
SUMOylation of SUMOylation proteins 35 1.62e-01 5.61e-01 0.17700 -1.56e-01 -8.35e-02 1.11e-01 3.92e-01
GOBP BINDING OF SPERM TO ZONA PELLUCIDA 38 1.91e-01 5.99e-01 0.17700 1.64e-01 -6.46e-02 7.97e-02 4.91e-01
p75NTR signals via NF-kB 15 5.25e-01 8.42e-01 0.17700 7.85e-02 -1.58e-01 5.99e-01 2.89e-01
Elevation of cytosolic Ca2+ levels 16 5.07e-01 8.33e-01 0.17700 -1.52e-01 8.97e-02 2.92e-01 5.34e-01
GOBP ROOF OF MOUTH DEVELOPMENT 90 1.35e-02 1.85e-01 0.17700 -1.76e-01 -1.05e-02 3.86e-03 8.63e-01
GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE 10 6.16e-01 8.80e-01 0.17600 1.67e-02 1.76e-01 9.27e-01 3.36e-01
GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE 24 2.89e-01 7.02e-01 0.17600 -7.83e-02 -1.58e-01 5.07e-01 1.80e-01
GOBP GOLGI TO ENDOSOME TRANSPORT 17 4.86e-01 8.23e-01 0.17600 -1.53e-01 8.75e-02 2.75e-01 5.32e-01
GOBP REGULATION OF ERAD PATHWAY 22 3.14e-01 7.22e-01 0.17600 -1.32e-01 -1.17e-01 2.85e-01 3.41e-01
GOBP MORPHOGENESIS OF AN ENDOTHELIUM 17 4.55e-01 8.09e-01 0.17600 1.42e-02 -1.76e-01 9.19e-01 2.10e-01
GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE 6 7.49e-01 9.28e-01 0.17600 -1.59e-02 -1.75e-01 9.46e-01 4.57e-01
GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION 12 5.86e-01 8.67e-01 0.17600 4.19e-02 -1.71e-01 8.02e-01 3.05e-01
GOBP TRANSFERRIN TRANSPORT 10 6.45e-01 8.91e-01 0.17600 1.67e-01 -5.50e-02 3.60e-01 7.63e-01
GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS 26 3.17e-01 7.25e-01 0.17600 1.69e-01 -4.87e-02 1.35e-01 6.67e-01
GOBP NEGATIVE REGULATION OF FERROPTOSIS 8 6.59e-01 8.95e-01 0.17600 1.47e-01 9.67e-02 4.71e-01 6.36e-01
GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 24 2.98e-01 7.09e-01 0.17600 -1.66e-01 -5.91e-02 1.60e-01 6.17e-01
Keratan sulfate/keratin metabolism 36 1.51e-01 5.46e-01 0.17600 1.28e-01 1.20e-01 1.83e-01 2.11e-01
GOMF PHOSPHOLIPASE A2 ACTIVITY 34 2.39e-01 6.55e-01 0.17600 1.50e-01 -9.16e-02 1.30e-01 3.55e-01
NFE2L2 regulating tumorigenic genes 11 6.32e-01 8.86e-01 0.17600 1.43e-01 -1.02e-01 4.10e-01 5.59e-01
GOBP ENTEROENDOCRINE CELL DIFFERENTIATION 35 1.74e-01 5.78e-01 0.17600 -1.68e-01 -5.12e-02 8.51e-02 6.00e-01
GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION 33 2.02e-01 6.17e-01 0.17600 -2.43e-02 -1.74e-01 8.09e-01 8.35e-02
GOMF FLAP ENDONUCLEASE ACTIVITY 6 7.68e-01 9.34e-01 0.17600 -1.69e-01 4.82e-02 4.73e-01 8.38e-01
Ca2+ activated K+ channels 9 6.77e-01 9.04e-01 0.17600 1.65e-01 -5.99e-02 3.91e-01 7.56e-01
GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION 10 6.58e-01 8.95e-01 0.17600 -9.36e-02 1.49e-01 6.08e-01 4.16e-01
GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE 12 5.35e-01 8.47e-01 0.17600 -1.02e-01 -1.43e-01 5.41e-01 3.91e-01
GOCC HOPS COMPLEX 14 5.20e-01 8.40e-01 0.17600 -1.76e-01 3.18e-03 2.55e-01 9.84e-01
Other interleukin signaling 24 2.85e-01 6.97e-01 0.17600 1.29e-01 1.19e-01 2.75e-01 3.11e-01
GOBP DORSAL VENTRAL AXIS SPECIFICATION 14 5.03e-01 8.31e-01 0.17600 3.66e-02 1.72e-01 8.12e-01 2.66e-01
GOCC CELL BODY FIBER 8 6.94e-01 9.10e-01 0.17500 -1.87e-02 1.75e-01 9.27e-01 3.93e-01
GOCC PLATELET DENSE GRANULE 20 4.36e-01 7.97e-01 0.17500 -1.04e-01 1.41e-01 4.19e-01 2.75e-01
GOMF PROTEIN DEMETHYLASE ACTIVITY 26 3.39e-01 7.39e-01 0.17500 -1.45e-01 9.95e-02 2.02e-01 3.80e-01
GOBP PIGMENT ACCUMULATION 11 6.35e-01 8.86e-01 0.17500 1.20e-01 -1.28e-01 4.90e-01 4.63e-01
GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION 19 3.85e-01 7.68e-01 0.17500 5.85e-02 1.65e-01 6.59e-01 2.12e-01
GOCC CLATHRIN COATED PIT 75 4.56e-02 3.26e-01 0.17500 -1.25e-01 1.23e-01 6.20e-02 6.45e-02
GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION 7 7.49e-01 9.28e-01 0.17500 -1.16e-01 1.31e-01 5.94e-01 5.47e-01
GOBP REGULATION OF ENDOSOME ORGANIZATION 5 8.07e-01 9.48e-01 0.17500 -1.63e-01 6.59e-02 5.29e-01 7.98e-01
GOCC RETROMER COMPLEX 20 3.58e-01 7.50e-01 0.17500 -1.55e-01 -8.19e-02 2.30e-01 5.26e-01
GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST 14 4.90e-01 8.26e-01 0.17500 7.48e-02 1.59e-01 6.28e-01 3.04e-01
GOBP DNA TEMPLATED TRANSCRIPTION INITIATION 188 8.38e-05 5.12e-03 0.17500 -6.05e-02 -1.65e-01 1.53e-01 9.89e-05
Downregulation of TGF-beta receptor signaling 26 3.28e-01 7.32e-01 0.17500 6.62e-02 -1.62e-01 5.59e-01 1.52e-01
GOCC SEH1 ASSOCIATED COMPLEX 13 5.21e-01 8.41e-01 0.17500 -1.65e-01 -5.81e-02 3.02e-01 7.17e-01
GOMF ALPHA GLUCOSIDASE ACTIVITY 6 7.80e-01 9.39e-01 0.17500 1.42e-01 -1.03e-01 5.47e-01 6.62e-01
GOMF LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY 54 6.04e-02 3.73e-01 0.17500 1.10e-01 1.36e-01 1.60e-01 8.36e-02
GOBP ENTRAINMENT OF CIRCADIAN CLOCK 29 2.79e-01 6.92e-01 0.17500 -1.70e-01 4.38e-02 1.14e-01 6.83e-01
GOBP TRNA DECAY 16 5.00e-01 8.30e-01 0.17500 -1.66e-01 5.75e-02 2.52e-01 6.91e-01
GOBP HORMONE BIOSYNTHETIC PROCESS 65 5.79e-02 3.66e-01 0.17500 1.69e-01 -4.51e-02 1.82e-02 5.29e-01
Complement cascade 54 8.55e-02 4.33e-01 0.17500 1.74e-01 -1.67e-02 2.66e-02 8.32e-01
GOBP RENAL WATER TRANSPORT 9 6.55e-01 8.93e-01 0.17500 6.75e-03 1.75e-01 9.72e-01 3.63e-01
GOBP MATURATION OF 5 8S RRNA 34 1.75e-01 5.80e-01 0.17500 -8.55e-02 -1.53e-01 3.88e-01 1.23e-01
GOMF ABC TYPE TRANSPORTER ACTIVITY 46 1.40e-01 5.31e-01 0.17500 -6.56e-02 1.62e-01 4.42e-01 5.66e-02
GOBP OXYGEN METABOLIC PROCESS 6 7.32e-01 9.22e-01 0.17500 -1.34e-01 -1.13e-01 5.69e-01 6.33e-01
ISG15 antiviral mechanism 74 2.64e-02 2.57e-01 0.17500 -4.41e-02 -1.69e-01 5.12e-01 1.17e-02
GOBP CARDIAC SEPTUM MORPHOGENESIS 73 3.16e-02 2.79e-01 0.17500 -1.75e-01 -1.37e-02 9.93e-03 8.39e-01
KSRP (KHSRP) binds and destabilizes mRNA 17 4.32e-01 7.96e-01 0.17500 -4.57e-02 -1.69e-01 7.44e-01 2.28e-01
GOBP DNA CATABOLIC PROCESS 29 2.43e-01 6.58e-01 0.17500 -1.71e-01 -3.56e-02 1.10e-01 7.40e-01
GOBP ACETATE ESTER TRANSPORT 9 6.84e-01 9.06e-01 0.17500 -1.57e-01 7.71e-02 4.14e-01 6.89e-01
SUMOylation of DNA damage response and repair proteins 74 2.81e-02 2.66e-01 0.17500 -1.72e-01 -3.01e-02 1.03e-02 6.54e-01
GOMF C METHYLTRANSFERASE ACTIVITY 6 7.77e-01 9.38e-01 0.17500 1.55e-01 -8.19e-02 5.12e-01 7.28e-01
GOBP COCHLEA MORPHOGENESIS 23 3.89e-01 7.70e-01 0.17500 1.24e-01 -1.23e-01 3.02e-01 3.07e-01
GOBP LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE 8 7.06e-01 9.13e-01 0.17500 -5.02e-02 1.68e-01 8.06e-01 4.12e-01
GOBP CELLULAR RESPONSE TO STEROL 25 3.58e-01 7.50e-01 0.17500 -1.33e-01 1.14e-01 2.51e-01 3.24e-01
GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION 24 3.23e-01 7.28e-01 0.17500 -1.75e-01 -9.40e-03 1.39e-01 9.36e-01
GOBP NADH METABOLIC PROCESS 32 2.10e-01 6.26e-01 0.17500 3.96e-02 1.70e-01 6.98e-01 9.55e-02
GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS 9 6.78e-01 9.04e-01 0.17500 5.48e-02 -1.66e-01 7.76e-01 3.89e-01
GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION 35 1.76e-01 5.81e-01 0.17500 1.66e-01 5.57e-02 8.98e-02 5.69e-01
GOBP LAYER FORMATION IN CEREBRAL CORTEX 14 5.00e-01 8.30e-01 0.17500 -1.67e-01 -5.08e-02 2.79e-01 7.42e-01
GOBP REGULATION OF GLUCONEOGENESIS 50 1.25e-01 5.05e-01 0.17500 -8.72e-02 1.51e-01 2.86e-01 6.40e-02
GOMF ATPASE INHIBITOR ACTIVITY 5 7.74e-01 9.37e-01 0.17500 -1.50e-01 -8.93e-02 5.61e-01 7.30e-01
GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY 91 1.52e-02 1.97e-01 0.17500 -1.75e-01 3.22e-03 3.97e-03 9.58e-01
GOBP REGULATION OF ANTIMICROBIAL PEPTIDE PRODUCTION 9 6.43e-01 8.89e-01 0.17500 -1.69e-01 -4.44e-02 3.80e-01 8.17e-01
GOBP PENILE ERECTION 7 7.44e-01 9.26e-01 0.17500 -1.59e-01 7.27e-02 4.67e-01 7.39e-01
GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE 11 5.66e-01 8.59e-01 0.17500 -1.30e-01 -1.17e-01 4.56e-01 5.02e-01
GOBP NEUTROPHIL MEDIATED CYTOTOXICITY 15 5.40e-01 8.49e-01 0.17500 -1.41e-01 1.04e-01 3.46e-01 4.87e-01
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS 10 6.55e-01 8.93e-01 0.17500 -7.05e-02 1.60e-01 6.99e-01 3.82e-01
GOBP PROTEIN DNA COMPLEX DISASSEMBLY 23 3.72e-01 7.60e-01 0.17500 5.57e-02 -1.65e-01 6.44e-01 1.69e-01
GOMF SYNDECAN BINDING 5 7.73e-01 9.36e-01 0.17500 -1.03e-01 -1.41e-01 6.90e-01 5.85e-01
GOBP HEAT GENERATION 18 4.21e-01 7.90e-01 0.17500 -2.89e-02 -1.72e-01 8.32e-01 2.06e-01
GOMF LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL 15 4.70e-01 8.15e-01 0.17400 -1.59e-01 -7.07e-02 2.85e-01 6.36e-01
VLDL clearance 6 7.82e-01 9.40e-01 0.17400 1.38e-01 -1.07e-01 5.59e-01 6.50e-01
GOCC KINETOCHORE MICROTUBULE 20 3.69e-01 7.58e-01 0.17400 -6.18e-02 -1.63e-01 6.33e-01 2.07e-01
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation 14 5.05e-01 8.31e-01 0.17400 -4.35e-02 -1.69e-01 7.78e-01 2.74e-01
GOBP POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT 12 6.03e-01 8.76e-01 0.17400 7.13e-02 -1.59e-01 6.69e-01 3.40e-01
GOBP NEUTROPHIL CLEARANCE 6 7.81e-01 9.40e-01 0.17400 -9.46e-02 1.46e-01 6.88e-01 5.34e-01
mRNA Splicing 199 5.56e-05 3.59e-03 0.17400 -5.81e-02 -1.64e-01 1.58e-01 6.35e-05
GOMF NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 10 6.04e-01 8.76e-01 0.17400 7.54e-02 1.57e-01 6.80e-01 3.89e-01
GOCC NURD COMPLEX 15 5.18e-01 8.39e-01 0.17400 -3.86e-02 1.70e-01 7.96e-01 2.54e-01
GOMF PEPTIDOGLYCAN IMMUNE RECEPTOR ACTIVITY 5 8.15e-01 9.50e-01 0.17400 -1.04e-01 1.40e-01 6.87e-01 5.88e-01
GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL 5 8.07e-01 9.48e-01 0.17400 -5.75e-02 1.65e-01 8.24e-01 5.24e-01
GOBP ICOSANOID CATABOLIC PROCESS 9 6.36e-01 8.86e-01 0.17400 -7.33e-02 -1.58e-01 7.03e-01 4.11e-01
Integration of energy metabolism 105 1.39e-02 1.88e-01 0.17400 -1.09e-01 1.36e-01 5.28e-02 1.63e-02
GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 9 6.36e-01 8.86e-01 0.17400 -1.58e-01 -7.26e-02 4.10e-01 7.06e-01
GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS 7 7.39e-01 9.24e-01 0.17400 -4.95e-02 1.67e-01 8.21e-01 4.44e-01
Synthesis of GDP-mannose 6 7.53e-01 9.30e-01 0.17400 -1.73e-01 -1.73e-02 4.62e-01 9.41e-01
GOCC REPLICATION FORK 72 3.40e-02 2.86e-01 0.17400 -1.74e-01 -1.56e-02 1.09e-02 8.19e-01
GOBP ANDROGEN METABOLIC PROCESS 29 2.98e-01 7.09e-01 0.17400 1.56e-01 -7.68e-02 1.45e-01 4.74e-01
GOBP GLUTATHIONE METABOLIC PROCESS 47 1.04e-01 4.70e-01 0.17400 1.71e-01 3.41e-02 4.28e-02 6.86e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 129 5.31e-03 1.03e-01 0.17400 -1.08e-01 1.36e-01 3.37e-02 7.46e-03
GOCC CHROMOSOME CENTROMERIC REGION 246 3.74e-06 3.48e-04 0.17400 -1.38e-01 -1.06e-01 1.87e-04 4.25e-03
Purine catabolism 17 4.44e-01 8.01e-01 0.17400 -1.72e-01 -2.89e-02 2.20e-01 8.37e-01
GOCC SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX 79 1.74e-02 2.11e-01 0.17400 -1.23e-01 -1.23e-01 5.85e-02 5.88e-02
GOBP POSITIVE REGULATION OF VASCULAR WOUND HEALING 6 7.83e-01 9.40e-01 0.17400 1.07e-01 -1.37e-01 6.50e-01 5.61e-01
GOMF THIAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY 7 6.98e-01 9.11e-01 0.17400 -1.07e-01 -1.37e-01 6.24e-01 5.30e-01
GOBP ETHER BIOSYNTHETIC PROCESS 12 5.90e-01 8.68e-01 0.17400 3.21e-02 -1.71e-01 8.47e-01 3.05e-01
GOMF ANTIGEN BINDING 66 6.05e-02 3.73e-01 0.17400 1.64e-01 -5.74e-02 2.11e-02 4.20e-01
GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION 37 1.86e-01 5.92e-01 0.17400 7.68e-03 -1.74e-01 9.36e-01 6.75e-02
Collagen degradation 61 8.21e-02 4.25e-01 0.17400 -9.13e-02 1.48e-01 2.18e-01 4.57e-02
GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY 67 3.35e-02 2.85e-01 0.17400 -1.45e-01 -9.53e-02 3.98e-02 1.77e-01
GOCC ROUGH ENDOPLASMIC RETICULUM 56 5.82e-02 3.66e-01 0.17400 -1.44e-01 -9.76e-02 6.29e-02 2.06e-01
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT 24 3.75e-01 7.63e-01 0.17400 -9.66e-02 1.44e-01 4.12e-01 2.21e-01
GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 26 3.24e-01 7.28e-01 0.17400 4.00e-02 -1.69e-01 7.24e-01 1.36e-01
GOBP B CELL PROLIFERATION 97 1.12e-02 1.65e-01 0.17400 1.73e-01 1.11e-02 3.19e-03 8.50e-01
RAB geranylgeranylation 57 9.03e-02 4.41e-01 0.17400 1.63e-01 -6.09e-02 3.37e-02 4.27e-01
GOBP FATTY ACID BETA OXIDATION 73 5.24e-02 3.46e-01 0.17400 -1.34e-01 1.10e-01 4.76e-02 1.03e-01
Synthesis of bile acids and bile salts via 24-hydroxycholesterol 13 5.60e-01 8.57e-01 0.17400 1.73e-01 -1.88e-02 2.81e-01 9.07e-01
NTRK2 activates RAC1 5 8.02e-01 9.46e-01 0.17400 -2.48e-02 1.72e-01 9.23e-01 5.06e-01
GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN 9 6.46e-01 8.91e-01 0.17300 -1.67e-01 -4.58e-02 3.85e-01 8.12e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION 33 2.64e-01 6.79e-01 0.17300 1.21e-01 -1.24e-01 2.27e-01 2.18e-01
GOBP MAST CELL CHEMOTAXIS 11 5.71e-01 8.61e-01 0.17300 1.09e-01 1.35e-01 5.32e-01 4.38e-01
GOBP SECONDARY HEART FIELD SPECIFICATION 11 5.74e-01 8.62e-01 0.17300 1.47e-01 9.23e-02 3.99e-01 5.96e-01
Signaling by PDGFR in disease 20 3.86e-01 7.68e-01 0.17300 -1.70e-01 -3.15e-02 1.87e-01 8.07e-01
GOBP REGULATION OF OSTEOCLAST DEVELOPMENT 11 6.04e-01 8.76e-01 0.17300 -1.73e-01 -1.26e-03 3.19e-01 9.94e-01
GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION 21 4.10e-01 7.84e-01 0.17300 5.56e-02 -1.64e-01 6.59e-01 1.93e-01
GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY 24 3.68e-01 7.57e-01 0.17300 -1.59e-01 6.95e-02 1.78e-01 5.56e-01
GOCC CONDENSED NUCLEAR CHROMOSOME 74 2.86e-02 2.68e-01 0.17300 -1.68e-01 -4.25e-02 1.25e-02 5.27e-01
GOBP STOMACH DEVELOPMENT 5 7.76e-01 9.38e-01 0.17300 -1.06e-01 -1.37e-01 6.81e-01 5.96e-01
GOBP COMPLEMENT ACTIVATION 56 7.87e-02 4.18e-01 0.17300 1.73e-01 -2.31e-03 2.49e-02 9.76e-01
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY 5 7.76e-01 9.38e-01 0.17300 -1.06e-01 -1.37e-01 6.81e-01 5.96e-01
GOBP MUSCLE CELL DIFFERENTIATION 417 4.61e-08 6.99e-06 0.17300 -1.54e-01 7.92e-02 6.77e-08 5.50e-03
NOSTRIN mediated eNOS trafficking 5 8.18e-01 9.51e-01 0.17300 -1.26e-01 1.19e-01 6.25e-01 6.46e-01
GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 15 5.00e-01 8.30e-01 0.17300 -1.10e-02 -1.73e-01 9.41e-01 2.47e-01
GOBP NEGATIVE REGULATION OF CELL FATE COMMITMENT 10 6.14e-01 8.79e-01 0.17300 5.32e-02 1.65e-01 7.71e-01 3.67e-01
GOMF NUCLEOTIDASE ACTIVITY 14 5.65e-01 8.58e-01 0.17300 -8.86e-02 1.49e-01 5.66e-01 3.35e-01
GOCC NONHOMOLOGOUS END JOINING COMPLEX 9 6.53e-01 8.93e-01 0.17300 2.82e-02 1.71e-01 8.83e-01 3.75e-01
Formation of the dystrophin-glycoprotein complex (DGC) 34 2.29e-01 6.47e-01 0.17300 -1.69e-01 3.53e-02 8.74e-02 7.21e-01
GOBP REGULATION OF CELLULAR EXTRAVASATION 39 1.74e-01 5.78e-01 0.17300 -9.78e-03 1.73e-01 9.16e-01 6.19e-02
GOBP RESPONSE TO VITAMIN D 37 1.55e-01 5.51e-01 0.17300 -1.43e-01 -9.75e-02 1.32e-01 3.05e-01
GOBP NEGATIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 5 7.78e-01 9.39e-01 0.17300 -8.96e-02 -1.48e-01 7.29e-01 5.67e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 54 6.86e-02 3.95e-01 0.17300 -7.67e-02 -1.55e-01 3.30e-01 4.87e-02
GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION 15 4.67e-01 8.14e-01 0.17300 -1.28e-01 -1.17e-01 3.92e-01 4.34e-01
GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY 10 6.68e-01 9.00e-01 0.17300 -1.02e-01 1.39e-01 5.75e-01 4.46e-01
GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS 6 7.43e-01 9.26e-01 0.17300 7.36e-02 1.56e-01 7.55e-01 5.07e-01
Hormone ligand-binding receptors 13 5.23e-01 8.41e-01 0.17300 8.34e-02 1.51e-01 6.02e-01 3.45e-01
GOBP NUCLEAR PORE ORGANIZATION 15 4.67e-01 8.14e-01 0.17300 -1.25e-01 -1.19e-01 4.01e-01 4.24e-01
GOMF AMINO ACID PROTON SYMPORTER ACTIVITY 6 7.42e-01 9.26e-01 0.17300 1.53e-01 8.02e-02 5.16e-01 7.34e-01
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST 19 3.86e-01 7.68e-01 0.17300 -8.94e-02 -1.48e-01 5.00e-01 2.65e-01
Azathioprine ADME 22 4.15e-01 7.85e-01 0.17300 1.25e-01 -1.19e-01 3.09e-01 3.34e-01
Interleukin-3, Interleukin-5 and GM-CSF signaling 44 1.45e-01 5.38e-01 0.17300 2.39e-02 -1.71e-01 7.84e-01 4.96e-02
GOCC PHOTORECEPTOR INNER SEGMENT 69 3.22e-02 2.81e-01 0.17300 1.50e-01 8.48e-02 3.07e-02 2.23e-01
GOBP POSITIVE REGULATION OF COA TRANSFERASE ACTIVITY 8 7.11e-01 9.14e-01 0.17300 -1.67e-01 4.40e-02 4.13e-01 8.29e-01
GOCC MYELIN SHEATH 43 1.79e-01 5.83e-01 0.17300 -1.15e-01 1.29e-01 1.94e-01 1.43e-01
Signaling by VEGF 102 1.45e-02 1.91e-01 0.17300 -1.61e-01 6.29e-02 5.03e-03 2.72e-01
Transcription-Coupled Nucleotide Excision Repair (TC-NER) 74 2.41e-02 2.50e-01 0.17300 -1.08e-01 -1.35e-01 1.08e-01 4.52e-02
GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION 8 6.78e-01 9.04e-01 0.17300 1.63e-01 5.79e-02 4.26e-01 7.77e-01
GOBP PULMONARY ARTERY MORPHOGENESIS 6 7.48e-01 9.28e-01 0.17300 5.15e-02 1.65e-01 8.27e-01 4.85e-01
GOBP LEUKOCYTE APOPTOTIC PROCESS 115 8.80e-03 1.42e-01 0.17300 6.91e-02 -1.58e-01 2.00e-01 3.40e-03
Degradation of GLI1 by the proteasome 47 9.51e-02 4.50e-01 0.17300 -9.49e-02 -1.44e-01 2.60e-01 8.75e-02
GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 23 3.24e-01 7.28e-01 0.17300 -1.59e-01 -6.76e-02 1.88e-01 5.75e-01
GOMF TRANSCRIPTION REGULATOR ACTIVITY 1836 2.53e-35 3.10e-31 0.17300 -1.70e-01 -3.16e-02 1.54e-33 2.50e-02
GOBP VENTRICULAR SEPTUM MORPHOGENESIS 44 1.49e-01 5.44e-01 0.17300 -1.70e-01 3.19e-02 5.16e-02 7.15e-01
GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION 8 7.17e-01 9.15e-01 0.17300 1.61e-01 -6.30e-02 4.32e-01 7.58e-01
Proteasome assembly 51 1.10e-01 4.81e-01 0.17200 3.13e-02 -1.70e-01 6.99e-01 3.61e-02
GOBP ACTIVATION OF JANUS KINASE ACTIVITY 13 5.76e-01 8.63e-01 0.17200 -1.66e-01 4.62e-02 3.00e-01 7.73e-01
GOMF SULFOTRANSFERASE ACTIVITY 49 1.40e-01 5.31e-01 0.17200 -1.01e-01 1.40e-01 2.21e-01 9.06e-02
GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 126 2.24e-03 5.86e-02 0.17200 -1.62e-01 -5.97e-02 1.70e-03 2.47e-01
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER 54 1.12e-01 4.84e-01 0.17200 -8.57e-02 1.50e-01 2.76e-01 5.71e-02
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis 42 1.35e-01 5.22e-01 0.17200 -4.31e-02 -1.67e-01 6.29e-01 6.11e-02
GOCC PRERIBOSOME 102 1.13e-02 1.66e-01 0.17200 1.74e-02 -1.72e-01 7.61e-01 2.75e-03
GOBP ANOIKIS 32 2.21e-01 6.38e-01 0.17200 -1.69e-01 -3.40e-02 9.79e-02 7.39e-01
Regulation of HMOX1 expression and activity 5 8.06e-01 9.48e-01 0.17200 -1.69e-01 3.38e-02 5.13e-01 8.96e-01
GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY 9 6.92e-01 9.09e-01 0.17200 1.53e-01 -7.95e-02 4.27e-01 6.80e-01
GOBP PIGMENT BIOSYNTHETIC PROCESS 51 1.31e-01 5.17e-01 0.17200 1.23e-01 -1.21e-01 1.30e-01 1.34e-01
Chromosome Maintenance 109 4.75e-03 9.63e-02 0.17200 -7.39e-02 -1.56e-01 1.82e-01 4.97e-03
APC/C:Cdc20 mediated degradation of Securin 55 7.67e-02 4.14e-01 0.17200 -2.64e-02 -1.70e-01 7.34e-01 2.89e-02
GOBP ALDITOL METABOLIC PROCESS 22 4.03e-01 7.80e-01 0.17200 1.59e-01 -6.64e-02 1.97e-01 5.90e-01
GOBP REGULATION OF HEART GROWTH 70 5.66e-02 3.62e-01 0.17200 -1.57e-01 7.16e-02 2.33e-02 3.00e-01
GOMF DNA METHYLTRANSFERASE ACTIVITY 7 7.46e-01 9.28e-01 0.17200 -1.62e-01 5.81e-02 4.57e-01 7.90e-01
GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY 25 3.55e-01 7.48e-01 0.17200 1.60e-01 -6.36e-02 1.66e-01 5.82e-01
GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION 77 3.07e-02 2.74e-01 0.17200 -1.72e-01 -4.09e-03 8.96e-03 9.50e-01
GOBP OLFACTORY BULB INTERNEURON DIFFERENTIATION 12 6.16e-01 8.80e-01 0.17200 8.95e-02 -1.47e-01 5.91e-01 3.77e-01
GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION 8 6.87e-01 9.06e-01 0.17200 -1.70e-01 -2.98e-02 4.06e-01 8.84e-01
GOBP G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY 11 5.88e-01 8.68e-01 0.17200 5.27e-02 1.64e-01 7.62e-01 3.46e-01
GOBP DICARBOXYLIC ACID TRANSPORT 100 1.45e-02 1.91e-01 0.17200 -4.39e-02 1.67e-01 4.48e-01 3.99e-03
GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING 32 2.09e-01 6.25e-01 0.17200 -1.59e-01 -6.74e-02 1.21e-01 5.09e-01
Degradation of the extracellular matrix 134 3.97e-03 8.75e-02 0.17200 -6.30e-02 1.60e-01 2.08e-01 1.35e-03
GOBP INDUCTION OF BACTERIAL AGGLUTINATION 6 7.63e-01 9.32e-01 0.17200 -8.82e-04 -1.72e-01 9.97e-01 4.65e-01
Nucleotide biosynthesis 12 6.16e-01 8.80e-01 0.17200 8.97e-02 -1.47e-01 5.91e-01 3.78e-01
Respiratory electron transport 142 1.34e-03 4.10e-02 0.17200 -2.90e-02 -1.70e-01 5.51e-01 4.78e-04
IRS-mediated signalling 47 1.49e-01 5.43e-01 0.17200 -1.51e-01 8.22e-02 7.27e-02 3.29e-01
GOMF NEUREGULIN BINDING 5 7.83e-01 9.40e-01 0.17200 1.59e-01 6.71e-02 5.39e-01 7.95e-01
GOMF DYNEIN INTERMEDIATE CHAIN BINDING 35 2.44e-01 6.58e-01 0.17200 -1.47e-01 9.04e-02 1.33e-01 3.55e-01
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 13 5.54e-01 8.54e-01 0.17200 -6.86e-03 -1.72e-01 9.66e-01 2.83e-01
GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS 11 6.20e-01 8.80e-01 0.17200 2.66e-02 -1.70e-01 8.78e-01 3.29e-01
GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY 42 1.21e-01 4.99e-01 0.17200 1.20e-01 1.24e-01 1.80e-01 1.65e-01
GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY 13 5.87e-01 8.67e-01 0.17200 -1.55e-01 7.40e-02 3.32e-01 6.44e-01
GOMF ACTININ BINDING 36 2.38e-01 6.55e-01 0.17200 -1.08e-01 1.34e-01 2.62e-01 1.64e-01
GOBP DOPAMINE TRANSPORT 44 1.70e-01 5.71e-01 0.17200 -1.48e-01 8.82e-02 8.98e-02 3.12e-01
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest 14 5.08e-01 8.33e-01 0.17200 1.62e-01 5.83e-02 2.94e-01 7.06e-01
GOBP 2 OXOGLUTARATE METABOLIC PROCESS 16 5.29e-01 8.43e-01 0.17200 -1.12e-01 1.31e-01 4.39e-01 3.65e-01
GOCC LIPID DROPLET 96 2.18e-02 2.36e-01 0.17200 -1.41e-01 9.89e-02 1.71e-02 9.40e-02
GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 82 2.55e-02 2.55e-01 0.17200 -1.72e-01 1.93e-03 7.08e-03 9.76e-01
GOBP NUCLEAR RNA SURVEILLANCE 15 4.75e-01 8.18e-01 0.17200 -8.76e-02 -1.48e-01 5.57e-01 3.21e-01
Regulation of TNFR1 signaling 46 1.60e-01 5.59e-01 0.17200 1.02e-01 -1.38e-01 2.30e-01 1.05e-01
GOMF MANNOSE BINDING 24 3.86e-01 7.68e-01 0.17200 -1.17e-01 1.26e-01 3.21e-01 2.85e-01
SARS-CoV-2-host interactions 189 3.86e-04 1.58e-02 0.17200 5.08e-02 -1.64e-01 2.28e-01 9.91e-05
GOCC MAIN AXON 68 6.73e-02 3.91e-01 0.17200 -1.03e-01 1.37e-01 1.41e-01 5.03e-02
GOBP REGULATION OF MACROPHAGE ACTIVATION 60 6.03e-02 3.73e-01 0.17200 -3.41e-02 -1.68e-01 6.47e-01 2.41e-02
GOBP POSITIVE REGULATION OF DNA BINDING 37 1.66e-01 5.67e-01 0.17200 -1.58e-01 -6.62e-02 9.53e-02 4.86e-01
GOBP CEREBROSPINAL FLUID CIRCULATION 15 5.20e-01 8.40e-01 0.17200 1.71e-01 -2.01e-02 2.53e-01 8.93e-01
GOMF 4 IRON 4 SULFUR CLUSTER BINDING 45 1.67e-01 5.68e-01 0.17200 -1.38e-01 1.02e-01 1.09e-01 2.38e-01
GOCC CONDENSED CHROMOSOME 268 2.10e-06 2.13e-04 0.17200 -1.49e-01 -8.55e-02 2.72e-05 1.60e-02
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs 11 6.46e-01 8.91e-01 0.17200 1.37e-01 -1.04e-01 4.32e-01 5.52e-01
GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY 5 7.86e-01 9.41e-01 0.17200 -1.62e-01 -5.72e-02 5.31e-01 8.25e-01
Formation of paraxial mesoderm 58 5.54e-02 3.58e-01 0.17200 -1.17e-01 -1.25e-01 1.22e-01 9.93e-02
GOBP SARCOMERE ORGANIZATION 51 1.32e-01 5.19e-01 0.17200 -9.89e-02 1.40e-01 2.22e-01 8.34e-02
GOBP RESPONSE TO DIETARY EXCESS 35 2.21e-01 6.39e-01 0.17200 -1.70e-01 2.59e-02 8.26e-02 7.91e-01
GOCC EXON EXON JUNCTION COMPLEX 19 4.52e-01 8.07e-01 0.17100 5.01e-02 -1.64e-01 7.06e-01 2.16e-01
Defective RIPK1-mediated regulated necrosis 7 7.53e-01 9.30e-01 0.17100 1.54e-01 -7.62e-02 4.82e-01 7.27e-01
GOMF RIBONUCLEOPROTEIN COMPLEX BINDING 154 6.03e-04 2.18e-02 0.17100 -6.66e-02 -1.58e-01 1.53e-01 7.16e-04
GOBP HEART FIELD SPECIFICATION 17 4.33e-01 7.96e-01 0.17100 1.47e-01 8.82e-02 2.94e-01 5.29e-01
GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION 19 4.51e-01 8.06e-01 0.17100 1.65e-01 -4.63e-02 2.13e-01 7.27e-01
GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING 10 6.65e-01 8.98e-01 0.17100 -6.64e-02 1.58e-01 7.16e-01 3.87e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 46 1.57e-01 5.55e-01 0.17100 -8.04e-02 1.51e-01 3.45e-01 7.60e-02
GOMF PRENYLTRANSFERASE ACTIVITY 16 4.93e-01 8.27e-01 0.17100 6.15e-03 -1.71e-01 9.66e-01 2.36e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN 42 1.92e-01 6.00e-01 0.17100 1.15e-01 -1.27e-01 1.96e-01 1.56e-01
GOBP ENUCLEATE ERYTHROCYTE DEVELOPMENT 6 7.44e-01 9.26e-01 0.17100 -9.06e-02 -1.45e-01 7.01e-01 5.38e-01
GOBP RESPONSE TO HEPARIN 6 7.85e-01 9.41e-01 0.17100 1.52e-01 -7.78e-02 5.18e-01 7.41e-01
GOCC SPECIFIC GRANULE LUMEN 60 5.08e-02 3.43e-01 0.17100 1.20e-01 1.22e-01 1.07e-01 1.03e-01
GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 49 1.15e-01 4.89e-01 0.17100 3.30e-03 -1.71e-01 9.68e-01 3.83e-02
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION 8 7.11e-01 9.14e-01 0.17100 1.68e-01 -3.12e-02 4.10e-01 8.78e-01
GOBP PROTEIN LOCALIZATION TO CHROMOSOME 122 2.78e-03 6.92e-02 0.17100 -7.29e-02 -1.55e-01 1.64e-01 3.17e-03
GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION 37 2.08e-01 6.24e-01 0.17100 -1.68e-01 3.16e-02 7.70e-02 7.39e-01
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) 14 5.01e-01 8.30e-01 0.17100 -1.40e-01 -9.85e-02 3.66e-01 5.23e-01
GOBP FACE DEVELOPMENT 50 1.24e-01 5.04e-01 0.17100 -1.65e-01 4.46e-02 4.36e-02 5.85e-01
GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE 46 1.29e-01 5.13e-01 0.17100 2.77e-03 1.71e-01 9.74e-01 4.50e-02
GOCC CAVEOLA 81 2.23e-02 2.40e-01 0.17100 -1.64e-01 -4.63e-02 1.05e-02 4.71e-01
Sulfur amino acid metabolism 26 3.62e-01 7.52e-01 0.17100 1.28e-01 -1.13e-01 2.60e-01 3.17e-01
GOBP ENDODERM FORMATION 59 6.29e-02 3.77e-01 0.17100 -1.65e-01 -4.52e-02 2.87e-02 5.48e-01
GOMF GAMMA CATENIN BINDING 12 5.78e-01 8.64e-01 0.17100 -2.36e-02 -1.69e-01 8.88e-01 3.10e-01
GOBP CELLULAR RESPONSE TO CGMP 7 7.40e-01 9.25e-01 0.17100 -1.69e-01 2.24e-02 4.38e-01 9.18e-01
GOBP PROTEIN LOCALIZATION TO CHROMATIN 58 5.70e-02 3.63e-01 0.17100 -1.13e-01 -1.28e-01 1.36e-01 9.21e-02
GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION 33 2.23e-01 6.41e-01 0.17100 -2.01e-02 -1.70e-01 8.42e-01 9.19e-02
GOBP GALACTOSE METABOLIC PROCESS 9 6.43e-01 8.90e-01 0.17100 9.20e-02 1.44e-01 6.33e-01 4.55e-01
GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING 29 3.10e-01 7.19e-01 0.17100 6.99e-02 -1.56e-01 5.15e-01 1.47e-01
GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 21 3.59e-01 7.51e-01 0.17100 1.49e-01 8.38e-02 2.38e-01 5.06e-01
GOBP REGULATION OF MEMBRANE DEPOLARIZATION 46 1.37e-01 5.26e-01 0.17100 -1.70e-01 1.58e-02 4.62e-02 8.53e-01
GOBP REPRODUCTIVE BEHAVIOR 44 1.78e-01 5.83e-01 0.17100 -1.36e-01 1.04e-01 1.20e-01 2.35e-01
GOMF CAMP RESPONSE ELEMENT BINDING 12 5.77e-01 8.64e-01 0.17100 -1.69e-01 -2.64e-02 3.12e-01 8.74e-01
GOBP MYELOID DENDRITIC CELL DIFFERENTIATION 20 4.31e-01 7.96e-01 0.17100 1.67e-01 -3.61e-02 1.97e-01 7.80e-01
Formation of Fibrin Clot (Clotting Cascade) 37 1.82e-01 5.86e-01 0.17100 3.25e-02 1.67e-01 7.32e-01 7.80e-02
GOBP NEGATIVE REGULATION OF OSSIFICATION 38 2.27e-01 6.46e-01 0.17100 1.28e-01 -1.13e-01 1.72e-01 2.30e-01
GOBP POTASSIUM ION HOMEOSTASIS 34 2.61e-01 6.76e-01 0.17100 -1.44e-01 9.09e-02 1.45e-01 3.59e-01
GOBP DNA ALKYLATION REPAIR 11 6.51e-01 8.92e-01 0.17000 -1.25e-01 1.15e-01 4.71e-01 5.08e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS 17 4.33e-01 7.96e-01 0.17000 1.10e-01 1.30e-01 4.33e-01 3.53e-01
GOBP REGULATION OF MONOCYTE DIFFERENTIATION 20 4.46e-01 8.03e-01 0.17000 1.56e-01 -6.78e-02 2.26e-01 6.00e-01
GOBP REGULATION OF MAST CELL DEGRANULATION 24 3.89e-01 7.70e-01 0.17000 9.27e-02 -1.43e-01 4.32e-01 2.25e-01
GOBP DORSAL VENTRAL PATTERN FORMATION 90 2.03e-02 2.28e-01 0.17000 -1.70e-01 1.09e-02 5.31e-03 8.58e-01
GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION 39 1.47e-01 5.40e-01 0.17000 1.24e-01 1.17e-01 1.80e-01 2.08e-01
GOBP REGULATION OF B CELL DIFFERENTIATION 33 2.55e-01 6.70e-01 0.17000 4.44e-02 -1.64e-01 6.59e-01 1.02e-01
GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY 13 5.63e-01 8.58e-01 0.17000 1.70e-01 1.82e-03 2.88e-01 9.91e-01
GOBP CELLULAR RESPONSE TO HEAT 63 6.18e-02 3.76e-01 0.17000 -3.29e-03 -1.70e-01 9.64e-01 1.94e-02
GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 170 5.57e-04 2.05e-02 0.17000 -4.82e-03 -1.70e-01 9.14e-01 1.28e-04
GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 42 1.61e-01 5.59e-01 0.17000 -1.70e-01 7.69e-03 5.64e-02 9.31e-01
GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 37 2.37e-01 6.54e-01 0.17000 -1.28e-01 1.12e-01 1.78e-01 2.38e-01
GOBP PERICARDIUM DEVELOPMENT 19 4.58e-01 8.10e-01 0.17000 -1.63e-01 4.98e-02 2.19e-01 7.07e-01
GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS 25 3.54e-01 7.47e-01 0.17000 -1.65e-01 4.20e-02 1.53e-01 7.16e-01
Signaling by SCF-KIT 42 1.30e-01 5.14e-01 0.17000 -9.28e-02 -1.43e-01 2.98e-01 1.10e-01
GOMF TRANSCRIPTION COACTIVATOR BINDING 42 1.95e-01 6.05e-01 0.17000 -1.35e-01 1.04e-01 1.31e-01 2.44e-01
GOMF COLLAGEN BINDING INVOLVED IN CELL MATRIX ADHESION 5 8.22e-01 9.52e-01 0.17000 -9.40e-02 1.42e-01 7.16e-01 5.83e-01
GOBP REGULATION OF ENDODERMAL CELL DIFFERENTIATION 7 7.34e-01 9.23e-01 0.17000 -1.70e-01 -3.74e-03 4.36e-01 9.86e-01
GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS 12 6.22e-01 8.82e-01 0.17000 8.28e-02 -1.48e-01 6.19e-01 3.73e-01
GOBP MRNA SPLICE SITE RECOGNITION 35 1.81e-01 5.84e-01 0.17000 -1.07e-01 -1.32e-01 2.73e-01 1.77e-01
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION 7 7.59e-01 9.32e-01 0.17000 -8.46e-02 1.47e-01 6.98e-01 5.00e-01
GOBP T CELL RECEPTOR SIGNALING PATHWAY 136 4.46e-03 9.27e-02 0.17000 6.96e-02 -1.55e-01 1.61e-01 1.80e-03
GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY 16 5.19e-01 8.39e-01 0.17000 5.00e-02 -1.62e-01 7.29e-01 2.61e-01
Reproduction 119 4.04e-03 8.82e-02 0.17000 -4.63e-02 -1.63e-01 3.83e-01 2.08e-03
GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY 15 5.59e-01 8.57e-01 0.17000 -1.30e-01 1.09e-01 3.82e-01 4.65e-01
GOCC CONDENSED CHROMOSOME CENTROMERIC REGION 174 2.62e-04 1.20e-02 0.17000 -1.54e-01 -7.11e-02 4.49e-04 1.06e-01
GOMF TAU PROTEIN BINDING 42 1.51e-01 5.46e-01 0.17000 -1.69e-01 -2.04e-02 5.88e-02 8.19e-01
GOBP REGULATION OF B CELL APOPTOTIC PROCESS 19 4.56e-01 8.09e-01 0.17000 4.16e-02 -1.64e-01 7.53e-01 2.15e-01
GOCC NADH DEHYDROGENASE COMPLEX 42 1.61e-01 5.59e-01 0.17000 2.29e-03 -1.70e-01 9.79e-01 5.71e-02
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 45 1.21e-01 4.99e-01 0.17000 -5.56e-02 -1.60e-01 5.18e-01 6.29e-02
GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT 8 7.34e-01 9.23e-01 0.17000 -1.15e-01 1.25e-01 5.74e-01 5.41e-01
GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION 34 1.95e-01 6.05e-01 0.17000 -1.48e-01 -8.36e-02 1.36e-01 3.99e-01
GOBP RESPONSE TO PHEROMONE 7 7.22e-01 9.17e-01 0.17000 1.63e-01 4.74e-02 4.56e-01 8.28e-01
GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 73 4.63e-02 3.27e-01 0.17000 -2.51e-02 1.68e-01 7.10e-01 1.32e-02
Regulation of endogenous retroelements 103 1.02e-02 1.55e-01 0.17000 -1.69e-01 -1.66e-02 3.08e-03 7.71e-01
GOBP ORGAN GROWTH 171 9.08e-04 3.03e-02 0.17000 -1.64e-01 4.18e-02 2.09e-04 3.46e-01
GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE 9 6.69e-01 9.00e-01 0.17000 -1.69e-01 -1.66e-02 3.81e-01 9.31e-01
GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY 64 4.67e-02 3.28e-01 0.17000 -8.04e-02 -1.49e-01 2.66e-01 3.89e-02
GOBP PROTEIN LOCALIZATION TO SYNAPSE 73 6.04e-02 3.73e-01 0.17000 -1.21e-01 1.19e-01 7.37e-02 7.96e-02
GOBP RESPONSE TO INTERLEUKIN 15 11 6.33e-01 8.86e-01 0.17000 3.60e-02 -1.66e-01 8.36e-01 3.41e-01
GOBP REGULATION OF PANCREATIC JUICE SECRETION 7 7.42e-01 9.26e-01 0.16900 -1.69e-01 1.78e-02 4.40e-01 9.35e-01
GOCC IMMUNOGLOBULIN COMPLEX 10 6.17e-01 8.80e-01 0.16900 1.45e-01 8.82e-02 4.28e-01 6.29e-01
GOBP REGULATION OF ASTROCYTE DIFFERENTIATION 31 3.00e-01 7.11e-01 0.16900 -1.40e-01 9.50e-02 1.77e-01 3.60e-01
GOBP POSITIVE REGULATION OF ORGAN GROWTH 49 1.52e-01 5.48e-01 0.16900 -1.20e-01 1.20e-01 1.46e-01 1.47e-01
GOBP NEGATIVE REGULATION OF LYASE ACTIVITY 18 4.94e-01 8.28e-01 0.16900 -1.47e-01 8.42e-02 2.80e-01 5.36e-01
GOBP EXTRACELLULAR MATRIX ASSEMBLY 51 1.41e-01 5.32e-01 0.16900 -1.13e-01 1.26e-01 1.63e-01 1.19e-01
GOBP RESPONSE TO NITROSATIVE STRESS 10 6.80e-01 9.04e-01 0.16900 1.10e-01 -1.29e-01 5.47e-01 4.80e-01
GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION 9 6.91e-01 9.09e-01 0.16900 1.64e-01 -4.40e-02 3.96e-01 8.19e-01
Metabolism of non-coding RNA 52 1.01e-01 4.65e-01 0.16900 -9.37e-03 -1.69e-01 9.07e-01 3.49e-02
snRNP Assembly 52 1.01e-01 4.65e-01 0.16900 -9.37e-03 -1.69e-01 9.07e-01 3.49e-02
GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION 83 1.88e-02 2.18e-01 0.16900 -8.67e-02 -1.45e-01 1.72e-01 2.20e-02
GOBP SPINDLE ELONGATION 13 6.03e-01 8.76e-01 0.16900 -1.43e-01 8.97e-02 3.70e-01 5.75e-01
GOMF SPHINGOLIPID TRANSPORTER ACTIVITY 20 4.61e-01 8.12e-01 0.16900 -1.39e-01 9.70e-02 2.83e-01 4.53e-01
G1/S-Specific Transcription 28 3.04e-01 7.14e-01 0.16900 1.68e-01 -1.46e-02 1.23e-01 8.93e-01
GOBP REGULATION OF T CELL COSTIMULATION 5 7.86e-01 9.41e-01 0.16900 9.55e-02 1.39e-01 7.11e-01 5.89e-01
GOBP GALACTOLIPID METABOLIC PROCESS 9 6.63e-01 8.97e-01 0.16900 1.65e-01 3.71e-02 3.92e-01 8.47e-01
GOBP INTEGRIN MEDIATED SIGNALING PATHWAY 110 1.16e-02 1.69e-01 0.16900 -1.62e-01 4.71e-02 3.27e-03 3.93e-01
GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS 9 6.48e-01 8.91e-01 0.16900 1.40e-01 9.41e-02 4.66e-01 6.25e-01
GOCC LAMELLAR BODY 18 4.19e-01 7.87e-01 0.16900 1.33e-01 1.05e-01 3.30e-01 4.41e-01
GOCC DESMOSOME 26 2.86e-01 6.99e-01 0.16900 1.40e-01 9.39e-02 2.15e-01 4.07e-01
GOBP NEURAL NUCLEUS DEVELOPMENT 61 5.61e-02 3.60e-01 0.16900 -1.53e-01 -7.16e-02 3.87e-02 3.33e-01
GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION 7 7.56e-01 9.30e-01 0.16900 6.09e-02 -1.58e-01 7.80e-01 4.70e-01
GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE 22 3.56e-01 7.49e-01 0.16900 -1.57e-01 -6.32e-02 2.03e-01 6.08e-01
GOMF TELETHONIN BINDING 7 7.20e-01 9.16e-01 0.16900 6.47e-02 1.56e-01 7.67e-01 4.75e-01
GOMF ISOPRENOID BINDING 45 1.39e-01 5.31e-01 0.16900 1.69e-01 8.41e-03 5.03e-02 9.22e-01
Cohesin Loading onto Chromatin 8 6.88e-01 9.07e-01 0.16900 -1.58e-01 -5.92e-02 4.39e-01 7.72e-01
Amino acids regulate mTORC1 50 1.11e-01 4.83e-01 0.16900 -1.68e-01 -1.09e-02 3.93e-02 8.94e-01
GOBP NEURAL CREST CELL DIFFERENTIATION 92 1.69e-02 2.08e-01 0.16900 -1.68e-01 -2.05e-02 5.48e-03 7.34e-01
GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION 6 7.52e-01 9.30e-01 0.16900 -7.76e-02 -1.50e-01 7.42e-01 5.25e-01
GOBP VITAMIN TRANSPORT 50 1.44e-01 5.36e-01 0.16900 -8.44e-02 1.46e-01 3.02e-01 7.40e-02
GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT 17 5.07e-01 8.33e-01 0.16900 -5.83e-02 1.58e-01 6.77e-01 2.59e-01
GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY 17 5.18e-01 8.39e-01 0.16900 -8.78e-02 1.44e-01 5.31e-01 3.04e-01
GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY 17 5.10e-01 8.34e-01 0.16900 6.58e-02 -1.55e-01 6.38e-01 2.68e-01
GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS 63 8.94e-02 4.39e-01 0.16900 9.85e-02 -1.37e-01 1.76e-01 6.02e-02
GOBP DNA REPLICATION SYNTHESIS OF PRIMER 6 7.71e-01 9.36e-01 0.16900 -1.69e-01 -1.13e-03 4.75e-01 9.96e-01
GOMF AP 2 ADAPTOR COMPLEX BINDING 10 6.18e-01 8.80e-01 0.16900 -1.08e-01 -1.29e-01 5.54e-01 4.78e-01
GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS 15 4.93e-01 8.27e-01 0.16900 -7.30e-02 -1.52e-01 6.24e-01 3.08e-01
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY 6 7.86e-01 9.41e-01 0.16900 5.32e-02 -1.60e-01 8.21e-01 4.98e-01
GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME 12 5.86e-01 8.67e-01 0.16800 2.42e-02 1.67e-01 8.85e-01 3.17e-01
GOBP MEIOTIC CELL CYCLE PHASE TRANSITION 14 5.62e-01 8.57e-01 0.16800 3.20e-02 -1.65e-01 8.36e-01 2.84e-01
Netrin-1 signaling 42 2.03e-01 6.18e-01 0.16800 1.25e-01 -1.13e-01 1.62e-01 2.06e-01
GOBP FEMALE MEIOSIS CHROMOSOME SEGREGATION 6 7.91e-01 9.42e-01 0.16800 -1.52e-01 7.15e-02 5.18e-01 7.62e-01
GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY 10 6.84e-01 9.06e-01 0.16800 1.27e-01 -1.11e-01 4.88e-01 5.44e-01
GOCC INO80 TYPE COMPLEX 27 2.80e-01 6.92e-01 0.16800 -1.48e-01 -8.01e-02 1.83e-01 4.71e-01
GOBP INTERFERON ALPHA PRODUCTION 27 2.87e-01 7.00e-01 0.16800 -5.68e-02 -1.58e-01 6.09e-01 1.55e-01
GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 48 1.13e-01 4.86e-01 0.16800 -4.47e-02 -1.62e-01 5.92e-01 5.21e-02
GOBP MINERALOCORTICOID SECRETION 7 7.40e-01 9.25e-01 0.16800 -1.68e-01 -1.81e-03 4.41e-01 9.93e-01
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY 11 6.33e-01 8.86e-01 0.16800 -1.66e-01 2.29e-02 3.39e-01 8.95e-01
GOBP REGULATION OF PHOSPHOLIPASE A2 ACTIVITY 7 7.37e-01 9.23e-01 0.16800 -1.22e-02 -1.68e-01 9.55e-01 4.43e-01
GOMF COLLAGEN BINDING 68 7.63e-02 4.14e-01 0.16800 -1.30e-01 1.06e-01 6.31e-02 1.31e-01
GOBP TRANSMISSION OF NERVE IMPULSE 73 5.51e-02 3.57e-01 0.16800 -1.59e-01 5.35e-02 1.87e-02 4.29e-01
GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION 44 1.60e-01 5.58e-01 0.16800 1.91e-02 -1.67e-01 8.26e-01 5.55e-02
GOCC SET1C COMPASS COMPLEX 14 5.89e-01 8.68e-01 0.16800 -1.21e-01 1.16e-01 4.31e-01 4.53e-01
GOBP AUTOPHAGY OF PEROXISOME 15 5.67e-01 8.59e-01 0.16800 -1.14e-01 1.24e-01 4.47e-01 4.07e-01
GOBP PULMONARY VALVE MORPHOGENESIS 20 4.70e-01 8.14e-01 0.16800 -1.11e-01 1.26e-01 3.91e-01 3.29e-01
GOBP REGULATION OF URINE VOLUME 21 3.79e-01 7.64e-01 0.16800 -1.56e-01 -6.09e-02 2.15e-01 6.29e-01
GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION 7 7.67e-01 9.34e-01 0.16800 1.35e-01 -9.98e-02 5.37e-01 6.47e-01
GOBP POSITIVE REGULATION OF AXONOGENESIS 71 6.12e-02 3.74e-01 0.16800 -1.57e-01 5.88e-02 2.21e-02 3.92e-01
GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS 20 4.44e-01 8.01e-01 0.16800 -1.64e-01 3.66e-02 2.05e-01 7.77e-01
Meiotic synapsis 54 8.08e-02 4.21e-01 0.16800 -7.45e-02 -1.50e-01 3.44e-01 5.64e-02
GOMF ACETYLCHOLINE GATED MONOATOMIC CATION SELECTIVE CHANNEL ACTIVITY 17 5.01e-01 8.30e-01 0.16700 3.46e-02 -1.64e-01 8.05e-01 2.42e-01
The role of GTSE1 in G2/M progression after G2 checkpoint 64 8.77e-02 4.37e-01 0.16700 8.92e-02 -1.42e-01 2.17e-01 4.99e-02
RUNX1 regulates transcription of genes involved in differentiation of keratinocytes 8 7.35e-01 9.23e-01 0.16700 -1.47e-01 7.99e-02 4.71e-01 6.96e-01
GOBP GLYCINE METABOLIC PROCESS 13 5.39e-01 8.49e-01 0.16700 -1.08e-01 -1.28e-01 5.00e-01 4.24e-01
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 19 4.05e-01 7.81e-01 0.16700 -1.24e-01 -1.13e-01 3.51e-01 3.94e-01
GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 35 2.48e-01 6.62e-01 0.16700 -4.67e-02 1.61e-01 6.33e-01 9.97e-02
GOMF HISTONE H3 KINASE ACTIVITY 11 6.59e-01 8.96e-01 0.16700 -1.37e-01 9.62e-02 4.31e-01 5.81e-01
GOBP CELLULAR RESPONSE TO ACIDIC PH 14 5.16e-01 8.38e-01 0.16700 9.54e-02 1.38e-01 5.37e-01 3.73e-01
GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH 22 4.17e-01 7.86e-01 0.16700 -1.60e-01 4.92e-02 1.94e-01 6.89e-01
GOMF QUINONE BINDING 15 5.64e-01 8.58e-01 0.16700 -1.44e-01 8.58e-02 3.35e-01 5.65e-01
GOMF NUCLEOTIDE RECEPTOR ACTIVITY 17 4.46e-01 8.02e-01 0.16700 1.03e-01 1.32e-01 4.61e-01 3.47e-01
GOBP ALANINE TRANSPORT 16 4.97e-01 8.29e-01 0.16700 1.66e-01 1.99e-02 2.50e-01 8.90e-01
GOBP POSITIVE REGULATION OF THYROID HORMONE GENERATION 5 8.24e-01 9.52e-01 0.16700 -1.52e-01 7.08e-02 5.57e-01 7.84e-01
GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION 10 6.86e-01 9.06e-01 0.16700 -1.08e-01 1.28e-01 5.54e-01 4.84e-01
GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY 10 6.25e-01 8.83e-01 0.16700 -8.65e-02 -1.43e-01 6.36e-01 4.33e-01
GOMF DEATH RECEPTOR BINDING 19 4.05e-01 7.81e-01 0.16700 -1.19e-01 -1.18e-01 3.69e-01 3.75e-01
GOMF ARACHIDONIC ACID MONOOXYGENASE ACTIVITY 17 4.54e-01 8.08e-01 0.16700 -7.31e-02 -1.50e-01 6.02e-01 2.83e-01
GOCC HFE TRANSFERRIN RECEPTOR COMPLEX 8 6.92e-01 9.09e-01 0.16700 -6.22e-02 -1.55e-01 7.61e-01 4.47e-01
GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION 15 4.91e-01 8.26e-01 0.16700 -1.14e-01 -1.22e-01 4.44e-01 4.12e-01
GOBP POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE 8 6.89e-01 9.08e-01 0.16700 -1.50e-01 -7.44e-02 4.63e-01 7.16e-01
GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION 40 1.80e-01 5.84e-01 0.16700 6.82e-03 1.67e-01 9.40e-01 6.76e-02
Transcriptional Regulation by E2F6 32 2.66e-01 6.81e-01 0.16700 -1.66e-01 1.74e-02 1.04e-01 8.65e-01
ADORA2B mediated anti-inflammatory cytokines production 42 2.03e-01 6.17e-01 0.16700 -1.44e-01 8.43e-02 1.06e-01 3.44e-01
Conjugation of salicylate with glycine 8 6.88e-01 9.07e-01 0.16700 -8.70e-02 -1.43e-01 6.70e-01 4.85e-01
GOCC CILIARY ROOTLET 14 5.74e-01 8.62e-01 0.16700 1.60e-01 -4.68e-02 2.99e-01 7.62e-01
GOBP PROTEIN LIPID COMPLEX ORGANIZATION 54 1.33e-01 5.21e-01 0.16700 -1.16e-01 1.20e-01 1.41e-01 1.27e-01
Loss of MECP2 binding ability to the NCoR/SMRT complex 5 8.11e-01 9.49e-01 0.16700 -7.71e-03 1.67e-01 9.76e-01 5.19e-01
GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS 7 7.31e-01 9.22e-01 0.16700 4.04e-02 1.62e-01 8.53e-01 4.58e-01
GOBP RESPONSE TO INTERFERON ALPHA 17 4.56e-01 8.09e-01 0.16700 -7.15e-02 -1.51e-01 6.10e-01 2.82e-01
GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT 8 7.11e-01 9.14e-01 0.16700 5.67e-03 1.67e-01 9.78e-01 4.14e-01
GOMF GLUTATHIONE TRANSFERASE ACTIVITY 24 3.62e-01 7.53e-01 0.16700 -1.45e-03 -1.67e-01 9.90e-01 1.58e-01
GOBP AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION 14 5.22e-01 8.41e-01 0.16700 1.45e-01 8.26e-02 3.48e-01 5.93e-01
GOBP IMMUNOGLOBULIN V D J RECOMBINATION 8 7.20e-01 9.16e-01 0.16700 -1.92e-02 1.65e-01 9.25e-01 4.18e-01
GOBP CEREBRAL CORTEX GABAERGIC INTERNEURON DEVELOPMENT 5 7.95e-01 9.44e-01 0.16700 -1.52e-01 -6.72e-02 5.55e-01 7.95e-01
GOMF UBIQUITIN MODIFIED HISTONE READER ACTIVITY 7 7.22e-01 9.17e-01 0.16700 -8.76e-02 -1.42e-01 6.88e-01 5.16e-01
GOBP RESPONSE TO CGMP 8 6.90e-01 9.08e-01 0.16700 -1.45e-01 -8.23e-02 4.78e-01 6.87e-01
GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS 15 5.68e-01 8.59e-01 0.16700 8.68e-02 -1.42e-01 5.60e-01 3.41e-01
GOBP HUMORAL IMMUNE RESPONSE 255 6.26e-05 3.94e-03 0.16600 1.51e-01 -6.97e-02 3.21e-05 5.52e-02
Gene Silencing by RNA 104 7.85e-03 1.32e-01 0.16600 -1.36e-01 -9.62e-02 1.67e-02 9.01e-02
GOBP EMBRYONIC PLACENTA DEVELOPMENT 85 4.20e-02 3.13e-01 0.16600 9.63e-02 -1.36e-01 1.25e-01 3.06e-02
GOMF MYOSIN LIGHT CHAIN BINDING 8 6.96e-01 9.11e-01 0.16600 5.87e-02 1.56e-01 7.74e-01 4.46e-01
GOBP RESPONSE TO PEPTIDOGLYCAN 13 5.75e-01 8.63e-01 0.16600 -1.66e-01 -7.59e-03 2.99e-01 9.62e-01
GOBP CARDIAC SEPTUM DEVELOPMENT 109 1.17e-02 1.70e-01 0.16600 -1.65e-01 1.78e-02 2.85e-03 7.48e-01
GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING 8 6.96e-01 9.11e-01 0.16600 -5.69e-02 -1.56e-01 7.81e-01 4.44e-01
RMTs methylate histone arginines 43 1.37e-01 5.27e-01 0.16600 -1.45e-01 -8.13e-02 9.98e-02 3.57e-01
GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE 7 7.21e-01 9.17e-01 0.16600 -9.74e-02 -1.35e-01 6.55e-01 5.37e-01
GOBP GLYCEROL ETHER METABOLIC PROCESS 21 4.59e-01 8.10e-01 0.16600 1.10e-01 -1.24e-01 3.81e-01 3.24e-01
GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY 456 2.12e-09 4.20e-07 0.16600 -1.59e-01 -4.70e-02 5.36e-09 8.51e-02
TRAF3-dependent IRF activation pathway 15 5.54e-01 8.54e-01 0.16600 4.43e-02 -1.60e-01 7.66e-01 2.83e-01
GOBP ADAPTIVE THERMOGENESIS 166 1.36e-03 4.13e-02 0.16600 -1.63e-01 3.29e-02 2.94e-04 4.64e-01
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE 67 5.93e-02 3.70e-01 0.16600 -5.20e-03 -1.66e-01 9.41e-01 1.87e-02
GOBP MALE SEX DETERMINATION 11 6.29e-01 8.85e-01 0.16600 1.66e-01 3.53e-03 3.40e-01 9.84e-01
GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY 7 7.21e-01 9.17e-01 0.16600 -1.30e-01 -1.03e-01 5.50e-01 6.37e-01
Leading Strand Synthesis 13 5.65e-01 8.58e-01 0.16600 -3.55e-02 -1.62e-01 8.25e-01 3.11e-01
Polymerase switching 13 5.65e-01 8.58e-01 0.16600 -3.55e-02 -1.62e-01 8.25e-01 3.11e-01
GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY 30 3.23e-01 7.28e-01 0.16600 -8.00e-02 1.46e-01 4.48e-01 1.68e-01
GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION 23 4.07e-01 7.81e-01 0.16600 5.02e-02 -1.58e-01 6.77e-01 1.89e-01
GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS 5 8.14e-01 9.50e-01 0.16600 -1.66e-01 1.21e-02 5.21e-01 9.63e-01
GOBP EPIDERMAL CELL FATE SPECIFICATION 5 7.97e-01 9.44e-01 0.16600 1.53e-01 6.55e-02 5.55e-01 8.00e-01
GOBP SPONTANEOUS SYNAPTIC TRANSMISSION 14 5.84e-01 8.66e-01 0.16600 -6.20e-02 1.54e-01 6.88e-01 3.18e-01
GOMF LIPOTEICHOIC ACID BINDING 5 8.31e-01 9.54e-01 0.16600 1.32e-01 -1.01e-01 6.10e-01 6.95e-01
GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT 15 5.74e-01 8.63e-01 0.16600 -1.22e-01 1.13e-01 4.14e-01 4.50e-01
GOBP POSITIVE REGULATION OF PLATELET AGGREGATION 12 6.24e-01 8.83e-01 0.16600 -1.59e-01 4.59e-02 3.39e-01 7.83e-01
GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY 12 6.35e-01 8.86e-01 0.16600 -1.48e-01 7.52e-02 3.75e-01 6.52e-01
Ribavirin ADME 11 6.29e-01 8.85e-01 0.16600 -1.66e-01 -5.59e-03 3.41e-01 9.74e-01
GOCC SAGA TYPE COMPLEX 35 1.95e-01 6.05e-01 0.16600 -1.18e-01 -1.17e-01 2.29e-01 2.31e-01
GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE 32 2.89e-01 7.02e-01 0.16600 1.57e-01 -5.40e-02 1.25e-01 5.97e-01
Chemokine receptors bind chemokines 55 9.62e-02 4.52e-01 0.16600 1.65e-01 1.39e-02 3.39e-02 8.58e-01
GOCC ESC E Z COMPLEX 15 5.66e-01 8.59e-01 0.16600 7.21e-02 -1.49e-01 6.29e-01 3.16e-01
GOBP HIPPOCAMPUS DEVELOPMENT 91 1.44e-02 1.91e-01 0.16600 -1.20e-01 -1.15e-01 4.81e-02 5.87e-02
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors 11 6.62e-01 8.97e-01 0.16600 1.44e-01 -8.28e-02 4.09e-01 6.34e-01
GOMF ADP PHOSPHATASE ACTIVITY 6 7.72e-01 9.36e-01 0.16600 1.64e-01 2.31e-02 4.86e-01 9.22e-01
GOBP DEHYDROASCORBIC ACID TRANSPORT 9 6.92e-01 9.09e-01 0.16600 1.65e-01 -1.56e-02 3.91e-01 9.35e-01
GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN 47 1.60e-01 5.57e-01 0.16600 1.59e-01 -4.69e-02 5.94e-02 5.78e-01
GOBP NUCLEAR MEMBRANE REASSEMBLY 25 3.90e-01 7.71e-01 0.16600 7.70e-02 -1.47e-01 5.05e-01 2.04e-01
GOBP REGULATION OF DENDRITE MORPHOGENESIS 58 1.19e-01 4.94e-01 0.16600 -1.12e-01 1.22e-01 1.39e-01 1.09e-01
GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY 14 5.21e-01 8.40e-01 0.16600 -1.13e-01 -1.22e-01 4.66e-01 4.31e-01
GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT 7 7.52e-01 9.30e-01 0.16600 -1.85e-02 1.65e-01 9.32e-01 4.51e-01
GOBP POSITIVE REGULATION OF EPITHELIAL TUBE FORMATION 8 7.05e-01 9.13e-01 0.16600 -1.62e-01 -3.38e-02 4.27e-01 8.69e-01
HDR through Homologous Recombination (HRR) 68 4.26e-02 3.14e-01 0.16600 -1.06e-01 -1.27e-01 1.29e-01 7.02e-02
GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS 11 6.64e-01 8.97e-01 0.16600 -1.38e-01 9.13e-02 4.27e-01 6.00e-01
GOBP GLYCOSIDE METABOLIC PROCESS 20 4.75e-01 8.18e-01 0.16600 -9.07e-02 1.39e-01 4.83e-01 2.83e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE DIFFERENTIATION 8 6.94e-01 9.10e-01 0.16600 1.47e-01 7.69e-02 4.72e-01 7.07e-01
GOMF VITAMIN D BINDING 6 7.67e-01 9.34e-01 0.16600 -4.24e-02 -1.60e-01 8.57e-01 4.97e-01
Mismatch Repair 15 4.98e-01 8.29e-01 0.16600 -1.25e-01 -1.09e-01 4.03e-01 4.65e-01
GOBP ANATOMICAL STRUCTURE REGRESSION 15 5.38e-01 8.49e-01 0.16600 -1.65e-01 4.90e-03 2.67e-01 9.74e-01
GOBP KERATINOCYTE APOPTOTIC PROCESS 8 7.01e-01 9.12e-01 0.16600 -4.92e-02 -1.58e-01 8.10e-01 4.39e-01
GOBP MEMBRANE RAFT ORGANIZATION 26 3.85e-01 7.68e-01 0.16500 -1.24e-01 1.10e-01 2.75e-01 3.32e-01
GOBP MYOTUBE DIFFERENTIATION 129 8.47e-03 1.38e-01 0.16500 -1.41e-01 8.68e-02 5.79e-03 8.87e-02
GOBP NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL 13 6.21e-01 8.81e-01 0.16500 -1.17e-01 1.17e-01 4.67e-01 4.65e-01
Signaling by RNF43 mutants 8 7.02e-01 9.12e-01 0.16500 4.63e-02 1.59e-01 8.21e-01 4.37e-01
GOMF 3 5 DNA EXONUCLEASE ACTIVITY 14 5.80e-01 8.65e-01 0.16500 -4.68e-02 1.58e-01 7.62e-01 3.05e-01
GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY 8 7.23e-01 9.17e-01 0.16500 -1.48e-02 1.65e-01 9.42e-01 4.20e-01
GOCC DNA DEPENDENT PROTEIN KINASE DNA LIGASE 4 COMPLEX 7 7.55e-01 9.30e-01 0.16500 -2.33e-02 1.64e-01 9.15e-01 4.54e-01
GOMF POLY G BINDING 7 7.35e-01 9.23e-01 0.16500 -4.31e-02 -1.59e-01 8.44e-01 4.65e-01
GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION 9 7.06e-01 9.13e-01 0.16500 1.57e-01 -4.98e-02 4.13e-01 7.96e-01
GOBP VENTRICULAR SEPTUM DEVELOPMENT 75 4.61e-02 3.26e-01 0.16500 -1.65e-01 4.93e-03 1.35e-02 9.41e-01
GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 12 5.75e-01 8.63e-01 0.16500 9.79e-02 1.33e-01 5.57e-01 4.25e-01
GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM 86 4.36e-02 3.18e-01 0.16500 1.20e-01 -1.13e-01 5.36e-02 7.03e-02
GOBP CELL KILLING 216 3.91e-04 1.59e-02 0.16500 1.29e-01 -1.03e-01 1.07e-03 9.20e-03
Signaling by NOTCH4 71 3.91e-02 3.05e-01 0.16500 -8.71e-02 -1.40e-01 2.05e-01 4.11e-02
DNA Replication 146 1.86e-03 5.14e-02 0.16500 -3.33e-02 -1.62e-01 4.88e-01 7.47e-04
Dual incision in TC-NER 61 6.47e-02 3.82e-01 0.16500 -6.74e-02 -1.51e-01 3.63e-01 4.20e-02
GOBP BONE DEVELOPMENT 205 4.02e-04 1.63e-02 0.16500 -1.57e-01 5.16e-02 1.10e-04 2.03e-01
GOBP DIET INDUCED THERMOGENESIS 13 6.22e-01 8.82e-01 0.16500 -1.22e-01 1.11e-01 4.45e-01 4.90e-01
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND 15 5.04e-01 8.31e-01 0.16500 -1.41e-01 -8.57e-02 3.45e-01 5.66e-01
GOBP MITOTIC SPINDLE ELONGATION 11 6.46e-01 8.91e-01 0.16500 -1.63e-01 2.71e-02 3.50e-01 8.76e-01
Platelet homeostasis 84 3.87e-02 3.03e-01 0.16500 -1.59e-01 4.40e-02 1.18e-02 4.86e-01
GOBP ANIMAL ORGAN FORMATION 68 6.08e-02 3.73e-01 0.16500 -1.65e-01 4.94e-04 1.87e-02 9.94e-01
GOBP FORMATION OF PRIMARY GERM LAYER 129 3.61e-03 8.28e-02 0.16500 -1.59e-01 -4.42e-02 1.84e-03 3.86e-01
GOBP INTRACILIARY TRANSPORT 48 1.10e-01 4.81e-01 0.16500 -1.31e-01 -1.01e-01 1.18e-01 2.27e-01
GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 52 1.36e-01 5.25e-01 0.16500 -1.57e-01 5.13e-02 5.07e-02 5.22e-01
GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 20 3.98e-01 7.76e-01 0.16500 -1.26e-01 -1.06e-01 3.29e-01 4.11e-01
GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY 68 4.66e-02 3.28e-01 0.16500 -1.46e-01 -7.55e-02 3.67e-02 2.82e-01
Erythropoietin activates STAT5 7 7.44e-01 9.26e-01 0.16500 -1.64e-01 -1.57e-02 4.52e-01 9.43e-01
GOBP BLOOD VESSEL REMODELING 46 1.82e-01 5.86e-01 0.16500 -8.00e-02 1.44e-01 3.48e-01 9.12e-02
GOBP CIRCADIAN SLEEP WAKE CYCLE 22 4.16e-01 7.86e-01 0.16500 -1.63e-01 2.32e-02 1.86e-01 8.50e-01
GOBP GOLGI TO VACUOLE TRANSPORT 20 4.42e-01 8.00e-01 0.16500 -1.64e-01 7.01e-03 2.03e-01 9.57e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I 37 2.58e-01 6.72e-01 0.16500 1.35e-01 -9.44e-02 1.56e-01 3.21e-01
GOBP GOLGI LUMEN ACIDIFICATION 10 6.33e-01 8.86e-01 0.16500 -1.33e-01 -9.69e-02 4.66e-01 5.96e-01
GOCC RESPIRASOME 88 3.08e-02 2.74e-01 0.16500 2.59e-02 -1.63e-01 6.75e-01 8.39e-03
GOBP POSITIVE REGULATION OF MITOCHONDRIAL FUSION 5 8.08e-01 9.49e-01 0.16500 1.63e-01 2.41e-02 5.28e-01 9.26e-01
GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY 6 7.66e-01 9.33e-01 0.16500 -1.53e-01 -5.97e-02 5.15e-01 8.00e-01
GOBP REGULATION OF CATION CHANNEL ACTIVITY 106 1.75e-02 2.11e-01 0.16500 -1.56e-01 5.10e-02 5.38e-03 3.64e-01
GOBP CARDIAC MYOFIBRIL ASSEMBLY 19 5.01e-01 8.30e-01 0.16500 -1.23e-01 1.10e-01 3.54e-01 4.08e-01
GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING 47 1.82e-01 5.86e-01 0.16400 1.22e-01 -1.10e-01 1.48e-01 1.91e-01
GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 23 4.20e-01 7.89e-01 0.16400 6.17e-02 -1.52e-01 6.09e-01 2.06e-01
EGFR downregulation 30 2.71e-01 6.85e-01 0.16400 -4.45e-02 -1.58e-01 6.73e-01 1.34e-01
GOBP MACROPHAGE CYTOKINE PRODUCTION 36 2.56e-01 6.71e-01 0.16400 5.85e-02 -1.54e-01 5.44e-01 1.11e-01
GOBP REGULATION OF STRESS GRANULE ASSEMBLY 11 6.29e-01 8.85e-01 0.16400 -1.91e-02 -1.63e-01 9.13e-01 3.48e-01
GOBP WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY 5 8.30e-01 9.53e-01 0.16400 7.10e-02 -1.48e-01 7.83e-01 5.66e-01
GOMF METHYLATION DEPENDENT PROTEIN BINDING 69 7.88e-02 4.18e-01 0.16400 -7.96e-02 1.44e-01 2.53e-01 3.90e-02
GOBP RESPONSE TO IRON ION 27 3.77e-01 7.63e-01 0.16400 1.18e-01 -1.14e-01 2.87e-01 3.06e-01
GOBP PALLIUM DEVELOPMENT 182 3.38e-04 1.44e-02 0.16400 -1.53e-01 -5.92e-02 3.64e-04 1.68e-01
GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 23 3.50e-01 7.45e-01 0.16400 9.90e-02 1.31e-01 4.11e-01 2.77e-01
GOBP POSITIVE REGULATION OF TISSUE REMODELING 23 4.35e-01 7.96e-01 0.16400 -1.05e-01 1.27e-01 3.86e-01 2.93e-01
GOBP INTESTINAL CHOLESTEROL ABSORPTION 18 4.83e-01 8.22e-01 0.16400 -7.74e-03 1.64e-01 9.55e-01 2.29e-01
GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT 5 8.09e-01 9.49e-01 0.16400 -2.54e-02 -1.62e-01 9.22e-01 5.30e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION 9 6.97e-01 9.11e-01 0.16400 -1.47e-02 1.63e-01 9.39e-01 3.96e-01
GOBP ACETYL COA BIOSYNTHETIC PROCESS 16 5.38e-01 8.48e-01 0.16400 -3.65e-02 1.60e-01 8.00e-01 2.68e-01
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 24 4.18e-01 7.87e-01 0.16400 -1.33e-01 9.56e-02 2.58e-01 4.18e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA 10 6.39e-01 8.88e-01 0.16400 -7.34e-02 -1.47e-01 6.88e-01 4.22e-01
GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY 10 6.66e-01 8.99e-01 0.16400 4.30e-03 -1.64e-01 9.81e-01 3.69e-01
GOMF CARD DOMAIN BINDING 16 4.87e-01 8.23e-01 0.16400 1.41e-01 8.28e-02 3.27e-01 5.66e-01
HIV Transcription Initiation 43 1.50e-01 5.44e-01 0.16400 -6.33e-02 -1.51e-01 4.72e-01 8.63e-02
RNA Polymerase II HIV Promoter Escape 43 1.50e-01 5.44e-01 0.16400 -6.33e-02 -1.51e-01 4.72e-01 8.63e-02
RNA Polymerase II Promoter Escape 43 1.50e-01 5.44e-01 0.16400 -6.33e-02 -1.51e-01 4.72e-01 8.63e-02
RNA Polymerase II Transcription Initiation 43 1.50e-01 5.44e-01 0.16400 -6.33e-02 -1.51e-01 4.72e-01 8.63e-02
RNA Polymerase II Transcription Initiation And Promoter Clearance 43 1.50e-01 5.44e-01 0.16400 -6.33e-02 -1.51e-01 4.72e-01 8.63e-02
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening 43 1.50e-01 5.44e-01 0.16400 -6.33e-02 -1.51e-01 4.72e-01 8.63e-02
GOBP ENDOCARDIAL CUSHION MORPHOGENESIS 44 1.44e-01 5.36e-01 0.16400 -1.52e-01 -6.09e-02 8.09e-02 4.84e-01
GOBP CELL ADHESION MOLECULE PRODUCTION 18 4.40e-01 7.99e-01 0.16400 1.22e-01 1.10e-01 3.71e-01 4.21e-01
GOBP REGULATION OF PRESYNAPSE ORGANIZATION 30 3.02e-01 7.13e-01 0.16400 -1.39e-02 1.63e-01 8.95e-01 1.22e-01
GOCC COLLAGEN TRIMER 83 3.90e-02 3.04e-01 0.16400 -2.72e-02 1.62e-01 6.69e-01 1.10e-02
Spry regulation of FGF signaling 16 4.89e-01 8.25e-01 0.16400 -7.68e-02 -1.45e-01 5.95e-01 3.17e-01
G alpha (z) signalling events 48 1.27e-01 5.10e-01 0.16400 -1.58e-01 -4.11e-02 5.76e-02 6.23e-01
GOBP MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION 8 7.06e-01 9.13e-01 0.16400 -1.55e-01 -5.15e-02 4.47e-01 8.01e-01
GOBP CARDIAC MUSCLE MYOBLAST PROLIFERATION 7 7.74e-01 9.36e-01 0.16400 1.43e-01 -7.93e-02 5.12e-01 7.17e-01
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 60 1.11e-01 4.83e-01 0.16400 -1.43e-01 7.89e-02 5.47e-02 2.91e-01
GOBP RESPONSE TO MAGNESIUM ION 20 4.73e-01 8.16e-01 0.16400 -1.53e-01 5.91e-02 2.37e-01 6.47e-01
GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY 9 6.76e-01 9.04e-01 0.16400 -1.56e-01 -5.01e-02 4.18e-01 7.95e-01
GOCC ACETYLTRANSFERASE COMPLEX 91 1.63e-02 2.04e-01 0.16400 -1.25e-01 -1.05e-01 3.88e-02 8.30e-02
GOBP SPINDLE MIDZONE ASSEMBLY 13 6.26e-01 8.83e-01 0.16400 -1.30e-01 9.98e-02 4.18e-01 5.33e-01
GOCC PRECATALYTIC SPLICEOSOME 50 1.16e-01 4.90e-01 0.16400 -4.25e-02 -1.58e-01 6.03e-01 5.33e-02
RHOJ GTPase cycle 50 1.49e-01 5.44e-01 0.16400 -1.57e-01 4.54e-02 5.46e-02 5.78e-01
Synthesis of UDP-N-acetyl-glucosamine 7 7.76e-01 9.38e-01 0.16300 -1.37e-01 8.94e-02 5.31e-01 6.82e-01
RHOC GTPase cycle 70 8.04e-02 4.20e-01 0.16300 -1.33e-01 9.51e-02 5.43e-02 1.69e-01
GOBP BILE ACID SIGNALING PATHWAY 11 6.74e-01 9.03e-01 0.16300 -1.19e-01 1.12e-01 4.95e-01 5.19e-01
GOMF ATPASE REGULATOR ACTIVITY 47 1.19e-01 4.95e-01 0.16300 -1.12e-01 -1.19e-01 1.85e-01 1.57e-01
Insulin processing 24 3.96e-01 7.74e-01 0.16300 -1.60e-01 3.33e-02 1.75e-01 7.78e-01
GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE 23 3.68e-01 7.57e-01 0.16300 1.54e-01 5.34e-02 2.00e-01 6.58e-01
GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS 16 5.18e-01 8.39e-01 0.16300 -1.63e-01 -9.63e-03 2.59e-01 9.47e-01
GOBP FREE UBIQUITIN CHAIN POLYMERIZATION 9 7.25e-01 9.18e-01 0.16300 1.17e-01 -1.14e-01 5.43e-01 5.55e-01
Circadian Clock 65 8.50e-02 4.32e-01 0.16300 -1.57e-01 4.42e-02 2.85e-02 5.38e-01
GOCC RNAI EFFECTOR COMPLEX 358 4.42e-07 5.37e-05 0.16300 1.77e-02 1.62e-01 5.65e-01 1.34e-07
GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION 12 5.87e-01 8.67e-01 0.16300 -7.78e-02 -1.43e-01 6.41e-01 3.90e-01
GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE 7 7.77e-01 9.38e-01 0.16300 1.35e-01 -9.21e-02 5.37e-01 6.73e-01
GOBP HEPATOCYTE DIFFERENTIATION 14 6.04e-01 8.76e-01 0.16300 1.36e-01 -9.06e-02 3.80e-01 5.57e-01
GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY 7 7.79e-01 9.39e-01 0.16300 -1.07e-01 1.23e-01 6.24e-01 5.72e-01
GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 5 8.16e-01 9.51e-01 0.16300 1.63e-01 3.35e-03 5.28e-01 9.90e-01
RAF activation 32 3.09e-01 7.19e-01 0.16300 -1.47e-01 7.14e-02 1.51e-01 4.84e-01
GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR 8 6.97e-01 9.11e-01 0.16300 -1.12e-01 -1.19e-01 5.83e-01 5.62e-01
GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 23 4.29e-01 7.94e-01 0.16300 -6.81e-02 1.48e-01 5.72e-01 2.19e-01
GOBP ANTEROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT 6 8.02e-01 9.46e-01 0.16300 1.48e-01 -6.88e-02 5.31e-01 7.70e-01
Nicotinate metabolism 31 3.10e-01 7.19e-01 0.16300 -4.58e-02 1.56e-01 6.59e-01 1.32e-01
GOBP CELLULAR RESPONSE TO ATP 16 5.63e-01 8.58e-01 0.16300 -1.32e-01 9.49e-02 3.59e-01 5.11e-01
GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS 55 1.16e-01 4.90e-01 0.16300 1.98e-02 -1.62e-01 8.00e-01 3.81e-02
GOBP ANIMAL ORGAN MATURATION 30 3.00e-01 7.11e-01 0.16300 -3.02e-03 1.63e-01 9.77e-01 1.23e-01
GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 25 3.25e-01 7.29e-01 0.16300 -1.23e-01 -1.07e-01 2.87e-01 3.56e-01
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER 150 1.64e-03 4.67e-02 0.16300 -5.00e-02 -1.55e-01 2.90e-01 1.06e-03
GOCC CHROMOSOMAL REGION 384 4.18e-08 6.56e-06 0.16300 -1.18e-01 -1.12e-01 6.82e-05 1.72e-04
GOBP CRANIAL NERVE DEVELOPMENT 62 9.36e-02 4.47e-01 0.16300 -1.59e-01 3.43e-02 3.03e-02 6.40e-01
GOMF HYALURONIC ACID BINDING 24 4.24e-01 7.92e-01 0.16300 -1.35e-01 9.14e-02 2.54e-01 4.38e-01
GOBP HEART VALVE MORPHOGENESIS 61 1.04e-01 4.70e-01 0.16300 -1.53e-01 5.63e-02 3.93e-02 4.47e-01
GOBP PRIMARY ALCOHOL METABOLIC PROCESS 96 1.68e-02 2.08e-01 0.16300 1.56e-01 4.52e-02 8.16e-03 4.44e-01
GOMF MELANOCORTIN RECEPTOR ACTIVITY 6 8.08e-01 9.49e-01 0.16300 1.14e-01 -1.16e-01 6.29e-01 6.22e-01
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) 52 1.50e-01 5.44e-01 0.16300 -1.48e-01 6.83e-02 6.57e-02 3.94e-01
GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS 35 2.80e-01 6.92e-01 0.16300 -7.25e-02 1.46e-01 4.58e-01 1.36e-01
GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS 30 3.41e-01 7.40e-01 0.16300 -1.36e-01 8.86e-02 1.96e-01 4.01e-01
GOBP PIGMENT METABOLIC PROCESS 74 7.06e-02 3.99e-01 0.16300 1.38e-01 -8.64e-02 4.05e-02 1.99e-01
GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT 176 6.69e-04 2.37e-02 0.16300 -1.60e-01 -2.92e-02 2.52e-04 5.04e-01
Anti-inflammatory response favouring Leishmania parasite infection 73 7.29e-02 4.04e-01 0.16300 -1.39e-01 8.41e-02 3.99e-02 2.14e-01
Leishmania parasite growth and survival 73 7.29e-02 4.04e-01 0.16300 -1.39e-01 8.41e-02 3.99e-02 2.14e-01
GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY 13 5.62e-01 8.57e-01 0.16300 8.33e-02 1.40e-01 6.03e-01 3.83e-01
Semaphorin interactions 61 8.90e-02 4.38e-01 0.16300 -1.62e-01 7.16e-03 2.83e-02 9.23e-01
Degradation of DVL 44 1.54e-01 5.50e-01 0.16200 -4.48e-02 -1.56e-01 6.07e-01 7.31e-02
GOBP THYROID HORMONE METABOLIC PROCESS 28 3.55e-01 7.48e-01 0.16200 -1.52e-01 5.77e-02 1.64e-01 5.97e-01
MET receptor recycling 10 6.90e-01 9.08e-01 0.16200 1.53e-01 -5.50e-02 4.03e-01 7.63e-01
GOBP HETEROCHROMATIN ORGANIZATION 13 5.72e-01 8.61e-01 0.16200 -1.53e-01 -5.37e-02 3.39e-01 7.38e-01
GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION 9 6.70e-01 9.00e-01 0.16200 -9.48e-02 -1.32e-01 6.22e-01 4.94e-01
GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 28 3.08e-01 7.16e-01 0.16200 -3.64e-02 -1.58e-01 7.39e-01 1.47e-01
GOBP KILLING BY HOST OF SYMBIONT CELLS 24 3.42e-01 7.40e-01 0.16200 1.23e-01 1.06e-01 2.98e-01 3.68e-01
GOBP RESPONSE TO PHENYLPROPANOID 5 8.38e-01 9.55e-01 0.16200 -1.27e-01 1.01e-01 6.22e-01 6.96e-01
GOBP THIAMINE TRANSPORT 8 7.04e-01 9.13e-01 0.16200 -1.44e-01 -7.51e-02 4.81e-01 7.13e-01
GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC 35 2.73e-01 6.85e-01 0.16200 1.53e-01 -5.28e-02 1.16e-01 5.89e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION 7 7.33e-01 9.23e-01 0.16200 -8.81e-02 -1.36e-01 6.87e-01 5.33e-01
Sensory Perception 550 1.41e-09 2.94e-07 0.16200 1.58e-01 -3.54e-02 2.19e-10 1.55e-01
GOBP REGULATION OF AUTOPHAGOSOME MATURATION 16 4.92e-01 8.26e-01 0.16200 -9.48e-02 -1.31e-01 5.12e-01 3.63e-01
GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY 12 6.26e-01 8.83e-01 0.16200 -1.61e-01 1.39e-02 3.33e-01 9.33e-01
GOBP 10 FORMYLTETRAHYDROFOLATE METABOLIC PROCESS 5 8.37e-01 9.55e-01 0.16200 -8.94e-02 1.35e-01 7.29e-01 6.01e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION 10 6.75e-01 9.03e-01 0.16200 -9.31e-03 1.62e-01 9.59e-01 3.76e-01
GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET 64 9.13e-02 4.43e-01 0.16200 -1.56e-01 4.20e-02 3.05e-02 5.61e-01
GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS 14 6.06e-01 8.76e-01 0.16200 -8.12e-02 1.40e-01 5.99e-01 3.64e-01
GOBP ANTERIOR COMMISSURE MORPHOGENESIS 7 7.52e-01 9.30e-01 0.16200 1.68e-02 1.61e-01 9.39e-01 4.61e-01
Glutathione conjugation 33 2.80e-01 6.92e-01 0.16200 1.60e-01 -2.15e-02 1.11e-01 8.31e-01
GOBP STRIATED MUSCLE ADAPTATION 56 1.41e-01 5.32e-01 0.16200 -1.16e-01 1.12e-01 1.32e-01 1.46e-01
GOMF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVATOR ACTIVITY 6 7.88e-01 9.41e-01 0.16200 -1.52e-05 1.62e-01 1.00e+00 4.93e-01
GOBP PURINE NUCLEOSIDE METABOLIC PROCESS 25 3.63e-01 7.53e-01 0.16200 -1.61e-01 -1.44e-02 1.63e-01 9.01e-01
GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING 32 3.05e-01 7.15e-01 0.16200 -1.55e-01 4.76e-02 1.30e-01 6.41e-01
GOBP REGULATION OF SPINDLE ASSEMBLY 31 3.21e-01 7.28e-01 0.16200 5.67e-02 -1.51e-01 5.85e-01 1.45e-01
GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY 12 5.87e-01 8.67e-01 0.16200 -1.14e-01 -1.15e-01 4.96e-01 4.90e-01
GOBP DIAPHRAGM DEVELOPMENT 9 6.74e-01 9.03e-01 0.16200 -8.20e-02 -1.39e-01 6.70e-01 4.69e-01
GOCC APOLIPOPROTEIN B MRNA EDITING ENZYME COMPLEX 5 8.06e-01 9.48e-01 0.16200 1.48e-01 6.41e-02 5.66e-01 8.04e-01
GOBP PEPTIDYL HISTIDINE MODIFICATION 9 6.73e-01 9.02e-01 0.16200 -8.94e-02 -1.35e-01 6.42e-01 4.84e-01
GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL 35 2.21e-01 6.38e-01 0.16200 6.77e-02 1.47e-01 4.88e-01 1.33e-01
GOBP DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS 6 8.10e-01 9.49e-01 0.16200 -1.03e-01 1.24e-01 6.61e-01 5.98e-01
Beta oxidation of octanoyl-CoA to hexanoyl-CoA 5 8.37e-01 9.55e-01 0.16200 1.39e-01 -8.23e-02 5.91e-01 7.50e-01
Lysine catabolism 12 6.06e-01 8.76e-01 0.16200 -1.57e-01 -3.72e-02 3.46e-01 8.24e-01
GOMF COMPLEMENT BINDING 23 4.39e-01 7.99e-01 0.16100 1.43e-01 -7.43e-02 2.34e-01 5.37e-01
GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE 10 6.95e-01 9.11e-01 0.16100 1.49e-01 -6.12e-02 4.13e-01 7.38e-01
GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE 46 1.37e-01 5.26e-01 0.16100 7.30e-02 1.44e-01 3.92e-01 9.11e-02
Unfolded Protein Response (UPR) 86 2.31e-02 2.43e-01 0.16100 -1.32e-01 -9.29e-02 3.44e-02 1.36e-01
GOBP CIRCADIAN REGULATION OF GENE EXPRESSION 66 6.39e-02 3.79e-01 0.16100 -1.56e-01 -3.94e-02 2.79e-02 5.80e-01
GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS 137 8.42e-03 1.38e-01 0.16100 -1.28e-01 9.80e-02 9.61e-03 4.77e-02
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX 14 5.90e-01 8.68e-01 0.16100 1.58e-01 -3.21e-02 3.06e-01 8.35e-01
GOBP MITOTIC G2 M TRANSITION CHECKPOINT 52 1.01e-01 4.65e-01 0.16100 -1.19e-01 -1.08e-01 1.36e-01 1.77e-01
Regulation of RUNX2 expression and activity 59 7.61e-02 4.13e-01 0.16100 -8.71e-02 -1.36e-01 2.47e-01 7.14e-02
GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY 10 6.98e-01 9.11e-01 0.16100 1.47e-01 -6.67e-02 4.22e-01 7.15e-01
GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 41 2.07e-01 6.22e-01 0.16100 -1.60e-01 1.76e-02 7.59e-02 8.45e-01
GOBP INOSITOL METABOLIC PROCESS 8 7.03e-01 9.12e-01 0.16100 -1.21e-01 -1.06e-01 5.53e-01 6.02e-01
GOBP RENAL VESICLE FORMATION 8 7.19e-01 9.15e-01 0.16100 1.58e-01 3.24e-02 4.39e-01 8.74e-01
GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS 24 3.80e-01 7.65e-01 0.16100 1.49e-02 1.60e-01 8.99e-01 1.74e-01
GOBP REGULATION OF NEURON DIFFERENTIATION 186 7.10e-04 2.48e-02 0.16100 -1.61e-01 3.28e-03 1.51e-04 9.39e-01
GOBP RESPONSE TO IRON II ION 6 8.08e-01 9.49e-01 0.16100 -1.41e-01 7.75e-02 5.49e-01 7.42e-01
GOBP GERM CELL PROLIFERATION 10 6.74e-01 9.03e-01 0.16100 1.61e-01 1.15e-03 3.78e-01 9.95e-01
GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT 24 3.64e-01 7.54e-01 0.16100 -4.82e-02 -1.54e-01 6.83e-01 1.92e-01
Viral Messenger RNA Synthesis 44 1.49e-01 5.43e-01 0.16100 -1.40e-01 -7.92e-02 1.08e-01 3.63e-01
GOMF RNA STEM LOOP BINDING 14 5.88e-01 8.68e-01 0.16100 -2.73e-02 1.59e-01 8.60e-01 3.04e-01
GOCC ER UBIQUITIN LIGASE COMPLEX 5 8.19e-01 9.52e-01 0.16100 9.65e-03 1.61e-01 9.70e-01 5.34e-01
GOBP FUNGIFORM PAPILLA DEVELOPMENT 6 8.12e-01 9.49e-01 0.16100 1.10e-01 -1.18e-01 6.42e-01 6.17e-01
GOMF MOLECULAR CARRIER ACTIVITY 93 1.85e-02 2.17e-01 0.16100 -7.10e-02 -1.44e-01 2.37e-01 1.61e-02
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING 28 2.94e-01 7.07e-01 0.16100 -9.36e-02 -1.31e-01 3.92e-01 2.30e-01
GOCC PROTEIN COMPLEX INVOLVED IN CELL CELL ADHESION 5 8.03e-01 9.47e-01 0.16100 -1.30e-01 -9.45e-02 6.14e-01 7.14e-01
APC/C:Cdc20 mediated degradation of Cyclin B 24 4.21e-01 7.90e-01 0.16100 6.17e-02 -1.49e-01 6.01e-01 2.08e-01
GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION 38 2.39e-01 6.55e-01 0.16100 2.83e-02 -1.58e-01 7.63e-01 9.12e-02
GOBP EMBRYONIC APPENDAGE MORPHOGENESIS 121 7.52e-03 1.28e-01 0.16100 -1.59e-01 -2.25e-02 2.48e-03 6.69e-01
DARPP-32 events 24 3.72e-01 7.60e-01 0.16100 -1.57e-01 -3.40e-02 1.83e-01 7.73e-01
GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY 68 5.81e-02 3.66e-01 0.16100 -1.53e-01 -4.81e-02 2.86e-02 4.92e-01
GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS 52 1.54e-01 5.51e-01 0.16100 -1.48e-01 6.25e-02 6.46e-02 4.35e-01
GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT 16 5.45e-01 8.51e-01 0.16100 -2.32e-02 1.59e-01 8.72e-01 2.71e-01
GOBP REGULATION OF EXCRETION 11 6.30e-01 8.85e-01 0.16100 -5.20e-02 -1.52e-01 7.65e-01 3.83e-01
GOBP POSITIVE REGULATION OF HEART GROWTH 39 2.59e-01 6.73e-01 0.16100 -1.23e-01 1.03e-01 1.84e-01 2.65e-01
GOMF SINGLE STRANDED DNA 5 3 DNA EXONUCLEASE ACTIVITY 5 8.41e-01 9.56e-01 0.16100 -1.05e-01 1.22e-01 6.85e-01 6.37e-01
Biosynthesis of E-series 18(S)-resolvins 5 8.27e-01 9.52e-01 0.16100 -1.59e-01 2.08e-02 5.37e-01 9.36e-01
GOMF POLY A BINDING 22 4.50e-01 8.06e-01 0.16100 -1.51e-01 5.40e-02 2.19e-01 6.61e-01
GOBP TRACHEA MORPHOGENESIS 11 6.83e-01 9.06e-01 0.16100 -1.24e-01 1.02e-01 4.75e-01 5.60e-01
GOMF CYCLOSPORIN A BINDING 17 5.21e-01 8.40e-01 0.16100 -1.60e-01 1.33e-02 2.53e-01 9.24e-01
GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS 40 1.80e-01 5.84e-01 0.16100 7.52e-02 1.42e-01 4.10e-01 1.21e-01
GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY 13 5.67e-01 8.59e-01 0.16100 -1.01e-01 -1.25e-01 5.29e-01 4.36e-01
GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY 29 3.47e-01 7.44e-01 0.16000 4.75e-02 -1.53e-01 6.58e-01 1.53e-01
GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY 10 6.54e-01 8.93e-01 0.16000 -6.28e-02 -1.48e-01 7.31e-01 4.19e-01
GOBP DENSE CORE GRANULE TRANSPORT 10 6.93e-01 9.09e-01 0.16000 1.55e-01 -4.30e-02 3.97e-01 8.14e-01
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY 8 7.20e-01 9.16e-01 0.16000 1.57e-01 3.42e-02 4.43e-01 8.67e-01
GOCC CHITOSOME 20 4.19e-01 7.87e-01 0.16000 1.27e-01 9.76e-02 3.25e-01 4.50e-01
GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS 63 6.74e-02 3.91e-01 0.16000 -1.41e-01 -7.61e-02 5.27e-02 2.96e-01
Extra-nuclear estrogen signaling 74 4.45e-02 3.22e-01 0.16000 -1.49e-01 -5.82e-02 2.63e-02 3.87e-01
GOBP CELL FATE DETERMINATION 42 1.78e-01 5.83e-01 0.16000 -1.56e-01 -3.71e-02 8.04e-02 6.77e-01
GOBP PLASMA MEMBRANE RAFT ORGANIZATION 12 6.50e-01 8.92e-01 0.16000 -1.49e-01 5.97e-02 3.72e-01 7.20e-01
GOBP RENAL SODIUM EXCRETION 12 6.07e-01 8.76e-01 0.16000 -4.59e-02 -1.54e-01 7.83e-01 3.57e-01
GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE 13 5.68e-01 8.59e-01 0.16000 1.27e-01 9.83e-02 4.30e-01 5.40e-01
GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION 49 1.67e-01 5.68e-01 0.16000 4.50e-02 -1.54e-01 5.86e-01 6.26e-02
Drug ADME 101 2.89e-02 2.69e-01 0.16000 1.42e-01 -7.47e-02 1.39e-02 1.95e-01
GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 7 7.65e-01 9.33e-01 0.16000 1.15e-02 -1.60e-01 9.58e-01 4.64e-01
GOMF BETA GALACTOSIDASE ACTIVITY 5 8.18e-01 9.52e-01 0.16000 -2.09e-02 -1.59e-01 9.35e-01 5.39e-01
GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT 11 6.48e-01 8.91e-01 0.16000 7.27e-03 1.60e-01 9.67e-01 3.58e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 19 4.80e-01 8.21e-01 0.16000 -5.03e-03 1.60e-01 9.70e-01 2.27e-01
GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY 9 7.07e-01 9.13e-01 0.16000 -8.27e-03 1.60e-01 9.66e-01 4.06e-01
GOCC NUCLEOID 43 1.92e-01 6.00e-01 0.16000 8.90e-03 -1.60e-01 9.20e-01 6.98e-02
GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR 41 1.70e-01 5.71e-01 0.16000 -1.30e-01 -9.29e-02 1.49e-01 3.03e-01
GOBP GENERAL ADAPTATION SYNDROME BEHAVIORAL PROCESS 5 8.40e-01 9.56e-01 0.16000 -8.15e-02 1.38e-01 7.52e-01 5.94e-01
GOBP INTEGRATED STRESS RESPONSE SIGNALING 48 1.68e-01 5.69e-01 0.16000 3.00e-02 -1.57e-01 7.20e-01 5.95e-02
GOBP GLUCAN METABOLIC PROCESS 81 5.24e-02 3.47e-01 0.16000 -1.54e-01 4.36e-02 1.66e-02 4.97e-01
Neurotoxicity of clostridium toxins 10 6.79e-01 9.04e-01 0.16000 -1.60e-01 4.34e-03 3.81e-01 9.81e-01
E2F mediated regulation of DNA replication 20 4.37e-01 7.97e-01 0.16000 -1.53e-01 -4.61e-02 2.36e-01 7.21e-01
Signaling by FGFR1 51 1.55e-01 5.51e-01 0.16000 -1.55e-01 3.94e-02 5.56e-02 6.26e-01
GOCC MICROBODY MEMBRANE 61 9.20e-02 4.44e-01 0.16000 -6.00e-03 -1.60e-01 9.35e-01 3.09e-02
GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE 15 5.98e-01 8.73e-01 0.16000 -1.08e-01 1.18e-01 4.69e-01 4.29e-01
G beta:gamma signalling through PI3Kgamma 25 4.02e-01 7.80e-01 0.16000 -1.54e-01 4.30e-02 1.83e-01 7.10e-01
CRMPs in Sema3A signaling 15 5.98e-01 8.73e-01 0.16000 -1.19e-01 1.07e-01 4.25e-01 4.74e-01
GOBP SYNAPTIC VESICLE PRIMING 19 5.11e-01 8.35e-01 0.16000 -6.62e-02 1.45e-01 6.17e-01 2.72e-01
GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 27 3.57e-01 7.49e-01 0.16000 1.59e-01 -1.09e-02 1.52e-01 9.22e-01
GOBP L ASCORBIC ACID METABOLIC PROCESS 10 6.63e-01 8.97e-01 0.16000 -1.54e-01 -4.19e-02 3.99e-01 8.18e-01
GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 18 5.40e-01 8.49e-01 0.16000 1.20e-01 -1.05e-01 3.78e-01 4.38e-01
GOBP POSITIVE REGULATION OF STEROL TRANSPORT 36 2.88e-01 7.01e-01 0.16000 -1.33e-01 8.78e-02 1.66e-01 3.62e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS 47 1.32e-01 5.19e-01 0.16000 1.30e-01 9.23e-02 1.22e-01 2.73e-01
GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS 10 7.00e-01 9.12e-01 0.16000 1.48e-01 -5.89e-02 4.16e-01 7.47e-01
GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 93 1.94e-02 2.23e-01 0.16000 -1.41e-01 -7.53e-02 1.89e-02 2.09e-01
GOBP POLYAMINE TRANSPORT 16 5.02e-01 8.31e-01 0.16000 -9.14e-02 -1.31e-01 5.27e-01 3.64e-01
GOBP OLIGOPEPTIDE TRANSPORT 19 4.39e-01 7.99e-01 0.16000 1.15e-01 1.11e-01 3.86e-01 4.03e-01
GOBP PROTEIN EXPORT FROM NUCLEUS 57 1.34e-01 5.22e-01 0.16000 6.65e-02 -1.45e-01 3.85e-01 5.81e-02
GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION 35 2.25e-01 6.43e-01 0.16000 -1.37e-01 -8.17e-02 1.60e-01 4.03e-01
GOBP MUSCLE CELL CELLULAR HOMEOSTASIS 23 3.77e-01 7.64e-01 0.16000 -7.43e-02 -1.41e-01 5.38e-01 2.41e-01
GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING 14 6.20e-01 8.80e-01 0.16000 -1.10e-01 1.15e-01 4.74e-01 4.56e-01
Signaling by FGFR4 in disease 11 6.87e-01 9.06e-01 0.15900 -1.21e-01 1.04e-01 4.87e-01 5.51e-01
Metal ion SLC transporters 23 4.39e-01 7.99e-01 0.15900 1.50e-01 -5.36e-02 2.13e-01 6.57e-01
GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 22 4.72e-01 8.15e-01 0.15900 -1.02e-01 1.22e-01 4.06e-01 3.21e-01
GOBP MITOTIC RECOMBINATION 25 3.65e-01 7.55e-01 0.15900 -1.57e-01 -3.00e-02 1.75e-01 7.95e-01
GOBP CELLULAR RESPONSE TO COCAINE 10 6.86e-01 9.06e-01 0.15900 -1.55e-02 1.59e-01 9.32e-01 3.85e-01
GOBP ERBB4 SIGNALING PATHWAY 10 7.00e-01 9.12e-01 0.15900 1.50e-01 -5.50e-02 4.13e-01 7.63e-01
GOMF POLY A RNA POLYMERASE ACTIVITY 11 6.61e-01 8.97e-01 0.15900 -1.58e-01 1.71e-02 3.63e-01 9.22e-01
GOBP REGULATION OF FEVER GENERATION 9 7.35e-01 9.23e-01 0.15900 1.25e-01 -9.93e-02 5.17e-01 6.06e-01
GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS 68 6.32e-02 3.79e-01 0.15900 -1.55e-01 -3.81e-02 2.74e-02 5.87e-01
IGF1R signaling cascade 51 1.65e-01 5.65e-01 0.15900 -1.48e-01 5.99e-02 6.83e-02 4.59e-01
Recycling of bile acids and salts 18 5.14e-01 8.36e-01 0.15900 -2.82e-02 1.57e-01 8.36e-01 2.50e-01
GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 78 6.66e-02 3.90e-01 0.15900 -7.33e-02 1.41e-01 2.63e-01 3.09e-02
Synthesis of PI 5 8.44e-01 9.57e-01 0.15900 -1.13e-01 1.12e-01 6.62e-01 6.63e-01
RA biosynthesis pathway 22 4.67e-01 8.14e-01 0.15900 7.83e-02 -1.39e-01 5.25e-01 2.61e-01
P2Y receptors 9 6.85e-01 9.06e-01 0.15900 6.91e-02 1.43e-01 7.20e-01 4.56e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY 34 2.79e-01 6.92e-01 0.15900 1.58e-01 -1.63e-02 1.10e-01 8.69e-01
GOCC INTEGRIN COMPLEX 30 3.43e-01 7.41e-01 0.15900 -1.50e-01 5.27e-02 1.55e-01 6.18e-01
GOCC MITOTIC SPINDLE MICROTUBULE 13 6.40e-01 8.88e-01 0.15900 8.78e-02 -1.33e-01 5.83e-01 4.08e-01
GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION 17 4.84e-01 8.23e-01 0.15900 -1.32e-01 -8.88e-02 3.46e-01 5.26e-01
GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION 21 4.68e-01 8.14e-01 0.15900 -1.53e-01 4.18e-02 2.23e-01 7.40e-01
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY 23 4.12e-01 7.84e-01 0.15900 -3.23e-03 -1.59e-01 9.79e-01 1.87e-01
GOBP LIPID EXPORT FROM CELL 50 1.37e-01 5.27e-01 0.15900 -1.57e-01 -2.42e-02 5.45e-02 7.67e-01
GOBP LINOLEIC ACID METABOLIC PROCESS 19 4.71e-01 8.15e-01 0.15900 -2.20e-02 -1.57e-01 8.68e-01 2.35e-01
GOBP CARTILAGE DEVELOPMENT 200 9.35e-04 3.09e-02 0.15900 -1.46e-01 6.23e-02 3.61e-04 1.29e-01
GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 117 1.77e-02 2.11e-01 0.15900 -1.40e-01 7.50e-02 8.82e-03 1.61e-01
GOBP RESPONSE TO VITAMIN 86 2.52e-02 2.54e-01 0.15900 -1.13e-01 -1.12e-01 7.07e-02 7.24e-02
GOCC CILIARY BASAL BODY 162 1.61e-03 4.65e-02 0.15900 -1.57e-01 -2.76e-02 5.83e-04 5.45e-01
Glycogen synthesis 13 5.77e-01 8.64e-01 0.15900 -1.37e-01 -8.05e-02 3.92e-01 6.15e-01
GOBP INSEMINATION 13 6.25e-01 8.83e-01 0.15900 -1.53e-01 4.15e-02 3.38e-01 7.96e-01
GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL 12 5.98e-01 8.73e-01 0.15900 -1.15e-01 -1.10e-01 4.91e-01 5.10e-01
GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY 46 1.96e-01 6.07e-01 0.15900 -1.49e-01 5.37e-02 7.94e-02 5.28e-01
Sensory perception of sweet, bitter, and umami (glutamate) taste 41 1.74e-01 5.78e-01 0.15900 1.01e-01 1.23e-01 2.65e-01 1.73e-01
Degradation of AXIN 42 1.90e-01 5.96e-01 0.15900 -2.29e-02 -1.57e-01 7.97e-01 7.80e-02
GOCC SUMO LIGASE COMPLEX 13 5.73e-01 8.62e-01 0.15900 -1.17e-01 -1.07e-01 4.65e-01 5.03e-01
GOBP SECRETION BY TISSUE 46 1.42e-01 5.33e-01 0.15900 1.30e-01 9.15e-02 1.28e-01 2.83e-01
GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS 13 5.90e-01 8.69e-01 0.15900 -4.10e-02 -1.53e-01 7.98e-01 3.38e-01
Defective ST3GAL3 causes MCT12 and EIEE15 8 7.62e-01 9.32e-01 0.15900 -9.77e-02 1.25e-01 6.32e-01 5.40e-01
Wax and plasmalogen biosynthesis 5 8.37e-01 9.55e-01 0.15900 5.10e-02 -1.50e-01 8.43e-01 5.60e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 50 1.37e-01 5.26e-01 0.15900 -1.56e-01 -2.81e-02 5.59e-02 7.31e-01
GOCC NUCLEAR OUTER MEMBRANE 28 3.63e-01 7.53e-01 0.15900 -3.75e-02 1.54e-01 7.31e-01 1.58e-01
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 31 3.45e-01 7.42e-01 0.15900 -1.38e-01 7.90e-02 1.85e-01 4.46e-01
GOMF TASTE RECEPTOR ACTIVITY 30 3.36e-01 7.36e-01 0.15900 -3.50e-02 1.55e-01 7.40e-01 1.42e-01
GOBP SPERM EGG RECOGNITION 51 1.48e-01 5.42e-01 0.15900 1.58e-01 -1.24e-02 5.07e-02 8.78e-01
GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE 22 3.96e-01 7.75e-01 0.15900 7.81e-02 1.38e-01 5.26e-01 2.62e-01
GOBP POSITIVE REGULATION OF CELL SIZE 10 7.13e-01 9.14e-01 0.15900 1.24e-01 -9.90e-02 4.97e-01 5.88e-01
GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER 14 6.19e-01 8.80e-01 0.15900 -1.37e-01 8.02e-02 3.75e-01 6.03e-01
GOBP ANTIBACTERIAL PEPTIDE PRODUCTION 10 6.85e-01 9.06e-01 0.15900 6.01e-03 -1.58e-01 9.74e-01 3.85e-01
GOBP MEDIUM CHAIN FATTY ACID BIOSYNTHETIC PROCESS 6 8.14e-01 9.50e-01 0.15900 1.38e-01 -7.82e-02 5.58e-01 7.40e-01
G beta:gamma signalling through PLC beta 20 4.74e-01 8.17e-01 0.15900 -1.58e-01 1.50e-02 2.22e-01 9.08e-01
GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE 14 6.23e-01 8.82e-01 0.15900 1.22e-01 -1.01e-01 4.28e-01 5.14e-01
GOBP FEEDING BEHAVIOR 104 2.02e-02 2.28e-01 0.15900 -1.58e-01 9.54e-03 5.30e-03 8.66e-01
GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY 57 1.19e-01 4.95e-01 0.15800 -1.58e-01 1.36e-02 3.92e-02 8.59e-01
GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS 62 9.47e-02 4.50e-01 0.15800 7.16e-04 -1.58e-01 9.92e-01 3.10e-02
GOBP ECTODERMAL PLACODE DEVELOPMENT 13 6.32e-01 8.86e-01 0.15800 5.40e-02 -1.49e-01 7.36e-01 3.53e-01
GOBP CARDIAC MUSCLE CELL PROLIFERATION 58 1.41e-01 5.32e-01 0.15800 -1.29e-01 9.13e-02 8.83e-02 2.29e-01
GOMF GLUTAMATE RECEPTOR BINDING 44 2.24e-01 6.42e-01 0.15800 -8.60e-02 1.33e-01 3.24e-01 1.27e-01
GOBP REGULATION OF NEUROBLAST PROLIFERATION 54 1.38e-01 5.28e-01 0.15800 -1.56e-01 2.40e-02 4.67e-02 7.60e-01
GOBP B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE 6 7.85e-01 9.41e-01 0.15800 1.53e-01 4.07e-02 5.17e-01 8.63e-01
Heme signaling 45 2.12e-01 6.28e-01 0.15800 -1.42e-01 6.91e-02 9.85e-02 4.22e-01
NRAGE signals death through JNK 53 1.54e-01 5.50e-01 0.15800 -4.98e-02 1.50e-01 5.31e-01 5.85e-02
GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT 112 9.79e-03 1.51e-01 0.15800 1.43e-01 6.70e-02 8.78e-03 2.20e-01
TNFs bind their physiological receptors 25 3.76e-01 7.63e-01 0.15800 1.57e-01 2.04e-02 1.74e-01 8.60e-01
GOBP GLYCOPHAGY 11 6.84e-01 9.06e-01 0.15800 -6.96e-02 1.42e-01 6.89e-01 4.15e-01
GOBP SKIN DEVELOPMENT 312 5.47e-06 4.83e-04 0.15800 1.56e-01 2.39e-02 2.04e-06 4.68e-01
GOBP VERY LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS 13 6.21e-01 8.81e-01 0.15800 1.56e-01 -2.38e-02 3.29e-01 8.82e-01
GOMF TOLL LIKE RECEPTOR 4 BINDING 5 8.09e-01 9.49e-01 0.15800 1.16e-01 1.07e-01 6.53e-01 6.78e-01
GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY 5 8.19e-01 9.52e-01 0.15800 1.54e-01 3.60e-02 5.51e-01 8.89e-01
GOBP CENTRIOLE ASSEMBLY 46 1.73e-01 5.78e-01 0.15800 -3.31e-03 -1.58e-01 9.69e-01 6.36e-02
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS 19 4.48e-01 8.04e-01 0.15800 -1.24e-01 -9.75e-02 3.48e-01 4.62e-01
GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS 7 7.89e-01 9.42e-01 0.15800 -8.89e-02 1.31e-01 6.84e-01 5.49e-01
GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS 30 3.65e-01 7.55e-01 0.15800 -1.25e-01 9.69e-02 2.36e-01 3.58e-01
GOMF METALLOCHAPERONE ACTIVITY 12 6.54e-01 8.93e-01 0.15800 4.90e-02 -1.50e-01 7.69e-01 3.68e-01
GOBP POSITIVE REGULATION OF PYROPTOSIS 5 8.14e-01 9.50e-01 0.15800 -6.06e-02 -1.46e-01 8.14e-01 5.72e-01
GOBP CENTROSOME DUPLICATION 73 5.27e-02 3.47e-01 0.15800 -4.58e-02 -1.51e-01 4.98e-01 2.55e-02
GOBP MYELIN ASSEMBLY 24 3.90e-01 7.71e-01 0.15800 2.33e-02 1.56e-01 8.44e-01 1.85e-01
GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY 92 3.24e-02 2.81e-01 0.15800 8.99e-03 -1.58e-01 8.82e-01 8.94e-03
RUNX1 regulates estrogen receptor mediated transcription 6 7.76e-01 9.38e-01 0.15800 -1.07e-01 -1.16e-01 6.48e-01 6.23e-01
GOBP VASOCONSTRICTION 85 4.49e-02 3.23e-01 0.15800 -1.56e-01 2.31e-02 1.28e-02 7.12e-01
GOMF DNA ENDONUCLEASE ACTIVITY 39 1.92e-01 6.00e-01 0.15800 -1.10e-01 -1.13e-01 2.35e-01 2.20e-01
GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 14 6.25e-01 8.83e-01 0.15800 -1.26e-01 9.45e-02 4.13e-01 5.40e-01
RUNX3 regulates YAP1-mediated transcription 7 7.44e-01 9.26e-01 0.15800 9.40e-02 1.27e-01 6.67e-01 5.61e-01
GOCC CIS GOLGI NETWORK 54 1.05e-01 4.71e-01 0.15800 -1.34e-01 -8.39e-02 8.92e-02 2.86e-01
GOCC VESICLE TETHERING COMPLEX 65 8.53e-02 4.33e-01 0.15800 -1.58e-01 -1.27e-03 2.77e-02 9.86e-01
GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION 7 7.48e-01 9.28e-01 0.15800 -1.40e-01 -7.26e-02 5.21e-01 7.39e-01
GOBP REGULATION OF TELOMERE MAINTENANCE 100 1.86e-02 2.17e-01 0.15800 -3.96e-02 -1.53e-01 4.94e-01 8.29e-03
GOBP IRON ION TRANSMEMBRANE TRANSPORT 19 4.81e-01 8.21e-01 0.15800 -1.57e-01 -1.15e-02 2.35e-01 9.31e-01
GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY 14 5.94e-01 8.71e-01 0.15800 1.22e-02 -1.57e-01 9.37e-01 3.08e-01
GOBP REGULATION OF SULFUR METABOLIC PROCESS 13 6.17e-01 8.80e-01 0.15800 -1.57e-01 1.27e-02 3.26e-01 9.37e-01
GOBP NEGATIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION 7 7.66e-01 9.33e-01 0.15800 -1.58e-01 -5.55e-03 4.70e-01 9.80e-01
GOBP CELL FATE COMMITMENT 284 2.86e-05 2.05e-03 0.15800 -1.57e-01 9.85e-03 4.94e-06 7.75e-01
GOBP PENTOSE METABOLIC PROCESS 12 6.40e-01 8.88e-01 0.15800 1.12e-02 -1.57e-01 9.47e-01 3.45e-01
GOBP REGULATION OF T CELL EXTRAVASATION 5 8.44e-01 9.57e-01 0.15800 -8.34e-02 1.34e-01 7.47e-01 6.04e-01
GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS 23 3.79e-01 7.64e-01 0.15800 -1.16e-01 -1.07e-01 3.35e-01 3.75e-01
Acyl chain remodelling of PG 18 5.06e-01 8.32e-01 0.15800 1.58e-01 1.03e-03 2.47e-01 9.94e-01
GOBP RESPONSE TO CORTICOTROPIN RELEASING HORMONE 5 8.10e-01 9.49e-01 0.15800 1.01e-01 1.21e-01 6.95e-01 6.40e-01
GOMF N METHYLTRANSFERASE ACTIVITY 97 2.73e-02 2.62e-01 0.15800 -1.57e-01 8.87e-03 7.41e-03 8.80e-01
GOBP MECHANOSENSORY BEHAVIOR 14 5.87e-01 8.67e-01 0.15800 5.03e-03 1.57e-01 9.74e-01 3.08e-01
GOBP CELL MATRIX ADHESION 234 3.71e-04 1.54e-02 0.15800 -1.40e-01 7.25e-02 2.28e-04 5.60e-02
Export of Viral Ribonucleoproteins from Nucleus 33 2.49e-01 6.63e-01 0.15800 -1.09e-01 -1.13e-01 2.77e-01 2.59e-01
Negative feedback regulation of MAPK pathway 6 8.19e-01 9.52e-01 0.15700 -1.20e-01 1.02e-01 6.11e-01 6.65e-01
GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING 10 7.17e-01 9.15e-01 0.15700 1.07e-01 -1.15e-01 5.56e-01 5.28e-01
GOBP CELLULAR RESPONSE TO SALT STRESS 14 6.25e-01 8.83e-01 0.15700 1.32e-01 -8.55e-02 3.92e-01 5.80e-01
GOBP POSITIVE REGULATION OF THE FORCE OF HEART CONTRACTION 5 8.32e-01 9.54e-01 0.15700 1.75e-02 -1.56e-01 9.46e-01 5.45e-01
GOBP CORNEA DEVELOPMENT IN CAMERA TYPE EYE 12 6.56e-01 8.94e-01 0.15700 -1.50e-01 4.70e-02 3.68e-01 7.78e-01
GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT 8 7.19e-01 9.15e-01 0.15700 1.39e-01 7.30e-02 4.95e-01 7.21e-01
GOBP MUSCLE STRUCTURE DEVELOPMENT 693 5.16e-11 1.32e-08 0.15700 -1.51e-01 4.40e-02 1.20e-11 4.85e-02
Aquaporin-mediated transport 51 1.43e-01 5.35e-01 0.15700 1.12e-02 1.57e-01 8.90e-01 5.28e-02
GOCC INO80 COMPLEX 16 5.12e-01 8.36e-01 0.15700 -9.51e-02 -1.25e-01 5.10e-01 3.86e-01
GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA 16 5.31e-01 8.44e-01 0.15700 -3.78e-02 -1.52e-01 7.94e-01 2.91e-01
GOBP REGULATION OF LYMPHANGIOGENESIS 7 7.47e-01 9.28e-01 0.15700 1.29e-01 8.95e-02 5.54e-01 6.82e-01
GOBP PHOSPHATE ION TRANSPORT 27 3.86e-01 7.68e-01 0.15700 1.52e-01 -3.96e-02 1.72e-01 7.22e-01
GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 16 5.62e-01 8.57e-01 0.15700 2.65e-02 -1.55e-01 8.55e-01 2.84e-01
GOMF OPSONIN BINDING 18 5.37e-01 8.48e-01 0.15700 5.62e-02 -1.47e-01 6.80e-01 2.82e-01
Nucleotide Excision Repair 105 1.27e-02 1.77e-01 0.15700 -1.02e-01 -1.19e-01 7.13e-02 3.46e-02
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 34 2.42e-01 6.58e-01 0.15700 -1.20e-01 -1.01e-01 2.25e-01 3.08e-01
CDC6 association with the ORC:origin complex 8 7.16e-01 9.15e-01 0.15700 -1.08e-01 -1.14e-01 5.96e-01 5.78e-01
Basigin interactions 24 4.28e-01 7.94e-01 0.15700 1.52e-01 -3.83e-02 1.97e-01 7.45e-01
GOBP INTRACELLULAR OXYGEN HOMEOSTASIS 7 7.90e-01 9.42e-01 0.15700 1.36e-01 -7.83e-02 5.33e-01 7.20e-01
GOBP CELLULAR RESPONSE TO X RAY 11 6.31e-01 8.86e-01 0.15700 -1.12e-01 -1.10e-01 5.22e-01 5.26e-01
GOBP ENDOSOME TO LYSOSOME TRANSPORT 70 7.70e-02 4.14e-01 0.15700 -1.56e-01 1.22e-02 2.36e-02 8.60e-01
GOBP MACROMOLECULE METHYLATION 123 6.84e-03 1.21e-01 0.15700 -6.51e-02 -1.43e-01 2.12e-01 6.27e-03
GOMF NADPH BINDING 16 5.60e-01 8.57e-01 0.15700 -2.01e-02 1.56e-01 8.89e-01 2.81e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 95 2.78e-02 2.64e-01 0.15700 -1.57e-01 -8.48e-03 8.33e-03 8.86e-01
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 80 4.39e-02 3.18e-01 0.15700 -1.53e-01 -3.32e-02 1.78e-02 6.07e-01
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 24 4.18e-01 7.87e-01 0.15700 1.56e-01 -1.86e-02 1.87e-01 8.75e-01
Presynaptic function of Kainate receptors 21 4.64e-01 8.13e-01 0.15700 -1.56e-01 1.52e-02 2.16e-01 9.04e-01
GOMF GTPASE INHIBITOR ACTIVITY 12 6.50e-01 8.91e-01 0.15700 -2.58e-02 1.55e-01 8.77e-01 3.54e-01
GOMF FOLIC ACID BINDING 13 6.00e-01 8.74e-01 0.15700 3.61e-02 1.53e-01 8.22e-01 3.41e-01
TNFR1-mediated ceramide production 6 8.20e-01 9.52e-01 0.15700 1.02e-01 -1.19e-01 6.65e-01 6.14e-01
GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY 26 3.43e-01 7.40e-01 0.15700 7.98e-02 1.35e-01 4.81e-01 2.34e-01
GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 182 2.26e-03 5.90e-02 0.15700 1.39e-01 -7.27e-02 1.23e-03 9.06e-02
GOMF SHORT CHAIN FATTY ACYL COA DEHYDROGENASE ACTIVITY 5 8.12e-01 9.49e-01 0.15700 1.23e-01 9.67e-02 6.33e-01 7.08e-01
GOMF DNA N GLYCOSYLASE ACTIVITY 14 5.89e-01 8.68e-01 0.15700 1.56e-01 8.27e-03 3.11e-01 9.57e-01
GOBP POSITIVE T CELL SELECTION 44 1.61e-01 5.59e-01 0.15700 -1.24e-01 -9.56e-02 1.54e-01 2.73e-01
GOCC PHOTORECEPTOR CONNECTING CILIUM 39 2.22e-01 6.40e-01 0.15700 -2.28e-02 -1.55e-01 8.05e-01 9.39e-02
Cyclin D associated events in G1 46 1.81e-01 5.84e-01 0.15700 9.76e-04 -1.57e-01 9.91e-01 6.60e-02
G1 Phase 46 1.81e-01 5.84e-01 0.15700 9.76e-04 -1.57e-01 9.91e-01 6.60e-02
GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION 12 6.72e-01 9.01e-01 0.15700 9.17e-02 -1.27e-01 5.82e-01 4.46e-01
GOBP CELLULAR EXTRAVASATION 72 8.86e-02 4.37e-01 0.15700 -7.00e-02 1.40e-01 3.05e-01 3.99e-02
GOBP FIBROBLAST ACTIVATION 15 6.09e-01 8.77e-01 0.15700 -1.24e-01 9.55e-02 4.05e-01 5.22e-01
GOBP GLIAL CELL PROLIFERATION 55 1.55e-01 5.51e-01 0.15700 -1.43e-01 6.39e-02 6.68e-02 4.12e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY 12 6.32e-01 8.86e-01 0.15700 -1.90e-02 -1.55e-01 9.09e-01 3.51e-01
GOCC PROTEIN DNA COMPLEX 1362 5.62e-23 1.38e-19 0.15600 -1.47e-01 -5.28e-02 7.05e-20 1.09e-03
GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 26 4.01e-01 7.78e-01 0.15600 1.52e-01 -3.66e-02 1.79e-01 7.47e-01
Activated NTRK2 signals through CDK5 6 7.98e-01 9.45e-01 0.15600 5.75e-03 1.56e-01 9.81e-01 5.07e-01
GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 101 3.52e-02 2.90e-01 0.15600 -1.33e-01 8.23e-02 2.09e-02 1.53e-01
GOBP COPPER ION TRANSPORT 15 5.67e-01 8.59e-01 0.15600 1.22e-02 1.56e-01 9.35e-01 2.96e-01
GOCC PLATELET DENSE GRANULE LUMEN 14 6.30e-01 8.85e-01 0.15600 -9.27e-02 1.26e-01 5.48e-01 4.15e-01
GOBP GOLGI TO LYSOSOME TRANSPORT 12 6.15e-01 8.80e-01 0.15600 -1.42e-01 -6.54e-02 3.94e-01 6.95e-01
GOBP REGULATION OF TRANSLATIONAL INITIATION 77 6.89e-02 3.95e-01 0.15600 4.29e-02 -1.50e-01 5.15e-01 2.26e-02
mRNA Splicing - Major Pathway 189 5.25e-04 1.98e-02 0.15600 -6.09e-02 -1.44e-01 1.49e-01 6.41e-04
Signaling by ERBB4 57 9.62e-02 4.52e-01 0.15600 -8.68e-02 -1.30e-01 2.57e-01 8.97e-02
Transport of nucleotide sugars 8 7.19e-01 9.16e-01 0.15600 8.93e-02 1.28e-01 6.62e-01 5.30e-01
GOBP MULTICELLULAR ORGANISMAL MOVEMENT 59 1.21e-01 4.99e-01 0.15600 -2.29e-02 1.55e-01 7.61e-01 4.00e-02
GOBP REGULATION OF MESONEPHROS DEVELOPMENT 5 8.37e-01 9.55e-01 0.15600 2.84e-02 -1.54e-01 9.13e-01 5.52e-01
GOBP METALLO SULFUR CLUSTER ASSEMBLY 26 3.75e-01 7.62e-01 0.15600 -1.18e-02 -1.56e-01 9.17e-01 1.69e-01
GOBP EPITHELIAL MESENCHYMAL CELL SIGNALING 5 8.48e-01 9.58e-01 0.15600 1.23e-01 -9.60e-02 6.33e-01 7.10e-01
GOBP GLOMERULUS VASCULATURE MORPHOGENESIS 6 7.95e-01 9.44e-01 0.15600 -1.55e-01 -2.00e-02 5.11e-01 9.32e-01
GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM 50 1.55e-01 5.51e-01 0.15600 -1.56e-01 -6.18e-03 5.64e-02 9.40e-01
GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE 16 5.22e-01 8.41e-01 0.15600 -1.38e-01 -7.27e-02 3.39e-01 6.15e-01
GOBP LUNG LOBE DEVELOPMENT 7 7.57e-01 9.31e-01 0.15600 -1.48e-01 -5.04e-02 4.99e-01 8.17e-01
GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION 69 6.32e-02 3.78e-01 0.15600 -6.07e-02 -1.44e-01 3.83e-01 3.90e-02
GOBP TRNA SURVEILLANCE 8 7.36e-01 9.23e-01 0.15600 -2.32e-02 -1.54e-01 9.10e-01 4.50e-01
GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION 13 6.20e-01 8.80e-01 0.15600 -1.56e-01 2.82e-03 3.30e-01 9.86e-01
GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA 34 2.49e-01 6.63e-01 0.15600 -1.32e-01 -8.35e-02 1.84e-01 3.99e-01
GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS 14 5.61e-01 8.57e-01 0.15600 1.19e-01 1.01e-01 4.40e-01 5.14e-01
GOMF TYPE 5 METABOTROPIC GLUTAMATE RECEPTOR BINDING 6 8.22e-01 9.52e-01 0.15600 -1.20e-01 9.93e-02 6.10e-01 6.74e-01
GOBP NERVE DEVELOPMENT 95 3.04e-02 2.73e-01 0.15600 -1.56e-01 9.82e-04 8.63e-03 9.87e-01
GOBP POSITIVE REGULATION OF NEURON MIGRATION 16 5.83e-01 8.66e-01 0.15600 -1.43e-01 6.22e-02 3.23e-01 6.67e-01
GOBP CELL CELL JUNCTION MAINTENANCE 18 5.19e-01 8.39e-01 0.15600 -7.10e-03 1.56e-01 9.58e-01 2.53e-01
GPVI-mediated activation cascade 34 2.54e-01 6.70e-01 0.15600 -6.88e-02 -1.40e-01 4.88e-01 1.59e-01
Thrombin signalling through proteinase activated receptors (PARs) 32 3.45e-01 7.42e-01 0.15600 -1.38e-01 7.22e-02 1.77e-01 4.79e-01
GOBP COPULATION 19 5.39e-01 8.49e-01 0.15600 -1.17e-01 1.03e-01 3.78e-01 4.37e-01
GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS 100 3.30e-02 2.84e-01 0.15600 -1.48e-01 4.92e-02 1.07e-02 3.95e-01
Signaling by Insulin receptor 79 7.07e-02 3.99e-01 0.15600 -1.42e-01 6.27e-02 2.86e-02 3.35e-01
Defective EXT1 causes exostoses 1, TRPS2 and CHDS 12 6.30e-01 8.85e-01 0.15600 1.52e-01 3.18e-02 3.61e-01 8.49e-01
Defective EXT2 causes exostoses 2 12 6.30e-01 8.85e-01 0.15600 1.52e-01 3.18e-02 3.61e-01 8.49e-01
Cargo concentration in the ER 32 2.85e-01 6.97e-01 0.15600 -4.65e-02 -1.48e-01 6.49e-01 1.46e-01
GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER 37 2.96e-01 7.08e-01 0.15600 -8.25e-02 1.32e-01 3.85e-01 1.65e-01
NEP/NS2 Interacts with the Cellular Export Machinery 32 2.71e-01 6.85e-01 0.15600 -1.27e-01 -8.97e-02 2.13e-01 3.80e-01
GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION 89 2.61e-02 2.56e-01 0.15600 -1.09e-01 -1.11e-01 7.43e-02 7.14e-02
IRF3-mediated induction of type I IFN 13 6.52e-01 8.93e-01 0.15600 -8.35e-02 1.31e-01 6.02e-01 4.13e-01
GOCC U6 SNRNP 8 7.31e-01 9.22e-01 0.15600 -4.37e-02 -1.49e-01 8.31e-01 4.65e-01
GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY 5 8.23e-01 9.52e-01 0.15600 -4.13e-02 -1.50e-01 8.73e-01 5.61e-01
GOMF DEUBIQUITINASE ACTIVATOR ACTIVITY 7 7.60e-01 9.32e-01 0.15600 -4.49e-02 -1.49e-01 8.37e-01 4.95e-01
GOMF GDP DISSOCIATION INHIBITOR ACTIVITY 15 5.42e-01 8.50e-01 0.15500 1.28e-01 8.88e-02 3.92e-01 5.51e-01
Mitochondrial protein degradation 86 5.60e-02 3.60e-01 0.15500 5.97e-02 -1.43e-01 3.39e-01 2.15e-02
GOCC ALPHA KETOACID DEHYDROGENASE COMPLEX 14 6.36e-01 8.86e-01 0.15500 -1.08e-01 1.12e-01 4.84e-01 4.70e-01
GOBP PROLINE TRANSPORT 11 6.42e-01 8.89e-01 0.15500 7.50e-02 1.36e-01 6.67e-01 4.35e-01
GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE 20 5.13e-01 8.36e-01 0.15500 1.41e-01 -6.56e-02 2.76e-01 6.12e-01
GOBP REGULATION OF TELOMERASE ACTIVITY 43 2.12e-01 6.28e-01 0.15500 9.28e-03 -1.55e-01 9.16e-01 7.86e-02
GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 115 9.43e-03 1.48e-01 0.15500 -1.26e-01 -9.11e-02 1.98e-02 9.15e-02
GOCC REPLISOME 22 4.59e-01 8.10e-01 0.15500 -1.54e-01 2.33e-02 2.13e-01 8.50e-01
GOBP FATTY ACID ELONGATION SATURATED FATTY ACID 8 7.45e-01 9.27e-01 0.15500 1.55e-01 2.72e-03 4.47e-01 9.89e-01
GOMF INITIATOR METHIONYL AMINOPEPTIDASE ACTIVITY 5 8.29e-01 9.53e-01 0.15500 -1.54e-01 -1.63e-02 5.50e-01 9.50e-01
GOBP HEAD DEVELOPMENT 734 2.70e-12 8.48e-10 0.15500 -1.54e-01 -1.57e-02 1.02e-12 4.69e-01
GOBP POLYSACCHARIDE METABOLIC PROCESS 104 2.75e-02 2.63e-01 0.15500 -1.51e-01 3.57e-02 7.77e-03 5.30e-01
GOMF EXTRACELLULARLY ATP GATED MONOATOMIC CATION CHANNEL ACTIVITY 7 7.97e-01 9.44e-01 0.15500 -9.80e-02 1.20e-01 6.53e-01 5.81e-01
GOBP ANTEROGRADE DENDRITIC TRANSPORT 9 7.47e-01 9.28e-01 0.15500 1.23e-01 -9.43e-02 5.22e-01 6.24e-01
Insulin receptor recycling 28 3.82e-01 7.66e-01 0.15500 -1.50e-01 4.15e-02 1.71e-01 7.04e-01
GOMF MONOOXYGENASE ACTIVITY 104 2.45e-02 2.51e-01 0.15500 1.55e-01 -1.37e-02 6.48e-03 8.09e-01
GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION 26 3.62e-01 7.53e-01 0.15500 -4.76e-02 -1.48e-01 6.74e-01 1.93e-01
GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT 7 7.71e-01 9.36e-01 0.15500 1.55e-01 1.24e-02 4.79e-01 9.55e-01
GOBP CELLULAR RESPONSE TO CHOLESTEROL 20 5.25e-01 8.42e-01 0.15500 -1.09e-01 1.10e-01 3.99e-01 3.93e-01
GOMF HELICASE ACTIVITY 149 7.93e-03 1.33e-01 0.15500 -1.31e-01 8.22e-02 5.62e-03 8.33e-02
GOMF MAP KINASE KINASE ACTIVITY 15 5.92e-01 8.70e-01 0.15500 -1.52e-01 2.82e-02 3.07e-01 8.50e-01
GOBP CELLULAR RESPONSE TO OXYGEN LEVELS 161 1.48e-03 4.36e-02 0.15500 -1.17e-01 -1.02e-01 1.07e-02 2.54e-02
GOMF IMMUNE RECEPTOR ACTIVITY 134 9.15e-03 1.46e-01 0.15500 1.53e-01 -2.31e-02 2.20e-03 6.44e-01
GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY 35 2.68e-01 6.82e-01 0.15500 2.20e-02 1.53e-01 8.22e-01 1.16e-01
Transport of Ribonucleoproteins into the Host Nucleus 32 2.73e-01 6.85e-01 0.15500 -1.22e-01 -9.60e-02 2.34e-01 3.47e-01
GOBP NEGATIVE REGULATION OF PROTEIN MATURATION 26 3.54e-01 7.47e-01 0.15500 1.37e-01 7.19e-02 2.26e-01 5.26e-01
GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 40 1.96e-01 6.08e-01 0.15500 1.11e-01 1.08e-01 2.24e-01 2.38e-01
IKK complex recruitment mediated by RIP1 22 4.83e-01 8.22e-01 0.15500 6.68e-02 -1.40e-01 5.88e-01 2.57e-01
GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS 8 7.48e-01 9.28e-01 0.15500 -1.55e-01 1.39e-03 4.48e-01 9.95e-01
GOBP PRENYLATION 11 6.55e-01 8.93e-01 0.15500 -3.93e-02 -1.50e-01 8.21e-01 3.90e-01
GOBP CALCIUM ACTIVATED PHOSPHOLIPID SCRAMBLING 5 8.32e-01 9.54e-01 0.15500 -6.62e-03 -1.55e-01 9.80e-01 5.49e-01
GOBP RESPONSE TO SELENIUM ION 9 7.17e-01 9.15e-01 0.15500 -1.16e-02 -1.54e-01 9.52e-01 4.23e-01
GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE 25 3.69e-01 7.58e-01 0.15500 -7.18e-02 -1.37e-01 5.35e-01 2.36e-01
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 67 1.07e-01 4.74e-01 0.15500 -1.45e-01 5.47e-02 4.07e-02 4.38e-01
MITF-M-dependent gene expression 106 2.16e-02 2.34e-01 0.15500 -1.55e-01 -7.93e-04 5.97e-03 9.89e-01
GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION 13 5.92e-01 8.70e-01 0.15500 -1.27e-01 -8.83e-02 4.29e-01 5.81e-01
GOBP SECONDARY METABOLITE BIOSYNTHETIC PROCESS 24 4.14e-01 7.85e-01 0.15500 1.54e-01 7.92e-03 1.91e-01 9.46e-01
GOBP PROTEIN AUTO ADP RIBOSYLATION 11 6.93e-01 9.09e-01 0.15400 -5.64e-02 1.44e-01 7.46e-01 4.09e-01
Diseases associated with the TLR signaling cascade 29 3.80e-01 7.65e-01 0.15400 1.44e-01 -5.51e-02 1.79e-01 6.07e-01
Diseases of Immune System 29 3.80e-01 7.65e-01 0.15400 1.44e-01 -5.51e-02 1.79e-01 6.07e-01
GOBP NADP METABOLIC PROCESS 42 2.57e-01 6.71e-01 0.15400 -8.32e-02 1.30e-01 3.51e-01 1.44e-01
GOMF SEQUENCE SPECIFIC MRNA BINDING 12 6.47e-01 8.91e-01 0.15400 -1.54e-01 -6.92e-04 3.54e-01 9.97e-01
GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS 15 5.54e-01 8.54e-01 0.15400 -6.36e-02 -1.41e-01 6.70e-01 3.46e-01
GOBP BERGMANN GLIAL CELL DIFFERENTIATION 11 6.95e-01 9.11e-01 0.15400 -1.41e-01 6.34e-02 4.19e-01 7.16e-01
GOMF LIGAND GATED MONOATOMIC ANION CHANNEL ACTIVITY 43 2.02e-01 6.16e-01 0.15400 -1.53e-01 -1.95e-02 8.23e-02 8.25e-01
GOBP HOMOLOGOUS RECOMBINATION 66 7.01e-02 3.97e-01 0.15400 -9.66e-02 -1.20e-01 1.75e-01 9.07e-02
GOBP BEHAVIORAL RESPONSE TO COCAINE 16 5.39e-01 8.49e-01 0.15400 -1.47e-01 -4.58e-02 3.07e-01 7.51e-01
GOBP CELLULAR RESPONSE TO LUTEINIZING HORMONE STIMULUS 5 8.31e-01 9.54e-01 0.15400 -1.70e-02 -1.53e-01 9.48e-01 5.53e-01
O-linked glycosylation 110 1.21e-02 1.74e-01 0.15400 1.23e-01 9.32e-02 2.59e-02 9.12e-02
GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL 5 8.52e-01 9.59e-01 0.15400 1.11e-01 -1.07e-01 6.68e-01 6.77e-01
GOMF ESTROGEN 2 HYDROXYLASE ACTIVITY 5 8.29e-01 9.53e-01 0.15400 2.48e-02 1.52e-01 9.24e-01 5.56e-01
GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY 10 7.24e-01 9.18e-01 0.15400 -8.15e-02 1.31e-01 6.55e-01 4.73e-01
GOCC 90S PRERIBOSOME 27 3.78e-01 7.64e-01 0.15400 -1.54e-01 2.29e-03 1.65e-01 9.84e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION 14 5.88e-01 8.68e-01 0.15400 3.28e-02 1.51e-01 8.32e-01 3.29e-01
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 47 2.24e-01 6.42e-01 0.15400 -1.01e-01 1.17e-01 2.33e-01 1.66e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 13 6.18e-01 8.80e-01 0.15400 1.76e-02 1.53e-01 9.12e-01 3.39e-01
GOBP DEVELOPMENTAL INDUCTION 32 3.59e-01 7.51e-01 0.15400 -1.24e-01 9.10e-02 2.23e-01 3.73e-01
GOBP VESICLE TRANSPORT ALONG MICROTUBULE 46 1.65e-01 5.65e-01 0.15400 -6.43e-02 -1.40e-01 4.51e-01 1.01e-01
GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 45 2.18e-01 6.36e-01 0.15400 4.03e-02 -1.49e-01 6.40e-01 8.46e-02
Late endosomal microautophagy 33 3.49e-01 7.45e-01 0.15400 1.21e-01 -9.46e-02 2.27e-01 3.47e-01
Vitamin D (calciferol) metabolism 12 6.18e-01 8.80e-01 0.15400 -1.19e-01 -9.78e-02 4.76e-01 5.57e-01
GOMF MANNOSYLTRANSFERASE ACTIVITY 24 4.57e-01 8.09e-01 0.15400 -1.39e-01 6.71e-02 2.40e-01 5.69e-01
GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY 12 6.36e-01 8.86e-01 0.15400 -3.24e-02 -1.50e-01 8.46e-01 3.67e-01
Vasopressin regulates renal water homeostasis via Aquaporins 42 2.62e-01 6.77e-01 0.15400 -9.39e-02 1.22e-01 2.93e-01 1.71e-01
GOBP CAP DEPENDENT TRANSLATIONAL INITIATION 7 8.00e-01 9.46e-01 0.15400 9.50e-02 -1.21e-01 6.63e-01 5.79e-01
GOMF GDP PHOSPHATASE ACTIVITY 10 7.16e-01 9.15e-01 0.15400 1.45e-01 -5.03e-02 4.26e-01 7.83e-01
RNA polymerase II transcribes snRNA genes 74 5.42e-02 3.54e-01 0.15400 -7.26e-02 -1.36e-01 2.80e-01 4.37e-02
GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY 8 7.29e-01 9.21e-01 0.15400 -1.35e-01 -7.41e-02 5.09e-01 7.17e-01
GOBP CARDIAC ATRIUM DEVELOPMENT 37 2.46e-01 6.60e-01 0.15400 -1.49e-01 -3.82e-02 1.17e-01 6.87e-01
Synthesis of bile acids and bile salts via 27-hydroxycholesterol 14 5.85e-01 8.67e-01 0.15400 4.55e-02 1.47e-01 7.68e-01 3.41e-01
MITF-M-regulated melanocyte development 155 2.66e-03 6.71e-02 0.15400 -1.46e-01 -4.91e-02 1.74e-03 2.91e-01
GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS 29 3.98e-01 7.76e-01 0.15400 1.18e-01 -9.81e-02 2.70e-01 3.60e-01
GOBP EPITHELIAL CELL MATURATION 27 3.88e-01 7.69e-01 0.15400 -1.48e-02 1.53e-01 8.94e-01 1.69e-01
GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 11 7.01e-01 9.12e-01 0.15400 -1.33e-01 7.71e-02 4.45e-01 6.58e-01
GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY 32 2.78e-01 6.91e-01 0.15400 -1.02e-01 -1.15e-01 3.20e-01 2.59e-01
GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY 7 7.83e-01 9.40e-01 0.15400 1.53e-01 -1.67e-02 4.84e-01 9.39e-01
GOCC SPLICEOSOMAL COMPLEX 186 7.31e-04 2.54e-02 0.15400 -6.47e-02 -1.39e-01 1.28e-01 1.04e-03
GOBP COPII COATED VESICLE BUDDING 43 1.90e-01 5.97e-01 0.15400 -1.44e-01 -5.40e-02 1.03e-01 5.40e-01
Mitochondrial protein import 58 1.18e-01 4.92e-01 0.15400 -2.03e-02 -1.52e-01 7.90e-01 4.48e-02
Asymmetric localization of PCP proteins 51 1.34e-01 5.21e-01 0.15400 -7.60e-02 -1.34e-01 3.48e-01 9.89e-02
GOCC BRUSH BORDER 103 1.67e-02 2.07e-01 0.15400 1.24e-01 9.09e-02 2.99e-02 1.11e-01
GOBP BASE EXCISION REPAIR 42 2.55e-01 6.70e-01 0.15400 -6.59e-02 1.39e-01 4.60e-01 1.20e-01
GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS 12 6.79e-01 9.04e-01 0.15400 -7.35e-02 1.35e-01 6.59e-01 4.19e-01
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 12 6.20e-01 8.81e-01 0.15400 -8.77e-02 -1.26e-01 5.99e-01 4.50e-01
GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS 289 1.19e-05 9.68e-04 0.15400 -8.56e-02 -1.27e-01 1.23e-02 1.93e-04
GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY 17 5.09e-01 8.34e-01 0.15300 -8.84e-02 -1.25e-01 5.28e-01 3.70e-01
GOBP AGGRESOME ASSEMBLY 5 8.21e-01 9.52e-01 0.15300 7.90e-02 1.32e-01 7.60e-01 6.10e-01
GOMF INTERLEUKIN 12 RECEPTOR BINDING 5 8.36e-01 9.55e-01 0.15300 1.53e-01 -1.03e-03 5.52e-01 9.97e-01
GOBP EATING BEHAVIOR 39 2.88e-01 7.01e-01 0.15300 -1.28e-01 8.44e-02 1.66e-01 3.62e-01
GOBP REGULATION OF BEHAVIOR 73 9.82e-02 4.58e-01 0.15300 -1.27e-01 8.55e-02 5.99e-02 2.07e-01
GOBP REGULATION OF ISOTYPE SWITCHING 36 2.38e-01 6.55e-01 0.15300 -1.02e-01 -1.15e-01 2.90e-01 2.34e-01
RUNX2 regulates osteoblast differentiation 22 4.99e-01 8.30e-01 0.15300 -1.17e-01 9.86e-02 3.40e-01 4.23e-01
GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING 10 7.29e-01 9.21e-01 0.15300 -1.08e-01 1.09e-01 5.55e-01 5.50e-01
GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 40 2.03e-01 6.18e-01 0.15300 -1.16e-01 -1.00e-01 2.05e-01 2.72e-01
GOBP REGULATION OF DNA STRAND ELONGATION 17 5.09e-01 8.34e-01 0.15300 -1.25e-01 -8.88e-02 3.72e-01 5.26e-01
Nectin/Necl trans heterodimerization 7 8.02e-01 9.46e-01 0.15300 1.08e-01 -1.08e-01 6.19e-01 6.20e-01
GOMF PROTEIN PHOSPHATASE 2B BINDING 6 7.93e-01 9.43e-01 0.15300 -5.70e-02 -1.42e-01 8.09e-01 5.46e-01
GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION 16 5.99e-01 8.74e-01 0.15300 -1.31e-01 7.90e-02 3.63e-01 5.84e-01
GOBP RECOGNITION OF APOPTOTIC CELL 7 7.69e-01 9.35e-01 0.15300 1.49e-01 3.39e-02 4.93e-01 8.77e-01
GOMF CYCLIC NUCLEOTIDE ACTIVATED MONOATOMIC ION CHANNEL ACTIVITY 10 6.77e-01 9.04e-01 0.15300 1.37e-01 6.90e-02 4.54e-01 7.06e-01
Interleukin-20 family signaling 24 3.84e-01 7.68e-01 0.15300 1.03e-01 1.13e-01 3.82e-01 3.36e-01
G alpha (12/13) signalling events 74 9.62e-02 4.52e-01 0.15300 -1.25e-01 8.85e-02 6.28e-02 1.88e-01
GOBP IMP BIOSYNTHETIC PROCESS 10 6.79e-01 9.04e-01 0.15300 1.42e-01 5.83e-02 4.38e-01 7.50e-01
GOCC ATG12 ATG5 ATG16 COMPLEX 6 8.06e-01 9.48e-01 0.15300 1.53e-01 4.73e-03 5.16e-01 9.84e-01
GOMF QUATERNARY AMMONIUM GROUP BINDING 37 3.08e-01 7.16e-01 0.15300 -1.31e-01 7.91e-02 1.68e-01 4.05e-01
GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES 16 6.04e-01 8.76e-01 0.15300 -1.21e-01 9.31e-02 4.00e-01 5.19e-01
GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA 27 3.88e-01 7.70e-01 0.15300 -1.53e-01 9.49e-03 1.70e-01 9.32e-01
GOBP RNA LOCALIZATION 187 1.12e-03 3.60e-02 0.15300 -1.88e-02 -1.52e-01 6.58e-01 3.42e-04
GOBP SMOOTH MUSCLE CELL PROLIFERATION 162 3.20e-03 7.68e-02 0.15300 -1.53e-01 -2.18e-03 7.80e-04 9.62e-01
GOMF 1 PHOSPHATIDYLINOSITOL BINDING 15 6.23e-01 8.82e-01 0.15300 -1.22e-01 9.28e-02 4.15e-01 5.34e-01
GOBP HOMOLOGOUS CHROMOSOME SEGREGATION 65 1.12e-01 4.83e-01 0.15300 -1.49e-01 3.27e-02 3.72e-02 6.48e-01
Epigenetic regulation of gene expression 269 5.94e-05 3.82e-03 0.15300 -1.52e-01 -1.93e-02 1.84e-05 5.86e-01
mRNA 3’-end processing 53 1.41e-01 5.33e-01 0.15300 -2.75e-02 -1.50e-01 7.29e-01 5.82e-02
GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION 22 4.97e-01 8.29e-01 0.15300 1.30e-01 -7.98e-02 2.90e-01 5.17e-01
GOMF TRANSCRIPTION COREPRESSOR BINDING 45 2.41e-01 6.56e-01 0.15300 -1.28e-01 8.31e-02 1.37e-01 3.35e-01
GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS 28 4.10e-01 7.84e-01 0.15300 1.31e-01 -7.86e-02 2.30e-01 4.72e-01
GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK 27 3.45e-01 7.42e-01 0.15300 -1.23e-01 -9.07e-02 2.69e-01 4.14e-01
GOBP AUTOPHAGOSOME LYSOSOME FUSION 12 6.51e-01 8.92e-01 0.15300 5.05e-03 1.53e-01 9.76e-01 3.60e-01
GOBP PHOSPHATE ION HOMEOSTASIS 20 4.53e-01 8.07e-01 0.15300 1.10e-01 1.06e-01 3.94e-01 4.13e-01
IRS-related events triggered by IGF1R 50 2.03e-01 6.18e-01 0.15300 -1.33e-01 7.49e-02 1.03e-01 3.60e-01
GOBP DELAMINATION 7 7.67e-01 9.34e-01 0.15300 1.45e-01 4.68e-02 5.05e-01 8.30e-01
GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION 16 5.67e-01 8.59e-01 0.15300 -1.53e-01 -3.14e-04 2.90e-01 9.98e-01
GOBP SEQUESTERING OF ACTIN MONOMERS 6 7.91e-01 9.42e-01 0.15300 -1.33e-01 -7.46e-02 5.72e-01 7.52e-01
GOCC DENDRITE TERMINUS 12 6.37e-01 8.87e-01 0.15300 -4.09e-02 -1.47e-01 8.06e-01 3.78e-01
GOBP CELLULAR RESPONSE TO COLD 13 6.52e-01 8.92e-01 0.15300 -4.79e-02 1.45e-01 7.65e-01 3.65e-01
GOBP DNA STRAND ELONGATION 36 2.62e-01 6.76e-01 0.15300 -1.49e-01 -3.46e-02 1.23e-01 7.19e-01
GOBP SPINDLE LOCALIZATION 62 1.07e-01 4.75e-01 0.15300 -1.52e-01 -1.31e-02 3.84e-02 8.58e-01
GOBP RESPONSE TO ISCHEMIA 64 1.03e-01 4.69e-01 0.15300 -1.53e-01 -3.38e-03 3.48e-02 9.63e-01
GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY 6 7.91e-01 9.42e-01 0.15300 1.31e-01 7.87e-02 5.79e-01 7.39e-01
GOBP PEPTIDYL LYSINE ACETYLATION 22 5.00e-01 8.30e-01 0.15200 -1.28e-01 8.34e-02 3.00e-01 4.98e-01
Collagen biosynthesis and modifying enzymes 65 1.21e-01 4.99e-01 0.15200 -5.53e-02 1.42e-01 4.41e-01 4.76e-02
ATF4 activates genes in response to endoplasmic reticulum stress 27 3.76e-01 7.63e-01 0.15200 -1.81e-02 -1.51e-01 8.71e-01 1.73e-01
RNA Polymerase II Transcription Termination 62 1.10e-01 4.79e-01 0.15200 -8.05e-03 -1.52e-01 9.13e-01 3.82e-02
GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION 56 1.65e-01 5.65e-01 0.15200 -1.40e-01 6.10e-02 7.08e-02 4.30e-01
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 26 4.45e-01 8.02e-01 0.15200 -1.12e-01 1.03e-01 3.22e-01 3.64e-01
GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE 6 8.24e-01 9.52e-01 0.15200 -5.95e-02 1.40e-01 8.01e-01 5.52e-01
GOCC TRANSCRIPTION FACTOR TFTC COMPLEX 17 5.19e-01 8.39e-01 0.15200 -1.36e-01 -6.87e-02 3.32e-01 6.24e-01
GOBP EPIDERMIS DEVELOPMENT 376 1.27e-06 1.35e-04 0.15200 1.49e-01 2.85e-02 6.47e-07 3.42e-01
GOBP KERATINOCYTE PROLIFERATION 60 1.53e-01 5.48e-01 0.15200 8.41e-02 -1.27e-01 2.60e-01 8.95e-02
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY 17 5.14e-01 8.36e-01 0.15200 -9.65e-02 -1.18e-01 4.91e-01 4.02e-01
GOBP RESPONSE TO COCAINE 54 1.84e-01 5.89e-01 0.15200 -1.29e-01 8.07e-02 1.02e-01 3.05e-01
GOBP MRNA EXPORT FROM NUCLEUS 64 8.41e-02 4.31e-01 0.15200 -7.88e-02 -1.30e-01 2.76e-01 7.22e-02
GOBP REGULATION OF TRANSLATIONAL FIDELITY 18 5.73e-01 8.61e-01 0.15200 1.09e-01 -1.06e-01 4.23e-01 4.37e-01
GOBP REGULATION OF FATTY ACID BETA OXIDATION 19 5.26e-01 8.42e-01 0.15200 -1.50e-01 2.29e-02 2.57e-01 8.63e-01
GOBP RIBOSOME DISASSEMBLY 40 2.19e-01 6.37e-01 0.15200 -5.94e-02 -1.40e-01 5.16e-01 1.26e-01
GOBP RENAL VESICLE DEVELOPMENT 18 4.94e-01 8.28e-01 0.15200 -1.08e-01 -1.07e-01 4.27e-01 4.34e-01
GOBP EMBRYONIC CLEAVAGE 8 7.63e-01 9.32e-01 0.15200 -1.50e-01 2.29e-02 4.62e-01 9.11e-01
Pexophagy 10 7.12e-01 9.14e-01 0.15200 1.94e-02 -1.51e-01 9.15e-01 4.09e-01
GOBP POSITIVE REGULATION OF DNA RECOMBINATION 73 5.78e-02 3.66e-01 0.15200 -1.11e-01 -1.04e-01 1.01e-01 1.26e-01
GOBP MHC CLASS II BIOSYNTHETIC PROCESS 19 5.55e-01 8.55e-01 0.15200 1.15e-01 -9.90e-02 3.85e-01 4.55e-01
GOBP LUNG ASSOCIATED MESENCHYME DEVELOPMENT 9 7.04e-01 9.13e-01 0.15200 -8.90e-02 -1.23e-01 6.44e-01 5.23e-01
Global Genome Nucleotide Excision Repair (GG-NER) 81 4.25e-02 3.14e-01 0.15200 -1.01e-01 -1.13e-01 1.15e-01 7.89e-02
GOMF MITOCHONDRIAL RIBOSOME BINDING 9 7.38e-01 9.24e-01 0.15200 -1.50e-01 2.32e-02 4.36e-01 9.04e-01
Autodegradation of Cdh1 by Cdh1:APC/C 54 1.29e-01 5.13e-01 0.15200 -5.97e-02 -1.40e-01 4.48e-01 7.61e-02
GOBP REGULATION OF NOTCH SIGNALING PATHWAY 95 2.93e-02 2.70e-01 0.15200 4.43e-02 1.45e-01 4.55e-01 1.45e-02
Mitochondrial tRNA aminoacylation 20 5.34e-01 8.46e-01 0.15200 7.68e-02 -1.31e-01 5.52e-01 3.11e-01
GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE 150 1.00e-02 1.54e-01 0.15200 -1.04e-01 1.10e-01 2.73e-02 2.00e-02
GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX 15 5.61e-01 8.57e-01 0.15200 -1.31e-01 -7.63e-02 3.80e-01 6.09e-01
GOBP REGULATORY T CELL DIFFERENTIATION 39 2.93e-01 7.06e-01 0.15200 1.33e-01 -7.27e-02 1.51e-01 4.32e-01
GOBP CHONDROCYTE DIFFERENTIATION 113 3.09e-02 2.75e-01 0.15200 -1.17e-01 9.68e-02 3.21e-02 7.55e-02
G0 and Early G1 27 4.21e-01 7.90e-01 0.15200 5.66e-02 -1.41e-01 6.11e-01 2.06e-01
GOBP SENSORY PERCEPTION OF BITTER TASTE 44 1.84e-01 5.89e-01 0.15200 7.91e-02 1.29e-01 3.64e-01 1.38e-01
GOBP MUSCLE ORGAN MORPHOGENESIS 82 7.99e-02 4.20e-01 0.15100 -1.20e-01 9.21e-02 5.98e-02 1.49e-01
GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING 12 6.36e-01 8.86e-01 0.15100 -1.40e-01 -5.67e-02 4.00e-01 7.34e-01
GOBP GASTRULATION WITH MOUTH FORMING SECOND 26 3.70e-01 7.58e-01 0.15100 -7.15e-02 -1.33e-01 5.28e-01 2.39e-01
Disassembly of the destruction complex and recruitment of AXIN to the membrane 30 3.88e-01 7.69e-01 0.15100 -1.36e-01 6.66e-02 1.97e-01 5.28e-01
GOBP CYTOCHROME COMPLEX ASSEMBLY 38 3.06e-01 7.15e-01 0.15100 7.82e-02 -1.30e-01 4.04e-01 1.67e-01
GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS 7 7.72e-01 9.36e-01 0.15100 1.46e-01 4.01e-02 5.04e-01 8.54e-01
GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE 61 1.18e-01 4.92e-01 0.15100 1.51e-01 6.74e-03 4.11e-02 9.27e-01
GOBP HYDROCARBON METABOLIC PROCESS 7 7.68e-01 9.34e-01 0.15100 -5.97e-02 -1.39e-01 7.84e-01 5.24e-01
GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS 13 6.03e-01 8.76e-01 0.15100 9.85e-02 1.15e-01 5.39e-01 4.73e-01
GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 25 4.46e-01 8.02e-01 0.15100 -4.80e-02 1.43e-01 6.78e-01 2.14e-01
Regulation of APC/C activators between G1/S and early anaphase 68 8.63e-02 4.35e-01 0.15100 -2.47e-02 -1.49e-01 7.25e-01 3.33e-02
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest 18 5.74e-01 8.62e-01 0.15100 9.00e-02 -1.22e-01 5.08e-01 3.72e-01
GOBP CELLULAR RESPONSE TO GAMMA RADIATION 26 3.66e-01 7.56e-01 0.15100 -1.22e-01 -8.95e-02 2.82e-01 4.29e-01
GOMF ANKYRIN REPEAT BINDING 6 8.32e-01 9.54e-01 0.15100 1.08e-01 -1.05e-01 6.46e-01 6.55e-01
GOBP LYSOSOMAL LUMEN ACIDIFICATION 21 4.45e-01 8.02e-01 0.15100 -1.25e-01 -8.49e-02 3.21e-01 5.01e-01
GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 19 4.99e-01 8.30e-01 0.15100 -3.51e-02 -1.47e-01 7.91e-01 2.67e-01
GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS 32 3.42e-01 7.40e-01 0.15100 2.07e-02 -1.50e-01 8.40e-01 1.43e-01
GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS 15 5.73e-01 8.61e-01 0.15100 1.43e-01 4.85e-02 3.37e-01 7.45e-01
GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY 159 3.15e-03 7.60e-02 0.15100 -1.47e-01 -3.38e-02 1.35e-03 4.63e-01
GOBP MEMBRANE DISASSEMBLY 13 6.48e-01 8.91e-01 0.15100 -1.49e-01 2.40e-02 3.52e-01 8.81e-01
Diseases of DNA repair 51 1.59e-01 5.57e-01 0.15100 -2.83e-02 -1.48e-01 7.26e-01 6.68e-02
Glucagon signaling in metabolic regulation 32 3.59e-01 7.51e-01 0.15100 -1.42e-01 5.20e-02 1.65e-01 6.11e-01
GOBP GANGLIOSIDE CATABOLIC PROCESS 7 7.63e-01 9.32e-01 0.15100 -1.07e-01 -1.06e-01 6.24e-01 6.26e-01
GOMF RETINOIC ACID BINDING 27 4.12e-01 7.84e-01 0.15100 1.47e-01 -3.34e-02 1.86e-01 7.64e-01
GOBP MAINTENANCE OF ORGANELLE LOCATION 12 6.50e-01 8.91e-01 0.15100 -1.49e-01 -2.45e-02 3.72e-01 8.83e-01
GOBP REGULATION OF MEMBRANE INVAGINATION 15 6.07e-01 8.76e-01 0.15100 2.50e-02 -1.49e-01 8.67e-01 3.18e-01
GOMF STAT FAMILY PROTEIN BINDING 11 7.12e-01 9.14e-01 0.15100 -1.27e-01 8.09e-02 4.65e-01 6.42e-01
Mitochondrial iron-sulfur cluster biogenesis 13 6.16e-01 8.80e-01 0.15100 -5.36e-02 -1.41e-01 7.38e-01 3.79e-01
GOBP PROTEIN STABILIZATION 203 7.64e-04 2.62e-02 0.15100 -2.06e-02 -1.49e-01 6.13e-01 2.43e-04
GOBP SMOOTH MUSCLE CELL MIGRATION 88 6.70e-02 3.91e-01 0.15100 -1.26e-01 8.26e-02 4.09e-02 1.80e-01
GOBP KERATINOCYTE DEVELOPMENT 13 6.70e-01 9.01e-01 0.15100 8.42e-02 -1.25e-01 5.99e-01 4.35e-01
GOCC DYNEIN COMPLEX 52 2.01e-01 6.14e-01 0.15100 -1.29e-01 7.85e-02 1.08e-01 3.27e-01
GOCC PALMITOYLTRANSFERASE COMPLEX 10 6.83e-01 9.06e-01 0.15100 -1.30e-01 -7.70e-02 4.78e-01 6.73e-01
GOMF SODIUM CHANNEL ACTIVITY 47 1.83e-01 5.87e-01 0.15100 1.47e-01 3.17e-02 8.05e-02 7.07e-01
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 36 2.82e-01 6.95e-01 0.15100 -1.50e-01 -1.28e-02 1.19e-01 8.94e-01
Cell Cycle Checkpoints 252 8.42e-05 5.12e-03 0.15100 -6.36e-02 -1.37e-01 8.20e-02 1.88e-04
GOCC PHAGOPHORE ASSEMBLY SITE 37 3.09e-01 7.18e-01 0.15100 -1.41e-01 5.38e-02 1.39e-01 5.71e-01
GOCC ORIGIN RECOGNITION COMPLEX 8 7.79e-01 9.39e-01 0.15100 -6.71e-02 1.35e-01 7.42e-01 5.09e-01
GOBP AMINO ACID BETAINE METABOLIC PROCESS 16 5.41e-01 8.49e-01 0.15100 -9.81e-02 -1.14e-01 4.97e-01 4.29e-01
GOBP HYPEROSMOTIC RESPONSE 25 4.37e-01 7.97e-01 0.15100 2.53e-02 -1.48e-01 8.26e-01 1.99e-01
GOMF OXYGEN CARRIER ACTIVITY 14 6.53e-01 8.93e-01 0.15000 1.12e-01 -1.00e-01 4.67e-01 5.17e-01
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 80 5.71e-02 3.63e-01 0.15000 -2.84e-02 -1.48e-01 6.61e-01 2.23e-02
GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION 12 6.31e-01 8.86e-01 0.15000 -1.16e-01 -9.62e-02 4.88e-01 5.64e-01
GOCC AMPHISOME 13 6.70e-01 9.01e-01 0.15000 7.90e-02 -1.28e-01 6.22e-01 4.24e-01
GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE 6 8.09e-01 9.49e-01 0.15000 1.50e-01 1.61e-02 5.26e-01 9.46e-01
GOBP REGULATION OF RESPONSE TO FOOD 16 5.47e-01 8.52e-01 0.15000 -1.34e-01 -6.83e-02 3.53e-01 6.36e-01
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal 91 3.24e-02 2.81e-01 0.15000 -1.31e-01 -7.35e-02 3.06e-02 2.25e-01
Amplification of signal from the kinetochores 91 3.24e-02 2.81e-01 0.15000 -1.31e-01 -7.35e-02 3.06e-02 2.25e-01
GOBP CELLULAR DETOXIFICATION OF ALDEHYDE 9 7.17e-01 9.15e-01 0.15000 1.41e-01 5.29e-02 4.65e-01 7.84e-01
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids 6 8.09e-01 9.49e-01 0.15000 1.81e-02 1.49e-01 9.39e-01 5.27e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS 44 2.08e-01 6.24e-01 0.15000 -2.66e-02 -1.48e-01 7.60e-01 8.96e-02
GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT 41 2.34e-01 6.51e-01 0.15000 -1.49e-01 -2.08e-02 9.92e-02 8.18e-01
GOBP REGULATION OF CRISTAE FORMATION 5 8.48e-01 9.58e-01 0.15000 2.32e-02 -1.48e-01 9.28e-01 5.65e-01
GOBP STEROL TRANSPORT 128 1.83e-02 2.16e-01 0.15000 -5.82e-02 1.38e-01 2.56e-01 6.82e-03
Integrin signaling 27 3.66e-01 7.55e-01 0.15000 -1.37e-01 -6.16e-02 2.18e-01 5.79e-01
GOBP POSITIVE REGULATION OF TOR SIGNALING 68 7.99e-02 4.20e-01 0.15000 -1.37e-01 -6.06e-02 5.01e-02 3.88e-01
GOBP RELAXATION OF SMOOTH MUSCLE 9 7.35e-01 9.23e-01 0.15000 -2.14e-03 1.50e-01 9.91e-01 4.36e-01
GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS 5 8.60e-01 9.60e-01 0.15000 -9.76e-02 1.14e-01 7.05e-01 6.59e-01
GOBP REGULATION OF EOSINOPHIL MIGRATION 5 8.59e-01 9.60e-01 0.15000 1.25e-01 -8.30e-02 6.28e-01 7.48e-01
GOBP REGULATION OF FIBRINOLYSIS 18 5.45e-01 8.51e-01 0.15000 -8.69e-03 1.50e-01 9.49e-01 2.71e-01
GOBP MUSCLE ORGAN DEVELOPMENT 348 1.36e-05 1.08e-03 0.15000 -1.47e-01 2.86e-02 2.36e-06 3.60e-01
GOBP CELLULAR RESPONSE TO LEUCINE STARVATION 11 6.57e-01 8.94e-01 0.15000 -9.85e-02 -1.13e-01 5.72e-01 5.16e-01
GOBP PROTEIN DESTABILIZATION 47 2.43e-01 6.58e-01 0.15000 -1.07e-01 1.05e-01 2.04e-01 2.13e-01
GOBP REGULATION OF SISTER CHROMATID SEGREGATION 104 2.29e-02 2.43e-01 0.15000 -1.43e-01 -4.46e-02 1.16e-02 4.32e-01
Regulation of endogenous retroelements by KRAB-ZFP proteins 70 7.07e-02 3.99e-01 0.15000 -1.24e-01 -8.51e-02 7.39e-02 2.18e-01
GOBP REGULATION OF PIGMENTATION 17 5.29e-01 8.43e-01 0.15000 -6.87e-02 -1.33e-01 6.24e-01 3.42e-01
RUNX3 regulates NOTCH signaling 13 6.13e-01 8.78e-01 0.15000 -7.74e-02 -1.28e-01 6.29e-01 4.23e-01
GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION 27 3.66e-01 7.56e-01 0.15000 -1.35e-01 -6.44e-02 2.24e-01 5.62e-01
Signaling by FGFR3 39 2.95e-01 7.07e-01 0.15000 -1.39e-01 5.52e-02 1.32e-01 5.51e-01
GOMF UNIPORTER ACTIVITY 9 7.62e-01 9.32e-01 0.15000 -1.17e-01 9.40e-02 5.44e-01 6.25e-01
GOBP VALINE METABOLIC PROCESS 7 8.08e-01 9.49e-01 0.15000 1.24e-01 -8.33e-02 5.68e-01 7.03e-01
GOBP REGULATION OF GOLGI ORGANIZATION 17 5.24e-01 8.42e-01 0.15000 -9.39e-02 -1.17e-01 5.03e-01 4.05e-01
GOBP REGULATION OF FERTILIZATION 17 5.26e-01 8.42e-01 0.15000 1.25e-01 8.27e-02 3.73e-01 5.55e-01
GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING 24 4.09e-01 7.83e-01 0.15000 -6.75e-02 -1.34e-01 5.67e-01 2.57e-01
Activation of NIMA Kinases NEK9, NEK6, NEK7 7 8.10e-01 9.49e-01 0.15000 1.10e-01 -1.02e-01 6.14e-01 6.42e-01
GOBP N TERMINAL PROTEIN LIPIDATION 6 8.34e-01 9.54e-01 0.15000 1.23e-01 -8.54e-02 6.02e-01 7.17e-01
MyD88 deficiency (TLR2/4) 16 6.18e-01 8.80e-01 0.15000 1.08e-01 -1.04e-01 4.55e-01 4.72e-01
GOMF NADPLUS BINDING 18 5.82e-01 8.66e-01 0.15000 1.12e-01 -9.93e-02 4.11e-01 4.66e-01
GOBP MAINTENANCE OF CELL NUMBER 179 1.62e-03 4.66e-02 0.15000 -1.44e-01 -4.10e-02 8.94e-04 3.45e-01
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING 37 2.95e-01 7.07e-01 0.15000 1.85e-02 -1.48e-01 8.45e-01 1.18e-01
Phase I - Functionalization of compounds 102 3.42e-02 2.87e-01 0.14900 1.49e-01 -1.40e-02 9.39e-03 8.07e-01
GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 55 1.62e-01 5.60e-01 0.14900 1.43e-02 -1.49e-01 8.54e-01 5.63e-02
GOCC IKAPPAB KINASE COMPLEX 7 8.11e-01 9.49e-01 0.14900 -9.80e-02 1.13e-01 6.53e-01 6.05e-01
GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION 20 5.39e-01 8.49e-01 0.14900 1.36e-01 -6.17e-02 2.92e-01 6.33e-01
GOBP REGULATION OF ODONTOBLAST DIFFERENTIATION 10 7.41e-01 9.26e-01 0.14900 -1.02e-01 1.09e-01 5.75e-01 5.51e-01
GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS 5 8.51e-01 9.58e-01 0.14900 -3.09e-02 1.46e-01 9.05e-01 5.71e-01
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 19 5.56e-01 8.55e-01 0.14900 6.14e-02 -1.36e-01 6.43e-01 3.04e-01
GOBP ERYTHROCYTE DEVELOPMENT 40 2.97e-01 7.09e-01 0.14900 7.81e-02 -1.27e-01 3.93e-01 1.64e-01
GOBP AEROBIC RESPIRATION 169 3.88e-03 8.62e-02 0.14900 1.54e-02 -1.49e-01 7.29e-01 8.62e-04
GOMF AP 1 ADAPTOR COMPLEX BINDING 5 8.47e-01 9.58e-01 0.14900 -1.38e-02 1.49e-01 9.57e-01 5.65e-01
GOBP PROTEIN INSERTION INTO MEMBRANE 42 2.05e-01 6.21e-01 0.14900 -9.14e-02 -1.18e-01 3.06e-01 1.85e-01
GOCC GATOR2 COMPLEX 9 7.19e-01 9.16e-01 0.14900 -1.38e-01 -5.60e-02 4.72e-01 7.71e-01
GOCC DENDRITIC SPINE MEMBRANE 13 6.18e-01 8.80e-01 0.14900 -1.34e-01 -6.64e-02 4.04e-01 6.78e-01
GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY 32 3.56e-01 7.49e-01 0.14900 1.46e-01 -2.98e-02 1.52e-01 7.71e-01
GOBP PROTEIN LOCALIZATION TO CELL CORTEX 11 7.18e-01 9.15e-01 0.14900 -1.22e-01 8.52e-02 4.82e-01 6.25e-01
GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION 30 3.74e-01 7.61e-01 0.14900 1.48e-01 -1.84e-02 1.61e-01 8.61e-01
GOCC INNER ACROSOMAL MEMBRANE 5 8.46e-01 9.58e-01 0.14900 -1.49e-01 6.62e-03 5.64e-01 9.80e-01
GOBP TROPHOBLAST GIANT CELL DIFFERENTIATION 12 6.49e-01 8.91e-01 0.14900 1.43e-01 4.33e-02 3.92e-01 7.95e-01
GOBP REGULATION OF CHROMOSOME ORGANIZATION 240 1.27e-04 7.23e-03 0.14900 -1.03e-01 -1.08e-01 5.83e-03 4.11e-03
GOCC NLRP1 INFLAMMASOME COMPLEX 6 7.97e-01 9.44e-01 0.14900 1.05e-01 1.05e-01 6.55e-01 6.55e-01
GOBP AMELOBLAST DIFFERENTIATION 5 8.49e-01 9.58e-01 0.14900 1.89e-02 -1.48e-01 9.42e-01 5.67e-01
NOTCH3 Activation and Transmission of Signal to the Nucleus 25 4.68e-01 8.14e-01 0.14900 7.39e-02 -1.29e-01 5.22e-01 2.63e-01
GOCC HAPTOGLOBIN HEMOGLOBIN COMPLEX 11 6.86e-01 9.06e-01 0.14900 1.49e-01 9.54e-03 3.93e-01 9.56e-01
GOBP REGULATION OF MITOCHONDRIAL TRANSLATION 25 3.98e-01 7.76e-01 0.14900 -6.73e-02 -1.33e-01 5.60e-01 2.50e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 15 6.30e-01 8.85e-01 0.14900 5.95e-02 -1.36e-01 6.90e-01 3.60e-01
GOBP REGULATION OF RECEPTOR CLUSTERING 16 6.20e-01 8.80e-01 0.14900 -1.20e-01 8.87e-02 4.08e-01 5.39e-01
GOMF SNORNA BINDING 31 3.95e-01 7.74e-01 0.14900 1.22e-01 -8.49e-02 2.39e-01 4.13e-01
GOBP SCHWANN CELL MIGRATION 5 8.33e-01 9.54e-01 0.14900 -1.36e-01 -6.08e-02 5.99e-01 8.14e-01
GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY 14 6.49e-01 8.91e-01 0.14900 -5.64e-02 1.38e-01 7.15e-01 3.72e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT 12 6.97e-01 9.11e-01 0.14900 -8.06e-02 1.25e-01 6.29e-01 4.53e-01
GOBP PROTEIN RNA COMPLEX ORGANIZATION 201 7.40e-04 2.55e-02 0.14900 -4.95e-02 -1.40e-01 2.26e-01 6.00e-04
GOBP REGULATION OF RUFFLE ASSEMBLY 31 3.29e-01 7.32e-01 0.14900 1.42e-01 4.42e-02 1.71e-01 6.70e-01
GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS 31 3.68e-01 7.57e-01 0.14900 2.65e-02 -1.46e-01 7.98e-01 1.58e-01
GOBP AMP BIOSYNTHETIC PROCESS 12 6.68e-01 8.99e-01 0.14900 1.49e-01 3.58e-04 3.72e-01 9.98e-01
GOCC POSTSYNAPTIC ACTIN CYTOSKELETON 8 7.41e-01 9.25e-01 0.14900 -9.24e-02 -1.17e-01 6.51e-01 5.68e-01
GOBP REGULATION OF ACTION POTENTIAL 57 1.40e-01 5.31e-01 0.14900 1.82e-02 1.48e-01 8.12e-01 5.39e-02
GOCC IMMUNOLOGICAL SYNAPSE 45 2.17e-01 6.35e-01 0.14900 1.49e-01 6.44e-03 8.46e-02 9.40e-01
GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY 64 1.48e-01 5.42e-01 0.14900 -1.24e-01 8.22e-02 8.64e-02 2.56e-01
GOBP MYOBLAST DIFFERENTIATION 112 2.24e-02 2.40e-01 0.14900 -1.48e-01 -8.66e-03 6.65e-03 8.74e-01
GOBP NON MOTILE CILIUM ASSEMBLY 62 1.02e-01 4.67e-01 0.14900 -1.32e-01 -6.85e-02 7.24e-02 3.51e-01
GOBP PIGMENT GRANULE MATURATION 10 7.43e-01 9.26e-01 0.14900 9.41e-02 -1.15e-01 6.06e-01 5.29e-01
GOBP STEROL BIOSYNTHETIC PROCESS 63 1.19e-01 4.95e-01 0.14900 5.03e-03 1.49e-01 9.45e-01 4.15e-02
Regulation of localization of FOXO transcription factors 11 6.89e-01 9.07e-01 0.14900 6.53e-03 1.48e-01 9.70e-01 3.94e-01
GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING 10 7.43e-01 9.26e-01 0.14900 -1.15e-01 9.35e-02 5.27e-01 6.09e-01
GOBP ANTIMICROBIAL HUMORAL RESPONSE 139 1.62e-02 2.04e-01 0.14900 8.61e-02 -1.21e-01 7.98e-02 1.37e-02
GOMF P TYPE POTASSIUM TRANSMEMBRANE TRANSPORTER ACTIVITY 8 7.41e-01 9.25e-01 0.14900 1.09e-01 1.00e-01 5.92e-01 6.23e-01
GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY 42 2.40e-01 6.55e-01 0.14900 -1.48e-01 -8.51e-03 9.62e-02 9.24e-01
GOBP MUSCLE CELL MIGRATION 102 4.69e-02 3.28e-01 0.14900 -1.28e-01 7.51e-02 2.53e-02 1.90e-01
GOBP AXONAL FASCICULATION 20 4.94e-01 8.28e-01 0.14900 3.25e-02 1.45e-01 8.01e-01 2.62e-01
DNA Double-Strand Break Repair 146 4.36e-03 9.17e-02 0.14900 -9.79e-02 -1.12e-01 4.12e-02 1.97e-02
Mitochondrial Fatty Acid Beta-Oxidation 36 3.02e-01 7.13e-01 0.14800 -1.48e-01 4.58e-03 1.23e-01 9.62e-01
GOBP DENDRITIC TRANSPORT 12 6.82e-01 9.06e-01 0.14800 3.19e-02 -1.45e-01 8.48e-01 3.85e-01
GOBP POSITIVE REGULATION OF IMMATURE T CELL PROLIFERATION 5 8.29e-01 9.53e-01 0.14800 -1.02e-01 -1.08e-01 6.93e-01 6.76e-01
GOBP ASYMMETRIC CELL DIVISION 18 5.75e-01 8.63e-01 0.14800 -1.38e-01 5.55e-02 3.12e-01 6.83e-01
Tryptophan catabolism 14 6.05e-01 8.76e-01 0.14800 1.40e-01 4.96e-02 3.65e-01 7.48e-01
GOBP MEGAKARYOCYTE DIFFERENTIATION 62 1.01e-01 4.65e-01 0.14800 -8.35e-02 -1.23e-01 2.56e-01 9.51e-02
GOBP MESENCHYMAL CELL DIFFERENTIATION 267 1.44e-04 7.90e-03 0.14800 -1.48e-01 -2.02e-03 3.04e-05 9.55e-01
GOBP SKELETAL MUSCLE TISSUE GROWTH 10 7.25e-01 9.18e-01 0.14800 2.32e-02 -1.46e-01 8.99e-01 4.23e-01
GOBP SEMINIFEROUS TUBULE DEVELOPMENT 14 6.11e-01 8.78e-01 0.14800 -3.42e-02 -1.44e-01 8.24e-01 3.50e-01
GOBP REGULATION OF STEROL TRANSPORT 77 9.95e-02 4.61e-01 0.14800 -7.23e-02 1.29e-01 2.73e-01 4.96e-02
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell 124 2.47e-02 2.51e-01 0.14800 7.47e-02 -1.28e-01 1.51e-01 1.38e-02
GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION 9 7.56e-01 9.30e-01 0.14800 -1.41e-01 4.64e-02 4.65e-01 8.09e-01
GOBP BRADYKININ CATABOLIC PROCESS 7 8.12e-01 9.49e-01 0.14800 -1.21e-01 8.56e-02 5.79e-01 6.95e-01
GOBP MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 53 1.97e-01 6.09e-01 0.14800 5.40e-02 -1.38e-01 4.96e-01 8.23e-02
GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM 12 6.63e-01 8.97e-01 0.14800 -1.77e-02 -1.47e-01 9.15e-01 3.78e-01
GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS 15 6.34e-01 8.86e-01 0.14800 1.35e-01 -6.12e-02 3.66e-01 6.82e-01
Phase 1 - inactivation of fast Na+ channels 6 8.00e-01 9.46e-01 0.14800 1.16e-01 9.20e-02 6.23e-01 6.96e-01
GOBP STEM CELL DEVELOPMENT 86 6.02e-02 3.73e-01 0.14800 -1.48e-01 1.01e-02 1.79e-02 8.71e-01
GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS 33 3.74e-01 7.61e-01 0.14800 1.27e-01 -7.57e-02 2.06e-01 4.52e-01
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY 9 7.67e-01 9.34e-01 0.14800 -1.13e-01 9.53e-02 5.56e-01 6.21e-01
GOBP APOPTOTIC MITOCHONDRIAL CHANGES 103 4.24e-02 3.14e-01 0.14800 4.95e-02 -1.39e-01 3.85e-01 1.45e-02
GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION 13 6.83e-01 9.06e-01 0.14800 -1.07e-01 1.02e-01 5.02e-01 5.26e-01
GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY 52 1.45e-01 5.38e-01 0.14800 -1.08e-01 -1.01e-01 1.77e-01 2.08e-01
GOBP NUCLEOTIDE EXCISION REPAIR 79 7.94e-02 4.19e-01 0.14800 -1.46e-01 2.05e-02 2.44e-02 7.52e-01
GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CHROMOSOMAL CPG ISLAND METHYLATION 14 6.10e-01 8.77e-01 0.14800 -4.13e-02 -1.42e-01 7.89e-01 3.58e-01
GOBP REGULATION OF GONAD DEVELOPMENT 12 6.63e-01 8.97e-01 0.14800 1.90e-02 1.47e-01 9.09e-01 3.79e-01
GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT 29 4.17e-01 7.86e-01 0.14800 -6.40e-02 1.33e-01 5.51e-01 2.14e-01
GOMF CYCLIN BINDING 34 3.40e-01 7.39e-01 0.14800 2.59e-02 -1.45e-01 7.94e-01 1.42e-01
GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT 33 3.04e-01 7.14e-01 0.14800 -1.34e-01 -6.16e-02 1.82e-01 5.40e-01
GOMF SYMPORTER ACTIVITY 145 5.08e-03 1.00e-01 0.14800 7.91e-02 1.25e-01 1.00e-01 9.58e-03
RHOBTB1 GTPase cycle 22 5.25e-01 8.42e-01 0.14800 -1.12e-01 9.62e-02 3.63e-01 4.35e-01
GOCC SORTING ENDOSOME 6 8.28e-01 9.53e-01 0.14800 -1.44e-01 3.37e-02 5.42e-01 8.86e-01
GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS 12 6.46e-01 8.91e-01 0.14800 1.29e-01 7.21e-02 4.40e-01 6.65e-01
GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY 16 6.08e-01 8.76e-01 0.14800 3.87e-02 -1.42e-01 7.88e-01 3.24e-01
GOBP MESODERMAL CELL FATE SPECIFICATION 13 6.32e-01 8.86e-01 0.14800 -1.41e-01 -4.48e-02 3.80e-01 7.80e-01
GOBP ISOPENTENYL DIPHOSPHATE BIOSYNTHETIC PROCESS 5 8.32e-01 9.54e-01 0.14800 -8.21e-02 -1.23e-01 7.51e-01 6.35e-01
GOBP PROTEIN O LINKED GLYCOSYLATION 99 4.70e-02 3.29e-01 0.14800 -4.13e-02 1.42e-01 4.78e-01 1.49e-02
GOBP RESPONSE TO FUNGUS 60 1.53e-01 5.48e-01 0.14800 1.44e-01 -3.34e-02 5.42e-02 6.55e-01
GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY 60 1.12e-01 4.84e-01 0.14800 1.26e-01 7.75e-02 9.26e-02 2.99e-01
GOBP ESTABLISHMENT OF RNA LOCALIZATION 150 6.09e-03 1.13e-01 0.14700 -2.20e-02 -1.46e-01 6.41e-01 2.05e-03
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III 28 3.86e-01 7.68e-01 0.14700 -1.46e-01 -1.92e-02 1.80e-01 8.60e-01
GOMF HISTONE MODIFYING ACTIVITY 197 2.09e-03 5.61e-02 0.14700 -1.45e-01 2.78e-02 4.58e-04 5.02e-01
GOCC LSM2 8 COMPLEX 7 7.96e-01 9.44e-01 0.14700 8.78e-03 -1.47e-01 9.68e-01 5.00e-01
GOBP HEMATOPOIETIC STEM CELL PROLIFERATION 33 3.28e-01 7.31e-01 0.14700 -1.46e-01 -1.71e-02 1.46e-01 8.65e-01
Transport of inorganic cations/anions and amino acids/oligopeptides 102 2.43e-02 2.51e-01 0.14700 8.48e-02 1.20e-01 1.39e-01 3.57e-02
GOBP ANTIBACTERIAL INNATE IMMUNE RESPONSE 10 7.43e-01 9.26e-01 0.14700 -1.29e-01 7.11e-02 4.80e-01 6.97e-01
GOBP RESPONSE TO INTERLEUKIN 6 43 2.83e-01 6.95e-01 0.14700 -1.25e-01 7.83e-02 1.57e-01 3.75e-01
GOMF BILE ACID SODIUM SYMPORTER ACTIVITY 5 8.64e-01 9.62e-01 0.14700 -8.66e-02 1.19e-01 7.38e-01 6.45e-01
GOBP QUINOLINATE METABOLIC PROCESS 5 8.44e-01 9.57e-01 0.14700 1.90e-02 1.46e-01 9.41e-01 5.72e-01
GOBP REGULATION OF RESPIRATORY BURST 16 5.56e-01 8.55e-01 0.14700 9.83e-02 1.09e-01 4.96e-01 4.49e-01
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 133 1.75e-02 2.11e-01 0.14700 -1.40e-01 4.54e-02 5.35e-03 3.66e-01
Potassium Channels 102 4.36e-02 3.18e-01 0.14700 -4.02e-02 1.41e-01 4.83e-01 1.36e-02
GOBP INSULIN RECEPTOR SIGNALING PATHWAY 128 2.49e-02 2.52e-01 0.14700 -1.08e-01 9.99e-02 3.50e-02 5.10e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR 32 3.15e-01 7.22e-01 0.14700 7.11e-02 1.29e-01 4.87e-01 2.08e-01
GOBP OXIDATIVE DEMETHYLATION 10 7.48e-01 9.28e-01 0.14700 1.13e-01 -9.40e-02 5.36e-01 6.07e-01
GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS 75 1.14e-01 4.88e-01 0.14700 -9.16e-02 1.15e-01 1.70e-01 8.50e-02
GOBP RESPONSE TO INCREASED OXYGEN LEVELS 23 4.71e-01 8.15e-01 0.14700 -1.47e-01 9.15e-04 2.22e-01 9.94e-01
GOBP POSITIVE REGULATION OF ERAD PATHWAY 15 5.80e-01 8.64e-01 0.14700 -1.23e-01 -8.04e-02 4.10e-01 5.90e-01
GOCC ATAC COMPLEX 13 6.37e-01 8.87e-01 0.14700 -3.77e-02 -1.42e-01 8.14e-01 3.75e-01
GOBP HISTONE MRNA CATABOLIC PROCESS 15 5.79e-01 8.64e-01 0.14700 -1.18e-01 -8.72e-02 4.28e-01 5.59e-01
GOBP EMBRYONIC DIGIT MORPHOGENESIS 58 1.31e-01 5.17e-01 0.14700 -1.40e-01 -4.60e-02 6.61e-02 5.45e-01
GOBP VIRAL PROTEIN PROCESSING 31 3.33e-01 7.35e-01 0.14700 5.69e-02 1.35e-01 5.83e-01 1.92e-01
GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY 12 7.06e-01 9.13e-01 0.14700 -1.18e-01 8.73e-02 4.79e-01 6.00e-01
GOCC PLASMA MEMBRANE RAFT 112 1.74e-02 2.11e-01 0.14700 -1.21e-01 -8.35e-02 2.73e-02 1.27e-01
PCNA-Dependent Long Patch Base Excision Repair 21 4.97e-01 8.29e-01 0.14700 -1.10e-02 -1.46e-01 9.31e-01 2.46e-01
Aspartate and asparagine metabolism 11 6.81e-01 9.05e-01 0.14700 4.30e-02 1.40e-01 8.05e-01 4.20e-01
ERKs are inactivated 13 6.77e-01 9.04e-01 0.14700 -1.35e-01 5.67e-02 3.98e-01 7.23e-01
GOBP REGULATION OF NUCLEASE ACTIVITY 21 5.41e-01 8.50e-01 0.14700 7.82e-02 -1.24e-01 5.35e-01 3.25e-01
GOBP INTERSTRAND CROSS LINK REPAIR 40 3.16e-01 7.23e-01 0.14700 -1.05e-01 1.03e-01 2.51e-01 2.62e-01
GOCC DISTAL AXON 258 4.87e-04 1.89e-02 0.14700 -1.35e-01 5.85e-02 1.99e-04 1.06e-01
GOBP HORMONE MEDIATED SIGNALING PATHWAY 185 3.33e-03 7.86e-02 0.14700 -1.43e-01 3.18e-02 7.82e-04 4.56e-01
GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS 9 7.26e-01 9.19e-01 0.14700 -1.34e-01 -5.90e-02 4.86e-01 7.59e-01
GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY 6 8.16e-01 9.51e-01 0.14700 2.26e-02 1.45e-01 9.23e-01 5.39e-01
SLC-mediated transmembrane transport 238 2.02e-04 1.01e-02 0.14700 1.25e-01 7.64e-02 8.80e-04 4.23e-02
GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS 14 6.14e-01 8.79e-01 0.14700 1.40e-01 4.41e-02 3.65e-01 7.75e-01
GOBP OLFACTORY LOBE DEVELOPMENT 36 3.01e-01 7.11e-01 0.14700 -1.46e-01 -1.45e-02 1.30e-01 8.80e-01
GOBP ELECTRON TRANSPORT CHAIN 114 1.79e-02 2.12e-01 0.14700 -5.94e-02 -1.34e-01 2.73e-01 1.35e-02
GOMF BITTER TASTE RECEPTOR ACTIVITY 24 4.92e-01 8.27e-01 0.14600 -6.54e-02 1.31e-01 5.79e-01 2.66e-01
GOBP VESICLE TARGETING 65 1.28e-01 5.12e-01 0.14600 -1.45e-01 1.80e-02 4.27e-02 8.02e-01
GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY 39 2.55e-01 6.70e-01 0.14600 -5.15e-02 -1.37e-01 5.78e-01 1.39e-01
GOBP CUT METABOLIC PROCESS 5 8.66e-01 9.62e-01 0.14600 -1.15e-01 9.11e-02 6.57e-01 7.24e-01
GOBP PHOSPHOLIPID CATABOLIC PROCESS 55 1.44e-01 5.36e-01 0.14600 1.34e-01 5.80e-02 8.48e-02 4.57e-01
GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY 13 6.85e-01 9.06e-01 0.14600 -1.23e-01 7.90e-02 4.42e-01 6.22e-01
GOMF K63 LINKED DEUBIQUITINASE ACTIVITY 11 7.28e-01 9.21e-01 0.14600 8.67e-02 -1.18e-01 6.18e-01 4.99e-01
GOBP RESPONSE TO BMP 173 6.09e-03 1.13e-01 0.14600 -1.34e-01 5.89e-02 2.38e-03 1.81e-01
Viral Infection Pathways 743 2.40e-10 5.45e-08 0.14600 3.34e-02 -1.42e-01 1.21e-01 3.84e-11
GOBP HISTONE MRNA METABOLIC PROCESS 24 4.40e-01 7.99e-01 0.14600 -3.31e-02 -1.42e-01 7.79e-01 2.27e-01
GOMF CYTOKINE ACTIVITY 225 4.54e-04 1.78e-02 0.14600 1.41e-01 4.04e-02 2.80e-04 2.97e-01
GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY 14 6.03e-01 8.76e-01 0.14600 8.44e-02 1.19e-01 5.84e-01 4.39e-01
GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY 8 7.52e-01 9.30e-01 0.14600 -6.76e-02 -1.30e-01 7.40e-01 5.26e-01
Signaling by CSF3 (G-CSF) 30 3.78e-01 7.64e-01 0.14600 3.90e-04 -1.46e-01 9.97e-01 1.66e-01
GOMF TRANSCRIPTION COREGULATOR BINDING 110 4.22e-02 3.14e-01 0.14600 -1.20e-01 8.33e-02 2.95e-02 1.31e-01
GOBP REGULATION OF MELANOCYTE DIFFERENTIATION 6 8.29e-01 9.53e-01 0.14600 -1.44e-01 2.27e-02 5.40e-01 9.23e-01
GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 54 1.59e-01 5.57e-01 0.14600 3.26e-02 1.42e-01 6.78e-01 7.02e-02
TCR signaling 100 3.39e-02 2.86e-01 0.14600 -3.01e-02 -1.43e-01 6.03e-01 1.35e-02
GOBP T CELL CHEMOTAXIS 24 4.85e-01 8.23e-01 0.14600 4.54e-02 -1.39e-01 7.00e-01 2.39e-01
GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY 6 8.40e-01 9.56e-01 0.14600 1.25e-01 -7.53e-02 5.96e-01 7.49e-01
GOBP ANTERIOR POSTERIOR AXON GUIDANCE 7 7.91e-01 9.42e-01 0.14600 -1.44e-01 -2.31e-02 5.09e-01 9.16e-01
GOMF COMPLEMENT RECEPTOR ACTIVITY 11 7.11e-01 9.14e-01 0.14600 2.78e-02 -1.43e-01 8.73e-01 4.11e-01
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE 33 3.07e-01 7.16e-01 0.14600 -1.24e-01 -7.65e-02 2.16e-01 4.47e-01
GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS 33 3.83e-01 7.67e-01 0.14600 7.26e-02 -1.27e-01 4.70e-01 2.08e-01
GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE 24 4.70e-01 8.15e-01 0.14600 1.72e-02 -1.45e-01 8.84e-01 2.19e-01
GOBP FEVER GENERATION 11 7.30e-01 9.22e-01 0.14600 1.08e-01 -9.77e-02 5.34e-01 5.75e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 145 1.59e-02 2.01e-01 0.14600 8.52e-02 -1.18e-01 7.64e-02 1.39e-02
GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING 5 8.56e-01 9.60e-01 0.14600 -1.44e-01 2.59e-02 5.78e-01 9.20e-01
GOBP NUCLEAR PORE COMPLEX ASSEMBLY 11 6.78e-01 9.04e-01 0.14600 -6.57e-02 -1.30e-01 7.06e-01 4.55e-01
GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY 15 6.17e-01 8.80e-01 0.14600 -1.46e-03 1.46e-01 9.92e-01 3.28e-01
GOCC SCHAFFER COLLATERAL CA1 SYNAPSE 89 5.82e-02 3.66e-01 0.14600 -1.46e-01 4.99e-03 1.75e-02 9.35e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT 18 5.83e-01 8.66e-01 0.14600 4.77e-02 -1.38e-01 7.26e-01 3.11e-01
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT 112 2.13e-02 2.33e-01 0.14600 -1.39e-01 -4.51e-02 1.12e-02 4.10e-01
GOBP O GLYCAN PROCESSING 42 2.37e-01 6.54e-01 0.14600 3.98e-02 1.40e-01 6.55e-01 1.16e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION 32 3.49e-01 7.44e-01 0.14600 1.29e-02 1.45e-01 9.00e-01 1.55e-01
GOMF METALLOEXOPEPTIDASE ACTIVITY 64 1.62e-01 5.61e-01 0.14600 -1.02e-01 1.04e-01 1.59e-01 1.49e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 46 2.70e-01 6.85e-01 0.14600 -1.01e-01 1.05e-01 2.38e-01 2.16e-01
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 109 4.30e-02 3.15e-01 0.14600 7.29e-02 -1.26e-01 1.89e-01 2.28e-02
GOBP T HELPER 17 CELL DIFFERENTIATION 34 3.11e-01 7.20e-01 0.14600 -4.22e-02 -1.39e-01 6.70e-01 1.59e-01
GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS 14 6.07e-01 8.76e-01 0.14600 -7.79e-02 -1.23e-01 6.14e-01 4.25e-01
GOCC AXONEMAL A TUBULE INNER SHEATH 23 5.12e-01 8.36e-01 0.14600 1.28e-01 -6.94e-02 2.88e-01 5.65e-01
GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY 18 5.95e-01 8.72e-01 0.14600 -1.24e-01 7.67e-02 3.63e-01 5.73e-01
GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 30 4.25e-01 7.93e-01 0.14600 -8.96e-02 1.15e-01 3.95e-01 2.76e-01
GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION 44 2.66e-01 6.81e-01 0.14600 4.29e-02 -1.39e-01 6.22e-01 1.10e-01
Postmitotic nuclear pore complex (NPC) reformation 27 3.79e-01 7.64e-01 0.14600 -1.12e-01 -9.36e-02 3.16e-01 4.00e-01
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR 88 4.63e-02 3.27e-01 0.14600 -1.33e-01 -5.93e-02 3.10e-02 3.37e-01
GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY 6 8.19e-01 9.52e-01 0.14600 2.10e-02 1.44e-01 9.29e-01 5.41e-01
GOCC EUCHROMATIN 59 1.48e-01 5.43e-01 0.14600 -1.46e-01 -4.29e-03 5.32e-02 9.55e-01
GOBP CELLULAR COMPONENT MAINTENANCE 70 1.35e-01 5.24e-01 0.14600 -8.36e-02 1.19e-01 2.27e-01 8.47e-02
GOBP MESENDODERM DEVELOPMENT 9 7.34e-01 9.23e-01 0.14500 -1.39e-01 -4.34e-02 4.71e-01 8.22e-01
APC/C-mediated degradation of cell cycle proteins 75 9.15e-02 4.44e-01 0.14500 3.57e-03 -1.45e-01 9.57e-01 2.94e-02
Regulation of mitotic cell cycle 75 9.15e-02 4.44e-01 0.14500 3.57e-03 -1.45e-01 9.57e-01 2.94e-02
Molecules associated with elastic fibres 37 3.27e-01 7.31e-01 0.14500 -1.40e-01 3.92e-02 1.40e-01 6.80e-01
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS 32 3.94e-01 7.74e-01 0.14500 -6.57e-02 1.30e-01 5.20e-01 2.04e-01
GOBP LEUKOCYTE TETHERING OR ROLLING 34 3.80e-01 7.65e-01 0.14500 -8.83e-02 1.16e-01 3.73e-01 2.44e-01
GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION 19 5.83e-01 8.66e-01 0.14500 1.04e-01 -1.02e-01 4.34e-01 4.42e-01
ERBB2 Regulates Cell Motility 15 6.52e-01 8.93e-01 0.14500 1.14e-01 -8.97e-02 4.43e-01 5.48e-01
Hedgehog ligand biogenesis 52 1.79e-01 5.83e-01 0.14500 -2.06e-02 -1.44e-01 7.97e-01 7.26e-02
GOBP SYNAPSE MATURATION 33 3.12e-01 7.21e-01 0.14500 -7.10e-02 -1.27e-01 4.80e-01 2.07e-01
GOMF OLIGOPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 14 6.51e-01 8.92e-01 0.14500 -2.72e-02 1.43e-01 8.60e-01 3.55e-01
Cyclin E associated events during G1/S transition 73 8.38e-02 4.31e-01 0.14500 -3.93e-02 -1.40e-01 5.61e-01 3.88e-02
Activation of PUMA and translocation to mitochondria 9 7.53e-01 9.30e-01 0.14500 -1.14e-02 1.45e-01 9.53e-01 4.52e-01
Degradation of beta-catenin by the destruction complex 71 8.33e-02 4.30e-01 0.14500 -6.55e-02 -1.30e-01 3.40e-01 5.90e-02
GOBP SMOOTH MUSCLE CELL DIFFERENTIATION 75 9.33e-02 4.46e-01 0.14500 -1.45e-01 6.42e-03 2.98e-02 9.23e-01
GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION 50 1.67e-01 5.68e-01 0.14500 -1.03e-01 -1.02e-01 2.07e-01 2.11e-01
Signaling by ALK 27 4.49e-01 8.04e-01 0.14500 4.80e-02 -1.37e-01 6.66e-01 2.18e-01
Regulation of commissural axon pathfinding by SLIT and ROBO 10 7.29e-01 9.21e-01 0.14500 9.15e-03 -1.45e-01 9.60e-01 4.28e-01
GOBP LUNG VASCULATURE DEVELOPMENT 9 7.71e-01 9.36e-01 0.14500 -6.66e-02 1.29e-01 7.29e-01 5.03e-01
GOBP CHOLESTEROL EFFLUX 74 1.25e-01 5.05e-01 0.14500 -1.00e-01 1.05e-01 1.35e-01 1.19e-01
GOCC I BAND 140 1.66e-02 2.06e-01 0.14500 -1.36e-01 5.13e-02 5.62e-03 2.95e-01
SUMO E3 ligases SUMOylate target proteins 164 5.95e-03 1.11e-01 0.14500 -1.45e-01 8.97e-03 1.39e-03 8.43e-01
GOBP PROSTANOID BIOSYNTHETIC PROCESS 30 3.72e-01 7.60e-01 0.14500 1.43e-01 2.08e-02 1.74e-01 8.43e-01
Interleukin-9 signaling 7 7.82e-01 9.40e-01 0.14500 -1.26e-01 -7.12e-02 5.63e-01 7.44e-01
GOBP NEUROTRANSMITTER LOADING INTO SYNAPTIC VESICLE 7 7.99e-01 9.45e-01 0.14500 -1.45e-01 -3.15e-03 5.07e-01 9.88e-01
GOBP PROTEIN LOCALIZATION TO LYSOSOME 57 1.74e-01 5.78e-01 0.14500 -1.43e-01 2.26e-02 6.17e-02 7.68e-01
GOMF O METHYLTRANSFERASE ACTIVITY 20 4.91e-01 8.26e-01 0.14500 -9.55e-02 -1.09e-01 4.60e-01 3.99e-01
GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 13 6.35e-01 8.86e-01 0.14500 1.28e-01 6.84e-02 4.26e-01 6.70e-01
Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) 60 1.31e-01 5.16e-01 0.14500 -1.38e-01 -4.33e-02 6.42e-02 5.62e-01
GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION 26 4.49e-01 8.05e-01 0.14500 2.10e-02 -1.43e-01 8.53e-01 2.06e-01
GOCC NUCLEAR CHROMOSOME 221 4.44e-04 1.75e-02 0.14500 -1.22e-01 -7.80e-02 1.78e-03 4.57e-02
GOMF LRR DOMAIN BINDING 16 5.66e-01 8.59e-01 0.14500 -1.04e-01 -1.00e-01 4.70e-01 4.87e-01
GOBP MESODERMAL CELL FATE COMMITMENT 18 5.72e-01 8.61e-01 0.14500 -1.44e-01 1.53e-02 2.91e-01 9.11e-01
GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION 8 7.98e-01 9.45e-01 0.14500 1.11e-01 -9.26e-02 5.86e-01 6.50e-01
GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY 47 2.59e-01 6.73e-01 0.14500 6.61e-02 -1.29e-01 4.33e-01 1.27e-01
GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY 46 2.35e-01 6.52e-01 0.14500 -5.70e-03 1.45e-01 9.47e-01 8.98e-02
GOMF R SMAD BINDING 25 4.58e-01 8.10e-01 0.14500 -1.44e-01 1.08e-02 2.12e-01 9.25e-01
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING 170 8.68e-03 1.42e-01 0.14500 -1.11e-01 9.33e-02 1.29e-02 3.59e-02
GOBP RNA SPLICING 423 4.60e-07 5.48e-05 0.14500 -7.64e-02 -1.23e-01 7.02e-03 1.48e-05
GOMF NUCLEAR STEROID RECEPTOR ACTIVITY 25 4.89e-01 8.26e-01 0.14500 -7.04e-02 1.26e-01 5.42e-01 2.74e-01
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE 37 3.32e-01 7.35e-01 0.14400 -3.80e-02 1.39e-01 6.89e-01 1.42e-01
GOBP FOREBRAIN DEVELOPMENT 393 2.23e-06 2.24e-04 0.14400 -1.39e-01 -3.92e-02 2.22e-06 1.82e-01
GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME 69 8.93e-02 4.38e-01 0.14400 -1.22e-01 -7.73e-02 7.96e-02 2.67e-01
Downstream TCR signaling 81 6.19e-02 3.76e-01 0.14400 -5.81e-02 -1.32e-01 3.66e-01 3.96e-02
GOBP PYRIMIDINE DIMER REPAIR 9 7.37e-01 9.23e-01 0.14400 -4.61e-02 -1.37e-01 8.11e-01 4.77e-01
Amyloid fiber formation 73 9.26e-02 4.45e-01 0.14400 -1.99e-02 -1.43e-01 7.69e-01 3.47e-02
GOBP GLOMERULUS MORPHOGENESIS 9 7.54e-01 9.30e-01 0.14400 -1.44e-01 4.81e-03 4.54e-01 9.80e-01
GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY 15 6.44e-01 8.90e-01 0.14400 -1.36e-01 4.71e-02 3.60e-01 7.52e-01
GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 11 7.32e-01 9.22e-01 0.14400 7.40e-02 -1.24e-01 6.71e-01 4.77e-01
Peptide ligand-binding receptors 188 5.23e-03 1.02e-01 0.14400 -1.19e-01 8.20e-02 5.00e-03 5.24e-02
GOCC ESCRT I COMPLEX 12 7.15e-01 9.15e-01 0.14400 -9.66e-02 1.07e-01 5.62e-01 5.20e-01
GOBP MIRNA PROCESSING 44 2.17e-01 6.35e-01 0.14400 -1.25e-01 -7.20e-02 1.52e-01 4.09e-01
GOBP CELLULAR RESPONSE TO UV B 12 7.14e-01 9.15e-01 0.14400 -1.18e-01 8.23e-02 4.78e-01 6.22e-01
GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY 15 5.99e-01 8.73e-01 0.14400 5.52e-02 1.33e-01 7.11e-01 3.72e-01
GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY 7 7.87e-01 9.41e-01 0.14400 -5.37e-02 -1.34e-01 8.05e-01 5.40e-01
GOBP CHOLINE TRANSPORT 9 7.48e-01 9.28e-01 0.14400 -1.44e-01 -1.26e-02 4.56e-01 9.48e-01
GOMF G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR ACTIVITY 7 7.83e-01 9.40e-01 0.14400 1.19e-01 8.19e-02 5.87e-01 7.07e-01
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers 28 4.35e-01 7.97e-01 0.14400 3.66e-02 -1.39e-01 7.37e-01 2.02e-01
GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT 42 2.85e-01 6.97e-01 0.14400 -3.23e-02 1.40e-01 7.18e-01 1.16e-01
GOBP REGULATION OF PIGMENT CELL DIFFERENTIATION 8 7.55e-01 9.30e-01 0.14400 -1.14e-01 -8.84e-02 5.78e-01 6.65e-01
GOBP SPLICEOSOMAL COMPLEX ASSEMBLY 76 6.96e-02 3.97e-01 0.14400 -1.07e-01 -9.62e-02 1.07e-01 1.47e-01
GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY 10 7.09e-01 9.13e-01 0.14400 -6.27e-02 -1.30e-01 7.32e-01 4.78e-01
GOBP PROTEIN TRANSMEMBRANE TRANSPORT 71 8.48e-02 4.32e-01 0.14400 -7.79e-02 -1.21e-01 2.56e-01 7.80e-02
GOMF TRANSCRIPTION COACTIVATOR ACTIVITY 257 4.23e-04 1.68e-02 0.14400 -1.43e-01 1.78e-02 8.10e-05 6.23e-01
GOBP VIRAL RELEASE FROM HOST CELL 28 3.98e-01 7.76e-01 0.14400 -2.95e-02 -1.41e-01 7.87e-01 1.97e-01
Vif-mediated degradation of APOBEC3G 41 2.48e-01 6.63e-01 0.14400 -5.42e-02 -1.33e-01 5.48e-01 1.40e-01
GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA 9 7.31e-01 9.22e-01 0.14400 -7.71e-02 -1.21e-01 6.89e-01 5.28e-01
GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION 65 1.61e-01 5.59e-01 0.14400 -1.24e-01 7.35e-02 8.48e-02 3.06e-01
Transferrin endocytosis and recycling 29 4.00e-01 7.78e-01 0.14400 -1.44e-01 -4.26e-03 1.80e-01 9.68e-01
tRNA processing 105 2.56e-02 2.55e-01 0.14400 -1.10e-01 -9.24e-02 5.11e-02 1.02e-01
GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE 14 6.22e-01 8.81e-01 0.14400 -1.33e-01 -5.34e-02 3.87e-01 7.29e-01
GOBP MESODERMAL CELL DIFFERENTIATION 35 3.03e-01 7.13e-01 0.14400 -1.29e-01 -6.22e-02 1.85e-01 5.24e-01
GOCC EPSILON DNA POLYMERASE COMPLEX 5 8.59e-01 9.60e-01 0.14400 1.66e-02 -1.43e-01 9.49e-01 5.81e-01
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION 40 2.57e-01 6.71e-01 0.14300 -1.32e-01 -5.73e-02 1.50e-01 5.30e-01
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION 24 4.36e-01 7.97e-01 0.14300 1.21e-01 7.70e-02 3.05e-01 5.14e-01
GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX 118 1.91e-02 2.21e-01 0.14300 -5.03e-02 -1.34e-01 3.45e-01 1.17e-02
GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE 87 8.21e-02 4.25e-01 0.14300 1.34e-01 -5.06e-02 3.05e-02 4.14e-01
GOMF HISTONE H2AX KINASE ACTIVITY 5 8.63e-01 9.61e-01 0.14300 -1.39e-01 3.50e-02 5.90e-01 8.92e-01
GOMF OXIDIZED DNA BINDING 11 6.97e-01 9.11e-01 0.14300 3.24e-02 1.40e-01 8.52e-01 4.23e-01
GOBP TEMPERATURE HOMEOSTASIS 182 3.75e-03 8.47e-02 0.14300 -1.43e-01 5.94e-03 8.61e-04 8.90e-01
GOBP ACETYL COA METABOLIC PROCESS 31 4.04e-01 7.80e-01 0.14300 -3.95e-02 1.38e-01 7.04e-01 1.84e-01
GOBP NEGATIVE REGULATION OF ORGAN GROWTH 35 3.63e-01 7.53e-01 0.14300 -1.36e-01 4.58e-02 1.65e-01 6.39e-01
GOBP NEGATIVE REGULATION OF MRNA PROCESSING 20 5.58e-01 8.56e-01 0.14300 -1.37e-01 4.03e-02 2.87e-01 7.55e-01
GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS 79 8.16e-02 4.23e-01 0.14300 -1.23e-02 -1.43e-01 8.51e-01 2.83e-02
GOBP NEURAL PRECURSOR CELL PROLIFERATION 165 7.51e-03 1.28e-01 0.14300 -1.41e-01 2.66e-02 1.81e-03 5.56e-01
GOMF PSEUDOURIDINE SYNTHASE ACTIVITY 12 6.85e-01 9.06e-01 0.14300 -6.31e-03 -1.43e-01 9.70e-01 3.91e-01
PI3K/AKT activation 9 7.54e-01 9.30e-01 0.14300 -1.43e-01 -3.05e-03 4.57e-01 9.87e-01
GOBP REGULATION OF CIRCADIAN RHYTHM 109 3.40e-02 2.86e-01 0.14300 -1.43e-01 1.87e-04 9.79e-03 9.97e-01
GOBP SUBSTANTIA NIGRA DEVELOPMENT 40 2.49e-01 6.63e-01 0.14300 -9.78e-02 -1.05e-01 2.85e-01 2.53e-01
GOCC SERINE TYPE PEPTIDASE COMPLEX 13 6.44e-01 8.90e-01 0.14300 5.76e-02 1.31e-01 7.19e-01 4.13e-01
GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 35 3.81e-01 7.65e-01 0.14300 -1.15e-01 8.55e-02 2.40e-01 3.81e-01
GOBP QUATERNARY AMMONIUM GROUP TRANSPORT 17 6.23e-01 8.82e-01 0.14300 7.52e-02 -1.22e-01 5.91e-01 3.85e-01
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) 32 3.33e-01 7.35e-01 0.14300 -1.22e-01 -7.43e-02 2.31e-01 4.67e-01
Regulation of Glucokinase by Glucokinase Regulatory Protein 32 3.33e-01 7.35e-01 0.14300 -1.22e-01 -7.43e-02 2.31e-01 4.67e-01
GOMF ACTIN MONOMER BINDING 24 4.45e-01 8.02e-01 0.14300 -5.68e-02 -1.31e-01 6.30e-01 2.66e-01
RNA Polymerase I Transcription Initiation 45 2.16e-01 6.34e-01 0.14300 -1.27e-01 -6.65e-02 1.42e-01 4.40e-01
GOBP VITAMIN D3 METABOLIC PROCESS 7 8.11e-01 9.49e-01 0.14300 -1.41e-01 2.39e-02 5.18e-01 9.13e-01
GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE 7 8.06e-01 9.48e-01 0.14300 -4.83e-03 1.43e-01 9.82e-01 5.13e-01
GOBP PEPTIDE METABOLIC PROCESS 72 1.23e-01 5.02e-01 0.14300 -3.84e-02 1.38e-01 5.74e-01 4.33e-02
GOCC U2 TYPE SPLICEOSOMAL COMPLEX 91 4.61e-02 3.26e-01 0.14300 -6.28e-02 -1.28e-01 3.00e-01 3.43e-02
GOBP INTESTINAL LIPID ABSORPTION 22 5.25e-01 8.42e-01 0.14300 -3.53e-02 1.38e-01 7.75e-01 2.61e-01
GOBP MAINTENANCE OF CELL POLARITY 17 6.18e-01 8.80e-01 0.14300 5.71e-02 -1.31e-01 6.84e-01 3.50e-01
GOBP REGULATION OF BLOOD VOLUME BY RENIN ANGIOTENSIN 5 8.51e-01 9.58e-01 0.14300 2.61e-02 1.40e-01 9.19e-01 5.86e-01
CDK-mediated phosphorylation and removal of Cdc6 60 1.38e-01 5.27e-01 0.14300 -4.31e-02 -1.36e-01 5.63e-01 6.81e-02
GOBP POSITIVE REGULATION OF CONNECTIVE TISSUE REPLACEMENT 12 7.10e-01 9.13e-01 0.14300 -1.34e-01 5.07e-02 4.23e-01 7.61e-01
GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE 182 2.09e-03 5.61e-02 0.14300 -7.19e-02 -1.23e-01 9.41e-02 4.11e-03
RNA Pol II CTD phosphorylation and interaction with CE 26 4.07e-01 7.81e-01 0.14300 -1.05e-01 -9.67e-02 3.55e-01 3.93e-01
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection 26 4.07e-01 7.81e-01 0.14300 -1.05e-01 -9.67e-02 3.55e-01 3.93e-01
Negative regulation of FGFR3 signaling 28 4.59e-01 8.10e-01 0.14300 -1.24e-01 7.00e-02 2.55e-01 5.21e-01
GOBP POSITIVE REGULATION OF B CELL PROLIFERATION 43 2.39e-01 6.55e-01 0.14300 1.33e-01 5.09e-02 1.31e-01 5.64e-01
GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT 32 3.38e-01 7.38e-01 0.14300 -6.76e-02 -1.26e-01 5.08e-01 2.19e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION 61 1.89e-01 5.96e-01 0.14300 1.11e-01 -9.00e-02 1.35e-01 2.24e-01
GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION 13 6.96e-01 9.11e-01 0.14300 1.25e-01 -6.78e-02 4.33e-01 6.72e-01
GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION 187 3.39e-03 7.92e-02 0.14300 -1.42e-01 4.24e-03 7.80e-04 9.20e-01
GOBP LIPID DROPLET FUSION 5 8.59e-01 9.60e-01 0.14200 -1.42e-01 1.03e-02 5.82e-01 9.68e-01
GOBP REGULATION OF SYNAPTIC VESICLE MEMBRANE ORGANIZATION 12 7.07e-01 9.13e-01 0.14200 4.07e-02 -1.37e-01 8.07e-01 4.13e-01
SUMOylation of DNA replication proteins 46 2.19e-01 6.37e-01 0.14200 -1.35e-01 -4.58e-02 1.13e-01 5.91e-01
GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 26 4.28e-01 7.94e-01 0.14200 -1.37e-01 -3.76e-02 2.25e-01 7.40e-01
GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 26 4.70e-01 8.14e-01 0.14200 -1.38e-01 3.52e-02 2.23e-01 7.56e-01
Defects in vitamin and cofactor metabolism 21 5.05e-01 8.31e-01 0.14200 -1.38e-01 -3.60e-02 2.74e-01 7.75e-01
GOBP REGULATION OF CENTROSOME CYCLE 53 2.01e-01 6.14e-01 0.14200 9.28e-03 -1.42e-01 9.07e-01 7.36e-02
GOMF INORGANIC DIPHOSPHATE PHOSPHATASE ACTIVITY 5 8.42e-01 9.56e-01 0.14200 1.11e-01 8.91e-02 6.67e-01 7.30e-01
ESR-mediated signaling 183 2.01e-03 5.46e-02 0.14200 -1.17e-01 -8.15e-02 6.48e-03 5.73e-02
GOBP REGULATION OF XENOPHAGY 9 7.77e-01 9.38e-01 0.14200 -1.29e-01 6.06e-02 5.04e-01 7.53e-01
GOBP REGULATION OF HIPPO SIGNALING 35 3.70e-01 7.58e-01 0.14200 -1.34e-01 4.82e-02 1.71e-01 6.21e-01
Opioid Signalling 89 8.60e-02 4.33e-01 0.14200 -1.24e-01 6.96e-02 4.31e-02 2.56e-01
GOBP RESPONSE TO PROSTAGLANDIN 32 3.37e-01 7.37e-01 0.14200 -7.47e-02 -1.21e-01 4.64e-01 2.36e-01
Deubiquitination 231 5.08e-04 1.94e-02 0.14200 -5.18e-02 -1.32e-01 1.75e-01 5.28e-04
GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM 47 2.75e-01 6.87e-01 0.14200 7.19e-02 -1.23e-01 3.94e-01 1.46e-01
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH 42 2.56e-01 6.71e-01 0.14200 3.58e-02 1.38e-01 6.88e-01 1.23e-01
GOBP SPHINGOMYELIN METABOLIC PROCESS 20 5.61e-01 8.57e-01 0.14200 -3.55e-02 1.38e-01 7.84e-01 2.87e-01
GOBP TYPE 2 IMMUNE RESPONSE 42 3.21e-01 7.28e-01 0.14200 -9.74e-02 1.03e-01 2.75e-01 2.46e-01
GOBP SKELETAL SYSTEM MORPHOGENESIS 226 1.28e-03 3.97e-02 0.14200 -1.41e-01 1.78e-02 2.61e-04 6.45e-01
GOCC UNCONVENTIONAL MYOSIN COMPLEX 9 7.71e-01 9.36e-01 0.14200 -1.37e-01 3.69e-02 4.76e-01 8.48e-01
GOBP ACTIN MODIFICATION 5 8.71e-01 9.64e-01 0.14200 6.59e-02 -1.26e-01 7.98e-01 6.26e-01
GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 18 5.41e-01 8.49e-01 0.14200 1.09e-01 9.10e-02 4.23e-01 5.04e-01
GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY 13 6.87e-01 9.07e-01 0.14200 3.60e-02 -1.37e-01 8.22e-01 3.91e-01
TRAF6-mediated induction of TAK1 complex within TLR4 complex 15 6.31e-01 8.86e-01 0.14200 -1.86e-03 -1.42e-01 9.90e-01 3.41e-01
GOMF GLUTAMATE GATED RECEPTOR ACTIVITY 15 6.00e-01 8.75e-01 0.14200 -8.13e-02 -1.16e-01 5.86e-01 4.35e-01
GOBP MESENCHYME DEVELOPMENT 322 4.62e-05 3.03e-03 0.14200 -1.41e-01 -1.60e-02 1.35e-05 6.22e-01
LGI-ADAM interactions 14 6.44e-01 8.90e-01 0.14200 1.55e-02 1.41e-01 9.20e-01 3.61e-01
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION 8 7.78e-01 9.39e-01 0.14200 -1.41e-01 -1.41e-02 4.89e-01 9.45e-01
GOBP POSITIVE REGULATION OF MHC CLASS I BIOSYNTHETIC PROCESS 6 8.23e-01 9.52e-01 0.14200 -1.36e-01 -3.98e-02 5.63e-01 8.66e-01
G-protein beta:gamma signalling 30 4.30e-01 7.94e-01 0.14200 -1.32e-01 5.16e-02 2.10e-01 6.25e-01
Protein methylation 15 6.18e-01 8.80e-01 0.14200 -2.95e-02 -1.39e-01 8.43e-01 3.52e-01
GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY 265 1.51e-04 8.11e-03 0.14200 -1.25e-01 -6.74e-02 4.69e-04 5.90e-02
GOMF STRUCTURAL CONSTITUENT OF MYELIN SHEATH 9 7.81e-01 9.40e-01 0.14200 -1.23e-01 7.10e-02 5.24e-01 7.12e-01
GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE 43 3.02e-01 7.13e-01 0.14200 -1.30e-01 5.76e-02 1.42e-01 5.13e-01
Estrogen-dependent nuclear events downstream of ESR-membrane signaling 23 4.56e-01 8.09e-01 0.14200 -9.89e-02 -1.01e-01 4.11e-01 3.99e-01
GOBP RNA 3 END PROCESSING 84 6.35e-02 3.79e-01 0.14200 -1.32e-01 -5.09e-02 3.61e-02 4.20e-01
Metabolism of amino acids and derivatives 330 1.53e-04 8.19e-03 0.14200 9.05e-02 -1.09e-01 4.72e-03 6.60e-04
GOMF CHITIN BINDING 8 7.63e-01 9.32e-01 0.14200 1.17e-01 7.92e-02 5.65e-01 6.98e-01
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 13 6.42e-01 8.89e-01 0.14200 8.99e-02 1.10e-01 5.75e-01 4.94e-01
GOBP REGULATION OF PHOSPHATASE ACTIVITY 53 1.79e-01 5.83e-01 0.14200 -1.35e-01 -4.23e-02 8.87e-02 5.94e-01
GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING 18 5.80e-01 8.64e-01 0.14200 -4.41e-03 1.42e-01 9.74e-01 2.98e-01
GOBP INTERLEUKIN 12 PRODUCTION 62 1.88e-01 5.95e-01 0.14200 1.10e-01 -8.88e-02 1.33e-01 2.26e-01
GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS 88 9.33e-02 4.46e-01 0.14200 -8.44e-02 1.14e-01 1.71e-01 6.53e-02
Trafficking and processing of endosomal TLR 11 6.93e-01 9.09e-01 0.14200 -1.26e-01 -6.41e-02 4.68e-01 7.13e-01
GOBP REGULATION OF MEMBRANE PERMEABILITY 70 1.50e-01 5.44e-01 0.14200 7.59e-02 -1.19e-01 2.72e-01 8.39e-02
GOBP DERMATAN SULFATE METABOLIC PROCESS 8 8.00e-01 9.46e-01 0.14100 -5.27e-02 1.31e-01 7.96e-01 5.20e-01
Effects of PIP2 hydrolysis 26 4.91e-01 8.26e-01 0.14100 -1.23e-01 6.96e-02 2.77e-01 5.39e-01
GOMF ADENYLATE KINASE ACTIVITY 9 7.45e-01 9.27e-01 0.14100 1.33e-01 4.75e-02 4.89e-01 8.05e-01
GOCC DNA RECOMBINASE MEDIATOR COMPLEX 7 7.97e-01 9.44e-01 0.14100 -1.35e-01 -4.34e-02 5.38e-01 8.42e-01
Activation of AMPK downstream of NMDARs 27 4.02e-01 7.80e-01 0.14100 1.15e-01 8.17e-02 2.99e-01 4.63e-01
GOBP POSTSYNAPSE ASSEMBLY 41 2.54e-01 6.69e-01 0.14100 1.22e-01 7.18e-02 1.77e-01 4.26e-01
GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS 7 8.08e-01 9.49e-01 0.14100 -1.41e-01 -2.41e-04 5.17e-01 9.99e-01
GOMF PHOSPHATIDYLINOSITOL BINDING 263 9.42e-04 3.10e-02 0.14100 -1.02e-01 9.83e-02 4.59e-03 6.04e-03
GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS 13 6.93e-01 9.09e-01 0.14100 -4.48e-02 1.34e-01 7.80e-01 4.03e-01
GOBP PROTEIN LOCALIZATION TO CELL SURFACE 65 1.75e-01 5.80e-01 0.14100 -8.83e-02 1.10e-01 2.18e-01 1.24e-01
GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS 7 8.28e-01 9.53e-01 0.14100 -1.16e-01 7.99e-02 5.94e-01 7.14e-01
GOMF UBIQUITIN LIKE PROTEIN READER ACTIVITY 20 5.82e-01 8.66e-01 0.14100 -7.77e-02 1.18e-01 5.48e-01 3.61e-01
ABC transporter disorders 64 1.32e-01 5.18e-01 0.14100 -2.91e-02 -1.38e-01 6.87e-01 5.58e-02
GLI proteins bind promoters of Hh responsive genes to promote transcription 7 8.28e-01 9.53e-01 0.14100 -8.12e-02 1.16e-01 7.10e-01 5.97e-01
GOBP EPIGENETIC REGULATION OF GENE EXPRESSION 265 1.91e-04 9.64e-03 0.14100 -5.10e-02 -1.32e-01 1.53e-01 2.25e-04
GOBP CERAMIDE METABOLIC PROCESS 109 3.15e-02 2.77e-01 0.14100 3.25e-02 1.37e-01 5.58e-01 1.32e-02
GOBP MUSCLE CELL PROLIFERATION 233 8.44e-04 2.86e-02 0.14100 -1.41e-01 -8.18e-03 2.12e-04 8.30e-01
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding 38 3.27e-01 7.30e-01 0.14100 1.53e-02 -1.40e-01 8.71e-01 1.35e-01
SUMO is conjugated to E1 (UBA2:SAE1) 5 8.74e-01 9.65e-01 0.14100 1.16e-01 -8.03e-02 6.53e-01 7.56e-01
GOBP METANEPHRIC MESENCHYMAL CELL DIFFERENTIATION 5 8.59e-01 9.60e-01 0.14100 -1.41e-01 -2.31e-03 5.85e-01 9.93e-01
GOBP DECIDUALIZATION 24 4.56e-01 8.09e-01 0.14100 -1.31e-01 -5.28e-02 2.67e-01 6.54e-01
GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 67 1.66e-01 5.67e-01 0.14100 8.30e-02 -1.14e-01 2.40e-01 1.06e-01
GOMF HISTONE DEACETYLASE BINDING 109 2.57e-02 2.55e-01 0.14100 -1.08e-01 -9.10e-02 5.20e-02 1.01e-01
GOBP MEMBRANE LIPID CATABOLIC PROCESS 52 1.93e-01 6.02e-01 0.14100 2.93e-02 1.38e-01 7.15e-01 8.53e-02
GOBP REGULATION OF MICROTUBULE BASED MOVEMENT 53 1.68e-01 5.68e-01 0.14100 -9.51e-02 -1.04e-01 2.31e-01 1.90e-01
GOBP SULFUR COMPOUND CATABOLIC PROCESS 40 3.18e-01 7.25e-01 0.14100 1.38e-01 -3.07e-02 1.32e-01 7.37e-01
GOBP BASE EXCISION REPAIR AP SITE FORMATION 12 6.77e-01 9.04e-01 0.14100 4.93e-02 1.32e-01 7.68e-01 4.28e-01
GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE 13 6.80e-01 9.04e-01 0.14100 -9.05e-03 1.41e-01 9.55e-01 3.80e-01
GOMF RNA POLYMERASE CORE ENZYME BINDING 42 3.13e-01 7.22e-01 0.14100 -1.30e-01 5.33e-02 1.44e-01 5.50e-01
GOCC MITOTIC SPINDLE POLE 36 3.33e-01 7.35e-01 0.14100 -1.41e-01 -8.26e-03 1.44e-01 9.32e-01
GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX 141 1.41e-02 1.89e-01 0.14100 -5.09e-03 -1.41e-01 9.17e-01 3.91e-03
GOBP MYELOID CELL APOPTOTIC PROCESS 37 2.92e-01 7.05e-01 0.14100 -1.20e-01 -7.31e-02 2.05e-01 4.42e-01
GOBP PHOSPHATIDIC ACID METABOLIC PROCESS 36 3.07e-01 7.16e-01 0.14100 1.28e-01 5.88e-02 1.84e-01 5.41e-01
GOBP CMP METABOLIC PROCESS 8 7.95e-01 9.44e-01 0.14100 -1.37e-01 3.07e-02 5.01e-01 8.80e-01
GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY 10 7.66e-01 9.34e-01 0.14100 -9.41e-02 1.05e-01 6.07e-01 5.66e-01
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 79 1.19e-01 4.95e-01 0.14100 1.21e-01 -7.16e-02 6.26e-02 2.71e-01
GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 31 4.00e-01 7.78e-01 0.14100 -1.40e-01 1.08e-02 1.76e-01 9.17e-01
GOBP TENDON DEVELOPMENT 5 8.45e-01 9.57e-01 0.14100 9.35e-02 1.05e-01 7.17e-01 6.84e-01
Cross-presentation of soluble exogenous antigens (endosomes) 34 3.31e-01 7.34e-01 0.14100 -5.37e-02 -1.30e-01 5.88e-01 1.90e-01
GOMF ESTROGEN RESPONSE ELEMENT BINDING 10 7.66e-01 9.33e-01 0.14100 8.40e-02 -1.13e-01 6.45e-01 5.37e-01
GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE 19 5.53e-01 8.54e-01 0.14100 2.19e-02 1.39e-01 8.69e-01 2.94e-01
GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS 27 4.15e-01 7.85e-01 0.14100 1.29e-01 5.58e-02 2.46e-01 6.16e-01
GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS 50 2.13e-01 6.31e-01 0.14100 1.39e-01 1.80e-02 8.81e-02 8.25e-01
GOMF ACYLGLYCEROL LIPASE ACTIVITY 15 6.69e-01 9.00e-01 0.14100 -7.62e-02 1.18e-01 6.09e-01 4.28e-01
GOCC BOX C D RNP COMPLEX 6 8.26e-01 9.52e-01 0.14100 1.35e-01 3.90e-02 5.67e-01 8.69e-01
GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING 7 8.03e-01 9.47e-01 0.14100 -2.64e-02 -1.38e-01 9.04e-01 5.27e-01
GOCC PI BODY 10 7.24e-01 9.18e-01 0.14100 4.69e-02 1.32e-01 7.97e-01 4.68e-01
GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY 129 1.86e-02 2.17e-01 0.14100 -1.39e-01 -2.05e-02 6.39e-03 6.88e-01
GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION 54 1.64e-01 5.64e-01 0.14100 -1.04e-01 -9.41e-02 1.85e-01 2.32e-01
GOBP POLYKETIDE METABOLIC PROCESS 10 7.60e-01 9.32e-01 0.14000 -5.71e-02 1.28e-01 7.55e-01 4.82e-01
GOBP CARDIOBLAST PROLIFERATION 12 6.77e-01 9.04e-01 0.14000 -5.30e-02 -1.30e-01 7.51e-01 4.35e-01
TNFR2 non-canonical NF-kB pathway 83 1.10e-01 4.81e-01 0.14000 8.21e-02 -1.14e-01 1.96e-01 7.27e-02
GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME 52 1.79e-01 5.83e-01 0.14000 -1.19e-01 -7.43e-02 1.37e-01 3.54e-01
GOBP DOUBLE STRAND BREAK REPAIR INVOLVED IN MEIOTIC RECOMBINATION 11 7.10e-01 9.13e-01 0.14000 -2.46e-02 -1.38e-01 8.88e-01 4.27e-01
GOBP NEGATIVE REGULATION OF FAT CELL PROLIFERATION 5 8.71e-01 9.64e-01 0.14000 -1.32e-01 4.90e-02 6.11e-01 8.50e-01
GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS 161 6.94e-03 1.22e-01 0.14000 1.38e-01 2.29e-02 2.43e-03 6.15e-01
GOMF PHOSPHOLIPASE BINDING 20 5.22e-01 8.41e-01 0.14000 -5.66e-02 -1.28e-01 6.61e-01 3.20e-01
GOMF PHOSPHOLIPASE ACTIVITY 107 4.66e-02 3.28e-01 0.14000 1.38e-01 -2.28e-02 1.34e-02 6.83e-01
GOBP PANCREATIC JUICE SECRETION 11 7.48e-01 9.28e-01 0.14000 -8.72e-02 1.10e-01 6.17e-01 5.28e-01
GOMF ACYLTRANSFERASE ACTIVITY ACYL GROUPS CONVERTED INTO ALKYL ON TRANSFER 5 8.74e-01 9.65e-01 0.14000 -1.24e-01 6.51e-02 6.31e-01 8.01e-01
GOBP CENTRAL NERVOUS SYSTEM MATURATION 6 8.24e-01 9.52e-01 0.14000 -1.31e-01 -5.07e-02 5.79e-01 8.30e-01
GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS 206 1.47e-03 4.34e-02 0.14000 -1.33e-01 -4.40e-02 9.94e-04 2.76e-01
GOBP DEVELOPMENTAL CELL GROWTH 213 3.07e-03 7.47e-02 0.14000 -1.30e-01 5.24e-02 1.08e-03 1.87e-01
GOMF POLY PURINE TRACT BINDING 27 4.72e-01 8.15e-01 0.14000 -1.34e-01 4.16e-02 2.29e-01 7.08e-01
GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING 78 8.82e-02 4.37e-01 0.14000 -2.82e-02 -1.37e-01 6.67e-01 3.61e-02
GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR 46 2.20e-01 6.37e-01 0.14000 -1.18e-01 -7.52e-02 1.66e-01 3.78e-01
GOBP PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY 7 7.98e-01 9.45e-01 0.14000 -4.99e-02 -1.31e-01 8.19e-01 5.49e-01
GOBP MITOCHONDRIAL TRANSCRIPTION 22 5.38e-01 8.49e-01 0.14000 3.39e-02 -1.36e-01 7.83e-01 2.70e-01
GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY 34 3.45e-01 7.43e-01 0.14000 1.36e-01 3.12e-02 1.68e-01 7.53e-01
GOBP KETONE BIOSYNTHETIC PROCESS 47 2.63e-01 6.78e-01 0.14000 1.37e-01 -2.76e-02 1.04e-01 7.43e-01
GOBP MAINTENANCE OF SYNAPSE STRUCTURE 24 5.32e-01 8.45e-01 0.14000 -1.02e-01 9.54e-02 3.85e-01 4.19e-01
GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE 5 8.54e-01 9.59e-01 0.14000 -3.80e-02 -1.35e-01 8.83e-01 6.02e-01
GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS 20 5.15e-01 8.38e-01 0.14000 -8.52e-02 -1.11e-01 5.09e-01 3.90e-01
Transport of Mature mRNA derived from an Intron-Containing Transcript 69 1.04e-01 4.70e-01 0.14000 -7.60e-02 -1.17e-01 2.75e-01 9.16e-02
GOBP PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION 15 6.07e-01 8.76e-01 0.14000 -9.97e-02 -9.82e-02 5.04e-01 5.10e-01
Sodium/Proton exchangers 7 8.00e-01 9.46e-01 0.14000 4.54e-02 1.32e-01 8.35e-01 5.44e-01
GOCC SEX CHROMOSOME 33 3.61e-01 7.52e-01 0.14000 -1.37e-01 -2.55e-02 1.72e-01 8.00e-01
GOBP RESPONSE TO ODORANT 5 8.68e-01 9.63e-01 0.14000 -2.94e-02 1.37e-01 9.09e-01 5.97e-01
GOBP INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY 6 8.27e-01 9.53e-01 0.14000 4.03e-02 1.34e-01 8.64e-01 5.70e-01
GOBP ANTEROGRADE AXONAL TRANSPORT OF MITOCHONDRION 6 8.21e-01 9.52e-01 0.14000 -1.13e-01 -8.18e-02 6.31e-01 7.29e-01
G alpha (q) signalling events 207 4.26e-03 9.04e-02 0.14000 -1.20e-01 7.10e-02 2.85e-03 7.82e-02
GOBP VACUOLE FUSION 12 7.18e-01 9.15e-01 0.14000 4.22e-02 -1.33e-01 8.00e-01 4.25e-01
DNA Repair 298 6.05e-05 3.87e-03 0.14000 -1.09e-01 -8.67e-02 1.16e-03 1.00e-02
GOBP GLYCOLIPID BIOSYNTHETIC PROCESS 77 1.33e-01 5.21e-01 0.14000 1.10e-01 -8.58e-02 9.48e-02 1.93e-01
Laminin interactions 28 4.59e-01 8.10e-01 0.14000 -3.79e-02 1.34e-01 7.29e-01 2.19e-01
GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION 56 2.03e-01 6.17e-01 0.14000 -1.38e-01 2.13e-02 7.42e-02 7.83e-01
GOBP VENTRAL MIDLINE DEVELOPMENT 6 8.38e-01 9.55e-01 0.14000 -1.39e-01 4.94e-03 5.54e-01 9.83e-01
GOBP REGULATION OF PLASMA CELL DIFFERENTIATION 6 8.25e-01 9.52e-01 0.13900 -5.53e-02 -1.28e-01 8.15e-01 5.87e-01
SUMOylation of chromatin organization proteins 57 2.06e-01 6.21e-01 0.13900 -1.35e-01 3.66e-02 7.90e-02 6.33e-01
GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS 6 8.35e-01 9.55e-01 0.13900 -1.39e-01 -9.29e-03 5.55e-01 9.69e-01
GOBP ISOTYPE SWITCHING TO IGA ISOTYPES 7 8.20e-01 9.52e-01 0.13900 2.49e-02 -1.37e-01 9.09e-01 5.30e-01
GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX 11 7.44e-01 9.26e-01 0.13900 -5.64e-02 1.27e-01 7.46e-01 4.65e-01
GOMF FILAMIN BINDING 14 6.65e-01 8.98e-01 0.13900 -7.96e-03 1.39e-01 9.59e-01 3.68e-01
Urea cycle 9 7.47e-01 9.28e-01 0.13900 -6.76e-02 -1.22e-01 7.25e-01 5.27e-01
GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY 12 6.77e-01 9.04e-01 0.13900 -7.08e-02 -1.20e-01 6.71e-01 4.72e-01
GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY 22 5.02e-01 8.30e-01 0.13900 -1.33e-01 -3.96e-02 2.78e-01 7.48e-01
Regulation of innate immune responses to cytosolic DNA 15 6.77e-01 9.04e-01 0.13900 9.88e-02 -9.82e-02 5.08e-01 5.10e-01
Regulation of ornithine decarboxylase (ODC) 38 2.92e-01 7.04e-01 0.13900 -6.96e-02 -1.21e-01 4.58e-01 1.98e-01
GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION 158 1.55e-02 1.98e-01 0.13900 -1.22e-01 6.63e-02 7.92e-03 1.50e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION 27 4.52e-01 8.07e-01 0.13900 -1.98e-04 1.39e-01 9.99e-01 2.10e-01
GOBP CGAS STING SIGNALING PATHWAY 17 6.02e-01 8.75e-01 0.13900 -1.39e-01 -9.09e-03 3.21e-01 9.48e-01
GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY 14 6.60e-01 8.96e-01 0.13900 1.39e-01 4.13e-03 3.68e-01 9.79e-01
GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY 86 1.08e-01 4.76e-01 0.13900 -1.04e-01 9.30e-02 9.71e-02 1.36e-01
Common Pathway of Fibrin Clot Formation 21 5.11e-01 8.35e-01 0.13900 5.65e-02 1.27e-01 6.54e-01 3.13e-01
GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION 20 5.60e-01 8.57e-01 0.13900 1.39e-01 -8.63e-03 2.82e-01 9.47e-01
GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY 94 8.77e-02 4.37e-01 0.13900 -9.16e-02 1.05e-01 1.25e-01 7.95e-02
GOMF LIPID TRANSFER ACTIVITY 56 2.32e-01 6.50e-01 0.13900 -1.13e-01 8.07e-02 1.43e-01 2.96e-01
GOCC CILIARY TRANSITION ZONE 72 1.15e-01 4.90e-01 0.13900 -1.35e-02 -1.38e-01 8.43e-01 4.22e-02
GOMF SNAP RECEPTOR ACTIVITY 36 3.23e-01 7.28e-01 0.13900 -1.32e-01 -4.28e-02 1.69e-01 6.57e-01
GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS 17 5.82e-01 8.66e-01 0.13900 1.29e-01 5.29e-02 3.59e-01 7.06e-01
GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY 27 4.29e-01 7.94e-01 0.13900 4.16e-02 1.33e-01 7.08e-01 2.33e-01
GOMF CHEMOREPELLENT ACTIVITY 28 4.37e-01 7.97e-01 0.13900 4.73e-03 1.39e-01 9.65e-01 2.03e-01
GOMF OXYGEN BINDING 32 4.19e-01 7.87e-01 0.13900 1.32e-01 -4.49e-02 1.98e-01 6.60e-01
GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION 29 4.16e-01 7.86e-01 0.13900 -1.38e-01 -1.86e-02 1.99e-01 8.63e-01
GOCC AP 1 ADAPTOR COMPLEX 11 7.02e-01 9.12e-01 0.13900 6.24e-02 1.24e-01 7.20e-01 4.76e-01
GOBP CELL CELL RECOGNITION 73 1.31e-01 5.16e-01 0.13900 1.36e-01 -2.87e-02 4.46e-02 6.72e-01
GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 42 3.04e-01 7.14e-01 0.13900 -1.92e-02 1.38e-01 8.30e-01 1.23e-01
GOBP RNA EXPORT FROM NUCLEUS 84 7.33e-02 4.05e-01 0.13900 -3.97e-02 -1.33e-01 5.30e-01 3.49e-02
GOMF DIOXYGENASE ACTIVITY 86 8.83e-02 4.37e-01 0.13900 -1.37e-01 2.06e-02 2.77e-02 7.42e-01
GOBP SYNAPTIC VESICLE RECYCLING 77 1.37e-01 5.26e-01 0.13900 -8.81e-02 1.07e-01 1.81e-01 1.03e-01
GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE 12 7.00e-01 9.12e-01 0.13900 1.39e-01 8.32e-03 4.06e-01 9.60e-01
GOBP MITOCHONDRIAL DNA METABOLIC PROCESS 22 5.23e-01 8.42e-01 0.13900 -2.76e-03 -1.39e-01 9.82e-01 2.60e-01
GOBP EMBRYONIC EYE MORPHOGENESIS 35 3.59e-01 7.50e-01 0.13900 -1.39e-01 -5.31e-04 1.55e-01 9.96e-01
GOBP NUCLEAR EXPORT 157 1.05e-02 1.58e-01 0.13900 1.58e-03 -1.39e-01 9.73e-01 2.68e-03
GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION 13 7.13e-01 9.14e-01 0.13900 -1.14e-01 7.89e-02 4.76e-01 6.22e-01
GOBP DETECTION OF STIMULUS 574 2.97e-07 3.76e-05 0.13900 1.28e-01 -5.29e-02 1.47e-07 3.04e-02
GOBP NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 9 7.61e-01 9.32e-01 0.13900 -1.37e-01 -2.34e-02 4.77e-01 9.03e-01
GOCC CALCITONIN FAMILY RECEPTOR COMPLEX 5 8.77e-01 9.66e-01 0.13900 -1.20e-01 7.01e-02 6.43e-01 7.86e-01
Lagging Strand Synthesis 19 5.41e-01 8.50e-01 0.13900 -7.24e-02 -1.18e-01 5.85e-01 3.72e-01
GOBP NEGATIVE REGULATION OF GLIAL CELL APOPTOTIC PROCESS 9 7.89e-01 9.42e-01 0.13900 6.74e-02 -1.21e-01 7.26e-01 5.29e-01
GOCC CCR4 NOT CORE COMPLEX 6 8.50e-01 9.58e-01 0.13900 -1.31e-01 4.40e-02 5.77e-01 8.52e-01
GOBP RAS PROTEIN SIGNAL TRANSDUCTION 116 3.83e-02 3.01e-01 0.13900 -1.37e-01 1.91e-02 1.06e-02 7.22e-01
GOBP DENDRITIC CELL CYTOKINE PRODUCTION 18 6.05e-01 8.76e-01 0.13900 2.55e-02 -1.36e-01 8.51e-01 3.17e-01
GOCC SPLICEOSOMAL TRI SNRNP COMPLEX 40 2.77e-01 6.91e-01 0.13900 -1.21e-01 -6.72e-02 1.85e-01 4.62e-01
GOBP ESTABLISHMENT OF CELL POLARITY 151 2.08e-02 2.30e-01 0.13900 -1.06e-01 8.87e-02 2.39e-02 5.99e-02
GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT 11 7.12e-01 9.14e-01 0.13900 3.44e-02 1.34e-01 8.44e-01 4.41e-01
GOMF ALCOHOL TRANSMEMBRANE TRANSPORTER ACTIVITY 6 8.50e-01 9.58e-01 0.13900 1.32e-01 -4.35e-02 5.77e-01 8.54e-01
GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS 79 9.58e-02 4.52e-01 0.13900 1.38e-01 1.22e-02 3.40e-02 8.51e-01
GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT 30 4.15e-01 7.85e-01 0.13800 -1.38e-01 -4.15e-03 1.89e-01 9.69e-01
GOCC RADIAL SPOKE 15 6.80e-01 9.04e-01 0.13800 -9.17e-02 1.04e-01 5.39e-01 4.87e-01
tRNA processing in the nucleus 58 1.53e-01 5.48e-01 0.13800 -8.63e-02 -1.08e-01 2.55e-01 1.54e-01
GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION 17 5.75e-01 8.63e-01 0.13800 -1.03e-01 -9.25e-02 4.62e-01 5.09e-01
GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE 12 7.09e-01 9.13e-01 0.13800 -8.46e-03 1.38e-01 9.60e-01 4.07e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT 67 1.30e-01 5.15e-01 0.13800 -1.35e-01 -2.90e-02 5.55e-02 6.81e-01
GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT 64 1.82e-01 5.86e-01 0.13800 -1.28e-01 5.26e-02 7.66e-02 4.67e-01
GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE 7 8.03e-01 9.46e-01 0.13800 -4.97e-02 -1.29e-01 8.20e-01 5.54e-01
GOCC PHAGOCYTIC VESICLE MEMBRANE 73 1.43e-01 5.35e-01 0.13800 5.13e-02 -1.28e-01 4.49e-01 5.78e-02
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES 6 8.24e-01 9.52e-01 0.13800 1.12e-01 8.13e-02 6.35e-01 7.30e-01
GOCC PERIKARYON 144 1.75e-02 2.11e-01 0.13800 -1.37e-01 1.58e-02 4.46e-03 7.43e-01
GOBP REGULATION OF MACROPHAGE MIGRATION 45 2.92e-01 7.05e-01 0.13800 -1.34e-01 3.39e-02 1.20e-01 6.94e-01
GOBP INTERLEUKIN 4 PRODUCTION 32 3.59e-01 7.50e-01 0.13800 7.37e-02 1.17e-01 4.71e-01 2.53e-01
GOMF NUCLEAR ESTROGEN RECEPTOR BINDING 39 2.83e-01 6.95e-01 0.13800 -9.56e-02 -9.97e-02 3.02e-01 2.81e-01
GOBP NOTCH RECEPTOR PROCESSING 9 7.49e-01 9.28e-01 0.13800 -7.60e-02 -1.15e-01 6.93e-01 5.49e-01
GOBP REGULATION OF PLASMA MEMBRANE REPAIR 6 8.57e-01 9.60e-01 0.13800 -8.61e-02 1.08e-01 7.15e-01 6.47e-01
GOCC DYNEIN AXONEMAL PARTICLE 20 5.64e-01 8.58e-01 0.13800 1.38e-01 -7.07e-03 2.86e-01 9.56e-01
GOBP DEFENSE RESPONSE TO FUNGUS 50 2.69e-01 6.84e-01 0.13800 1.24e-01 -6.01e-02 1.28e-01 4.62e-01
GOMF CUPRIC ION BINDING 5 8.79e-01 9.67e-01 0.13800 -1.17e-01 7.39e-02 6.52e-01 7.75e-01
GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING 34 3.53e-01 7.46e-01 0.13800 -1.33e-01 -3.59e-02 1.79e-01 7.17e-01
Choline catabolism 6 8.27e-01 9.52e-01 0.13800 1.23e-01 6.18e-02 6.00e-01 7.93e-01
GOBP V D J RECOMBINATION 19 5.85e-01 8.67e-01 0.13800 -1.37e-01 1.53e-02 3.00e-01 9.08e-01
Activation of TRKA receptors 6 8.24e-01 9.52e-01 0.13800 8.14e-02 1.11e-01 7.30e-01 6.36e-01
GOMF INSULIN LIKE GROWTH FACTOR I BINDING 13 6.66e-01 8.99e-01 0.13800 -1.29e-01 -5.03e-02 4.22e-01 7.54e-01
GOBP POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION 6 8.43e-01 9.56e-01 0.13800 1.38e-01 -9.31e-03 5.59e-01 9.69e-01
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS 43 3.24e-01 7.29e-01 0.13800 6.10e-02 -1.24e-01 4.89e-01 1.60e-01
Epigenetic regulation by WDR5-containing histone modifying complexes 123 2.46e-02 2.51e-01 0.13800 -1.35e-01 -2.79e-02 9.66e-03 5.93e-01
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN 23 5.09e-01 8.34e-01 0.13800 -1.01e-02 -1.38e-01 9.33e-01 2.53e-01
GOMF ALPHA KETOGLUTARATE TRANSMEMBRANE TRANSPORTER ACTIVITY 6 8.50e-01 9.58e-01 0.13800 -3.95e-02 1.32e-01 8.67e-01 5.75e-01
GOMF RNA POLYMERASE BINDING 58 2.07e-01 6.23e-01 0.13800 -1.33e-01 3.54e-02 7.93e-02 6.41e-01
GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 21 5.53e-01 8.54e-01 0.13800 -1.37e-01 1.32e-02 2.76e-01 9.17e-01
GOCC LAMELLIPODIUM 196 4.94e-03 9.85e-02 0.13800 -1.34e-01 3.24e-02 1.22e-03 4.34e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION 40 3.38e-01 7.38e-01 0.13800 1.33e-01 -3.62e-02 1.46e-01 6.92e-01
GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS 15 6.64e-01 8.97e-01 0.13800 -3.17e-02 1.34e-01 8.32e-01 3.69e-01
GOMF ASPARTIC TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY 7 8.00e-01 9.46e-01 0.13800 -7.42e-02 -1.16e-01 7.34e-01 5.95e-01
GOBP TRANSLATION 704 5.54e-09 1.05e-06 0.13800 2.02e-02 -1.36e-01 3.60e-01 7.12e-10
Signaling by MAPK mutants 6 8.56e-01 9.60e-01 0.13800 -7.02e-02 1.18e-01 7.66e-01 6.15e-01
GOMF SODIUM PHOSPHATE SYMPORTER ACTIVITY 13 6.67e-01 8.99e-01 0.13800 1.28e-01 5.18e-02 4.26e-01 7.46e-01
GOBP MRNA CIS SPLICING VIA SPLICEOSOME 30 3.83e-01 7.67e-01 0.13800 -8.02e-02 -1.12e-01 4.47e-01 2.89e-01
GOBP SENSORY PERCEPTION OF TASTE 66 1.21e-01 4.99e-01 0.13800 8.22e-02 1.10e-01 2.48e-01 1.21e-01
GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION 25 5.30e-01 8.43e-01 0.13800 8.99e-02 -1.04e-01 4.37e-01 3.67e-01
mitochondrial fatty acid beta-oxidation of saturated fatty acids 11 7.46e-01 9.27e-01 0.13800 -1.30e-01 4.61e-02 4.56e-01 7.91e-01
GOBP NEGATIVE REGULATION OF DENDRITE DEVELOPMENT 8 8.15e-01 9.51e-01 0.13800 1.09e-01 -8.40e-02 5.94e-01 6.81e-01
GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY 36 3.21e-01 7.28e-01 0.13800 -6.42e-02 -1.22e-01 5.05e-01 2.06e-01
GOBP AMINOGLYCAN METABOLIC PROCESS 119 4.81e-02 3.32e-01 0.13800 -7.77e-02 1.14e-01 1.43e-01 3.24e-02
GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY 7 8.29e-01 9.53e-01 0.13800 1.31e-01 -4.21e-02 5.49e-01 8.47e-01
GOBP BARBED END ACTIN FILAMENT CAPPING 25 4.52e-01 8.07e-01 0.13700 7.52e-02 1.15e-01 5.15e-01 3.19e-01
GOMF BMP RECEPTOR BINDING 12 7.35e-01 9.23e-01 0.13700 1.15e-01 -7.52e-02 4.90e-01 6.52e-01
GOBP RIBOSOME BIOGENESIS 298 2.04e-04 1.02e-02 0.13700 -3.05e-03 -1.37e-01 9.28e-01 4.47e-05
Biological oxidations 211 3.03e-03 7.43e-02 0.13700 1.36e-01 -2.05e-02 6.66e-04 6.08e-01
GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION 64 1.88e-01 5.95e-01 0.13700 -5.71e-02 1.25e-01 4.30e-01 8.37e-02
GOBP INTERLEUKIN 10 PRODUCTION 58 1.80e-01 5.84e-01 0.13700 1.36e-01 1.87e-02 7.30e-02 8.05e-01
GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS 44 2.54e-01 6.69e-01 0.13700 5.62e-02 1.25e-01 5.19e-01 1.50e-01
GOBP PSEUDOURIDINE SYNTHESIS 17 5.96e-01 8.72e-01 0.13700 -3.92e-02 -1.32e-01 7.80e-01 3.48e-01
GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS 7 8.36e-01 9.55e-01 0.13700 -1.17e-01 7.18e-02 5.92e-01 7.42e-01
GOBP EPHRIN RECEPTOR SIGNALING PATHWAY 49 2.76e-01 6.89e-01 0.13700 -5.06e-02 1.28e-01 5.40e-01 1.22e-01
GOCC CYTOSKELETON OF PRESYNAPTIC ACTIVE ZONE 8 8.12e-01 9.49e-01 0.13700 -1.23e-01 6.08e-02 5.47e-01 7.66e-01
GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION 16 6.67e-01 8.99e-01 0.13700 -1.06e-01 8.66e-02 4.61e-01 5.49e-01
GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA 117 5.11e-02 3.44e-01 0.13700 -1.15e-01 7.52e-02 3.20e-02 1.60e-01
GOBP NEURON PROJECTION REGENERATION 57 2.36e-01 6.53e-01 0.13700 -8.20e-02 1.10e-01 2.84e-01 1.51e-01
GOBP REGULATION OF AMPA RECEPTOR ACTIVITY 18 5.78e-01 8.64e-01 0.13700 -1.31e-01 -3.92e-02 3.34e-01 7.73e-01
Mitotic Spindle Checkpoint 108 3.36e-02 2.85e-01 0.13700 -1.18e-01 -7.00e-02 3.42e-02 2.09e-01
Activation of the AP-1 family of transcription factors 10 7.55e-01 9.30e-01 0.13700 1.37e-01 -1.02e-02 4.54e-01 9.55e-01
GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS 11 7.57e-01 9.31e-01 0.13700 -1.08e-01 8.47e-02 5.36e-01 6.27e-01
The canonical retinoid cycle in rods (twilight vision) 22 4.98e-01 8.30e-01 0.13700 7.57e-02 1.14e-01 5.39e-01 3.53e-01
Activation of Ca-permeable Kainate Receptor 9 7.83e-01 9.40e-01 0.13700 -3.02e-02 1.34e-01 8.75e-01 4.87e-01
Ionotropic activity of kainate receptors 9 7.83e-01 9.40e-01 0.13700 -3.02e-02 1.34e-01 8.75e-01 4.87e-01
GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION 21 5.34e-01 8.46e-01 0.13700 -2.82e-02 -1.34e-01 8.23e-01 2.87e-01
GOBP DETOXIFICATION OF INORGANIC COMPOUND 22 5.04e-01 8.31e-01 0.13700 1.24e-01 5.92e-02 3.16e-01 6.31e-01
GOMF MDM2 MDM4 FAMILY PROTEIN BINDING 11 7.47e-01 9.28e-01 0.13700 1.30e-01 -4.38e-02 4.56e-01 8.02e-01
GOMF SULFURIC ESTER HYDROLASE ACTIVITY 11 7.56e-01 9.30e-01 0.13700 -1.15e-01 7.48e-02 5.10e-01 6.68e-01
GOBP CARDIAC MUSCLE TISSUE REGENERATION 8 7.85e-01 9.41e-01 0.13700 -1.32e-01 -3.54e-02 5.17e-01 8.62e-01
Mucopolysaccharidoses 10 7.55e-01 9.30e-01 0.13700 -1.37e-01 9.84e-03 4.54e-01 9.57e-01
GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION 15 6.40e-01 8.88e-01 0.13700 2.70e-02 1.34e-01 8.57e-01 3.68e-01
GOBP ASPARTATE METABOLIC PROCESS 8 7.85e-01 9.41e-01 0.13700 1.32e-01 3.71e-02 5.19e-01 8.56e-01
GOBP CYTOSOLIC RIBOSOME ASSEMBLY 8 7.75e-01 9.38e-01 0.13700 -1.05e-01 -8.75e-02 6.06e-01 6.68e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET 7 8.25e-01 9.52e-01 0.13700 1.35e-01 -2.04e-02 5.35e-01 9.26e-01
GOBP MESENCHYMAL CELL PROLIFERATION 44 2.56e-01 6.71e-01 0.13700 -1.24e-01 -5.71e-02 1.53e-01 5.12e-01
GOCC EXOCYST 16 6.56e-01 8.93e-01 0.13700 -4.50e-02 1.29e-01 7.56e-01 3.71e-01
Phase II - Conjugation of compounds 103 6.48e-02 3.83e-01 0.13700 1.31e-01 -3.81e-02 2.12e-02 5.04e-01
GOCC SPINDLE POLE CENTROSOME 13 7.17e-01 9.15e-01 0.13700 6.70e-02 -1.19e-01 6.76e-01 4.56e-01
GOBP COPPER ION TRANSMEMBRANE TRANSPORT 7 8.09e-01 9.49e-01 0.13700 3.79e-02 1.31e-01 8.62e-01 5.47e-01
Syndecan interactions 26 4.49e-01 8.04e-01 0.13700 -1.26e-01 -5.38e-02 2.67e-01 6.35e-01
GOBP POSITIVE REGULATION OF MRNA PROCESSING 30 4.43e-01 8.01e-01 0.13700 2.68e-02 -1.34e-01 8.00e-01 2.04e-01
Telomere C-strand synthesis initiation 12 7.11e-01 9.14e-01 0.13700 1.16e-03 -1.37e-01 9.94e-01 4.12e-01
Downstream signaling of activated FGFR4 26 5.18e-01 8.39e-01 0.13700 -1.14e-01 7.53e-02 3.14e-01 5.07e-01
GOMF PROTEIN LIPID COMPLEX BINDING 31 4.59e-01 8.10e-01 0.13700 -1.06e-01 8.68e-02 3.09e-01 4.03e-01
Transcriptional Regulation by NPAS4 32 3.88e-01 7.69e-01 0.13700 -1.34e-01 -2.65e-02 1.89e-01 7.95e-01
GOBP HEART DEVELOPMENT 601 1.80e-07 2.39e-05 0.13700 -1.31e-01 3.89e-02 4.15e-08 1.03e-01
GOBP ASTROCYTE ACTIVATION 26 4.42e-01 8.00e-01 0.13700 -1.14e-01 -7.54e-02 3.15e-01 5.06e-01
Mitotic Prophase 104 3.94e-02 3.06e-01 0.13700 -6.80e-02 -1.18e-01 2.31e-01 3.69e-02
GOBP MEMBRANE DEPOLARIZATION DURING AV NODE CELL ACTION POTENTIAL 6 8.28e-01 9.53e-01 0.13700 7.55e-02 1.14e-01 7.49e-01 6.29e-01
GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 84 1.23e-01 5.02e-01 0.13700 9.99e-02 -9.30e-02 1.13e-01 1.40e-01
GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY 19 5.97e-01 8.73e-01 0.13600 -1.34e-01 2.46e-02 3.11e-01 8.53e-01
Extension of Telomeres 49 2.31e-01 6.50e-01 0.13600 -1.32e-01 -3.39e-02 1.09e-01 6.81e-01
GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 26 4.75e-01 8.18e-01 0.13600 6.65e-03 1.36e-01 9.53e-01 2.29e-01
GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION 32 3.94e-01 7.74e-01 0.13600 1.35e-01 1.77e-02 1.85e-01 8.62e-01
GOBP CELLULAR RESPONSE TO ACID CHEMICAL 89 7.95e-02 4.19e-01 0.13600 -1.36e-01 -5.38e-03 2.62e-02 9.30e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE 17 6.13e-01 8.79e-01 0.13600 -1.01e-02 -1.36e-01 9.42e-01 3.32e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION 21 5.71e-01 8.61e-01 0.13600 -3.22e-02 1.32e-01 7.98e-01 2.93e-01
Downstream signal transduction 29 4.24e-01 7.92e-01 0.13600 -1.33e-01 -2.87e-02 2.14e-01 7.89e-01
GOBP REGULATORY NCRNA MEDIATED GENE SILENCING 601 4.22e-08 6.56e-06 0.13600 1.58e-02 1.35e-01 5.09e-01 1.41e-08
GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA 7 8.40e-01 9.56e-01 0.13600 -1.04e-01 8.76e-02 6.32e-01 6.88e-01
GOMF PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY 16 6.50e-01 8.91e-01 0.13600 1.34e-01 -2.61e-02 3.54e-01 8.57e-01
Deadenylation-dependent mRNA decay 53 1.89e-01 5.95e-01 0.13600 -9.64e-02 -9.63e-02 2.25e-01 2.25e-01
GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS 8 7.85e-01 9.41e-01 0.13600 -4.38e-02 -1.29e-01 8.30e-01 5.27e-01
Activation of GABAB receptors 43 3.43e-01 7.41e-01 0.13600 -9.37e-02 9.89e-02 2.88e-01 2.62e-01
GABA B receptor activation 43 3.43e-01 7.41e-01 0.13600 -9.37e-02 9.89e-02 2.88e-01 2.62e-01
GOCC MICROVILLUS 97 4.75e-02 3.30e-01 0.13600 9.51e-02 9.75e-02 1.05e-01 9.70e-02
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 30 3.95e-01 7.74e-01 0.13600 -1.19e-01 -6.54e-02 2.57e-01 5.35e-01
GOBP NEGATIVE REGULATION OF CELL ADHESION MOLECULE PRODUCTION 10 7.57e-01 9.31e-01 0.13600 -6.90e-03 1.36e-01 9.70e-01 4.56e-01
CDC42 GTPase cycle 143 2.84e-02 2.67e-01 0.13600 -1.11e-01 7.95e-02 2.25e-02 1.01e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 8 7.81e-01 9.40e-01 0.13600 -1.22e-01 -6.12e-02 5.51e-01 7.64e-01
Translocation of ZAP-70 to Immunological synapse 17 6.21e-01 8.81e-01 0.13600 2.98e-03 -1.36e-01 9.83e-01 3.31e-01
GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE 150 1.97e-02 2.25e-01 0.13600 1.31e-01 -3.86e-02 5.80e-03 4.15e-01
GOBP NEGATIVE REGULATION OF SATELLITE CELL DIFFERENTIATION 5 8.66e-01 9.62e-01 0.13600 -1.44e-02 -1.35e-01 9.56e-01 6.00e-01
GOBP REGULATION OF FIBROBLAST PROLIFERATION 89 1.00e-01 4.64e-01 0.13600 4.89e-02 -1.27e-01 4.25e-01 3.84e-02
GOCC DNA REPAIR COMPLEX 22 5.46e-01 8.51e-01 0.13600 -1.35e-01 1.28e-02 2.71e-01 9.18e-01
GOCC PHOSPHATASE COMPLEX 52 2.13e-01 6.30e-01 0.13600 -1.31e-01 -3.51e-02 1.01e-01 6.62e-01
GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT 975 3.17e-12 9.49e-10 0.13600 -1.36e-01 -4.90e-03 6.41e-13 7.95e-01
GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT 37 3.57e-01 7.49e-01 0.13600 -4.56e-03 1.36e-01 9.62e-01 1.52e-01
PI3K events in ERBB2 signaling 16 6.67e-01 8.99e-01 0.13600 6.55e-02 -1.19e-01 6.50e-01 4.09e-01
GOBP HAIR CELL DIFFERENTIATION 54 1.93e-01 6.01e-01 0.13600 1.24e-01 5.50e-02 1.14e-01 4.85e-01
GOBP REGULATION OF EMBRYONIC DEVELOPMENT 88 6.61e-02 3.88e-01 0.13600 -1.18e-01 -6.81e-02 5.63e-02 2.70e-01
GOCC PROTEASOME ACCESSORY COMPLEX 23 4.86e-01 8.23e-01 0.13600 -9.56e-02 -9.67e-02 4.28e-01 4.22e-01
GOBP IRON IMPORT INTO CELL 10 7.79e-01 9.39e-01 0.13600 8.13e-02 -1.09e-01 6.56e-01 5.51e-01
GOBP IMP CATABOLIC PROCESS 5 8.55e-01 9.59e-01 0.13600 -8.33e-02 -1.07e-01 7.47e-01 6.77e-01
GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS 13 7.22e-01 9.17e-01 0.13600 -1.13e-01 7.55e-02 4.80e-01 6.37e-01
GOBP RESPONSE TO HEAT 99 4.76e-02 3.31e-01 0.13600 -6.55e-02 -1.19e-01 2.60e-01 4.06e-02
GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE 45 2.96e-01 7.08e-01 0.13600 -2.11e-02 1.34e-01 8.06e-01 1.19e-01
Inactivation of CSF3 (G-CSF) signaling 25 5.32e-01 8.45e-01 0.13600 6.59e-02 -1.19e-01 5.68e-01 3.04e-01
GOBP REGULATION OF CELL JUNCTION ASSEMBLY 205 6.23e-03 1.15e-01 0.13600 -1.13e-01 7.60e-02 5.46e-03 6.05e-02
GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION 25 4.64e-01 8.12e-01 0.13600 -1.20e-01 -6.39e-02 3.00e-01 5.80e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 18 6.40e-01 8.88e-01 0.13600 1.07e-01 -8.36e-02 4.32e-01 5.39e-01
GOBP MELANOCYTE DIFFERENTIATION 24 4.72e-01 8.16e-01 0.13600 -8.67e-02 -1.05e-01 4.62e-01 3.75e-01
GOCC CYTOSOLIC REGION 19 6.14e-01 8.79e-01 0.13600 -1.25e-01 5.31e-02 3.46e-01 6.88e-01
GOCC PROTEASOME COMPLEX 61 2.00e-01 6.12e-01 0.13600 3.28e-02 -1.32e-01 6.58e-01 7.51e-02
GOBP REGULATION OF VASCULAR WOUND HEALING 14 7.03e-01 9.12e-01 0.13600 1.18e-01 -6.67e-02 4.44e-01 6.66e-01
Activation of Matrix Metalloproteinases 30 4.18e-01 7.87e-01 0.13600 2.29e-02 1.34e-01 8.28e-01 2.05e-01
GOCC CYTOPLASMIC STRESS GRANULE 86 6.87e-02 3.95e-01 0.13600 -1.04e-01 -8.66e-02 9.39e-02 1.65e-01
GOMF GAP JUNCTION CHANNEL ACTIVITY INVOLVED IN CARDIAC CONDUCTION ELECTRICAL COUPLING 5 8.55e-01 9.59e-01 0.13600 -9.07e-02 -1.01e-01 7.25e-01 6.96e-01
GOBP APPENDAGE DEVELOPMENT 182 6.36e-03 1.16e-01 0.13600 -1.36e-01 -3.47e-04 1.59e-03 9.94e-01
GOBP STEROL METABOLIC PROCESS 152 1.56e-02 1.99e-01 0.13600 -9.11e-03 1.35e-01 8.46e-01 3.97e-03
GOBP AMINE CATABOLIC PROCESS 16 6.09e-01 8.77e-01 0.13600 1.12e-01 7.58e-02 4.36e-01 5.99e-01
GOBP REGULATION OF RNA EXPORT FROM NUCLEUS 15 6.35e-01 8.86e-01 0.13600 -1.25e-01 -5.17e-02 4.01e-01 7.29e-01
GOBP SUCCINYL COA METABOLIC PROCESS 10 7.81e-01 9.40e-01 0.13600 1.04e-01 -8.67e-02 5.68e-01 6.35e-01
GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS 42 3.08e-01 7.16e-01 0.13600 1.36e-01 3.38e-03 1.29e-01 9.70e-01
GOBP REGULATION OF APPETITE 21 5.92e-01 8.70e-01 0.13600 -7.10e-02 1.15e-01 5.73e-01 3.60e-01
GOBP REGULATION OF MITOCHONDRIAL FISSION 30 4.63e-01 8.12e-01 0.13500 -4.96e-02 1.26e-01 6.39e-01 2.32e-01
mRNA Editing 10 7.65e-01 9.33e-01 0.13500 2.31e-02 -1.33e-01 8.99e-01 4.65e-01
GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING 58 2.19e-01 6.37e-01 0.13500 3.50e-02 -1.31e-01 6.44e-01 8.48e-02
GOBP VASCULOGENESIS 82 1.33e-01 5.21e-01 0.13500 -1.02e-01 8.90e-02 1.10e-01 1.63e-01
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 24 5.54e-01 8.54e-01 0.13500 -1.04e-01 8.66e-02 3.78e-01 4.62e-01
GOBP REGULATION OF STEM CELL PROLIFERATION 92 6.34e-02 3.79e-01 0.13500 -4.96e-02 -1.26e-01 4.11e-01 3.68e-02
GOCC CONTRACTILE MUSCLE FIBER 243 2.14e-03 5.70e-02 0.13500 -1.25e-01 5.09e-02 7.57e-04 1.72e-01
GOBP RESPONSE TO AUDITORY STIMULUS 33 4.34e-01 7.96e-01 0.13500 -5.88e-02 1.22e-01 5.59e-01 2.25e-01
GOMF PEPTIDE ANTIGEN BINDING 35 4.11e-01 7.84e-01 0.13500 1.24e-01 -5.39e-02 2.04e-01 5.81e-01
SUMOylation 170 9.24e-03 1.46e-01 0.13500 -1.35e-01 1.79e-03 2.34e-03 9.68e-01
GOBP LEUKOTRIENE METABOLIC PROCESS 30 4.68e-01 8.14e-01 0.13500 -1.23e-01 5.67e-02 2.44e-01 5.91e-01
GOMF AMINO ACID BINDING 47 2.88e-01 7.01e-01 0.13500 -1.32e-01 2.82e-02 1.17e-01 7.38e-01
Signaling by ALK fusions and activated point mutants 91 6.10e-02 3.73e-01 0.13500 -7.51e-02 -1.13e-01 2.16e-01 6.35e-02
Signaling by ALK in cancer 91 6.10e-02 3.73e-01 0.13500 -7.51e-02 -1.13e-01 2.16e-01 6.35e-02
GOMF ARGININE BINDING 8 8.00e-01 9.46e-01 0.13500 -7.99e-04 -1.35e-01 9.97e-01 5.08e-01
GOBP ACINAR CELL DIFFERENTIATION 5 8.84e-01 9.69e-01 0.13500 -9.98e-02 9.14e-02 6.99e-01 7.23e-01
GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY 40 3.52e-01 7.46e-01 0.13500 3.62e-02 -1.30e-01 6.92e-01 1.54e-01
GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY 31 3.83e-01 7.67e-01 0.13500 -1.06e-01 -8.39e-02 3.07e-01 4.19e-01
GOBP NEPHRIC DUCT DEVELOPMENT 14 6.77e-01 9.04e-01 0.13500 -1.35e-01 -2.54e-03 3.81e-01 9.87e-01
Insulin receptor signalling cascade 53 2.71e-01 6.85e-01 0.13500 -1.10e-01 7.83e-02 1.65e-01 3.24e-01
GOBP GASTRULATION 192 3.30e-03 7.85e-02 0.13500 -1.25e-01 -5.09e-02 2.79e-03 2.24e-01
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 37 3.21e-01 7.28e-01 0.13500 -1.12e-01 -7.54e-02 2.38e-01 4.28e-01
GOBP RESPONSE TO INSULIN 269 1.47e-03 4.34e-02 0.13500 -8.42e-02 1.06e-01 1.74e-02 2.89e-03
Cellular response to heat stress 97 5.12e-02 3.44e-01 0.13500 -7.68e-02 -1.11e-01 1.91e-01 5.87e-02
GOMF HISTONE ACETYLTRANSFERASE BINDING 23 5.08e-01 8.33e-01 0.13500 -3.85e-02 -1.29e-01 7.49e-01 2.83e-01
GOBP REGULATION OF TOLL SIGNALING PATHWAY 5 8.58e-01 9.60e-01 0.13500 -1.13e-01 -7.33e-02 6.61e-01 7.76e-01
GOBP POSITIVE REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE 8 8.12e-01 9.49e-01 0.13500 -1.30e-01 3.50e-02 5.23e-01 8.64e-01
GOBP CERAMIDE 1 PHOSPHATE TRANSPORT 7 8.16e-01 9.51e-01 0.13500 -3.04e-02 -1.31e-01 8.89e-01 5.47e-01
GOMF CERAMIDE 1 PHOSPHATE TRANSFER ACTIVITY 7 8.16e-01 9.51e-01 0.13500 -3.04e-02 -1.31e-01 8.89e-01 5.47e-01
GOBP POSITIVE REGULATION OF P38MAPK CASCADE 30 4.80e-01 8.21e-01 0.13500 -1.05e-01 8.45e-02 3.19e-01 4.23e-01
GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE 7 8.05e-01 9.48e-01 0.13500 -9.86e-02 -9.21e-02 6.51e-01 6.73e-01
GOCC SPINDLE MIDZONE 36 3.81e-01 7.66e-01 0.13500 -1.34e-01 1.78e-02 1.65e-01 8.54e-01
Vpr-mediated nuclear import of PICs 34 3.52e-01 7.46e-01 0.13500 -7.98e-02 -1.09e-01 4.21e-01 2.72e-01
GOBP PIGMENT GRANULE LOCALIZATION 23 5.48e-01 8.52e-01 0.13500 3.23e-02 -1.31e-01 7.89e-01 2.77e-01
GOCC MLL3 4 COMPLEX 10 7.56e-01 9.30e-01 0.13500 -1.35e-01 -6.68e-03 4.61e-01 9.71e-01
GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION 6 8.48e-01 9.58e-01 0.13500 1.35e-01 -1.89e-03 5.67e-01 9.94e-01
GOBP REGULATION OF BRANCHING INVOLVED IN LUNG MORPHOGENESIS 6 8.46e-01 9.57e-01 0.13500 -6.74e-03 -1.35e-01 9.77e-01 5.68e-01
GOCC SITE OF DOUBLE STRAND BREAK 94 7.41e-02 4.08e-01 0.13500 -3.62e-03 -1.35e-01 9.52e-01 2.40e-02
GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS 12 6.94e-01 9.10e-01 0.13500 6.76e-02 1.17e-01 6.85e-01 4.84e-01
GOBP T CELL CYTOKINE PRODUCTION 36 3.47e-01 7.44e-01 0.13500 1.29e-01 3.94e-02 1.81e-01 6.82e-01
GOBP REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE 15 6.30e-01 8.85e-01 0.13500 8.45e-02 1.05e-01 5.71e-01 4.82e-01
GOBP TELOMERASE RNA LOCALIZATION 18 6.06e-01 8.76e-01 0.13500 -3.97e-03 -1.35e-01 9.77e-01 3.22e-01
Chromatin modifying enzymes 216 1.82e-03 5.07e-02 0.13500 -1.28e-01 -4.11e-02 1.16e-03 2.98e-01
Chromatin organization 216 1.82e-03 5.07e-02 0.13500 -1.28e-01 -4.11e-02 1.16e-03 2.98e-01
GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX 33 3.85e-01 7.68e-01 0.13500 -2.87e-02 -1.32e-01 7.75e-01 1.91e-01
GOCC STEREOCILIA ANKLE LINK COMPLEX 6 8.37e-01 9.55e-01 0.13500 -4.71e-02 -1.26e-01 8.41e-01 5.93e-01
Sodium/Calcium exchangers 11 7.54e-01 9.30e-01 0.13500 -4.11e-02 1.28e-01 8.14e-01 4.62e-01
GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE 63 1.79e-01 5.83e-01 0.13500 -1.35e-01 4.07e-03 6.48e-02 9.55e-01
GOBP TELOMERE MAINTENANCE 152 1.12e-02 1.65e-01 0.13500 -4.89e-02 -1.25e-01 2.98e-01 7.63e-03
GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY 8 8.16e-01 9.51e-01 0.13500 -4.86e-02 1.26e-01 8.12e-01 5.39e-01
GOMF HISTONE H4K20 MONOMETHYLTRANSFERASE ACTIVITY 6 8.54e-01 9.59e-01 0.13500 -1.32e-01 2.44e-02 5.75e-01 9.18e-01
GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS 437 3.91e-06 3.58e-04 0.13500 -3.29e-02 -1.30e-01 2.39e-01 2.91e-06
GOBP NEGATIVE REGULATION OF BLOOD PRESSURE 48 2.39e-01 6.55e-01 0.13500 -1.23e-01 -5.44e-02 1.40e-01 5.14e-01
MAP kinase activation 58 1.69e-01 5.70e-01 0.13500 -1.03e-01 -8.65e-02 1.75e-01 2.55e-01
GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS 13 7.09e-01 9.13e-01 0.13400 -2.07e-02 1.33e-01 8.97e-01 4.07e-01
GOMF DISORDERED DOMAIN SPECIFIC BINDING 29 4.13e-01 7.85e-01 0.13400 -7.51e-02 -1.12e-01 4.84e-01 2.99e-01
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS 14 7.12e-01 9.14e-01 0.13400 9.88e-02 -9.12e-02 5.22e-01 5.55e-01
Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence 6 8.48e-01 9.58e-01 0.13400 -1.34e-01 1.49e-03 5.69e-01 9.95e-01
GOBP REGULATION OF PROTEIN ACETYLATION 20 5.42e-01 8.50e-01 0.13400 -1.03e-01 -8.58e-02 4.24e-01 5.06e-01
GOBP ENERGY HOMEOSTASIS 81 1.22e-01 4.99e-01 0.13400 -1.31e-01 2.83e-02 4.11e-02 6.59e-01
GOBP NEGATIVE REGULATION OF KIDNEY DEVELOPMENT 5 8.70e-01 9.64e-01 0.13400 -1.34e-01 -1.11e-02 6.04e-01 9.66e-01
GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS 37 4.01e-01 7.78e-01 0.13400 -1.19e-01 6.25e-02 2.11e-01 5.11e-01
GOBP REGULATION OF PLATELET ACTIVATION 51 2.79e-01 6.92e-01 0.13400 -1.24e-01 5.19e-02 1.26e-01 5.22e-01
GOCC RNA CAP BINDING COMPLEX 16 6.42e-01 8.89e-01 0.13400 -6.13e-03 -1.34e-01 9.66e-01 3.53e-01
Activation of ATR in response to replication stress 37 3.48e-01 7.44e-01 0.13400 -2.55e-02 -1.32e-01 7.88e-01 1.66e-01
GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 43 3.16e-01 7.23e-01 0.13400 9.76e-03 -1.34e-01 9.12e-01 1.29e-01
GOBP NEGATIVE REGULATION OF CELL SIZE 9 8.02e-01 9.46e-01 0.13400 -1.16e-01 6.78e-02 5.48e-01 7.25e-01
GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY 9 7.90e-01 9.42e-01 0.13400 2.44e-02 -1.32e-01 8.99e-01 4.93e-01
GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION 31 4.06e-01 7.81e-01 0.13400 -3.87e-02 -1.28e-01 7.09e-01 2.16e-01
Nuclear Pore Complex (NPC) Disassembly 36 3.35e-01 7.35e-01 0.13400 -1.02e-01 -8.73e-02 2.91e-01 3.65e-01
GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION 22 5.17e-01 8.39e-01 0.13400 1.17e-01 6.52e-02 3.42e-01 5.97e-01
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION 33 4.52e-01 8.07e-01 0.13400 9.28e-02 -9.66e-02 3.56e-01 3.37e-01
GOMF GALACTOSIDASE ACTIVITY 6 8.33e-01 9.54e-01 0.13400 -1.01e-01 -8.82e-02 6.69e-01 7.08e-01
GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS 18 5.81e-01 8.65e-01 0.13400 7.49e-02 1.11e-01 5.82e-01 4.15e-01
GOMF LIPASE BINDING 7 8.13e-01 9.49e-01 0.13400 -1.22e-01 -5.48e-02 5.76e-01 8.02e-01
GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS 38 3.43e-01 7.41e-01 0.13400 1.97e-02 1.32e-01 8.34e-01 1.58e-01
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN 19 5.63e-01 8.58e-01 0.13400 -1.08e-01 -7.94e-02 4.16e-01 5.49e-01
Processing of Capped Intronless Pre-mRNA 28 4.81e-01 8.21e-01 0.13400 2.22e-02 -1.32e-01 8.39e-01 2.27e-01
GOMF SIGNAL SEQUENCE BINDING 47 2.40e-01 6.55e-01 0.13400 -9.21e-02 -9.71e-02 2.75e-01 2.49e-01
GOBP SEMICIRCULAR CANAL DEVELOPMENT 9 7.96e-01 9.44e-01 0.13400 4.09e-02 -1.27e-01 8.32e-01 5.08e-01
GOBP CARDIOBLAST DIFFERENTIATION 17 5.98e-01 8.73e-01 0.13400 -7.67e-02 -1.10e-01 5.84e-01 4.34e-01
GOBP MEIOTIC CHROMOSOME CONDENSATION 6 8.41e-01 9.56e-01 0.13400 -3.68e-02 -1.29e-01 8.76e-01 5.86e-01
GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY 82 1.01e-01 4.65e-01 0.13400 -1.33e-01 -1.76e-02 3.80e-02 7.83e-01
GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 46 2.97e-01 7.09e-01 0.13400 1.48e-02 -1.33e-01 8.62e-01 1.19e-01
GOBP ASSOCIATIVE LEARNING 86 1.28e-01 5.11e-01 0.13400 -1.02e-01 8.62e-02 1.02e-01 1.67e-01
IRAK4 deficiency (TLR2/4) 17 6.63e-01 8.97e-01 0.13400 1.11e-01 -7.44e-02 4.28e-01 5.95e-01
Scavenging by Class B Receptors 6 8.37e-01 9.55e-01 0.13400 1.21e-01 5.67e-02 6.08e-01 8.10e-01
GOBP EXECUTION PHASE OF APOPTOSIS 79 1.27e-01 5.10e-01 0.13400 -1.32e-01 1.89e-02 4.21e-02 7.71e-01
GOBP FOLIC ACID CONTAINING COMPOUND CATABOLIC PROCESS 5 8.61e-01 9.61e-01 0.13400 7.18e-02 1.13e-01 7.81e-01 6.63e-01
GOBP MONOACYLGLYCEROL BIOSYNTHETIC PROCESS 7 8.30e-01 9.54e-01 0.13400 -1.13e-02 1.33e-01 9.59e-01 5.42e-01
GOBP REGULATION OF CILIUM MOVEMENT 40 3.00e-01 7.11e-01 0.13400 -1.09e-01 -7.76e-02 2.34e-01 3.96e-01
GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS 13 6.79e-01 9.04e-01 0.13400 -6.44e-02 -1.17e-01 6.88e-01 4.65e-01
GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING 14 7.04e-01 9.13e-01 0.13300 1.26e-01 -4.49e-02 4.15e-01 7.71e-01
GOMF LNCRNA BINDING 23 5.55e-01 8.55e-01 0.13300 -1.30e-01 3.12e-02 2.81e-01 7.96e-01
GOBP VACUOLAR ACIDIFICATION 33 3.83e-01 7.67e-01 0.13300 -1.26e-01 -4.50e-02 2.12e-01 6.55e-01
GOBP LYMPHOCYTE MEDIATED IMMUNITY 289 8.29e-04 2.81e-02 0.13300 1.24e-01 -4.99e-02 2.94e-04 1.45e-01
GOBP MAMMARY GLAND DUCT MORPHOGENESIS 31 4.34e-01 7.96e-01 0.13300 -1.33e-01 2.68e-03 1.99e-01 9.79e-01
GOBP METANEPHRIC TUBULE FORMATION 6 8.35e-01 9.55e-01 0.13300 8.25e-02 1.05e-01 7.26e-01 6.57e-01
GOCC NODE OF RANVIER 16 6.41e-01 8.89e-01 0.13300 1.32e-01 1.69e-02 3.60e-01 9.07e-01
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 29 4.93e-01 8.27e-01 0.13300 -6.05e-02 1.19e-01 5.73e-01 2.68e-01
GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS 18 5.81e-01 8.65e-01 0.13300 -9.63e-02 -9.21e-02 4.79e-01 4.99e-01
GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS 21 6.05e-01 8.76e-01 0.13300 8.02e-02 -1.06e-01 5.25e-01 3.98e-01
Signaling by EGFR 52 2.11e-01 6.28e-01 0.13300 -7.65e-02 -1.09e-01 3.40e-01 1.74e-01
IkBA variant leads to EDA-ID 6 8.59e-01 9.60e-01 0.13300 -3.68e-02 1.28e-01 8.76e-01 5.87e-01
GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY 19 6.09e-01 8.77e-01 0.13300 -1.82e-02 1.32e-01 8.91e-01 3.19e-01
GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS 7 8.10e-01 9.49e-01 0.13300 9.04e-02 9.78e-02 6.79e-01 6.54e-01
GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION 13 7.09e-01 9.13e-01 0.13300 -1.07e-02 1.33e-01 9.47e-01 4.07e-01
GOCC MUSCLE MYOSIN COMPLEX 15 6.72e-01 9.01e-01 0.13300 -8.96e-03 1.33e-01 9.52e-01 3.73e-01
GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 29 4.58e-01 8.10e-01 0.13300 3.20e-04 1.33e-01 9.98e-01 2.15e-01
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT 41 2.93e-01 7.06e-01 0.13300 -1.04e-01 -8.22e-02 2.47e-01 3.62e-01
GOBP LEPTIN MEDIATED SIGNALING PATHWAY 10 7.41e-01 9.25e-01 0.13300 -1.01e-01 -8.61e-02 5.79e-01 6.37e-01
GOBP GMP BIOSYNTHETIC PROCESS 13 7.14e-01 9.15e-01 0.13300 2.05e-02 -1.31e-01 8.98e-01 4.13e-01
GOBP DIGESTIVE SYSTEM PROCESS 105 4.37e-02 3.18e-01 0.13300 8.62e-02 1.01e-01 1.27e-01 7.35e-02
GOBP REGULATION OF HUMORAL IMMUNE RESPONSE 46 3.36e-01 7.36e-01 0.13300 1.03e-01 -8.44e-02 2.29e-01 3.22e-01
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 17 6.07e-01 8.76e-01 0.13300 6.21e-02 1.17e-01 6.58e-01 4.02e-01
Heparan sulfate/heparin (HS-GAG) metabolism 53 2.62e-01 6.77e-01 0.13300 -1.29e-01 3.28e-02 1.05e-01 6.80e-01
GOCC NUCLEOLAR EXOSOME RNASE COMPLEX 10 7.42e-01 9.26e-01 0.13300 -7.98e-02 -1.06e-01 6.62e-01 5.61e-01
GOBP REGULATION OF NEURON MIGRATION 44 3.44e-01 7.41e-01 0.13300 -1.20e-01 5.71e-02 1.69e-01 5.12e-01
GOCC LUMENAL SIDE OF MEMBRANE 42 3.55e-01 7.48e-01 0.13300 1.24e-01 -4.66e-02 1.64e-01 6.01e-01
Pyroptosis 27 4.92e-01 8.26e-01 0.13300 1.32e-01 -9.12e-03 2.34e-01 9.35e-01
GOBP UBIQUITIN RECYCLING 13 7.32e-01 9.22e-01 0.13300 6.72e-02 -1.14e-01 6.75e-01 4.75e-01
GOBP REGULATION OF B CELL PROLIFERATION 62 1.75e-01 5.80e-01 0.13300 1.29e-01 3.09e-02 7.90e-02 6.74e-01
GOBP POSITIVE REGULATION OF CAMP MEDIATED SIGNALING 9 7.95e-01 9.44e-01 0.13300 2.82e-02 -1.30e-01 8.84e-01 5.01e-01
GOBP NUCLEOBASE BIOSYNTHETIC PROCESS 15 6.65e-01 8.98e-01 0.13300 -9.37e-03 -1.32e-01 9.50e-01 3.75e-01
GOBP NEGATIVE REGULATION OF MYOFIBROBLAST DIFFERENTIATION 6 8.38e-01 9.55e-01 0.13300 -6.40e-02 -1.16e-01 7.86e-01 6.22e-01
GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY 8 8.24e-01 9.52e-01 0.13300 -5.92e-02 1.19e-01 7.72e-01 5.61e-01
Interactions of Vpr with host cellular proteins 35 3.53e-01 7.46e-01 0.13300 -8.34e-02 -1.03e-01 3.93e-01 2.91e-01
GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS 30 4.62e-01 8.12e-01 0.13300 -1.31e-01 1.95e-02 2.14e-01 8.53e-01
GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY 10 7.44e-01 9.26e-01 0.13200 7.32e-02 1.10e-01 6.88e-01 5.45e-01
GOBP BIOGENIC AMINE METABOLIC PROCESS 86 7.77e-02 4.15e-01 0.13200 8.87e-02 9.84e-02 1.55e-01 1.15e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 101 7.17e-02 4.03e-01 0.13200 1.03e-02 -1.32e-01 8.58e-01 2.18e-02
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION 188 7.61e-03 1.29e-01 0.13200 -1.32e-01 1.06e-02 1.80e-03 8.01e-01
GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION 44 3.49e-01 7.45e-01 0.13200 1.15e-01 -6.47e-02 1.85e-01 4.58e-01
GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS 21 5.82e-01 8.66e-01 0.13200 -1.31e-01 1.83e-02 2.98e-01 8.85e-01
Ca2+ pathway 62 1.82e-01 5.86e-01 0.13200 -1.31e-01 -1.90e-02 7.45e-02 7.95e-01
GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION 28 4.50e-01 8.05e-01 0.13200 -1.25e-01 -4.31e-02 2.52e-01 6.93e-01
GOBP PEPTIDYL LYSINE METHYLATION 23 5.41e-01 8.50e-01 0.13200 -1.32e-01 -1.56e-03 2.72e-01 9.90e-01
GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS 28 4.52e-01 8.07e-01 0.13200 1.26e-01 3.90e-02 2.47e-01 7.21e-01
GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY 114 3.74e-02 2.96e-01 0.13200 5.46e-02 1.21e-01 3.14e-01 2.62e-02
GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 37 3.52e-01 7.46e-01 0.13200 -1.27e-01 -3.71e-02 1.81e-01 6.96e-01
GOBP RESPONSE TO INTERLEUKIN 4 34 4.51e-01 8.06e-01 0.13200 9.20e-02 -9.51e-02 3.53e-01 3.37e-01
GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY 12 7.07e-01 9.13e-01 0.13200 -5.35e-02 -1.21e-01 7.48e-01 4.68e-01
GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON 11 7.69e-01 9.35e-01 0.13200 6.65e-02 -1.14e-01 7.02e-01 5.12e-01
GOBP AZOLE TRANSMEMBRANE TRANSPORT 14 6.92e-01 9.09e-01 0.13200 6.16e-03 -1.32e-01 9.68e-01 3.92e-01
GOCC DNA POLYMERASE COMPLEX 19 5.71e-01 8.61e-01 0.13200 -1.08e-01 -7.62e-02 4.15e-01 5.65e-01
GOBP BLASTODERM SEGMENTATION 25 5.46e-01 8.51e-01 0.13200 -5.40e-02 1.21e-01 6.40e-01 2.97e-01
Regulation of cholesterol biosynthesis by SREBP (SREBF) 53 2.83e-01 6.95e-01 0.13200 -1.15e-01 6.44e-02 1.46e-01 4.17e-01
GOBP CELLULAR RESPONSE TO INSULIN STIMULUS 210 7.47e-03 1.27e-01 0.13200 -7.99e-02 1.05e-01 4.59e-02 8.60e-03
GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE 10 7.61e-01 9.32e-01 0.13200 1.69e-02 1.31e-01 9.26e-01 4.73e-01
GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 14 6.93e-01 9.09e-01 0.13200 -1.32e-01 5.65e-03 3.93e-01 9.71e-01
GOBP MRNA PROCESSING 455 1.86e-06 1.90e-04 0.13200 -8.52e-02 -1.01e-01 1.83e-03 2.26e-04
Neddylation 221 1.55e-03 4.50e-02 0.13200 -9.93e-02 -8.69e-02 1.10e-02 2.60e-02
GOBP NATURAL KILLER CELL DEGRANULATION 10 7.88e-01 9.41e-01 0.13200 6.27e-02 -1.16e-01 7.31e-01 5.25e-01
Recognition of DNA damage by PCNA-containing replication complex 29 4.67e-01 8.14e-01 0.13200 3.60e-03 -1.32e-01 9.73e-01 2.19e-01
GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION 13 7.36e-01 9.23e-01 0.13200 7.19e-02 -1.11e-01 6.54e-01 4.90e-01
GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 52 2.87e-01 7.00e-01 0.13200 -1.19e-01 5.63e-02 1.37e-01 4.82e-01
Inwardly rectifying K+ channels 35 4.26e-01 7.93e-01 0.13200 -4.56e-02 1.24e-01 6.40e-01 2.05e-01
GOBP MODULATION BY HOST OF SYMBIONT PROCESS 81 1.49e-01 5.43e-01 0.13200 7.16e-02 -1.11e-01 2.66e-01 8.49e-02
GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION 33 3.82e-01 7.66e-01 0.13200 -1.12e-01 -6.96e-02 2.66e-01 4.89e-01
Recycling pathway of L1 42 2.95e-01 7.07e-01 0.13200 6.51e-02 1.15e-01 4.66e-01 1.99e-01
GOMF ENDOPEPTIDASE REGULATOR ACTIVITY 177 9.60e-03 1.50e-01 0.13200 1.32e-01 8.50e-04 2.49e-03 9.84e-01
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II 841 7.99e-11 1.96e-08 0.13200 -1.20e-01 -5.39e-02 3.12e-09 7.99e-03
GOBP REGULATION OF CALCIUM ION IMPORT 46 2.73e-01 6.85e-01 0.13200 -1.25e-01 -4.21e-02 1.43e-01 6.21e-01
GOMF OLIGOSACCHARIDE BINDING 17 6.32e-01 8.86e-01 0.13200 -1.31e-01 -1.36e-02 3.50e-01 9.22e-01
GOBP LEUKOCYTE HOMEOSTASIS 103 8.00e-02 4.20e-01 0.13200 3.90e-02 -1.26e-01 4.94e-01 2.74e-02
GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY 8 7.90e-01 9.42e-01 0.13200 9.59e-02 9.03e-02 6.39e-01 6.58e-01
GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION 30 4.82e-01 8.22e-01 0.13200 4.64e-02 -1.23e-01 6.60e-01 2.43e-01
Switching of origins to a post-replicative state 79 1.09e-01 4.77e-01 0.13200 -4.13e-02 -1.25e-01 5.26e-01 5.47e-02
GOMF MUTSALPHA COMPLEX BINDING 7 8.40e-01 9.56e-01 0.13200 -1.27e-01 3.30e-02 5.59e-01 8.80e-01
GOBP SECRETORY GRANULE LOCALIZATION 22 5.57e-01 8.56e-01 0.13200 1.32e-01 6.19e-03 2.86e-01 9.60e-01
GOBP GLOMERULAR MESANGIAL CELL DEVELOPMENT 5 8.88e-01 9.71e-01 0.13200 6.04e-02 -1.17e-01 8.15e-01 6.51e-01
GOMF CTPASE ACTIVITY 5 8.64e-01 9.62e-01 0.13200 -1.06e-01 -7.74e-02 6.80e-01 7.64e-01
MAP2K and MAPK activation 38 3.31e-01 7.34e-01 0.13200 -7.29e-02 -1.10e-01 4.37e-01 2.43e-01
GOCC RUFFLE 179 1.31e-02 1.81e-01 0.13200 -1.24e-01 4.24e-02 4.07e-03 3.28e-01
GOBP OOGENESIS 112 7.44e-02 4.09e-01 0.13200 -1.05e-01 7.98e-02 5.60e-02 1.45e-01
GOBP REGULATION OF CYTOPLASMIC TRANSLATION 32 4.13e-01 7.84e-01 0.13100 -1.28e-01 -3.10e-02 2.11e-01 7.61e-01
InlA-mediated entry of Listeria monocytogenes into host cells 9 7.83e-01 9.40e-01 0.13100 -2.09e-02 -1.30e-01 9.13e-01 5.00e-01
GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY 12 7.52e-01 9.30e-01 0.13100 -1.16e-01 6.10e-02 4.85e-01 7.15e-01
GOBP REGULATION OF NEURON MATURATION 8 8.02e-01 9.46e-01 0.13100 1.28e-01 2.86e-02 5.30e-01 8.89e-01
Electric Transmission Across Gap Junctions 5 8.66e-01 9.62e-01 0.13100 -1.15e-01 -6.43e-02 6.57e-01 8.04e-01
Transmission across Electrical Synapses 5 8.66e-01 9.62e-01 0.13100 -1.15e-01 -6.43e-02 6.57e-01 8.04e-01
GOBP ENDOCARDIAL CUSHION TO MESENCHYMAL TRANSITION 6 8.39e-01 9.56e-01 0.13100 7.78e-02 1.06e-01 7.41e-01 6.53e-01
GOCC MRNA CLEAVAGE FACTOR COMPLEX 22 5.81e-01 8.65e-01 0.13100 -1.27e-01 3.33e-02 3.02e-01 7.87e-01
GOBP NUCLEOLUS ORGANIZATION 16 6.86e-01 9.06e-01 0.13100 -6.49e-02 1.14e-01 6.53e-01 4.29e-01
GOBP SULFUR COMPOUND TRANSPORT 62 1.84e-01 5.89e-01 0.13100 1.29e-01 2.46e-02 7.88e-02 7.38e-01
GOBP GALACTOSYLCERAMIDE BIOSYNTHETIC PROCESS 6 8.51e-01 9.58e-01 0.13100 1.35e-02 1.31e-01 9.54e-01 5.80e-01
GOBP CONNECTIVE TISSUE DEVELOPMENT 281 1.32e-03 4.06e-02 0.13100 -1.20e-01 5.35e-02 5.46e-04 1.22e-01
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways 53 2.77e-01 6.91e-01 0.13100 4.32e-02 -1.24e-01 5.86e-01 1.19e-01
GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE 15 7.04e-01 9.13e-01 0.13100 6.98e-02 -1.11e-01 6.40e-01 4.56e-01
GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 238 4.26e-03 9.04e-02 0.13100 1.04e-01 -7.98e-02 5.69e-03 3.39e-02
RUNX3 regulates CDKN1A transcription 7 8.51e-01 9.58e-01 0.13100 9.75e-02 -8.76e-02 6.55e-01 6.88e-01
GOBP NON CANONICAL WNT SIGNALING PATHWAY 69 2.05e-01 6.20e-01 0.13100 -9.07e-02 9.46e-02 1.93e-01 1.74e-01
GOMF DNA POLYMERASE BINDING 21 5.43e-01 8.51e-01 0.13100 1.03e-01 8.08e-02 4.13e-01 5.21e-01
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain 19 6.29e-01 8.85e-01 0.13100 3.76e-02 -1.25e-01 7.77e-01 3.44e-01
GOBP NEURON MIGRATION 173 7.38e-03 1.27e-01 0.13100 -1.16e-01 -6.05e-02 8.40e-03 1.70e-01
Regulation of gene expression by Hypoxia-inducible Factor 10 7.53e-01 9.30e-01 0.13100 -1.20e-01 -5.31e-02 5.12e-01 7.71e-01
GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS 15 6.48e-01 8.91e-01 0.13100 -7.37e-02 -1.08e-01 6.21e-01 4.68e-01
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 141 2.84e-02 2.67e-01 0.13100 -1.30e-01 1.36e-02 7.62e-03 7.81e-01
Cellular Senescence 159 1.05e-02 1.58e-01 0.13100 -7.29e-02 -1.09e-01 1.13e-01 1.80e-02
Cyclin A:Cdk2-associated events at S phase entry 75 1.24e-01 5.04e-01 0.13100 -4.29e-02 -1.24e-01 5.20e-01 6.42e-02
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT POSTSYNAPTIC ENDOSOME TO LYSOSOME 7 8.26e-01 9.52e-01 0.13100 2.94e-02 1.27e-01 8.93e-01 5.59e-01
GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 32 4.51e-01 8.06e-01 0.13100 -1.29e-01 2.33e-02 2.08e-01 8.19e-01
GOBP NEUTROPHIL MEDIATED IMMUNITY 37 3.87e-01 7.68e-01 0.13100 -1.31e-01 6.08e-03 1.69e-01 9.49e-01
Release of Hh-Np from the secreting cell 8 7.98e-01 9.45e-01 0.13100 5.20e-02 1.20e-01 7.99e-01 5.57e-01
GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS 28 5.15e-01 8.37e-01 0.13100 1.20e-01 -5.30e-02 2.74e-01 6.27e-01
Aerobic respiration and respiratory electron transport 236 2.47e-03 6.31e-02 0.13100 6.07e-03 -1.31e-01 8.72e-01 5.48e-04
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY 97 8.21e-02 4.25e-01 0.13100 -2.11e-03 1.31e-01 9.71e-01 2.61e-02
GOMF KINASE INHIBITOR ACTIVITY 79 1.07e-01 4.75e-01 0.13100 -5.72e-02 -1.18e-01 3.80e-01 7.10e-02
GOBP T CELL EXTRAVASATION 11 7.35e-01 9.23e-01 0.13100 -4.72e-02 -1.22e-01 7.86e-01 4.84e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY 36 3.64e-01 7.54e-01 0.13100 4.98e-02 1.21e-01 6.05e-01 2.10e-01
GOMF HISTONE KINASE ACTIVITY 23 5.38e-01 8.49e-01 0.13100 -1.29e-01 -2.17e-02 2.85e-01 8.57e-01
GOBP POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS 8 7.93e-01 9.43e-01 0.13100 9.17e-02 9.29e-02 6.53e-01 6.49e-01
GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY 17 6.17e-01 8.80e-01 0.13100 5.95e-02 1.16e-01 6.71e-01 4.07e-01
GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY 35 4.05e-01 7.81e-01 0.13100 -1.31e-01 5.68e-04 1.81e-01 9.95e-01
GOBP RRNA PROCESSING 212 3.87e-03 8.62e-02 0.13100 -1.13e-02 -1.30e-01 7.76e-01 1.10e-03
GOBP HISTAMINE TRANSPORT 15 6.80e-01 9.04e-01 0.13000 -1.30e-01 3.76e-03 3.82e-01 9.80e-01
GOMF UNFOLDED PROTEIN BINDING 114 6.42e-02 3.81e-01 0.13000 3.76e-02 -1.25e-01 4.87e-01 2.12e-02
GOBP TELOMERE CAPPING 39 3.53e-01 7.46e-01 0.13000 -1.91e-02 -1.29e-01 8.37e-01 1.63e-01
GOCC TRICARBOXYLIC ACID CYCLE HETEROMERIC ENZYME COMPLEX 17 6.59e-01 8.96e-01 0.13000 -1.27e-01 2.95e-02 3.64e-01 8.33e-01
GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION 19 5.78e-01 8.64e-01 0.13000 -8.48e-02 -9.91e-02 5.22e-01 4.55e-01
GOBP PROTEIN FOLDING 211 3.76e-03 8.47e-02 0.13000 -1.85e-02 -1.29e-01 6.43e-01 1.23e-03
GOBP GLYCOLIPID CATABOLIC PROCESS 25 5.58e-01 8.56e-01 0.13000 -6.03e-02 1.16e-01 6.02e-01 3.17e-01
tRNA modification in the nucleus and cytosol 41 3.33e-01 7.35e-01 0.13000 -1.28e-01 -2.20e-02 1.55e-01 8.07e-01
GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION 11 7.38e-01 9.24e-01 0.13000 1.23e-01 4.21e-02 4.79e-01 8.09e-01
MECP2 regulates transcription of neuronal ligands 7 8.30e-01 9.53e-01 0.13000 -1.29e-01 -1.83e-02 5.54e-01 9.33e-01
GOBP ACTOMYOSIN STRUCTURE ORGANIZATION 212 8.35e-03 1.37e-01 0.13000 -9.63e-02 8.77e-02 1.56e-02 2.77e-02
CS/DS degradation 12 7.11e-01 9.14e-01 0.13000 -1.12e-01 -6.58e-02 5.00e-01 6.93e-01
GOBP MAINTENANCE OF BLOOD BRAIN BARRIER 37 3.84e-01 7.67e-01 0.13000 -1.30e-01 -2.54e-03 1.70e-01 9.79e-01
GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON 104 5.13e-02 3.44e-01 0.13000 1.06e-01 7.63e-02 6.28e-02 1.79e-01
GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY 10 7.96e-01 9.44e-01 0.13000 -1.02e-01 8.10e-02 5.76e-01 6.58e-01
GOBP RESPONSE TO HYDROSTATIC PRESSURE 7 8.34e-01 9.54e-01 0.13000 -1.30e-01 -5.03e-03 5.51e-01 9.82e-01
GOBP MULTICELLULAR ORGANISM GROWTH 146 1.64e-02 2.06e-01 0.13000 -1.15e-01 -6.20e-02 1.69e-02 1.96e-01
Estrogen-dependent gene expression 113 4.02e-02 3.07e-01 0.13000 -7.31e-02 -1.08e-01 1.79e-01 4.80e-02
GOBP LYSOSOMAL TRANSPORT 131 3.63e-02 2.94e-01 0.13000 -1.30e-01 6.07e-03 1.02e-02 9.05e-01
GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX 19 5.85e-01 8.67e-01 0.13000 -1.15e-01 -6.14e-02 3.87e-01 6.43e-01
GOBP RHO PROTEIN SIGNAL TRANSDUCTION 137 4.33e-02 3.16e-01 0.13000 -1.12e-01 6.69e-02 2.42e-02 1.77e-01
GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS 26 5.21e-01 8.41e-01 0.13000 1.29e-01 -1.36e-02 2.54e-01 9.04e-01
Neurotransmitter receptors and postsynaptic signal transmission 192 1.32e-02 1.82e-01 0.13000 -1.00e-01 8.27e-02 1.66e-02 4.80e-02
GOMF EXOPEPTIDASE ACTIVITY 100 1.05e-01 4.71e-01 0.13000 -9.11e-02 9.27e-02 1.15e-01 1.09e-01
GOBP TRICARBOXYLIC ACID CYCLE 28 4.69e-01 8.14e-01 0.13000 -1.26e-01 -3.07e-02 2.47e-01 7.79e-01
GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS 110 5.93e-02 3.70e-01 0.13000 -2.60e-03 -1.30e-01 9.62e-01 1.85e-02
GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING 30 4.25e-01 7.93e-01 0.13000 -7.59e-02 -1.05e-01 4.72e-01 3.17e-01
Pre-NOTCH Expression and Processing 84 1.06e-01 4.74e-01 0.13000 -2.39e-02 -1.28e-01 7.05e-01 4.30e-02
GOBP TETRAHYDROFOLATE METABOLIC PROCESS 18 6.29e-01 8.85e-01 0.13000 1.30e-01 2.64e-03 3.40e-01 9.85e-01
Nuclear events mediated by NFE2L2 85 1.28e-01 5.10e-01 0.13000 3.03e-02 -1.26e-01 6.29e-01 4.41e-02
GOMF NUCLEAR ANDROGEN RECEPTOR BINDING 25 5.43e-01 8.51e-01 0.13000 -1.27e-01 2.68e-02 2.71e-01 8.16e-01
GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING 52 2.85e-01 6.97e-01 0.13000 -1.26e-01 3.23e-02 1.17e-01 6.87e-01
GOMF NADPLUS PROTEIN ARGININE ADP RIBOSYLTRANSFERASE ACTIVITY 6 8.44e-01 9.57e-01 0.13000 6.66e-02 1.11e-01 7.77e-01 6.36e-01
GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY 12 7.26e-01 9.19e-01 0.13000 -2.23e-02 -1.28e-01 8.94e-01 4.43e-01
GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS 6 8.50e-01 9.58e-01 0.13000 -1.26e-01 -3.11e-02 5.93e-01 8.95e-01
GOBP CELLULAR RESPONSE TO PH 25 5.43e-01 8.51e-01 0.13000 1.27e-01 -2.60e-02 2.71e-01 8.22e-01
GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT 11 7.31e-01 9.22e-01 0.13000 -1.04e-01 -7.74e-02 5.50e-01 6.57e-01
GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 19 5.87e-01 8.67e-01 0.13000 -1.15e-01 -5.99e-02 3.85e-01 6.51e-01
Regulation of Complement cascade 43 3.61e-01 7.52e-01 0.13000 1.23e-01 -4.11e-02 1.63e-01 6.41e-01
GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 26 5.04e-01 8.31e-01 0.13000 -1.28e-01 -1.77e-02 2.57e-01 8.76e-01
GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY 27 4.68e-01 8.14e-01 0.13000 -6.38e-02 -1.13e-01 5.66e-01 3.10e-01
GOBP LEUKOCYTE DEGRANULATION 74 1.56e-01 5.52e-01 0.13000 8.76e-03 -1.29e-01 8.96e-01 5.43e-02
GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC 28 5.23e-01 8.41e-01 0.13000 -1.17e-01 5.65e-02 2.85e-01 6.05e-01
GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS 34 4.09e-01 7.82e-01 0.13000 1.79e-02 1.28e-01 8.57e-01 1.95e-01
GOCC BARR BODY 7 8.20e-01 9.52e-01 0.13000 -7.85e-02 -1.03e-01 7.19e-01 6.37e-01
GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS 86 9.61e-02 4.52e-01 0.13000 -1.23e-01 -4.12e-02 4.89e-02 5.09e-01
GOBP ARTERY MORPHOGENESIS 82 1.11e-01 4.83e-01 0.13000 -1.26e-01 -2.94e-02 4.83e-02 6.45e-01
GOCC SPECTRIN 9 7.86e-01 9.41e-01 0.13000 2.59e-02 1.27e-01 8.93e-01 5.10e-01
GOMF INTRACILIARY TRANSPORT PARTICLE B BINDING 5 8.73e-01 9.65e-01 0.13000 1.25e-01 3.53e-02 6.29e-01 8.91e-01
GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE 23 5.96e-01 8.72e-01 0.13000 -8.52e-02 9.75e-02 4.79e-01 4.18e-01
GOBP REGULATION OF VESICLE SIZE 20 6.08e-01 8.76e-01 0.12900 -1.29e-01 1.23e-02 3.18e-01 9.24e-01
GOBP DETECTION OF LIGHT STIMULUS 60 1.82e-01 5.86e-01 0.12900 8.58e-02 9.69e-02 2.50e-01 1.94e-01
GOCC LEADING EDGE MEMBRANE 174 1.54e-02 1.98e-01 0.12900 -1.26e-01 2.88e-02 4.10e-03 5.12e-01
DDX58/IFIH1-mediated induction of interferon-alpha/beta 76 1.68e-01 5.69e-01 0.12900 4.42e-02 -1.22e-01 5.05e-01 6.69e-02
Budding and maturation of HIV virion 28 5.22e-01 8.41e-01 0.12900 5.17e-02 -1.19e-01 6.36e-01 2.77e-01
GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE 5 8.69e-01 9.64e-01 0.12900 6.73e-02 1.10e-01 7.94e-01 6.69e-01
GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 357 3.14e-04 1.37e-02 0.12900 -1.14e-01 6.01e-02 2.03e-04 5.10e-02
GOMF GALACTOSYLTRANSFERASE ACTIVITY 32 4.04e-01 7.80e-01 0.12900 9.78e-02 8.45e-02 3.38e-01 4.08e-01
GOCC HISTONE METHYLTRANSFERASE COMPLEX 63 1.86e-01 5.92e-01 0.12900 -1.26e-01 -2.99e-02 8.44e-02 6.81e-01
GOBP FEMALE SEX DIFFERENTIATION 118 4.36e-02 3.18e-01 0.12900 -1.26e-01 -2.89e-02 1.81e-02 5.88e-01
Other semaphorin interactions 18 6.37e-01 8.87e-01 0.12900 -1.29e-01 6.51e-03 3.43e-01 9.62e-01
GOBP METHYLATION 209 3.04e-03 7.43e-02 0.12900 -1.11e-01 -6.63e-02 5.74e-03 9.85e-02
Activation of kainate receptors upon glutamate binding 29 5.11e-01 8.35e-01 0.12900 -1.18e-01 5.19e-02 2.70e-01 6.29e-01
Nuclear Events (kinase and transcription factor activation) 59 2.15e-01 6.32e-01 0.12900 -1.66e-02 -1.28e-01 8.26e-01 8.89e-02
GOMF FLOPPASE ACTIVITY 15 6.71e-01 9.01e-01 0.12900 2.80e-02 1.26e-01 8.51e-01 3.98e-01
GOMF 5 3 EXONUCLEASE ACTIVITY 18 6.50e-01 8.92e-01 0.12900 -1.25e-01 3.17e-02 3.58e-01 8.16e-01
GOMF FIBRINOGEN BINDING 6 8.55e-01 9.59e-01 0.12900 -1.28e-01 -1.52e-02 5.87e-01 9.49e-01
GOBP NEGATIVE REGULATION OF JNK CASCADE 35 3.85e-01 7.68e-01 0.12900 -4.66e-02 -1.20e-01 6.33e-01 2.18e-01
GOBP POSITIVE REGULATION OF LIPASE ACTIVITY 50 2.47e-01 6.61e-01 0.12900 -7.13e-02 -1.07e-01 3.83e-01 1.89e-01
Regulation of PTEN stability and activity 55 2.27e-01 6.46e-01 0.12900 -3.90e-02 -1.23e-01 6.17e-01 1.15e-01
GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE 76 1.62e-01 5.61e-01 0.12900 -2.74e-02 1.26e-01 6.80e-01 5.76e-02
GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL 22 5.85e-01 8.67e-01 0.12900 -1.93e-02 1.27e-01 8.75e-01 3.01e-01
GOCC NEUROTRANSMITTER RECEPTOR COMPLEX 42 3.74e-01 7.62e-01 0.12900 -1.22e-01 4.21e-02 1.72e-01 6.37e-01
GOBP MYELOID DENDRITIC CELL ACTIVATION 29 5.23e-01 8.42e-01 0.12900 8.15e-02 -9.99e-02 4.48e-01 3.52e-01
GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY 15 6.55e-01 8.93e-01 0.12900 -9.00e-02 -9.22e-02 5.46e-01 5.36e-01
GOCC CELL LEADING EDGE 412 6.18e-05 3.91e-03 0.12900 -1.26e-01 2.86e-02 1.21e-05 3.19e-01
GOBP HAIR FOLLICLE MATURATION 15 6.86e-01 9.06e-01 0.12900 -1.29e-01 1.38e-03 3.88e-01 9.93e-01
GOBP EXTRACELLULAR EXOSOME ASSEMBLY 7 8.37e-01 9.55e-01 0.12900 5.47e-03 1.29e-01 9.80e-01 5.55e-01
GOBP DNA DEMETHYLATION 22 6.02e-01 8.75e-01 0.12900 -1.19e-01 5.03e-02 3.36e-01 6.83e-01
GOBP MITOTIC CYTOKINESIS 88 1.05e-01 4.72e-01 0.12900 -1.28e-01 -1.07e-02 3.74e-02 8.63e-01
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX 48 2.71e-01 6.85e-01 0.12900 -4.80e-02 -1.19e-01 5.65e-01 1.52e-01
GOBP PLATELET DENSE GRANULE ORGANIZATION 24 5.86e-01 8.67e-01 0.12900 -8.21e-02 9.92e-02 4.86e-01 4.00e-01
GOMF HORMONE BINDING 89 9.59e-02 4.52e-01 0.12900 -1.26e-01 -2.74e-02 4.02e-02 6.55e-01
GOBP RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION 15 6.84e-01 9.06e-01 0.12900 2.45e-03 1.29e-01 9.87e-01 3.88e-01
GOMF AMP BINDING 15 7.16e-01 9.15e-01 0.12900 -8.00e-02 1.01e-01 5.91e-01 4.99e-01
GOCC PINOSOME 9 8.19e-01 9.52e-01 0.12900 -8.76e-02 9.42e-02 6.49e-01 6.25e-01
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT 142 2.36e-02 2.45e-01 0.12900 -1.25e-01 -3.10e-02 1.02e-02 5.23e-01
Glucagon-type ligand receptors 32 4.07e-01 7.81e-01 0.12900 -8.76e-02 -9.41e-02 3.91e-01 3.57e-01
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING 12 7.60e-01 9.32e-01 0.12900 -1.17e-01 5.31e-02 4.82e-01 7.50e-01
GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS 15 6.57e-01 8.94e-01 0.12900 -9.95e-02 -8.14e-02 5.04e-01 5.85e-01
GOBP DIGESTIVE TRACT MORPHOGENESIS 48 2.67e-01 6.82e-01 0.12900 -5.89e-02 -1.14e-01 4.80e-01 1.71e-01
GOMF PROTEIN PHOSPHATASE 2A BINDING 27 4.71e-01 8.15e-01 0.12900 -1.05e-01 -7.48e-02 3.47e-01 5.01e-01
GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY 6 8.62e-01 9.61e-01 0.12900 -1.28e-01 9.86e-03 5.87e-01 9.67e-01
GOBP GLOMERULUS DEVELOPMENT 71 1.46e-01 5.40e-01 0.12900 -1.20e-01 -4.72e-02 8.15e-02 4.92e-01
GOCC PRESYNAPTIC CYTOSOL 12 7.19e-01 9.16e-01 0.12900 -1.15e-01 -5.73e-02 4.90e-01 7.31e-01
GOBP REGULATION OF MESODERMAL CELL DIFFERENTIATION 10 7.91e-01 9.42e-01 0.12800 -3.76e-02 1.23e-01 8.37e-01 5.01e-01
GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY 20 5.82e-01 8.66e-01 0.12800 -1.20e-01 -4.60e-02 3.53e-01 7.22e-01
GOMF ATPASE BINDING 82 1.17e-01 4.91e-01 0.12800 -2.67e-02 -1.26e-01 6.76e-01 4.92e-02
GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE 23 6.00e-01 8.75e-01 0.12800 9.97e-02 -8.10e-02 4.08e-01 5.02e-01
GOBP SYNAPSE ASSEMBLY 196 6.63e-03 1.18e-01 0.12800 -1.27e-01 -1.60e-02 2.09e-03 6.99e-01
GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY 52 2.75e-01 6.87e-01 0.12800 -3.52e-03 1.28e-01 9.65e-01 1.09e-01
SARS-CoV-1 activates/modulates innate immune responses 39 4.05e-01 7.81e-01 0.12800 4.33e-02 -1.21e-01 6.40e-01 1.91e-01
GOBP HIPPO SIGNALING 52 2.95e-01 7.07e-01 0.12800 -1.24e-01 3.41e-02 1.23e-01 6.71e-01
GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION 19 6.55e-01 8.93e-01 0.12800 7.50e-02 -1.04e-01 5.71e-01 4.32e-01
GOBP NEURONAL ACTION POTENTIAL 34 4.45e-01 8.02e-01 0.12800 -1.26e-01 2.66e-02 2.05e-01 7.88e-01
GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS 251 4.14e-03 8.91e-02 0.12800 8.58e-02 -9.53e-02 1.92e-02 9.28e-03
GOBP RECEPTOR INTERNALIZATION 125 6.39e-02 3.79e-01 0.12800 -8.23e-02 9.84e-02 1.12e-01 5.75e-02
GOBP DNA STRAND INVASION 6 8.75e-01 9.66e-01 0.12800 -7.24e-02 1.06e-01 7.59e-01 6.53e-01
GOBP RESPONSE TO IONIZING RADIATION 138 2.55e-02 2.54e-01 0.12800 -4.04e-02 -1.22e-01 4.13e-01 1.36e-02
GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY 28 4.78e-01 8.20e-01 0.12800 3.08e-02 1.24e-01 7.78e-01 2.54e-01
GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION 8 8.34e-01 9.55e-01 0.12800 -1.16e-01 5.54e-02 5.71e-01 7.86e-01
GOBP MRNA TRANSPORT 118 4.53e-02 3.24e-01 0.12800 -3.12e-02 -1.24e-01 5.58e-01 1.97e-02
GOMF PROTEIN HETERODIMERIZATION ACTIVITY 308 3.22e-04 1.39e-02 0.12800 -3.37e-02 -1.24e-01 3.09e-01 1.90e-04
GOBP INTERLEUKIN 1 ALPHA PRODUCTION 11 7.36e-01 9.23e-01 0.12800 -8.37e-02 -9.70e-02 6.31e-01 5.78e-01
GOBP REGULATION OF ORGAN GROWTH 96 1.16e-01 4.90e-01 0.12800 -1.12e-01 6.14e-02 5.70e-02 2.98e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL 28 4.59e-01 8.10e-01 0.12800 8.61e-02 9.49e-02 4.30e-01 3.85e-01
GOBP REGULATION OF KERATINOCYTE PROLIFERATION 48 3.42e-01 7.40e-01 0.12800 6.46e-02 -1.11e-01 4.39e-01 1.85e-01
GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS 10 7.93e-01 9.43e-01 0.12800 3.92e-02 -1.22e-01 8.30e-01 5.05e-01
GOCC RNA POLYMERASE COMPLEX 96 6.99e-02 3.97e-01 0.12800 -8.79e-02 -9.31e-02 1.37e-01 1.15e-01
GOBP LYMPHOCYTE CHEMOTAXIS 42 3.98e-01 7.76e-01 0.12800 9.28e-02 -8.81e-02 2.98e-01 3.23e-01
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription 36 4.01e-01 7.78e-01 0.12800 -1.19e-02 -1.27e-01 9.02e-01 1.86e-01
Signaling by KIT in disease 20 5.79e-01 8.64e-01 0.12800 -6.05e-02 -1.13e-01 6.40e-01 3.83e-01
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants 20 5.79e-01 8.64e-01 0.12800 -6.05e-02 -1.13e-01 6.40e-01 3.83e-01
GOBP PARATHYROID GLAND DEVELOPMENT 7 8.58e-01 9.60e-01 0.12800 9.15e-02 -8.94e-02 6.75e-01 6.82e-01
GOMF MODIFICATION DEPENDENT PROTEIN BINDING 169 2.51e-02 2.53e-01 0.12800 -9.46e-02 8.61e-02 3.38e-02 5.36e-02
GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL 10 7.93e-01 9.43e-01 0.12800 1.22e-01 -3.96e-02 5.06e-01 8.28e-01
GOMF THREONINE TYPE PEPTIDASE ACTIVITY 16 6.86e-01 9.06e-01 0.12800 1.25e-01 -2.83e-02 3.88e-01 8.45e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 64 2.46e-01 6.61e-01 0.12800 -9.50e-02 8.56e-02 1.89e-01 2.36e-01
GOMF ACID THIOL LIGASE ACTIVITY 30 5.19e-01 8.39e-01 0.12800 -9.04e-02 9.03e-02 3.91e-01 3.92e-01
Extracellular matrix organization 311 1.13e-03 3.60e-02 0.12800 -7.16e-02 1.06e-01 2.99e-02 1.33e-03
Plasma lipoprotein assembly, remodeling, and clearance 74 1.61e-01 5.59e-01 0.12800 -1.28e-01 8.80e-04 5.74e-02 9.90e-01
MET activates RAS signaling 11 7.38e-01 9.24e-01 0.12800 -8.06e-02 -9.91e-02 6.43e-01 5.69e-01
GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY 52 2.39e-01 6.55e-01 0.12800 1.02e-01 7.71e-02 2.04e-01 3.36e-01
GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 33 4.11e-01 7.84e-01 0.12800 -1.17e-01 -5.20e-02 2.46e-01 6.05e-01
GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN 11 7.59e-01 9.32e-01 0.12800 -1.28e-01 -6.29e-03 4.64e-01 9.71e-01
GOCC CILIARY TIP 47 2.73e-01 6.85e-01 0.12800 -9.68e-02 -8.33e-02 2.51e-01 3.23e-01
GOBP PROTEIN CONTAINING COMPLEX REMODELING 37 4.44e-01 8.01e-01 0.12800 -7.58e-02 1.03e-01 4.25e-01 2.80e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS 123 3.41e-02 2.87e-01 0.12800 -7.98e-02 -9.96e-02 1.26e-01 5.64e-02
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 156 2.91e-02 2.69e-01 0.12800 -4.46e-02 1.20e-01 3.37e-01 9.99e-03
GOMF AROMATASE ACTIVITY 26 5.11e-01 8.35e-01 0.12800 -2.43e-02 -1.25e-01 8.30e-01 2.69e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION 5 8.76e-01 9.66e-01 0.12800 3.75e-02 1.22e-01 8.84e-01 6.37e-01
GOCC ATPASE COMPLEX 142 2.92e-02 2.70e-01 0.12800 -1.27e-01 -6.75e-03 8.80e-03 8.90e-01
GOBP NEGATIVE REGULATION OF TORC1 SIGNALING 47 2.99e-01 7.11e-01 0.12700 -2.20e-02 -1.26e-01 7.94e-01 1.36e-01
GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX 12 7.65e-01 9.33e-01 0.12700 6.03e-02 -1.12e-01 7.17e-01 5.01e-01
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) 16 7.06e-01 9.13e-01 0.12700 8.55e-02 -9.45e-02 5.54e-01 5.13e-01
GOBP SEBACEOUS GLAND DEVELOPMENT 10 8.04e-01 9.47e-01 0.12700 9.91e-02 -8.00e-02 5.87e-01 6.61e-01
GOBP REGULATION OF MITOTIC CYTOKINESIS 16 7.06e-01 9.13e-01 0.12700 -8.95e-02 9.06e-02 5.36e-01 5.30e-01
GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 277 5.44e-04 2.03e-02 0.12700 8.27e-02 9.66e-02 1.78e-02 5.64e-03
GOBP INTERMEMBRANE LIPID TRANSFER 34 4.67e-01 8.14e-01 0.12700 -1.16e-01 5.24e-02 2.42e-01 5.97e-01
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane 20 5.78e-01 8.64e-01 0.12700 -8.17e-02 -9.75e-02 5.27e-01 4.50e-01
GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY 7 8.44e-01 9.57e-01 0.12700 -1.27e-01 9.73e-03 5.61e-01 9.64e-01
GOBP PROTEIN SUMOYLATION 64 1.75e-01 5.79e-01 0.12700 -1.02e-01 -7.57e-02 1.57e-01 2.95e-01
Protein localization 153 2.07e-02 2.30e-01 0.12700 -2.10e-02 -1.25e-01 6.53e-01 7.43e-03
GOBP CARBOHYDRATE DERIVATIVE TRANSPORT 89 1.22e-01 5.00e-01 0.12700 -1.86e-02 1.26e-01 7.62e-01 4.04e-02
GOBP POSITIVE REGULATION OF ARTERY MORPHOGENESIS 6 8.56e-01 9.60e-01 0.12700 1.23e-01 3.22e-02 6.02e-01 8.91e-01
GOBP REGULATION OF BLOOD PRESSURE 175 1.91e-02 2.21e-01 0.12700 -1.20e-01 4.09e-02 6.06e-03 3.51e-01
GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING 59 2.09e-01 6.25e-01 0.12700 -4.87e-02 -1.17e-01 5.18e-01 1.19e-01
GOBP REGULATION OF VACUOLE ORGANIZATION 56 2.93e-01 7.05e-01 0.12700 -1.09e-01 6.50e-02 1.58e-01 4.00e-01
GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR 29 4.52e-01 8.07e-01 0.12700 -8.90e-02 -9.06e-02 4.07e-01 3.98e-01
Inactivation of APC/C via direct inhibition of the APC/C complex 21 6.21e-01 8.81e-01 0.12700 4.17e-02 -1.20e-01 7.41e-01 3.41e-01
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components 21 6.21e-01 8.81e-01 0.12700 4.17e-02 -1.20e-01 7.41e-01 3.41e-01
Post-translational protein phosphorylation 100 1.08e-01 4.77e-01 0.12700 -1.15e-01 5.33e-02 4.65e-02 3.57e-01
GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING 8 8.22e-01 9.52e-01 0.12700 -1.27e-01 -9.24e-04 5.34e-01 9.96e-01
GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC 161 1.55e-02 1.98e-01 0.12700 -3.58e-02 -1.22e-01 4.33e-01 7.65e-03
GOBP REGULATION OF CHOLESTEROL STORAGE 19 6.63e-01 8.97e-01 0.12700 -9.11e-02 8.84e-02 4.92e-01 5.05e-01
Association of TriC/CCT with target proteins during biosynthesis 38 3.84e-01 7.67e-01 0.12700 -1.64e-02 -1.26e-01 8.61e-01 1.79e-01
GOBP REGULATION OF CELL SUBSTRATE ADHESION 214 6.95e-03 1.22e-01 0.12700 -1.25e-01 2.36e-02 1.67e-03 5.51e-01
Acyl chain remodeling of CL 5 8.96e-01 9.73e-01 0.12700 6.14e-02 -1.11e-01 8.12e-01 6.67e-01
GOBP HETEROCHROMATIN FORMATION 127 3.81e-02 3.00e-01 0.12700 -3.16e-02 -1.23e-01 5.39e-01 1.68e-02
GOBP CHROMOSOME LOCALIZATION 122 3.65e-02 2.94e-01 0.12700 -1.00e-01 -7.78e-02 5.59e-02 1.38e-01
GOMF ODORANT BINDING 99 1.16e-01 4.90e-01 0.12700 7.03e-02 -1.06e-01 2.27e-01 6.94e-02
GOBP CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS 9 7.82e-01 9.40e-01 0.12700 9.97e-02 7.84e-02 6.05e-01 6.84e-01
GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE 86 1.15e-01 4.89e-01 0.12700 -1.26e-01 -1.76e-02 4.40e-02 7.78e-01
Dual Incision in GG-NER 39 3.57e-01 7.49e-01 0.12700 -4.68e-02 -1.18e-01 6.13e-01 2.03e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II 1191 1.13e-13 4.93e-11 0.12700 -1.18e-01 -4.71e-02 7.49e-12 6.23e-03
Activation of the pre-replicative complex 31 4.32e-01 7.96e-01 0.12700 -7.16e-02 -1.05e-01 4.90e-01 3.13e-01
GOBP REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC 8 8.41e-01 9.56e-01 0.12700 -9.99e-02 7.79e-02 6.25e-01 7.03e-01
GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY 48 2.89e-01 7.02e-01 0.12700 -1.22e-01 -3.40e-02 1.43e-01 6.84e-01
PI-3K cascade:FGFR4 19 6.56e-01 8.94e-01 0.12700 -5.45e-02 1.14e-01 6.81e-01 3.88e-01
GOBP RESCUE OF STALLED RIBOSOME 33 4.11e-01 7.84e-01 0.12700 -1.08e-01 -6.64e-02 2.84e-01 5.09e-01
GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 52 3.25e-01 7.29e-01 0.12700 -1.03e-01 7.37e-02 1.99e-01 3.58e-01
GOBP MESODERM DEVELOPMENT 126 3.65e-02 2.94e-01 0.12700 -1.17e-01 -4.86e-02 2.34e-02 3.46e-01
GOBP NEUROTROPHIN SIGNALING PATHWAY 39 4.04e-01 7.81e-01 0.12700 -1.24e-01 2.49e-02 1.80e-01 7.88e-01
GOBP PEPTIDYL LYSINE MODIFICATION 141 2.50e-02 2.53e-01 0.12700 -1.17e-01 -4.71e-02 1.60e-02 3.35e-01
GOBP REGULATION OF LIPASE ACTIVITY 65 1.80e-01 5.84e-01 0.12700 -1.15e-01 -5.19e-02 1.08e-01 4.69e-01
GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION 15 6.83e-01 9.06e-01 0.12700 -2.40e-02 -1.24e-01 8.72e-01 4.05e-01
Gene expression (Transcription) 1503 2.29e-16 1.80e-13 0.12600 -1.23e-01 -3.08e-02 1.77e-15 4.62e-02
GOCC RUFFLE MEMBRANE 99 1.04e-01 4.70e-01 0.12600 -1.23e-01 3.11e-02 3.51e-02 5.93e-01
GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 14 7.35e-01 9.23e-01 0.12600 1.12e-01 -5.82e-02 4.67e-01 7.06e-01
GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 58 2.57e-01 6.72e-01 0.12600 -1.25e-01 1.88e-02 9.97e-02 8.05e-01
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 61 2.17e-01 6.35e-01 0.12600 -1.81e-02 -1.25e-01 8.07e-01 9.11e-02
GOBP CORTICOSPINAL TRACT MORPHOGENESIS 8 8.15e-01 9.51e-01 0.12600 1.23e-01 2.87e-02 5.47e-01 8.88e-01
GOCC FILOPODIUM TIP 18 6.57e-01 8.94e-01 0.12600 1.25e-01 -2.06e-02 3.60e-01 8.80e-01
Calcineurin activates NFAT 9 7.92e-01 9.42e-01 0.12600 -3.99e-02 -1.20e-01 8.36e-01 5.34e-01
GOBP PHOTOTRANSDUCTION VISIBLE LIGHT 17 6.46e-01 8.91e-01 0.12600 1.22e-01 3.40e-02 3.85e-01 8.08e-01
GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING 34 4.42e-01 8.00e-01 0.12600 3.48e-03 -1.26e-01 9.72e-01 2.03e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS 120 7.79e-02 4.16e-01 0.12600 8.99e-02 -8.86e-02 8.90e-02 9.36e-02
GOMF PHOSPHATE ION BINDING 11 7.62e-01 9.32e-01 0.12600 1.26e-01 1.08e-02 4.70e-01 9.50e-01
GOMF MACROLIDE BINDING 12 7.72e-01 9.36e-01 0.12600 7.30e-02 -1.03e-01 6.62e-01 5.37e-01
GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 147 3.52e-02 2.90e-01 0.12600 -1.23e-01 2.97e-02 1.03e-02 5.35e-01
GOBP NAD METABOLIC PROCESS 63 1.83e-01 5.87e-01 0.12600 8.65e-02 9.18e-02 2.35e-01 2.08e-01
GOMF BASAL TRANSCRIPTION MACHINERY BINDING 58 2.37e-01 6.54e-01 0.12600 -1.25e-01 -1.67e-02 9.97e-02 8.26e-01
GOBP REGULATION OF EXOSOMAL SECRETION 19 6.01e-01 8.75e-01 0.12600 7.35e-02 1.02e-01 5.79e-01 4.40e-01
GOMF GTP DEPENDENT PROTEIN BINDING 20 6.05e-01 8.76e-01 0.12600 -2.24e-02 -1.24e-01 8.62e-01 3.37e-01
GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING 142 2.23e-02 2.40e-01 0.12600 -8.01e-02 -9.73e-02 9.94e-02 4.53e-02
GOMF MRNA CDS BINDING 5 8.79e-01 9.67e-01 0.12600 -1.20e-01 -3.71e-02 6.41e-01 8.86e-01
GOBP CELL CYCLE CHECKPOINT SIGNALING 189 6.39e-03 1.16e-01 0.12600 -8.49e-02 -9.31e-02 4.42e-02 2.73e-02
GOBP REGULATION OF NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY 14 6.87e-01 9.07e-01 0.12600 -1.02e-01 -7.44e-02 5.11e-01 6.30e-01
GOCC GINS COMPLEX 5 8.97e-01 9.73e-01 0.12600 5.72e-02 -1.12e-01 8.25e-01 6.64e-01
GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS 64 1.89e-01 5.95e-01 0.12600 -1.16e-01 -4.92e-02 1.09e-01 4.96e-01
GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS 42 3.24e-01 7.29e-01 0.12600 7.96e-02 9.75e-02 3.72e-01 2.74e-01
GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE 99 1.16e-01 4.90e-01 0.12600 5.38e-02 -1.14e-01 3.55e-01 5.04e-02
Activated NTRK3 signals through RAS 8 8.07e-01 9.48e-01 0.12600 -9.78e-02 -7.91e-02 6.32e-01 6.98e-01
GOMF TRANSCRIPTION FACTOR BINDING 570 1.29e-06 1.35e-04 0.12600 -1.26e-01 -7.79e-03 2.98e-07 7.51e-01
GOBP TRANSLATIONAL READTHROUGH 9 7.92e-01 9.42e-01 0.12600 4.60e-02 1.17e-01 8.11e-01 5.43e-01
HSF1-dependent transactivation 34 4.22e-01 7.90e-01 0.12600 -3.18e-02 -1.22e-01 7.48e-01 2.20e-01
Maturation of nucleoprotein 9683610 11 7.91e-01 9.42e-01 0.12600 -7.72e-02 9.93e-02 6.58e-01 5.69e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 66 1.71e-01 5.73e-01 0.12600 -8.44e-02 -9.31e-02 2.36e-01 1.91e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS 8 8.41e-01 9.56e-01 0.12600 1.11e-01 -5.91e-02 5.87e-01 7.72e-01
GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 101 1.01e-01 4.65e-01 0.12600 -1.23e-01 2.69e-02 3.31e-02 6.41e-01
GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS 17 6.54e-01 8.93e-01 0.12600 -2.23e-02 -1.24e-01 8.74e-01 3.78e-01
GOMF MICROFILAMENT MOTOR ACTIVITY 37 4.57e-01 8.09e-01 0.12600 -9.61e-02 8.08e-02 3.12e-01 3.95e-01
GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS 6 8.58e-01 9.60e-01 0.12600 -1.21e-01 -3.48e-02 6.09e-01 8.82e-01
GOCC TRANSCRIPTION REGULATOR COMPLEX 488 3.27e-06 3.09e-04 0.12500 -1.07e-01 -6.58e-02 5.31e-05 1.27e-02
GOBP CHORIONIC TROPHOBLAST CELL PROLIFERATION 5 8.88e-01 9.71e-01 0.12500 -1.25e-01 5.76e-03 6.28e-01 9.82e-01
GOBP SYNAPTIC SIGNALING 756 8.41e-08 1.23e-05 0.12500 -1.20e-01 3.73e-02 2.12e-08 8.11e-02
GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 48 3.39e-01 7.39e-01 0.12500 3.08e-02 -1.22e-01 7.12e-01 1.45e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS 10 8.09e-01 9.49e-01 0.12500 -7.72e-02 9.87e-02 6.72e-01 5.89e-01
GOCC BASAL PART OF CELL 300 5.38e-04 2.01e-02 0.12500 1.20e-01 3.60e-02 3.48e-04 2.83e-01
GOBP RESPONSE TO HYDROPEROXIDE 19 6.04e-01 8.76e-01 0.12500 7.54e-02 1.00e-01 5.69e-01 4.50e-01
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEDIFFERENTIATION 5 8.84e-01 9.69e-01 0.12500 -1.75e-02 -1.24e-01 9.46e-01 6.31e-01
GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS 15 6.72e-01 9.02e-01 0.12500 7.24e-02 1.02e-01 6.27e-01 4.93e-01
GOBP POST GOLGI VESICLE MEDIATED TRANSPORT 108 9.07e-02 4.43e-01 0.12500 -1.20e-01 3.52e-02 3.10e-02 5.27e-01
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE 45 3.32e-01 7.35e-01 0.12500 1.24e-01 1.67e-02 1.50e-01 8.47e-01
GOCC OXOGLUTARATE DEHYDROGENASE COMPLEX 10 7.86e-01 9.41e-01 0.12500 -1.25e-01 -6.41e-03 4.94e-01 9.72e-01
GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY 29 4.82e-01 8.22e-01 0.12500 -1.21e-01 -3.11e-02 2.59e-01 7.72e-01
GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT 142 5.00e-02 3.39e-01 0.12500 6.94e-02 -1.04e-01 1.53e-01 3.22e-02
GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY 139 4.31e-02 3.16e-01 0.12500 -1.23e-01 2.40e-02 1.24e-02 6.25e-01
GOBP NEGATIVE REGULATION OF STEROL TRANSPORT 30 5.19e-01 8.39e-01 0.12500 -4.50e-02 1.17e-01 6.70e-01 2.69e-01
GOBP OLIGODENDROCYTE DEVELOPMENT 45 3.89e-01 7.70e-01 0.12500 -9.55e-02 8.07e-02 2.68e-01 3.49e-01
GOCC METHYLTRANSFERASE COMPLEX 94 9.36e-02 4.47e-01 0.12500 -3.56e-02 -1.20e-01 5.51e-01 4.46e-02
GOBP BLASTOCYST FORMATION 45 3.05e-01 7.15e-01 0.12500 -7.28e-02 -1.02e-01 3.98e-01 2.38e-01
GOMF TBP CLASS PROTEIN BINDING 24 5.29e-01 8.43e-01 0.12500 -8.94e-02 -8.74e-02 4.49e-01 4.59e-01
GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS 43 4.06e-01 7.81e-01 0.12500 -8.11e-02 9.50e-02 3.57e-01 2.81e-01
GOBP CALCIUM ION TRANSPORT INTO CYTOSOL 28 5.02e-01 8.30e-01 0.12500 -2.10e-02 -1.23e-01 8.47e-01 2.59e-01
GOMF CERAMIDE 1 PHOSPHATE BINDING 7 8.38e-01 9.55e-01 0.12500 -3.70e-02 -1.19e-01 8.65e-01 5.85e-01
GOBP PROTEIN K27 LINKED UBIQUITINATION 12 7.49e-01 9.28e-01 0.12500 -8.84e-03 -1.25e-01 9.58e-01 4.55e-01
GOBP PURINE NUCLEOTIDE SALVAGE 10 7.67e-01 9.34e-01 0.12500 8.88e-02 8.78e-02 6.27e-01 6.31e-01
Processive synthesis on the C-strand of the telomere 19 6.21e-01 8.81e-01 0.12500 -1.21e-01 -3.20e-02 3.62e-01 8.09e-01
GOBP REGULATION OF THE FORCE OF HEART CONTRACTION 26 5.04e-01 8.31e-01 0.12500 -1.01e-01 -7.36e-02 3.73e-01 5.16e-01
GOBP VACUOLAR TRANSPORT 166 2.58e-02 2.55e-01 0.12500 -1.20e-01 3.49e-02 7.71e-03 4.38e-01
Glycogen storage diseases 15 7.12e-01 9.14e-01 0.12500 2.37e-02 -1.23e-01 8.74e-01 4.11e-01
GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION 25 5.17e-01 8.39e-01 0.12500 9.54e-02 8.04e-02 4.09e-01 4.86e-01
GOBP TELENCEPHALON DEVELOPMENT 266 1.55e-03 4.50e-02 0.12500 -1.23e-01 -2.15e-02 5.60e-04 5.46e-01
GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 10 8.11e-01 9.49e-01 0.12500 7.50e-02 -9.97e-02 6.81e-01 5.85e-01
GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY 17 6.78e-01 9.04e-01 0.12500 1.71e-02 -1.24e-01 9.03e-01 3.78e-01
Signal attenuation 10 8.02e-01 9.46e-01 0.12500 -3.57e-02 1.19e-01 8.45e-01 5.13e-01
GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN 28 5.58e-01 8.56e-01 0.12500 8.55e-02 -9.07e-02 4.34e-01 4.06e-01
GOCC SPERM PRINCIPAL PIECE 33 4.68e-01 8.14e-01 0.12500 1.24e-01 -1.38e-02 2.18e-01 8.91e-01
GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 48 3.14e-01 7.22e-01 0.12500 -1.24e-01 -1.24e-02 1.37e-01 8.82e-01
GOBP REGULATION OF BONE MINERALIZATION 77 1.81e-01 5.84e-01 0.12500 -1.21e-01 3.01e-02 6.66e-02 6.48e-01
GOBP DNA INTEGRITY CHECKPOINT SIGNALING 132 3.18e-02 2.79e-01 0.12400 -8.26e-02 -9.30e-02 1.01e-01 6.50e-02
GOBP POSITIVE REGULATION OF CELLULAR PH REDUCTION 5 9.00e-01 9.74e-01 0.12400 -1.07e-01 6.34e-02 6.79e-01 8.06e-01
GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS 11 7.74e-01 9.36e-01 0.12400 -1.24e-01 4.43e-03 4.75e-01 9.80e-01
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION 26 5.41e-01 8.50e-01 0.12400 -1.24e-01 -2.83e-03 2.73e-01 9.80e-01
Regulation of BACH1 activity 15 7.29e-01 9.21e-01 0.12400 6.26e-02 -1.07e-01 6.75e-01 4.72e-01
GOBP LEARNED VOCALIZATION BEHAVIOR OR VOCAL LEARNING 10 7.98e-01 9.45e-01 0.12400 -2.09e-02 1.22e-01 9.09e-01 5.02e-01
GOBP VESICLE CYTOSKELETAL TRAFFICKING 58 2.34e-01 6.50e-01 0.12400 -3.95e-02 -1.18e-01 6.03e-01 1.21e-01
GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX 7 8.36e-01 9.55e-01 0.12400 -1.13e-01 -5.11e-02 6.04e-01 8.15e-01
GOBP RRNA METHYLATION 23 5.67e-01 8.59e-01 0.12400 -2.86e-02 -1.21e-01 8.12e-01 3.16e-01
GOBP CELLULAR RESPIRATION 214 6.87e-03 1.21e-01 0.12400 -1.41e-03 -1.24e-01 9.72e-01 1.75e-03
GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION 62 2.34e-01 6.50e-01 0.12400 -2.35e-03 -1.24e-01 9.74e-01 9.11e-02
Somitogenesis 45 3.15e-01 7.22e-01 0.12400 -5.95e-02 -1.09e-01 4.90e-01 2.07e-01
GOBP SENSORY SYSTEM DEVELOPMENT 395 2.22e-04 1.07e-02 0.12400 -1.17e-01 4.08e-02 6.47e-05 1.64e-01
GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS 25 5.81e-01 8.65e-01 0.12400 -3.92e-02 1.18e-01 7.34e-01 3.09e-01
E2F-enabled inhibition of pre-replication complex formation 9 7.98e-01 9.45e-01 0.12400 -3.91e-02 -1.18e-01 8.39e-01 5.41e-01
GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS 9 8.23e-01 9.52e-01 0.12400 1.17e-01 -4.17e-02 5.44e-01 8.29e-01
GOBP ADULT LOCOMOTORY BEHAVIOR 80 1.34e-01 5.22e-01 0.12400 -1.16e-01 -4.47e-02 7.38e-02 4.90e-01
Sealing of the nuclear envelope (NE) by ESCRT-III 30 4.71e-01 8.15e-01 0.12400 1.17e-01 4.19e-02 2.69e-01 6.91e-01
Amino Acid conjugation 9 8.01e-01 9.46e-01 0.12400 -3.13e-02 -1.20e-01 8.71e-01 5.34e-01
Conjugation of carboxylic acids 9 8.01e-01 9.46e-01 0.12400 -3.13e-02 -1.20e-01 8.71e-01 5.34e-01
GOBP LYMPHOCYTE COSTIMULATION 45 3.97e-01 7.76e-01 0.12400 9.00e-02 -8.51e-02 2.96e-01 3.23e-01
GOBP MODULATION BY HOST OF VIRAL PROCESS 45 3.71e-01 7.60e-01 0.12400 2.91e-02 -1.20e-01 7.36e-01 1.63e-01
GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION 5 8.79e-01 9.67e-01 0.12400 6.96e-02 1.02e-01 7.88e-01 6.92e-01
GOBP COLLAGEN METABOLIC PROCESS 104 1.19e-01 4.95e-01 0.12400 -8.31e-02 9.18e-02 1.43e-01 1.06e-01
GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS 55 2.40e-01 6.55e-01 0.12400 -8.51e-02 -8.98e-02 2.75e-01 2.49e-01
GOMF ROUNDABOUT BINDING 8 8.21e-01 9.52e-01 0.12400 1.20e-01 3.14e-02 5.58e-01 8.78e-01
GOBP REGULATION OF CARTILAGE DEVELOPMENT 71 2.30e-01 6.48e-01 0.12400 -1.03e-01 6.83e-02 1.33e-01 3.20e-01
GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY 10 7.97e-01 9.44e-01 0.12400 -1.23e-01 1.30e-02 5.01e-01 9.43e-01
GOMF DNA DNA TETHERING ACTIVITY 7 8.45e-01 9.57e-01 0.12400 -1.71e-02 -1.22e-01 9.38e-01 5.75e-01
GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT 9 8.20e-01 9.52e-01 0.12400 1.20e-01 -2.85e-02 5.32e-01 8.82e-01
GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 63 2.29e-01 6.47e-01 0.12400 -5.93e-03 -1.23e-01 9.35e-01 9.01e-02
GOBP L ARGININE TRANSMEMBRANE TRANSPORT 14 7.02e-01 9.12e-01 0.12400 -1.13e-01 -5.00e-02 4.64e-01 7.46e-01
GOMF BETA CATENIN BINDING 101 1.05e-01 4.72e-01 0.12400 -1.22e-01 1.89e-02 3.39e-02 7.43e-01
GOBP LIPID MODIFICATION 187 2.03e-02 2.28e-01 0.12400 -5.52e-02 1.10e-01 1.93e-01 9.18e-03
GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS 70 1.86e-01 5.92e-01 0.12300 -2.14e-02 -1.21e-01 7.57e-01 7.88e-02
GOBP COLLAGEN BIOSYNTHETIC PROCESS 46 3.87e-01 7.68e-01 0.12300 -1.05e-01 6.54e-02 2.20e-01 4.43e-01
GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION 14 7.37e-01 9.23e-01 0.12300 -1.19e-01 3.07e-02 4.39e-01 8.43e-01
GOBP PROTEIN K29 LINKED UBIQUITINATION 11 7.77e-01 9.38e-01 0.12300 1.23e-01 -2.68e-03 4.79e-01 9.88e-01
HCMV Early Events 99 9.04e-02 4.42e-01 0.12300 -2.98e-02 -1.20e-01 6.08e-01 3.97e-02
GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 11 7.80e-01 9.40e-01 0.12300 -1.25e-02 1.23e-01 9.43e-01 4.81e-01
GOBP TOLL SIGNALING PATHWAY 11 7.69e-01 9.35e-01 0.12300 1.22e-01 1.81e-02 4.84e-01 9.17e-01
GOBP POSITIVE REGULATION OF ACTION POTENTIAL 8 8.19e-01 9.52e-01 0.12300 4.72e-02 1.14e-01 8.17e-01 5.77e-01
GOMF PRERIBOSOME BINDING 8 8.50e-01 9.58e-01 0.12300 8.55e-02 -8.88e-02 6.76e-01 6.64e-01
GOBP SYNAPTIC MEMBRANE ADHESION 26 5.80e-01 8.65e-01 0.12300 -1.11e-01 5.38e-02 3.28e-01 6.35e-01
GOBP L AMINO ACID CATABOLIC PROCESS 64 2.44e-01 6.58e-01 0.12300 -1.21e-01 2.22e-02 9.36e-02 7.59e-01
GOBP ENDOPLASMIC RETICULUM PLASMA MEMBRANE TETHERING 6 8.84e-01 9.69e-01 0.12300 -9.92e-02 7.30e-02 6.74e-01 7.57e-01
GOMF N ACETYLTRANSFERASE ACTIVITY 62 2.21e-01 6.39e-01 0.12300 -1.19e-01 -3.19e-02 1.05e-01 6.64e-01
GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS 18 6.65e-01 8.98e-01 0.12300 -7.61e-03 1.23e-01 9.55e-01 3.67e-01
GOBP TRIPEPTIDE TRANSPORT 12 7.53e-01 9.30e-01 0.12300 1.22e-01 1.48e-02 4.64e-01 9.29e-01
GOBP PEPTIDYL ARGININE METHYLATION 10 7.87e-01 9.41e-01 0.12300 -1.21e-01 -2.24e-02 5.08e-01 9.02e-01
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) 8 8.39e-01 9.56e-01 0.12300 -1.20e-01 2.49e-02 5.55e-01 9.03e-01
PI3K events in ERBB4 signaling 10 8.12e-01 9.49e-01 0.12300 5.34e-02 -1.11e-01 7.70e-01 5.44e-01
Signaling by NTRK3 (TRKC) 17 6.47e-01 8.91e-01 0.12300 -9.76e-02 -7.49e-02 4.86e-01 5.93e-01
Co-inhibition by CTLA4 21 6.36e-01 8.86e-01 0.12300 -1.18e-01 3.33e-02 3.48e-01 7.91e-01
GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY 14 7.49e-01 9.28e-01 0.12300 6.19e-02 -1.06e-01 6.88e-01 4.91e-01
GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING 451 3.06e-05 2.13e-03 0.12300 -1.22e-01 -1.18e-02 8.29e-06 6.68e-01
GOBP RHYTHMIC PROCESS 289 1.11e-03 3.58e-02 0.12300 -1.21e-01 -1.91e-02 3.79e-04 5.76e-01
GOBP IMMATURE T CELL PROLIFERATION 12 7.52e-01 9.30e-01 0.12300 1.85e-02 1.22e-01 9.11e-01 4.66e-01
GOBP RECEPTOR CLUSTERING 57 3.15e-01 7.22e-01 0.12300 -9.09e-02 8.28e-02 2.35e-01 2.80e-01
GOBP POSITIVE REGULATION OF MUSCLE ADAPTATION 13 7.17e-01 9.15e-01 0.12300 9.71e-02 7.52e-02 5.44e-01 6.39e-01
GOBP MIDBRAIN DEVELOPMENT 85 1.27e-01 5.10e-01 0.12300 -1.18e-01 -3.34e-02 5.95e-02 5.94e-01
GOBP RESPONSE TO INTERLEUKIN 1 110 1.08e-01 4.77e-01 0.12300 7.68e-02 -9.58e-02 1.64e-01 8.25e-02
GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING 56 3.05e-01 7.15e-01 0.12300 4.05e-02 -1.16e-01 6.00e-01 1.34e-01
Mitotic Telophase/Cytokinesis 11 7.62e-01 9.32e-01 0.12300 -1.14e-01 -4.52e-02 5.12e-01 7.95e-01
SHC-related events triggered by IGF1R 9 7.96e-01 9.44e-01 0.12300 -6.69e-02 -1.03e-01 7.28e-01 5.93e-01
Regulation of HSF1-mediated heat shock response 80 1.34e-01 5.22e-01 0.12300 -5.95e-02 -1.07e-01 3.58e-01 9.68e-02
GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION 43 4.19e-01 7.87e-01 0.12300 -9.49e-02 7.78e-02 2.81e-01 3.78e-01
GOBP AXIAL MESODERM DEVELOPMENT 8 8.43e-01 9.56e-01 0.12300 3.56e-02 -1.17e-01 8.61e-01 5.66e-01
GOBP HEART VALVE FORMATION 15 7.01e-01 9.12e-01 0.12300 -1.90e-02 -1.21e-01 8.99e-01 4.17e-01
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 8 8.24e-01 9.52e-01 0.12300 -1.19e-01 -3.14e-02 5.62e-01 8.78e-01
GOMF MICROFIBRIL BINDING 6 8.58e-01 9.60e-01 0.12300 9.54e-02 7.70e-02 6.86e-01 7.44e-01
GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE 10 7.83e-01 9.40e-01 0.12200 1.16e-01 3.84e-02 5.24e-01 8.34e-01
GOBP REGULATION OF VASOCONSTRICTION 65 2.37e-01 6.54e-01 0.12200 -1.22e-01 1.31e-02 8.95e-02 8.55e-01
Synthesis of very long-chain fatty acyl-CoAs 23 5.77e-01 8.64e-01 0.12200 2.69e-02 1.19e-01 8.23e-01 3.21e-01
GOCC POTASSIUM CHANNEL COMPLEX 99 1.35e-01 5.22e-01 0.12200 -6.71e-02 1.02e-01 2.48e-01 7.83e-02
GOBP PROSTATE GLAND MORPHOGENESIS 27 5.03e-01 8.31e-01 0.12200 -8.83e-02 -8.48e-02 4.27e-01 4.46e-01
GOBP BONE MINERALIZATION INVOLVED IN BONE MATURATION 13 7.34e-01 9.23e-01 0.12200 2.29e-02 1.20e-01 8.86e-01 4.53e-01
GOBP GOLGI VESICLE BUDDING 10 8.16e-01 9.51e-01 0.12200 -1.04e-01 6.43e-02 5.68e-01 7.25e-01
GOBP CELLULAR RESPONSE TO CADMIUM ION 35 4.60e-01 8.10e-01 0.12200 -1.22e-01 1.24e-02 2.12e-01 8.99e-01
GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY 9 7.95e-01 9.44e-01 0.12200 8.04e-02 9.23e-02 6.76e-01 6.32e-01
GOCC AXON INITIAL SEGMENT 21 6.41e-01 8.89e-01 0.12200 -1.16e-01 3.86e-02 3.57e-01 7.59e-01
GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS 22 5.89e-01 8.68e-01 0.12200 1.18e-01 3.07e-02 3.36e-01 8.03e-01
GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS 53 2.61e-01 6.76e-01 0.12200 7.87e-02 9.37e-02 3.22e-01 2.38e-01
GOBP PSEUDOPODIUM ORGANIZATION 15 6.85e-01 9.06e-01 0.12200 -6.81e-02 -1.02e-01 6.48e-01 4.96e-01
GOBP RESPONSE TO LEAD ION 19 6.76e-01 9.04e-01 0.12200 -5.45e-02 1.10e-01 6.81e-01 4.09e-01
GOMF G PROTEIN ALPHA SUBUNIT BINDING 29 5.57e-01 8.56e-01 0.12200 -9.80e-02 7.32e-02 3.61e-01 4.95e-01
GOBP PLASMA MEMBRANE FUSION 30 4.74e-01 8.17e-01 0.12200 1.09e-01 5.61e-02 3.03e-01 5.95e-01
GOBP MOTOR NEURON AXON GUIDANCE 25 5.96e-01 8.72e-01 0.12200 -5.05e-02 1.11e-01 6.62e-01 3.35e-01
GOBP PROTEIN DEPALMITOYLATION 8 8.24e-01 9.52e-01 0.12200 -3.46e-02 -1.17e-01 8.65e-01 5.66e-01
Hedgehog ‘on’ state 73 1.82e-01 5.86e-01 0.12200 -1.21e-01 -1.61e-02 7.34e-02 8.12e-01
GOBP DOUBLE STRAND BREAK REPAIR 304 6.85e-04 2.41e-02 0.12200 -1.16e-01 -3.78e-02 4.89e-04 2.57e-01
Transport of Mature Transcript to Cytoplasm 78 1.41e-01 5.33e-01 0.12200 -6.90e-02 -1.01e-01 2.92e-01 1.23e-01
GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 158 3.91e-02 3.05e-01 0.12200 -1.11e-01 5.20e-02 1.64e-02 2.59e-01
GOBP LUNG MORPHOGENESIS 55 3.05e-01 7.15e-01 0.12200 -1.20e-01 2.49e-02 1.25e-01 7.50e-01
Generic Transcription Pathway 1169 3.00e-12 9.22e-10 0.12200 -1.18e-01 -2.97e-02 8.48e-12 8.75e-02
GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI 25 5.31e-01 8.44e-01 0.12200 -8.24e-02 -9.02e-02 4.76e-01 4.35e-01
Formation of Incision Complex in GG-NER 40 3.70e-01 7.58e-01 0.12200 -5.80e-02 -1.07e-01 5.26e-01 2.39e-01
GOCC ASTROCYTE END FOOT 11 7.65e-01 9.33e-01 0.12200 4.22e-02 1.15e-01 8.08e-01 5.11e-01
GOBP BEHAVIORAL RESPONSE TO PAIN 19 6.76e-01 9.04e-01 0.12200 -5.08e-02 1.11e-01 7.02e-01 4.02e-01
GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 81 1.84e-01 5.89e-01 0.12200 -4.22e-02 1.15e-01 5.12e-01 7.46e-02
GOBP METANEPHRIC EPITHELIUM DEVELOPMENT 28 5.71e-01 8.61e-01 0.12200 -9.13e-02 8.11e-02 4.03e-01 4.58e-01
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY 13 7.27e-01 9.20e-01 0.12200 1.13e-01 4.56e-02 4.80e-01 7.76e-01
GOBP MEIOTIC CHROMOSOME SEGREGATION 91 1.29e-01 5.13e-01 0.12200 -1.22e-01 7.21e-04 4.42e-02 9.91e-01
GOCC SARCOLEMMA 136 5.87e-02 3.69e-01 0.12200 -1.15e-01 4.05e-02 2.05e-02 4.14e-01
GOCC ENDOPLASMIC RETICULUM EXIT SITE 29 5.00e-01 8.30e-01 0.12200 -3.12e-02 -1.18e-01 7.71e-01 2.72e-01
InlB-mediated entry of Listeria monocytogenes into host cell 14 7.48e-01 9.28e-01 0.12200 4.65e-02 -1.13e-01 7.63e-01 4.65e-01
GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME 100 8.06e-02 4.21e-01 0.12200 -8.48e-02 -8.77e-02 1.43e-01 1.30e-01
LDL clearance 19 6.32e-01 8.86e-01 0.12200 -1.16e-01 -3.77e-02 3.82e-01 7.76e-01
GOBP ACTIVATION OF GTPASE ACTIVITY 82 1.96e-01 6.07e-01 0.12200 -9.14e-02 8.07e-02 1.53e-01 2.06e-01
GOBP STRIATED MUSCLE CELL PROLIFERATION 81 1.67e-01 5.67e-01 0.12200 -1.22e-01 9.17e-03 5.86e-02 8.87e-01
GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY 29 4.81e-01 8.21e-01 0.12200 8.42e-02 8.82e-02 4.33e-01 4.11e-01
FCGR activation 11 8.03e-01 9.47e-01 0.12200 8.82e-02 -8.41e-02 6.12e-01 6.29e-01
GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS 106 8.49e-02 4.32e-01 0.12200 -1.84e-02 -1.20e-01 7.43e-01 3.21e-02
GOCC NUCLEAR PORE NUCLEAR BASKET 11 7.73e-01 9.36e-01 0.12200 -1.20e-01 -2.02e-02 4.90e-01 9.08e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS 62 2.90e-01 7.03e-01 0.12200 9.69e-02 -7.38e-02 1.87e-01 3.15e-01
Disorders of Developmental Biology 11 7.90e-01 9.42e-01 0.12200 -2.53e-02 1.19e-01 8.84e-01 4.94e-01
Disorders of Nervous System Development 11 7.90e-01 9.42e-01 0.12200 -2.53e-02 1.19e-01 8.84e-01 4.94e-01
Loss of function of MECP2 in Rett syndrome 11 7.90e-01 9.42e-01 0.12200 -2.53e-02 1.19e-01 8.84e-01 4.94e-01
Pervasive developmental disorders 11 7.90e-01 9.42e-01 0.12200 -2.53e-02 1.19e-01 8.84e-01 4.94e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING 69 2.11e-01 6.27e-01 0.12200 -1.22e-01 -2.18e-03 8.03e-02 9.75e-01
GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY 36 4.80e-01 8.21e-01 0.12200 5.52e-02 -1.08e-01 5.66e-01 2.60e-01
GOMF CYTOKINE RECEPTOR ACTIVITY 88 1.43e-01 5.35e-01 0.12200 1.21e-01 -7.03e-03 4.88e-02 9.09e-01
GOBP RESPONSE TO DSRNA 53 3.45e-01 7.43e-01 0.12200 1.03e-01 -6.56e-02 1.97e-01 4.09e-01
GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS 65 2.51e-01 6.66e-01 0.12200 2.87e-02 -1.18e-01 6.89e-01 9.92e-02
GOBP RESPONSE TO LIPOTEICHOIC ACID 10 8.02e-01 9.46e-01 0.12200 9.09e-03 -1.21e-01 9.60e-01 5.07e-01
GOBP RETINAL PIGMENT EPITHELIUM DEVELOPMENT 6 8.60e-01 9.60e-01 0.12200 -8.07e-02 -9.09e-02 7.32e-01 7.00e-01
GOMF MIRNA BINDING 38 4.00e-01 7.78e-01 0.12200 -4.01e-02 -1.15e-01 6.69e-01 2.21e-01
GOCC NUCLEAR ENVELOPE LUMEN 11 7.80e-01 9.39e-01 0.12200 -1.21e-01 -4.21e-03 4.85e-01 9.81e-01
GOBP REGULATION OF CALCIUM MEDIATED SIGNALING 95 9.50e-02 4.50e-01 0.12200 -6.68e-02 -1.01e-01 2.60e-01 8.74e-02
Glycosaminoglycan metabolism 121 9.01e-02 4.41e-01 0.12200 -6.80e-02 1.01e-01 1.97e-01 5.57e-02
GOMF HYALURONONGLUCOSAMINIDASE ACTIVITY 8 8.51e-01 9.58e-01 0.12100 -1.06e-01 5.91e-02 6.03e-01 7.72e-01
GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 121 7.51e-02 4.11e-01 0.12100 -1.20e-01 2.14e-02 2.31e-02 6.84e-01
GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION 6 8.76e-01 9.66e-01 0.12100 -1.21e-01 8.81e-03 6.07e-01 9.70e-01
Base Excision Repair 68 2.18e-01 6.37e-01 0.12100 -8.51e-04 -1.21e-01 9.90e-01 8.35e-02
GOMF GLUCOSIDASE ACTIVITY 14 7.49e-01 9.28e-01 0.12100 -4.31e-02 1.13e-01 7.80e-01 4.63e-01
GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 16 7.28e-01 9.21e-01 0.12100 7.35e-02 -9.64e-02 6.11e-01 5.04e-01
GOMF CADMIUM ION BINDING 5 9.01e-01 9.74e-01 0.12100 3.74e-02 -1.15e-01 8.85e-01 6.55e-01
GOBP REGULATION OF COMPLEMENT ACTIVATION CLASSICAL PATHWAY 9 8.29e-01 9.53e-01 0.12100 1.16e-01 -3.57e-02 5.47e-01 8.53e-01
GOBP ADP TRANSPORT 10 8.18e-01 9.52e-01 0.12100 -1.05e-01 6.03e-02 5.65e-01 7.41e-01
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING 9 8.13e-01 9.50e-01 0.12100 -1.57e-02 -1.20e-01 9.35e-01 5.32e-01
GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE 128 7.71e-02 4.14e-01 0.12100 5.80e-02 -1.06e-01 2.57e-01 3.76e-02
GOBP VIRION ASSEMBLY 34 5.00e-01 8.30e-01 0.12100 4.80e-02 -1.11e-01 6.28e-01 2.62e-01
GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS 30 5.51e-01 8.54e-01 0.12100 6.57e-02 -1.02e-01 5.34e-01 3.35e-01
GOMF FMN BINDING 15 6.98e-01 9.11e-01 0.12100 -4.15e-02 -1.14e-01 7.81e-01 4.46e-01
GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 85 1.89e-01 5.96e-01 0.12100 -9.15e-02 7.91e-02 1.45e-01 2.07e-01
GOMF DNA INSERTION OR DELETION BINDING 6 8.89e-01 9.71e-01 0.12100 7.54e-02 -9.46e-02 7.49e-01 6.88e-01
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY 36 4.40e-01 7.99e-01 0.12100 -1.38e-02 -1.20e-01 8.86e-01 2.12e-01
GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS 8 8.20e-01 9.52e-01 0.12100 9.46e-02 7.54e-02 6.43e-01 7.12e-01
GOMF 5 3 DNA EXONUCLEASE ACTIVITY 9 8.27e-01 9.53e-01 0.12100 -1.18e-01 2.81e-02 5.41e-01 8.84e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL 40 3.85e-01 7.68e-01 0.12100 -1.14e-01 -4.02e-02 2.12e-01 6.60e-01
GOMF NEUROTROPHIN BINDING 10 7.95e-01 9.44e-01 0.12100 1.20e-01 1.62e-02 5.12e-01 9.29e-01
Retrograde transport at the Trans-Golgi-Network 47 3.14e-01 7.22e-01 0.12100 -6.89e-02 -9.94e-02 4.14e-01 2.38e-01
GOBP MODIFICATION OF SYNAPTIC STRUCTURE 27 5.14e-01 8.36e-01 0.12100 -9.94e-02 -6.89e-02 3.71e-01 5.36e-01
GOBP REGULATION OF RRNA PROCESSING 16 6.90e-01 9.08e-01 0.12100 -1.18e-01 -2.43e-02 4.12e-01 8.66e-01
GOMF GLUTATHIONE PEROXIDASE ACTIVITY 21 6.59e-01 8.95e-01 0.12100 -1.03e-01 6.28e-02 4.13e-01 6.18e-01
Activated NOTCH1 Transmits Signal to the Nucleus 30 4.90e-01 8.26e-01 0.12100 1.14e-01 3.88e-02 2.78e-01 7.13e-01
GOCC NUCLEAR PERIPHERY 142 3.07e-02 2.74e-01 0.12100 -7.14e-02 -9.75e-02 1.42e-01 4.49e-02
GOCC A BAND 39 3.81e-01 7.66e-01 0.12100 -9.02e-02 -8.04e-02 3.30e-01 3.85e-01
Interleukin-1 signaling 98 9.15e-02 4.44e-01 0.12100 -6.36e-02 -1.03e-01 2.77e-01 7.90e-02
Kinesins 59 2.59e-01 6.73e-01 0.12100 1.19e-01 1.84e-02 1.13e-01 8.07e-01
GOBP CHROMOSOME ORGANIZATION 614 4.60e-07 5.48e-05 0.12100 -1.03e-01 -6.21e-02 1.20e-05 8.59e-03
GOMF DIACYLGLYCEROL DEPENDENT SERINE THREONINE KINASE ACTIVITY 16 7.07e-01 9.13e-01 0.12100 -1.20e-01 9.71e-03 4.05e-01 9.46e-01
GOBP ARACHIDONIC ACID SECRETION 31 5.44e-01 8.51e-01 0.12100 9.84e-02 -6.97e-02 3.43e-01 5.02e-01
Surfactant metabolism 27 5.23e-01 8.42e-01 0.12100 4.83e-02 1.11e-01 6.64e-01 3.20e-01
GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE 60 2.71e-01 6.85e-01 0.12100 6.54e-03 -1.20e-01 9.30e-01 1.07e-01
RNA Polymerase II Transcription 1287 3.52e-13 1.27e-10 0.12100 -1.15e-01 -3.69e-02 4.30e-12 2.63e-02
GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON 7 8.72e-01 9.65e-01 0.12100 -8.04e-02 8.99e-02 7.13e-01 6.81e-01
GOBP CELL SURFACE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 401 2.93e-04 1.29e-02 0.12100 -1.15e-01 3.52e-02 7.37e-05 2.27e-01
GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY 405 4.17e-04 1.67e-02 0.12100 -9.42e-02 7.53e-02 1.15e-03 9.32e-03
Regulation of insulin secretion 77 2.21e-01 6.38e-01 0.12100 -6.74e-02 1.00e-01 3.06e-01 1.29e-01
Regulation of TP53 Degradation 36 4.37e-01 7.97e-01 0.12100 -1.19e-01 -2.17e-02 2.18e-01 8.22e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS 11 8.00e-01 9.46e-01 0.12100 1.12e-01 -4.50e-02 5.21e-01 7.96e-01
GOBP MRNA 3 END PROCESSING 38 4.02e-01 7.80e-01 0.12100 -4.82e-02 -1.10e-01 6.07e-01 2.39e-01
GOCC CATALYTIC STEP 2 SPLICEOSOME 86 1.30e-01 5.14e-01 0.12100 -4.39e-02 -1.12e-01 4.81e-01 7.20e-02
GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY 36 4.12e-01 7.84e-01 0.12100 -9.00e-02 -8.01e-02 3.50e-01 4.05e-01
GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY 23 5.93e-01 8.71e-01 0.12100 -1.20e-01 -1.51e-02 3.21e-01 9.00e-01
GOMF TELOMERASE ACTIVITY 6 8.73e-01 9.65e-01 0.12000 1.17e-02 1.20e-01 9.60e-01 6.11e-01
GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION 93 1.15e-01 4.89e-01 0.12000 -3.14e-02 -1.16e-01 6.01e-01 5.25e-02
GOMF LIPASE ACTIVITY 133 4.63e-02 3.27e-01 0.12000 1.17e-01 2.79e-02 1.96e-02 5.78e-01
GOBP INTRACELLULAR TRANSPORT OF VIRUS 10 8.06e-01 9.48e-01 0.12000 9.74e-03 -1.20e-01 9.57e-01 5.11e-01
GOBP PROTEIN C LINKED GLYCOSYLATION 5 8.96e-01 9.73e-01 0.12000 -1.20e-01 3.77e-03 6.41e-01 9.88e-01
GOMF METAL CATION PROTON ANTIPORTER ACTIVITY 23 6.39e-01 8.88e-01 0.12000 9.12e-02 -7.87e-02 4.49e-01 5.14e-01
NOTCH4 Intracellular Domain Regulates Transcription 19 6.64e-01 8.97e-01 0.12000 -1.20e-01 1.01e-02 3.65e-01 9.39e-01
GOCC GLIAL CELL PROJECTION 38 3.93e-01 7.73e-01 0.12000 7.81e-02 9.16e-02 4.05e-01 3.29e-01
Rev-mediated nuclear export of HIV RNA 35 4.35e-01 7.97e-01 0.12000 -1.12e-01 -4.40e-02 2.51e-01 6.53e-01
GOBP CARNITINE TRANSPORT 8 8.56e-01 9.60e-01 0.12000 9.20e-02 -7.75e-02 6.52e-01 7.04e-01
GOMF CERAMIDE BINDING 19 6.88e-01 9.07e-01 0.12000 -1.03e-01 6.19e-02 4.37e-01 6.40e-01
GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY 5 9.00e-01 9.74e-01 0.12000 1.97e-02 -1.19e-01 9.39e-01 6.46e-01
GOBP MRNA TRANSCRIPTION 47 3.67e-01 7.57e-01 0.12000 -1.19e-01 1.47e-02 1.57e-01 8.62e-01
GOMF TRANSLATION REPRESSOR ACTIVITY 290 1.31e-03 4.05e-02 0.12000 2.92e-02 1.17e-01 3.92e-01 6.34e-04
GOBP C TERMINAL PROTEIN LIPIDATION 8 8.39e-01 9.55e-01 0.12000 -1.20e-01 -4.45e-04 5.56e-01 9.98e-01
Non-integrin membrane-ECM interactions 75 1.99e-01 6.12e-01 0.12000 -1.20e-01 8.15e-03 7.26e-02 9.03e-01
Gap-filling DNA repair synthesis and ligation in TC-NER 60 2.37e-01 6.54e-01 0.12000 -5.54e-02 -1.07e-01 4.58e-01 1.53e-01
GOMF LIGAND ACTIVATED TRANSCRIPTION FACTOR ACTIVITY 52 3.63e-01 7.53e-01 0.12000 -9.96e-02 6.72e-02 2.14e-01 4.02e-01
GOBP TORC1 SIGNALING 98 9.13e-02 4.43e-01 0.12000 -8.63e-02 -8.36e-02 1.40e-01 1.53e-01
GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS 5 8.85e-01 9.69e-01 0.12000 -8.59e-02 -8.40e-02 7.39e-01 7.45e-01
GOBP RIBONUCLEOSIDE METABOLIC PROCESS 35 4.43e-01 8.00e-01 0.12000 -1.15e-01 -3.35e-02 2.38e-01 7.31e-01
GOBP TRANSPOSITION 37 4.43e-01 8.00e-01 0.12000 3.75e-03 1.20e-01 9.69e-01 2.07e-01
Post-translational modification: synthesis of GPI-anchored proteins 91 1.16e-01 4.90e-01 0.12000 -4.62e-02 -1.11e-01 4.46e-01 6.79e-02
GOBP CELLULAR HYPEROSMOTIC RESPONSE 19 6.89e-01 9.07e-01 0.12000 6.05e-02 -1.04e-01 6.48e-01 4.34e-01
GOMF MISMATCH REPAIR COMPLEX BINDING 11 7.87e-01 9.41e-01 0.12000 -1.20e-01 1.90e-03 4.91e-01 9.91e-01
GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING 85 1.26e-01 5.08e-01 0.12000 -8.37e-02 -8.60e-02 1.82e-01 1.71e-01
ATF6 (ATF6-alpha) activates chaperone genes 10 7.86e-01 9.41e-01 0.12000 -6.09e-02 -1.03e-01 7.39e-01 5.72e-01
GOBP TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION 11 7.66e-01 9.33e-01 0.12000 9.98e-02 6.64e-02 5.66e-01 7.03e-01
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY 55 3.33e-01 7.35e-01 0.12000 4.58e-02 -1.11e-01 5.57e-01 1.55e-01
COPII-mediated vesicle transport 67 2.05e-01 6.20e-01 0.12000 -1.10e-01 -4.84e-02 1.21e-01 4.94e-01
GOCC INNER KINETOCHORE 17 6.67e-01 8.99e-01 0.12000 -5.24e-02 -1.08e-01 7.08e-01 4.42e-01
BMAL1:CLOCK,NPAS2 activates circadian gene expression 24 6.25e-01 8.83e-01 0.12000 -5.90e-02 1.04e-01 6.17e-01 3.76e-01
GOBP ODONTOBLAST DIFFERENTIATION 16 6.98e-01 9.11e-01 0.12000 -1.19e-01 -1.60e-02 4.11e-01 9.12e-01
GOBP REGULATORY NCRNA PROCESSING 69 2.31e-01 6.48e-01 0.12000 -1.19e-01 1.17e-02 8.68e-02 8.66e-01
GOBP INTERFERON MEDIATED SIGNALING PATHWAY 100 1.32e-01 5.19e-01 0.12000 1.14e-01 -3.63e-02 4.85e-02 5.31e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 49 3.89e-01 7.70e-01 0.12000 7.61e-02 -9.26e-02 3.57e-01 2.62e-01
GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT 6 8.66e-01 9.62e-01 0.12000 1.06e-01 5.64e-02 6.54e-01 8.11e-01
GOMF I SMAD BINDING 16 7.33e-01 9.23e-01 0.12000 -6.62e-02 9.98e-02 6.47e-01 4.90e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 42 4.46e-01 8.02e-01 0.12000 8.78e-02 -8.14e-02 3.25e-01 3.62e-01
GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING 43 4.28e-01 7.94e-01 0.12000 -1.08e-01 5.25e-02 2.22e-01 5.52e-01
GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION 31 4.89e-01 8.25e-01 0.12000 -3.17e-02 -1.15e-01 7.60e-01 2.66e-01
Downregulation of ERBB2:ERBB3 signaling 13 7.48e-01 9.28e-01 0.12000 1.19e-01 1.21e-02 4.57e-01 9.40e-01
GOCC SNARE COMPLEX 49 3.06e-01 7.15e-01 0.12000 -9.62e-02 -7.11e-02 2.44e-01 3.89e-01
GOMF EXTRACELLULAR MATRIX BINDING 63 2.68e-01 6.83e-01 0.12000 -1.95e-02 1.18e-01 7.89e-01 1.05e-01
GOBP RRNA METABOLIC PROCESS 253 2.41e-03 6.22e-02 0.12000 -6.48e-02 -1.01e-01 7.58e-02 5.88e-03
GOBP BONE MINERALIZATION 120 7.82e-02 4.17e-01 0.12000 -1.19e-01 9.53e-03 2.41e-02 8.57e-01
GOBP OSSIFICATION 434 1.10e-04 6.50e-03 0.12000 -1.19e-01 7.91e-03 2.01e-05 7.77e-01
GOBP CHROMOSOME SEPARATION 81 1.46e-01 5.40e-01 0.12000 -1.07e-01 -5.43e-02 9.75e-02 3.98e-01
GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE 20 6.26e-01 8.83e-01 0.12000 -1.11e-01 -4.35e-02 3.89e-01 7.37e-01
FRS-mediated FGFR4 signaling 21 6.47e-01 8.91e-01 0.12000 -2.41e-02 1.17e-01 8.48e-01 3.53e-01
GOBP SKELETAL MUSCLE TISSUE REGENERATION 42 4.43e-01 8.00e-01 0.12000 -1.02e-01 6.25e-02 2.53e-01 4.83e-01
GOBP L AMINO ACID TRANSPORT 90 1.75e-01 5.80e-01 0.11900 -6.35e-02 1.01e-01 2.98e-01 9.70e-02
Peroxisomal lipid metabolism 27 5.83e-01 8.66e-01 0.11900 4.19e-02 -1.12e-01 7.06e-01 3.15e-01
NF-kB is activated and signals survival 12 7.84e-01 9.40e-01 0.11900 3.35e-02 -1.15e-01 8.41e-01 4.92e-01
GOCC MANCHETTE 21 6.54e-01 8.93e-01 0.11900 -3.49e-02 1.14e-01 7.82e-01 3.65e-01
GOBP SYNAPTIC VESICLE BUDDING 12 7.91e-01 9.42e-01 0.11900 -1.06e-01 5.49e-02 5.25e-01 7.42e-01
GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING 10 8.21e-01 9.52e-01 0.11900 -1.08e-01 5.12e-02 5.55e-01 7.79e-01
Signaling by ERBB2 TMD/JMD mutants 22 6.30e-01 8.85e-01 0.11900 1.42e-02 -1.18e-01 9.08e-01 3.36e-01
GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY 54 2.86e-01 6.99e-01 0.11900 -1.13e-01 -3.84e-02 1.51e-01 6.25e-01
GOBP POSITIVE REGULATION OF EXOCYTOSIS 72 2.33e-01 6.50e-01 0.11900 1.15e-01 -3.35e-02 9.29e-02 6.23e-01
GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION 57 2.91e-01 7.03e-01 0.11900 -2.05e-03 -1.19e-01 9.79e-01 1.19e-01
GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY 18 6.74e-01 9.03e-01 0.11900 7.08e-03 1.19e-01 9.59e-01 3.82e-01
GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS 7 8.64e-01 9.62e-01 0.11900 1.18e-01 -1.93e-02 5.90e-01 9.29e-01
GOBP IMPORT ACROSS PLASMA MEMBRANE 194 1.44e-02 1.91e-01 0.11900 9.77e-03 1.19e-01 8.14e-01 4.31e-03
GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION 6 8.84e-01 9.69e-01 0.11900 2.58e-02 -1.16e-01 9.13e-01 6.21e-01
GOBP STEM CELL FATE COMMITMENT 10 7.88e-01 9.41e-01 0.11900 -5.88e-02 -1.04e-01 7.47e-01 5.70e-01
Nuclear import of Rev protein 34 4.43e-01 8.00e-01 0.11900 -6.74e-02 -9.83e-02 4.96e-01 3.21e-01
GOBP FIBROBLAST PROLIFERATION 107 1.24e-01 5.03e-01 0.11900 5.09e-02 -1.08e-01 3.63e-01 5.42e-02
GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS 20 6.20e-01 8.80e-01 0.11900 9.94e-02 6.57e-02 4.42e-01 6.11e-01
GOBP OLIGOSACCHARIDE METABOLIC PROCESS 62 2.36e-01 6.54e-01 0.11900 1.10e-01 4.45e-02 1.32e-01 5.45e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME 27 5.36e-01 8.48e-01 0.11900 -1.13e-01 -3.80e-02 3.10e-01 7.33e-01
GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY 141 4.50e-02 3.23e-01 0.11900 1.39e-02 1.18e-01 7.76e-01 1.54e-02
Synthesis of DNA 107 8.42e-02 4.32e-01 0.11900 -4.24e-02 -1.11e-01 4.49e-01 4.68e-02
GOMF SINGLE STRANDED DNA BINDING 115 6.36e-02 3.79e-01 0.11900 -8.71e-02 -8.11e-02 1.07e-01 1.33e-01
TGF-beta receptor signaling activates SMADs 47 3.47e-01 7.44e-01 0.11900 -2.43e-02 -1.17e-01 7.73e-01 1.67e-01
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION 15 7.35e-01 9.23e-01 0.11900 -2.31e-02 1.17e-01 8.77e-01 4.34e-01
Reversible hydration of carbon dioxide 11 8.05e-01 9.47e-01 0.11900 -1.10e-01 4.42e-02 5.26e-01 8.00e-01
GOBP DEDIFFERENTIATION 11 7.74e-01 9.37e-01 0.11900 -1.10e-01 -4.44e-02 5.26e-01 7.99e-01
Processing of Intronless Pre-mRNAs 19 6.56e-01 8.93e-01 0.11900 -1.77e-02 -1.18e-01 8.94e-01 3.75e-01
GOCC CMG COMPLEX 11 7.82e-01 9.40e-01 0.11900 1.17e-01 2.02e-02 5.01e-01 9.08e-01
GOBP ATRIOVENTRICULAR VALVE FORMATION 8 8.51e-01 9.58e-01 0.11900 -3.07e-02 1.15e-01 8.80e-01 5.74e-01
GOBP REGULATION OF B CELL MEDIATED IMMUNITY 58 3.24e-01 7.29e-01 0.11900 5.25e-02 -1.07e-01 4.89e-01 1.60e-01
GOBP FOREBRAIN CELL MIGRATION 62 2.54e-01 6.69e-01 0.11900 -1.18e-01 -1.71e-02 1.09e-01 8.16e-01
GOBP NEGATIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS 18 6.98e-01 9.11e-01 0.11900 1.13e-01 -3.68e-02 4.07e-01 7.87e-01
GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING 22 6.13e-01 8.78e-01 0.11900 -2.07e-02 -1.17e-01 8.66e-01 3.43e-01
GOMF CILIARY NEUROTROPHIC FACTOR RECEPTOR BINDING 6 8.85e-01 9.69e-01 0.11900 -2.29e-02 1.16e-01 9.23e-01 6.21e-01
Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes 94 1.11e-01 4.82e-01 0.11900 -1.04e-01 -5.62e-02 8.02e-02 3.46e-01
Epigenetic regulation of gene expression by MLL3 and MLL4 complexes 94 1.11e-01 4.82e-01 0.11900 -1.04e-01 -5.62e-02 8.02e-02 3.46e-01
MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis 94 1.11e-01 4.82e-01 0.11900 -1.04e-01 -5.62e-02 8.02e-02 3.46e-01
GOMF CATALYTIC ACTIVITY ACTING ON DNA 234 1.01e-02 1.55e-01 0.11900 -1.12e-01 3.86e-02 3.13e-03 3.09e-01
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA 6 8.90e-01 9.71e-01 0.11900 5.37e-02 -1.06e-01 8.20e-01 6.54e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE 9 8.39e-01 9.56e-01 0.11800 -4.86e-02 1.08e-01 8.01e-01 5.75e-01
GOBP SINGLE STRAND BREAK REPAIR 11 7.74e-01 9.37e-01 0.11800 1.08e-01 4.96e-02 5.37e-01 7.76e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE 40 4.59e-01 8.10e-01 0.11800 -4.77e-02 1.08e-01 6.01e-01 2.35e-01
GOMF GAMMA AMINOBUTYRIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 8 8.27e-01 9.53e-01 0.11800 -7.13e-02 -9.46e-02 7.27e-01 6.43e-01
Maturation of nucleoprotein 9694631 15 7.52e-01 9.30e-01 0.11800 -6.66e-02 9.79e-02 6.55e-01 5.11e-01
GOBP THYMIC T CELL SELECTION 24 5.94e-01 8.71e-01 0.11800 1.18e-01 9.30e-03 3.17e-01 9.37e-01
GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION 60 2.47e-01 6.62e-01 0.11800 1.05e-01 5.44e-02 1.59e-01 4.66e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN 69 2.73e-01 6.85e-01 0.11800 9.27e-02 -7.36e-02 1.83e-01 2.90e-01
GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 33 5.18e-01 8.39e-01 0.11800 3.35e-02 -1.14e-01 7.39e-01 2.59e-01
GOBP POSITIVE REGULATION OF GLUCOSE IMPORT 35 4.81e-01 8.21e-01 0.11800 -8.26e-03 1.18e-01 9.33e-01 2.27e-01
GOCC F ACTIN CAPPING PROTEIN COMPLEX 8 8.47e-01 9.58e-01 0.11800 -1.18e-02 1.18e-01 9.54e-01 5.64e-01
GOBP CARBOHYDRATE HOMEOSTASIS 255 5.52e-03 1.05e-01 0.11800 -1.17e-01 1.49e-02 1.26e-03 6.81e-01
GOBP REGULATION OF ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS 5 9.11e-01 9.77e-01 0.11800 -8.47e-02 8.24e-02 7.43e-01 7.50e-01
GOBP DEFENSE RESPONSE TO BACTERIUM 296 3.97e-03 8.75e-02 0.11800 6.62e-02 -9.79e-02 5.01e-02 3.75e-03
Antigen processing-Cross presentation 87 1.79e-01 5.83e-01 0.11800 3.41e-02 -1.13e-01 5.82e-01 6.81e-02
GOBP PROTEIN K6 LINKED UBIQUITINATION 16 7.29e-01 9.21e-01 0.11800 3.59e-02 -1.13e-01 8.04e-01 4.36e-01
GOBP CENTRIOLE CENTRIOLE COHESION 15 7.23e-01 9.18e-01 0.11800 -1.18e-01 -8.76e-03 4.30e-01 9.53e-01
GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS 118 9.63e-02 4.52e-01 0.11800 -3.15e-02 1.14e-01 5.55e-01 3.27e-02
GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS 66 2.74e-01 6.86e-01 0.11800 -3.79e-02 1.12e-01 5.94e-01 1.16e-01
GOBP CAVEOLIN MEDIATED ENDOCYTOSIS 11 7.88e-01 9.41e-01 0.11800 1.18e-01 1.14e-02 5.00e-01 9.48e-01
GOBP REGULATION OF COLLATERAL SPROUTING 19 6.88e-01 9.07e-01 0.11800 -1.12e-01 3.74e-02 3.98e-01 7.78e-01
GOBP PROTEIN LOCALIZATION TO CELL JUNCTION 102 1.50e-01 5.44e-01 0.11800 -8.87e-02 7.79e-02 1.22e-01 1.74e-01
GOMF HYDRO LYASE ACTIVITY 56 3.42e-01 7.40e-01 0.11800 -5.23e-02 1.06e-01 4.98e-01 1.71e-01
GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS 18 6.58e-01 8.95e-01 0.11800 1.04e-01 5.57e-02 4.45e-01 6.82e-01
GOBP NEGATIVE REGULATION OF HEART RATE 11 8.14e-01 9.50e-01 0.11800 -8.47e-02 8.22e-02 6.27e-01 6.37e-01
GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT 12 7.53e-01 9.30e-01 0.11800 8.75e-02 7.91e-02 6.00e-01 6.35e-01
GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION 71 2.55e-01 6.70e-01 0.11800 -1.08e-01 4.79e-02 1.16e-01 4.86e-01
GOMF LBD DOMAIN BINDING 6 8.76e-01 9.66e-01 0.11800 2.18e-02 1.16e-01 9.26e-01 6.23e-01
GOBP NODAL SIGNALING PATHWAY 16 7.42e-01 9.26e-01 0.11800 -7.72e-02 8.91e-02 5.93e-01 5.37e-01
GOMF MALATE DEHYDROGENASE ACTIVITY 8 8.44e-01 9.57e-01 0.11800 -3.76e-03 -1.18e-01 9.85e-01 5.64e-01
GOBP CELLULAR RESPONSE TO INTERFERON BETA 26 5.53e-01 8.54e-01 0.11800 1.09e-01 4.36e-02 3.34e-01 7.00e-01
Intra-Golgi traffic 43 4.24e-01 7.93e-01 0.11800 -1.15e-01 2.75e-02 1.94e-01 7.55e-01
Inositol phosphate metabolism 45 4.18e-01 7.87e-01 0.11800 -1.10e-01 4.24e-02 2.02e-01 6.22e-01
GOBP REGULATION OF HELICASE ACTIVITY 9 8.31e-01 9.54e-01 0.11800 1.29e-02 -1.17e-01 9.47e-01 5.43e-01
GOCC ENDONUCLEASE COMPLEX 38 4.09e-01 7.83e-01 0.11800 -8.91e-02 -7.70e-02 3.42e-01 4.11e-01
GOCC SPERM PLASMA MEMBRANE 14 7.54e-01 9.30e-01 0.11800 1.16e-01 -2.20e-02 4.54e-01 8.87e-01
GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY 12 7.81e-01 9.40e-01 0.11800 1.17e-01 -1.01e-02 4.82e-01 9.52e-01
GOBP DIGESTION 131 4.67e-02 3.28e-01 0.11800 8.87e-02 7.73e-02 7.95e-02 1.26e-01
GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY 18 6.94e-01 9.10e-01 0.11800 -1.16e-01 1.83e-02 3.93e-01 8.93e-01
GOBP ANATOMICAL STRUCTURE ARRANGEMENT 16 7.19e-01 9.15e-01 0.11800 -1.17e-01 9.73e-03 4.17e-01 9.46e-01
GOBP PROGRAMMED NECROTIC CELL DEATH 57 3.47e-01 7.44e-01 0.11800 8.82e-02 -7.78e-02 2.49e-01 3.09e-01
GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY 17 7.26e-01 9.19e-01 0.11800 6.18e-02 -1.00e-01 6.59e-01 4.75e-01
GOBP SKELETAL MUSCLE CONTRACTION 44 3.57e-01 7.49e-01 0.11800 7.82e-02 8.79e-02 3.70e-01 3.13e-01
GOBP REGULATION OF MONOATOMIC ANION TRANSPORT 13 7.86e-01 9.41e-01 0.11800 -8.36e-02 8.27e-02 6.02e-01 6.06e-01
Glutamate and glutamine metabolism 12 7.86e-01 9.41e-01 0.11800 2.28e-02 -1.15e-01 8.91e-01 4.89e-01
Chondroitin sulfate/dermatan sulfate metabolism 46 4.24e-01 7.92e-01 0.11800 -9.65e-02 6.71e-02 2.57e-01 4.31e-01
GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY 258 2.52e-03 6.37e-02 0.11700 8.19e-02 8.43e-02 2.36e-02 1.98e-02
GOMF WNT PROTEIN BINDING 31 5.62e-01 8.57e-01 0.11700 -9.50e-02 6.90e-02 3.60e-01 5.06e-01
Signaling by Nuclear Receptors 258 3.66e-03 8.33e-02 0.11700 -1.15e-01 -2.49e-02 1.50e-03 4.91e-01
Signaling by the B Cell Receptor (BCR) 94 1.32e-01 5.19e-01 0.11700 -1.54e-02 -1.16e-01 7.97e-01 5.11e-02
GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING 51 3.04e-01 7.14e-01 0.11700 -8.35e-02 -8.26e-02 3.02e-01 3.08e-01
GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY 17 7.20e-01 9.16e-01 0.11700 4.04e-02 -1.10e-01 7.73e-01 4.31e-01
GOBP PEPTIDYL THREONINE MODIFICATION 103 1.34e-01 5.22e-01 0.11700 -3.37e-02 1.12e-01 5.54e-01 4.87e-02
GOBP ADAPTIVE IMMUNE RESPONSE 454 2.62e-04 1.20e-02 0.11700 9.18e-02 -7.30e-02 7.96e-04 7.64e-03
GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION 36 4.32e-01 7.96e-01 0.11700 -7.55e-02 -8.98e-02 4.33e-01 3.51e-01
Synthesis of PC 27 6.02e-01 8.75e-01 0.11700 5.72e-02 -1.02e-01 6.07e-01 3.57e-01
GOBP RESPONSE TO OSMOTIC STRESS 80 2.28e-01 6.46e-01 0.11700 9.48e-02 -6.91e-02 1.43e-01 2.86e-01
GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY 37 4.22e-01 7.90e-01 0.11700 -8.46e-02 -8.12e-02 3.73e-01 3.93e-01
GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS 21 6.34e-01 8.86e-01 0.11700 -1.16e-01 -1.97e-02 3.59e-01 8.76e-01
GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN 20 6.46e-01 8.91e-01 0.11700 1.15e-01 2.43e-02 3.75e-01 8.51e-01
GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS 23 6.11e-01 8.78e-01 0.11700 1.28e-02 1.16e-01 9.15e-01 3.34e-01
GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS 11 7.74e-01 9.37e-01 0.11700 -9.30e-02 -7.13e-02 5.93e-01 6.82e-01
GOBP RESPONSE TO CAFFEINE 15 7.05e-01 9.13e-01 0.11700 8.26e-02 8.30e-02 5.80e-01 5.78e-01
GOBP GLUCOSE METABOLIC PROCESS 182 3.38e-02 2.86e-01 0.11700 -5.74e-02 1.02e-01 1.82e-01 1.75e-02
GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY 32 5.36e-01 8.47e-01 0.11700 -3.34e-02 1.12e-01 7.44e-01 2.72e-01
GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION 15 7.24e-01 9.18e-01 0.11700 -1.16e-01 -1.67e-02 4.37e-01 9.11e-01
GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS 12 7.98e-01 9.45e-01 0.11700 -5.66e-02 1.03e-01 7.34e-01 5.39e-01
GOMF 3 5 DNA HELICASE ACTIVITY 15 7.47e-01 9.28e-01 0.11700 -3.37e-02 1.12e-01 8.21e-01 4.52e-01
Protein hydroxylation 17 6.86e-01 9.06e-01 0.11700 1.12e-01 3.37e-02 4.24e-01 8.10e-01
GOMF TRNA PSEUDOURIDINE SYNTHASE ACTIVITY 8 8.34e-01 9.55e-01 0.11700 -4.72e-02 -1.07e-01 8.17e-01 6.00e-01
GOBP NEGATIVE REGULATION OF AUTOPHAGY 87 1.56e-01 5.53e-01 0.11700 -1.16e-01 -1.43e-02 6.12e-02 8.18e-01
GOBP LYMPH NODE DEVELOPMENT 19 7.02e-01 9.12e-01 0.11700 5.95e-02 -1.01e-01 6.53e-01 4.48e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS 49 3.51e-01 7.45e-01 0.11700 -1.16e-01 -1.49e-02 1.60e-01 8.57e-01
Assembly and cell surface presentation of NMDA receptors 40 4.33e-01 7.96e-01 0.11700 1.17e-01 4.57e-03 2.01e-01 9.60e-01
GOCC NUCLEAR SPECK 393 1.29e-04 7.35e-03 0.11700 -8.77e-02 -7.72e-02 2.84e-03 8.61e-03
GOBP REGULATION OF CHROMOSOME SEGREGATION 129 5.88e-02 3.69e-01 0.11700 -1.12e-01 -3.32e-02 2.80e-02 5.15e-01
GOBP REGULATION OF HORMONE METABOLIC PROCESS 39 4.76e-01 8.18e-01 0.11700 1.09e-01 -4.29e-02 2.40e-01 6.43e-01
GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION 12 7.63e-01 9.32e-01 0.11700 -1.06e-01 -4.82e-02 5.24e-01 7.72e-01
GOCC RESPIRATORY CHAIN COMPLEX IV 22 6.60e-01 8.96e-01 0.11700 4.91e-02 -1.06e-01 6.90e-01 3.90e-01
GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS 24 6.43e-01 8.90e-01 0.11700 -9.43e-02 6.87e-02 4.24e-01 5.60e-01
GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE 121 6.72e-02 3.91e-01 0.11700 4.50e-02 1.08e-01 3.93e-01 4.08e-02
GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST 55 3.51e-01 7.45e-01 0.11700 -4.07e-02 1.09e-01 6.02e-01 1.61e-01
GOBP NEGATIVE REGULATION OF KERATINOCYTE DIFFERENTIATION 8 8.45e-01 9.57e-01 0.11700 9.98e-03 1.16e-01 9.61e-01 5.69e-01
GOBP EMBRYONIC MORPHOGENESIS 605 2.68e-06 2.63e-04 0.11700 -1.13e-01 -2.79e-02 1.97e-06 2.42e-01
Transport of Mature mRNA Derived from an Intronless Transcript 42 4.09e-01 7.83e-01 0.11700 -1.15e-01 -1.61e-02 1.95e-01 8.57e-01
GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY 23 6.52e-01 8.93e-01 0.11700 -5.67e-02 1.02e-01 6.38e-01 3.98e-01
GOBP REGULATION OF HAIR CYCLE 29 5.22e-01 8.41e-01 0.11700 1.07e-01 4.72e-02 3.21e-01 6.60e-01
Fanconi Anemia Pathway 34 4.95e-01 8.28e-01 0.11600 -1.16e-01 -2.23e-03 2.40e-01 9.82e-01
GOBP PROTEIN AUTOPROCESSING 27 5.98e-01 8.73e-01 0.11600 -1.09e-01 3.97e-02 3.25e-01 7.21e-01
Interleukin-35 Signalling 12 7.73e-01 9.36e-01 0.11600 1.14e-01 2.22e-02 4.93e-01 8.94e-01
GOMF SNARE BINDING 103 1.49e-01 5.44e-01 0.11600 -1.02e-01 5.62e-02 7.40e-02 3.24e-01
HS-GAG degradation 21 6.74e-01 9.03e-01 0.11600 1.06e-01 -4.72e-02 3.99e-01 7.08e-01
GOMF CHLORIDE CHANNEL INHIBITOR ACTIVITY 7 8.52e-01 9.59e-01 0.11600 -6.55e-02 -9.62e-02 7.64e-01 6.59e-01
p38MAPK events 13 7.64e-01 9.33e-01 0.11600 1.16e-01 2.57e-03 4.68e-01 9.87e-01
GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY 23 6.35e-01 8.86e-01 0.11600 1.15e-01 -1.92e-02 3.41e-01 8.73e-01
GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 53 3.72e-01 7.60e-01 0.11600 4.99e-02 -1.05e-01 5.30e-01 1.86e-01
GOBP B CELL HOMEOSTASIS 31 5.62e-01 8.57e-01 0.11600 5.09e-02 -1.04e-01 6.24e-01 3.14e-01
GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY 6 8.89e-01 9.71e-01 0.11600 1.14e-01 -2.10e-02 6.28e-01 9.29e-01
GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS 22 6.04e-01 8.76e-01 0.11600 8.59e-02 7.82e-02 4.85e-01 5.25e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 53 3.35e-01 7.35e-01 0.11600 -1.16e-01 -3.68e-03 1.44e-01 9.63e-01
GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION 17 6.78e-01 9.04e-01 0.11600 7.42e-02 8.94e-02 5.96e-01 5.24e-01
GOBP NEGATIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS 5 9.07e-01 9.76e-01 0.11600 -2.31e-02 1.14e-01 9.29e-01 6.59e-01
GOBP PROSTANOID METABOLIC PROCESS 50 3.91e-01 7.71e-01 0.11600 1.08e-01 -4.37e-02 1.88e-01 5.93e-01
GOMF TESTOSTERONE DEHYDROGENASE NAD P ACTIVITY 10 8.03e-01 9.46e-01 0.11600 1.10e-01 3.73e-02 5.47e-01 8.38e-01
GOBP REGULATION OF RNA SPLICING 168 2.24e-02 2.40e-01 0.11600 -6.75e-02 -9.44e-02 1.31e-01 3.47e-02
GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON 5 9.13e-01 9.78e-01 0.11600 -9.32e-02 6.93e-02 7.18e-01 7.89e-01
GOBP PROTEIN LOCALIZATION TO CILIUM 72 1.93e-01 6.02e-01 0.11600 -8.65e-02 -7.74e-02 2.04e-01 2.56e-01
GOBP AMYLOID BETA CLEARANCE 38 4.21e-01 7.90e-01 0.11600 -6.87e-02 -9.35e-02 4.63e-01 3.18e-01
Metabolism of steroid hormones 35 4.71e-01 8.15e-01 0.11600 1.13e-01 2.67e-02 2.48e-01 7.84e-01
GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS 30 5.73e-01 8.61e-01 0.11600 -5.06e-02 1.04e-01 6.32e-01 3.22e-01
GOMF G PROTEIN ACTIVITY 46 3.50e-01 7.45e-01 0.11600 -8.22e-02 -8.19e-02 3.35e-01 3.37e-01
GOBP SPERM DNA CONDENSATION 17 6.86e-01 9.06e-01 0.11600 1.07e-01 4.58e-02 4.47e-01 7.44e-01
GOBP SKELETAL SYSTEM DEVELOPMENT 510 8.57e-05 5.18e-03 0.11600 -1.08e-01 4.36e-02 3.23e-05 9.21e-02
GOBP PROTEIN IMPORT 9 8.14e-01 9.50e-01 0.11600 -8.20e-02 -8.20e-02 6.70e-01 6.70e-01
GOCC BASOLATERAL PLASMA MEMBRANE 249 5.08e-03 1.00e-01 0.11600 1.13e-01 2.44e-02 2.06e-03 5.07e-01
GOMF MHC CLASS II PROTEIN BINDING 7 8.59e-01 9.60e-01 0.11600 -3.16e-02 -1.12e-01 8.85e-01 6.09e-01
GOCC ENDOSOME LUMEN 38 4.27e-01 7.93e-01 0.11600 5.57e-02 1.02e-01 5.52e-01 2.78e-01
GOCC ASTROCYTE PROJECTION 21 6.20e-01 8.80e-01 0.11600 8.57e-02 7.80e-02 4.96e-01 5.36e-01
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE 6 8.80e-01 9.67e-01 0.11600 -1.97e-02 -1.14e-01 9.34e-01 6.28e-01
GOBP REGULATION OF MICROTUBULE POLYMERIZATION 59 3.14e-01 7.22e-01 0.11600 -1.15e-01 1.75e-02 1.28e-01 8.16e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS 11 7.92e-01 9.43e-01 0.11600 -1.85e-02 -1.14e-01 9.16e-01 5.11e-01
GOBP AMINO ACID TRANSPORT 150 6.48e-02 3.83e-01 0.11600 -5.60e-02 1.01e-01 2.36e-01 3.21e-02
COPI-mediated anterograde transport 100 1.24e-01 5.04e-01 0.11600 -1.15e-01 -1.41e-02 4.70e-02 8.07e-01
GOBP CELLULAR RESPONSE TO ETHANOL 12 7.91e-01 9.42e-01 0.11600 -1.14e-01 1.89e-02 4.93e-01 9.10e-01
GOMF DYNEIN LIGHT CHAIN BINDING 9 8.36e-01 9.55e-01 0.11600 -1.15e-02 1.15e-01 9.52e-01 5.50e-01
GOBP REGULATION OF POSTSYNAPSE ORGANIZATION 100 1.36e-01 5.25e-01 0.11600 -8.32e-03 1.15e-01 8.86e-01 4.61e-02
GOBP TYPE B PANCREATIC CELL DIFFERENTIATION 29 5.32e-01 8.44e-01 0.11600 -1.10e-01 -3.69e-02 3.07e-01 7.31e-01
GOBP SEGMENT SPECIFICATION 16 6.97e-01 9.11e-01 0.11600 -9.39e-02 -6.75e-02 5.16e-01 6.40e-01
GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT 30 5.10e-01 8.34e-01 0.11600 -6.11e-02 -9.82e-02 5.62e-01 3.52e-01
Platelet sensitization by LDL 17 6.92e-01 9.09e-01 0.11600 -1.11e-01 -3.31e-02 4.29e-01 8.13e-01
TCF dependent signaling in response to WNT 180 1.86e-02 2.17e-01 0.11600 -5.51e-02 -1.02e-01 2.02e-01 1.87e-02
GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY 21 6.42e-01 8.89e-01 0.11600 1.99e-02 1.14e-01 8.75e-01 3.66e-01
GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION 16 7.48e-01 9.28e-01 0.11600 -9.69e-02 6.29e-02 5.02e-01 6.63e-01
GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY 14 7.55e-01 9.30e-01 0.11600 1.15e-01 -4.17e-03 4.55e-01 9.78e-01
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION 46 4.35e-01 7.97e-01 0.11500 6.17e-02 -9.76e-02 4.69e-01 2.52e-01
GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING 12 7.85e-01 9.41e-01 0.11500 3.53e-03 -1.15e-01 9.83e-01 4.89e-01
GOBP SNRNA CATABOLIC PROCESS 5 9.14e-01 9.78e-01 0.11500 6.39e-02 -9.62e-02 8.04e-01 7.10e-01
GOBP NEUROINFLAMMATORY RESPONSE 84 1.72e-01 5.76e-01 0.11500 -1.14e-01 -1.80e-02 7.07e-02 7.76e-01
GOBP REGULATION OF ATPASE COUPLED CALCIUM TRANSMEMBRANE TRANSPORTER ACTIVITY 5 8.95e-01 9.73e-01 0.11500 -1.02e-01 -5.34e-02 6.92e-01 8.36e-01
GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE 99 1.69e-01 5.70e-01 0.11500 -9.49e-02 6.56e-02 1.03e-01 2.59e-01
GOBP AUTOPHAGOSOME MATURATION 64 2.76e-01 6.89e-01 0.11500 1.39e-03 -1.15e-01 9.85e-01 1.10e-01
TBC/RABGAPs 41 4.62e-01 8.12e-01 0.11500 -3.55e-02 1.10e-01 6.94e-01 2.24e-01
GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY 32 5.65e-01 8.58e-01 0.11500 -8.34e-02 7.97e-02 4.14e-01 4.35e-01
GOMF PROMOTER SPECIFIC CHROMATIN BINDING 64 2.80e-01 6.92e-01 0.11500 -1.15e-01 6.82e-03 1.11e-01 9.25e-01
GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS 8 8.64e-01 9.62e-01 0.11500 5.42e-02 -1.02e-01 7.91e-01 6.18e-01
GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS 9 8.19e-01 9.52e-01 0.11500 5.26e-02 1.03e-01 7.85e-01 5.94e-01
GOBP PYRUVATE METABOLIC PROCESS 114 7.75e-02 4.15e-01 0.11500 7.98e-02 8.31e-02 1.41e-01 1.25e-01
GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX 37 4.42e-01 8.00e-01 0.11500 -1.03e-01 -5.15e-02 2.78e-01 5.88e-01
GOBP RESPONSE TO PEPTIDE HORMONE 427 5.80e-04 2.12e-02 0.11500 -7.92e-02 8.36e-02 5.01e-03 3.05e-03
GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE 31 5.76e-01 8.64e-01 0.11500 -7.77e-02 8.50e-02 4.54e-01 4.13e-01
GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY 26 5.65e-01 8.58e-01 0.11500 4.99e-02 1.04e-01 6.60e-01 3.60e-01
GOBP RECEPTOR MEDIATED ENDOCYTOSIS 254 1.08e-02 1.61e-01 0.11500 -9.88e-02 5.90e-02 6.72e-03 1.05e-01
GOBP RESPONSE TO POTASSIUM ION 18 7.11e-01 9.14e-01 0.11500 -2.96e-02 1.11e-01 8.28e-01 4.14e-01
Beta-catenin independent WNT signaling 133 5.71e-02 3.63e-01 0.11500 -1.08e-01 -3.97e-02 3.16e-02 4.29e-01
GOMF VITAMIN BINDING 143 7.89e-02 4.18e-01 0.11500 -6.71e-02 9.34e-02 1.66e-01 5.38e-02
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 190 3.47e-02 2.88e-01 0.11500 -9.22e-02 6.87e-02 2.84e-02 1.02e-01
GOBP MEGAKARYOCYTE DEVELOPMENT 22 6.76e-01 9.04e-01 0.11500 -8.89e-02 7.29e-02 4.70e-01 5.54e-01
GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY 101 1.07e-01 4.75e-01 0.11500 -9.61e-02 -6.30e-02 9.50e-02 2.74e-01
GOCC ORGANELLE INNER MEMBRANE 521 4.31e-05 2.86e-03 0.11500 7.96e-03 -1.15e-01 7.56e-01 7.52e-06
GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION 11 7.82e-01 9.40e-01 0.11500 8.77e-02 7.42e-02 6.14e-01 6.70e-01
GOBP ACROSOME REACTION 41 4.20e-01 7.89e-01 0.11500 1.11e-01 2.79e-02 2.17e-01 7.57e-01
GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY 40 4.37e-01 7.98e-01 0.11500 1.14e-01 1.58e-02 2.13e-01 8.63e-01
Inactivation, recovery and regulation of the phototransduction cascade 31 5.00e-01 8.30e-01 0.11500 8.55e-02 7.66e-02 4.10e-01 4.60e-01
GOBP REGULATION OF SYNAPSE MATURATION 21 6.78e-01 9.04e-01 0.11500 -1.08e-01 3.88e-02 3.91e-01 7.58e-01
S Phase 147 4.47e-02 3.23e-01 0.11500 -3.13e-02 -1.10e-01 5.12e-01 2.08e-02
GOBP RESPONSE TO PAIN 36 5.29e-01 8.43e-01 0.11500 -8.78e-02 7.39e-02 3.62e-01 4.43e-01
GOBP PROTEIN ACETYLATION 53 3.33e-01 7.35e-01 0.11500 -1.13e-01 -1.84e-02 1.54e-01 8.17e-01
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 111 1.41e-01 5.33e-01 0.11500 -7.27e-02 8.87e-02 1.86e-01 1.06e-01
GOMF TRIPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 9 8.50e-01 9.58e-01 0.11500 -5.18e-02 1.02e-01 7.88e-01 5.95e-01
GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 46 4.07e-01 7.81e-01 0.11500 -1.14e-01 1.01e-02 1.80e-01 9.06e-01
GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION 46 3.70e-01 7.58e-01 0.11500 4.46e-02 1.06e-01 6.01e-01 2.15e-01
GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 54 3.81e-01 7.65e-01 0.11500 -9.87e-02 5.82e-02 2.09e-01 4.59e-01
Chylomicron remodeling 10 8.35e-01 9.55e-01 0.11500 -1.00e-01 5.59e-02 5.84e-01 7.59e-01
GOBP REGULATION OF SUPEROXIDE ANION GENERATION 20 6.63e-01 8.97e-01 0.11500 1.14e-01 1.44e-02 3.79e-01 9.11e-01
Regulation of gene expression in beta cells 21 6.27e-01 8.84e-01 0.11500 -6.79e-02 -9.23e-02 5.90e-01 4.64e-01
GOMF CO RECEPTOR BINDING 13 7.84e-01 9.40e-01 0.11500 3.08e-02 -1.10e-01 8.47e-01 4.91e-01
GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE 204 2.84e-02 2.67e-01 0.11500 8.42e-02 -7.77e-02 3.82e-02 5.56e-02
SHC1 events in ERBB4 signaling 14 7.61e-01 9.32e-01 0.11500 1.04e-02 -1.14e-01 9.46e-01 4.60e-01
Aberrant regulation of mitotic exit in cancer due to RB1 defects 20 6.86e-01 9.06e-01 0.11500 -1.11e-01 2.71e-02 3.89e-01 8.34e-01
GOMF SIALYLTRANSFERASE ACTIVITY 21 6.54e-01 8.93e-01 0.11500 7.55e-03 1.14e-01 9.52e-01 3.65e-01
GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS 123 6.64e-02 3.89e-01 0.11400 -6.78e-02 -9.23e-02 1.94e-01 7.71e-02
GOMF ARMADILLO REPEAT DOMAIN BINDING 8 8.46e-01 9.57e-01 0.11400 -1.11e-01 -2.64e-02 5.85e-01 8.97e-01
GOBP REGULATION OF METANEPHROS DEVELOPMENT 5 9.05e-01 9.76e-01 0.11400 -1.14e-01 9.40e-04 6.58e-01 9.97e-01
GOCC MRE11 COMPLEX 5 8.98e-01 9.73e-01 0.11400 -4.36e-02 -1.06e-01 8.66e-01 6.82e-01
GOCC AXONAL GROWTH CONE 25 6.45e-01 8.90e-01 0.11400 -8.62e-02 7.52e-02 4.55e-01 5.15e-01
GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY 10 8.28e-01 9.53e-01 0.11400 -1.11e-01 2.65e-02 5.42e-01 8.85e-01
GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS 155 4.19e-02 3.12e-01 0.11400 -1.13e-01 -1.80e-02 1.53e-02 6.98e-01
NS1 Mediated Effects on Host Pathways 41 4.03e-01 7.80e-01 0.11400 -7.98e-02 -8.18e-02 3.76e-01 3.64e-01
GOBP GLYCOLIPID TRANSPORT 8 8.52e-01 9.59e-01 0.11400 -1.14e-01 -2.60e-03 5.76e-01 9.90e-01
GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE 103 1.59e-01 5.57e-01 0.11400 -5.27e-02 1.01e-01 3.55e-01 7.54e-02
GOMF PEPTIDE RECEPTOR ACTIVITY 120 1.15e-01 4.90e-01 0.11400 -1.04e-01 4.63e-02 4.82e-02 3.81e-01
GOBP CHROMATIN REMODELING 630 1.45e-06 1.51e-04 0.11400 -9.57e-02 -6.23e-02 4.12e-05 7.63e-03
GOBP PROTEIN DNA COMPLEX ORGANIZATION 851 1.46e-08 2.64e-06 0.11400 -9.25e-02 -6.70e-02 4.62e-06 9.08e-04
GOBP HOMOTYPIC CELL CELL ADHESION 96 1.86e-01 5.92e-01 0.11400 6.80e-02 -9.17e-02 2.49e-01 1.21e-01
GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS 161 4.18e-02 3.12e-01 0.11400 -1.14e-01 -1.23e-03 1.24e-02 9.78e-01
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 32 4.98e-01 8.29e-01 0.11400 -9.85e-02 -5.77e-02 3.35e-01 5.72e-01
GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS 15 7.46e-01 9.28e-01 0.11400 7.42e-03 -1.14e-01 9.60e-01 4.45e-01
GOBP ALPHA BETA T CELL PROLIFERATION 41 4.28e-01 7.94e-01 0.11400 1.12e-01 2.28e-02 2.15e-01 8.01e-01
GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION 74 2.75e-01 6.88e-01 0.11400 8.36e-02 -7.77e-02 2.14e-01 2.48e-01
GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX 8 8.54e-01 9.59e-01 0.11400 7.30e-04 -1.14e-01 9.97e-01 5.76e-01
GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS 17 7.00e-01 9.12e-01 0.11400 1.10e-01 3.00e-02 4.32e-01 8.30e-01
GOBP REGULATION OF SYNAPTIC PLASTICITY 210 2.04e-02 2.29e-01 0.11400 -1.11e-01 2.73e-02 5.67e-03 4.95e-01
GOBP REGULATION OF BLOOD VESSEL REMODELING 12 7.67e-01 9.34e-01 0.11400 7.33e-02 8.73e-02 6.60e-01 6.00e-01
GOBP REGULATION OF NEUROGENESIS 362 1.78e-03 4.97e-02 0.11400 -9.93e-02 5.60e-02 1.17e-03 6.74e-02
GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 12 7.67e-01 9.34e-01 0.11400 8.30e-02 7.81e-02 6.19e-01 6.39e-01
GOBP VASCULAR TRANSPORT 84 1.72e-01 5.76e-01 0.11400 3.31e-02 1.09e-01 6.00e-01 8.41e-02
GOBP 4 HYDROXYPROLINE METABOLIC PROCESS 12 8.05e-01 9.48e-01 0.11400 -1.05e-01 4.33e-02 5.27e-01 7.95e-01
GOBP ADULT BEHAVIOR 143 6.76e-02 3.92e-01 0.11400 -1.12e-01 1.94e-02 2.05e-02 6.89e-01
GOCC CONNEXIN COMPLEX 19 7.16e-01 9.15e-01 0.11400 -6.13e-02 9.60e-02 6.44e-01 4.69e-01
GOCC GOLGI MEDIAL CISTERNA 11 8.08e-01 9.49e-01 0.11400 -8.79e-03 1.14e-01 9.60e-01 5.14e-01
Collagen chain trimerization 42 4.09e-01 7.83e-01 0.11400 4.23e-02 1.06e-01 6.35e-01 2.36e-01
GOBP AMIDE CATABOLIC PROCESS 16 7.13e-01 9.14e-01 0.11400 3.77e-02 1.07e-01 7.94e-01 4.57e-01
GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING 9 8.47e-01 9.58e-01 0.11400 3.34e-02 -1.09e-01 8.62e-01 5.72e-01
Cargo recognition for clathrin-mediated endocytosis 100 1.12e-01 4.84e-01 0.11400 -8.52e-02 -7.54e-02 1.41e-01 1.93e-01
GOBP VITAMIN TRANSMEMBRANE TRANSPORT 19 7.17e-01 9.15e-01 0.11400 -9.28e-02 6.57e-02 4.84e-01 6.20e-01
GOBP CAMP CATABOLIC PROCESS 9 8.26e-01 9.52e-01 0.11400 4.08e-02 1.06e-01 8.32e-01 5.81e-01
RUNX3 regulates BCL2L11 (BIM) transcription 5 9.14e-01 9.78e-01 0.11400 -1.04e-01 4.57e-02 6.87e-01 8.60e-01
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR 135 6.96e-02 3.97e-01 0.11400 -1.14e-01 -4.79e-03 2.27e-02 9.24e-01
GOCC GOLGI CISTERNA 98 1.51e-01 5.46e-01 0.11400 -6.97e-03 1.13e-01 9.05e-01 5.22e-02
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST 40 4.96e-01 8.29e-01 0.11400 -9.58e-02 6.13e-02 2.95e-01 5.03e-01
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) 117 1.05e-01 4.73e-01 0.11400 -1.13e-01 7.97e-03 3.41e-02 8.82e-01
GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION 226 9.15e-03 1.46e-01 0.11400 -3.42e-02 -1.08e-01 3.76e-01 4.97e-03
GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY 45 4.37e-01 7.97e-01 0.11400 3.15e-02 -1.09e-01 7.14e-01 2.05e-01
Interactions of Rev with host cellular proteins 37 4.44e-01 8.01e-01 0.11400 -8.17e-02 -7.90e-02 3.90e-01 4.06e-01
GOCC PROTEIN LIPID COMPLEX 38 4.96e-01 8.29e-01 0.11400 -1.10e-01 2.89e-02 2.41e-01 7.58e-01
Cyclin A/B1/B2 associated events during G2/M transition 24 5.94e-01 8.71e-01 0.11400 -5.98e-02 -9.66e-02 6.12e-01 4.13e-01
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects 17 7.44e-01 9.26e-01 0.11400 9.26e-02 -6.58e-02 5.09e-01 6.39e-01
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) 17 7.44e-01 9.26e-01 0.11400 9.26e-02 -6.58e-02 5.09e-01 6.39e-01
GOMF LACTATE DEHYDROGENASE ACTIVITY 6 8.89e-01 9.71e-01 0.11400 -5.63e-04 -1.14e-01 9.98e-01 6.30e-01
GOBP TERPENOID BIOSYNTHETIC PROCESS 16 7.39e-01 9.25e-01 0.11300 1.75e-02 -1.12e-01 9.03e-01 4.37e-01
GOBP RESPONSE TO ACID CHEMICAL 132 5.97e-02 3.70e-01 0.11300 -1.01e-01 -5.26e-02 4.60e-02 2.97e-01
GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS 90 1.78e-01 5.83e-01 0.11300 -7.96e-03 1.13e-01 8.96e-01 6.35e-02
Caspase-mediated cleavage of cytoskeletal proteins 12 8.13e-01 9.50e-01 0.11300 -8.08e-02 7.96e-02 6.28e-01 6.33e-01
GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT 17 7.43e-01 9.26e-01 0.11300 -9.62e-02 6.01e-02 4.92e-01 6.68e-01
GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH 6 8.78e-01 9.67e-01 0.11300 9.09e-02 6.78e-02 7.00e-01 7.74e-01
GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY 28 5.71e-01 8.61e-01 0.11300 -1.21e-02 -1.13e-01 9.12e-01 3.02e-01
GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 42 4.55e-01 8.09e-01 0.11300 1.12e-01 -1.94e-02 2.10e-01 8.28e-01
GOBP NEUROMUSCULAR PROCESS 163 6.14e-02 3.74e-01 0.11300 -7.74e-02 8.28e-02 8.81e-02 6.82e-02
GOMF RECEPTOR SERINE THREONINE KINASE BINDING 27 5.57e-01 8.56e-01 0.11300 -6.65e-02 -9.18e-02 5.50e-01 4.09e-01
GOBP ALCOHOL BIOSYNTHETIC PROCESS 136 5.26e-02 3.47e-01 0.11300 8.63e-02 7.34e-02 8.21e-02 1.40e-01
GOCC FIBRILLAR CENTER 144 6.45e-02 3.81e-01 0.11300 -1.13e-01 8.87e-03 1.93e-02 8.54e-01
GOBP PEPTIDYL CYSTEINE MODIFICATION 40 4.86e-01 8.23e-01 0.11300 1.07e-01 -3.74e-02 2.42e-01 6.82e-01
Methionine salvage pathway 6 8.78e-01 9.67e-01 0.11300 6.81e-02 9.05e-02 7.73e-01 7.01e-01
GOBP HEART VALVE DEVELOPMENT 73 2.49e-01 6.63e-01 0.11300 -1.13e-01 9.75e-03 9.56e-02 8.85e-01
GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS 48 3.73e-01 7.61e-01 0.11300 1.10e-01 2.81e-02 1.89e-01 7.36e-01
GOMF SODIUM PROTON ANTIPORTER ACTIVITY 13 7.72e-01 9.36e-01 0.11300 1.13e-01 1.18e-02 4.82e-01 9.41e-01
GOBP EXPORT ACROSS PLASMA MEMBRANE 79 2.22e-01 6.39e-01 0.11300 -8.28e-03 1.13e-01 8.99e-01 8.30e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN 38 4.65e-01 8.13e-01 0.11300 1.12e-01 1.84e-02 2.34e-01 8.44e-01
GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE 29 5.67e-01 8.59e-01 0.11300 4.42e-03 1.13e-01 9.67e-01 2.92e-01
GOMF FRIZZLED BINDING 36 4.74e-01 8.18e-01 0.11300 1.08e-01 3.38e-02 2.63e-01 7.26e-01
GOBP REGULATION OF LYSOSOME SIZE 8 8.68e-01 9.63e-01 0.11300 -4.94e-02 1.02e-01 8.09e-01 6.18e-01
GOCC BORC COMPLEX 8 8.68e-01 9.63e-01 0.11300 -4.94e-02 1.02e-01 8.09e-01 6.18e-01
GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE 24 6.32e-01 8.86e-01 0.11300 -6.41e-03 1.13e-01 9.57e-01 3.39e-01
GOCC JUNCTIONAL MEMBRANE COMPLEX 6 8.98e-01 9.74e-01 0.11300 -1.05e-01 4.09e-02 6.55e-01 8.62e-01
GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY 7 8.61e-01 9.61e-01 0.11300 -9.75e-02 -5.71e-02 6.55e-01 7.94e-01
GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX 44 4.11e-01 7.84e-01 0.11300 1.11e-01 2.07e-02 2.02e-01 8.13e-01
SARS-CoV-2 Infection 279 7.79e-03 1.31e-01 0.11300 4.93e-02 -1.02e-01 1.57e-01 3.47e-03
RHO GTPase Effectors 273 2.89e-03 7.13e-02 0.11300 -8.25e-02 -7.72e-02 1.90e-02 2.81e-02
GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS 103 1.18e-01 4.94e-01 0.11300 -1.07e-01 -3.72e-02 6.15e-02 5.15e-01
GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 98 1.88e-01 5.95e-01 0.11300 -8.02e-02 7.95e-02 1.70e-01 1.74e-01
GOBP AXON EXTENSION 96 1.83e-01 5.88e-01 0.11300 -1.04e-01 4.43e-02 7.86e-02 4.53e-01
GOCC OTHER ORGANISM PART 5 9.02e-01 9.75e-01 0.11300 -3.22e-02 -1.08e-01 9.01e-01 6.75e-01
GOCC FC RECEPTOR COMPLEX 5 9.16e-01 9.79e-01 0.11300 -5.21e-02 1.00e-01 8.40e-01 6.98e-01
Diseases associated with glycosylation precursor biosynthesis 15 7.65e-01 9.33e-01 0.11300 4.05e-02 -1.05e-01 7.86e-01 4.80e-01
GOBP PONS DEVELOPMENT 11 8.24e-01 9.52e-01 0.11300 -1.01e-01 5.01e-02 5.61e-01 7.74e-01
GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 286 8.05e-03 1.34e-01 0.11300 -8.20e-02 7.75e-02 1.71e-02 2.41e-02
Signaling by LTK in cancer 7 8.64e-01 9.62e-01 0.11300 -1.05e-01 -4.19e-02 6.31e-01 8.48e-01
GOBP PIRNA PROCESSING 21 6.82e-01 9.06e-01 0.11300 -2.88e-02 1.09e-01 8.19e-01 3.87e-01
GOBP REGULATION OF JUN KINASE ACTIVITY 40 4.54e-01 8.07e-01 0.11300 -1.11e-02 -1.12e-01 9.03e-01 2.19e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS 133 6.89e-02 3.95e-01 0.11300 2.24e-02 1.11e-01 6.56e-01 2.77e-02
GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX 13 7.93e-01 9.43e-01 0.11300 4.01e-02 -1.05e-01 8.02e-01 5.10e-01
GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE 19 7.18e-01 9.15e-01 0.11300 5.35e-02 -9.93e-02 6.86e-01 4.54e-01
GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION 209 1.45e-02 1.91e-01 0.11300 -1.09e-01 -2.87e-02 6.59e-03 4.74e-01
GOBP REGULATION OF DEPHOSPHORYLATION 97 1.29e-01 5.13e-01 0.11300 -9.99e-02 -5.22e-02 8.91e-02 3.74e-01
GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER 13 7.58e-01 9.31e-01 0.11300 -9.63e-02 -5.85e-02 5.48e-01 7.15e-01
GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 40 4.52e-01 8.07e-01 0.11300 1.50e-02 1.12e-01 8.70e-01 2.22e-01
Constitutive Signaling by Overexpressed ERBB2 11 7.92e-01 9.42e-01 0.11300 -9.82e-02 -5.52e-02 5.73e-01 7.51e-01
GOBP TISSUE REMODELING 183 4.54e-02 3.25e-01 0.11300 -7.97e-02 7.96e-02 6.28e-02 6.33e-02
Cellular responses to stress 735 5.87e-07 6.73e-05 0.11300 -2.23e-02 -1.10e-01 3.03e-01 3.41e-07
GOBP R LOOP PROCESSING 9 8.27e-01 9.52e-01 0.11300 -5.13e-02 -1.00e-01 7.90e-01 6.03e-01
Class A/1 (Rhodopsin-like receptors) 313 5.23e-03 1.02e-01 0.11300 -7.92e-02 8.01e-02 1.60e-02 1.48e-02
GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS 41 4.14e-01 7.85e-01 0.11300 8.19e-02 7.73e-02 3.64e-01 3.92e-01
GOBP GLIAL CELL APOPTOTIC PROCESS 16 7.37e-01 9.23e-01 0.11300 1.12e-01 -3.89e-03 4.36e-01 9.79e-01
GOCC CCR4 NOT COMPLEX 16 7.41e-01 9.25e-01 0.11300 1.24e-02 -1.12e-01 9.31e-01 4.39e-01
GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR 15 7.25e-01 9.18e-01 0.11300 -8.83e-02 -6.98e-02 5.54e-01 6.40e-01
GOBP CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS 10 8.22e-01 9.52e-01 0.11200 -1.12e-01 -1.02e-02 5.40e-01 9.56e-01
GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY 17 7.25e-01 9.18e-01 0.11200 -1.12e-01 7.19e-03 4.23e-01 9.59e-01
Signaling by ERBB2 KD Mutants 25 6.06e-01 8.76e-01 0.11200 -2.07e-02 -1.11e-01 8.58e-01 3.39e-01
GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY 28 5.86e-01 8.67e-01 0.11200 3.28e-03 -1.12e-01 9.76e-01 3.03e-01
GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING 29 5.94e-01 8.71e-01 0.11200 3.26e-02 -1.08e-01 7.61e-01 3.16e-01
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS 60 3.41e-01 7.40e-01 0.11200 -1.08e-01 3.22e-02 1.49e-01 6.66e-01
GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION 15 7.44e-01 9.26e-01 0.11200 -1.12e-01 -1.21e-02 4.54e-01 9.35e-01
GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS 106 1.55e-01 5.51e-01 0.11200 -3.99e-02 1.05e-01 4.78e-01 6.17e-02
GOBP LIPID DROPLET ORGANIZATION 35 5.08e-01 8.33e-01 0.11200 -1.12e-01 -5.12e-03 2.51e-01 9.58e-01
GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS 35 5.13e-01 8.36e-01 0.11200 -1.12e-01 2.12e-03 2.50e-01 9.83e-01
Dopamine Neurotransmitter Release Cycle 21 6.54e-01 8.93e-01 0.11200 1.09e-01 2.68e-02 3.87e-01 8.31e-01
GOCC POSTSYNAPTIC MEMBRANE 261 9.28e-03 1.46e-01 0.11200 -1.09e-01 2.61e-02 2.39e-03 4.67e-01
GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION 10 8.33e-01 9.54e-01 0.11200 2.09e-02 -1.10e-01 9.09e-01 5.46e-01
Notch-HLH transcription pathway 24 6.67e-01 8.99e-01 0.11200 -8.03e-02 7.84e-02 4.96e-01 5.06e-01
GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE 43 4.14e-01 7.85e-01 0.11200 1.06e-01 3.76e-02 2.30e-01 6.70e-01
RHO GTPases Activate WASPs and WAVEs 34 5.30e-01 8.43e-01 0.11200 1.02e-02 -1.12e-01 9.18e-01 2.60e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY 71 2.95e-01 7.07e-01 0.11200 -5.23e-02 9.92e-02 4.46e-01 1.48e-01
Prefoldin mediated transfer of substrate to CCT/TriC 26 6.35e-01 8.86e-01 0.11200 1.03e-01 -4.41e-02 3.63e-01 6.97e-01
GOBP RESPONSE TO MANGANESE ION 17 7.15e-01 9.15e-01 0.11200 -1.53e-02 -1.11e-01 9.13e-01 4.28e-01
GOMF KINASE REGULATOR ACTIVITY 268 4.95e-03 9.85e-02 0.11200 -2.44e-02 -1.09e-01 4.91e-01 2.06e-03
GOBP POSITIVE REGULATION OF BLOOD PRESSURE 31 5.46e-01 8.52e-01 0.11200 -1.12e-01 -1.09e-02 2.83e-01 9.17e-01
GOBP SUPEROXIDE METABOLIC PROCESS 64 3.41e-01 7.40e-01 0.11200 -7.51e-02 8.31e-02 2.99e-01 2.50e-01
GOBP RESPONSE TO ELECTRICAL STIMULUS 44 4.06e-01 7.81e-01 0.11200 -1.05e-01 -3.81e-02 2.27e-01 6.62e-01
Signaling by Erythropoietin 25 5.88e-01 8.67e-01 0.11200 -8.75e-02 -6.98e-02 4.49e-01 5.46e-01
GOBP SENSORY ORGAN DEVELOPMENT 581 4.01e-05 2.69e-03 0.11200 -1.08e-01 3.05e-02 9.06e-06 2.09e-01
GOBP REGULATION OF TRANSLATION AT SYNAPSE MODULATING SYNAPTIC TRANSMISSION 5 9.17e-01 9.79e-01 0.11200 1.02e-01 -4.66e-02 6.93e-01 8.57e-01
GOBP LIPID IMPORT INTO CELL 21 6.82e-01 9.06e-01 0.11200 -2.05e-02 1.10e-01 8.71e-01 3.83e-01
Organic cation transport 10 8.41e-01 9.56e-01 0.11200 -1.01e-01 4.83e-02 5.80e-01 7.91e-01
GOBP T HELPER 2 CELL CYTOKINE PRODUCTION 13 7.93e-01 9.43e-01 0.11200 -2.99e-02 1.08e-01 8.52e-01 5.01e-01
Separation of Sister Chromatids 170 2.85e-02 2.68e-01 0.11200 -6.05e-02 -9.41e-02 1.73e-01 3.42e-02
Infectious disease 925 6.93e-08 1.02e-05 0.11200 1.13e-02 -1.11e-01 5.61e-01 9.39e-09
GOBP PHENOTYPIC SWITCHING 16 7.60e-01 9.32e-01 0.11200 -9.87e-02 5.26e-02 4.94e-01 7.16e-01
GOCC RIBONUCLEOPROTEIN GRANULE 261 4.16e-03 8.92e-02 0.11200 -8.33e-02 -7.47e-02 2.06e-02 3.78e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR 56 3.81e-01 7.66e-01 0.11200 -1.00e-01 4.91e-02 1.93e-01 5.25e-01
GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE 40 4.83e-01 8.22e-01 0.11200 -1.93e-02 1.10e-01 8.33e-01 2.28e-01
GOBP PROTEIN O LINKED MANNOSYLATION 19 7.06e-01 9.13e-01 0.11200 -1.58e-02 1.11e-01 9.05e-01 4.04e-01
GOBP CRANIAL NERVE MORPHOGENESIS 30 5.89e-01 8.68e-01 0.11200 -1.06e-01 3.51e-02 3.15e-01 7.40e-01
GOBP CENTROMERE COMPLEX ASSEMBLY 28 5.55e-01 8.55e-01 0.11200 -9.35e-02 -6.12e-02 3.92e-01 5.75e-01
GOBP SECONDARY METABOLIC PROCESS 54 3.25e-01 7.29e-01 0.11200 9.77e-02 5.41e-02 2.14e-01 4.91e-01
GOBP PROSTATE GLAND GROWTH 10 8.12e-01 9.49e-01 0.11200 -5.20e-02 -9.89e-02 7.76e-01 5.88e-01
GOBP CARBOHYDRATE TRANSPORT 137 5.95e-02 3.70e-01 0.11200 4.88e-02 1.00e-01 3.25e-01 4.23e-02
GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 15 7.77e-01 9.38e-01 0.11200 -8.80e-02 6.87e-02 5.55e-01 6.45e-01
GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS 21 6.46e-01 8.91e-01 0.11200 9.79e-02 5.37e-02 4.37e-01 6.70e-01
GOBP NEURONAL STEM CELL POPULATION MAINTENANCE 25 6.20e-01 8.80e-01 0.11200 -1.12e-01 -5.41e-03 3.35e-01 9.63e-01
GOMF ALDO KETO REDUCTASE NADPH ACTIVITY 30 5.94e-01 8.71e-01 0.11200 -4.18e-02 1.04e-01 6.92e-01 3.26e-01
GOMF PEPTIDASE ACTIVATOR ACTIVITY 57 3.07e-01 7.16e-01 0.11200 -9.88e-02 -5.19e-02 1.97e-01 4.98e-01
Fc epsilon receptor (FCERI) signaling 115 8.95e-02 4.39e-01 0.11200 -6.97e-02 -8.71e-02 1.96e-01 1.07e-01
GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS 71 2.41e-01 6.56e-01 0.11200 1.07e-01 3.14e-02 1.19e-01 6.47e-01
GOBP PEXOPHAGY 7 8.72e-01 9.65e-01 0.11200 1.67e-02 1.10e-01 9.39e-01 6.13e-01
GOBP REGULATION OF VIRAL GENOME REPLICATION 83 1.99e-01 6.12e-01 0.11200 -1.56e-02 -1.10e-01 8.06e-01 8.20e-02
GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION 12 7.77e-01 9.38e-01 0.11200 -6.44e-02 -9.11e-02 6.99e-01 5.85e-01
GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 21 6.94e-01 9.10e-01 0.11100 -1.04e-01 4.05e-02 4.10e-01 7.48e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 90 2.19e-01 6.37e-01 0.11100 5.67e-02 -9.59e-02 3.53e-01 1.16e-01
GOBP MONOSACCHARIDE METABOLIC PROCESS 242 1.57e-02 1.99e-01 0.11100 -4.08e-02 1.04e-01 2.74e-01 5.48e-03
GOCC ORGANELLE ENVELOPE LUMEN 89 1.62e-01 5.61e-01 0.11100 -4.53e-02 -1.02e-01 4.61e-01 9.70e-02
GOMF STEROID DEHYDROGENASE ACTIVITY 35 4.89e-01 8.25e-01 0.11100 -4.39e-02 -1.02e-01 6.53e-01 2.95e-01
GOBP CYTOSKELETON DEPENDENT CYTOKINESIS 116 1.07e-01 4.75e-01 0.11100 -1.11e-01 -1.21e-02 3.94e-02 8.21e-01
GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING 9 8.35e-01 9.55e-01 0.11100 1.07e-01 2.99e-02 5.78e-01 8.77e-01
GOBP LIPOPROTEIN METABOLIC PROCESS 133 6.24e-02 3.77e-01 0.11100 -8.80e-02 -6.81e-02 7.96e-02 1.75e-01
GOBP LUNG EPITHELIUM DEVELOPMENT 45 4.39e-01 7.99e-01 0.11100 -1.10e-01 1.30e-02 2.00e-01 8.80e-01
Downregulation of ERBB2 signaling 29 6.18e-01 8.80e-01 0.11100 8.51e-02 -7.16e-02 4.27e-01 5.05e-01
GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS 310 6.21e-03 1.15e-01 0.11100 -7.38e-02 8.32e-02 2.54e-02 1.18e-02
GOBP HISTAMINE SECRETION 12 8.14e-01 9.50e-01 0.11100 -4.70e-02 1.01e-01 7.78e-01 5.46e-01
GOCC SITE OF POLARIZED GROWTH 159 7.28e-02 4.04e-01 0.11100 -7.72e-02 8.00e-02 9.30e-02 8.16e-02
GOCC NUCLEAR BODY 812 1.38e-07 1.90e-05 0.11100 -1.05e-01 -3.72e-02 3.87e-07 7.17e-02
SHC-mediated cascade:FGFR4 19 7.14e-01 9.15e-01 0.11100 -2.67e-02 1.08e-01 8.41e-01 4.15e-01
Signaling by BRAF and RAF1 fusions 63 3.24e-01 7.29e-01 0.11100 -1.09e-01 2.25e-02 1.35e-01 7.58e-01
GOBP RENAL WATER HOMEOSTASIS 24 6.46e-01 8.91e-01 0.11100 -1.43e-02 1.10e-01 9.03e-01 3.50e-01
GOBP CYTIDINE TO URIDINE EDITING 12 7.86e-01 9.41e-01 0.11100 1.06e-01 3.34e-02 5.25e-01 8.41e-01
GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION 24 6.52e-01 8.93e-01 0.11100 2.27e-02 -1.09e-01 8.48e-01 3.57e-01
GOCC PERINUCLEAR ENDOPLASMIC RETICULUM 19 7.22e-01 9.17e-01 0.11100 -1.03e-01 4.20e-02 4.38e-01 7.52e-01
GOBP POSITIVE REGULATION OF GLUCONEOGENESIS 20 7.00e-01 9.12e-01 0.11100 -1.09e-01 2.20e-02 4.00e-01 8.64e-01
GOBP ONCOGENE INDUCED CELL SENESCENCE 6 8.96e-01 9.73e-01 0.11100 -1.13e-02 1.10e-01 9.62e-01 6.40e-01
NOTCH2 intracellular domain regulates transcription 11 7.97e-01 9.44e-01 0.11100 -5.65e-02 -9.54e-02 7.46e-01 5.84e-01
Biosynthesis of maresin-like SPMs 6 9.01e-01 9.74e-01 0.11100 -3.47e-02 1.05e-01 8.83e-01 6.55e-01
GOMF SH3 DOMAIN BINDING 114 1.50e-01 5.44e-01 0.11100 -5.51e-02 9.60e-02 3.09e-01 7.66e-02
Visual phototransduction 92 1.48e-01 5.43e-01 0.11100 7.69e-02 7.97e-02 2.02e-01 1.87e-01
GOBP EPITHELIAL CELL APOPTOTIC PROCESS 146 4.89e-02 3.35e-01 0.11100 -8.39e-02 -7.23e-02 8.03e-02 1.32e-01
GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY 28 5.78e-01 8.64e-01 0.11100 -1.08e-01 -2.50e-02 3.23e-01 8.19e-01
GOBP MATURE B CELL DIFFERENTIATION 34 5.09e-01 8.34e-01 0.11100 3.34e-02 1.06e-01 7.36e-01 2.87e-01
GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 309 4.52e-03 9.31e-02 0.11100 -1.08e-01 2.37e-02 1.08e-03 4.75e-01
GOBP CRISTAE FORMATION 17 7.03e-01 9.12e-01 0.11100 -8.52e-02 -7.06e-02 5.43e-01 6.15e-01
GOBP CELLULAR RESPONSE TO POTASSIUM ION 12 7.83e-01 9.40e-01 0.11100 5.09e-02 9.82e-02 7.60e-01 5.56e-01
GOMF ATPASE ACTIVATOR ACTIVITY 25 6.03e-01 8.76e-01 0.11100 -1.01e-01 -4.58e-02 3.84e-01 6.92e-01
GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 140 1.00e-01 4.63e-01 0.11100 9.02e-02 -6.40e-02 6.55e-02 1.91e-01
GOMF CALCIUM CHANNEL REGULATOR ACTIVITY 49 4.05e-01 7.81e-01 0.11100 -1.11e-01 2.79e-03 1.81e-01 9.73e-01
GOBP NEGATIVE REGULATION OF AXON EXTENSION 28 5.88e-01 8.67e-01 0.11100 1.10e-01 1.05e-02 3.14e-01 9.23e-01
Defective B4GALT7 causes EDS, progeroid type 17 7.05e-01 9.13e-01 0.11100 9.32e-02 5.94e-02 5.06e-01 6.72e-01
GOBP DETECTION OF CELL DENSITY 8 8.76e-01 9.66e-01 0.11000 9.16e-02 -6.17e-02 6.54e-01 7.62e-01
GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY 13 7.74e-01 9.37e-01 0.11000 -3.02e-02 -1.06e-01 8.50e-01 5.07e-01
GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE 158 7.57e-02 4.12e-01 0.11000 -8.83e-02 6.64e-02 5.56e-02 1.50e-01
mRNA Capping 28 5.60e-01 8.57e-01 0.11000 -7.78e-02 -7.84e-02 4.76e-01 4.73e-01
GOBP NEGATIVE REGULATION OF RELAXATION OF MUSCLE 7 8.90e-01 9.71e-01 0.11000 -9.52e-02 5.59e-02 6.63e-01 7.98e-01
GOBP MUSCLE SYSTEM PROCESS 449 3.16e-04 1.37e-02 0.11000 -1.10e-01 5.46e-03 6.19e-05 8.43e-01
GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 8 8.77e-01 9.66e-01 0.11000 -6.29e-02 9.07e-02 7.58e-01 6.57e-01
GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION 55 3.23e-01 7.28e-01 0.11000 -6.45e-02 -8.95e-02 4.08e-01 2.51e-01
GOMF ENDONUCLEASE ACTIVITY 119 9.85e-02 4.58e-01 0.11000 -1.07e-01 -2.80e-02 4.43e-02 5.98e-01
GOBP REGULATION OF APOPTOTIC CELL CLEARANCE 10 8.33e-01 9.54e-01 0.11000 -1.10e-01 4.67e-03 5.46e-01 9.80e-01
GOBP RESPONSE TO UV C 14 7.81e-01 9.40e-01 0.11000 -1.08e-01 2.14e-02 4.83e-01 8.90e-01
GOBP TRIPEPTIDE TRANSMEMBRANE TRANSPORT 10 8.19e-01 9.52e-01 0.11000 4.04e-02 1.03e-01 8.25e-01 5.74e-01
GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT 15 7.70e-01 9.35e-01 0.11000 -1.07e-01 2.64e-02 4.73e-01 8.59e-01
RHO GTPases activate KTN1 11 8.03e-01 9.47e-01 0.11000 -1.03e-01 -3.99e-02 5.55e-01 8.19e-01
GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY 5 9.12e-01 9.77e-01 0.11000 1.10e-01 1.18e-03 6.70e-01 9.96e-01
GOBP RNA MODIFICATION 162 5.15e-02 3.44e-01 0.11000 5.36e-04 -1.10e-01 9.91e-01 1.55e-02
Removal of the Flap Intermediate from the C-strand 17 7.05e-01 9.13e-01 0.11000 -8.81e-02 -6.62e-02 5.30e-01 6.37e-01
GOBP CELLULAR RESPONSE TO RADIATION 171 3.08e-02 2.74e-01 0.11000 -6.42e-02 -8.95e-02 1.48e-01 4.34e-02
GOBP XENOBIOTIC METABOLIC PROCESS 122 9.11e-02 4.43e-01 0.11000 1.05e-01 3.46e-02 4.60e-02 5.09e-01
GOBP CELLULAR RESPONSE TO NUTRIENT LEVELS 232 1.53e-02 1.98e-01 0.11000 -1.10e-01 6.03e-03 3.90e-03 8.74e-01
GOBP RESPONSE TO GROWTH FACTOR 752 3.55e-06 3.33e-04 0.11000 -1.06e-01 3.06e-02 7.97e-07 1.53e-01
GOBP TRIGEMINAL NERVE DEVELOPMENT 12 7.89e-01 9.42e-01 0.11000 -1.04e-01 -3.60e-02 5.33e-01 8.29e-01
GOBP REGULATION OF PROTEIN UBIQUITINATION 177 3.54e-02 2.90e-01 0.11000 -1.56e-02 -1.09e-01 7.20e-01 1.24e-02
GOBP ZYGOTIC DETERMINATION OF ANTERIOR POSTERIOR AXIS EMBRYO 6 9.06e-01 9.76e-01 0.11000 9.26e-02 -5.95e-02 6.95e-01 8.01e-01
TP53 Regulates Transcription of Cell Cycle Genes 47 4.62e-01 8.12e-01 0.11000 9.32e-02 -5.85e-02 2.69e-01 4.88e-01
GOBP ENAMEL MINERALIZATION 20 7.14e-01 9.15e-01 0.11000 1.01e-01 -4.27e-02 4.32e-01 7.41e-01
GOMF CARBONYL REDUCTASE NADPH ACTIVITY 9 8.64e-01 9.62e-01 0.11000 7.97e-02 -7.57e-02 6.79e-01 6.94e-01
GOMF ACTIN BINDING 412 1.38e-03 4.14e-02 0.11000 -8.65e-02 6.79e-02 2.58e-03 1.81e-02
Ephrin signaling 17 7.33e-01 9.23e-01 0.11000 -2.79e-03 1.10e-01 9.84e-01 4.33e-01
GOCC MITOCHONDRIAL MATRIX 479 1.67e-04 8.71e-03 0.11000 -4.22e-03 -1.10e-01 8.74e-01 3.79e-05
GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 82 2.43e-01 6.58e-01 0.11000 -1.06e-01 2.73e-02 9.57e-02 6.69e-01
GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 146 9.49e-02 4.50e-01 0.11000 -8.43e-02 7.04e-02 7.85e-02 1.42e-01
GOBP REGULATION OF SPROUTING ANGIOGENESIS 65 2.70e-01 6.85e-01 0.11000 5.27e-02 9.64e-02 4.62e-01 1.79e-01
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY 36 4.84e-01 8.23e-01 0.11000 -5.31e-02 -9.62e-02 5.82e-01 3.18e-01
GOMF ENOYL COA HYDRATASE ACTIVITY 11 8.25e-01 9.52e-01 0.11000 2.23e-02 -1.08e-01 8.98e-01 5.37e-01
GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY 25 6.47e-01 8.91e-01 0.11000 1.07e-01 -2.42e-02 3.54e-01 8.34e-01
GOBP REGULATION OF PROTEIN SUMOYLATION 21 6.52e-01 8.93e-01 0.11000 -6.29e-02 -9.00e-02 6.18e-01 4.75e-01
GOBP HEMOGLOBIN METABOLIC PROCESS 17 7.07e-01 9.13e-01 0.11000 6.44e-02 8.90e-02 6.46e-01 5.25e-01
GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION 113 1.26e-01 5.07e-01 0.11000 -2.75e-03 -1.10e-01 9.60e-01 4.38e-02
GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS 17 7.29e-01 9.21e-01 0.11000 -7.63e-03 -1.09e-01 9.57e-01 4.34e-01
GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE 6 9.08e-01 9.77e-01 0.11000 -7.86e-02 7.66e-02 7.39e-01 7.45e-01
GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS 19 6.85e-01 9.06e-01 0.11000 4.43e-02 1.00e-01 7.38e-01 4.49e-01
GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY 21 6.57e-01 8.94e-01 0.11000 -5.01e-02 -9.75e-02 6.91e-01 4.39e-01
GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY 72 3.04e-01 7.14e-01 0.11000 -4.83e-02 9.84e-02 4.79e-01 1.49e-01
GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX 11 8.12e-01 9.49e-01 0.11000 1.67e-02 1.08e-01 9.23e-01 5.34e-01
GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY 32 5.52e-01 8.54e-01 0.11000 7.99e-03 1.09e-01 9.38e-01 2.84e-01
GOBP ERBB2 SIGNALING PATHWAY 23 6.88e-01 9.07e-01 0.11000 6.17e-02 -9.06e-02 6.08e-01 4.52e-01
GOMF ARYL HYDROCARBON RECEPTOR BINDING 8 8.49e-01 9.58e-01 0.11000 -7.65e-02 -7.85e-02 7.08e-01 7.01e-01
GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY 15 7.79e-01 9.39e-01 0.11000 4.49e-02 -1.00e-01 7.64e-01 5.03e-01
GOBP SERTOLI CELL DEVELOPMENT 12 8.22e-01 9.52e-01 0.11000 5.78e-02 -9.31e-02 7.29e-01 5.77e-01
GOBP INSULIN METABOLIC PROCESS 16 7.22e-01 9.17e-01 0.11000 -8.17e-02 -7.31e-02 5.72e-01 6.13e-01
GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS 61 3.54e-01 7.47e-01 0.10900 -3.07e-02 1.05e-01 6.78e-01 1.56e-01
GOBP HETEROTYPIC CELL CELL ADHESION 62 3.25e-01 7.29e-01 0.10900 -1.09e-01 4.75e-04 1.36e-01 9.95e-01
GOBP GOLGI VESICLE TRANSPORT 290 5.68e-03 1.08e-01 0.10900 -1.09e-01 3.86e-03 1.35e-03 9.10e-01
GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING 25 6.56e-01 8.94e-01 0.10900 1.04e-01 -3.55e-02 3.70e-01 7.59e-01
GOBP MICROTUBULE POLYMERIZATION 91 2.22e-01 6.39e-01 0.10900 -9.99e-02 4.47e-02 9.97e-02 4.61e-01
Clathrin-mediated endocytosis 139 6.71e-02 3.91e-01 0.10900 -1.03e-01 -3.67e-02 3.59e-02 4.55e-01
GOMF ADP BINDING 36 5.48e-01 8.52e-01 0.10900 -1.01e-01 4.10e-02 2.92e-01 6.70e-01
GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS 108 1.66e-01 5.66e-01 0.10900 1.01e-01 -4.10e-02 6.86e-02 4.62e-01
GOCC PRESYNAPTIC CYTOSKELETON 11 8.09e-01 9.49e-01 0.10900 -1.06e-01 -2.78e-02 5.44e-01 8.73e-01
GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 232 1.61e-02 2.03e-01 0.10900 5.16e-03 -1.09e-01 8.92e-01 4.15e-03
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 95 1.47e-01 5.40e-01 0.10900 -6.91e-02 -8.48e-02 2.45e-01 1.53e-01
GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE 35 5.68e-01 8.59e-01 0.10900 -9.09e-02 6.08e-02 3.52e-01 5.33e-01
GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS 6 8.95e-01 9.73e-01 0.10900 7.91e-03 1.09e-01 9.73e-01 6.44e-01
GOBP LAMELLIPODIUM MORPHOGENESIS 18 7.49e-01 9.28e-01 0.10900 -7.11e-02 8.30e-02 6.02e-01 5.42e-01
GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION 23 6.40e-01 8.88e-01 0.10900 -1.04e-01 -3.45e-02 3.89e-01 7.75e-01
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY 15 7.53e-01 9.30e-01 0.10900 -1.94e-02 -1.08e-01 8.96e-01 4.71e-01
GOBP CELL JUNCTION MAINTENANCE 44 4.83e-01 8.22e-01 0.10900 -4.36e-02 1.00e-01 6.16e-01 2.50e-01
GOCC SPECIFIC GRANULE MEMBRANE 88 2.46e-01 6.61e-01 0.10900 -7.66e-02 7.78e-02 2.14e-01 2.07e-01
GOMF RNA 7 METHYLGUANOSINE CAP BINDING 13 8.12e-01 9.49e-01 0.10900 -8.64e-02 6.68e-02 5.90e-01 6.77e-01
GOMF ICOSANOID RECEPTOR ACTIVITY 14 7.99e-01 9.45e-01 0.10900 8.59e-02 -6.72e-02 5.78e-01 6.63e-01
GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION 67 3.32e-01 7.35e-01 0.10900 9.99e-02 -4.37e-02 1.57e-01 5.36e-01
GOBP EPITHELIAL FLUID TRANSPORT 12 7.97e-01 9.44e-01 0.10900 2.32e-02 1.07e-01 8.90e-01 5.23e-01
GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS 6 9.08e-01 9.77e-01 0.10900 6.29e-02 -8.90e-02 7.90e-01 7.06e-01
Synthesis of bile acids and bile salts 33 5.91e-01 8.70e-01 0.10900 -7.21e-02 8.17e-02 4.73e-01 4.17e-01
GOBP PROTEIN POLY ADP RIBOSYLATION 10 8.20e-01 9.52e-01 0.10900 9.40e-02 5.51e-02 6.07e-01 7.63e-01
GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS 10 8.17e-01 9.51e-01 0.10900 8.02e-02 7.37e-02 6.60e-01 6.86e-01
GOBP SYNAPTIC VESICLE COATING 5 9.14e-01 9.78e-01 0.10900 3.75e-03 -1.09e-01 9.88e-01 6.73e-01
GOCC B WICH COMPLEX 7 8.69e-01 9.64e-01 0.10900 -8.65e-02 -6.61e-02 6.92e-01 7.62e-01
GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS 23 6.35e-01 8.86e-01 0.10900 -9.59e-02 -5.16e-02 4.26e-01 6.69e-01
GOCC MYOSIN COMPLEX 57 3.50e-01 7.45e-01 0.10900 1.14e-02 1.08e-01 8.82e-01 1.57e-01
GOBP PARTURITION 14 7.76e-01 9.38e-01 0.10900 1.09e-01 2.49e-03 4.81e-01 9.87e-01
GOBP CELLULAR RESPONSE TO GLUCAGON STIMULUS 11 8.02e-01 9.46e-01 0.10900 -6.99e-02 -8.35e-02 6.88e-01 6.32e-01
GOBP VESTIBULOCOCHLEAR NERVE MORPHOGENESIS 7 8.94e-01 9.73e-01 0.10900 -8.85e-02 6.34e-02 6.85e-01 7.72e-01
GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY 31 6.01e-01 8.75e-01 0.10900 4.39e-02 -9.96e-02 6.72e-01 3.37e-01
GOBP REGULATION OF KIDNEY DEVELOPMENT 33 5.46e-01 8.51e-01 0.10900 -9.82e-03 -1.08e-01 9.22e-01 2.81e-01
GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 89 1.74e-01 5.79e-01 0.10900 -9.72e-02 -4.89e-02 1.13e-01 4.25e-01
GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY 6 9.09e-01 9.77e-01 0.10900 -8.70e-02 6.53e-02 7.12e-01 7.82e-01
Downstream signaling events of B Cell Receptor (BCR) 67 2.73e-01 6.85e-01 0.10900 -4.01e-02 -1.01e-01 5.70e-01 1.52e-01
GOBP ADIPOSE TISSUE DEVELOPMENT 60 3.84e-01 7.68e-01 0.10900 -8.81e-02 6.38e-02 2.38e-01 3.93e-01
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION 41 4.69e-01 8.14e-01 0.10900 1.32e-02 1.08e-01 8.84e-01 2.32e-01
GOBP L SERINE BIOSYNTHETIC PROCESS 6 9.03e-01 9.75e-01 0.10900 -1.06e-01 2.53e-02 6.54e-01 9.15e-01
Serotonin Neurotransmitter Release Cycle 17 7.23e-01 9.17e-01 0.10900 1.05e-01 2.98e-02 4.55e-01 8.32e-01
GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 121 1.27e-01 5.10e-01 0.10900 1.07e-01 -2.13e-02 4.29e-02 6.85e-01
GOBP PROTEIN HETEROOLIGOMERIZATION 29 6.30e-01 8.85e-01 0.10900 -6.47e-02 8.73e-02 5.46e-01 4.16e-01
GOBP NUCLEAR MEMBRANE ORGANIZATION 45 4.22e-01 7.90e-01 0.10900 -3.50e-02 -1.03e-01 6.84e-01 2.33e-01
GOBP POSITIVE REGULATION OF NEUROGENESIS 231 2.64e-02 2.57e-01 0.10900 -8.56e-02 6.69e-02 2.51e-02 7.97e-02
CREB phosphorylation 6 8.88e-01 9.71e-01 0.10900 5.28e-02 9.49e-02 8.23e-01 6.87e-01
Prolonged ERK activation events 14 7.98e-01 9.45e-01 0.10900 -5.23e-02 9.52e-02 7.35e-01 5.38e-01
GOBP SYNAPTIC VESICLE TRANSPORT 42 4.39e-01 7.99e-01 0.10900 -4.99e-02 -9.64e-02 5.76e-01 2.80e-01
GOBP ERBB3 SIGNALING PATHWAY 10 8.53e-01 9.59e-01 0.10900 -6.83e-02 8.43e-02 7.08e-01 6.44e-01
GOBP MITOTIC SPINDLE ASSEMBLY 70 3.11e-01 7.20e-01 0.10900 3.14e-02 -1.04e-01 6.49e-01 1.33e-01
GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING 329 2.93e-03 7.21e-02 0.10900 -1.08e-01 -2.27e-03 7.18e-04 9.44e-01
GOBP REGULATION OF BILE ACID BIOSYNTHETIC PROCESS 12 7.93e-01 9.43e-01 0.10800 1.01e-01 3.91e-02 5.44e-01 8.14e-01
Induction of Cell-Cell Fusion 12 7.92e-01 9.42e-01 0.10800 9.86e-02 4.51e-02 5.54e-01 7.87e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE 101 1.71e-01 5.73e-01 0.10800 -8.39e-03 1.08e-01 8.84e-01 6.04e-02
GOBP SPERMATID NUCLEUS DIFFERENTIATION 27 6.49e-01 8.91e-01 0.10800 5.44e-02 -9.38e-02 6.24e-01 3.99e-01
GOBP ACTIVATION OF IMMUNE RESPONSE 530 2.85e-04 1.26e-02 0.10800 8.24e-02 -7.03e-02 1.17e-03 5.59e-03
GOBP REGULATION OF SALIVA SECRETION 7 8.85e-01 9.69e-01 0.10800 -1.08e-01 1.20e-02 6.22e-01 9.56e-01
GOMF PALMITOYLTRANSFERASE ACTIVITY 34 5.83e-01 8.66e-01 0.10800 -8.96e-02 6.09e-02 3.66e-01 5.39e-01
GOCC FILAMENTOUS ACTIN 32 5.67e-01 8.59e-01 0.10800 -1.08e-01 2.30e-03 2.89e-01 9.82e-01
GOCC HETEROCHROMATIN 77 2.24e-01 6.43e-01 0.10800 -9.75e-02 -4.71e-02 1.39e-01 4.75e-01
GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS 37 5.25e-01 8.42e-01 0.10800 -1.08e-01 9.33e-03 2.56e-01 9.22e-01
GOBP RECOMBINATIONAL REPAIR 181 2.80e-02 2.65e-01 0.10800 -7.58e-02 -7.73e-02 7.85e-02 7.30e-02
GOMF NUCLEAR RECEPTOR BINDING 131 7.52e-02 4.12e-01 0.10800 -8.38e-02 -6.85e-02 9.77e-02 1.76e-01
GOMF PHOSPHOLIPASE D ACTIVITY 6 9.09e-01 9.77e-01 0.10800 -5.77e-02 9.16e-02 8.07e-01 6.98e-01
Transport of the SLBP independent Mature mRNA 35 5.03e-01 8.31e-01 0.10800 -9.27e-02 -5.58e-02 3.43e-01 5.68e-01
GOMF ELECTRON TRANSFER ACTIVITY 99 1.70e-01 5.71e-01 0.10800 -4.41e-03 -1.08e-01 9.39e-01 6.31e-02
GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 105 1.61e-01 5.59e-01 0.10800 -1.08e-01 8.59e-03 5.62e-02 8.79e-01
GOBP REGULATION OF CELLULAR SENESCENCE 53 4.26e-01 7.93e-01 0.10800 4.76e-02 -9.71e-02 5.49e-01 2.21e-01
Amino acid transport across the plasma membrane 30 5.53e-01 8.54e-01 0.10800 6.35e-02 8.76e-02 5.47e-01 4.07e-01
GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS 91 2.42e-01 6.57e-01 0.10800 -7.24e-02 8.02e-02 2.33e-01 1.86e-01
Abortive elongation of HIV-1 transcript in the absence of Tat 23 6.97e-01 9.11e-01 0.10800 -8.59e-02 6.54e-02 4.76e-01 5.87e-01
Synthesis of 5-eicosatetraenoic acids 9 8.52e-01 9.59e-01 0.10800 1.08e-01 1.86e-03 5.75e-01 9.92e-01
GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 65 3.32e-01 7.35e-01 0.10800 -1.06e-01 1.85e-02 1.38e-01 7.96e-01
Toll Like Receptor 9 (TLR9) Cascade 102 1.41e-01 5.32e-01 0.10800 -4.53e-02 -9.80e-02 4.29e-01 8.72e-02
GOBP REGULATION OF DENDRITE DEVELOPMENT 92 2.38e-01 6.55e-01 0.10800 -7.41e-02 7.86e-02 2.19e-01 1.93e-01
GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM 15 7.46e-01 9.27e-01 0.10800 9.32e-02 5.45e-02 5.32e-01 7.15e-01
GOBP REGULATION OF FLAGELLATED SPERM MOTILITY 20 6.90e-01 9.08e-01 0.10800 -1.06e-01 -2.25e-02 4.14e-01 8.61e-01
GOMF ACID PHOSPHATASE ACTIVITY 9 8.54e-01 9.59e-01 0.10800 1.08e-01 -3.48e-03 5.75e-01 9.86e-01
GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX 51 4.16e-01 7.86e-01 0.10800 -1.19e-02 1.07e-01 8.83e-01 1.85e-01
GOBP GOLGI DISASSEMBLY 6 8.95e-01 9.73e-01 0.10800 -1.05e-01 -2.24e-02 6.55e-01 9.24e-01
GOBP EXTRACELLULAR MATRIX DISASSEMBLY 62 3.79e-01 7.64e-01 0.10800 -8.73e-02 6.32e-02 2.34e-01 3.89e-01
GOBP RENAL ABSORPTION 34 5.70e-01 8.61e-01 0.10800 -2.99e-02 1.04e-01 7.63e-01 2.96e-01
GOBP DENDRITIC CELL DIFFERENTIATION 44 4.83e-01 8.22e-01 0.10800 1.04e-01 -2.94e-02 2.34e-01 7.36e-01
GOBP MACROMOLECULE DEPALMITOYLATION 14 7.62e-01 9.32e-01 0.10800 -9.49e-02 -5.11e-02 5.39e-01 7.41e-01
GOMF PALMITOYL HYDROLASE ACTIVITY 14 7.62e-01 9.32e-01 0.10800 -9.49e-02 -5.11e-02 5.39e-01 7.41e-01
GOBP CARDIAC CHAMBER DEVELOPMENT 169 5.31e-02 3.49e-01 0.10800 -1.08e-01 3.81e-03 1.58e-02 9.32e-01
GOBP PURINE NUCLEOTIDE TRANSPORT 38 5.51e-01 8.53e-01 0.10800 -6.04e-02 8.92e-02 5.19e-01 3.41e-01
GOMF COA LIGASE ACTIVITY 26 6.66e-01 8.98e-01 0.10800 -6.31e-02 8.72e-02 5.77e-01 4.41e-01
GOBP RESPONSE TO PROGESTERONE 44 4.26e-01 7.93e-01 0.10800 -5.49e-02 -9.26e-02 5.29e-01 2.88e-01
GOBP MACROPHAGE MIGRATION 61 3.67e-01 7.56e-01 0.10800 -1.03e-01 3.08e-02 1.64e-01 6.77e-01
GOBP MYOBLAST MIGRATION 13 8.04e-01 9.47e-01 0.10800 -1.05e-01 2.27e-02 5.11e-01 8.87e-01
GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS 1835 2.63e-14 1.20e-11 0.10800 -1.04e-01 -2.59e-02 1.17e-13 6.55e-02
GOCC GOLGI CISTERNA MEMBRANE 74 2.57e-01 6.71e-01 0.10700 2.29e-02 1.05e-01 7.34e-01 1.18e-01
GOCC CAJAL BODY 78 2.36e-01 6.54e-01 0.10700 -1.04e-01 -2.64e-02 1.12e-01 6.87e-01
GOBP POSITIVE REGULATION OF SPINDLE CHECKPOINT 13 7.98e-01 9.45e-01 0.10700 -1.07e-01 4.03e-03 5.03e-01 9.80e-01
GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY 21 6.75e-01 9.03e-01 0.10700 -3.30e-02 -1.02e-01 7.94e-01 4.17e-01
GOCC MITOCHONDRIAL ENVELOPE 763 2.79e-06 2.72e-04 0.10700 4.53e-03 -1.07e-01 8.31e-01 4.59e-07
GOBP N GLYCAN PROCESSING 17 7.25e-01 9.18e-01 0.10700 4.04e-02 9.95e-02 7.73e-01 4.78e-01
GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE 23 6.54e-01 8.93e-01 0.10700 -1.04e-01 -2.49e-02 3.86e-01 8.37e-01
RHOH GTPase cycle 36 5.71e-01 8.61e-01 0.10700 8.87e-02 -6.05e-02 3.57e-01 5.30e-01
GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 330 6.57e-03 1.18e-01 0.10700 7.49e-02 -7.68e-02 1.93e-02 1.64e-02
GOBP DEVELOPMENTAL GROWTH 631 2.48e-05 1.81e-03 0.10700 -1.07e-01 5.64e-03 4.31e-06 8.09e-01
Mitochondrial unfolded protein response (UPRmt) 18 7.14e-01 9.15e-01 0.10700 1.02e-01 3.30e-02 4.53e-01 8.08e-01
Glutamate Neurotransmitter Release Cycle 24 6.32e-01 8.86e-01 0.10700 9.61e-02 4.78e-02 4.15e-01 6.85e-01
GOBP VASCULAR WOUND HEALING 23 7.01e-01 9.12e-01 0.10700 -8.06e-02 7.08e-02 5.03e-01 5.57e-01
GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY 11 8.15e-01 9.51e-01 0.10700 -2.98e-02 -1.03e-01 8.64e-01 5.54e-01
TNF signaling 54 4.34e-01 7.96e-01 0.10700 6.69e-02 -8.38e-02 3.95e-01 2.87e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 13 7.90e-01 9.42e-01 0.10700 -1.06e-01 -1.69e-02 5.09e-01 9.16e-01
GOBP MAGNESIUM ION TRANSPORT 17 7.68e-01 9.34e-01 0.10700 8.93e-02 -5.92e-02 5.24e-01 6.73e-01
GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION 70 2.73e-01 6.85e-01 0.10700 1.02e-01 3.12e-02 1.38e-01 6.52e-01
GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM 148 5.94e-02 3.70e-01 0.10700 -9.33e-02 -5.26e-02 5.00e-02 2.69e-01
GOMF CHEMOKINE RECEPTOR BINDING 63 3.72e-01 7.60e-01 0.10700 9.46e-02 -5.03e-02 1.94e-01 4.90e-01
GOMF CARBON NITROGEN LYASE ACTIVITY 13 7.97e-01 9.44e-01 0.10700 7.97e-04 1.07e-01 9.96e-01 5.04e-01
GOBP ENDOCARDIAL CELL DIFFERENTIATION 6 8.97e-01 9.73e-01 0.10700 -1.87e-02 -1.05e-01 9.37e-01 6.55e-01
GOBP DETECTION OF TEMPERATURE STIMULUS 26 6.40e-01 8.88e-01 0.10700 1.07e-01 -6.12e-03 3.45e-01 9.57e-01
GOBP NEGATIVE REGULATION OF COAGULATION 53 3.77e-01 7.64e-01 0.10700 2.68e-02 1.04e-01 7.36e-01 1.92e-01
GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS 11 8.44e-01 9.57e-01 0.10700 7.74e-02 -7.40e-02 6.57e-01 6.71e-01
GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION 7 8.84e-01 9.69e-01 0.10700 -1.07e-01 -5.21e-03 6.24e-01 9.81e-01
Ciprofloxacin ADME 5 9.09e-01 9.77e-01 0.10700 -9.38e-02 -5.15e-02 7.16e-01 8.42e-01
GOBP POSITIVE REGULATION OF LIPID TRANSPORT 86 1.96e-01 6.07e-01 0.10700 -9.61e-02 -4.70e-02 1.23e-01 4.51e-01
Ovarian tumor domain proteases 36 5.35e-01 8.46e-01 0.10700 -6.60e-05 -1.07e-01 9.99e-01 2.67e-01
GOCC AZUROPHIL GRANULE MEMBRANE 56 4.06e-01 7.81e-01 0.10700 -1.01e-01 3.46e-02 1.90e-01 6.54e-01
GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT 436 1.21e-03 3.81e-02 0.10700 -9.47e-02 4.98e-02 7.00e-04 7.48e-02
GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION 47 4.56e-01 8.09e-01 0.10700 -1.06e-01 1.65e-02 2.10e-01 8.44e-01
GOBP REGULATION OF XENOBIOTIC DETOXIFICATION BY TRANSMEMBRANE EXPORT ACROSS THE PLASMA MEMBRANE 12 8.22e-01 9.52e-01 0.10700 1.03e-01 -2.65e-02 5.35e-01 8.74e-01
GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 46 4.79e-01 8.21e-01 0.10700 -3.70e-02 1.00e-01 6.65e-01 2.40e-01
Resolution of AP sites via the multiple-nucleotide patch replacement pathway 25 6.18e-01 8.80e-01 0.10700 -6.64e-02 -8.36e-02 5.66e-01 4.70e-01
Activation of NF-kappaB in B cells 53 3.72e-01 7.60e-01 0.10700 -3.83e-02 -9.96e-02 6.29e-01 2.10e-01
GOBP L AMINO ACID BIOSYNTHETIC PROCESS 56 4.11e-01 7.84e-01 0.10700 9.92e-02 -3.92e-02 1.99e-01 6.12e-01
GOBP PURINE NUCLEOBASE METABOLIC PROCESS 18 7.49e-01 9.28e-01 0.10700 1.01e-01 -3.54e-02 4.60e-01 7.95e-01
GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA 75 3.06e-01 7.16e-01 0.10700 -9.80e-02 4.19e-02 1.42e-01 5.30e-01
GOBP RESPONSE TO AMPHETAMINE 34 5.87e-01 8.67e-01 0.10700 -9.63e-02 4.59e-02 3.31e-01 6.43e-01
Transcriptional regulation by RUNX2 104 1.35e-01 5.24e-01 0.10700 -7.78e-02 -7.29e-02 1.70e-01 1.99e-01
GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS 15 7.57e-01 9.31e-01 0.10700 1.00e-01 3.70e-02 5.03e-01 8.04e-01
GOBP INTRACELLULAR ZINC ION HOMEOSTASIS 36 5.71e-01 8.61e-01 0.10700 9.43e-02 -4.97e-02 3.28e-01 6.06e-01
GOMF DNA NUCLEASE ACTIVITY 60 3.17e-01 7.25e-01 0.10700 -8.63e-02 -6.26e-02 2.48e-01 4.02e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 14 7.66e-01 9.33e-01 0.10700 9.16e-02 5.44e-02 5.53e-01 7.24e-01
GOBP PATTERN SPECIFICATION PROCESS 453 3.36e-04 1.43e-02 0.10600 -1.04e-01 -2.08e-02 1.39e-04 4.48e-01
GOCC PRC1 COMPLEX 18 7.60e-01 9.32e-01 0.10600 -8.53e-02 6.38e-02 5.31e-01 6.40e-01
The phototransduction cascade 32 5.43e-01 8.51e-01 0.10600 5.96e-02 8.82e-02 5.60e-01 3.88e-01
Negative regulation of TCF-dependent signaling by DVL-interacting proteins 5 9.09e-01 9.77e-01 0.10600 8.40e-02 6.53e-02 7.45e-01 8.00e-01
GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION 5 9.19e-01 9.79e-01 0.10600 1.06e-01 -1.01e-02 6.82e-01 9.69e-01
GOBP OVARIAN FOLLICLE DEVELOPMENT 55 3.88e-01 7.70e-01 0.10600 -1.06e-01 -1.17e-03 1.72e-01 9.88e-01
GOCC TRANSCRIPTION PREINITIATION COMPLEX 13 7.95e-01 9.44e-01 0.10600 -1.06e-01 -1.11e-02 5.09e-01 9.45e-01
GOMF SH2 DOMAIN BINDING 41 4.56e-01 8.09e-01 0.10600 -7.36e-02 -7.67e-02 4.15e-01 3.95e-01
Cytochrome c-mediated apoptotic response 12 8.11e-01 9.49e-01 0.10600 -6.20e-03 -1.06e-01 9.70e-01 5.24e-01
GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION 48 4.46e-01 8.02e-01 0.10600 1.06e-01 -8.39e-03 2.04e-01 9.20e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE 33 6.03e-01 8.76e-01 0.10600 -5.61e-02 9.02e-02 5.77e-01 3.70e-01
GOBP TRANSLATIONAL ELONGATION 70 2.64e-01 6.79e-01 0.10600 -6.50e-02 -8.40e-02 3.47e-01 2.24e-01
GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 156 5.14e-02 3.44e-01 0.10600 7.72e-02 7.29e-02 9.62e-02 1.16e-01
GOBP KETONE CATABOLIC PROCESS 15 7.96e-01 9.44e-01 0.10600 6.07e-02 -8.71e-02 6.84e-01 5.59e-01
GOBP WALKING BEHAVIOR 35 5.29e-01 8.43e-01 0.10600 -1.02e-01 -2.96e-02 2.97e-01 7.62e-01
GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 47 4.48e-01 8.04e-01 0.10600 -9.48e-04 1.06e-01 9.91e-01 2.08e-01
Complex IV assembly 44 4.83e-01 8.22e-01 0.10600 1.55e-02 -1.05e-01 8.59e-01 2.28e-01
GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY 23 6.54e-01 8.93e-01 0.10600 3.94e-02 9.85e-02 7.43e-01 4.14e-01
GOCC FACIT COLLAGEN TRIMER 6 8.93e-01 9.72e-01 0.10600 5.02e-02 9.34e-02 8.32e-01 6.92e-01
GOBP RESPONSE TO ZINC ION 48 4.12e-01 7.84e-01 0.10600 9.81e-02 4.02e-02 2.40e-01 6.30e-01
GOMF CATALYTIC ACTIVITY ACTING ON A TRNA 134 9.75e-02 4.56e-01 0.10600 -1.03e-02 -1.06e-01 8.37e-01 3.49e-02
GOMF INTERFERON RECEPTOR ACTIVITY 5 9.24e-01 9.81e-01 0.10600 -1.00e-01 3.38e-02 6.97e-01 8.96e-01
GOBP NEURON PROJECTION GUIDANCE 226 3.35e-02 2.85e-01 0.10600 -8.62e-02 6.17e-02 2.56e-02 1.10e-01
GOBP NUCLEAR ENVELOPE ORGANIZATION 55 3.58e-01 7.50e-01 0.10600 -4.93e-02 -9.38e-02 5.27e-01 2.29e-01
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY 10 8.40e-01 9.56e-01 0.10600 -1.06e-01 -9.10e-03 5.63e-01 9.60e-01
GOBP STEM CELL DIFFERENTIATION 243 1.35e-02 1.85e-01 0.10600 -1.03e-01 -2.38e-02 5.60e-03 5.23e-01
GOCC INCLUSION BODY 70 2.90e-01 7.03e-01 0.10600 -1.04e-01 -1.87e-02 1.32e-01 7.87e-01
GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION 35 5.82e-01 8.66e-01 0.10600 -9.55e-02 4.55e-02 3.28e-01 6.41e-01
GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION 49 3.95e-01 7.74e-01 0.10600 -8.15e-02 -6.74e-02 3.23e-01 4.14e-01
GOMF NADPLUS NUCLEOSIDASE ACTIVITY 9 8.63e-01 9.62e-01 0.10600 -1.83e-02 1.04e-01 9.24e-01 5.88e-01
GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY 23 7.08e-01 9.13e-01 0.10600 -7.82e-02 7.12e-02 5.16e-01 5.55e-01
GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY 118 1.58e-01 5.56e-01 0.10600 9.93e-02 -3.62e-02 6.23e-02 4.97e-01
GOBP RRNA 5 END PROCESSING 5 9.28e-01 9.82e-01 0.10600 -7.91e-02 7.01e-02 7.59e-01 7.86e-01
GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 18 7.15e-01 9.15e-01 0.10600 9.37e-02 4.89e-02 4.91e-01 7.19e-01
GOBP SPLICEOSOMAL SNRNP ASSEMBLY 43 4.81e-01 8.21e-01 0.10600 -1.06e-01 -1.65e-03 2.30e-01 9.85e-01
GOBP PROTEIN METHYLATION 50 3.89e-01 7.70e-01 0.10600 -6.38e-02 -8.42e-02 4.35e-01 3.03e-01
Signaling by WNT 276 5.84e-03 1.10e-01 0.10600 -8.66e-02 -6.06e-02 1.33e-02 8.29e-02
GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY 6 9.14e-01 9.78e-01 0.10600 7.93e-02 -6.98e-02 7.36e-01 7.67e-01
GOMF CHROMATIN DNA BINDING 135 8.18e-02 4.24e-01 0.10600 -9.28e-02 -5.05e-02 6.26e-02 3.11e-01
GOBP HYALURONAN METABOLIC PROCESS 33 6.08e-01 8.77e-01 0.10600 -8.60e-02 6.13e-02 3.93e-01 5.42e-01
GOBP MITOTIC CHROMOSOME CONDENSATION 19 7.01e-01 9.12e-01 0.10600 -5.45e-02 -9.04e-02 6.81e-01 4.95e-01
GOBP MRNA PSEUDOURIDINE SYNTHESIS 8 8.71e-01 9.64e-01 0.10600 -1.05e-01 -8.61e-03 6.06e-01 9.66e-01
GOMF LIGAND GATED SODIUM CHANNEL ACTIVITY 16 7.40e-01 9.25e-01 0.10600 8.78e-02 5.86e-02 5.43e-01 6.85e-01
GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY 43 5.16e-01 8.38e-01 0.10600 4.43e-02 -9.58e-02 6.15e-01 2.77e-01
GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH 64 3.13e-01 7.22e-01 0.10600 -9.95e-02 -3.52e-02 1.69e-01 6.27e-01
Synthesis of PE 13 7.95e-01 9.44e-01 0.10600 -2.06e-02 -1.03e-01 8.98e-01 5.18e-01
GOBP APOPTOTIC PROCESS IN BONE MARROW CELL 6 8.95e-01 9.73e-01 0.10600 -9.47e-02 -4.66e-02 6.88e-01 8.43e-01
GOBP REGULATION OF SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION 6 9.12e-01 9.78e-01 0.10600 -4.96e-02 9.31e-02 8.33e-01 6.93e-01
GOBP TOXIN METABOLIC PROCESS 15 7.79e-01 9.39e-01 0.10500 -7.50e-03 1.05e-01 9.60e-01 4.81e-01
GOBP INTERFERON BETA PRODUCTION 56 3.68e-01 7.57e-01 0.10500 -2.74e-02 -1.02e-01 7.23e-01 1.88e-01
GOBP NEURON PROJECTION EXTENSION 153 1.02e-01 4.66e-01 0.10500 -8.65e-02 6.03e-02 6.49e-02 1.98e-01
Signaling by NOTCH2 32 6.06e-01 8.76e-01 0.10500 3.49e-02 -9.95e-02 7.33e-01 3.30e-01
GOBP OXYGEN TRANSPORT 15 8.00e-01 9.46e-01 0.10500 7.38e-02 -7.52e-02 6.21e-01 6.14e-01
GOBP CYTOLYSIS BY HOST OF SYMBIONT CELLS 6 8.94e-01 9.72e-01 0.10500 6.04e-02 8.64e-02 7.98e-01 7.14e-01
GOMF CARBOHYDRATE BINDING 264 1.37e-02 1.86e-01 0.10500 -1.13e-02 1.05e-01 7.51e-01 3.39e-03
GOBP POSITIVE REGULATION OF GROWTH 240 2.90e-02 2.69e-01 0.10500 -7.11e-02 7.78e-02 5.78e-02 3.80e-02
GOMF CHROMATIN BINDING 581 2.99e-05 2.13e-03 0.10500 -9.53e-02 -4.50e-02 8.66e-05 6.41e-02
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE 11 8.46e-01 9.58e-01 0.10500 -5.12e-02 9.21e-02 7.69e-01 5.97e-01
GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY 19 6.99e-01 9.12e-01 0.10500 7.01e-02 7.86e-02 5.97e-01 5.53e-01
GOBP MICROTUBULE NUCLEATION 42 5.28e-01 8.42e-01 0.10500 -9.38e-02 4.77e-02 2.93e-01 5.93e-01
GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT 42 4.79e-01 8.21e-01 0.10500 -1.04e-01 -1.90e-02 2.46e-01 8.31e-01
GOBP CYTOKINESIS 179 3.92e-02 3.05e-01 0.10500 -9.74e-02 -3.99e-02 2.46e-02 3.58e-01
GOBP REGULATION OF PROSTATIC BUD FORMATION 5 9.14e-01 9.78e-01 0.10500 -3.18e-02 -1.00e-01 9.02e-01 6.98e-01
GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS 58 4.16e-01 7.86e-01 0.10500 -9.23e-02 5.05e-02 2.24e-01 5.06e-01
GOBP NON LYTIC VIRAL RELEASE 14 8.12e-01 9.49e-01 0.10500 7.25e-02 -7.62e-02 6.39e-01 6.22e-01
GOBP POSITIVE REGULATION OF IMMUNE RESPONSE 723 3.04e-05 2.13e-03 0.10500 6.78e-02 -8.04e-02 1.91e-03 2.31e-04
Activation of G protein gated Potassium channels 29 6.51e-01 8.92e-01 0.10500 -7.86e-02 6.97e-02 4.64e-01 5.16e-01
G protein gated Potassium channels 29 6.51e-01 8.92e-01 0.10500 -7.86e-02 6.97e-02 4.64e-01 5.16e-01
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits 29 6.51e-01 8.92e-01 0.10500 -7.86e-02 6.97e-02 4.64e-01 5.16e-01
GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION 25 6.46e-01 8.91e-01 0.10500 -2.02e-02 -1.03e-01 8.62e-01 3.72e-01
GOBP CENTROSOME SEPARATION 16 7.43e-01 9.26e-01 0.10500 5.71e-02 8.81e-02 6.93e-01 5.42e-01
GOMF MEMBRANE POTENTIAL DRIVEN UNIPORTER ACTIVITY 5 9.13e-01 9.78e-01 0.10500 9.70e-02 4.03e-02 7.07e-01 8.76e-01
GOBP REGULATION OF PROTEIN DEACETYLATION 26 6.76e-01 9.04e-01 0.10500 -5.19e-02 9.13e-02 6.47e-01 4.21e-01
GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY 7 8.95e-01 9.73e-01 0.10500 -2.58e-02 1.02e-01 9.06e-01 6.41e-01
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY 7 8.77e-01 9.67e-01 0.10500 -8.23e-02 -6.52e-02 7.06e-01 7.65e-01
GOMF NERVE GROWTH FACTOR BINDING 6 9.15e-01 9.78e-01 0.10500 -8.19e-02 6.55e-02 7.28e-01 7.81e-01
GOMF NADP BINDING 51 4.69e-01 8.14e-01 0.10500 -8.66e-02 5.92e-02 2.85e-01 4.65e-01
GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY 113 1.80e-01 5.84e-01 0.10500 9.57e-02 -4.28e-02 7.88e-02 4.32e-01
GOBP EPITHELIAL CELL MORPHOGENESIS 30 6.05e-01 8.76e-01 0.10500 1.05e-01 2.18e-03 3.20e-01 9.84e-01
RHO GTPases Activate Formins 134 8.45e-02 4.32e-01 0.10500 -8.62e-02 -5.96e-02 8.48e-02 2.33e-01
GOBP LIPID OXIDATION 111 1.95e-01 6.05e-01 0.10500 -8.29e-02 6.41e-02 1.31e-01 2.43e-01
GOBP PROTEIN KINASE C SIGNALING 35 5.96e-01 8.72e-01 0.10500 -8.25e-02 6.47e-02 3.99e-01 5.08e-01
GOBP ALKANESULFONATE TRANSMEMBRANE TRANSPORT 8 8.89e-01 9.71e-01 0.10500 -7.46e-02 7.36e-02 7.15e-01 7.18e-01
GOBP REGULATION OF SYSTEM PROCESS 552 3.46e-04 1.46e-02 0.10500 -8.36e-02 6.31e-02 7.79e-04 1.12e-02
GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY 12 8.36e-01 9.55e-01 0.10500 -5.40e-02 8.98e-02 7.46e-01 5.90e-01
GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS 28 6.39e-01 8.88e-01 0.10500 1.03e-01 -1.84e-02 3.45e-01 8.66e-01
GOBP POSITIVE REGULATION OF DNA REPAIR 129 9.24e-02 4.45e-01 0.10500 -8.24e-02 -6.46e-02 1.06e-01 2.05e-01
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT 196 3.29e-02 2.83e-01 0.10500 -1.02e-01 -2.49e-02 1.41e-02 5.48e-01
ER to Golgi Anterograde Transport 152 6.84e-02 3.94e-01 0.10500 -9.96e-02 -3.19e-02 3.41e-02 4.97e-01
GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS 176 7.57e-02 4.12e-01 0.10500 -6.02e-02 8.55e-02 1.68e-01 5.05e-02
GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION 69 3.37e-01 7.36e-01 0.10500 2.15e-02 -1.02e-01 7.57e-01 1.42e-01
GOBP NUCLEAR CHROMOSOME SEGREGATION 312 4.45e-03 9.27e-02 0.10500 -1.01e-01 -2.74e-02 2.18e-03 4.06e-01
GOBP EMBRYONIC ORGAN MORPHOGENESIS 293 6.40e-03 1.16e-01 0.10400 -1.02e-01 -2.43e-02 2.78e-03 4.74e-01
GOBP GLAND MORPHOGENESIS 124 1.02e-01 4.66e-01 0.10400 -7.05e-02 -7.70e-02 1.75e-01 1.38e-01
GOMF TRANSLATION ACTIVATOR ACTIVITY 9 8.74e-01 9.65e-01 0.10400 4.73e-02 -9.30e-02 8.06e-01 6.29e-01
GOBP REGULATION OF MICROTUBULE NUCLEATION 17 7.54e-01 9.30e-01 0.10400 -6.20e-04 -1.04e-01 9.96e-01 4.56e-01
GOBP ARTERY DEVELOPMENT 113 1.62e-01 5.61e-01 0.10400 -1.04e-01 1.01e-02 5.66e-02 8.53e-01
Sema4D mediated inhibition of cell attachment and migration 8 8.63e-01 9.62e-01 0.10400 8.42e-02 6.15e-02 6.80e-01 7.63e-01
GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT 50 4.00e-01 7.78e-01 0.10400 6.05e-02 8.49e-02 4.59e-01 2.99e-01
GOBP EOSINOPHIL MIGRATION 28 6.31e-01 8.86e-01 0.10400 1.04e-01 -1.80e-03 3.40e-01 9.87e-01
GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY 18 7.69e-01 9.35e-01 0.10400 6.79e-02 -7.90e-02 6.18e-01 5.62e-01
GOBP METAPHASE ANAPHASE TRANSITION OF MEIOTIC CELL CYCLE 7 8.80e-01 9.67e-01 0.10400 -5.94e-02 -8.56e-02 7.86e-01 6.95e-01
GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS 29 5.91e-01 8.69e-01 0.10400 5.08e-02 9.10e-02 6.36e-01 3.96e-01
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING 27 6.71e-01 9.01e-01 0.10400 -8.88e-02 5.44e-02 4.24e-01 6.25e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION 61 3.42e-01 7.40e-01 0.10400 9.90e-02 3.24e-02 1.81e-01 6.61e-01
GOBP LEUKOCYTE MEDIATED IMMUNITY 386 3.92e-03 8.67e-02 0.10400 8.25e-02 -6.36e-02 5.42e-03 3.20e-02
GOMF RNA EXONUCLEASE ACTIVITY 45 4.59e-01 8.10e-01 0.10400 -2.42e-02 -1.01e-01 7.79e-01 2.40e-01
GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY 378 3.68e-03 8.38e-02 0.10400 4.01e-02 -9.60e-02 1.80e-01 1.35e-03
Chaperonin-mediated protein folding 89 2.56e-01 6.71e-01 0.10400 3.00e-02 -9.96e-02 6.25e-01 1.04e-01
GOBP RESPONSE TO ALKALOID 98 2.37e-01 6.54e-01 0.10400 -9.01e-02 5.19e-02 1.23e-01 3.74e-01
GOBP RESPONSE TO OXYGEN LEVELS 323 3.41e-03 7.96e-02 0.10400 -9.53e-02 -4.15e-02 3.22e-03 2.00e-01
GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 77 2.75e-01 6.88e-01 0.10400 -1.01e-02 -1.03e-01 8.78e-01 1.17e-01
GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY 6 8.99e-01 9.74e-01 0.10400 -3.90e-02 -9.64e-02 8.69e-01 6.83e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS 60 3.70e-01 7.58e-01 0.10400 5.36e-03 1.04e-01 9.43e-01 1.64e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR 17 7.38e-01 9.24e-01 0.10400 4.26e-02 9.48e-02 7.61e-01 4.99e-01
GPCR downstream signalling 603 2.04e-04 1.02e-02 0.10400 -7.45e-02 7.24e-02 1.77e-03 2.39e-03
GOBP IMPORT INTO NUCLEUS 165 5.21e-02 3.45e-01 0.10400 -9.12e-02 -4.98e-02 4.32e-02 2.70e-01
GOBP REGULATION OF ORGANIC ACID TRANSPORT 76 3.32e-01 7.35e-01 0.10400 -8.35e-02 6.18e-02 2.08e-01 3.52e-01
GOBP UTP BIOSYNTHETIC PROCESS 10 8.64e-01 9.62e-01 0.10400 -5.71e-02 8.67e-02 7.55e-01 6.35e-01
GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION 23 7.17e-01 9.15e-01 0.10400 6.96e-02 -7.71e-02 5.63e-01 5.22e-01
GOMF SOLUTE SODIUM SYMPORTER ACTIVITY 77 2.50e-01 6.65e-01 0.10400 5.20e-02 8.98e-02 4.30e-01 1.73e-01
GOBP HINDGUT DEVELOPMENT 8 8.70e-01 9.64e-01 0.10400 9.96e-02 2.91e-02 6.26e-01 8.87e-01
GOBP BROWN FAT CELL DIFFERENTIATION 53 4.65e-01 8.14e-01 0.10400 -7.87e-02 6.76e-02 3.22e-01 3.94e-01
HS-GAG biosynthesis 28 6.62e-01 8.97e-01 0.10400 -9.16e-02 4.86e-02 4.01e-01 6.56e-01
GOBP REGULATION OF VIRAL TRANSCRIPTION 18 7.20e-01 9.16e-01 0.10400 -7.73e-02 -6.92e-02 5.70e-01 6.11e-01
GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS 15 8.05e-01 9.48e-01 0.10400 7.50e-02 -7.16e-02 6.15e-01 6.31e-01
GOBP NEGATIVE REGULATION OF RNA SPLICING 24 6.45e-01 8.91e-01 0.10400 -7.74e-02 -6.90e-02 5.11e-01 5.59e-01
Norepinephrine Neurotransmitter Release Cycle 17 7.61e-01 9.32e-01 0.10400 -6.59e-03 1.03e-01 9.62e-01 4.60e-01
GOBP RESPONSE TO AMYLOID BETA 55 4.13e-01 7.85e-01 0.10400 -1.03e-01 6.36e-03 1.84e-01 9.35e-01
GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE 15 7.67e-01 9.34e-01 0.10400 3.98e-02 9.57e-02 7.90e-01 5.21e-01
GOBP CELL SUBSTRATE ADHESION 346 6.02e-03 1.12e-01 0.10400 -9.62e-02 3.85e-02 2.10e-03 2.18e-01
Transmission across Chemical Synapses 255 2.59e-02 2.55e-01 0.10400 -8.32e-02 6.18e-02 2.22e-02 8.95e-02
GOBP RESPONSE TO CORTICOSTEROID 152 8.09e-02 4.21e-01 0.10400 -9.05e-03 -1.03e-01 8.47e-01 2.81e-02
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION 190 3.23e-02 2.81e-01 0.10400 -7.80e-02 -6.82e-02 6.37e-02 1.05e-01
GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE 30 6.15e-01 8.80e-01 0.10400 1.04e-01 -3.14e-03 3.26e-01 9.76e-01
GOBP REGULATION OF MACROPHAGE CHEMOTAXIS 28 6.09e-01 8.77e-01 0.10400 -9.50e-02 -4.11e-02 3.84e-01 7.06e-01
GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 94 2.24e-01 6.42e-01 0.10400 8.13e-03 -1.03e-01 8.92e-01 8.37e-02
GOBP COLLAGEN CATABOLIC PROCESS 44 4.69e-01 8.14e-01 0.10400 2.67e-02 1.00e-01 7.59e-01 2.51e-01
GOCC OXIDOREDUCTASE COMPLEX 104 1.69e-01 5.70e-01 0.10400 -2.46e-02 -1.01e-01 6.65e-01 7.63e-02
GOCC NUCLEAR PROTEIN CONTAINING COMPLEX 1191 1.22e-09 2.62e-07 0.10400 -7.71e-02 -6.90e-02 7.29e-06 5.97e-05
GOBP RETINA LAYER FORMATION 23 7.12e-01 9.14e-01 0.10400 -9.29e-02 4.56e-02 4.40e-01 7.05e-01
Signaling by TGFB family members 157 7.27e-02 4.04e-01 0.10400 -1.03e-01 -1.43e-02 2.66e-02 7.58e-01
GOBP COMMON BILE DUCT DEVELOPMENT 5 9.14e-01 9.78e-01 0.10300 -5.16e-02 -8.97e-02 8.42e-01 7.28e-01
GOBP GLIOGENESIS 338 6.47e-03 1.17e-01 0.10300 -9.84e-02 3.17e-02 1.87e-03 3.16e-01
GRB2 events in ERBB2 signaling 16 7.95e-01 9.44e-01 0.10300 6.98e-02 -7.63e-02 6.29e-01 5.97e-01
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) 15 7.69e-01 9.35e-01 0.10300 3.69e-02 9.66e-02 8.05e-01 5.17e-01
GOBP FATTY ACID TRANSMEMBRANE TRANSPORT 19 7.12e-01 9.14e-01 0.10300 -9.01e-02 -5.07e-02 4.97e-01 7.02e-01
GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION 8 8.66e-01 9.62e-01 0.10300 5.67e-02 8.64e-02 7.81e-01 6.72e-01
Cholesterol biosynthesis 25 6.97e-01 9.11e-01 0.10300 -8.46e-02 5.93e-02 4.64e-01 6.08e-01
GOBP NEGATIVE REGULATION OF HORMONE SECRETION 66 3.56e-01 7.49e-01 0.10300 -1.02e-01 1.48e-02 1.51e-01 8.35e-01
GOMF MRF BINDING 5 9.26e-01 9.82e-01 0.10300 -1.01e-01 2.31e-02 6.97e-01 9.29e-01
GOBP REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY 9 8.54e-01 9.59e-01 0.10300 9.60e-02 3.79e-02 6.18e-01 8.44e-01
GOBP NEURAL TUBE DEVELOPMENT 156 8.14e-02 4.23e-01 0.10300 -1.03e-01 6.48e-06 2.61e-02 1.00e+00
GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS 47 5.12e-01 8.35e-01 0.10300 -7.49e-02 7.10e-02 3.75e-01 4.00e-01
GOBP SYNAPTIC VESICLE UNCOATING 7 9.04e-01 9.75e-01 0.10300 -5.50e-02 8.73e-02 8.01e-01 6.89e-01
GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 26 6.54e-01 8.93e-01 0.10300 -1.03e-01 -4.97e-03 3.63e-01 9.65e-01
GOBP RECEPTOR DIFFUSION TRAPPING 10 8.40e-01 9.56e-01 0.10300 -9.67e-02 -3.58e-02 5.97e-01 8.44e-01
GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS 38 5.61e-01 8.57e-01 0.10300 9.99e-02 -2.53e-02 2.86e-01 7.88e-01
GOCC WEIBEL PALADE BODY 5 9.14e-01 9.78e-01 0.10300 -7.72e-02 -6.82e-02 7.65e-01 7.92e-01
GOBP BIOLOGICAL PHASE 11 8.32e-01 9.54e-01 0.10300 -1.62e-02 -1.02e-01 9.26e-01 5.59e-01
GOCC CILIARY BASE 45 5.26e-01 8.42e-01 0.10300 -8.16e-02 6.29e-02 3.44e-01 4.66e-01
GOMF CLATHRIN LIGHT CHAIN BINDING 7 8.84e-01 9.69e-01 0.10300 4.77e-02 9.13e-02 8.27e-01 6.76e-01
GOBP DORSAL AORTA DEVELOPMENT 10 8.62e-01 9.61e-01 0.10300 -3.63e-02 9.63e-02 8.43e-01 5.98e-01
GOCC FILOPODIUM MEMBRANE 17 7.78e-01 9.39e-01 0.10300 9.46e-02 -4.07e-02 5.00e-01 7.72e-01
Signaling by PDGFRA extracellular domain mutants 12 8.11e-01 9.49e-01 0.10300 -3.96e-02 -9.50e-02 8.12e-01 5.69e-01
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants 12 8.11e-01 9.49e-01 0.10300 -3.96e-02 -9.50e-02 8.12e-01 5.69e-01
GOMF PHOSPHOLIPID BINDING 463 1.53e-03 4.49e-02 0.10300 -6.17e-02 8.24e-02 2.30e-02 2.38e-03
GOBP POSITIVE REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY 8 8.90e-01 9.71e-01 0.10300 4.46e-02 -9.27e-02 8.27e-01 6.50e-01
GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 20 7.36e-01 9.23e-01 0.10300 -2.07e-02 1.01e-01 8.73e-01 4.35e-01
Oncogenic MAPK signaling 78 3.00e-01 7.11e-01 0.10300 -1.01e-01 1.68e-02 1.21e-01 7.98e-01
GOBP VOCALIZATION BEHAVIOR 15 7.92e-01 9.42e-01 0.10300 -1.02e-01 1.43e-02 4.95e-01 9.24e-01
GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION 51 4.31e-01 7.95e-01 0.10300 -1.02e-01 -1.26e-02 2.07e-01 8.76e-01
GOBP HEART MORPHOGENESIS 267 1.58e-02 2.00e-01 0.10300 -1.02e-01 9.83e-03 3.99e-03 7.82e-01
Mitotic G1 phase and G1/S transition 136 1.04e-01 4.70e-01 0.10300 -1.88e-02 -1.01e-01 7.05e-01 4.18e-02
GOCC NUCLEAR PORE 90 2.12e-01 6.29e-01 0.10300 -3.56e-02 -9.64e-02 5.60e-01 1.14e-01
GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT 128 1.12e-01 4.84e-01 0.10300 -9.76e-02 -3.23e-02 5.66e-02 5.28e-01
GOMF NUCLEOSIDE KINASE ACTIVITY 9 8.52e-01 9.59e-01 0.10300 -8.73e-02 -5.43e-02 6.50e-01 7.78e-01
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 168 6.26e-02 3.77e-01 0.10300 -1.02e-01 -1.55e-02 2.31e-02 7.29e-01
GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY 6 9.16e-01 9.79e-01 0.10300 -9.40e-02 4.14e-02 6.90e-01 8.60e-01
GOCC U7 SNRNP 7 9.03e-01 9.75e-01 0.10300 4.22e-02 -9.37e-02 8.47e-01 6.68e-01
GOBP NEGATIVE REGULATION OF LIPOPROTEIN METABOLIC PROCESS 5 9.16e-01 9.79e-01 0.10300 -9.36e-02 -4.24e-02 7.17e-01 8.70e-01
GOBP REGULATION OF LIGASE ACTIVITY 7 8.82e-01 9.68e-01 0.10300 7.52e-02 6.99e-02 7.30e-01 7.49e-01
GOMF LIPOPOLYSACCHARIDE BINDING 39 4.99e-01 8.30e-01 0.10300 -6.25e-02 -8.15e-02 4.99e-01 3.78e-01
GOBP POSITIVE REGULATION OF PROTEIN BINDING 49 4.32e-01 7.96e-01 0.10300 -9.77e-02 -3.17e-02 2.37e-01 7.01e-01
ABC-family proteins mediated transport 87 2.38e-01 6.55e-01 0.10300 -1.40e-02 -1.02e-01 8.21e-01 1.01e-01
GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS 21 6.96e-01 9.11e-01 0.10300 -3.55e-02 -9.63e-02 7.79e-01 4.45e-01
GOBP CARDIAC CHAMBER MORPHOGENESIS 128 1.37e-01 5.26e-01 0.10300 -1.02e-01 1.05e-02 4.61e-02 8.37e-01
GOMF DNA REPLICATION ORIGIN BINDING 15 7.70e-01 9.35e-01 0.10300 -9.34e-02 -4.25e-02 5.31e-01 7.76e-01
GOBP RESPONSE TO NUTRIENT 157 7.00e-02 3.97e-01 0.10300 -9.82e-02 -2.98e-02 3.37e-02 5.20e-01
NFE2L2 regulating anti-oxidant/detoxification enzymes 19 7.18e-01 9.15e-01 0.10300 9.24e-02 4.46e-02 4.86e-01 7.36e-01
GOMF DNA POLYMERASE ACTIVITY 28 6.36e-01 8.86e-01 0.10300 -1.02e-01 -5.41e-03 3.48e-01 9.61e-01
Gap junction assembly 35 5.36e-01 8.47e-01 0.10300 6.69e-02 7.78e-02 4.94e-01 4.26e-01
GOBP METHIONINE BIOSYNTHETIC PROCESS 12 8.16e-01 9.51e-01 0.10300 -2.76e-02 -9.88e-02 8.68e-01 5.54e-01
GOBP EXOCRINE SYSTEM DEVELOPMENT 48 4.42e-01 8.00e-01 0.10300 -9.83e-02 -2.93e-02 2.39e-01 7.26e-01
GOBP PIGMENT CELL DIFFERENTIATION 35 5.55e-01 8.55e-01 0.10300 -2.42e-02 -9.96e-02 8.04e-01 3.08e-01
GOBP POSITIVE REGULATION OF ANOIKIS 5 9.31e-01 9.83e-01 0.10300 -8.77e-02 5.31e-02 7.34e-01 8.37e-01
GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN 13 8.20e-01 9.52e-01 0.10300 -1.00e-01 2.08e-02 5.31e-01 8.97e-01
GOCC DENDRITIC TREE 590 2.27e-04 1.08e-02 0.10300 -9.41e-02 4.08e-02 9.46e-05 9.07e-02
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 276 2.05e-02 2.29e-01 0.10200 -8.63e-02 5.54e-02 1.36e-02 1.13e-01
GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY 15 7.99e-01 9.45e-01 0.10200 2.81e-02 -9.86e-02 8.51e-01 5.09e-01
GOBP ADHERENS JUNCTION ORGANIZATION 57 4.40e-01 7.99e-01 0.10200 -9.11e-02 4.68e-02 2.34e-01 5.41e-01
GOBP ORGANELLE INHERITANCE 15 7.73e-01 9.36e-01 0.10200 3.48e-02 9.63e-02 8.15e-01 5.19e-01
GOBP INTERLEUKIN 8 PRODUCTION 97 2.22e-01 6.39e-01 0.10200 1.02e-01 -9.25e-03 8.28e-02 8.75e-01
Metabolism of carbohydrates 276 1.77e-02 2.12e-01 0.10200 -3.26e-02 9.70e-02 3.51e-01 5.55e-03
GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION 18 7.61e-01 9.32e-01 0.10200 -2.09e-02 1.00e-01 8.78e-01 4.62e-01
GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT 18 7.64e-01 9.33e-01 0.10200 -9.90e-02 2.57e-02 4.67e-01 8.50e-01
GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS 19 7.18e-01 9.15e-01 0.10200 -4.88e-02 -8.99e-02 7.12e-01 4.98e-01
GOBP SALIVARY GLAND DEVELOPMENT 36 5.66e-01 8.59e-01 0.10200 -1.02e-01 2.47e-03 2.88e-01 9.80e-01
GOBP B CELL APOPTOTIC PROCESS 25 6.95e-01 9.11e-01 0.10200 3.96e-02 -9.43e-02 7.32e-01 4.14e-01
Neuronal System 389 4.38e-03 9.19e-02 0.10200 -5.48e-02 8.63e-02 6.33e-02 3.48e-03
GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION 10 8.41e-01 9.56e-01 0.10200 4.11e-02 9.36e-02 8.22e-01 6.08e-01
GOBP RESPONSE TO TYPE I INTERFERON 84 2.95e-01 7.07e-01 0.10200 9.48e-02 -3.82e-02 1.33e-01 5.45e-01
Glycosphingolipid catabolism 33 6.06e-01 8.76e-01 0.10200 -1.01e-01 1.85e-02 3.18e-01 8.54e-01
GOBP ICOSANOID SECRETION 47 4.80e-01 8.21e-01 0.10200 5.80e-03 -1.02e-01 9.45e-01 2.26e-01
GOBP NUCLEAR TRANSPORT 317 4.15e-03 8.91e-02 0.10200 -5.37e-02 -8.70e-02 1.00e-01 7.76e-03
GOCC POLE PLASM 24 7.12e-01 9.14e-01 0.10200 -5.63e-02 8.52e-02 6.33e-01 4.70e-01
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT 96 2.24e-01 6.42e-01 0.10200 -1.02e-01 5.46e-03 8.43e-02 9.26e-01
GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 22 6.78e-01 9.04e-01 0.10200 -7.11e-02 -7.32e-02 5.64e-01 5.52e-01
GOMF ADENYLYLTRANSFERASE ACTIVITY 29 6.41e-01 8.89e-01 0.10200 -1.01e-01 1.40e-02 3.46e-01 8.96e-01
GOBP TRNA PROCESSING 131 1.18e-01 4.92e-01 0.10200 -1.71e-02 -1.01e-01 7.35e-01 4.69e-02
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 81 2.40e-01 6.55e-01 0.10200 6.93e-02 7.48e-02 2.81e-01 2.44e-01
GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS 7 9.06e-01 9.76e-01 0.10200 5.73e-02 -8.44e-02 7.93e-01 6.99e-01
GOMF METALLOENDOPEPTIDASE ACTIVITY 106 1.55e-01 5.51e-01 0.10200 7.02e-02 7.40e-02 2.12e-01 1.88e-01
GOBP SECRETORY GRANULE ORGANIZATION 66 3.97e-01 7.76e-01 0.10200 -8.15e-02 6.13e-02 2.52e-01 3.89e-01
GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 17 7.63e-01 9.32e-01 0.10200 -1.02e-01 -3.35e-03 4.67e-01 9.81e-01
GOCC ENDOCYTIC VESICLE LUMEN 23 6.75e-01 9.03e-01 0.10200 -9.44e-02 -3.86e-02 4.33e-01 7.49e-01
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION 9 8.81e-01 9.67e-01 0.10200 5.51e-02 -8.57e-02 7.75e-01 6.56e-01
GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION MICROTUBULE MEDIATED 24 6.55e-01 8.93e-01 0.10200 -7.76e-02 -6.60e-02 5.10e-01 5.75e-01
GOMF SPHINGOLIPID BINDING 28 6.77e-01 9.04e-01 0.10200 -7.15e-02 7.27e-02 5.13e-01 5.06e-01
Interconversion of nucleotide di- and triphosphates 29 6.01e-01 8.75e-01 0.10200 6.02e-02 8.22e-02 5.74e-01 4.44e-01
GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE 213 5.26e-02 3.47e-01 0.10200 -7.89e-02 6.45e-02 4.73e-02 1.05e-01
GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS 123 1.20e-01 4.98e-01 0.10200 4.83e-02 8.97e-02 3.55e-01 8.58e-02
GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 25 7.06e-01 9.13e-01 0.10200 7.30e-02 -7.11e-02 5.28e-01 5.38e-01
GOMF ADRENERGIC RECEPTOR BINDING 18 7.56e-01 9.30e-01 0.10200 -1.02e-01 6.09e-03 4.55e-01 9.64e-01
Advanced glycosylation endproduct receptor signaling 13 8.22e-01 9.52e-01 0.10200 -1.97e-02 9.98e-02 9.02e-01 5.33e-01
GOCC PRESYNAPSE 547 3.62e-04 1.51e-02 0.10200 -9.85e-02 2.54e-02 8.08e-05 3.10e-01
GOBP NEUROTRANSMITTER TRANSPORT 200 6.09e-02 3.73e-01 0.10200 -5.18e-02 8.75e-02 2.06e-01 3.28e-02
GOCC GRANULAR COMPONENT 7 9.06e-01 9.76e-01 0.10200 5.17e-02 -8.76e-02 8.13e-01 6.88e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 212 3.03e-02 2.73e-01 0.10200 -9.82e-02 -2.64e-02 1.37e-02 5.07e-01
GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 40 4.98e-01 8.29e-01 0.10200 -6.12e-02 -8.12e-02 5.03e-01 3.74e-01
GOBP REGULATION OF TUBE SIZE 148 1.05e-01 4.72e-01 0.10200 -1.01e-01 1.05e-02 3.38e-02 8.26e-01
GOBP METHIONINE METABOLIC PROCESS 15 7.86e-01 9.41e-01 0.10200 -1.02e-02 -1.01e-01 9.46e-01 4.98e-01
GOBP SENSORY ORGAN MORPHOGENESIS 274 2.02e-02 2.28e-01 0.10200 -9.43e-02 3.79e-02 7.24e-03 2.81e-01
MTOR signalling 40 5.30e-01 8.43e-01 0.10200 -1.01e-01 -6.09e-03 2.67e-01 9.47e-01
GOCC SYNAPTIC MEMBRANE 375 5.18e-03 1.02e-01 0.10200 -9.22e-02 4.25e-02 2.17e-03 1.57e-01
GOBP POSITIVE REGULATION OF T CELL MIGRATION 33 6.31e-01 8.86e-01 0.10100 5.70e-02 -8.40e-02 5.71e-01 4.04e-01
GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY 17 7.76e-01 9.38e-01 0.10100 -2.12e-02 9.92e-02 8.80e-01 4.79e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 46 4.81e-01 8.21e-01 0.10100 -1.01e-01 -7.94e-03 2.35e-01 9.26e-01
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL 99 1.80e-01 5.84e-01 0.10100 -8.34e-02 -5.78e-02 1.52e-01 3.20e-01
GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT 68 3.88e-01 7.70e-01 0.10100 -8.49e-02 5.54e-02 2.26e-01 4.29e-01
GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 14 8.08e-01 9.49e-01 0.10100 -1.01e-01 1.13e-02 5.14e-01 9.42e-01
NCAM signaling for neurite out-growth 62 3.54e-01 7.47e-01 0.10100 3.44e-02 9.54e-02 6.40e-01 1.94e-01
GOMF TRANSCRIPTION COREGULATOR ACTIVITY 467 5.35e-04 2.00e-02 0.10100 -9.86e-02 -2.38e-02 2.62e-04 3.79e-01
Host Interactions of HIV factors 115 1.45e-01 5.38e-01 0.10100 -3.64e-02 -9.46e-02 5.00e-01 7.97e-02
GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE 26 6.80e-01 9.04e-01 0.10100 9.89e-02 -2.23e-02 3.83e-01 8.44e-01
GOBP NEPHRON EPITHELIUM DEVELOPMENT 118 1.59e-01 5.57e-01 0.10100 -1.01e-01 -7.16e-04 5.73e-02 9.89e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 36 5.41e-01 8.50e-01 0.10100 -4.58e-02 -9.03e-02 6.34e-01 3.48e-01
Signaling by WNT in cancer 32 6.35e-01 8.86e-01 0.10100 -9.24e-02 4.15e-02 3.66e-01 6.85e-01
GOBP MITOTIC SISTER CHROMATID SEPARATION 62 3.47e-01 7.44e-01 0.10100 -8.92e-02 -4.79e-02 2.24e-01 5.14e-01
GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 56 4.61e-01 8.11e-01 0.10100 -8.28e-02 5.84e-02 2.84e-01 4.50e-01
GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY 10 8.48e-01 9.58e-01 0.10100 -2.70e-02 -9.76e-02 8.82e-01 5.93e-01
GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 42 5.00e-01 8.30e-01 0.10100 2.76e-02 9.74e-02 7.57e-01 2.75e-01
GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY 5 9.26e-01 9.82e-01 0.10100 1.01e-01 -5.12e-03 6.95e-01 9.84e-01
GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS 34 5.86e-01 8.67e-01 0.10100 -1.01e-01 -3.52e-03 3.07e-01 9.72e-01
Activation of RAS in B cells 5 9.17e-01 9.79e-01 0.10100 -5.92e-02 -8.21e-02 8.19e-01 7.50e-01
M-decay: degradation of maternal mRNAs by maternally stored factors 45 4.67e-01 8.14e-01 0.10100 4.14e-02 9.24e-02 6.31e-01 2.84e-01
GOBP RENAL TUBULAR SECRETION 20 7.06e-01 9.13e-01 0.10100 -7.15e-02 -7.16e-02 5.80e-01 5.79e-01
GOBP REGULATION OF VESICLE FUSION 23 6.82e-01 9.06e-01 0.10100 9.59e-02 3.21e-02 4.26e-01 7.90e-01
Unwinding of DNA 12 8.40e-01 9.56e-01 0.10100 9.63e-02 -3.09e-02 5.64e-01 8.53e-01
GOBP LIPID DIGESTION 21 7.19e-01 9.16e-01 0.10100 4.73e-03 1.01e-01 9.70e-01 4.23e-01
GOMF DEUBIQUITINASE ACTIVITY 88 2.37e-01 6.54e-01 0.10100 -9.81e-02 -2.44e-02 1.12e-01 6.92e-01
GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 119 1.97e-01 6.08e-01 0.10100 6.70e-02 -7.57e-02 2.07e-01 1.54e-01
GOBP MANNOSYLATION 25 7.04e-01 9.13e-01 0.10100 -4.76e-02 8.92e-02 6.80e-01 4.40e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR 50 4.28e-01 7.94e-01 0.10100 -4.62e-02 -9.00e-02 5.72e-01 2.71e-01
GOBP EPITHELIAL TUBE FORMATION 134 1.06e-01 4.74e-01 0.10100 -9.29e-02 -3.98e-02 6.33e-02 4.27e-01
GOCC SMOOTH ENDOPLASMIC RETICULUM 28 6.81e-01 9.05e-01 0.10100 6.49e-02 -7.74e-02 5.52e-01 4.78e-01
GOBP COPPER ION HOMEOSTASIS 18 7.81e-01 9.40e-01 0.10100 -6.15e-02 8.02e-02 6.52e-01 5.56e-01
GOBP ADHERENS JUNCTION MAINTENANCE 7 8.89e-01 9.71e-01 0.10100 9.41e-02 3.67e-02 6.66e-01 8.67e-01
Arachidonate metabolism 57 4.47e-01 8.03e-01 0.10100 4.09e-02 -9.23e-02 5.93e-01 2.28e-01
G1/S Transition 118 1.56e-01 5.52e-01 0.10100 -8.39e-03 -1.01e-01 8.75e-01 5.90e-02
GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION 40 5.78e-01 8.64e-01 0.10100 6.25e-02 -7.93e-02 4.94e-01 3.86e-01
N-glycan trimming and elongation in the cis-Golgi 5 9.32e-01 9.83e-01 0.10100 9.01e-02 -4.55e-02 7.27e-01 8.60e-01
GOBP NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS 12 8.14e-01 9.50e-01 0.10100 8.55e-02 5.36e-02 6.08e-01 7.48e-01
Platelet activation, signaling and aggregation 249 1.76e-02 2.11e-01 0.10100 -9.74e-02 -2.63e-02 8.12e-03 4.75e-01
GOBP MALE GENITALIA DEVELOPMENT 23 6.74e-01 9.03e-01 0.10100 -8.26e-02 -5.79e-02 4.93e-01 6.30e-01
GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 132 1.65e-01 5.65e-01 0.10100 5.86e-02 -8.20e-02 2.45e-01 1.04e-01
Carboxyterminal post-translational modifications of tubulin 43 5.55e-01 8.55e-01 0.10100 8.05e-02 -6.07e-02 3.61e-01 4.91e-01
GOBP ADULT HEART DEVELOPMENT 14 8.26e-01 9.52e-01 0.10100 -7.38e-02 6.87e-02 6.33e-01 6.56e-01
GOBP REGULATION OF GLIOGENESIS 108 2.29e-01 6.47e-01 0.10100 -8.17e-02 5.89e-02 1.42e-01 2.90e-01
GOBP RETINAL CONE CELL DIFFERENTIATION 13 8.00e-01 9.46e-01 0.10100 7.67e-02 6.53e-02 6.32e-01 6.84e-01
GOBP RESPONSE TO ACTIVITY 77 3.19e-01 7.27e-01 0.10100 -9.95e-02 1.52e-02 1.31e-01 8.17e-01
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation 10 8.71e-01 9.64e-01 0.10100 5.00e-02 -8.73e-02 7.84e-01 6.33e-01
GOBP AMINO SUGAR BIOSYNTHETIC PROCESS 11 8.60e-01 9.60e-01 0.10100 -8.30e-02 5.68e-02 6.33e-01 7.44e-01
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation 95 2.02e-01 6.16e-01 0.10100 -4.82e-02 -8.83e-02 4.17e-01 1.37e-01
GOBP VIRAL TRANSCRIPTION 50 4.47e-01 8.03e-01 0.10100 -2.21e-02 -9.81e-02 7.87e-01 2.30e-01
GOBP PEPTIDYL LYSINE MONOMETHYLATION 9 8.80e-01 9.67e-01 0.10100 -9.50e-02 3.28e-02 6.21e-01 8.65e-01
GOBP TORC2 SIGNALING 11 8.54e-01 9.59e-01 0.10100 -2.95e-02 9.61e-02 8.66e-01 5.81e-01
RHOA GTPase cycle 140 1.48e-01 5.43e-01 0.10100 -8.40e-02 5.52e-02 8.61e-02 2.60e-01
FCERI mediated NF-kB activation 66 3.26e-01 7.30e-01 0.10000 -8.34e-02 -5.60e-02 2.41e-01 4.31e-01
Aggrephagy 40 5.50e-01 8.53e-01 0.10000 9.99e-02 -1.04e-02 2.74e-01 9.10e-01
GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION 22 7.11e-01 9.14e-01 0.10000 4.81e-03 1.00e-01 9.69e-01 4.15e-01
GOBP MATERNAL PLACENTA DEVELOPMENT 33 5.70e-01 8.60e-01 0.10000 -7.98e-02 -6.09e-02 4.27e-01 5.45e-01
GOCC PIGMENT GRANULE 109 2.02e-01 6.16e-01 0.10000 -1.63e-02 9.91e-02 7.68e-01 7.39e-02
GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 47 5.30e-01 8.43e-01 0.10000 -7.49e-02 6.68e-02 3.74e-01 4.28e-01
GOBP DEMETHYLATION 41 5.73e-01 8.61e-01 0.10000 -8.24e-02 5.72e-02 3.61e-01 5.26e-01
GOBP ODONTOGENESIS 129 1.61e-01 5.60e-01 0.10000 -9.53e-02 3.12e-02 6.17e-02 5.40e-01
GOCC CELL DIVISION SITE 71 3.82e-01 7.67e-01 0.10000 -8.16e-02 5.82e-02 2.34e-01 3.96e-01
Activation of BAD and translocation to mitochondria 15 7.90e-01 9.42e-01 0.10000 -1.32e-02 -9.94e-02 9.30e-01 5.05e-01
GOBP BILE ACID SECRETION 12 8.18e-01 9.52e-01 0.10000 4.61e-02 8.90e-02 7.82e-01 5.93e-01
GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION 9 8.58e-01 9.60e-01 0.10000 5.92e-02 8.09e-02 7.58e-01 6.74e-01
GOBP REGULATION OF PROTEIN STABILITY 308 6.88e-03 1.21e-01 0.10000 -3.32e-02 -9.45e-02 3.16e-01 4.32e-03
Signaling by FGFR4 40 5.56e-01 8.55e-01 0.10000 -9.90e-02 1.54e-02 2.79e-01 8.66e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION 111 2.25e-01 6.43e-01 0.10000 6.28e-02 -7.80e-02 2.53e-01 1.56e-01
GOBP REGULATION OF HEART RATE 100 2.48e-01 6.63e-01 0.10000 -9.27e-02 3.78e-02 1.09e-01 5.14e-01
GOMF LYASE ACTIVITY 191 7.59e-02 4.12e-01 0.10000 -5.41e-02 8.42e-02 1.97e-01 4.47e-02
GOBP ENDOPLASMIC RETICULUM ORGANIZATION 95 2.00e-01 6.12e-01 0.10000 -7.06e-02 -7.10e-02 2.34e-01 2.32e-01
GOMF NEUROPEPTIDE BINDING 30 6.48e-01 8.91e-01 0.10000 -9.78e-02 2.13e-02 3.54e-01 8.40e-01
GOCC TRANSCRIPTION REPRESSOR COMPLEX 75 2.81e-01 6.94e-01 0.10000 -7.85e-02 -6.20e-02 2.40e-01 3.53e-01
GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY 30 6.68e-01 8.99e-01 0.10000 -7.82e-02 6.24e-02 4.59e-01 5.54e-01
GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 302 1.23e-02 1.75e-01 0.10000 -9.92e-02 1.23e-02 3.01e-03 7.13e-01
GOBP CHONDROCYTE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS 8 8.77e-01 9.66e-01 0.10000 3.77e-02 9.26e-02 8.53e-01 6.50e-01
GOCC AXONEMAL DYNEIN COMPLEX 21 7.29e-01 9.21e-01 0.10000 -4.26e-03 9.99e-02 9.73e-01 4.28e-01
GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY 12 8.51e-01 9.58e-01 0.10000 7.21e-02 -6.93e-02 6.65e-01 6.78e-01
GOBP MEMBRANE DEPOLARIZATION 91 2.50e-01 6.65e-01 0.10000 -1.00e-01 -2.11e-03 9.93e-02 9.72e-01
Signal regulatory protein family interactions 15 7.88e-01 9.41e-01 0.10000 2.09e-02 9.78e-02 8.89e-01 5.12e-01
GOBP NEURON NEURON SYNAPTIC TRANSMISSION 8 8.84e-01 9.69e-01 0.09990 -7.22e-03 -9.97e-02 9.72e-01 6.25e-01
GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS 304 6.29e-03 1.15e-01 0.09990 -6.13e-02 -7.89e-02 6.59e-02 1.80e-02
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL 72 3.69e-01 7.58e-01 0.09990 3.91e-02 -9.19e-02 5.67e-01 1.78e-01
GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE 33 6.34e-01 8.86e-01 0.09980 9.09e-02 -4.12e-02 3.66e-01 6.82e-01
GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS 1158 1.62e-08 2.89e-06 0.09980 -9.33e-02 -3.56e-02 8.74e-08 4.13e-02
GOBP URETERIC BUD ELONGATION 8 8.99e-01 9.74e-01 0.09980 6.75e-02 -7.35e-02 7.41e-01 7.19e-01
GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 1235 6.15e-08 9.21e-06 0.09980 -9.63e-02 2.63e-02 1.25e-08 1.20e-01
GOBP NEUTROPHIL HOMEOSTASIS 19 7.26e-01 9.19e-01 0.09980 -6.54e-02 -7.53e-02 6.21e-01 5.70e-01
GOBP SISTER CHROMATID SEGREGATION 226 2.33e-02 2.44e-01 0.09970 -8.12e-02 -5.79e-02 3.54e-02 1.34e-01
GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION 10 8.57e-01 9.60e-01 0.09970 -9.93e-02 -8.63e-03 5.86e-01 9.62e-01
Receptor-type tyrosine-protein phosphatases 16 7.81e-01 9.40e-01 0.09970 9.93e-02 8.79e-03 4.92e-01 9.51e-01
GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS 76 2.79e-01 6.92e-01 0.09970 -7.58e-02 -6.48e-02 2.53e-01 3.29e-01
GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION 13 8.38e-01 9.55e-01 0.09970 4.85e-02 -8.71e-02 7.62e-01 5.87e-01
GOBP PROTEIN K48 LINKED DEUBIQUITINATION 24 6.75e-01 9.03e-01 0.09960 -3.99e-02 -9.13e-02 7.35e-01 4.39e-01
GOBP XENOBIOTIC EXPORT FROM CELL 26 6.52e-01 8.93e-01 0.09960 8.99e-02 4.28e-02 4.27e-01 7.05e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS 62 4.22e-01 7.90e-01 0.09960 3.33e-02 -9.39e-02 6.51e-01 2.01e-01
GOBP REGULATION OF DNA BINDING 72 3.50e-01 7.45e-01 0.09950 -9.87e-02 1.27e-02 1.47e-01 8.53e-01
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION 13 8.05e-01 9.48e-01 0.09950 5.35e-02 8.39e-02 7.38e-01 6.00e-01
GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION 5 9.29e-01 9.83e-01 0.09950 9.92e-02 -7.84e-03 7.01e-01 9.76e-01
GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS 68 3.20e-01 7.28e-01 0.09950 7.69e-02 6.32e-02 2.73e-01 3.67e-01
GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY 9 8.76e-01 9.66e-01 0.09950 9.92e-02 -7.89e-03 6.06e-01 9.67e-01
GOCC L TYPE VOLTAGE GATED CALCIUM CHANNEL COMPLEX 12 8.46e-01 9.58e-01 0.09950 -3.34e-02 9.37e-02 8.41e-01 5.74e-01
GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY 12 8.23e-01 9.52e-01 0.09950 3.59e-02 9.28e-02 8.30e-01 5.78e-01
GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY 6 9.21e-01 9.80e-01 0.09950 -9.15e-02 3.89e-02 6.98e-01 8.69e-01
GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX 10 8.66e-01 9.62e-01 0.09940 1.80e-02 -9.78e-02 9.21e-01 5.92e-01
GOBP REGULATION OF CYCLASE ACTIVITY 51 4.95e-01 8.28e-01 0.09940 -9.25e-02 3.64e-02 2.53e-01 6.53e-01
Defective B3GALTL causes PpS 37 5.65e-01 8.58e-01 0.09940 9.86e-02 1.22e-02 2.99e-01 8.98e-01
GOBP AMINOPHOSPHOLIPID TRANSPORT 8 8.99e-01 9.74e-01 0.09940 -8.13e-02 5.71e-02 6.90e-01 7.80e-01
GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 82 3.34e-01 7.35e-01 0.09930 8.45e-02 -5.23e-02 1.86e-01 4.13e-01
GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 33 5.75e-01 8.63e-01 0.09930 7.17e-02 6.88e-02 4.76e-01 4.94e-01
GOBP RESPONSE TO GLUCAGON 20 7.27e-01 9.20e-01 0.09930 -2.72e-02 -9.55e-02 8.33e-01 4.60e-01
GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION 29 6.24e-01 8.82e-01 0.09930 -9.10e-02 -3.99e-02 3.97e-01 7.10e-01
GOMF STEROID HORMONE BINDING 6 9.23e-01 9.81e-01 0.09930 6.04e-02 -7.88e-02 7.98e-01 7.38e-01
GOBP REGULATION OF AEROBIC RESPIRATION 30 6.47e-01 8.91e-01 0.09930 9.85e-02 -1.27e-02 3.51e-01 9.04e-01
GOCC RNA POLYMERASE II HOLOENZYME 67 3.29e-01 7.33e-01 0.09930 -8.24e-02 -5.54e-02 2.43e-01 4.33e-01
GOBP AUTOPHAGOSOME MEMBRANE DOCKING 7 9.10e-01 9.77e-01 0.09930 8.60e-02 -4.95e-02 6.93e-01 8.21e-01
GOBP MIDGUT DEVELOPMENT 11 8.65e-01 9.62e-01 0.09920 7.41e-02 -6.60e-02 6.71e-01 7.04e-01
GOBP RETINAL ROD CELL DIFFERENTIATION 16 8.08e-01 9.49e-01 0.09920 8.29e-02 -5.44e-02 5.66e-01 7.07e-01
GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION 44 5.21e-01 8.41e-01 0.09920 3.26e-03 -9.91e-02 9.70e-01 2.55e-01
RET signaling 41 5.79e-01 8.64e-01 0.09910 -8.36e-02 5.34e-02 3.55e-01 5.54e-01
Signaling by FGFR2 72 3.35e-01 7.35e-01 0.09910 -9.88e-02 -7.73e-03 1.47e-01 9.10e-01
GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION 90 2.68e-01 6.83e-01 0.09910 -9.89e-02 7.37e-03 1.05e-01 9.04e-01
GOBP MUSCLE CELL APOPTOTIC PROCESS 98 2.71e-01 6.85e-01 0.09910 -8.46e-02 5.16e-02 1.48e-01 3.77e-01
GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION 15 8.21e-01 9.52e-01 0.09910 6.66e-02 -7.33e-02 6.55e-01 6.23e-01
GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION 324 1.24e-02 1.76e-01 0.09900 -3.55e-02 9.24e-02 2.72e-01 4.23e-03
GOBP LYTIC VACUOLE ORGANIZATION 105 1.90e-01 5.96e-01 0.09900 -9.45e-02 -2.95e-02 9.43e-02 6.01e-01
GOBP METAPHASE CHROMOSOME ALIGNMENT 102 1.84e-01 5.89e-01 0.09900 -7.19e-02 -6.80e-02 2.10e-01 2.35e-01
GOBP REGULATION OF INTEGRIN ACTIVATION 17 7.97e-01 9.44e-01 0.09900 5.21e-02 -8.41e-02 7.10e-01 5.48e-01
Programmed Cell Death 190 7.15e-02 4.02e-01 0.09890 2.60e-02 -9.55e-02 5.36e-01 2.33e-02
GOBP TISSUE MORPHOGENESIS 604 1.65e-04 8.64e-03 0.09890 -9.89e-02 1.80e-03 3.28e-05 9.40e-01
GOMF ACTIN FILAMENT BINDING 203 5.43e-02 3.55e-01 0.09890 -1.16e-02 9.83e-02 7.77e-01 1.58e-02
GOBP CELLULAR SENESCENCE 107 1.76e-01 5.81e-01 0.09890 -4.60e-02 -8.76e-02 4.11e-01 1.17e-01
GOBP DNA RECOMBINATION 327 4.79e-03 9.66e-02 0.09890 -6.13e-02 -7.76e-02 5.66e-02 1.58e-02
GOBP REGULATION OF AXON EXTENSION 71 3.94e-01 7.74e-01 0.09890 -7.62e-02 6.30e-02 2.67e-01 3.58e-01
GOBP BEHAVIOR 636 1.17e-04 6.78e-03 0.09890 -9.87e-02 6.18e-03 2.15e-05 7.90e-01
GOBP GLIAL CELL DEVELOPMENT 131 1.79e-01 5.83e-01 0.09890 -7.97e-02 5.85e-02 1.15e-01 2.48e-01
GOBP CLUSTERING OF VOLTAGE GATED SODIUM CHANNELS 6 9.10e-01 9.77e-01 0.09890 9.56e-02 2.50e-02 6.85e-01 9.15e-01
GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY 34 5.92e-01 8.70e-01 0.09880 1.76e-02 9.72e-02 8.59e-01 3.27e-01
GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 153 8.35e-02 4.30e-01 0.09880 -8.57e-02 -4.91e-02 6.74e-02 2.94e-01
Sensory processing of sound by outer hair cells of the cochlea 50 5.00e-01 8.30e-01 0.09870 2.69e-02 -9.50e-02 7.42e-01 2.45e-01
GOBP PROSTAGLANDIN SECRETION 18 7.43e-01 9.26e-01 0.09870 -7.82e-02 -6.01e-02 5.65e-01 6.59e-01
GOMF ENDOPEPTIDASE ACTIVITY 373 2.39e-03 6.19e-02 0.09870 7.97e-02 5.82e-02 8.20e-03 5.38e-02
GOBP DNA CONFORMATION CHANGE 87 2.96e-01 7.08e-01 0.09860 -9.63e-02 2.15e-02 1.21e-01 7.28e-01
Pyruvate metabolism 46 4.69e-01 8.14e-01 0.09860 7.52e-02 6.38e-02 3.78e-01 4.54e-01
GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 179 8.35e-02 4.30e-01 0.09860 -9.57e-02 2.36e-02 2.71e-02 5.86e-01
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY 19 7.42e-01 9.26e-01 0.09860 -9.49e-02 -2.69e-02 4.74e-01 8.39e-01
GOBP MONOATOMIC ANION HOMEOSTASIS 20 7.69e-01 9.35e-01 0.09860 -8.03e-02 5.72e-02 5.34e-01 6.58e-01
GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 240 4.04e-02 3.08e-01 0.09850 -9.06e-02 3.86e-02 1.56e-02 3.02e-01
CD28 dependent PI3K/Akt signaling 27 7.03e-01 9.12e-01 0.09850 -6.02e-02 7.79e-02 5.88e-01 4.83e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 20 7.68e-01 9.34e-01 0.09850 4.99e-02 -8.49e-02 6.99e-01 5.11e-01
GOBP STEM CELL FATE SPECIFICATION 6 9.08e-01 9.77e-01 0.09840 -8.77e-02 -4.46e-02 7.10e-01 8.50e-01
GOMF ANTIPORTER ACTIVITY 128 1.24e-01 5.03e-01 0.09830 7.25e-02 6.64e-02 1.56e-01 1.94e-01
GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING 20 7.57e-01 9.31e-01 0.09830 2.22e-02 -9.58e-02 8.64e-01 4.58e-01
Nucleotide catabolism 35 6.28e-01 8.85e-01 0.09830 4.47e-02 -8.76e-02 6.47e-01 3.70e-01
Regulation of NFE2L2 gene expression 8 8.94e-01 9.73e-01 0.09830 -2.09e-02 9.61e-02 9.19e-01 6.38e-01
GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS 7 9.13e-01 9.78e-01 0.09830 7.87e-02 -5.90e-02 7.18e-01 7.87e-01
GOBP NEUROEPITHELIAL CELL DIFFERENTIATION 42 5.10e-01 8.34e-01 0.09830 -8.83e-02 -4.33e-02 3.22e-01 6.27e-01
GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING 40 5.38e-01 8.49e-01 0.09830 -2.40e-02 -9.53e-02 7.93e-01 2.97e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION 21 7.36e-01 9.23e-01 0.09830 1.59e-03 -9.82e-02 9.90e-01 4.36e-01
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY 26 7.12e-01 9.14e-01 0.09830 8.20e-02 -5.41e-02 4.69e-01 6.33e-01
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer 49 4.63e-01 8.12e-01 0.09820 -3.15e-02 -9.31e-02 7.03e-01 2.60e-01
GOMF WW DOMAIN BINDING 22 7.38e-01 9.24e-01 0.09820 2.43e-02 -9.52e-02 8.44e-01 4.40e-01
GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC 111 2.30e-01 6.48e-01 0.09820 -8.79e-02 4.37e-02 1.10e-01 4.26e-01
GOCC FICOLIN 1 RICH GRANULE MEMBRANE 59 4.67e-01 8.14e-01 0.09820 -6.62e-02 7.25e-02 3.79e-01 3.35e-01
Infection with Mycobacterium tuberculosis 25 7.12e-01 9.14e-01 0.09820 3.19e-02 -9.28e-02 7.83e-01 4.22e-01
GOMF N ACYLTRANSFERASE ACTIVITY 86 2.72e-01 6.85e-01 0.09810 -9.69e-02 -1.54e-02 1.20e-01 8.05e-01
Muscle contraction 196 6.71e-02 3.91e-01 0.09810 -2.09e-02 9.58e-02 6.14e-01 2.07e-02
GOCC MICROFIBRIL 13 8.45e-01 9.57e-01 0.09810 -6.34e-02 7.48e-02 6.92e-01 6.40e-01
GOBP LOCOMOTORY BEHAVIOR 200 6.24e-02 3.77e-01 0.09810 -9.63e-02 1.82e-02 1.88e-02 6.57e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT 110 2.44e-01 6.58e-01 0.09800 6.89e-02 -6.96e-02 2.12e-01 2.07e-01
Miscellaneous transport and binding events 24 7.01e-01 9.12e-01 0.09800 9.77e-02 7.17e-03 4.07e-01 9.52e-01
GOBP ALDITOL PHOSPHATE METABOLIC PROCESS 9 8.65e-01 9.62e-01 0.09800 4.81e-02 8.53e-02 8.03e-01 6.58e-01
GOMF FATZ BINDING 5 9.37e-01 9.85e-01 0.09790 -7.88e-02 5.82e-02 7.60e-01 8.22e-01
GOBP SYNCYTIUM FORMATION 64 3.59e-01 7.51e-01 0.09790 -8.54e-02 -4.80e-02 2.38e-01 5.07e-01
GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION 94 2.57e-01 6.71e-01 0.09790 -1.83e-03 9.79e-02 9.76e-01 1.01e-01
GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS 13 8.37e-01 9.55e-01 0.09790 -2.63e-02 9.43e-02 8.69e-01 5.56e-01
GOMF IMMUNOGLOBULIN RECEPTOR BINDING 10 8.56e-01 9.60e-01 0.09790 2.90e-02 9.35e-02 8.74e-01 6.09e-01
GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS 95 2.18e-01 6.36e-01 0.09780 -5.24e-02 -8.26e-02 3.77e-01 1.64e-01
GOBP VESTIBULOCOCHLEAR NERVE FORMATION 5 9.28e-01 9.82e-01 0.09780 9.71e-02 1.14e-02 7.07e-01 9.65e-01
GOBP REGULATION OF NERVOUS SYSTEM PROCESS 115 2.21e-01 6.39e-01 0.09780 -4.37e-02 8.75e-02 4.19e-01 1.05e-01
GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY 10 8.50e-01 9.58e-01 0.09780 6.23e-02 7.54e-02 7.33e-01 6.80e-01
GOCC DENSE BODY 5 9.37e-01 9.84e-01 0.09780 4.92e-02 -8.45e-02 8.49e-01 7.43e-01
GOBP CELL CYCLE G2 M PHASE TRANSITION 148 9.55e-02 4.51e-01 0.09780 -4.69e-02 -8.58e-02 3.25e-01 7.16e-02
GOBP FACULTATIVE HETEROCHROMATIN FORMATION 40 5.25e-01 8.42e-01 0.09770 -8.01e-02 -5.60e-02 3.81e-01 5.40e-01
RND3 GTPase cycle 41 5.62e-01 8.57e-01 0.09760 -1.16e-02 9.69e-02 8.97e-01 2.83e-01
Defective CHST6 causes MCDC1 8 8.80e-01 9.67e-01 0.09760 5.07e-02 8.34e-02 8.04e-01 6.83e-01
GOBP REGULATION OF CELLULAR RESPONSE TO STRESS 499 3.88e-04 1.59e-02 0.09760 -5.80e-02 -7.85e-02 2.67e-02 2.68e-03
GOBP POSITIVE REGULATION OF GENE EXPRESSION VIA CHROMOSOMAL CPG ISLAND DEMETHYLATION 14 8.01e-01 9.46e-01 0.09760 -8.66e-02 -4.50e-02 5.75e-01 7.71e-01
Regulation of pyruvate metabolism 31 6.33e-01 8.86e-01 0.09750 9.36e-03 9.71e-02 9.28e-01 3.49e-01
GOBP MEMBRANE HYPERPOLARIZATION 11 8.54e-01 9.59e-01 0.09750 -4.53e-03 9.74e-02 9.79e-01 5.76e-01
GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY 33 6.03e-01 8.76e-01 0.09750 2.64e-02 9.39e-02 7.93e-01 3.51e-01
GOMF VOLTAGE GATED CHANNEL ACTIVITY 168 7.69e-02 4.14e-01 0.09750 2.78e-02 9.34e-02 5.34e-01 3.66e-02
GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM 34 6.08e-01 8.77e-01 0.09750 -5.32e-03 -9.73e-02 9.57e-01 3.26e-01
GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION 20 7.73e-01 9.36e-01 0.09740 -5.23e-02 8.22e-02 6.86e-01 5.24e-01
GOBP FEMALE GAMETE GENERATION 162 1.15e-01 4.90e-01 0.09740 -9.25e-02 3.05e-02 4.21e-02 5.03e-01
GOBP MONOCYTE ACTIVATION 12 8.53e-01 9.59e-01 0.09740 -9.03e-02 3.65e-02 5.88e-01 8.27e-01
GOBP CELLULAR RESPONSE TO AMYLOID BETA 44 5.44e-01 8.51e-01 0.09740 -9.61e-02 1.63e-02 2.70e-01 8.52e-01
GOCC CALCIUM AND CALMODULIN DEPENDENT PROTEIN KINASE COMPLEX 5 9.23e-01 9.81e-01 0.09740 7.10e-02 6.67e-02 7.83e-01 7.96e-01
GOMF TRANSLATION ELONGATION FACTOR ACTIVITY 18 7.49e-01 9.28e-01 0.09740 -7.87e-02 -5.74e-02 5.63e-01 6.73e-01
Signaling by ERBB2 in Cancer 26 6.72e-01 9.01e-01 0.09740 -2.64e-02 -9.37e-02 8.16e-01 4.08e-01
GOBP VACUOLAR TRANSMEMBRANE TRANSPORT 8 8.96e-01 9.73e-01 0.09740 -9.54e-02 1.95e-02 6.40e-01 9.24e-01
GOBP CEREBRAL CORTEX TANGENTIAL MIGRATION 5 9.23e-01 9.81e-01 0.09740 5.90e-02 7.75e-02 8.19e-01 7.64e-01
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY 35 6.11e-01 8.78e-01 0.09740 -8.71e-03 9.70e-02 9.29e-01 3.21e-01
GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS 33 5.96e-01 8.72e-01 0.09730 4.03e-02 8.86e-02 6.89e-01 3.78e-01
Organic cation/anion/zwitterion transport 15 7.87e-01 9.41e-01 0.09730 5.45e-02 8.06e-02 7.15e-01 5.89e-01
GOBP SEGMENTATION 99 2.80e-01 6.92e-01 0.09730 -8.36e-02 4.98e-02 1.50e-01 3.92e-01
FOXO-mediated transcription of cell death genes 15 7.86e-01 9.41e-01 0.09730 -7.63e-02 -6.04e-02 6.09e-01 6.85e-01
GOBP VESICLE BUDDING FROM MEMBRANE 84 2.88e-01 7.01e-01 0.09730 -9.64e-02 -1.35e-02 1.27e-01 8.30e-01
GOBP SOMITOGENESIS 63 4.48e-01 8.04e-01 0.09730 -7.72e-02 5.92e-02 2.89e-01 4.16e-01
GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY VIA STAT 178 5.90e-02 3.69e-01 0.09730 5.93e-02 7.71e-02 1.73e-01 7.58e-02
Transport of Mature mRNAs Derived from Intronless Transcripts 43 5.18e-01 8.39e-01 0.09730 -9.31e-02 -2.82e-02 2.91e-01 7.49e-01
GOBP RNA STABILIZATION 68 3.79e-01 7.64e-01 0.09730 1.75e-03 -9.73e-02 9.80e-01 1.65e-01
GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING 27 6.56e-01 8.94e-01 0.09730 -3.80e-02 -8.95e-02 7.33e-01 4.21e-01
GOMF PROTEIN KINASE B BINDING 10 8.80e-01 9.67e-01 0.09720 8.06e-02 -5.43e-02 6.59e-01 7.66e-01
Selective autophagy 84 3.39e-01 7.39e-01 0.09720 4.85e-02 -8.42e-02 4.42e-01 1.82e-01
GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION 51 4.75e-01 8.18e-01 0.09720 -7.55e-03 -9.69e-02 9.26e-01 2.31e-01
GOBP AMINO ACID TRANSMEMBRANE TRANSPORT 96 2.96e-01 7.08e-01 0.09710 -5.72e-02 7.85e-02 3.33e-01 1.84e-01
STING mediated induction of host immune responses 16 8.09e-01 9.49e-01 0.09710 -3.29e-02 9.13e-02 8.20e-01 5.27e-01
GOBP STEM CELL PROLIFERATION 121 1.45e-01 5.38e-01 0.09710 -6.68e-02 -7.05e-02 2.04e-01 1.81e-01
GOBP LONG TERM SYNAPTIC POTENTIATION 105 2.19e-01 6.37e-01 0.09710 -9.70e-02 -5.14e-03 8.61e-02 9.28e-01
GOBP EPITHELIAL CELL CELL ADHESION 15 8.06e-01 9.48e-01 0.09710 4.41e-04 9.71e-02 9.98e-01 5.15e-01
GOBP URETER MORPHOGENESIS 7 8.95e-01 9.73e-01 0.09710 5.49e-02 8.00e-02 8.01e-01 7.14e-01
SLC transporter disorders 94 2.43e-01 6.58e-01 0.09700 2.29e-02 9.43e-02 7.01e-01 1.14e-01
GOCC FILOPODIUM 101 2.63e-01 6.78e-01 0.09700 -3.08e-02 9.20e-02 5.92e-01 1.10e-01
GOBP PROSTATE GLAND DEVELOPMENT 48 4.67e-01 8.14e-01 0.09700 -5.69e-02 -7.85e-02 4.95e-01 3.47e-01
GOBP GLYCINE TRANSPORT 14 8.27e-01 9.52e-01 0.09700 -2.00e-02 9.49e-02 8.97e-01 5.39e-01
GOBP REGULATION OF LIPID TRANSPORT 153 1.36e-01 5.25e-01 0.09690 -8.97e-02 3.67e-02 5.54e-02 4.34e-01
GOBP MITOTIC CYTOKINETIC PROCESS 31 6.12e-01 8.78e-01 0.09690 -5.55e-02 -7.94e-02 5.93e-01 4.44e-01
GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION 129 1.80e-01 5.84e-01 0.09690 -9.28e-02 2.79e-02 6.87e-02 5.85e-01
GOCC CHLORIDE CHANNEL COMPLEX 51 5.27e-01 8.42e-01 0.09690 -6.94e-02 6.76e-02 3.92e-01 4.03e-01
GOCC MISMATCH REPAIR COMPLEX 10 8.77e-01 9.67e-01 0.09690 -3.67e-02 8.97e-02 8.41e-01 6.23e-01
GOBP RESPONSE TO STEROID HORMONE 325 6.09e-03 1.13e-01 0.09680 -6.46e-02 -7.21e-02 4.51e-02 2.55e-02
Signaling by GPCR 674 2.67e-04 1.21e-02 0.09680 -7.21e-02 6.46e-02 1.41e-03 4.22e-03
GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT 99 2.17e-01 6.35e-01 0.09680 -3.99e-02 -8.81e-02 4.93e-01 1.30e-01
Triglyceride metabolism 35 6.10e-01 8.77e-01 0.09670 -2.42e-03 9.67e-02 9.80e-01 3.22e-01
GOBP REGULATION OF AXONOGENESIS 129 1.99e-01 6.12e-01 0.09670 -7.41e-02 6.22e-02 1.46e-01 2.23e-01
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 26 7.04e-01 9.13e-01 0.09670 -2.08e-02 9.44e-02 8.55e-01 4.04e-01
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS 47 5.09e-01 8.34e-01 0.09670 5.09e-03 9.66e-02 9.52e-01 2.52e-01
GOCC DNA DEPENDENT PROTEIN KINASE COMPLEX 5 9.24e-01 9.81e-01 0.09670 7.36e-02 6.27e-02 7.76e-01 8.08e-01
GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 73 3.95e-01 7.74e-01 0.09670 -4.85e-02 8.36e-02 4.74e-01 2.17e-01
GOBP INNATE IMMUNE RESPONSE 906 1.78e-05 1.34e-03 0.09670 7.59e-02 -5.98e-02 1.06e-04 2.27e-03
GOBP AXON DEVELOPMENT 489 1.97e-03 5.40e-02 0.09670 -8.92e-02 3.72e-02 7.27e-04 1.59e-01
GOBP INTERLEUKIN 18 PRODUCTION 14 8.02e-01 9.46e-01 0.09660 -7.88e-02 -5.60e-02 6.10e-01 7.17e-01
GOBP PROTEIN REPAIR 7 8.98e-01 9.73e-01 0.09660 -3.76e-02 -8.90e-02 8.63e-01 6.83e-01
GOBP LUNG CELL DIFFERENTIATION 29 6.57e-01 8.94e-01 0.09660 -8.51e-03 -9.62e-02 9.37e-01 3.70e-01
Diseases of glycosylation 139 1.14e-01 4.88e-01 0.09660 8.00e-02 5.41e-02 1.03e-01 2.71e-01
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE 15 8.16e-01 9.51e-01 0.09660 1.82e-02 -9.48e-02 9.03e-01 5.25e-01
GOCC CHECKPOINT CLAMP COMPLEX 5 9.24e-01 9.81e-01 0.09650 -6.87e-02 -6.78e-02 7.90e-01 7.93e-01
GOBP REGULATION OF EXTENT OF CELL GROWTH 87 3.29e-01 7.32e-01 0.09650 -8.63e-02 4.32e-02 1.64e-01 4.86e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 81 3.49e-01 7.45e-01 0.09650 -3.51e-02 8.99e-02 5.85e-01 1.62e-01
GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 26 7.17e-01 9.15e-01 0.09650 4.53e-02 -8.52e-02 6.90e-01 4.52e-01
GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS 11 8.54e-01 9.59e-01 0.09650 -9.63e-02 -5.70e-03 5.80e-01 9.74e-01
GOBP PROTEIN LOCALIZATION TO ORGANELLE 930 8.36e-07 9.25e-05 0.09650 -7.97e-02 -5.44e-02 3.80e-05 4.93e-03
GOBP RESPONSE TO TYPE II INTERFERON 115 1.98e-01 6.09e-01 0.09640 -7.98e-04 -9.64e-02 9.88e-01 7.40e-02
Gap junction trafficking 46 4.85e-01 8.23e-01 0.09640 5.92e-02 7.62e-02 4.88e-01 3.71e-01
GOBP OSTEOBLAST PROLIFERATION 36 6.26e-01 8.83e-01 0.09640 -9.02e-02 3.41e-02 3.49e-01 7.23e-01
GOMF HISTONE H3K9ME2 H3K9ME3 DEMETHYLASE ACTIVITY 5 9.33e-01 9.83e-01 0.09640 -9.62e-02 5.08e-03 7.09e-01 9.84e-01
GOBP IMP METABOLIC PROCESS 17 7.67e-01 9.34e-01 0.09640 8.07e-02 5.27e-02 5.65e-01 7.07e-01
GOBP RESPONSE TO MERCURY ION 10 8.54e-01 9.59e-01 0.09640 7.47e-02 6.09e-02 6.83e-01 7.39e-01
GOCC ACTIN CYTOSKELETON 503 2.17e-03 5.76e-02 0.09640 -7.22e-02 6.39e-02 5.59e-03 1.42e-02
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 57 4.90e-01 8.26e-01 0.09630 -7.89e-02 5.53e-02 3.03e-01 4.70e-01
GOMF GTPASE BINDING 298 2.34e-02 2.45e-01 0.09630 -8.59e-02 4.35e-02 1.07e-02 1.97e-01
GOBP POLYOL CATABOLIC PROCESS 9 8.71e-01 9.64e-01 0.09630 -4.18e-02 -8.67e-02 8.28e-01 6.52e-01
GOBP REGULATION OF I KAPPAB PHOSPHORYLATION 8 8.95e-01 9.73e-01 0.09630 -9.61e-02 5.92e-03 6.38e-01 9.77e-01
GOMF RNA CAP BINDING 19 7.59e-01 9.32e-01 0.09620 -9.54e-02 -1.24e-02 4.71e-01 9.25e-01
Mitotic Metaphase and Anaphase 214 3.67e-02 2.95e-01 0.09620 -5.18e-02 -8.11e-02 1.91e-01 4.09e-02
GOBP MALE MEIOTIC NUCLEAR DIVISION 54 4.80e-01 8.21e-01 0.09620 -9.54e-02 1.28e-02 2.25e-01 8.70e-01
GOBP HEPOXILIN METABOLIC PROCESS 8 8.90e-01 9.71e-01 0.09620 1.27e-02 9.54e-02 9.51e-01 6.40e-01
NCAM1 interactions 41 5.29e-01 8.43e-01 0.09620 5.27e-02 8.04e-02 5.59e-01 3.73e-01
Regulation of TP53 Expression and Degradation 37 5.72e-01 8.61e-01 0.09620 -9.03e-02 -3.32e-02 3.42e-01 7.27e-01
GOBP VESICLE UNCOATING 9 8.79e-01 9.67e-01 0.09620 7.41e-03 9.59e-02 9.69e-01 6.18e-01
Mitotic Anaphase 213 3.73e-02 2.96e-01 0.09620 -5.35e-02 -7.99e-02 1.78e-01 4.44e-02
GOBP REGULATION OF CELLULAR PH REDUCTION 7 9.11e-01 9.77e-01 0.09610 -9.40e-02 1.98e-02 6.67e-01 9.28e-01
GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT 28 7.05e-01 9.13e-01 0.09610 -5.42e-02 7.94e-02 6.20e-01 4.67e-01
GOMF RNA ENDONUCLEASE ACTIVITY 70 3.96e-01 7.75e-01 0.09610 -9.33e-02 2.28e-02 1.77e-01 7.42e-01
Transport of the SLBP Dependant Mature mRNA 36 5.69e-01 8.60e-01 0.09610 -6.66e-02 -6.92e-02 4.89e-01 4.72e-01
GOBP EAR MORPHOGENESIS 125 1.66e-01 5.66e-01 0.09610 -9.53e-02 -1.24e-02 6.59e-02 8.11e-01
GOBP REGULATION OF CAMP MEDIATED SIGNALING 21 7.36e-01 9.23e-01 0.09610 -1.64e-02 -9.47e-02 8.97e-01 4.53e-01
GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 157 9.87e-02 4.59e-01 0.09610 2.48e-02 9.28e-02 5.91e-01 4.48e-02
MyD88 dependent cascade initiated on endosome 96 2.33e-01 6.50e-01 0.09610 -3.80e-02 -8.82e-02 5.20e-01 1.35e-01
GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS 19 7.64e-01 9.33e-01 0.09610 9.59e-02 4.45e-03 4.69e-01 9.73e-01
GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION 41 5.27e-01 8.42e-01 0.09600 -6.40e-02 -7.16e-02 4.78e-01 4.28e-01
M Phase 354 4.34e-03 9.13e-02 0.09600 -5.94e-02 -7.54e-02 5.48e-02 1.48e-02
GOBP NEURON MATURATION 46 5.46e-01 8.51e-01 0.09600 -9.28e-02 2.45e-02 2.76e-01 7.74e-01
GOBP REGULATION OF LIPID CATABOLIC PROCESS 65 4.10e-01 7.84e-01 0.09590 -7.52e-03 9.56e-02 9.17e-01 1.82e-01
GOBP EMBRYO DEVELOPMENT 1097 3.37e-07 4.17e-05 0.09590 -9.55e-02 -8.77e-03 9.18e-08 6.24e-01
GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS 21 7.45e-01 9.26e-01 0.09580 -2.27e-03 -9.58e-02 9.86e-01 4.47e-01
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT 123 2.02e-01 6.16e-01 0.09580 -9.21e-02 2.63e-02 7.77e-02 6.14e-01
NOD1/2 Signaling Pathway 33 6.56e-01 8.94e-01 0.09580 3.67e-02 -8.84e-02 7.15e-01 3.79e-01
GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS 155 9.12e-02 4.43e-01 0.09570 -7.17e-02 -6.34e-02 1.23e-01 1.73e-01
GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI 14 8.25e-01 9.52e-01 0.09570 -9.56e-02 5.23e-03 5.36e-01 9.73e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM 7 9.13e-01 9.78e-01 0.09570 -2.86e-02 9.13e-02 8.96e-01 6.76e-01
GOBP EXTRACELLULAR VESICLE BIOGENESIS 25 7.05e-01 9.13e-01 0.09570 3.03e-03 9.56e-02 9.79e-01 4.08e-01
GOCC TERMINAL BOUTON 44 5.75e-01 8.63e-01 0.09570 -8.59e-02 4.22e-02 3.24e-01 6.28e-01
GOBP ISOPRENOID BIOSYNTHETIC PROCESS 29 6.86e-01 9.06e-01 0.09560 2.72e-02 -9.17e-02 8.00e-01 3.93e-01
GOBP ORGANIC HYDROXY COMPOUND TRANSPORT 280 3.34e-02 2.85e-01 0.09560 -6.23e-02 7.26e-02 7.29e-02 3.67e-02
GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS 37 6.35e-01 8.86e-01 0.09560 -7.46e-02 5.98e-02 4.32e-01 5.29e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE 20 7.50e-01 9.28e-01 0.09560 1.55e-02 9.44e-02 9.04e-01 4.65e-01
GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS 81 3.48e-01 7.44e-01 0.09560 2.51e-02 -9.22e-02 6.96e-01 1.51e-01
GOMF CALMODULIN BINDING 199 8.90e-02 4.38e-01 0.09560 -6.53e-02 6.98e-02 1.12e-01 8.95e-02
GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 166 7.75e-02 4.15e-01 0.09560 -7.11e-02 -6.38e-02 1.14e-01 1.56e-01
Gap junction trafficking and regulation 48 4.78e-01 8.20e-01 0.09560 5.34e-02 7.93e-02 5.22e-01 3.42e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 57 4.62e-01 8.12e-01 0.09560 9.52e-02 -8.63e-03 2.14e-01 9.10e-01
Calnexin/calreticulin cycle 26 7.23e-01 9.18e-01 0.09560 4.76e-02 -8.28e-02 6.74e-01 4.65e-01
GOBP TONGUE MORPHOGENESIS 10 8.57e-01 9.60e-01 0.09550 -7.49e-02 -5.93e-02 6.82e-01 7.45e-01
GOBP CELL REDOX HOMEOSTASIS 38 6.28e-01 8.85e-01 0.09550 6.85e-02 -6.65e-02 4.65e-01 4.78e-01
GOBP MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY 7 9.17e-01 9.79e-01 0.09550 -8.18e-02 4.93e-02 7.08e-01 8.21e-01
GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS 100 2.22e-01 6.40e-01 0.09540 4.11e-02 8.61e-02 4.78e-01 1.37e-01
GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 31 6.79e-01 9.04e-01 0.09540 -4.38e-02 8.47e-02 6.73e-01 4.14e-01
GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 42 5.99e-01 8.73e-01 0.09540 7.44e-02 -5.97e-02 4.04e-01 5.03e-01
Interleukin-4 and Interleukin-13 signaling 103 2.59e-01 6.73e-01 0.09530 1.99e-02 -9.32e-02 7.27e-01 1.02e-01
GOBP T HELPER 1 TYPE IMMUNE RESPONSE 48 5.46e-01 8.52e-01 0.09530 -8.73e-02 3.82e-02 2.95e-01 6.47e-01
GOMF CHEMOATTRACTANT ACTIVITY 34 6.61e-01 8.96e-01 0.09530 7.27e-02 -6.17e-02 4.63e-01 5.34e-01
GOCC RECYCLING ENDOSOME MEMBRANE 100 2.26e-01 6.45e-01 0.09530 3.51e-02 8.86e-02 5.44e-01 1.26e-01
GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS 26 7.17e-01 9.15e-01 0.09530 -2.99e-02 9.05e-02 7.92e-01 4.25e-01
Antiviral mechanism by IFN-stimulated genes 144 1.36e-01 5.24e-01 0.09530 -4.77e-03 -9.51e-02 9.21e-01 4.87e-02
GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY 27 7.19e-01 9.16e-01 0.09520 -5.78e-02 7.57e-02 6.03e-01 4.96e-01
GOBP 3 UTR MEDIATED MRNA STABILIZATION 21 7.35e-01 9.23e-01 0.09520 -9.11e-02 -2.76e-02 4.70e-01 8.26e-01
RAC3 GTPase cycle 85 3.03e-01 7.14e-01 0.09520 -9.48e-02 -8.58e-03 1.31e-01 8.91e-01
GOMF ARYLSULFATASE ACTIVITY 9 8.96e-01 9.73e-01 0.09520 -6.73e-02 6.73e-02 7.27e-01 7.26e-01
GOBP ACTIN NUCLEATION 56 4.74e-01 8.17e-01 0.09520 1.22e-02 -9.44e-02 8.75e-01 2.22e-01
GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 61 4.01e-01 7.78e-01 0.09520 -4.02e-02 -8.63e-02 5.87e-01 2.44e-01
GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY 19 7.90e-01 9.42e-01 0.09520 4.54e-02 -8.36e-02 7.32e-01 5.28e-01
GOCC BASEMENT MEMBRANE 87 3.35e-01 7.35e-01 0.09510 -3.67e-02 8.78e-02 5.54e-01 1.57e-01
GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION 6 9.24e-01 9.81e-01 0.09510 -9.32e-02 1.90e-02 6.93e-01 9.36e-01
Signaling by NTRK1 (TRKA) 113 1.83e-01 5.87e-01 0.09510 -8.36e-02 -4.52e-02 1.25e-01 4.06e-01
GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION 52 5.33e-01 8.45e-01 0.09510 -6.74e-02 6.70e-02 4.00e-01 4.03e-01
GOBP REGULATION OF GLIAL CELL DIFFERENTIATION 78 3.89e-01 7.70e-01 0.09500 -7.25e-02 6.15e-02 2.68e-01 3.48e-01
GOBP ZYMOGEN ACTIVATION 56 4.39e-01 7.99e-01 0.09500 3.09e-02 8.99e-02 6.89e-01 2.45e-01
GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS 111 2.04e-01 6.20e-01 0.09500 -9.30e-02 -1.95e-02 9.05e-02 7.23e-01
GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING 17 8.01e-01 9.46e-01 0.09500 1.89e-02 -9.31e-02 8.92e-01 5.06e-01
GOBP POSITIVE REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS 5 9.34e-01 9.84e-01 0.09500 -9.50e-02 2.36e-03 7.13e-01 9.93e-01
TRAF6 mediated NF-kB activation 24 6.98e-01 9.11e-01 0.09500 -8.51e-02 -4.20e-02 4.70e-01 7.21e-01
GOMF INTRACELLULARLY LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY 30 6.76e-01 9.04e-01 0.09500 -1.90e-02 9.30e-02 8.57e-01 3.78e-01
SUMO is proteolytically processed 6 9.18e-01 9.79e-01 0.09490 -9.38e-02 -1.44e-02 6.91e-01 9.51e-01
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 12 8.43e-01 9.57e-01 0.09490 -1.48e-02 -9.38e-02 9.29e-01 5.74e-01
GOBP RRNA PSEUDOURIDINE SYNTHESIS 7 9.11e-01 9.77e-01 0.09490 9.51e-03 -9.44e-02 9.65e-01 6.65e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY 11 8.74e-01 9.65e-01 0.09490 -5.18e-02 7.95e-02 7.66e-01 6.48e-01
GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX 13 8.20e-01 9.52e-01 0.09480 -5.71e-02 -7.58e-02 7.22e-01 6.36e-01
GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION 16 8.24e-01 9.52e-01 0.09480 -6.97e-02 6.43e-02 6.29e-01 6.56e-01
GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS 27 6.62e-01 8.97e-01 0.09480 6.35e-02 7.04e-02 5.68e-01 5.27e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DEVELOPMENT 6 9.30e-01 9.83e-01 0.09480 -6.41e-02 6.98e-02 7.86e-01 7.67e-01
HCMV Infection 123 1.70e-01 5.71e-01 0.09470 -2.51e-02 -9.14e-02 6.30e-01 8.01e-02
GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION 6 9.13e-01 9.78e-01 0.09470 6.82e-02 6.58e-02 7.72e-01 7.80e-01
GOBP REGULATION OF MUSCLE SYSTEM PROCESS 244 4.56e-02 3.25e-01 0.09470 -9.11e-02 2.59e-02 1.42e-02 4.86e-01
GOCC HISTONE DEACETYLASE COMPLEX 76 3.19e-01 7.26e-01 0.09470 -7.98e-02 -5.10e-02 2.29e-01 4.42e-01
GOBP REGULATION OF COLLAGEN METABOLIC PROCESS 41 6.10e-01 8.77e-01 0.09470 -5.92e-02 7.39e-02 5.12e-01 4.13e-01
SUMOylation of RNA binding proteins 47 5.39e-01 8.49e-01 0.09470 -9.37e-02 1.36e-02 2.66e-01 8.72e-01
GOBP LYMPHANGIOGENESIS 19 7.84e-01 9.41e-01 0.09470 -2.61e-02 9.10e-02 8.44e-01 4.92e-01
GOCC DENDRITIC SHAFT 40 6.17e-01 8.80e-01 0.09470 -7.53e-02 5.74e-02 4.10e-01 5.30e-01
GOBP STRESS GRANULE ASSEMBLY 32 6.16e-01 8.80e-01 0.09470 -7.48e-02 -5.80e-02 4.64e-01 5.70e-01
GOBP MALE MEIOSIS I 28 6.62e-01 8.97e-01 0.09460 -8.72e-02 -3.68e-02 4.24e-01 7.36e-01
RHO GTPases Activate NADPH Oxidases 21 7.28e-01 9.21e-01 0.09460 5.46e-02 7.73e-02 6.65e-01 5.40e-01
GOBP REGULATION OF INNATE IMMUNE RESPONSE 430 6.08e-03 1.13e-01 0.09460 7.72e-02 -5.47e-02 6.04e-03 5.18e-02
GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION 8 9.08e-01 9.77e-01 0.09460 -7.12e-02 6.23e-02 7.27e-01 7.60e-01
GOBP PRESYNAPSE ORGANIZATION 48 5.41e-01 8.50e-01 0.09460 -2.36e-02 9.16e-02 7.78e-01 2.72e-01
GOBP REGULATION OF CELL MORPHOGENESIS 231 6.30e-02 3.78e-01 0.09460 -7.70e-02 5.49e-02 4.37e-02 1.51e-01
G alpha (i) signalling events 304 2.73e-02 2.62e-01 0.09460 -6.41e-02 6.95e-02 5.47e-02 3.70e-02
GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS 9 8.93e-01 9.72e-01 0.09450 -8.86e-02 3.30e-02 6.45e-01 8.64e-01
GOBP ORGANOPHOSPHATE CATABOLIC PROCESS 229 3.31e-02 2.84e-01 0.09450 7.98e-02 5.06e-02 3.74e-02 1.87e-01
Cell Cycle 620 1.09e-04 6.49e-03 0.09450 -5.79e-02 -7.47e-02 1.39e-02 1.49e-03
GOBP POSITIVE REGULATION OF LIPID LOCALIZATION 111 2.00e-01 6.13e-01 0.09450 -8.91e-02 -3.13e-02 1.05e-01 5.68e-01
GOBP EYE MORPHOGENESIS 160 1.49e-01 5.44e-01 0.09440 -6.79e-02 6.56e-02 1.38e-01 1.52e-01
GOBP CELL JUNCTION ASSEMBLY 433 3.36e-03 7.89e-02 0.09440 -9.43e-02 4.32e-03 7.61e-04 8.78e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 221 7.27e-02 4.04e-01 0.09440 -7.12e-02 6.20e-02 6.80e-02 1.12e-01
GOBP DICARBOXYLIC ACID METABOLIC PROCESS 93 2.52e-01 6.68e-01 0.09440 4.41e-02 8.35e-02 4.63e-01 1.64e-01
GOCC PERINEURONAL NET 10 8.61e-01 9.61e-01 0.09440 5.29e-02 7.81e-02 7.72e-01 6.69e-01
Xenobiotics 23 7.34e-01 9.23e-01 0.09440 -2.64e-03 9.43e-02 9.82e-01 4.34e-01
GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION 872 3.01e-05 2.13e-03 0.09440 -8.74e-02 3.56e-02 1.19e-05 7.41e-02
GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS 303 2.67e-02 2.59e-01 0.09430 8.06e-02 -4.90e-02 1.58e-02 1.42e-01
GOBP OPTIC NERVE MORPHOGENESIS 6 9.26e-01 9.82e-01 0.09430 -2.26e-02 9.16e-02 9.24e-01 6.98e-01
Biosynthesis of maresins 8 9.09e-01 9.77e-01 0.09430 -7.09e-02 6.23e-02 7.29e-01 7.60e-01
GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY 45 5.40e-01 8.49e-01 0.09430 -9.41e-02 -5.48e-03 2.75e-01 9.49e-01
GOCC ZYMOGEN GRANULE 19 7.83e-01 9.40e-01 0.09430 9.25e-02 -1.84e-02 4.85e-01 8.90e-01
GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 24 7.49e-01 9.28e-01 0.09420 -7.94e-02 5.08e-02 5.01e-01 6.66e-01
GOCC PRESYNAPTIC MEMBRANE 161 1.45e-01 5.38e-01 0.09420 -7.95e-02 5.07e-02 8.19e-02 2.67e-01
GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 34 6.00e-01 8.74e-01 0.09420 7.01e-02 6.29e-02 4.80e-01 5.25e-01
GOMF CATALYTIC ACTIVITY ACTING ON RNA 389 3.16e-03 7.61e-02 0.09410 -6.49e-02 -6.82e-02 2.79e-02 2.10e-02
GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY 87 2.99e-01 7.10e-01 0.09410 1.38e-02 9.31e-02 8.23e-01 1.33e-01
GOBP NEURON CELLULAR HOMEOSTASIS 60 4.82e-01 8.22e-01 0.09410 -8.40e-02 4.24e-02 2.60e-01 5.70e-01
GOBP DETECTION OF OTHER ORGANISM 19 7.60e-01 9.32e-01 0.09410 8.92e-02 3.00e-02 5.01e-01 8.21e-01
GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE 33 6.11e-01 8.78e-01 0.09410 -5.49e-02 -7.65e-02 5.85e-01 4.47e-01
GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL 81 2.97e-01 7.09e-01 0.09410 6.20e-02 7.08e-02 3.35e-01 2.71e-01
Nuclear Envelope Breakdown 52 4.58e-01 8.10e-01 0.09410 -6.36e-02 -6.93e-02 4.27e-01 3.87e-01
GOMF THIOLESTER HYDROLASE ACTIVITY 40 6.22e-01 8.82e-01 0.09400 -6.99e-02 6.29e-02 4.44e-01 4.91e-01
GOBP MAMMARY GLAND MORPHOGENESIS 45 5.30e-01 8.43e-01 0.09400 -9.16e-02 -2.10e-02 2.87e-01 8.07e-01
GOBP EXCITATORY SYNAPSE ASSEMBLY 34 6.33e-01 8.86e-01 0.09400 6.61e-04 9.40e-02 9.95e-01 3.43e-01
GOBP RESPONSE TO ETHANOL 120 2.34e-01 6.50e-01 0.09400 -4.17e-02 8.42e-02 4.30e-01 1.11e-01
GOBP STEM CELL DIVISION 32 6.84e-01 9.06e-01 0.09400 -7.17e-02 6.08e-02 4.83e-01 5.52e-01
RUNX2 regulates bone development 29 7.10e-01 9.13e-01 0.09400 -6.55e-02 6.74e-02 5.42e-01 5.30e-01
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY 52 4.98e-01 8.30e-01 0.09400 9.40e-02 -2.64e-05 2.41e-01 1.00e+00
GOBP CELLULAR RESPONSE TO ANGIOTENSIN 34 6.68e-01 9.00e-01 0.09400 -7.12e-02 6.14e-02 4.73e-01 5.36e-01
GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS 20 7.79e-01 9.39e-01 0.09390 -2.95e-02 8.92e-02 8.19e-01 4.90e-01
GOBP CIRCADIAN RHYTHM 198 5.82e-02 3.66e-01 0.09390 -8.75e-02 -3.42e-02 3.38e-02 4.07e-01
GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE 52 4.61e-01 8.12e-01 0.09390 -5.42e-02 -7.67e-02 4.99e-01 3.39e-01
GOCC T TUBULE 52 5.25e-01 8.42e-01 0.09390 -8.83e-02 3.21e-02 2.71e-01 6.89e-01
GOBP B CELL ACTIVATION 261 4.42e-02 3.20e-01 0.09390 8.27e-02 -4.45e-02 2.15e-02 2.15e-01
GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT 332 1.30e-02 1.80e-01 0.09390 -9.38e-02 3.86e-03 3.31e-03 9.04e-01
GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY 27 6.68e-01 9.00e-01 0.09390 5.90e-02 7.30e-02 5.96e-01 5.12e-01
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE 76 3.60e-01 7.52e-01 0.09390 -9.38e-02 -2.35e-03 1.57e-01 9.72e-01
GOCC PCG PROTEIN COMPLEX 46 5.33e-01 8.45e-01 0.09380 -9.76e-03 -9.33e-02 9.09e-01 2.73e-01
GOMF N ACETYLGALACTOSAMINE 4 O SULFOTRANSFERASE ACTIVITY 5 9.38e-01 9.85e-01 0.09380 -9.21e-02 1.80e-02 7.21e-01 9.44e-01
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein 77 4.01e-01 7.78e-01 0.09380 -5.32e-02 7.73e-02 4.20e-01 2.41e-01
GOMF PDZ DOMAIN BINDING 85 3.66e-01 7.55e-01 0.09380 -7.59e-02 5.51e-02 2.26e-01 3.80e-01
GOBP ROUNDABOUT SIGNALING PATHWAY 5 9.37e-01 9.84e-01 0.09380 1.01e-02 -9.32e-02 9.69e-01 7.18e-01
GOBP TUBULIN DEACETYLATION 19 7.96e-01 9.44e-01 0.09380 -4.47e-02 8.24e-02 7.36e-01 5.34e-01
GOBP NUCLEOTIDE TRANSPORT 44 5.83e-01 8.66e-01 0.09380 -3.39e-02 8.74e-02 6.97e-01 3.16e-01
GOBP MRNA METABOLIC PROCESS 778 1.45e-05 1.13e-03 0.09370 -7.57e-02 -5.52e-02 3.31e-04 8.76e-03
GOMF PROTEIN RNA ADAPTOR ACTIVITY 19 7.97e-01 9.44e-01 0.09370 8.02e-02 -4.84e-02 5.45e-01 7.15e-01
GOBP RESPONSE TO ESTROGEN 67 4.55e-01 8.09e-01 0.09360 -7.28e-02 5.89e-02 3.03e-01 4.05e-01
GOBP OSTEOBLAST DIFFERENTIATION 254 3.80e-02 3.00e-01 0.09360 -9.32e-02 9.14e-03 1.06e-02 8.02e-01
GOBP GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY 15 8.35e-01 9.55e-01 0.09360 8.23e-02 -4.46e-02 5.81e-01 7.65e-01
GOMF SEMAPHORIN RECEPTOR BINDING 23 7.17e-01 9.15e-01 0.09360 3.90e-02 8.51e-02 7.46e-01 4.80e-01
GOBP CELLULAR RESPONSE TO OSMOTIC STRESS 53 4.76e-01 8.18e-01 0.09360 9.09e-02 2.21e-02 2.52e-01 7.80e-01
GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY 11 8.74e-01 9.65e-01 0.09360 -3.31e-02 8.75e-02 8.49e-01 6.15e-01
Diseases associated with glycosaminoglycan metabolism 38 6.40e-01 8.89e-01 0.09360 -6.76e-02 6.47e-02 4.71e-01 4.90e-01
GOBP REGULATION OF MRNA PROCESSING 121 1.68e-01 5.69e-01 0.09350 -7.35e-02 -5.79e-02 1.63e-01 2.72e-01
GOBP REGULATION OF PROTEIN MONOUBIQUITINATION 6 9.22e-01 9.80e-01 0.09350 9.46e-03 9.30e-02 9.68e-01 6.93e-01
Activation of RAC1 12 8.51e-01 9.58e-01 0.09350 3.51e-03 9.35e-02 9.83e-01 5.75e-01
Regulation of RAS by GAPs 54 4.55e-01 8.09e-01 0.09350 -4.52e-02 -8.18e-02 5.65e-01 2.98e-01
GOCC PLATELET ALPHA GRANULE LUMEN 60 4.16e-01 7.86e-01 0.09350 -4.72e-02 -8.07e-02 5.27e-01 2.80e-01
PPARA activates gene expression 113 2.49e-01 6.64e-01 0.09350 -8.86e-02 2.98e-02 1.04e-01 5.84e-01
GOMF PROTEIN SERINE KINASE ACTIVITY 342 1.89e-02 2.19e-01 0.09350 -7.50e-02 5.57e-02 1.71e-02 7.65e-02
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 171 1.17e-01 4.91e-01 0.09350 -9.14e-02 1.95e-02 3.92e-02 6.61e-01
GOBP NEGATIVE REGULATION OF SYNAPSE ORGANIZATION 11 8.56e-01 9.60e-01 0.09350 2.57e-02 8.99e-02 8.83e-01 6.06e-01
GOBP NOTCH SIGNALING PATHWAY 176 9.85e-02 4.58e-01 0.09340 -1.56e-04 9.34e-02 9.97e-01 3.25e-02
GOBP MISMATCH REPAIR 34 6.71e-01 9.01e-01 0.09340 -7.25e-02 5.90e-02 4.65e-01 5.52e-01
Interleukin-17 signaling 66 3.77e-01 7.64e-01 0.09340 -6.13e-02 -7.04e-02 3.89e-01 3.22e-01
GOBP NEUTRAL AMINO ACID TRANSPORT 54 4.84e-01 8.23e-01 0.09340 5.89e-03 9.32e-02 9.40e-01 2.36e-01
GOBP TRANSPORT OF VIRUS 21 7.66e-01 9.33e-01 0.09340 -9.18e-02 1.69e-02 4.66e-01 8.93e-01
SARS-CoV-2 activates/modulates innate and adaptive immune responses 118 2.13e-01 6.29e-01 0.09340 1.96e-03 -9.33e-02 9.71e-01 7.99e-02
GOBP RESPONSE TO CARBOHYDRATE 233 3.75e-02 2.97e-01 0.09340 -8.79e-02 -3.15e-02 2.08e-02 4.08e-01
GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE 13 8.26e-01 9.52e-01 0.09330 -7.61e-02 -5.40e-02 6.35e-01 7.36e-01
GOMF POTASSIUM CHANNEL ACTIVITY 123 1.66e-01 5.66e-01 0.09330 5.26e-02 7.70e-02 3.13e-01 1.40e-01
GOBP MUSCLE CONTRACTION 344 1.05e-02 1.58e-01 0.09330 -9.31e-02 -6.22e-03 3.01e-03 8.43e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS 7 9.10e-01 9.77e-01 0.09330 9.28e-02 9.73e-03 6.71e-01 9.64e-01
Cellular responses to stimuli 844 7.85e-06 6.65e-04 0.09330 -4.18e-02 -8.34e-02 3.91e-02 3.88e-05
GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE 12 8.61e-01 9.61e-01 0.09320 -9.05e-02 2.24e-02 5.87e-01 8.93e-01
GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL SIGNALING 9 8.76e-01 9.66e-01 0.09320 5.38e-02 7.61e-02 7.80e-01 6.92e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 106 2.43e-01 6.58e-01 0.09320 -9.30e-02 -6.43e-03 9.81e-02 9.09e-01
Signaling by NTRKs 132 1.47e-01 5.41e-01 0.09320 -7.87e-02 -4.99e-02 1.19e-01 3.22e-01
GOBP PARACRINE SIGNALING 7 9.22e-01 9.80e-01 0.09310 6.48e-02 -6.69e-02 7.66e-01 7.59e-01
GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING 99 2.74e-01 6.87e-01 0.09310 -9.31e-02 1.63e-03 1.09e-01 9.78e-01
GOBP EMBRYONIC ORGAN DEVELOPMENT 448 1.90e-03 5.25e-02 0.09310 -8.61e-02 -3.54e-02 1.78e-03 1.99e-01
GOBP NEGATIVE REGULATION OF LIPID STORAGE 22 7.72e-01 9.36e-01 0.09310 -7.82e-02 5.05e-02 5.25e-01 6.82e-01
GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS 31 6.34e-01 8.86e-01 0.09310 6.65e-02 6.51e-02 5.21e-01 5.31e-01
GOBP MODIFIED AMINO ACID TRANSPORT 40 6.16e-01 8.80e-01 0.09310 8.67e-02 -3.38e-02 3.43e-01 7.11e-01
GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS 94 2.57e-01 6.71e-01 0.09310 -8.02e-02 -4.72e-02 1.79e-01 4.29e-01
GOBP TROPHECTODERMAL CELL DIFFERENTIATION 19 7.83e-01 9.40e-01 0.09310 9.07e-03 -9.26e-02 9.45e-01 4.85e-01
GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION 97 2.88e-01 7.01e-01 0.09300 8.05e-03 -9.27e-02 8.91e-01 1.15e-01
GOBP REGULATION OF STEM CELL DIVISION 12 8.44e-01 9.57e-01 0.09300 3.01e-02 8.80e-02 8.57e-01 5.98e-01
GOBP CARBOHYDRATE CATABOLIC PROCESS 162 1.01e-01 4.65e-01 0.09300 3.52e-02 8.61e-02 4.40e-01 5.86e-02
GOBP REGULATION OF GLIAL CELL PROLIFERATION 38 6.43e-01 8.90e-01 0.09300 -6.01e-02 7.09e-02 5.21e-01 4.49e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE 436 1.96e-03 5.38e-02 0.09300 -7.69e-02 -5.23e-02 5.91e-03 6.12e-02
GOBP MICROVILLUS ORGANIZATION 28 7.06e-01 9.13e-01 0.09300 9.03e-02 -2.20e-02 4.08e-01 8.40e-01
GOBP CELL DIVISION 617 1.56e-04 8.28e-03 0.09290 -7.48e-02 -5.52e-02 1.51e-03 1.92e-02
GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN 19 7.68e-01 9.35e-01 0.09290 8.99e-02 2.35e-02 4.98e-01 8.59e-01
GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS 74 4.14e-01 7.85e-01 0.09290 8.42e-02 -3.91e-02 2.10e-01 5.61e-01
GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS 9 9.01e-01 9.74e-01 0.09290 -7.27e-02 5.78e-02 7.06e-01 7.64e-01
GOCC DNA REPLICATION PREINITIATION COMPLEX 13 8.59e-01 9.60e-01 0.09290 7.75e-02 -5.12e-02 6.29e-01 7.49e-01
GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 177 7.64e-02 4.14e-01 0.09280 6.78e-02 6.34e-02 1.20e-01 1.46e-01
GOBP DAMP METABOLIC PROCESS 7 9.03e-01 9.75e-01 0.09280 -5.23e-02 -7.67e-02 8.11e-01 7.25e-01
GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION 8 9.10e-01 9.77e-01 0.09280 4.76e-02 -7.97e-02 8.16e-01 6.96e-01
Synthesis of Dolichyl-phosphate 6 9.16e-01 9.79e-01 0.09280 6.77e-02 6.34e-02 7.74e-01 7.88e-01
GOBP MONOSACCHARIDE TRANSMEMBRANE TRANSPORT 121 1.80e-01 5.84e-01 0.09280 3.78e-02 8.47e-02 4.73e-01 1.08e-01
GOCC MIDBODY 199 7.27e-02 4.04e-01 0.09280 -9.25e-02 -6.30e-03 2.44e-02 8.78e-01
PTEN Regulation 139 1.46e-01 5.40e-01 0.09270 -8.90e-02 -2.60e-02 7.00e-02 5.96e-01
GOBP NEGATIVE REGULATION OF CHEMOTAXIS 47 5.04e-01 8.31e-01 0.09270 7.09e-02 5.97e-02 4.00e-01 4.79e-01
COPI-independent Golgi-to-ER retrograde traffic 51 5.48e-01 8.52e-01 0.09270 -8.19e-02 4.35e-02 3.12e-01 5.91e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS 55 5.11e-01 8.35e-01 0.09270 8.90e-02 -2.62e-02 2.54e-01 7.37e-01
GOCC SARCOPLASM 94 3.33e-01 7.35e-01 0.09270 -4.55e-02 8.07e-02 4.45e-01 1.76e-01
TRIF-mediated programmed cell death 9 8.99e-01 9.74e-01 0.09260 4.05e-02 -8.33e-02 8.33e-01 6.65e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN 20 7.66e-01 9.33e-01 0.09260 8.76e-03 9.22e-02 9.46e-01 4.75e-01
GOBP FATTY ACID ELONGATION 13 8.61e-01 9.61e-01 0.09260 7.26e-02 -5.74e-02 6.50e-01 7.20e-01
KEAP1-NFE2L2 pathway 113 2.34e-01 6.50e-01 0.09260 3.39e-03 -9.25e-02 9.50e-01 8.93e-02
GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT 94 3.32e-01 7.35e-01 0.09260 -4.19e-02 8.25e-02 4.82e-01 1.67e-01
GOMF HISTONE BINDING 217 8.38e-02 4.31e-01 0.09250 -5.66e-02 7.32e-02 1.51e-01 6.32e-02
GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION 16 8.32e-01 9.54e-01 0.09250 -5.95e-02 7.08e-02 6.80e-01 6.24e-01
Energy dependent regulation of mTOR by LKB1-AMPK 28 7.17e-01 9.15e-01 0.09240 -8.47e-02 3.70e-02 4.38e-01 7.35e-01
GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 48 5.70e-01 8.61e-01 0.09240 -8.16e-02 4.35e-02 3.28e-01 6.02e-01
GOBP MICROTUBULE DEPOLYMERIZATION 43 5.39e-01 8.49e-01 0.09240 -7.55e-02 -5.32e-02 3.91e-01 5.46e-01
GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION 10 8.84e-01 9.69e-01 0.09240 2.05e-02 -9.01e-02 9.10e-01 6.22e-01
Negative regulation of NMDA receptor-mediated neuronal transmission 20 7.51e-01 9.30e-01 0.09240 -8.01e-02 -4.61e-02 5.35e-01 7.21e-01
GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 20 7.54e-01 9.30e-01 0.09240 -8.44e-02 -3.76e-02 5.14e-01 7.71e-01
Plasma lipoprotein clearance 37 6.24e-01 8.82e-01 0.09240 -9.22e-02 5.64e-03 3.32e-01 9.53e-01
GOBP REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE 12 8.51e-01 9.58e-01 0.09240 -1.51e-02 -9.11e-02 9.28e-01 5.85e-01
GOMF PHOSPHOTYROSINE RESIDUE BINDING 46 5.75e-01 8.63e-01 0.09230 2.88e-02 -8.77e-02 7.36e-01 3.03e-01
GOMF AMMONIA LYASE ACTIVITY 5 9.44e-01 9.87e-01 0.09230 7.07e-02 -5.93e-02 7.84e-01 8.18e-01
GOBP LIPOPROTEIN CATABOLIC PROCESS 15 8.18e-01 9.52e-01 0.09230 -1.35e-02 -9.13e-02 9.28e-01 5.40e-01
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling 25 7.35e-01 9.23e-01 0.09230 -1.86e-02 9.04e-02 8.72e-01 4.34e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 21 7.50e-01 9.29e-01 0.09220 8.92e-02 2.37e-02 4.79e-01 8.51e-01
GOBP REGULATION OF MYELINATION 46 5.82e-01 8.66e-01 0.09220 -3.83e-02 8.39e-02 6.53e-01 3.25e-01
GOBP REGULATION OF DNA REPAIR 215 5.00e-02 3.39e-01 0.09220 -8.43e-02 -3.74e-02 3.31e-02 3.44e-01
GOCC TRANSFERASE COMPLEX 793 1.61e-05 1.24e-03 0.09220 -5.89e-02 -7.09e-02 4.76e-03 6.81e-04
SARS-CoV Infections 390 9.43e-03 1.48e-01 0.09220 2.38e-02 -8.91e-02 4.20e-01 2.53e-03
GOBP AMIDE BIOSYNTHETIC PROCESS 150 1.41e-01 5.33e-01 0.09210 7.08e-03 9.19e-02 8.81e-01 5.21e-02
GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION 28 6.72e-01 9.02e-01 0.09210 -4.44e-02 -8.07e-02 6.84e-01 4.60e-01
GOMF DOPAMINE RECEPTOR BINDING 14 8.37e-01 9.55e-01 0.09210 -4.81e-03 9.20e-02 9.75e-01 5.51e-01
GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 26 6.90e-01 9.08e-01 0.09210 7.73e-02 5.00e-02 4.95e-01 6.59e-01
RUNX1 regulates expression of components of tight junctions 5 9.31e-01 9.83e-01 0.09210 5.73e-02 7.21e-02 8.24e-01 7.80e-01
Synthesis, secretion, and deacylation of Ghrelin 19 7.65e-01 9.33e-01 0.09210 -8.22e-02 -4.14e-02 5.35e-01 7.55e-01
GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX 8 8.93e-01 9.72e-01 0.09200 -8.05e-02 -4.46e-02 6.93e-01 8.27e-01
GOMF GLYCINE TRANSMEMBRANE TRANSPORTER ACTIVITY 9 8.88e-01 9.71e-01 0.09200 9.14e-02 1.05e-02 6.35e-01 9.57e-01
GOBP REGULATION OF DEVELOPMENTAL GROWTH 299 2.85e-02 2.67e-01 0.09200 -8.83e-02 2.59e-02 8.61e-03 4.41e-01
Signal transduction by L1 20 7.59e-01 9.32e-01 0.09200 -8.75e-02 -2.85e-02 4.98e-01 8.26e-01
GOBP CELL PROJECTION MORPHOGENESIS 636 7.12e-04 2.48e-02 0.09200 -8.37e-02 3.81e-02 3.13e-04 1.01e-01
GOBP MITOTIC SISTER CHROMATID SEGREGATION 185 7.45e-02 4.09e-01 0.09200 -4.45e-02 -8.05e-02 2.96e-01 5.90e-02
GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 92 3.13e-01 7.21e-01 0.09200 -9.18e-02 5.54e-03 1.28e-01 9.27e-01
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION 24 7.10e-01 9.14e-01 0.09200 7.57e-02 5.23e-02 5.21e-01 6.58e-01
GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS 39 6.37e-01 8.87e-01 0.09200 4.38e-02 -8.08e-02 6.36e-01 3.82e-01
GOBP ACTIN FILAMENT BASED PROCESS 797 1.65e-04 8.64e-03 0.09190 -6.82e-02 6.16e-02 1.06e-03 3.13e-03
GOBP PHAGOCYTOSIS RECOGNITION 27 6.97e-01 9.11e-01 0.09190 1.64e-02 9.04e-02 8.83e-01 4.16e-01
Post NMDA receptor activation events 75 3.82e-01 7.66e-01 0.09180 2.30e-03 9.18e-02 9.73e-01 1.69e-01
GOBP LEARNING 149 1.85e-01 5.89e-01 0.09180 -7.61e-02 5.13e-02 1.09e-01 2.80e-01
GOBP DNA DAMAGE RESPONSE 857 7.69e-06 6.62e-04 0.09180 -7.04e-02 -5.89e-02 4.66e-04 3.43e-03
EML4 and NUDC in mitotic spindle formation 112 2.04e-01 6.19e-01 0.09180 -7.12e-02 -5.78e-02 1.93e-01 2.90e-01
GOBP NEGATIVE REGULATION OF PROTEOLYSIS 206 9.95e-02 4.61e-01 0.09180 6.80e-02 -6.17e-02 9.26e-02 1.27e-01
GOBP RESPONSE TO PARATHYROID HORMONE 10 8.74e-01 9.65e-01 0.09180 -8.90e-02 -2.22e-02 6.26e-01 9.03e-01
GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS 34 6.32e-01 8.86e-01 0.09170 8.89e-02 2.25e-02 3.70e-01 8.20e-01
GOMF CORTICOTROPIN RELEASING HORMONE RECEPTOR BINDING 6 9.32e-01 9.83e-01 0.09170 -3.41e-02 8.51e-02 8.85e-01 7.18e-01
Metabolism of proteins 1922 3.68e-11 1.00e-08 0.09160 -2.96e-02 -8.67e-02 3.17e-02 3.15e-10
GOBP AMELOGENESIS 25 7.55e-01 9.30e-01 0.09160 6.02e-02 -6.91e-02 6.03e-01 5.50e-01
GOBP POSITIVE REGULATION OF CELL DEVELOPMENT 439 7.38e-03 1.27e-01 0.09160 -7.77e-02 4.85e-02 5.24e-03 8.17e-02
GOBP LIPID STORAGE 93 3.14e-01 7.22e-01 0.09160 -9.12e-02 7.85e-03 1.28e-01 8.96e-01
GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING 61 4.91e-01 8.26e-01 0.09150 -8.48e-02 3.44e-02 2.52e-01 6.42e-01
GOBP REGULATION OF IMMUNE RESPONSE 900 6.08e-05 3.87e-03 0.09150 6.89e-02 -6.01e-02 4.52e-04 2.22e-03
GOBP RETINAL CONE CELL DEVELOPMENT 11 8.84e-01 9.69e-01 0.09150 -6.76e-02 6.17e-02 6.98e-01 7.23e-01
GOBP MANGANESE ION TRANSPORT 11 8.77e-01 9.66e-01 0.09140 2.38e-02 -8.83e-02 8.91e-01 6.12e-01
GOCC 9PLUS0 NON MOTILE CILIUM 120 1.95e-01 6.05e-01 0.09140 3.27e-02 8.54e-02 5.37e-01 1.06e-01
GOBP REGULATION OF BLOOD CIRCULATION 252 5.70e-02 3.63e-01 0.09140 -8.14e-02 4.15e-02 2.60e-02 2.56e-01
GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 103 2.66e-01 6.81e-01 0.09140 -9.12e-02 -6.25e-03 1.10e-01 9.13e-01
GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION 12 8.48e-01 9.58e-01 0.09130 8.34e-02 3.72e-02 6.17e-01 8.23e-01
GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT 22 7.68e-01 9.34e-01 0.09130 2.03e-02 -8.90e-02 8.69e-01 4.70e-01
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE 127 1.85e-01 5.89e-01 0.09130 -8.86e-02 -2.21e-02 8.48e-02 6.67e-01
GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS 289 2.13e-02 2.33e-01 0.09130 -2.65e-02 -8.73e-02 4.38e-01 1.06e-02
GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX 18 7.78e-01 9.39e-01 0.09120 -7.95e-02 -4.48e-02 5.59e-01 7.42e-01
GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY 49 5.04e-01 8.31e-01 0.09120 -7.56e-02 -5.10e-02 3.60e-01 5.37e-01
GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS 114 2.65e-01 6.79e-01 0.09120 2.99e-02 -8.61e-02 5.81e-01 1.12e-01
GOBP GOLGI ORGANIZATION 138 1.96e-01 6.08e-01 0.09110 -8.78e-02 2.44e-02 7.49e-02 6.21e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H 75 4.08e-01 7.82e-01 0.09110 -8.88e-02 2.05e-02 1.84e-01 7.59e-01
GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS 1386 1.84e-08 3.18e-06 0.09110 -8.35e-02 -3.64e-02 1.86e-07 2.31e-02
GOMF METALLOPEPTIDASE ACTIVITY 179 1.14e-01 4.89e-01 0.09110 -1.24e-02 9.02e-02 7.74e-01 3.73e-02
GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION 70 3.80e-01 7.65e-01 0.09100 -4.41e-02 -7.96e-02 5.23e-01 2.49e-01
GOBP B CELL DIFFERENTIATION 145 1.83e-01 5.87e-01 0.09100 8.73e-02 -2.58e-02 6.96e-02 5.91e-01
GOBP INTRACELLULAR PROTEIN TRANSPORT 646 1.50e-04 8.11e-03 0.09100 -7.21e-02 -5.55e-02 1.76e-03 1.60e-02
GOBP NEURON CELL CELL ADHESION 13 8.50e-01 9.58e-01 0.09100 9.09e-02 -3.70e-03 5.70e-01 9.82e-01
GOBP PURINE CONTAINING COMPOUND SALVAGE 14 8.23e-01 9.52e-01 0.09100 -5.06e-02 -7.56e-02 7.43e-01 6.24e-01
Growth hormone receptor signaling 23 7.32e-01 9.22e-01 0.09090 8.43e-02 3.41e-02 4.84e-01 7.77e-01
SARS-CoV-2 targets host intracellular signalling and regulatory pathways 12 8.71e-01 9.64e-01 0.09090 -8.42e-02 3.44e-02 6.14e-01 8.37e-01
GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE 20 8.01e-01 9.46e-01 0.09090 -7.15e-02 5.61e-02 5.80e-01 6.64e-01
GPCR ligand binding 445 7.87e-03 1.32e-01 0.09080 -7.07e-02 5.70e-02 1.05e-02 3.92e-02
GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI 32 6.50e-01 8.91e-01 0.09080 -8.53e-02 -3.11e-02 4.03e-01 7.61e-01
GOBP NEUTROPHIL DEGRANULATION 13 8.35e-01 9.55e-01 0.09080 -7.82e-02 -4.61e-02 6.25e-01 7.73e-01
GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 57 4.91e-01 8.26e-01 0.09080 9.08e-02 -8.45e-04 2.36e-01 9.91e-01
GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 197 9.55e-02 4.51e-01 0.09080 -8.94e-02 1.59e-02 3.05e-02 7.00e-01
Regulation of TP53 Activity 155 1.16e-01 4.90e-01 0.09080 -6.59e-02 -6.24e-02 1.57e-01 1.80e-01
GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS 311 1.37e-02 1.86e-01 0.09080 -6.07e-02 -6.75e-02 6.56e-02 4.07e-02
GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY 7 9.09e-01 9.77e-01 0.09080 -8.16e-02 -3.98e-02 7.09e-01 8.55e-01
Toll Like Receptor 7/8 (TLR7/8) Cascade 98 2.65e-01 6.79e-01 0.09080 -3.66e-02 -8.31e-02 5.31e-01 1.55e-01
GOMF PHOSPHATASE INHIBITOR ACTIVITY 46 6.02e-01 8.75e-01 0.09080 6.67e-02 -6.16e-02 4.34e-01 4.70e-01
NOTCH2 Activation and Transmission of Signal to the Nucleus 22 7.82e-01 9.40e-01 0.09070 4.89e-02 -7.64e-02 6.91e-01 5.35e-01
Iron uptake and transport 56 4.60e-01 8.10e-01 0.09070 -7.30e-02 -5.38e-02 3.45e-01 4.86e-01
GOBP SKELETAL MUSCLE FIBER DIFFERENTIATION 12 8.58e-01 9.60e-01 0.09070 -9.03e-02 -8.51e-03 5.88e-01 9.59e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 139 1.46e-01 5.40e-01 0.09070 -7.23e-02 -5.47e-02 1.41e-01 2.65e-01
AKT phosphorylates targets in the cytosol 14 8.43e-01 9.56e-01 0.09070 -9.02e-02 8.80e-03 5.59e-01 9.55e-01
GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID 597 4.34e-04 1.71e-02 0.09060 -8.66e-02 -2.69e-02 3.02e-04 2.62e-01
GOCC EXTRINSIC COMPONENT OF MEMBRANE 170 1.31e-01 5.16e-01 0.09060 -8.96e-02 1.35e-02 4.38e-02 7.62e-01
GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE 31 7.11e-01 9.14e-01 0.09060 6.90e-02 -5.87e-02 5.06e-01 5.72e-01
GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT 17 7.90e-01 9.42e-01 0.09060 5.60e-02 7.12e-02 6.89e-01 6.11e-01
GOBP GENERATION OF NEURONS 1444 1.17e-07 1.65e-05 0.09060 -8.82e-02 2.09e-02 2.03e-08 1.84e-01
GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX 45 5.46e-01 8.51e-01 0.09060 -8.40e-02 -3.38e-02 3.29e-01 6.95e-01
GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS 127 1.82e-01 5.86e-01 0.09060 3.38e-02 8.40e-02 5.10e-01 1.02e-01
Cytochrome P450 - arranged by substrate type 64 4.66e-01 8.14e-01 0.09060 8.91e-02 -1.61e-02 2.18e-01 8.24e-01
GOBP REGULATION OF RIG I SIGNALING PATHWAY 19 7.69e-01 9.35e-01 0.09050 7.32e-02 5.33e-02 5.81e-01 6.87e-01
GOCC XY BODY 15 8.12e-01 9.49e-01 0.09050 -6.74e-02 -6.05e-02 6.51e-01 6.85e-01
GOCC SITE OF DNA DAMAGE 125 1.88e-01 5.94e-01 0.09050 -3.29e-02 -8.43e-02 5.26e-01 1.03e-01
GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY 9 9.04e-01 9.76e-01 0.09050 -7.88e-02 4.46e-02 6.82e-01 8.17e-01
Signaling by high-kinase activity BRAF mutants 34 6.28e-01 8.84e-01 0.09050 -4.58e-02 -7.80e-02 6.44e-01 4.31e-01
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION 98 2.58e-01 6.72e-01 0.09050 -5.64e-02 -7.07e-02 3.35e-01 2.26e-01
Toll Like Receptor 3 (TLR3) Cascade 100 2.84e-01 6.96e-01 0.09040 -6.29e-03 -9.02e-02 9.13e-01 1.19e-01
GOMF GAP JUNCTION CHANNEL ACTIVITY 22 7.86e-01 9.41e-01 0.09040 -6.61e-02 6.16e-02 5.91e-01 6.17e-01
GOCC CILIARY MEMBRANE 74 4.16e-01 7.86e-01 0.09040 -1.68e-02 8.88e-02 8.03e-01 1.87e-01
GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY 50 5.01e-01 8.30e-01 0.09040 -5.72e-02 -7.00e-02 4.84e-01 3.92e-01
GOBP GANGLIOSIDE METABOLIC PROCESS 28 6.82e-01 9.05e-01 0.09040 7.77e-02 4.61e-02 4.76e-01 6.73e-01
Sialic acid metabolism 33 6.47e-01 8.91e-01 0.09040 2.59e-02 8.66e-02 7.97e-01 3.89e-01
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 940 7.76e-06 6.62e-04 0.09040 -8.80e-02 -2.07e-02 4.87e-06 2.81e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 86 3.05e-01 7.15e-01 0.09030 -5.80e-02 -6.93e-02 3.53e-01 2.67e-01
GOBP POST EMBRYONIC DEVELOPMENT 86 3.84e-01 7.67e-01 0.09030 -7.93e-02 4.32e-02 2.04e-01 4.88e-01
Co-stimulation by CD28 47 5.66e-01 8.59e-01 0.09030 -8.99e-02 8.78e-03 2.86e-01 9.17e-01
GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY 53 5.29e-01 8.43e-01 0.09030 -8.96e-02 1.09e-02 2.59e-01 8.91e-01
GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX 10 8.95e-01 9.73e-01 0.09030 -7.50e-02 5.02e-02 6.81e-01 7.83e-01
Cell recruitment (pro-inflammatory response) 26 7.43e-01 9.26e-01 0.09030 3.23e-02 -8.43e-02 7.76e-01 4.57e-01
Purinergic signaling in leishmaniasis infection 26 7.43e-01 9.26e-01 0.09030 3.23e-02 -8.43e-02 7.76e-01 4.57e-01
Protein folding 95 3.28e-01 7.31e-01 0.09020 1.90e-02 -8.82e-02 7.49e-01 1.37e-01
GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT 195 7.57e-02 4.12e-01 0.09020 -8.43e-02 -3.22e-02 4.24e-02 4.38e-01
GOCC EXCITATORY SYNAPSE 58 4.66e-01 8.14e-01 0.09020 -8.60e-02 -2.72e-02 2.57e-01 7.20e-01
GOCC APICAL PART OF CELL 451 2.26e-03 5.90e-02 0.09020 5.78e-02 6.92e-02 3.55e-02 1.17e-02
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 59 4.73e-01 8.17e-01 0.09010 1.15e-02 8.94e-02 8.79e-01 2.35e-01
Synthesis of substrates in N-glycan biosythesis 63 4.90e-01 8.26e-01 0.09010 -3.34e-02 8.37e-02 6.47e-01 2.50e-01
GOMF INSULIN RECEPTOR SUBSTRATE BINDING 13 8.67e-01 9.63e-01 0.09010 -5.38e-02 7.23e-02 7.37e-01 6.52e-01
GOBP POSITIVE REGULATION OF CELL GROWTH 152 1.85e-01 5.89e-01 0.09010 -4.07e-02 8.04e-02 3.87e-01 8.71e-02
GOBP PROTEIN KINASE A SIGNALING 39 6.50e-01 8.92e-01 0.09000 7.75e-02 -4.59e-02 4.02e-01 6.20e-01
GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS 240 4.10e-02 3.09e-01 0.09000 3.89e-02 8.12e-02 2.99e-01 3.03e-02
GOBP SOMITE DEVELOPMENT 81 4.01e-01 7.78e-01 0.09000 -8.37e-02 3.32e-02 1.93e-01 6.06e-01
GOBP REGULATION OF NEUTROPHIL MIGRATION 40 5.80e-01 8.64e-01 0.09000 7.55e-02 4.89e-02 4.09e-01 5.92e-01
GOBP CARDIAC VENTRICLE DEVELOPMENT 128 2.14e-01 6.32e-01 0.09000 -8.97e-02 6.57e-03 7.95e-02 8.98e-01
GOBP RESPONSE TO AMMONIUM ION 6 9.29e-01 9.83e-01 0.08990 -8.99e-02 2.17e-03 7.03e-01 9.93e-01
GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE 71 3.84e-01 7.68e-01 0.08990 -7.86e-02 -4.36e-02 2.52e-01 5.26e-01
Eicosanoid ligand-binding receptors 14 8.25e-01 9.52e-01 0.08990 -5.84e-02 -6.83e-02 7.05e-01 6.58e-01
GOBP RESPONSE TO CHEMOKINE 96 3.41e-01 7.40e-01 0.08990 8.30e-02 -3.46e-02 1.60e-01 5.59e-01
GOBP ANIMAL ORGAN MORPHOGENESIS 999 1.76e-05 1.33e-03 0.08990 -8.60e-02 2.61e-02 4.24e-06 1.62e-01
GOBP REGULATION OF IMMUNE EFFECTOR PROCESS 377 1.76e-02 2.11e-01 0.08990 7.21e-02 -5.37e-02 1.63e-02 7.36e-02
GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX 6 9.24e-01 9.81e-01 0.08980 -3.16e-02 -8.41e-02 8.93e-01 7.21e-01
GOBP BASE CONVERSION OR SUBSTITUTION EDITING 18 7.91e-01 9.42e-01 0.08980 2.59e-02 8.60e-02 8.49e-01 5.28e-01
GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS 25 7.63e-01 9.33e-01 0.08980 6.26e-02 -6.43e-02 5.88e-01 5.78e-01
GOMF SERINE HYDROLASE ACTIVITY 188 7.96e-02 4.19e-01 0.08980 4.89e-02 7.53e-02 2.47e-01 7.50e-02
GOBP MITOCHONDRIAL FUSION 34 6.49e-01 8.91e-01 0.08980 -8.86e-02 -1.44e-02 3.71e-01 8.84e-01
GOMF HSP90 PROTEIN BINDING 40 5.84e-01 8.66e-01 0.08980 -7.82e-02 -4.41e-02 3.92e-01 6.29e-01
trans-Golgi Network Vesicle Budding 67 4.02e-01 7.79e-01 0.08970 -5.59e-02 -7.02e-02 4.29e-01 3.20e-01
GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS 28 6.96e-01 9.11e-01 0.08970 8.68e-02 2.28e-02 4.27e-01 8.35e-01
GOMF OLEATE TRANSMEMBRANE TRANSPORTER ACTIVITY 6 9.21e-01 9.80e-01 0.08970 7.06e-02 5.53e-02 7.64e-01 8.15e-01
GOBP SYNAPSE ORGANIZATION 459 4.05e-03 8.82e-02 0.08970 -8.97e-02 -8.87e-04 9.94e-04 9.74e-01
GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM 17 8.24e-01 9.52e-01 0.08970 8.50e-02 -2.84e-02 5.44e-01 8.39e-01
GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION 52 5.46e-01 8.51e-01 0.08970 1.73e-02 -8.80e-02 8.29e-01 2.73e-01
GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS 110 2.91e-01 7.04e-01 0.08960 8.38e-02 -3.17e-02 1.29e-01 5.66e-01
GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS 111 2.30e-01 6.48e-01 0.08960 3.80e-02 8.11e-02 4.89e-01 1.40e-01
GOMF UBIQUITIN SPECIFIC PROTEASE BINDING 18 7.88e-01 9.41e-01 0.08950 3.69e-02 8.16e-02 7.87e-01 5.49e-01
GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 88 3.08e-01 7.17e-01 0.08940 -4.65e-02 -7.64e-02 4.51e-01 2.15e-01
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 69 4.72e-01 8.15e-01 0.08940 7.73e-02 -4.50e-02 2.67e-01 5.18e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN 46 5.84e-01 8.66e-01 0.08940 8.83e-02 -1.37e-02 3.00e-01 8.72e-01
GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS 14 8.53e-01 9.59e-01 0.08940 -2.64e-02 8.54e-02 8.64e-01 5.80e-01
GOBP RNA PROCESSING 1247 1.06e-06 1.15e-04 0.08940 1.46e-02 -8.82e-02 3.86e-01 1.61e-07
GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE 16 8.41e-01 9.56e-01 0.08940 -5.24e-02 7.24e-02 7.17e-01 6.16e-01
GOBP CHAPERONE MEDIATED AUTOPHAGY 14 8.31e-01 9.54e-01 0.08940 8.12e-02 3.74e-02 5.99e-01 8.08e-01
GOBP POSITIVE REGULATION OF CELL CYCLE 323 1.45e-02 1.91e-01 0.08940 -7.98e-02 -4.02e-02 1.36e-02 2.14e-01
GOBP REGULATION OF PLATELET AGGREGATION 29 7.33e-01 9.23e-01 0.08940 -6.62e-02 6.00e-02 5.37e-01 5.76e-01
SLBP independent Processing of Histone Pre-mRNAs 10 8.98e-01 9.74e-01 0.08940 6.60e-02 -6.02e-02 7.18e-01 7.42e-01
GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 555 2.74e-03 6.88e-02 0.08930 -7.74e-02 4.45e-02 1.81e-03 7.27e-02
GOBP REGULATION OF T CELL MIGRATION 47 5.52e-01 8.54e-01 0.08930 8.77e-02 1.68e-02 2.98e-01 8.42e-01
GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE 75 4.45e-01 8.01e-01 0.08930 7.56e-02 -4.75e-02 2.57e-01 4.77e-01
GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS 39 6.17e-01 8.80e-01 0.08930 -8.89e-02 -8.70e-03 3.37e-01 9.25e-01
GOMF NEUROTRANSMITTER TRANSMEMBRANE TRANSPORTER ACTIVITY 20 7.76e-01 9.38e-01 0.08920 -8.72e-02 -1.91e-02 5.00e-01 8.83e-01
GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION 68 4.00e-01 7.78e-01 0.08920 -5.85e-02 -6.74e-02 4.04e-01 3.37e-01
GOCC CATALYTIC COMPLEX 1617 1.56e-09 3.20e-07 0.08920 -6.48e-02 -6.14e-02 1.41e-05 3.90e-05
GOBP PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT 7 9.25e-01 9.81e-01 0.08910 -8.33e-02 3.15e-02 7.03e-01 8.85e-01
GOBP LATERAL MESODERM DEVELOPMENT 16 8.27e-01 9.53e-01 0.08910 -8.88e-02 6.55e-03 5.38e-01 9.64e-01
GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE 10 8.85e-01 9.69e-01 0.08900 -8.89e-02 -5.03e-03 6.27e-01 9.78e-01
GOBP REGULATION OF CYTOKINESIS 89 3.03e-01 7.14e-01 0.08900 -6.55e-02 -6.03e-02 2.86e-01 3.26e-01
Maternal to zygotic transition (MZT) 96 3.51e-01 7.45e-01 0.08900 3.74e-02 -8.07e-02 5.27e-01 1.72e-01
GOBP PROSTATE GLANDULAR ACINUS DEVELOPMENT 10 8.96e-01 9.73e-01 0.08900 -8.03e-02 3.83e-02 6.60e-01 8.34e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 62 4.60e-01 8.11e-01 0.08890 -8.74e-02 -1.67e-02 2.34e-01 8.21e-01
GOBP DITERPENOID METABOLIC PROCESS 87 3.52e-01 7.46e-01 0.08890 8.89e-02 1.06e-03 1.52e-01 9.86e-01
GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS 8 9.08e-01 9.77e-01 0.08890 8.89e-02 1.28e-03 6.63e-01 9.95e-01
GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 15 8.34e-01 9.55e-01 0.08890 -8.88e-02 -3.37e-03 5.51e-01 9.82e-01
GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS 28 7.09e-01 9.13e-01 0.08890 8.25e-03 8.85e-02 9.40e-01 4.18e-01
GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION 9 8.92e-01 9.72e-01 0.08890 -2.25e-02 -8.60e-02 9.07e-01 6.55e-01
GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 122 2.42e-01 6.58e-01 0.08890 -8.82e-02 1.05e-02 9.23e-02 8.41e-01
GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE 52 5.75e-01 8.63e-01 0.08880 -7.16e-02 5.26e-02 3.72e-01 5.12e-01
GOBP DNA MODIFICATION 43 6.33e-01 8.86e-01 0.08880 -7.30e-02 5.05e-02 4.07e-01 5.67e-01
GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX 236 4.38e-02 3.18e-01 0.08880 -6.24e-02 -6.32e-02 9.87e-02 9.47e-02
GOBP REGULATION OF TRANSPORTER ACTIVITY 230 7.49e-02 4.11e-01 0.08870 -8.67e-02 1.89e-02 2.35e-02 6.22e-01
GOCC PML BODY 103 2.83e-01 6.95e-01 0.08870 -8.80e-02 -1.10e-02 1.23e-01 8.47e-01
GOCC PHAGOCYTIC VESICLE 132 1.78e-01 5.83e-01 0.08870 -4.25e-02 -7.78e-02 3.99e-01 1.23e-01
GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 20 7.94e-01 9.44e-01 0.08860 -1.28e-02 8.77e-02 9.21e-01 4.97e-01
GOBP REGULATION OF MITOPHAGY 35 6.58e-01 8.95e-01 0.08860 1.43e-03 8.86e-02 9.88e-01 3.64e-01
GOMF N ACETYLLACTOSAMINE SYNTHASE ACTIVITY 5 9.47e-01 9.87e-01 0.08860 -3.54e-02 8.12e-02 8.91e-01 7.53e-01
GOMF GTPASE ACTIVATOR ACTIVITY 243 7.83e-02 4.17e-01 0.08860 -5.24e-02 7.15e-02 1.60e-01 5.50e-02
GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION 26 7.61e-01 9.32e-01 0.08860 5.85e-02 -6.65e-02 6.05e-01 5.57e-01
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain 13 8.59e-01 9.60e-01 0.08850 -6.90e-03 8.83e-02 9.66e-01 5.82e-01
GOBP PEPTIDYL SERINE DEPHOSPHORYLATION 14 8.61e-01 9.61e-01 0.08850 4.52e-02 -7.61e-02 7.70e-01 6.22e-01
GOBP SYNAPTIC TRANSMISSION GABAERGIC 58 4.63e-01 8.12e-01 0.08850 -6.55e-02 -5.96e-02 3.88e-01 4.33e-01
GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING 8 9.10e-01 9.77e-01 0.08850 -8.85e-02 1.89e-03 6.65e-01 9.93e-01
MyD88-independent TLR4 cascade 104 2.75e-01 6.88e-01 0.08850 -1.82e-02 -8.66e-02 7.49e-01 1.27e-01
TRIF (TICAM1)-mediated TLR4 signaling 104 2.75e-01 6.88e-01 0.08850 -1.82e-02 -8.66e-02 7.49e-01 1.27e-01
GOBP CIRCULATORY SYSTEM DEVELOPMENT 1190 4.09e-06 3.69e-04 0.08850 -8.33e-02 2.99e-02 1.29e-06 8.28e-02
GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY 23 7.65e-01 9.33e-01 0.08850 7.75e-03 -8.81e-02 9.49e-01 4.64e-01
GOMF CARBON OXYGEN LYASE ACTIVITY 74 4.35e-01 7.97e-01 0.08840 -2.00e-02 8.62e-02 7.67e-01 2.00e-01
GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION 49 5.24e-01 8.42e-01 0.08840 5.16e-02 7.18e-02 5.32e-01 3.84e-01
GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION 69 4.25e-01 7.93e-01 0.08840 8.66e-02 1.80e-02 2.14e-01 7.96e-01
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE 12 8.59e-01 9.60e-01 0.08840 -2.62e-02 -8.44e-02 8.75e-01 6.13e-01
GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS 39 6.24e-01 8.82e-01 0.08840 -8.81e-02 -7.48e-03 3.41e-01 9.36e-01
GOBP ICOSANOID BIOSYNTHETIC PROCESS 55 5.47e-01 8.52e-01 0.08840 8.34e-02 -2.93e-02 2.85e-01 7.07e-01
GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT 76 4.33e-01 7.96e-01 0.08830 -2.69e-02 8.41e-02 6.85e-01 2.05e-01
GOBP KIDNEY EPITHELIUM DEVELOPMENT 148 1.78e-01 5.83e-01 0.08830 -8.82e-02 3.81e-03 6.39e-02 9.36e-01
GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION 45 5.59e-01 8.57e-01 0.08830 3.87e-02 7.94e-02 6.54e-01 3.57e-01
GOMF GLYCOSAMINOGLYCAN BINDING 235 8.73e-02 4.36e-01 0.08830 -6.87e-02 5.55e-02 6.98e-02 1.43e-01
GOCC POSTSYNAPSE 626 9.97e-04 3.26e-02 0.08820 -8.69e-02 1.53e-02 2.06e-04 5.14e-01
GOCC CELL CORTEX 305 4.06e-02 3.08e-01 0.08820 -4.27e-02 7.72e-02 2.00e-01 2.04e-02
GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS 96 3.04e-01 7.14e-01 0.08820 2.08e-02 8.57e-02 7.25e-01 1.47e-01
GOCC SPECIFIC GRANULE 155 1.56e-01 5.52e-01 0.08820 8.47e-03 8.78e-02 8.56e-01 5.93e-02
GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION 12 8.68e-01 9.63e-01 0.08810 -4.11e-04 -8.81e-02 9.98e-01 5.97e-01
GOBP ER NUCLEUS SIGNALING PATHWAY 47 6.13e-01 8.78e-01 0.08810 5.58e-02 -6.82e-02 5.08e-01 4.18e-01
GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION 7 9.13e-01 9.78e-01 0.08810 -7.44e-02 -4.72e-02 7.33e-01 8.29e-01
Transcriptional regulation by RUNX1 192 8.46e-02 4.32e-01 0.08810 -7.74e-02 -4.22e-02 6.45e-02 3.14e-01
Beta-oxidation of very long chain fatty acids 10 8.99e-01 9.74e-01 0.08810 4.31e-02 -7.68e-02 8.13e-01 6.74e-01
GOBP REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION 10 8.95e-01 9.73e-01 0.08810 8.51e-02 -2.27e-02 6.41e-01 9.01e-01
GOBP CARBOHYDRATE IMPORT ACROSS PLASMA MEMBRANE 6 9.34e-01 9.84e-01 0.08800 8.72e-02 -1.23e-02 7.12e-01 9.58e-01
GOBP RRNA MODIFICATION 31 6.76e-01 9.04e-01 0.08800 -2.95e-02 -8.29e-02 7.76e-01 4.24e-01
GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 998 4.06e-05 2.71e-03 0.08800 -7.71e-02 4.25e-02 3.76e-05 2.32e-02
Signaling by Interleukins 421 1.21e-02 1.73e-01 0.08800 3.87e-02 -7.90e-02 1.73e-01 5.41e-03
GOBP POSTSYNAPSE ORGANIZATION 183 1.38e-01 5.28e-01 0.08800 -2.92e-02 8.30e-02 4.96e-01 5.28e-02
GOBP MACROPHAGE ACTIVATION 110 2.43e-01 6.58e-01 0.08790 -4.15e-02 -7.75e-02 4.52e-01 1.60e-01
GOCC CHYLOMICRON 13 8.73e-01 9.65e-01 0.08790 6.98e-02 -5.35e-02 6.63e-01 7.38e-01
GOMF NUCLEOSOME BINDING 89 3.30e-01 7.34e-01 0.08790 -2.46e-02 -8.44e-02 6.88e-01 1.69e-01
GOBP EOSINOPHIL ACTIVATION 8 9.20e-01 9.80e-01 0.08790 -6.51e-02 5.91e-02 7.50e-01 7.72e-01
GOBP AMINO ACID ACTIVATION 43 6.19e-01 8.80e-01 0.08790 1.85e-02 -8.59e-02 8.33e-01 3.30e-01
GOBP REGULATION OF FATTY ACID METABOLIC PROCESS 94 3.68e-01 7.57e-01 0.08790 -3.77e-02 7.94e-02 5.28e-01 1.83e-01
GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE 13 8.53e-01 9.59e-01 0.08790 -8.67e-02 -1.47e-02 5.88e-01 9.27e-01
GOMF RECEPTOR ANTAGONIST ACTIVITY 16 8.46e-01 9.58e-01 0.08790 -7.25e-02 4.96e-02 6.15e-01 7.31e-01
MET activates PTK2 signaling 30 6.98e-01 9.11e-01 0.08790 -8.75e-02 -8.51e-03 4.07e-01 9.36e-01
GOBP GROWTH 881 6.63e-05 4.13e-03 0.08790 -8.71e-02 1.17e-02 1.15e-05 5.55e-01
GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS 43 6.30e-01 8.85e-01 0.08780 -3.31e-02 8.14e-02 7.08e-01 3.56e-01
GOBP CEREBELLAR CORTEX DEVELOPMENT 50 5.22e-01 8.41e-01 0.08780 -7.20e-02 -5.03e-02 3.79e-01 5.38e-01
GOBP COMMISSURAL NEURON AXON GUIDANCE 13 8.64e-01 9.62e-01 0.08780 -8.62e-02 1.64e-02 5.90e-01 9.18e-01
GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES 10 8.79e-01 9.67e-01 0.08780 4.11e-02 7.76e-02 8.22e-01 6.71e-01
GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH 12 8.81e-01 9.67e-01 0.08770 4.33e-02 -7.63e-02 7.95e-01 6.47e-01
GOCC AXON 623 1.33e-03 4.09e-02 0.08770 -8.39e-02 2.58e-02 3.51e-04 2.72e-01
GOBP RENAL FILTRATION 27 7.09e-01 9.13e-01 0.08770 -8.00e-02 -3.61e-02 4.72e-01 7.45e-01
GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 138 2.29e-01 6.47e-01 0.08770 -3.26e-02 8.14e-02 5.09e-01 9.87e-02
Regulation of PTEN gene transcription 59 5.28e-01 8.43e-01 0.08770 -8.28e-02 2.88e-02 2.71e-01 7.02e-01
GOBP EMBRYONIC HEART TUBE DEVELOPMENT 84 3.51e-01 7.46e-01 0.08770 -8.34e-02 -2.70e-02 1.86e-01 6.69e-01
Signaling by NOTCH 197 8.78e-02 4.37e-01 0.08760 -2.62e-02 -8.36e-02 5.25e-01 4.31e-02
GOMF HEPARIN BINDING 169 1.78e-01 5.83e-01 0.08760 -6.17e-02 6.23e-02 1.67e-01 1.63e-01
GOCC PEPTIDASE COMPLEX 118 2.53e-01 6.69e-01 0.08760 -1.21e-03 -8.76e-02 9.82e-01 1.00e-01
Synthesis of 12-eicosatetraenoic acid derivatives 7 9.18e-01 9.79e-01 0.08760 1.94e-02 8.54e-02 9.29e-01 6.96e-01
GOBP TRNA METABOLIC PROCESS 195 9.09e-02 4.43e-01 0.08760 -2.49e-02 -8.40e-02 5.50e-01 4.32e-02
GOBP NEUROTRANSMITTER SECRETION 141 2.23e-01 6.42e-01 0.08750 -3.29e-02 8.11e-02 5.00e-01 9.64e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR 11 8.92e-01 9.72e-01 0.08750 -7.40e-02 4.67e-02 6.71e-01 7.88e-01
GOMF LEUCINE ZIPPER DOMAIN BINDING 11 8.68e-01 9.63e-01 0.08750 -7.34e-02 -4.76e-02 6.73e-01 7.85e-01
GOBP DETECTION OF MECHANICAL STIMULUS 54 5.37e-01 8.48e-01 0.08740 2.71e-03 -8.74e-02 9.73e-01 2.67e-01
GOBP POSITIVE REGULATION OF CYTOKINESIS 47 5.71e-01 8.61e-01 0.08740 -8.66e-02 -1.13e-02 3.04e-01 8.94e-01
GOMF MYOSIN PHOSPHATASE ACTIVITY 73 4.59e-01 8.10e-01 0.08740 3.04e-02 -8.19e-02 6.54e-01 2.26e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 173 1.14e-01 4.88e-01 0.08730 -7.89e-02 -3.74e-02 7.33e-02 3.96e-01
RUNX3 Regulates Immune Response and Cell Migration 6 9.30e-01 9.83e-01 0.08730 -1.83e-02 -8.54e-02 9.38e-01 7.17e-01
GOMF CARBOXYPEPTIDASE ACTIVITY 45 6.11e-01 8.78e-01 0.08730 -2.11e-02 8.47e-02 8.07e-01 3.25e-01
GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY 28 7.01e-01 9.12e-01 0.08730 -3.93e-02 -7.79e-02 7.19e-01 4.75e-01
GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY 11 8.91e-01 9.72e-01 0.08720 -7.72e-02 4.07e-02 6.58e-01 8.15e-01
GOBP MORPHOGENESIS OF AN EPITHELIUM 489 3.14e-03 7.59e-02 0.08720 -8.58e-02 -1.56e-02 1.15e-03 5.54e-01
GOBP REGULATION OF NK T CELL ACTIVATION 11 8.90e-01 9.71e-01 0.08720 -3.35e-02 8.05e-02 8.47e-01 6.44e-01
RHOBTB GTPase Cycle 34 6.99e-01 9.11e-01 0.08720 -7.97e-02 3.53e-02 4.21e-01 7.22e-01
GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 1331 1.27e-06 1.35e-04 0.08710 -8.40e-02 2.31e-02 2.66e-07 1.57e-01
Cell Cycle, Mitotic 495 2.12e-03 5.68e-02 0.08710 -4.45e-02 -7.48e-02 9.01e-02 4.35e-03
GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION 7 9.29e-01 9.83e-01 0.08710 -7.99e-02 3.46e-02 7.14e-01 8.74e-01
GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT 36 6.30e-01 8.85e-01 0.08700 6.04e-02 6.27e-02 5.31e-01 5.15e-01
GOCC SCF UBIQUITIN LIGASE COMPLEX 66 4.35e-01 7.96e-01 0.08700 -4.15e-02 -7.65e-02 5.60e-01 2.82e-01
GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS 72 4.79e-01 8.21e-01 0.08700 7.12e-02 -5.01e-02 2.96e-01 4.63e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION 54 5.00e-01 8.30e-01 0.08700 5.93e-02 6.37e-02 4.51e-01 4.18e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION 28 7.23e-01 9.17e-01 0.08700 3.15e-03 8.69e-02 9.77e-01 4.26e-01
GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS 120 2.49e-01 6.63e-01 0.08700 8.68e-02 4.86e-03 1.00e-01 9.27e-01
Resolution of Sister Chromatid Cohesion 119 2.20e-01 6.37e-01 0.08690 -5.34e-02 -6.86e-02 3.14e-01 1.96e-01
GOCC GOLGI STACK 129 2.12e-01 6.28e-01 0.08690 2.03e-02 8.45e-02 6.90e-01 9.75e-02
GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION 41 6.26e-01 8.84e-01 0.08690 -8.69e-02 1.53e-03 3.36e-01 9.86e-01
GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS 10 9.03e-01 9.75e-01 0.08690 -6.75e-02 5.47e-02 7.12e-01 7.65e-01
GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS 10 8.80e-01 9.67e-01 0.08690 -6.34e-02 -5.94e-02 7.29e-01 7.45e-01
GOBP AMINE METABOLIC PROCESS 106 2.59e-01 6.73e-01 0.08690 6.50e-02 5.76e-02 2.48e-01 3.05e-01
GOBP ENSHEATHMENT OF NEURONS 154 2.06e-01 6.22e-01 0.08680 -4.27e-02 7.56e-02 3.60e-01 1.05e-01
GOMF IGG BINDING 7 9.24e-01 9.81e-01 0.08680 -4.88e-03 8.67e-02 9.82e-01 6.91e-01
GOBP ONE CARBON METABOLIC PROCESS 37 6.61e-01 8.97e-01 0.08680 -8.64e-02 8.30e-03 3.63e-01 9.30e-01
GOCC DOPAMINERGIC SYNAPSE 15 8.28e-01 9.53e-01 0.08680 -7.65e-02 -4.10e-02 6.08e-01 7.83e-01
GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS 22 7.63e-01 9.32e-01 0.08680 -2.97e-02 -8.15e-02 8.09e-01 5.08e-01
GOBP APOLIPOPROTEIN A I MEDIATED SIGNALING PATHWAY 7 9.28e-01 9.82e-01 0.08670 -8.20e-02 2.83e-02 7.07e-01 8.97e-01
GOCC NUCLEOLUS 1319 2.45e-06 2.42e-04 0.08670 3.62e-02 -7.88e-02 2.71e-02 1.54e-06
GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 200 1.31e-01 5.16e-01 0.08670 4.40e-02 -7.47e-02 2.83e-01 6.85e-02
GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT 68 4.43e-01 8.00e-01 0.08670 -8.45e-02 -1.94e-02 2.28e-01 7.82e-01
GOBP NEGATIVE REGULATION OF DOPAMINE SECRETION 5 9.47e-01 9.87e-01 0.08670 -8.46e-02 1.91e-02 7.43e-01 9.41e-01
GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION 12 8.85e-01 9.69e-01 0.08670 -7.41e-02 4.50e-02 6.57e-01 7.87e-01
GOCC LATE ENDOSOME MEMBRANE 164 1.39e-01 5.31e-01 0.08660 -8.34e-02 -2.34e-02 6.54e-02 6.05e-01
GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE 205 1.20e-01 4.98e-01 0.08660 -7.96e-02 3.40e-02 4.93e-02 4.02e-01
GOBP WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 48 5.86e-01 8.67e-01 0.08660 -7.55e-03 8.62e-02 9.28e-01 3.01e-01
GOBP SPHINGOLIPID METABOLIC PROCESS 170 1.20e-01 4.98e-01 0.08650 4.37e-02 7.47e-02 3.26e-01 9.29e-02
GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION 5 9.51e-01 9.88e-01 0.08650 7.23e-02 -4.76e-02 7.80e-01 8.54e-01
GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER 8 9.15e-01 9.78e-01 0.08650 8.12e-03 -8.61e-02 9.68e-01 6.73e-01
GOBP LACTATION 38 6.71e-01 9.01e-01 0.08650 2.97e-02 -8.12e-02 7.52e-01 3.86e-01
GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY 19 8.24e-01 9.52e-01 0.08650 -4.41e-02 7.44e-02 7.39e-01 5.75e-01
GOMF DNA HELICASE ACTIVITY 59 5.53e-01 8.54e-01 0.08650 -6.81e-02 5.33e-02 3.66e-01 4.79e-01
GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION 21 7.70e-01 9.35e-01 0.08650 3.89e-02 7.72e-02 7.58e-01 5.40e-01
GOBP GTP METABOLIC PROCESS 24 7.44e-01 9.26e-01 0.08650 -3.29e-02 -8.00e-02 7.81e-01 4.98e-01
GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION 677 3.08e-04 1.35e-02 0.08650 -7.98e-02 -3.34e-02 4.02e-04 1.39e-01
GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE 192 1.24e-01 5.04e-01 0.08640 8.54e-02 -1.33e-02 4.13e-02 7.51e-01
GOMF PHOSPHOPROTEIN BINDING 87 3.63e-01 7.53e-01 0.08640 -1.06e-02 -8.58e-02 8.64e-01 1.67e-01
GOMF SINGLE STRANDED DNA HELICASE ACTIVITY 23 7.73e-01 9.36e-01 0.08640 8.63e-02 -4.79e-03 4.74e-01 9.68e-01
GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 41 6.44e-01 8.90e-01 0.08640 1.97e-02 -8.41e-02 8.27e-01 3.51e-01
GOBP REGULATION OF CELLULAR RESPIRATION 45 6.18e-01 8.80e-01 0.08640 8.37e-02 -2.13e-02 3.31e-01 8.04e-01
RAS signaling downstream of NF1 loss-of-function variants 7 9.15e-01 9.79e-01 0.08640 6.74e-02 5.40e-02 7.57e-01 8.05e-01
Signaling by Hedgehog 135 2.30e-01 6.48e-01 0.08630 -8.55e-02 1.21e-02 8.64e-02 8.08e-01
Vesicle-mediated transport 642 7.46e-04 2.57e-02 0.08630 -8.60e-02 -7.14e-03 1.99e-04 7.58e-01
GOBP CELLULAR RESPONSE TO HORMONE STIMULUS 596 2.77e-03 6.91e-02 0.08630 -7.41e-02 4.41e-02 1.99e-03 6.57e-02
GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY 86 3.75e-01 7.63e-01 0.08630 8.62e-02 3.77e-03 1.67e-01 9.52e-01
GOBP REGULATION OF CARDIAC CONDUCTION 26 7.60e-01 9.32e-01 0.08620 -8.24e-02 2.55e-02 4.67e-01 8.22e-01
GOBP POSITIVE REGULATION OF MACROAUTOPHAGY 83 4.37e-01 7.97e-01 0.08620 -6.90e-02 5.16e-02 2.77e-01 4.17e-01
Activation of NMDA receptors and postsynaptic events 86 3.72e-01 7.60e-01 0.08620 7.87e-03 8.58e-02 9.00e-01 1.69e-01
GOBP POSTSYNAPTIC DENSITY ASSEMBLY 24 7.46e-01 9.28e-01 0.08620 3.21e-02 8.00e-02 7.85e-01 4.98e-01
GOMF ALL TRANS RETINOL DEHYDROGENASE NADPPLUS ACTIVITY 13 8.74e-01 9.65e-01 0.08610 3.25e-02 -7.98e-02 8.39e-01 6.18e-01
GOBP POSITIVE REGULATION OF GLIOGENESIS 70 4.16e-01 7.86e-01 0.08610 5.42e-02 6.69e-02 4.33e-01 3.33e-01
GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION 54 5.27e-01 8.42e-01 0.08610 -2.02e-02 -8.37e-02 7.98e-01 2.87e-01
Uptake and actions of bacterial toxins 28 7.03e-01 9.12e-01 0.08610 -5.97e-02 -6.20e-02 5.84e-01 5.70e-01
GOCC SPERM MITOCHONDRIAL SHEATH 6 9.34e-01 9.83e-01 0.08600 6.81e-03 8.58e-02 9.77e-01 7.16e-01
GOBP CYTOKINETIC PROCESS 46 5.78e-01 8.64e-01 0.08600 -8.26e-02 -2.40e-02 3.33e-01 7.78e-01
GOCC M BAND 27 7.13e-01 9.15e-01 0.08600 -6.75e-02 -5.32e-02 5.44e-01 6.32e-01
GOBP ACYL COA METABOLIC PROCESS 89 4.12e-01 7.84e-01 0.08600 -7.11e-02 4.83e-02 2.46e-01 4.31e-01
GOMF DEACETYLASE ACTIVITY 36 6.95e-01 9.11e-01 0.08600 -4.25e-02 7.48e-02 6.59e-01 4.38e-01
GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS 26 7.22e-01 9.17e-01 0.08600 -6.03e-02 -6.13e-02 5.95e-01 5.89e-01
GOMF NUCLEASE ACTIVITY 210 7.81e-02 4.17e-01 0.08590 -7.76e-02 -3.70e-02 5.27e-02 3.56e-01
GOCC MULTIVESICULAR BODY MEMBRANE 28 7.14e-01 9.15e-01 0.08590 -2.88e-02 -8.09e-02 7.92e-01 4.58e-01
GOMF KINASE ACTIVITY 706 1.14e-03 3.62e-02 0.08590 -5.62e-02 6.49e-02 1.09e-02 3.29e-03
GOMF OXYSTEROL BINDING 16 8.48e-01 9.58e-01 0.08590 -3.04e-02 8.03e-02 8.33e-01 5.78e-01
GOBP TETRAHYDROFOLATE INTERCONVERSION 9 9.00e-01 9.74e-01 0.08580 8.43e-02 1.61e-02 6.61e-01 9.33e-01
GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 55 5.71e-01 8.61e-01 0.08580 -3.57e-02 7.80e-02 6.47e-01 3.17e-01
GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE 28 7.12e-01 9.14e-01 0.08580 7.87e-02 3.41e-02 4.71e-01 7.55e-01
EPHB-mediated forward signaling 41 6.63e-01 8.97e-01 0.08580 7.44e-02 -4.28e-02 4.10e-01 6.36e-01
GOBP NEPHRON MORPHOGENESIS 78 3.78e-01 7.64e-01 0.08580 -5.82e-02 -6.31e-02 3.74e-01 3.36e-01
GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION 15 8.29e-01 9.53e-01 0.08570 6.38e-02 5.72e-02 6.69e-01 7.01e-01
GOBP DNA REPAIR 579 9.93e-04 3.25e-02 0.08570 -7.57e-02 -4.02e-02 1.86e-03 9.80e-02
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION 71 4.26e-01 7.93e-01 0.08570 8.02e-02 3.03e-02 2.43e-01 6.59e-01
GOBP NEUROGENESIS 1676 9.51e-08 1.37e-05 0.08570 -8.21e-02 2.46e-02 2.23e-08 9.39e-02
GOBP REPRODUCTIVE SYSTEM DEVELOPMENT 291 3.08e-02 2.74e-01 0.08560 -7.84e-02 -3.45e-02 2.15e-02 3.11e-01
GOBP REGULATION OF DNA RECOMBINATION 135 1.89e-01 5.96e-01 0.08560 -6.84e-02 -5.14e-02 1.70e-01 3.02e-01
GOBP PLATELET AGGREGATION 74 4.34e-01 7.96e-01 0.08560 -6.24e-03 -8.53e-02 9.26e-01 2.04e-01
GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION 11 8.73e-01 9.65e-01 0.08550 -7.18e-02 -4.65e-02 6.80e-01 7.90e-01
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS 71 4.69e-01 8.14e-01 0.08550 1.42e-02 -8.43e-02 8.37e-01 2.19e-01
ECM proteoglycans 73 4.80e-01 8.21e-01 0.08550 -7.65e-02 3.83e-02 2.59e-01 5.71e-01
GOBP RESPONSE TO LEPTIN 21 7.74e-01 9.36e-01 0.08550 -4.15e-02 -7.48e-02 7.42e-01 5.53e-01
GOBP PROTEIN LOCALIZATION TO NUCLEUS 307 2.32e-02 2.44e-01 0.08550 -5.98e-02 -6.11e-02 7.17e-02 6.54e-02
GOBP MIRNA METABOLIC PROCESS 104 3.53e-01 7.47e-01 0.08550 -7.60e-02 3.91e-02 1.80e-01 4.91e-01
MyD88 cascade initiated on plasma membrane 91 3.28e-01 7.32e-01 0.08540 -4.65e-02 -7.17e-02 4.43e-01 2.37e-01
Toll Like Receptor 10 (TLR10) Cascade 91 3.28e-01 7.32e-01 0.08540 -4.65e-02 -7.17e-02 4.43e-01 2.37e-01
Toll Like Receptor 5 (TLR5) Cascade 91 3.28e-01 7.32e-01 0.08540 -4.65e-02 -7.17e-02 4.43e-01 2.37e-01
Fatty acyl-CoA biosynthesis 36 6.96e-01 9.11e-01 0.08540 -3.69e-02 7.71e-02 7.02e-01 4.24e-01
GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE 23 7.56e-01 9.30e-01 0.08540 4.11e-02 7.49e-02 7.33e-01 5.34e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE 171 1.68e-01 5.68e-01 0.08540 -1.91e-02 8.33e-02 6.67e-01 6.03e-02
GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY 7 9.17e-01 9.79e-01 0.08540 -6.02e-02 -6.05e-02 7.83e-01 7.81e-01
GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY 62 4.92e-01 8.27e-01 0.08530 -8.44e-02 -1.28e-02 2.51e-01 8.61e-01
GOBP REGULATION OF LEUKOCYTE DEGRANULATION 39 6.66e-01 8.98e-01 0.08530 2.13e-02 -8.26e-02 8.18e-01 3.72e-01
GOBP NEGATIVE REGULATION OF CELL GROWTH 161 1.53e-01 5.48e-01 0.08530 -8.22e-02 -2.31e-02 7.20e-02 6.13e-01
Competing endogenous RNAs (ceRNAs) regulate PTEN translation 16 8.37e-01 9.55e-01 0.08530 -8.53e-02 -1.40e-03 5.55e-01 9.92e-01
GOBP REGULATION OF B CELL ACTIVATION 124 2.95e-01 7.07e-01 0.08530 4.53e-02 -7.23e-02 3.84e-01 1.65e-01
GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY 182 1.50e-01 5.44e-01 0.08520 8.33e-02 -1.81e-02 5.26e-02 6.74e-01
GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY 333 3.94e-02 3.06e-01 0.08520 -7.14e-02 4.66e-02 2.51e-02 1.44e-01
GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT 22 7.71e-01 9.36e-01 0.08520 2.72e-02 8.08e-02 8.25e-01 5.12e-01
Branched-chain amino acid catabolism 20 7.96e-01 9.44e-01 0.08520 -1.14e-02 -8.45e-02 9.30e-01 5.13e-01
GOMF SYNTAXIN BINDING 59 5.63e-01 8.58e-01 0.08520 -6.49e-02 5.52e-02 3.88e-01 4.63e-01
GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS 15 8.44e-01 9.57e-01 0.08520 8.13e-03 8.48e-02 9.57e-01 5.70e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM 41 6.55e-01 8.93e-01 0.08520 2.32e-02 -8.19e-02 7.97e-01 3.64e-01
HIV Infection 211 8.97e-02 4.40e-01 0.08510 -1.71e-02 -8.34e-02 6.68e-01 3.68e-02
GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION 35 6.76e-01 9.04e-01 0.08510 5.72e-03 8.49e-02 9.53e-01 3.84e-01
PCP/CE pathway 79 3.79e-01 7.65e-01 0.08510 -5.96e-02 -6.08e-02 3.60e-01 3.50e-01
GOBP MESONEPHRIC TUBULE MORPHOGENESIS 65 4.52e-01 8.07e-01 0.08510 -5.22e-02 -6.72e-02 4.67e-01 3.49e-01
N-glycan trimming in the ER and Calnexin/Calreticulin cycle 35 7.07e-01 9.13e-01 0.08510 7.44e-02 -4.13e-02 4.46e-01 6.72e-01
GOBP PROTEOGLYCAN CATABOLIC PROCESS 9 9.16e-01 9.79e-01 0.08510 6.56e-02 -5.41e-02 7.33e-01 7.79e-01
GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX 860 3.90e-05 2.63e-03 0.08500 -5.69e-02 -6.32e-02 4.63e-03 1.65e-03
GOBP MICROTUBULE BASED TRANSPORT 208 9.08e-02 4.43e-01 0.08500 -8.20e-02 -2.24e-02 4.15e-02 5.78e-01
GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 219 7.27e-02 4.04e-01 0.08500 -7.39e-02 -4.20e-02 5.96e-02 2.84e-01
Triglyceride catabolism 23 8.00e-01 9.46e-01 0.08500 -6.43e-02 5.56e-02 5.94e-01 6.44e-01
GOBP VESICLE DOCKING 56 5.10e-01 8.34e-01 0.08500 -7.47e-02 -4.05e-02 3.34e-01 6.00e-01
GOBP FLOOR PLATE DEVELOPMENT 11 8.84e-01 9.69e-01 0.08490 -8.47e-02 -6.97e-03 6.27e-01 9.68e-01
GOCC SOMATODENDRITIC COMPARTMENT 802 3.81e-04 1.57e-02 0.08490 -8.04e-02 2.73e-02 1.07e-04 1.89e-01
GOBP MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION 8 9.20e-01 9.79e-01 0.08490 1.66e-02 -8.33e-02 9.35e-01 6.83e-01
GOBP HINDBRAIN DEVELOPMENT 149 1.64e-01 5.64e-01 0.08490 -6.64e-02 -5.28e-02 1.62e-01 2.66e-01
TAK1-dependent IKK and NF-kappa-B activation 41 6.11e-01 8.78e-01 0.08490 -4.05e-02 -7.46e-02 6.54e-01 4.09e-01
Signaling by PDGF 57 5.58e-01 8.56e-01 0.08480 -8.17e-02 2.29e-02 2.86e-01 7.65e-01
DNA strand elongation 31 7.08e-01 9.13e-01 0.08480 -7.11e-03 -8.45e-02 9.45e-01 4.16e-01
GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE 275 7.27e-02 4.04e-01 0.08480 -5.65e-02 6.32e-02 1.07e-01 7.14e-02
GOMF HEAT SHOCK PROTEIN BINDING 126 2.17e-01 6.35e-01 0.08470 -6.61e-02 -5.31e-02 2.00e-01 3.03e-01
GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS 10 8.92e-01 9.72e-01 0.08470 1.58e-02 8.33e-02 9.31e-01 6.48e-01
GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY 105 2.79e-01 6.92e-01 0.08470 -6.26e-02 -5.71e-02 2.68e-01 3.12e-01
GOBP RESPONSE TO ATP 31 7.42e-01 9.26e-01 0.08470 -5.98e-02 6.00e-02 5.64e-01 5.63e-01
GOMF PROTEIN KINASE ACTIVITY 551 5.58e-03 1.06e-01 0.08470 -6.60e-02 5.31e-02 8.07e-03 3.31e-02
GOBP ERYTHROCYTE HOMEOSTASIS 139 2.47e-01 6.62e-01 0.08470 2.73e-02 -8.02e-02 5.79e-01 1.03e-01
GOCC CORTICAL ACTIN CYTOSKELETON 74 4.87e-01 8.24e-01 0.08470 -4.48e-02 7.18e-02 5.05e-01 2.86e-01
GOBP ERAD PATHWAY 109 2.84e-01 6.96e-01 0.08460 -2.49e-02 -8.09e-02 6.53e-01 1.45e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS 130 2.60e-01 6.74e-01 0.08460 1.48e-02 -8.33e-02 7.71e-01 1.01e-01
GOBP CELLULAR RESPONSE TO UV A 10 8.88e-01 9.71e-01 0.08450 -3.78e-02 -7.56e-02 8.36e-01 6.79e-01
Apoptosis 160 1.67e-01 5.68e-01 0.08450 -1.32e-02 -8.35e-02 7.73e-01 6.84e-02
GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY 18 8.24e-01 9.52e-01 0.08450 2.37e-03 -8.45e-02 9.86e-01 5.35e-01
GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING 11 8.86e-01 9.69e-01 0.08450 -6.03e-03 -8.43e-02 9.72e-01 6.28e-01
GOBP ACROSOME ASSEMBLY 30 7.39e-01 9.24e-01 0.08450 -8.02e-02 2.64e-02 4.47e-01 8.02e-01
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 150 1.99e-01 6.12e-01 0.08450 1.19e-04 -8.45e-02 9.98e-01 7.41e-02
GOMF FOUR WAY JUNCTION HELICASE ACTIVITY 6 9.38e-01 9.85e-01 0.08450 -8.43e-02 5.54e-03 7.21e-01 9.81e-01
GOBP TRIPARTITE REGIONAL SUBDIVISION 20 8.21e-01 9.52e-01 0.08440 -3.45e-02 7.71e-02 7.90e-01 5.51e-01
GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 79 3.92e-01 7.71e-01 0.08440 4.05e-02 7.41e-02 5.34e-01 2.55e-01
GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY 28 7.13e-01 9.15e-01 0.08440 6.59e-02 5.28e-02 5.46e-01 6.29e-01
CLEC7A (Dectin-1) signaling 85 3.59e-01 7.51e-01 0.08430 -5.99e-02 -5.93e-02 3.40e-01 3.44e-01
GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY 13 8.68e-01 9.63e-01 0.08430 3.10e-03 8.42e-02 9.85e-01 5.99e-01
RHOV GTPase cycle 36 7.09e-01 9.13e-01 0.08430 -5.17e-02 6.66e-02 5.92e-01 4.89e-01
GOMF UBIQUITIN LIKE LIGASE SUBSTRATE ADAPTOR ACTIVITY 56 5.36e-01 8.47e-01 0.08430 -1.25e-02 -8.33e-02 8.71e-01 2.81e-01
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors 34 6.96e-01 9.11e-01 0.08420 -8.41e-02 3.52e-03 3.96e-01 9.72e-01
GOBP CHROMOSOME SEGREGATION 409 1.10e-02 1.64e-01 0.08420 -8.28e-02 -1.53e-02 4.07e-03 5.95e-01
GOBP CARBOHYDRATE METABOLIC PROCESS 542 4.84e-03 9.71e-02 0.08420 -2.40e-02 8.07e-02 3.40e-01 1.31e-03
GOBP AMYLOID BETA METABOLIC PROCESS 64 5.43e-01 8.51e-01 0.08410 6.81e-02 -4.94e-02 3.46e-01 4.94e-01
GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING 16 8.59e-01 9.60e-01 0.08410 -5.52e-02 6.35e-02 7.02e-01 6.60e-01
GOBP HORMONE TRANSPORT 315 4.80e-02 3.31e-01 0.08410 -7.60e-02 3.61e-02 2.04e-02 2.71e-01
Netrin mediated repulsion signals 8 9.18e-01 9.79e-01 0.08410 4.28e-03 -8.40e-02 9.83e-01 6.81e-01
GOBP RELAXATION OF MUSCLE 33 7.31e-01 9.22e-01 0.08410 -5.28e-02 6.55e-02 6.00e-01 5.15e-01
GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION 151 2.07e-01 6.22e-01 0.08410 -8.37e-02 8.06e-03 7.59e-02 8.64e-01
GOBP REGULATION OF RENAL SYSTEM PROCESS 21 8.16e-01 9.51e-01 0.08400 4.11e-02 -7.33e-02 7.44e-01 5.61e-01
GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 202 9.32e-02 4.46e-01 0.08400 -4.35e-02 -7.19e-02 2.87e-01 7.81e-02
GOMF PROTEIN ANTIGEN BINDING 7 9.31e-01 9.83e-01 0.08400 -1.83e-02 8.20e-02 9.33e-01 7.07e-01
GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION 29 7.18e-01 9.15e-01 0.08400 2.56e-02 8.00e-02 8.12e-01 4.56e-01
Gap-filling DNA repair synthesis and ligation in GG-NER 25 7.60e-01 9.32e-01 0.08400 -9.81e-03 -8.34e-02 9.32e-01 4.70e-01
HIV Life Cycle 145 2.20e-01 6.37e-01 0.08400 6.95e-03 -8.37e-02 8.85e-01 8.20e-02
GOBP EPITHELIAL TUBE MORPHOGENESIS 326 2.36e-02 2.45e-01 0.08390 -7.63e-02 -3.49e-02 1.78e-02 2.79e-01
GOMF REGULATORY RNA BINDING 50 5.89e-01 8.68e-01 0.08390 3.67e-03 -8.39e-02 9.64e-01 3.05e-01
GOBP CELL GROWTH 460 1.11e-02 1.64e-01 0.08390 -8.01e-02 2.51e-02 3.24e-03 3.57e-01
ERK/MAPK targets 20 8.28e-01 9.53e-01 0.08390 -5.71e-02 6.14e-02 6.58e-01 6.34e-01
GOBP MICROGLIA DIFFERENTIATION 12 8.89e-01 9.71e-01 0.08380 -3.14e-02 7.77e-02 8.51e-01 6.41e-01
GOBP REGULATION OF PROTEIN BINDING 120 3.18e-01 7.25e-01 0.08380 -7.29e-02 4.14e-02 1.68e-01 4.33e-01
GOBP ENDOSOMAL TRANSPORT 276 7.35e-02 4.06e-01 0.08380 -7.20e-02 4.30e-02 3.97e-02 2.19e-01
Axon guidance 510 7.19e-03 1.25e-01 0.08380 2.74e-02 -7.92e-02 2.90e-01 2.20e-03
GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS 51 5.54e-01 8.54e-01 0.08380 7.65e-02 3.42e-02 3.45e-01 6.73e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II 48 6.02e-01 8.75e-01 0.08380 3.19e-03 -8.37e-02 9.70e-01 3.16e-01
GOBP SKIN EPIDERMIS DEVELOPMENT 128 2.46e-01 6.61e-01 0.08370 8.29e-02 1.19e-02 1.05e-01 8.17e-01
GOBP SYNAPTIC TRANSMISSION CHOLINERGIC 32 7.31e-01 9.22e-01 0.08370 -7.81e-02 2.99e-02 4.44e-01 7.70e-01
Diseases of signal transduction by growth factor receptors and second messengers 440 6.84e-03 1.21e-01 0.08360 -7.63e-02 -3.41e-02 6.04e-03 2.21e-01
Phase 0 - rapid depolarisation 31 7.01e-01 9.12e-01 0.08360 7.79e-02 3.04e-02 4.53e-01 7.70e-01
GOBP POSITIVE REGULATION OF RESPONSE TO TYPE II INTERFERON 6 9.31e-01 9.83e-01 0.08360 -6.28e-02 -5.51e-02 7.90e-01 8.15e-01
GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY 20 8.22e-01 9.52e-01 0.08340 2.75e-02 -7.88e-02 8.31e-01 5.42e-01
GOBP RENAL SYSTEM DEVELOPMENT 322 3.19e-02 2.80e-01 0.08340 -8.28e-02 -9.68e-03 1.06e-02 7.65e-01
GOCC SPERM MIDPIECE 54 6.05e-01 8.76e-01 0.08330 6.29e-02 -5.47e-02 4.24e-01 4.87e-01
GOBP PROTEIN TARGETING TO MEMBRANE 111 3.42e-01 7.40e-01 0.08330 -3.09e-02 7.74e-02 5.74e-01 1.59e-01
GOBP HORMONE CATABOLIC PROCESS 12 8.79e-01 9.67e-01 0.08330 7.26e-03 8.30e-02 9.65e-01 6.19e-01
GOBP REVERSIBLE DIFFERENTIATION 11 8.79e-01 9.67e-01 0.08330 5.24e-02 6.47e-02 7.63e-01 7.10e-01
GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING 17 8.53e-01 9.59e-01 0.08320 -6.80e-02 4.80e-02 6.28e-01 7.32e-01
GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION 8 9.10e-01 9.77e-01 0.08320 6.31e-02 5.42e-02 7.57e-01 7.91e-01
GOBP TRACHEA DEVELOPMENT 18 8.21e-01 9.52e-01 0.08320 -8.17e-02 -1.54e-02 5.48e-01 9.10e-01
O-glycosylation of TSR domain-containing proteins 38 6.50e-01 8.92e-01 0.08320 7.77e-02 2.97e-02 4.07e-01 7.51e-01
GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY 46 6.26e-01 8.84e-01 0.08320 -8.24e-02 1.10e-02 3.33e-01 8.97e-01
GOBP RESPONSE TO TESTOSTERONE 41 6.47e-01 8.91e-01 0.08310 -8.31e-02 -3.79e-03 3.57e-01 9.67e-01
GOMF UBIQUITIN CONJUGATING ENZYME BINDING 31 7.43e-01 9.26e-01 0.08310 -7.63e-02 3.30e-02 4.62e-01 7.50e-01
GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 19 8.07e-01 9.48e-01 0.08310 -7.76e-02 -2.97e-02 5.58e-01 8.23e-01
GOBP BILE ACID BIOSYNTHETIC PROCESS 37 6.99e-01 9.11e-01 0.08310 -2.84e-02 7.81e-02 7.65e-01 4.11e-01
GOBP REGULATION OF VASCULAR PERMEABILITY 49 6.15e-01 8.80e-01 0.08310 -8.08e-02 1.91e-02 3.28e-01 8.17e-01
GOBP PEROXISOME FISSION 9 9.01e-01 9.74e-01 0.08300 -4.45e-02 -7.01e-02 8.17e-01 7.16e-01
GOMF MOLECULAR SEQUESTERING ACTIVITY 44 5.98e-01 8.73e-01 0.08300 5.47e-02 6.24e-02 5.30e-01 4.74e-01
GOBP RESPONSE TO FATTY ACID 55 5.79e-01 8.64e-01 0.08290 -8.11e-02 1.74e-02 2.98e-01 8.24e-01
TP53 Regulates Transcription of DNA Repair Genes 61 5.16e-01 8.38e-01 0.08290 -1.49e-02 -8.15e-02 8.40e-01 2.71e-01
GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE 6 9.38e-01 9.85e-01 0.08290 -8.24e-02 -8.93e-03 7.27e-01 9.70e-01
GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 16 8.59e-01 9.60e-01 0.08280 3.47e-02 -7.52e-02 8.10e-01 6.02e-01
GOBP POSITIVE REGULATION OF TRANSLATION 119 2.90e-01 7.03e-01 0.08280 -5.04e-04 -8.28e-02 9.92e-01 1.19e-01
GOBP REGULATION OF CELLULAR CATABOLIC PROCESS 440 1.43e-02 1.90e-01 0.08280 -8.03e-02 2.02e-02 3.87e-03 4.67e-01
GOBP REGULATION OF CILIUM BEAT FREQUENCY 17 8.52e-01 9.59e-01 0.08280 3.87e-02 -7.32e-02 7.82e-01 6.01e-01
GOCC POLYPRENYL DIPHOSPHATE SYNTHASE COMPLEX 10 8.94e-01 9.73e-01 0.08280 -2.70e-02 -7.83e-02 8.83e-01 6.68e-01
GOBP CALCIUM ION IMPORT 80 4.37e-01 7.97e-01 0.08270 -8.27e-02 1.14e-03 2.01e-01 9.86e-01
GOBP INNER EAR RECEPTOR CELL DEVELOPMENT 47 5.85e-01 8.67e-01 0.08270 7.24e-02 4.00e-02 3.90e-01 6.36e-01
GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS 50 6.20e-01 8.80e-01 0.08270 2.93e-02 -7.74e-02 7.20e-01 3.44e-01
GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION 120 2.87e-01 7.00e-01 0.08270 -1.72e-03 -8.27e-02 9.74e-01 1.18e-01
GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT 62 5.26e-01 8.42e-01 0.08270 2.07e-04 -8.27e-02 9.98e-01 2.60e-01
GOBP CELLULAR RESPONSE TO CAFFEINE 11 9.02e-01 9.75e-01 0.08270 3.97e-02 -7.25e-02 8.19e-01 6.77e-01
GOBP ZINC ION TRANSPORT 29 7.65e-01 9.33e-01 0.08270 6.84e-02 -4.64e-02 5.24e-01 6.66e-01
Regulation of lipid metabolism by PPARalpha 115 3.32e-01 7.35e-01 0.08260 -7.84e-02 2.58e-02 1.46e-01 6.32e-01
GOBP POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE 9 9.14e-01 9.78e-01 0.08260 8.14e-02 -1.38e-02 6.72e-01 9.43e-01
GOMF PEPTIDASE REGULATOR ACTIVITY 221 1.11e-01 4.83e-01 0.08260 8.18e-02 -1.13e-02 3.62e-02 7.73e-01
GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY 19 8.38e-01 9.55e-01 0.08260 -7.23e-02 3.99e-02 5.85e-01 7.64e-01
GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY 20 8.31e-01 9.54e-01 0.08250 7.10e-02 -4.22e-02 5.83e-01 7.44e-01
GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY 67 4.62e-01 8.12e-01 0.08250 -5.45e-02 -6.20e-02 4.40e-01 3.80e-01
GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION 132 2.19e-01 6.37e-01 0.08250 -5.56e-02 -6.10e-02 2.70e-01 2.26e-01
GOBP I KAPPAB PHOSPHORYLATION 14 8.74e-01 9.65e-01 0.08250 -7.79e-02 2.71e-02 6.14e-01 8.61e-01
GOMF SPECTRIN BINDING 26 7.89e-01 9.42e-01 0.08250 -5.88e-02 5.78e-02 6.04e-01 6.10e-01
MECP2 regulates neuronal receptors and channels 17 8.31e-01 9.54e-01 0.08250 -1.86e-02 -8.04e-02 8.94e-01 5.66e-01
GOBP RESPONSE TO ENDOGENOUS STIMULUS 1659 4.77e-07 5.63e-05 0.08250 -7.62e-02 3.15e-02 2.32e-07 3.27e-02
GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION 13 8.80e-01 9.67e-01 0.08240 1.86e-02 -8.03e-02 9.08e-01 6.16e-01
GOMF PHOSPHOLIPID TRANSFER ACTIVITY 25 7.91e-01 9.42e-01 0.08240 -7.39e-02 3.66e-02 5.23e-01 7.52e-01
GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY 41 6.42e-01 8.89e-01 0.08240 1.66e-02 8.07e-02 8.54e-01 3.71e-01
GOBP NEPHRON DEVELOPMENT 156 1.72e-01 5.75e-01 0.08240 -7.20e-02 -4.02e-02 1.21e-01 3.86e-01
GOBP NEURON PROJECTION ARBORIZATION 32 7.29e-01 9.21e-01 0.08240 -8.10e-02 1.54e-02 4.28e-01 8.80e-01
GOMF CYCLIC NUCLEOTIDE BINDING 36 7.15e-01 9.15e-01 0.08240 -3.85e-02 7.29e-02 6.90e-01 4.49e-01
GOMF ZINC ION BINDING 787 5.32e-04 2.00e-02 0.08240 -8.13e-02 1.35e-02 1.05e-04 5.21e-01
GOBP HEME B METABOLIC PROCESS 9 9.07e-01 9.76e-01 0.08240 -1.77e-02 -8.05e-02 9.27e-01 6.76e-01
GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY 20 8.14e-01 9.50e-01 0.08240 8.24e-02 -5.21e-04 5.24e-01 9.97e-01
GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS 14 8.80e-01 9.67e-01 0.08230 5.85e-02 -5.80e-02 7.05e-01 7.07e-01
GOBP IP 10 PRODUCTION 5 9.50e-01 9.88e-01 0.08230 -2.31e-03 -8.22e-02 9.93e-01 7.50e-01
GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY 5 9.55e-01 9.88e-01 0.08230 -7.19e-02 4.00e-02 7.81e-01 8.77e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY 130 2.89e-01 7.01e-01 0.08220 -2.39e-02 7.87e-02 6.39e-01 1.21e-01
GOBP RUFFLE ASSEMBLY 44 6.04e-01 8.76e-01 0.08220 5.16e-02 6.40e-02 5.54e-01 4.62e-01
GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION 59 5.14e-01 8.36e-01 0.08220 4.06e-02 7.15e-02 5.89e-01 3.42e-01
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 71 5.23e-01 8.42e-01 0.08220 4.58e-02 -6.82e-02 5.04e-01 3.20e-01
GOBP NUCLEIC ACID CATABOLIC PROCESS 755 2.40e-04 1.13e-02 0.08220 -4.94e-02 -6.56e-02 2.08e-02 2.15e-03
SUMO is transferred from E1 to E2 (UBE2I, UBC9) 7 9.26e-01 9.82e-01 0.08220 -7.76e-02 -2.69e-02 7.22e-01 9.02e-01
GOBP SENSORY PERCEPTION 871 3.55e-04 1.49e-02 0.08210 7.73e-02 -2.78e-02 1.08e-04 1.64e-01
Factors involved in megakaryocyte development and platelet production 148 2.19e-01 6.37e-01 0.08210 8.21e-02 2.48e-03 8.47e-02 9.59e-01
GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION 48 6.40e-01 8.88e-01 0.08210 7.45e-02 -3.45e-02 3.72e-01 6.79e-01
GOBP FEMALE MEIOTIC NUCLEAR DIVISION 39 6.41e-01 8.89e-01 0.08210 -5.23e-02 -6.33e-02 5.72e-01 4.94e-01
FCERI mediated MAPK activation 32 7.02e-01 9.12e-01 0.08210 -3.00e-02 -7.64e-02 7.69e-01 4.54e-01
GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 450 1.78e-02 2.12e-01 0.08210 -4.48e-02 6.88e-02 1.03e-01 1.24e-02
GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS 30 7.11e-01 9.14e-01 0.08210 -6.76e-02 -4.66e-02 5.22e-01 6.59e-01
GOBP LEUKOTRIENE CATABOLIC PROCESS 6 9.46e-01 9.87e-01 0.08210 3.47e-02 -7.43e-02 8.83e-01 7.52e-01
GOCC RIBONUCLEOPROTEIN COMPLEX 1008 3.56e-05 2.41e-03 0.08200 -1.43e-02 -8.08e-02 4.43e-01 1.43e-05
GOBP NECROPTOTIC PROCESS 45 6.54e-01 8.93e-01 0.08200 7.73e-02 -2.75e-02 3.70e-01 7.50e-01
GOBP UDP N ACETYLGLUCOSAMINE TRANSMEMBRANE TRANSPORT 5 9.53e-01 9.88e-01 0.08200 1.90e-02 -7.97e-02 9.41e-01 7.58e-01
GOMF UDP N ACETYLGLUCOSAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY 5 9.53e-01 9.88e-01 0.08200 1.90e-02 -7.97e-02 9.41e-01 7.58e-01
GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY 7 9.23e-01 9.81e-01 0.08200 -5.32e-02 -6.23e-02 8.07e-01 7.75e-01
GOBP IMMUNE EFFECTOR PROCESS 621 4.09e-03 8.87e-02 0.08190 6.85e-02 -4.49e-02 3.55e-03 5.59e-02
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY 309 5.81e-02 3.66e-01 0.08190 3.22e-02 -7.53e-02 3.30e-01 2.27e-02
GOBP MEMBRANE FISSION 44 6.72e-01 9.01e-01 0.08190 -6.57e-02 4.89e-02 4.51e-01 5.75e-01
GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 71 4.66e-01 8.14e-01 0.08190 7.94e-02 2.02e-02 2.48e-01 7.68e-01
GOBP CELL SURFACE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 630 4.03e-03 8.81e-02 0.08190 -6.15e-02 5.40e-02 8.37e-03 2.06e-02
GOBP PROTEIN HETEROTETRAMERIZATION 15 8.54e-01 9.59e-01 0.08190 -1.25e-02 -8.09e-02 9.33e-01 5.87e-01
GOMF OLIGOPEPTIDE BINDING 11 8.93e-01 9.72e-01 0.08180 3.66e-03 8.18e-02 9.83e-01 6.39e-01
GOBP POLYOL METABOLIC PROCESS 101 3.31e-01 7.34e-01 0.08180 7.60e-02 3.04e-02 1.87e-01 5.97e-01
Plasma lipoprotein remodeling 33 6.92e-01 9.09e-01 0.08180 -7.23e-02 -3.82e-02 4.72e-01 7.04e-01
GOCC GOLGI ASSOCIATED VESICLE MEMBRANE 55 5.50e-01 8.53e-01 0.08180 2.68e-02 7.73e-02 7.31e-01 3.22e-01
EPH-Ephrin signaling 90 4.25e-01 7.93e-01 0.08180 -7.86e-02 2.25e-02 1.97e-01 7.12e-01
GOBP CELL CELL SIGNALING 1255 1.34e-05 1.07e-03 0.08180 -7.79e-02 2.47e-02 3.40e-06 1.41e-01
GOBP REGULATION OF OSSIFICATION 119 2.85e-01 6.97e-01 0.08170 -8.02e-02 -1.58e-02 1.31e-01 7.65e-01
TP53 Regulates Metabolic Genes 80 4.77e-01 8.19e-01 0.08170 -7.51e-02 3.23e-02 2.46e-01 6.18e-01
GOBP PROTEIN N LINKED GLYCOSYLATION 70 5.25e-01 8.42e-01 0.08160 7.45e-02 -3.33e-02 2.81e-01 6.30e-01
GOBP CORTICAL CYTOSKELETON ORGANIZATION 52 6.24e-01 8.82e-01 0.08160 -7.04e-02 4.14e-02 3.80e-01 6.06e-01
GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 217 1.40e-01 5.31e-01 0.08150 -3.68e-02 7.27e-02 3.50e-01 6.48e-02
GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS 171 1.50e-01 5.44e-01 0.08150 6.82e-02 4.47e-02 1.24e-01 3.13e-01
GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 201 1.18e-01 4.94e-01 0.08150 -7.86e-02 -2.17e-02 5.48e-02 5.96e-01
GOBP FILOPODIUM ASSEMBLY 64 5.02e-01 8.30e-01 0.08150 2.55e-02 7.74e-02 7.24e-01 2.84e-01
GOBP CERAMIDE BIOSYNTHETIC PROCESS 69 4.82e-01 8.22e-01 0.08150 1.77e-02 7.95e-02 7.99e-01 2.53e-01
GOBP POSITIVE REGULATION OF NUCLEAR DIVISION 61 5.68e-01 8.59e-01 0.08140 7.59e-02 -2.95e-02 3.05e-01 6.90e-01
GOBP BONE REMODELING 90 4.50e-01 8.06e-01 0.08140 -6.05e-02 5.45e-02 3.21e-01 3.71e-01
Golgi Associated Vesicle Biogenesis 51 5.82e-01 8.66e-01 0.08140 -1.90e-02 -7.92e-02 8.14e-01 3.28e-01
GOBP NEGATIVE REGULATION OF CELL CYCLE 391 1.34e-02 1.84e-01 0.08140 -5.01e-02 -6.42e-02 8.90e-02 2.94e-02
GOBP NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS 8 9.31e-01 9.83e-01 0.08140 -5.60e-02 5.91e-02 7.84e-01 7.72e-01
GOBP REGULATION OF AUTOPHAGY 349 3.20e-02 2.80e-01 0.08140 -8.14e-02 2.03e-03 9.00e-03 9.48e-01
GOBP REGULATION OF HEAT GENERATION 13 8.88e-01 9.71e-01 0.08140 3.46e-02 -7.37e-02 8.29e-01 6.46e-01
GOBP REGULATION OF NUCLEOTIDE CATABOLIC PROCESS 50 5.72e-01 8.61e-01 0.08130 6.57e-02 4.80e-02 4.22e-01 5.57e-01
GOCC SARCOPLASMIC RETICULUM MEMBRANE 42 6.49e-01 8.91e-01 0.08130 8.44e-03 8.09e-02 9.25e-01 3.64e-01
Cytokine Signaling in Immune system 723 1.85e-03 5.12e-02 0.08130 4.23e-02 -6.94e-02 5.29e-02 1.47e-03
GOBP GLIAL CELL DIFFERENTIATION 256 8.13e-02 4.22e-01 0.08130 -8.12e-02 4.49e-03 2.54e-02 9.02e-01
GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY 35 7.31e-01 9.22e-01 0.08130 -6.84e-02 4.39e-02 4.84e-01 6.53e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY 14 8.61e-01 9.61e-01 0.08130 -2.21e-02 -7.82e-02 8.86e-01 6.12e-01
GOBP ANTIVIRAL INNATE IMMUNE RESPONSE 54 5.47e-01 8.52e-01 0.08130 -6.17e-02 -5.29e-02 4.33e-01 5.01e-01
Glycolysis 72 5.29e-01 8.43e-01 0.08130 -5.14e-02 6.29e-02 4.50e-01 3.56e-01
GOBP GLYCOSYLCERAMIDE BIOSYNTHETIC PROCESS 8 9.14e-01 9.78e-01 0.08120 5.19e-02 6.25e-02 7.99e-01 7.59e-01
Adherens junctions interactions 58 5.52e-01 8.54e-01 0.08120 -8.08e-02 -8.30e-03 2.87e-01 9.13e-01
GOBP RESPONSE TO THYROID HORMONE 24 7.79e-01 9.39e-01 0.08120 1.41e-02 8.00e-02 9.05e-01 4.98e-01
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS 20 8.28e-01 9.53e-01 0.08120 7.86e-02 -2.03e-02 5.43e-01 8.75e-01
GOBP P38MAPK CASCADE 59 5.18e-01 8.39e-01 0.08120 -6.25e-02 -5.19e-02 4.07e-01 4.91e-01
GOBP INTERMEDIATE FILAMENT BUNDLE ASSEMBLY 8 9.16e-01 9.79e-01 0.08120 3.92e-02 7.11e-02 8.48e-01 7.28e-01
GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY 32 7.54e-01 9.30e-01 0.08120 5.85e-02 -5.63e-02 5.67e-01 5.82e-01
GOBP NEURON APOPTOTIC PROCESS 279 6.03e-02 3.73e-01 0.08110 -8.08e-02 -6.80e-03 2.02e-02 8.45e-01
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE 243 6.93e-02 3.96e-01 0.08110 -4.77e-02 -6.55e-02 2.01e-01 7.84e-02
GOBP GOLGI RIBBON FORMATION 11 9.07e-01 9.76e-01 0.08100 -6.70e-02 4.57e-02 7.01e-01 7.93e-01
GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION 39 6.63e-01 8.97e-01 0.08100 -7.86e-02 -1.99e-02 3.96e-01 8.30e-01
GOBP SENSORY PERCEPTION OF LIGHT STIMULUS 207 1.63e-01 5.62e-01 0.08100 -4.91e-02 6.45e-02 2.24e-01 1.10e-01
GOBP TERPENOID METABOLIC PROCESS 98 3.62e-01 7.52e-01 0.08100 7.93e-02 1.60e-02 1.75e-01 7.84e-01
GOBP RESPONSE TO CADMIUM ION 57 5.92e-01 8.70e-01 0.08090 -7.63e-02 2.72e-02 3.19e-01 7.23e-01
GOBP SENSORY PERCEPTION OF PAIN 79 4.92e-01 8.26e-01 0.08090 3.62e-02 -7.24e-02 5.78e-01 2.66e-01
Synthesis of PA 38 7.07e-01 9.13e-01 0.08090 3.06e-02 -7.49e-02 7.44e-01 4.24e-01
Signaling by Non-Receptor Tyrosine Kinases 54 6.18e-01 8.80e-01 0.08090 7.00e-02 -4.06e-02 3.74e-01 6.06e-01
Signaling by PTK6 54 6.18e-01 8.80e-01 0.08090 7.00e-02 -4.06e-02 3.74e-01 6.06e-01
GOBP DENDRITE MORPHOGENESIS 133 3.11e-01 7.20e-01 0.08090 -6.49e-02 4.84e-02 1.97e-01 3.35e-01
GOMF PROTEIN FOLDING CHAPERONE BINDING 129 2.44e-01 6.58e-01 0.08090 -6.88e-02 -4.25e-02 1.77e-01 4.04e-01
GOBP REGULATION OF FILOPODIUM ASSEMBLY 45 6.13e-01 8.78e-01 0.08090 3.78e-02 7.15e-02 6.61e-01 4.07e-01
GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT 13 8.77e-01 9.66e-01 0.08090 -8.06e-02 -5.98e-03 6.15e-01 9.70e-01
GOMF TRANSCRIPTION COREPRESSOR ACTIVITY 183 1.38e-01 5.29e-01 0.08090 -7.19e-02 -3.70e-02 9.35e-02 3.88e-01
GOBP INHIBITORY POSTSYNAPTIC POTENTIAL 16 8.57e-01 9.60e-01 0.08080 -9.00e-03 8.03e-02 9.50e-01 5.78e-01
GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION 14 8.59e-01 9.60e-01 0.08080 -3.71e-02 -7.18e-02 8.10e-01 6.42e-01
GOCC CORTICAL CYTOSKELETON 105 4.00e-01 7.78e-01 0.08080 -5.15e-02 6.22e-02 3.62e-01 2.71e-01
GOBP POSITIVE REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY 5 9.47e-01 9.87e-01 0.08070 -6.88e-02 -4.23e-02 7.90e-01 8.70e-01
MyD88:MAL(TIRAP) cascade initiated on plasma membrane 106 3.24e-01 7.28e-01 0.08070 -2.90e-02 -7.54e-02 6.06e-01 1.80e-01
Toll Like Receptor TLR6:TLR2 Cascade 106 3.24e-01 7.28e-01 0.08070 -2.90e-02 -7.54e-02 6.06e-01 1.80e-01
GOBP MITOCHONDRION LOCALIZATION 47 5.97e-01 8.73e-01 0.08070 -4.56e-02 -6.66e-02 5.88e-01 4.30e-01
GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX 13 8.69e-01 9.64e-01 0.08070 -3.30e-02 -7.37e-02 8.37e-01 6.46e-01
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT 139 2.64e-01 6.79e-01 0.08070 -8.02e-02 8.99e-03 1.03e-01 8.55e-01
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE 30 7.35e-01 9.23e-01 0.08060 7.96e-02 1.31e-02 4.51e-01 9.02e-01
GOCC PERICENTRIOLAR MATERIAL 22 8.06e-01 9.48e-01 0.08060 2.71e-03 -8.06e-02 9.82e-01 5.13e-01
GOBP INORGANIC ANION TRANSPORT 162 1.82e-01 5.86e-01 0.08060 7.62e-02 2.64e-02 9.43e-02 5.62e-01
GOBP PROTEIN PALMITOYLATION 28 7.78e-01 9.39e-01 0.08060 -7.22e-02 3.59e-02 5.09e-01 7.42e-01
Mitotic Prometaphase 192 1.22e-01 5.01e-01 0.08060 -5.75e-02 -5.64e-02 1.69e-01 1.78e-01
GOCC MALE GERM CELL NUCLEUS 52 6.32e-01 8.86e-01 0.08060 4.15e-02 -6.90e-02 6.04e-01 3.89e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY 29 7.39e-01 9.25e-01 0.08050 -7.79e-02 -2.03e-02 4.68e-01 8.50e-01
GOBP THIOESTER BIOSYNTHETIC PROCESS 43 6.75e-01 9.03e-01 0.08050 -2.54e-02 7.64e-02 7.73e-01 3.86e-01
GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY 515 1.26e-02 1.77e-01 0.08050 6.03e-02 -5.33e-02 1.93e-02 3.83e-02
GOBP NEURONAL ION CHANNEL CLUSTERING 12 8.98e-01 9.74e-01 0.08040 -7.22e-02 3.54e-02 6.65e-01 8.32e-01
GOBP ADRENAL GLAND DEVELOPMENT 26 7.55e-01 9.30e-01 0.08040 -7.05e-02 -3.87e-02 5.34e-01 7.33e-01
GOBP BASIC AMINO ACID TRANSPORT 21 8.02e-01 9.46e-01 0.08040 -7.62e-02 -2.57e-02 5.45e-01 8.38e-01
GOBP ASTROCYTE DIFFERENTIATION 85 4.29e-01 7.94e-01 0.08040 -8.02e-02 -5.91e-03 2.01e-01 9.25e-01
GOBP PLATELET ACTIVATION 132 2.37e-01 6.54e-01 0.08040 -5.10e-02 -6.21e-02 3.12e-01 2.18e-01
GOBP CHEMOKINE PRODUCTION 101 3.92e-01 7.71e-01 0.08040 -1.78e-02 7.84e-02 7.57e-01 1.74e-01
Opsins 7 9.31e-01 9.83e-01 0.08040 1.17e-02 7.95e-02 9.57e-01 7.16e-01
GOBP ACTIVATION OF INNATE IMMUNE RESPONSE 291 7.63e-02 4.14e-01 0.08040 7.34e-02 -3.28e-02 3.13e-02 3.36e-01
GOBP PHOSPHOLIPID TRANSPORT 101 4.05e-01 7.81e-01 0.08030 -7.39e-02 3.15e-02 1.99e-01 5.84e-01
GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS 40 6.64e-01 8.97e-01 0.08030 7.89e-02 1.53e-02 3.88e-01 8.67e-01
GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 55 6.08e-01 8.77e-01 0.08030 2.79e-02 -7.53e-02 7.21e-01 3.34e-01
GOCC ACROSOMAL MEMBRANE 32 7.42e-01 9.26e-01 0.08030 1.67e-02 -7.85e-02 8.70e-01 4.42e-01
GOBP RESPONSE TO ANTIBIOTIC 36 7.19e-01 9.15e-01 0.08030 -7.72e-02 2.20e-02 4.23e-01 8.19e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION 15 8.70e-01 9.64e-01 0.08030 -7.82e-02 1.81e-02 6.00e-01 9.04e-01
GOCC GAMMA TUBULIN COMPLEX 18 8.26e-01 9.52e-01 0.08020 -7.33e-02 -3.27e-02 5.90e-01 8.10e-01
GOBP LIPOXYGENASE PATHWAY 11 8.97e-01 9.73e-01 0.08020 5.15e-03 8.01e-02 9.76e-01 6.46e-01
GOBP SEX CHROMOSOME DOSAGE COMPENSATION 15 8.49e-01 9.58e-01 0.08020 -5.77e-02 -5.57e-02 6.99e-01 7.09e-01
GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY 23 8.18e-01 9.51e-01 0.08020 4.19e-02 -6.84e-02 7.28e-01 5.70e-01
GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION 348 2.93e-02 2.70e-01 0.08020 -7.79e-02 -1.91e-02 1.26e-02 5.41e-01
GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS 30 7.34e-01 9.23e-01 0.08020 -7.75e-02 -2.04e-02 4.62e-01 8.47e-01
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 49 6.55e-01 8.93e-01 0.08020 6.17e-02 -5.11e-02 4.55e-01 5.36e-01
GOCC PLATELET ALPHA GRANULE 82 4.11e-01 7.84e-01 0.08010 -5.22e-02 -6.08e-02 4.14e-01 3.42e-01
GOMF LYSOPHOSPHATIDIC ACID PHOSPHATASE ACTIVITY 7 9.27e-01 9.82e-01 0.08000 6.03e-02 5.27e-02 7.82e-01 8.09e-01
GOMF MODIFIED AMINO ACID BINDING 95 4.14e-01 7.85e-01 0.08000 -1.44e-02 7.87e-02 8.08e-01 1.85e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT 6 9.44e-01 9.87e-01 0.08000 2.63e-03 -7.99e-02 9.91e-01 7.35e-01
GOCC ACTIN BASED CELL PROJECTION 221 9.60e-02 4.52e-01 0.08000 6.95e-02 3.96e-02 7.51e-02 3.10e-01
GOBP DETOXIFICATION OF COPPER ION 15 8.52e-01 9.59e-01 0.08000 3.74e-02 7.07e-02 8.02e-01 6.35e-01
GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX 177 1.49e-01 5.44e-01 0.08000 -6.36e-02 -4.85e-02 1.45e-01 2.66e-01
Cardiac conduction 125 2.71e-01 6.85e-01 0.07990 2.96e-02 7.43e-02 5.68e-01 1.52e-01
GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY 14 8.59e-01 9.60e-01 0.07990 -5.17e-02 -6.10e-02 7.38e-01 6.93e-01
GOBP REGULATION OF CELL SIZE 163 2.39e-01 6.55e-01 0.07990 -7.26e-02 3.34e-02 1.10e-01 4.62e-01
GOCC SPINDLE POLE 171 2.14e-01 6.31e-01 0.07990 -7.68e-02 2.22e-02 8.33e-02 6.17e-01
GOCC U5 SNRNP 22 8.28e-01 9.53e-01 0.07990 -6.07e-02 5.19e-02 6.22e-01 6.73e-01
GOBP REGULATION OF SPINDLE CHECKPOINT 22 8.20e-01 9.52e-01 0.07990 -7.63e-02 2.36e-02 5.36e-01 8.48e-01
GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY 13 8.85e-01 9.69e-01 0.07990 7.90e-02 -1.18e-02 6.22e-01 9.41e-01
GOBP AMEBOIDAL TYPE CELL MIGRATION 481 1.04e-02 1.58e-01 0.07980 -7.98e-02 -1.15e-05 2.70e-03 1.00e+00
GOBP CELL CYCLE PHASE TRANSITION 539 3.58e-03 8.26e-02 0.07980 -6.76e-02 -4.24e-02 7.26e-03 9.21e-02
GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT 123 2.71e-01 6.85e-01 0.07980 6.86e-02 4.08e-02 1.89e-01 4.35e-01
GOMF CATALYTIC ACTIVITY ACTING ON A RRNA 22 7.95e-01 9.44e-01 0.07980 -2.83e-02 -7.46e-02 8.18e-01 5.45e-01
GOBP POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 7 9.42e-01 9.86e-01 0.07980 -5.65e-02 5.63e-02 7.96e-01 7.96e-01
GOBP NEUTRAL LIPID CATABOLIC PROCESS 37 7.19e-01 9.15e-01 0.07970 -2.71e-02 7.50e-02 7.75e-01 4.30e-01
GOBP APICAL PROTEIN LOCALIZATION 14 8.81e-01 9.67e-01 0.07970 -7.67e-02 2.17e-02 6.19e-01 8.88e-01
GOMF TRANSPORTER REGULATOR ACTIVITY 145 2.90e-01 7.02e-01 0.07960 -6.66e-02 4.36e-02 1.66e-01 3.65e-01
GOBP CIRCULATORY SYSTEM PROCESS 588 7.73e-03 1.31e-01 0.07960 -5.56e-02 5.70e-02 2.13e-02 1.83e-02
Antigen processing: Ubiquitination & Proteasome degradation 283 5.05e-02 3.41e-01 0.07960 -6.53e-02 -4.54e-02 5.87e-02 1.88e-01
Peroxisomal protein import 62 5.44e-01 8.51e-01 0.07950 -8.12e-03 -7.91e-02 9.12e-01 2.81e-01
Regulation of FZD by ubiquitination 21 8.30e-01 9.53e-01 0.07950 2.68e-02 -7.48e-02 8.32e-01 5.53e-01
GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS 64 5.05e-01 8.32e-01 0.07950 -4.72e-02 -6.39e-02 5.13e-01 3.76e-01
GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY 15 8.74e-01 9.65e-01 0.07950 -2.26e-02 7.62e-02 8.79e-01 6.09e-01
GOBP REGULATION OF RESTING MEMBRANE POTENTIAL 10 8.98e-01 9.74e-01 0.07940 5.47e-02 5.76e-02 7.64e-01 7.53e-01
GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS 17 8.46e-01 9.57e-01 0.07940 -7.89e-02 -9.44e-03 5.73e-01 9.46e-01
Golgi-to-ER retrograde transport 132 2.98e-01 7.09e-01 0.07940 -7.84e-02 1.29e-02 1.20e-01 7.97e-01
GOBP SPERM CAPACITATION 32 7.10e-01 9.14e-01 0.07940 6.04e-02 5.16e-02 5.54e-01 6.14e-01
GOMF KINASE ACTIVATOR ACTIVITY 137 2.33e-01 6.50e-01 0.07940 -5.14e-02 -6.06e-02 2.99e-01 2.21e-01
GOBP RESPONSE TO TEMPERATURE STIMULUS 166 1.86e-01 5.92e-01 0.07940 -2.25e-02 -7.61e-02 6.17e-01 9.06e-02
IL-6-type cytokine receptor ligand interactions 17 8.34e-01 9.55e-01 0.07940 4.92e-02 6.23e-02 7.26e-01 6.56e-01
Metabolism of polyamines 44 6.60e-01 8.96e-01 0.07930 3.35e-03 -7.93e-02 9.69e-01 3.63e-01
GOBP FARNESYL DIPHOSPHATE METABOLIC PROCESS 6 9.38e-01 9.85e-01 0.07930 6.07e-02 5.10e-02 7.97e-01 8.29e-01
GOBP NEGATIVE REGULATION OF RECEPTOR BINDING 12 8.96e-01 9.73e-01 0.07930 -7.76e-02 1.62e-02 6.41e-01 9.22e-01
GOBP REGULATION OF LIPID KINASE ACTIVITY 8 9.18e-01 9.79e-01 0.07930 6.31e-02 4.81e-02 7.57e-01 8.14e-01
GOBP SUPPRESSION OF VIRAL RELEASE BY HOST 15 8.74e-01 9.65e-01 0.07930 -2.12e-02 7.64e-02 8.87e-01 6.08e-01
GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS 34 7.42e-01 9.26e-01 0.07930 2.97e-02 -7.35e-02 7.64e-01 4.58e-01
GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY 21 8.07e-01 9.48e-01 0.07920 7.47e-02 2.63e-02 5.53e-01 8.35e-01
GOCC CELL BODY MEMBRANE 32 7.58e-01 9.31e-01 0.07920 7.15e-02 -3.41e-02 4.84e-01 7.39e-01
GOBP REGULATION OF NEURON PROJECTION REGENERATION 31 7.66e-01 9.33e-01 0.07920 -3.64e-02 7.03e-02 7.26e-01 4.98e-01
GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS 33 7.47e-01 9.28e-01 0.07920 -7.50e-02 2.53e-02 4.56e-01 8.01e-01
GOCC SYNAPSE 1414 3.80e-06 3.51e-04 0.07910 -7.91e-02 3.40e-03 6.30e-07 8.31e-01
GOMF NUCLEOSOMAL DNA BINDING 60 5.47e-01 8.52e-01 0.07910 -2.03e-02 -7.65e-02 7.86e-01 3.05e-01
GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY 90 4.01e-01 7.78e-01 0.07910 -2.58e-02 -7.48e-02 6.72e-01 2.20e-01
GOBP SMALL MOLECULE CATABOLIC PROCESS 364 2.88e-02 2.68e-01 0.07910 1.42e-02 7.78e-02 6.42e-01 1.08e-02
GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS 332 3.98e-02 3.06e-01 0.07910 -1.25e-02 -7.81e-02 6.95e-01 1.45e-02
GOBP REGULATION OF LYMPHOCYTE ACTIVATION 491 1.43e-02 1.91e-01 0.07910 2.48e-02 -7.51e-02 3.48e-01 4.38e-03
GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY 28 7.48e-01 9.28e-01 0.07910 3.57e-02 7.05e-02 7.44e-01 5.18e-01
GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS 18 8.53e-01 9.59e-01 0.07900 2.37e-02 -7.54e-02 8.62e-01 5.80e-01
tRNA Aminoacylation 40 6.99e-01 9.12e-01 0.07900 1.97e-02 -7.65e-02 8.29e-01 4.02e-01
Response to elevated platelet cytosolic Ca2+ 122 2.81e-01 6.93e-01 0.07900 -6.83e-02 -3.96e-02 1.92e-01 4.50e-01
A tetrasaccharide linker sequence is required for GAG synthesis 24 8.09e-01 9.49e-01 0.07890 -2.28e-02 7.56e-02 8.47e-01 5.22e-01
GOBP GLIAL CELL ACTIVATION 58 5.43e-01 8.51e-01 0.07890 -4.80e-02 -6.26e-02 5.27e-01 4.09e-01
GOBP REGULATION OF DNA METABOLIC PROCESS 494 6.33e-03 1.16e-01 0.07890 -4.30e-02 -6.62e-02 1.02e-01 1.18e-02
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION 75 4.57e-01 8.09e-01 0.07890 -6.62e-02 -4.29e-02 3.22e-01 5.20e-01
Hedgehog ‘off’ state 98 3.60e-01 7.51e-01 0.07890 -6.59e-02 -4.34e-02 2.60e-01 4.58e-01
GOBP VACUOLE ORGANIZATION 224 1.22e-01 5.00e-01 0.07880 -7.88e-02 -8.95e-04 4.20e-02 9.82e-01
GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION 109 3.86e-01 7.68e-01 0.07880 2.52e-02 -7.47e-02 6.49e-01 1.78e-01
Thromboxane signalling through TP receptor 24 7.85e-01 9.41e-01 0.07880 -2.45e-02 -7.49e-02 8.35e-01 5.25e-01
GOBP CERAMIDE TRANSPORT 17 8.37e-01 9.55e-01 0.07880 -6.55e-02 -4.39e-02 6.40e-01 7.54e-01
Metabolism of nitric oxide: NOS3 activation and regulation 17 8.38e-01 9.55e-01 0.07880 -6.75e-02 -4.06e-02 6.30e-01 7.72e-01
GOMF INTEGRIN BINDING 154 2.76e-01 6.88e-01 0.07870 -4.20e-02 6.66e-02 3.69e-01 1.54e-01
GOBP TRNA MODIFICATION 90 4.03e-01 7.80e-01 0.07870 -2.74e-02 -7.38e-02 6.53e-01 2.26e-01
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 53 6.02e-01 8.75e-01 0.07870 7.85e-02 5.84e-03 3.23e-01 9.41e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 91 3.90e-01 7.71e-01 0.07870 -6.83e-02 -3.92e-02 2.60e-01 5.18e-01
GOBP AMINO SUGAR METABOLIC PROCESS 40 6.59e-01 8.95e-01 0.07870 4.42e-02 6.51e-02 6.28e-01 4.76e-01
GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS 214 1.64e-01 5.64e-01 0.07870 -6.99e-02 3.61e-02 7.78e-02 3.63e-01
GOBP MHC CLASS I BIOSYNTHETIC PROCESS 8 9.22e-01 9.80e-01 0.07870 -2.99e-02 -7.28e-02 8.84e-01 7.21e-01
GOBP RENAL TUBULE DEVELOPMENT 100 3.80e-01 7.65e-01 0.07870 -7.80e-02 -1.06e-02 1.78e-01 8.54e-01
GOMF PHOSPHOLIPASE C ACTIVITY 29 7.62e-01 9.32e-01 0.07870 7.87e-02 -4.90e-04 4.63e-01 9.96e-01
GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS 16 8.50e-01 9.58e-01 0.07860 -7.28e-02 -2.97e-02 6.14e-01 8.37e-01
Signal amplification 33 7.16e-01 9.15e-01 0.07860 -7.37e-02 -2.74e-02 4.64e-01 7.86e-01
GOBP NEGATIVE REGULATION OF TISSUE REMODELING 21 8.33e-01 9.54e-01 0.07860 2.62e-02 -7.41e-02 8.35e-01 5.57e-01
GOBP PHAGOSOME LYSOSOME FUSION 13 8.78e-01 9.67e-01 0.07860 2.24e-02 7.54e-02 8.89e-01 6.38e-01
Metabolism of amine-derived hormones 17 8.41e-01 9.56e-01 0.07860 7.16e-02 3.24e-02 6.09e-01 8.17e-01
GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY 34 7.17e-01 9.15e-01 0.07850 -7.72e-02 -1.46e-02 4.36e-01 8.83e-01
GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY 23 8.23e-01 9.52e-01 0.07850 3.55e-02 -7.00e-02 7.68e-01 5.61e-01
GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX 405 2.95e-02 2.70e-01 0.07850 -1.86e-02 7.63e-02 5.22e-01 8.44e-03
GOBP L LEUCINE METABOLIC PROCESS 8 9.32e-01 9.83e-01 0.07850 7.53e-02 -2.20e-02 7.12e-01 9.14e-01
GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY 66 5.60e-01 8.57e-01 0.07850 7.57e-02 -2.09e-02 2.88e-01 7.69e-01
GOBP TUBE DEVELOPMENT 1135 6.60e-05 4.13e-03 0.07850 -7.69e-02 1.53e-02 1.23e-05 3.84e-01
Peptide hormone metabolism 81 4.78e-01 8.20e-01 0.07840 -7.80e-02 7.75e-03 2.25e-01 9.04e-01
GOBP POSITIVE REGULATION OF BINDING 104 3.82e-01 7.67e-01 0.07840 -7.84e-02 1.87e-03 1.67e-01 9.74e-01
GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY 23 7.87e-01 9.41e-01 0.07840 5.29e-02 5.78e-02 6.60e-01 6.32e-01
GOBP REGULATION OF ARACHIDONIC ACID SECRETION 7 9.32e-01 9.83e-01 0.07830 -2.92e-02 -7.27e-02 8.94e-01 7.39e-01
GOCC SYNAPTIC VESICLE MEMBRANE 130 3.19e-01 7.27e-01 0.07830 -7.63e-02 1.76e-02 1.33e-01 7.29e-01
GOBP REGULATION OF MITOTIC NUCLEAR DIVISION 118 3.62e-01 7.53e-01 0.07830 2.51e-02 -7.42e-02 6.38e-01 1.64e-01
GOBP PEPTIDYL METHIONINE MODIFICATION 11 9.14e-01 9.78e-01 0.07830 -5.62e-02 5.45e-02 7.47e-01 7.54e-01
GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 8 9.36e-01 9.84e-01 0.07820 -4.19e-02 6.61e-02 8.38e-01 7.46e-01
GOBP POSITIVE REGULATION OF COLLATERAL SPROUTING 9 9.11e-01 9.77e-01 0.07820 -6.37e-02 -4.53e-02 7.41e-01 8.14e-01
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 16 8.50e-01 9.58e-01 0.07820 6.97e-02 3.55e-02 6.29e-01 8.06e-01
GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 138 3.25e-01 7.29e-01 0.07820 5.52e-02 -5.53e-02 2.63e-01 2.62e-01
Formation of xylulose-5-phosphate 5 9.49e-01 9.88e-01 0.07810 -5.50e-02 -5.55e-02 8.31e-01 8.30e-01
GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE 5 9.49e-01 9.88e-01 0.07810 -5.50e-02 -5.55e-02 8.31e-01 8.30e-01
GOBP POSITIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS 7 9.42e-01 9.86e-01 0.07810 -2.97e-02 7.23e-02 8.92e-01 7.41e-01
GOBP REGULATION OF MACROAUTOPHAGY 174 2.10e-01 6.26e-01 0.07810 -7.77e-02 8.40e-03 7.71e-02 8.48e-01
GOBP NUCLEUS ORGANIZATION 145 2.25e-01 6.43e-01 0.07810 -5.53e-02 -5.52e-02 2.51e-01 2.51e-01
GOBP MITOTIC CELL CYCLE PROCESS 746 7.03e-04 2.46e-02 0.07810 -7.16e-02 -3.11e-02 8.64e-04 1.49e-01
GOBP CELL CYCLE G1 S PHASE TRANSITION 251 8.48e-02 4.32e-01 0.07810 -7.39e-02 -2.53e-02 4.38e-02 4.90e-01
GOBP PLASMA MEMBRANE ORGANIZATION 161 2.70e-01 6.85e-01 0.07810 -5.20e-02 5.82e-02 2.55e-01 2.03e-01
GOBP CARDIAC VENTRICLE MORPHOGENESIS 72 5.55e-01 8.55e-01 0.07800 -6.26e-02 4.65e-02 3.58e-01 4.95e-01
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters 20 8.33e-01 9.54e-01 0.07800 -3.31e-03 7.79e-02 9.80e-01 5.46e-01
GOBP RESPONSE TO ACIDIC PH 26 7.72e-01 9.36e-01 0.07800 2.69e-02 7.32e-02 8.12e-01 5.18e-01
GOBP PLASMA MEMBRANE REPAIR 27 7.70e-01 9.35e-01 0.07800 -1.73e-02 -7.60e-02 8.76e-01 4.94e-01
GOBP RESPONSE TO MINERALOCORTICOID 36 6.90e-01 9.08e-01 0.07790 -5.35e-02 -5.67e-02 5.79e-01 5.56e-01
p75 NTR receptor-mediated signalling 90 4.62e-01 8.12e-01 0.07790 -2.28e-02 7.45e-02 7.08e-01 2.22e-01
GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION 19 8.24e-01 9.52e-01 0.07790 -4.03e-02 -6.66e-02 7.61e-01 6.15e-01
GOBP REGULATION OF CELL CYCLE PHASE TRANSITION 441 1.29e-02 1.79e-01 0.07790 -7.04e-02 -3.34e-02 1.13e-02 2.29e-01
GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION 34 7.54e-01 9.30e-01 0.07790 3.80e-02 -6.80e-02 7.01e-01 4.93e-01
GOBP GLYCEROLIPID CATABOLIC PROCESS 64 5.51e-01 8.54e-01 0.07780 7.77e-02 4.10e-03 2.82e-01 9.55e-01
GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY 21 8.10e-01 9.49e-01 0.07780 3.21e-02 7.09e-02 7.99e-01 5.74e-01
GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS 40 6.79e-01 9.04e-01 0.07780 -1.87e-02 -7.55e-02 8.38e-01 4.08e-01
GOBP CELL MIGRATION INVOLVED IN METANEPHROS DEVELOPMENT 5 9.60e-01 9.90e-01 0.07770 5.18e-02 -5.80e-02 8.41e-01 8.22e-01
Cell death signalling via NRAGE, NRIF and NADE 69 5.73e-01 8.61e-01 0.07770 -5.47e-02 5.52e-02 4.32e-01 4.28e-01
GOBP CELLULAR RESPONSE TO STEROL DEPLETION 16 8.54e-01 9.59e-01 0.07770 7.36e-02 2.51e-02 6.10e-01 8.62e-01
GOBP RESPONSE TO RETINOIC ACID 105 3.43e-01 7.40e-01 0.07770 -5.54e-02 -5.44e-02 3.27e-01 3.35e-01
GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 29 7.44e-01 9.26e-01 0.07770 6.24e-02 4.62e-02 5.61e-01 6.67e-01
GOBP LOCALIZATION OF CELL 6 9.49e-01 9.88e-01 0.07760 1.57e-02 -7.60e-02 9.47e-01 7.47e-01
Membrane Trafficking 604 4.58e-03 9.37e-02 0.07760 -7.76e-02 -6.35e-04 1.13e-03 9.79e-01
NrCAM interactions 6 9.50e-01 9.88e-01 0.07750 -2.25e-02 7.42e-02 9.24e-01 7.53e-01
GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 45 6.95e-01 9.11e-01 0.07750 6.12e-02 -4.76e-02 4.78e-01 5.80e-01
GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE 13 8.76e-01 9.66e-01 0.07750 5.18e-02 5.77e-02 7.47e-01 7.19e-01
GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS 144 2.53e-01 6.69e-01 0.07750 1.74e-02 7.55e-02 7.18e-01 1.18e-01
GOBP CELL CYCLE PROCESS 1244 1.04e-05 8.55e-04 0.07750 -7.35e-02 -2.44e-02 1.29e-05 1.47e-01
GOBP NEGATIVE REGULATION OF CELL DIVISION 17 8.71e-01 9.64e-01 0.07750 4.51e-02 -6.30e-02 7.48e-01 6.53e-01
GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS 273 6.76e-02 3.92e-01 0.07750 -3.49e-02 -6.91e-02 3.21e-01 4.93e-02
GOCC CLATHRIN COATED VESICLE 208 1.80e-01 5.84e-01 0.07750 -7.04e-02 3.24e-02 8.02e-02 4.21e-01
GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS 10 9.07e-01 9.77e-01 0.07740 2.33e-02 7.38e-02 8.98e-01 6.86e-01
GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE 19 8.34e-01 9.55e-01 0.07740 1.55e-02 7.59e-02 9.07e-01 5.67e-01
GOBP IMPORT INTO CELL 887 1.03e-03 3.35e-02 0.07740 -4.76e-02 6.10e-02 1.61e-02 2.05e-03
GOBP PROTEIN DEGLUTAMYLATION 6 9.45e-01 9.87e-01 0.07740 7.68e-02 9.37e-03 7.45e-01 9.68e-01
GOMF ALPHA 2A ADRENERGIC RECEPTOR BINDING 5 9.50e-01 9.88e-01 0.07740 -5.23e-02 -5.70e-02 8.39e-01 8.25e-01
RAC2 GTPase cycle 81 5.06e-01 8.32e-01 0.07740 -7.33e-02 2.48e-02 2.54e-01 6.99e-01
GOMF MAGNESIUM ION BINDING 217 1.78e-01 5.83e-01 0.07730 -5.09e-02 5.82e-02 1.96e-01 1.40e-01
Regulation of CDH11 gene transcription 10 9.21e-01 9.80e-01 0.07730 -3.39e-02 6.94e-02 8.53e-01 7.04e-01
GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS 128 3.46e-01 7.43e-01 0.07730 -2.86e-02 7.18e-02 5.77e-01 1.61e-01
GOBP NEURON DEVELOPMENT 1106 1.53e-04 8.19e-03 0.07720 -7.21e-02 2.76e-02 5.14e-05 1.21e-01
GOCC TERTIARY GRANULE LUMEN 54 5.80e-01 8.64e-01 0.07720 5.07e-02 5.82e-02 5.19e-01 4.59e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN 37 7.06e-01 9.13e-01 0.07720 7.61e-02 1.31e-02 4.23e-01 8.90e-01
GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR 117 3.95e-01 7.74e-01 0.07720 -5.29e-02 5.62e-02 3.23e-01 2.94e-01
GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY 7 9.44e-01 9.87e-01 0.07710 3.11e-02 -7.06e-02 8.87e-01 7.46e-01
GOBP RESPONSE TO NUTRIENT LEVELS 476 1.59e-02 2.01e-01 0.07710 -7.69e-02 5.66e-03 4.03e-03 8.32e-01
GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION 73 4.92e-01 8.27e-01 0.07710 -7.23e-02 -2.70e-02 2.86e-01 6.90e-01
GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION 70 5.56e-01 8.55e-01 0.07710 2.34e-02 -7.34e-02 7.35e-01 2.88e-01
GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION 337 3.64e-02 2.94e-01 0.07710 -4.04e-02 -6.56e-02 2.02e-01 3.84e-02
GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 23 8.30e-01 9.54e-01 0.07710 -3.90e-02 6.65e-02 7.46e-01 5.81e-01
FGFR2 alternative splicing 26 7.96e-01 9.44e-01 0.07710 9.20e-03 -7.65e-02 9.35e-01 5.00e-01
GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY 41 7.08e-01 9.13e-01 0.07700 -2.19e-02 7.38e-02 8.08e-01 4.13e-01
GOCC CHROMATIN SILENCING COMPLEX 12 8.96e-01 9.73e-01 0.07700 7.69e-02 4.72e-03 6.45e-01 9.77e-01
GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE 18 8.37e-01 9.55e-01 0.07700 3.67e-02 6.77e-02 7.87e-01 6.19e-01
GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 8 9.38e-01 9.85e-01 0.07700 -4.49e-02 6.26e-02 8.26e-01 7.59e-01
GOBP LONG TERM MEMORY 37 7.19e-01 9.15e-01 0.07700 -7.69e-02 2.43e-03 4.18e-01 9.80e-01
Defects in biotin (Btn) metabolism 8 9.23e-01 9.81e-01 0.07700 -4.83e-02 -6.00e-02 8.13e-01 7.69e-01
GOBP BLOOD VESSEL MORPHOGENESIS 694 3.64e-03 8.31e-02 0.07700 -7.27e-02 2.53e-02 1.10e-03 2.56e-01
GOMF GLUTATHIONE TRANSMEMBRANE TRANSPORTER ACTIVITY 7 9.33e-01 9.83e-01 0.07690 3.50e-02 6.85e-02 8.73e-01 7.53e-01
Signaling by TGF-beta Receptor Complex 92 4.21e-01 7.90e-01 0.07690 -1.59e-02 -7.53e-02 7.92e-01 2.12e-01
GOBP ACTIN FILAMENT BUNDLE ORGANIZATION 163 2.45e-01 6.59e-01 0.07680 -1.01e-02 7.62e-02 8.24e-01 9.33e-02
GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY 39 6.79e-01 9.04e-01 0.07680 -6.40e-02 -4.26e-02 4.89e-01 6.46e-01
Transport of bile salts and organic acids, metal ions and amine compounds 82 4.68e-01 8.14e-01 0.07680 7.60e-02 1.14e-02 2.34e-01 8.58e-01
Metabolism of folate and pterines 17 8.61e-01 9.61e-01 0.07680 -7.65e-02 5.97e-03 5.85e-01 9.66e-01
GOCC AXON CYTOPLASM 61 5.48e-01 8.52e-01 0.07670 -6.51e-02 -4.06e-02 3.79e-01 5.84e-01
GOBP REGULATION OF TRANS SYNAPTIC SIGNALING 477 2.43e-02 2.50e-01 0.07670 -6.32e-02 4.34e-02 1.80e-02 1.04e-01
GOBP DNA METABOLIC PROCESS 957 1.12e-04 6.57e-03 0.07670 -6.28e-02 -4.40e-02 9.94e-04 2.12e-02
GOBP RESPONSE TO AXON INJURY 81 4.89e-01 8.26e-01 0.07670 -7.66e-02 3.17e-03 2.33e-01 9.61e-01
Formation of the Early Elongation Complex 32 7.65e-01 9.33e-01 0.07670 -7.39e-02 2.04e-02 4.69e-01 8.42e-01
Formation of the HIV-1 Early Elongation Complex 32 7.65e-01 9.33e-01 0.07670 -7.39e-02 2.04e-02 4.69e-01 8.42e-01
GOCC CELL BODY 530 1.39e-02 1.88e-01 0.07670 -7.22e-02 2.58e-02 4.46e-03 3.10e-01
GOBP ORGANELLE LOCALIZATION 581 4.01e-03 8.80e-02 0.07670 -6.92e-02 -3.30e-02 4.37e-03 1.74e-01
GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION 45 6.45e-01 8.91e-01 0.07660 -6.84e-02 -3.44e-02 4.27e-01 6.89e-01
GOBP STEROL HOMEOSTASIS 101 4.40e-01 7.99e-01 0.07660 -3.02e-02 7.04e-02 6.00e-01 2.22e-01
GOBP DNA REPLICATION 273 7.25e-02 4.04e-01 0.07650 -6.89e-02 -3.34e-02 5.01e-02 3.43e-01
GOBP DEFENSE RESPONSE TO OTHER ORGANISM 1162 1.63e-04 8.63e-03 0.07650 6.26e-02 -4.41e-02 3.24e-04 1.13e-02
GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY 12 9.10e-01 9.77e-01 0.07650 4.97e-02 -5.82e-02 7.66e-01 7.27e-01
GOCC CENTRIOLE 155 2.71e-01 6.85e-01 0.07650 -7.48e-02 1.59e-02 1.08e-01 7.33e-01
GOMF HEXOSAMINIDASE ACTIVITY 15 8.81e-01 9.67e-01 0.07650 -7.44e-02 1.79e-02 6.18e-01 9.05e-01
GOBP MECHANORECEPTOR DIFFERENTIATION 70 5.00e-01 8.30e-01 0.07640 5.24e-02 5.57e-02 4.49e-01 4.20e-01
GOMF PROTEIN HORMONE RECEPTOR ACTIVITY 20 8.30e-01 9.54e-01 0.07640 -7.49e-02 -1.53e-02 5.62e-01 9.05e-01
GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND 626 7.42e-03 1.27e-01 0.07640 -6.87e-02 3.35e-02 3.35e-03 1.52e-01
GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY 28 7.91e-01 9.42e-01 0.07640 1.82e-02 -7.42e-02 8.68e-01 4.97e-01
GOBP CHOLESTEROL STORAGE 25 7.82e-01 9.40e-01 0.07640 -6.42e-02 -4.15e-02 5.79e-01 7.20e-01
GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 183 2.40e-01 6.55e-01 0.07640 4.67e-02 -6.04e-02 2.75e-01 1.59e-01
GOMF GROWTH FACTOR BINDING 130 3.41e-01 7.40e-01 0.07640 -7.34e-02 2.10e-02 1.48e-01 6.79e-01
GOBP REGULATION OF CELL DIFFERENTIATION 1553 5.18e-06 4.61e-04 0.07640 -7.46e-02 1.65e-02 9.23e-07 2.79e-01
GOBP STORE OPERATED CALCIUM ENTRY 22 8.17e-01 9.51e-01 0.07630 1.18e-02 7.54e-02 9.24e-01 5.40e-01
GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 159 2.47e-01 6.61e-01 0.07630 -7.63e-02 -3.03e-04 9.68e-02 9.95e-01
GOBP REGULATION OF T CELL ACTIVATION 374 4.97e-02 3.39e-01 0.07630 2.72e-02 -7.13e-02 3.67e-01 1.79e-02
GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 102 4.25e-01 7.93e-01 0.07630 -1.59e-02 7.46e-02 7.82e-01 1.93e-01
GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT 36 7.33e-01 9.23e-01 0.07630 7.59e-02 -7.53e-03 4.31e-01 9.38e-01
Erythropoietin activates RAS 14 8.72e-01 9.64e-01 0.07620 -4.36e-02 -6.25e-02 7.78e-01 6.85e-01
GOCC CATENIN COMPLEX 31 7.40e-01 9.25e-01 0.07620 -6.69e-02 -3.65e-02 5.19e-01 7.25e-01
GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS 20 8.44e-01 9.57e-01 0.07620 -1.35e-02 7.50e-02 9.17e-01 5.62e-01
GOBP PROTEIN ACYLATION 87 4.75e-01 8.18e-01 0.07610 -7.57e-02 7.76e-03 2.22e-01 9.00e-01
GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM 70 5.64e-01 8.58e-01 0.07610 2.32e-02 -7.24e-02 7.37e-01 2.95e-01
GOBP GLYCOSYLATION 238 1.16e-01 4.90e-01 0.07610 1.34e-02 7.49e-02 7.23e-01 4.66e-02
GOMF PHOSPHATASE REGULATOR ACTIVITY 101 4.32e-01 7.96e-01 0.07610 -7.41e-02 1.70e-02 1.98e-01 7.67e-01
GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 154 3.00e-01 7.11e-01 0.07600 -6.45e-02 4.03e-02 1.67e-01 3.88e-01
GOCC EARLY ENDOSOME LUMEN 5 9.58e-01 9.89e-01 0.07600 8.77e-03 -7.55e-02 9.73e-01 7.70e-01
GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 1429 1.21e-05 9.80e-04 0.07600 -7.51e-02 1.20e-02 2.00e-06 4.46e-01
GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY 48 6.90e-01 9.08e-01 0.07600 -5.61e-02 5.14e-02 5.02e-01 5.38e-01
GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY 248 1.07e-01 4.75e-01 0.07600 -1.22e-02 -7.50e-02 7.40e-01 4.20e-02
GOBP REGULATION OF STEROID METABOLIC PROCESS 101 3.91e-01 7.71e-01 0.07600 7.28e-02 2.18e-02 2.06e-01 7.05e-01
GOBP MONOCYTE CHEMOTAXIS 50 6.38e-01 8.87e-01 0.07590 -9.35e-03 -7.54e-02 9.09e-01 3.57e-01
GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION 32 7.38e-01 9.24e-01 0.07590 -2.89e-02 -7.02e-02 7.77e-01 4.92e-01
GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 237 1.61e-01 5.59e-01 0.07590 -6.24e-02 4.32e-02 9.78e-02 2.52e-01
Frs2-mediated activation 12 9.00e-01 9.74e-01 0.07590 1.74e-03 7.59e-02 9.92e-01 6.49e-01
GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION 29 7.56e-01 9.30e-01 0.07590 -3.71e-02 -6.62e-02 7.30e-01 5.37e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 129 2.85e-01 6.97e-01 0.07590 -5.14e-02 -5.59e-02 3.14e-01 2.73e-01
GOBP REGULATION OF LIPID LOCALIZATION 184 2.34e-01 6.50e-01 0.07590 -6.85e-02 3.27e-02 1.09e-01 4.45e-01
GOBP FATTY ACID CATABOLIC PROCESS 104 4.42e-01 8.00e-01 0.07590 -6.65e-02 3.65e-02 2.41e-01 5.20e-01
GOMF DAMAGED DNA BINDING 72 4.97e-01 8.29e-01 0.07580 -6.04e-02 -4.59e-02 3.76e-01 5.01e-01
GOMF LIPID TRANSPORTER ACTIVITY 164 2.55e-01 6.70e-01 0.07580 -1.26e-02 7.47e-02 7.81e-01 9.86e-02
GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION 7 9.35e-01 9.84e-01 0.07580 -3.97e-02 -6.46e-02 8.56e-01 7.67e-01
GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 84 5.07e-01 8.32e-01 0.07580 -2.33e-02 7.21e-02 7.13e-01 2.53e-01
GOCC CLEAVAGE FURROW 52 6.11e-01 8.78e-01 0.07570 -6.90e-02 -3.13e-02 3.90e-01 6.96e-01
GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS 44 6.53e-01 8.93e-01 0.07570 -6.19e-02 -4.37e-02 4.78e-01 6.16e-01
GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS 103 4.54e-01 8.08e-01 0.07570 -5.40e-02 5.31e-02 3.43e-01 3.52e-01
Potential therapeutics for SARS 92 4.39e-01 7.99e-01 0.07570 -7.51e-02 -9.79e-03 2.13e-01 8.71e-01
GOBP TOR SIGNALING 158 2.17e-01 6.35e-01 0.07570 -5.72e-02 -4.96e-02 2.14e-01 2.82e-01
GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 44 6.94e-01 9.10e-01 0.07570 7.41e-02 -1.51e-02 3.95e-01 8.62e-01
GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY 36 7.36e-01 9.23e-01 0.07570 6.27e-03 -7.54e-02 9.48e-01 4.34e-01
GOBP ESTABLISHMENT OF LOCALIZATION IN CELL 1868 1.43e-07 1.95e-05 0.07570 -7.31e-02 -1.95e-02 1.64e-07 1.63e-01
GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 255 1.06e-01 4.74e-01 0.07560 -7.52e-02 -7.81e-03 3.87e-02 8.30e-01
GOBP MYELOID LEUKOCYTE ACTIVATION 238 1.41e-01 5.33e-01 0.07550 1.36e-02 -7.43e-02 7.17e-01 4.83e-02
GOBP T CELL DIFFERENTIATION IN THYMUS 85 4.85e-01 8.23e-01 0.07550 7.54e-02 -4.86e-03 2.30e-01 9.38e-01
GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 296 1.04e-01 4.70e-01 0.07550 4.05e-02 -6.37e-02 2.30e-01 5.93e-02
GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 1044 4.76e-04 1.85e-02 0.07550 4.55e-02 -6.02e-02 1.29e-02 1.00e-03
GOBP ENDOMEMBRANE SYSTEM ORGANIZATION 570 9.49e-03 1.49e-01 0.07550 -7.48e-02 1.04e-02 2.28e-03 6.70e-01
GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY 1526 1.10e-06 1.19e-04 0.07550 -4.66e-02 -5.94e-02 2.33e-03 1.07e-04
GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY 150 2.70e-01 6.84e-01 0.07550 7.53e-02 4.88e-03 1.11e-01 9.18e-01
GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS 89 4.31e-01 7.95e-01 0.07550 3.51e-02 6.68e-02 5.67e-01 2.76e-01
GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY 69 5.48e-01 8.52e-01 0.07540 -2.93e-03 -7.54e-02 9.66e-01 2.79e-01
GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 147 2.66e-01 6.80e-01 0.07540 -7.38e-02 -1.57e-02 1.23e-01 7.42e-01
GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE 55 6.26e-01 8.83e-01 0.07540 3.85e-03 -7.53e-02 9.61e-01 3.34e-01
GOBP MITOTIC CELL CYCLE PHASE TRANSITION 441 1.74e-02 2.11e-01 0.07540 -6.97e-02 -2.88e-02 1.21e-02 3.00e-01
GOBP POSITIVE REGULATION OF WOUND HEALING 64 6.06e-01 8.76e-01 0.07540 -3.25e-02 6.80e-02 6.53e-01 3.46e-01
GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR 17 8.49e-01 9.58e-01 0.07540 6.06e-02 4.48e-02 6.65e-01 7.49e-01
GOBP GTP BIOSYNTHETIC PROCESS 11 9.00e-01 9.74e-01 0.07530 -4.58e-02 -5.98e-02 7.93e-01 7.31e-01
GOBP CELLULAR RESPONSE TO UV 87 4.65e-01 8.13e-01 0.07530 -7.82e-03 -7.49e-02 9.00e-01 2.27e-01
GOMF METHYL CPG BINDING 24 8.07e-01 9.49e-01 0.07530 7.45e-02 1.10e-02 5.27e-01 9.25e-01
Diseases of metabolism 250 9.74e-02 4.56e-01 0.07530 6.78e-02 3.28e-02 6.49e-02 3.72e-01
GOBP NEGATIVE REGULATION OF CGAS STING SIGNALING PATHWAY 12 8.92e-01 9.72e-01 0.07530 -6.57e-02 -3.68e-02 6.94e-01 8.25e-01
GOBP NEGATIVE REGULATION OF GROWTH 216 1.37e-01 5.26e-01 0.07530 -7.03e-02 -2.69e-02 7.50e-02 4.95e-01
Glucose metabolism 83 4.87e-01 8.23e-01 0.07530 3.56e-03 7.52e-02 9.55e-01 2.36e-01
GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING 16 8.59e-01 9.60e-01 0.07520 -6.28e-02 -4.14e-02 6.64e-01 7.74e-01
Intra-Golgi and retrograde Golgi-to-ER traffic 198 1.67e-01 5.68e-01 0.07520 -7.26e-02 -1.95e-02 7.80e-02 6.36e-01
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY 222 1.54e-01 5.51e-01 0.07510 3.04e-03 -7.51e-02 9.38e-01 5.40e-02
GOMF CYTOKINE RECEPTOR BINDING 254 1.09e-01 4.77e-01 0.07510 7.44e-02 1.02e-02 4.12e-02 7.80e-01
GOBP POSITIVE CHEMOTAXIS 62 5.54e-01 8.54e-01 0.07510 5.78e-02 4.79e-02 4.31e-01 5.14e-01
GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE 124 3.21e-01 7.28e-01 0.07510 -7.04e-02 -2.60e-02 1.75e-01 6.17e-01
GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 662 4.15e-03 8.91e-02 0.07500 -7.50e-02 8.66e-04 9.90e-04 9.70e-01
GOMF CELL ADHESION MEDIATOR ACTIVITY 67 5.60e-01 8.57e-01 0.07500 4.11e-03 7.49e-02 9.54e-01 2.89e-01
GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS 76 4.94e-01 8.28e-01 0.07500 6.84e-02 3.09e-02 3.03e-01 6.42e-01
GOBP MITOCHONDRIAL TRANSPORT 176 2.48e-01 6.62e-01 0.07500 2.20e-02 -7.17e-02 6.15e-01 1.01e-01
GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 31 7.85e-01 9.41e-01 0.07500 -2.97e-02 6.89e-02 7.75e-01 5.07e-01
GOBP CHOLESTEROL CATABOLIC PROCESS 9 9.28e-01 9.82e-01 0.07500 7.84e-03 -7.46e-02 9.67e-01 6.98e-01
GOBP RESPONSE TO GONADOTROPIN 27 7.73e-01 9.36e-01 0.07500 5.04e-02 5.55e-02 6.50e-01 6.18e-01
Loss of Nlp from mitotic centrosomes 65 5.94e-01 8.71e-01 0.07500 -7.25e-02 1.91e-02 3.12e-01 7.90e-01
Loss of proteins required for interphase microtubule organization from the centrosome 65 5.94e-01 8.71e-01 0.07500 -7.25e-02 1.91e-02 3.12e-01 7.90e-01
GOBP POSITIVE REGULATION OF MRNA CATABOLIC PROCESS 193 2.25e-01 6.43e-01 0.07490 -6.84e-02 3.07e-02 1.01e-01 4.62e-01
GOBP SIGNAL RELEASE 472 2.92e-02 2.70e-01 0.07490 -6.40e-02 3.91e-02 1.73e-02 1.46e-01
GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE 9 9.23e-01 9.81e-01 0.07490 -7.36e-02 -1.38e-02 7.02e-01 9.43e-01
GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE 27 7.85e-01 9.41e-01 0.07490 1.78e-02 7.27e-02 8.73e-01 5.13e-01
GOMF INTRACELLULARLY CALCIUM GATED CHLORIDE CHANNEL ACTIVITY 20 8.27e-01 9.52e-01 0.07490 5.13e-02 5.45e-02 6.91e-01 6.73e-01
GOBP NEGATIVE REGULATION OF B CELL ACTIVATION 29 7.78e-01 9.38e-01 0.07490 -6.21e-03 -7.46e-02 9.54e-01 4.87e-01
GOBP REGULATION OF MICROTUBULE BASED PROCESS 248 9.83e-02 4.58e-01 0.07480 -6.13e-02 -4.29e-02 9.64e-02 2.44e-01
GOBP CALCIUM IMPORT INTO THE MITOCHONDRION 16 8.79e-01 9.67e-01 0.07480 -1.64e-02 7.30e-02 9.10e-01 6.13e-01
GOMF CHEMOKINE ACTIVITY 46 6.73e-01 9.02e-01 0.07480 7.47e-02 4.36e-03 3.81e-01 9.59e-01
Class I MHC mediated antigen processing & presentation 349 3.82e-02 3.01e-01 0.07480 -4.98e-02 -5.58e-02 1.10e-01 7.31e-02
GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX 21 8.24e-01 9.52e-01 0.07480 -2.79e-02 -6.94e-02 8.25e-01 5.82e-01
GOBP MAMMARY GLAND INVOLUTION 8 9.34e-01 9.84e-01 0.07470 -2.20e-03 -7.47e-02 9.91e-01 7.14e-01
GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY 255 9.17e-02 4.44e-01 0.07470 -5.72e-02 -4.81e-02 1.16e-01 1.86e-01
GOBP VESICLE COATING 38 7.01e-01 9.12e-01 0.07470 -6.33e-02 -3.97e-02 5.00e-01 6.72e-01
GOBP RESPONSE TO ISOQUINOLINE ALKALOID 13 9.01e-01 9.74e-01 0.07470 -7.25e-02 1.79e-02 6.51e-01 9.11e-01
GOBP POSITIVE REGULATION OF CATABOLIC PROCESS 601 1.01e-02 1.55e-01 0.07470 -7.04e-02 2.50e-02 3.20e-03 2.96e-01
GOBP ASTROCYTE DEVELOPMENT 43 6.78e-01 9.04e-01 0.07460 -7.11e-02 -2.28e-02 4.20e-01 7.96e-01
GOBP INTRACELLULAR TRANSPORT 1295 1.55e-05 1.20e-03 0.07460 -7.05e-02 -2.43e-02 1.99e-05 1.41e-01
RND2 GTPase cycle 41 7.34e-01 9.23e-01 0.07460 -6.24e-02 4.09e-02 4.89e-01 6.51e-01
GOMF CYTOSKELETAL PROTEIN BINDING 946 8.81e-04 2.96e-02 0.07460 -6.90e-02 2.83e-02 3.21e-04 1.40e-01
RHOBTB2 GTPase cycle 22 8.13e-01 9.49e-01 0.07450 4.89e-02 5.62e-02 6.91e-01 6.48e-01
GOMF GLUTAMATE RECEPTOR ACTIVITY 25 8.11e-01 9.49e-01 0.07450 -7.45e-02 2.16e-03 5.19e-01 9.85e-01
GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION 8 9.30e-01 9.83e-01 0.07450 2.51e-02 7.01e-02 9.02e-01 7.31e-01
GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY 45 7.08e-01 9.13e-01 0.07440 -3.07e-02 6.78e-02 7.22e-01 4.31e-01
Prolactin receptor signaling 14 8.86e-01 9.69e-01 0.07440 -7.39e-02 -9.20e-03 6.32e-01 9.52e-01
GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS 86 5.04e-01 8.31e-01 0.07440 7.26e-02 -1.63e-02 2.44e-01 7.94e-01
GOBP TUBE FORMATION 148 2.58e-01 6.73e-01 0.07440 -6.70e-02 -3.25e-02 1.60e-01 4.95e-01
GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS 57 5.97e-01 8.73e-01 0.07440 -6.96e-02 -2.62e-02 3.63e-01 7.33e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE 33 7.76e-01 9.38e-01 0.07440 -6.81e-02 2.99e-02 4.98e-01 7.67e-01
GOBP REGULATION OF LYASE ACTIVITY 55 6.33e-01 8.86e-01 0.07440 -7.43e-02 2.72e-03 3.40e-01 9.72e-01
GOCC AXONEMAL MICROTUBULE 53 6.39e-01 8.88e-01 0.07440 -2.76e-03 -7.43e-02 9.72e-01 3.49e-01
Response of Mtb to phagocytosis 22 8.48e-01 9.58e-01 0.07440 4.15e-02 -6.17e-02 7.36e-01 6.16e-01
Acetylcholine Neurotransmitter Release Cycle 17 8.66e-01 9.62e-01 0.07430 -7.43e-02 -2.66e-03 5.96e-01 9.85e-01
GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION 17 8.65e-01 9.62e-01 0.07430 7.42e-02 3.98e-03 5.96e-01 9.77e-01
Intracellular signaling by second messengers 312 8.78e-02 4.37e-01 0.07430 -7.18e-02 1.91e-02 2.91e-02 5.62e-01
GOMF UBIQUITIN LIKE PROTEIN BINDING 118 4.03e-01 7.80e-01 0.07430 -6.93e-02 2.68e-02 1.93e-01 6.15e-01
GOBP STEROID CATABOLIC PROCESS 24 8.05e-01 9.48e-01 0.07430 -6.99e-02 -2.53e-02 5.54e-01 8.30e-01
GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 11 9.20e-01 9.80e-01 0.07430 -6.55e-02 3.51e-02 7.07e-01 8.40e-01
GOCC TERTIARY GRANULE MEMBRANE 69 5.77e-01 8.64e-01 0.07430 -7.27e-02 1.55e-02 2.97e-01 8.24e-01
GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS 315 7.81e-02 4.17e-01 0.07420 -6.55e-03 7.40e-02 8.42e-01 2.40e-02
GOBP PROTEIN LOCALIZATION TO MITOCHONDRION 123 3.71e-01 7.59e-01 0.07420 1.01e-02 -7.35e-02 8.47e-01 1.59e-01
GOBP ALPHA BETA T CELL DIFFERENTIATION 122 3.23e-01 7.28e-01 0.07420 -6.07e-02 -4.27e-02 2.47e-01 4.15e-01
GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 471 3.29e-02 2.83e-01 0.07420 -5.73e-02 4.72e-02 3.32e-02 7.93e-02
GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 220 2.00e-01 6.13e-01 0.07420 4.90e-02 -5.57e-02 2.11e-01 1.54e-01
GOBP REGULATION OF OSTEOBLAST PROLIFERATION 30 8.01e-01 9.46e-01 0.07420 -5.09e-02 5.40e-02 6.30e-01 6.09e-01
GOCC LATE ENDOSOME 295 9.23e-02 4.45e-01 0.07420 -7.39e-02 6.91e-03 2.91e-02 8.38e-01
GOBP LIPID HOMEOSTASIS 175 2.78e-01 6.91e-01 0.07420 -5.20e-02 5.29e-02 2.35e-01 2.28e-01
GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY 12 9.12e-01 9.77e-01 0.07410 -6.95e-02 2.59e-02 6.77e-01 8.76e-01
GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS 22 8.17e-01 9.51e-01 0.07410 -6.54e-02 -3.48e-02 5.95e-01 7.78e-01
GOMF SUMO POLYMER BINDING 5 9.55e-01 9.88e-01 0.07410 4.41e-02 5.96e-02 8.65e-01 8.18e-01
GOBP CANONICAL WNT SIGNALING PATHWAY 310 6.03e-02 3.73e-01 0.07410 -6.44e-02 -3.67e-02 5.13e-02 2.67e-01
GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH 17 8.54e-01 9.59e-01 0.07410 6.03e-02 4.30e-02 6.67e-01 7.59e-01
GOBP RESPONSE TO HORMONE 854 2.01e-03 5.45e-02 0.07400 -6.67e-02 3.22e-02 9.41e-04 1.10e-01
GOBP EXTRACELLULAR TRANSPORT 44 6.99e-01 9.11e-01 0.07400 7.37e-02 -5.99e-03 3.97e-01 9.45e-01
GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 27 8.14e-01 9.50e-01 0.07400 6.80e-02 -2.92e-02 5.41e-01 7.93e-01
GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING 20 8.31e-01 9.54e-01 0.07400 4.89e-02 5.55e-02 7.05e-01 6.67e-01
GOBP OLIGODENDROCYTE DIFFERENTIATION 105 4.26e-01 7.93e-01 0.07400 -7.37e-02 6.08e-03 1.92e-01 9.14e-01
GOCC AZUROPHIL GRANULE LUMEN 86 4.68e-01 8.14e-01 0.07390 7.05e-02 2.21e-02 2.58e-01 7.23e-01
GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY 57 6.23e-01 8.82e-01 0.07390 -7.39e-02 -4.97e-04 3.34e-01 9.95e-01
GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 219 1.79e-01 5.83e-01 0.07390 -7.24e-02 1.46e-02 6.47e-02 7.09e-01
GOBP CELL JUNCTION ORGANIZATION 724 4.08e-03 8.86e-02 0.07390 -7.18e-02 1.75e-02 1.00e-03 4.23e-01
GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION 74 5.55e-01 8.55e-01 0.07390 -7.29e-02 1.20e-02 2.78e-01 8.58e-01
GOBP TUBE MORPHOGENESIS 928 8.74e-04 2.94e-02 0.07390 -7.24e-02 1.47e-02 1.84e-04 4.49e-01
GOMF RNA NUCLEASE ACTIVITY 127 3.15e-01 7.22e-01 0.07390 -6.39e-02 -3.71e-02 2.14e-01 4.70e-01
GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT 13 8.95e-01 9.73e-01 0.07390 -9.57e-03 -7.33e-02 9.52e-01 6.47e-01
GOBP GLAND DEVELOPMENT 435 2.04e-02 2.28e-01 0.07390 -3.65e-02 -6.42e-02 1.92e-01 2.16e-02
GOBP STEROID BIOSYNTHETIC PROCESS 178 1.96e-01 6.06e-01 0.07380 5.79e-02 4.58e-02 1.83e-01 2.92e-01
GOBP ORGANIC ANION TRANSPORT 439 2.02e-02 2.28e-01 0.07380 3.36e-02 6.57e-02 2.28e-01 1.82e-02
GOBP AUTOPHAGY OF MITOCHONDRION 100 4.67e-01 8.14e-01 0.07380 -2.60e-02 6.91e-02 6.53e-01 2.33e-01
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION 60 6.44e-01 8.90e-01 0.07380 -6.06e-02 4.20e-02 4.17e-01 5.73e-01
GOBP NEURAL TUBE FORMATION 101 3.96e-01 7.75e-01 0.07380 -5.93e-02 -4.39e-02 3.03e-01 4.46e-01
GOBP RAC PROTEIN SIGNAL TRANSDUCTION 48 6.78e-01 9.04e-01 0.07370 7.35e-02 -6.39e-03 3.79e-01 9.39e-01
GOBP INTEGRIN ACTIVATION 26 8.21e-01 9.52e-01 0.07370 2.64e-02 -6.88e-02 8.16e-01 5.44e-01
GOBP LEYDIG CELL DIFFERENTIATION 9 9.32e-01 9.83e-01 0.07370 -7.14e-02 1.83e-02 7.11e-01 9.24e-01
GOBP POSITIVE REGULATION OF CELL ACTIVATION 368 4.96e-02 3.38e-01 0.07370 -1.79e-03 -7.37e-02 9.53e-01 1.52e-02
GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION 371 5.11e-02 3.44e-01 0.07370 -7.36e-02 3.86e-03 1.50e-02 8.98e-01
GOBP POSITIVE REGULATION OF T CELL PROLIFERATION 98 4.89e-01 8.25e-01 0.07360 4.25e-02 -6.02e-02 4.68e-01 3.03e-01
MAPK family signaling cascades 299 6.75e-02 3.92e-01 0.07360 -4.08e-02 -6.13e-02 2.25e-01 6.83e-02
GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING 20 8.65e-01 9.62e-01 0.07360 5.06e-02 -5.34e-02 6.95e-01 6.79e-01
GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE 8 9.33e-01 9.83e-01 0.07360 1.58e-02 7.19e-02 9.38e-01 7.25e-01
GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY 41 7.41e-01 9.26e-01 0.07350 4.13e-02 -6.08e-02 6.47e-01 5.01e-01
GOBP REGULATION OF CELL SHAPE 132 3.65e-01 7.55e-01 0.07350 -7.03e-02 2.15e-02 1.63e-01 6.69e-01
Unblocking of NMDA receptors, glutamate binding and activation 19 8.49e-01 9.58e-01 0.07350 -7.15e-02 -1.67e-02 5.89e-01 9.00e-01
GOBP CHOLESTEROL IMPORT 9 9.32e-01 9.83e-01 0.07350 -7.19e-02 1.53e-02 7.09e-01 9.37e-01
GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY 150 2.59e-01 6.73e-01 0.07350 3.81e-02 6.28e-02 4.21e-01 1.84e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS 1628 1.58e-05 1.22e-03 0.07340 6.21e-02 -3.92e-02 2.96e-05 8.38e-03
GOBP METENCEPHALON DEVELOPMENT 107 4.11e-01 7.84e-01 0.07340 -7.32e-02 -5.41e-03 1.91e-01 9.23e-01
GOBP CELL RECOGNITION 154 2.79e-01 6.92e-01 0.07340 7.32e-02 5.36e-03 1.17e-01 9.09e-01
GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY 13 9.06e-01 9.76e-01 0.07340 6.88e-02 -2.54e-02 6.67e-01 8.74e-01
GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS 117 4.29e-01 7.94e-01 0.07340 4.24e-02 -5.99e-02 4.28e-01 2.63e-01
Diseases of branched-chain amino acid catabolism 13 8.91e-01 9.72e-01 0.07330 -6.80e-02 -2.75e-02 6.71e-01 8.64e-01
GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 855 2.18e-03 5.76e-02 0.07330 -6.68e-02 3.03e-02 9.15e-04 1.32e-01
GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY 24 8.29e-01 9.53e-01 0.07330 -1.39e-02 7.20e-02 9.06e-01 5.42e-01
GOBP PROTEIN TRANSPORT 1361 1.64e-05 1.25e-03 0.07330 -7.10e-02 -1.81e-02 1.11e-05 2.63e-01
GOBP ANATOMICAL STRUCTURE MATURATION 263 1.52e-01 5.48e-01 0.07320 -4.40e-02 5.86e-02 2.19e-01 1.02e-01
GOCC STEREOCILIUM MEMBRANE 6 9.54e-01 9.88e-01 0.07320 -7.17e-02 1.43e-02 7.61e-01 9.52e-01
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST 29 8.04e-01 9.47e-01 0.07310 -6.86e-02 2.55e-02 5.23e-01 8.12e-01
GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX 18 8.52e-01 9.59e-01 0.07310 -3.29e-02 -6.53e-02 8.09e-01 6.32e-01
GOBP POSITIVE REGULATION OF AUTOPHAGY 151 2.89e-01 7.02e-01 0.07300 -7.28e-02 -6.08e-03 1.23e-01 8.97e-01
GOBP SEMI LUNAR VALVE DEVELOPMENT 48 7.02e-01 9.12e-01 0.07300 -6.67e-02 2.99e-02 4.24e-01 7.20e-01
Signalling to RAS 20 8.44e-01 9.57e-01 0.07300 7.14e-02 1.55e-02 5.81e-01 9.05e-01
Mitochondrial biogenesis 88 5.18e-01 8.39e-01 0.07300 2.37e-02 -6.90e-02 7.01e-01 2.63e-01
GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT 28 7.80e-01 9.39e-01 0.07300 3.40e-02 6.45e-02 7.55e-01 5.54e-01
GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI 98 4.15e-01 7.86e-01 0.07290 -4.45e-02 -5.78e-02 4.47e-01 3.23e-01
GOBP ENDOCYTOSIS 675 9.12e-03 1.46e-01 0.07290 -5.89e-02 4.29e-02 9.03e-03 5.73e-02
GOBP PHAGOLYSOSOME ASSEMBLY 17 8.67e-01 9.63e-01 0.07280 7.15e-02 1.36e-02 6.10e-01 9.22e-01
GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 97 4.29e-01 7.94e-01 0.07280 6.65e-02 2.96e-02 2.58e-01 6.14e-01
GOCC CHROMOSOME TELOMERIC REPEAT REGION 14 9.00e-01 9.74e-01 0.07280 -6.98e-02 2.06e-02 6.51e-01 8.94e-01
GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS 15 8.74e-01 9.65e-01 0.07280 4.24e-02 5.92e-02 7.76e-01 6.92e-01
GOBP MAST CELL MIGRATION 14 8.84e-01 9.69e-01 0.07280 3.34e-02 6.46e-02 8.29e-01 6.75e-01
GOBP B CELL MEDIATED IMMUNITY 130 3.80e-01 7.65e-01 0.07270 6.91e-02 -2.26e-02 1.74e-01 6.56e-01
GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 108 3.83e-01 7.67e-01 0.07270 -4.28e-02 -5.88e-02 4.43e-01 2.91e-01
GOBP CAMERA TYPE EYE MORPHOGENESIS 131 3.95e-01 7.74e-01 0.07270 -4.27e-02 5.88e-02 3.99e-01 2.45e-01
GOBP NEURON GLIAL CELL SIGNALING 5 9.64e-01 9.91e-01 0.07270 -2.91e-02 6.66e-02 9.10e-01 7.97e-01
GOBP PROTEIN TARGETING TO MITOCHONDRION 101 4.41e-01 8.00e-01 0.07260 -4.72e-03 -7.25e-02 9.35e-01 2.08e-01
GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY 28 7.80e-01 9.39e-01 0.07260 4.10e-02 5.99e-02 7.07e-01 5.83e-01
GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION 17 8.64e-01 9.62e-01 0.07260 -6.78e-02 -2.58e-02 6.28e-01 8.54e-01
GOMF MICROTUBULE MOTOR ACTIVITY 67 5.57e-01 8.56e-01 0.07260 3.23e-02 6.50e-02 6.48e-01 3.58e-01
Nervous system development 534 1.95e-02 2.24e-01 0.07250 1.75e-02 -7.04e-02 4.88e-01 5.40e-03
GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE 54 6.65e-01 8.98e-01 0.07250 -7.06e-02 1.65e-02 3.69e-01 8.34e-01
GOCC ANAPHASE PROMOTING COMPLEX 22 8.26e-01 9.52e-01 0.07250 -6.64e-02 -2.91e-02 5.90e-01 8.13e-01
GOBP SEX DIFFERENTIATION 268 1.04e-01 4.70e-01 0.07250 -6.86e-02 -2.33e-02 5.31e-02 5.12e-01
GOBP REGULATION OF NEUROTRANSMITTER SECRETION 78 5.40e-01 8.49e-01 0.07240 -1.81e-03 7.24e-02 9.78e-01 2.69e-01
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 1189 2.70e-04 1.22e-02 0.07240 -6.67e-02 2.81e-02 1.06e-04 1.02e-01
GOMF MOLECULAR ADAPTOR ACTIVITY 1097 2.62e-04 1.20e-02 0.07230 -7.23e-02 1.94e-03 5.25e-05 9.14e-01
GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN 151 2.98e-01 7.10e-01 0.07230 -4.25e-03 -7.22e-02 9.28e-01 1.26e-01
GOBP ACTION POTENTIAL 163 2.66e-01 6.80e-01 0.07230 9.89e-03 7.16e-02 8.28e-01 1.15e-01
GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 41 6.96e-01 9.11e-01 0.07230 -4.90e-02 -5.31e-02 5.88e-01 5.56e-01
GOBP CARNITINE METABOLIC PROCESS 11 9.07e-01 9.76e-01 0.07230 -5.53e-02 -4.65e-02 7.51e-01 7.89e-01
GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING 42 7.27e-01 9.20e-01 0.07220 -7.11e-02 1.28e-02 4.25e-01 8.86e-01
GOBP MITOTIC NUCLEAR DIVISION 274 1.06e-01 4.74e-01 0.07220 -1.40e-02 -7.09e-02 6.90e-01 4.35e-02
GOMF CELL CELL ADHESION MEDIATOR ACTIVITY 51 6.40e-01 8.88e-01 0.07220 6.11e-02 3.84e-02 4.50e-01 6.35e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES 71 5.57e-01 8.56e-01 0.07210 1.45e-02 7.07e-02 8.33e-01 3.03e-01
Late Phase of HIV Life Cycle 132 3.43e-01 7.40e-01 0.07210 -1.02e-02 -7.14e-02 8.40e-01 1.57e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION 1627 3.18e-06 3.02e-04 0.07200 -6.91e-02 -2.04e-02 3.40e-06 1.69e-01
RUNX1 regulates transcription of genes involved in WNT signaling 5 9.61e-01 9.90e-01 0.07200 -3.08e-03 -7.20e-02 9.90e-01 7.80e-01
GOBP RESPONSE TO SYMBIONT 6 9.50e-01 9.88e-01 0.07200 -3.09e-02 -6.51e-02 8.96e-01 7.82e-01
GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION 29 7.75e-01 9.37e-01 0.07200 -4.56e-02 -5.57e-02 6.71e-01 6.03e-01
GOBP REGULATION OF LIPID STORAGE 54 6.82e-01 9.06e-01 0.07200 -6.28e-02 3.52e-02 4.24e-01 6.55e-01
GOBP AMINO ACID BIOSYNTHETIC PROCESS 72 6.04e-01 8.76e-01 0.07200 3.99e-02 -5.99e-02 5.58e-01 3.80e-01
GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY 6 9.56e-01 9.89e-01 0.07200 -1.83e-02 6.96e-02 9.38e-01 7.68e-01
GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING 7 9.44e-01 9.87e-01 0.07200 1.17e-02 7.10e-02 9.57e-01 7.45e-01
GOCC UBIQUITIN LIGASE COMPLEX 298 8.45e-02 4.32e-01 0.07200 -6.86e-02 -2.17e-02 4.17e-02 5.19e-01
GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 74 5.24e-01 8.42e-01 0.07190 4.51e-02 5.60e-02 5.02e-01 4.05e-01
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS 30 7.70e-01 9.35e-01 0.07190 -5.98e-02 -3.99e-02 5.71e-01 7.05e-01
GOCC MICROTUBULE ORGANIZING CENTER 842 1.38e-03 4.14e-02 0.07190 -7.11e-02 -1.08e-02 4.61e-04 5.94e-01
GOBP SPERM AXONEME ASSEMBLY 31 7.67e-01 9.34e-01 0.07180 -3.14e-02 -6.46e-02 7.62e-01 5.34e-01
GOBP REGULATION OF ATP METABOLIC PROCESS 68 6.02e-01 8.75e-01 0.07180 7.04e-02 -1.38e-02 3.15e-01 8.44e-01
GOCC GAMMA TUBULIN RING COMPLEX 9 9.34e-01 9.84e-01 0.07180 9.26e-03 -7.12e-02 9.62e-01 7.12e-01
GOBP OSTEOCLAST DIFFERENTIATION 106 4.38e-01 7.98e-01 0.07180 -7.17e-02 3.57e-04 2.02e-01 9.95e-01
GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS 32 7.61e-01 9.32e-01 0.07170 3.11e-02 6.46e-02 7.60e-01 5.27e-01
GOBP REGULATION OF CORE PROMOTER BINDING 5 9.61e-01 9.90e-01 0.07170 7.16e-02 3.62e-03 7.82e-01 9.89e-01
GOBP RETINOL METABOLIC PROCESS 50 6.96e-01 9.11e-01 0.07170 6.79e-02 -2.29e-02 4.06e-01 7.79e-01
GOBP REGULATION OF BINDING 221 2.11e-01 6.28e-01 0.07170 -6.50e-02 3.03e-02 9.60e-02 4.38e-01
Polymerase switching on the C-strand of the telomere 25 8.38e-01 9.55e-01 0.07170 3.14e-02 -6.44e-02 7.86e-01 5.77e-01
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION 73 5.37e-01 8.48e-01 0.07170 -6.40e-02 -3.23e-02 3.45e-01 6.33e-01
GOBP ORGANIC CATION TRANSPORT 110 4.04e-01 7.80e-01 0.07160 -6.88e-02 -1.98e-02 2.12e-01 7.19e-01
GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 30 8.06e-01 9.48e-01 0.07160 -2.52e-02 6.70e-02 8.11e-01 5.25e-01
GOBP REGULATION OF TRANSMEMBRANE TRANSPORT 465 3.28e-02 2.83e-01 0.07160 -7.07e-02 1.16e-02 9.02e-03 6.68e-01
GOCC NON MOTILE CILIUM 155 2.77e-01 6.90e-01 0.07160 2.25e-02 6.80e-02 6.28e-01 1.44e-01
GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION 459 2.13e-02 2.33e-01 0.07160 -6.28e-02 -3.43e-02 2.11e-02 2.08e-01
GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING 37 7.27e-01 9.20e-01 0.07150 -5.96e-02 -3.95e-02 5.30e-01 6.77e-01
GOBP RESPONSE TO AMINO ACID STARVATION 54 6.39e-01 8.88e-01 0.07150 -2.14e-02 -6.82e-02 7.85e-01 3.86e-01
GOMF CALCIUM ION BINDING 679 1.00e-02 1.54e-01 0.07150 -3.50e-02 6.24e-02 1.20e-01 5.58e-03
GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT 422 5.79e-02 3.66e-01 0.07150 -4.47e-02 5.58e-02 1.15e-01 4.93e-02
GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 864 3.39e-03 7.92e-02 0.07150 -5.18e-02 4.93e-02 9.81e-03 1.40e-02
GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS 14 9.07e-01 9.77e-01 0.07140 -6.05e-02 3.80e-02 6.95e-01 8.06e-01
GOBP REGULATION OF CALCIUM ION TRANSPORT 243 1.51e-01 5.46e-01 0.07140 -7.13e-02 -4.28e-03 5.56e-02 9.09e-01
GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES 10 9.33e-01 9.83e-01 0.07140 4.05e-02 -5.88e-02 8.24e-01 7.48e-01
GOBP ENGULFMENT OF APOPTOTIC CELL 15 8.80e-01 9.67e-01 0.07140 3.24e-02 6.36e-02 8.28e-01 6.70e-01
GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS 137 3.82e-01 7.66e-01 0.07140 -2.93e-02 6.51e-02 5.54e-01 1.88e-01
GOBP GLYCOPROTEIN CATABOLIC PROCESS 33 7.71e-01 9.36e-01 0.07140 7.11e-02 6.47e-03 4.80e-01 9.49e-01
GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND 67 5.67e-01 8.59e-01 0.07140 -6.35e-02 -3.25e-02 3.68e-01 6.46e-01
GOBP REGULATION OF LYMPHOCYTE MIGRATION 66 6.20e-01 8.80e-01 0.07130 6.86e-02 -1.94e-02 3.35e-01 7.85e-01
Anchoring of the basal body to the plasma membrane 92 4.59e-01 8.10e-01 0.07130 -6.26e-02 -3.41e-02 2.99e-01 5.72e-01
GOBP CELLULAR LIPID CATABOLIC PROCESS 234 1.66e-01 5.67e-01 0.07130 6.33e-04 7.13e-02 9.87e-01 6.01e-02
GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY 7 9.53e-01 9.88e-01 0.07130 5.49e-02 -4.55e-02 8.01e-01 8.35e-01
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand 54 6.83e-01 9.06e-01 0.07130 2.81e-02 -6.55e-02 7.21e-01 4.05e-01
GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT 51 6.92e-01 9.09e-01 0.07130 -2.09e-02 6.82e-02 7.96e-01 4.00e-01
MET activates RAP1 and RAC1 11 9.20e-01 9.79e-01 0.07130 4.66e-03 -7.11e-02 9.79e-01 6.83e-01
GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY 33 7.53e-01 9.30e-01 0.07130 -5.45e-02 -4.59e-02 5.88e-01 6.48e-01
GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY 64 5.94e-01 8.71e-01 0.07120 1.80e-02 6.89e-02 8.04e-01 3.40e-01
Lipophagy 9 9.41e-01 9.86e-01 0.07120 4.73e-02 -5.32e-02 8.06e-01 7.82e-01
GOBP VIRAL GENOME REPLICATION 123 3.60e-01 7.51e-01 0.07120 -2.76e-02 -6.57e-02 5.97e-01 2.08e-01
GOBP RHYTHMIC BEHAVIOR 46 7.15e-01 9.15e-01 0.07120 -6.92e-02 1.67e-02 4.17e-01 8.45e-01
Strand-asynchronous mitochondrial DNA replication 10 9.17e-01 9.79e-01 0.07120 5.12e-02 4.95e-02 7.79e-01 7.86e-01
GOCC FLEMMING BODY 34 7.50e-01 9.29e-01 0.07120 -6.20e-02 -3.50e-02 5.32e-01 7.24e-01
GOBP REGULATION OF MACROPHAGE DIFFERENTIATION 25 8.33e-01 9.54e-01 0.07110 -1.57e-02 6.93e-02 8.92e-01 5.48e-01
GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR 21 8.60e-01 9.60e-01 0.07110 -6.84e-02 1.95e-02 5.88e-01 8.77e-01
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE 494 3.78e-02 2.98e-01 0.07110 4.96e-02 -5.09e-02 5.88e-02 5.28e-02
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 123 4.20e-01 7.89e-01 0.07110 -2.51e-02 6.65e-02 6.31e-01 2.03e-01
GOBP DEVELOPMENTAL PIGMENTATION 46 6.91e-01 9.09e-01 0.07110 -1.44e-02 -6.96e-02 8.66e-01 4.14e-01
GOMF MYRISTOYLTRANSFERASE ACTIVITY 10 9.34e-01 9.84e-01 0.07100 -4.53e-02 5.48e-02 8.04e-01 7.64e-01
GOMF PHOSPHATIDYLSERINE BINDING 66 6.12e-01 8.78e-01 0.07100 -8.70e-03 7.05e-02 9.03e-01 3.22e-01
GOMF C2H2 ZINC FINGER DOMAIN BINDING 12 9.22e-01 9.81e-01 0.07100 -4.98e-02 5.06e-02 7.65e-01 7.61e-01
GOBP CELL CYCLE 1601 4.66e-06 4.17e-04 0.07100 -6.63e-02 -2.55e-02 9.75e-06 8.94e-02
GOBP SYNAPTIC VESICLE CLUSTERING 15 8.86e-01 9.70e-01 0.07090 1.59e-02 6.91e-02 9.15e-01 6.43e-01
GOBP TYPE I INTERFERON PRODUCTION 119 3.86e-01 7.68e-01 0.07090 -1.56e-02 -6.92e-02 7.69e-01 1.92e-01
GOBP APOPTOTIC SIGNALING PATHWAY 597 1.42e-02 1.90e-01 0.07090 1.25e-02 -6.98e-02 6.01e-01 3.59e-03
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 34 7.62e-01 9.32e-01 0.07080 -6.90e-02 -1.59e-02 4.86e-01 8.73e-01
GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 139 3.15e-01 7.22e-01 0.07080 -3.26e-02 -6.29e-02 5.07e-01 2.01e-01
GOBP MITOCHONDRIAL FISSION 40 7.59e-01 9.32e-01 0.07080 -6.34e-02 3.16e-02 4.88e-01 7.30e-01
GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 35 7.55e-01 9.30e-01 0.07080 1.62e-02 6.89e-02 8.68e-01 4.80e-01
GOBP PHOSPHOLIPID EFFLUX 14 9.05e-01 9.76e-01 0.07080 -6.75e-02 2.13e-02 6.62e-01 8.90e-01
GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING 306 8.69e-02 4.36e-01 0.07080 -1.94e-02 -6.81e-02 5.60e-01 4.05e-02
GOBP BODY FLUID SECRETION 89 5.32e-01 8.45e-01 0.07080 6.77e-02 -2.06e-02 2.69e-01 7.37e-01
GOCC CUTICULAR PLATE 8 9.38e-01 9.85e-01 0.07080 6.93e-02 1.43e-02 7.34e-01 9.44e-01
Transcription of the HIV genome 66 6.14e-01 8.79e-01 0.07070 7.99e-03 -7.03e-02 9.11e-01 3.23e-01
GOMF CHLORIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 110 4.29e-01 7.94e-01 0.07070 4.89e-03 7.06e-02 9.29e-01 2.01e-01
GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 59 6.07e-01 8.76e-01 0.07070 -4.72e-02 -5.26e-02 5.30e-01 4.84e-01
GOBP NEGATIVE REGULATION OF DNA RECOMBINATION 47 7.05e-01 9.13e-01 0.07070 -7.05e-02 5.27e-03 4.03e-01 9.50e-01
GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 22 8.58e-01 9.60e-01 0.07070 -6.55e-02 2.65e-02 5.95e-01 8.30e-01
GOBP ACTIN FILAMENT BASED TRANSPORT 10 9.35e-01 9.84e-01 0.07060 -4.45e-02 5.48e-02 8.07e-01 7.64e-01
Sema3A PAK dependent Axon repulsion 14 9.09e-01 9.77e-01 0.07060 3.41e-02 -6.18e-02 8.25e-01 6.89e-01
GOMF EXONUCLEASE ACTIVITY 86 4.84e-01 8.23e-01 0.07060 -4.83e-02 -5.15e-02 4.39e-01 4.09e-01
GOCC CELL PROJECTION MEMBRANE 340 9.88e-02 4.59e-01 0.07050 -2.82e-02 6.46e-02 3.71e-01 4.06e-02
GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION 12 9.17e-01 9.79e-01 0.07050 1.35e-02 -6.92e-02 9.35e-01 6.78e-01
GOBP RESPONSE TO KETONE 209 1.83e-01 5.87e-01 0.07050 -2.76e-02 -6.49e-02 4.91e-01 1.06e-01
GOBP REGULATION OF PEPTIDASE ACTIVITY 287 1.51e-01 5.46e-01 0.07050 4.59e-02 -5.34e-02 1.81e-01 1.19e-01
GOBP MEMBRANE PROTEIN PROTEOLYSIS 59 6.09e-01 8.77e-01 0.07050 -4.91e-02 -5.05e-02 5.14e-01 5.02e-01
GOBP SPROUTING ANGIOGENESIS 190 2.68e-01 6.82e-01 0.07040 -2.31e-02 6.65e-02 5.82e-01 1.14e-01
GOBP EXIT FROM MITOSIS 31 8.04e-01 9.47e-01 0.07040 -6.75e-02 2.02e-02 5.16e-01 8.46e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION 27 8.17e-01 9.51e-01 0.07040 -7.04e-02 1.37e-03 5.27e-01 9.90e-01
GOMF UBIQUITIN BINDING 100 4.87e-01 8.23e-01 0.07040 -6.93e-02 1.22e-02 2.31e-01 8.33e-01
GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION 12 9.15e-01 9.79e-01 0.07030 -7.01e-02 5.53e-03 6.74e-01 9.74e-01
GOBP SEQUESTERING OF CALCIUM ION 133 3.63e-01 7.53e-01 0.07030 -7.00e-02 -6.17e-03 1.63e-01 9.02e-01
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING 15 8.91e-01 9.72e-01 0.07030 -6.99e-02 -7.26e-03 6.39e-01 9.61e-01
GOMF TRNA BINDING 75 5.45e-01 8.51e-01 0.07020 -2.59e-02 -6.53e-02 6.98e-01 3.28e-01
GOBP MITOTIC DNA REPLICATION 16 8.99e-01 9.74e-01 0.07020 -4.35e-02 5.51e-02 7.63e-01 7.03e-01
GOBP MEMORY 122 3.62e-01 7.53e-01 0.07020 -4.96e-02 -4.97e-02 3.44e-01 3.43e-01
GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS 30 7.88e-01 9.41e-01 0.07010 1.93e-02 6.74e-02 8.55e-01 5.23e-01
AURKA Activation by TPX2 68 6.07e-01 8.76e-01 0.07010 -6.99e-02 4.15e-03 3.19e-01 9.53e-01
GOCC ZONA PELLUCIDA RECEPTOR COMPLEX 8 9.44e-01 9.87e-01 0.07010 1.18e-02 -6.91e-02 9.54e-01 7.35e-01
GOBP REGULATION OF CELL DIVISION 180 2.26e-01 6.44e-01 0.07010 -5.18e-02 -4.72e-02 2.31e-01 2.75e-01
GOBP REGULATION OF COAGULATION 74 5.45e-01 8.51e-01 0.07000 3.59e-02 6.02e-02 5.94e-01 3.71e-01
Nucleotide salvage 20 8.50e-01 9.58e-01 0.07000 -2.92e-02 -6.37e-02 8.21e-01 6.22e-01
GOMF TRANSPORTER INHIBITOR ACTIVITY 40 7.60e-01 9.32e-01 0.07000 -6.57e-02 2.43e-02 4.72e-01 7.91e-01
GOCC BLOC 1 COMPLEX 15 8.96e-01 9.73e-01 0.07000 5.73e-03 -6.97e-02 9.69e-01 6.40e-01
GOCC VACUOLAR MEMBRANE 470 3.99e-02 3.06e-01 0.07000 -6.75e-02 1.82e-02 1.21e-02 4.98e-01
GOBP LUNG SACCULE DEVELOPMENT 10 9.31e-01 9.83e-01 0.06990 -6.90e-02 1.12e-02 7.05e-01 9.51e-01
Signaling by Hippo 19 8.64e-01 9.62e-01 0.06990 -9.90e-03 -6.92e-02 9.40e-01 6.01e-01
GOBP POSITIVE REGULATION OF CELL CELL ADHESION 318 1.00e-01 4.63e-01 0.06990 3.88e-03 -6.98e-02 9.05e-01 3.23e-02
GOBP NEGATIVE REGULATION OF DNA BINDING 29 8.27e-01 9.52e-01 0.06990 -4.43e-02 5.41e-02 6.80e-01 6.14e-01
GOBP CELLULAR RESPONSE TO TYPE II INTERFERON 93 5.18e-01 8.39e-01 0.06990 1.34e-02 -6.86e-02 8.24e-01 2.53e-01
GOMF MISFOLDED PROTEIN BINDING 15 9.05e-01 9.76e-01 0.06990 3.36e-02 -6.13e-02 8.22e-01 6.81e-01
GOMF ATP GATED ION CHANNEL ACTIVITY 9 9.34e-01 9.84e-01 0.06980 -6.96e-02 -6.11e-03 7.18e-01 9.75e-01
GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 433 3.06e-02 2.74e-01 0.06980 3.82e-02 5.85e-02 1.73e-01 3.70e-02
GOBP PLACENTA DEVELOPMENT 145 3.89e-01 7.70e-01 0.06980 4.62e-02 -5.24e-02 3.37e-01 2.76e-01
GOBP SELF PROTEOLYSIS 12 9.15e-01 9.78e-01 0.06980 -6.98e-02 -8.82e-04 6.75e-01 9.96e-01
GOBP REGULATION OF VASCULATURE DEVELOPMENT 349 9.73e-02 4.56e-01 0.06980 -6.43e-02 2.72e-02 3.91e-02 3.82e-01
GOCC COATED VESICLE MEMBRANE 194 2.05e-01 6.20e-01 0.06980 -5.50e-02 -4.29e-02 1.86e-01 3.03e-01
GOBP REGULATION OF SYNAPSE ASSEMBLY 109 4.91e-01 8.26e-01 0.06980 -4.36e-02 5.45e-02 4.32e-01 3.26e-01
GOBP GLUTAMATE METABOLIC PROCESS 33 7.63e-01 9.32e-01 0.06980 4.00e-02 5.71e-02 6.91e-01 5.70e-01
GOBP T CELL PROLIFERATION 204 2.65e-01 6.79e-01 0.06980 4.10e-02 -5.64e-02 3.12e-01 1.65e-01
GOBP REGULATION OF HEART CONTRACTION 201 2.60e-01 6.75e-01 0.06970 -6.38e-02 2.82e-02 1.19e-01 4.91e-01
GOMF ENZYME ACTIVATOR ACTIVITY 565 1.29e-02 1.79e-01 0.06970 -6.64e-02 -2.13e-02 6.97e-03 3.87e-01
GOMF SCAVENGER RECEPTOR ACTIVITY 27 8.01e-01 9.46e-01 0.06970 -5.68e-02 -4.04e-02 6.09e-01 7.16e-01
GOBP PHOTORECEPTOR CELL DIFFERENTIATION 65 5.87e-01 8.67e-01 0.06970 4.03e-02 5.69e-02 5.74e-01 4.28e-01
GOBP ANTEROGRADE AXONAL TRANSPORT 49 6.69e-01 9.00e-01 0.06970 -5.70e-02 -4.01e-02 4.90e-01 6.27e-01
Nuclear Envelope (NE) Reassembly 73 6.17e-01 8.80e-01 0.06970 3.51e-02 -6.02e-02 6.04e-01 3.74e-01
GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 148 3.53e-01 7.46e-01 0.06970 -6.86e-02 1.23e-02 1.50e-01 7.97e-01
Interferon Signaling 263 1.64e-01 5.63e-01 0.06960 1.71e-02 -6.75e-02 6.33e-01 5.94e-02
GOBP PHOTORECEPTOR CELL DEVELOPMENT 51 6.60e-01 8.96e-01 0.06960 3.70e-02 5.90e-02 6.48e-01 4.66e-01
GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 54 6.83e-01 9.06e-01 0.06960 1.20e-02 -6.86e-02 8.78e-01 3.83e-01
GOMF PROTEIN DIMERIZATION ACTIVITY 1023 3.27e-04 1.40e-02 0.06960 -5.23e-02 -4.59e-02 4.64e-03 1.31e-02
GOCC PHOTORECEPTOR RIBBON SYNAPSE 9 9.41e-01 9.86e-01 0.06960 -2.51e-02 6.49e-02 8.96e-01 7.36e-01
GOBP MONOCYTE DIFFERENTIATION 34 7.58e-01 9.32e-01 0.06960 3.82e-02 5.81e-02 7.00e-01 5.58e-01
GOMF ADENYL NUCLEOTIDE BINDING 1565 7.73e-05 4.77e-03 0.06960 -5.42e-02 4.36e-02 3.46e-04 3.99e-03
GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS 167 2.74e-01 6.87e-01 0.06950 1.93e-02 6.68e-02 6.67e-01 1.36e-01
GOBP MESENCHYMAL CELL APOPTOTIC PROCESS 15 8.90e-01 9.71e-01 0.06950 -1.94e-02 -6.67e-02 8.96e-01 6.55e-01
GOBP PROTEIN K63 LINKED DEUBIQUITINATION 26 8.20e-01 9.52e-01 0.06950 1.31e-02 6.82e-02 9.08e-01 5.47e-01
GOBP APOPTOTIC CELL CLEARANCE 47 7.11e-01 9.14e-01 0.06950 -6.94e-02 3.09e-03 4.10e-01 9.71e-01
GOCC NEURON PROJECTION 1260 3.70e-04 1.54e-02 0.06940 -6.25e-02 3.03e-02 1.93e-04 7.05e-02
GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS 9 9.43e-01 9.87e-01 0.06940 3.83e-02 -5.78e-02 8.42e-01 7.64e-01
GOBP REGULATION OF CELL CYCLE PROCESS 718 3.73e-03 8.44e-02 0.06940 -6.05e-02 -3.39e-02 5.76e-03 1.21e-01
GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 55 7.02e-01 9.12e-01 0.06930 4.82e-02 -4.98e-02 5.36e-01 5.23e-01
GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 140 3.66e-01 7.56e-01 0.06930 3.54e-03 -6.92e-02 9.42e-01 1.57e-01
Apoptotic execution phase 49 6.74e-01 9.03e-01 0.06930 -5.91e-02 -3.62e-02 4.75e-01 6.61e-01
GOMF DYSTROGLYCAN BINDING 10 9.24e-01 9.81e-01 0.06920 -2.82e-02 -6.32e-02 8.77e-01 7.29e-01
Synthesis of PIPs at the plasma membrane 48 7.08e-01 9.13e-01 0.06920 -2.42e-03 6.91e-02 9.77e-01 4.07e-01
GOCC CELL CELL CONTACT ZONE 72 6.19e-01 8.80e-01 0.06920 -2.60e-02 6.41e-02 7.03e-01 3.47e-01
GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE 20 8.78e-01 9.67e-01 0.06920 3.85e-02 -5.75e-02 7.66e-01 6.56e-01
GOBP WNT SIGNALING PATHWAY 446 3.60e-02 2.93e-01 0.06920 -6.78e-02 -1.36e-02 1.41e-02 6.22e-01
GOBP MEIOTIC DNA DOUBLE STRAND BREAK FORMATION 8 9.44e-01 9.87e-01 0.06910 -6.91e-02 7.19e-04 7.35e-01 9.97e-01
GOCC ZONULA ADHERENS 8 9.49e-01 9.88e-01 0.06910 -3.25e-02 6.10e-02 8.74e-01 7.65e-01
GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 161 3.12e-01 7.21e-01 0.06910 -6.91e-02 -1.38e-03 1.31e-01 9.76e-01
GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 96 5.10e-01 8.34e-01 0.06910 -6.85e-02 8.63e-03 2.46e-01 8.84e-01
GOBP REGULATION OF BILE ACID METABOLIC PROCESS 15 9.08e-01 9.77e-01 0.06900 5.58e-02 -4.06e-02 7.08e-01 7.85e-01
GOBP CELLULAR DEFENSE RESPONSE 48 7.02e-01 9.12e-01 0.06900 -6.28e-03 -6.87e-02 9.40e-01 4.10e-01
Macroautophagy 135 3.64e-01 7.54e-01 0.06890 -1.31e-02 -6.76e-02 7.92e-01 1.75e-01
Platelet degranulation 117 3.96e-01 7.74e-01 0.06890 -5.89e-02 -3.57e-02 2.71e-01 5.05e-01
GOBP LOCOMOTOR RHYTHM 16 8.79e-01 9.67e-01 0.06890 4.55e-02 5.17e-02 7.52e-01 7.21e-01
GOBP ESTROUS CYCLE 16 9.00e-01 9.74e-01 0.06890 6.32e-02 -2.74e-02 6.62e-01 8.49e-01
GOBP NITROGEN UTILIZATION 5 9.62e-01 9.90e-01 0.06880 6.51e-02 2.22e-02 8.01e-01 9.31e-01
GOBP COLLATERAL SPROUTING 26 8.43e-01 9.56e-01 0.06880 -6.32e-02 2.73e-02 5.77e-01 8.10e-01
GOBP MYELOID CELL HOMEOSTASIS 169 3.17e-01 7.25e-01 0.06880 1.47e-02 -6.72e-02 7.42e-01 1.32e-01
GOBP LIPOSACCHARIDE METABOLIC PROCESS 111 4.90e-01 8.26e-01 0.06880 5.95e-02 -3.45e-02 2.79e-01 5.30e-01
Centrosome maturation 77 6.13e-01 8.78e-01 0.06880 -5.42e-02 4.23e-02 4.11e-01 5.21e-01
Recruitment of mitotic centrosome proteins and complexes 77 6.13e-01 8.78e-01 0.06880 -5.42e-02 4.23e-02 4.11e-01 5.21e-01
GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS 200 2.79e-01 6.92e-01 0.06880 -3.63e-02 5.84e-02 3.76e-01 1.54e-01
GOBP IMMUNE SYSTEM DEVELOPMENT 197 2.17e-01 6.35e-01 0.06880 -2.85e-02 -6.26e-02 4.91e-01 1.30e-01
GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY 134 3.60e-01 7.51e-01 0.06880 2.04e-02 6.57e-02 6.84e-01 1.89e-01
GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY 24 8.39e-01 9.55e-01 0.06880 -6.85e-02 -5.93e-03 5.61e-01 9.60e-01
GOBP MITOCHONDRIAL GENOME MAINTENANCE 30 8.22e-01 9.52e-01 0.06880 2.91e-02 -6.23e-02 7.83e-01 5.55e-01
GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION 45 7.08e-01 9.13e-01 0.06880 -6.55e-02 -2.10e-02 4.47e-01 8.07e-01
GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS 258 1.36e-01 5.24e-01 0.06870 -6.23e-02 -2.90e-02 8.49e-02 4.23e-01
GOBP OLIGODENDROCYTE PROGENITOR PROLIFERATION 8 9.38e-01 9.85e-01 0.06870 -5.58e-02 -4.01e-02 7.85e-01 8.44e-01
GOBP ETHER METABOLIC PROCESS 26 8.39e-01 9.55e-01 0.06870 6.66e-02 -1.67e-02 5.56e-01 8.83e-01
Biotin transport and metabolism 10 9.33e-01 9.83e-01 0.06870 -6.78e-02 1.10e-02 7.10e-01 9.52e-01
EPH-ephrin mediated repulsion of cells 50 7.21e-01 9.17e-01 0.06870 -2.69e-02 6.32e-02 7.42e-01 4.40e-01
GOBP PLACENTA BLOOD VESSEL DEVELOPMENT 31 8.09e-01 9.49e-01 0.06870 1.40e-02 -6.72e-02 8.92e-01 5.17e-01
GOCC RECYCLING ENDOSOME 198 2.17e-01 6.35e-01 0.06870 2.79e-02 6.27e-02 4.99e-01 1.28e-01
GOBP MACROPHAGE CHEMOTAXIS 41 7.35e-01 9.23e-01 0.06860 -6.71e-02 -1.44e-02 4.57e-01 8.73e-01
GOBP REGULATION OF MYELOID CELL DIFFERENTIATION 209 2.12e-01 6.28e-01 0.06860 -1.38e-02 -6.72e-02 7.31e-01 9.39e-02
RND1 GTPase cycle 41 7.41e-01 9.25e-01 0.06860 6.82e-02 7.51e-03 4.50e-01 9.34e-01
GOBP STRESS FIBER ASSEMBLY 109 4.91e-01 8.26e-01 0.06860 -2.69e-02 6.31e-02 6.27e-01 2.55e-01
GOBP CELLULAR RESPONSE TO STRESS 1768 2.41e-06 2.41e-04 0.06860 -5.52e-02 -4.06e-02 1.14e-04 4.57e-03
GOBP MONOATOMIC ANION TRANSPORT 162 2.82e-01 6.94e-01 0.06860 3.45e-02 5.92e-02 4.49e-01 1.93e-01
GOBP REGULATION OF SENSORY PERCEPTION 17 8.89e-01 9.71e-01 0.06850 9.21e-03 -6.79e-02 9.48e-01 6.28e-01
GOBP LIPID HYDROXYLATION 7 9.52e-01 9.88e-01 0.06850 6.82e-02 -6.90e-03 7.55e-01 9.75e-01
GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE 206 2.69e-01 6.83e-01 0.06850 6.04e-02 -3.25e-02 1.35e-01 4.22e-01
GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 76 5.47e-01 8.52e-01 0.06850 -5.37e-02 -4.25e-02 4.18e-01 5.22e-01
GOBP POSITIVE REGULATION OF COAGULATION 30 7.97e-01 9.44e-01 0.06850 1.94e-02 6.57e-02 8.54e-01 5.33e-01
GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION 11 9.18e-01 9.79e-01 0.06850 3.15e-02 6.08e-02 8.56e-01 7.27e-01
GOCC SPINDLE MICROTUBULE 77 5.70e-01 8.61e-01 0.06840 -7.98e-03 -6.80e-02 9.04e-01 3.02e-01
GOBP CELL MATURATION 201 2.85e-01 6.97e-01 0.06840 -4.40e-02 5.24e-02 2.82e-01 2.00e-01
Protein-protein interactions at synapses 78 5.40e-01 8.49e-01 0.06840 5.31e-02 4.31e-02 4.18e-01 5.10e-01
GOBP MEIOTIC CELL CYCLE 279 1.28e-01 5.10e-01 0.06840 -6.67e-02 -1.51e-02 5.52e-02 6.64e-01
GOBP RESPONSE TO HUMAN CHORIONIC GONADOTROPIN 5 9.69e-01 9.91e-01 0.06840 -5.50e-02 4.06e-02 8.31e-01 8.75e-01
FCGR3A-mediated phagocytosis 57 6.42e-01 8.89e-01 0.06830 -3.28e-02 -5.99e-02 6.69e-01 4.34e-01
Leishmania phagocytosis 57 6.42e-01 8.89e-01 0.06830 -3.28e-02 -5.99e-02 6.69e-01 4.34e-01
Parasite infection 57 6.42e-01 8.89e-01 0.06830 -3.28e-02 -5.99e-02 6.69e-01 4.34e-01
GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 28 8.28e-01 9.53e-01 0.06830 -1.43e-02 6.68e-02 8.96e-01 5.41e-01
GOBP VIRAL RNA GENOME REPLICATION 29 8.34e-01 9.55e-01 0.06830 -4.78e-02 4.87e-02 6.56e-01 6.50e-01
GOBP VIRAL BUDDING 25 8.55e-01 9.59e-01 0.06820 4.20e-02 -5.38e-02 7.16e-01 6.42e-01
GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS 25 8.49e-01 9.58e-01 0.06820 6.43e-02 -2.29e-02 5.78e-01 8.43e-01
GOBP REGULATION OF MYOBLAST FUSION 20 8.69e-01 9.64e-01 0.06820 -6.82e-02 2.65e-03 5.98e-01 9.84e-01
Processing and activation of SUMO 10 9.25e-01 9.81e-01 0.06820 -3.88e-02 -5.61e-02 8.32e-01 7.59e-01
GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY 18 8.83e-01 9.68e-01 0.06820 5.10e-03 -6.80e-02 9.70e-01 6.18e-01
GOBP POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS 21 8.69e-01 9.64e-01 0.06820 -1.58e-02 6.63e-02 9.00e-01 5.99e-01
GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION 8 9.51e-01 9.88e-01 0.06810 4.93e-02 -4.70e-02 8.09e-01 8.18e-01
Autophagy 149 3.51e-01 7.45e-01 0.06800 -1.18e-03 -6.80e-02 9.80e-01 1.52e-01
GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX 26 8.17e-01 9.51e-01 0.06800 -5.83e-02 -3.50e-02 6.07e-01 7.58e-01
GOBP PROTEIN MATURATION 517 2.42e-02 2.50e-01 0.06800 -1.46e-02 -6.64e-02 5.69e-01 9.81e-03
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 62 6.19e-01 8.80e-01 0.06790 3.55e-02 5.79e-02 6.29e-01 4.30e-01
GOBP LUNG ALVEOLUS DEVELOPMENT 52 7.25e-01 9.19e-01 0.06790 -4.93e-02 4.68e-02 5.39e-01 5.60e-01
GOBP MULTIVESICULAR BODY ORGANIZATION 32 8.08e-01 9.49e-01 0.06790 1.37e-02 -6.65e-02 8.93e-01 5.15e-01
Signaling by Rho GTPases 629 1.16e-02 1.68e-01 0.06780 -6.67e-02 -1.25e-02 4.31e-03 5.92e-01
GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION 101 5.37e-01 8.48e-01 0.06780 -5.16e-02 4.41e-02 3.70e-01 4.44e-01
GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 27 8.16e-01 9.51e-01 0.06780 -6.39e-02 -2.29e-02 5.66e-01 8.37e-01
GOBP ACUTE PHASE RESPONSE 45 7.58e-01 9.31e-01 0.06780 4.86e-02 -4.73e-02 5.73e-01 5.83e-01
GOBP ARGININE METABOLIC PROCESS 18 8.86e-01 9.70e-01 0.06780 1.16e-02 -6.68e-02 9.32e-01 6.24e-01
GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE 15 9.06e-01 9.76e-01 0.06780 -1.86e-02 6.52e-02 9.01e-01 6.62e-01
Class B/2 (Secretin family receptors) 93 4.94e-01 8.28e-01 0.06780 -2.87e-02 -6.14e-02 6.32e-01 3.06e-01
GOBP REGULATION OF STEM CELL DIFFERENTIATION 83 5.77e-01 8.64e-01 0.06770 -6.64e-02 1.35e-02 2.96e-01 8.31e-01
GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE 200 2.13e-01 6.30e-01 0.06770 -4.66e-02 -4.92e-02 2.56e-01 2.30e-01
GOBP CONNECTIVE TISSUE REPLACEMENT 21 8.58e-01 9.60e-01 0.06770 -1.33e-02 -6.64e-02 9.16e-01 5.98e-01
GOCC LATERAL PLASMA MEMBRANE 64 6.09e-01 8.77e-01 0.06770 5.19e-02 4.35e-02 4.73e-01 5.48e-01
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 643 1.02e-02 1.55e-01 0.06770 -6.57e-02 -1.63e-02 4.48e-03 4.80e-01
GOBP REGULATION OF PROTON TRANSPORT 16 9.06e-01 9.76e-01 0.06770 -5.36e-02 4.13e-02 7.10e-01 7.75e-01
GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES 20 8.74e-01 9.65e-01 0.06770 -6.70e-02 9.10e-03 6.04e-01 9.44e-01
SHC1 events in ERBB2 signaling 22 8.55e-01 9.59e-01 0.06760 -6.50e-03 -6.73e-02 9.58e-01 5.85e-01
GOBP METANEPHRIC TUBULE DEVELOPMENT 24 8.42e-01 9.56e-01 0.06760 8.86e-03 6.71e-02 9.40e-01 5.70e-01
GOBP POSITIVE REGULATION OF CELL DIVISION 93 5.04e-01 8.31e-01 0.06760 -6.48e-02 -1.93e-02 2.80e-01 7.48e-01
PI Metabolism 78 6.15e-01 8.80e-01 0.06760 -5.88e-02 3.33e-02 3.69e-01 6.11e-01
GOBP INTERLEUKIN 17 PRODUCTION 47 6.95e-01 9.11e-01 0.06760 5.05e-02 4.49e-02 5.49e-01 5.94e-01
GOBP VASCULATURE DEVELOPMENT 811 6.39e-03 1.16e-01 0.06760 -6.43e-02 2.06e-02 1.84e-03 3.18e-01
GOCC POSTSYNAPTIC SPECIALIZATION 335 9.63e-02 4.52e-01 0.06760 -6.73e-02 -6.28e-03 3.43e-02 8.43e-01
GOBP PEPTIDE TRANSPORT 253 1.86e-01 5.91e-01 0.06750 -6.70e-02 8.67e-03 6.66e-02 8.12e-01
GOBP NEURON RECOGNITION 46 7.53e-01 9.30e-01 0.06750 -5.71e-02 3.60e-02 5.03e-01 6.72e-01
GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY 97 5.09e-01 8.34e-01 0.06750 6.74e-02 3.13e-03 2.51e-01 9.58e-01
GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY 26 8.23e-01 9.52e-01 0.06740 -2.73e-02 -6.17e-02 8.09e-01 5.86e-01
GOBP ATP METABOLIC PROCESS 205 2.89e-01 7.02e-01 0.06740 4.45e-02 -5.06e-02 2.72e-01 2.12e-01
GOBP REGULATION OF PHAGOCYTOSIS 95 5.62e-01 8.57e-01 0.06740 4.56e-02 -4.96e-02 4.42e-01 4.03e-01
RAC1 GTPase cycle 171 3.49e-01 7.45e-01 0.06740 -5.82e-02 3.39e-02 1.89e-01 4.45e-01
GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL 182 3.00e-01 7.11e-01 0.06740 -6.67e-02 9.70e-03 1.21e-01 8.21e-01
GOBP ORGANIC ACID CATABOLIC PROCESS 242 2.05e-01 6.20e-01 0.06740 -1.16e-02 6.64e-02 7.56e-01 7.54e-02
Vasopressin-like receptors 5 9.68e-01 9.91e-01 0.06730 -6.60e-02 1.31e-02 7.98e-01 9.59e-01
GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION 8 9.45e-01 9.87e-01 0.06730 -7.39e-03 -6.69e-02 9.71e-01 7.43e-01
GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY 164 3.37e-01 7.37e-01 0.06730 8.62e-03 -6.67e-02 8.49e-01 1.40e-01
GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE 34 8.01e-01 9.46e-01 0.06730 1.54e-02 -6.55e-02 8.77e-01 5.09e-01
GOBP CELLULAR RESPONSE TO CALCIUM ION 69 6.24e-01 8.83e-01 0.06730 -6.73e-02 1.11e-03 3.34e-01 9.87e-01
GOBP CILIARY BASAL BODY ORGANIZATION 5 9.64e-01 9.91e-01 0.06720 2.38e-02 6.29e-02 9.26e-01 8.08e-01
GOBP REGULATION OF DNA REPLICATION 124 3.95e-01 7.74e-01 0.06720 -3.08e-02 -5.98e-02 5.54e-01 2.50e-01
GOMF OPIOID RECEPTOR BINDING 7 9.58e-01 9.89e-01 0.06720 -3.30e-02 5.85e-02 8.80e-01 7.89e-01
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION 34 8.04e-01 9.47e-01 0.06720 6.46e-02 -1.85e-02 5.15e-01 8.52e-01
GOBP REGULATION OF MUSCLE CONTRACTION 165 3.58e-01 7.50e-01 0.06720 -6.18e-02 2.62e-02 1.71e-01 5.62e-01
GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY 18 8.76e-01 9.66e-01 0.06710 -2.16e-02 -6.36e-02 8.74e-01 6.41e-01
GOBP PROTEIN HOMOOLIGOMERIZATION 192 3.12e-01 7.21e-01 0.06710 -5.70e-02 3.54e-02 1.73e-01 3.98e-01
GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX 11 9.23e-01 9.81e-01 0.06700 2.10e-02 6.36e-02 9.04e-01 7.15e-01
GOBP CALCINEURIN MEDIATED SIGNALING 47 7.36e-01 9.23e-01 0.06700 1.15e-02 -6.60e-02 8.92e-01 4.34e-01
GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY 9 9.40e-01 9.85e-01 0.06690 4.23e-03 6.68e-02 9.82e-01 7.29e-01
GOBP CELLULAR RESPONSE TO AMMONIUM ION 5 9.66e-01 9.91e-01 0.06690 -6.68e-02 -4.66e-03 7.96e-01 9.86e-01
GOCC CENTROSOME 705 6.88e-03 1.21e-01 0.06690 -6.33e-02 -2.17e-02 4.20e-03 3.26e-01
GOBP VACUOLAR LOCALIZATION 80 5.46e-01 8.51e-01 0.06690 -4.92e-02 -4.53e-02 4.47e-01 4.84e-01
GOCC BLOC COMPLEX 20 8.77e-01 9.66e-01 0.06690 -9.95e-03 6.61e-02 9.39e-01 6.09e-01
GOBP TIGHT JUNCTION ORGANIZATION 80 5.87e-01 8.67e-01 0.06680 6.67e-02 -4.37e-03 3.03e-01 9.46e-01
Activation of PPARGC1A (PGC-1alpha) by phosphorylation 10 9.34e-01 9.84e-01 0.06680 6.68e-02 6.48e-04 7.14e-01 9.97e-01
GOBP RESPONSE TO PH 40 7.42e-01 9.26e-01 0.06680 5.73e-02 3.43e-02 5.31e-01 7.07e-01
GOBP NEGATIVE REGULATION OF PROTEIN SECRETION 72 6.07e-01 8.76e-01 0.06680 7.67e-03 6.63e-02 9.10e-01 3.30e-01
GOCC MITOCHONDRION 1596 3.06e-05 2.13e-03 0.06670 -1.09e-02 -6.58e-02 4.68e-01 1.16e-05
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY 118 4.25e-01 7.93e-01 0.06670 -2.37e-02 -6.23e-02 6.56e-01 2.42e-01
GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS 25 8.39e-01 9.56e-01 0.06670 6.58e-02 1.09e-02 5.69e-01 9.25e-01
GOBP PROTEIN AUTOPHOSPHORYLATION 179 3.45e-01 7.43e-01 0.06670 -4.06e-02 5.29e-02 3.49e-01 2.22e-01
GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND 14 9.16e-01 9.79e-01 0.06660 6.25e-02 -2.32e-02 6.86e-01 8.80e-01
GOBP REGULATION OF MONOATOMIC ION TRANSPORT 445 5.94e-02 3.70e-01 0.06660 -6.56e-02 1.16e-02 1.77e-02 6.76e-01
GOCC AUTOPHAGOSOME MEMBRANE 52 6.98e-01 9.11e-01 0.06660 8.34e-03 6.61e-02 9.17e-01 4.10e-01
GOBP DNA BIOSYNTHETIC PROCESS 187 2.55e-01 6.70e-01 0.06660 -2.94e-02 -5.97e-02 4.87e-01 1.59e-01
GOBP LOCALIZATION WITHIN MEMBRANE 653 1.95e-02 2.24e-01 0.06650 -6.23e-02 2.33e-02 6.60e-03 3.09e-01
GOBP SUPEROXIDE ANION GENERATION 37 7.91e-01 9.42e-01 0.06650 -1.73e-02 6.42e-02 8.56e-01 4.99e-01
GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY 26 8.52e-01 9.59e-01 0.06650 -6.13e-02 2.58e-02 5.88e-01 8.20e-01
GOBP RESPONSE TO ESTRADIOL 116 4.47e-01 8.04e-01 0.06650 -6.57e-02 -1.05e-02 2.22e-01 8.45e-01
GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 28 8.47e-01 9.58e-01 0.06650 4.50e-02 -4.89e-02 6.80e-01 6.54e-01
GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS 16 8.99e-01 9.74e-01 0.06650 -6.64e-02 3.83e-03 6.46e-01 9.79e-01
GOBP DETECTION OF VISIBLE LIGHT 45 7.28e-01 9.21e-01 0.06650 6.49e-02 1.46e-02 4.52e-01 8.66e-01
GOBP NEGATIVE CHEMOTAXIS 46 7.10e-01 9.13e-01 0.06640 5.20e-02 4.13e-02 5.41e-01 6.28e-01
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY 140 3.63e-01 7.53e-01 0.06640 -6.09e-02 -2.66e-02 2.14e-01 5.87e-01
GOMF RACEMASE AND EPIMERASE ACTIVITY 17 9.04e-01 9.76e-01 0.06640 -4.43e-02 4.95e-02 7.52e-01 7.24e-01
GOBP REGULATION OF T CELL PROLIFERATION 172 3.59e-01 7.51e-01 0.06630 5.69e-02 -3.41e-02 1.98e-01 4.41e-01
GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 20 8.65e-01 9.62e-01 0.06630 6.11e-02 2.59e-02 6.36e-01 8.41e-01
MASTL Facilitates Mitotic Progression 10 9.28e-01 9.82e-01 0.06630 -4.72e-02 -4.66e-02 7.96e-01 7.99e-01
GOMF EXOGENOUS PROTEIN BINDING 79 6.14e-01 8.79e-01 0.06630 6.27e-02 -2.16e-02 3.35e-01 7.40e-01
GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS 27 8.20e-01 9.52e-01 0.06630 -3.38e-02 -5.71e-02 7.61e-01 6.08e-01
GOCC AXONEMAL OUTER DOUBLET 37 8.01e-01 9.46e-01 0.06630 5.75e-02 -3.31e-02 5.45e-01 7.27e-01
GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 92 5.50e-01 8.53e-01 0.06630 -6.59e-02 7.03e-03 2.74e-01 9.07e-01
GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION 112 4.37e-01 7.97e-01 0.06630 -3.93e-02 -5.34e-02 4.73e-01 3.29e-01
GOBP SULFUR AMINO ACID METABOLIC PROCESS 31 8.16e-01 9.51e-01 0.06620 6.61e-02 -4.68e-03 5.24e-01 9.64e-01
GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY 163 3.65e-01 7.55e-01 0.06620 1.95e-02 -6.33e-02 6.68e-01 1.63e-01
GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS 88 5.97e-01 8.73e-01 0.06620 -4.60e-02 4.76e-02 4.56e-01 4.40e-01
Maturation of spike protein 9694548 35 7.72e-01 9.36e-01 0.06610 4.40e-02 4.93e-02 6.52e-01 6.13e-01
GOCC EXTERNAL ENCAPSULATING STRUCTURE 537 2.54e-02 2.54e-01 0.06610 1.59e-02 6.42e-02 5.28e-01 1.10e-02
GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION 25 8.62e-01 9.61e-01 0.06610 3.61e-02 -5.54e-02 7.55e-01 6.32e-01
GOCC MEMBRANE MICRODOMAIN 282 1.48e-01 5.43e-01 0.06600 -6.53e-02 -9.71e-03 5.91e-02 7.79e-01
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING 37 7.82e-01 9.40e-01 0.06600 -6.60e-02 -1.95e-03 4.87e-01 9.84e-01
GOBP MITOTIC CELL CYCLE 893 2.09e-03 5.61e-02 0.06600 -6.04e-02 -2.65e-02 2.18e-03 1.79e-01
GOBP POSITIVE REGULATION OF PROTEIN MATURATION 26 8.38e-01 9.55e-01 0.06600 7.87e-03 6.55e-02 9.45e-01 5.63e-01
GOBP REGULATION OF IMMUNE SYSTEM PROCESS 1511 2.67e-04 1.21e-02 0.06600 4.34e-02 -4.96e-02 4.76e-03 1.26e-03
GOBP RECEPTOR CATABOLIC PROCESS 27 8.41e-01 9.56e-01 0.06600 6.54e-02 -8.25e-03 5.56e-01 9.41e-01
GOCC ORGANELLE ENVELOPE 1207 5.55e-04 2.04e-02 0.06590 1.76e-03 -6.59e-02 9.18e-01 1.15e-04
GOBP PROTEIN COMPLEX OLIGOMERIZATION 256 2.03e-01 6.18e-01 0.06590 -6.46e-02 1.32e-02 7.53e-02 7.15e-01
GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 51 7.35e-01 9.23e-01 0.06590 2.60e-02 -6.05e-02 7.48e-01 4.55e-01
GOBP MITOCHONDRION ORGANIZATION 490 3.45e-02 2.88e-01 0.06590 -1.87e-02 -6.32e-02 4.78e-01 1.66e-02
GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY 39 7.53e-01 9.30e-01 0.06580 5.65e-02 3.38e-02 5.42e-01 7.15e-01
GOBP INTERLEUKIN 1 PRODUCTION 122 4.16e-01 7.86e-01 0.06580 5.80e-02 3.12e-02 2.69e-01 5.52e-01
GOBP PYROPTOSIS 36 7.81e-01 9.40e-01 0.06580 6.43e-02 1.36e-02 5.04e-01 8.88e-01
GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 75 5.95e-01 8.71e-01 0.06580 1.64e-02 6.37e-02 8.06e-01 3.40e-01
GOMF TPR DOMAIN BINDING 7 9.58e-01 9.89e-01 0.06570 1.97e-02 -6.27e-02 9.28e-01 7.74e-01
GOBP REGULATION OF CELL CYCLE 1072 5.85e-04 2.13e-02 0.06570 -5.35e-02 -3.82e-02 3.10e-03 3.47e-02
GOMF CARGO RECEPTOR ACTIVITY 72 6.02e-01 8.75e-01 0.06570 -6.17e-02 -2.26e-02 3.66e-01 7.40e-01
GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY 6 9.61e-01 9.90e-01 0.06570 -6.53e-02 -6.87e-03 7.82e-01 9.77e-01
GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT 16 9.06e-01 9.76e-01 0.06560 1.70e-02 -6.34e-02 9.06e-01 6.61e-01
GOBP SINGLE FERTILIZATION 161 3.69e-01 7.58e-01 0.06560 6.43e-02 -1.29e-02 1.59e-01 7.78e-01
GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION 16 9.04e-01 9.75e-01 0.06550 -6.50e-02 8.31e-03 6.53e-01 9.54e-01
GOMF GDP BINDING 71 6.14e-01 8.79e-01 0.06550 -1.63e-02 -6.35e-02 8.12e-01 3.55e-01
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE ADAPTATION 9 9.41e-01 9.86e-01 0.06550 8.56e-03 6.50e-02 9.65e-01 7.36e-01
GOBP GLYCOSYL COMPOUND METABOLIC PROCESS 81 6.16e-01 8.80e-01 0.06550 -6.10e-02 2.38e-02 3.42e-01 7.11e-01
GOCC CATION CHANNEL COMPLEX 200 2.58e-01 6.72e-01 0.06550 1.39e-02 6.40e-02 7.35e-01 1.19e-01
GOBP ALCOHOL METABOLIC PROCESS 354 7.91e-02 4.19e-01 0.06550 4.85e-02 4.40e-02 1.17e-01 1.55e-01
Regulation of actin dynamics for phagocytic cup formation 58 6.67e-01 8.99e-01 0.06550 -2.18e-02 -6.17e-02 7.74e-01 4.16e-01
GOBP RESPONSE TO STEROL DEPLETION 18 8.93e-01 9.72e-01 0.06550 6.49e-02 -8.51e-03 6.34e-01 9.50e-01
Stimuli-sensing channels 101 4.87e-01 8.23e-01 0.06550 5.75e-02 3.13e-02 3.18e-01 5.87e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS 8 9.53e-01 9.88e-01 0.06540 6.24e-02 -1.98e-02 7.60e-01 9.23e-01
GOMF ACETYLTRANSFERASE ACTIVITY 89 5.32e-01 8.45e-01 0.06540 -2.90e-02 -5.86e-02 6.37e-01 3.39e-01
GOBP ATP TRANSPORT 19 8.96e-01 9.73e-01 0.06540 -5.08e-02 4.12e-02 7.01e-01 7.56e-01
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 1079 1.40e-03 4.19e-02 0.06540 -6.52e-02 4.01e-03 2.95e-04 8.24e-01
Downregulation of SMAD2/3:SMAD4 transcriptional activity 29 8.12e-01 9.49e-01 0.06540 -3.70e-02 -5.39e-02 7.30e-01 6.16e-01
GOBP COGNITION 305 1.43e-01 5.35e-01 0.06530 -6.53e-02 2.88e-04 4.99e-02 9.93e-01
GOBP POSITIVE REGULATION OF HELICASE ACTIVITY 6 9.64e-01 9.91e-01 0.06530 6.25e-02 -1.87e-02 7.91e-01 9.37e-01
GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX 10 9.32e-01 9.83e-01 0.06530 -5.98e-02 -2.61e-02 7.43e-01 8.86e-01
GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 102 5.40e-01 8.49e-01 0.06520 1.78e-02 -6.28e-02 7.56e-01 2.73e-01
GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 509 3.12e-02 2.76e-01 0.06520 -6.07e-02 -2.38e-02 1.91e-02 3.59e-01
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT 329 1.42e-01 5.33e-01 0.06520 -6.23e-02 1.90e-02 5.20e-02 5.54e-01
Regulation of RUNX1 Expression and Activity 25 8.37e-01 9.55e-01 0.06510 -3.25e-02 -5.65e-02 7.79e-01 6.25e-01
GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION 38 7.96e-01 9.44e-01 0.06510 -6.19e-02 2.00e-02 5.09e-01 8.31e-01
GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION 12 9.24e-01 9.81e-01 0.06510 -6.46e-02 -7.72e-03 6.98e-01 9.63e-01
GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS 383 1.18e-01 4.93e-01 0.06510 4.56e-02 -4.65e-02 1.26e-01 1.19e-01
GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY 355 8.82e-02 4.37e-01 0.06500 -6.05e-02 -2.39e-02 5.02e-02 4.40e-01
GOBP REGULATION OF TISSUE REMODELING 88 5.82e-01 8.66e-01 0.06500 -1.07e-02 6.41e-02 8.62e-01 2.99e-01
GOBP ACTIN FILAMENT BASED MOVEMENT 135 4.34e-01 7.96e-01 0.06500 -8.61e-03 6.44e-02 8.63e-01 1.96e-01
GOBP SODIUM ION TRANSMEMBRANE TRANSPORT 179 2.80e-01 6.92e-01 0.06490 4.87e-02 4.29e-02 2.61e-01 3.22e-01
GOCC MICROBODY 143 3.72e-01 7.60e-01 0.06480 -2.68e-02 -5.90e-02 5.80e-01 2.23e-01
Transcriptional regulation of white adipocyte differentiation 81 5.89e-01 8.68e-01 0.06480 -7.36e-03 -6.44e-02 9.09e-01 3.16e-01
GOCC PRESPLICEOSOME 17 8.87e-01 9.71e-01 0.06480 -3.16e-02 -5.66e-02 8.21e-01 6.86e-01
GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 113 5.30e-01 8.43e-01 0.06480 5.02e-02 -4.09e-02 3.56e-01 4.52e-01
GOBP REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION 11 9.32e-01 9.83e-01 0.06480 5.39e-05 -6.48e-02 1.00e+00 7.10e-01
GOCC EXTERNAL SIDE OF PLASMA MEMBRANE 373 1.23e-01 5.01e-01 0.06470 3.21e-02 -5.62e-02 2.87e-01 6.24e-02
GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS 183 3.21e-01 7.28e-01 0.06470 4.57e-03 -6.45e-02 9.15e-01 1.32e-01
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING 25 8.40e-01 9.56e-01 0.06470 -5.66e-02 -3.13e-02 6.24e-01 7.87e-01
GOBP LYMPHOCYTE ACTIVATION 766 1.51e-02 1.96e-01 0.06470 3.54e-02 -5.41e-02 9.55e-02 1.08e-02
GOBP UNSATURATED FATTY ACID METABOLIC PROCESS 109 5.27e-01 8.42e-01 0.06460 6.13e-02 -2.05e-02 2.69e-01 7.12e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION 110 4.82e-01 8.22e-01 0.06460 1.39e-02 6.31e-02 8.00e-01 2.53e-01
GOBP VESICLE TRANSPORT ALONG ACTIN FILAMENT 8 9.49e-01 9.88e-01 0.06460 -7.67e-03 -6.42e-02 9.70e-01 7.53e-01
GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX 27 8.56e-01 9.60e-01 0.06460 -5.82e-02 2.81e-02 6.01e-01 8.00e-01
GOBP REGULATION OF WNT SIGNALING PATHWAY 328 1.05e-01 4.72e-01 0.06460 -5.67e-02 -3.09e-02 7.76e-02 3.35e-01
GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY 518 2.90e-02 2.69e-01 0.06460 5.53e-02 3.33e-02 3.12e-02 1.94e-01
ADP signalling through P2Y purinoceptor 1 25 8.61e-01 9.61e-01 0.06460 -6.27e-02 1.54e-02 5.87e-01 8.94e-01
GOBP MONOCARBOXYLIC ACID TRANSPORT 179 3.00e-01 7.11e-01 0.06450 6.13e-02 2.01e-02 1.57e-01 6.43e-01
GOBP RESPIRATORY SYSTEM DEVELOPMENT 217 2.63e-01 6.78e-01 0.06450 -6.43e-02 4.77e-03 1.02e-01 9.04e-01
GOBP CELL MORPHOGENESIS 930 5.39e-03 1.04e-01 0.06450 -6.09e-02 2.11e-02 1.64e-03 2.76e-01
GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION 31 8.32e-01 9.54e-01 0.06450 6.23e-02 -1.65e-02 5.48e-01 8.74e-01
GOBP RIG I SIGNALING PATHWAY 27 8.47e-01 9.58e-01 0.06440 7.27e-03 -6.40e-02 9.48e-01 5.65e-01
GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 175 3.59e-01 7.51e-01 0.06440 -6.16e-02 1.88e-02 1.60e-01 6.68e-01
GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS 212 2.45e-01 6.60e-01 0.06440 -1.73e-02 -6.20e-02 6.64e-01 1.20e-01
GOBP RESPONSE TO DEXAMETHASONE 44 7.48e-01 9.28e-01 0.06440 -1.34e-02 -6.30e-02 8.78e-01 4.70e-01
GOBP CELLULAR RESPONSE TO LIGHT STIMULUS 113 4.56e-01 8.09e-01 0.06440 -5.39e-02 -3.51e-02 3.22e-01 5.19e-01
GOBP METANEPHROS MORPHOGENESIS 30 8.41e-01 9.56e-01 0.06440 -5.96e-02 2.43e-02 5.72e-01 8.17e-01
GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY 51 7.25e-01 9.18e-01 0.06430 -6.43e-02 -1.18e-03 4.27e-01 9.88e-01
GOBP POTASSIUM ION TRANSPORT 239 2.69e-01 6.83e-01 0.06430 -4.92e-02 4.14e-02 1.90e-01 2.70e-01
GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY 15 9.16e-01 9.79e-01 0.06430 6.15e-02 -1.87e-02 6.80e-01 9.00e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION 269 2.01e-01 6.14e-01 0.06430 1.02e-02 -6.34e-02 7.73e-01 7.33e-02
GOBP DNA CYTOSINE DEAMINATION 9 9.51e-01 9.88e-01 0.06420 -3.85e-02 5.14e-02 8.41e-01 7.89e-01
GOBP REGULATION OF BONE RESORPTION 43 7.42e-01 9.26e-01 0.06420 3.69e-02 5.25e-02 6.75e-01 5.51e-01
GOBP DENDRITIC CELL MIGRATION 30 8.45e-01 9.57e-01 0.06420 5.59e-02 -3.16e-02 5.96e-01 7.65e-01
GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY 6 9.65e-01 9.91e-01 0.06420 1.77e-02 -6.17e-02 9.40e-01 7.93e-01
GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT 53 7.07e-01 9.13e-01 0.06420 6.30e-02 1.24e-02 4.28e-01 8.76e-01
GOBP POSITIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 6 9.60e-01 9.90e-01 0.06420 2.94e-02 5.71e-02 9.01e-01 8.09e-01
GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 60 6.81e-01 9.04e-01 0.06420 -6.38e-02 -7.18e-03 3.93e-01 9.23e-01
GOBP LOW DENSITY LIPOPROTEIN PARTICLE REMODELING 16 9.11e-01 9.77e-01 0.06420 -1.98e-02 6.10e-02 8.91e-01 6.73e-01
Bacterial Infection Pathways 67 6.31e-01 8.86e-01 0.06420 -3.13e-02 -5.61e-02 6.58e-01 4.28e-01
GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 67 6.92e-01 9.09e-01 0.06410 -4.56e-02 4.51e-02 5.18e-01 5.23e-01
GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION 17 9.04e-01 9.76e-01 0.06410 1.45e-02 -6.25e-02 9.17e-01 6.56e-01
GOMF MONOCARBOXYLIC ACID BINDING 87 5.49e-01 8.53e-01 0.06410 3.42e-02 5.42e-02 5.82e-01 3.82e-01
GOMF UBIQUINONE BINDING 5 9.66e-01 9.91e-01 0.06410 -5.09e-02 -3.89e-02 8.44e-01 8.80e-01
GOBP REGULATION OF ENDOCYTOSIS 285 1.90e-01 5.96e-01 0.06410 -6.23e-02 1.49e-02 7.03e-02 6.66e-01
GOBP CELL MIGRATION INVOLVED IN KIDNEY DEVELOPMENT 6 9.67e-01 9.91e-01 0.06410 -2.94e-02 5.69e-02 9.01e-01 8.09e-01
GOBP CELLULAR RESPONSE TO CAMP 49 7.55e-01 9.30e-01 0.06410 -2.35e-02 5.96e-02 7.76e-01 4.71e-01
GOBP EPITHELIAL CELL PROLIFERATION 471 4.04e-02 3.08e-01 0.06400 -4.84e-02 -4.19e-02 7.19e-02 1.19e-01
GOBP MRNA 5 SPLICE SITE RECOGNITION 10 9.43e-01 9.87e-01 0.06400 1.74e-02 -6.16e-02 9.24e-01 7.36e-01
Post-translational protein modification 1362 1.43e-04 7.89e-03 0.06400 -5.18e-02 -3.76e-02 1.35e-03 1.98e-02
GOBP GLYCOPROTEIN METABOLIC PROCESS 373 9.92e-02 4.61e-01 0.06400 3.14e-03 6.39e-02 9.17e-01 3.40e-02
GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION 32 8.24e-01 9.52e-01 0.06400 -6.35e-02 8.04e-03 5.34e-01 9.37e-01
GOBP REGULATION OF NEURON APOPTOTIC PROCESS 235 2.36e-01 6.53e-01 0.06400 -6.40e-02 7.38e-04 9.11e-02 9.84e-01
GOBP POLYOL BIOSYNTHETIC PROCESS 59 6.65e-01 8.98e-01 0.06400 5.00e-02 3.98e-02 5.06e-01 5.97e-01
GOBP LACTATE TRANSMEMBRANE TRANSPORT 8 9.57e-01 9.89e-01 0.06390 4.78e-02 -4.25e-02 8.15e-01 8.35e-01
GOMF GAMMA AMINOBUTYRIC ACID SODIUM CHLORIDE SYMPORTER ACTIVITY 5 9.72e-01 9.93e-01 0.06390 5.82e-02 -2.65e-02 8.22e-01 9.18e-01
GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 76 6.14e-01 8.79e-01 0.06390 1.06e-02 6.30e-02 8.73e-01 3.43e-01
GOMF CARBON SULFUR LYASE ACTIVITY 12 9.33e-01 9.83e-01 0.06380 1.70e-02 -6.15e-02 9.19e-01 7.12e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 104 5.26e-01 8.42e-01 0.06380 5.34e-04 6.38e-02 9.92e-01 2.61e-01
GOBP VIRAL GENE EXPRESSION 99 5.30e-01 8.43e-01 0.06370 -1.23e-02 -6.25e-02 8.33e-01 2.82e-01
GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY 134 4.14e-01 7.85e-01 0.06370 6.00e-02 2.13e-02 2.30e-01 6.71e-01
GOBP REGULATION OF CELL ACTIVATION 615 2.96e-02 2.70e-01 0.06370 1.24e-02 -6.24e-02 5.99e-01 8.19e-03
Nuclear signaling by ERBB4 32 8.17e-01 9.51e-01 0.06360 -7.63e-03 -6.31e-02 9.40e-01 5.36e-01
GOBP SYNAPTIC VESICLE EXOCYTOSIS 91 6.09e-01 8.77e-01 0.06360 -3.56e-02 5.26e-02 5.57e-01 3.86e-01
GOBP CELL CELL ADHESION MEDIATED BY CADHERIN 49 7.21e-01 9.17e-01 0.06350 5.77e-02 2.66e-02 4.85e-01 7.48e-01
GOMF CYTOKINE BINDING 134 4.83e-01 8.22e-01 0.06350 -5.29e-02 3.50e-02 2.90e-01 4.84e-01
GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY 743 1.23e-02 1.75e-01 0.06340 6.34e-02 1.67e-04 3.25e-03 9.94e-01
GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION 17 8.91e-01 9.72e-01 0.06340 -5.17e-02 -3.67e-02 7.12e-01 7.93e-01
GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 19 8.93e-01 9.72e-01 0.06340 -5.78e-03 6.31e-02 9.65e-01 6.34e-01
GOBP POSITIVE REGULATION OF ENDOCYTOSIS 147 4.29e-01 7.94e-01 0.06340 -6.18e-02 1.41e-02 1.96e-01 7.68e-01
GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS 61 6.68e-01 9.00e-01 0.06340 -5.83e-02 -2.50e-02 4.31e-01 7.36e-01
GOMF APOLIPOPROTEIN BINDING 17 9.03e-01 9.75e-01 0.06340 4.33e-03 -6.32e-02 9.75e-01 6.52e-01
GOBP RESPONSE TO CALCIUM ION 125 4.62e-01 8.12e-01 0.06340 -6.32e-02 -4.46e-03 2.22e-01 9.31e-01
GOBP VESICLE MEDIATED TRANSPORT 1476 4.91e-04 1.89e-02 0.06330 -5.68e-02 2.80e-02 2.62e-04 7.16e-02
GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY 30 8.37e-01 9.55e-01 0.06330 -6.29e-02 7.32e-03 5.51e-01 9.45e-01
GOBP ENDOTHELIUM DEVELOPMENT 144 4.48e-01 8.04e-01 0.06330 -5.91e-02 2.27e-02 2.21e-01 6.39e-01
GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY 129 4.44e-01 8.01e-01 0.06330 6.22e-02 1.14e-02 2.22e-01 8.23e-01
GOBP SEMICIRCULAR CANAL MORPHOGENESIS 7 9.55e-01 9.88e-01 0.06320 -2.85e-02 -5.64e-02 8.96e-01 7.96e-01
G alpha (s) signalling events 155 4.30e-01 7.95e-01 0.06320 -2.94e-02 5.59e-02 5.28e-01 2.29e-01
GOBP RESPONSE TO INTERLEUKIN 18 12 9.23e-01 9.81e-01 0.06310 5.48e-02 3.13e-02 7.43e-01 8.51e-01
GOMF SYNTAXIN 1 BINDING 19 9.01e-01 9.74e-01 0.06310 -2.78e-02 5.66e-02 8.34e-01 6.69e-01
GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION 24 8.63e-01 9.61e-01 0.06300 -6.27e-02 -5.93e-03 5.95e-01 9.60e-01
GOBP RESPONSE TO NICOTINE 51 7.30e-01 9.21e-01 0.06300 6.94e-03 6.26e-02 9.32e-01 4.39e-01
GOMF RECEPTOR TYROSINE KINASE BINDING 79 5.89e-01 8.68e-01 0.06290 -4.44e-02 -4.45e-02 4.95e-01 4.94e-01
GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY 6 9.69e-01 9.91e-01 0.06290 -4.61e-02 4.28e-02 8.45e-01 8.56e-01
GOBP NITROGEN COMPOUND TRANSPORT 1808 3.32e-05 2.28e-03 0.06290 -6.23e-02 -8.91e-03 1.12e-05 5.30e-01
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 123 4.51e-01 8.06e-01 0.06290 -5.80e-02 -2.43e-02 2.66e-01 6.42e-01
Sphingolipid metabolism 101 5.14e-01 8.36e-01 0.06290 5.46e-02 3.12e-02 3.43e-01 5.88e-01
GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION 17 8.93e-01 9.72e-01 0.06290 5.30e-02 3.38e-02 7.05e-01 8.09e-01
Paradoxical activation of RAF signaling by kinase inactive BRAF 42 7.60e-01 9.32e-01 0.06290 -5.73e-02 -2.58e-02 5.20e-01 7.73e-01
Signaling by RAS mutants 42 7.60e-01 9.32e-01 0.06290 -5.73e-02 -2.58e-02 5.20e-01 7.73e-01
Signaling by moderate kinase activity BRAF mutants 42 7.60e-01 9.32e-01 0.06290 -5.73e-02 -2.58e-02 5.20e-01 7.73e-01
Signaling downstream of RAS mutants 42 7.60e-01 9.32e-01 0.06290 -5.73e-02 -2.58e-02 5.20e-01 7.73e-01
GOBP REGULATION OF SODIUM ION TRANSPORT 79 5.90e-01 8.68e-01 0.06280 -4.29e-02 -4.59e-02 5.09e-01 4.81e-01
GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS 134 4.53e-01 8.07e-01 0.06280 -6.28e-02 2.62e-03 2.10e-01 9.58e-01
GOBP REGULATION OF GROWTH 575 4.48e-02 3.23e-01 0.06280 -5.90e-02 2.14e-02 1.56e-02 3.80e-01
GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE 89 6.15e-01 8.80e-01 0.06280 2.51e-02 -5.75e-02 6.82e-01 3.48e-01
GOBP NK T CELL ACTIVATION 14 9.19e-01 9.79e-01 0.06280 1.46e-03 6.28e-02 9.92e-01 6.84e-01
GOBP RESPONSE TO BACTERIUM 660 3.35e-02 2.85e-01 0.06280 3.98e-02 -4.86e-02 8.12e-02 3.34e-02
GOMF ACTIVIN RECEPTOR BINDING 9 9.45e-01 9.87e-01 0.06280 -6.14e-02 -1.31e-02 7.50e-01 9.46e-01
GOCC ENDOPLASMIC RETICULUM LUMEN 295 2.15e-01 6.32e-01 0.06280 -4.37e-02 4.50e-02 1.96e-01 1.83e-01
GOMF ATP DEPENDENT ACTIVITY 561 5.00e-02 3.39e-01 0.06280 -5.76e-02 2.49e-02 1.96e-02 3.13e-01
GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS 515 6.93e-02 3.96e-01 0.06280 4.96e-02 -3.85e-02 5.43e-02 1.35e-01
GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION 14 9.28e-01 9.82e-01 0.06270 -5.38e-02 3.23e-02 7.28e-01 8.34e-01
GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 428 6.51e-02 3.84e-01 0.06270 2.60e-02 5.70e-02 3.56e-01 4.30e-02
GOCC CELL SUBSTRATE JUNCTION 419 7.67e-02 4.14e-01 0.06270 -6.14e-02 -1.24e-02 3.10e-02 6.64e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING 21 8.95e-01 9.73e-01 0.06260 3.95e-02 -4.86e-02 7.54e-01 7.00e-01
GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 34 8.10e-01 9.49e-01 0.06260 6.17e-02 1.08e-02 5.34e-01 9.13e-01
GOBP ESCRT COMPLEX DISASSEMBLY 10 9.40e-01 9.85e-01 0.06260 -1.27e-02 -6.13e-02 9.45e-01 7.37e-01
GOBP SECONDARY PALATE DEVELOPMENT 26 8.59e-01 9.60e-01 0.06260 -6.25e-02 3.77e-03 5.81e-01 9.73e-01
GOBP CELLULAR RESPONSE TO ALKALOID 37 7.88e-01 9.41e-01 0.06260 2.39e-02 5.78e-02 8.02e-01 5.43e-01
GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS 41 7.62e-01 9.32e-01 0.06250 4.14e-02 4.69e-02 6.47e-01 6.03e-01
GOMF AMIDE BINDING 236 2.34e-01 6.50e-01 0.06250 -6.12e-02 -1.27e-02 1.05e-01 7.37e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 161 4.04e-01 7.81e-01 0.06250 1.24e-02 -6.12e-02 7.86e-01 1.80e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION 160 4.34e-01 7.96e-01 0.06250 3.95e-02 -4.84e-02 3.88e-01 2.91e-01
GOCC ADHERENS JUNCTION 179 3.84e-01 7.68e-01 0.06250 -2.71e-02 5.63e-02 5.32e-01 1.94e-01
GOBP INTRACELLULAR PH REDUCTION 52 7.10e-01 9.14e-01 0.06240 -5.01e-02 -3.73e-02 5.32e-01 6.42e-01
Signaling by NOTCH3 48 7.51e-01 9.29e-01 0.06240 -2.89e-03 -6.23e-02 9.72e-01 4.55e-01
GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY 94 5.53e-01 8.54e-01 0.06240 -1.98e-02 -5.91e-02 7.40e-01 3.22e-01
Detoxification of Reactive Oxygen Species 33 8.06e-01 9.48e-01 0.06240 5.20e-02 3.45e-02 6.05e-01 7.32e-01
GOMF ANTIOXIDANT ACTIVITY 82 6.34e-01 8.86e-01 0.06230 -1.51e-02 6.04e-02 8.13e-01 3.44e-01
GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY 74 6.52e-01 8.93e-01 0.06230 4.33e-03 -6.21e-02 9.49e-01 3.56e-01
GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT 214 2.64e-01 6.79e-01 0.06220 -1.87e-02 -5.94e-02 6.37e-01 1.34e-01
GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY 18 8.89e-01 9.71e-01 0.06220 3.82e-02 4.92e-02 7.79e-01 7.18e-01
GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 514 7.20e-02 4.04e-01 0.06220 5.11e-02 -3.55e-02 4.74e-02 1.68e-01
GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS 20 8.96e-01 9.73e-01 0.06220 1.70e-02 -5.98e-02 8.95e-01 6.43e-01
GOBP BLASTOCYST DEVELOPMENT 113 4.83e-01 8.22e-01 0.06220 -5.40e-02 -3.09e-02 3.21e-01 5.71e-01
GOCC AGGRESOME 33 8.43e-01 9.56e-01 0.06210 -4.12e-02 4.65e-02 6.82e-01 6.44e-01
GOBP NEGATIVE REGULATION OF WOUND HEALING 74 6.20e-01 8.80e-01 0.06200 3.46e-02 5.15e-02 6.07e-01 4.44e-01
GOBP AXONAL TRANSPORT 63 6.70e-01 9.00e-01 0.06200 -5.59e-02 -2.67e-02 4.43e-01 7.14e-01
NGF-independant TRKA activation 5 9.68e-01 9.91e-01 0.06200 4.98e-02 3.69e-02 8.47e-01 8.87e-01
G2/M Transition 178 3.17e-01 7.24e-01 0.06190 -4.05e-02 -4.69e-02 3.52e-01 2.80e-01
GOBP EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 110 5.39e-01 8.49e-01 0.06190 -6.13e-02 8.77e-03 2.67e-01 8.74e-01
GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS 17 9.16e-01 9.79e-01 0.06190 -4.61e-02 4.14e-02 7.42e-01 7.68e-01
GOBP REGULATION OF RESPONSE TO DRUG 16 9.02e-01 9.75e-01 0.06190 5.21e-02 3.35e-02 7.18e-01 8.17e-01
GOMF PURINE NUCLEOTIDE BINDING 1884 1.36e-04 7.60e-03 0.06190 -4.94e-02 3.73e-02 3.79e-04 7.41e-03
GOBP TRIGLYCERIDE CATABOLIC PROCESS 27 8.41e-01 9.56e-01 0.06190 5.34e-02 3.13e-02 6.31e-01 7.79e-01
GOBP NEURON PROJECTION ORGANIZATION 87 6.40e-01 8.88e-01 0.06190 -3.92e-02 4.79e-02 5.27e-01 4.40e-01
GOMF NADPLUS NUCLEOTIDASE CYCLIC ADP RIBOSE GENERATING 14 9.19e-01 9.79e-01 0.06190 1.01e-02 6.11e-02 9.48e-01 6.92e-01
GOBP DOLICHYL DIPHOSPHATE METABOLIC PROCESS 5 9.68e-01 9.91e-01 0.06190 4.89e-02 3.79e-02 8.50e-01 8.83e-01
GOBP BONE RESORPTION 66 6.99e-01 9.11e-01 0.06190 -1.78e-02 5.93e-02 8.02e-01 4.05e-01
GOBP INTRACELLULAR PHOSPHATE ION HOMEOSTASIS 10 9.43e-01 9.87e-01 0.06190 4.02e-03 6.17e-02 9.82e-01 7.35e-01
GOCC GLUTAMATERGIC SYNAPSE 401 1.17e-01 4.92e-01 0.06180 -5.94e-02 1.73e-02 4.13e-02 5.53e-01
GOBP NEGATIVE REGULATION OF EXOCYTOSIS 31 8.50e-01 9.58e-01 0.06180 5.53e-02 -2.77e-02 5.94e-01 7.90e-01
GOBP REGULATION OF MITOTIC CELL CYCLE 515 3.99e-02 3.06e-01 0.06180 -5.34e-02 -3.11e-02 3.80e-02 2.27e-01
GOBP CELLULAR COMPONENT DISASSEMBLY 521 4.12e-02 3.09e-01 0.06180 -5.74e-02 -2.29e-02 2.50e-02 3.72e-01
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 25 8.78e-01 9.67e-01 0.06180 -5.33e-02 3.12e-02 6.45e-01 7.87e-01
GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS 370 1.54e-01 5.51e-01 0.06180 -4.85e-02 3.82e-02 1.09e-01 2.07e-01
GOBP LONG CHAIN FATTY ACID TRANSPORT 66 6.58e-01 8.95e-01 0.06170 5.50e-02 2.81e-02 4.40e-01 6.93e-01
GOBP ORGANOPHOSPHATE ESTER TRANSPORT 151 4.64e-01 8.13e-01 0.06170 -4.20e-02 4.52e-02 3.73e-01 3.38e-01
ATF6 (ATF6-alpha) activates chaperones 11 9.32e-01 9.83e-01 0.06170 -3.20e-02 -5.28e-02 8.54e-01 7.62e-01
GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT 259 2.30e-01 6.48e-01 0.06170 -6.17e-02 2.24e-03 8.75e-02 9.51e-01
GOBP ACYLGLYCEROL HOMEOSTASIS 44 7.81e-01 9.40e-01 0.06170 -6.13e-02 7.06e-03 4.82e-01 9.35e-01
GOBP MAMMARY GLAND DEVELOPMENT 131 4.35e-01 7.97e-01 0.06170 -3.18e-02 -5.29e-02 5.29e-01 2.96e-01
GOBP SUPRAMOLECULAR FIBER ORGANIZATION 821 1.62e-02 2.04e-01 0.06170 -2.92e-02 5.43e-02 1.55e-01 8.16e-03
GOBP DEVELOPMENTAL MATURATION 326 1.89e-01 5.95e-01 0.06170 -5.34e-02 3.09e-02 9.77e-02 3.37e-01
GOBP OSTEOBLAST DEVELOPMENT 17 9.16e-01 9.79e-01 0.06170 5.20e-02 -3.32e-02 7.11e-01 8.13e-01
GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS 30 8.51e-01 9.58e-01 0.06170 1.83e-02 -5.89e-02 8.62e-01 5.77e-01
GOBP IMMUNOGLOBULIN PRODUCTION 102 5.91e-01 8.70e-01 0.06170 3.24e-02 -5.25e-02 5.72e-01 3.60e-01
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION 485 7.33e-02 4.05e-01 0.06160 6.04e-02 -1.24e-02 2.27e-02 6.40e-01
GOMF CORECEPTOR ACTIVITY 55 7.09e-01 9.13e-01 0.06160 2.50e-02 5.63e-02 7.49e-01 4.70e-01
GOBP AUTOPHAGOSOME ORGANIZATION 118 5.08e-01 8.33e-01 0.06160 -6.16e-02 -2.44e-04 2.48e-01 9.96e-01
GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN 102 5.85e-01 8.67e-01 0.06150 2.36e-02 -5.68e-02 6.80e-01 3.22e-01
Mitotic G2-G2/M phases 180 3.19e-01 7.27e-01 0.06150 -3.53e-02 -5.04e-02 4.14e-01 2.44e-01
Bile acid and bile salt metabolism 44 7.80e-01 9.39e-01 0.06150 -3.84e-03 6.14e-02 9.65e-01 4.81e-01
GOMF CARNITINE TRANSMEMBRANE TRANSPORTER ACTIVITY 5 9.71e-01 9.92e-01 0.06140 -1.08e-02 -6.05e-02 9.67e-01 8.15e-01
GOBP RESPONSE TO OXIDATIVE STRESS 386 1.44e-01 5.36e-01 0.06140 -5.05e-02 3.49e-02 8.83e-02 2.39e-01
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 75 6.71e-01 9.01e-01 0.06140 -1.96e-02 5.82e-02 7.69e-01 3.84e-01
GOBP NEGATIVE REGULATION OF TOR SIGNALING 68 6.58e-01 8.95e-01 0.06140 -2.08e-02 -5.78e-02 7.66e-01 4.10e-01
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 62 7.24e-01 9.18e-01 0.06130 -2.42e-02 5.63e-02 7.42e-01 4.43e-01
GOBP SPINDLE ASSEMBLY 124 5.06e-01 8.32e-01 0.06130 8.35e-03 -6.07e-02 8.72e-01 2.43e-01
Intrinsic Pathway for Apoptosis 53 7.65e-01 9.33e-01 0.06130 4.97e-02 -3.59e-02 5.32e-01 6.51e-01
GOBP TISSUE MIGRATION 369 1.12e-01 4.84e-01 0.06130 -5.94e-02 -1.50e-02 5.00e-02 6.20e-01
GOBP AXO DENDRITIC TRANSPORT 75 6.45e-01 8.91e-01 0.06120 -7.03e-03 -6.08e-02 9.16e-01 3.62e-01
GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION 212 3.41e-01 7.40e-01 0.06120 3.10e-02 -5.28e-02 4.37e-01 1.85e-01
GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS 200 2.83e-01 6.95e-01 0.06120 -4.15e-02 -4.50e-02 3.12e-01 2.73e-01
GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 77 6.79e-01 9.04e-01 0.06120 -3.69e-02 4.88e-02 5.75e-01 4.59e-01
GOBP ASTRAL MICROTUBULE ORGANIZATION 9 9.44e-01 9.87e-01 0.06120 4.54e-02 4.10e-02 8.14e-01 8.31e-01
GOMF PHOSPHATIDYLETHANOLAMINE BINDING 17 8.98e-01 9.73e-01 0.06120 -4.94e-02 -3.61e-02 7.24e-01 7.97e-01
GOMF PROTEOGLYCAN BINDING 36 8.13e-01 9.50e-01 0.06110 6.11e-02 2.79e-03 5.26e-01 9.77e-01
GOMF NEUROLIGIN FAMILY PROTEIN BINDING 5 9.73e-01 9.93e-01 0.06110 -6.00e-02 1.18e-02 8.16e-01 9.64e-01
GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS 507 4.33e-02 3.16e-01 0.06110 -4.05e-02 -4.57e-02 1.18e-01 7.80e-02
GOMF CIS TRANS ISOMERASE ACTIVITY 38 7.96e-01 9.44e-01 0.06110 -1.60e-02 -5.90e-02 8.65e-01 5.29e-01
GOBP TRACHEA CARTILAGE DEVELOPMENT 7 9.65e-01 9.91e-01 0.06100 5.31e-02 -3.01e-02 8.08e-01 8.90e-01
GOMF MANGANESE ION BINDING 64 6.86e-01 9.06e-01 0.06100 -6.00e-02 -1.11e-02 4.07e-01 8.78e-01
GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM 265 2.69e-01 6.84e-01 0.06100 -4.86e-02 3.69e-02 1.73e-01 3.02e-01
GOBP XENOBIOTIC TRANSPORT 60 7.13e-01 9.14e-01 0.06100 1.22e-05 6.10e-02 1.00e+00 4.14e-01
GOBP DENDRITIC SPINE DEVELOPMENT 88 5.90e-01 8.69e-01 0.06100 5.84e-02 1.75e-02 3.44e-01 7.77e-01
GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION 49 7.82e-01 9.40e-01 0.06090 -3.45e-02 5.02e-02 6.76e-01 5.43e-01
GOBP RESPONSE TO ABIOTIC STIMULUS 1086 1.58e-03 4.59e-02 0.06090 -5.11e-02 -3.31e-02 4.44e-03 6.56e-02
NOTCH1 Intracellular Domain Regulates Transcription 44 7.83e-01 9.40e-01 0.06090 3.16e-03 -6.08e-02 9.71e-01 4.85e-01
Cell junction organization 113 5.02e-01 8.30e-01 0.06090 2.49e-02 5.55e-02 6.47e-01 3.08e-01
GOBP EXOCYTIC PROCESS 77 6.82e-01 9.06e-01 0.06090 -4.61e-02 3.98e-02 4.84e-01 5.46e-01
GOBP CELLULAR METABOLIC COMPOUND SALVAGE 32 8.34e-01 9.54e-01 0.06080 -6.08e-02 -2.92e-03 5.52e-01 9.77e-01
GOBP LEUKOCYTE PROLIFERATION 335 1.84e-01 5.88e-01 0.06080 5.56e-02 -2.46e-02 8.01e-02 4.39e-01
GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY 14 9.33e-01 9.83e-01 0.06080 -4.28e-02 4.32e-02 7.82e-01 7.79e-01
GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON 14 9.21e-01 9.80e-01 0.06080 -5.95e-02 -1.27e-02 7.00e-01 9.34e-01
GOBP NEGATIVE REGULATION OF ENDOCYTOSIS 75 6.88e-01 9.07e-01 0.06080 -3.49e-02 4.98e-02 6.02e-01 4.56e-01
GOBP REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS 7 9.66e-01 9.91e-01 0.06080 3.33e-02 -5.08e-02 8.79e-01 8.16e-01
Constitutive Signaling by Aberrant PI3K in Cancer 85 6.35e-01 8.86e-01 0.06070 1.11e-02 -5.97e-02 8.59e-01 3.41e-01
GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS 28 8.50e-01 9.58e-01 0.06070 6.01e-02 8.94e-03 5.82e-01 9.35e-01
GOMF GROWTH FACTOR RECEPTOR BINDING 135 4.94e-01 8.28e-01 0.06070 -1.69e-02 5.83e-02 7.34e-01 2.42e-01
GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN 11 9.44e-01 9.87e-01 0.06070 -1.94e-02 5.75e-02 9.11e-01 7.41e-01
GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 37 8.20e-01 9.52e-01 0.06070 1.09e-02 -5.97e-02 9.08e-01 5.30e-01
Lysosphingolipid and LPA receptors 14 9.31e-01 9.83e-01 0.06070 5.47e-02 -2.63e-02 7.23e-01 8.65e-01
GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS 91 5.96e-01 8.72e-01 0.06070 -4.94e-03 -6.05e-02 9.35e-01 3.19e-01
GOMF PROTEIN PHOSPHATASE 1 BINDING 25 8.72e-01 9.65e-01 0.06070 -6.04e-02 5.44e-03 6.01e-01 9.62e-01
GOBP KIDNEY MORPHOGENESIS 95 5.70e-01 8.61e-01 0.06070 -1.62e-02 -5.85e-02 7.85e-01 3.25e-01
GOCC STEREOCILIA COUPLING LINK 8 9.60e-01 9.90e-01 0.06060 -2.83e-02 5.37e-02 8.90e-01 7.93e-01
GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT 21 8.95e-01 9.73e-01 0.06060 1.42e-02 -5.90e-02 9.10e-01 6.40e-01
GOBP REGULATION OF HORMONE SECRETION 252 2.75e-01 6.88e-01 0.06050 -5.74e-02 1.89e-02 1.16e-01 6.05e-01
GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH 877 5.72e-03 1.08e-01 0.06050 -3.07e-02 -5.21e-02 1.23e-01 8.85e-03
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN 24 8.63e-01 9.61e-01 0.06050 -5.14e-02 -3.18e-02 6.63e-01 7.87e-01
GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 115 4.92e-01 8.26e-01 0.06040 -4.44e-02 -4.10e-02 4.11e-01 4.48e-01
GOCC CILIARY PLASM 178 3.73e-01 7.61e-01 0.06040 -1.74e-03 -6.04e-02 9.68e-01 1.65e-01
GOMF DOUBLE STRANDED RNA BINDING 71 6.45e-01 8.91e-01 0.06040 -4.55e-02 -3.97e-02 5.08e-01 5.63e-01
GOBP MESONEPHROS DEVELOPMENT 101 5.41e-01 8.50e-01 0.06040 -5.20e-02 -3.05e-02 3.66e-01 5.96e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE 6 9.71e-01 9.92e-01 0.06040 5.16e-02 -3.12e-02 8.27e-01 8.95e-01
GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 74 6.87e-01 9.06e-01 0.06030 2.22e-02 -5.61e-02 7.41e-01 4.04e-01
GOBP LIPID LOCALIZATION 497 9.33e-02 4.46e-01 0.06030 -4.03e-02 4.48e-02 1.24e-01 8.70e-02
GOBP AMYLOID FIBRIL FORMATION 38 8.21e-01 9.52e-01 0.06030 5.81e-02 -1.60e-02 5.35e-01 8.64e-01
GOBP POSITIVE REGULATION OF LYASE ACTIVITY 36 8.09e-01 9.49e-01 0.06020 -5.76e-02 -1.75e-02 5.50e-01 8.55e-01
GOMF CAMP BINDING 22 8.85e-01 9.69e-01 0.06020 2.59e-03 6.02e-02 9.83e-01 6.25e-01
GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS 60 6.93e-01 9.09e-01 0.06020 3.52e-02 4.88e-02 6.37e-01 5.13e-01
GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS 264 2.15e-01 6.32e-01 0.06020 1.90e-02 5.71e-02 5.96e-01 1.10e-01
GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION 370 1.62e-01 5.61e-01 0.06010 -5.47e-02 2.49e-02 7.10e-02 4.10e-01
GOCC SECRETORY GRANULE MEMBRANE 307 2.25e-01 6.43e-01 0.06010 -5.18e-02 3.05e-02 1.19e-01 3.59e-01
GOBP NEGATIVE REGULATION OF LOCOMOTION 387 1.59e-01 5.57e-01 0.06010 -4.22e-02 4.28e-02 1.54e-01 1.49e-01
GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION 15 9.27e-01 9.82e-01 0.06000 -2.31e-02 5.54e-02 8.77e-01 7.10e-01
GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE 7 9.66e-01 9.91e-01 0.06000 2.87e-02 -5.27e-02 8.95e-01 8.09e-01
GOBP RNA CATABOLIC PROCESS 382 1.18e-01 4.94e-01 0.06000 -5.90e-02 -1.04e-02 4.76e-02 7.27e-01
GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 208 2.84e-01 6.96e-01 0.05990 -4.39e-02 -4.09e-02 2.76e-01 3.10e-01
GOBP DENDRITE DEVELOPMENT 223 3.32e-01 7.35e-01 0.05980 -5.53e-02 2.28e-02 1.54e-01 5.58e-01
GOBP SYNAPSE PRUNING 14 9.18e-01 9.79e-01 0.05980 -4.45e-02 -4.01e-02 7.73e-01 7.95e-01
GOCC TRANSCRIPTION FACTOR TFIID COMPLEX 30 8.36e-01 9.55e-01 0.05980 -2.81e-02 -5.28e-02 7.90e-01 6.17e-01
GOBP HOMEOSTASIS OF NUMBER OF CELLS 306 2.32e-01 6.50e-01 0.05980 3.37e-02 -4.94e-02 3.10e-01 1.38e-01
GOMF PROTEIN KINASE A BINDING 50 7.87e-01 9.41e-01 0.05970 -3.83e-02 4.59e-02 6.40e-01 5.75e-01
GOBP AXONAL TRANSPORT OF MITOCHONDRION 16 9.12e-01 9.78e-01 0.05970 -1.61e-02 -5.75e-02 9.11e-01 6.90e-01
GOCC MITOCHONDRIAL CRISTA JUNCTION 6 9.70e-01 9.92e-01 0.05970 -5.80e-02 1.43e-02 8.06e-01 9.52e-01
GOBP PROTEASOME MEDIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 387 1.03e-01 4.69e-01 0.05970 -5.14e-02 -3.03e-02 8.26e-02 3.06e-01
GOCC CD40 RECEPTOR COMPLEX 11 9.48e-01 9.88e-01 0.05970 -3.20e-02 5.04e-02 8.54e-01 7.72e-01
Disease 1704 2.06e-04 1.02e-02 0.05970 6.69e-04 -5.97e-02 9.63e-01 4.18e-05
GOBP CORPUS CALLOSUM DEVELOPMENT 26 8.62e-01 9.61e-01 0.05960 5.75e-02 1.55e-02 6.12e-01 8.91e-01
GOMF PROTEIN CONTAINING COMPLEX BINDING 1684 1.94e-04 9.75e-03 0.05960 -5.94e-02 -4.58e-03 4.95e-05 7.55e-01
GOBP POST TRANSLATIONAL PROTEIN MODIFICATION 918 5.32e-03 1.03e-01 0.05950 -5.08e-02 -3.10e-02 9.07e-03 1.11e-01
GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION 22 8.91e-01 9.72e-01 0.05950 6.00e-03 -5.92e-02 9.61e-01 6.31e-01
GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS 30 8.63e-01 9.61e-01 0.05950 -5.47e-02 2.35e-02 6.04e-01 8.24e-01
GOBP FOAM CELL DIFFERENTIATION 41 8.03e-01 9.46e-01 0.05950 5.95e-02 -4.65e-04 5.10e-01 9.96e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING 9 9.55e-01 9.88e-01 0.05940 5.83e-02 -1.15e-02 7.62e-01 9.52e-01
GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 73 6.61e-01 8.97e-01 0.05940 -5.73e-02 -1.58e-02 3.98e-01 8.15e-01
GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 198 3.18e-01 7.25e-01 0.05940 -5.40e-02 -2.47e-02 1.90e-01 5.49e-01
GOMF CALCIUM DEPENDENT PROTEIN BINDING 76 6.56e-01 8.94e-01 0.05940 9.85e-03 5.85e-02 8.82e-01 3.78e-01
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION 785 1.08e-02 1.61e-01 0.05940 -4.50e-02 -3.87e-02 3.22e-02 6.48e-02
GOBP RESPONSE TO INTERFERON BETA 33 8.33e-01 9.54e-01 0.05930 5.87e-02 8.55e-03 5.59e-01 9.32e-01
GOBP CELL ADHESION MEDIATED BY INTEGRIN 87 5.97e-01 8.73e-01 0.05930 -3.47e-02 -4.81e-02 5.76e-01 4.38e-01
GOBP SULFUR COMPOUND METABOLIC PROCESS 301 2.47e-01 6.61e-01 0.05930 -4.18e-02 4.21e-02 2.13e-01 2.09e-01
Interleukin-2 family signaling 39 8.15e-01 9.51e-01 0.05930 5.91e-02 -4.49e-03 5.23e-01 9.61e-01
GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 165 4.08e-01 7.82e-01 0.05930 5.89e-02 6.38e-03 1.92e-01 8.88e-01
GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS 321 1.76e-01 5.81e-01 0.05920 -7.01e-03 -5.88e-02 8.29e-01 7.00e-02
Adaptive Immune System 720 1.76e-02 2.11e-01 0.05920 -2.37e-02 -5.43e-02 2.78e-01 1.31e-02
GOBP PROTEIN DEPHOSPHORYLATION 199 3.10e-01 7.19e-01 0.05920 -3.55e-02 -4.74e-02 3.87e-01 2.49e-01
GOMF O ACYLTRANSFERASE ACTIVITY 50 7.45e-01 9.27e-01 0.05920 3.24e-02 4.96e-02 6.92e-01 5.44e-01
GOMF CHOLESTEROL BINDING 52 7.78e-01 9.39e-01 0.05920 -2.61e-02 5.31e-02 7.44e-01 5.08e-01
GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS 38 8.05e-01 9.48e-01 0.05920 -5.59e-02 -1.94e-02 5.51e-01 8.36e-01
GOBP DENDRITIC SPINE MORPHOGENESIS 54 7.28e-01 9.21e-01 0.05920 5.00e-02 3.16e-02 5.25e-01 6.88e-01
GOBP ENDOSOME ORGANIZATION 94 5.76e-01 8.63e-01 0.05920 -3.32e-02 -4.89e-02 5.78e-01 4.12e-01
GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION 396 9.96e-02 4.62e-01 0.05910 -4.51e-02 -3.82e-02 1.23e-01 1.92e-01
GOBP RESPONSE TO UV A 13 9.29e-01 9.83e-01 0.05910 -5.61e-02 -1.85e-02 7.26e-01 9.08e-01
Defective B3GAT3 causes JDSSDHD 17 9.19e-01 9.79e-01 0.05910 5.69e-02 -1.57e-02 6.84e-01 9.11e-01
GOBP TISSUE REGENERATION 79 6.85e-01 9.06e-01 0.05910 -2.64e-02 5.28e-02 6.84e-01 4.17e-01
GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 1147 5.44e-03 1.04e-01 0.05900 -5.26e-02 2.68e-02 2.66e-03 1.26e-01
GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX 183 3.74e-01 7.62e-01 0.05900 -5.88e-02 -5.53e-03 1.70e-01 8.97e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II 28 8.56e-01 9.60e-01 0.05900 5.78e-02 1.20e-02 5.97e-01 9.12e-01
GOCC APICAL JUNCTION COMPLEX 138 4.58e-01 8.10e-01 0.05900 5.54e-02 2.03e-02 2.61e-01 6.81e-01
GOCC SMAD PROTEIN COMPLEX 9 9.52e-01 9.88e-01 0.05900 -5.81e-02 -1.02e-02 7.63e-01 9.58e-01
GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS 16 9.28e-01 9.82e-01 0.05900 4.05e-02 -4.29e-02 7.79e-01 7.66e-01
GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC 104 6.10e-01 8.78e-01 0.05890 -5.20e-02 2.78e-02 3.59e-01 6.25e-01
GOCC PRESYNAPTIC ACTIVE ZONE 76 6.71e-01 9.01e-01 0.05890 -9.14e-04 5.89e-02 9.89e-01 3.74e-01
GOBP RESPONSE TO REACTIVE OXYGEN SPECIES 197 3.79e-01 7.65e-01 0.05890 -5.69e-02 1.51e-02 1.68e-01 7.15e-01
GOBP REGULATION OF MRNA 3 END PROCESSING 9 9.59e-01 9.89e-01 0.05890 -3.61e-02 4.65e-02 8.51e-01 8.09e-01
GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 621 6.06e-02 3.73e-01 0.05880 4.25e-02 -4.07e-02 7.08e-02 8.33e-02
GOMF STRUCTURAL MOLECULE ACTIVITY 750 3.22e-02 2.81e-01 0.05880 2.81e-02 -5.17e-02 1.91e-01 1.60e-02
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE 191 3.76e-01 7.63e-01 0.05880 -4.71e-03 5.86e-02 9.11e-01 1.62e-01
GOBP REGULATION OF NADP METABOLIC PROCESS 8 9.55e-01 9.88e-01 0.05880 2.88e-02 5.13e-02 8.88e-01 8.02e-01
GOBP MAINTENANCE OF DNA REPEAT ELEMENTS 7 9.63e-01 9.90e-01 0.05880 5.82e-02 8.49e-03 7.90e-01 9.69e-01
Regulation of signaling by NODAL 9 9.54e-01 9.88e-01 0.05880 -2.69e-04 -5.88e-02 9.99e-01 7.60e-01
GOCC GOLGI TRANS CISTERNA 9 9.59e-01 9.89e-01 0.05880 4.99e-02 -3.11e-02 7.95e-01 8.72e-01
GOBP ORGANIC ACID TRANSPORT 340 1.64e-01 5.64e-01 0.05880 6.89e-03 5.84e-02 8.27e-01 6.45e-02
GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS 86 6.12e-01 8.78e-01 0.05870 5.24e-02 2.65e-02 4.01e-01 6.71e-01
PI5P Regulates TP53 Acetylation 8 9.62e-01 9.90e-01 0.05870 -2.00e-02 5.51e-02 9.22e-01 7.87e-01
RHO GTPase cycle 419 1.42e-01 5.33e-01 0.05860 -5.30e-02 2.50e-02 6.27e-02 3.79e-01
GOMF S ACYLTRANSFERASE ACTIVITY 27 8.79e-01 9.67e-01 0.05860 -2.33e-02 5.38e-02 8.34e-01 6.29e-01
GOBP CELL SURFACE RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGNALING PATHWAY 6 9.73e-01 9.93e-01 0.05860 3.44e-02 -4.74e-02 8.84e-01 8.41e-01
Regulation of PLK1 Activity at G2/M Transition 83 6.42e-01 8.89e-01 0.05860 -5.81e-02 -7.29e-03 3.60e-01 9.09e-01
GOBP REGULATION OF RELAXATION OF MUSCLE 14 9.30e-01 9.83e-01 0.05850 -5.85e-02 6.59e-04 7.05e-01 9.97e-01
GOBP RESPONSE TO UV 150 4.28e-01 7.94e-01 0.05850 -2.57e-02 -5.26e-02 5.87e-01 2.66e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION 92 6.04e-01 8.76e-01 0.05850 5.67e-02 1.44e-02 3.47e-01 8.11e-01
GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 7 9.66e-01 9.91e-01 0.05850 1.13e-02 -5.74e-02 9.59e-01 7.93e-01
GOBP POSITIVE REGULATION OF VASOCONSTRICTION 31 8.53e-01 9.59e-01 0.05850 -2.48e-03 5.84e-02 9.81e-01 5.73e-01
GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION 151 4.19e-01 7.87e-01 0.05850 -3.70e-02 -4.52e-02 4.32e-01 3.37e-01
GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM 396 1.64e-01 5.64e-01 0.05840 -4.97e-02 3.07e-02 8.96e-02 2.94e-01
GOBP DNA TEMPLATED DNA REPLICATION 160 4.05e-01 7.81e-01 0.05840 -5.19e-02 -2.69e-02 2.58e-01 5.57e-01
GOMF PROTEIN ARGININE OMEGA N MONOMETHYLTRANSFERASE ACTIVITY 5 9.77e-01 9.93e-01 0.05840 -4.23e-02 4.03e-02 8.70e-01 8.76e-01
GOBP VESICLE ORGANIZATION 357 1.56e-01 5.52e-01 0.05840 -5.82e-02 -5.09e-03 5.90e-02 8.69e-01
GOBP MITOCHONDRIAL PROTEIN PROCESSING 13 9.28e-01 9.82e-01 0.05840 -5.04e-02 -2.94e-02 7.53e-01 8.54e-01
GOMF INSULIN RECEPTOR BINDING 21 8.98e-01 9.73e-01 0.05840 2.68e-03 -5.83e-02 9.83e-01 6.44e-01
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 20 9.09e-01 9.77e-01 0.05840 -2.22e-02 5.40e-02 8.64e-01 6.76e-01
GOBP BILE ACID METABOLIC PROCESS 50 7.54e-01 9.30e-01 0.05830 2.55e-02 5.24e-02 7.55e-01 5.21e-01
GOBP AMINOPHOSPHOLIPID TRANSLOCATION 6 9.69e-01 9.91e-01 0.05820 5.81e-02 4.17e-03 8.05e-01 9.86e-01
GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY 6 9.69e-01 9.91e-01 0.05820 5.81e-02 4.17e-03 8.05e-01 9.86e-01
GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS 53 7.66e-01 9.33e-01 0.05810 -4.22e-03 5.80e-02 9.58e-01 4.65e-01
Deadenylation of mRNA 22 9.05e-01 9.76e-01 0.05810 4.52e-02 -3.65e-02 7.14e-01 7.67e-01
GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING 76 7.00e-01 9.12e-01 0.05810 -2.24e-02 5.36e-02 7.35e-01 4.19e-01
GOMF INSULIN BINDING 5 9.75e-01 9.93e-01 0.05800 -5.80e-02 1.55e-04 8.22e-01 1.00e+00
GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION 501 6.26e-02 3.77e-01 0.05800 -4.93e-02 -3.06e-02 5.89e-02 2.41e-01
GOCC GOLGI ASSOCIATED VESICLE 89 6.43e-01 8.89e-01 0.05800 -6.54e-03 5.76e-02 9.15e-01 3.47e-01
GOBP REGULATION OF TRANSFERASE ACTIVITY 606 4.02e-02 3.07e-01 0.05800 -1.72e-02 -5.54e-02 4.70e-01 1.99e-02
GOMF LAMIN BINDING 16 9.29e-01 9.83e-01 0.05800 -4.97e-02 2.98e-02 7.31e-01 8.37e-01
Synthesis of IP3 and IP4 in the cytosol 25 8.90e-01 9.71e-01 0.05800 -2.27e-02 5.33e-02 8.44e-01 6.44e-01
Cytosolic sensors of pathogen-associated DNA 63 7.50e-01 9.29e-01 0.05800 3.07e-02 -4.92e-02 6.74e-01 4.99e-01
GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE 8 9.56e-01 9.89e-01 0.05800 5.20e-02 2.57e-02 7.99e-01 9.00e-01
Interleukin-1 family signaling 134 4.82e-01 8.22e-01 0.05800 -5.49e-02 -1.86e-02 2.73e-01 7.10e-01
Leishmania infection 155 4.77e-01 8.19e-01 0.05800 -5.59e-02 1.52e-02 2.29e-01 7.44e-01
Parasitic Infection Pathways 155 4.77e-01 8.19e-01 0.05800 -5.59e-02 1.52e-02 2.29e-01 7.44e-01
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 92 6.10e-01 8.78e-01 0.05790 -5.60e-02 -1.46e-02 3.53e-01 8.09e-01
GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY 15 9.35e-01 9.84e-01 0.05790 -4.11e-02 4.08e-02 7.83e-01 7.85e-01
Cilium Assembly 189 3.46e-01 7.43e-01 0.05790 -4.75e-02 -3.31e-02 2.60e-01 4.33e-01
GOBP ENDOTHELIAL CELL MORPHOGENESIS 9 9.55e-01 9.88e-01 0.05790 2.37e-03 5.78e-02 9.90e-01 7.64e-01
GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND 34 8.59e-01 9.60e-01 0.05780 3.86e-02 -4.31e-02 6.97e-01 6.64e-01
GOCC AXONEMAL B TUBULE INNER SHEATH 11 9.51e-01 9.88e-01 0.05780 -5.21e-02 2.50e-02 7.65e-01 8.86e-01
Toll Like Receptor 4 (TLR4) Cascade 139 5.32e-01 8.45e-01 0.05770 2.78e-02 -5.06e-02 5.71e-01 3.03e-01
GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 25 8.93e-01 9.72e-01 0.05770 -4.80e-02 3.21e-02 6.78e-01 7.81e-01
GOBP ACTIN MEDIATED CELL CONTRACTION 111 5.67e-01 8.59e-01 0.05770 3.94e-03 5.75e-02 9.43e-01 2.95e-01
GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX 21 9.11e-01 9.77e-01 0.05760 -3.93e-02 4.20e-02 7.55e-01 7.39e-01
GOBP AMINOGLYCAN CATABOLIC PROCESS 33 8.35e-01 9.55e-01 0.05750 5.24e-02 2.36e-02 6.02e-01 8.14e-01
Estrogen biosynthesis 6 9.67e-01 9.91e-01 0.05750 -3.09e-02 -4.85e-02 8.96e-01 8.37e-01
GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS 25 8.92e-01 9.72e-01 0.05750 2.49e-02 -5.18e-02 8.29e-01 6.54e-01
GOBP CYTOSOLIC TRANSPORT 135 4.74e-01 8.17e-01 0.05740 -4.76e-02 -3.21e-02 3.39e-01 5.19e-01
GOBP INSULIN SECRETION 195 3.89e-01 7.70e-01 0.05740 -5.71e-02 6.44e-03 1.69e-01 8.77e-01
GOBP POSITIVE REGULATION OF SIGNALING 1747 2.76e-04 1.24e-02 0.05740 -5.73e-02 -3.90e-03 6.91e-05 7.86e-01
GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY 17 9.09e-01 9.77e-01 0.05740 -4.49e-02 -3.57e-02 7.48e-01 7.99e-01
GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT 141 5.25e-01 8.42e-01 0.05730 -2.12e-02 5.33e-02 6.64e-01 2.75e-01
GOMF ALPHA TUBULIN BINDING 38 8.25e-01 9.52e-01 0.05730 3.06e-03 5.72e-02 9.74e-01 5.42e-01
GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 133 4.99e-01 8.30e-01 0.05730 -1.34e-02 -5.57e-02 7.89e-01 2.67e-01
GOBP INNER EAR MORPHOGENESIS 105 6.06e-01 8.76e-01 0.05730 -5.64e-02 1.01e-02 3.18e-01 8.58e-01
GOBP REGULATION OF PROTEIN POLYMERIZATION 194 3.71e-01 7.59e-01 0.05730 -5.66e-02 -8.57e-03 1.74e-01 8.37e-01
GOBP REGULATION OF MITOCHONDRIAL FUSION 13 9.44e-01 9.87e-01 0.05720 -4.13e-02 3.96e-02 7.96e-01 8.05e-01
GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 72 6.80e-01 9.04e-01 0.05720 -2.12e-02 -5.32e-02 7.56e-01 4.35e-01
GOBP ORGANELLE FISSION 485 7.22e-02 4.04e-01 0.05720 -3.42e-02 -4.58e-02 1.97e-01 8.37e-02
GOBP MEIOTIC CELL CYCLE PROCESS 212 3.26e-01 7.30e-01 0.05720 -5.39e-02 -1.90e-02 1.76e-01 6.33e-01
GOBP REGULATION OF FATTY ACID TRANSPORT 33 8.34e-01 9.55e-01 0.05710 -3.36e-02 -4.61e-02 7.38e-01 6.47e-01
GOCC CYTOPLASMIC MICROTUBULE 113 5.57e-01 8.56e-01 0.05700 -1.40e-02 -5.52e-02 7.97e-01 3.11e-01
RHOG GTPase cycle 71 7.34e-01 9.23e-01 0.05700 -4.47e-02 3.54e-02 5.15e-01 6.06e-01
GOCC FICOLIN 1 RICH GRANULE LUMEN 121 5.92e-01 8.70e-01 0.05690 3.91e-02 -4.14e-02 4.58e-01 4.31e-01
GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS 21 9.01e-01 9.74e-01 0.05690 2.79e-03 5.69e-02 9.82e-01 6.52e-01
GOBP RESPONSE TO ORGANOPHOSPHORUS 123 5.87e-01 8.67e-01 0.05690 -4.36e-02 3.66e-02 4.04e-01 4.83e-01
GOMF LIGASE ACTIVITY 161 4.39e-01 7.99e-01 0.05690 -1.12e-02 -5.58e-02 8.07e-01 2.22e-01
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 1633 1.01e-03 3.28e-02 0.05680 -5.39e-02 1.80e-02 2.84e-04 2.26e-01
GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN 18 9.12e-01 9.78e-01 0.05680 -1.14e-02 -5.57e-02 9.34e-01 6.83e-01
GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY 10 9.53e-01 9.88e-01 0.05680 -5.67e-02 3.40e-03 7.56e-01 9.85e-01
GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS 60 7.21e-01 9.17e-01 0.05680 -4.44e-02 -3.54e-02 5.52e-01 6.35e-01
GOBP NEGATIVE REGULATION OF CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 51 7.64e-01 9.33e-01 0.05680 -1.98e-02 -5.32e-02 8.07e-01 5.11e-01
GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 102 6.28e-01 8.85e-01 0.05680 1.69e-02 -5.42e-02 7.68e-01 3.44e-01
GOBP PROTEIN POLYMERIZATION 272 2.64e-01 6.79e-01 0.05680 -5.67e-02 -2.59e-03 1.07e-01 9.41e-01
The role of Nef in HIV-1 replication and disease pathogenesis 27 8.90e-01 9.71e-01 0.05670 -3.60e-02 4.38e-02 7.46e-01 6.94e-01
GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 65 7.56e-01 9.30e-01 0.05670 3.99e-02 -4.03e-02 5.78e-01 5.75e-01
Telomere C-strand (Lagging Strand) Synthesis 33 8.36e-01 9.55e-01 0.05670 -3.85e-02 -4.15e-02 7.02e-01 6.80e-01
GOBP POSITIVE REGULATION OF GONADOTROPIN SECRETION 7 9.67e-01 9.91e-01 0.05660 -5.65e-02 3.25e-03 7.96e-01 9.88e-01
GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM 12 9.49e-01 9.88e-01 0.05650 4.81e-02 -2.97e-02 7.73e-01 8.59e-01
GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS 221 3.57e-01 7.49e-01 0.05650 -5.60e-02 7.35e-03 1.51e-01 8.51e-01
GOBP REGULATION OF CYTOSKELETON ORGANIZATION 500 1.09e-01 4.79e-01 0.05650 -5.40e-02 1.68e-02 3.89e-02 5.20e-01
GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR 35 8.36e-01 9.55e-01 0.05650 1.37e-02 5.48e-02 8.88e-01 5.75e-01
GOBP POSITIVE REGULATION OF LIPID STORAGE 27 8.78e-01 9.67e-01 0.05650 -5.65e-02 9.93e-04 6.11e-01 9.93e-01
GOBP MEMBRANE REPOLARIZATION 53 7.97e-01 9.44e-01 0.05640 -4.48e-02 3.43e-02 5.72e-01 6.66e-01
GOMF SINGLE STRANDED RNA BINDING 79 7.01e-01 9.12e-01 0.05640 -5.40e-02 1.62e-02 4.07e-01 8.04e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 97 6.51e-01 8.92e-01 0.05630 5.26e-02 -2.01e-02 3.70e-01 7.33e-01
GOCC POLYMERIC CYTOSKELETAL FIBER 762 1.96e-02 2.24e-01 0.05630 3.13e-02 4.68e-02 1.41e-01 2.79e-02
Cellular response to chemical stress 188 4.30e-01 7.94e-01 0.05630 1.48e-02 -5.43e-02 7.26e-01 1.99e-01
GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS 243 2.76e-01 6.89e-01 0.05630 -3.36e-02 -4.51e-02 3.67e-01 2.25e-01
GOBP CYTOKINE MEDIATED SIGNALING PATHWAY 501 9.96e-02 4.62e-01 0.05630 5.60e-02 -5.07e-03 3.18e-02 8.46e-01
GOCC SARCOPLASMIC RETICULUM 74 7.28e-01 9.20e-01 0.05620 -4.82e-02 2.90e-02 4.73e-01 6.67e-01
GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION 18 9.20e-01 9.80e-01 0.05620 -8.72e-03 5.55e-02 9.49e-01 6.83e-01
GOCC PLASMA MEMBRANE PROTEIN COMPLEX 579 9.18e-02 4.44e-01 0.05620 -3.91e-02 4.04e-02 1.08e-01 9.68e-02
Cytosolic iron-sulfur cluster assembly 12 9.43e-01 9.87e-01 0.05620 6.28e-03 5.58e-02 9.70e-01 7.38e-01
GOBP RESPONSE TO STEROL 35 8.62e-01 9.61e-01 0.05610 -3.44e-02 4.44e-02 7.25e-01 6.50e-01
GOBP BRAIN MORPHOGENESIS 38 8.52e-01 9.59e-01 0.05610 -3.93e-02 4.00e-02 6.75e-01 6.70e-01
GOMF TRANSITION METAL ION BINDING 1051 8.43e-03 1.38e-01 0.05610 -5.61e-02 7.96e-04 2.11e-03 9.65e-01
GOMF PROTEIN TYROSINE KINASE ACTIVITY 140 5.39e-01 8.49e-01 0.05610 -1.80e-02 5.31e-02 7.12e-01 2.78e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION 41 8.09e-01 9.49e-01 0.05610 2.16e-02 5.18e-02 8.11e-01 5.66e-01
GOBP PROTEIN K11 LINKED DEUBIQUITINATION 9 9.53e-01 9.88e-01 0.05600 4.20e-02 3.70e-02 8.27e-01 8.48e-01
GOCC PERICENTRIC HETEROCHROMATIN 29 8.70e-01 9.64e-01 0.05590 -1.56e-03 -5.59e-02 9.88e-01 6.02e-01
GOBP TROPHOBLAST CELL MIGRATION 17 9.20e-01 9.80e-01 0.05590 5.54e-02 7.41e-03 6.92e-01 9.58e-01
GOCC MICROTUBULE ASSOCIATED COMPLEX 149 5.31e-01 8.44e-01 0.05590 -4.91e-02 2.68e-02 3.01e-01 5.73e-01
GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY 13 9.47e-01 9.87e-01 0.05590 3.45e-02 -4.39e-02 8.29e-01 7.84e-01
GOMF AMINOACYL TRNA EDITING ACTIVITY 13 9.47e-01 9.87e-01 0.05590 3.45e-02 -4.39e-02 8.29e-01 7.84e-01
GOBP GLUTAMINE METABOLIC PROCESS 26 8.81e-01 9.67e-01 0.05590 -5.54e-02 -7.50e-03 6.25e-01 9.47e-01
GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS 47 8.12e-01 9.49e-01 0.05590 1.51e-02 -5.38e-02 8.58e-01 5.24e-01
GOMF IRON ION BINDING 146 5.38e-01 8.49e-01 0.05580 2.69e-02 -4.89e-02 5.75e-01 3.07e-01
GOBP MALE SEX DIFFERENTIATION 164 4.22e-01 7.91e-01 0.05580 -3.75e-02 -4.13e-02 4.07e-01 3.61e-01
GOBP T CELL ACTIVATION 551 1.02e-01 4.67e-01 0.05580 2.90e-02 -4.77e-02 2.45e-01 5.53e-02
GOCC CELL TRAILING EDGE 14 9.29e-01 9.83e-01 0.05580 -3.35e-02 -4.46e-02 8.28e-01 7.73e-01
GOBP REGULATION OF CELL GROWTH 383 1.88e-01 5.93e-01 0.05580 -5.38e-02 1.47e-02 7.07e-02 6.21e-01
GOBP MEMBRANE DOCKING 83 6.49e-01 8.91e-01 0.05570 -4.63e-02 -3.09e-02 4.66e-01 6.27e-01
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes 29 8.68e-01 9.63e-01 0.05570 5.49e-02 9.20e-03 6.09e-01 9.32e-01
GOBP COCHLEA DEVELOPMENT 49 8.16e-01 9.51e-01 0.05570 3.95e-02 -3.93e-02 6.33e-01 6.34e-01
GOBP MACROPHAGE DIFFERENTIATION 62 7.73e-01 9.36e-01 0.05560 -4.40e-02 3.40e-02 5.49e-01 6.43e-01
GOBP HEART FORMATION 34 8.66e-01 9.62e-01 0.05560 -2.80e-02 4.81e-02 7.78e-01 6.27e-01
GOBP REGULATION OF PROGRAMMED CELL DEATH 1462 7.80e-04 2.67e-02 0.05560 -3.43e-02 -4.38e-02 2.83e-02 5.05e-03
GOBP CGMP MEDIATED SIGNALING 32 8.76e-01 9.66e-01 0.05560 -4.17e-02 3.68e-02 6.83e-01 7.18e-01
GOBP ALPHA BETA T CELL ACTIVATION 172 4.20e-01 7.89e-01 0.05560 -2.09e-02 -5.15e-02 6.36e-01 2.44e-01
GOBP CHLORIDE TRANSPORT 116 5.47e-01 8.52e-01 0.05560 3.34e-02 4.44e-02 5.35e-01 4.09e-01
GOBP CELL PROJECTION ORGANIZATION 1566 1.64e-03 4.67e-02 0.05560 -5.35e-02 1.48e-02 4.06e-04 3.28e-01
GOBP NEGATIVE REGULATION OF HEMOPOIESIS 113 6.26e-01 8.83e-01 0.05550 3.17e-02 -4.55e-02 5.61e-01 4.03e-01
Nuclear Receptor transcription pathway 51 8.05e-01 9.48e-01 0.05550 -5.03e-02 2.35e-02 5.35e-01 7.72e-01
GOBP MEMBRANE ORGANIZATION 768 2.47e-02 2.51e-01 0.05550 -5.29e-02 -1.65e-02 1.25e-02 4.35e-01
GOBP MEIOSIS I CELL CYCLE PROCESS 135 5.09e-01 8.34e-01 0.05530 -5.16e-02 -2.01e-02 3.01e-01 6.87e-01
C-type lectin receptors (CLRs) 126 5.68e-01 8.59e-01 0.05530 7.35e-03 -5.48e-02 8.87e-01 2.88e-01
GOBP NEGATIVE REGULATION OF KINASE ACTIVITY 176 4.17e-01 7.86e-01 0.05530 -5.18e-02 -1.95e-02 2.36e-01 6.56e-01
GOCC 9PLUS2 MOTILE CILIUM 180 4.29e-01 7.94e-01 0.05530 5.51e-02 4.96e-03 2.03e-01 9.09e-01
Neurotransmitter release cycle 48 7.86e-01 9.41e-01 0.05520 -5.10e-02 -2.13e-02 5.41e-01 7.98e-01
GOBP ACUTE INFLAMMATORY RESPONSE 100 6.09e-01 8.77e-01 0.05520 5.22e-02 1.80e-02 3.67e-01 7.55e-01
GOBP CELL MIGRATION IN HINDBRAIN 16 9.31e-01 9.83e-01 0.05520 7.88e-03 -5.46e-02 9.56e-01 7.05e-01
GOBP MAINTENANCE OF LOCATION 329 2.52e-01 6.67e-01 0.05520 -5.11e-02 2.08e-02 1.11e-01 5.16e-01
GOBP METANEPHRIC NEPHRON MORPHOGENESIS 24 8.90e-01 9.71e-01 0.05520 -5.37e-02 -1.28e-02 6.49e-01 9.14e-01
GOBP BIOMINERAL TISSUE DEVELOPMENT 170 4.76e-01 8.18e-01 0.05520 -5.39e-02 1.19e-02 2.25e-01 7.90e-01
GOBP NEUTROPHIL CHEMOTAXIS 81 7.13e-01 9.15e-01 0.05520 -4.89e-02 2.57e-02 4.47e-01 6.90e-01
GOBP GENITALIA DEVELOPMENT 46 7.96e-01 9.44e-01 0.05520 -5.21e-02 -1.81e-02 5.41e-01 8.32e-01
Innate Immune System 989 2.10e-02 2.32e-01 0.05520 3.65e-02 -4.14e-02 5.18e-02 2.77e-02
GOBP POSITIVE REGULATION OF MAPK CASCADE 458 1.12e-01 4.84e-01 0.05520 -5.35e-02 -1.35e-02 4.98e-02 6.21e-01
Interferon gamma signaling 92 6.87e-01 9.06e-01 0.05510 4.44e-02 -3.26e-02 4.61e-01 5.89e-01
GOBP HYALURONAN BIOSYNTHETIC PROCESS 14 9.45e-01 9.87e-01 0.05510 -3.64e-02 4.13e-02 8.14e-01 7.89e-01
GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS 5 9.75e-01 9.93e-01 0.05510 4.99e-02 2.34e-02 8.47e-01 9.28e-01
Transport to the Golgi and subsequent modification 183 4.44e-01 8.01e-01 0.05500 -5.46e-02 6.65e-03 2.03e-01 8.77e-01
GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY 141 4.96e-01 8.29e-01 0.05500 4.98e-02 2.33e-02 3.08e-01 6.32e-01
GOBP HINDBRAIN MORPHOGENESIS 44 8.22e-01 9.52e-01 0.05480 5.29e-03 -5.46e-02 9.52e-01 5.31e-01
GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 63 7.50e-01 9.29e-01 0.05480 -8.21e-05 5.48e-02 9.99e-01 4.52e-01
GOBP REGULATION OF NEUTROPHIL ACTIVATION 6 9.70e-01 9.92e-01 0.05480 -2.60e-02 -4.83e-02 9.12e-01 8.38e-01
GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 188 4.30e-01 7.95e-01 0.05470 -5.47e-02 1.78e-03 1.96e-01 9.66e-01
GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 126 5.73e-01 8.61e-01 0.05470 5.64e-03 -5.44e-02 9.13e-01 2.91e-01
GOBP REGULATION OF CELL DEVELOPMENT 812 3.34e-02 2.85e-01 0.05470 -5.36e-02 1.07e-02 9.37e-03 6.03e-01
GOBP NEPHRIC DUCT FORMATION 5 9.80e-01 9.94e-01 0.05470 4.75e-02 -2.71e-02 8.54e-01 9.17e-01
GOBP REGULATION OF ORGANELLE ORGANIZATION 1165 4.63e-03 9.42e-02 0.05470 -5.18e-02 -1.74e-02 2.86e-03 3.16e-01
GOBP DETOXIFICATION 157 4.66e-01 8.14e-01 0.05470 1.93e-02 5.11e-02 6.76e-01 2.69e-01
GOBP RESPONSE TO NITROGEN COMPOUND 1055 1.35e-02 1.85e-01 0.05470 -5.30e-02 1.36e-02 3.66e-03 4.55e-01
GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 32 8.65e-01 9.62e-01 0.05470 -5.85e-04 -5.47e-02 9.95e-01 5.93e-01
GOBP FUNGIFORM PAPILLA MORPHOGENESIS 5 9.80e-01 9.94e-01 0.05460 4.05e-02 -3.67e-02 8.75e-01 8.87e-01
GOBP ACTIN FILAMENT ORGANIZATION 442 1.74e-01 5.78e-01 0.05460 -4.47e-02 3.14e-02 1.07e-01 2.58e-01
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 42 8.43e-01 9.57e-01 0.05450 2.73e-02 -4.72e-02 7.60e-01 5.96e-01
GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY 402 1.37e-01 5.26e-01 0.05450 -4.23e-02 -3.44e-02 1.46e-01 2.36e-01
GOBP REGULATION OF PH 97 6.17e-01 8.80e-01 0.05450 3.04e-02 4.52e-02 6.05e-01 4.42e-01
GOBP INOSITOL PHOSPHATE METABOLIC PROCESS 39 8.22e-01 9.52e-01 0.05450 -4.08e-02 -3.61e-02 6.59e-01 6.97e-01
GOCC COATED VESICLE 304 2.62e-01 6.77e-01 0.05440 -5.44e-02 2.33e-03 1.03e-01 9.44e-01
GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 340 2.57e-01 6.71e-01 0.05440 -4.78e-02 2.60e-02 1.30e-01 4.10e-01
GOCC FEMALE GERM CELL NUCLEUS 17 9.34e-01 9.84e-01 0.05440 3.19e-02 -4.41e-02 8.20e-01 7.53e-01
GOBP PLATELET MORPHOGENESIS 25 9.05e-01 9.76e-01 0.05440 -4.31e-02 3.32e-02 7.09e-01 7.74e-01
GOBP REGULATION OF MEMBRANE LIPID METABOLIC PROCESS 20 9.14e-01 9.78e-01 0.05440 -5.44e-02 -8.26e-04 6.74e-01 9.95e-01
GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 38 8.32e-01 9.54e-01 0.05430 1.97e-02 5.06e-02 8.34e-01 5.89e-01
GOCC EXTERNAL SIDE OF APICAL PLASMA MEMBRANE 6 9.75e-01 9.93e-01 0.05430 5.09e-02 -1.89e-02 8.29e-01 9.36e-01
GOMF STEROL BINDING 66 7.65e-01 9.33e-01 0.05430 -2.31e-02 4.91e-02 7.45e-01 4.90e-01
GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION 57 7.77e-01 9.38e-01 0.05420 1.56e-03 -5.42e-02 9.84e-01 4.79e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY 40 8.42e-01 9.56e-01 0.05420 8.78e-03 -5.35e-02 9.23e-01 5.58e-01
GOBP PROTEIN TARGETING 307 2.32e-01 6.50e-01 0.05420 -5.07e-02 -1.93e-02 1.27e-01 5.61e-01
GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 843 2.54e-02 2.54e-01 0.05420 -3.54e-03 -5.41e-02 8.61e-01 7.68e-03
Signaling by Receptor Tyrosine Kinases 514 1.02e-01 4.66e-01 0.05420 -5.40e-02 -4.60e-03 3.62e-02 8.58e-01
GOCC ENDOCYTIC VESICLE MEMBRANE 189 4.49e-01 8.04e-01 0.05420 9.53e-03 -5.33e-02 8.21e-01 2.06e-01
GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 485 9.79e-02 4.57e-01 0.05420 4.76e-02 2.59e-02 7.27e-02 3.29e-01
GOMF DNA EXONUCLEASE ACTIVITY 24 9.06e-01 9.76e-01 0.05410 -5.11e-02 1.77e-02 6.65e-01 8.81e-01
GOMF P53 BINDING 65 7.39e-01 9.24e-01 0.05410 -5.27e-02 -1.20e-02 4.62e-01 8.68e-01
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION 168 4.37e-01 7.97e-01 0.05410 -3.59e-02 -4.04e-02 4.22e-01 3.66e-01
Epithelial-Mesenchymal Transition (EMT) during gastrulation 7 9.66e-01 9.91e-01 0.05400 4.74e-02 2.58e-02 8.28e-01 9.06e-01
Transcriptional activation of mitochondrial biogenesis 51 7.78e-01 9.39e-01 0.05400 -3.21e-02 -4.34e-02 6.91e-01 5.92e-01
GOBP TYPE II INTERFERON PRODUCTION 113 5.95e-01 8.72e-01 0.05400 5.32e-02 9.41e-03 3.29e-01 8.63e-01
GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX 23 9.07e-01 9.76e-01 0.05400 5.32e-02 -9.34e-03 6.59e-01 9.38e-01
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) 12 9.50e-01 9.88e-01 0.05400 -8.54e-03 5.33e-02 9.59e-01 7.49e-01
GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT 19 9.13e-01 9.78e-01 0.05400 -4.92e-02 -2.21e-02 7.10e-01 8.68e-01
GOBP CELLULAR RESPONSE TO KETONE 101 6.75e-01 9.03e-01 0.05400 4.07e-02 -3.54e-02 4.80e-01 5.38e-01
GOBP NEURAL RETINA DEVELOPMENT 80 7.14e-01 9.15e-01 0.05390 -5.29e-02 1.08e-02 4.14e-01 8.68e-01
Toll-like Receptor Cascades 161 5.25e-01 8.42e-01 0.05390 2.19e-02 -4.93e-02 6.31e-01 2.81e-01
GOMF CYTOSKELETAL MOTOR ACTIVITY 111 6.20e-01 8.81e-01 0.05380 -4.35e-03 5.37e-02 9.37e-01 3.29e-01
GOMF GROWTH FACTOR ACTIVITY 152 5.06e-01 8.32e-01 0.05380 5.40e-03 5.36e-02 9.09e-01 2.54e-01
GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 131 5.27e-01 8.42e-01 0.05380 -3.41e-02 -4.16e-02 5.01e-01 4.10e-01
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS 153 5.36e-01 8.48e-01 0.05380 1.64e-02 -5.12e-02 7.27e-01 2.74e-01
GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 25 9.03e-01 9.75e-01 0.05380 -1.77e-02 5.08e-02 8.78e-01 6.60e-01
GOCC GERM CELL NUCLEUS 68 7.64e-01 9.33e-01 0.05370 2.46e-02 -4.78e-02 7.26e-01 4.96e-01
GOBP POSITIVE REGULATION OF VASCULOGENESIS 12 9.52e-01 9.88e-01 0.05370 -5.17e-02 1.46e-02 7.57e-01 9.30e-01
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 182 4.69e-01 8.14e-01 0.05370 1.01e-02 -5.27e-02 8.14e-01 2.20e-01
GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM 9 9.64e-01 9.91e-01 0.05370 5.03e-02 -1.86e-02 7.94e-01 9.23e-01
GOMF BETA TUBULIN BINDING 37 8.37e-01 9.55e-01 0.05360 -2.64e-02 -4.66e-02 7.81e-01 6.24e-01
GOBP MICROTUBULE SEVERING 9 9.64e-01 9.91e-01 0.05360 5.17e-02 -1.42e-02 7.88e-01 9.41e-01
GOBP LYMPHOCYTE DIFFERENTIATION 418 1.96e-01 6.07e-01 0.05360 4.86e-02 -2.25e-02 8.80e-02 4.31e-01
Gastrin-CREB signalling pathway via PKC and MAPK 17 9.28e-01 9.82e-01 0.05350 -5.34e-02 -3.02e-03 7.03e-01 9.83e-01
GOCC DENDRITIC GROWTH CONE 8 9.62e-01 9.90e-01 0.05350 3.38e-02 4.15e-02 8.69e-01 8.39e-01
Translocation of SLC2A4 (GLUT4) to the plasma membrane 70 7.52e-01 9.30e-01 0.05350 -1.43e-02 5.15e-02 8.37e-01 4.56e-01
GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS 160 5.30e-01 8.43e-01 0.05340 -1.95e-02 4.98e-02 6.71e-01 2.77e-01
Early SARS-CoV-2 Infection Events 34 8.77e-01 9.67e-01 0.05340 3.16e-02 -4.30e-02 7.50e-01 6.64e-01
GOBP REGULATION OF LYSOSOMAL LUMEN PH 28 8.81e-01 9.67e-01 0.05340 -5.24e-02 -1.01e-02 6.31e-01 9.26e-01
GOBP STEROID METABOLIC PROCESS 315 2.28e-01 6.46e-01 0.05330 2.61e-02 4.65e-02 4.26e-01 1.56e-01
GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY 353 2.12e-01 6.29e-01 0.05330 -7.14e-03 -5.29e-02 8.18e-01 8.80e-02
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS 160 4.67e-01 8.14e-01 0.05330 -4.34e-02 -3.08e-02 3.43e-01 5.01e-01
GOMF CARBON CARBON LYASE ACTIVITY 51 8.24e-01 9.52e-01 0.05330 -3.70e-02 3.83e-02 6.47e-01 6.36e-01
GOBP RESPONSE TO HYDROGEN PEROXIDE 94 6.70e-01 9.00e-01 0.05320 8.54e-04 -5.32e-02 9.89e-01 3.73e-01
GOBP RESPONSE TO COPPER ION 34 8.56e-01 9.60e-01 0.05320 -5.11e-02 -1.47e-02 6.06e-01 8.82e-01
GOMF MONOATOMIC CATION CHANNEL ACTIVITY 326 2.19e-01 6.37e-01 0.05310 4.65e-02 2.57e-02 1.49e-01 4.25e-01
GOBP POSITIVE REGULATION OF B CELL ACTIVATION 80 6.86e-01 9.06e-01 0.05310 -2.66e-02 -4.60e-02 6.81e-01 4.77e-01
GOBP RECEPTOR RECYCLING 45 8.26e-01 9.52e-01 0.05310 -1.42e-03 5.31e-02 9.87e-01 5.38e-01
GOBP PROTEIN HOMOTETRAMERIZATION 60 7.84e-01 9.40e-01 0.05310 -1.17e-02 5.18e-02 8.76e-01 4.88e-01
GOBP TYPE B PANCREATIC CELL DEVELOPMENT 24 9.13e-01 9.78e-01 0.05310 -3.22e-02 4.22e-02 7.85e-01 7.20e-01
GOBP REGULATION OF CATABOLIC PROCESS 1061 1.18e-02 1.71e-01 0.05300 -5.27e-02 -6.19e-03 3.74e-03 7.33e-01
GOBP REGULATION OF LEUKOCYTE MIGRATION 220 3.72e-01 7.60e-01 0.05300 5.09e-02 1.48e-02 1.93e-01 7.06e-01
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 489 1.40e-01 5.31e-01 0.05300 -5.23e-02 8.75e-03 4.77e-02 7.40e-01
Depolymerization of the Nuclear Lamina 14 9.45e-01 9.87e-01 0.05300 1.25e-02 -5.15e-02 9.36e-01 7.39e-01
GOCC MOTILE CILIUM 266 3.66e-01 7.56e-01 0.05290 4.56e-02 -2.69e-02 2.01e-01 4.49e-01
GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION 148 4.99e-01 8.30e-01 0.05280 -4.08e-02 -3.36e-02 3.92e-01 4.81e-01
GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM 60 7.99e-01 9.45e-01 0.05280 3.19e-02 -4.20e-02 6.69e-01 5.73e-01
GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS 295 2.82e-01 6.94e-01 0.05280 -6.47e-03 -5.24e-02 8.48e-01 1.22e-01
GOBP LYMPHOCYTE MIGRATION 99 6.37e-01 8.87e-01 0.05270 4.89e-02 1.98e-02 4.01e-01 7.33e-01
GOBP REGULATION OF P38MAPK CASCADE 46 8.22e-01 9.52e-01 0.05270 -5.26e-02 -2.80e-03 5.37e-01 9.74e-01
GOBP UDP GLUCOSE METABOLIC PROCESS 6 9.73e-01 9.93e-01 0.05270 4.71e-02 2.37e-02 8.42e-01 9.20e-01
GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION 36 8.49e-01 9.58e-01 0.05270 -4.87e-02 -2.01e-02 6.13e-01 8.35e-01
GOBP NEGATIVE REGULATION OF BONE MINERALIZATION 18 9.35e-01 9.84e-01 0.05260 3.52e-02 -3.91e-02 7.96e-01 7.74e-01
GOBP RESPONSE TO PURINE CONTAINING COMPOUND 138 6.00e-01 8.74e-01 0.05260 -3.29e-02 4.11e-02 5.05e-01 4.05e-01
GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY 9 9.61e-01 9.90e-01 0.05260 5.05e-02 1.48e-02 7.93e-01 9.39e-01
GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 128 5.73e-01 8.62e-01 0.05250 5.17e-02 9.44e-03 3.13e-01 8.54e-01
Nephron development 13 9.46e-01 9.87e-01 0.05250 -5.24e-02 -3.67e-03 7.44e-01 9.82e-01
GOCC MICROTUBULE CYTOSKELETON 1348 4.71e-03 9.55e-02 0.05250 -5.24e-02 -2.28e-03 1.23e-03 8.88e-01
Purine salvage 11 9.51e-01 9.88e-01 0.05250 -4.86e-02 -1.99e-02 7.80e-01 9.09e-01
GOBP L LEUCINE CATABOLIC PROCESS 6 9.76e-01 9.93e-01 0.05250 -4.23e-03 5.23e-02 9.86e-01 8.24e-01
GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE 8 9.63e-01 9.91e-01 0.05250 4.23e-02 3.11e-02 8.36e-01 8.79e-01
GOCC EXOCYTIC VESICLE 227 4.17e-01 7.86e-01 0.05250 -4.98e-02 1.64e-02 1.96e-01 6.71e-01
GOBP ISOPRENOID METABOLIC PROCESS 134 5.69e-01 8.60e-01 0.05240 5.24e-02 2.80e-03 2.95e-01 9.55e-01
GOCC MONOATOMIC ION CHANNEL COMPLEX 327 2.58e-01 6.72e-01 0.05240 1.48e-03 5.24e-02 9.63e-01 1.03e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 589 6.98e-02 3.97e-01 0.05240 -3.06e-02 -4.26e-02 2.05e-01 7.76e-02
GOBP MAINTENANCE OF PROTEIN LOCATION 83 7.19e-01 9.15e-01 0.05240 -9.69e-03 5.15e-02 8.79e-01 4.17e-01
GOBP NUCLEOTIDE SALVAGE 17 9.37e-01 9.84e-01 0.05240 -1.94e-02 4.87e-02 8.90e-01 7.28e-01
Cell surface interactions at the vascular wall 129 5.54e-01 8.54e-01 0.05230 -2.84e-02 -4.39e-02 5.77e-01 3.89e-01
FBXW7 Mutants and NOTCH1 in Cancer 5 9.77e-01 9.93e-01 0.05230 -4.15e-02 -3.18e-02 8.72e-01 9.02e-01
Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling 5 9.77e-01 9.93e-01 0.05230 -4.15e-02 -3.18e-02 8.72e-01 9.02e-01
GOBP EAR DEVELOPMENT 221 4.26e-01 7.93e-01 0.05220 -5.03e-02 1.40e-02 1.97e-01 7.20e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS 38 8.61e-01 9.61e-01 0.05220 5.09e-02 -1.17e-02 5.87e-01 9.01e-01
GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION 938 1.63e-02 2.04e-01 0.05220 -4.46e-02 -2.72e-02 2.08e-02 1.57e-01
GOMF PEPTIDASE ACTIVITY 557 8.38e-02 4.31e-01 0.05220 2.58e-02 4.54e-02 2.98e-01 6.70e-02
GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS 729 3.95e-02 3.06e-01 0.05220 -2.77e-02 -4.43e-02 2.03e-01 4.17e-02
GOBP SUBSTRATE DEPENDENT CELL MIGRATION 25 9.10e-01 9.77e-01 0.05220 4.67e-02 -2.34e-02 6.86e-01 8.40e-01
Toll Like Receptor 2 (TLR2) Cascade 109 6.32e-01 8.86e-01 0.05220 -4.71e-03 -5.20e-02 9.32e-01 3.48e-01
Toll Like Receptor TLR1:TLR2 Cascade 109 6.32e-01 8.86e-01 0.05220 -4.71e-03 -5.20e-02 9.32e-01 3.48e-01
GOBP HOMOCYSTEINE METABOLIC PROCESS 12 9.55e-01 9.88e-01 0.05210 -1.50e-02 4.99e-02 9.28e-01 7.65e-01
GOBP ENDOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY 40 8.64e-01 9.62e-01 0.05210 -4.15e-02 3.16e-02 6.50e-01 7.30e-01
GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION 154 4.94e-01 8.28e-01 0.05210 -3.55e-02 -3.81e-02 4.47e-01 4.15e-01
GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 16 9.38e-01 9.85e-01 0.05210 6.59e-03 -5.16e-02 9.64e-01 7.21e-01
GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION 71 7.72e-01 9.36e-01 0.05200 -4.14e-02 3.15e-02 5.47e-01 6.46e-01
GOCC SUPRAMOLECULAR POLYMER 1007 2.32e-02 2.44e-01 0.05200 -1.07e-02 5.09e-02 5.65e-01 6.30e-03
GOBP CYTIDINE METABOLIC PROCESS 13 9.54e-01 9.88e-01 0.05200 -2.87e-02 4.33e-02 8.58e-01 7.87e-01
GOBP LACTATE METABOLIC PROCESS 18 9.27e-01 9.82e-01 0.05190 5.13e-02 7.78e-03 7.06e-01 9.54e-01
GOCC ACROSOMAL VESICLE 142 5.25e-01 8.42e-01 0.05190 -3.28e-02 -4.03e-02 5.00e-01 4.08e-01
GOBP RESPONSE TO VIRUS 396 2.41e-01 6.56e-01 0.05190 4.40e-02 -2.76e-02 1.33e-01 3.46e-01
GOBP RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY 10 9.58e-01 9.89e-01 0.05180 -1.36e-02 -5.00e-02 9.40e-01 7.84e-01
GOBP MACROAUTOPHAGY 346 2.48e-01 6.62e-01 0.05180 -5.18e-02 -8.04e-04 9.77e-02 9.79e-01
GOCC INTERCELLULAR BRIDGE 90 6.68e-01 9.00e-01 0.05180 4.46e-02 2.63e-02 4.64e-01 6.67e-01
GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION 58 7.69e-01 9.35e-01 0.05180 -3.35e-02 -3.95e-02 6.59e-01 6.03e-01
GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE 36 8.69e-01 9.64e-01 0.05180 -5.09e-02 9.63e-03 5.97e-01 9.20e-01
Integrin cell surface interactions 83 7.24e-01 9.18e-01 0.05170 -5.10e-02 8.43e-03 4.22e-01 8.94e-01
GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 41 8.48e-01 9.58e-01 0.05170 -5.17e-02 1.20e-03 5.67e-01 9.89e-01
GOBP REGULATION OF BILE ACID SECRETION 6 9.74e-01 9.93e-01 0.05170 4.70e-02 2.16e-02 8.42e-01 9.27e-01
GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT 21 9.17e-01 9.79e-01 0.05170 2.23e-03 5.16e-02 9.86e-01 6.82e-01
Negative regulation of FGFR4 signaling 30 8.98e-01 9.73e-01 0.05170 -3.98e-02 3.30e-02 7.06e-01 7.55e-01
GOBP HORMONE METABOLIC PROCESS 231 4.32e-01 7.96e-01 0.05170 4.60e-02 -2.35e-02 2.28e-01 5.39e-01
GOMF MAP KINASE PHOSPHATASE ACTIVITY 15 9.39e-01 9.85e-01 0.05170 5.09e-02 8.71e-03 7.33e-01 9.53e-01
MAPK targets/ Nuclear events mediated by MAP kinases 29 8.91e-01 9.72e-01 0.05160 -5.14e-02 4.55e-03 6.32e-01 9.66e-01
GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 130 5.79e-01 8.64e-01 0.05160 -5.06e-02 -9.99e-03 3.19e-01 8.44e-01
GOMF ENZYME INHIBITOR ACTIVITY 379 2.47e-01 6.61e-01 0.05160 4.88e-02 -1.66e-02 1.03e-01 5.79e-01
GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE 69 7.53e-01 9.30e-01 0.05160 4.53e-03 5.14e-02 9.48e-01 4.61e-01
RHOD GTPase cycle 49 8.40e-01 9.56e-01 0.05150 -3.69e-02 3.59e-02 6.55e-01 6.64e-01
GOBP APICAL JUNCTION ASSEMBLY 75 7.17e-01 9.15e-01 0.05150 4.42e-02 2.64e-02 5.08e-01 6.92e-01
GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION 48 8.27e-01 9.52e-01 0.05150 2.95e-03 -5.14e-02 9.72e-01 5.38e-01
GOMF CHROMO SHADOW DOMAIN BINDING 5 9.78e-01 9.93e-01 0.05150 -3.90e-02 -3.35e-02 8.80e-01 8.97e-01
GOMF PROTEASE BINDING 136 5.73e-01 8.61e-01 0.05140 -5.37e-03 -5.12e-02 9.14e-01 3.03e-01
GOBP CELLULAR RESPONSE TO STARVATION 165 5.58e-01 8.56e-01 0.05140 -3.94e-02 3.31e-02 3.83e-01 4.63e-01
GOBP DETERMINATION OF LEFT RIGHT ASYMMETRY IN LATERAL MESODERM 8 9.65e-01 9.91e-01 0.05140 2.26e-02 4.62e-02 9.12e-01 8.21e-01
GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 16 9.44e-01 9.87e-01 0.05140 4.50e-02 -2.49e-02 7.55e-01 8.63e-01
GOBP PROSTAGLANDIN TRANSPORT 29 8.78e-01 9.67e-01 0.05140 4.00e-02 3.23e-02 7.09e-01 7.63e-01
GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS 14 9.41e-01 9.86e-01 0.05140 2.08e-02 4.70e-02 8.93e-01 7.61e-01
GOBP CARDIAC MUSCLE CELL CONTRACTION 81 7.16e-01 9.15e-01 0.05140 7.49e-03 5.08e-02 9.07e-01 4.29e-01
GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 400 1.77e-01 5.83e-01 0.05130 -2.44e-02 -4.52e-02 4.03e-01 1.21e-01
GOBP VITAMIN A METABOLIC PROCESS 8 9.65e-01 9.91e-01 0.05130 3.65e-02 3.60e-02 8.58e-01 8.60e-01
GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS 19 9.29e-01 9.83e-01 0.05130 -5.09e-02 5.97e-03 7.01e-01 9.64e-01
GOBP MEMBRANE LIPID METABOLIC PROCESS 217 4.07e-01 7.81e-01 0.05130 5.01e-02 1.06e-02 2.03e-01 7.87e-01
Organelle biogenesis and maintenance 277 3.00e-01 7.11e-01 0.05130 -2.49e-02 -4.48e-02 4.75e-01 2.00e-01
GOBP PRO B CELL DIFFERENTIATION 12 9.54e-01 9.88e-01 0.05130 -5.61e-03 5.10e-02 9.73e-01 7.60e-01
GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 44 8.39e-01 9.56e-01 0.05120 -5.12e-02 -2.08e-04 5.56e-01 9.98e-01
GOBP MITOCHONDRION DISTRIBUTION 17 9.37e-01 9.84e-01 0.05120 5.05e-02 -8.24e-03 7.18e-01 9.53e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION 143 6.07e-01 8.76e-01 0.05120 3.91e-02 -3.30e-02 4.20e-01 4.96e-01
PIP3 activates AKT signaling 273 3.27e-01 7.31e-01 0.05110 -5.03e-02 -9.31e-03 1.53e-01 7.91e-01
GOBP ENDOTHELIAL CELL MIGRATION 274 3.17e-01 7.25e-01 0.05110 -4.86e-02 -1.57e-02 1.66e-01 6.55e-01
GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 36 8.68e-01 9.63e-01 0.05100 -5.10e-02 1.91e-03 5.96e-01 9.84e-01
GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY 25 9.02e-01 9.75e-01 0.05100 -9.47e-03 -5.02e-02 9.35e-01 6.64e-01
Recruitment of NuMA to mitotic centrosomes 89 7.34e-01 9.23e-01 0.05100 -3.54e-02 3.68e-02 5.64e-01 5.49e-01
Negative regulation of MAPK pathway 41 8.66e-01 9.62e-01 0.05100 4.20e-02 -2.89e-02 6.42e-01 7.49e-01
GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS 17 9.42e-01 9.86e-01 0.05100 2.84e-02 -4.23e-02 8.40e-01 7.63e-01
GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM 75 7.40e-01 9.25e-01 0.05090 4.97e-03 5.07e-02 9.41e-01 4.48e-01
GOBP REGULATION OF GTPASE ACTIVITY 249 3.69e-01 7.58e-01 0.05090 6.13e-03 5.05e-02 8.68e-01 1.70e-01
GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS 29 8.84e-01 9.69e-01 0.05090 4.71e-02 1.91e-02 6.60e-01 8.59e-01
GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION 305 3.36e-01 7.36e-01 0.05090 -4.75e-02 1.81e-02 1.53e-01 5.87e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS 18 9.39e-01 9.85e-01 0.05080 -4.19e-02 2.89e-02 7.59e-01 8.32e-01
GOCC SEPTIN CYTOSKELETON 14 9.48e-01 9.87e-01 0.05080 3.98e-03 -5.06e-02 9.79e-01 7.43e-01
Rap1 signalling 16 9.38e-01 9.85e-01 0.05080 -5.04e-02 -6.18e-03 7.27e-01 9.66e-01
GOBP POLYSACCHARIDE CATABOLIC PROCESS 27 9.11e-01 9.77e-01 0.05070 -3.46e-02 3.71e-02 7.56e-01 7.38e-01
GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY 691 5.41e-02 3.54e-01 0.05060 3.71e-02 3.45e-02 9.65e-02 1.22e-01
GOMF ATP HYDROLYSIS ACTIVITY 404 2.40e-01 6.55e-01 0.05060 -4.74e-02 1.79e-02 1.02e-01 5.37e-01
GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION 32 8.94e-01 9.72e-01 0.05060 -2.44e-02 4.44e-02 8.11e-01 6.64e-01
GOBP CEREBELLAR CORTEX MORPHOGENESIS 35 8.59e-01 9.60e-01 0.05060 -3.85e-02 -3.28e-02 6.93e-01 7.37e-01
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 55 8.27e-01 9.52e-01 0.05060 2.82e-02 -4.20e-02 7.18e-01 5.90e-01
Asparagine N-linked glycosylation 300 3.21e-01 7.28e-01 0.05060 -5.05e-02 3.02e-03 1.32e-01 9.28e-01
GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 255 3.39e-01 7.39e-01 0.05060 -4.34e-02 -2.60e-02 2.33e-01 4.75e-01
GOBP CARDIAC MUSCLE CONTRACTION 138 5.54e-01 8.54e-01 0.05050 2.83e-02 4.18e-02 5.65e-01 3.96e-01
GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY 45 8.57e-01 9.60e-01 0.05050 -2.98e-02 4.08e-02 7.29e-01 6.36e-01
GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION 16 9.37e-01 9.85e-01 0.05050 9.48e-03 4.96e-02 9.48e-01 7.31e-01
GOBP REGULATION OF LEUKOCYTE PROLIFERATION 256 3.88e-01 7.69e-01 0.05050 4.99e-02 -7.60e-03 1.69e-01 8.34e-01
GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM 571 1.14e-01 4.89e-01 0.05050 -5.05e-02 -1.22e-03 3.92e-02 9.60e-01
GOBP HYALURONAN CATABOLIC PROCESS 16 9.33e-01 9.83e-01 0.05040 -3.45e-02 -3.67e-02 8.11e-01 7.99e-01
GOCC ENDOPEPTIDASE COMPLEX 85 7.48e-01 9.28e-01 0.05040 2.86e-02 -4.15e-02 6.49e-01 5.09e-01
GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY 26 9.04e-01 9.75e-01 0.05030 2.47e-03 5.03e-02 9.83e-01 6.57e-01
Polo-like kinase mediated events 16 9.42e-01 9.86e-01 0.05030 5.00e-02 -5.40e-03 7.29e-01 9.70e-01
GOBP PROTEIN POLYUBIQUITINATION 264 3.48e-01 7.44e-01 0.05030 -4.89e-02 -1.15e-02 1.71e-01 7.47e-01
GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS 186 5.22e-01 8.41e-01 0.05030 1.89e-02 -4.66e-02 6.57e-01 2.73e-01
GOCC NEUROMUSCULAR JUNCTION 72 7.59e-01 9.32e-01 0.05020 -9.92e-05 -5.02e-02 9.99e-01 4.61e-01
ABC transporters in lipid homeostasis 17 9.44e-01 9.87e-01 0.05020 -4.10e-02 2.90e-02 7.70e-01 8.36e-01
GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE 64 8.06e-01 9.48e-01 0.05020 -3.39e-02 3.70e-02 6.39e-01 6.08e-01
Fatty acid metabolism 169 5.12e-01 8.35e-01 0.05020 -4.93e-02 -9.31e-03 2.69e-01 8.35e-01
GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 141 6.23e-01 8.82e-01 0.05010 -3.42e-02 3.67e-02 4.83e-01 4.52e-01
GOBP VESICLE LOCALIZATION 209 4.43e-01 8.01e-01 0.05010 -4.97e-02 -6.32e-03 2.16e-01 8.75e-01
GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION 9 9.64e-01 9.91e-01 0.05010 -4.80e-02 -1.44e-02 8.03e-01 9.40e-01
GOBP REGULATION OF VASCULOGENESIS 16 9.43e-01 9.87e-01 0.05010 -7.89e-03 4.94e-02 9.56e-01 7.32e-01
GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION 18 9.36e-01 9.84e-01 0.05010 -6.20e-03 4.97e-02 9.64e-01 7.15e-01
GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 62 8.12e-01 9.49e-01 0.05010 -3.92e-02 3.12e-02 5.94e-01 6.71e-01
GOMF EPHRIN RECEPTOR BINDING 26 9.10e-01 9.77e-01 0.05000 -4.89e-02 1.04e-02 6.66e-01 9.27e-01
GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 158 5.42e-01 8.50e-01 0.05000 -5.47e-03 -4.97e-02 9.05e-01 2.81e-01
GOBP REGULATION OF OPSIN MEDIATED SIGNALING PATHWAY 9 9.66e-01 9.91e-01 0.05000 4.56e-05 -5.00e-02 1.00e+00 7.95e-01
Resolution of Abasic Sites (AP sites) 38 8.81e-01 9.67e-01 0.04980 -3.80e-02 3.23e-02 6.85e-01 7.30e-01
GOBP HEART PROCESS 251 4.37e-01 7.97e-01 0.04980 -3.73e-02 3.30e-02 3.09e-01 3.68e-01
Sensory processing of sound by inner hair cells of the cochlea 63 8.11e-01 9.49e-01 0.04980 3.94e-02 -3.04e-02 5.88e-01 6.77e-01
GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 119 6.09e-01 8.77e-01 0.04970 -3.76e-02 -3.25e-02 4.78e-01 5.41e-01
GOBP REGULATION OF MEIOTIC CELL CYCLE 68 7.81e-01 9.40e-01 0.04970 4.93e-02 -5.93e-03 4.82e-01 9.33e-01
GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 54 8.34e-01 9.54e-01 0.04960 -2.36e-02 4.37e-02 7.64e-01 5.79e-01
Adipogenesis 105 6.53e-01 8.93e-01 0.04960 -4.50e-02 -2.09e-02 4.25e-01 7.12e-01
GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX 8 9.70e-01 9.92e-01 0.04960 -4.93e-02 -5.81e-03 8.09e-01 9.77e-01
GOMF ARP2 3 COMPLEX BINDING 14 9.44e-01 9.87e-01 0.04960 2.69e-02 4.17e-02 8.62e-01 7.87e-01
GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY 132 5.79e-01 8.64e-01 0.04960 2.89e-02 4.03e-02 5.66e-01 4.24e-01
GOBP PROTEIN AUTOUBIQUITINATION 72 7.64e-01 9.33e-01 0.04950 4.95e-02 1.13e-03 4.68e-01 9.87e-01
GOBP AMIDE METABOLIC PROCESS 435 1.98e-01 6.09e-01 0.04950 4.44e-03 4.93e-02 8.74e-01 7.79e-02
GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY 21 9.28e-01 9.82e-01 0.04950 -4.87e-02 8.65e-03 6.99e-01 9.45e-01
GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE 52 8.42e-01 9.56e-01 0.04950 -2.70e-02 4.15e-02 7.36e-01 6.05e-01
GOBP NON PROTEINOGENIC AMINO ACID METABOLIC PROCESS 71 7.45e-01 9.27e-01 0.04950 -3.62e-02 -3.38e-02 5.98e-01 6.23e-01
GOBP REGULATION OF REGULATED SECRETORY PATHWAY 104 7.09e-01 9.13e-01 0.04950 2.65e-02 -4.18e-02 6.41e-01 4.62e-01
GOBP DNA REPLICATION INITIATION 35 8.70e-01 9.64e-01 0.04940 -1.56e-02 -4.69e-02 8.73e-01 6.31e-01
NOTCH3 Intracellular Domain Regulates Transcription 24 9.11e-01 9.77e-01 0.04930 -4.82e-02 -1.08e-02 6.83e-01 9.27e-01
GOBP CELL ACTIVATION 1077 3.19e-02 2.80e-01 0.04930 2.12e-02 -4.45e-02 2.39e-01 1.36e-02
GOBP RENAL SYSTEM PROCESS 120 6.24e-01 8.82e-01 0.04930 1.54e-02 4.68e-02 7.70e-01 3.76e-01
GOBP RESPONSE TO NITRIC OXIDE 19 9.25e-01 9.81e-01 0.04930 -2.91e-02 -3.98e-02 8.26e-01 7.64e-01
GOCC SYNAPSE ASSOCIATED EXTRACELLULAR MATRIX 12 9.52e-01 9.88e-01 0.04930 4.15e-02 2.66e-02 8.04e-01 8.73e-01
GOBP RESPONSE TO PROTOZOAN 29 9.07e-01 9.76e-01 0.04930 -4.49e-02 2.03e-02 6.75e-01 8.50e-01
GOBP SERTOLI CELL PROLIFERATION 5 9.84e-01 9.95e-01 0.04930 3.39e-02 -3.58e-02 8.96e-01 8.90e-01
GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 54 8.04e-01 9.47e-01 0.04910 -4.22e-02 -2.52e-02 5.92e-01 7.49e-01
GOBP REGULATION OF ANGIOTENSIN LEVELS IN BLOOD 8 9.73e-01 9.93e-01 0.04910 -4.67e-02 1.53e-02 8.19e-01 9.40e-01
GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION 31 9.04e-01 9.76e-01 0.04910 3.85e-02 -3.05e-02 7.11e-01 7.69e-01
GOBP MYELOID LEUKOCYTE MIGRATION 228 4.80e-01 8.21e-01 0.04910 -2.86e-02 3.99e-02 4.58e-01 2.99e-01
GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS 40 8.59e-01 9.60e-01 0.04910 4.84e-02 8.15e-03 5.96e-01 9.29e-01
GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 1015 1.93e-02 2.22e-01 0.04910 -3.88e-02 -3.01e-02 3.67e-02 1.05e-01
GOBP SYMBIONT ENTRY INTO HOST 159 5.55e-01 8.55e-01 0.04910 3.81e-03 4.89e-02 9.34e-01 2.87e-01
GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE 15 9.49e-01 9.88e-01 0.04910 8.64e-03 -4.83e-02 9.54e-01 7.46e-01
Signal Transduction 2475 4.28e-04 1.70e-02 0.04900 -4.85e-02 7.32e-03 8.27e-05 5.53e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS 99 7.22e-01 9.17e-01 0.04900 -4.41e-02 2.14e-02 4.49e-01 7.13e-01
GOBP REGULATION OF MEMBRANE REPOLARIZATION 38 8.85e-01 9.69e-01 0.04900 -3.03e-02 3.84e-02 7.46e-01 6.82e-01
GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY 435 1.84e-01 5.88e-01 0.04900 -4.44e-02 -2.07e-02 1.13e-01 4.59e-01
GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS 14 9.47e-01 9.87e-01 0.04900 -1.37e-02 -4.70e-02 9.29e-01 7.61e-01
GOBP CYTOSKELETON ORGANIZATION 1456 1.25e-02 1.77e-01 0.04900 -3.22e-02 3.68e-02 3.95e-02 1.86e-02
GOBP PHAGOSOME MATURATION 28 9.14e-01 9.78e-01 0.04890 -2.93e-02 3.92e-02 7.88e-01 7.20e-01
GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 27 9.16e-01 9.79e-01 0.04890 2.78e-02 -4.03e-02 8.03e-01 7.17e-01
GOBP RUFFLE ORGANIZATION 56 8.10e-01 9.49e-01 0.04890 7.85e-03 4.83e-02 9.19e-01 5.32e-01
GOBP NEURON REMODELING 15 9.45e-01 9.87e-01 0.04890 7.43e-03 4.83e-02 9.60e-01 7.46e-01
GOCC CEREBELLAR MOSSY FIBER 7 9.77e-01 9.93e-01 0.04890 -2.51e-02 4.20e-02 9.08e-01 8.47e-01
Metabolism of Angiotensinogen to Angiotensins 15 9.52e-01 9.88e-01 0.04890 2.32e-02 -4.30e-02 8.76e-01 7.73e-01
GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY 40 8.63e-01 9.62e-01 0.04870 3.71e-03 4.86e-02 9.68e-01 5.95e-01
GOBP GLUCOSE IMPORT 77 7.37e-01 9.23e-01 0.04870 2.50e-02 4.18e-02 7.05e-01 5.26e-01
GOBP CELLULAR RESPONSE TO LIPID 592 1.05e-01 4.73e-01 0.04870 -4.50e-02 -1.86e-02 6.14e-02 4.39e-01
GOBP COLLATERAL SPROUTING IN ABSENCE OF INJURY 5 9.81e-01 9.94e-01 0.04870 -4.39e-02 -2.10e-02 8.65e-01 9.35e-01
GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS 11 9.61e-01 9.90e-01 0.04870 -1.68e-03 4.86e-02 9.92e-01 7.80e-01
GOCC OUTER MEMBRANE 233 3.97e-01 7.76e-01 0.04870 -3.87e-02 -2.95e-02 3.09e-01 4.37e-01
GOBP GRANULOCYTE ACTIVATION 48 8.50e-01 9.58e-01 0.04860 -1.26e-02 4.70e-02 8.80e-01 5.73e-01
GOBP MAINTENANCE OF PRESYNAPTIC ACTIVE ZONE STRUCTURE 5 9.82e-01 9.94e-01 0.04850 7.11e-03 4.80e-02 9.78e-01 8.52e-01
GOCC INTERCALATED DISC 50 8.34e-01 9.55e-01 0.04850 -4.84e-02 -3.50e-03 5.54e-01 9.66e-01
GOCC TRANS GOLGI NETWORK 251 3.91e-01 7.71e-01 0.04850 -4.68e-02 -1.27e-02 2.02e-01 7.28e-01
GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 177 4.97e-01 8.29e-01 0.04840 -3.26e-02 -3.58e-02 4.54e-01 4.11e-01
GOBP MDA 5 SIGNALING PATHWAY 10 9.65e-01 9.91e-01 0.04840 4.84e-02 -1.52e-03 7.91e-01 9.93e-01
GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY 34 8.93e-01 9.72e-01 0.04840 -1.31e-02 4.66e-02 8.95e-01 6.38e-01
GOMF K48 LINKED DEUBIQUITINASE ACTIVITY 14 9.52e-01 9.88e-01 0.04840 -4.84e-02 1.51e-03 7.54e-01 9.92e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO NUTRIENT LEVELS 12 9.63e-01 9.90e-01 0.04840 3.89e-02 -2.88e-02 8.16e-01 8.63e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 72 7.80e-01 9.39e-01 0.04830 -4.81e-02 4.98e-03 4.81e-01 9.42e-01
GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY 8 9.69e-01 9.91e-01 0.04830 -3.18e-02 -3.64e-02 8.76e-01 8.59e-01
GOBP OLEFINIC COMPOUND METABOLIC PROCESS 156 5.48e-01 8.52e-01 0.04830 4.32e-02 2.16e-02 3.52e-01 6.41e-01
GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY 39 8.61e-01 9.61e-01 0.04830 -1.94e-02 -4.42e-02 8.34e-01 6.33e-01
GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION 22 9.18e-01 9.79e-01 0.04830 4.31e-02 2.17e-02 7.26e-01 8.60e-01
GOBP CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 160 5.65e-01 8.58e-01 0.04830 -3.37e-03 -4.81e-02 9.41e-01 2.93e-01
GOBP REGULATION OF PROTEIN TARGETING 75 7.47e-01 9.28e-01 0.04820 2.39e-02 4.19e-02 7.20e-01 5.30e-01
GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS 44 8.71e-01 9.64e-01 0.04820 -2.94e-02 3.82e-02 7.36e-01 6.61e-01
GOMF PHOSPHATASE ACTIVITY 259 3.92e-01 7.71e-01 0.04820 7.78e-03 4.75e-02 8.29e-01 1.88e-01
GOMF NF KAPPAB BINDING 28 9.05e-01 9.76e-01 0.04820 -4.81e-02 -2.52e-03 6.60e-01 9.82e-01
GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION 29 9.05e-01 9.76e-01 0.04810 4.47e-03 -4.79e-02 9.67e-01 6.55e-01
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY 405 2.29e-01 6.47e-01 0.04810 -4.67e-02 -1.13e-02 1.07e-01 6.96e-01
GOBP REGULATION OF ACTIN FILAMENT LENGTH 148 5.62e-01 8.57e-01 0.04810 -3.38e-02 -3.42e-02 4.78e-01 4.73e-01
GOCC NEURON PROJECTION CYTOPLASM 83 7.33e-01 9.23e-01 0.04800 -4.58e-02 -1.46e-02 4.71e-01 8.18e-01
GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH 557 1.21e-01 4.99e-01 0.04800 -4.05e-02 -2.58e-02 1.02e-01 2.98e-01
GOBP MAINTENANCE OF LENS TRANSPARENCY 7 9.74e-01 9.93e-01 0.04800 4.61e-02 1.32e-02 8.33e-01 9.52e-01
GOCC X CHROMOSOME 11 9.64e-01 9.91e-01 0.04790 -4.64e-02 1.20e-02 7.90e-01 9.45e-01
GOBP NEGATIVE REGULATION OF CELL CELL ADHESION 197 4.82e-01 8.22e-01 0.04790 4.55e-02 1.49e-02 2.70e-01 7.18e-01
GOBP CELLULAR RESPONSE TO RETINOIC ACID 67 7.71e-01 9.36e-01 0.04790 -3.70e-02 -3.04e-02 6.01e-01 6.67e-01
GOBP VENTRICULAR SYSTEM DEVELOPMENT 32 9.03e-01 9.75e-01 0.04790 1.89e-02 -4.40e-02 8.54e-01 6.67e-01
GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS 192 5.33e-01 8.45e-01 0.04780 -4.68e-02 9.57e-03 2.63e-01 8.19e-01
GOMF STEROID BINDING 103 6.84e-01 9.06e-01 0.04780 4.55e-02 1.47e-02 4.25e-01 7.97e-01
GOBP AXONEME ASSEMBLY 96 6.99e-01 9.11e-01 0.04780 4.43e-02 1.80e-02 4.54e-01 7.61e-01
GOBP UROGENITAL SYSTEM DEVELOPMENT 65 7.81e-01 9.40e-01 0.04770 -4.21e-02 -2.25e-02 5.57e-01 7.54e-01
GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 540 1.60e-01 5.57e-01 0.04770 1.39e-03 4.77e-02 9.56e-01 5.81e-02
GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 92 7.03e-01 9.12e-01 0.04770 -3.83e-02 -2.84e-02 5.26e-01 6.37e-01
GOBP MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS 594 1.07e-01 4.75e-01 0.04770 -3.46e-02 -3.28e-02 1.50e-01 1.72e-01
Retinoid metabolism and transport 42 8.55e-01 9.59e-01 0.04760 4.39e-02 1.85e-02 6.23e-01 8.35e-01
MAPK1/MAPK3 signaling 258 3.77e-01 7.64e-01 0.04760 -2.69e-02 -3.92e-02 4.56e-01 2.78e-01
Immune System 1913 4.80e-03 9.68e-02 0.04760 2.76e-02 -3.87e-02 4.54e-02 5.10e-03
GOBP TETRAPYRROLE METABOLIC PROCESS 59 8.09e-01 9.49e-01 0.04750 -1.06e-02 -4.63e-02 8.88e-01 5.38e-01
GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY 23 9.18e-01 9.79e-01 0.04750 1.74e-02 4.42e-02 8.85e-01 7.14e-01
GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS 13 9.58e-01 9.89e-01 0.04750 -5.66e-03 4.71e-02 9.72e-01 7.69e-01
GOBP REGULATION OF WNT PROTEIN SECRETION 5 9.85e-01 9.95e-01 0.04740 4.32e-02 -1.97e-02 8.67e-01 9.39e-01
GOBP WNT PROTEIN SECRETION 5 9.85e-01 9.95e-01 0.04740 4.32e-02 -1.97e-02 8.67e-01 9.39e-01
GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS 115 7.08e-01 9.13e-01 0.04740 -3.27e-02 3.43e-02 5.45e-01 5.25e-01
GOBP CELL CYCLE DNA REPLICATION 43 8.75e-01 9.66e-01 0.04740 -2.04e-02 4.27e-02 8.17e-01 6.28e-01
GOBP VITAMIN METABOLIC PROCESS 112 6.70e-01 9.00e-01 0.04730 -1.13e-02 -4.60e-02 8.36e-01 4.01e-01
GOBP FIBROBLAST APOPTOTIC PROCESS 25 9.25e-01 9.81e-01 0.04730 1.81e-02 -4.37e-02 8.76e-01 7.05e-01
GOCC CLATHRIN COATED VESICLE MEMBRANE 129 6.28e-01 8.85e-01 0.04730 -4.52e-02 -1.39e-02 3.75e-01 7.85e-01
GOBP RESPONSE TO MECHANICAL STIMULUS 216 5.08e-01 8.33e-01 0.04720 -4.52e-02 1.37e-02 2.52e-01 7.28e-01
GOBP REGULATION OF PROTEIN CATABOLIC PROCESS 338 2.84e-01 6.96e-01 0.04720 -3.63e-02 -3.02e-02 2.51e-01 3.40e-01
GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 299 4.10e-01 7.84e-01 0.04720 2.60e-02 -3.94e-02 4.40e-01 2.41e-01
GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH 37 8.95e-01 9.73e-01 0.04720 3.59e-02 -3.06e-02 7.06e-01 7.47e-01
GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS 23 9.25e-01 9.81e-01 0.04710 4.71e-02 1.75e-03 6.96e-01 9.88e-01
GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS 30 9.11e-01 9.77e-01 0.04710 4.44e-02 -1.56e-02 6.74e-01 8.83e-01
GOMF TROPOMYOSIN BINDING 15 9.45e-01 9.87e-01 0.04710 -2.78e-02 -3.80e-02 8.52e-01 7.99e-01
Listeria monocytogenes entry into host cells 19 9.32e-01 9.83e-01 0.04710 -2.16e-02 -4.18e-02 8.71e-01 7.52e-01
GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION 186 5.13e-01 8.36e-01 0.04710 -4.44e-02 -1.57e-02 2.96e-01 7.12e-01
Signaling by Retinoic Acid 39 8.70e-01 9.64e-01 0.04710 -4.51e-02 -1.36e-02 6.26e-01 8.83e-01
GOCC ACTIN FILAMENT 108 7.26e-01 9.19e-01 0.04710 -3.62e-02 3.01e-02 5.16e-01 5.89e-01
GOBP GLOMERULAR MESANGIUM DEVELOPMENT 18 9.39e-01 9.85e-01 0.04710 -4.61e-02 -9.30e-03 7.35e-01 9.46e-01
GOBP MAST CELL CYTOKINE PRODUCTION 6 9.78e-01 9.93e-01 0.04710 -3.92e-02 -2.60e-02 8.68e-01 9.12e-01
GOBP MOLTING CYCLE 115 6.51e-01 8.92e-01 0.04700 2.99e-02 3.63e-02 5.79e-01 5.01e-01
GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY 63 8.23e-01 9.52e-01 0.04700 -4.40e-02 1.67e-02 5.46e-01 8.19e-01
GOBP PROTEIN DEUBIQUITINATION 79 7.61e-01 9.32e-01 0.04700 -4.65e-02 -6.55e-03 4.74e-01 9.20e-01
GOBP ORGANELLE ASSEMBLY 988 3.72e-02 2.96e-01 0.04700 -4.64e-02 -7.74e-03 1.37e-02 6.80e-01
GOBP FATTY ACYL COA METABOLIC PROCESS 37 8.87e-01 9.70e-01 0.04700 6.94e-03 -4.65e-02 9.42e-01 6.25e-01
GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS 259 4.12e-01 7.84e-01 0.04690 -6.88e-03 -4.64e-02 8.49e-01 1.98e-01
GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS 1697 6.56e-03 1.18e-01 0.04690 8.53e-03 -4.62e-02 5.59e-01 1.56e-03
GOBP SPERM FLAGELLUM ASSEMBLY 47 8.48e-01 9.58e-01 0.04690 -4.59e-02 -9.58e-03 5.86e-01 9.10e-01
GOBP LEUKOCYTE CELL CELL ADHESION 407 2.79e-01 6.92e-01 0.04690 9.37e-03 -4.60e-02 7.46e-01 1.12e-01
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release 20 9.28e-01 9.82e-01 0.04690 -3.05e-02 -3.56e-02 8.13e-01 7.83e-01
GOBP MACROMOLECULE CATABOLIC PROCESS 1407 8.22e-03 1.36e-01 0.04690 -4.23e-02 -2.01e-02 7.79e-03 2.06e-01
GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS 63 8.30e-01 9.53e-01 0.04680 3.88e-02 -2.63e-02 5.95e-01 7.18e-01
GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS 38 8.90e-01 9.71e-01 0.04680 -1.74e-02 4.35e-02 8.52e-01 6.43e-01
GOBP NEGATIVE REGULATION OF PHOSPHORYLATION 306 3.26e-01 7.30e-01 0.04680 -3.61e-02 -2.98e-02 2.78e-01 3.69e-01
GOBP SYNAPTIC VESICLE LOCALIZATION 55 8.18e-01 9.51e-01 0.04680 -2.31e-02 -4.07e-02 7.67e-01 6.01e-01
Malate-aspartate shuttle 9 9.67e-01 9.91e-01 0.04680 -3.92e-02 -2.55e-02 8.39e-01 8.94e-01
GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 53 8.27e-01 9.53e-01 0.04680 4.37e-02 1.68e-02 5.82e-01 8.33e-01
Signaling by RAF1 mutants 39 8.68e-01 9.63e-01 0.04680 -4.22e-02 -2.02e-02 6.48e-01 8.27e-01
GOBP NEGATIVE REGULATION OF CELL ACTIVATION 210 5.11e-01 8.35e-01 0.04670 5.38e-03 -4.64e-02 8.93e-01 2.46e-01
GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 56 8.21e-01 9.52e-01 0.04670 -1.28e-02 -4.49e-02 8.69e-01 5.61e-01
GOCC SPINDLE 411 2.35e-01 6.51e-01 0.04670 -4.31e-02 -1.81e-02 1.34e-01 5.29e-01
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 52 8.36e-01 9.55e-01 0.04660 -4.56e-02 -9.45e-03 5.69e-01 9.06e-01
GOMF PHOSPHATASE BINDING 185 5.08e-01 8.34e-01 0.04660 -3.40e-02 -3.19e-02 4.25e-01 4.55e-01
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 59 8.09e-01 9.49e-01 0.04640 -4.13e-02 -2.13e-02 5.83e-01 7.78e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION 157 6.28e-01 8.85e-01 0.04640 4.23e-02 -1.91e-02 3.60e-01 6.79e-01
GOCC NUCLEAR LAMINA 10 9.67e-01 9.91e-01 0.04640 5.10e-03 4.61e-02 9.78e-01 8.01e-01
GOBP LIPID PHOSPHORYLATION 10 9.66e-01 9.91e-01 0.04640 -4.47e-02 -1.26e-02 8.07e-01 9.45e-01
GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY 10 9.66e-01 9.91e-01 0.04640 -4.47e-02 -1.26e-02 8.07e-01 9.45e-01
GOBP REGULATION OF MEMBRANE POTENTIAL 445 2.72e-01 6.85e-01 0.04630 -4.24e-02 1.86e-02 1.25e-01 5.01e-01
RHOF GTPase cycle 40 8.66e-01 9.62e-01 0.04630 -3.98e-02 -2.37e-02 6.63e-01 7.95e-01
GOBP PROTEIN K48 LINKED UBIQUITINATION 98 7.45e-01 9.27e-01 0.04630 -4.35e-02 1.58e-02 4.57e-01 7.87e-01
GOBP POSITIVE REGULATION OF GTPASE ACTIVITY 187 5.87e-01 8.67e-01 0.04630 -3.28e-02 3.26e-02 4.39e-01 4.42e-01
GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY 5 9.86e-01 9.95e-01 0.04630 3.31e-02 -3.23e-02 8.98e-01 9.00e-01
GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY 26 9.13e-01 9.78e-01 0.04620 -4.29e-02 -1.72e-02 7.05e-01 8.80e-01
GOBP REGULATION OF EPITHELIAL CELL MIGRATION 287 4.10e-01 7.83e-01 0.04620 -4.58e-02 6.26e-03 1.82e-01 8.55e-01
GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS 268 4.65e-01 8.14e-01 0.04620 2.59e-02 -3.82e-02 4.65e-01 2.81e-01
GOBP CILIUM ORGANIZATION 421 2.51e-01 6.66e-01 0.04610 -4.57e-02 -6.46e-03 1.08e-01 8.20e-01
Cytosolic tRNA aminoacylation 22 9.26e-01 9.82e-01 0.04610 -1.71e-02 -4.28e-02 8.89e-01 7.28e-01
GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE 46 8.48e-01 9.58e-01 0.04610 -2.72e-02 -3.73e-02 7.50e-01 6.62e-01
GOBP REGULATION OF PROTEOLYSIS 565 1.83e-01 5.87e-01 0.04610 9.12e-03 -4.52e-02 7.11e-01 6.63e-02
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY 192 5.28e-01 8.42e-01 0.04610 -7.92e-03 -4.54e-02 8.50e-01 2.78e-01
GOBP REGULATION OF INFLAMMATORY RESPONSE 410 2.34e-01 6.50e-01 0.04610 3.12e-02 3.39e-02 2.79e-01 2.38e-01
GOMF HEXOSYLTRANSFERASE ACTIVITY 193 5.26e-01 8.42e-01 0.04610 8.03e-03 4.54e-02 8.47e-01 2.77e-01
GOBP CHEMOSENSORY BEHAVIOR 19 9.36e-01 9.84e-01 0.04600 -1.61e-02 -4.31e-02 9.03e-01 7.45e-01
GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE 476 2.27e-01 6.46e-01 0.04600 -4.60e-02 2.38e-03 8.59e-02 9.29e-01
GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY 106 7.40e-01 9.25e-01 0.04600 2.88e-02 -3.59e-02 6.08e-01 5.24e-01
GOBP RESPONSE TO RADIATION 414 2.32e-01 6.50e-01 0.04600 -3.23e-02 -3.28e-02 2.60e-01 2.53e-01
Apoptotic factor-mediated response 18 9.49e-01 9.88e-01 0.04600 4.16e-02 -1.96e-02 7.60e-01 8.86e-01
GOBP T CELL MIGRATION 66 8.22e-01 9.52e-01 0.04600 4.35e-02 -1.50e-02 5.41e-01 8.33e-01
GOMF CARBOXY LYASE ACTIVITY 33 8.94e-01 9.72e-01 0.04600 -1.26e-02 -4.42e-02 9.00e-01 6.60e-01
GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE 155 6.34e-01 8.86e-01 0.04600 -4.28e-02 1.66e-02 3.57e-01 7.21e-01
GOBP CELLULAR OXIDANT DETOXIFICATION 93 7.63e-01 9.33e-01 0.04600 -1.97e-02 4.15e-02 7.42e-01 4.89e-01
GOBP LOCOMOTION 1278 3.10e-02 2.75e-01 0.04590 -4.01e-02 2.25e-02 1.60e-02 1.77e-01
GOBP SKELETAL MUSCLE ADAPTATION 25 9.27e-01 9.82e-01 0.04590 -4.50e-02 9.27e-03 6.97e-01 9.36e-01
GOBP CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS 12 9.60e-01 9.90e-01 0.04590 -4.48e-02 -1.02e-02 7.88e-01 9.51e-01
GOBP EXPORT FROM CELL 881 9.15e-02 4.44e-01 0.04590 -3.33e-02 3.16e-02 9.33e-02 1.12e-01
GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY 14 9.51e-01 9.88e-01 0.04590 -3.64e-02 -2.80e-02 8.14e-01 8.56e-01
GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING 9 9.68e-01 9.91e-01 0.04590 -2.81e-02 -3.62e-02 8.84e-01 8.51e-01
GOBP T CELL DIFFERENTIATION 307 4.26e-01 7.93e-01 0.04580 3.07e-02 -3.40e-02 3.55e-01 3.05e-01
Intraflagellar transport 51 8.35e-01 9.55e-01 0.04580 -3.58e-02 -2.86e-02 6.58e-01 7.24e-01
GOBP POSITIVE REGULATION OF VIRAL PROCESS 62 8.38e-01 9.55e-01 0.04580 2.41e-02 -3.89e-02 7.43e-01 5.96e-01
GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 1767 3.34e-03 7.86e-02 0.04580 -3.96e-02 -2.29e-02 5.68e-03 1.10e-01
GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY 17 9.47e-01 9.87e-01 0.04570 -1.73e-03 -4.57e-02 9.90e-01 7.44e-01
GOBP RESPONSE TO AMINE 50 8.69e-01 9.64e-01 0.04570 -3.22e-02 3.24e-02 6.93e-01 6.92e-01
Signaling by FGFR 87 7.78e-01 9.39e-01 0.04570 -4.17e-02 1.88e-02 5.02e-01 7.62e-01
GOBP EMBRYONIC HEART TUBE MORPHOGENESIS 70 7.81e-01 9.40e-01 0.04570 -3.00e-02 -3.44e-02 6.65e-01 6.18e-01
GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION 10 9.72e-01 9.93e-01 0.04560 -2.78e-02 3.62e-02 8.79e-01 8.43e-01
GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS 9 9.74e-01 9.93e-01 0.04560 -4.30e-02 1.51e-02 8.23e-01 9.37e-01
GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT 34 8.89e-01 9.71e-01 0.04560 2.01e-02 4.09e-02 8.39e-01 6.80e-01
GOBP UTP METABOLIC PROCESS 12 9.59e-01 9.89e-01 0.04560 3.41e-02 3.03e-02 8.38e-01 8.56e-01
Developmental Biology 1331 2.33e-02 2.44e-01 0.04550 9.35e-03 -4.46e-02 5.67e-01 6.33e-03
GOBP REGULATION OF CELL PROJECTION ORGANIZATION 649 1.63e-01 5.63e-01 0.04550 -1.86e-02 4.16e-02 4.19e-01 7.08e-02
GOCC RECEPTOR COMPLEX 387 3.33e-01 7.35e-01 0.04550 -4.21e-02 1.75e-02 1.56e-01 5.56e-01
GOBP PROTEIN MONOUBIQUITINATION 46 8.74e-01 9.65e-01 0.04550 -4.35e-02 1.35e-02 6.10e-01 8.74e-01
GOCC TELOMERASE HOLOENZYME COMPLEX 20 9.44e-01 9.87e-01 0.04550 -4.22e-02 1.69e-02 7.44e-01 8.96e-01
GOBP CALCIUM ION HOMEOSTASIS 318 3.62e-01 7.53e-01 0.04550 -4.51e-02 -5.91e-03 1.67e-01 8.56e-01
GOMF MONOCARBOXYLATE SODIUM SYMPORTER ACTIVITY 13 9.58e-01 9.89e-01 0.04540 9.19e-03 4.45e-02 9.54e-01 7.81e-01
GOBP REGULATION OF HEMOPOIESIS 413 2.89e-01 7.02e-01 0.04540 4.23e-03 -4.52e-02 8.83e-01 1.15e-01
Pregnenolone biosynthesis 12 9.60e-01 9.90e-01 0.04530 1.84e-02 4.14e-02 9.12e-01 8.04e-01
GOMF POLYSACCHARIDE BINDING 21 9.39e-01 9.85e-01 0.04520 -6.36e-03 4.48e-02 9.60e-01 7.22e-01
Signaling by ERBB2 50 8.48e-01 9.58e-01 0.04520 -1.34e-02 -4.32e-02 8.70e-01 5.97e-01
MET promotes cell motility 41 8.93e-01 9.72e-01 0.04520 -3.82e-02 2.42e-02 6.72e-01 7.89e-01
GOBP MITOTIC SPINDLE ORGANIZATION 127 6.53e-01 8.93e-01 0.04510 -1.92e-02 -4.08e-02 7.09e-01 4.27e-01
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 40 8.90e-01 9.71e-01 0.04510 -1.11e-02 4.37e-02 9.04e-01 6.32e-01
GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS 244 4.68e-01 8.14e-01 0.04510 -4.49e-02 -3.54e-03 2.27e-01 9.24e-01
GOBP IN UTERO EMBRYONIC DEVELOPMENT 389 2.69e-01 6.84e-01 0.04500 -2.77e-02 -3.55e-02 3.49e-01 2.29e-01
GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS 239 4.43e-01 8.01e-01 0.04500 -3.17e-02 -3.19e-02 3.98e-01 3.96e-01
GOBP OLIGOSACCHARIDE CATABOLIC PROCESS 15 9.60e-01 9.90e-01 0.04490 -3.88e-02 2.27e-02 7.95e-01 8.79e-01
GOBP AMIDE TRANSPORT 308 4.18e-01 7.87e-01 0.04490 -4.30e-02 1.30e-02 1.94e-01 6.95e-01
GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS 29 9.10e-01 9.77e-01 0.04490 1.19e-02 4.33e-02 9.12e-01 6.87e-01
GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS 208 5.11e-01 8.35e-01 0.04490 -1.27e-02 -4.30e-02 7.51e-01 2.85e-01
GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY 346 3.13e-01 7.22e-01 0.04480 2.91e-02 3.41e-02 3.52e-01 2.76e-01
GOMF PROTEIN SEQUESTERING ACTIVITY 27 9.22e-01 9.80e-01 0.04480 -4.47e-02 1.26e-03 6.87e-01 9.91e-01
GOBP CRANIAL NERVE FORMATION 10 9.67e-01 9.91e-01 0.04470 -2.22e-02 -3.88e-02 9.03e-01 8.32e-01
GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 104 7.55e-01 9.30e-01 0.04470 -3.73e-02 2.47e-02 5.11e-01 6.64e-01
GOBP PROTEIN DEACETYLATION 38 9.03e-01 9.75e-01 0.04470 -2.80e-02 3.48e-02 7.65e-01 7.10e-01
GOMF HYDROPEROXY ICOSATETRAENOATE DEHYDRATASE ACTIVITY 7 9.77e-01 9.93e-01 0.04470 2.98e-02 3.33e-02 8.91e-01 8.79e-01
GOMF N ACETYLGLUCOSAMINE 6 O SULFOTRANSFERASE ACTIVITY 6 9.81e-01 9.94e-01 0.04470 4.36e-02 9.72e-03 8.53e-01 9.67e-01
Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation 51 8.44e-01 9.57e-01 0.04460 -3.92e-02 -2.15e-02 6.29e-01 7.91e-01
GOCC CENTRIOLAR SATELLITE 116 7.34e-01 9.23e-01 0.04460 -3.32e-02 2.98e-02 5.36e-01 5.79e-01
GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION 259 4.77e-01 8.19e-01 0.04460 -4.38e-02 8.46e-03 2.25e-01 8.15e-01
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 33 9.16e-01 9.79e-01 0.04460 -3.49e-02 2.77e-02 7.28e-01 7.83e-01
Metabolism of fat-soluble vitamins 46 8.81e-01 9.67e-01 0.04460 4.10e-02 -1.74e-02 6.30e-01 8.38e-01
Diseases associated with N-glycosylation of proteins 19 9.50e-01 9.88e-01 0.04450 -3.87e-02 2.21e-02 7.70e-01 8.68e-01
GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS 557 1.91e-01 5.98e-01 0.04450 -2.26e-03 -4.45e-02 9.27e-01 7.27e-02
GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY 45 8.78e-01 9.67e-01 0.04450 7.39e-03 -4.39e-02 9.32e-01 6.10e-01
GOMF ESTROGEN 16 ALPHA HYDROXYLASE ACTIVITY 8 9.78e-01 9.93e-01 0.04450 4.15e-02 -1.61e-02 8.39e-01 9.37e-01
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 44 8.78e-01 9.67e-01 0.04450 4.44e-02 -2.67e-03 6.11e-01 9.76e-01
GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 25 9.36e-01 9.84e-01 0.04440 -2.61e-02 3.59e-02 8.21e-01 7.56e-01
Transcriptional Regulation by TP53 347 3.19e-01 7.26e-01 0.04440 -3.10e-02 -3.18e-02 3.21e-01 3.09e-01
GOBP THYMUS DEVELOPMENT 49 8.59e-01 9.60e-01 0.04440 -8.05e-03 -4.36e-02 9.22e-01 5.97e-01
GOBP AMINO ACID SALVAGE 7 9.78e-01 9.93e-01 0.04440 -4.20e-02 -1.43e-02 8.48e-01 9.48e-01
GOBP REGULATION OF MRNA METABOLIC PROCESS 375 3.06e-01 7.16e-01 0.04430 -4.18e-02 -1.47e-02 1.64e-01 6.26e-01
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA 5 9.87e-01 9.95e-01 0.04430 3.77e-02 -2.33e-02 8.84e-01 9.28e-01
GOBP REGULATION OF MONOOXYGENASE ACTIVITY 37 9.06e-01 9.76e-01 0.04430 -3.73e-02 2.39e-02 6.94e-01 8.02e-01
GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND 1609 1.54e-02 1.98e-01 0.04430 -4.26e-02 1.19e-02 4.34e-03 4.26e-01
Transport of small molecules 693 1.07e-01 4.75e-01 0.04430 3.24e-02 3.02e-02 1.46e-01 1.76e-01
GOCC PLASMA MEMBRANE REGION 1223 3.38e-02 2.86e-01 0.04420 -2.91e-03 4.42e-02 8.64e-01 9.36e-03
GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND 861 6.49e-02 3.83e-01 0.04420 -3.60e-02 -2.57e-02 7.31e-02 2.00e-01
GOCC KINESIN COMPLEX 47 8.63e-01 9.61e-01 0.04420 4.27e-02 1.12e-02 6.12e-01 8.94e-01
Defective HLCS causes multiple carboxylase deficiency 7 9.82e-01 9.94e-01 0.04420 -2.19e-02 3.84e-02 9.20e-01 8.60e-01
GOBP REGULATION OF NUCLEAR DIVISION 146 6.76e-01 9.04e-01 0.04410 1.78e-02 -4.04e-02 7.10e-01 4.00e-01
GOCC MEMBRANE PROTEIN COMPLEX 1214 2.59e-02 2.55e-01 0.04410 -4.14e-02 -1.51e-02 1.51e-02 3.74e-01
GOCC EARLY ENDOSOME MEMBRANE 188 5.46e-01 8.51e-01 0.04410 2.10e-02 3.88e-02 6.19e-01 3.59e-01
GOBP CELL VOLUME HOMEOSTASIS 34 9.13e-01 9.78e-01 0.04410 -3.98e-02 1.90e-02 6.88e-01 8.48e-01
GOBP APOPTOTIC PROCESS 1853 3.77e-03 8.47e-02 0.04400 -2.79e-02 -3.41e-02 4.69e-02 1.50e-02
GOBP EMBRYONIC PATTERN SPECIFICATION 69 8.31e-01 9.54e-01 0.04400 -4.03e-02 1.76e-02 5.62e-01 8.01e-01
GOBP REGULATION OF PROTEIN DEPOLYMERIZATION 83 7.62e-01 9.32e-01 0.04400 -2.84e-02 -3.36e-02 6.55e-01 5.97e-01
GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS 25 9.34e-01 9.84e-01 0.04400 -1.35e-02 4.19e-02 9.07e-01 7.17e-01
GOBP CELLULAR RESPONSE TO ZINC ION 23 9.27e-01 9.82e-01 0.04400 3.34e-02 2.86e-02 7.81e-01 8.13e-01
GOMF TRANSPORTER ACTIVITY 1173 2.63e-02 2.57e-01 0.04400 3.48e-02 2.69e-02 4.47e-02 1.21e-01
GOMF LYSOPHOSPHATIDIC ACID BINDING 7 9.79e-01 9.94e-01 0.04390 5.73e-03 4.36e-02 9.79e-01 8.42e-01
GOMF PROTEIN HOMODIMERIZATION ACTIVITY 684 1.42e-01 5.33e-01 0.04390 -4.39e-02 -8.85e-04 5.03e-02 9.69e-01
GOMF ORGANIC ACID BINDING 202 5.93e-01 8.71e-01 0.04390 -2.48e-02 3.62e-02 5.43e-01 3.75e-01
GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION 18 9.54e-01 9.88e-01 0.04390 2.14e-02 -3.83e-02 8.75e-01 7.78e-01
GOBP REGULATION OF PROTEIN POLYUBIQUITINATION 26 9.20e-01 9.80e-01 0.04380 -3.90e-02 -2.01e-02 7.31e-01 8.59e-01
GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT 45 8.76e-01 9.66e-01 0.04380 -4.37e-02 -1.65e-03 6.12e-01 9.85e-01
GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE 9 9.72e-01 9.93e-01 0.04370 -1.32e-02 -4.17e-02 9.45e-01 8.29e-01
GOBP ICOSANOID METABOLIC PROCESS 117 7.00e-01 9.12e-01 0.04370 4.24e-02 1.05e-02 4.28e-01 8.44e-01
GOBP CHEMICAL HOMEOSTASIS 1016 8.09e-02 4.21e-01 0.04360 -3.75e-02 2.23e-02 4.31e-02 2.30e-01
GOCC GOLGI APPARATUS 1550 2.54e-02 2.54e-01 0.04350 -2.77e-02 3.36e-02 6.87e-02 2.72e-02
GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE 69 8.19e-01 9.52e-01 0.04350 -1.43e-03 -4.35e-02 9.84e-01 5.32e-01
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY 77 7.86e-01 9.41e-01 0.04340 -1.99e-02 -3.86e-02 7.63e-01 5.58e-01
GOBP FOLIC ACID METABOLIC PROCESS 14 9.61e-01 9.90e-01 0.04340 1.70e-03 -4.34e-02 9.91e-01 7.79e-01
Phosphorylation of the APC/C 20 9.51e-01 9.88e-01 0.04330 2.75e-02 -3.35e-02 8.31e-01 7.96e-01
GOCC PERINUCLEOLAR COMPARTMENT 5 9.86e-01 9.95e-01 0.04330 -4.28e-02 7.05e-03 8.69e-01 9.78e-01
MHC class II antigen presentation 121 7.37e-01 9.23e-01 0.04330 -3.64e-02 2.34e-02 4.90e-01 6.57e-01
GOBP REGULATORY NCRNA MEDIATED HETEROCHROMATIN FORMATION 19 9.47e-01 9.87e-01 0.04320 -1.03e-04 4.32e-02 9.99e-01 7.44e-01
GOBP ORGANELLE DISASSEMBLY 175 5.93e-01 8.71e-01 0.04320 -4.18e-02 -1.10e-02 3.40e-01 8.02e-01
GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY 802 8.75e-02 4.37e-01 0.04320 -2.51e-02 -3.51e-02 2.26e-01 9.09e-02
Cargo trafficking to the periciliary membrane 49 8.71e-01 9.64e-01 0.04320 1.27e-03 -4.31e-02 9.88e-01 6.01e-01
Abacavir ADME 8 9.76e-01 9.93e-01 0.04310 -3.82e-02 -2.00e-02 8.52e-01 9.22e-01
GOBP LATERAL VENTRICLE DEVELOPMENT 12 9.67e-01 9.91e-01 0.04310 1.43e-03 -4.31e-02 9.93e-01 7.96e-01
GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH 15 9.55e-01 9.88e-01 0.04310 -1.86e-02 -3.89e-02 9.01e-01 7.94e-01
GOBP RESPONSE TO LIPID 896 6.67e-02 3.90e-01 0.04310 -3.21e-02 -2.87e-02 1.03e-01 1.45e-01
GOMF FERROUS IRON BINDING 24 9.42e-01 9.86e-01 0.04310 2.93e-02 -3.15e-02 8.04e-01 7.89e-01
GOMF MOLECULAR TRANSDUCER ACTIVITY 1364 2.59e-02 2.55e-01 0.04300 4.30e-02 2.64e-03 7.80e-03 8.70e-01
GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS 49 8.75e-01 9.66e-01 0.04300 -4.91e-03 4.27e-02 9.53e-01 6.05e-01
GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 63 8.32e-01 9.54e-01 0.04300 4.21e-02 8.38e-03 5.63e-01 9.08e-01
GOBP RESPONSE TO IMMOBILIZATION STRESS 25 9.30e-01 9.83e-01 0.04300 -7.98e-03 -4.22e-02 9.45e-01 7.15e-01
GOCC MCM COMPLEX 11 9.66e-01 9.91e-01 0.04290 3.57e-02 2.38e-02 8.38e-01 8.91e-01
NPAS4 regulates expression of target genes 20 9.42e-01 9.86e-01 0.04290 -4.05e-02 -1.41e-02 7.54e-01 9.13e-01
GOCC SPERM HEAD 17 9.54e-01 9.88e-01 0.04290 -1.34e-05 4.29e-02 1.00e+00 7.59e-01
GOBP REGULATION OF ENDOSOME SIZE 13 9.68e-01 9.91e-01 0.04270 -1.93e-02 3.81e-02 9.04e-01 8.12e-01
GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 685 1.28e-01 5.10e-01 0.04270 -3.23e-02 -2.80e-02 1.49e-01 2.12e-01
GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 368 3.41e-01 7.40e-01 0.04270 -1.35e-02 -4.05e-02 6.56e-01 1.82e-01
Signaling by NODAL 20 9.47e-01 9.87e-01 0.04270 -4.27e-03 4.25e-02 9.74e-01 7.42e-01
GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION 1104 3.96e-02 3.06e-01 0.04270 -3.53e-02 -2.41e-02 4.78e-02 1.77e-01
GOBP REGULATION OF JNK CASCADE 134 6.67e-01 8.99e-01 0.04270 -1.94e-02 -3.80e-02 6.99e-01 4.47e-01
GOBP REGULATION OF LOCOMOTION 1106 7.18e-02 4.03e-01 0.04270 -3.82e-02 1.91e-02 3.22e-02 2.84e-01
GOBP RESPONSE TO CAMP 83 8.11e-01 9.49e-01 0.04260 -3.95e-02 1.61e-02 5.34e-01 8.00e-01
GOBP INFLAMMATORY RESPONSE 856 1.18e-01 4.94e-01 0.04260 -1.09e-02 4.12e-02 5.88e-01 4.09e-02
GOCC CLATHRIN COMPLEX 8 9.81e-01 9.94e-01 0.04250 2.63e-02 -3.35e-02 8.98e-01 8.70e-01
GOBP POSITIVE REGULATION OF PEPTIDE SECRETION 112 7.48e-01 9.28e-01 0.04250 9.65e-03 -4.14e-02 8.60e-01 4.49e-01
GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS 251 5.48e-01 8.52e-01 0.04250 2.77e-02 -3.22e-02 4.49e-01 3.80e-01
GOMF PROTEIN PHOSPHATASE BINDING 140 6.65e-01 8.98e-01 0.04240 -1.41e-02 -4.00e-02 7.73e-01 4.14e-01
GOBP IMMUNOLOGICAL MEMORY PROCESS 19 9.45e-01 9.87e-01 0.04240 3.73e-02 2.01e-02 7.78e-01 8.79e-01
GOBP REGULATION OF CELL POPULATION PROLIFERATION 1690 9.77e-03 1.51e-01 0.04240 -3.89e-02 -1.69e-02 7.86e-03 2.47e-01
GOBP DETECTION OF BACTERIUM 16 9.56e-01 9.88e-01 0.04240 4.18e-02 7.08e-03 7.72e-01 9.61e-01
GOBP REGULATION OF COPII VESICLE COATING 5 9.85e-01 9.95e-01 0.04240 -2.06e-02 -3.70e-02 9.36e-01 8.86e-01
GOBP CALCIUM ION TRANSPORT 420 3.34e-01 7.35e-01 0.04230 -4.21e-02 4.32e-03 1.39e-01 8.79e-01
GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION 153 6.49e-01 8.91e-01 0.04230 -4.15e-02 -8.35e-03 3.76e-01 8.59e-01
GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 76 8.25e-01 9.52e-01 0.04230 1.26e-02 -4.04e-02 8.50e-01 5.42e-01
GOBP RIBONUCLEOSIDE CATABOLIC PROCESS 20 9.42e-01 9.86e-01 0.04230 -2.39e-02 -3.49e-02 8.53e-01 7.87e-01
GOBP L SERINE METABOLIC PROCESS 11 9.73e-01 9.93e-01 0.04220 -3.82e-02 1.79e-02 8.26e-01 9.18e-01
Fcgamma receptor (FCGR) dependent phagocytosis 83 7.89e-01 9.42e-01 0.04220 -4.08e-02 -1.08e-02 5.20e-01 8.65e-01
Negative regulation of MET activity 20 9.49e-01 9.88e-01 0.04220 4.29e-03 -4.19e-02 9.74e-01 7.45e-01
GOBP ACTIN FILAMENT SEVERING 16 9.53e-01 9.88e-01 0.04220 2.20e-02 3.59e-02 8.79e-01 8.03e-01
GOBP REGULATION OF MICROTUBULE BINDING 7 9.80e-01 9.94e-01 0.04210 -4.12e-02 -8.86e-03 8.50e-01 9.68e-01
GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY 265 4.85e-01 8.23e-01 0.04210 4.21e-03 4.19e-02 9.06e-01 2.40e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE 256 5.19e-01 8.39e-01 0.04210 -4.15e-02 6.65e-03 2.52e-01 8.55e-01
GOBP REGULATION OF SPINDLE ORGANIZATION 45 8.98e-01 9.73e-01 0.04200 2.14e-02 -3.62e-02 8.04e-01 6.75e-01
GOMF PROTEIN DOMAIN SPECIFIC BINDING 622 1.89e-01 5.96e-01 0.04200 -4.17e-02 -4.68e-03 7.55e-02 8.42e-01
GOBP MAPK CASCADE 736 1.32e-01 5.18e-01 0.04200 -4.03e-02 -1.18e-02 6.26e-02 5.87e-01
GOBP POSITIVE REGULATION OF DNA REPLICATION 42 8.85e-01 9.69e-01 0.04200 -3.84e-02 -1.69e-02 6.66e-01 8.50e-01
GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY 239 4.95e-01 8.28e-01 0.04200 -2.46e-02 -3.40e-02 5.13e-01 3.65e-01
GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE 20 9.53e-01 9.88e-01 0.04200 -2.30e-02 3.51e-02 8.58e-01 7.86e-01
GOCC MICOS COMPLEX 7 9.82e-01 9.94e-01 0.04190 -7.76e-04 4.19e-02 9.97e-01 8.48e-01
GOCC JUNCTIONAL SARCOPLASMIC RETICULUM MEMBRANE 9 9.77e-01 9.93e-01 0.04190 5.33e-03 -4.16e-02 9.78e-01 8.29e-01
GOBP IRON ION TRANSPORT 52 8.71e-01 9.64e-01 0.04180 2.04e-04 4.18e-02 9.98e-01 6.02e-01
GOCC SPERM CONNECTING PIECE 11 9.69e-01 9.92e-01 0.04180 3.98e-02 1.25e-02 8.19e-01 9.43e-01
GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION 976 7.71e-02 4.14e-01 0.04180 6.59e-03 4.12e-02 7.28e-01 2.92e-02
GOBP TISSUE HOMEOSTASIS 254 5.12e-01 8.35e-01 0.04170 4.17e-02 1.24e-03 2.52e-01 9.73e-01
GOCC PROTEIN KINASE COMPLEX 137 7.04e-01 9.13e-01 0.04170 4.86e-03 -4.14e-02 9.22e-01 4.02e-01
GOBP INTRACELLULAR IRON ION HOMEOSTASIS 66 8.31e-01 9.54e-01 0.04170 -1.17e-02 -4.01e-02 8.70e-01 5.74e-01
GOBP REGULATION OF PROTEIN OLIGOMERIZATION 5 9.88e-01 9.96e-01 0.04170 -1.85e-02 3.74e-02 9.43e-01 8.85e-01
GOCC GTPASE COMPLEX 38 9.04e-01 9.76e-01 0.04170 1.06e-03 4.17e-02 9.91e-01 6.57e-01
GOBP REGULATION OF EXOCYTOSIS 159 6.70e-01 9.00e-01 0.04170 4.11e-02 -7.21e-03 3.72e-01 8.75e-01
GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION 744 1.21e-01 4.98e-01 0.04160 -3.23e-02 -2.63e-02 1.34e-01 2.21e-01
GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS 44 8.84e-01 9.69e-01 0.04160 4.01e-02 1.14e-02 6.46e-01 8.96e-01
GOMF GATED CHANNEL ACTIVITY 307 4.11e-01 7.84e-01 0.04160 2.60e-02 3.25e-02 4.33e-01 3.27e-01
GOMF TRANSLATION REGULATOR ACTIVITY 380 3.34e-01 7.35e-01 0.04160 2.66e-02 3.20e-02 3.73e-01 2.84e-01
GOBP UREA CYCLE 10 9.76e-01 9.93e-01 0.04150 -3.94e-02 1.30e-02 8.29e-01 9.43e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION 9 9.78e-01 9.93e-01 0.04150 -3.95e-02 1.29e-02 8.38e-01 9.47e-01
GOBP NEUROENDOCRINE CELL DIFFERENTIATION 16 9.54e-01 9.88e-01 0.04150 -3.33e-02 -2.49e-02 8.18e-01 8.63e-01
GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 93 8.00e-01 9.46e-01 0.04150 -1.52e-02 3.86e-02 8.00e-01 5.20e-01
GOBP CELLULAR RESPONSE TO OXYGEN RADICAL 22 9.38e-01 9.85e-01 0.04150 -2.63e-02 -3.21e-02 8.31e-01 7.94e-01
GOMF ALCOHOL BINDING 88 8.17e-01 9.51e-01 0.04150 -3.06e-02 2.79e-02 6.19e-01 6.51e-01
GOBP MYOBLAST FUSION 46 8.99e-01 9.74e-01 0.04150 -2.93e-02 2.93e-02 7.31e-01 7.31e-01
GOBP REGULATION OF GERM CELL PROLIFERATION 7 9.82e-01 9.94e-01 0.04150 4.14e-02 -1.75e-03 8.49e-01 9.94e-01
GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY 430 2.99e-01 7.10e-01 0.04140 -3.66e-02 -1.94e-02 1.93e-01 4.90e-01
GOBP NUCLEOBASE METABOLIC PROCESS 37 8.98e-01 9.73e-01 0.04140 3.24e-02 2.58e-02 7.33e-01 7.86e-01
Mitochondrial calcium ion transport 21 9.44e-01 9.87e-01 0.04140 4.04e-02 9.20e-03 7.49e-01 9.42e-01
GOBP RESPONSE TO REDOX STATE 14 9.61e-01 9.90e-01 0.04140 -2.07e-02 -3.58e-02 8.93e-01 8.17e-01
GOBP STRIATED MUSCLE CONTRACTION 182 5.94e-01 8.71e-01 0.04130 3.37e-02 2.39e-02 4.33e-01 5.78e-01
TP53 Regulates Transcription of Cell Death Genes 43 9.03e-01 9.75e-01 0.04130 -1.67e-02 3.78e-02 8.50e-01 6.68e-01
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE 20 9.47e-01 9.87e-01 0.04130 -4.00e-02 -1.01e-02 7.57e-01 9.38e-01
GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS 21 9.44e-01 9.87e-01 0.04130 -1.03e-02 -4.00e-02 9.35e-01 7.51e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II 34 9.25e-01 9.81e-01 0.04130 2.71e-02 -3.11e-02 7.85e-01 7.54e-01
GOBP CLEAVAGE FURROW FORMATION 7 9.81e-01 9.94e-01 0.04120 -1.14e-02 -3.96e-02 9.58e-01 8.56e-01
GOBP MOTILE CILIUM ASSEMBLY 70 8.53e-01 9.59e-01 0.04120 -3.14e-02 2.68e-02 6.50e-01 6.99e-01
GOBP RESPONSE TO CATECHOLAMINE 59 8.73e-01 9.65e-01 0.04110 -3.54e-02 2.10e-02 6.38e-01 7.81e-01
GOBP REGULATION OF COMPLEMENT ACTIVATION 22 9.39e-01 9.85e-01 0.04110 2.89e-02 2.92e-02 8.14e-01 8.12e-01
GOMF G PROTEIN COUPLED RECEPTOR BINDING 274 5.09e-01 8.34e-01 0.04110 -4.76e-03 4.08e-02 8.92e-01 2.45e-01
GOMF ANDROSTAN 3 ALPHA 17 BETA DIOL DEHYDROGENASE ACTIVITY 8 9.77e-01 9.93e-01 0.04110 2.84e-02 2.97e-02 8.89e-01 8.84e-01
Death Receptor Signaling 144 6.68e-01 8.99e-01 0.04110 3.58e-02 2.01e-02 4.58e-01 6.77e-01
GOCC NEURON TO NEURON SYNAPSE 349 4.19e-01 7.87e-01 0.04110 -4.10e-02 2.06e-03 1.88e-01 9.47e-01
GOMF C ACYLTRANSFERASE ACTIVITY 20 9.48e-01 9.88e-01 0.04100 4.04e-02 7.12e-03 7.54e-01 9.56e-01
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT 128 7.15e-01 9.15e-01 0.04100 -4.05e-02 -6.15e-03 4.29e-01 9.04e-01
GOBP JNK CASCADE 163 6.34e-01 8.86e-01 0.04090 -2.15e-02 -3.48e-02 6.36e-01 4.43e-01
GOBP SPECIFICATION OF SYMMETRY 138 7.16e-01 9.15e-01 0.04090 -4.02e-02 7.67e-03 4.15e-01 8.76e-01
GOBP CELLULAR PIGMENTATION 60 8.63e-01 9.61e-01 0.04090 5.01e-03 -4.06e-02 9.47e-01 5.87e-01
GOBP CHONDROCYTE DEVELOPMENT 32 9.28e-01 9.82e-01 0.04090 -3.79e-02 1.54e-02 7.11e-01 8.80e-01
GOBP PEPTIDOGLYCAN METABOLIC PROCESS 6 9.84e-01 9.95e-01 0.04080 7.25e-03 4.02e-02 9.75e-01 8.65e-01
RAF/MAP kinase cascade 252 5.00e-01 8.30e-01 0.04080 -1.92e-02 -3.60e-02 5.99e-01 3.25e-01
GOBP REGULATION OF KINASE ACTIVITY 503 2.53e-01 6.69e-01 0.04080 -2.08e-02 -3.51e-02 4.24e-01 1.78e-01
GOMF CHEMOKINE BINDING 31 9.25e-01 9.81e-01 0.04080 4.08e-02 -1.90e-04 6.94e-01 9.99e-01
GOBP REGULATION OF EXIT FROM MITOSIS 18 9.57e-01 9.89e-01 0.04080 4.01e-02 -7.25e-03 7.68e-01 9.58e-01
GOMF TRANSMEMBRANE TRANSPORTER BINDING 128 7.53e-01 9.30e-01 0.04070 -2.58e-02 3.15e-02 6.14e-01 5.38e-01
GOBP RESPONSE TO COLD 42 8.97e-01 9.73e-01 0.04050 -7.62e-03 -3.97e-02 9.32e-01 6.56e-01
GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION 24 9.49e-01 9.88e-01 0.04040 -2.60e-02 3.10e-02 8.26e-01 7.93e-01
GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY 28 9.35e-01 9.84e-01 0.04040 -4.00e-02 5.58e-03 7.14e-01 9.59e-01
GOBP CELL CELL ADHESION 937 8.68e-02 4.36e-01 0.04040 -3.58e-02 -1.88e-02 6.33e-02 3.30e-01
GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION 39 9.03e-01 9.75e-01 0.04040 9.35e-03 3.93e-02 9.20e-01 6.71e-01
GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION 88 8.14e-01 9.50e-01 0.04040 9.03e-03 -3.94e-02 8.84e-01 5.23e-01
GOBP CELLULAR CATABOLIC PROCESS 1087 1.04e-01 4.70e-01 0.04040 -2.68e-02 3.02e-02 1.35e-01 9.32e-02
GOBP CELL MOTILITY 1764 2.29e-02 2.43e-01 0.04040 -3.89e-02 1.10e-02 6.71e-03 4.45e-01
GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 83 8.27e-01 9.52e-01 0.04030 1.22e-02 -3.84e-02 8.47e-01 5.45e-01
GOBP POSITIVE REGULATION OF CELL ADHESION 473 2.88e-01 7.01e-01 0.04030 -1.68e-02 -3.66e-02 5.30e-01 1.73e-01
GOCC ESCRT COMPLEX 29 9.39e-01 9.85e-01 0.04030 -2.63e-02 3.05e-02 8.06e-01 7.76e-01
GOBP REGULATION OF ATP DEPENDENT ACTIVITY 60 8.49e-01 9.58e-01 0.04030 -2.18e-02 -3.38e-02 7.70e-01 6.51e-01
GOBP CELL PROJECTION ASSEMBLY 597 2.50e-01 6.65e-01 0.04020 -3.99e-02 5.01e-03 9.59e-02 8.34e-01
GOBP REGULATION OF ERBB SIGNALING PATHWAY 72 8.40e-01 9.56e-01 0.04020 1.95e-03 -4.01e-02 9.77e-01 5.56e-01
RNA Polymerase II Pre-transcription Events 77 8.14e-01 9.50e-01 0.04020 -1.71e-02 -3.64e-02 7.95e-01 5.81e-01
GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS 149 6.83e-01 9.06e-01 0.04020 3.93e-02 8.26e-03 4.07e-01 8.62e-01
GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION 29 9.25e-01 9.81e-01 0.04010 -1.80e-02 -3.59e-02 8.66e-01 7.38e-01
GOBP EMBRYO IMPLANTATION 58 8.66e-01 9.62e-01 0.04010 4.01e-02 2.18e-03 5.98e-01 9.77e-01
GOBP DNA DEAMINATION 13 9.66e-01 9.91e-01 0.04010 -3.43e-02 -2.08e-02 8.31e-01 8.97e-01
GOBP REGULATION OF PROTEIN SECRETION 261 5.72e-01 8.61e-01 0.04010 -2.34e-02 3.25e-02 5.16e-01 3.66e-01
GOBP CGMP CATABOLIC PROCESS 5 9.89e-01 9.97e-01 0.04000 -2.80e-02 2.86e-02 9.14e-01 9.12e-01
GOBP REGULATION OF PROTEIN MATURATION 65 8.66e-01 9.62e-01 0.04000 3.68e-02 -1.57e-02 6.08e-01 8.27e-01
GOCC LOW DENSITY LIPOPROTEIN PARTICLE 14 9.69e-01 9.91e-01 0.03990 -1.29e-02 3.78e-02 9.34e-01 8.07e-01
GOCC TIGHT JUNCTION 121 7.29e-01 9.21e-01 0.03990 3.65e-02 1.61e-02 4.88e-01 7.60e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN 171 6.33e-01 8.86e-01 0.03990 2.99e-02 2.64e-02 5.01e-01 5.51e-01
GOBP POSITIVE REGULATION OF TRANSPORT 806 1.45e-01 5.38e-01 0.03990 -3.95e-02 -4.98e-03 5.64e-02 8.10e-01
GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS 190 6.05e-01 8.76e-01 0.03980 3.36e-02 2.14e-02 4.24e-01 6.11e-01
GOMF LIPID BINDING 826 1.60e-01 5.57e-01 0.03980 -7.43e-03 3.91e-02 7.17e-01 5.61e-02
GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR 5 9.87e-01 9.96e-01 0.03980 -8.39e-03 -3.89e-02 9.74e-01 8.80e-01
GOBP TOOTH MINERALIZATION 30 9.23e-01 9.81e-01 0.03980 -3.36e-02 -2.12e-02 7.50e-01 8.41e-01
GOBP MICROTUBULE BASED PROCESS 909 9.81e-02 4.58e-01 0.03970 -3.24e-02 -2.30e-02 9.81e-02 2.39e-01
GOBP GLYCEROLIPID METABOLIC PROCESS 381 4.15e-01 7.85e-01 0.03970 2.96e-03 -3.96e-02 9.21e-01 1.85e-01
GOMF HORMONE ACTIVITY 122 7.73e-01 9.36e-01 0.03970 -3.18e-02 2.38e-02 5.45e-01 6.50e-01
GOBP REGULATION OF CATALYTIC ACTIVITY 1302 4.38e-02 3.18e-01 0.03970 -1.21e-02 -3.78e-02 4.65e-01 2.20e-02
GOBP EPIGENETIC PROGRAMMING OF GENE EXPRESSION 30 9.30e-01 9.83e-01 0.03970 -3.96e-02 -1.14e-03 7.07e-01 9.91e-01
GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS 71 8.54e-01 9.59e-01 0.03960 -3.79e-02 1.16e-02 5.81e-01 8.66e-01
GOBP POSITIVE REGULATION OF HORMONE SECRETION 142 6.87e-01 9.07e-01 0.03960 -3.10e-02 -2.46e-02 5.23e-01 6.12e-01
Metabolism of nucleotides 92 8.17e-01 9.51e-01 0.03960 3.70e-02 -1.40e-02 5.39e-01 8.16e-01
GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 22 9.49e-01 9.88e-01 0.03950 3.95e-02 9.30e-04 7.48e-01 9.94e-01
GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE 6 9.86e-01 9.95e-01 0.03950 -3.54e-03 -3.93e-02 9.88e-01 8.67e-01
GOBP RESPONSE TO XENOBIOTIC STIMULUS 435 3.99e-01 7.77e-01 0.03950 -1.73e-02 3.55e-02 5.36e-01 2.04e-01
GOMF CHLORIDE CHANNEL ACTIVITY 74 8.57e-01 9.60e-01 0.03940 -2.37e-02 3.15e-02 7.25e-01 6.39e-01
GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER 15 9.62e-01 9.90e-01 0.03940 3.53e-02 1.76e-02 8.13e-01 9.06e-01
GOCC VESICLE MEMBRANE 1199 9.21e-02 4.44e-01 0.03940 -2.21e-02 3.26e-02 1.98e-01 5.70e-02
GOBP NEUTROPHIL MIGRATION 100 8.02e-01 9.46e-01 0.03940 -1.02e-02 3.80e-02 8.60e-01 5.11e-01
Caspase activation via Dependence Receptors in the absence of ligand 9 9.79e-01 9.94e-01 0.03940 3.93e-02 1.76e-03 8.38e-01 9.93e-01
GOMF MISMATCHED DNA BINDING 14 9.71e-01 9.92e-01 0.03930 2.55e-02 -2.99e-02 8.69e-01 8.46e-01
GOBP MAINTENANCE OF LOCATION IN CELL 220 5.98e-01 8.73e-01 0.03930 -3.93e-02 -4.12e-04 3.15e-01 9.92e-01
GOBP PROTON TRANSMEMBRANE TRANSPORT 143 7.30e-01 9.21e-01 0.03930 9.28e-03 -3.82e-02 8.48e-01 4.31e-01
GOBP PORE COMPLEX ASSEMBLY 19 9.52e-01 9.88e-01 0.03920 -3.03e-02 -2.49e-02 8.19e-01 8.51e-01
GOBP MITOPHAGY 63 8.77e-01 9.67e-01 0.03920 -3.21e-02 2.25e-02 6.59e-01 7.58e-01
GOBP MICROTUBULE BASED MOVEMENT 417 3.79e-01 7.64e-01 0.03920 -3.91e-02 -2.67e-03 1.71e-01 9.25e-01
GOBP REGULATION OF TRANSLATION 428 3.71e-01 7.59e-01 0.03910 -2.73e-03 -3.90e-02 9.23e-01 1.66e-01
GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE 30 9.40e-01 9.86e-01 0.03910 2.78e-02 -2.75e-02 7.92e-01 7.94e-01
GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION 15 9.64e-01 9.91e-01 0.03910 9.30e-03 3.79e-02 9.50e-01 7.99e-01
GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT 24 9.46e-01 9.87e-01 0.03900 -5.48e-04 -3.90e-02 9.96e-01 7.41e-01
GOCC VACUOLAR LUMEN 167 6.52e-01 8.93e-01 0.03900 2.38e-02 3.09e-02 5.96e-01 4.90e-01
GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 63 8.50e-01 9.58e-01 0.03900 2.87e-02 2.64e-02 6.94e-01 7.17e-01
GOMF NAD BINDING 55 8.69e-01 9.64e-01 0.03900 -2.06e-02 -3.31e-02 7.92e-01 6.71e-01
GOBP REGULATION OF PROTEIN MODIFICATION PROCESS 1175 6.10e-02 3.73e-01 0.03890 -3.46e-02 -1.76e-02 4.55e-02 3.09e-01
GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 76 8.26e-01 9.52e-01 0.03890 -3.40e-02 -1.87e-02 6.08e-01 7.78e-01
GOBP GENOMIC IMPRINTING 17 9.58e-01 9.89e-01 0.03880 -1.77e-02 -3.45e-02 8.99e-01 8.05e-01
GOBP POSITIVE REGULATION OF CHEMOTAXIS 137 7.50e-01 9.29e-01 0.03880 1.36e-02 -3.63e-02 7.84e-01 4.63e-01
GOBP REGULATION OF WOUND HEALING 134 7.21e-01 9.17e-01 0.03870 1.34e-02 3.63e-02 7.89e-01 4.68e-01
GOBP VISUAL BEHAVIOR 56 8.94e-01 9.72e-01 0.03870 -2.84e-02 2.63e-02 7.13e-01 7.34e-01
Rab regulation of trafficking 110 7.96e-01 9.44e-01 0.03870 -1.47e-02 3.58e-02 7.90e-01 5.17e-01
GOCC ORGANELLE MEMBRANE CONTACT SITE 46 8.97e-01 9.73e-01 0.03870 6.18e-03 3.82e-02 9.42e-01 6.54e-01
GOCC NUCLEAR INNER MEMBRANE 54 8.81e-01 9.67e-01 0.03870 -3.82e-02 -6.02e-03 6.27e-01 9.39e-01
GOBP MONONUCLEAR CELL DIFFERENTIATION 507 3.39e-01 7.39e-01 0.03860 3.82e-02 -5.87e-03 1.41e-01 8.21e-01
GOBP NEURAL CREST FORMATION 15 9.70e-01 9.92e-01 0.03860 -1.61e-02 3.51e-02 9.14e-01 8.14e-01
Serine biosynthesis 9 9.81e-01 9.94e-01 0.03850 3.80e-02 -6.46e-03 8.44e-01 9.73e-01
Golgi Cisternae Pericentriolar Stack Reorganization 14 9.65e-01 9.91e-01 0.03850 2.72e-02 2.73e-02 8.60e-01 8.60e-01
Glycerophospholipid biosynthesis 123 7.38e-01 9.24e-01 0.03850 3.32e-02 1.94e-02 5.24e-01 7.10e-01
GOBP LIPOPROTEIN LOCALIZATION 24 9.44e-01 9.87e-01 0.03840 1.05e-02 3.70e-02 9.29e-01 7.54e-01
GOBP MALATE METABOLIC PROCESS 9 9.81e-01 9.94e-01 0.03840 3.82e-02 -4.59e-03 8.43e-01 9.81e-01
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT 10 9.76e-01 9.93e-01 0.03840 1.92e-02 3.33e-02 9.16e-01 8.55e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION 144 7.21e-01 9.17e-01 0.03840 3.83e-02 3.18e-03 4.28e-01 9.48e-01
GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS 965 1.25e-01 5.06e-01 0.03840 -3.83e-02 -1.06e-03 4.37e-02 9.55e-01
GOBP MICROTUBULE BUNDLE FORMATION 125 7.54e-01 9.30e-01 0.03830 2.64e-03 3.82e-02 9.59e-01 4.60e-01
GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER 51 8.93e-01 9.72e-01 0.03830 -4.98e-04 3.83e-02 9.95e-01 6.36e-01
GOCC TERTIARY GRANULE 158 7.32e-01 9.23e-01 0.03830 -2.10e-02 3.19e-02 6.48e-01 4.88e-01
GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY 31 9.41e-01 9.86e-01 0.03820 -2.41e-02 2.97e-02 8.16e-01 7.75e-01
GOBP NEGATIVE REGULATION OF SIGNALING 1450 4.86e-02 3.35e-01 0.03820 -3.81e-02 -1.32e-03 1.51e-02 9.33e-01
GOBP EPITHELIAL CELL DIFFERENTIATION 724 2.07e-01 6.23e-01 0.03820 3.81e-02 2.48e-03 8.10e-02 9.09e-01
GOBP VACUOLAR PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY 5 9.89e-01 9.96e-01 0.03810 -6.67e-03 -3.76e-02 9.79e-01 8.84e-01
GOBP RESPONSE TO OXYGEN RADICAL 26 9.39e-01 9.85e-01 0.03810 -3.49e-02 -1.55e-02 7.58e-01 8.91e-01
Signaling by Activin 17 9.66e-01 9.91e-01 0.03810 1.46e-02 -3.52e-02 9.17e-01 8.02e-01
GOBP POSITIVE REGULATION OF HEMOPOIESIS 189 6.78e-01 9.04e-01 0.03810 -3.66e-02 1.06e-02 3.85e-01 8.02e-01
GOBP POSITIVE REGULATION OF PHAGOCYTOSIS 66 8.51e-01 9.58e-01 0.03810 2.99e-02 2.35e-02 6.74e-01 7.41e-01
GOBP MULTICELLULAR ORGANISMAL REPRODUCTIVE PROCESS 893 1.55e-01 5.51e-01 0.03810 -3.80e-02 1.88e-03 5.40e-02 9.24e-01
GOBP SODIUM ION HOMEOSTASIS 47 8.93e-01 9.72e-01 0.03810 -1.76e-02 -3.37e-02 8.34e-01 6.89e-01
GOBP POSITIVE REGULATION OF COMPLEMENT ACTIVATION 7 9.83e-01 9.95e-01 0.03800 -2.51e-02 -2.86e-02 9.08e-01 8.96e-01
GOBP PROTEIN CATABOLIC PROCESS 953 1.07e-01 4.75e-01 0.03800 -2.95e-02 -2.40e-02 1.23e-01 2.10e-01
GOBP REGULATION OF INSULIN SECRETION 164 6.91e-01 9.09e-01 0.03800 -3.77e-02 -5.13e-03 4.05e-01 9.10e-01
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 70 8.73e-01 9.65e-01 0.03800 3.07e-02 -2.24e-02 6.57e-01 7.45e-01
GOBP INTRACELLULAR SIGNALING CASSETTE 1856 2.74e-02 2.62e-01 0.03800 -3.76e-02 5.62e-03 7.33e-03 6.88e-01
GOBP ICOSANOID TRANSPORT 64 8.79e-01 9.67e-01 0.03800 3.53e-02 -1.39e-02 6.25e-01 8.48e-01
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION 23 9.49e-01 9.88e-01 0.03790 -6.05e-03 -3.75e-02 9.60e-01 7.56e-01
GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE 20 9.62e-01 9.90e-01 0.03790 -2.11e-02 3.15e-02 8.70e-01 8.07e-01
GOBP NUCLEOSIDE METABOLIC PROCESS 55 8.79e-01 9.67e-01 0.03790 -3.58e-02 -1.24e-02 6.46e-01 8.73e-01
GOMF AMYLOID BETA BINDING 80 8.31e-01 9.54e-01 0.03790 -3.64e-02 -1.05e-02 5.73e-01 8.71e-01
GOBP POSITIVE REGULATION OF KINASE ACTIVITY 285 5.11e-01 8.35e-01 0.03790 -1.67e-02 -3.40e-02 6.28e-01 3.23e-01
GOCC CYTOPLASMIC REGION 295 5.03e-01 8.31e-01 0.03780 -3.43e-02 -1.57e-02 3.10e-01 6.42e-01
GOBP SKELETAL MUSCLE SATELLITE CELL DIFFERENTIATION 13 9.72e-01 9.92e-01 0.03780 -3.17e-03 -3.76e-02 9.84e-01 8.14e-01
GOBP PHOSPHORYLATION 1334 8.28e-02 4.27e-01 0.03780 -3.48e-02 1.46e-02 3.27e-02 3.70e-01
GOMF SCAFFOLD PROTEIN BINDING 66 8.78e-01 9.67e-01 0.03770 -3.46e-02 1.51e-02 6.27e-01 8.32e-01
GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION 12 9.72e-01 9.92e-01 0.03770 -1.96e-02 -3.22e-02 9.06e-01 8.47e-01
GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS 67 8.60e-01 9.60e-01 0.03770 -7.99e-03 -3.68e-02 9.10e-01 6.02e-01
GOBP REGULATION OF GLUCOSE IMPORT 58 8.74e-01 9.65e-01 0.03770 1.33e-02 3.53e-02 8.61e-01 6.42e-01
GOBP PROTEIN K11 LINKED UBIQUITINATION 34 9.27e-01 9.82e-01 0.03760 -3.73e-02 -4.98e-03 7.07e-01 9.60e-01
GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS 22 9.52e-01 9.88e-01 0.03760 -3.69e-02 -6.90e-03 7.64e-01 9.55e-01
GOMF TUBULIN BINDING 364 4.32e-01 7.96e-01 0.03750 -3.35e-02 -1.70e-02 2.73e-01 5.78e-01
GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS 38 9.24e-01 9.81e-01 0.03750 -3.74e-02 3.42e-03 6.90e-01 9.71e-01
GOBP PHOSPHOLIPASE C ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY 9 9.83e-01 9.95e-01 0.03750 -2.98e-02 2.27e-02 8.77e-01 9.06e-01
GOCC PERINUCLEAR REGION OF CYTOPLASM 706 2.38e-01 6.55e-01 0.03750 -3.74e-02 2.87e-03 9.05e-02 8.97e-01
GOCC TRANSPORT VESICLE MEMBRANE 232 6.13e-01 8.78e-01 0.03750 -3.75e-02 2.93e-04 3.25e-01 9.94e-01
GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS 23 9.58e-01 9.89e-01 0.03750 2.67e-02 -2.63e-02 8.25e-01 8.27e-01
GOBP MYELOID CELL DIFFERENTIATION 424 3.87e-01 7.69e-01 0.03750 -1.15e-02 -3.57e-02 6.85e-01 2.08e-01
Aberrant regulation of mitotic cell cycle due to RB1 defects 36 9.21e-01 9.80e-01 0.03750 -1.14e-02 -3.57e-02 9.06e-01 7.11e-01
GOMF COPPER ION BINDING 58 8.90e-01 9.71e-01 0.03740 8.54e-03 -3.65e-02 9.10e-01 6.31e-01
GOBP FERTILIZATION 197 6.87e-01 9.06e-01 0.03740 3.32e-02 -1.74e-02 4.22e-01 6.74e-01
GOBP GRANULOCYTE DIFFERENTIATION 39 9.28e-01 9.82e-01 0.03740 3.36e-02 -1.63e-02 7.16e-01 8.60e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN 15 9.71e-01 9.92e-01 0.03730 -3.48e-02 1.34e-02 8.15e-01 9.28e-01
Metabolism of steroids 149 7.54e-01 9.30e-01 0.03720 -1.75e-02 3.29e-02 7.12e-01 4.88e-01
GOMF SULFUR COMPOUND BINDING 260 6.09e-01 8.77e-01 0.03720 -3.43e-02 1.45e-02 3.41e-01 6.86e-01
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION 359 4.76e-01 8.18e-01 0.03710 5.13e-04 3.71e-02 9.87e-01 2.27e-01
GOBP REGULATION OF MRNA CATABOLIC PROCESS 271 5.78e-01 8.64e-01 0.03710 -3.69e-02 2.98e-03 2.95e-01 9.33e-01
GOBP CELLULAR KETONE METABOLIC PROCESS 219 6.17e-01 8.80e-01 0.03700 3.49e-02 1.22e-02 3.73e-01 7.56e-01
GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT 93 8.10e-01 9.49e-01 0.03700 -1.73e-02 -3.27e-02 7.73e-01 5.86e-01
GOBP RESPIRATORY BURST 32 9.38e-01 9.85e-01 0.03690 5.31e-03 -3.65e-02 9.59e-01 7.21e-01
GOCC VESICLE LUMEN 311 5.70e-01 8.61e-01 0.03680 3.02e-02 -2.10e-02 3.60e-01 5.24e-01
GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION 35 9.23e-01 9.81e-01 0.03670 2.74e-02 2.44e-02 7.79e-01 8.03e-01
GOBP RESPONSE TO INORGANIC SUBSTANCE 492 3.76e-01 7.63e-01 0.03670 -3.66e-02 8.42e-04 1.64e-01 9.74e-01
GOBP REGULATION OF LIPID METABOLIC PROCESS 314 5.19e-01 8.39e-01 0.03660 5.93e-03 3.62e-02 8.57e-01 2.71e-01
GOBP REGULATION OF CELLULAR COMPONENT SIZE 335 5.20e-01 8.40e-01 0.03650 -3.63e-02 3.85e-03 2.53e-01 9.04e-01
GOMF PEPTIDE BINDING 243 5.81e-01 8.65e-01 0.03650 -2.92e-02 -2.19e-02 4.33e-01 5.56e-01
GOBP TRNA WOBBLE BASE MODIFICATION 20 9.65e-01 9.91e-01 0.03650 2.43e-02 -2.73e-02 8.51e-01 8.33e-01
GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION 89 8.20e-01 9.52e-01 0.03630 -2.52e-02 -2.61e-02 6.81e-01 6.70e-01
Late SARS-CoV-2 Infection Events 67 8.61e-01 9.61e-01 0.03630 2.51e-02 2.62e-02 7.23e-01 7.10e-01
GOBP LAMELLIPODIUM ORGANIZATION 86 8.60e-01 9.60e-01 0.03620 -2.73e-02 2.38e-02 6.62e-01 7.03e-01
GOBP POSITIVE REGULATION OF LOCOMOTION 608 3.03e-01 7.14e-01 0.03620 -3.62e-02 -1.79e-03 1.28e-01 9.40e-01
GOBP POSITIVE REGULATION OF INSULIN SECRETION 85 8.52e-01 9.59e-01 0.03620 7.87e-03 -3.53e-02 9.00e-01 5.73e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY 55 8.92e-01 9.72e-01 0.03620 3.54e-02 7.59e-03 6.50e-01 9.22e-01
GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 64 8.88e-01 9.71e-01 0.03620 -1.10e-02 3.45e-02 8.79e-01 6.33e-01
GOBP REGULATION OF CILIUM ASSEMBLY 95 8.45e-01 9.57e-01 0.03610 -3.05e-02 1.93e-02 6.07e-01 7.45e-01
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION 44 9.08e-01 9.77e-01 0.03610 3.06e-02 1.91e-02 7.26e-01 8.27e-01
GOCC LYSOSOMAL LUMEN 91 8.52e-01 9.59e-01 0.03600 -1.95e-02 3.03e-02 7.48e-01 6.17e-01
GOBP NEGATIVE REGULATION OF TRANSPORT 438 4.61e-01 8.11e-01 0.03590 -3.33e-02 1.34e-02 2.32e-01 6.30e-01
GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING 24 9.53e-01 9.88e-01 0.03590 3.07e-03 3.58e-02 9.79e-01 7.61e-01
GOBP AORTIC VALVE MORPHOGENESIS 39 9.35e-01 9.84e-01 0.03590 -2.20e-02 2.84e-02 8.12e-01 7.59e-01
GOBP RESPONSE TO TUMOR NECROSIS FACTOR 232 6.47e-01 8.91e-01 0.03580 3.56e-02 -4.47e-03 3.51e-01 9.07e-01
GOBP ACTIVATED T CELL PROLIFERATION 46 9.05e-01 9.76e-01 0.03580 -2.19e-02 -2.83e-02 7.97e-01 7.40e-01
GOBP CELL ADHESION 1475 8.41e-02 4.31e-01 0.03570 -3.38e-02 1.17e-02 3.01e-02 4.52e-01
GOBP MYOBLAST FATE COMMITMENT 6 9.87e-01 9.96e-01 0.03570 -3.00e-02 -1.93e-02 8.99e-01 9.35e-01
GOBP TAXIS 440 4.48e-01 8.04e-01 0.03560 -5.17e-03 3.52e-02 8.52e-01 2.05e-01
GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS 68 8.64e-01 9.62e-01 0.03560 2.71e-02 2.31e-02 6.99e-01 7.41e-01
GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 345 5.55e-01 8.55e-01 0.03560 -3.13e-02 1.68e-02 3.18e-01 5.91e-01
GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS 24 9.60e-01 9.90e-01 0.03550 -1.86e-02 3.03e-02 8.74e-01 7.97e-01
GOCC SUPRAMOLECULAR COMPLEX 1357 1.08e-01 4.77e-01 0.03550 -3.24e-02 1.45e-02 4.52e-02 3.69e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY 42 9.17e-01 9.79e-01 0.03550 -3.28e-02 -1.36e-02 7.13e-01 8.79e-01
GOBP RESPONSE TO STARVATION 204 7.04e-01 9.13e-01 0.03550 -1.59e-02 3.17e-02 6.95e-01 4.35e-01
GOBP FAT CELL DIFFERENTIATION 244 6.44e-01 8.90e-01 0.03550 -3.47e-02 7.15e-03 3.50e-01 8.47e-01
GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY 8 9.85e-01 9.95e-01 0.03550 3.49e-02 -6.21e-03 8.64e-01 9.76e-01
GOBP REGULATION OF T HELPER CELL DIFFERENTIATION 44 9.15e-01 9.78e-01 0.03540 -3.39e-02 -1.03e-02 6.97e-01 9.06e-01
GOBP NEGATIVE REGULATION OF CELL ADHESION 299 5.34e-01 8.46e-01 0.03540 2.39e-02 2.61e-02 4.78e-01 4.37e-01
GOBP ACTIN FILAMENT DEPOLYMERIZATION 58 8.92e-01 9.72e-01 0.03530 3.47e-02 6.81e-03 6.48e-01 9.29e-01
GOMF THYROID HORMONE BINDING 6 9.88e-01 9.96e-01 0.03530 1.75e-02 3.07e-02 9.41e-01 8.96e-01
GOBP RETINAL GANGLION CELL AXON GUIDANCE 22 9.55e-01 9.88e-01 0.03530 2.85e-02 2.08e-02 8.17e-01 8.66e-01
GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS 124 7.73e-01 9.36e-01 0.03520 -2.95e-02 -1.92e-02 5.70e-01 7.11e-01
GOBP DEFENSE RESPONSE 1762 6.26e-02 3.77e-01 0.03520 3.16e-02 -1.54e-02 2.74e-02 2.82e-01
GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR 10 9.80e-01 9.94e-01 0.03520 1.15e-02 3.33e-02 9.50e-01 8.56e-01
GOBP MULTI MULTICELLULAR ORGANISM PROCESS 199 7.11e-01 9.14e-01 0.03520 1.26e-02 -3.28e-02 7.60e-01 4.25e-01
GOBP ERBB SIGNALING PATHWAY 131 7.84e-01 9.40e-01 0.03500 -3.50e-02 -3.91e-04 4.89e-01 9.94e-01
Creatine metabolism 8 9.83e-01 9.95e-01 0.03500 2.66e-02 2.28e-02 8.96e-01 9.11e-01
GOBP MICROVILLUS ASSEMBLY 20 9.62e-01 9.90e-01 0.03500 -3.44e-02 -6.39e-03 7.90e-01 9.61e-01
GOBP LIPID CATABOLIC PROCESS 342 5.04e-01 8.31e-01 0.03500 1.61e-02 3.11e-02 6.10e-01 3.24e-01
GOBP REGULATION OF SECRETION 588 3.92e-01 7.71e-01 0.03490 -2.46e-02 2.48e-02 3.08e-01 3.04e-01
GOCC MULTIVESICULAR BODY 65 8.82e-01 9.68e-01 0.03490 -3.44e-02 -6.04e-03 6.31e-01 9.33e-01
GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS 25 9.60e-01 9.90e-01 0.03490 2.70e-02 -2.21e-02 8.15e-01 8.49e-01
GOCC MICROBODY LUMEN 51 9.09e-01 9.77e-01 0.03480 -3.47e-02 -2.36e-03 6.68e-01 9.77e-01
GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE 129 7.96e-01 9.44e-01 0.03480 -5.28e-03 3.44e-02 9.18e-01 5.00e-01
GOBP REGULATION OF RESPONSE TO STRESS 1376 7.54e-02 4.12e-01 0.03470 -1.54e-02 -3.11e-02 3.38e-01 5.30e-02
GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY 723 2.40e-01 6.55e-01 0.03470 2.64e-02 2.25e-02 2.27e-01 3.02e-01
GOBP ORGANELLE FUSION 162 7.26e-01 9.19e-01 0.03460 -3.09e-02 -1.57e-02 4.98e-01 7.31e-01
GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE 19 9.68e-01 9.91e-01 0.03460 -3.34e-02 8.72e-03 8.01e-01 9.48e-01
GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY 6 9.88e-01 9.96e-01 0.03450 2.65e-02 2.21e-02 9.10e-01 9.25e-01
GOBP ENDOTHELIAL CELL DEVELOPMENT 65 8.87e-01 9.71e-01 0.03450 2.91e-03 3.43e-02 9.68e-01 6.32e-01
Glycosphingolipid metabolism 52 9.06e-01 9.76e-01 0.03440 3.36e-02 7.56e-03 6.75e-01 9.25e-01
GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY 18 9.72e-01 9.92e-01 0.03440 2.81e-02 -1.98e-02 8.36e-01 8.84e-01
GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY 43 9.20e-01 9.80e-01 0.03440 -1.27e-02 -3.20e-02 8.86e-01 7.17e-01
GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS 54 9.18e-01 9.79e-01 0.03440 2.45e-02 -2.41e-02 7.56e-01 7.59e-01
GOBP RESPONSE TO LIGHT STIMULUS 304 5.94e-01 8.71e-01 0.03430 -3.40e-02 4.53e-03 3.07e-01 8.92e-01
GOCC CYTOPLASMIC SIDE OF MEMBRANE 195 7.29e-01 9.21e-01 0.03430 -3.12e-02 1.43e-02 4.53e-01 7.30e-01
GOBP RECEPTOR METABOLIC PROCESS 69 8.72e-01 9.65e-01 0.03430 2.81e-02 1.97e-02 6.86e-01 7.77e-01
GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY 30 9.46e-01 9.87e-01 0.03430 5.18e-03 3.39e-02 9.61e-01 7.48e-01
GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY 78 8.85e-01 9.69e-01 0.03420 2.19e-02 -2.63e-02 7.38e-01 6.88e-01
GOMF METAL CLUSTER BINDING 71 8.82e-01 9.68e-01 0.03420 -3.42e-02 8.18e-04 6.18e-01 9.90e-01
GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION 16 9.73e-01 9.93e-01 0.03420 3.39e-02 -4.81e-03 8.15e-01 9.73e-01
GOMF KINASE BINDING 749 2.42e-01 6.57e-01 0.03420 -2.95e-02 -1.73e-02 1.70e-01 4.19e-01
GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 26 9.50e-01 9.88e-01 0.03420 -2.06e-02 -2.73e-02 8.56e-01 8.10e-01
GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS 179 7.26e-01 9.19e-01 0.03420 3.41e-02 2.16e-03 4.31e-01 9.60e-01
GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING 25 9.61e-01 9.90e-01 0.03420 2.07e-02 -2.72e-02 8.58e-01 8.14e-01
Activation of BH3-only proteins 30 9.54e-01 9.88e-01 0.03410 2.64e-02 -2.17e-02 8.03e-01 8.37e-01
GOCC BLOOD MICROPARTICLE 111 8.07e-01 9.48e-01 0.03410 3.01e-02 1.61e-02 5.84e-01 7.70e-01
GOMF GLYCOSYLTRANSFERASE ACTIVITY 266 6.07e-01 8.76e-01 0.03410 1.17e-02 3.20e-02 7.43e-01 3.68e-01
GOBP REGULATION OF PEPTIDE TRANSPORT 196 7.01e-01 9.12e-01 0.03410 -3.37e-02 -5.03e-03 4.16e-01 9.03e-01
GOBP REGULATION OF MONOCYTE CHEMOTAXIS 26 9.50e-01 9.88e-01 0.03400 2.71e-02 2.05e-02 8.11e-01 8.56e-01
GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS 138 7.93e-01 9.43e-01 0.03400 -5.58e-03 3.35e-02 9.10e-01 4.97e-01
GOBP NEGATIVE REGULATION OF BINDING 106 8.42e-01 9.56e-01 0.03390 -3.24e-02 1.02e-02 5.65e-01 8.57e-01
GOBP REGULATION OF AMINE METABOLIC PROCESS 29 9.49e-01 9.88e-01 0.03380 -3.35e-02 -4.78e-03 7.55e-01 9.64e-01
GOBP LEUKOCYTE DIFFERENTIATION 605 3.66e-01 7.56e-01 0.03370 3.37e-02 -2.05e-03 1.57e-01 9.31e-01
GOBP RESPONSE TO ALDOSTERONE 17 9.73e-01 9.93e-01 0.03370 3.27e-02 -8.14e-03 8.16e-01 9.54e-01
GOBP SPINDLE ORGANIZATION 191 6.95e-01 9.11e-01 0.03360 -2.51e-02 -2.24e-02 5.50e-01 5.94e-01
VLDL assembly 5 9.91e-01 9.98e-01 0.03360 -1.95e-02 -2.74e-02 9.40e-01 9.15e-01
GOCC ENDOSOME MEMBRANE 541 4.39e-01 7.99e-01 0.03360 -1.42e-02 3.04e-02 5.72e-01 2.26e-01
GOBP DETECTION OF ABIOTIC STIMULUS 135 7.80e-01 9.40e-01 0.03360 3.13e-02 1.20e-02 5.30e-01 8.09e-01
GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY 31 9.51e-01 9.88e-01 0.03350 7.08e-03 -3.28e-02 9.46e-01 7.52e-01
GOBP REGULATION OF REPRODUCTIVE PROCESS 198 7.15e-01 9.15e-01 0.03350 3.35e-02 3.70e-04 4.17e-01 9.93e-01
GOMF DNA BINDING BENDING 16 9.76e-01 9.93e-01 0.03350 -2.26e-02 2.46e-02 8.75e-01 8.65e-01
Cell-Cell communication 148 7.82e-01 9.40e-01 0.03350 -2.42e-03 3.34e-02 9.60e-01 4.83e-01
GOBP REGULATION OF MIRNA METABOLIC PROCESS 87 8.69e-01 9.64e-01 0.03340 -3.27e-02 6.93e-03 5.98e-01 9.11e-01
GOBP T CELL SELECTION 57 8.99e-01 9.74e-01 0.03340 -1.64e-02 -2.91e-02 8.30e-01 7.04e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING 97 8.36e-01 9.55e-01 0.03340 2.96e-02 1.55e-02 6.15e-01 7.91e-01
GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 350 5.97e-01 8.72e-01 0.03330 2.00e-02 -2.67e-02 5.21e-01 3.91e-01
GOBP RESPONSE TO METAL ION 330 5.90e-01 8.68e-01 0.03330 -3.29e-02 5.25e-03 3.05e-01 8.70e-01
GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION 18 9.71e-01 9.92e-01 0.03330 -3.27e-02 6.08e-03 8.10e-01 9.64e-01
GOCC CHROMOCENTER 13 9.80e-01 9.94e-01 0.03330 3.09e-02 -1.24e-02 8.47e-01 9.39e-01
GOCC CELL CELL JUNCTION 487 4.48e-01 8.04e-01 0.03320 4.89e-04 3.32e-02 9.85e-01 2.09e-01
GOBP REGULATION OF TRANSPORT 1559 1.14e-01 4.89e-01 0.03320 -2.78e-02 1.82e-02 6.67e-02 2.31e-01
Keratan sulfate degradation 15 9.75e-01 9.93e-01 0.03320 1.85e-03 3.31e-02 9.90e-01 8.24e-01
GOBP MAMMARY GLAND BRANCHING INVOLVED IN PREGNANCY 6 9.91e-01 9.98e-01 0.03310 2.23e-02 -2.45e-02 9.25e-01 9.17e-01
GOBP RESPONSE TO WOUNDING 552 4.31e-01 7.96e-01 0.03310 -3.19e-02 8.68e-03 2.00e-01 7.27e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS 5 9.91e-01 9.98e-01 0.03310 2.97e-02 1.46e-02 9.09e-01 9.55e-01
GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION 27 9.60e-01 9.90e-01 0.03300 -3.00e-02 1.39e-02 7.87e-01 9.01e-01
GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS 616 3.38e-01 7.38e-01 0.03300 2.95e-02 1.48e-02 2.11e-01 5.31e-01
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY 26 9.62e-01 9.90e-01 0.03300 -2.99e-02 1.40e-02 7.92e-01 9.01e-01
Diseases of mitotic cell cycle 37 9.35e-01 9.84e-01 0.03300 -1.83e-02 -2.74e-02 8.47e-01 7.73e-01
GOBP POSITIVE REGULATION OF PROTEOLYSIS 326 5.65e-01 8.59e-01 0.03300 -1.12e-02 -3.10e-02 7.29e-01 3.36e-01
GOBP TRNA PSEUDOURIDINE SYNTHESIS 6 9.91e-01 9.98e-01 0.03290 2.66e-02 -1.94e-02 9.10e-01 9.34e-01
GOCC TRANSPORT VESICLE 414 4.75e-01 8.18e-01 0.03290 -2.70e-02 -1.89e-02 3.46e-01 5.09e-01
GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY 136 7.88e-01 9.41e-01 0.03290 -3.14e-02 -9.98e-03 5.28e-01 8.41e-01
GOBP GMP METABOLIC PROCESS 25 9.57e-01 9.89e-01 0.03290 -3.04e-02 -1.24e-02 7.92e-01 9.15e-01
GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION 322 6.31e-01 8.86e-01 0.03280 1.94e-02 -2.64e-02 5.50e-01 4.15e-01
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION 628 3.37e-01 7.37e-01 0.03280 -2.96e-02 -1.41e-02 2.05e-01 5.48e-01
GOBP CYTOKINE PRODUCTION 841 2.72e-01 6.85e-01 0.03270 3.27e-02 -1.90e-03 1.07e-01 9.26e-01
GOCC CALCIUM CHANNEL COMPLEX 68 8.84e-01 9.69e-01 0.03270 2.58e-02 2.02e-02 7.13e-01 7.73e-01
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 41 9.39e-01 9.85e-01 0.03270 8.82e-03 -3.15e-02 9.22e-01 7.27e-01
GOBP REGULATION OF MONONUCLEAR CELL MIGRATION 137 7.87e-01 9.41e-01 0.03270 3.00e-02 1.29e-02 5.44e-01 7.95e-01
GOCC ENDOCYTIC VESICLE 329 5.80e-01 8.64e-01 0.03260 -3.22e-02 -5.24e-03 3.15e-01 8.70e-01
Gap junction degradation 12 9.80e-01 9.94e-01 0.03260 6.44e-03 3.20e-02 9.69e-01 8.48e-01
Pausing and recovery of Tat-mediated HIV elongation 31 9.46e-01 9.87e-01 0.03260 2.81e-02 1.64e-02 7.87e-01 8.74e-01
Tat-mediated HIV elongation arrest and recovery 31 9.46e-01 9.87e-01 0.03260 2.81e-02 1.64e-02 7.87e-01 8.74e-01
GOMF GLYCOLIPID BINDING 29 9.56e-01 9.88e-01 0.03250 3.41e-03 -3.23e-02 9.75e-01 7.63e-01
GOBP DEPHOSPHORYLATION 272 6.19e-01 8.80e-01 0.03250 -2.54e-02 -2.02e-02 4.71e-01 5.66e-01
GOBP SPONTANEOUS NEUROTRANSMITTER SECRETION 8 9.89e-01 9.96e-01 0.03240 -2.18e-02 2.39e-02 9.15e-01 9.07e-01
GOBP ORGANIC ACID METABOLIC PROCESS 901 2.28e-01 6.46e-01 0.03230 1.22e-02 2.99e-02 5.34e-01 1.28e-01
GOBP REGULATION OF VESICLE MEDIATED TRANSPORT 490 5.03e-01 8.31e-01 0.03220 -1.40e-02 2.90e-02 5.96e-01 2.71e-01
GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS 177 7.36e-01 9.23e-01 0.03210 2.54e-02 1.97e-02 5.60e-01 6.51e-01
IFNG signaling activates MAPKs 8 9.87e-01 9.96e-01 0.03210 3.16e-02 5.59e-03 8.77e-01 9.78e-01
GOBP SECRETION 937 2.87e-01 7.00e-01 0.03210 -1.85e-02 2.62e-02 3.36e-01 1.75e-01
GOBP LEUKOCYTE CHEMOTAXIS 226 7.35e-01 9.23e-01 0.03200 2.28e-02 -2.24e-02 5.54e-01 5.62e-01
GOBP REGULATION OF CELLULAR LOCALIZATION 947 2.72e-01 6.85e-01 0.03200 -3.00e-02 1.11e-02 1.18e-01 5.63e-01
GOBP CELL CELL JUNCTION ORGANIZATION 208 7.22e-01 9.17e-01 0.03190 3.33e-03 3.17e-02 9.34e-01 4.31e-01
GOCC GOLGI APPARATUS SUBCOMPARTMENT 354 6.14e-01 8.79e-01 0.03180 -2.88e-02 1.36e-02 3.53e-01 6.59e-01
Metabolism of water-soluble vitamins and cofactors 125 8.43e-01 9.56e-01 0.03180 -1.64e-02 2.72e-02 7.51e-01 5.99e-01
GOBP SPERM MOTILITY 140 7.95e-01 9.44e-01 0.03170 1.10e-02 2.97e-02 8.22e-01 5.44e-01
Assembly of active LPL and LIPC lipase complexes 18 9.72e-01 9.93e-01 0.03170 3.15e-02 3.75e-03 8.17e-01 9.78e-01
GOBP PEPTIDYL AMINO ACID MODIFICATION 801 3.21e-01 7.28e-01 0.03150 -3.13e-02 3.22e-03 1.32e-01 8.77e-01
Defective B3GALT6 causes EDSP2 and SEMDJL1 17 9.75e-01 9.93e-01 0.03140 3.14e-02 -1.41e-03 8.23e-01 9.92e-01
GOBP POSITIVE REGULATION OF GENE EXPRESSION 1145 1.77e-01 5.81e-01 0.03140 -9.09e-03 -3.01e-02 6.04e-01 8.64e-02
GOBP CELLULAR RESPONSE TO ALCOHOL 102 8.71e-01 9.64e-01 0.03140 -2.81e-02 1.40e-02 6.24e-01 8.07e-01
GOBP EXCRETION 30 9.51e-01 9.88e-01 0.03140 -1.83e-02 -2.55e-02 8.62e-01 8.09e-01
GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 20 9.72e-01 9.93e-01 0.03140 8.11e-03 -3.03e-02 9.50e-01 8.15e-01
GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 43 9.31e-01 9.83e-01 0.03140 -1.74e-02 -2.61e-02 8.43e-01 7.67e-01
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 31 9.58e-01 9.89e-01 0.03140 -3.01e-02 8.79e-03 7.72e-01 9.32e-01
GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 938 2.70e-01 6.84e-01 0.03130 -3.12e-02 3.05e-03 1.06e-01 8.74e-01
GOBP NITROGEN CYCLE METABOLIC PROCESS 12 9.83e-01 9.95e-01 0.03130 8.09e-03 -3.02e-02 9.61e-01 8.56e-01
GOMF CADHERIN BINDING 329 5.93e-01 8.71e-01 0.03130 -2.87e-02 -1.24e-02 3.71e-01 7.00e-01
GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY 16 9.74e-01 9.93e-01 0.03120 -2.48e-02 -1.91e-02 8.64e-01 8.95e-01
PKR-mediated signaling 70 9.12e-01 9.78e-01 0.03120 2.50e-02 -1.88e-02 7.18e-01 7.86e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM 11 9.83e-01 9.95e-01 0.03120 -3.08e-02 -5.04e-03 8.60e-01 9.77e-01
GOMF FATTY ACID BINDING 48 9.36e-01 9.84e-01 0.03120 -1.01e-02 2.95e-02 9.03e-01 7.24e-01
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS 43 9.35e-01 9.84e-01 0.03110 -9.61e-03 -2.96e-02 9.13e-01 7.37e-01
GOBP POLYPRENOL METABOLIC PROCESS 25 9.64e-01 9.91e-01 0.03110 -3.11e-02 -3.56e-04 7.88e-01 9.98e-01
HIV elongation arrest and recovery 33 9.48e-01 9.87e-01 0.03100 2.48e-02 1.86e-02 8.05e-01 8.53e-01
Pausing and recovery of HIV elongation 33 9.48e-01 9.87e-01 0.03100 2.48e-02 1.86e-02 8.05e-01 8.53e-01
Processing of SMDT1 14 9.82e-01 9.94e-01 0.03090 2.20e-02 -2.17e-02 8.87e-01 8.88e-01
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase 20 9.68e-01 9.91e-01 0.03080 -2.40e-02 -1.94e-02 8.53e-01 8.81e-01
GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS 1051 2.25e-01 6.43e-01 0.03080 4.27e-03 3.05e-02 8.15e-01 9.46e-02
GOBP MEMBRANE INVAGINATION 63 9.17e-01 9.79e-01 0.03080 -3.01e-02 6.46e-03 6.79e-01 9.29e-01
GOBP CARDIAC CONDUCTION 95 8.60e-01 9.60e-01 0.03070 2.32e-02 2.01e-02 6.96e-01 7.35e-01
GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 35 9.53e-01 9.88e-01 0.03070 -3.01e-02 5.65e-03 7.58e-01 9.54e-01
GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS 6 9.91e-01 9.98e-01 0.03060 2.72e-02 1.41e-02 9.08e-01 9.52e-01
Regulation of T cell activation by CD28 family 69 9.04e-01 9.76e-01 0.03050 -3.89e-03 -3.03e-02 9.55e-01 6.63e-01
GOBP MONONUCLEAR CELL MIGRATION 216 7.35e-01 9.23e-01 0.03050 3.04e-02 2.41e-03 4.41e-01 9.51e-01
Interleukin-27 signaling 11 9.85e-01 9.95e-01 0.03050 -3.03e-02 3.27e-03 8.62e-01 9.85e-01
GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE 85 8.82e-01 9.67e-01 0.03040 -2.95e-02 -7.47e-03 6.38e-01 9.05e-01
GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 6 9.92e-01 9.98e-01 0.03040 -2.97e-02 6.39e-03 9.00e-01 9.78e-01
GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 129 8.51e-01 9.58e-01 0.03040 2.61e-02 -1.56e-02 6.08e-01 7.60e-01
GOBP NEGATIVE REGULATION OF MAPK CASCADE 159 8.22e-01 9.52e-01 0.03040 2.40e-02 -1.86e-02 6.02e-01 6.85e-01
GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS 39 9.52e-01 9.88e-01 0.03040 1.64e-02 -2.56e-02 8.59e-01 7.82e-01
GOBP ERYTHROCYTE MATURATION 20 9.75e-01 9.93e-01 0.03020 1.34e-02 -2.71e-02 9.17e-01 8.34e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION 297 6.76e-01 9.04e-01 0.03020 2.98e-02 -4.97e-03 3.77e-01 8.83e-01
GOBP LACTONE METABOLIC PROCESS 13 9.80e-01 9.94e-01 0.03020 -1.77e-02 -2.45e-02 9.12e-01 8.78e-01
GOBP CALCIUM MEDIATED SIGNALING 220 7.33e-01 9.23e-01 0.03010 -3.95e-03 -2.99e-02 9.20e-01 4.45e-01
Displacement of DNA glycosylase by APEX1 9 9.87e-01 9.95e-01 0.03010 1.16e-02 2.78e-02 9.52e-01 8.85e-01
GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS 93 8.93e-01 9.72e-01 0.03010 1.99e-02 -2.26e-02 7.40e-01 7.06e-01
GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE 65 9.17e-01 9.79e-01 0.03000 3.75e-03 -2.98e-02 9.58e-01 6.78e-01
GOCC CELL SURFACE 845 3.05e-01 7.15e-01 0.03000 2.87e-02 8.71e-03 1.56e-01 6.67e-01
GOBP NEGATIVE REGULATION OF SECRETION 163 8.21e-01 9.52e-01 0.03000 -2.46e-02 1.72e-02 5.87e-01 7.05e-01
GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 171 7.71e-01 9.36e-01 0.03000 -2.11e-02 -2.14e-02 6.35e-01 6.30e-01
GOBP VIRAL LIFE CYCLE 309 6.89e-01 9.08e-01 0.03000 1.60e-02 -2.54e-02 6.28e-01 4.43e-01
GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 55 9.32e-01 9.83e-01 0.03000 -2.87e-02 8.59e-03 7.13e-01 9.12e-01
GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT 39 9.54e-01 9.88e-01 0.02990 -1.76e-02 2.42e-02 8.50e-01 7.93e-01
GOMF 3 5 EXONUCLEASE ACTIVITY 59 9.16e-01 9.79e-01 0.02990 -2.70e-02 -1.29e-02 7.20e-01 8.64e-01
GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 612 4.09e-01 7.83e-01 0.02990 2.51e-02 1.62e-02 2.89e-01 4.94e-01
GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS 319 6.40e-01 8.88e-01 0.02990 6.35e-03 2.92e-02 8.45e-01 3.70e-01
GOBP REGULATION OF FAT CELL DIFFERENTIATION 141 8.42e-01 9.56e-01 0.02980 1.29e-02 -2.69e-02 7.91e-01 5.81e-01
Uptake and function of anthrax toxins 11 9.87e-01 9.95e-01 0.02980 -2.72e-02 1.22e-02 8.76e-01 9.44e-01
L1CAM interactions 111 8.54e-01 9.59e-01 0.02960 2.83e-02 8.92e-03 6.07e-01 8.71e-01
GOBP L KYNURENINE METABOLIC PROCESS 7 9.91e-01 9.98e-01 0.02960 -5.99e-03 2.90e-02 9.78e-01 8.94e-01
GOBP REGULATION OF CELL CELL ADHESION 486 5.68e-01 8.59e-01 0.02960 1.55e-02 -2.52e-02 5.58e-01 3.42e-01
GOBP REGULATION OF ACTIN NUCLEATION 38 9.49e-01 9.88e-01 0.02960 -4.05e-03 -2.93e-02 9.65e-01 7.55e-01
GOBP RESPONSE TO ACETYLCHOLINE 46 9.47e-01 9.87e-01 0.02960 1.56e-02 -2.51e-02 8.55e-01 7.68e-01
GOMF SMALL MOLECULE SENSOR ACTIVITY 48 9.39e-01 9.85e-01 0.02940 5.58e-04 -2.94e-02 9.95e-01 7.24e-01
GOCC SECONDARY LYSOSOME 20 9.77e-01 9.93e-01 0.02940 -1.55e-02 2.50e-02 9.04e-01 8.46e-01
GOBP VIRAL PROCESS 412 6.25e-01 8.83e-01 0.02940 1.87e-02 -2.27e-02 5.16e-01 4.29e-01
GOMF HSP70 PROTEIN BINDING 50 9.32e-01 9.83e-01 0.02940 -1.01e-02 -2.76e-02 9.02e-01 7.36e-01
GOCC ENDOSOME 1010 3.23e-01 7.28e-01 0.02940 -1.54e-02 2.50e-02 4.06e-01 1.80e-01
GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 125 8.65e-01 9.62e-01 0.02930 1.56e-02 -2.49e-02 7.63e-01 6.31e-01
Formation of RNA Pol II elongation complex 57 9.37e-01 9.84e-01 0.02930 -1.96e-02 2.18e-02 7.98e-01 7.76e-01
RNA Polymerase II Transcription Elongation 57 9.37e-01 9.84e-01 0.02930 -1.96e-02 2.18e-02 7.98e-01 7.76e-01
GOBP REGULATION OF HORMONE LEVELS 524 5.55e-01 8.55e-01 0.02930 -2.19e-02 1.94e-02 3.91e-01 4.47e-01
GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION 114 8.51e-01 9.58e-01 0.02920 -2.62e-02 -1.29e-02 6.29e-01 8.12e-01
GOBP ACTIN MYOSIN FILAMENT SLIDING 16 9.82e-01 9.94e-01 0.02920 1.66e-02 -2.40e-02 9.09e-01 8.68e-01
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE 14 9.83e-01 9.95e-01 0.02910 -3.80e-03 2.89e-02 9.80e-01 8.52e-01
GOBP REGULATION OF BONE REMODELING 51 9.33e-01 9.83e-01 0.02910 2.82e-02 7.22e-03 7.28e-01 9.29e-01
Translation of Structural Proteins 9683701 29 9.68e-01 9.91e-01 0.02900 -2.24e-02 1.84e-02 8.34e-01 8.64e-01
GOCC AUTOPHAGOSOME 109 8.85e-01 9.69e-01 0.02900 -1.93e-02 2.16e-02 7.28e-01 6.96e-01
GOBP SODIUM ION TRANSPORT 237 7.16e-01 9.15e-01 0.02890 2.10e-02 1.99e-02 5.77e-01 5.98e-01
GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY 168 8.22e-01 9.52e-01 0.02890 -9.49e-03 2.73e-02 8.32e-01 5.41e-01
GOMF MRNA 3 UTR BINDING 231 7.52e-01 9.30e-01 0.02880 -2.88e-02 1.41e-03 4.51e-01 9.70e-01
GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY 6 9.93e-01 9.98e-01 0.02880 1.86e-02 -2.20e-02 9.37e-01 9.26e-01
GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS 17 9.76e-01 9.93e-01 0.02880 -2.30e-02 -1.73e-02 8.69e-01 9.02e-01
GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT 36 9.53e-01 9.88e-01 0.02880 7.44e-03 2.78e-02 9.38e-01 7.73e-01
GOBP ERK1 AND ERK2 CASCADE 314 6.88e-01 9.07e-01 0.02880 -2.83e-02 5.03e-03 3.88e-01 8.78e-01
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE 280 6.84e-01 9.06e-01 0.02880 2.61e-02 1.20e-02 4.52e-01 7.29e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 413 5.83e-01 8.66e-01 0.02880 2.79e-02 7.09e-03 3.31e-01 8.05e-01
GOCC VACUOLE 817 3.85e-01 7.68e-01 0.02880 -2.84e-02 4.20e-03 1.67e-01 8.38e-01
GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY 38 9.51e-01 9.88e-01 0.02870 -8.59e-03 -2.74e-02 9.27e-01 7.70e-01
GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION 21 9.75e-01 9.93e-01 0.02850 2.82e-02 -3.91e-03 8.23e-01 9.75e-01
GOMF PENTOSYLTRANSFERASE ACTIVITY 53 9.44e-01 9.87e-01 0.02850 2.14e-02 -1.87e-02 7.87e-01 8.13e-01
GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY 22 9.70e-01 9.92e-01 0.02850 2.26e-02 1.73e-02 8.54e-01 8.88e-01
GOBP ENDOTHELIAL CELL PROLIFERATION 196 7.77e-01 9.38e-01 0.02840 -2.76e-02 -7.00e-03 5.06e-01 8.66e-01
GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS 63 9.18e-01 9.79e-01 0.02840 -2.20e-02 -1.80e-02 7.63e-01 8.05e-01
RAF-independent MAPK1/3 activation 22 9.72e-01 9.92e-01 0.02840 -9.05e-03 -2.69e-02 9.41e-01 8.27e-01
GOBP GRANULOCYTE CHEMOTAXIS 121 8.74e-01 9.65e-01 0.02830 -2.62e-02 1.09e-02 6.19e-01 8.36e-01
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 1173 2.43e-01 6.58e-01 0.02830 2.77e-02 5.88e-03 1.10e-01 7.34e-01
Long-term potentiation 22 9.73e-01 9.93e-01 0.02830 -9.71e-04 -2.83e-02 9.94e-01 8.19e-01
GOMF LIPID KINASE ACTIVITY 40 9.59e-01 9.89e-01 0.02810 -1.90e-02 2.07e-02 8.35e-01 8.21e-01
GOBP PEPTIDYL TYROSINE MODIFICATION 257 7.40e-01 9.25e-01 0.02810 -1.46e-03 2.81e-02 9.68e-01 4.38e-01
GOBP RESPONSE TO CYTOKINE 918 3.87e-01 7.68e-01 0.02810 2.45e-02 -1.38e-02 2.09e-01 4.77e-01
GOBP REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE 5 9.95e-01 9.98e-01 0.02810 1.51e-02 -2.37e-02 9.53e-01 9.27e-01
GOBP NEGATIVE REGULATION OF DNA REPLICATION 25 9.73e-01 9.93e-01 0.02810 2.42e-02 -1.42e-02 8.34e-01 9.02e-01
GOBP REGULATION OF EPIDERMIS DEVELOPMENT 65 9.31e-01 9.83e-01 0.02800 2.65e-02 -9.06e-03 7.11e-01 8.99e-01
DCC mediated attractive signaling 14 9.83e-01 9.95e-01 0.02800 -1.75e-03 -2.79e-02 9.91e-01 8.56e-01
GOBP SMALL MOLECULE METABOLIC PROCESS 1746 1.25e-01 5.06e-01 0.02800 1.12e-02 2.56e-02 4.36e-01 7.52e-02
GOBP XENOBIOTIC CATABOLIC PROCESS 24 9.74e-01 9.93e-01 0.02790 -2.67e-02 8.10e-03 8.21e-01 9.45e-01
Signalling to ERKs 34 9.57e-01 9.89e-01 0.02790 -2.44e-02 -1.35e-02 8.05e-01 8.91e-01
GOBP DETECTION OF BIOTIC STIMULUS 36 9.61e-01 9.90e-01 0.02790 2.67e-02 -8.18e-03 7.82e-01 9.32e-01
Cell-cell junction organization 88 9.07e-01 9.76e-01 0.02780 2.70e-02 -6.69e-03 6.62e-01 9.14e-01
GOBP AMINO ACID CATABOLIC PROCESS 98 9.04e-01 9.75e-01 0.02780 -2.17e-02 1.74e-02 7.11e-01 7.66e-01
GOBP VESICLE FUSION TO PLASMA MEMBRANE 24 9.74e-01 9.93e-01 0.02770 2.71e-02 -5.77e-03 8.18e-01 9.61e-01
PIWI-interacting RNA (piRNA) biogenesis 29 9.68e-01 9.91e-01 0.02770 -2.71e-02 5.97e-03 8.01e-01 9.56e-01
GOCC SIDE OF MEMBRANE 691 4.87e-01 8.23e-01 0.02760 8.70e-03 -2.62e-02 6.97e-01 2.41e-01
GOBP FATTY ACID BIOSYNTHETIC PROCESS 159 8.17e-01 9.51e-01 0.02760 1.58e-02 2.26e-02 7.31e-01 6.23e-01
GOBP T HELPER 17 TYPE IMMUNE RESPONSE 48 9.41e-01 9.86e-01 0.02750 -2.18e-02 -1.67e-02 7.94e-01 8.41e-01
GOBP POSITIVE REGULATION OF MYOBLAST FUSION 15 9.85e-01 9.95e-01 0.02740 -2.21e-02 1.63e-02 8.82e-01 9.13e-01
Mitochondrial Uncoupling 6 9.94e-01 9.98e-01 0.02740 -7.24e-03 2.64e-02 9.76e-01 9.11e-01
GOMF MICROTUBULE BINDING 267 7.16e-01 9.15e-01 0.02740 -2.20e-02 -1.63e-02 5.37e-01 6.46e-01
GOBP VITAMIN CATABOLIC PROCESS 15 9.81e-01 9.94e-01 0.02730 1.71e-02 2.13e-02 9.09e-01 8.87e-01
GOBP CELLULAR RESPONSE TO CHEMICAL STRESS 307 6.87e-01 9.06e-01 0.02720 -2.35e-02 -1.38e-02 4.79e-01 6.78e-01
GOBP PEPTIDYL SERINE MODIFICATION 268 7.54e-01 9.30e-01 0.02710 -4.81e-03 2.66e-02 8.92e-01 4.53e-01
GOMF GTPASE ACTIVITY 303 6.99e-01 9.11e-01 0.02700 -1.01e-02 -2.50e-02 7.61e-01 4.54e-01
GOBP NEGATIVE REGULATION OF TRANSLATION 200 7.92e-01 9.43e-01 0.02700 -7.37e-03 -2.59e-02 8.57e-01 5.27e-01
GOBP MACROMOLECULE DEACYLATION 54 9.49e-01 9.88e-01 0.02690 -2.02e-02 1.78e-02 7.97e-01 8.21e-01
GOBP CILIUM MOVEMENT 204 7.82e-01 9.40e-01 0.02690 2.34e-02 1.34e-02 5.65e-01 7.42e-01
GOBP GAMETE GENERATION 743 4.64e-01 8.13e-01 0.02690 -2.67e-02 3.37e-03 2.15e-01 8.76e-01
TYSND1 cleaves peroxisomal proteins 7 9.91e-01 9.98e-01 0.02690 -1.68e-02 -2.10e-02 9.39e-01 9.23e-01
GOBP REGULATION OF DENDRITE EXTENSION 26 9.74e-01 9.93e-01 0.02670 2.52e-02 -9.04e-03 8.24e-01 9.36e-01
GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY 8 9.92e-01 9.98e-01 0.02670 9.61e-03 -2.49e-02 9.62e-01 9.03e-01
GOBP RESPONSE TO TOXIC SUBSTANCE 255 7.38e-01 9.24e-01 0.02660 2.10e-02 1.64e-02 5.64e-01 6.52e-01
GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS 208 7.87e-01 9.41e-01 0.02660 -2.47e-02 -9.76e-03 5.39e-01 8.08e-01
GOBP RESPONSE TO ALCOHOL 253 7.88e-01 9.41e-01 0.02660 -1.50e-02 2.19e-02 6.82e-01 5.48e-01
GOBP EARLY ENDOSOME TO GOLGI TRANSPORT 17 9.84e-01 9.95e-01 0.02650 1.32e-02 -2.30e-02 9.25e-01 8.70e-01
GOBP DIGESTIVE SYSTEM DEVELOPMENT 140 8.57e-01 9.60e-01 0.02640 -5.15e-03 -2.59e-02 9.16e-01 5.96e-01
GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY 489 6.39e-01 8.88e-01 0.02640 1.87e-02 -1.87e-02 4.79e-01 4.79e-01
GOBP REGULATION OF CIRCULATING FIBRINOGEN LEVELS 5 9.95e-01 9.98e-01 0.02640 7.44e-03 -2.54e-02 9.77e-01 9.22e-01
GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY 7 9.93e-01 9.98e-01 0.02640 2.34e-02 -1.21e-02 9.15e-01 9.56e-01
Hemostasis 577 5.61e-01 8.57e-01 0.02630 -2.62e-02 2.83e-03 2.83e-01 9.07e-01
GOBP CELL CHEMOTAXIS 302 7.06e-01 9.13e-01 0.02630 2.14e-02 1.53e-02 5.23e-01 6.48e-01
GOMF CYTIDINE DEAMINASE ACTIVITY 12 9.87e-01 9.95e-01 0.02620 9.49e-03 2.45e-02 9.55e-01 8.83e-01
GOBP REGULATION OF RESPONSE TO WOUNDING 172 8.24e-01 9.52e-01 0.02620 1.03e-02 2.41e-02 8.15e-01 5.85e-01
Signaling by NOTCH1 69 9.33e-01 9.83e-01 0.02620 2.58e-02 -5.05e-03 7.11e-01 9.42e-01
GOCC POSTSYNAPTIC DENSITY MEMBRANE 97 8.94e-01 9.72e-01 0.02620 -1.54e-02 -2.12e-02 7.93e-01 7.18e-01
GOCC EARLY ENDOSOME 424 6.57e-01 8.94e-01 0.02620 -3.83e-03 2.60e-02 8.92e-01 3.59e-01
Metabolism of lipids 722 5.14e-01 8.36e-01 0.02620 -1.08e-02 2.39e-02 6.22e-01 2.74e-01
GOBP POSITIVE REGULATION OF PROTEIN TRANSPORT 241 7.58e-01 9.32e-01 0.02610 -1.92e-02 -1.77e-02 6.08e-01 6.35e-01
Ion channel transport 172 8.45e-01 9.57e-01 0.02590 -3.80e-03 2.56e-02 9.31e-01 5.62e-01
Ras activation upon Ca2+ influx through NMDA receptor 19 9.81e-01 9.94e-01 0.02590 -2.58e-02 2.64e-03 8.46e-01 9.84e-01
GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION 54 9.41e-01 9.86e-01 0.02590 -2.01e-02 -1.63e-02 7.99e-01 8.36e-01
GOBP CELLULAR HOMEOSTASIS 799 4.64e-01 8.13e-01 0.02590 -2.58e-02 2.16e-03 2.16e-01 9.17e-01
GOBP INTERLEUKIN 2 PRODUCTION 61 9.43e-01 9.87e-01 0.02570 5.12e-03 -2.52e-02 9.45e-01 7.34e-01
GOBP GRANULOCYTE MIGRATION 144 8.63e-01 9.61e-01 0.02570 3.30e-03 2.55e-02 9.45e-01 5.98e-01
GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 663 5.65e-01 8.58e-01 0.02560 -1.48e-02 2.09e-02 5.15e-01 3.59e-01
GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS 688 5.46e-01 8.51e-01 0.02560 -2.34e-02 1.03e-02 2.95e-01 6.44e-01
GOBP SERTOLI CELL DIFFERENTIATION 17 9.85e-01 9.95e-01 0.02560 -2.03e-02 1.56e-02 8.85e-01 9.11e-01
GOBP HOMEOSTATIC PROCESS 1676 2.43e-01 6.58e-01 0.02560 -2.38e-02 9.44e-03 1.05e-01 5.20e-01
Ion homeostasis 52 9.49e-01 9.88e-01 0.02550 1.35e-03 2.55e-02 9.87e-01 7.50e-01
GOBP PIGMENTATION 107 8.97e-01 9.73e-01 0.02550 -3.20e-03 -2.53e-02 9.54e-01 6.51e-01
GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS 576 5.40e-01 8.49e-01 0.02550 1.51e-02 2.05e-02 5.35e-01 4.00e-01
GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK 1170 3.17e-01 7.25e-01 0.02550 -5.49e-03 -2.49e-02 7.51e-01 1.51e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION 463 6.74e-01 9.03e-01 0.02550 -1.71e-02 1.89e-02 5.28e-01 4.86e-01
GOBP FC RECEPTOR SIGNALING PATHWAY 53 9.46e-01 9.87e-01 0.02550 -2.46e-02 -6.58e-03 7.57e-01 9.34e-01
Phospholipid metabolism 200 8.21e-01 9.52e-01 0.02550 1.21e-03 2.54e-02 9.76e-01 5.35e-01
GOBP NEGATIVE REGULATION OF PROTEIN BINDING 68 9.43e-01 9.87e-01 0.02530 -2.08e-02 1.44e-02 7.66e-01 8.38e-01
GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING 24 9.74e-01 9.93e-01 0.02530 -2.11e-02 -1.39e-02 8.58e-01 9.06e-01
GOBP L AMINO ACID METABOLIC PROCESS 171 8.44e-01 9.57e-01 0.02530 -2.51e-02 -2.77e-03 5.71e-01 9.50e-01
GOBP NEGATIVE REGULATION OF GENE EXPRESSION 1518 2.80e-01 6.92e-01 0.02520 -7.99e-03 2.39e-02 6.03e-01 1.19e-01
GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY 9 9.90e-01 9.98e-01 0.02520 -1.88e-02 -1.67e-02 9.22e-01 9.31e-01
FOXO-mediated transcription 65 9.33e-01 9.83e-01 0.02510 -1.93e-02 -1.61e-02 7.87e-01 8.23e-01
GOMF SIRNA BINDING 9 9.92e-01 9.98e-01 0.02500 1.73e-02 -1.81e-02 9.28e-01 9.25e-01
GOBP REGULATION OF PHOSPHORYLATION 950 4.05e-01 7.81e-01 0.02500 -2.45e-02 -5.11e-03 2.01e-01 7.90e-01
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY 31 9.74e-01 9.93e-01 0.02500 -2.17e-02 1.23e-02 8.34e-01 9.05e-01
GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY 420 6.78e-01 9.04e-01 0.02500 9.11e-04 -2.50e-02 9.74e-01 3.80e-01
GOMF TUMOR NECROSIS FACTOR BINDING 7 9.94e-01 9.98e-01 0.02500 3.44e-03 -2.47e-02 9.87e-01 9.10e-01
GOBP INTERLEUKIN 6 PRODUCTION 164 8.43e-01 9.56e-01 0.02500 -1.44e-02 -2.04e-02 7.51e-01 6.52e-01
GOBP NEGATIVE REGULATION OF LIPOPROTEIN LIPASE ACTIVITY 7 9.93e-01 9.98e-01 0.02490 -1.65e-02 -1.87e-02 9.40e-01 9.32e-01
GOCC SHELTERIN COMPLEX 7 9.94e-01 9.98e-01 0.02480 -6.14e-03 2.40e-02 9.78e-01 9.12e-01
GOBP NEGATIVE REGULATION OF DNA REPAIR 37 9.69e-01 9.91e-01 0.02480 -2.24e-02 1.05e-02 8.13e-01 9.12e-01
GOBP PIGMENT GRANULE ORGANIZATION 37 9.65e-01 9.91e-01 0.02470 -5.41e-03 -2.41e-02 9.55e-01 8.00e-01
ER Quality Control Compartment (ERQC) 21 9.80e-01 9.94e-01 0.02470 -2.84e-03 -2.45e-02 9.82e-01 8.46e-01
GOBP MEMBRANE BIOGENESIS 61 9.50e-01 9.88e-01 0.02470 1.08e-02 -2.22e-02 8.84e-01 7.65e-01
Formation of HIV-1 elongation complex containing HIV-1 Tat 42 9.62e-01 9.90e-01 0.02460 2.46e-02 -5.55e-04 7.83e-01 9.95e-01
HIV Transcription Elongation 42 9.62e-01 9.90e-01 0.02460 2.46e-02 -5.55e-04 7.83e-01 9.95e-01
Tat-mediated elongation of the HIV-1 transcript 42 9.62e-01 9.90e-01 0.02460 2.46e-02 -5.55e-04 7.83e-01 9.95e-01
GOBP PROTEIN ACTIVATION CASCADE 18 9.85e-01 9.95e-01 0.02460 2.16e-02 -1.17e-02 8.74e-01 9.31e-01
GOBP MULTIVESICULAR BODY SORTING PATHWAY 47 9.63e-01 9.90e-01 0.02440 -2.09e-02 1.25e-02 8.04e-01 8.82e-01
GOBP REGULATION OF AMIDE METABOLIC PROCESS 79 9.39e-01 9.85e-01 0.02430 -1.80e-02 1.64e-02 7.83e-01 8.01e-01
GOBP REGULATION OF MOLECULAR FUNCTION 1871 1.79e-01 5.83e-01 0.02430 -1.79e-02 -1.65e-02 2.01e-01 2.37e-01
GOBP FAT SOLUBLE VITAMIN CATABOLIC PROCESS 12 9.90e-01 9.97e-01 0.02430 -7.64e-03 2.31e-02 9.63e-01 8.90e-01
GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR 100 9.18e-01 9.79e-01 0.02420 -2.39e-02 3.92e-03 6.79e-01 9.46e-01
GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 26 9.78e-01 9.93e-01 0.02420 -3.43e-03 2.40e-02 9.76e-01 8.32e-01
Ion transport by P-type ATPases 51 9.56e-01 9.89e-01 0.02420 -2.02e-03 2.41e-02 9.80e-01 7.65e-01
G-protein activation 24 9.79e-01 9.94e-01 0.02420 -2.42e-02 -9.02e-04 8.38e-01 9.94e-01
GOMF TAURINE TRANSMEMBRANE TRANSPORTER ACTIVITY 5 9.96e-01 9.98e-01 0.02410 2.04e-02 -1.28e-02 9.37e-01 9.61e-01
GOBP RENAL RESPONSE TO BLOOD FLOW INVOLVED IN CIRCULATORY RENIN ANGIOTENSIN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 7 9.94e-01 9.98e-01 0.02410 -2.13e-02 1.12e-02 9.22e-01 9.59e-01
Translation of Structural Proteins 9694635 55 9.50e-01 9.88e-01 0.02380 8.98e-03 2.21e-02 9.08e-01 7.77e-01
GOBP CELLULAR RESPONSE TO ORGANIC SUBSTANCE 1898 2.60e-01 6.74e-01 0.02380 -2.11e-02 1.09e-02 1.28e-01 4.31e-01
GOBP RENAL WATER ABSORPTION 6 9.94e-01 9.98e-01 0.02370 1.17e-02 2.07e-02 9.60e-01 9.30e-01
GOMF ACYLTRANSFERASE ACTIVITY 677 5.54e-01 8.54e-01 0.02370 -2.30e-02 -5.66e-03 3.07e-01 8.02e-01
Sphingolipid de novo biosynthesis 37 9.71e-01 9.92e-01 0.02360 -2.30e-02 5.46e-03 8.09e-01 9.54e-01
Cytoprotection by HMOX1 54 9.59e-01 9.90e-01 0.02360 -1.06e-02 2.11e-02 8.93e-01 7.88e-01
GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION 183 8.48e-01 9.58e-01 0.02360 -8.14e-03 -2.22e-02 8.49e-01 6.05e-01
GOBP EPITHELIAL CELL DEVELOPMENT 211 8.28e-01 9.53e-01 0.02360 7.39e-03 2.24e-02 8.53e-01 5.75e-01
GOMF MONOATOMIC ANION CHANNEL ACTIVITY 90 9.24e-01 9.81e-01 0.02350 4.52e-03 2.31e-02 9.41e-01 7.05e-01
Formation of annular gap junctions 11 9.92e-01 9.98e-01 0.02350 -1.66e-02 1.67e-02 9.24e-01 9.24e-01
GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY 17 9.86e-01 9.95e-01 0.02350 -3.20e-03 2.32e-02 9.82e-01 8.68e-01
GOBP DETERMINATION OF ADULT LIFESPAN 35 9.68e-01 9.91e-01 0.02340 -1.40e-02 -1.87e-02 8.86e-01 8.48e-01
GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS 1100 4.00e-01 7.78e-01 0.02330 -2.25e-02 -6.19e-03 2.08e-01 7.29e-01
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants 54 9.53e-01 9.88e-01 0.02330 -9.89e-03 -2.11e-02 9.00e-01 7.89e-01
Constitutive Signaling by NOTCH1 PEST Domain Mutants 54 9.53e-01 9.88e-01 0.02330 -9.89e-03 -2.11e-02 9.00e-01 7.89e-01
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer 54 9.53e-01 9.88e-01 0.02330 -9.89e-03 -2.11e-02 9.00e-01 7.89e-01
Signaling by NOTCH1 PEST Domain Mutants in Cancer 54 9.53e-01 9.88e-01 0.02330 -9.89e-03 -2.11e-02 9.00e-01 7.89e-01
Signaling by NOTCH1 in Cancer 54 9.53e-01 9.88e-01 0.02330 -9.89e-03 -2.11e-02 9.00e-01 7.89e-01
GOCC ANCHORING JUNCTION 863 5.47e-01 8.52e-01 0.02330 -1.48e-02 1.79e-02 4.60e-01 3.71e-01
GOBP PROTEIN HEXAMERIZATION 9 9.93e-01 9.98e-01 0.02320 8.96e-03 -2.15e-02 9.63e-01 9.11e-01
GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES 763 5.51e-01 8.54e-01 0.02320 -2.32e-02 1.52e-03 2.76e-01 9.43e-01
GOBP CAMP MEDIATED SIGNALING 57 9.51e-01 9.88e-01 0.02320 2.16e-02 8.62e-03 7.78e-01 9.10e-01
GOBP RESPONSE TO UV B 21 9.84e-01 9.95e-01 0.02310 2.26e-02 -4.41e-03 8.57e-01 9.72e-01
GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY 25 9.80e-01 9.94e-01 0.02310 -2.13e-03 -2.30e-02 9.85e-01 8.42e-01
GOMF PROMOTER ENHANCER LOOP ANCHORING ACTIVITY 6 9.95e-01 9.98e-01 0.02300 -2.28e-02 2.49e-03 9.23e-01 9.92e-01
GOBP INORGANIC ION HOMEOSTASIS 515 6.60e-01 8.96e-01 0.02290 -2.27e-02 -3.05e-03 3.77e-01 9.06e-01
GOCC MICROTUBULE 460 7.15e-01 9.15e-01 0.02280 -2.21e-02 5.87e-03 4.18e-01 8.29e-01
GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION 225 8.31e-01 9.54e-01 0.02280 -2.21e-02 -5.52e-03 5.68e-01 8.86e-01
GOMF MYOSIN BINDING 72 9.39e-01 9.85e-01 0.02280 1.63e-02 1.59e-02 8.11e-01 8.15e-01
GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS 28 9.78e-01 9.93e-01 0.02250 2.22e-02 3.86e-03 8.39e-01 9.72e-01
GOBP NERVOUS SYSTEM PROCESS 1383 3.78e-01 7.64e-01 0.02250 2.24e-02 -2.06e-03 1.63e-01 8.98e-01
GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY 37 9.75e-01 9.93e-01 0.02250 -1.41e-02 1.75e-02 8.82e-01 8.54e-01
GOBP HEMOPOIESIS 928 5.41e-01 8.50e-01 0.02240 9.97e-03 -2.01e-02 6.07e-01 3.00e-01
GOBP REGULATION OF VIRAL PROCESS 164 8.96e-01 9.73e-01 0.02240 1.67e-02 -1.50e-02 7.13e-01 7.41e-01
GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION 39 9.70e-01 9.92e-01 0.02240 2.22e-02 2.77e-03 8.10e-01 9.76e-01
Formation of HIV elongation complex in the absence of HIV Tat 44 9.67e-01 9.91e-01 0.02240 2.23e-02 1.86e-03 7.98e-01 9.83e-01
GOMF SIGNALING ADAPTOR ACTIVITY 111 9.23e-01 9.81e-01 0.02230 -3.75e-03 2.20e-02 9.46e-01 6.89e-01
GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS 26 9.79e-01 9.94e-01 0.02230 9.32e-03 2.03e-02 9.34e-01 8.58e-01
GOCC SECRETORY VESICLE 1032 5.03e-01 8.31e-01 0.02220 -2.10e-02 7.21e-03 2.53e-01 6.95e-01
GOBP WOUND HEALING 416 7.61e-01 9.32e-01 0.02210 -1.12e-02 1.91e-02 6.95e-01 5.05e-01
GOBP ANTIMICROBIAL PEPTIDE PRODUCTION 12 9.92e-01 9.98e-01 0.02210 2.08e-02 -7.48e-03 9.01e-01 9.64e-01
GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION 7 9.94e-01 9.98e-01 0.02210 -1.18e-02 -1.86e-02 9.57e-01 9.32e-01
Metabolism 2055 2.96e-01 7.08e-01 0.02200 1.71e-02 -1.39e-02 2.02e-01 2.97e-01
GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY 37 9.70e-01 9.92e-01 0.02200 1.75e-02 1.34e-02 8.54e-01 8.88e-01
GOBP AXIS SPECIFICATION 93 9.32e-01 9.83e-01 0.02200 -2.69e-03 -2.18e-02 9.64e-01 7.16e-01
GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 1179 4.04e-01 7.81e-01 0.02190 -1.82e-02 -1.23e-02 2.93e-01 4.77e-01
GOMF PROTEIN TYROSINE KINASE BINDING 120 9.17e-01 9.79e-01 0.02190 -2.19e-02 3.37e-04 6.79e-01 9.95e-01
GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY 8 9.95e-01 9.98e-01 0.02180 2.05e-02 -7.34e-03 9.20e-01 9.71e-01
GOBP PROTEIN K63 LINKED UBIQUITINATION 67 9.58e-01 9.89e-01 0.02180 -1.37e-02 1.70e-02 8.47e-01 8.10e-01
Synthesis of 15-eicosatetraenoic acid derivatives 6 9.96e-01 9.98e-01 0.02180 2.14e-02 3.76e-03 9.28e-01 9.87e-01
GOMF CELL ADHESION MOLECULE BINDING 545 6.91e-01 9.09e-01 0.02170 -2.15e-02 2.85e-03 3.90e-01 9.09e-01
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 35 9.75e-01 9.93e-01 0.02170 2.17e-02 -2.39e-04 8.24e-01 9.98e-01
GOBP PHOSPHOLIPID METABOLIC PROCESS 373 7.75e-01 9.37e-01 0.02170 2.39e-03 -2.15e-02 9.37e-01 4.75e-01
GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 207 8.76e-01 9.66e-01 0.02160 -1.96e-02 9.21e-03 6.27e-01 8.19e-01
Signaling by MET 78 9.40e-01 9.85e-01 0.02160 1.36e-02 1.68e-02 8.35e-01 7.98e-01
GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS 251 8.55e-01 9.59e-01 0.02150 1.10e-02 -1.85e-02 7.64e-01 6.13e-01
GOBP ARACHIDONIC ACID METABOLIC PROCESS 55 9.58e-01 9.89e-01 0.02150 1.62e-02 1.41e-02 8.35e-01 8.57e-01
GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS 6 9.96e-01 9.98e-01 0.02150 -2.13e-02 2.28e-03 9.28e-01 9.92e-01
GOBP MOLTING CYCLE PROCESS 95 9.38e-01 9.85e-01 0.02140 2.12e-02 -2.98e-03 7.21e-01 9.60e-01
GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 721 6.18e-01 8.80e-01 0.02140 -2.13e-02 5.74e-04 3.29e-01 9.79e-01
Interleukin-6 family signaling 24 9.82e-01 9.94e-01 0.02130 -1.37e-02 -1.63e-02 9.07e-01 8.90e-01
GOBP LONG CHAIN FATTY ACID CATABOLIC PROCESS 8 9.95e-01 9.98e-01 0.02130 1.29e-02 -1.69e-02 9.50e-01 9.34e-01
GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS 6 9.96e-01 9.98e-01 0.02120 -6.75e-03 2.01e-02 9.77e-01 9.32e-01
GOCC ORGANELLE SUBCOMPARTMENT 1445 3.60e-01 7.51e-01 0.02110 -1.32e-02 -1.65e-02 4.00e-01 2.94e-01
GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 121 9.23e-01 9.81e-01 0.02110 2.10e-02 -1.24e-03 6.90e-01 9.81e-01
Neurexins and neuroligins 52 9.70e-01 9.92e-01 0.02100 -1.37e-02 1.60e-02 8.65e-01 8.42e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST 198 8.81e-01 9.67e-01 0.02100 -3.16e-03 2.08e-02 9.39e-01 6.15e-01
GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE 22 9.84e-01 9.95e-01 0.02100 9.36e-03 1.88e-02 9.39e-01 8.79e-01
GOBP REGULATION OF MIRNA TRANSCRIPTION 74 9.56e-01 9.88e-01 0.02090 -1.96e-02 7.32e-03 7.71e-01 9.13e-01
GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 109 9.38e-01 9.85e-01 0.02090 1.62e-02 -1.31e-02 7.70e-01 8.13e-01
Sensory processing of sound 70 9.59e-01 9.89e-01 0.02080 8.02e-03 -1.91e-02 9.08e-01 7.82e-01
COPI-dependent Golgi-to-ER retrograde traffic 98 9.40e-01 9.85e-01 0.02060 -2.06e-02 9.43e-04 7.25e-01 9.87e-01
GOBP LIPID BIOSYNTHETIC PROCESS 709 6.19e-01 8.80e-01 0.02040 1.03e-02 1.76e-02 6.41e-01 4.23e-01
GOBP FATTY ACID TRANSPORT 119 9.36e-01 9.84e-01 0.02040 1.20e-02 -1.64e-02 8.21e-01 7.57e-01
GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 174 9.02e-01 9.75e-01 0.02030 -1.98e-02 4.35e-03 6.52e-01 9.21e-01
GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL 63 9.60e-01 9.90e-01 0.02000 6.69e-03 1.89e-02 9.27e-01 7.95e-01
GOCC TRANSPORTER COMPLEX 439 7.93e-01 9.43e-01 0.02000 -1.39e-02 1.45e-02 6.18e-01 6.04e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION 207 8.82e-01 9.68e-01 0.02000 4.89e-04 2.00e-02 9.90e-01 6.20e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS 1706 3.79e-01 7.64e-01 0.02000 -2.00e-02 -1.20e-03 1.70e-01 9.34e-01
GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS 217 8.87e-01 9.71e-01 0.02000 -8.05e-03 1.83e-02 8.38e-01 6.42e-01
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 62 9.67e-01 9.91e-01 0.02000 -9.61e-03 1.75e-02 8.96e-01 8.11e-01
GOCC DENDRITE CYTOPLASM 26 9.85e-01 9.95e-01 0.01990 1.93e-02 -5.15e-03 8.65e-01 9.64e-01
GOBP RESPIRATORY SYSTEM PROCESS 42 9.77e-01 9.93e-01 0.01990 1.77e-02 -8.95e-03 8.42e-01 9.20e-01
PI3K/AKT Signaling in Cancer 111 9.36e-01 9.84e-01 0.01980 -1.98e-02 -8.14e-04 7.19e-01 9.88e-01
GOBP REGULATION OF CELL PROJECTION ASSEMBLY 217 8.67e-01 9.63e-01 0.01970 1.38e-02 1.41e-02 7.26e-01 7.20e-01
GOBP REGULATION OF MITOCHONDRION ORGANIZATION 143 9.12e-01 9.78e-01 0.01970 -8.78e-03 -1.77e-02 8.56e-01 7.16e-01
GOBP OSTEOCLAST FUSION 6 9.97e-01 9.98e-01 0.01960 2.80e-03 -1.94e-02 9.91e-01 9.34e-01
GOBP DEFENSE RESPONSE TO VIRUS 297 8.61e-01 9.61e-01 0.01950 1.41e-02 -1.35e-02 6.77e-01 6.88e-01
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER UPTAKE 6 9.96e-01 9.98e-01 0.01950 -5.83e-03 -1.86e-02 9.80e-01 9.37e-01
GOBP NEGATIVE REGULATION OF VIRAL PROCESS 91 9.47e-01 9.87e-01 0.01950 1.91e-02 3.88e-03 7.53e-01 9.49e-01
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 30 9.84e-01 9.95e-01 0.01950 1.88e-02 -5.12e-03 8.59e-01 9.61e-01
GOBP PHAGOCYTOSIS ENGULFMENT 47 9.73e-01 9.93e-01 0.01950 -1.94e-02 -1.97e-03 8.18e-01 9.81e-01
GOMF NUCLEAR RETINOID X RECEPTOR BINDING 17 9.91e-01 9.98e-01 0.01950 -1.38e-02 1.37e-02 9.21e-01 9.22e-01
GOCC NEURON SPINE 167 9.01e-01 9.74e-01 0.01940 -1.68e-02 -9.64e-03 7.08e-01 8.30e-01
GOBP POSITIVE REGULATION OF ACTIN NUCLEATION 14 9.92e-01 9.98e-01 0.01930 -1.88e-02 -4.41e-03 9.03e-01 9.77e-01
RAB GEFs exchange GTP for GDP on RABs 80 9.58e-01 9.89e-01 0.01910 -1.88e-02 3.30e-03 7.71e-01 9.59e-01
GOBP NEURONAL SIGNAL TRANSDUCTION 7 9.96e-01 9.98e-01 0.01910 1.66e-03 1.90e-02 9.94e-01 9.31e-01
GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS 633 7.04e-01 9.13e-01 0.01910 2.43e-03 1.89e-02 9.17e-01 4.16e-01
GOBP MYELOID CELL DEVELOPMENT 84 9.57e-01 9.89e-01 0.01900 3.61e-03 -1.87e-02 9.54e-01 7.68e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION 38 9.82e-01 9.94e-01 0.01890 1.66e-02 -8.93e-03 8.59e-01 9.24e-01
Metabolism of vitamins and cofactors 194 9.10e-01 9.77e-01 0.01890 1.68e-02 -8.59e-03 6.87e-01 8.37e-01
GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 121 9.31e-01 9.83e-01 0.01880 -9.31e-03 -1.63e-02 8.60e-01 7.56e-01
Endosomal Sorting Complex Required For Transport (ESCRT) 31 9.82e-01 9.94e-01 0.01880 -1.46e-02 -1.18e-02 8.88e-01 9.09e-01
GOMF AMINOACYLTRANSFERASE ACTIVITY 461 7.72e-01 9.36e-01 0.01880 -1.79e-02 -5.75e-03 5.11e-01 8.32e-01
GOBP ESTABLISHMENT OF TISSUE POLARITY 36 9.83e-01 9.95e-01 0.01880 1.51e-02 -1.11e-02 8.75e-01 9.08e-01
GOBP PURINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS 5 9.97e-01 9.99e-01 0.01870 1.87e-02 -7.76e-04 9.42e-01 9.98e-01
GOMF SODIUM CHANNEL REGULATOR ACTIVITY 38 9.82e-01 9.94e-01 0.01870 -1.63e-02 9.17e-03 8.62e-01 9.22e-01
GOMF ENZYME REGULATOR ACTIVITY 1239 5.07e-01 8.33e-01 0.01850 -1.39e-02 -1.22e-02 4.10e-01 4.71e-01
GOBP REGULATED EXOCYTOSIS 211 9.03e-01 9.75e-01 0.01840 4.04e-03 -1.80e-02 9.19e-01 6.53e-01
TRP channels 27 9.85e-01 9.95e-01 0.01840 1.68e-02 7.50e-03 8.80e-01 9.46e-01
GOBP CELLULAR RESPONSE TO FATTY ACID 33 9.83e-01 9.95e-01 0.01840 -1.83e-02 -1.64e-03 8.56e-01 9.87e-01
GOBP REGULATION OF DEFENSE RESPONSE 810 6.86e-01 9.06e-01 0.01830 1.78e-02 -4.21e-03 3.89e-01 8.39e-01
GOMF ISOMERASE ACTIVITY 165 9.28e-01 9.82e-01 0.01830 9.63e-03 -1.56e-02 8.31e-01 7.30e-01
GOBP CALCIUM ION REGULATED EXOCYTOSIS 63 9.65e-01 9.91e-01 0.01830 1.08e-02 1.47e-02 8.82e-01 8.40e-01
GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN 77 9.57e-01 9.89e-01 0.01830 1.22e-02 1.36e-02 8.54e-01 8.36e-01
GOCC ER MEMBRANE INSERTION COMPLEX 10 9.95e-01 9.98e-01 0.01830 -6.82e-03 1.69e-02 9.70e-01 9.26e-01
GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY 32 9.86e-01 9.95e-01 0.01820 -1.11e-02 1.45e-02 9.14e-01 8.87e-01
GOBP NEGATIVE REGULATION OF AXONOGENESIS 45 9.77e-01 9.93e-01 0.01810 4.24e-03 1.76e-02 9.61e-01 8.38e-01
GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT 969 6.62e-01 8.97e-01 0.01810 -9.40e-03 1.55e-02 6.20e-01 4.15e-01
GOBP PROTEIN TETRAMERIZATION 92 9.54e-01 9.88e-01 0.01800 -1.77e-02 -3.63e-03 7.70e-01 9.52e-01
GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE 18 9.92e-01 9.98e-01 0.01790 1.34e-02 -1.19e-02 9.22e-01 9.31e-01
GOBP MAST CELL PROLIFERATION 7 9.97e-01 9.98e-01 0.01790 -1.78e-02 -1.40e-03 9.35e-01 9.95e-01
GOBP PROTEOLYSIS 1529 5.05e-01 8.31e-01 0.01770 -7.94e-04 -1.77e-02 9.59e-01 2.48e-01
GOMF PROTEIN SERINE THREONINE KINASE BINDING 10 9.96e-01 9.98e-01 0.01760 -1.18e-02 1.31e-02 9.49e-01 9.43e-01
GOBP SPERMATID DIFFERENTIATION 215 9.16e-01 9.79e-01 0.01750 -1.18e-02 1.30e-02 7.66e-01 7.43e-01
GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH 91 9.55e-01 9.88e-01 0.01750 -1.47e-02 -9.48e-03 8.09e-01 8.76e-01
GOBP REGULATION OF PROTEIN TRANSPORT 421 8.35e-01 9.55e-01 0.01720 -1.71e-02 2.18e-03 5.48e-01 9.39e-01
GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS 1373 5.83e-01 8.66e-01 0.01720 -1.64e-02 5.31e-03 3.09e-01 7.41e-01
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 44 9.79e-01 9.94e-01 0.01710 -8.41e-03 -1.49e-02 9.23e-01 8.64e-01
GOMF GUANYL RIBONUCLEOTIDE BINDING 368 8.46e-01 9.57e-01 0.01700 -1.66e-02 -3.88e-03 5.85e-01 8.98e-01
GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION 15 9.93e-01 9.98e-01 0.01700 -1.70e-02 5.78e-05 9.09e-01 1.00e+00
GOBP TRIGLYCERIDE METABOLIC PROCESS 104 9.61e-01 9.90e-01 0.01700 1.37e-02 -1.00e-02 8.10e-01 8.60e-01
GOBP REGULATION OF HYDROLASE ACTIVITY 673 7.52e-01 9.30e-01 0.01690 -6.32e-04 -1.69e-02 9.78e-01 4.56e-01
GOBP LEUKOCYTE MIGRATION 382 8.47e-01 9.58e-01 0.01680 2.28e-03 1.66e-02 9.39e-01 5.76e-01
GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS 729 7.38e-01 9.24e-01 0.01660 1.56e-03 1.66e-02 9.43e-01 4.46e-01
GOBP POSITIVE REGULATION OF PHOSPHORYLATION 590 8.07e-01 9.48e-01 0.01660 -8.75e-03 1.41e-02 7.17e-01 5.59e-01
GOBP REGULATION OF STRIATED MUSCLE CONTRACTION 93 9.60e-01 9.90e-01 0.01660 3.49e-03 1.62e-02 9.54e-01 7.87e-01
GOBP REPRODUCTIVE PROCESS 1435 5.55e-01 8.55e-01 0.01660 -1.61e-02 -3.87e-03 3.07e-01 8.06e-01
GOCC TRANS GOLGI NETWORK MEMBRANE 103 9.56e-01 9.89e-01 0.01660 -1.62e-02 -3.55e-03 7.77e-01 9.50e-01
GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS 84 9.69e-01 9.91e-01 0.01650 1.51e-02 -6.74e-03 8.11e-01 9.15e-01
GOBP SEXUAL REPRODUCTION 1011 6.66e-01 8.99e-01 0.01640 -1.63e-02 -2.13e-03 3.82e-01 9.09e-01
GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS 31 9.87e-01 9.95e-01 0.01630 1.56e-02 4.97e-03 8.81e-01 9.62e-01
GOBP FATTY ACID METABOLIC PROCESS 387 8.70e-01 9.64e-01 0.01630 -7.30e-03 1.46e-02 8.05e-01 6.23e-01
GOMF METALLOCARBOXYPEPTIDASE ACTIVITY 29 9.90e-01 9.97e-01 0.01620 -1.17e-02 1.13e-02 9.14e-01 9.16e-01
GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS 49 9.79e-01 9.94e-01 0.01620 1.42e-02 7.80e-03 8.64e-01 9.25e-01
GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS 31 9.87e-01 9.96e-01 0.01620 -3.97e-03 -1.57e-02 9.69e-01 8.80e-01
GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA 16 9.93e-01 9.98e-01 0.01620 -5.29e-03 -1.53e-02 9.71e-01 9.16e-01
GOBP LIPID METABOLIC PROCESS 1350 5.76e-01 8.63e-01 0.01610 9.29e-03 1.31e-02 5.67e-01 4.19e-01
GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION 22 9.92e-01 9.98e-01 0.01600 1.59e-02 -1.85e-03 8.97e-01 9.88e-01
GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS 41 9.86e-01 9.95e-01 0.01600 -7.78e-03 1.40e-02 9.31e-01 8.77e-01
GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS 23 9.92e-01 9.98e-01 0.01600 -6.52e-03 1.46e-02 9.57e-01 9.03e-01
GOBP DENDRITE EXTENSION 35 9.88e-01 9.96e-01 0.01600 1.41e-02 -7.60e-03 8.85e-01 9.38e-01
GOBP REGULATION OF BODY FLUID LEVELS 357 8.73e-01 9.65e-01 0.01590 1.59e-02 2.99e-04 6.06e-01 9.92e-01
GOBP TRANSMEMBRANE TRANSPORT 1509 5.72e-01 8.61e-01 0.01580 2.92e-03 1.56e-02 8.50e-01 3.13e-01
GOBP AMINO ACID METABOLIC PROCESS 285 9.09e-01 9.77e-01 0.01580 1.31e-02 -8.82e-03 7.03e-01 7.98e-01
GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT 811 7.74e-01 9.36e-01 0.01560 -1.15e-02 1.06e-02 5.79e-01 6.06e-01
GOCC SECRETORY GRANULE 865 7.55e-01 9.30e-01 0.01560 -1.43e-02 6.26e-03 4.75e-01 7.54e-01
GOBP CELLULAR LIPID METABOLIC PROCESS 990 6.78e-01 9.04e-01 0.01550 1.16e-02 1.04e-02 5.37e-01 5.81e-01
GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 37 9.85e-01 9.95e-01 0.01550 9.33e-03 1.24e-02 9.22e-01 8.96e-01
GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY 12 9.96e-01 9.98e-01 0.01520 8.50e-03 -1.27e-02 9.59e-01 9.39e-01
GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS 785 7.71e-01 9.36e-01 0.01520 1.74e-03 -1.51e-02 9.34e-01 4.71e-01
GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 209 9.26e-01 9.82e-01 0.01520 4.29e-03 1.46e-02 9.15e-01 7.17e-01
GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY 76 9.74e-01 9.93e-01 0.01510 5.12e-04 -1.51e-02 9.94e-01 8.20e-01
GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION 10 9.96e-01 9.98e-01 0.01510 -1.46e-02 -3.53e-03 9.36e-01 9.85e-01
GOCC CILIUM 733 7.79e-01 9.39e-01 0.01490 -1.48e-02 -2.34e-03 4.96e-01 9.14e-01
Diseases of carbohydrate metabolism 31 9.89e-01 9.97e-01 0.01490 -1.49e-02 -8.86e-04 8.86e-01 9.93e-01
GOBP HYDROGEN PEROXIDE METABOLIC PROCESS 50 9.82e-01 9.94e-01 0.01490 -6.46e-03 -1.34e-02 9.37e-01 8.70e-01
GOBP ALPHA KETOGLUTARATE TRANSPORT 7 9.97e-01 9.99e-01 0.01490 6.90e-03 1.32e-02 9.75e-01 9.52e-01
GOBP ORGANELLE MEMBRANE FUSION 120 9.62e-01 9.90e-01 0.01480 1.54e-03 -1.47e-02 9.77e-01 7.80e-01
GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY 343 9.05e-01 9.76e-01 0.01470 -7.65e-03 1.26e-02 8.08e-01 6.89e-01
GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION 9 9.97e-01 9.99e-01 0.01460 1.39e-02 4.57e-03 9.43e-01 9.81e-01
GOBP REGULATION OF ORGANELLE ASSEMBLY 239 9.18e-01 9.79e-01 0.01460 -1.03e-02 -1.03e-02 7.83e-01 7.84e-01
GOBP MONOATOMIC ION HOMEOSTASIS 589 8.26e-01 9.52e-01 0.01460 -1.44e-02 -1.99e-03 5.50e-01 9.34e-01
GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY 1073 7.44e-01 9.26e-01 0.01440 -1.34e-02 5.18e-03 4.57e-01 7.74e-01
GOCC KAINATE SELECTIVE GLUTAMATE RECEPTOR COMPLEX 5 9.98e-01 9.99e-01 0.01430 1.24e-02 7.22e-03 9.62e-01 9.78e-01
GOMF KAINATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY 5 9.98e-01 9.99e-01 0.01430 1.24e-02 7.22e-03 9.62e-01 9.78e-01
GOBP ALPHA AMINO ACID METABOLIC PROCESS 205 9.46e-01 9.87e-01 0.01420 9.12e-03 -1.09e-02 8.22e-01 7.88e-01
GOBP POSITIVE REGULATION OF PROTEIN SECRETION 145 9.52e-01 9.88e-01 0.01410 1.02e-02 9.75e-03 8.32e-01 8.39e-01
GOCC NUCLEAR MEMBRANE 299 9.24e-01 9.81e-01 0.01410 -8.69e-03 1.11e-02 7.96e-01 7.41e-01
GOBP LAMELLIPODIUM ASSEMBLY 67 9.80e-01 9.94e-01 0.01400 -3.22e-04 -1.40e-02 9.96e-01 8.43e-01
GOBP MALE GAMETE GENERATION 590 8.31e-01 9.54e-01 0.01400 -1.31e-02 -4.98e-03 5.87e-01 8.36e-01
GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION 20 9.93e-01 9.98e-01 0.01400 7.99e-03 1.15e-02 9.51e-01 9.29e-01
GOBP EXOCYTOSIS 330 9.09e-01 9.77e-01 0.01370 1.35e-02 2.23e-03 6.74e-01 9.44e-01
GOCC GOLGI MEMBRANE 655 8.42e-01 9.56e-01 0.01330 -1.33e-02 -1.90e-04 5.61e-01 9.93e-01
GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS 27 9.94e-01 9.98e-01 0.01330 8.22e-03 -1.04e-02 9.41e-01 9.25e-01
GOBP EMBRYONIC AXIS SPECIFICATION 40 9.89e-01 9.96e-01 0.01330 -1.27e-02 -3.70e-03 8.89e-01 9.68e-01
GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS 15 9.96e-01 9.98e-01 0.01320 7.06e-03 -1.11e-02 9.62e-01 9.41e-01
GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS 16 9.96e-01 9.98e-01 0.01300 -4.77e-03 1.21e-02 9.74e-01 9.33e-01
GOCC PROXIMAL DENDRITE 6 9.98e-01 9.99e-01 0.01300 -1.29e-02 1.10e-03 9.56e-01 9.96e-01
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS 19 9.95e-01 9.98e-01 0.01290 -3.31e-03 -1.25e-02 9.80e-01 9.25e-01
GOBP PROTEIN DEPOLYMERIZATION 114 9.69e-01 9.91e-01 0.01280 -1.00e-02 -7.97e-03 8.54e-01 8.83e-01
GOBP ORGANOPHOSPHATE METABOLIC PROCESS 981 8.19e-01 9.52e-01 0.01260 8.44e-03 -9.35e-03 6.54e-01 6.20e-01
Apoptotic cleavage of cellular proteins 35 9.93e-01 9.98e-01 0.01250 -7.62e-03 9.91e-03 9.38e-01 9.19e-01
GOCC CLATHRIN COATED ENDOCYTIC VESICLE 87 9.81e-01 9.94e-01 0.01220 1.22e-02 -1.13e-03 8.44e-01 9.86e-01
GOMF OXIDOREDUCTASE ACTIVITY 682 8.48e-01 9.58e-01 0.01220 6.88e-03 1.00e-02 7.59e-01 6.55e-01
GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION 35 9.93e-01 9.98e-01 0.01190 -1.13e-02 3.95e-03 9.08e-01 9.68e-01
GOMF DNA DAMAGE SENSOR ACTIVITY 23 9.96e-01 9.98e-01 0.01180 -9.94e-03 6.43e-03 9.34e-01 9.57e-01
GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS 50 9.90e-01 9.97e-01 0.01180 -2.19e-03 1.16e-02 9.79e-01 8.87e-01
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 312 9.32e-01 9.83e-01 0.01180 -4.46e-03 -1.09e-02 8.92e-01 7.40e-01
GOBP CELL CELL JUNCTION ASSEMBLY 151 9.71e-01 9.92e-01 0.01180 3.70e-03 -1.12e-02 9.37e-01 8.13e-01
GOMF INTERLEUKIN 1 BINDING 9 9.98e-01 9.99e-01 0.01140 7.96e-03 8.19e-03 9.67e-01 9.66e-01
GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY 154 9.67e-01 9.91e-01 0.01140 -6.84e-03 -9.11e-03 8.84e-01 8.45e-01
GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 151 9.74e-01 9.93e-01 0.01130 1.05e-02 -4.15e-03 8.23e-01 9.30e-01
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 511 9.18e-01 9.79e-01 0.01120 -9.72e-03 5.58e-03 7.07e-01 8.29e-01
RHO GTPases activate IQGAPs 30 9.94e-01 9.98e-01 0.01120 -1.12e-02 5.42e-04 9.16e-01 9.96e-01
GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY 7 9.99e-01 9.99e-01 0.01120 4.18e-03 1.03e-02 9.85e-01 9.62e-01
GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 99 9.83e-01 9.95e-01 0.01120 -3.01e-03 1.07e-02 9.59e-01 8.54e-01
GOBP POSITIVE REGULATION OF JNK CASCADE 91 9.81e-01 9.94e-01 0.01110 8.27e-03 7.44e-03 8.92e-01 9.02e-01
Lysosome Vesicle Biogenesis 33 9.93e-01 9.98e-01 0.01080 7.86e-03 7.41e-03 9.38e-01 9.41e-01
GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION 10 9.98e-01 9.99e-01 0.01070 -2.38e-03 1.05e-02 9.90e-01 9.54e-01
GOMF TETRAPYRROLE BINDING 144 9.75e-01 9.93e-01 0.01070 1.05e-03 1.07e-02 9.83e-01 8.25e-01
GOBP EPITHELIUM DEVELOPMENT 1194 8.31e-01 9.54e-01 0.01060 -1.04e-02 2.11e-03 5.45e-01 9.02e-01
GOBP MEMBRANE FUSION 177 9.74e-01 9.93e-01 0.01050 8.67e-03 -5.91e-03 8.42e-01 8.92e-01
Interleukin receptor SHC signaling 23 9.96e-01 9.98e-01 0.01050 8.00e-03 6.76e-03 9.47e-01 9.55e-01
GOCC MITOTIC SPINDLE 175 9.72e-01 9.93e-01 0.01020 -1.02e-02 -9.54e-04 8.16e-01 9.83e-01
GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION 696 9.10e-01 9.77e-01 0.01000 -3.59e-03 9.34e-03 8.72e-01 6.75e-01
GOBP MYELOID LEUKOCYTE DIFFERENTIATION 231 9.67e-01 9.91e-01 0.00971 -9.69e-03 -6.29e-04 8.00e-01 9.87e-01
GOMF LIGAND GATED CHANNEL ACTIVITY 180 9.76e-01 9.93e-01 0.00971 9.62e-03 -1.34e-03 8.24e-01 9.75e-01
GOBP MONOATOMIC ION TRANSPORT 1183 8.43e-01 9.56e-01 0.00970 3.02e-03 9.22e-03 8.61e-01 5.93e-01
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling 112 9.84e-01 9.95e-01 0.00927 -6.24e-03 -6.86e-03 9.09e-01 9.00e-01
GOCC AZUROPHIL GRANULE 149 9.81e-01 9.94e-01 0.00925 -9.22e-03 -6.91e-04 8.46e-01 9.88e-01
GOBP METANEPHRIC NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION 6 9.99e-01 1.00e+00 0.00923 6.31e-03 6.74e-03 9.79e-01 9.77e-01
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS 639 9.30e-01 9.83e-01 0.00900 8.79e-03 -1.94e-03 7.05e-01 9.33e-01
GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS 49 9.94e-01 9.98e-01 0.00891 7.87e-03 4.18e-03 9.24e-01 9.60e-01
GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 185 9.76e-01 9.93e-01 0.00885 7.68e-03 4.39e-03 8.57e-01 9.18e-01
GOBP REGULATION OF INTRACELLULAR TRANSPORT 252 9.68e-01 9.91e-01 0.00877 -6.23e-03 -6.18e-03 8.65e-01 8.66e-01
GOBP IMPORT INTO THE MITOCHONDRION 49 9.94e-01 9.98e-01 0.00874 -1.55e-03 -8.60e-03 9.85e-01 9.17e-01
GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS 220 9.75e-01 9.93e-01 0.00828 -6.78e-03 -4.75e-03 8.62e-01 9.03e-01
GOBP REGENERATION 192 9.83e-01 9.95e-01 0.00822 -6.02e-03 5.59e-03 8.86e-01 8.94e-01
GOBP NEUTRAL LIPID METABOLIC PROCESS 130 9.89e-01 9.96e-01 0.00815 -5.01e-03 6.43e-03 9.21e-01 8.99e-01
GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY 10 9.99e-01 1.00e+00 0.00813 -6.64e-03 4.69e-03 9.71e-01 9.80e-01
GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS 532 9.48e-01 9.87e-01 0.00810 8.01e-03 1.21e-03 7.52e-01 9.62e-01
GOBP HEMOSTASIS 223 9.76e-01 9.93e-01 0.00802 -4.35e-03 -6.74e-03 9.11e-01 8.62e-01
GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY 17 9.99e-01 9.99e-01 0.00785 5.23e-03 -5.85e-03 9.70e-01 9.67e-01
GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS 1073 9.18e-01 9.79e-01 0.00780 7.08e-03 -3.29e-03 6.95e-01 8.56e-01
GOBP TRANSITION METAL ION TRANSPORT 93 9.91e-01 9.98e-01 0.00774 5.45e-03 5.50e-03 9.28e-01 9.27e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION 48 9.95e-01 9.98e-01 0.00770 3.62e-03 6.80e-03 9.65e-01 9.35e-01
GOBP RIBOSE PHOSPHATE METABOLIC PROCESS 446 9.59e-01 9.90e-01 0.00747 -5.36e-03 -5.20e-03 8.46e-01 8.51e-01
Neutrophil degranulation 458 9.61e-01 9.90e-01 0.00743 7.10e-03 2.20e-03 7.95e-01 9.36e-01
GOBP ORGANIC ACID BIOSYNTHETIC PROCESS 319 9.77e-01 9.93e-01 0.00728 6.77e-03 -2.68e-03 8.35e-01 9.34e-01
GOBP CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 226 9.81e-01 9.94e-01 0.00720 6.38e-03 3.33e-03 8.69e-01 9.31e-01
GOBP REGULATION OF CHEMOTAXIS 200 9.87e-01 9.95e-01 0.00702 -3.25e-03 6.22e-03 9.37e-01 8.80e-01
GOBP POSITIVE REGULATION OF SECRETION 307 9.76e-01 9.93e-01 0.00695 -6.40e-03 -2.70e-03 8.47e-01 9.35e-01
GOMF FLIPPASE ACTIVITY 15 9.99e-01 9.99e-01 0.00692 4.11e-03 5.57e-03 9.78e-01 9.70e-01
GOBP PROTEIN PROCESSING 230 9.86e-01 9.95e-01 0.00647 1.53e-03 -6.29e-03 9.68e-01 8.69e-01
GOMF SIGNALING RECEPTOR BINDING 1409 9.25e-01 9.81e-01 0.00636 -1.23e-03 6.24e-03 9.38e-01 6.95e-01
GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING 24 9.98e-01 9.99e-01 0.00631 4.62e-03 4.29e-03 9.69e-01 9.71e-01
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT 36 9.98e-01 9.99e-01 0.00616 4.94e-03 -3.68e-03 9.59e-01 9.69e-01
GOMF SUPEROXIDE DISMUTASE ACTIVITY 5 1.00e+00 1.00e+00 0.00613 5.69e-03 2.29e-03 9.82e-01 9.93e-01
GOCC FICOLIN 1 RICH GRANULE 180 9.91e-01 9.98e-01 0.00605 4.53e-03 -4.02e-03 9.17e-01 9.26e-01
Negative regulation of the PI3K/AKT network 119 9.94e-01 9.98e-01 0.00536 2.86e-03 4.54e-03 9.57e-01 9.32e-01
GOBP REGULATION OF CELL ADHESION 781 9.67e-01 9.91e-01 0.00523 -2.11e-03 -4.79e-03 9.20e-01 8.20e-01
GOBP REGULATION OF CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 107 9.95e-01 9.98e-01 0.00516 4.80e-03 1.91e-03 9.32e-01 9.73e-01
GOBP MONOATOMIC CATION TRANSPORT 990 9.72e-01 9.92e-01 0.00454 -4.51e-03 4.92e-04 8.10e-01 9.79e-01
GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 168 9.95e-01 9.98e-01 0.00407 3.46e-03 2.15e-03 9.38e-01 9.62e-01
GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 170 9.96e-01 9.98e-01 0.00405 -1.64e-03 3.70e-03 9.71e-01 9.34e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY 25 9.99e-01 1.00e+00 0.00403 -4.02e-03 -3.01e-04 9.72e-01 9.98e-01
GOMF MRNA BINDING 576 9.88e-01 9.96e-01 0.00356 -1.76e-03 -3.10e-03 9.43e-01 8.99e-01
GOBP PHAGOCYTOSIS 231 9.97e-01 9.99e-01 0.00272 4.81e-04 2.68e-03 9.90e-01 9.44e-01
GOCC NUCLEAR ENVELOPE 473 9.96e-01 9.98e-01 0.00224 4.90e-04 2.18e-03 9.85e-01 9.35e-01
Disorders of transmembrane transporters 158 9.99e-01 1.00e+00 0.00186 1.86e-03 3.90e-05 9.68e-01 9.99e-01
GOBP REGULATION OF MAP KINASE ACTIVITY 128 1.00e+00 1.00e+00 0.00114 -9.39e-04 -6.48e-04 9.85e-01 9.90e-01
GOMF WIDE PORE CHANNEL ACTIVITY 33 1.00e+00 1.00e+00 0.00061 -3.75e-04 -4.80e-04 9.97e-01 9.96e-01


Detailed Gene set reports


GOBP THELARCHE
GOBP THELARCHE
metric value
setSize 5
pMANOVA 0.00192
p.adjustMANOVA 0.0527
s.dist 0.965
s.cancer 0.713
s.incidence -0.651
p.cancer 0.00577
p.incidence 0.0117



Top 20 genes
Gene cancer incidence
AREG 11192 -10153
PHB2 9765 -8026
TGFB1 8028 -6706
MED1 3208 -7530
WNT5A 8726 -2379

Click HERE to show all gene set members

All member genes
cancer incidence
AREG 11192 -10153
MED1 3208 -7530
PHB2 9765 -8026
TGFB1 8028 -6706
WNT5A 8726 -2379



GOMF N ACETYLLACTOSAMINIDE BETA 1 3 N ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY
GOMF N ACETYLLACTOSAMINIDE BETA 1 3 N ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY
metric value
setSize 6
pMANOVA 0.000324
p.adjustMANOVA 0.0139
s.dist 0.889
s.cancer 0.712
s.incidence 0.534
p.cancer 0.00254
p.incidence 0.0236



Top 20 genes
Gene cancer incidence
B3GNT7 8875 10842
B4GAT1 10930 8300
B3GNT4 9371 8438
B3GNT5 9047 5960
B3GNT3 7846 921
B3GNT2 2949 1662

Click HERE to show all gene set members

All member genes
cancer incidence
B3GNT2 2949 1662
B3GNT3 7846 921
B3GNT4 9371 8438
B3GNT5 9047 5960
B3GNT7 8875 10842
B4GAT1 10930 8300



Tachykinin receptors bind tachykinins
Tachykinin receptors bind tachykinins
metric value
setSize 5
pMANOVA 0.002
p.adjustMANOVA 0.0543
s.dist 0.881
s.cancer -0.856
s.incidence -0.208
p.cancer 0.000919
p.incidence 0.421



Top 20 genes
Gene cancer incidence
TAC3 -9062 -10282
TAC1 -10236 -5734
TACR3 -10346 -3204
TACR2 -10364 -103

Click HERE to show all gene set members

All member genes
cancer incidence
TAC1 -10236 -5734
TAC3 -9062 -10282
TACR1 -5020 8796
TACR2 -10364 -103
TACR3 -10346 -3204



GOBP LOBAR BRONCHUS EPITHELIUM DEVELOPMENT
GOBP LOBAR BRONCHUS EPITHELIUM DEVELOPMENT
metric value
setSize 5
pMANOVA 0.00453
p.adjustMANOVA 0.0931
s.dist 0.876
s.cancer 0.825
s.incidence -0.294
p.cancer 0.00141
p.incidence 0.254



Top 20 genes
Gene cancer incidence
HOXA5 11212 -5428
AGR2 11067 -4415
SPDEF 10947 -4381
IL13 4523 -1821

Click HERE to show all gene set members

All member genes
cancer incidence
ADAMTSL2 9297 777
AGR2 11067 -4415
HOXA5 11212 -5428
IL13 4523 -1821
SPDEF 10947 -4381



GOBP AORTA SMOOTH MUSCLE TISSUE MORPHOGENESIS
GOBP AORTA SMOOTH MUSCLE TISSUE MORPHOGENESIS
metric value
setSize 6
pMANOVA 0.00138
p.adjustMANOVA 0.0414
s.dist 0.831
s.cancer -0.814
s.incidence -0.164
p.cancer 0.000552
p.incidence 0.486



Top 20 genes
Gene cancer incidence
COL3A1 -9548 -6256
MIR143 -10137 -4827
EFEMP2 -7312 -2314
PROX1 -7302 -29

Click HERE to show all gene set members

All member genes
cancer incidence
COL3A1 -9548 -6256
EFEMP2 -7312 -2314
MIR143 -10137 -4827
MIR145 -10224 491
MYLK -6773 3168
PROX1 -7302 -29



GOBP REGULATION OF CORTICOTROPIN SECRETION
GOBP REGULATION OF CORTICOTROPIN SECRETION
metric value
setSize 5
pMANOVA 0.00673
p.adjustMANOVA 0.119
s.dist 0.83
s.cancer -0.814
s.incidence 0.163
p.cancer 0.00162
p.incidence 0.528



Top 20 genes
Gene cancer incidence
UCN -9324 10809
CRHBP -7802 5176
RAB8B -6990 1569
GHRL -9374 153

Click HERE to show all gene set members

All member genes
cancer incidence
CRH -9239 -7919
CRHBP -7802 5176
GHRL -9374 153
RAB8B -6990 1569
UCN -9324 10809



GOCC ATP BINDING CASSETTE ABC TRANSPORTER COMPLEX
GOCC ATP BINDING CASSETTE ABC TRANSPORTER COMPLEX
metric value
setSize 6
pMANOVA 0.00334
p.adjustMANOVA 0.0786
s.dist 0.83
s.cancer -0.362
s.incidence 0.747
p.cancer 0.124
p.incidence 0.00154



Top 20 genes
Gene cancer incidence
ABCG8 -8101 9553
ABCB8 -7641 9207
ABCB6 -7978 7928
ABCG5 -4212 9550
ABCD4 -1619 4031

Click HERE to show all gene set members

All member genes
cancer incidence
ABCA2 7956 9854
ABCB6 -7978 7928
ABCB8 -7641 9207
ABCD4 -1619 4031
ABCG5 -4212 9550
ABCG8 -8101 9553



GOBP TACHYKININ RECEPTOR SIGNALING PATHWAY
GOBP TACHYKININ RECEPTOR SIGNALING PATHWAY
metric value
setSize 8
pMANOVA 0.000324
p.adjustMANOVA 0.0139
s.dist 0.828
s.cancer -0.817
s.incidence 0.135
p.cancer 6.23e-05
p.incidence 0.508



Top 20 genes
Gene cancer incidence
TAC4 -9672 10683
GRK2 -7667 7943
TACR1 -5020 8796
GRK5 -6297 5141

Click HERE to show all gene set members

All member genes
cancer incidence
GRK2 -7667 7943
GRK5 -6297 5141
TAC1 -10236 -5734
TAC3 -9062 -10282
TAC4 -9672 10683
TACR1 -5020 8796
TACR2 -10364 -103
TACR3 -10346 -3204



GOCC TROPONIN COMPLEX
GOCC TROPONIN COMPLEX
metric value
setSize 9
pMANOVA 3.07e-05
p.adjustMANOVA 0.00213
s.dist 0.825
s.cancer 0.642
s.incidence 0.518
p.cancer 0.00085
p.incidence 0.0071



Top 20 genes
Gene cancer incidence
TNNC2 8805 10111
TNNT2 10781 7550
PVALEF 8659 7019
TNNI2 8442 6590
TNNI3 6198 7383
TNNI1 9367 1648
TNNC1 7947 1611
TNNT3 10038 1048

Click HERE to show all gene set members

All member genes
cancer incidence
PVALEF 8659 7019
TNNC1 7947 1611
TNNC2 8805 10111
TNNI1 9367 1648
TNNI2 8442 6590
TNNI3 6198 7383
TNNT1 -3571 9700
TNNT2 10781 7550
TNNT3 10038 1048



GOBP CHONDROBLAST DIFFERENTIATION
GOBP CHONDROBLAST DIFFERENTIATION
metric value
setSize 5
pMANOVA 0.0115
p.adjustMANOVA 0.167
s.dist 0.809
s.cancer -0.699
s.incidence 0.407
p.cancer 0.00677
p.incidence 0.115



Top 20 genes
Gene cancer incidence
RARA -9308 7090
GDF5 -5777 10107
FGF4 -4701 8689
FGF2 -6793 5298

Click HERE to show all gene set members

All member genes
cancer incidence
CCN1 -9872 -8034
FGF2 -6793 5298
FGF4 -4701 8689
GDF5 -5777 10107
RARA -9308 7090



GOBP EPINEPHRINE SECRETION
GOBP EPINEPHRINE SECRETION
metric value
setSize 7
pMANOVA 0.000521
p.adjustMANOVA 0.0197
s.dist 0.803
s.cancer -0.695
s.incidence -0.402
p.cancer 0.00145
p.incidence 0.0655



Top 20 genes
Gene cancer incidence
CRH -9239 -7919
CARTPT -10295 -6421
ADRA2B -7341 -8608
VIP -3679 -10012
ADRA2C -5163 -7022

Click HERE to show all gene set members

All member genes
cancer incidence
ADRA2A -8858 1714
ADRA2B -7341 -8608
ADRA2C -5163 -7022
CARTPT -10295 -6421
CRH -9239 -7919
GABBR1 -6116 8648
VIP -3679 -10012



GOMF CCR6 CHEMOKINE RECEPTOR BINDING
GOMF CCR6 CHEMOKINE RECEPTOR BINDING
metric value
setSize 5
pMANOVA 0.0126
p.adjustMANOVA 0.177
s.dist 0.799
s.cancer 0.699
s.incidence -0.387
p.cancer 0.00676
p.incidence 0.134



Top 20 genes
Gene cancer incidence
DEFB114 10971 -8595
DEFB110 10779 -8709
DEFB133 9329 -2374

Click HERE to show all gene set members

All member genes
cancer incidence
CCL20 10907 9945
DEFB1 -1806 -10581
DEFB110 10779 -8709
DEFB114 10971 -8595
DEFB133 9329 -2374



GOMF 3 KETO STEROL REDUCTASE ACTIVITY
GOMF 3 KETO STEROL REDUCTASE ACTIVITY
metric value
setSize 5
pMANOVA 0.0108
p.adjustMANOVA 0.161
s.dist 0.797
s.cancer 0.218
s.incidence -0.766
p.cancer 0.399
p.incidence 0.003



Top 20 genes
Gene cancer incidence
HSD3B1 8053 -9088
CBR3 6496 -8143
DHRS11 6374 -8084
DHRS4 2574 -8719

Click HERE to show all gene set members

All member genes
cancer incidence
CBR3 6496 -8143
DHRS11 6374 -8084
DHRS4 2574 -8719
HSD17B7 -9702 -7088
HSD3B1 8053 -9088



GOBP LOBAR BRONCHUS DEVELOPMENT
GOBP LOBAR BRONCHUS DEVELOPMENT
metric value
setSize 6
pMANOVA 0.00429
p.adjustMANOVA 0.0905
s.dist 0.787
s.cancer 0.778
s.incidence -0.124
p.cancer 0.00097
p.incidence 0.6



Top 20 genes
Gene cancer incidence
HOXA5 11212 -5428
AGR2 11067 -4415
SPDEF 10947 -4381
IL13 4523 -1821

Click HERE to show all gene set members

All member genes
cancer incidence
ADAMTSL2 9297 777
AGR2 11067 -4415
HOXA5 11212 -5428
IL13 4523 -1821
SPDEF 10947 -4381
WNT7B 6320 8187



GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT
GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT
metric value
setSize 7
pMANOVA 0.00277
p.adjustMANOVA 0.0691
s.dist 0.786
s.cancer -0.414
s.incidence 0.669
p.cancer 0.0581
p.incidence 0.00218



Top 20 genes
Gene cancer incidence
MAP1A -10115 9182
MTOR -9388 7373
ITPR1 -7078 4874
HIPK2 -2288 8074
VTI1A -2367 6561

Click HERE to show all gene set members

All member genes
cancer incidence
HIPK2 -2288 8074
ITPR1 -7078 4874
MAP1A -10115 9182
MTOR -9388 7373
VPS35 159 6982
VTI1A -2367 6561
XRCC1 1962 9462



GOMF KERATIN FILAMENT BINDING
GOMF KERATIN FILAMENT BINDING
metric value
setSize 6
pMANOVA 0.00191
p.adjustMANOVA 0.0525
s.dist 0.784
s.cancer 0.601
s.incidence 0.504
p.cancer 0.0109
p.incidence 0.0324



Top 20 genes
Gene cancer incidence
KRT14 10668 10812
EPPK1 9449 9200
KRT74 8887 6623
FAM83H 6067 8328
VIM 706 318

Click HERE to show all gene set members

All member genes
cancer incidence
EPPK1 9449 9200
FAM83H 6067 8328
KRT14 10668 10812
KRT74 8887 6623
SIRT1 5940 -1074
VIM 706 318



GOBP NEURAL FOLD FORMATION
GOBP NEURAL FOLD FORMATION
metric value
setSize 7
pMANOVA 0.00221
p.adjustMANOVA 0.0582
s.dist 0.781
s.cancer 0.205
s.incidence -0.754
p.cancer 0.348
p.incidence 0.000549



Top 20 genes
Gene cancer incidence
NODAL 10811 -9690
BMP7 6671 -9205
BMP5 5530 -10118
HIF1A 8587 -6142

Click HERE to show all gene set members

All member genes
cancer incidence
BMP5 5530 -10118
BMP7 6671 -9205
CECR2 -4527 -5116
HIF1A 8587 -6142
LUZP1 -384 -7126
NODAL 10811 -9690
OVOL2 -8365 -9234



GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB
GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB
metric value
setSize 5
pMANOVA 0.0168
p.adjustMANOVA 0.208
s.dist 0.78
s.cancer 0.505
s.incidence -0.594
p.cancer 0.0504
p.incidence 0.0215



Top 20 genes
Gene cancer incidence
CD1C 10662 -10649
CD1E 7194 -10624
CD1D 9620 -7113
CD1B 9496 -3665

Click HERE to show all gene set members

All member genes
cancer incidence
CD1A -7420 398
CD1B 9496 -3665
CD1C 10662 -10649
CD1D 9620 -7113
CD1E 7194 -10624



GOMF LIPID ANTIGEN BINDING
GOMF LIPID ANTIGEN BINDING
metric value
setSize 5
pMANOVA 0.0168
p.adjustMANOVA 0.208
s.dist 0.78
s.cancer 0.505
s.incidence -0.594
p.cancer 0.0504
p.incidence 0.0215



Top 20 genes
Gene cancer incidence
CD1C 10662 -10649
CD1E 7194 -10624
CD1D 9620 -7113
CD1B 9496 -3665

Click HERE to show all gene set members

All member genes
cancer incidence
CD1A -7420 398
CD1B 9496 -3665
CD1C 10662 -10649
CD1D 9620 -7113
CD1E 7194 -10624



GOMF PROSTAGLANDIN E RECEPTOR ACTIVITY
GOMF PROSTAGLANDIN E RECEPTOR ACTIVITY
metric value
setSize 5
pMANOVA 0.0173
p.adjustMANOVA 0.211
s.dist 0.777
s.cancer 0.571
s.incidence -0.527
p.cancer 0.027
p.incidence 0.0411



Top 20 genes
Gene cancer incidence
PTGER1 9065 -9608
PTGER4 10496 -5825
PTGER2 3846 -9655
PTGER3 8602 -3942

Click HERE to show all gene set members

All member genes
cancer incidence
HPGD 1152 1004
PTGER1 9065 -9608
PTGER2 3846 -9655
PTGER3 8602 -3942
PTGER4 10496 -5825



GOBP PROTEIN O LINKED FUCOSYLATION
GOBP PROTEIN O LINKED FUCOSYLATION
metric value
setSize 5
pMANOVA 0.0145
p.adjustMANOVA 0.191
s.dist 0.777
s.cancer -0.276
s.incidence 0.726
p.cancer 0.285
p.incidence 0.00492



Top 20 genes
Gene cancer incidence
SLC35C2 -9017 8186
SLC35C1 -6455 8959
POFUT2 -7270 7610

Click HERE to show all gene set members

All member genes
cancer incidence
B3GLCT 2761 8085
POFUT1 6710 7815
POFUT2 -7270 7610
SLC35C1 -6455 8959
SLC35C2 -9017 8186



GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS
GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS
metric value
setSize 7
pMANOVA 0.00359
p.adjustMANOVA 0.0826
s.dist 0.774
s.cancer 0.513
s.incidence -0.579
p.cancer 0.0188
p.incidence 0.00795



Top 20 genes
Gene cancer incidence
AREG 11192 -10153
PHB2 9765 -8026
TGFB1 8028 -6706
MED1 3208 -7530
IRF2BPL 4727 -4990
WNT5A 8726 -2379

Click HERE to show all gene set members

All member genes
cancer incidence
AREG 11192 -10153
IRF2BPL 4727 -4990
MED1 3208 -7530
PHB2 9765 -8026
STAT5B -3695 -3432
TGFB1 8028 -6706
WNT5A 8726 -2379



GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY
GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY
metric value
setSize 10
pMANOVA 0.000362
p.adjustMANOVA 0.0151
s.dist 0.766
s.cancer -0.612
s.incidence 0.462
p.cancer 0.000806
p.incidence 0.0115



Top 20 genes
Gene cancer incidence
KMT2D -8895 10824
KMT2B -7166 10807
KMT2C -8087 8531
PRDM9 -8158 4842
SMYD1 -9989 3413
SETD1A -2671 7338
SETD1B -3838 4905
SMYD2 -8625 274

Click HERE to show all gene set members

All member genes
cancer incidence
KMT2A -5896 -3350
KMT2B -7166 10807
KMT2C -8087 8531
KMT2D -8895 10824
PRDM9 -8158 4842
SETD1A -2671 7338
SETD1B -3838 4905
SMYD1 -9989 3413
SMYD2 -8625 274
SMYD3 17 4727



GOCC ALPHA BETA T CELL RECEPTOR COMPLEX
GOCC ALPHA BETA T CELL RECEPTOR COMPLEX
metric value
setSize 5
pMANOVA 0.0183
p.adjustMANOVA 0.215
s.dist 0.752
s.cancer 0.231
s.incidence -0.715
p.cancer 0.37
p.incidence 0.00559



Top 20 genes
Gene cancer incidence
PTPN6 10846 -9179
CD3D 2744 -10567
CD3E 312 -10313

Click HERE to show all gene set members

All member genes
cancer incidence
CD247 1251 2337
CD3D 2744 -10567
CD3E 312 -10313
CD3G -612 -10611
PTPN6 10846 -9179



GOBP NEGATIVE REGULATION OF EPINEPHRINE SECRETION
GOBP NEGATIVE REGULATION OF EPINEPHRINE SECRETION
metric value
setSize 5
pMANOVA 0.0101
p.adjustMANOVA 0.155
s.dist 0.749
s.cancer -0.704
s.incidence -0.257
p.cancer 0.0064
p.incidence 0.321



Top 20 genes
Gene cancer incidence
CRH -9239 -7919
ADRA2B -7341 -8608
ADRA2C -5163 -7022

Click HERE to show all gene set members

All member genes
cancer incidence
ADRA2A -8858 1714
ADRA2B -7341 -8608
ADRA2C -5163 -7022
CRH -9239 -7919
GABBR1 -6116 8648



GOBP MESENCHYME MIGRATION
GOBP MESENCHYME MIGRATION
metric value
setSize 5
pMANOVA 0.0111
p.adjustMANOVA 0.164
s.dist 0.746
s.cancer -0.717
s.incidence -0.207
p.cancer 0.0055
p.incidence 0.422



Top 20 genes
Gene cancer incidence
ACTG2 -10129 -3905
ACTC1 -5869 -4460
FOXF1 -1768 -7102

Click HERE to show all gene set members

All member genes
cancer incidence
ACTA1 -10088 3998
ACTA2 -9566 980
ACTC1 -5869 -4460
ACTG2 -10129 -3905
FOXF1 -1768 -7102



GOBP BRANCH ELONGATION INVOLVED IN MAMMARY GLAND DUCT BRANCHING
GOBP BRANCH ELONGATION INVOLVED IN MAMMARY GLAND DUCT BRANCHING
metric value
setSize 5
pMANOVA 0.0246
p.adjustMANOVA 0.251
s.dist 0.743
s.cancer 0.52
s.incidence -0.531
p.cancer 0.044
p.incidence 0.0399



Top 20 genes
Gene cancer incidence
AREG 11192 -10153
TGFB1 8028 -6706
MED1 3208 -7530
WNT5A 8726 -2379

Click HERE to show all gene set members

All member genes
cancer incidence
AREG 11192 -10153
ESR1 -791 -1441
MED1 3208 -7530
TGFB1 8028 -6706
WNT5A 8726 -2379



GOBP REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY
GOBP REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY
metric value
setSize 7
pMANOVA 0.00387
p.adjustMANOVA 0.0862
s.dist 0.734
s.cancer -0.727
s.incidence 0.0992
p.cancer 0.000861
p.incidence 0.65



Top 20 genes
Gene cancer incidence
LMO3 -10101 5290
PER1 -9829 4924
CRY2 -9534 3282
CLOCK -5707 4963
BMAL1 -3413 4530

Click HERE to show all gene set members

All member genes
cancer incidence
BMAL1 -3413 4530
CLOCK -5707 4963
CRY1 -7886 -6597
CRY2 -9534 3282
LMO3 -10101 5290
PER1 -9829 4924
PHB1 -6703 -7572



GOBP NEGATIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE
GOBP NEGATIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE
metric value
setSize 6
pMANOVA 0.0139
p.adjustMANOVA 0.188
s.dist 0.728
s.cancer -0.55
s.incidence 0.476
p.cancer 0.0195
p.incidence 0.0433



Top 20 genes
Gene cancer incidence
HCRT -9725 9505
GLRA1 -9027 2772
GPR35 -2112 8597
MTNR1B -9180 257
AVPR1A -9922 212

Click HERE to show all gene set members

All member genes
cancer incidence
AVP 6007 11023
AVPR1A -9922 212
GLRA1 -9027 2772
GPR35 -2112 8597
HCRT -9725 9505
MTNR1B -9180 257



GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR
metric value
setSize 7
pMANOVA 0.00583
p.adjustMANOVA 0.11
s.dist 0.726
s.cancer 0.279
s.incidence -0.671
p.cancer 0.202
p.incidence 0.00212



Top 20 genes
Gene cancer incidence
RPL26 5732 -9567
MYC 5912 -8821
EIF5A 5095 -9112
RPS7 5109 -7111
UBB 6644 -5048

Click HERE to show all gene set members

All member genes
cancer incidence
EIF5A 5095 -9112
MIR186 -1359 -5333
MSX1 -3147 -5225
MYC 5912 -8821
RPL26 5732 -9567
RPS7 5109 -7111
UBB 6644 -5048



GOMF AMINOACYL TRNA HYDROLASE ACTIVITY
GOMF AMINOACYL TRNA HYDROLASE ACTIVITY
metric value
setSize 5
pMANOVA 0.0234
p.adjustMANOVA 0.245
s.dist 0.725
s.cancer 0.193
s.incidence -0.699
p.cancer 0.455
p.incidence 0.00682



Top 20 genes
Gene cancer incidence
PTRHD1 7366 -6676
ETF1 8754 -4846
PTRH1 3286 -9542

Click HERE to show all gene set members

All member genes
cancer incidence
ETF1 8754 -4846
MRPL58 -6518 -8398
PTRH1 3286 -9542
PTRH2 -450 -7950
PTRHD1 7366 -6676



GOBP REGULATION OF GLUCOSYLCERAMIDE CATABOLIC PROCESS
GOBP REGULATION OF GLUCOSYLCERAMIDE CATABOLIC PROCESS
metric value
setSize 5
pMANOVA 0.0214
p.adjustMANOVA 0.234
s.dist 0.723
s.cancer -0.105
s.incidence 0.716
p.cancer 0.683
p.incidence 0.00559



Top 20 genes
Gene cancer incidence
MIR195 -10237 9965
SCARB2 -7113 4553
PRKCD -1083 5987

Click HERE to show all gene set members

All member genes
cancer incidence
MIR127 6809 10438
MIR16-1 7708 9132
MIR195 -10237 9965
PRKCD -1083 5987
SCARB2 -7113 4553



GOBP N ACYLETHANOLAMINE METABOLIC PROCESS
GOBP N ACYLETHANOLAMINE METABOLIC PROCESS
metric value
setSize 5
pMANOVA 0.0277
p.adjustMANOVA 0.264
s.dist 0.72
s.cancer 0.65
s.incidence -0.31
p.cancer 0.0118
p.incidence 0.231



Top 20 genes
Gene cancer incidence
GDPD3 7697 -9454
GDPD1 5479 -9396
NAAA 9589 -3888
GDE1 7738 -789

Click HERE to show all gene set members

All member genes
cancer incidence
GDE1 7738 -789
GDPD1 5479 -9396
GDPD3 7697 -9454
NAAA 9589 -3888
NAPEPLD 6995 7431



GOBP ADENYLATE CYCLASE INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY
GOBP ADENYLATE CYCLASE INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY
metric value
setSize 7
pMANOVA 0.00723
p.adjustMANOVA 0.125
s.dist 0.717
s.cancer -0.626
s.incidence 0.35
p.cancer 0.00412
p.incidence 0.109



Top 20 genes
Gene cancer incidence
HTR1B -10202 6989
HTR1F -9116 7799
HTR1E -6732 4622
HTR5A -8914 2622
HTR1A -10459 676
DRD4 -4 8938

Click HERE to show all gene set members

All member genes
cancer incidence
DRD4 -4 8938
HTR1A -10459 676
HTR1B -10202 6989
HTR1D 7 -3572
HTR1E -6732 4622
HTR1F -9116 7799
HTR5A -8914 2622



GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE
GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE
metric value
setSize 8
pMANOVA 0.00377
p.adjustMANOVA 0.0847
s.dist 0.716
s.cancer 0.384
s.incidence -0.605
p.cancer 0.0603
p.incidence 0.00304



Top 20 genes
Gene cancer incidence
LTA 10909 -9369
TNF 10231 -7936
CCL5 7123 -10402
IDO1 9807 -7503
ADORA2B 8470 -936
CYP19A1 3120 -1184

Click HERE to show all gene set members

All member genes
cancer incidence
ADORA2B 8470 -936
CCL5 7123 -10402
CYP19A1 3120 -1184
IDO1 9807 -7503
IL10 -7972 -8520
LTA 10909 -9369
TNF 10231 -7936
TNFAIP3 -5084 -5798



GOMF ALCOHOL DEHYDROGENASE NADPLUS ACTIVITY ZINC DEPENDENT
GOMF ALCOHOL DEHYDROGENASE NADPLUS ACTIVITY ZINC DEPENDENT
metric value
setSize 7
pMANOVA 0.00816
p.adjustMANOVA 0.135
s.dist 0.714
s.cancer 0.565
s.incidence -0.437
p.cancer 0.00968
p.incidence 0.0452



Top 20 genes
Gene cancer incidence
ADH1A 10186 -9677
ADH1C 11100 -8081
ADH7 5354 -9695
ADH5 4078 -3797

Click HERE to show all gene set members

All member genes
cancer incidence
ADH1A 10186 -9677
ADH1B -5954 -9973
ADH1C 11100 -8081
ADH4 10048 7016
ADH5 4078 -3797
ADH6 11106 1901
ADH7 5354 -9695



GOCC GARP COMPLEX
GOCC GARP COMPLEX
metric value
setSize 5
pMANOVA 0.0333
p.adjustMANOVA 0.285
s.dist 0.711
s.cancer -0.552
s.incidence 0.449
p.cancer 0.0326
p.incidence 0.0824



Top 20 genes
Gene cancer incidence
VPS51 -5664 9686
EIPR1 -7095 7531
VPS53 -8636 4045
VPS54 -3962 1910
VPS52 -3008 2274

Click HERE to show all gene set members

All member genes
cancer incidence
EIPR1 -7095 7531
VPS51 -5664 9686
VPS52 -3008 2274
VPS53 -8636 4045
VPS54 -3962 1910



GOBP POSITIVE REGULATION OF FEAR RESPONSE
GOBP POSITIVE REGULATION OF FEAR RESPONSE
metric value
setSize 7
pMANOVA 0.00459
p.adjustMANOVA 0.0937
s.dist 0.709
s.cancer -0.709
s.incidence -0.0175
p.cancer 0.00116
p.incidence 0.936



Top 20 genes
Gene cancer incidence
GRP -8659 -9306
CRH -9239 -7919
PENK -10355 -1657
NPAS2 -2602 -1966

Click HERE to show all gene set members

All member genes
cancer incidence
CRH -9239 -7919
GRP -8659 -9306
MEF2C -6591 644
NPAS2 -2602 -1966
PENK -10355 -1657
PRKAR1B -4993 9269
UCN -9324 10809



GOBP CORTISOL SECRETION
GOBP CORTISOL SECRETION
metric value
setSize 5
pMANOVA 0.0199
p.adjustMANOVA 0.226
s.dist 0.708
s.cancer -0.703
s.incidence -0.0839
p.cancer 0.00647
p.incidence 0.745



Top 20 genes
Gene cancer incidence
CRH -9239 -7919
PTPN11 -842 -5938

Click HERE to show all gene set members

All member genes
cancer incidence
CRH -9239 -7919
GAL -7600 6027
GALR1 -9608 3948
GHRL -9374 153
PTPN11 -842 -5938



GOMF MHC CLASS IB RECEPTOR ACTIVITY
GOMF MHC CLASS IB RECEPTOR ACTIVITY
metric value
setSize 7
pMANOVA 0.00875
p.adjustMANOVA 0.142
s.dist 0.708
s.cancer 0.573
s.incidence -0.415
p.cancer 0.0086
p.incidence 0.0571



Top 20 genes
Gene cancer incidence
KLRD1 10110 -10605
KLRK1 9433 -9347
KIR2DL4 7779 -10528
KLRC4-KLRK1 5564 -4894
LILRB1 3507 -4558
CD160 1249 -111

Click HERE to show all gene set members

All member genes
cancer incidence
CD160 1249 -111
KIR2DL4 7779 -10528
KLRC1 8949 9412
KLRC4-KLRK1 5564 -4894
KLRD1 10110 -10605
KLRK1 9433 -9347
LILRB1 3507 -4558



GOCC EARP COMPLEX
GOCC EARP COMPLEX
metric value
setSize 5
pMANOVA 0.0339
p.adjustMANOVA 0.286
s.dist 0.701
s.cancer -0.624
s.incidence 0.321
p.cancer 0.0157
p.incidence 0.214



Top 20 genes
Gene cancer incidence
VPS51 -5664 9686
EIPR1 -7095 7531
VPS53 -8636 4045
VPS52 -3008 2274

Click HERE to show all gene set members

All member genes
cancer incidence
EIPR1 -7095 7531
VPS50 -7920 -5100
VPS51 -5664 9686
VPS52 -3008 2274
VPS53 -8636 4045



Zinc efflux and compartmentalization by the SLC30 family
Zinc efflux and compartmentalization by the SLC30 family
metric value
setSize 5
pMANOVA 0.036
p.adjustMANOVA 0.293
s.dist 0.699
s.cancer 0.366
s.incidence -0.595
p.cancer 0.156
p.incidence 0.0212



Top 20 genes
Gene cancer incidence
SLC30A3 7648 -6905
SLC30A8 6332 -7702
SLC30A1 5052 -4766
SLC30A2 2407 -6632
SLC30A5 489 -5736

Click HERE to show all gene set members

All member genes
cancer incidence
SLC30A1 5052 -4766
SLC30A2 2407 -6632
SLC30A3 7648 -6905
SLC30A5 489 -5736
SLC30A8 6332 -7702



GOBP THYMOCYTE MIGRATION
GOBP THYMOCYTE MIGRATION
metric value
setSize 7
pMANOVA 0.00314
p.adjustMANOVA 0.0759
s.dist 0.698
s.cancer 0.574
s.incidence 0.398
p.cancer 0.00851
p.incidence 0.0685



Top 20 genes
Gene cancer incidence
CCL20 10907 9945
XCL1 10657 8349
AIRE 7782 10596
ADAM8 6772 10252
CCR6 7305 48

Click HERE to show all gene set members

All member genes
cancer incidence
ADAM8 6772 10252
AIRE 7782 10596
CCL20 10907 9945
CCR2 -6815 1657
CCR6 7305 48
CORO1A 10046 -9140
XCL1 10657 8349



GOMF HEMOGLOBIN ALPHA BINDING
GOMF HEMOGLOBIN ALPHA BINDING
metric value
setSize 5
pMANOVA 0.0259
p.adjustMANOVA 0.255
s.dist 0.697
s.cancer 0.696
s.incidence -0.0367
p.cancer 0.00699
p.incidence 0.887



Top 20 genes
Gene cancer incidence
HBD 9649 -6257
HBB 10220 -3760
HBG2 6464 -4389

Click HERE to show all gene set members

All member genes
cancer incidence
HBB 10220 -3760
HBD 9649 -6257
HBE1 8623 8110
HBG1 5068 5154
HBG2 6464 -4389



GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION
GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION
metric value
setSize 6
pMANOVA 0.0124
p.adjustMANOVA 0.175
s.dist 0.693
s.cancer -0.00295
s.incidence -0.693
p.cancer 0.99
p.incidence 0.00327



Top 20 genes
Gene cancer incidence
PRAP1 -9238 -8849
NUMA1 -8948 -1595

Click HERE to show all gene set members

All member genes
cancer incidence
AURKB 8537 -9965
CDK1 4482 -8116
KAT5 2598 -7375
MAD2L1BP 4610 -8649
NUMA1 -8948 -1595
PRAP1 -9238 -8849



GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX
GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX
metric value
setSize 6
pMANOVA 0.0145
p.adjustMANOVA 0.191
s.dist 0.693
s.cancer 0.0977
s.incidence -0.686
p.cancer 0.679
p.incidence 0.00362



Top 20 genes
Gene cancer incidence
DENR 7913.0 -6873.0
RPL13A 10415.5 -4086.5
EIF2S2 3654.0 -6376.0

Click HERE to show all gene set members

All member genes
cancer incidence
DENR 7913.0 -6873.0
DHX29 -3048.0 -7665.0
EIF2D -7181.0 -9612.0
EIF2S2 3654.0 -6376.0
MCTS2 -3095.0 -9436.0
RPL13A 10415.5 -4086.5



GOBP NEGATIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT
GOBP NEGATIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT
metric value
setSize 5
pMANOVA 0.0367
p.adjustMANOVA 0.295
s.dist 0.689
s.cancer 0.633
s.incidence -0.273
p.cancer 0.0142
p.incidence 0.29



Top 20 genes
Gene cancer incidence
DKK4 10408 -5982
CDH3 6630 -7239
NGFR 7871 -2618
SMO 2003 -2634

Click HERE to show all gene set members

All member genes
cancer incidence
CDH3 6630 -7239
DKK4 10408 -5982
FERMT1 9639 4381
NGFR 7871 -2618
SMO 2003 -2634



GOMF CARBOHYDRATE PROTON SYMPORTER ACTIVITY
GOMF CARBOHYDRATE PROTON SYMPORTER ACTIVITY
metric value
setSize 7
pMANOVA 0.0044
p.adjustMANOVA 0.0919
s.dist 0.682
s.cancer 0.318
s.incidence 0.603
p.cancer 0.145
p.incidence 0.00575



Top 20 genes
Gene cancer incidence
SLC45A3 9598 9591
SLC2A10 8008 8889
SLC45A1 5471 6601
SLC2A9 4923 6706

Click HERE to show all gene set members

All member genes
cancer incidence
SLC17A5 7318 -2533
SLC2A10 8008 8889
SLC2A9 4923 6706
SLC45A1 5471 6601
SLC45A2 -3074 9527
SLC45A3 9598 9591
SLC45A4 -5216 8667



GOBP NEGATIVE REGULATION OF NOREPINEPHRINE SECRETION
GOBP NEGATIVE REGULATION OF NOREPINEPHRINE SECRETION
metric value
setSize 6
pMANOVA 0.0099
p.adjustMANOVA 0.153
s.dist 0.681
s.cancer -0.619
s.incidence -0.284
p.cancer 0.0086
p.incidence 0.228



Top 20 genes
Gene cancer incidence
CRH -9239 -7919
ADRA2B -7341 -8608
ADRA2C -5163 -7022

Click HERE to show all gene set members

All member genes
cancer incidence
ADRA2A -8858 1714
ADRA2B -7341 -8608
ADRA2C -5163 -7022
CRH -9239 -7919
GHSR -10273 304
P2RY1 2387 3884



GOBP MAINTENANCE OF ANIMAL ORGAN IDENTITY
GOBP MAINTENANCE OF ANIMAL ORGAN IDENTITY
metric value
setSize 5
pMANOVA 0.0415
p.adjustMANOVA 0.311
s.dist 0.681
s.cancer 0.598
s.incidence -0.326
p.cancer 0.0205
p.incidence 0.207



Top 20 genes
Gene cancer incidence
USH2A 8863 -5311
NPHP3 8436 -4938
PKP2 8127 -3688
IQCB1 5227 -1733
ADGRV1 3996 -1326

Click HERE to show all gene set members

All member genes
cancer incidence
ADGRV1 3996 -1326
IQCB1 5227 -1733
NPHP3 8436 -4938
PKP2 8127 -3688
USH2A 8863 -5311



Here is the session info with all the versions of packages used.

sessionInfo()
## R version 4.4.1 (2024-06-14)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 22.04.5 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0 
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
## 
## locale:
##  [1] LC_CTYPE=en_US.UTF-8       LC_NUMERIC=C              
##  [3] LC_TIME=en_US.UTF-8        LC_COLLATE=en_US.UTF-8    
##  [5] LC_MONETARY=en_US.UTF-8    LC_MESSAGES=en_US.UTF-8   
##  [7] LC_PAPER=en_US.UTF-8       LC_NAME=C                 
##  [9] LC_ADDRESS=C               LC_TELEPHONE=C            
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C       
## 
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
## 
## attached base packages:
## [1] parallel  stats4    stats     graphics  grDevices utils     datasets 
## [8] methods   base     
## 
## other attached packages:
##  [1] pkgload_1.4.0                                      
##  [2] GGally_2.2.1                                       
##  [3] ggplot2_3.5.1                                      
##  [4] reshape2_1.4.4                                     
##  [5] gtools_3.9.5                                       
##  [6] tibble_3.2.1                                       
##  [7] dplyr_1.1.4                                        
##  [8] echarts4r_0.4.5                                    
##  [9] gplots_3.2.0                                       
## [10] eulerr_7.0.2                                       
## [11] RhpcBLASctl_0.23-42                                
## [12] beeswarm_0.4.0                                     
## [13] vioplot_0.5.0                                      
## [14] zoo_1.8-12                                         
## [15] sm_2.2-6.0                                         
## [16] kableExtra_1.4.0                                   
## [17] IlluminaHumanMethylationEPICanno.ilm10b4.hg19_0.6.0
## [18] IlluminaHumanMethylation450kanno.ilmn12.hg19_0.6.1 
## [19] minfi_1.50.0                                       
## [20] bumphunter_1.46.0                                  
## [21] locfit_1.5-9.10                                    
## [22] iterators_1.0.14                                   
## [23] foreach_1.5.2                                      
## [24] Biostrings_2.72.1                                  
## [25] XVector_0.44.0                                     
## [26] SummarizedExperiment_1.34.0                        
## [27] Biobase_2.64.0                                     
## [28] MatrixGenerics_1.16.0                              
## [29] matrixStats_1.4.1                                  
## [30] GenomicRanges_1.56.2                               
## [31] GenomeInfoDb_1.40.1                                
## [32] IRanges_2.38.1                                     
## [33] S4Vectors_0.42.1                                   
## [34] BiocGenerics_0.50.0                                
## [35] HGNChelper_0.8.15                                  
## [36] mitch_1.19.3                                       
## 
## loaded via a namespace (and not attached):
##   [1] splines_4.4.1             later_1.4.0              
##   [3] BiocIO_1.14.0             bitops_1.0-9             
##   [5] polyclip_1.10-7           preprocessCore_1.66.0    
##   [7] XML_3.99-0.17             lifecycle_1.0.4          
##   [9] lattice_0.22-6            MASS_7.3-61              
##  [11] base64_2.0.2              scrime_1.3.5             
##  [13] magrittr_2.0.3            sass_0.4.9               
##  [15] limma_3.60.6              rmarkdown_2.29           
##  [17] jquerylib_0.1.4           yaml_2.3.10              
##  [19] httpuv_1.6.15             doRNG_1.8.6              
##  [21] askpass_1.2.1             DBI_1.2.3                
##  [23] RColorBrewer_1.1-3        abind_1.4-8              
##  [25] zlibbioc_1.50.0           quadprog_1.5-8           
##  [27] purrr_1.0.2               RCurl_1.98-1.16          
##  [29] GenomeInfoDbData_1.2.12   genefilter_1.86.0        
##  [31] annotate_1.82.0           svglite_2.1.3            
##  [33] DelayedMatrixStats_1.26.0 codetools_0.2-20         
##  [35] DelayedArray_0.30.1       xml2_1.3.6               
##  [37] tidyselect_1.2.1          farver_2.1.2             
##  [39] UCSC.utils_1.0.0          beanplot_1.3.1           
##  [41] illuminaio_0.46.0         GenomicAlignments_1.40.0 
##  [43] jsonlite_1.8.9            multtest_2.60.0          
##  [45] survival_3.7-0            systemfonts_1.1.0        
##  [47] polylabelr_0.3.0          tools_4.4.1              
##  [49] Rcpp_1.0.13-1             glue_1.8.0               
##  [51] gridExtra_2.3             SparseArray_1.4.8        
##  [53] xfun_0.49                 HDF5Array_1.32.1         
##  [55] withr_3.0.2               fastmap_1.2.0            
##  [57] rhdf5filters_1.16.0       fansi_1.0.6              
##  [59] openssl_2.2.2             caTools_1.18.3           
##  [61] digest_0.6.37             R6_2.5.1                 
##  [63] mime_0.12                 colorspace_2.1-1         
##  [65] RSQLite_2.3.8             utf8_1.2.4               
##  [67] tidyr_1.3.1               generics_0.1.3           
##  [69] data.table_1.16.2         rtracklayer_1.64.0       
##  [71] httr_1.4.7                htmlwidgets_1.6.4        
##  [73] S4Arrays_1.4.1            ggstats_0.7.0            
##  [75] pkgconfig_2.0.3           gtable_0.3.6             
##  [77] blob_1.2.4                siggenes_1.78.0          
##  [79] htmltools_0.5.8.1         scales_1.3.0             
##  [81] png_0.1-8                 knitr_1.49               
##  [83] rstudioapi_0.17.1         tzdb_0.4.0               
##  [85] rjson_0.2.23              nlme_3.1-166             
##  [87] curl_6.0.1                cachem_1.1.0             
##  [89] rhdf5_2.48.0              stringr_1.5.1            
##  [91] KernSmooth_2.23-24        AnnotationDbi_1.66.0     
##  [93] restfulr_0.0.15           GEOquery_2.72.0          
##  [95] pillar_1.9.0              grid_4.4.1               
##  [97] reshape_0.8.9             vctrs_0.6.5              
##  [99] promises_1.3.1            xtable_1.8-4             
## [101] evaluate_1.0.1            readr_2.1.5              
## [103] GenomicFeatures_1.56.0    cli_3.6.3                
## [105] compiler_4.4.1            Rsamtools_2.20.0         
## [107] rlang_1.1.4               crayon_1.5.3             
## [109] rngtools_1.5.2            labeling_0.4.3           
## [111] nor1mix_1.3-3             mclust_6.1.1             
## [113] plyr_1.8.9                stringi_1.8.4            
## [115] viridisLite_0.4.2         BiocParallel_1.38.0      
## [117] munsell_0.5.1             Matrix_1.7-1             
## [119] hms_1.1.3                 sparseMatrixStats_1.16.0 
## [121] bit64_4.5.2               Rhdf5lib_1.26.0          
## [123] KEGGREST_1.44.1           statmod_1.5.0            
## [125] shiny_1.9.1               memoise_2.0.1.9000       
## [127] bslib_0.8.0               bit_4.5.0                
## [129] splitstackshape_1.4.8

END of report